TAK-715	ERK3	85.0	10000.0
Torin2	AURKC	100.0	10000.0
A443654	AXL	14.0	10000.0
MPS-1-IN-1	STK36	100.0	1000.0
SP600125	PKMYT1	100.0	10000.0
XMD8-92	PLK4	2.8	10000.0
QL-XI-92	ABL1(Y253F)-phosphorylated	63.0	10000.0
Alpelisib	PIK3C2G	50.0	1000.0
WZ-4-145	JNK3	100.0	10000.0
TAK-715	KPCD3	26.0	10000.0
Ibrutinib	EGFR(L861Q)	0.5	1000.0
BI-D1870	NEK2	16.0	10000.0
XMD11-50	CDK2	100.0	10000.0
RO-3306	NEK4	80.0	10000.0
CP466722	ERBB3	9.0	10000.0
ALW-II-38-3	PIK3CA(C420R)	100.0	10000.0
WYE-125132	FLT3(D835H)	82.0	10000.0
CGP60474	CAMK1D	100.0	10000.0
PHA-767491	PIK3CA(E545A)	76.0	10000.0
BI-D1870	RPS6KA1(Kin.Dom.1-N-terminal)	0.0	10000.0
KIN001-220	DAPK1	3.8	10000.0
JNK-IN-11	RET(V804M)	100.0	1000.0
HG-14-8-02	TNK1	3.4	10000.0
OTSSP167	MYO3B	100.0	10000.0
WZ-7043	MP2K6	100.0	10000.0
Torin1	CAMK1	50.0	10000.0
Torkinib	EPHA4	36.0	10000.0
Abemaciclib	SLK	23.0	1000.0
HG-5-113-01	ADCK3	100.0	10000.0
JW-7-24-1	PAK3	100.0	10000.0
Barasertib	AKT2	90.0	10000.0
JWE-035	PIK3CG	0.0	10000.0
PD0325901	ABL2	90.0	10000.0
XMD11-50	M4K1	100.0	10000.0
HG-14-8-02	PIK3CA(E545K)	92.0	10000.0
SB590885	FGFR1	99.0	10000.0
PD0325901	CLK1	95.0	10000.0
XMD16-144	PLK1	22.0	10000.0
THZ1	EGFR	21.0	10000.0
5z-7-oxozeaenol	PKAC-beta	100.0	10000.0
MPS-1-IN-1	CLK2	17.0	1000.0
KIN001-021	AURKA	100.0	1000.0
WZ3105	TESK1	93.0	10000.0
Abemaciclib	WNK2	100.0	1000.0
Baricitinib	TSSK1	1.4	10000.0
Sorafenib	OSR1	100.0	10000.0
BMX-IN-1	LYN	91.0	10000.0
TGX221	CLK4	100.0	1000.0
PD0325901	CAMK2A	100.0	10000.0
AZD4547	RIOK1	14.0	10000.0
(s)-CR8	YES	84.0	10000.0
ALW-II-49-7	RAF1	4.5	1000.0
XMD14-99	NEK2	100.0	10000.0
JNK-IN-11	ERBB3	43.0	1000.0
CGP74514A	TYK2(JH2domain-pseudokinase)	37.0	10000.0
THZ1	MAP3K1	69.0	10000.0
Dinaciclib	ULK3	81.0	10000.0
Torin2	YANK2	100.0	10000.0
BMS345541	RIPK2	100.0	10000.0
GSK429286A	CDC2L5	24.0	10000.0
AG1478	PLK2	44.0	10000.0
QL-XII-47	RSK2(Kin.Dom.1-N-terminal)	100.0	1000.0
5z-7-oxozeaenol	CDKL3	24.0	10000.0
HG-6-64-01	JNK1	19.0	10000.0
Canertinib	MST3	100.0	1000.0
CP466722	LOK	12.0	10000.0
PHA-767491	LCK	100.0	10000.0
BI-2536	SRMS	100.0	10000.0
GSK461364	PHKG2	43.0	10000.0
PHA-767491	AURKA	100.0	10000.0
XMD14-99	FGFR4	89.0	10000.0
Ceritinib	SRPK2	100.0	1000.0
XMD11-50	PAK4	94.0	10000.0
Seliciclib	MARK3	100.0	10000.0
GW843682X	PIK3CA(E545A)	54.0	10000.0
Ceritinib	RIOK1	64.0	1000.0
HG-5-113-01	EPHB2	100.0	10000.0
NPK76-II-72-1	PKN2	100.0	10000.0
Ribociclib	PAK6	82.0	1000.0
CGP60474	LOK	100.0	10000.0
Alpelisib	KCC2D	100.0	1000.0
HG-5-113-01	ULK2	9.1	10000.0
JWE-035	PGFRB	56.0	10000.0
AZD7762	EGFR	0.3	10000.0
AZD 5438	OSR1	60.0	10000.0
AZD7762	MAP3K3	0.0	10000.0
CP724714	KKCC1	96.0	10000.0
Lapatinib	JAK1(JH2domain-pseudokinase)	96.0	10000.0
Momelotinib	FGFR4	91.0	10000.0
XMD11-50	FGFR3	80.0	10000.0
SP600125	PAK4	100.0	10000.0
MLN8054	RSK1(Kin.Dom.1-N-terminal)	19.0	10000.0
OTSSP167	CLK2	100.0	10000.0
JNK-9L	CDK15	55.0	10000.0
ZSTK474	TAOK1	100.0	1000.0
QL-XI-92	DAPK1	80.0	10000.0
WYE-125132	PLK4	75.0	10000.0
AG1478	ABL1(Y253F)-phosphorylated	2.3	10000.0
PD173074	MK01	100.0	10000.0
SCH772984	TYRO3	100.0	1000.0
XMD11-85h	PAK2	100.0	10000.0
JWE-035	PIK3CA(H1047Y)	3.3	10000.0
XMD8-85	PGFRA	100.0	10000.0
BI-D1870	TRKC	16.0	10000.0
Dinaciclib	FLT3	81.0	10000.0
HG-5-88-01	BMX	100.0	10000.0
CGP60474	VGFR1	100.0	10000.0
Barasertib	WEE1	100.0	10000.0
Ibrutinib	RIPK5	9.2	1000.0
QL-XII-47	ABL1(M351T)-phosphorylated	92.0	1000.0
Momelotinib	SNRK	89.0	10000.0
CGP60474	CDK7	100.0	10000.0
KIN001-123	TRKB	100.0	1000.0
AZD-6482	BIKE	94.0	10000.0
Ceritinib	CLK1	3.6	1000.0
BMS-536924	PIK3C2B	100.0	1000.0
JWE-035	NDR2	90.0	10000.0
BI-2536	TYK2(Kin.Dom.1)	100.0	10000.0
Momelotinib	HUNK	100.0	10000.0
WZ3105	EGFR(L747-T751del,Sins)	90.0	10000.0
Buparlisib	SgK110	100.0	1000.0
Baricitinib	PIK3CA(E542K)	83.0	10000.0
BI-2536	MP2K3	100.0	10000.0
A443654	PAK3	100.0	10000.0
HG-5-88-01	SIK1	100.0	10000.0
RO-3306	PLK3	73.0	10000.0
AZD 5438	ERK5	0.5	10000.0
QL-X-138	ROCK2	72.0	10000.0
JNK-IN-8	PIM3	56.0	1000.0
GW-5074	GSK3B	91.0	10000.0
Taselisib	ERN1	89.0	1000.0
PLX-4720	PRKX	100.0	10000.0
AZD7762	DAPK2	5.4	10000.0
Momelotinib	STK36	95.0	10000.0
MLN8054	FAK1	23.0	10000.0
Sorafenib	PKN1	99.0	10000.0
GSK461364	HIPK1	40.0	10000.0
PHA-793887	TESK1	100.0	10000.0
Torkinib	FGFR1	8.5	10000.0
XMD11-85h	PGFRB	100.0	10000.0
Momelotinib	YSK4	1.7	10000.0
CP466722	AMPK-alpha2	27.0	10000.0
WZ3105	S6K1	87.0	10000.0
HG-6-64-01	EGFR(L747-S752del,P753S)	0.6	10000.0
Dabrafenib	FGR	11.0	10000.0
Torkinib	TRKA	46.0	10000.0
Barasertib	SRPK3	100.0	10000.0
KIN001-123	FGFR2	100.0	1000.0
RO-3306	SGK1	14.0	10000.0
CG-930	TLK2	99.0	10000.0
Ribociclib	RPS6KA4(Kin.Dom.1-N-terminal)	83.0	1000.0
KIN001-220	TIE1	10.0	10000.0
A443654	PAK2	4.6	10000.0
Barasertib	CSK	24.0	10000.0
Pictilisib	M3K6	100.0	1000.0
HG-5-88-01	TLK1	100.0	10000.0
ERK5-IN-1	ABL1(Y253F)-phosphorylated	100.0	1000.0
R406	PRKR	4.2	1000.0
AZD7762	MLK1	0.2	10000.0
BGJ398	ALK(L1196M)	100.0	1000.0
BS-181	CDK14	85.0	10000.0
KIN001-111	AMPK-alpha1	4.8	1000.0
QL-X-138	EPHA6	94.0	10000.0
QL-X-138	MK03	100.0	10000.0
BS-181	ERBB4	100.0	10000.0
ERK5-IN-1	TNIK	94.0	1000.0
XMD14-99	MET(Y1235D)	100.0	10000.0
AZD-6482	CAMK2G	98.0	10000.0
GSK461364	PI42C	62.0	10000.0
JNK-9L	LIMK1	62.0	10000.0
QL-XI-92	PIM2	96.0	10000.0
HG-9-91-01	VRK2	100.0	10000.0
CGP74514A	NIM1	29.0	10000.0
Seliciclib	MST3	91.0	10000.0
KIN001-123	TYRO3	100.0	1000.0
Ribociclib	WNK2	100.0	1000.0
Barasertib	ERK5	87.0	10000.0
XMD14-99	FLT3(ITD)	87.0	10000.0
GW-5074	MAP4K2	68.0	10000.0
Ceritinib	KIT-autoinhibited	80.0	1000.0
Palbociclib	PIK3CA(I800L)	80.0	1000.0
Dabrafenib	ZAP70	87.0	10000.0
AZD-6482	AMPK-alpha1	100.0	10000.0
OTSSP167	NEK7	96.0	10000.0
XMD16-144	HIPK2	89.0	10000.0
GSK461364	STK16	65.0	10000.0
ZSTK474	EGFR(L747-S752del,P753S)	100.0	1000.0
Baricitinib	IKKA	48.0	10000.0
GW-5074	CHK2	12.0	10000.0
XMD8-92	EPHB3	100.0	10000.0
JNK-IN-8	LYN	87.0	1000.0
XMD-12	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	1000.0
NPK76-II-72-1	TXK	100.0	10000.0
Canertinib	EPHA6	100.0	1000.0
Torin2	PIK3CA(H1047Y)	1.4	10000.0
HG-5-88-01	MARK3	100.0	10000.0
CP466722	FLT3	20.0	10000.0
KIN001-123	ABL1(Y253F)	100.0	1000.0
Barasertib	EGFR(G719C)	1.2	10000.0
Taselisib	PLK2	98.0	1000.0
XMD11-50	DYRK2	76.0	10000.0
SCH772984	MLTK	48.0	1000.0
AG1478	PIP5K1C	14.0	10000.0
Neratinib	INSR	46.0	10000.0
CP466722	IRAK3	12.0	10000.0
PD173074	FLT3	100.0	10000.0
Neratinib	NDR2	100.0	10000.0
AG1478	WNK1	71.0	10000.0
AG1478	BRAF(V600E)	55.0	10000.0
XMD8-85	EPHB6	34.0	10000.0
Crizotinib	MK14	100.0	10000.0
Vemurafenib	SRPK2	100.0	10000.0
Abemaciclib	PIK3CD	62.0	1000.0
Palbociclib	PIK3CA	100.0	1000.0
R406	M3K5	100.0	1000.0
Torin1	PIM3	96.0	10000.0
Baricitinib	PAK4	21.0	10000.0
RO-3306	LRRK2	48.0	10000.0
RO-3306	SRC	74.0	10000.0
A443654	FAK2	100.0	10000.0
CP724714	PIK3CD	100.0	10000.0
HG-9-91-01	PCTK3	100.0	10000.0
BMS-536924	TNK2	0.2	1000.0
GW-5074	FGFR2	59.0	10000.0
ZSTK474	RPS6KA1(Kin.Dom.2)	100.0	1000.0
JNK-IN-11	TLK1	67.0	1000.0
KIN001-021	ACVR2A	100.0	1000.0
JNK-IN-8	MERTK	100.0	1000.0
QL-XII-47	CAMK2G	100.0	1000.0
CP724714	PFPK5(P.falciparum)	100.0	10000.0
AZD-6482	MK09	66.0	10000.0
GSK461364	ACVR2A	100.0	10000.0
Baricitinib	EGFR(L747-S752del,P753S)	80.0	10000.0
Baricitinib	M4K1	61.0	10000.0
GSK461364	RIOK1	4.4	10000.0
GW843682X	MYO3B	100.0	10000.0
Crizotinib	CAMK1D	37.0	10000.0
GSK461364	CSNK1A1	91.0	10000.0
Neratinib	NEK3	41.0	10000.0
CGP74514A	MLK1	9.6	10000.0
KIN001-220	MAST1	100.0	10000.0
NVP-TAE684	GSK3A	100.0	1000.0
NU7441	SRPK1	100.0	10000.0
RO-3306	TAK1	61.0	10000.0
BI-D1870	ANKK1	13.0	10000.0
Pictilisib	ICK	100.0	1000.0
AZD 5438	CSNK1D	0.4	10000.0
Omipalisib	FLT4	100.0	10000.0
XMD8-92	CDK2	100.0	10000.0
BMX-IN-1	CDK16	100.0	10000.0
XMD-12	MK09	100.0	1000.0
Dinaciclib	ALK(L1196M)	71.0	10000.0
AZ-628	EGFR(L861Q)	34.0	10000.0
Neratinib	EGFR(L858R,T790M)	20.0	10000.0
KIN001-123	KPCL	100.0	1000.0
AZD4547	ABL1(Q252H)-nonphosphorylated	1.4	10000.0
WYE-125132	FLT3(ITD)	100.0	10000.0
XMD13-2	EPHA5	95.0	10000.0
Palbociclib	YANK3	100.0	1000.0
JWE-035	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
PHA-767491	ERBB2	100.0	10000.0
Sigma A6730	MELK	77.0	10000.0
TAK-715	EGFR	3.8	10000.0
QL-XI-92	EPHB3	99.0	10000.0
JNK-IN-5A	BUB1	100.0	10000.0
JNK-IN-8	CAMK1D	100.0	1000.0
Ibrutinib	SGK1	54.0	1000.0
(s)-CR8	JAK1(JH1domain-catalytic)	94.0	10000.0
HG-5-88-01	PAK7	100.0	10000.0
HG-14-8-02	CDC2L2	91.0	10000.0
THZ1	CSNK2A2	0.8	10000.0
ALW-II-38-3	DCAMKL3	100.0	10000.0
BMS345541	MK01	97.0	10000.0
CP466722	CDK4-cyclinD3	60.0	10000.0
HG-6-64-01	NLK	17.0	10000.0
Palbociclib	MAP3K1	100.0	1000.0
HG-5-113-01	PGFRB	8.4	10000.0
BGJ398	SNRK	81.0	1000.0
Baricitinib	EPHA3	35.0	10000.0
AZ-628	NIM1	100.0	10000.0
SCH772984	YANK1	85.0	1000.0
SP600125	EGFR(L747-T751del,Sins)	100.0	10000.0
QL-XI-92	OSR1	100.0	10000.0
5z-7-oxozeaenol	RPS6KA5(Kin.Dom.2-C-terminal)	87.0	10000.0
Ceritinib	JNK1	59.0	1000.0
QL-X-138	MK14	97.0	10000.0
Barasertib	NEK7	94.0	10000.0
SB590885	FLT3(D835H)	85.0	10000.0
OTSSP167	CAMK1G	23.0	10000.0
NPK76-II-72-1	JNK1	100.0	10000.0
THZ1	MST2	3.8	10000.0
Buparlisib	WNK1	100.0	1000.0
XMD14-99	TSSK1	87.0	10000.0
MPS-1-IN-1	TTK	6.1	1000.0
XMD8-85	PAK3	100.0	10000.0
QL-XII-47	BMPR1A	60.0	1000.0
Sorafenib	MELK	100.0	10000.0
QL-X-138	TNK2	100.0	10000.0
Pictilisib	FLT4	99.0	1000.0
HG-14-10-04	AXL	0.3	10000.0
OTSSP167	TNK1	3.7	10000.0
MLN8054	MLK2	67.0	10000.0
Lapatinib	FLT3(R834Q)	97.0	10000.0
XMD13-2	EIF2AK1	100.0	10000.0
NU7441	BRAF(V600E)	95.0	10000.0
BS-181	MELK	68.0	10000.0
THZ1	PI42C	5.4	10000.0
Ribociclib	SgK110	78.0	1000.0
HG-9-91-01	HIPK2	100.0	10000.0
GSK1059615	MERTK	14.0	10000.0
AZD7762	BRAF(V600E)	89.0	10000.0
AZD-6482	TNNI3K	88.0	10000.0
HG-5-113-01	NEK9	100.0	10000.0
KIN001-127	PRKX	100.0	10000.0
XMD8-92	LIMK1	100.0	10000.0
Torin1	PKNB(M.tuberculosis)	64.0	10000.0
Sorafenib	YANK3	100.0	10000.0
AS-252424	RIPK4	100.0	10000.0
HG-6-64-01	NEK1	89.0	10000.0
KIN001-220	MRCKA	100.0	10000.0
Omipalisib	TAK1	53.0	10000.0
GSK461364	SYK	100.0	10000.0
WZ3105	PIK3CA(M1043I)	100.0	10000.0
PD0325901	KIT-autoinhibited	92.0	10000.0
CGP74514A	KC1G2	0.3	10000.0
KIN001-220	ERBB3	45.0	10000.0
CH5424802	MAP3K1	86.0	1000.0
CP466722	EGFR(L858R)	55.0	10000.0
PD0325901	MRCKB	83.0	10000.0
WZ4003	INSR	19.0	1000.0
ALW-II-49-7	MRCKB	100.0	10000.0
Alpelisib	PKNB(M.tuberculosis)	100.0	1000.0
R406	MK12	7.5	1000.0
NG25	YES	0.3	10000.0
WZ3105	GRK7	8.7	10000.0
JWE-035	M3K13	53.0	10000.0
Ribociclib	PAK3	93.0	1000.0
Canertinib	PKAC-beta	100.0	1000.0
Barasertib	YANK3	78.0	10000.0
Torin2	MET(M1250T)	100.0	10000.0
JNK-IN-8	CAMK1G	100.0	1000.0
AZ-628	EPHB4	0.3	10000.0
THZ1	EGFR(T790M)	5.8	10000.0
Torin1	JAK1(JH1domain-catalytic)	82.0	10000.0
Alpelisib	MTOR	61.0	1000.0
WZ3105	GAK	44.0	10000.0
XMD14-99	ULK1	93.0	10000.0
AZ-628	ULK1	94.0	10000.0
ALW-II-38-3	RPS6KA3(Kin.Dom.1)	100.0	10000.0
QL-X-138	STK36	79.0	10000.0
5z-7-oxozeaenol	PAK4	86.0	10000.0
PLX-4720	MET	77.0	10000.0
KIN001-111	CDK2	100.0	1000.0
WZ3105	MAP4K4	53.0	10000.0
AZ-628	KIT(A829P)	100.0	10000.0
QL-X-138	EPHA3	100.0	10000.0
A443654	CSNK1G3	0.2	10000.0
WZ3105	FLT3	2.6	10000.0
Pictilisib	CHK2	100.0	1000.0
ALW-II-49-7	FGFR2	100.0	10000.0
MPS-1-IN-1	CLK3	100.0	1000.0
GSK429286A	RIPK1	84.0	10000.0
KIN001-021	EGFR	100.0	1000.0
XMD11-50	RET(M918T)	100.0	10000.0
NPK76-II-72-1	SRPK2	100.0	10000.0
CG-930	TTK	85.0	10000.0
XMD8-92	SIK3	100.0	10000.0
Dactolisib	BTK	100.0	1000.0
RO-3306	VRK2	62.0	10000.0
CP466722	HIPK1	0.6	10000.0
Sigma A6730	ADCK4	100.0	10000.0
AG1478	FLT3(D835Y)	11.0	10000.0
PD173074	MLTK	100.0	10000.0
KU63794	JAK1(JH2domain-pseudokinase)	100.0	10000.0
Canertinib	PLK4	100.0	1000.0
Torkinib	GSK3A	74.0	10000.0
PD173074	GAK	100.0	10000.0
GW-5074	TIE2	100.0	10000.0
Taselisib	LRRK2(G2019S)	79.0	1000.0
KU63794	IGF1R	100.0	10000.0
BX-912	MP2K6	22.0	10000.0
TGX221	PRKX	100.0	1000.0
PHA-793887	M3K12	99.0	10000.0
HG-5-88-01	MAP4K4	100.0	10000.0
AZD4547	MST2	5.6	10000.0
CH5424802	ANKK1	80.0	1000.0
AZD4547	CDKL1	77.0	10000.0
KIN001-127	ABL1	100.0	10000.0
AZ-628	WEE2	100.0	10000.0
Palbociclib	PKAC-beta	100.0	1000.0
THZ1	DCAMKL3	100.0	10000.0
HG-5-88-01	MARK1	100.0	10000.0
KIN001-111	IGF1R	100.0	1000.0
XMD14-99	MAP4K2	77.0	10000.0
HG-5-88-01	FGR	100.0	10000.0
JNK-IN-5A	JNK3	1.0	10000.0
XMD11-50	ZAP70	79.0	10000.0
KIN001-111	M3K12	14.0	1000.0
KIN001-021	LATS1	100.0	1000.0
Barasertib	DRAK1	46.0	10000.0
Taselisib	IGF1R	100.0	1000.0
XMD8-85	EGFR	100.0	10000.0
Taselisib	MLCK	85.0	1000.0
Omipalisib	MP2K2	80.0	10000.0
GSK429286A	MET(Y1235D)	65.0	10000.0
CP466722	ACVRL1	15.0	10000.0
KU63794	PLK4	100.0	10000.0
Buparlisib	AURKC	96.0	1000.0
JW-7-24-1	LOK	4.2	10000.0
JWE-035	MARK4	19.0	10000.0
Torin2	MLCK	100.0	10000.0
Buparlisib	EGFR(L747-S752del,P753S)	60.0	1000.0
PLX-4720	TEC	100.0	10000.0
KIN001-021	RPS6KA2(Kin.Dom.1)	100.0	1000.0
XMD8-92	ITK	100.0	10000.0
GW-5074	TAOK2	71.0	10000.0
Momelotinib	ADCK3	90.0	10000.0
CG-930	BMPR1A	100.0	10000.0
KIN001-220	PAK2	56.0	10000.0
A443654	CAMK2A	0.7	10000.0
CP724714	ICK	100.0	10000.0
HG-9-91-01	TNK2	0.9	10000.0
KU63794	MST3	89.0	10000.0
MPS-1-IN-1	CSF1R	100.0	1000.0
KU63794	SGK3	100.0	10000.0
Neratinib	FLT3(D835H)	94.0	10000.0
NPK76-II-72-1	RET	100.0	10000.0
HG-6-64-01	IKKB	0.2	10000.0
XMD14-99	RAF1	100.0	10000.0
A443654	TRKA	100.0	10000.0
(s)-CR8	PIK3C2B	90.0	10000.0
HG-5-113-01	PIM3	100.0	10000.0
KIN001-123	CDK16	100.0	1000.0
QL-XI-92	MLTK	6.0	10000.0
Pictilisib	RPS6KA2(Kin.Dom.1)	100.0	10000.0
WZ4002	TESK1	100.0	10000.0
Alpelisib	ROCK1	100.0	1000.0
Momelotinib	CSNK1G3	100.0	10000.0
XMD16-144	ULK1	0.2	10000.0
Sorafenib	ALK	69.0	10000.0
WZ4003	SRC	100.0	1000.0
AZD-6482	LIMK1	100.0	10000.0
TAK-715	DDR1	2.8	10000.0
AZD4547	RIOK3	16.0	10000.0
RO-3306	DMPK2	59.0	10000.0
QL-XI-92	DMPK	100.0	10000.0
SP600125	ANKK1	1.0	10000.0
Dabrafenib	TRPM6	53.0	10000.0
5z-7-oxozeaenol	MAP4K2	100.0	10000.0
ALW-II-38-3	MUSK	100.0	10000.0
CP466722	BRAF(V600E)	23.0	10000.0
KU63794	CDKL1	100.0	10000.0
SCH772984	EGFR(L747-E749del,A750P)	100.0	1000.0
XMD11-50	CDK9	100.0	10000.0
AZD4547	NEK11	83.0	10000.0
THZ1	TXK	13.0	10000.0
AZD7762	STK36	74.0	10000.0
XMD11-50	NEK9	100.0	10000.0
BMS-536924	MK13	100.0	1000.0
Dabrafenib	MYLK4	94.0	10000.0
GSK1059615	YANK2	100.0	10000.0
Sigma A6730	SLK	59.0	10000.0
THZ1	YANK2	11.0	10000.0
PHA-767491	GRK4	91.0	10000.0
Abemaciclib	BRAF(V600E)	97.0	1000.0
JNK-IN-11	M4K3	59.0	1000.0
JW-7-24-1	DDR2	100.0	10000.0
Ribociclib	HIPK4	100.0	1000.0
Sorafenib	KPCL	100.0	10000.0
GSK1059615	MLTK	16.0	10000.0
THZ1	MAK	2.6	10000.0
Barasertib	KPCI	96.0	10000.0
SP600125	RPS6KA5(Kin.Dom.1)	100.0	10000.0
BMS345541	BRSK1	90.0	10000.0
BMX-IN-1	KPCD1	84.0	10000.0
Neratinib	DDR1	93.0	10000.0
NVP-TAE684	FGFR4	0.0	1000.0
Buparlisib	MAP4K5	72.0	1000.0
XMD16-144	TAOK1	0.2	10000.0
AS-252424	CDKL2	100.0	10000.0
R406	ABL1(E255K)	100.0	1000.0
KIN001-111	KIT(D816V)	30.0	1000.0
BMX-IN-1	ABL1(T315I)-nonphosphorylated	100.0	10000.0
WZ3105	CDK15	100.0	10000.0
XMD11-85h	CDK14	100.0	10000.0
Baricitinib	EPHB4	83.0	10000.0
Seliciclib	PAK2	100.0	10000.0
BI-D1870	MYLK4	14.0	10000.0
Dactolisib	PIM3	100.0	1000.0
JNK-IN-5A	MLK3	98.0	10000.0
KIN001-127	KPCD	100.0	10000.0
WZ-7043	MRCKB	100.0	10000.0
Ibrutinib	LCK	0.4	1000.0
Ribociclib	EIF2AK1	100.0	1000.0
WZ-7043	PIM3	100.0	10000.0
NG25	MKNK1	100.0	10000.0
JNK-IN-11	KIT(A829P)	71.0	1000.0
KU63794	MP2K7	100.0	10000.0
KIN001-127	DMPK	100.0	10000.0
PHA-767491	DAPK3	1.7	10000.0
HG-9-91-01	PAK3	100.0	10000.0
BMS345541	KCC4	100.0	10000.0
KIN001-220	MAP4K4	69.0	10000.0
Pictilisib	MLCK	79.0	1000.0
HG-6-64-01	RPS6KA5(Kin.Dom.1-N-terminal)	34.0	10000.0
GSK1059615	RSK2(Kin.Dom.1-N-terminal)	41.0	10000.0
Baricitinib	ABL1(Q252H)-phosphorylated	22.0	10000.0
QL-XI-92	NDR1	90.0	10000.0
ERK5-IN-1	MYLK2	100.0	1000.0
SB590885	DCAMKL2	100.0	10000.0
XMD8-92	M3K2	100.0	10000.0
AZD 5438	CSNK1E	0.1	10000.0
NU7441	M3K12	90.0	10000.0
AZD7762	ACVR1B	28.0	10000.0
PD0325901	AURKB	99.0	10000.0
SB590885	TRPM6	100.0	10000.0
KIN001-220	PAK7	56.0	10000.0
JWE-035	CDKL1	98.0	10000.0
GW843682X	BMPR1B	100.0	10000.0
Torin2	TRKA	57.0	10000.0
ALW-II-49-7	EPHA7	100.0	10000.0
JNK-9L	PKNB(M.tuberculosis)	6.3	10000.0
MPS-1-IN-1	MERTK	34.0	1000.0
XMD11-85h	STK39	100.0	10000.0
R406	TIE2	0.5	1000.0
GSK1059615	LATS1	80.0	10000.0
NVP-TAE684	AKT1	100.0	1000.0
5z-7-oxozeaenol	EGFR(G719C)	76.0	10000.0
GW843682X	JAK3(JH1domain-catalytic)	40.0	10000.0
WZ3105	ABL1(M351T)-phosphorylated	71.0	10000.0
TAK-715	SGK3	100.0	10000.0
KU63794	CDC2L2	100.0	10000.0
BI-D1870	KIT(V559D,V654A)	1.1	10000.0
JNK-IN-11	CDK16	100.0	1000.0
Vemurafenib	AMPK-alpha2	63.0	10000.0
Vemurafenib	PHKG2	100.0	10000.0
QL-XII-47	PIM2	100.0	1000.0
ZSTK474	HCK	100.0	1000.0
Taselisib	TRKC	87.0	1000.0
WZ4003	PLK4	0.2	1000.0
Sorafenib	ULK3	92.0	10000.0
QL-XII-47	RIOK3	92.0	1000.0
A443654	DDR1	100.0	10000.0
ALW-II-49-7	ROCK2	100.0	10000.0
BI-2536	RPS6KA2(Kin.Dom.2)	7.2	10000.0
NPK76-II-72-1	KIT(V559D,T670I)	100.0	10000.0
Barasertib	TAOK1	59.0	10000.0
(s)-CR8	ROCK1	100.0	10000.0
BMX-IN-1	TYK2(JH2domain-pseudokinase)	100.0	10000.0
Abemaciclib	RPS6KA5(Kin.Dom.1-N-terminal)	91.0	1000.0
GW843682X	M3K2	100.0	10000.0
NVP-TAE684	TAK1	2.2	1000.0
BMS-536924	MAP4K5	0.3	1000.0
Omipalisib	EGFR(L858R)	64.0	10000.0
BS-181	M3K6	98.0	10000.0
CGP74514A	IGF1R	81.0	10000.0
PHA-793887	MET(Y1235D)	93.0	10000.0
THZ1	RIOK2	9.8	10000.0
KIN001-127	HIPK1	100.0	10000.0
Dactolisib	M3K5	100.0	1000.0
JW-7-24-1	VGFR2	100.0	10000.0
WYE-125132	LCK	100.0	10000.0
SP600125	ALK	100.0	10000.0
ERK5-IN-1	EPHA2	100.0	1000.0
KIN001-127	SgK110	100.0	10000.0
HG-9-91-01	DCLK1	20.0	10000.0
XMD11-50	ABL1(T315I)-phosphorylated	58.0	10000.0
Torin2	YSK1	56.0	10000.0
KIN001-123	CLK1	100.0	1000.0
WZ4002	KIT(V559D,V654A)	100.0	10000.0
JNK-IN-11	FGFR1	80.0	1000.0
Lapatinib	M3K5	100.0	10000.0
JNK-IN-5A	TRKA	100.0	10000.0
Vemurafenib	NIM1	100.0	10000.0
ZG-10	PAK7	52.0	10000.0
QL-XI-92	EGFR(T790M)	100.0	10000.0
HG-14-8-02	ERBB4	0.0	10000.0
HG-5-113-01	RPS6KA4(Kin.Dom.1)	2.2	10000.0
Lapatinib	MRCKB	60.0	10000.0
Lapatinib	INSR	100.0	10000.0
PHA-793887	CAMK1G	100.0	10000.0
SP600125	IRAK3	100.0	10000.0
WZ4003	LYN	100.0	1000.0
Ceritinib	CDK16	73.0	1000.0
SCH772984	CSNK1A1	66.0	1000.0
Sorafenib	PIK3CA	92.0	10000.0
Torkinib	ABL1(T315I)-nonphosphorylated	11.0	10000.0
AZD 5438	HIPK1	1.6	10000.0
THZ1	ABL1(F317L)-phosphorylated	8.2	10000.0
BI-D1870	PIK3CB	33.0	10000.0
BI-2536	WEE1	100.0	10000.0
PHA-793887	ERK5	0.7	10000.0
THZ1	KCC2D	83.0	10000.0
ALW-II-49-7	TRKB	32.0	10000.0
KIN001-220	CSNK2A1	18.0	10000.0
QL-XII-47	M3K13	100.0	1000.0
BS-181	TYK2(JH2domain-pseudokinase)	100.0	10000.0
GSK1059615	RIPK2	30.0	10000.0
HG-5-88-01	TGFBR2	100.0	10000.0
CH5424802	EGFR(G719C)	63.0	1000.0
Omipalisib	M4K1	71.0	10000.0
Abemaciclib	PIK3CA(I800L)	81.0	1000.0
JNK-IN-5A	IRAK4	100.0	10000.0
Abemaciclib	ULK2	31.0	1000.0
GSK461364	MYLK4	78.0	10000.0
Ibrutinib	FAK1	100.0	1000.0
Dabrafenib	LYN	6.7	10000.0
Neratinib	CAMKK2	89.0	10000.0
XMD-12	MLK2	100.0	1000.0
BGJ398	MET	85.0	1000.0
HG-9-91-01	MAP3K14	85.0	10000.0
HG-6-64-01	MAP4K2	0.0	10000.0
JNK-9L	MET(M1250T)	23.0	10000.0
MLN8054	STK39	100.0	10000.0
TAK-715	TRKB	100.0	10000.0
BMX-IN-1	MP2K6	70.0	10000.0
Ribociclib	KIT(V559D,T670I)	100.0	1000.0
XMD-12	ABL1(Y253F)-phosphorylated	1.9	1000.0
WZ-4-145	ACVR2B	100.0	10000.0
PD173074	BRAF	100.0	10000.0
AZD 5438	PI42C	3.6	10000.0
Ibrutinib	DCLK1	62.0	1000.0
PHA-767491	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
Omipalisib	IKKB	54.0	10000.0
Ribociclib	TNNI3K	100.0	1000.0
Alpelisib	NEK6	100.0	1000.0
JNK-IN-8	CLK3	100.0	1000.0
BMS345541	FAK1	97.0	10000.0
ALW-II-38-3	EGFR(L861Q)	100.0	10000.0
XMD-12	AKT3	100.0	1000.0
HG-5-113-01	PAK2	100.0	10000.0
Pictilisib	MP2K4	100.0	1000.0
XMD11-85h	MLK2	100.0	10000.0
GSK1059615	KPCD	20.0	10000.0
5z-7-oxozeaenol	DRAK1	100.0	10000.0
PHA-793887	MP2K3	12.0	10000.0
ERK5-IN-1	RET(V804M)	100.0	1000.0
Baricitinib	ERK4	100.0	10000.0
Barasertib	CDK16	79.0	10000.0
AS-252424	IRAK3	78.0	10000.0
OTSSP167	MP2K5	0.2	10000.0
A443654	ULK3	100.0	10000.0
XMD11-50	MET	100.0	10000.0
Vemurafenib	KIT	0.2	10000.0
MPS-1-IN-1	EPHA3	100.0	1000.0
CP466722	LRRK2(G2019S)	41.0	10000.0
KU63794	EPHA3	90.0	10000.0
WZ-4-145	CAMK1D	100.0	10000.0
CGP74514A	DCLK1	9.6	10000.0
AZD7762	PDPK1	0.7	10000.0
AZD4547	SGK3	87.0	10000.0
SCH772984	LIMK2	100.0	1000.0
AZD7762	MYLK2	67.0	10000.0
Sigma A6730	SNARK	67.0	10000.0
Palbociclib	EPHB4	95.0	1000.0
XMD11-50	CDKL2	100.0	10000.0
Ibrutinib	SLK	76.0	1000.0
Torin1	MTOR	0.0	10000.0
XMD8-92	MAP4K4	100.0	10000.0
Momelotinib	ABL1(T315I)-phosphorylated	78.0	10000.0
JNK-IN-5A	RET(M918T)	95.0	10000.0
WZ-4-145	SRMS	100.0	10000.0
HG-6-64-01	MK01	100.0	10000.0
JNK-IN-11	EPHA1	38.0	1000.0
Ceritinib	STK39	21.0	1000.0
AG1478	RIOK3	78.0	10000.0
QL-XII-47	PIK3CA(E545A)	47.0	1000.0
PD173074	MRCKA	100.0	10000.0
XMD16-144	ACVR2B	9.4	10000.0
GW843682X	RET(V804M)	62.0	10000.0
GSK1059615	EGFR(S752-I759del)	95.0	10000.0
KIN001-111	NEK9	100.0	1000.0
XMD8-92	NIM1	100.0	10000.0
Taselisib	TNK1	69.0	1000.0
BMS345541	MK12	100.0	10000.0
GSK1059615	CAMK1	65.0	10000.0
WYE-125132	RPS6KA4(Kin.Dom.1-N-terminal)	90.0	10000.0
CH5424802	FLT3	41.0	1000.0
XMD8-85	HCK	100.0	10000.0
5z-7-oxozeaenol	CDKL2	8.6	10000.0
HG-14-8-02	ABL1(Y253F)-phosphorylated	64.0	10000.0
Pictilisib	KPCT	85.0	1000.0
Dabrafenib	ROCK1	90.0	10000.0
BMS345541	MK14	98.0	10000.0
XMD16-144	TNK2	4.4	10000.0
GW843682X	EGFR(E746-A750del)	38.0	10000.0
CP466722	BMPR1A	1.4	10000.0
QL-X-138	CSNK1A1L	90.0	10000.0
JNK-IN-8	EPHB4	100.0	1000.0
PLX-4720	ACVRL1	100.0	10000.0
WZ-7043	AKT2	100.0	10000.0
BMX-IN-1	INSR	100.0	10000.0
ALW-II-38-3	RIPK2	100.0	10000.0
WH-4-023	GAK	5.6	10000.0
CP466722	TXK	43.0	10000.0
MLN8054	HIPK3	80.0	10000.0
Pictilisib	KIT-autoinhibited	82.0	1000.0
QL-XII-47	PGFRB	66.0	1000.0
Abemaciclib	FLT3-autoinhibited	100.0	1000.0
WZ4003	MYLK2	100.0	1000.0
BMS-536924	M3K12	12.0	1000.0
ZG-10	ABL1(T315I)-nonphosphorylated	37.0	10000.0
Crizotinib	YANK2	100.0	10000.0
Vemurafenib	BMPR2	67.0	10000.0
HG-5-113-01	SLK	0.0	10000.0
ZG-10	NDR2	100.0	10000.0
WYE-125132	CSNK1D	92.0	10000.0
NVP-TAE684	RPS6KA6(Kin.Dom.1)	1.1	1000.0
GW843682X	ERBB2	100.0	10000.0
HG-5-113-01	TAK1	0.4	10000.0
BS-181	CDK2	86.0	10000.0
GSK461364	ALK	100.0	10000.0
GSK1059615	EPHA1	85.0	10000.0
BMX-IN-1	VRK2	86.0	10000.0
XMD13-2	RET	86.0	10000.0
Lapatinib	IRAK4	100.0	10000.0
JNK-IN-8	PCTK2	100.0	1000.0
CG-930	PRKX	100.0	10000.0
Sigma A6730	KIT	95.0	10000.0
PLX-4720	ERN1	78.0	10000.0
WZ4003	GCN2(Kin.Dom.2,S808G)	0.6	1000.0
AZD7762	DDR2	0.0	10000.0
XMD8-85	VGFR2	100.0	10000.0
WZ-4-145	TYK2(Kin.Dom.2)	12.0	10000.0
BGJ398	RSK2(Kin.Dom.2-C-terminal)	76.0	1000.0
XMD13-2	ABL1(T315I)-nonphosphorylated	38.0	10000.0
Torkinib	PRKX	100.0	10000.0
WZ-4-145	INSRR	18.0	10000.0
Alpelisib	SGK2	100.0	1000.0
Ribociclib	WNK1	94.0	1000.0
JNK-IN-11	MET(Y1235D)	59.0	1000.0
THZ1	ULK2	22.0	10000.0
NU7441	CDK4-cyclinD1	100.0	10000.0
CGP74514A	KPCT	23.0	10000.0
NU7441	MET(M1250T)	67.0	10000.0
WH-4-023	RSK1(Kin.Dom.1-N-terminal)	58.0	10000.0
XMD8-92	LTK	100.0	10000.0
KIN001-123	FLT3(N841I)	8.7	1000.0
ZSTK474	PKN2	100.0	1000.0
Torin2	RIPK2	54.0	10000.0
QL-XII-47	RSK4(Kin.Dom.1-N-terminal)	92.0	1000.0
ZM-447439	ABL1(E255K)-phosphorylated	45.0	10000.0
Ibrutinib	PIK3CA(C420R)	72.0	1000.0
TGX221	NEK1	100.0	1000.0
PLX-4720	MLTK	6.0	10000.0
Neratinib	RSK4(Kin.Dom.1-N-terminal)	86.0	10000.0
Pictilisib	NLK	100.0	1000.0
BX-912	KPCD2	1.7	10000.0
XMD8-85	M4K1	100.0	10000.0
CH5424802	CLK3	90.0	1000.0
XMD8-92	ERK4	100.0	10000.0
AZD-6482	TAOK2	94.0	10000.0
AG1478	MET(Y1235D)	100.0	10000.0
XMD8-85	FRK	2.6	10000.0
KU63794	IRAK3	100.0	10000.0
OTSSP167	ABL1(E255K)-phosphorylated	0.9	10000.0
AZD 5438	PIP5K1C	18.0	10000.0
WZ-4-145	RPS6KA4(Kin.Dom.2)	100.0	10000.0
5z-7-oxozeaenol	MK09	100.0	10000.0
OTSSP167	NEK5	85.0	10000.0
WH-4-023	TESK1	0.0	10000.0
Dinaciclib	MP2K5	80.0	10000.0
JNK-IN-8	TIE2	76.0	1000.0
A443654	CSNK2A2	13.0	10000.0
ALW-II-49-7	TSSK1	100.0	10000.0
BMS-536924	KIT(V559D)	0.8	1000.0
AZD7762	CDK9	88.0	10000.0
CGP60474	MK14	100.0	10000.0
AZD-6482	EPHB3	100.0	10000.0
AG1478	RET(V804M)	94.0	10000.0
HG-14-8-02	DAPK2	9.4	10000.0
Barasertib	CIT	27.0	10000.0
BMS345541	PIM2	100.0	10000.0
JNK-IN-5A	EGFR(G719C)	100.0	10000.0
JNK-IN-11	PAK4	91.0	1000.0
HG-14-10-04	LIMK2	68.0	10000.0
JNK-IN-11	YSK1	100.0	1000.0
Torin1	DAPK1	96.0	10000.0
Momelotinib	FGR	92.0	10000.0
QL-XII-47	NUAK1	100.0	1000.0
KIN001-127	WEE2	3.6	10000.0
HG-9-91-01	SIK2	23.0	10000.0
KIN001-123	PCTK3	100.0	1000.0
MRT67307	GSK3B	66.0	10000.0
QL-XII-47	MAP4K4	100.0	1000.0
KIN001-021	FES	100.0	1000.0
Lapatinib	RSK2(Kin.Dom.1-N-terminal)	100.0	10000.0
TAK-715	MKNK2	94.0	10000.0
CG-930	PAK2	100.0	10000.0
TAK-715	BRAF	40.0	10000.0
TAK-715	IRAK3	84.0	10000.0
NG25	PLK1	100.0	10000.0
NG25	EGFR(L861Q)	15.0	10000.0
(s)-CR8	EPHB1	90.0	10000.0
ALW-II-38-3	EGFR	100.0	10000.0
Buparlisib	RET(V804L)	100.0	1000.0
XMD16-144	EGFR(L747-E749del,A750P)	71.0	10000.0
GW843682X	FLT3(N841I)	1.7	10000.0
HG-14-10-04	INSR	0.1	10000.0
TAK-715	S6K1	90.0	10000.0
KIN001-123	HCK	100.0	1000.0
Torin1	KCC4	90.0	10000.0
A443654	FES	100.0	10000.0
RO-3306	PAK7	59.0	10000.0
XMD13-2	KCC2D	84.0	10000.0
AZD-6482	PAK2	100.0	10000.0
Buparlisib	MAST1	99.0	1000.0
WZ-7043	EPHA5	100.0	10000.0
A443654	DAPK1	2.2	10000.0
Sigma A6730	MLK3	100.0	10000.0
Momelotinib	PIK3C2B	56.0	10000.0
KIN001-127	MRCKA	100.0	10000.0
MRT67307	EPHB2	88.0	10000.0
HG-5-88-01	CLK3	8.3	10000.0
AZD4547	EPHA2	41.0	10000.0
CP466722	MAPKAPK2	100.0	10000.0
CGP74514A	TLK2	35.0	10000.0
Dinaciclib	PGFRB	73.0	10000.0
AG1478	VGFR2	31.0	10000.0
QL-XI-92	YSK4	74.0	10000.0
HG-9-91-01	MK01	100.0	10000.0
GW-5074	CSNK1E	84.0	10000.0
JWE-035	MST1	72.0	10000.0
Pictilisib	FGFR2	100.0	1000.0
XMD13-2	LIMK1	100.0	10000.0
WZ-7043	RET	100.0	10000.0
R406	LOK	0.4	1000.0
GSK429286A	RIPK2	77.0	10000.0
HG-14-10-04	MP2K4	2.4	10000.0
Momelotinib	FLT3(N841I)	2.2	10000.0
Sigma A6730	MK03	100.0	10000.0
NVP-TAE684	PGFRB	0.3	1000.0
QL-XII-47	PAK4	100.0	1000.0
WZ4002	RET	100.0	10000.0
GSK429286A	CSNK1G3	90.0	10000.0
Taselisib	TRKA	97.0	1000.0
Barasertib	ANKK1	11.0	10000.0
BMS345541	TYK2(JH1domain-catalytic)	100.0	10000.0
GW-5074	FYN	52.0	10000.0
Lapatinib	FGFR1	95.0	10000.0
Canertinib	SRPK2	100.0	1000.0
HG-6-64-01	JAK2(JH1domain-catalytic)	12.0	10000.0
CGP74514A	PFPK5(P.falciparum)	38.0	10000.0
SB590885	MP2K4	100.0	10000.0
Torin2	CSNK2A1	79.0	10000.0
JNK-IN-8	PLK2	79.0	1000.0
MPS-1-IN-1	CAMKK2	100.0	1000.0
Omipalisib	ABL1(H396P)-phosphorylated	53.0	10000.0
MRT67307	AKT1	100.0	10000.0
BMX-IN-1	NEK5	84.0	10000.0
JNK-IN-5A	TNIK	100.0	10000.0
BMS-536924	RET(V804L)	0.0	1000.0
PHA-767491	EPHB2	86.0	10000.0
CH5424802	JAK2(JH1domain-catalytic)	91.0	1000.0
CGP60474	TNIK	100.0	10000.0
Torkinib	MLCK	5.4	10000.0
SP600125	CLK2	3.4	10000.0
AZD-6482	MLK1	91.0	10000.0
HG-9-91-01	GRK1	82.0	10000.0
(s)-CR8	NEK4	100.0	10000.0
GW843682X	RSK3(Kin.Dom.1-N-terminal)	61.0	10000.0
GSK1059615	KPCT	60.0	10000.0
HG-14-10-04	WNK1	100.0	10000.0
BMX-IN-1	FLT4	100.0	10000.0
CGP74514A	BTK	19.0	10000.0
5z-7-oxozeaenol	PKN2	93.0	10000.0
WZ3105	CSK	90.0	10000.0
WZ4002	ABL2	100.0	10000.0
AG1478	STK35	58.0	10000.0
WZ-7043	VGFR1	5.6	10000.0
BX-912	RET(M918T)	0.1	10000.0
CGP60474	MP2K6	100.0	10000.0
WZ3105	OSR1	33.0	10000.0
Taselisib	RET(V804L)	100.0	1000.0
AZ-628	CSNK1A1L	100.0	10000.0
JWE-035	PIP5K2B	31.0	10000.0
AZD7762	FLT4	0.0	10000.0
XMD8-92	DAPK2	100.0	10000.0
BMX-IN-1	MAP4K4	100.0	10000.0
ZSTK474	CDK11	100.0	1000.0
Alpelisib	EPHA1	81.0	1000.0
MRT67307	CDK5	100.0	10000.0
BS-181	TGFBR1	98.0	10000.0
CGP60474	GAK	100.0	10000.0
AS-252424	FLT3(D835Y)	100.0	10000.0
JNK-IN-11	TEC	100.0	1000.0
Neratinib	MKNK1	29.0	10000.0
XMD16-144	PGFRB	38.0	10000.0
Abemaciclib	EPHB3	100.0	1000.0
KU63794	TLK2	87.0	10000.0
JWE-035	MELK	75.0	10000.0
XMD11-50	PKAC-alpha	100.0	10000.0
ALW-II-49-7	PIK3CD	100.0	10000.0
Momelotinib	ULK1	40.0	10000.0
NG25	TYK2(Kin.Dom.2)	0.0	10000.0
AG1478	CDK15	75.0	10000.0
CG-930	PAK6	100.0	10000.0
BMX-IN-1	MLK1	83.0	10000.0
5z-7-oxozeaenol	KIT(V559D,V654A)	3.5	10000.0
Alpelisib	EPHA3	100.0	1000.0
JNK-IN-8	MST3	79.0	1000.0
HG-5-113-01	BMPR2	3.4	10000.0
XMD-12	SBK1	46.0	1000.0
Neratinib	LTK	100.0	10000.0
ALW-II-38-3	BMX	100.0	10000.0
JNK-IN-5A	PI42C	100.0	10000.0
Seliciclib	ERK4	100.0	10000.0
QL-X-138	FER	100.0	10000.0
XMD8-92	EGFR(L747-S752del,P753S)	100.0	10000.0
NG25	PLK4	100.0	10000.0
THZ1	ABL1(F317I)-phosphorylated	73.0	10000.0
BGJ398	CDC2L1	95.0	1000.0
GSK1059615	SNRK	100.0	10000.0
WYE-125132	DDR2	100.0	10000.0
BMS345541	ACVR1	100.0	10000.0
Sigma A6730	ALK(C1156Y)	55.0	10000.0
5z-7-oxozeaenol	CSNK1D	70.0	10000.0
5z-7-oxozeaenol	BMX	90.0	10000.0
NG25	BRAF	9.1	10000.0
JNK-IN-5A	WNK3	100.0	10000.0
MPS-1-IN-1	PGFRB	100.0	1000.0
GSK1059615	KPCL	88.0	10000.0
Sigma A6730	PIK3CA(E542K)	58.0	10000.0
AZD-6482	FGFR3	83.0	10000.0
Vemurafenib	ABL1(F317I)-nonphosphorylated	34.0	10000.0
Ibrutinib	DAPK3	91.0	1000.0
JW-7-24-1	ITK	100.0	10000.0
Dinaciclib	MAPKAPK2	88.0	10000.0
MLN8054	INSR	59.0	10000.0
GSK461364	NDR2	100.0	10000.0
BX-912	AURKA	1.6	10000.0
Vemurafenib	BTK	93.0	10000.0
Torkinib	ABL2	28.0	10000.0
HG-5-88-01	KPCD3	100.0	10000.0
NG25	TAOK1	3.0	10000.0
NU7441	PGFRA	100.0	10000.0
ZG-10	EGFR(L747-E749del,A750P)	100.0	10000.0
AZD4547	EPHB6	2.2	10000.0
Palbociclib	TAOK3	100.0	1000.0
BS-181	ERK3	78.0	10000.0
HG-5-88-01	MST2	100.0	10000.0
Neratinib	DMPK	98.0	10000.0
RO-3306	FGFR3	84.0	10000.0
Momelotinib	BLK	100.0	10000.0
KU63794	PIM2	100.0	10000.0
SCH772984	TTK	17.0	1000.0
XMD11-85h	PLK3	100.0	10000.0
NU7441	RSK3(Kin.Dom.2-C-terminal)	83.0	10000.0
KIN001-021	RIPK1	100.0	1000.0
JNK-9L	KC1G2	72.0	10000.0
CH5424802	EPHA8	94.0	1000.0
Vemurafenib	TESK1	29.0	10000.0
AZD 5438	SIK2	45.0	10000.0
JNK-9L	CDK9	2.1	10000.0
Baricitinib	M3K6	52.0	10000.0
QL-XI-92	MYLK2	100.0	10000.0
XMD-12	MAPKAPK5	92.0	1000.0
CGP74514A	LATS1	18.0	10000.0
AG1478	ABL1(E255K)-phosphorylated	6.6	10000.0
Ibrutinib	LATS1	55.0	1000.0
Abemaciclib	PIK3CA(M1043I)	100.0	1000.0
QL-XI-92	ROCK1	100.0	10000.0
QL-X-138	PIK3CA(I800L)	0.5	10000.0
HG-14-10-04	MK01	100.0	10000.0
KIN001-127	RIOK2	100.0	10000.0
MLN8054	EGFR(L858R)	29.0	10000.0
QL-XI-92	GSK3B	100.0	10000.0
CH5424802	GCN2(Kin.Dom.2,S808G)	82.0	1000.0
ALW-II-38-3	PCTK2	100.0	10000.0
THZ1	ABL1(Y253F)-phosphorylated	0.2	10000.0
JW-7-24-1	TRKA	100.0	10000.0
KIN001-220	CLK2	4.9	10000.0
XMD16-144	CTK	69.0	10000.0
MLN8054	ERBB2	100.0	10000.0
HG-14-10-04	PIK3CA(E542K)	100.0	10000.0
RO-3306	PIK3C2G	46.0	10000.0
Barasertib	RIOK2	58.0	10000.0
WZ3105	STK36	100.0	10000.0
CG-930	PIK3C2B	97.0	10000.0
ZSTK474	MARK2	100.0	1000.0
TAK-715	PIK4CB	100.0	10000.0
WZ-4-145	TRKC	100.0	10000.0
PLX-4720	RIPK1	53.0	10000.0
QL-XII-47	PIK4CB	100.0	1000.0
OTSSP167	YANK3	100.0	10000.0
WZ-4-145	PIK3CB	100.0	10000.0
Torin1	KIT(L576P)	48.0	10000.0
OTSSP167	RET(V804L)	0.0	10000.0
Palbociclib	ABL1(H396P)-nonphosphorylated	93.0	1000.0
SCH772984	EPHA5	89.0	1000.0
THZ1	MK11	98.0	10000.0
AZD4547	YANK2	100.0	10000.0
NU7441	PHKG1	100.0	10000.0
WZ-7043	MK09	100.0	10000.0
GW-5074	FLT3	3.6	10000.0
R406	TGFBR1	33.0	1000.0
ERK5-IN-1	FGFR3	100.0	1000.0
AG1478	MP2K2	25.0	10000.0
(s)-CR8	TAOK1	100.0	10000.0
GSK461364	NEK9	10.0	10000.0
ZG-10	PIK3CA	100.0	10000.0
HG-9-91-01	FLT4	16.0	10000.0
GSK1059615	ERK4	100.0	10000.0
QL-XI-92	CAMK1D	83.0	10000.0
Omipalisib	BRAF(V600E)	44.0	10000.0
JNK-IN-8	RIPK4	79.0	1000.0
BX-912	PGFRB	0.0	10000.0
KIN001-021	ADCK4	100.0	1000.0
PLX-4720	KIT(V559D)	0.1	10000.0
KU63794	KPCI	79.0	10000.0
ALW-II-38-3	SRPK2	100.0	10000.0
GSK1059615	AKT2	100.0	10000.0
BMX-IN-1	FGFR4	84.0	10000.0
Dabrafenib	CLK2	21.0	10000.0
WYE-125132	EPHA3	100.0	10000.0
NG25	M3K12	100.0	10000.0
BGJ398	IRAK3	77.0	1000.0
PLX-4720	EGFR(L747-S752del,P753S)	85.0	10000.0
Buparlisib	HIPK3	100.0	1000.0
XMD8-92	EGFR(L858R)	100.0	10000.0
Ceritinib	PKAC-beta	100.0	1000.0
HG-5-113-01	TTK	4.6	10000.0
GSK429286A	DRAK2	100.0	10000.0
Barasertib	KIT(L576P)	0.0	10000.0
QL-X-138	KIT(A829P)	36.0	10000.0
GSK429286A	TRPM6	70.0	10000.0
PD0325901	TBK1	85.0	10000.0
Crizotinib	PIK3C2B	46.0	10000.0
ZG-10	AURKA	11.0	10000.0
Dinaciclib	KIT	80.0	10000.0
CP466722	EPHB2	47.0	10000.0
XMD8-85	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
CGP60474	KIT(D816V)	100.0	10000.0
XMD16-144	KIT(V559D)	54.0	10000.0
CH5424802	PFCDPK1(P.falciparum)	83.0	1000.0
MLN8054	LATS2	72.0	10000.0
Pictilisib	CAMK2A	89.0	1000.0
AZD 5438	VGFR1	52.0	10000.0
MPS-1-IN-1	LATS2	100.0	1000.0
Momelotinib	M3K5	100.0	10000.0
Torkinib	KPCT	58.0	10000.0
GSK461364	CDKL3	100.0	10000.0
CGP74514A	PKMYT1	100.0	10000.0
5z-7-oxozeaenol	EGFR(L861Q)	100.0	10000.0
MPS-1-IN-1	FRK	100.0	1000.0
KU63794	MUSK	100.0	10000.0
KIN001-021	STK33	100.0	1000.0
PD0325901	SLK	93.0	10000.0
R406	STK36	1.4	1000.0
ERK5-IN-1	PKAC-alpha	100.0	1000.0
A443654	STK33	2.6	10000.0
JWE-035	MINK	68.0	10000.0
BI-2536	MYLK4	100.0	10000.0
BI-2536	SYK	100.0	10000.0
BX-912	EPHA3	21.0	10000.0
SB590885	MTOR	75.0	10000.0
Taselisib	CASK	76.0	1000.0
Torin1	DYRK1B	87.0	10000.0
RO-3306	ERBB3	71.0	10000.0
CGP74514A	MAP3K14	65.0	10000.0
PD173074	IRAK3	100.0	10000.0
Buparlisib	NLK	82.0	1000.0
NVP-TAE684	RET(M918T)	0.1	1000.0
Sorafenib	STK16	100.0	10000.0
KU63794	ABL1(Y253F)-phosphorylated	100.0	10000.0
Crizotinib	RET(V804L)	30.0	10000.0
Omipalisib	NEK4	80.0	10000.0
GSK429286A	NUAK1	28.0	10000.0
Sigma A6730	MLK2	84.0	10000.0
XMD11-85h	FRK	100.0	10000.0
Lapatinib	CAMK2B	100.0	10000.0
GW-5074	VGFR1	100.0	10000.0
TAK-715	ACVR2B	17.0	10000.0
KIN001-220	RAF1	81.0	10000.0
Torkinib	MAPKAPK5	86.0	10000.0
WZ3105	EGFR(L858R)	99.0	10000.0
A443654	PLK1	100.0	10000.0
Dactolisib	JNK1	100.0	1000.0
QL-XI-92	MYLK	100.0	10000.0
NU7441	FGR	92.0	10000.0
XMD16-144	MYO3A	100.0	10000.0
Ribociclib	TAK1	100.0	1000.0
NPK76-II-72-1	MAP4K2	100.0	10000.0
XMD14-99	PKN1	100.0	10000.0
NPK76-II-72-1	EPHB2	100.0	10000.0
ZG-10	STK16	1.2	10000.0
GW-5074	ABL1(M351T)-phosphorylated	77.0	10000.0
PHA-767491	SYK	95.0	10000.0
XMD14-99	NEK1	75.0	10000.0
HG-14-8-02	PKNB(M.tuberculosis)	100.0	10000.0
AZD4547	CSF1R	0.1	10000.0
ZM-447439	EPHB2	100.0	10000.0
Omipalisib	BUB1	82.0	10000.0
WZ3105	IKKE	95.0	10000.0
Dinaciclib	ERBB4	92.0	10000.0
GSK1059615	EIF2AK1	82.0	10000.0
CP466722	CDC2L5	17.0	10000.0
Canertinib	TNK2	100.0	1000.0
QL-X-138	CDKL2	17.0	10000.0
XMD-12	MET(Y1235D)	100.0	1000.0
WZ-7043	ROCK1	100.0	10000.0
XMD14-99	TIE1	100.0	10000.0
Torin1	DDR1	100.0	10000.0
Dabrafenib	ERK4	96.0	10000.0
KIN001-220	MAP3K4	83.0	10000.0
WZ-4-145	NDR2	100.0	10000.0
JNK-IN-11	BIKE	100.0	1000.0
SCH772984	MAP3K14	72.0	1000.0
QL-XI-92	MP2K4	100.0	10000.0
ALW-II-49-7	MYLK2	100.0	10000.0
BGJ398	FLT3	90.0	1000.0
WZ3105	FLT3(ITD)	1.0	10000.0
RO-3306	FLT3(D835H)	17.0	10000.0
NVP-TAE684	CLK2	0.0	1000.0
PHA-793887	TEC	100.0	10000.0
Crizotinib	CSNK2A1	65.0	10000.0
Seliciclib	RSK3(Kin.Dom.1-N-terminal)	97.0	10000.0
HG-14-10-04	ULK1	0.0	10000.0
WH-4-023	DMPK	0.1	10000.0
AZD 5438	PAK1	34.0	10000.0
KIN001-021	NEK1	100.0	1000.0
KIN001-111	MK03	24.0	1000.0
BI-D1870	IRAK1	0.2	10000.0
ZM-447439	SgK110	100.0	10000.0
KU63794	ABL1(H396P)-nonphosphorylated	100.0	10000.0
AG1478	M3K12	92.0	10000.0
CP724714	ABL1(T315I)-nonphosphorylated	100.0	10000.0
CGP74514A	PIM1	16.0	10000.0
AZD7762	CDC2L1	100.0	10000.0
Taselisib	IRAK4	100.0	1000.0
QL-XII-47	GRK7	92.0	1000.0
ZM-447439	NIM1	100.0	10000.0
AZD-6482	TRPM6	100.0	10000.0
Dinaciclib	JAK1(JH1domain-catalytic)	89.0	10000.0
Neratinib	SLK	1.4	10000.0
BI-D1870	KIT(V559D)	0.2	10000.0
Dabrafenib	CTK	82.0	10000.0
JNK-IN-5A	EPHB6	85.0	10000.0
AZD 5438	EPHB6	0.4	10000.0
XMD8-85	ROCK2	100.0	10000.0
HG-9-91-01	RSK4(Kin.Dom.2-C-terminal)	3.3	10000.0
Vemurafenib	PDPK1	70.0	10000.0
BGJ398	STK36	64.0	1000.0
AZD4547	NLK	100.0	10000.0
THZ1	MYO3B	63.0	10000.0
PHA-767491	ABL1(Q252H)-nonphosphorylated	15.0	10000.0
SB590885	BMX	81.0	10000.0
KIN001-220	ABL1(H396P)-phosphorylated	16.0	10000.0
Canertinib	DCAMKL3	100.0	1000.0
Seliciclib	TRKA	100.0	10000.0
MLN8054	WEE1	100.0	10000.0
HG-5-88-01	JAK2(Kin.Dom.2)	100.0	10000.0
KIN001-021	MUSK	100.0	1000.0
SCH772984	SBK1	100.0	1000.0
BMS-536924	MP2K3	7.0	1000.0
CGP74514A	NEK2	80.0	10000.0
NPK76-II-72-1	BRAF	100.0	10000.0
OTSSP167	MRCKA	46.0	10000.0
AZD4547	FGFR1	0.0	10000.0
JNK-IN-5A	TXK	100.0	10000.0
XMD11-85h	ABL1	100.0	10000.0
Palbociclib	KC1G1	100.0	1000.0
JNK-IN-8	KIT(A829P)	69.0	1000.0
ALW-II-38-3	RET(M918T)	100.0	10000.0
XMD-12	KCC4	100.0	1000.0
PD0325901	TRPM6	100.0	10000.0
Dactolisib	CDK14	100.0	1000.0
KU63794	FAK2	84.0	10000.0
XMD-12	BMPR1B	13.0	1000.0
BMS-536924	SNARK	4.0	1000.0
Omipalisib	GAK	0.2	10000.0
MPS-1-IN-1	CAMK1	100.0	1000.0
AZD7762	CTK	34.0	10000.0
Dinaciclib	CHEK1	82.0	10000.0
SB590885	RSK4(Kin.Dom.2-C-terminal)	88.0	10000.0
BMS-536924	KGP2	6.6	1000.0
Sorafenib	M4K3	54.0	10000.0
Canertinib	FLT3(N841I)	100.0	1000.0
CH5424802	MK13	100.0	1000.0
GW-5074	RIOK1	14.0	10000.0
AZD4547	ROCK1	76.0	10000.0
(s)-CR8	CDK2	67.0	10000.0
WZ4002	RIPK4	100.0	10000.0
MLN8054	TESK1	100.0	10000.0
Abemaciclib	CDK3	30.0	1000.0
GSK1059615	CSNK1A1L	55.0	10000.0
QL-XII-47	AURKC	78.0	1000.0
ZG-10	IKKA	54.0	10000.0
KIN001-127	RPS6KA3(Kin.Dom.1)	100.0	10000.0
XMD-12	CDKL2	100.0	1000.0
TAK-715	PIP5K2B	93.0	10000.0
QL-XII-47	TAOK3	97.0	1000.0
Neratinib	ABL1(Q252H)-phosphorylated	72.0	10000.0
NG25	EGFR(G719C)	11.0	10000.0
XMD11-50	KCC2D	28.0	10000.0
Torkinib	SRPK3	83.0	10000.0
Torin1	MYLK	87.0	10000.0
Dactolisib	PIK3CA	2.8	1000.0
Baricitinib	ALK(C1156Y)	5.8	10000.0
HG-5-88-01	TEC	100.0	10000.0
BMX-IN-1	AURKC	63.0	10000.0
PHA-793887	GSK3B	0.3	10000.0
WYE-125132	TRKA	100.0	10000.0
PD0325901	TYK2(JH1domain-catalytic)	100.0	10000.0
JNK-IN-11	AURKB	85.0	1000.0
WH-4-023	MST3	52.0	10000.0
XMD-12	ZAP70	87.0	1000.0
BGJ398	OSR1	100.0	1000.0
BS-181	INSRR	68.0	10000.0
AG1478	MK01	100.0	10000.0
Crizotinib	SIK2	12.0	10000.0
HG-5-113-01	SNARK	0.4	10000.0
AZD-6482	PFPK5(P.falciparum)	98.0	10000.0
AZD4547	EPHB3	91.0	10000.0
OTSSP167	DMPK2	1.2	10000.0
AZ-628	CASK	96.0	10000.0
PHA-793887	SGK1	100.0	10000.0
HG-6-64-01	TNNI3K	1.0	10000.0
Palbociclib	NEK7	100.0	1000.0
JNK-IN-5A	HASP	100.0	10000.0
CH5424802	MAP3K15	67.0	1000.0
Torkinib	PGFRB	0.0	10000.0
Buparlisib	NUAK1	83.0	1000.0
NG25	ULK3	0.1	10000.0
CP724714	DMPK	83.0	10000.0
AZD7762	ERK8	19.0	10000.0
Torin1	ABL2	99.0	10000.0
MRT67307	BMPR1A	100.0	10000.0
NG25	RIPK4	100.0	10000.0
BS-181	PCTK2	68.0	10000.0
Baricitinib	EPHB6	69.0	10000.0
AZD4547	SIK1	8.4	10000.0
CP724714	DCLK1	100.0	10000.0
JNK-9L	MK13	61.0	10000.0
QL-X-138	KPCT	100.0	10000.0
CGP60474	RET(M918T)	100.0	10000.0
Torin2	NEK1	87.0	10000.0
CGP74514A	CAMK2G	100.0	10000.0
Pictilisib	FES	100.0	1000.0
WYE-125132	AKT1	81.0	10000.0
HG-14-8-02	PIK3CG	76.0	10000.0
RO-3306	PIM1	9.9	10000.0
BI-2536	KIT	100.0	10000.0
PLX-4720	M3K6	96.0	10000.0
KIN001-111	MRCKB	0.8	1000.0
JNK-IN-11	KPCD1	20.0	1000.0
AZ-628	CAMKK2	28.0	10000.0
GSK429286A	ABL1(H396P)-phosphorylated	94.0	10000.0
ZSTK474	EGFR(L861Q)	100.0	1000.0
THZ1	EGFR(L858R)	17.0	10000.0
BX-912	PKMYT1	100.0	10000.0
NVP-TAE684	KCC2D	4.1	1000.0
Palbociclib	IRAK1	80.0	1000.0
HG-5-113-01	CAMK1D	100.0	10000.0
WH-4-023	EPHB6	1.2	10000.0
Taselisib	CSNK1E	90.0	1000.0
TGX221	MP2K2	100.0	1000.0
GW-5074	KCC2D	41.0	10000.0
ZSTK474	CAMK1D	100.0	1000.0
Dabrafenib	SNRK	100.0	10000.0
Taselisib	BRSK2	99.0	1000.0
THZ1	BIKE	0.2	10000.0
AZD4547	PAK7	4.1	10000.0
AZ-628	RIPK2	7.0	10000.0
Neratinib	LATS1	90.0	10000.0
SB590885	ABL1(F317L)-nonphosphorylated	59.0	10000.0
Dactolisib	CLK1	23.0	1000.0
QL-XI-92	DRAK2	89.0	10000.0
CP724714	CAMK1D	87.0	10000.0
CP724714	MTOR	79.0	10000.0
5z-7-oxozeaenol	PIK3CA(H1047Y)	63.0	10000.0
5z-7-oxozeaenol	CSNK1A1	98.0	10000.0
Torin2	EGFR(L747-S752del,P753S)	98.0	10000.0
XMD14-99	FER	82.0	10000.0
CGP74514A	MARK1	47.0	10000.0
(s)-CR8	GSK3A	64.0	10000.0
KIN001-220	RIPK4	31.0	10000.0
KIN001-111	CAMK1	23.0	1000.0
Pictilisib	ERK3	100.0	1000.0
Ribociclib	MET	100.0	1000.0
Taselisib	TRKB	100.0	1000.0
ZG-10	KC1G2	100.0	10000.0
HG-6-64-01	CSF1R	0.0	10000.0
Palbociclib	MK14	100.0	1000.0
PD173074	KPCD2	100.0	10000.0
JNK-9L	PRKR	48.0	10000.0
JNK-IN-5A	RET(V804M)	92.0	10000.0
BMX-IN-1	TIE1	89.0	10000.0
Momelotinib	KIT	24.0	10000.0
AZD-6482	MYLK4	98.0	10000.0
HG-5-113-01	RIPK4	100.0	10000.0
AS-252424	MST1	100.0	10000.0
PD173074	EGFR(L747-T751del,Sins)	100.0	10000.0
TGX221	EPHA3	100.0	1000.0
ZG-10	INSR	74.0	10000.0
WZ4002	CAMK2G	100.0	10000.0
KIN001-123	EGFR(G719S)	100.0	1000.0
Torkinib	MET(M1250T)	100.0	10000.0
ZM-447439	VRK2	100.0	10000.0
CH5424802	CDC2L2	98.0	1000.0
HG-14-10-04	FLT3(D835H)	0.2	10000.0
Barasertib	RSK4(Kin.Dom.2-C-terminal)	64.0	10000.0
CG-930	RET	100.0	10000.0
Sorafenib	KIT(D816V)	3.6	10000.0
JNK-IN-11	EPHB1	84.0	1000.0
HG-14-10-04	FLT3(R834Q)	0.1	10000.0
Pictilisib	LTK	100.0	1000.0
Buparlisib	PIK4CB	100.0	1000.0
TGX221	M3K5	100.0	1000.0
JW-7-24-1	RAF1	20.0	10000.0
HG-6-64-01	SNARK	95.0	10000.0
MLN8054	ERBB3	74.0	10000.0
Torin2	RSK4(Kin.Dom.2-C-terminal)	70.0	10000.0
(s)-CR8	ABL1(F317I)-nonphosphorylated	100.0	10000.0
5z-7-oxozeaenol	MAP3K4	86.0	10000.0
AS-252424	MK13	92.5	10000.0
Buparlisib	FGR	100.0	1000.0
PLX-4720	CDKL2	49.0	10000.0
Neratinib	PIK3CA	86.0	10000.0
JW-7-24-1	M4K1	100.0	10000.0
PHA-767491	MYLK	17.0	10000.0
Pictilisib	HIPK3	79.0	1000.0
PHA-793887	RIPK4	86.0	10000.0
OTSSP167	DAPK2	100.0	10000.0
Palbociclib	EPHA6	100.0	1000.0
XMD11-50	FAK2	78.0	10000.0
Baricitinib	RSK2(Kin.Dom.1-N-terminal)	26.0	10000.0
Pictilisib	SIK1	100.0	1000.0
XMD-12	ABL1-nonphosphorylated	3.2	1000.0
PD0325901	PIK3CA(E545A)	45.0	10000.0
WH-4-023	LRRK2(G2019S)	84.0	10000.0
Dabrafenib	KKCC1	40.0	10000.0
PD0325901	LRRK2	86.0	10000.0
Ribociclib	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	1000.0
RO-3306	TRKC	90.0	10000.0
PHA-793887	RAF1	100.0	10000.0
WZ3105	PIP5K2B	54.0	10000.0
XMD11-85h	KIT(V559D,T670I)	100.0	10000.0
XMD-12	FLT3(D835H)	28.0	1000.0
Torin1	PIK3CA(Q546K)	6.8	10000.0
Crizotinib	MST3	44.0	10000.0
WYE-125132	CLK1	29.0	10000.0
KIN001-127	NDR2	7.0	10000.0
Sorafenib	TRPM6	100.0	10000.0
5z-7-oxozeaenol	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
AG1478	PKMYT1	78.0	10000.0
Dactolisib	KPCD3	100.0	1000.0
HG-6-64-01	ACVRL1	100.0	10000.0
AZD4547	ABL1(F317L)-phosphorylated	8.2	10000.0
PHA-767491	TIE2	100.0	10000.0
XMD8-85	KIT(D816V)	100.0	10000.0
QL-XI-92	DYRK2	78.0	10000.0
SCH772984	PDPK1	93.0	1000.0
CP466722	LTK	24.0	10000.0
R406	ULK1	0.2	1000.0
Crizotinib	SBK1	6.0	10000.0
TAK-715	PAK3	82.0	10000.0
5z-7-oxozeaenol	MERTK	82.0	10000.0
KIN001-111	YANK3	100.0	1000.0
XMD11-50	JAK3(JH1domain-catalytic)	100.0	10000.0
Canertinib	KIT(D816V)	100.0	1000.0
Neratinib	PAK3	100.0	10000.0
CP724714	ERK4	100.0	10000.0
AZD7762	TRKB	0.4	10000.0
CP466722	ROCK1	21.0	10000.0
Sorafenib	EGFR(G719S)	91.0	10000.0
KIN001-111	CSNK2A2	100.0	1000.0
XMD11-85h	HIPK2	100.0	10000.0
WZ4002	TRKC	100.0	10000.0
Omipalisib	FLT3(N841I)	91.0	10000.0
JNK-IN-11	WEE2	100.0	1000.0
Palbociclib	RSK1(Kin.Dom.1-N-terminal)	96.0	1000.0
Barasertib	KPCT	100.0	10000.0
Sorafenib	CDK4-cyclinD3	79.0	10000.0
R406	RET(V804M)	0.0	1000.0
TGX221	PIK3CD	34.0	1000.0
CG-930	MUSK	63.0	10000.0
NVP-TAE684	ABL1(T315I)	0.1	1000.0
QL-X-138	RIPK2	56.0	10000.0
GSK429286A	YSK1	64.0	10000.0
AZD4547	WNK3	0.1	10000.0
WZ-4-145	YANK3	100.0	10000.0
PHA-793887	STK35	22.0	10000.0
XMD16-144	MLK1	89.0	10000.0
CGP60474	KGP2	100.0	10000.0
XMD16-144	MAST1	100.0	10000.0
R406	MST3	100.0	1000.0
Baricitinib	MLK2	74.0	10000.0
XMD11-50	KC1G1	100.0	10000.0
HG-6-64-01	EPHB6	1.8	10000.0
(s)-CR8	KPCL	100.0	10000.0
THZ1	CDK2	3.8	10000.0
JNK-9L	CSNK1G3	100.0	10000.0
QL-XII-47	MYLK2	63.0	1000.0
Alpelisib	FYV1	98.0	1000.0
MRT67307	EPHA3	90.0	10000.0
JNK-IN-11	MAP3K15	47.0	1000.0
WH-4-023	IRAK4	100.0	10000.0
Torin1	CDKL5	100.0	10000.0
AZD7762	DYRK1B	1.8	10000.0
Sorafenib	HIPK2	4.4	10000.0
AZD 5438	DCLK1	41.0	10000.0
Dabrafenib	ACVR1B	12.0	10000.0
MLN8054	YES	3.9	10000.0
HG-14-10-04	PKMYT1	98.0	10000.0
Barasertib	CDK3	95.0	10000.0
Vemurafenib	EPHB2	99.0	10000.0
NG25	MELK	100.0	10000.0
HG-9-91-01	PIK3C2B	0.1	10000.0
Canertinib	MLTK	100.0	1000.0
XMD16-144	MAP4K4	50.0	10000.0
AZD-6482	PIK3CD	0.0	10000.0
CG-930	CLK2	7.7	10000.0
GSK461364	KPCI	28.0	10000.0
Omipalisib	FLT3	100.0	10000.0
AZD4547	EIF2AK1	2.6	10000.0
GW843682X	PKN1	76.0	10000.0
XMD11-85h	BIKE	100.0	10000.0
HG-5-88-01	DAPK1	100.0	10000.0
AZD4547	PKNB(M.tuberculosis)	9.8	10000.0
Pictilisib	CSNK1G3	99.0	1000.0
Torkinib	TRPM6	70.0	10000.0
Abemaciclib	MLTK	99.0	1000.0
Dactolisib	CDK3	100.0	1000.0
JNK-IN-5A	RIPK1	87.0	10000.0
GW-5074	MK09	72.0	10000.0
QL-XI-92	EPHB4	87.0	10000.0
ALW-II-38-3	FGFR2	100.0	10000.0
Dabrafenib	KPCD2	1.0	10000.0
AG1478	AURKC	49.0	10000.0
Omipalisib	CDK5	93.0	10000.0
Ribociclib	ERBB3	97.0	1000.0
MLN8054	RSK3(Kin.Dom.1-N-terminal)	100.0	10000.0
PD0325901	DMPK2	85.0	10000.0
XMD13-2	MARK4	96.0	10000.0
XMD8-85	SRMS	100.0	10000.0
Abemaciclib	MST2	100.0	1000.0
QL-XI-92	JNK1	100.0	10000.0
ZSTK474	KKCC1	100.0	1000.0
SCH772984	GCN2(Kin.Dom.2,S808G)	100.0	1000.0
XMD14-99	TAOK2	8.2	10000.0
Ribociclib	CAMK1D	73.0	1000.0
XMD8-92	TYRO3	100.0	10000.0
Taselisib	MKNK1	100.0	1000.0
PD0325901	KIT(A829P)	72.0	10000.0
PD0325901	ERK3	83.0	10000.0
TAK-715	HUNK	15.0	10000.0
HG-14-8-02	SIK1	91.0	10000.0
Sorafenib	BRSK2	85.0	10000.0
BMX-IN-1	RIPK5	100.0	10000.0
CG-930	OSR1	100.0	10000.0
HG-5-88-01	CDK2	100.0	10000.0
PHA-793887	KCC2D	76.0	10000.0
PD173074	PTK6	100.0	10000.0
JWE-035	EPHB6	21.0	10000.0
Dinaciclib	YSK1	9.2	10000.0
Neratinib	CHK2	79.0	10000.0
Seliciclib	CDK7	1.6	10000.0
GW-5074	CDK5	83.0	10000.0
KIN001-220	MARK4	17.0	10000.0
CG-930	JAK1(JH2domain-pseudokinase)	70.0	10000.0
GW-5074	IKKB	100.0	10000.0
BMS-536924	RET(M918T)	0.0	1000.0
AG1478	EGFR(L747-S752del,P753S)	1.4	10000.0
NVP-TAE684	CAMK1D	0.1	1000.0
ZM-447439	KPCD3	100.0	10000.0
PD173074	EGFR(L858R)	100.0	10000.0
GW843682X	EPHB4	87.0	10000.0
NU7441	FLT3(R834Q)	100.0	10000.0
HG-14-8-02	PHKG2	30.0	10000.0
WYE-125132	PCTK3	92.0	10000.0
PHA-767491	RIOK2	37.0	10000.0
Alpelisib	IKKA	100.0	1000.0
BMX-IN-1	JAK1(JH2domain-pseudokinase)	93.0	10000.0
AZD7762	PLK3	39.0	10000.0
R406	SRPK2	26.0	1000.0
Dinaciclib	PRKX	100.0	10000.0
NPK76-II-72-1	AKT2	100.0	10000.0
KIN001-220	ABL1(H396P)-nonphosphorylated	6.0	10000.0
WYE-125132	ABL1(F317I)-phosphorylated	100.0	10000.0
WZ4003	RET(M918T)	100.0	1000.0
Torin1	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
QL-XI-92	ABL1(F317I)-phosphorylated	64.0	10000.0
Ribociclib	ABL1(Y253F)-phosphorylated	100.0	1000.0
SB590885	JAK3(JH1domain-catalytic)	93.0	10000.0
WYE-125132	SRPK3	100.0	10000.0
XMD11-50	NEK2	100.0	10000.0
ZG-10	DYRK2	29.0	10000.0
THZ1	TAOK1	8.0	10000.0
WYE-125132	PKN1	100.0	10000.0
ERK5-IN-1	AKT1	100.0	1000.0
Omipalisib	VGFR1	82.0	10000.0
Ribociclib	FGFR3	100.0	1000.0
THZ1	MLTK	35.0	10000.0
Pictilisib	CAMK1	100.0	1000.0
MRT67307	ERBB4	100.0	10000.0
GSK429286A	PIK3CA(E545K)	100.0	10000.0
NU7441	DMPK	89.0	10000.0
AZD-6482	BRAF	100.0	10000.0
KIN001-220	ADCK4	0.5	10000.0
MLN8054	TIE1	14.0	10000.0
R406	M4K3	13.0	1000.0
HG-14-10-04	SRPK3	20.0	10000.0
KIN001-123	MK12	100.0	1000.0
Alpelisib	PHKG2	79.0	1000.0
WYE-125132	SIK2	97.0	10000.0
PLX-4720	TAOK3	61.0	10000.0
JNK-IN-5A	AAK1	91.0	10000.0
HG-6-64-01	FLT3(D835Y)	2.8	10000.0
AZ-628	EGFR(S752-I759del)	17.0	10000.0
Dabrafenib	TSSK1	78.0	10000.0
Baricitinib	HIPK2	10.0	10000.0
QL-XI-92	PGFRB	1.2	10000.0
PD0325901	PDPK1	71.0	10000.0
QL-XII-47	HIPK3	68.0	1000.0
QL-X-138	JNK1	1.9	10000.0
Vemurafenib	LKB1	75.0	10000.0
Lapatinib	FGFR2	99.0	10000.0
GSK1059615	EGFR(T790M)	76.0	10000.0
AZD4547	MAP3K14	30.0	10000.0
KIN001-021	YANK2	100.0	1000.0
ZG-10	RIPK4	33.0	10000.0
QL-XI-92	YES	46.0	10000.0
CH5424802	KCC2D	34.0	1000.0
ZSTK474	KCC2D	100.0	1000.0
WZ4003	FGR	100.0	1000.0
AZD7762	EIF2AK1	88.0	10000.0
Canertinib	PLK3	100.0	1000.0
Baricitinib	CSF1R	6.3	10000.0
AZ-628	AAK1	100.0	10000.0
TAK-715	EPHA2	66.0	10000.0
NG25	MK12	0.0	10000.0
(s)-CR8	FGFR3(G697C)	86.0	10000.0
BGJ398	CAMK1D	42.0	1000.0
JWE-035	PHKG2	47.0	10000.0
JWE-035	LYN	61.0	10000.0
JWE-035	GRK7	73.0	10000.0
Crizotinib	YANK3	100.0	10000.0
PD173074	YANK2	100.0	10000.0
Abemaciclib	EGFR(L858R,T790M)	41.0	1000.0
WZ4002	CSNK1D	100.0	10000.0
AG1478	KIT(L576P)	56.0	10000.0
XMD11-50	PFPK5(P.falciparum)	100.0	10000.0
MPS-1-IN-1	CDK9	100.0	1000.0
Momelotinib	CSF1R	48.0	10000.0
MLN8054	TXK	46.0	10000.0
QL-XI-92	PIM1	100.0	10000.0
BGJ398	KPCI	65.0	1000.0
Neratinib	MAP3K4	4.8	10000.0
BX-912	ERK5	62.0	10000.0
Vemurafenib	GAK	84.0	10000.0
KIN001-021	BIKE	100.0	1000.0
JNK-IN-5A	CDC2L2	100.0	10000.0
AZD4547	ABL1-nonphosphorylated	1.4	10000.0
BS-181	PIK3CA(C420R)	88.0	10000.0
QL-XII-47	PLK3	100.0	1000.0
HG-5-88-01	PAK2	100.0	10000.0
PD0325901	EGFR(G719C)	86.0	10000.0
GSK429286A	MYLK	75.0	10000.0
JW-7-24-1	EPHA8	100.0	10000.0
NVP-TAE684	ANKK1	100.0	1000.0
Ribociclib	RSK3(Kin.Dom.2-C-terminal)	100.0	1000.0
BX-912	ABL1(F317I)-nonphosphorylated	26.0	10000.0
NVP-TAE684	NDR2	7.3	1000.0
R406	MARK1	2.0	1000.0
KIN001-127	FLT3(D835H)	14.0	10000.0
NG25	STK33	100.0	10000.0
AZD 5438	TAOK3	2.4	10000.0
Torin2	PAK4	100.0	10000.0
WZ4003	TAOK3	100.0	1000.0
Buparlisib	DDR2	54.0	1000.0
Seliciclib	CAMK2B	91.0	10000.0
GW843682X	IKKB	82.0	10000.0
Sigma A6730	CSNK2A2	92.0	10000.0
Dinaciclib	NDR2	77.0	10000.0
AZD 5438	ABL2	60.0	10000.0
KIN001-021	CAMK1G	100.0	1000.0
XMD11-85h	MKNK2	100.0	10000.0
Palbociclib	STK16	8.2	1000.0
Baricitinib	DCAMKL2	2.6	10000.0
NU7441	CIT	85.0	10000.0
Palbociclib	ADCK3	84.0	1000.0
NPK76-II-72-1	IKKB	100.0	10000.0
Barasertib	PIP5K2B	100.0	10000.0
PLX-4720	ERK4	100.0	10000.0
GW-5074	RIOK2	35.0	10000.0
TAK-715	ABL1-nonphosphorylated	13.0	10000.0
AZD 5438	ABL1(T315I)-nonphosphorylated	5.2	10000.0
Ceritinib	AMPK-alpha2	88.0	1000.0
Pictilisib	MK12	59.0	1000.0
CP724714	SRC	97.0	10000.0
BI-2536	ALK	6.2	10000.0
XMD13-2	NDR1	85.0	10000.0
(s)-CR8	MARK2	80.0	10000.0
CGP74514A	PIP5K2B	78.0	10000.0
GW843682X	MP2K7	87.0	10000.0
JW-7-24-1	SNARK	10.0	10000.0
Ribociclib	DDR1	100.0	1000.0
KU63794	CDK5	100.0	10000.0
GW843682X	FAK2	72.0	10000.0
Omipalisib	LOK	54.0	10000.0
Torin2	MP2K1	100.0	10000.0
CGP60474	PIM2	100.0	10000.0
AG1478	MAST1	79.0	10000.0
BMS345541	KPCI	88.0	10000.0
XMD8-92	MK11	100.0	10000.0
Barasertib	FLT3(ITD)	2.5	10000.0
Torin2	FGFR3(G697C)	89.0	10000.0
ERK5-IN-1	MARK3	100.0	1000.0
QL-X-138	NDR1	87.0	10000.0
HG-14-8-02	CDK5	100.0	10000.0
BMS345541	EGFR(L861Q)	100.0	10000.0
XMD-12	RSK3(Kin.Dom.1-N-terminal)	68.0	1000.0
BS-181	YSK1	100.0	10000.0
Dinaciclib	NEK6	100.0	10000.0
(s)-CR8	KGP1	100.0	10000.0
PD0325901	M3K12	78.0	10000.0
KIN001-021	TYRO3	100.0	1000.0
Lapatinib	ACVRL1	100.0	10000.0
Torkinib	FGFR2	5.8	10000.0
PHA-767491	TESK1	97.0	10000.0
WZ-4-145	SNARK	100.0	10000.0
JNK-9L	YES	79.0	10000.0
GSK461364	PRP4	39.0	10000.0
ZM-447439	FAK2	98.0	10000.0
ALW-II-49-7	MKNK1	100.0	10000.0
AZD7762	AURKC	0.7	10000.0
Pictilisib	MK11	100.0	1000.0
Baricitinib	EGFR(L861Q)	86.0	10000.0
JNK-IN-8	NEK9	100.0	1000.0
Canertinib	CDK5	100.0	1000.0
Alpelisib	SNARK	100.0	1000.0
NVP-TAE684	MAP4K4	5.4	1000.0
5z-7-oxozeaenol	DDR2	100.0	10000.0
CP466722	CASK	26.0	10000.0
Dabrafenib	RSK4(Kin.Dom.2-C-terminal)	65.0	10000.0
CP466722	PLK2	13.0	10000.0
WYE-125132	MELK	92.0	10000.0
THZ1	PIK3CB	100.0	10000.0
PHA-793887	PIK3CB	88.0	10000.0
AS-252424	KGP2	97.3	10000.0
XMD14-99	ROCK2	88.0	10000.0
WZ4003	MYO3A	31.0	1000.0
(s)-CR8	DYRK2	87.0	10000.0
CH5424802	TAK1	56.0	1000.0
HG-14-8-02	DDR1	59.0	10000.0
Vemurafenib	EPHA2	99.0	10000.0
GSK429286A	PAK1	81.0	10000.0
WZ-4-145	PIK3CD	100.0	10000.0
QL-X-138	YSK1	70.0	10000.0
HG-9-91-01	M3K6	100.0	10000.0
BX-912	CDK11	100.0	10000.0
JNK-IN-11	CDKL5	100.0	1000.0
KU63794	VRK2	87.0	10000.0
PD173074	MLK2	100.0	10000.0
Torkinib	MINK	7.7	10000.0
HG-5-88-01	FLT4	100.0	10000.0
QL-XII-47	KC1G2	100.0	1000.0
GW843682X	MINK	63.0	10000.0
PHA-767491	RIPK5	96.0	10000.0
AZD 5438	PIP5K2B	7.9	10000.0
WYE-125132	IKKA	100.0	10000.0
XMD11-50	HIPK1	100.0	10000.0
TGX221	IRAK3	100.0	1000.0
Ceritinib	BARK2	78.0	1000.0
BS-181	EPHB2	78.0	10000.0
Baricitinib	MAP4K4	80.0	10000.0
XMD8-92	RIOK3	100.0	10000.0
MRT67307	PFPK5(P.falciparum)	94.0	10000.0
CH5424802	BRSK1	96.0	1000.0
PLX-4720	SNARK	41.0	10000.0
AZD4547	LATS2	94.0	10000.0
WZ-7043	M4K3	100.0	10000.0
RO-3306	ACVR2A	98.0	10000.0
KIN001-220	CTK	100.0	10000.0
JNK-IN-5A	DMPK2	81.0	10000.0
AS-252424	AKT3	100.0	10000.0
KU63794	AURKC	100.0	10000.0
HG-14-10-04	CDK4-cyclinD3	44.0	10000.0
JWE-035	DCLK1	4.4	10000.0
Barasertib	RIPK5	14.0	10000.0
OTSSP167	M3K12	85.0	10000.0
Abemaciclib	GRK7	92.0	1000.0
XMD13-2	ERK5	93.0	10000.0
Palbociclib	EGFR(L858R,T790M)	100.0	1000.0
HG-14-10-04	JAK2(JH1domain-catalytic)	0.0	10000.0
SB590885	PIM2	78.0	10000.0
Buparlisib	PCTK2	98.0	1000.0
Crizotinib	EGFR(G719C)	71.0	10000.0
GSK1059615	FLT3(R834Q)	90.0	10000.0
Buparlisib	MP2K1	99.0	1000.0
AZ-628	MAPKAPK2	100.0	10000.0
ZM-447439	ABL1(F317I)-phosphorylated	55.0	10000.0
PD0325901	ACVR1	76.0	10000.0
XMD8-92	YANK2	100.0	10000.0
Dactolisib	BRSK1	100.0	1000.0
KIN001-123	ABL2	100.0	1000.0
PD173074	ABL1(M351T)	100.0	10000.0
KIN001-220	GRK7	71.0	10000.0
GW-5074	MK12	74.0	10000.0
QL-XI-92	MRCKB	91.0	10000.0
WYE-125132	CDK3	99.0	10000.0
HG-14-8-02	RSK3(Kin.Dom.1-N-terminal)	94.0	10000.0
WH-4-023	ABL1(F317L)-phosphorylated	1.4	10000.0
5z-7-oxozeaenol	TLK1	93.0	10000.0
NPK76-II-72-1	TNNI3K	100.0	10000.0
5z-7-oxozeaenol	KIT(V559D,T670I)	2.6	10000.0
CGP74514A	LRRK2	38.0	10000.0
XMD16-144	GSK3A	69.0	10000.0
WZ4003	DYRK1B	24.0	1000.0
Ibrutinib	TIE1	66.0	1000.0
Momelotinib	MET	100.0	10000.0
MRT67307	GRK7	56.0	10000.0
HG-9-91-01	SRPK2	98.0	10000.0
WZ4003	ABL1(F317I)	100.0	1000.0
Sorafenib	MP2K4	100.0	10000.0
Baricitinib	MAP3K1	12.0	10000.0
Pictilisib	CSNK2A1	97.0	1000.0
HG-9-91-01	TRKA	100.0	10000.0
SB590885	NDR2	100.0	10000.0
5z-7-oxozeaenol	JNK3	95.0	10000.0
JNK-IN-5A	FLT3(N841I)	86.0	10000.0
MPS-1-IN-1	CDC2L2	100.0	1000.0
PLX-4720	KIT(L576P)	6.4	10000.0
WZ4002	PKMYT1	100.0	10000.0
TGX221	SIK1	100.0	1000.0
WYE-125132	NDR1	100.0	10000.0
MLN8054	MK09	57.0	10000.0
KIN001-127	NEK6	34.0	10000.0
AZD7762	ERBB4	4.4	10000.0
AZD4547	PIK3CA(H1047Y)	82.0	10000.0
RO-3306	PIK3CA(E542K)	62.0	10000.0
Ceritinib	FLT3(N841I)	46.0	1000.0
WZ3105	SRPK2	92.0	10000.0
XMD13-2	CDC2L2	85.0	10000.0
HG-5-113-01	MK14	100.0	10000.0
CP724714	PKN2	99.0	10000.0
JNK-IN-5A	FLT3(D835Y)	80.0	10000.0
KIN001-127	TESK1	100.0	10000.0
AZD4547	EGFR(T790M)	54.0	10000.0
WYE-125132	PRP4	70.0	10000.0
ZM-447439	INSRR	100.0	10000.0
WZ4002	NUAK1	0.7	10000.0
5z-7-oxozeaenol	EPHB1	98.0	10000.0
JNK-9L	TAK1	15.0	10000.0
CH5424802	SYK	100.0	1000.0
SP600125	DRAK1	20.0	10000.0
XMD13-2	IRAK1	82.0	10000.0
WH-4-023	FGFR4	7.4	10000.0
HG-14-8-02	MST1	100.0	10000.0
Crizotinib	TIE2	1.0	10000.0
JW-7-24-1	FLT3(ITD)	4.0	10000.0
ZM-447439	CDC2L1	16.0	10000.0
KIN001-220	CDKL3	89.0	10000.0
Palbociclib	ABL1(M351T)-phosphorylated	100.0	1000.0
GSK461364	TGFBR2	100.0	10000.0
GSK461364	TAOK1	14.0	10000.0
Ceritinib	CSNK1E	96.0	1000.0
CP466722	KPCL	100.0	10000.0
BS-181	MYO3B	100.0	10000.0
ZSTK474	LKB1	100.0	1000.0
NU7441	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
Torkinib	MST3	67.0	10000.0
Ribociclib	KC1G2	100.0	1000.0
CGP60474	EGFR	100.0	10000.0
THZ1	RSK3(Kin.Dom.2-C-terminal)	81.0	10000.0
RO-3306	EPHB4	70.0	10000.0
MRT67307	BRAF(V600E)	100.0	10000.0
BS-181	EPHA6	94.0	10000.0
WH-4-023	MP2K2	46.0	10000.0
Crizotinib	HIPK2	93.0	10000.0
Ribociclib	MP2K3	85.0	1000.0
ERK5-IN-1	JAK2(JH1domain-catalytic)	100.0	1000.0
Ceritinib	IKKA	87.0	1000.0
PHA-793887	STK33	15.0	10000.0
Torkinib	JAK3(JH1domain-catalytic)	0.0	10000.0
NPK76-II-72-1	CSNK1E	100.0	10000.0
Dinaciclib	RIPK4	86.0	10000.0
PHA-793887	ABL1(E255K)-phosphorylated	46.0	10000.0
JW-7-24-1	TNIK	28.0	10000.0
AZD7762	FLT3(R834Q)	5.6	10000.0
PHA-793887	PGFRB	60.0	10000.0
ERK5-IN-1	GRK4	100.0	1000.0
BX-912	MERTK	0.5	10000.0
JWE-035	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
JW-7-24-1	MINK	100.0	10000.0
QL-XI-92	GSK3A	100.0	10000.0
ZSTK474	VGFR2	100.0	1000.0
Canertinib	MUSK	100.0	1000.0
NPK76-II-72-1	WEE2	100.0	10000.0
QL-XI-92	PLK2	100.0	10000.0
Crizotinib	CLK4	100.0	10000.0
THZ1	MYLK	42.0	10000.0
JNK-IN-5A	DCLK1	100.0	10000.0
AZD 5438	INSRR	90.0	10000.0
PD173074	PCTK3	100.0	10000.0
Neratinib	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
PD0325901	MINK	94.0	10000.0
WH-4-023	RIPK2	0.0	10000.0
Palbociclib	EGFR(L747-S752del,P753S)	71.0	1000.0
SCH772984	M3K13	95.0	1000.0
CH5424802	MST1R	100.0	1000.0
XMD14-99	PKN2	98.0	10000.0
JW-7-24-1	ERK4	100.0	10000.0
AS-252424	PCTK3	86.1	10000.0
GW-5074	NEK7	100.0	10000.0
QL-XII-47	KIT(A829P)	94.0	1000.0
XMD11-50	EGFR	84.0	10000.0
KIN001-123	PLK4	12.0	1000.0
JW-7-24-1	KPCD1	100.0	10000.0
Sorafenib	PTK6	100.0	10000.0
PLX-4720	DCLK1	52.0	10000.0
XMD8-92	EPHA7	100.0	10000.0
AG1478	RET	7.0	10000.0
AZ-628	CDK11	35.0	10000.0
CP466722	RSK4(Kin.Dom.2-C-terminal)	6.2	10000.0
BS-181	AKT1	100.0	10000.0
Torin2	CDK16	98.0	10000.0
JNK-IN-5A	SgK110	91.0	10000.0
Abemaciclib	PI42C	13.0	1000.0
Pictilisib	AURKC	100.0	1000.0
HG-5-113-01	EGFR(L861Q)	100.0	10000.0
R406	ULK3	0.0	1000.0
XMD8-92	PLK3	100.0	10000.0
SP600125	FGR	100.0	10000.0
CP724714	TSSK1	100.0	10000.0
BMS345541	FGFR4	100.0	10000.0
MLN8054	PIK3CA(E545A)	20.0	10000.0
JNK-IN-8	CHEK1	98.0	1000.0
Vemurafenib	ABL1(T315I)-phosphorylated	82.0	10000.0
AZD-6482	TLK2	88.0	10000.0
HG-14-8-02	ADCK4	57.0	10000.0
PLX-4720	CDK15	100.0	10000.0
OTSSP167	STK33	13.0	10000.0
KIN001-021	TIE1	100.0	1000.0
THZ1	CLK1	0.7	10000.0
BMX-IN-1	PHKG1	97.0	10000.0
GSK429286A	FLT3(D835H)	76.0	10000.0
JNK-IN-8	BIKE	94.0	1000.0
Omipalisib	INSR	79.0	10000.0
CP724714	ABL1(Q252H)-nonphosphorylated	100.0	10000.0
THZ1	KPCD1	3.2	10000.0
HG-5-88-01	MYO3B	24.0	10000.0
Ceritinib	JAK1(JH1domain-catalytic)	80.0	1000.0
AZD-6482	PIM1	100.0	10000.0
XMD16-144	FAK1	14.0	10000.0
WH-4-023	MARK3	4.8	10000.0
TAK-715	DCAMKL3	90.0	10000.0
ZM-447439	ACVRL1	85.0	10000.0
KU63794	DYRK2	63.0	10000.0
XMD16-144	EGFR(E746-A750del)	90.0	10000.0
PHA-793887	ADCK3	84.0	10000.0
CGP74514A	KKCC1	36.0	10000.0
SP600125	EGFR(L858R)	100.0	10000.0
HG-6-64-01	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
WZ4002	SIK1	100.0	10000.0
Canertinib	MYO3A	100.0	1000.0
TGX221	RPS6KA2(Kin.Dom.1)	100.0	1000.0
BGJ398	CSNK1G3	100.0	1000.0
ALW-II-38-3	BTK	100.0	10000.0
KIN001-021	ACVR1B	100.0	1000.0
XMD13-2	CDK8	76.0	10000.0
Barasertib	GSK3A	100.0	10000.0
Omipalisib	EGFR(T790M)	76.0	10000.0
A443654	IKKB	34.0	10000.0
SP600125	TIE2	100.0	10000.0
XMD8-85	KIT	100.0	10000.0
HG-6-64-01	WEE1	100.0	10000.0
AS-252424	TSSK1	100.0	10000.0
XMD11-85h	CLK2	100.0	10000.0
WZ4003	RIOK3	25.0	1000.0
Sorafenib	AURKB	0.7	10000.0
GSK461364	YANK2	100.0	10000.0
XMD8-92	JNK1	100.0	10000.0
ZG-10	AAK1	5.2	10000.0
Seliciclib	SLK	100.0	10000.0
QL-XI-92	HIPK4	100.0	10000.0
GSK461364	AAK1	40.0	10000.0
BGJ398	TRPM6	100.0	1000.0
XMD8-85	BMPR2	100.0	10000.0
PD0325901	PAK6	94.0	10000.0
Sigma A6730	SRPK1	99.0	10000.0
GSK461364	DDR2	77.0	10000.0
Neratinib	BRSK1	95.0	10000.0
JNK-IN-8	DDR1	93.0	1000.0
GW-5074	PIK3CD	81.0	10000.0
JNK-IN-5A	FGFR3	100.0	10000.0
XMD14-99	GSK3B	100.0	10000.0
MPS-1-IN-1	KPCD2	100.0	1000.0
(s)-CR8	KC1G1	93.0	10000.0
Ribociclib	LCK	100.0	1000.0
SB590885	KPCT	81.0	10000.0
CGP74514A	ACVR1B	100.0	10000.0
Torin2	DRAK1	100.0	10000.0
HG-9-91-01	S6K1	82.0	10000.0
CP724714	CSNK2A2	100.0	10000.0
Canertinib	AURKB	100.0	1000.0
ZSTK474	MAP3K3	100.0	1000.0
BI-D1870	BRSK1	24.0	10000.0
Dabrafenib	KCC2D	80.0	10000.0
HG-6-64-01	ROCK2	34.0	10000.0
GSK461364	EGFR(L747-E749del,A750P)	81.0	10000.0
MLN8054	DMPK	79.0	10000.0
JNK-IN-5A	PAK7	100.0	10000.0
XMD14-99	PLK3	88.0	10000.0
HG-9-91-01	MERTK	30.0	10000.0
PHA-793887	KC1G1	100.0	10000.0
5z-7-oxozeaenol	PIK3CA(E542K)	99.0	10000.0
GSK1059615	TLK1	81.0	10000.0
GW843682X	ROCK1	4.7	10000.0
Vemurafenib	GRK1	100.0	10000.0
QL-XI-92	LATS1	100.0	10000.0
GSK1059615	ALK(L1196M)	45.0	10000.0
WYE-125132	S6K1	100.0	10000.0
Taselisib	CDKL5	95.0	1000.0
BGJ398	RAF1	99.0	1000.0
GSK461364	SNARK	1.2	10000.0
KIN001-127	LKB1	100.0	10000.0
CGP74514A	MAPKAPK5	94.0	10000.0
Dactolisib	MK13	100.0	1000.0
WH-4-023	CDK8	100.0	10000.0
CGP60474	DAPK1	100.0	10000.0
THZ1	WEE2	0.2	10000.0
CP466722	FER	93.0	10000.0
Vemurafenib	EPHA5	98.0	10000.0
TAK-715	TNIK	5.5	10000.0
PLX-4720	PIK3CA(H1047Y)	90.0	10000.0
Taselisib	RIPK2	85.0	1000.0
PHA-767491	MLK3	97.0	10000.0
BX-912	FGFR3	1.0	10000.0
AZ-628	CLK1	100.0	10000.0
ZM-447439	EPHB4	100.0	10000.0
Pictilisib	MYO3B	100.0	1000.0
HG-6-64-01	ANKK1	5.7	10000.0
BX-912	TNIK	0.8	10000.0
CP724714	VGFR1	88.0	10000.0
THZ1	LATS2	26.0	10000.0
Neratinib	CDK8	100.0	10000.0
Momelotinib	TGFBR2	89.0	10000.0
CG-930	MP2K4	27.0	10000.0
Alpelisib	FAK1	100.0	1000.0
PD0325901	CSK	100.0	10000.0
HG-14-8-02	DCLK1	60.0	10000.0
ALW-II-38-3	WEE1	100.0	10000.0
BMX-IN-1	ERK5	100.0	10000.0
NG25	CDK15	5.8	10000.0
HG-14-10-04	PIK3CA(Q546K)	100.0	10000.0
Canertinib	MLK2	100.0	1000.0
HG-9-91-01	CDK2	100.0	10000.0
KU63794	EPHA7	86.0	10000.0
JNK-IN-8	EPHA1	99.0	1000.0
NG25	LTK	1.2	10000.0
Taselisib	MAP3K14	65.0	1000.0
AZ-628	SgK110	100.0	10000.0
NG25	ERK8	100.0	10000.0
GSK429286A	M3K6	80.0	10000.0
JNK-IN-8	HIPK1	100.0	1000.0
XMD8-92	STK35	100.0	10000.0
XMD16-144	CSNK1A1	26.0	10000.0
AS-252424	CDK15	92.6	10000.0
MRT67307	ABL1(H396P)-nonphosphorylated	3.6	10000.0
XMD13-2	EGFR(G719C)	73.0	10000.0
ZM-447439	MAP4K2	39.0	10000.0
Sorafenib	SRPK1	80.0	10000.0
CH5424802	KPCT	99.0	1000.0
BMX-IN-1	BRSK1	97.0	10000.0
GSK429286A	STK39	86.0	10000.0
Ceritinib	EGFR(G719S)	82.0	1000.0
TAK-715	RSK2(Kin.Dom.1-N-terminal)	93.0	10000.0
HG-5-88-01	MST3	100.0	10000.0
JWE-035	PIK3C2B	71.0	10000.0
ZSTK474	AKT3	100.0	1000.0
GW-5074	PKNB(M.tuberculosis)	64.0	10000.0
Canertinib	MKNK1	34.0	1000.0
CP466722	RIPK5	19.0	10000.0
NPK76-II-72-1	M3K5	100.0	10000.0
XMD8-85	LIMK1	100.0	10000.0
Sigma A6730	KGP2	91.0	10000.0
MPS-1-IN-1	MK03	23.0	1000.0
XMD8-85	STK16	100.0	10000.0
Alpelisib	TAOK3	100.0	1000.0
CG-930	PKN2	97.0	10000.0
XMD14-99	CHEK1	79.0	10000.0
Neratinib	ACVR2B	100.0	10000.0
GSK1059615	PIM3	2.4	10000.0
WZ3105	ROCK1	16.0	10000.0
CH5424802	SNRK	78.0	1000.0
JNK-IN-5A	ULK1	100.0	10000.0
R406	TAK1	0.2	1000.0
ZM-447439	KPCT	100.0	10000.0
CP466722	MAP3K1	66.0	10000.0
JNK-9L	ADCK3	38.0	10000.0
GW843682X	FER	100.0	10000.0
HG-14-10-04	LTK	0.0	10000.0
MRT67307	CAMK1G	25.0	10000.0
KU63794	SIK2	91.0	10000.0
Neratinib	S6K1	100.0	10000.0
Torin2	CSNK2A2	48.0	10000.0
Pictilisib	HIPK4	87.0	1000.0
MRT67307	PIK3C2G	100.0	10000.0
NPK76-II-72-1	PIP5K2B	100.0	10000.0
R406	JAK2(Kin.Dom.2)	0.4	1000.0
Taselisib	TAOK1	100.0	1000.0
SB590885	MAP3K3	76.0	10000.0
Sorafenib	AXL	7.8	10000.0
HG-14-8-02	CDK7	80.0	10000.0
WYE-125132	MYLK	100.0	10000.0
PHA-767491	SGK1	13.0	10000.0
Torin1	KIT(V559D,V654A)	92.0	10000.0
JW-7-24-1	PGFRA	1.6	10000.0
Dactolisib	MARK3	100.0	1000.0
XMD-12	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	1000.0
NU7441	M3K2	100.0	10000.0
Ibrutinib	CDK15	99.0	1000.0
JNK-IN-11	PIK3CA(H1047L)	77.0	1000.0
QL-XI-92	RET(V804L)	100.0	10000.0
Crizotinib	EPHB6	0.2	10000.0
GW-5074	BMX	100.0	10000.0
BX-912	PAK6	11.0	10000.0
WZ4003	PIK3CA(E545K)	100.0	1000.0
KIN001-220	DRAK1	2.6	10000.0
QL-XII-47	YANK1	100.0	1000.0
AZD4547	FGR	11.0	10000.0
XMD8-92	FGFR1	100.0	10000.0
QL-X-138	PLK2	89.0	10000.0
CG-930	WEE1	100.0	10000.0
PLX-4720	NLK	100.0	10000.0
KIN001-127	TRKB	23.0	10000.0
Palbociclib	ABL1(E255K)-phosphorylated	100.0	1000.0
CGP74514A	MYO3B	99.0	10000.0
XMD-12	MAK	100.0	1000.0
A443654	ERK3	100.0	10000.0
JNK-IN-8	TIE1	91.0	1000.0
AS-252424	TRKB	94.3	10000.0
Pictilisib	VGFR2	100.0	1000.0
GSK429286A	GRK7	75.0	10000.0
Lapatinib	PIK3CD	100.0	10000.0
TGX221	FLT4	100.0	1000.0
BMX-IN-1	MK01	100.0	10000.0
Taselisib	ABL1(Q252H)-nonphosphorylated	97.0	1000.0
WZ4003	CAMK1	100.0	1000.0
BX-912	MP2K1	0.2	10000.0
GW-5074	CDK15	100.0	10000.0
XMD11-50	ROCK2	87.0	10000.0
WZ-7043	ERN1	100.0	10000.0
PLX-4720	DYRK1B	87.0	10000.0
(s)-CR8	EGFR(G719S)	84.0	10000.0
QL-X-138	CDK15	49.0	10000.0
MPS-1-IN-1	JNK3	35.0	1000.0
Neratinib	VGFR1	95.0	10000.0
JW-7-24-1	BRAF(V600E)	1.6	10000.0
Palbociclib	SRPK2	92.0	1000.0
XMD8-92	CTK	100.0	10000.0
MRT67307	ABL1-phosphorylated	45.0	10000.0
Dactolisib	YES	100.0	1000.0
Neratinib	FYN	84.0	10000.0
WZ-4-145	M3K12	100.0	10000.0
ZM-447439	SRPK2	86.0	10000.0
Seliciclib	SRC	79.0	10000.0
PHA-767491	PKMYT1	99.0	10000.0
Seliciclib	FLT3(R834Q)	92.0	10000.0
PD173074	MLK3	100.0	10000.0
ERK5-IN-1	TLK2	100.0	1000.0
BMS-536924	BRAF	100.0	1000.0
THZ1	PAK7	0.8	10000.0
XMD13-2	RIOK3	6.8	10000.0
Buparlisib	TSSK1	100.0	1000.0
WZ4002	AURKC	4.5	10000.0
Dactolisib	SRMS	100.0	1000.0
CH5424802	LATS2	91.0	1000.0
HG-6-64-01	NEK3	77.0	10000.0
XMD8-92	HUNK	100.0	10000.0
Dinaciclib	TTK	35.0	10000.0
JNK-9L	CDK3	45.0	10000.0
BMS-536924	CAMKK2	100.0	1000.0
AZD4547	FGFR4	0.2	10000.0
ALW-II-38-3	TEC	100.0	10000.0
BS-181	MUSK	90.0	10000.0
GSK1059615	CAMKK2	2.0	10000.0
Ceritinib	ALK	0.0	1000.0
Torin2	BIKE	82.0	10000.0
GW843682X	PRKR	78.0	10000.0
MPS-1-IN-1	PTK6	100.0	1000.0
XMD8-85	CSK	100.0	10000.0
Barasertib	GRK4	100.0	10000.0
MLN8054	MP2K6	72.0	10000.0
WH-4-023	MYO3B	18.0	10000.0
JWE-035	WEE2	64.0	10000.0
NVP-TAE684	TNNI3K	15.0	1000.0
Dabrafenib	DCAMKL2	1.6	10000.0
CP724714	PAK1	81.0	10000.0
Taselisib	CDC2L1	100.0	1000.0
XMD13-2	NEK1	86.0	10000.0
XMD14-99	KPCD3	70.0	10000.0
WZ-4-145	HIPK1	100.0	10000.0
Momelotinib	CHK2	100.0	10000.0
HG-14-8-02	MLK2	88.0	10000.0
Ibrutinib	MRCKA	100.0	1000.0
CH5424802	CDK4-cyclinD1	95.0	1000.0
Crizotinib	EPHB2	24.0	10000.0
KIN001-220	CLK4	28.0	10000.0
CG-930	TSSK1	100.0	10000.0
Sigma A6730	KCC2D	100.0	10000.0
HG-14-8-02	FGFR3(G697C)	100.0	10000.0
JNK-IN-5A	PIM3	100.0	10000.0
ALW-II-38-3	EPHA1	100.0	10000.0
WH-4-023	M3K2	2.2	10000.0
WH-4-023	RIPK4	92.0	10000.0
ALW-II-49-7	BRSK2	100.0	10000.0
XMD-12	PTK6	86.0	1000.0
ALW-II-49-7	ABL2	21.0	10000.0
JNK-IN-5A	CDK7	82.0	10000.0
Torkinib	FLT3(D835Y)	7.0	10000.0
BS-181	EPHA3	90.0	10000.0
CP466722	CIT	30.0	10000.0
WZ-4-145	HCK	11.0	10000.0
Lapatinib	TEC	84.0	10000.0
OTSSP167	KIT(L576P)	77.0	10000.0
CP724714	NUAK1	100.0	10000.0
WH-4-023	PIP5K1A	0.5	10000.0
NG25	SRMS	4.6	10000.0
TAK-715	YANK3	35.0	10000.0
Dactolisib	KGP2	100.0	1000.0
CGP60474	HUNK	100.0	10000.0
SP600125	KCC4	100.0	10000.0
SP600125	YANK2	100.0	10000.0
AS-252424	MLK1	100.0	10000.0
CP466722	EPHA1	14.0	10000.0
Momelotinib	KIT(D816V)	16.0	10000.0
PD173074	NLK	100.0	10000.0
AZD-6482	PIK3CA(E542K)	0.2	10000.0
WZ-7043	MST3	13.0	10000.0
PHA-767491	JNK3	84.0	10000.0
Lapatinib	GSK3A	100.0	10000.0
XMD8-85	TRKC	100.0	10000.0
OTSSP167	TIE2	5.1	10000.0
Baricitinib	MLCK	73.0	10000.0
GSK429286A	MAP4K5	90.0	10000.0
NU7441	CDKL1	87.0	10000.0
AZD4547	VGFR1	0.1	10000.0
XMD11-50	PIP5K2B	100.0	10000.0
PLX-4720	PKMYT1	100.0	10000.0
HG-5-88-01	RPS6KA6(Kin.Dom.2)	9.0	10000.0
SP600125	EGFR(L747-S752del,P753S)	100.0	10000.0
JNK-IN-11	CHEK1	100.0	1000.0
Sorafenib	JAK1(JH2domain-pseudokinase)	100.0	10000.0
Momelotinib	BRSK2	100.0	10000.0
XMD8-85	SgK110	30.0	10000.0
Abemaciclib	CIT	0.4	1000.0
QL-X-138	KIT(D816V)	5.8	10000.0
PHA-767491	ALK(L1196M)	88.0	10000.0
Barasertib	RSK3(Kin.Dom.2-C-terminal)	77.0	10000.0
Barasertib	PCTK2	73.0	10000.0
PHA-767491	KIT(D816H)	35.0	10000.0
KIN001-127	MINK	100.0	10000.0
SP600125	PIK3CG	100.0	10000.0
AZD 5438	MAP3K4	100.0	10000.0
XMD8-85	MP2K6	100.0	10000.0
PHA-767491	TGFBR1	23.0	10000.0
THZ1	MST3	48.0	10000.0
AZD7762	ABL1(M351T)-phosphorylated	0.0	10000.0
Ibrutinib	MKNK2	53.0	1000.0
A443654	LATS2	0.0	10000.0
MRT67307	YANK1	100.0	10000.0
5z-7-oxozeaenol	CSNK2A1	55.0	10000.0
THZ1	FLT3(R834Q)	22.0	10000.0
XMD14-99	EPHA6	99.0	10000.0
KIN001-220	KIT(D816H)	25.0	10000.0
MRT67307	PRKR	63.0	10000.0
HG-14-10-04	RET(V804L)	0.0	10000.0
AG1478	RIOK2	43.0	10000.0
HG-6-64-01	ICK	99.0	10000.0
WZ-4-145	BRSK1	100.0	10000.0
SCH772984	CDK3	100.0	1000.0
Pictilisib	ACVR1B	100.0	1000.0
PHA-767491	CDK9	0.5	10000.0
AZ-628	MARK2	92.0	10000.0
KIN001-123	KKCC1	100.0	1000.0
AZD 5438	SRMS	86.0	10000.0
BMS-536924	FLT3(K663Q)	0.1	1000.0
XMD-12	LATS2	100.0	1000.0
ZSTK474	KPCL	100.0	1000.0
Seliciclib	PKN2	100.0	10000.0
BMS345541	RSK2(Kin.Dom.1-N-terminal)	100.0	10000.0
BGJ398	RSK1(Kin.Dom.1-N-terminal)	56.0	1000.0
BI-D1870	MINK	0.1	10000.0
NG25	IKKB	24.0	10000.0
JNK-IN-11	DRAK1	93.0	1000.0
5z-7-oxozeaenol	CDK15	90.0	10000.0
AZD 5438	CDK8	88.0	10000.0
HG-14-10-04	TGFBR2	14.0	10000.0
Lapatinib	AKT3	95.0	10000.0
HG-6-64-01	FLT3	1.0	10000.0
ERK5-IN-1	M3K12	100.0	1000.0
ALW-II-38-3	HIPK1	100.0	10000.0
AS-252424	TTK	100.0	10000.0
NG25	FAK1	23.0	10000.0
AZD-6482	MK03	95.0	10000.0
CGP60474	LYN	100.0	10000.0
XMD16-144	MK11	89.0	10000.0
WZ3105	CAMK1D	67.0	10000.0
PD0325901	PLK2	100.0	10000.0
KU63794	YANK1	67.0	10000.0
XMD11-50	ABL2	97.0	10000.0
WYE-125132	YANK3	90.0	10000.0
AZD 5438	CDK7	0.0	10000.0
AZD4547	ABL1(Y253F)-phosphorylated	0.9	10000.0
XMD14-99	SRPK3	77.0	10000.0
Taselisib	MAPKAPK2	95.0	1000.0
JNK-9L	TIE2	67.0	10000.0
BI-2536	CAMK2B	100.0	10000.0
Palbociclib	CDK9	97.0	1000.0
XMD11-85h	RPS6KA6(Kin.Dom.2)	100.0	10000.0
JWE-035	TXK	34.0	10000.0
WYE-125132	MLTK	77.0	10000.0
Dactolisib	ANKK1	100.0	1000.0
CH5424802	CLK2	3.1	1000.0
KIN001-021	ABL1(F317I)	100.0	1000.0
Vemurafenib	PTK6	0.8	10000.0
CH5424802	MST1	100.0	1000.0
ZM-447439	EGFR(L858R)	8.8	10000.0
Baricitinib	TIE1	69.0	10000.0
Ibrutinib	SNRK	60.0	1000.0
PD173074	BMX	100.0	10000.0
ZG-10	GSK3B	67.0	10000.0
XMD14-99	BLK	95.0	10000.0
QL-X-138	MAP3K4	100.0	10000.0
TGX221	NEK9	100.0	1000.0
Vemurafenib	CDKL2	49.0	10000.0
HG-9-91-01	PFPK5(P.falciparum)	100.0	10000.0
CH5424802	NEK7	97.0	1000.0
Crizotinib	VGFR1	25.0	10000.0
MPS-1-IN-1	MST3	100.0	1000.0
Vemurafenib	ACVR1B	78.0	10000.0
Abemaciclib	MARK3	100.0	1000.0
QL-X-138	RSK4(Kin.Dom.1-N-terminal)	74.0	10000.0
JWE-035	ABL1-phosphorylated	0.0	10000.0
Vemurafenib	LCK	1.6	10000.0
HG-14-8-02	MAP3K15	100.0	10000.0
HG-14-8-02	WNK1	100.0	10000.0
Torin1	RIOK1	81.0	10000.0
XMD11-85h	PIK3CA(C420R)	100.0	10000.0
JWE-035	IKKE	73.0	10000.0
XMD13-2	MK01	100.0	10000.0
CG-930	MK13	90.0	10000.0
ZG-10	TLK2	100.0	10000.0
JNK-IN-11	CSNK1D	3.1	1000.0
CH5424802	WNK1	100.0	1000.0
Dinaciclib	TSSK1	100.0	10000.0
BI-D1870	SLK	1.0	10000.0
CP724714	TEC	73.0	10000.0
PD173074	CHEK1	100.0	10000.0
Crizotinib	NEK4	25.0	10000.0
CG-930	PIK3C2G	93.0	10000.0
JNK-9L	IKKB	38.0	10000.0
Torin1	CAMK1G	74.0	10000.0
ERK5-IN-1	MP2K4	100.0	1000.0
CP466722	IRAK1	2.8	10000.0
TGX221	MST4	100.0	1000.0
RO-3306	ABL1(H396P)-nonphosphorylated	58.0	10000.0
AG1478	CSNK1D	54.0	10000.0
AZD-6482	ACVR2A	94.0	10000.0
BMS-536924	MAP4K2	11.0	1000.0
A443654	CDK15	16.0	10000.0
ALW-II-49-7	NEK6	100.0	10000.0
GSK461364	ERN1	34.0	10000.0
JNK-IN-8	SIK3	100.0	1000.0
GW-5074	PGFRA	22.0	10000.0
GW-5074	CDK3	90.0	10000.0
KIN001-111	PIM3	100.0	1000.0
ERK5-IN-1	ABL1(T315I)-phosphorylated	92.0	1000.0
PD0325901	STK36	74.0	10000.0
XMD13-2	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
Pictilisib	BRAF	92.0	1000.0
Sigma A6730	MET(Y1235D)	68.0	10000.0
QL-XII-47	ACVR1	99.0	1000.0
Omipalisib	PIK3C2B	0.0	10000.0
PHA-793887	FLT3(K663Q)	100.0	10000.0
BS-181	ALK	29.0	10000.0
NG25	KPCD2	100.0	10000.0
Alpelisib	TESK1	88.0	1000.0
Torin2	FGFR3	75.0	10000.0
KIN001-111	JNK1	100.0	1000.0
BMX-IN-1	SLK	100.0	10000.0
Pictilisib	SRPK1	100.0	1000.0
JNK-IN-8	CDK4-cyclinD1	92.0	1000.0
XMD-12	ULK3	77.0	1000.0
QL-XI-92	ADCK4	97.0	10000.0
Alpelisib	PCTK3	93.0	1000.0
BX-912	KPCD1	0.7	10000.0
WZ4002	KGP1	100.0	10000.0
Palbociclib	NEK11	100.0	1000.0
HG-6-64-01	DYRK1B	27.0	10000.0
GSK461364	ZAP70	69.0	10000.0
BMS-536924	CDK14	100.0	1000.0
NG25	MST3	31.0	10000.0
WZ-4-145	FGR	7.0	10000.0
CGP60474	CDK14	100.0	10000.0
XMD13-2	M4K1	68.0	10000.0
QL-X-138	TAOK2	76.0	10000.0
Palbociclib	IGF1R	100.0	1000.0
Baricitinib	EPHA6	100.0	10000.0
ZSTK474	CAMKK2	100.0	1000.0
KIN001-123	TSSK1	100.0	1000.0
Palbociclib	VGFR2	100.0	1000.0
JWE-035	IRAK4	100.0	10000.0
Omipalisib	FGFR3	69.0	10000.0
QL-XII-47	PIK3CA(E542K)	66.0	1000.0
JNK-IN-5A	KPCE	100.0	10000.0
Abemaciclib	RET	100.0	1000.0
WZ-7043	RAF1	100.0	10000.0
XMD13-2	SIK1	84.0	10000.0
JNK-IN-5A	MP2K7	100.0	10000.0
HG-5-88-01	PIK3CA	100.0	10000.0
Momelotinib	TYRO3	100.0	10000.0
AS-252424	KPCE	100.0	10000.0
CP466722	RET(M918T)	14.0	10000.0
THZ1	FGFR4	1.8	10000.0
GW843682X	MK03	100.0	10000.0
CP466722	HIPK3	0.0	10000.0
KIN001-021	CAMK1	100.0	1000.0
AZD 5438	RET(V804L)	68.0	10000.0
CGP60474	KIT(V559D,V654A)	100.0	10000.0
R406	FGFR4	0.3	1000.0
PLX-4720	PIM1	77.0	10000.0
CH5424802	KIT(V559D,V654A)	87.0	1000.0
XMD14-99	PKAC-alpha	91.0	10000.0
CG-930	MST2	73.0	10000.0
Torkinib	RIPK5	5.8	10000.0
GSK1059615	MAP3K15	100.0	10000.0
Vemurafenib	FGR	9.2	10000.0
BMS345541	AXL	100.0	10000.0
CH5424802	CLK4	7.8	1000.0
QL-XII-47	ALK(L1196M)	100.0	1000.0
JNK-IN-8	MYLK	93.0	1000.0
AZD-6482	EPHB6	41.0	10000.0
NU7441	PKAC-beta	92.0	10000.0
Ribociclib	CDC2L2	100.0	1000.0
Ribociclib	DRAK2	100.0	1000.0
GSK461364	PIK3CA(C420R)	55.0	10000.0
XMD11-85h	MLCK	100.0	10000.0
Palbociclib	ITK	100.0	1000.0
Neratinib	CSK	13.0	10000.0
CP466722	CHEK1	100.0	10000.0
HG-5-113-01	JNK1	7.3	10000.0
CGP74514A	PTK6	100.0	10000.0
NVP-TAE684	ACVR2A	12.0	1000.0
Dabrafenib	KPCE	94.0	10000.0
ERK5-IN-1	FAK2	43.0	1000.0
KIN001-220	TYK2(JH1domain-catalytic)	22.0	10000.0
AZD4547	YES	17.0	10000.0
XMD11-50	PIK3CG	15.0	10000.0
Pictilisib	CSF1R-autoinhibited	96.0	1000.0
A443654	CAMKK2	2.0	10000.0
THZ1	M4K3	10.0	10000.0
MRT67307	KIT(D816H)	12.0	10000.0
KU63794	PLK2	100.0	10000.0
XMD16-144	PRP4	100.0	10000.0
PHA-793887	CAMK1	100.0	10000.0
Sigma A6730	ULK3	80.0	10000.0
Ribociclib	PIK3CG	95.0	1000.0
Dactolisib	MAP3K3	100.0	1000.0
GSK429286A	AKT2	64.0	10000.0
SCH772984	SGK3	60.0	1000.0
GW843682X	NEK9	48.0	10000.0
KU63794	RPS6KA4(Kin.Dom.1-N-terminal)	96.0	10000.0
Dinaciclib	CDKL1	9.1	10000.0
PHA-793887	HIPK3	80.0	10000.0
AZD 5438	SBK1	47.0	10000.0
R406	MAP4K5	100.0	1000.0
Dactolisib	PDPK1	100.0	1000.0
KIN001-111	TYK2(Kin.Dom.1)	100.0	1000.0
JNK-IN-5A	KIT(V559D,T670I)	78.0	10000.0
Momelotinib	PIK3CA(M1043I)	100.0	10000.0
WZ4002	TAOK3	100.0	10000.0
AZD7762	ERK5	80.0	10000.0
BMS345541	PKN1	92.0	10000.0
Momelotinib	MKNK1	84.0	10000.0
Torkinib	CAMK2G	56.0	10000.0
CH5424802	CLK1	3.5	1000.0
Sigma A6730	RSK2(Kin.Dom.1-N-terminal)	67.0	10000.0
R406	MP2K3	5.4	1000.0
HG-5-88-01	CSNK1A1L	21.0	10000.0
ZSTK474	ACVR2B	100.0	1000.0
Alpelisib	MLK1	100.0	1000.0
Ceritinib	ACVR2B	95.0	1000.0
Crizotinib	RSK3(Kin.Dom.2-C-terminal)	28.0	10000.0
HG-5-88-01	PIK3C2B	100.0	10000.0
GSK461364	DYRK1A	100.0	10000.0
AG1478	TAOK3	78.0	10000.0
Taselisib	DAPK3	98.0	1000.0
XMD-12	SRMS	87.0	1000.0
AZ-628	CDK2	100.0	10000.0
WZ-7043	MP2K2	100.0	10000.0
Omipalisib	PIK3CA(M1043I)	5.6	10000.0
CP466722	MK14	50.0	10000.0
Buparlisib	ABL1(F317L)-nonphosphorylated	100.0	1000.0
CH5424802	GRK1	53.0	1000.0
PLX-4720	ERBB4	73.0	10000.0
PHA-767491	ABL1(Y253F)-phosphorylated	88.0	10000.0
MLN8054	RET(V804M)	89.0	10000.0
Torkinib	TLK2	79.0	10000.0
ZG-10	DRAK1	6.4	10000.0
QL-X-138	HIPK2	48.0	10000.0
NPK76-II-72-1	TYRO3	100.0	10000.0
Abemaciclib	KIT(D816H)	100.0	1000.0
ERK5-IN-1	SRMS	82.0	1000.0
AG1478	RSK3(Kin.Dom.1-N-terminal)	85.0	10000.0
SCH772984	LIMK1	100.0	1000.0
CH5424802	TAOK3	81.0	1000.0
RO-3306	CDK15	16.0	10000.0
GW843682X	NDR2	100.0	10000.0
Ceritinib	TAK1	69.0	1000.0
JNK-IN-11	TRPM6	100.0	1000.0
Neratinib	FLT3(R834Q)	100.0	10000.0
PHA-767491	BUB1	12.0	10000.0
Ribociclib	MYO3B	91.0	1000.0
Omipalisib	CDK15	80.0	10000.0
MLN8054	KGP1	100.0	10000.0
Dinaciclib	CDK14	0.0	10000.0
CP724714	EPHA1	88.0	10000.0
AZ-628	GSK3B	95.0	10000.0
GSK1059615	NEK3	77.0	10000.0
Sorafenib	LOK	0.0	10000.0
HG-14-10-04	KIT(D816V)	0.6	10000.0
ERK5-IN-1	PRP4	100.0	1000.0
WZ4003	FAK1	0.2	1000.0
AZD4547	PFCDPK1(P.falciparum)	4.0	10000.0
Dinaciclib	TAOK3	3.8	10000.0
AZD 5438	PIK3CA(E542K)	61.0	10000.0
CP724714	DAPK1	76.0	10000.0
WZ-7043	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
PD173074	AKT3	100.0	10000.0
HG-6-64-01	ULK1	8.5	10000.0
WZ-4-145	YSK1	100.0	10000.0
BS-181	TYK2(JH1domain-catalytic)	94.0	10000.0
Momelotinib	PGFRB	2.2	10000.0
CH5424802	GSK3A	100.0	1000.0
Baricitinib	PRKR	19.0	10000.0
HG-5-113-01	BLK	0.6	10000.0
Sorafenib	TGFBR2	35.0	10000.0
XMD8-85	CHEK1	100.0	10000.0
JWE-035	ULK1	0.0	10000.0
WH-4-023	MST2	23.0	10000.0
A443654	MK13	4.4	10000.0
BGJ398	TGFBR1	98.0	1000.0
NPK76-II-72-1	RIPK4	100.0	10000.0
TAK-715	MAP4K4	1.0	10000.0
ALW-II-49-7	JNK1	100.0	10000.0
Abemaciclib	DMPK	8.9	1000.0
ALW-II-38-3	ERK4	100.0	10000.0
WZ-4-145	RIOK1	100.0	10000.0
Buparlisib	KPCD3	100.0	1000.0
Seliciclib	HCK	100.0	10000.0
THZ1	CDKL2	0.1	10000.0
Canertinib	EPHB2	100.0	1000.0
AZ-628	TLK2	100.0	10000.0
XMD16-144	ABL1(Q252H)-phosphorylated	0.1	10000.0
ZSTK474	CDK8	100.0	1000.0
Sorafenib	FLT3(R834Q)	50.0	10000.0
XMD11-50	M3K5	100.0	10000.0
Sigma A6730	ACVR1B	100.0	10000.0
NVP-TAE684	NEK2	2.5	1000.0
Torin2	PIK3CA(I800L)	0.0	10000.0
Taselisib	ABL1(M351T)-phosphorylated	100.0	1000.0
Taselisib	FYN	81.0	1000.0
QL-X-138	CDKL1	33.0	10000.0
MLN8054	NEK6	100.0	10000.0
WZ3105	MK09	100.0	10000.0
Seliciclib	SIK3	100.0	10000.0
CH5424802	CDK4-cyclinD3	94.0	1000.0
CG-930	DYRK1B	100.0	10000.0
JNK-IN-11	CLK4	100.0	1000.0
JNK-9L	RET	100.0	10000.0
Sorafenib	DCAMKL2	100.0	10000.0
Sigma A6730	KPCD2	95.0	10000.0
QL-XII-47	GRK1	95.0	1000.0
XMD8-92	WEE2	100.0	10000.0
Torin2	MYO3B	87.0	10000.0
KIN001-111	PAK1	28.0	1000.0
CP724714	MYLK2	100.0	10000.0
CP466722	IKKE	9.6	10000.0
Palbociclib	FYN	94.0	1000.0
WZ4002	CDK16	100.0	10000.0
JNK-IN-8	MST2	48.0	1000.0
BGJ398	CDKL3	100.0	1000.0
Seliciclib	NEK3	99.0	10000.0
Dabrafenib	PAK7	5.8	10000.0
Baricitinib	HIPK1	7.2	10000.0
SB590885	SIK2	91.0	10000.0
JWE-035	IKKA	100.0	10000.0
Abemaciclib	ANKK1	100.0	1000.0
TGX221	KIT	100.0	1000.0
WZ4003	ROCK2	23.0	1000.0
Omipalisib	KIT(D816V)	66.0	10000.0
CG-930	CDC2L2	98.0	10000.0
PD173074	FLT4	6.0	10000.0
BX-912	CSNK1A1	28.0	10000.0
NVP-TAE684	KPCD1	1.0	1000.0
AG1478	MKNK2	3.9	10000.0
XMD8-92	ERK8	100.0	10000.0
A443654	PIK3CA(E545K)	100.0	10000.0
QL-XII-47	CSNK1D	90.0	1000.0
JNK-IN-11	LIMK2	100.0	1000.0
Alpelisib	TRKB	100.0	1000.0
QL-XII-47	HIPK1	89.0	1000.0
JNK-9L	FAK1	77.0	10000.0
Dinaciclib	PIM1	100.0	10000.0
WYE-125132	PIP5K1A	84.0	10000.0
KIN001-127	EPHB2	100.0	10000.0
SCH772984	CAMK1D	97.0	1000.0
ALW-II-49-7	M4K1	100.0	10000.0
Neratinib	MARK4	87.0	10000.0
HG-14-8-02	MAST1	83.0	10000.0
Buparlisib	MLK3	100.0	1000.0
GSK1059615	PIM2	1.0	10000.0
XMD8-85	YANK2	100.0	10000.0
TAK-715	TESK1	81.0	10000.0
BMS345541	AMPK-alpha1	82.0	10000.0
GSK461364	MST4	95.0	10000.0
CH5424802	ERBB3	89.0	1000.0
BMX-IN-1	MST3	93.0	10000.0
R406	CDK16	100.0	1000.0
XMD14-99	CDK14	91.0	10000.0
ALW-II-49-7	LATS2	100.0	10000.0
XMD16-144	PRKR	75.0	10000.0
QL-XII-47	KCC2D	94.0	1000.0
Dabrafenib	MYO3B	63.0	10000.0
Dabrafenib	MAP3K4	34.0	10000.0
BMS345541	FLT3(D835Y)	97.0	10000.0
BX-912	MAPKAPK5	28.0	10000.0
WYE-125132	MK14	100.0	10000.0
BMX-IN-1	MYLK	100.0	10000.0
BMS345541	PIK3CA(H1047L)	100.0	10000.0
Buparlisib	EGFR(L858R)	100.0	1000.0
THZ1	TAOK2	14.0	10000.0
ZM-447439	MAP3K1	92.0	10000.0
R406	RIOK1	0.9	1000.0
AS-252424	RSK4(Kin.Dom.2-C-terminal)	17.5	10000.0
Buparlisib	WNK2	100.0	1000.0
Taselisib	PKAC-beta	94.0	1000.0
PLX-4720	SRPK1	100.0	10000.0
MPS-1-IN-1	LTK	1.2	1000.0
BMS-536924	EPHA2	23.0	1000.0
QL-XII-47	MELK	100.0	1000.0
BI-D1870	FLT3(K663Q)	3.8	10000.0
GSK429286A	PKN1	19.0	10000.0
AZD 5438	MAST1	69.0	10000.0
WZ4003	FER	14.0	1000.0
WH-4-023	PIK3CA(H1047L)	100.0	10000.0
GSK1059615	ABL1(T315I)-nonphosphorylated	81.0	10000.0
TAK-715	KPCT	100.0	10000.0
KIN001-021	MAP4K4	100.0	1000.0
(s)-CR8	CDK7	92.0	10000.0
AS-252424	RSK3(Kin.Dom.2-C-terminal)	79.6	10000.0
HG-14-10-04	MKNK2	0.0	10000.0
XMD8-85	GSK3B	100.0	10000.0
QL-XI-92	AKT1	58.0	10000.0
AZD 5438	MP2K4	0.1	10000.0
HG-9-91-01	FGFR3	0.7	10000.0
KU63794	BLK	100.0	10000.0
KIN001-123	TNIK	100.0	1000.0
JNK-IN-5A	CDKL2	97.0	10000.0
QL-XII-47	AKT2	88.0	1000.0
XMD14-99	AURKB	93.0	10000.0
KU63794	KIT(V559D,T670I)	80.0	10000.0
Abemaciclib	ICK	1.9	1000.0
Momelotinib	SGK1	2.8	10000.0
XMD14-99	KIT(V559D,T670I)	100.0	10000.0
BMX-IN-1	EGFR(G719C)	90.0	10000.0
WZ4002	CDC2L2	100.0	10000.0
Buparlisib	PLK3	100.0	1000.0
NG25	FGFR2	1.4	10000.0
RO-3306	RIOK3	20.0	10000.0
AZD4547	PKN2	55.0	10000.0
BMX-IN-1	AKT3	100.0	10000.0
Barasertib	PKN1	90.0	10000.0
ERK5-IN-1	CDK7	57.0	1000.0
Ribociclib	PIK4CB	77.0	1000.0
CP466722	YES	77.0	10000.0
AZD4547	JAK1(JH2domain-pseudokinase)	100.0	10000.0
HG-14-10-04	RPS6KA5(Kin.Dom.2-C-terminal)	49.0	10000.0
AG1478	TRPM6	77.0	10000.0
OTSSP167	MKNK1	38.0	10000.0
BX-912	ABL1(Y253F)-phosphorylated	0.1	10000.0
CH5424802	FGFR1	95.0	1000.0
(s)-CR8	ERBB4	100.0	10000.0
5z-7-oxozeaenol	M4K1	76.0	10000.0
WZ-4-145	MP2K2	100.0	10000.0
XMD16-144	CDK14	100.0	10000.0
KIN001-021	FGFR4	100.0	1000.0
PD173074	MERTK	100.0	10000.0
5z-7-oxozeaenol	KPCD	100.0	10000.0
MPS-1-IN-1	PLK3	100.0	1000.0
QL-XII-47	IGF1R	100.0	1000.0
Lapatinib	MK09	100.0	10000.0
WZ4003	YANK2	100.0	1000.0
WYE-125132	PLK1	77.0	10000.0
CGP60474	FAK2	100.0	10000.0
Dabrafenib	CLK3	15.0	10000.0
CGP60474	CAMK2B	100.0	10000.0
CGP74514A	KPCE	16.0	10000.0
BMS345541	PCTK3	100.0	10000.0
JW-7-24-1	CDC2L2	100.0	10000.0
CG-930	SGK3	100.0	10000.0
KIN001-220	AURKC	1.2	10000.0
Lapatinib	PIK3CA(H1047Y)	100.0	10000.0
JNK-9L	VRK2	100.0	10000.0
WZ4003	EPHA2	100.0	1000.0
BS-181	MST2	70.0	10000.0
NG25	PIP5K2B	100.0	10000.0
Sigma A6730	DAPK3	85.0	10000.0
TAK-715	TIE2	94.0	10000.0
AG1478	CSNK1G3	100.0	10000.0
AZ-628	TNK1	100.0	10000.0
KIN001-021	KCC4	100.0	1000.0
BGJ398	JAK3(JH1domain-catalytic)	40.0	1000.0
WZ3105	TNIK	35.0	10000.0
SB590885	CDKL1	100.0	10000.0
ERK5-IN-1	SIK3	100.0	1000.0
WZ-4-145	EPHA7	100.0	10000.0
JNK-IN-5A	FAK1	91.0	10000.0
MRT67307	DRAK2	3.2	10000.0
WZ3105	ACVR2B	91.0	10000.0
R406	RIPK2	7.8	1000.0
XMD13-2	MET(M1250T)	73.0	10000.0
CP724714	TAK1	100.0	10000.0
GSK429286A	AXL	84.0	10000.0
QL-XI-92	MP2K2	93.0	10000.0
GW843682X	MET(Y1235D)	40.0	10000.0
GW-5074	KCC4	100.0	10000.0
TGX221	MP2K6	100.0	1000.0
Neratinib	TYK2(JH2domain-pseudokinase)	99.0	10000.0
JNK-9L	CLK3	59.0	10000.0
HG-6-64-01	RSK4(Kin.Dom.1-N-terminal)	42.0	10000.0
SCH772984	AAK1	12.0	1000.0
BMX-IN-1	CLK4	85.0	10000.0
Dabrafenib	INSR	78.0	10000.0
Ribociclib	IRAK1	94.0	1000.0
AZD7762	PCTK3	100.0	10000.0
JW-7-24-1	PKN1	100.0	10000.0
WZ4002	BMPR1A	100.0	10000.0
KIN001-220	SRPK3	7.8	10000.0
BX-912	PLK2	11.0	10000.0
XMD8-85	TXK	100.0	10000.0
PLX-4720	MLK3	88.0	10000.0
5z-7-oxozeaenol	PLK1	100.0	10000.0
Baricitinib	MK01	100.0	10000.0
Omipalisib	KPCI	63.0	10000.0
BMX-IN-1	LATS1	100.0	10000.0
KIN001-220	OSR1	100.0	10000.0
JW-7-24-1	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
ZM-447439	TYRO3	60.0	10000.0
5z-7-oxozeaenol	EPHB2	87.0	10000.0
XMD8-92	FGFR3	100.0	10000.0
GSK461364	FGFR3	80.0	10000.0
BX-912	EGFR(L858R)	65.0	10000.0
QL-XI-92	TRKA	87.0	10000.0
NU7441	MERTK	100.0	10000.0
JNK-IN-8	KPCD1	100.0	1000.0
THZ1	MAP4K2	4.0	10000.0
GSK1059615	MYLK2	46.0	10000.0
AZ-628	PIK3CD	99.0	10000.0
Dactolisib	NEK7	100.0	1000.0
HG-9-91-01	KPCD2	0.6	10000.0
THZ1	PGFRB	0.0	10000.0
Taselisib	MUSK	100.0	1000.0
A443654	MRCKA	6.6	10000.0
XMD8-85	EPHA8	100.0	10000.0
PHA-793887	WNK3	100.0	10000.0
Barasertib	STK33	51.0	10000.0
XMD11-85h	CDK8	100.0	10000.0
QL-XII-47	EPHA7	92.0	1000.0
JNK-IN-8	MET	100.0	1000.0
SB590885	AKT3	97.0	10000.0
Alpelisib	STK35	98.0	1000.0
XMD16-144	SgK110	0.3	10000.0
ZG-10	TYK2(JH1domain-catalytic)	15.0	10000.0
Momelotinib	DDR1	100.0	10000.0
JNK-IN-11	CDK5	100.0	1000.0
HG-14-10-04	JNK3	0.0	10000.0
(s)-CR8	EPHB6	49.0	10000.0
XMD16-144	NLK	36.0	10000.0
Sorafenib	PRP4	100.0	10000.0
5z-7-oxozeaenol	SNARK	100.0	10000.0
KIN001-021	CDK16	100.0	1000.0
A443654	ADCK4	100.0	10000.0
Momelotinib	AMPK-alpha2	74.0	10000.0
GW-5074	EGFR(L861Q)	55.0	10000.0
Alpelisib	NEK3	90.0	1000.0
HG-14-8-02	NEK11	96.0	10000.0
HG-5-88-01	LCK	14.0	10000.0
KIN001-220	PLK1	94.0	10000.0
Alpelisib	EPHA8	100.0	1000.0
PD0325901	KCC2D	100.0	10000.0
Momelotinib	EGFR(T790M)	38.0	10000.0
AZD-6482	RSK1(Kin.Dom.1-N-terminal)	73.0	10000.0
XMD11-85h	CAMKK2	100.0	10000.0
WZ-7043	BMPR2	100.0	10000.0
GSK429286A	IKKA	100.0	10000.0
AZD4547	PKAC-alpha	100.0	10000.0
NG25	EPHA1	100.0	10000.0
Momelotinib	ABL1-phosphorylated	54.0	10000.0
JNK-IN-5A	CDC2L5	87.0	10000.0
Palbociclib	DDR2	70.0	1000.0
ZSTK474	EPHB4	100.0	1000.0
WZ4003	ACVRL1	100.0	1000.0
WZ4003	MRCKB	100.0	1000.0
AZ-628	YANK2	100.0	10000.0
CGP74514A	PIK3CA(M1043I)	58.0	10000.0
TAK-715	AKT2	80.0	10000.0
GSK461364	NEK3	100.0	10000.0
AG1478	ACVR1	74.0	10000.0
BI-2536	CDK5	100.0	10000.0
PHA-793887	PAK7	2.8	10000.0
GSK429286A	CSNK1D	92.0	10000.0
Dabrafenib	EPHB1	74.0	10000.0
XMD13-2	NEK6	90.0	10000.0
NU7441	ABL1-nonphosphorylated	100.0	10000.0
A443654	FGR	100.0	10000.0
MLN8054	DAPK3	70.0	10000.0
QL-X-138	DCAMKL3	100.0	10000.0
PHA-767491	ABL1(M351T)-phosphorylated	92.0	10000.0
GSK429286A	ALK	77.0	10000.0
QL-XI-92	ABL1-nonphosphorylated	5.2	10000.0
TGX221	LATS2	100.0	1000.0
CG-930	RSK1(Kin.Dom.2-C-terminal)	70.0	10000.0
BMS345541	ERK4	89.0	10000.0
Alpelisib	YANK3	88.0	1000.0
GW843682X	RSK4(Kin.Dom.2-C-terminal)	62.0	10000.0
Ceritinib	CLK4	13.0	1000.0
XMD8-85	PHKG2	29.0	10000.0
Torkinib	CDC2L1	100.0	10000.0
Torin1	CHK2	100.0	10000.0
PD173074	PRKX	100.0	10000.0
Dactolisib	AKT2	100.0	1000.0
HG-9-91-01	ACVR2B	3.4	10000.0
Abemaciclib	MET(Y1235D)	13.0	1000.0
AZD 5438	JAK1(JH1domain-catalytic)	33.0	10000.0
Ceritinib	CAMK2G	72.0	1000.0
HG-6-64-01	M3K6	64.0	10000.0
JNK-IN-8	MP2K4	70.0	1000.0
PLX-4720	DAPK1	89.0	10000.0
XMD8-92	EPHB2	100.0	10000.0
HG-5-88-01	NUAK1	100.0	10000.0
PHA-767491	FGFR1	86.0	10000.0
HG-6-64-01	EGFR(L747-E749del,A750P)	1.1	10000.0
JNK-9L	TYK2(JH2domain-pseudokinase)	12.0	10000.0
Torin2	PKNB(M.tuberculosis)	63.0	10000.0
Crizotinib	PIP5K1C	63.0	10000.0
Seliciclib	EGFR(L747-S752del,P753S)	94.0	10000.0
SP600125	SgK110	100.0	10000.0
KU63794	TAK1	99.0	10000.0
WYE-125132	PAK1	100.0	10000.0
Torin2	TTK	42.0	10000.0
KIN001-220	PAK1	53.0	10000.0
GSK429286A	NEK2	100.0	10000.0
Torkinib	EPHB3	81.0	10000.0
WZ4003	ABL1(E255K)	100.0	1000.0
XMD8-92	MK14	100.0	10000.0
WZ4003	MK01	100.0	1000.0
Palbociclib	MAPKAPK2	100.0	1000.0
GSK461364	TIE2	78.0	10000.0
Ibrutinib	ROS1	100.0	1000.0
XMD14-99	RPS6KA5(Kin.Dom.2-C-terminal)	96.0	10000.0
HG-14-8-02	PIK3CD	41.0	10000.0
CGP60474	IGF1R	100.0	10000.0
Ribociclib	CDKL3	100.0	1000.0
Ibrutinib	TEC	5.7	1000.0
RO-3306	PLK4	50.0	10000.0
AZD7762	TLK1	0.9	10000.0
Neratinib	RPS6KA4(Kin.Dom.2-C-terminal)	94.0	10000.0
CP466722	SRPK1	83.0	10000.0
BI-D1870	MST4	5.0	10000.0
XMD8-92	ZAP70	100.0	10000.0
CGP60474	CLK4	14.0	10000.0
Dinaciclib	KKCC1	53.0	10000.0
PHA-793887	KGP1	89.0	10000.0
QL-XI-92	DAPK2	97.0	10000.0
CH5424802	MAP4K2	42.0	1000.0
TGX221	PKAC-alpha	100.0	1000.0
BGJ398	RIPK4	95.0	1000.0
Dactolisib	STK35	100.0	1000.0
Abemaciclib	FLT4	97.0	1000.0
TGX221	BTK	100.0	1000.0
TAK-715	PIM3	86.0	10000.0
Canertinib	CSNK1G3	100.0	1000.0
OTSSP167	KIT(D816H)	77.0	10000.0
KU63794	PHKG2	77.0	10000.0
JWE-035	PIM3	84.0	10000.0
NVP-TAE684	FGFR3	2.6	1000.0
XMD14-99	DAPK1	85.0	10000.0
Vemurafenib	MLK3	81.0	10000.0
5z-7-oxozeaenol	CDK16	100.0	10000.0
Ibrutinib	NEK6	91.0	1000.0
JNK-IN-11	TRKA	30.0	1000.0
CGP74514A	SRPK3	94.0	10000.0
5z-7-oxozeaenol	ABL1(F317I)-nonphosphorylated	93.0	10000.0
WZ4002	EGFR(G719C)	0.4	10000.0
QL-XII-47	TLK2	100.0	1000.0
Barasertib	MARK1	98.0	10000.0
CP724714	ABL1(H396P)-phosphorylated	99.0	10000.0
XMD14-99	PGFRB	100.0	10000.0
Barasertib	MYO3A	81.0	10000.0
CH5424802	ITK	48.0	1000.0
KIN001-111	LIMK2	0.0	1000.0
Crizotinib	MK12	79.0	10000.0
JW-7-24-1	AMPK-alpha2	100.0	10000.0
JWE-035	AKT3	100.0	10000.0
CG-930	LOK	97.0	10000.0
Palbociclib	ULK2	1.4	1000.0
BMX-IN-1	KC1G2	62.0	10000.0
KU63794	MERTK	100.0	10000.0
ZSTK474	RPS6KA5(Kin.Dom.1)	100.0	1000.0
SP600125	BLK	100.0	10000.0
Dinaciclib	CSNK1A1	43.0	10000.0
BI-D1870	MET(M1250T)	32.0	10000.0
WH-4-023	HIPK3	91.0	10000.0
Dinaciclib	KIT(V559D,V654A)	92.0	10000.0
5z-7-oxozeaenol	FLT3(N841I)	0.9	10000.0
BMS345541	PAK7	100.0	10000.0
Abemaciclib	MAST1	20.0	1000.0
CH5424802	YANK2	98.0	1000.0
WH-4-023	ACVRL1	2.7	10000.0
PLX-4720	PCTK3	73.0	10000.0
CGP60474	ABL1(E255K)	100.0	10000.0
Seliciclib	NEK5	100.0	10000.0
CP724714	FGFR3	100.0	10000.0
PLX-4720	NEK2	49.0	10000.0
GW-5074	KIT	3.4	10000.0
Vemurafenib	NEK5	100.0	10000.0
BMS-536924	TYK2(Kin.Dom.2)	0.9	1000.0
Sorafenib	EPHA3	5.6	10000.0
KU63794	WEE2	100.0	10000.0
Ribociclib	RET(V804M)	94.0	1000.0
Omipalisib	PIM2	59.0	10000.0
XMD-12	ROCK1	89.0	1000.0
CP466722	KPCE	65.0	10000.0
GSK1059615	MAPKAPK2	74.0	10000.0
JNK-IN-11	EIF2AK1	76.0	1000.0
AZD4547	CSNK1D	100.0	10000.0
WZ-7043	DDR1	0.2	10000.0
AZD 5438	CHK2	32.0	10000.0
KU63794	S6K1	100.0	10000.0
Dinaciclib	NEK9	93.0	10000.0
Abemaciclib	PIP5K2B	27.0	1000.0
Taselisib	PIK3CA(Q546K)	0.0	1000.0
JNK-IN-5A	FGFR3(G697C)	83.0	10000.0
HG-6-64-01	ERK5	73.0	10000.0
XMD14-99	CSNK1A1L	100.0	10000.0
XMD14-99	TAK1	78.0	10000.0
AZD-6482	ICK	100.0	10000.0
Ibrutinib	NEK1	100.0	1000.0
WZ4002	MYLK4	24.0	10000.0
CP724714	GRK4	100.0	10000.0
HG-6-64-01	MET(M1250T)	26.0	10000.0
Seliciclib	EPHB2	91.0	10000.0
JNK-IN-8	TESK1	100.0	1000.0
KU63794	EGFR(T790M)	100.0	10000.0
Seliciclib	NDR2	99.0	10000.0
CGP74514A	CAMK1D	40.0	10000.0
WZ-7043	PGFRA	100.0	10000.0
HG-14-10-04	TLK1	70.0	10000.0
QL-XII-47	BRSK2	100.0	1000.0
(s)-CR8	CDK15	85.0	10000.0
Dactolisib	PAK3	100.0	1000.0
XMD8-85	RIPK2	100.0	10000.0
KIN001-220	CDK2	80.0	10000.0
PD0325901	ROCK1	100.0	10000.0
ALW-II-49-7	CSF1R	1.4	1000.0
BMX-IN-1	ABL2	100.0	10000.0
HG-14-10-04	M3K12	11.0	10000.0
BX-912	FLT3(D835H)	0.2	10000.0
SB590885	EGFR(G719C)	59.0	10000.0
NVP-TAE684	KPCD2	0.1	1000.0
HG-6-64-01	PKMYT1	71.0	10000.0
PHA-767491	JNK1	69.0	10000.0
PD0325901	ABL1(T315I)-phosphorylated	86.0	10000.0
BMS345541	NEK4	100.0	10000.0
THZ1	PIK3CD	100.0	10000.0
AS-252424	MP2K2	73.5	10000.0
Canertinib	CDC2L1	100.0	1000.0
Alpelisib	PIK3CA(E545A)	0.1	1000.0
JNK-9L	MRCKB	61.0	10000.0
QL-XII-47	PIK3C2B	100.0	1000.0
PD0325901	MUSK	68.0	10000.0
KU63794	GRK1	98.0	10000.0
SCH772984	MAP3K1	92.0	1000.0
Barasertib	ABL1(F317L)-nonphosphorylated	5.4	10000.0
XMD14-99	MK01	100.0	10000.0
CP724714	M3K13	80.0	10000.0
NU7441	EGFR	94.0	10000.0
HG-9-91-01	ULK2	0.1	10000.0
HG-14-8-02	GCN2(Kin.Dom.2,S808G)	86.0	10000.0
(s)-CR8	LKB1	73.0	10000.0
KU63794	TYRO3	100.0	10000.0
XMD-12	RSK2(Kin.Dom.1-N-terminal)	85.0	1000.0
Palbociclib	ERK5	63.0	1000.0
NU7441	EPHA4	82.0	10000.0
ZSTK474	FGR	100.0	1000.0
GW-5074	DYRK1B	41.0	10000.0
AZD4547	OSR1	56.0	10000.0
NVP-TAE684	KIT(V559D,T670I)	1.0	1000.0
QL-XI-92	KPCD2	100.0	10000.0
AZD-6482	TGFBR1	100.0	10000.0
BX-912	MST2	0.5	10000.0
BX-912	ACVR1	76.0	10000.0
QL-XI-92	ABL1(E255K)-phosphorylated	86.0	10000.0
R406	EGFR(E746-A750del)	8.2	1000.0
Palbociclib	CSNK2A1	27.0	1000.0
CGP60474	PAK2	100.0	10000.0
AZD4547	RSK1(Kin.Dom.1-N-terminal)	46.0	10000.0
A443654	PIK3C2B	100.0	10000.0
A443654	PAK7	16.0	10000.0
Crizotinib	EPHA2	1.5	10000.0
Crizotinib	PIK3CA(E545K)	100.0	10000.0
JNK-IN-5A	YSK1	93.0	10000.0
WH-4-023	NEK7	80.0	10000.0
AZD4547	PIK3CA(M1043I)	73.0	10000.0
ALW-II-38-3	PAK4	100.0	10000.0
NPK76-II-72-1	MST1R	100.0	10000.0
NVP-TAE684	PIP5K1A	1.3	1000.0
Ceritinib	NDR2	78.0	1000.0
AG1478	TBK1	45.0	10000.0
BMS-536924	PKMYT1	100.0	1000.0
XMD14-99	NEK5	96.0	10000.0
Vemurafenib	KPCD3	44.0	10000.0
XMD8-92	EPHA1	100.0	10000.0
A443654	DYRK1B	0.0	10000.0
PLX-4720	FLT3(K663Q)	17.0	10000.0
Neratinib	NDR1	81.0	10000.0
QL-X-138	TRKC	93.0	10000.0
5z-7-oxozeaenol	DMPK2	91.0	10000.0
OTSSP167	PIP5K1A	81.0	10000.0
ZM-447439	PIK3CA(E542K)	100.0	10000.0
BS-181	EGFR(G719S)	93.0	10000.0
ZM-447439	TYK2(JH1domain-catalytic)	84.0	10000.0
Omipalisib	AMPK-alpha1	80.0	10000.0
Barasertib	EGFR(L858R)	16.0	10000.0
BMS345541	BMPR1A	100.0	10000.0
QL-X-138	YSK4	1.2	10000.0
XMD11-50	DAPK1	73.0	10000.0
Torin2	KGP1	83.0	10000.0
WZ-7043	MST1	100.0	10000.0
TGX221	FGFR3	100.0	1000.0
AS-252424	MYO3B	100.0	10000.0
XMD16-144	CDK2	94.0	10000.0
JNK-IN-8	EGFR(L861Q)	100.0	1000.0
CG-930	LTK	100.0	10000.0
Baricitinib	EGFR(L858R,T790M)	46.0	10000.0
BMX-IN-1	ERBB3	100.0	10000.0
THZ1	ERBB4	38.0	10000.0
Alpelisib	RSK2(Kin.Dom.2-C-terminal)	100.0	1000.0
HG-9-91-01	EPHA1	0.0	10000.0
AZD4547	PIK3CA(H1047L)	80.0	10000.0
SP600125	CDK14	100.0	10000.0
AZ-628	PCTK2	100.0	10000.0
Crizotinib	ACVRL1	45.0	10000.0
KIN001-111	JAK1(Kin.Dom.2)	100.0	1000.0
PHA-793887	FLT3(ITD)	91.0	10000.0
MRT67307	ULK3	0.2	10000.0
CH5424802	CSNK1D	49.0	1000.0
Torin2	MK09	89.0	10000.0
JNK-IN-11	CDK4-cyclinD1	79.0	1000.0
BGJ398	MK11	88.0	1000.0
GSK461364	BRAF(V600E)	58.0	10000.0
Ceritinib	TSSK1	7.2	1000.0
JWE-035	MP2K5	35.0	10000.0
MRT67307	ACVR2B	73.0	10000.0
CP724714	PKN1	100.0	10000.0
HG-14-10-04	PGFRA	1.2	10000.0
Alpelisib	ABL1(Y253F)-phosphorylated	100.0	1000.0
WZ4002	CDK11	100.0	10000.0
Canertinib	EGFR(L747-S752del,P753S)	0.1	1000.0
Sigma A6730	KIT(A829P)	100.0	10000.0
NU7441	ROS1	90.0	10000.0
CP466722	BTK	51.0	10000.0
XMD14-99	CAMK2A	20.0	10000.0
Baricitinib	FYN	20.0	10000.0
Torin1	KC1G1	100.0	10000.0
BGJ398	KCC2D	83.0	1000.0
CGP60474	AMPK-alpha1	100.0	10000.0
SCH772984	FGFR4	85.0	1000.0
R406	MLCK	24.0	1000.0
HG-14-8-02	KIT(D816H)	30.0	10000.0
PHA-793887	CLK1	4.2	10000.0
CGP60474	ACVR1	100.0	10000.0
BI-2536	CDK11	100.0	10000.0
JNK-IN-8	HIPK4	4.0	1000.0
XMD11-50	MAP4K2	100.0	10000.0
Torin1	MRCKB	3.4	10000.0
GSK1059615	MAP4K2	5.8	10000.0
5z-7-oxozeaenol	ROCK1	99.0	10000.0
SB590885	PIK3CA(I800L)	81.0	10000.0
A443654	CDK2	100.0	10000.0
HG-14-10-04	SIK2	14.0	10000.0
AZ-628	ERK3	100.0	10000.0
Crizotinib	RIPK4	8.2	10000.0
Buparlisib	ERBB3	100.0	1000.0
OTSSP167	ICK	0.5	10000.0
Palbociclib	ACVRL1	100.0	1000.0
KU63794	DMPK	86.0	10000.0
Momelotinib	MST2	52.0	10000.0
Dinaciclib	MERTK	77.0	10000.0
NPK76-II-72-1	PKN1	100.0	10000.0
MLN8054	CLK2	7.4	10000.0
SB590885	LIMK1	100.0	10000.0
GSK1059615	SBK1	73.0	10000.0
KIN001-127	MARK1	100.0	10000.0
XMD16-144	GCN2(Kin.Dom.2,S808G)	62.0	10000.0
Momelotinib	CDKL2	69.0	10000.0
JNK-9L	SRPK3	23.0	10000.0
TGX221	MST1R	100.0	1000.0
Sorafenib	CDK14	8.6	10000.0
BMS-536924	JNK1	33.0	1000.0
MLN8054	CAMK1D	98.0	10000.0
MRT67307	M3K12	46.0	10000.0
CH5424802	MKNK2	54.0	1000.0
Sigma A6730	LCK	72.0	10000.0
WZ4003	GSK3A	100.0	1000.0
Taselisib	BRAF	91.0	1000.0
Omipalisib	PIP5K1A	100.0	10000.0
HG-14-10-04	CSF1R-autoinhibited	4.5	10000.0
HG-14-8-02	ADCK3	97.0	10000.0
ALW-II-38-3	EPHB2	4.0	1000.0
CP466722	CLK4	2.2	10000.0
Dactolisib	IRAK3	100.0	1000.0
Seliciclib	ROCK1	100.0	10000.0
NG25	TYRO3	100.0	10000.0
XMD16-144	PIK3CA(H1047Y)	51.0	10000.0
NG25	TIE1	1.0	10000.0
ERK5-IN-1	HUNK	53.0	1000.0
ERK5-IN-1	PIK3CD	91.0	1000.0
XMD8-92	YSK4	100.0	10000.0
Neratinib	ERBB2	0.0	10000.0
GW-5074	ABL1(T315I)-phosphorylated	100.0	10000.0
XMD14-99	FLT3(D835H)	99.0	10000.0
KIN001-111	GSK3A	100.0	1000.0
SCH772984	PIK3CA(C420R)	94.0	1000.0
Dabrafenib	TRKA	47.0	10000.0
XMD13-2	BMPR2	91.0	10000.0
Pictilisib	CDK15	100.0	1000.0
Ibrutinib	SGK3	100.0	1000.0
TAK-715	CLK1	92.0	10000.0
CG-930	ABL1(F317L)-phosphorylated	30.0	10000.0
PHA-793887	ACVR2B	100.0	10000.0
BI-2536	MKNK1	100.0	10000.0
PHA-793887	MAP4K2	82.0	10000.0
KIN001-021	PIK3CB	100.0	1000.0
ZM-447439	SRMS	2.4	10000.0
Sigma A6730	JNK3	71.0	10000.0
WZ-7043	ABL1	100.0	10000.0
Abemaciclib	CDK5	92.0	1000.0
5z-7-oxozeaenol	TGFBR2	0.9	10000.0
Seliciclib	MK09	39.0	10000.0
WZ4002	MAPKAPK2	100.0	10000.0
Sigma A6730	ABL1-phosphorylated	90.0	10000.0
Pictilisib	TXK	100.0	1000.0
Dabrafenib	MLCK	99.0	10000.0
NVP-TAE684	CDK2	24.0	1000.0
CG-930	CAMK2G	100.0	10000.0
Ribociclib	ULK2	74.0	1000.0
(s)-CR8	NDR2	88.0	10000.0
Neratinib	SYK	65.0	10000.0
Dabrafenib	PKNB(M.tuberculosis)	15.0	10000.0
GW843682X	RPS6KA5(Kin.Dom.2-C-terminal)	76.0	10000.0
QL-XII-47	WEE2	100.0	1000.0
KU63794	PIK3C2G	43.0	10000.0
TGX221	EPHB1	100.0	1000.0
Dabrafenib	FLT3(D835Y)	52.0	10000.0
Neratinib	M4K1	45.0	10000.0
XMD8-92	CSNK1E	100.0	10000.0
BMS-536924	MLTK	100.0	1000.0
AG1478	IRAK4	8.9	10000.0
NVP-TAE684	RIOK2	5.3	1000.0
XMD8-92	SBK1	100.0	10000.0
Momelotinib	PLK1	100.0	10000.0
CGP60474	GSK3A	20.0	10000.0
SP600125	ABL1(Y253F)	100.0	10000.0
XMD11-85h	TYRO3	100.0	10000.0
NG25	MUSK	0.1	10000.0
Canertinib	RPS6KA6(Kin.Dom.1)	100.0	1000.0
HG-6-64-01	DCLK1	93.0	10000.0
WZ4002	CLK3	100.0	10000.0
AZD7762	RET(M918T)	0.0	10000.0
MLN8054	EPHA6	14.0	10000.0
Torkinib	CDK7	30.0	10000.0
WZ-7043	PCTK3	100.0	10000.0
CGP60474	MLK2	100.0	10000.0
QL-XII-47	ULK1	100.0	1000.0
Abemaciclib	PRKR	30.0	1000.0
Seliciclib	FGR	100.0	10000.0
Dabrafenib	FLT3(N841I)	36.0	10000.0
HG-5-113-01	BMPR1B	100.0	10000.0
AS-252424	RIOK3	95.5	10000.0
WZ4002	KPCD	100.0	10000.0
AS-252424	ALK	100.0	10000.0
JNK-IN-11	SYK	82.0	1000.0
JW-7-24-1	TYRO3	100.0	10000.0
KIN001-127	MELK	100.0	10000.0
Abemaciclib	CDK2	55.0	1000.0
NG25	KPCT	100.0	10000.0
XMD8-92	PAK2	100.0	10000.0
Sigma A6730	MK12	98.0	10000.0
HG-5-88-01	RPS6KA4(Kin.Dom.1)	100.0	10000.0
WH-4-023	PLK2	100.0	10000.0
ZSTK474	PCTK3	100.0	1000.0
WZ-4-145	PIP5K1A	100.0	10000.0
MLN8054	JAK3(JH1domain-catalytic)	69.0	10000.0
Taselisib	PIP5K1A	88.0	1000.0
BMX-IN-1	PAK3	100.0	10000.0
HG-6-64-01	FER	27.0	10000.0
XMD11-50	ROS1	12.0	10000.0
WH-4-023	SgK110	44.0	10000.0
A443654	PHKG1	8.0	10000.0
RO-3306	WEE1	90.0	10000.0
AZD4547	MTOR	100.0	10000.0
HG-14-8-02	RIPK4	100.0	10000.0
KIN001-111	PCTK2	100.0	1000.0
ERK5-IN-1	PKAC-beta	100.0	1000.0
AZ-628	NEK1	100.0	10000.0
PD173074	FAK2	100.0	10000.0
GW843682X	PGFRA	58.0	10000.0
QL-X-138	KPCI	99.0	10000.0
Taselisib	NEK10	99.0	1000.0
Barasertib	HIPK3	29.0	10000.0
AZD-6482	MAST1	100.0	10000.0
XMD13-2	CAMK1D	100.0	10000.0
JNK-IN-5A	MK11	100.0	10000.0
Torin1	TRKC	100.0	10000.0
BGJ398	IKKB	99.0	1000.0
JNK-9L	ABL1(F317I)-nonphosphorylated	95.0	10000.0
WZ4002	RPS6KA1(Kin.Dom.2)	100.0	10000.0
KIN001-123	TIE2	100.0	1000.0
TAK-715	PIK3C2B	100.0	10000.0
GSK461364	EPHA7	83.0	10000.0
CG-930	TLK1	50.0	10000.0
Sorafenib	RSK4(Kin.Dom.1-N-terminal)	94.0	10000.0
XMD14-99	M3K12	97.0	10000.0
XMD11-50	MYLK2	98.0	10000.0
Buparlisib	M3K2	100.0	1000.0
Pictilisib	STK36	100.0	1000.0
NG25	PIK3CG	100.0	10000.0
SP600125	BRSK1	100.0	10000.0
PD0325901	CSNK1D	100.0	10000.0
JNK-IN-11	LOK	23.0	1000.0
KIN001-127	YES	12.0	10000.0
CGP60474	WEE2	100.0	10000.0
Momelotinib	MP2K4	32.0	10000.0
XMD13-2	RSK1(Kin.Dom.2-C-terminal)	68.0	10000.0
PLX-4720	ABL1(H396P)-phosphorylated	53.0	10000.0
ERK5-IN-1	ULK1	100.0	1000.0
XMD16-144	EGFR(S752-I759del)	74.0	10000.0
NG25	MP2K6	100.0	10000.0
Ceritinib	ABL2	95.0	1000.0
R406	INSR	16.0	1000.0
Buparlisib	BIKE	100.0	1000.0
XMD14-99	CLK3	2.0	10000.0
WYE-125132	RAF1	100.0	10000.0
XMD8-85	TLK1	100.0	10000.0
PHA-767491	KGP2	2.4	10000.0
WZ3105	KPCD1	100.0	10000.0
NVP-TAE684	CSNK2A1	27.0	1000.0
QL-XI-92	EGFR(L747-S752del,P753S)	79.0	10000.0
TGX221	ULK1	100.0	1000.0
JWE-035	PCTK2	88.0	10000.0
RO-3306	MARK4	99.0	10000.0
CGP74514A	HIPK1	5.8	10000.0
WZ3105	RIPK5	86.0	10000.0
RO-3306	MAPKAPK2	11.0	10000.0
ALW-II-49-7	RET(M918T)	100.0	10000.0
Canertinib	CDC2L2	100.0	1000.0
WZ3105	MK03	100.0	10000.0
BI-2536	ABL2	100.0	10000.0
5z-7-oxozeaenol	MP2K6	21.0	10000.0
PHA-793887	MAK	10.0	10000.0
WZ4003	CSK	100.0	1000.0
XMD13-2	CDKL2	8.6	10000.0
Ribociclib	CLK2	93.0	1000.0
KIN001-111	AURKC	2.6	1000.0
PHA-767491	SLK	77.0	10000.0
GW843682X	BRAF	100.0	10000.0
ZM-447439	FLT3	8.8	10000.0
AZD7762	EPHA7	0.1	10000.0
XMD11-50	MYLK4	80.0	10000.0
QL-X-138	ABL1-nonphosphorylated	61.0	10000.0
PD173074	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
OTSSP167	MK14	41.0	10000.0
HG-9-91-01	NUAK1	18.0	10000.0
Ibrutinib	CDC2L2	81.0	1000.0
XMD11-50	PIK4CB	95.0	10000.0
AZ-628	KPCD2	99.0	10000.0
Crizotinib	ABL1(M351T)-phosphorylated	1.6	10000.0
BGJ398	BMPR2	96.0	1000.0
Abemaciclib	MAPKAPK5	100.0	1000.0
BMX-IN-1	BRSK2	100.0	10000.0
BS-181	LRRK2(G2019S)	88.0	10000.0
CGP74514A	PRP4	62.0	10000.0
Ibrutinib	RET	18.0	1000.0
JWE-035	MK03	99.0	10000.0
XMD8-92	TAK1	100.0	10000.0
Dabrafenib	DRAK2	99.0	10000.0
XMD11-50	TIE2	100.0	10000.0
XMD13-2	IGF1R	100.0	10000.0
HG-14-8-02	MST3	86.0	10000.0
GSK1059615	RPS6KA5(Kin.Dom.2-C-terminal)	4.6	10000.0
JNK-9L	ZAP70	70.0	10000.0
Seliciclib	BMPR2	99.0	10000.0
XMD16-144	EPHA4	79.0	10000.0
AG1478	SLK	2.0	10000.0
WYE-125132	FAK1	78.0	10000.0
AS-252424	HCK	100.0	10000.0
CGP60474	PIM3	100.0	10000.0
CH5424802	CIT	54.0	1000.0
PLX-4720	PAK3	34.0	10000.0
Sigma A6730	CDC2L5	98.0	10000.0
ALW-II-38-3	PLK2	100.0	10000.0
Omipalisib	TAOK3	77.0	10000.0
Dactolisib	MYO3A	100.0	1000.0
NVP-TAE684	STK33	0.1	1000.0
Alpelisib	RIOK2	100.0	1000.0
TGX221	AKT1	100.0	1000.0
WZ4002	KPCL	100.0	10000.0
NG25	ADCK4	100.0	10000.0
PD0325901	TLK1	89.0	10000.0
CP724714	FYN	100.0	10000.0
SB590885	PIK3CA(Q546K)	81.0	10000.0
Ibrutinib	PGFRA	34.0	1000.0
TGX221	ACVRL1	100.0	1000.0
QL-XII-47	SRPK2	100.0	1000.0
R406	NEK6	0.0	1000.0
GW-5074	YSK4	0.4	10000.0
BGJ398	ULK1	100.0	1000.0
SB590885	SIK1	100.0	10000.0
WZ-7043	ADCK3	100.0	10000.0
QL-X-138	SRC	100.0	10000.0
CH5424802	AKT3	100.0	1000.0
Momelotinib	ACVR2B	54.0	10000.0
Seliciclib	ABL1(H396P)-nonphosphorylated	100.0	10000.0
5z-7-oxozeaenol	ACVR1B	69.0	10000.0
Torkinib	YSK4	0.0	10000.0
JNK-IN-5A	ROCK1	100.0	10000.0
MLN8054	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
NU7441	SBK1	100.0	10000.0
TAK-715	MP2K2	90.0	10000.0
HG-5-113-01	MINK	100.0	10000.0
CGP60474	TRKC	100.0	10000.0
WZ-4-145	CLK1	100.0	10000.0
CH5424802	TTK	31.0	1000.0
Buparlisib	KIT(D816H)	91.0	1000.0
XMD13-2	KPCD1	100.0	10000.0
CP466722	CLK2	1.8	10000.0
BMX-IN-1	PIM1	86.0	10000.0
GSK461364	IKKB	74.0	10000.0
AZ-628	ABL1(H396P)-phosphorylated	2.6	10000.0
KIN001-127	PAK4	100.0	10000.0
Alpelisib	TSSK1	94.0	1000.0
CH5424802	FES	14.0	1000.0
Abemaciclib	ABL1(E255K)-phosphorylated	82.0	1000.0
BS-181	ZAP70	93.0	10000.0
JNK-9L	ACVRL1	100.0	10000.0
ALW-II-49-7	CSNK2A2	100.0	10000.0
HG-14-10-04	IKKB	30.0	10000.0
Ribociclib	SYK	81.0	1000.0
MRT67307	NIM1	46.0	10000.0
BS-181	PIP5K1A	100.0	10000.0
WZ3105	CSNK1G3	8.2	10000.0
CGP60474	EGFR(L858R,T790M)	100.0	10000.0
BX-912	CDK2	43.0	10000.0
ALW-II-49-7	MST4	100.0	10000.0
Pictilisib	EGFR(L747-T751del,Sins)	98.0	1000.0
BX-912	KIT(A829P)	28.0	10000.0
NG25	MST1	100.0	10000.0
AZ-628	LRRK2(G2019S)	69.0	10000.0
GW843682X	RIOK3	4.2	10000.0
WZ3105	PIM1	92.0	10000.0
BX-912	MTOR	87.0	10000.0
GW843682X	RIOK2	66.0	10000.0
TGX221	CDC2L1	100.0	1000.0
Sigma A6730	PIK3CA(Q546K)	80.0	10000.0
XMD13-2	CDK14	46.0	10000.0
Torin1	SYK	78.0	10000.0
XMD14-99	MYLK2	87.0	10000.0
Neratinib	PIM2	100.0	10000.0
Vemurafenib	SIK1	2.8	10000.0
WH-4-023	EGFR(L858R)	0.0	10000.0
ZM-447439	LRRK2(G2019S)	100.0	10000.0
THZ1	LKB1	4.2	10000.0
Ceritinib	PIK3CD	100.0	1000.0
SCH772984	RIPK1	96.0	1000.0
KIN001-220	ERK3	21.0	10000.0
BMX-IN-1	KIT(V559D,T670I)	91.0	10000.0
XMD16-144	FLT3(N841I)	9.2	10000.0
Crizotinib	ACVR1	0.6	10000.0
GSK1059615	PDPK1	62.0	10000.0
KIN001-127	ULK3	100.0	10000.0
HG-6-64-01	LATS2	79.0	10000.0
SCH772984	HUNK	88.0	1000.0
Momelotinib	DCAMKL3	0.5	10000.0
Torin1	CSF1R	24.0	10000.0
(s)-CR8	DAPK3	95.0	10000.0
Taselisib	SRPK3	75.0	1000.0
WYE-125132	TRPM6	100.0	10000.0
JNK-9L	MTOR	100.0	10000.0
JNK-IN-11	EGFR(L747-S752del,P753S)	7.0	1000.0
PLX-4720	EPHB4	100.0	10000.0
BS-181	DCAMKL3	61.0	10000.0
Omipalisib	JAK3(JH1domain-catalytic)	74.0	10000.0
Buparlisib	RSK1(Kin.Dom.2-C-terminal)	63.0	1000.0
BI-D1870	FGFR3(G697C)	32.0	10000.0
WZ-4-145	SLK	9.8	10000.0
CP724714	PKMYT1	100.0	10000.0
HG-9-91-01	AMPK-alpha2	43.0	10000.0
BI-2536	BRSK1	100.0	10000.0
Barasertib	MST2	100.0	10000.0
Abemaciclib	ALK	70.0	1000.0
JWE-035	FLT3	100.0	10000.0
KIN001-220	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
WZ4003	CDK14	100.0	1000.0
BGJ398	HCK	36.0	1000.0
PHA-767491	KPCD1	2.4	10000.0
PHA-793887	ABL1(Q252H)-nonphosphorylated	46.0	10000.0
PD0325901	TTK	100.0	10000.0
KIN001-021	CDK15	100.0	1000.0
NG25	RAF1	7.0	10000.0
XMD-12	RSK3(Kin.Dom.2-C-terminal)	91.0	1000.0
Sorafenib	M3K13	100.0	10000.0
WZ3105	MRCKB	76.0	10000.0
Neratinib	PKN2	72.0	10000.0
BI-2536	PCTK3	100.0	10000.0
GSK1059615	EPHA3	75.0	10000.0
AZD7762	MARK3	0.9	10000.0
WZ4003	CSNK1E	100.0	1000.0
RO-3306	TAOK3	59.0	10000.0
CG-930	M4K3	85.0	10000.0
QL-XII-47	SGK2	100.0	1000.0
THZ1	EGFR(L747-T751del,Sins)	20.0	10000.0
Torkinib	KC1G2	38.0	10000.0
NPK76-II-72-1	TIE2	100.0	10000.0
Ribociclib	ITK	100.0	1000.0
R406	HIPK1	9.2	1000.0
AG1478	FGFR3	99.0	10000.0
KIN001-021	CHK2	100.0	1000.0
Crizotinib	AMPK-alpha2	17.0	10000.0
Momelotinib	CAMK2G	36.0	10000.0
Barasertib	NEK2	83.0	10000.0
MLN8054	MAPKAPK5	100.0	10000.0
GSK1059615	PLK1	26.0	10000.0
CGP60474	ERBB2	100.0	10000.0
QL-XI-92	CSNK2A1	100.0	10000.0
CG-930	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
BI-2536	BLK	100.0	10000.0
HG-9-91-01	DMPK2	0.0	10000.0
ZSTK474	LIMK2	100.0	1000.0
Canertinib	HCK	100.0	1000.0
ZSTK474	EPHA4	100.0	1000.0
ZM-447439	RSK1(Kin.Dom.2-C-terminal)	72.0	10000.0
Ceritinib	RSK1(Kin.Dom.2-C-terminal)	31.0	1000.0
XMD11-85h	PIK3C2B	100.0	10000.0
Torin2	YANK3	100.0	10000.0
XMD16-144	LCK	1.2	10000.0
ALW-II-38-3	IKKA	100.0	10000.0
Barasertib	FGFR4	100.0	10000.0
CG-930	PAK3	100.0	10000.0
JWE-035	TRKB	60.0	10000.0
XMD11-85h	ERN1	100.0	10000.0
Baricitinib	ABL1(T315I)-phosphorylated	29.0	10000.0
WZ-4-145	EPHB3	100.0	10000.0
SB590885	EGFR(L858R)	54.0	10000.0
A443654	MP2K3	7.1	10000.0
(s)-CR8	CSNK1A1L	37.0	10000.0
GSK461364	SRMS	74.0	10000.0
Ibrutinib	ABL1(F317L)-phosphorylated	48.0	1000.0
PD173074	KIT(D816V)	100.0	10000.0
PD0325901	RAF1	99.0	10000.0
SP600125	MINK	1.9	10000.0
JW-7-24-1	EGFR(S752-I759del)	100.0	10000.0
HG-14-10-04	PIK3CA(H1047L)	94.0	10000.0
CGP60474	NIM1	100.0	10000.0
KIN001-021	EGFR(G719S)	100.0	1000.0
Neratinib	FLT3	100.0	10000.0
PLX-4720	FLT3(D835H)	43.0	10000.0
AZD 5438	KPCE	20.0	10000.0
ZSTK474	MK03	100.0	1000.0
Ceritinib	BIKE	85.0	1000.0
JNK-9L	PHKG2	81.0	10000.0
GSK1059615	AXL	7.6	10000.0
KIN001-220	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
NVP-TAE684	MARK2	4.6	1000.0
HG-9-91-01	DAPK1	89.0	10000.0
JNK-9L	TYK2(JH1domain-catalytic)	0.0	10000.0
BMS345541	KPCD1	47.0	10000.0
XMD16-144	LYN	52.0	10000.0
BI-2536	SRPK2	100.0	10000.0
A443654	BMPR1B	100.0	10000.0
NVP-TAE684	PLK1	0.1	1000.0
SB590885	TESK1	76.0	10000.0
SCH772984	PIM3	63.0	1000.0
WZ3105	MST3	43.0	10000.0
NPK76-II-72-1	MP2K3	100.0	10000.0
KU63794	BRSK1	100.0	10000.0
CGP74514A	ADCK3	100.0	10000.0
BGJ398	MP2K6	100.0	1000.0
(s)-CR8	PKN2	97.0	10000.0
XMD11-85h	PAK6	100.0	10000.0
Seliciclib	RIOK1	60.0	10000.0
QL-X-138	MAST1	85.0	10000.0
XMD14-99	NEK7	100.0	10000.0
Neratinib	PIK4CB	100.0	10000.0
Sorafenib	MARK3	74.0	10000.0
XMD8-85	ROS1	7.6	10000.0
JNK-IN-5A	LRRK2	94.0	10000.0
5z-7-oxozeaenol	AXL	85.0	10000.0
Sigma A6730	PIK3C2G	75.0	10000.0
PD0325901	MP2K3	89.0	10000.0
Sorafenib	AKT1	100.0	10000.0
PD173074	PKN2	100.0	10000.0
JNK-9L	BTK	74.0	10000.0
XMD14-99	AXL	100.0	10000.0
HG-5-113-01	RPS6KA1(Kin.Dom.2)	100.0	10000.0
BMS-536924	EPHB2	100.0	1000.0
Palbociclib	EGFR(E746-A750del)	92.0	1000.0
AG1478	ABL1(H396P)-nonphosphorylated	2.2	10000.0
MRT67307	CDK4-cyclinD3	45.0	10000.0
GW843682X	PDPK1	66.0	10000.0
TGX221	RET	100.0	1000.0
JNK-IN-5A	AURKC	87.0	10000.0
ZSTK474	MK14	100.0	1000.0
R406	MLK1	0.2	1000.0
NU7441	ABL1-phosphorylated	98.0	10000.0
NU7441	EGFR(L747-T751del,Sins)	100.0	10000.0
PHA-793887	EGFR(S752-I759del)	97.0	10000.0
JNK-9L	MARK3	100.0	10000.0
XMD-12	MRCKA	90.0	1000.0
HG-6-64-01	EPHB4	2.7	10000.0
AG1478	KKCC1	74.0	10000.0
Alpelisib	KIT(V559D,T670I)	100.0	1000.0
AZ-628	ABL1(M351T)-phosphorylated	3.3	10000.0
XMD16-144	CLK4	100.0	10000.0
Pictilisib	OSR1	100.0	1000.0
GW843682X	ABL1(F317I)-nonphosphorylated	94.0	10000.0
Torin1	PAK3	100.0	10000.0
HG-14-8-02	TNK2	4.3	10000.0
CH5424802	MUSK	100.0	1000.0
ZG-10	TGFBR2	50.0	10000.0
Seliciclib	ROS1	100.0	10000.0
PHA-767491	TNK1	49.0	10000.0
Palbociclib	MRCKB	100.0	1000.0
AS-252424	MST2	90.6	10000.0
AZD 5438	KPCD1	2.0	10000.0
Dactolisib	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	1000.0
WYE-125132	PTK6	55.0	10000.0
BS-181	MP2K2	97.0	10000.0
GSK1059615	FLT3	39.0	10000.0
XMD-12	IRAK1	86.0	1000.0
GW-5074	PHKG1	85.0	10000.0
Palbociclib	RIOK3	70.0	1000.0
BMS345541	EGFR(T790M)	50.0	10000.0
KIN001-021	MK09	100.0	1000.0
GW843682X	CDK8	94.0	10000.0
Pictilisib	TTK	93.0	1000.0
PLX-4720	BLK	1.7	10000.0
Dactolisib	CDK16	100.0	1000.0
ERK5-IN-1	MKNK2	100.0	1000.0
WZ4003	SRPK3	11.0	1000.0
Abemaciclib	ABL1(H396P)-phosphorylated	96.0	1000.0
NU7441	PIK3CA(H1047L)	4.4	10000.0
Ibrutinib	PCTK2	77.0	1000.0
Abemaciclib	HIPK1	0.3	1000.0
5z-7-oxozeaenol	EPHB6	12.0	10000.0
GSK429286A	KKCC1	72.0	10000.0
Neratinib	MST2	1.4	10000.0
A443654	DCAMKL3	2.0	10000.0
AG1478	NEK7	88.0	10000.0
ZM-447439	FGFR4	100.0	10000.0
PHA-767491	KPCE	0.0	10000.0
PD173074	AMPK-alpha1	100.0	10000.0
XMD-12	NEK2	100.0	1000.0
GW843682X	PIK3CA(H1047Y)	36.0	10000.0
KIN001-127	TIE1	11.0	10000.0
Ibrutinib	FER	100.0	1000.0
Taselisib	CDK14	100.0	1000.0
ZG-10	PIM1	95.0	10000.0
CGP60474	DCAMKL3	100.0	10000.0
Neratinib	MK12	100.0	10000.0
CP466722	ABL1(F317I)-phosphorylated	7.1	10000.0
Momelotinib	MK12	100.0	10000.0
Canertinib	RPS6KA4(Kin.Dom.2)	100.0	1000.0
TGX221	TGFBR2	100.0	1000.0
BMX-IN-1	BRAF	100.0	10000.0
RO-3306	M3K5	25.0	10000.0
NPK76-II-72-1	EGFR(G719C)	100.0	10000.0
Ceritinib	FLT3	58.0	1000.0
XMD14-99	MLK3	96.0	10000.0
XMD8-92	BRAF(V600E)	100.0	10000.0
TAK-715	KPCD1	65.0	10000.0
XMD13-2	JAK1(JH2domain-pseudokinase)	84.0	10000.0
QL-XI-92	STK39	86.0	10000.0
BGJ398	LOK	3.1	1000.0
JNK-9L	YSK4	0.3	10000.0
BI-2536	ABL1(T315I)	100.0	10000.0
QL-XI-92	MK13	90.0	10000.0
WZ-4-145	PCTK2	100.0	10000.0
JW-7-24-1	GAK	1.0	10000.0
JNK-IN-5A	PAK4	100.0	10000.0
AG1478	IKKE	55.0	10000.0
WZ3105	KPCI	93.0	10000.0
Omipalisib	FAK1	95.0	10000.0
Seliciclib	ABL1(F317I)-phosphorylated	100.0	10000.0
XMD8-85	PIK3CA(E545A)	100.0	10000.0
Barasertib	DDR1	12.0	10000.0
QL-X-138	CLK3	46.0	10000.0
BI-D1870	STK33	22.0	10000.0
SB590885	TRKA	90.0	10000.0
TGX221	TIE1	100.0	1000.0
SP600125	CSNK1G3	100.0	10000.0
ZSTK474	TAOK3	100.0	1000.0
XMD11-85h	HIPK4	100.0	10000.0
Baricitinib	CDKL2	85.0	10000.0
JWE-035	CDK11	95.0	10000.0
Sigma A6730	ERK5	100.0	10000.0
Taselisib	ICK	100.0	1000.0
Neratinib	PGFRA	100.0	10000.0
WZ4002	EGFR	0.1	10000.0
XMD8-92	TEC	100.0	10000.0
HG-5-113-01	FRK	33.0	10000.0
XMD14-99	LKB1	100.0	10000.0
Ibrutinib	MAP3K4	76.0	1000.0
BGJ398	LYN	46.0	1000.0
Canertinib	PIP5K1A	100.0	1000.0
JNK-9L	EGFR(L747-S752del,P753S)	76.0	10000.0
Torin2	CAMK1G	88.0	10000.0
(s)-CR8	HUNK	96.0	10000.0
BGJ398	FLT3(ITD)	79.0	1000.0
Torin2	MK11	83.0	10000.0
NVP-TAE684	STK35	16.0	1000.0
JNK-IN-11	JAK3(JH1domain-catalytic)	49.0	1000.0
NU7441	BRSK2	100.0	10000.0
JW-7-24-1	TNK1	100.0	10000.0
Vemurafenib	ABL1-phosphorylated	57.0	10000.0
ZG-10	MP2K2	87.0	10000.0
XMD-12	EGFR(L858R)	93.0	1000.0
XMD11-50	TAK1	98.0	10000.0
AZD7762	ITK	0.6	10000.0
JNK-IN-8	MELK	71.0	1000.0
Dinaciclib	MTOR	96.0	10000.0
AZD-6482	MP2K2	100.0	10000.0
JW-7-24-1	KPCD3	28.0	10000.0
CP724714	CDK15	71.0	10000.0
WH-4-023	MAST1	100.0	10000.0
Seliciclib	EPHB3	100.0	10000.0
KIN001-123	ANKK1	100.0	1000.0
AZD7762	JAK1(JH1domain-catalytic)	17.0	10000.0
JNK-IN-8	ABL1(M351T)-phosphorylated	81.0	1000.0
A443654	WEE2	100.0	10000.0
ZSTK474	EGFR(G719C)	100.0	1000.0
XMD11-50	ULK3	100.0	10000.0
BMX-IN-1	PAK6	73.0	10000.0
KIN001-111	ABL1(E255K)	5.1	1000.0
AZD7762	RAF1	100.0	10000.0
BMS345541	CSNK1A1L	100.0	10000.0
WH-4-023	HIPK1	100.0	10000.0
QL-XI-92	EPHA6	93.0	10000.0
GW843682X	CDKL2	90.0	10000.0
WZ4003	EGFR(E746-A750del)	13.0	1000.0
JNK-IN-5A	SLK	82.0	10000.0
SCH772984	RSK3(Kin.Dom.2-C-terminal)	78.0	1000.0
HG-9-91-01	PIK3CB	92.0	10000.0
Abemaciclib	LCK	100.0	1000.0
BMX-IN-1	CDKL3	96.0	10000.0
Torin2	EGFR(T790M)	100.0	10000.0
ERK5-IN-1	MK12	32.0	1000.0
WH-4-023	EGFR(L747-S752del,P753S)	0.0	10000.0
TAK-715	RET	66.0	10000.0
TGX221	JAK3(Kin.Dom.2)	100.0	1000.0
BX-912	SRC	4.0	10000.0
BI-D1870	VGFR1	4.2	10000.0
Vemurafenib	TNIK	15.0	10000.0
WYE-125132	MAP3K15	100.0	10000.0
XMD16-144	TLK1	100.0	10000.0
Ceritinib	RET(V804L)	87.0	1000.0
WZ3105	ADCK4	94.0	10000.0
BX-912	M3K12	21.0	10000.0
Taselisib	HCK	81.0	1000.0
Crizotinib	PIK4CB	100.0	10000.0
SB590885	KCC4	87.0	10000.0
WZ-7043	ANKK1	100.0	10000.0
R406	PHKG1	31.0	1000.0
AS-252424	MK14	100.0	10000.0
R406	PAK1	10.0	1000.0
XMD11-85h	HCK	100.0	10000.0
AZ-628	PAK1	100.0	10000.0
AZD7762	RSK2(Kin.Dom.1-N-terminal)	1.0	10000.0
PD0325901	YANK1	80.0	10000.0
Vemurafenib	CDK2	65.0	10000.0
Dinaciclib	CDK2	0.3	10000.0
Alpelisib	PIK3CA(Q546K)	0.0	1000.0
Sorafenib	TLK1	100.0	10000.0
Torin2	LTK	100.0	10000.0
CH5424802	NLK	100.0	1000.0
Pictilisib	PAK1	100.0	1000.0
KIN001-123	VGFR1	17.0	1000.0
Buparlisib	JNK1	100.0	1000.0
ALW-II-38-3	EGFR(L747-E749del,A750P)	100.0	10000.0
MLN8054	CDKL2	86.0	10000.0
ZSTK474	EPHA2	100.0	1000.0
WZ4003	ULK2	2.4	1000.0
NPK76-II-72-1	NDR2	100.0	10000.0
Taselisib	SBK1	88.0	1000.0
SCH772984	MYO3B	97.0	1000.0
PD173074	AAK1	100.0	10000.0
HG-14-10-04	MELK	7.2	10000.0
XMD11-50	NEK7	100.0	10000.0
AS-252424	PGFRA	100.0	10000.0
Sigma A6730	PIK3CA	77.0	10000.0
HG-9-91-01	CLK4	100.0	10000.0
KIN001-220	BTK	27.0	10000.0
AZD4547	ABL2	13.0	10000.0
BGJ398	MKNK1	94.0	1000.0
BX-912	TNK2	18.0	10000.0
NU7441	STK36	100.0	10000.0
Omipalisib	CDK14	85.0	10000.0
Pictilisib	PIM2	100.0	1000.0
Buparlisib	LIMK1	100.0	1000.0
XMD-12	M3K5	100.0	1000.0
5z-7-oxozeaenol	PIK3CD	100.0	10000.0
NVP-TAE684	FGFR2	1.0	1000.0
XMD11-85h	ACVR2B	100.0	10000.0
Baricitinib	WNK3	88.0	10000.0
PHA-767491	CDK16	76.0	10000.0
NU7441	DRAK2	100.0	10000.0
Vemurafenib	AURKC	72.0	10000.0
MRT67307	RIPK5	30.0	10000.0
Sigma A6730	MST4	100.0	10000.0
Buparlisib	PIK3CD	22.0	1000.0
Baricitinib	ERK8	26.0	10000.0
Dactolisib	MK14	100.0	1000.0
BMX-IN-1	KCC4	72.0	10000.0
ZM-447439	NDR1	92.0	10000.0
AZD-6482	DDR2	83.0	10000.0
GW843682X	DMPK	98.0	10000.0
SB590885	PKN2	100.0	10000.0
HG-14-8-02	CDK4-cyclinD1	98.0	10000.0
Canertinib	CSNK1D	100.0	1000.0
QL-X-138	TSSK1	87.0	10000.0
PHA-767491	CAMK1D	100.0	10000.0
Buparlisib	FLT3(D835Y)	100.0	1000.0
HG-5-88-01	ACVRL1	100.0	10000.0
HG-6-64-01	BRSK2	100.0	10000.0
AZD4547	MAP4K5	0.5	10000.0
GSK429286A	ABL1-phosphorylated	75.0	10000.0
AZD 5438	RPS6KA4(Kin.Dom.2-C-terminal)	52.0	10000.0
AZD 5438	CDK4-cyclinD1	0.1	10000.0
NVP-TAE684	FGR	2.8	1000.0
GSK429286A	WEE1	94.0	10000.0
CH5424802	MP2K7	99.0	1000.0
ZG-10	SRPK2	100.0	10000.0
GSK461364	TGFBR1	99.0	10000.0
GSK1059615	KIT(L576P)	34.0	10000.0
Buparlisib	ABL1(F317I)-nonphosphorylated	100.0	1000.0
JNK-IN-8	BMX	100.0	1000.0
Dinaciclib	FGFR4	88.0	10000.0
Dinaciclib	HIPK2	3.6	10000.0
Sigma A6730	FLT3(R834Q)	100.0	10000.0
KIN001-111	RPS6KA2(Kin.Dom.2)	100.0	1000.0
HG-14-8-02	EGFR(L861Q)	0.0	10000.0
WZ-4-145	ALK	100.0	10000.0
WZ4002	IRAK3	34.0	10000.0
WH-4-023	RIOK1	5.8	10000.0
WZ-7043	CTK	100.0	10000.0
PHA-793887	MAP3K14	89.0	10000.0
RO-3306	FAK2	87.0	10000.0
GSK429286A	BRSK2	90.0	10000.0
Abemaciclib	TTK	47.0	1000.0
CGP60474	TAK1	100.0	10000.0
Ceritinib	ABL1(M351T)-phosphorylated	100.0	1000.0
GW-5074	ABL1(Q252H)-phosphorylated	69.0	10000.0
BMX-IN-1	MST4	90.0	10000.0
ZM-447439	CSNK2A1	87.0	10000.0
Lapatinib	EPHA6	88.0	10000.0
BX-912	LKB1	3.2	10000.0
XMD8-92	FLT3(D835H)	100.0	10000.0
R406	BMX	5.0	1000.0
CG-930	ABL1(T315I)-phosphorylated	87.0	10000.0
THZ1	MST1	5.4	10000.0
(s)-CR8	CSF1R	83.0	10000.0
GSK429286A	TAOK2	96.0	10000.0
AZD4547	M4K1	21.0	10000.0
Dabrafenib	MAPKAPK2	100.0	10000.0
XMD11-85h	HIPK1	100.0	10000.0
JNK-9L	MK11	79.0	10000.0
KU63794	BMX	86.0	10000.0
GW843682X	GRK7	52.0	10000.0
XMD-12	LKB1	100.0	1000.0
Alpelisib	MP2K2	94.0	1000.0
(s)-CR8	CDK9	47.0	10000.0
MRT67307	RET(M918T)	14.0	10000.0
THZ1	EGFR(E746-A750del)	15.0	10000.0
Omipalisib	RSK2(Kin.Dom.1-N-terminal)	72.0	10000.0
WH-4-023	NEK2	100.0	10000.0
Sigma A6730	PIP5K1A	88.0	10000.0
ZM-447439	CLK2	80.0	10000.0
WZ4002	KKCC1	18.0	10000.0
ERK5-IN-1	PIK3CA(Q546K)	99.0	1000.0
CG-930	PGFRA	82.0	10000.0
CP724714	TTK	80.0	10000.0
MRT67307	NUAK1	3.2	10000.0
QL-XII-47	NEK3	82.0	1000.0
JNK-IN-11	ROCK2	75.0	1000.0
RO-3306	MK09	59.0	10000.0
GSK429286A	IKKB	86.0	10000.0
PLX-4720	MK03	100.0	10000.0
ZSTK474	RPS6KA4(Kin.Dom.1)	100.0	1000.0
MRT67307	PDPK1	11.0	10000.0
JNK-IN-11	FLT3(N841I)	4.0	1000.0
Crizotinib	ACVR2A	30.0	10000.0
CP724714	ACVR1B	100.0	10000.0
PD173074	PKMYT1	100.0	10000.0
MLN8054	ERN1	100.0	10000.0
BX-912	RET	0.1	10000.0
QL-X-138	NEK11	100.0	10000.0
BS-181	YANK1	83.0	10000.0
KIN001-111	AURKA	15.0	1000.0
PD0325901	PRKX	100.0	10000.0
WYE-125132	MET	93.0	10000.0
SB590885	NEK4	100.0	10000.0
SP600125	EPHA4	100.0	10000.0
Neratinib	YSK4	0.5	10000.0
ALW-II-38-3	LYN	3.3	1000.0
Abemaciclib	FRK	100.0	1000.0
Momelotinib	DDR2	100.0	10000.0
JNK-9L	PIP5K1A	17.0	10000.0
NG25	ALK	0.6	10000.0
JW-7-24-1	EPHA3	100.0	10000.0
WZ4003	ACVR2B	100.0	1000.0
ZM-447439	AKT1	100.0	10000.0
HG-9-91-01	ACVR1	0.2	10000.0
TAK-715	PIK3CA(H1047L)	100.0	10000.0
Ribociclib	IGF1R	100.0	1000.0
HG-5-113-01	SRC	0.3	10000.0
Torin1	MAP4K4	5.2	10000.0
Barasertib	DCAMKL3	86.0	10000.0
CG-930	TRPM6	100.0	10000.0
TGX221	AURKB	100.0	1000.0
SP600125	NEK9	100.0	10000.0
NPK76-II-72-1	KCC4	100.0	10000.0
QL-X-138	JAK1(JH1domain-catalytic)	97.0	10000.0
Ceritinib	CASK	88.0	1000.0
CGP74514A	FLT3(D835Y)	1.2	10000.0
Dinaciclib	MARK4	84.0	10000.0
GSK1059615	BRSK1	73.0	10000.0
Barasertib	PIK3CD	88.0	10000.0
XMD8-92	TLK1	100.0	10000.0
AZD4547	TGFBR2	12.0	10000.0
JNK-IN-5A	PCTK3	95.0	10000.0
WZ-7043	ERK3	100.0	10000.0
WH-4-023	FAK2	9.0	10000.0
XMD-12	KPCE	99.0	1000.0
Dabrafenib	ITK	4.8	10000.0
GW-5074	LRRK2(G2019S)	9.0	10000.0
BMS345541	PCTK2	92.0	10000.0
Barasertib	IRAK3	37.0	10000.0
Crizotinib	KPCI	35.0	10000.0
NPK76-II-72-1	INSR	100.0	10000.0
GSK1059615	ROCK1	51.0	10000.0
WYE-125132	M3K2	95.0	10000.0
NG25	FLT3(ITD)	0.7	10000.0
Torkinib	LTK	16.0	10000.0
CP724714	NEK4	100.0	10000.0
CP466722	AKT1	100.0	10000.0
BGJ398	TAOK3	23.0	1000.0
Seliciclib	MERTK	90.0	10000.0
Ribociclib	JAK3(JH1domain-catalytic)	100.0	1000.0
Sorafenib	ERBB3	100.0	10000.0
AZD 5438	MET(M1250T)	14.0	10000.0
NVP-TAE684	MAP4K2	9.4	1000.0
CP724714	CDC2L1	100.0	10000.0
XMD8-85	RIOK2	100.0	10000.0
CGP74514A	MELK	9.4	10000.0
PHA-767491	KPCT	5.8	10000.0
Sorafenib	ABL1(F317I)-phosphorylated	41.0	10000.0
OTSSP167	MP2K7	0.3	10000.0
ALW-II-38-3	ERN1	100.0	10000.0
JNK-IN-11	FLT3(D835H)	13.0	1000.0
NU7441	PRP4	78.0	10000.0
Momelotinib	EPHB3	100.0	10000.0
GSK429286A	KC1G1	100.0	10000.0
HG-9-91-01	PIK3CA(M1043I)	95.0	10000.0
5z-7-oxozeaenol	PFCDPK1(P.falciparum)	89.0	10000.0
5z-7-oxozeaenol	CDC2L1	100.0	10000.0
JNK-IN-8	EGFR(E746-A750del)	90.0	1000.0
BMX-IN-1	MST1	100.0	10000.0
NG25	CDKL2	0.9	10000.0
Barasertib	EPHB6	0.8	10000.0
AZ-628	CAMK1D	100.0	10000.0
XMD8-85	GAK	9.8	10000.0
HG-14-10-04	CSNK1A1L	12.0	10000.0
KU63794	RIOK2	60.0	10000.0
Ceritinib	KCC2D	64.0	1000.0
MLN8054	KIT(D816H)	96.0	10000.0
NPK76-II-72-1	TYK2(Kin.Dom.1)	100.0	10000.0
AZD4547	GCN2(Kin.Dom.2,S808G)	2.0	10000.0
BGJ398	MARK3	100.0	1000.0
PD0325901	CHK2	86.0	10000.0
AZD7762	SRPK2	4.4	10000.0
Lapatinib	RET(V804L)	100.0	10000.0
GW843682X	PKMYT1	60.0	10000.0
HG-5-88-01	JNK3	28.0	10000.0
R406	CAMK1D	2.2	1000.0
THZ1	CHEK1	15.0	10000.0
KU63794	NDR2	95.0	10000.0
SCH772984	BRAF	90.0	1000.0
Crizotinib	PLK1	83.0	10000.0
TGX221	FLT3(K663Q)	100.0	1000.0
XMD11-85h	SIK3	100.0	10000.0
XMD8-85	PCTK3	100.0	10000.0
BMS-536924	GAK	1.6	1000.0
AZD7762	PHKG1	0.1	10000.0
BMS345541	PKMYT1	84.0	10000.0
Torin1	PIK3CA(I800L)	0.0	10000.0
BX-912	PIM1	87.0	10000.0
WZ3105	SNARK	45.0	10000.0
WZ-4-145	DRAK1	100.0	10000.0
Momelotinib	PKN1	66.0	10000.0
WYE-125132	FLT3-autoinhibited	77.0	10000.0
Pictilisib	TAOK3	100.0	1000.0
CP724714	DRAK2	100.0	10000.0
GSK461364	PCTK3	100.0	10000.0
KIN001-021	KIT(V559D,V654A)	100.0	1000.0
Seliciclib	STK16	44.0	10000.0
BMS345541	IGF1R	90.0	10000.0
HG-6-64-01	GAK	2.2	10000.0
XMD16-144	EPHA3	43.0	10000.0
AZD-6482	BRSK1	99.0	10000.0
BGJ398	NEK4	91.0	1000.0
Alpelisib	EPHB1	99.0	1000.0
HG-6-64-01	ACVR2B	62.0	10000.0
ZG-10	PKAC-beta	100.0	10000.0
Lapatinib	ABL1(H396P)-phosphorylated	100.0	10000.0
TAK-715	DAPK3	83.0	10000.0
Torin2	TBK1	100.0	10000.0
KIN001-111	PLK3	100.0	1000.0
SCH772984	RIPK2	98.0	1000.0
MPS-1-IN-1	CSNK2A2	100.0	1000.0
JWE-035	FYN	20.0	10000.0
Sorafenib	CSNK2A1	100.0	10000.0
Pictilisib	DYRK1B	99.0	1000.0
HG-14-8-02	FLT3(D835H)	35.0	10000.0
KIN001-220	KGP2	62.0	10000.0
Vemurafenib	DAPK1	83.0	10000.0
AZ-628	ZAP70	100.0	10000.0
NU7441	MYO3B	100.0	10000.0
MPS-1-IN-1	TGFBR1	100.0	1000.0
TAK-715	DMPK	92.0	10000.0
Ibrutinib	MELK	75.0	1000.0
Sorafenib	EGFR	85.0	10000.0
OTSSP167	HASP	56.0	10000.0
ERK5-IN-1	ABL1(H396P)-phosphorylated	100.0	1000.0
AZ-628	BLK	1.0	10000.0
BS-181	NIM1	90.0	10000.0
BMS-536924	CDK3	100.0	1000.0
Vemurafenib	ERK8	89.0	10000.0
XMD16-144	EPHA2	82.0	10000.0
XMD11-50	KIT(A829P)	100.0	10000.0
R406	ABL1(F317I)	100.0	1000.0
KIN001-123	GSK3A	100.0	1000.0
NVP-TAE684	FLT4	0.1	1000.0
AG1478	YES	38.0	10000.0
PLX-4720	CSNK1A1L	100.0	10000.0
GSK461364	TBK1	84.0	10000.0
SP600125	MAP4K4	100.0	10000.0
BMS-536924	STK35	5.3	1000.0
HG-5-113-01	CDK8	100.0	10000.0
AG1478	JAK3(JH1domain-catalytic)	38.0	10000.0
Torin1	NEK11	65.0	10000.0
BX-912	KPCD3	0.5	10000.0
BMX-IN-1	SNARK	100.0	10000.0
Ribociclib	NEK5	100.0	1000.0
KIN001-123	MP2K2	100.0	1000.0
HG-9-91-01	MP2K3	8.4	10000.0
Alpelisib	PTK6	98.0	1000.0
Canertinib	LOK	100.0	1000.0
Taselisib	PIM3	100.0	1000.0
Sigma A6730	JNK1	79.0	10000.0
HG-6-64-01	EPHA7	16.0	10000.0
JNK-IN-11	MST3	88.0	1000.0
ALW-II-38-3	IGF1R	100.0	10000.0
Ibrutinib	MAP3K1	48.0	1000.0
Seliciclib	LYN	95.0	10000.0
CGP60474	ITK	100.0	10000.0
PLX-4720	DMPK	100.0	10000.0
THZ1	VGFR2	0.2	10000.0
Crizotinib	CLK2	68.0	10000.0
OTSSP167	PIM2	2.1	10000.0
ZG-10	KGP1	100.0	10000.0
CP724714	KGP1	100.0	10000.0
NU7441	FGFR3	80.0	10000.0
HG-14-10-04	MLK1	2.5	10000.0
A443654	CSNK1E	0.1	10000.0
PHA-793887	CDK3	0.4	10000.0
PLX-4720	MAP3K15	74.0	10000.0
AZD-6482	EPHB2	100.0	10000.0
ZSTK474	PAK3	100.0	1000.0
Barasertib	RAF1	100.0	10000.0
PD173074	M4K1	100.0	10000.0
RO-3306	TBK1	77.0	10000.0
MPS-1-IN-1	RET(V804M)	100.0	1000.0
BI-2536	DRAK1	100.0	10000.0
Canertinib	LATS2	100.0	1000.0
Ribociclib	ACVR2A	90.0	1000.0
OTSSP167	ABL1-nonphosphorylated	2.6	10000.0
CG-930	YANK1	62.0	10000.0
SB590885	BMPR1A	100.0	10000.0
XMD8-85	M3K2	32.0	10000.0
JNK-IN-5A	TRKC	86.0	10000.0
WZ4003	CDC2L2	100.0	1000.0
HG-14-8-02	MST4	67.0	10000.0
Ceritinib	CAMK1D	33.0	1000.0
(s)-CR8	VGFR2	84.0	10000.0
GSK1059615	JNK3	26.0	10000.0
CGP74514A	ADCK4	71.0	10000.0
NPK76-II-72-1	PAK1	100.0	10000.0
HG-14-10-04	EGFR(L858R,T790M)	0.0	10000.0
QL-XI-92	PKMYT1	83.0	10000.0
(s)-CR8	PAK6	86.0	10000.0
A443654	PTK6	100.0	10000.0
Abemaciclib	RPS6KA4(Kin.Dom.1-N-terminal)	98.0	1000.0
BGJ398	ERK8	100.0	1000.0
BMS345541	PKNB(M.tuberculosis)	0.0	10000.0
AZ-628	IRAK3	95.0	10000.0
Dinaciclib	DYRK1A	6.0	10000.0
PHA-793887	MP2K7	100.0	10000.0
ERK5-IN-1	PIK3CA(E542K)	100.0	1000.0
JNK-IN-11	YANK1	35.0	1000.0
Vemurafenib	KPCI	100.0	10000.0
(s)-CR8	SgK110	100.0	10000.0
PD0325901	EGFR(L747-S752del,P753S)	59.0	10000.0
WYE-125132	ABL1-nonphosphorylated	100.0	10000.0
PHA-793887	CDKL2	3.2	10000.0
CGP74514A	DCAMKL3	24.0	10000.0
PLX-4720	TXK	69.0	10000.0
AZD7762	PLK1	33.0	10000.0
Palbociclib	CSF1R-autoinhibited	85.0	1000.0
JWE-035	NEK9	72.0	10000.0
BX-912	PIK3CD	84.0	10000.0
XMD13-2	ABL1(Q252H)-nonphosphorylated	61.0	10000.0
Neratinib	TAK1	90.0	10000.0
JNK-IN-11	TYK2(JH1domain-catalytic)	76.0	1000.0
Baricitinib	PKMYT1	100.0	10000.0
Pictilisib	EGFR	100.0	1000.0
BMS-536924	DDR1	6.7	1000.0
SP600125	ABL1(M351T)	100.0	10000.0
THZ1	PAK3	6.0	10000.0
XMD13-2	LRRK2(G2019S)	87.0	10000.0
AZD-6482	CSNK1E	98.0	10000.0
ZSTK474	ERK8	100.0	1000.0
Sorafenib	EPHA7	25.0	10000.0
WZ3105	DYRK2	58.0	10000.0
PHA-793887	PIK3CA(H1047L)	100.0	10000.0
SCH772984	PKAC-alpha	95.0	1000.0
GW-5074	CDK2	97.0	10000.0
XMD-12	CSNK1A1L	98.0	1000.0
AG1478	AMPK-alpha1	100.0	10000.0
NG25	M4K3	22.0	10000.0
GSK1059615	LIMK1	88.0	10000.0
AG1478	TNIK	26.0	10000.0
GW843682X	NUAK1	21.0	10000.0
Torin1	ERK4	80.0	10000.0
Dabrafenib	ERK5	50.0	10000.0
Dactolisib	EPHB4	100.0	1000.0
PD0325901	PFPK5(P.falciparum)	100.0	10000.0
ALW-II-49-7	RPS6KA2(Kin.Dom.2)	100.0	10000.0
AG1478	CDK4-cyclinD3	93.0	10000.0
ERK5-IN-1	PIK3CG	82.0	1000.0
HG-6-64-01	CSNK1A1	87.0	10000.0
Vemurafenib	CDK4-cyclinD1	52.0	10000.0
BGJ398	MAP3K15	83.0	1000.0
QL-X-138	PAK2	87.0	10000.0
AG1478	DCAMKL3	52.0	10000.0
HG-14-8-02	AKT1	100.0	10000.0
NPK76-II-72-1	MINK	100.0	10000.0
NU7441	NEK5	100.0	10000.0
QL-XI-92	CDKL3	90.0	10000.0
CP466722	TNK2	54.0	10000.0
Crizotinib	SNRK	100.0	10000.0
Abemaciclib	TYRO3	81.0	1000.0
Alpelisib	EGFR(L861Q)	82.0	1000.0
A443654	PGFRB	28.0	10000.0
PD0325901	CAMK1	98.0	10000.0
QL-XI-92	EPHA2	28.0	10000.0
Omipalisib	GSK3B	81.0	10000.0
5z-7-oxozeaenol	YANK2	100.0	10000.0
THZ1	FER	1.2	10000.0
NPK76-II-72-1	ADCK4	100.0	10000.0
Dinaciclib	LOK	98.0	10000.0
QL-XI-92	EPHA7	77.0	10000.0
QL-XII-47	ERBB3	83.0	1000.0
CP466722	CAMK1	31.0	10000.0
Canertinib	ERK8	100.0	1000.0
WYE-125132	PAK2	99.0	10000.0
RO-3306	JAK1(JH2domain-pseudokinase)	100.0	10000.0
BX-912	MARK2	0.4	10000.0
Vemurafenib	PIP5K2B	100.0	10000.0
PLX-4720	IKKE	91.0	10000.0
Torin2	EPHB1	100.0	10000.0
5z-7-oxozeaenol	SRMS	84.0	10000.0
PHA-767491	WNK3	80.0	10000.0
XMD14-99	KPCD	68.0	10000.0
XMD14-99	KPCL	93.0	10000.0
Barasertib	EPHB4	100.0	10000.0
R406	KIT(V559D,T670I)	0.1	1000.0
XMD11-50	CDK4-cyclinD1	100.0	10000.0
AZD-6482	PKMYT1	100.0	10000.0
Dabrafenib	PKN2	96.0	10000.0
JWE-035	KGP1	100.0	10000.0
BS-181	DMPK2	100.0	10000.0
PHA-793887	GRK4	92.0	10000.0
JNK-9L	VGFR2	75.0	10000.0
Buparlisib	NEK4	100.0	1000.0
Baricitinib	HUNK	64.0	10000.0
AG1478	DRAK2	40.0	10000.0
Pictilisib	CAMK1D	99.0	1000.0
JW-7-24-1	PGFRB	0.1	10000.0
GW-5074	INSRR	81.0	10000.0
AZD-6482	CAMK2B	83.0	10000.0
BMS-536924	JAK1(Kin.Dom.1)	0.0	1000.0
GW-5074	MK01	87.0	10000.0
Baricitinib	CAMK2A	0.1	10000.0
Momelotinib	AURKA	12.0	10000.0
JNK-IN-8	RET	100.0	1000.0
PD0325901	ULK1	100.0	10000.0
HG-6-64-01	PKN1	16.0	10000.0
JNK-IN-5A	PIK3CA(H1047Y)	100.0	10000.0
Palbociclib	ALK	95.0	1000.0
QL-XII-47	PIK3CB	100.0	1000.0
GSK429286A	MP2K4	71.0	10000.0
JNK-9L	PLK2	98.0	10000.0
CGP60474	FLT4	100.0	10000.0
Crizotinib	FRK	15.0	10000.0
GSK1059615	DRAK2	0.6	10000.0
Neratinib	FGFR4	100.0	10000.0
XMD8-92	TNK2	17.0	10000.0
HG-14-10-04	NEK11	66.0	10000.0
PD0325901	VGFR1	94.0	10000.0
GSK429286A	TAK1	78.0	10000.0
GSK1059615	IRAK3	14.0	10000.0
BX-912	BMPR1A	80.0	10000.0
Sigma A6730	RIOK3	64.0	10000.0
XMD11-85h	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
TGX221	TTK	100.0	1000.0
NU7441	ADCK3	72.0	10000.0
Palbociclib	LYN	95.0	1000.0
BI-2536	PLK1	19.0	10000.0
OTSSP167	CLK1	15.0	10000.0
JNK-IN-8	FLT3(N841I)	93.0	1000.0
BMS345541	NUAK1	88.0	10000.0
A443654	AKT2	3.2	10000.0
PD173074	TYK2(Kin.Dom.2)	100.0	10000.0
XMD13-2	MK11	2.6	10000.0
JNK-9L	DCAMKL2	100.0	10000.0
GSK429286A	ACVR2A	88.0	10000.0
BX-912	SLK	0.4	10000.0
CH5424802	DCAMKL3	28.0	1000.0
RO-3306	NIM1	100.0	10000.0
CGP60474	TGFBR1	100.0	10000.0
AG1478	WEE2	81.0	10000.0
KU63794	ERBB3	85.0	10000.0
ZM-447439	RAF1	100.0	10000.0
BS-181	GSK3B	100.0	10000.0
MLN8054	TEC	2.0	10000.0
CH5424802	SIK1	97.0	1000.0
NU7441	TRKA	81.0	10000.0
AZD4547	PAK4	23.0	10000.0
Buparlisib	HIPK4	100.0	1000.0
XMD8-92	KPCL	100.0	10000.0
A443654	ACVRL1	100.0	10000.0
CG-930	EPHA6	79.0	10000.0
Torin2	STK33	100.0	10000.0
AZD-6482	STK16	77.0	10000.0
NG25	FGR	0.4	10000.0
ZG-10	CAMK1D	100.0	10000.0
Torkinib	SNRK	100.0	10000.0
SB590885	KCC2D	100.0	10000.0
XMD-12	PIK3CB	94.0	1000.0
WZ3105	M3K6	86.0	10000.0
AZ-628	NEK11	94.0	10000.0
Vemurafenib	AURKB	24.0	10000.0
GW-5074	PIK3CA	85.0	10000.0
QL-XI-92	MINK	84.0	10000.0
AZD 5438	PLK3	68.0	10000.0
HG-14-8-02	MP2K4	100.0	10000.0
JNK-IN-5A	IKKA	100.0	10000.0
KIN001-111	RPS6KA5(Kin.Dom.2)	100.0	1000.0
TGX221	RIOK1	100.0	1000.0
XMD8-85	CLK3	100.0	10000.0
GSK429286A	PKMYT1	100.0	10000.0
QL-XII-47	VRK2	89.0	1000.0
BX-912	TESK1	99.0	10000.0
WZ-4-145	RET	0.6	10000.0
XMD14-99	EGFR(L861Q)	100.0	10000.0
Pictilisib	M3K5	100.0	1000.0
Barasertib	PIK3CA(E545K)	100.0	10000.0
Lapatinib	CAMK2G	100.0	10000.0
PHA-767491	NLK	28.0	10000.0
GW843682X	NEK7	74.0	10000.0
BX-912	ABL1(F317L)-nonphosphorylated	11.0	10000.0
KIN001-111	BMPR1B	100.0	1000.0
(s)-CR8	RSK1(Kin.Dom.1-N-terminal)	85.0	10000.0
Ceritinib	NEK2	94.0	1000.0
Sigma A6730	PAK2	74.0	10000.0
Pictilisib	MP2K1	75.0	1000.0
WYE-125132	FLT4	88.0	10000.0
ZG-10	SIK1	100.0	10000.0
Ibrutinib	STK16	99.0	1000.0
KU63794	PGFRB	95.0	10000.0
PHA-767491	SNRK	100.0	10000.0
MPS-1-IN-1	ABL1(F317I)	100.0	1000.0
NU7441	DAPK1	72.0	10000.0
Sigma A6730	M4K3	100.0	10000.0
XMD11-50	FLT3(D835H)	100.0	10000.0
WZ3105	MAP3K4	100.0	10000.0
XMD11-50	CDC2L2	82.0	10000.0
BMX-IN-1	HIPK2	100.0	10000.0
CP466722	PIK3CA	38.0	10000.0
PHA-793887	LIMK1	100.0	10000.0
Dabrafenib	EGFR(L747-S752del,P753S)	97.0	10000.0
AZD4547	MRCKB	100.0	10000.0
THZ1	EPHB4	27.0	10000.0
XMD8-85	ICK	100.0	10000.0
XMD-12	EGFR(E746-A750del)	100.0	1000.0
Palbociclib	TNK2	100.0	1000.0
AZD7762	YSK1	0.0	10000.0
KU63794	LATS1	96.0	10000.0
PHA-767491	MAP3K15	88.0	10000.0
ZG-10	CLK1	4.6	10000.0
Sigma A6730	KC1G2	59.0	10000.0
QL-XII-47	M4K3	94.0	1000.0
5z-7-oxozeaenol	RIOK2	100.0	10000.0
Baricitinib	KPCE	13.0	10000.0
NVP-TAE684	YSK1	100.0	1000.0
WZ4003	MAPKAPK5	100.0	1000.0
WH-4-023	GRK4	7.9	10000.0
BMX-IN-1	SgK110	100.0	10000.0
MPS-1-IN-1	ABL1(Q252H)	100.0	1000.0
THZ1	PIP5K1A	0.0	10000.0
BGJ398	SRMS	86.0	1000.0
JNK-IN-8	STK35	68.0	1000.0
Alpelisib	IRAK1	97.0	1000.0
ALW-II-38-3	YANK2	100.0	10000.0
Dinaciclib	CSNK2A2	80.0	10000.0
NVP-TAE684	MP2K2	1.8	1000.0
NVP-TAE684	ACVR1B	0.1	1000.0
AZD-6482	CAMK1G	91.0	10000.0
Lapatinib	EPHB4	91.0	10000.0
JNK-IN-5A	NLK	65.0	10000.0
KU63794	AURKA	80.0	10000.0
Barasertib	FLT3(D835Y)	21.0	10000.0
Buparlisib	NDR1	89.0	1000.0
Abemaciclib	PIK3CB	100.0	1000.0
Canertinib	FRK	100.0	1000.0
AZD4547	CDK9	47.0	10000.0
NPK76-II-72-1	ULK3	100.0	10000.0
Buparlisib	SIK3	100.0	1000.0
Dabrafenib	ABL1(E255K)-phosphorylated	14.0	10000.0
GSK429286A	AURKA	46.0	10000.0
WZ3105	EGFR(L858R,T790M)	100.0	10000.0
PD173074	CLK3	100.0	10000.0
Lapatinib	PIK3CA(M1043I)	100.0	10000.0
OTSSP167	PKN2	27.0	10000.0
XMD8-92	MERTK	100.0	10000.0
WZ3105	CAMK1	93.0	10000.0
NG25	MYO3A	6.4	10000.0
Abemaciclib	BMX	100.0	1000.0
PHA-793887	KPCE	9.6	10000.0
NU7441	EPHB2	91.0	10000.0
NU7441	RIPK4	100.0	10000.0
Barasertib	BRAF	100.0	10000.0
XMD-12	IKKE	87.0	1000.0
MPS-1-IN-1	KIT	100.0	1000.0
Ceritinib	ABL1(F317I)-nonphosphorylated	68.0	1000.0
PHA-793887	MYLK2	100.0	10000.0
Barasertib	RET(M918T)	0.2	10000.0
Torkinib	MERTK	61.0	10000.0
Momelotinib	MYO3A	100.0	10000.0
OTSSP167	PAK3	100.0	10000.0
AS-252424	STK16	83.4	10000.0
TAK-715	PHKG1	100.0	10000.0
Dabrafenib	YANK3	92.0	10000.0
NG25	ROS1	100.0	10000.0
Vemurafenib	IGF1R	93.0	10000.0
ZM-447439	PKN2	100.0	10000.0
AZD7762	MP2K3	10.0	10000.0
CP724714	ROS1	100.0	10000.0
HG-5-88-01	M4K3	100.0	10000.0
Torin2	CDK14	97.0	10000.0
KIN001-127	MAPKAPK2	100.0	10000.0
Lapatinib	TRKA	77.0	10000.0
Momelotinib	ACVRL1	47.0	10000.0
A443654	ERBB2	100.0	10000.0
AG1478	CDKL3	76.0	10000.0
BS-181	ACVR1B	100.0	10000.0
WZ4003	MARK3	8.7	1000.0
XMD11-85h	PIM2	100.0	10000.0
Crizotinib	RIPK1	5.0	10000.0
AZD-6482	MLK2	96.0	10000.0
BGJ398	PIK3CA	74.0	1000.0
BGJ398	PLK4	74.0	1000.0
AG1478	FGFR2	99.0	10000.0
5z-7-oxozeaenol	EIF2AK1	100.0	10000.0
CP466722	LKB1	100.0	10000.0
CH5424802	EGFR(S752-I759del)	11.0	1000.0
Momelotinib	SRPK1	1.6	10000.0
Buparlisib	PLK1	98.0	1000.0
Omipalisib	TIE1	79.0	10000.0
AG1478	YANK2	100.0	10000.0
AZD 5438	RIOK3	13.0	10000.0
BS-181	EPHA7	87.0	10000.0
TGX221	BIKE	100.0	1000.0
Vemurafenib	TBK1	100.0	10000.0
5z-7-oxozeaenol	PIK4CB	100.0	10000.0
NG25	RPS6KA1(Kin.Dom.2)	100.0	10000.0
BX-912	RET(V804M)	0.1	10000.0
MLN8054	MARK2	93.0	10000.0
PHA-793887	EGFR(G719S)	81.0	10000.0
BMX-IN-1	IKKE	100.0	10000.0
HG-14-10-04	GSK3B	100.0	10000.0
Alpelisib	IRAK3	72.0	1000.0
WYE-125132	PKMYT1	75.0	10000.0
Omipalisib	BMPR1A	100.0	10000.0
ZSTK474	FGFR4	100.0	1000.0
Buparlisib	PCTK3	100.0	1000.0
ERK5-IN-1	JNK1	76.0	1000.0
CGP60474	RPS6KA6(Kin.Dom.2)	100.0	10000.0
HG-6-64-01	CLK3	100.0	10000.0
QL-XII-47	ULK2	100.0	1000.0
TAK-715	MP2K5	5.2	10000.0
PHA-767491	ABL1(Q252H)-phosphorylated	58.0	10000.0
XMD11-50	AXL	100.0	10000.0
SCH772984	MP2K7	95.0	1000.0
Omipalisib	FAK2	86.0	10000.0
Lapatinib	MP2K4	68.0	10000.0
Omipalisib	KIT(A829P)	67.0	10000.0
BMX-IN-1	PIP5K1A	54.0	10000.0
ALW-II-38-3	CLK3	100.0	10000.0
BMS345541	IKKA	86.0	10000.0
Crizotinib	SRPK1	26.0	10000.0
KU63794	RIPK2	100.0	10000.0
(s)-CR8	M4K3	15.0	10000.0
WZ4003	IGF1R	8.8	1000.0
Alpelisib	RIPK1	100.0	1000.0
MRT67307	KCC2D	24.0	10000.0
ZM-447439	MLCK	100.0	10000.0
WZ-4-145	MST1R	100.0	10000.0
GSK429286A	EPHA7	80.0	10000.0
PHA-793887	EGFR(L747-S752del,P753S)	86.0	10000.0
CGP74514A	PRKR	21.0	10000.0
WZ4002	TLK2	100.0	10000.0
CP724714	AKT1	100.0	10000.0
Dactolisib	GAK	100.0	1000.0
NG25	CLK1	100.0	10000.0
MRT67307	ERK5	86.0	10000.0
KIN001-021	TLK2	100.0	1000.0
XMD13-2	SgK110	100.0	10000.0
ZM-447439	OSR1	100.0	10000.0
BI-2536	MRCKA	100.0	10000.0
CGP60474	CAMK1G	100.0	10000.0
XMD8-92	ROS1	15.0	10000.0
Ceritinib	ROCK2	75.0	1000.0
BS-181	OSR1	76.0	10000.0
HG-6-64-01	PDPK1	65.0	10000.0
HG-14-10-04	MET(M1250T)	1.3	10000.0
QL-XI-92	TBK1	100.0	10000.0
QL-X-138	GRK1	75.0	10000.0
BX-912	DAPK1	1.2	10000.0
CG-930	BRAF	96.0	10000.0
Baricitinib	M3K2	0.0	10000.0
MPS-1-IN-1	TYRO3	100.0	1000.0
PD0325901	TLK2	98.0	10000.0
Dabrafenib	EGFR(L858R,T790M)	71.0	10000.0
Sigma A6730	TTK	100.0	10000.0
WH-4-023	DCLK1	84.0	10000.0
5z-7-oxozeaenol	YSK4	100.0	10000.0
XMD14-99	IRAK4	96.0	10000.0
A443654	KIT(D816V)	1.1	10000.0
XMD11-50	IKKA	100.0	10000.0
HG-6-64-01	PIK3CG	96.0	10000.0
XMD11-50	MKNK2	1.2	10000.0
A443654	NEK9	100.0	10000.0
Vemurafenib	MYO3A	57.0	10000.0
Momelotinib	CDK8	100.0	10000.0
AZD 5438	PKN2	4.6	10000.0
ZG-10	ACVR2B	98.0	10000.0
Abemaciclib	MYLK	32.0	1000.0
GSK429286A	TRKA	91.0	10000.0
NU7441	KKCC1	85.0	10000.0
CGP60474	EGFR(E746-A750del)	100.0	10000.0
BS-181	TSSK1	93.0	10000.0
Canertinib	MLK3	100.0	1000.0
Dabrafenib	ULK3	0.6	10000.0
TGX221	FAK2	100.0	1000.0
PHA-793887	KGP2	94.0	10000.0
PHA-793887	NEK11	98.0	10000.0
HG-5-113-01	TRKB	0.0	10000.0
SB590885	CDK5	100.0	10000.0
ALW-II-38-3	MST4	100.0	10000.0
5z-7-oxozeaenol	MP2K3	1.4	10000.0
PD173074	LOK	100.0	10000.0
AZD7762	RSK1(Kin.Dom.1-N-terminal)	11.0	10000.0
SB590885	NEK7	100.0	10000.0
SB590885	AURKC	100.0	10000.0
JNK-IN-8	PI42C	46.0	1000.0
BI-D1870	JAK2(JH1domain-catalytic)	11.0	10000.0
TAK-715	SNRK	100.0	10000.0
Dactolisib	TBK1	100.0	1000.0
JNK-IN-8	LATS1	91.0	1000.0
Dinaciclib	TESK1	83.0	10000.0
CG-930	AURKA	91.0	10000.0
JNK-IN-5A	NEK4	76.0	10000.0
Ribociclib	MST1R	98.0	1000.0
WH-4-023	MELK	46.0	10000.0
Abemaciclib	PIK3CG	54.0	1000.0
KIN001-127	CAMK1D	100.0	10000.0
CP466722	MAP3K4	100.0	10000.0
WZ3105	CDK11	100.0	10000.0
ZG-10	GCN2(Kin.Dom.2,S808G)	97.0	10000.0
R406	CDC2L2	100.0	1000.0
XMD11-50	GCN2(Kin.Dom.2,S808G)	95.0	10000.0
ERK5-IN-1	CLK2	86.0	1000.0
XMD11-50	EPHB6	31.0	10000.0
HG-6-64-01	CAMKK2	100.0	10000.0
NU7441	EGFR(L861Q)	100.0	10000.0
ZSTK474	MYLK	100.0	1000.0
BGJ398	KGP2	87.0	1000.0
XMD13-2	FGFR4	94.0	10000.0
WZ-7043	NLK	100.0	10000.0
Pictilisib	ZAP70	100.0	1000.0
QL-XII-47	FLT3(D835H)	100.0	1000.0
Lapatinib	ABL1(T315I)-phosphorylated	100.0	10000.0
GW843682X	DAPK2	36.0	10000.0
CG-930	CDKL2	100.0	10000.0
SB590885	MAP4K4	27.0	10000.0
Ribociclib	PRKX	100.0	1000.0
Ribociclib	PKMYT1	94.0	1000.0
XMD-12	NEK6	96.0	1000.0
BX-912	TEC	47.0	10000.0
KIN001-123	MAP3K4	100.0	1000.0
MPS-1-IN-1	EPHA8	100.0	1000.0
SCH772984	MLK3	100.0	1000.0
Torin2	MRCKB	96.0	10000.0
WZ4002	RPS6KA6(Kin.Dom.2)	27.0	10000.0
Ibrutinib	MYO3A	54.0	1000.0
AG1478	BRAF	64.0	10000.0
Ceritinib	MTOR	100.0	1000.0
HG-5-113-01	TEC	2.6	10000.0
Sigma A6730	ICK	91.0	10000.0
AZ-628	CDC2L1	11.0	10000.0
HG-9-91-01	NEK5	100.0	10000.0
NU7441	IRAK4	99.0	10000.0
Momelotinib	FYN	78.0	10000.0
JNK-IN-11	RSK3(Kin.Dom.2-C-terminal)	82.0	1000.0
5z-7-oxozeaenol	AKT2	93.0	10000.0
PHA-767491	PIK3C2B	81.0	10000.0
SCH772984	CDK11	91.0	1000.0
Dinaciclib	RET(V804L)	100.0	10000.0
BGJ398	MYLK	96.0	1000.0
CGP60474	AMPK-alpha2	100.0	10000.0
Torin1	EPHA4	90.0	10000.0
WH-4-023	PIK3CA(C420R)	100.0	10000.0
BGJ398	BMX	89.0	1000.0
HG-14-10-04	DMPK	10.0	10000.0
MRT67307	NDR1	33.0	10000.0
SB590885	PAK1	87.0	10000.0
Dinaciclib	SRPK1	85.0	10000.0
QL-XI-92	RIOK3	76.0	10000.0
A443654	ABL1(Q252H)	100.0	10000.0
PHA-793887	NUAK1	97.0	10000.0
THZ1	KPCD3	5.0	10000.0
HG-6-64-01	FLT4	0.2	10000.0
THZ1	ERK3	0.4	10000.0
SP600125	STK33	100.0	10000.0
Torin1	ULK1	100.0	10000.0
PHA-767491	PIK4CB	81.0	10000.0
QL-X-138	CAMK2B	44.0	10000.0
CG-930	SBK1	73.0	10000.0
XMD11-85h	MINK	100.0	10000.0
GSK1059615	GAK	0.0	10000.0
WZ-7043	MYLK4	100.0	10000.0
CP466722	CAMK2B	37.0	10000.0
JNK-IN-11	BLK	5.9	1000.0
Ceritinib	FES	0.9	1000.0
ZM-447439	FLT3(K663Q)	4.0	10000.0
Dactolisib	CAMKK2	100.0	1000.0
WZ-7043	MAPKAPK2	100.0	10000.0
XMD8-92	CDK3	100.0	10000.0
XMD11-50	RSK4(Kin.Dom.2-C-terminal)	2.2	10000.0
5z-7-oxozeaenol	SIK1	96.0	10000.0
AZD4547	MAPKAPK5	96.0	10000.0
5z-7-oxozeaenol	MARK4	93.0	10000.0
HG-6-64-01	PKAC-alpha	100.0	10000.0
Palbociclib	WNK4	100.0	1000.0
GW843682X	PIP5K1C	10.0	10000.0
ZG-10	CDK4-cyclinD1	100.0	10000.0
PHA-793887	PLK3	99.0	10000.0
Buparlisib	ABL1(T315I)-phosphorylated	100.0	1000.0
WZ4002	TLK1	100.0	10000.0
Dinaciclib	MAP4K4	79.0	10000.0
Taselisib	SYK	96.0	1000.0
Vemurafenib	LATS1	100.0	10000.0
CH5424802	CSNK2A1	8.5	1000.0
Ribociclib	SRPK3	84.0	1000.0
RO-3306	CDK5	80.0	10000.0
Buparlisib	MK13	79.0	1000.0
Torin1	INSRR	100.0	10000.0
ZSTK474	ERK4	100.0	1000.0
NG25	PAK1	100.0	10000.0
MRT67307	INSRR	100.0	10000.0
WZ3105	KCC4	100.0	10000.0
THZ1	AURKB	0.3	10000.0
HG-14-8-02	MINK	13.0	10000.0
Palbociclib	KCC4	100.0	1000.0
QL-XII-47	MST3	79.0	1000.0
Ceritinib	BMPR1B	60.0	1000.0
PLX-4720	EPHA1	100.0	10000.0
KIN001-127	NUAK1	100.0	10000.0
Momelotinib	ITK	98.0	10000.0
Lapatinib	ERBB3	37.0	10000.0
RO-3306	RSK2(Kin.Dom.2-C-terminal)	84.0	10000.0
BX-912	HIPK3	3.7	10000.0
NVP-TAE684	ERK5	0.0	1000.0
CP724714	ABL1(H396P)-nonphosphorylated	100.0	10000.0
MRT67307	TYK2(JH1domain-catalytic)	7.3	10000.0
Barasertib	ROS1	100.0	10000.0
MLN8054	ABL1(H396P)-phosphorylated	8.8	10000.0
A443654	FRK	100.0	10000.0
HG-5-113-01	FES	12.0	10000.0
MLN8054	TGFBR2	58.0	10000.0
QL-XII-47	HIPK4	99.0	1000.0
WZ-7043	HIPK2	100.0	10000.0
BMS-536924	NEK9	1.6	1000.0
JNK-IN-8	EPHA2	100.0	1000.0
XMD16-144	DYRK2	47.0	10000.0
KIN001-021	STK36	100.0	1000.0
AG1478	EPHA4	72.0	10000.0
Taselisib	KC1G2	100.0	1000.0
CH5424802	ULK3	90.0	1000.0
BMX-IN-1	STK36	100.0	10000.0
WZ4003	CSNK2A2	100.0	1000.0
GW843682X	GRK1	96.0	10000.0
5z-7-oxozeaenol	PIM1	89.0	10000.0
(s)-CR8	RSK4(Kin.Dom.1-N-terminal)	79.0	10000.0
BX-912	INSR	27.0	10000.0
MLN8054	MINK	100.0	10000.0
MLN8054	TIE2	3.0	10000.0
HG-14-10-04	IRAK3	0.0	10000.0
Sorafenib	KPCE	86.0	10000.0
Torin2	ABL1(F317I)-phosphorylated	90.0	10000.0
ZSTK474	ABL1(Q252H)	100.0	1000.0
ERK5-IN-1	HIPK2	100.0	1000.0
WZ-4-145	EGFR(L747-E749del,A750P)	0.6	10000.0
5z-7-oxozeaenol	MK13	95.0	10000.0
WZ4002	NEK7	12.0	10000.0
BI-2536	CDK14	100.0	10000.0
Dinaciclib	PIP5K1A	100.0	10000.0
KIN001-111	EPHA4	100.0	1000.0
Abemaciclib	TAOK3	1.4	1000.0
ERK5-IN-1	MLK3	100.0	1000.0
XMD8-85	ERK8	100.0	10000.0
BGJ398	FLT3(D835H)	69.0	1000.0
NG25	TEC	100.0	10000.0
KIN001-220	ACVR1B	45.0	10000.0
HG-14-8-02	YSK4	0.1	10000.0
KIN001-220	ABL1(Q252H)-nonphosphorylated	11.0	10000.0
Lapatinib	PKAC-alpha	93.0	10000.0
HG-14-8-02	CDKL5	100.0	10000.0
Pictilisib	KIT	99.0	1000.0
PHA-767491	HIPK3	2.8	10000.0
AZD7762	EPHB6	50.0	10000.0
WZ-4-145	CLK2	100.0	10000.0
Alpelisib	NEK10	100.0	1000.0
PLX-4720	KPCD3	100.0	10000.0
Seliciclib	AKT2	89.0	10000.0
KIN001-123	EPHA6	100.0	1000.0
KIN001-127	NEK2	18.0	10000.0
XMD8-85	RPS6KA6(Kin.Dom.2)	4.9	10000.0
BMS-536924	KC1G1	100.0	1000.0
HG-5-88-01	BRSK1	100.0	10000.0
Alpelisib	BMPR2	100.0	1000.0
GW843682X	MK12	76.0	10000.0
CG-930	EPHA4	93.0	10000.0
KIN001-021	DCAMKL2	100.0	1000.0
XMD-12	PAK6	100.0	1000.0
WZ-4-145	EPHA4	100.0	10000.0
AZD4547	IRAK4	63.0	10000.0
GSK461364	CAMK2G	15.0	10000.0
HG-6-64-01	MAP3K15	100.0	10000.0
HG-5-113-01	AURKB	0.7	10000.0
Sigma A6730	PFCDPK1(P.falciparum)	40.0	10000.0
NVP-TAE684	BRAF	100.0	1000.0
ERK5-IN-1	NLK	78.0	1000.0
BMX-IN-1	RIOK1	52.0	10000.0
NVP-TAE684	PIP5K2B	11.0	1000.0
Pictilisib	FGFR3(G697C)	100.0	1000.0
Canertinib	TESK1	100.0	1000.0
ZM-447439	DMPK	100.0	10000.0
OTSSP167	MUSK	1.0	10000.0
CG-930	PTK6	100.0	10000.0
ZG-10	MARK2	73.0	10000.0
JWE-035	NEK3	100.0	10000.0
ERK5-IN-1	MP2K3	86.0	1000.0
NU7441	CDKL3	100.0	10000.0
XMD13-2	PIK3C2G	100.0	10000.0
GSK429286A	CSNK1A1	86.0	10000.0
SCH772984	PIK3CA(E545A)	71.0	1000.0
HG-9-91-01	ABL1(E255K)-phosphorylated	0.6	10000.0
ERK5-IN-1	PFCDPK1(P.falciparum)	100.0	1000.0
GSK461364	PLK4	97.0	10000.0
ERK5-IN-1	EIF2AK1	100.0	1000.0
NVP-TAE684	AKT2	100.0	1000.0
Dabrafenib	AAK1	26.0	10000.0
AG1478	MAPKAPK5	9.9	10000.0
MPS-1-IN-1	NEK2	100.0	1000.0
Dactolisib	RET(M918T)	100.0	1000.0
Barasertib	AMPK-alpha2	77.0	10000.0
Sorafenib	BMPR1B	100.0	10000.0
HG-5-88-01	BIKE	100.0	10000.0
TGX221	KCC2D	100.0	1000.0
GSK1059615	WNK3	86.0	10000.0
Alpelisib	JNK3	100.0	1000.0
Lapatinib	TIE1	100.0	10000.0
MRT67307	BRSK2	100.0	10000.0
KIN001-127	EPHA4	100.0	10000.0
JNK-IN-11	MST1	4.2	1000.0
Palbociclib	AURKB	100.0	1000.0
BMX-IN-1	BTK	0.7	10000.0
Torkinib	RIPK1	100.0	10000.0
CGP60474	MAK	4.6	10000.0
Ceritinib	BLK	96.0	1000.0
OTSSP167	FLT3	7.6	10000.0
ZSTK474	ABL1(F317I)	100.0	1000.0
NPK76-II-72-1	MUSK	100.0	10000.0
NVP-TAE684	ERK8	0.3	1000.0
XMD8-85	JNK1	100.0	10000.0
AZD 5438	JNK3	0.0	10000.0
GSK1059615	ABL1(F317L)-phosphorylated	60.0	10000.0
XMD8-85	AURKB	100.0	10000.0
BI-D1870	RET(V804M)	24.0	10000.0
A443654	RPS6KA6(Kin.Dom.1)	100.0	10000.0
WH-4-023	DCAMKL3	100.0	10000.0
Alpelisib	MAPKAPK5	100.0	1000.0
Sorafenib	MAP4K2	100.0	10000.0
XMD11-85h	MAK	100.0	10000.0
Neratinib	SRPK1	100.0	10000.0
A443654	CAMK2B	1.4	10000.0
SP600125	CDK7	26.0	10000.0
ALW-II-38-3	ERK8	100.0	10000.0
BMS345541	CHK2	97.0	10000.0
Dabrafenib	NEK4	58.0	10000.0
XMD13-2	EGFR(E746-A750del)	90.0	10000.0
CGP60474	BIKE	100.0	10000.0
PHA-793887	EPHB1	100.0	10000.0
HG-14-8-02	SIK2	51.0	10000.0
BI-2536	DCAMKL3	100.0	10000.0
HG-6-64-01	DCAMKL2	100.0	10000.0
HG-6-64-01	GRK1	96.0	10000.0
JNK-IN-8	ABL1(T315I)-nonphosphorylated	100.0	1000.0
AZD 5438	FLT3(N841I)	1.8	10000.0
Ibrutinib	BMPR1B	75.0	1000.0
Dactolisib	FLT3(N841I)	100.0	1000.0
AZD4547	TAK1	9.0	10000.0
PLX-4720	CSNK2A2	12.0	10000.0
Taselisib	EPHB1	100.0	1000.0
ERK5-IN-1	MLK1	100.0	1000.0
XMD11-50	TNIK	100.0	10000.0
PD0325901	MARK2	100.0	10000.0
QL-XI-92	KC1G2	100.0	10000.0
PD0325901	YSK4	100.0	10000.0
QL-XII-47	DYRK2	96.0	1000.0
PD173074	EGFR(S752-I759del)	100.0	10000.0
SCH772984	SRC	100.0	1000.0
Vemurafenib	KC1G1	100.0	10000.0
BI-2536	SRPK1	100.0	10000.0
KIN001-127	BRAF	100.0	10000.0
Ceritinib	EIF2AK1	92.0	1000.0
GSK1059615	WEE1	100.0	10000.0
GSK461364	MRCKB	100.0	10000.0
ALW-II-38-3	MKNK2	100.0	10000.0
Buparlisib	AKT1	99.0	1000.0
XMD13-2	TEC	95.0	10000.0
BS-181	ROCK1	90.0	10000.0
JNK-9L	MELK	100.0	10000.0
MRT67307	TNIK	80.0	10000.0
CP724714	PKAC-alpha	100.0	10000.0
Torkinib	PIK3CA(E545K)	21.0	10000.0
BI-2536	ACVRL1	100.0	10000.0
Abemaciclib	M3K12	64.0	1000.0
WH-4-023	ADCK3	26.0	10000.0
Dabrafenib	KCC4	4.5	10000.0
GSK1059615	MET	32.0	10000.0
XMD14-99	YSK1	66.0	10000.0
AZD7762	KPCD1	0.3	10000.0
PHA-767491	STK35	5.0	10000.0
OTSSP167	EGFR(G719C)	36.0	10000.0
Omipalisib	CAMK1D	81.0	10000.0
AZD 5438	MAP4K2	3.4	10000.0
A443654	MELK	12.0	10000.0
Sorafenib	MRCKA	95.0	10000.0
KIN001-127	TAK1	100.0	10000.0
HG-5-88-01	PIM2	100.0	10000.0
CP466722	JNK1	12.0	10000.0
(s)-CR8	NEK1	95.0	10000.0
Dinaciclib	MP2K3	98.0	10000.0
NPK76-II-72-1	KPCD1	100.0	10000.0
Abemaciclib	PIK3C2G	97.0	1000.0
Dabrafenib	RIOK1	41.0	10000.0
XMD-12	ABL1(H396P)-nonphosphorylated	0.2	1000.0
MPS-1-IN-1	BRAF(V600E)	100.0	1000.0
BX-912	PIK3C2G	25.0	10000.0
CGP60474	MAP4K4	100.0	10000.0
GSK461364	ULK1	41.0	10000.0
MLN8054	KPCI	100.0	10000.0
HG-9-91-01	FAK1	52.0	10000.0
Sorafenib	NEK4	81.0	10000.0
NVP-TAE684	SRC	0.2	1000.0
PHA-793887	MAP3K15	100.0	10000.0
SB590885	EGFR(E746-A750del)	100.0	10000.0
WZ-7043	RIOK2	100.0	10000.0
Taselisib	CAMK1D	98.0	1000.0
JNK-9L	FES	91.0	10000.0
PHA-767491	RSK3(Kin.Dom.2-C-terminal)	15.0	10000.0
(s)-CR8	MAP4K4	96.0	10000.0
KIN001-127	SIK2	100.0	10000.0
HG-14-8-02	PIK3CB	87.0	10000.0
NU7441	HUNK	75.0	10000.0
GSK461364	MK09	100.0	10000.0
BMX-IN-1	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
QL-XI-92	SRPK3	100.0	10000.0
JNK-IN-5A	NIM1	100.0	10000.0
Torin2	ULK2	95.0	10000.0
HG-14-8-02	GRK7	61.0	10000.0
CH5424802	WNK2	76.0	1000.0
Pictilisib	ADCK4	87.0	1000.0
XMD-12	ALK	100.0	1000.0
HG-14-8-02	KGP1	100.0	10000.0
MRT67307	TNNI3K	73.0	10000.0
CH5424802	MP2K4	100.0	1000.0
TAK-715	CAMK2G	100.0	10000.0
BI-2536	SLK	3.0	10000.0
GSK429286A	AMPK-alpha1	13.0	10000.0
Palbociclib	FLT3(ITD,F691L)	58.0	1000.0
NVP-TAE684	MLK2	4.6	1000.0
XMD8-92	MK03	100.0	10000.0
ERK5-IN-1	DDR1	100.0	1000.0
CP724714	M3K6	100.0	10000.0
HG-5-113-01	ALK	1.8	10000.0
GW843682X	TAOK1	47.0	10000.0
XMD-12	IRAK4	93.0	1000.0
CP466722	RSK2(Kin.Dom.1-N-terminal)	2.8	10000.0
SCH772984	KIT-autoinhibited	100.0	1000.0
Torin2	RSK3(Kin.Dom.1-N-terminal)	100.0	10000.0
AZD 5438	CAMK2G	63.0	10000.0
CP724714	JAK1(JH2domain-pseudokinase)	68.0	10000.0
Alpelisib	FGFR3(G697C)	88.0	1000.0
Torin2	CDK15	94.0	10000.0
MPS-1-IN-1	MINK	100.0	1000.0
CGP74514A	MARK3	13.0	10000.0
AS-252424	AXL	100.0	10000.0
BMS345541	JAK1(JH2domain-pseudokinase)	47.0	10000.0
Buparlisib	SYK	90.0	1000.0
HG-14-10-04	PIM2	29.0	10000.0
Torin2	TAOK1	62.0	10000.0
AZD-6482	ACVR1B	93.0	10000.0
(s)-CR8	M3K13	100.0	10000.0
KIN001-127	MYO3B	100.0	10000.0
JNK-IN-5A	TNK1	74.0	10000.0
Palbociclib	MAST1	87.0	1000.0
Torin1	CHEK1	89.0	10000.0
Crizotinib	PIK3CA(I800L)	88.0	10000.0
AG1478	GAK	0.0	10000.0
Momelotinib	FLT3(D835H)	19.0	10000.0
ZSTK474	ABL1(F317L)	100.0	1000.0
AZ-628	NEK7	96.0	10000.0
SCH772984	MK09	4.1	1000.0
Torin2	RPS6KA4(Kin.Dom.1-N-terminal)	82.0	10000.0
CG-930	YANK2	87.0	10000.0
XMD-12	KCC2D	88.0	1000.0
XMD14-99	EGFR	100.0	10000.0
NU7441	TSSK1	83.0	10000.0
BMX-IN-1	ANKK1	77.0	10000.0
XMD13-2	NEK3	75.0	10000.0
HG-14-10-04	MK13	100.0	10000.0
Omipalisib	CDKL5	100.0	10000.0
AZD 5438	RSK4(Kin.Dom.2-C-terminal)	60.0	10000.0
(s)-CR8	DDR2	92.0	10000.0
KIN001-220	FAK2	33.0	10000.0
KIN001-123	YSK1	100.0	1000.0
XMD14-99	ERBB2	100.0	10000.0
Crizotinib	ABL1(Y253F)-phosphorylated	0.1	10000.0
JNK-IN-5A	ABL1-nonphosphorylated	93.0	10000.0
KIN001-220	PIM1	60.0	10000.0
Momelotinib	LOK	100.0	10000.0
GW843682X	MRCKB	64.0	10000.0
AG1478	CDK8	100.0	10000.0
Sigma A6730	DAPK2	100.0	10000.0
AZD 5438	SGK1	8.2	10000.0
Crizotinib	AKT3	100.0	10000.0
Torin1	SNARK	100.0	10000.0
Canertinib	ABL1(M351T)	100.0	1000.0
KIN001-111	PAK4	28.0	1000.0
JNK-IN-8	ABL1(F317L)-nonphosphorylated	65.0	1000.0
AZ-628	CTK	100.0	10000.0
KIN001-111	KCC4	5.6	1000.0
NG25	TLK1	100.0	10000.0
NVP-TAE684	CHEK1	0.0	1000.0
XMD13-2	MK12	24.0	10000.0
Pictilisib	CDK8	92.0	1000.0
KIN001-123	STK36	100.0	1000.0
BI-2536	ERK3	100.0	10000.0
QL-XII-47	DDR2	93.0	1000.0
KIN001-111	TIE2	13.0	1000.0
CG-930	PKAC-beta	100.0	10000.0
Torin2	PIK3CA(H1047L)	0.0	10000.0
XMD16-144	KIT(D816H)	33.0	10000.0
Omipalisib	SRPK3	88.0	10000.0
HG-9-91-01	MP2K2	8.7	10000.0
AZD7762	DCLK1	2.4	10000.0
AZD7762	NUAK1	0.0	10000.0
MLN8054	STK33	100.0	10000.0
CP724714	RSK1(Kin.Dom.2-C-terminal)	73.0	10000.0
Sigma A6730	DMPK2	92.0	10000.0
5z-7-oxozeaenol	EGFR(G719S)	93.0	10000.0
Ibrutinib	EGFR(G719C)	1.2	1000.0
PHA-767491	KIT(V559D)	72.0	10000.0
Crizotinib	MRCKA	43.0	10000.0
PHA-767491	AAK1	3.2	10000.0
ALW-II-38-3	ITK	100.0	10000.0
PHA-793887	FGFR3	90.0	10000.0
JNK-IN-11	EGFR(L858R,T790M)	36.0	1000.0
GSK429286A	MYO3A	85.0	10000.0
HG-5-113-01	MUSK	1.0	10000.0
CG-930	CLK1	79.0	10000.0
ALW-II-49-7	EPHA3	8.8	1000.0
Momelotinib	EGFR(G719C)	96.0	10000.0
XMD13-2	CDK2	3.4	10000.0
WYE-125132	MP2K3	89.0	10000.0
Dactolisib	DAPK2	100.0	1000.0
AZ-628	DMPK2	98.0	10000.0
GSK461364	MK01	100.0	10000.0
NU7441	MYLK2	100.0	10000.0
HG-9-91-01	CHK2	11.0	10000.0
CP466722	FGFR4	96.0	10000.0
Buparlisib	MAPKAPK5	100.0	1000.0
JNK-IN-11	MELK	100.0	1000.0
NPK76-II-72-1	SRMS	100.0	10000.0
Buparlisib	MINK	76.0	1000.0
CP724714	YANK2	92.0	10000.0
(s)-CR8	ABL1-phosphorylated	100.0	10000.0
RO-3306	PKAC-alpha	24.0	10000.0
CGP74514A	CLK3	24.0	10000.0
SP600125	EPHA8	100.0	10000.0
WYE-125132	NIM1	100.0	10000.0
CGP74514A	CLK1	0.5	10000.0
AS-252424	RPS6KA5(Kin.Dom.2-C-terminal)	43.5	10000.0
NPK76-II-72-1	CAMK2G	34.0	10000.0
Dinaciclib	SGK2	100.0	10000.0
BMX-IN-1	PFCDPK1(P.falciparum)	62.0	10000.0
XMD16-144	YANK2	100.0	10000.0
WZ4002	LIMK2	100.0	10000.0
Crizotinib	TTK	50.0	10000.0
Seliciclib	MRCKB	100.0	10000.0
HG-14-8-02	KPCD1	30.0	10000.0
KU63794	MKNK2	75.0	10000.0
JWE-035	EGFR(L858R)	76.0	10000.0
NVP-TAE684	EPHA2	27.0	1000.0
HG-14-8-02	MYLK4	43.0	10000.0
Taselisib	BTK	96.0	1000.0
Vemurafenib	RSK1(Kin.Dom.1-N-terminal)	57.0	10000.0
JNK-IN-5A	MAK	56.0	10000.0
BMS345541	CDK3	100.0	10000.0
KIN001-021	ABL1(F317L)	100.0	1000.0
CH5424802	STK39	11.0	1000.0
HG-5-88-01	MARK2	100.0	10000.0
PLX-4720	ABL1(E255K)-phosphorylated	46.0	10000.0
Dabrafenib	LOK	0.2	10000.0
ZSTK474	PAK1	100.0	1000.0
Crizotinib	RIPK2	11.0	10000.0
WH-4-023	AURKB	18.0	10000.0
Canertinib	MARK1	100.0	1000.0
ERK5-IN-1	CDK3	100.0	1000.0
BS-181	NEK4	97.0	10000.0
ALW-II-49-7	MERTK	100.0	10000.0
GSK429286A	PIP5K1A	89.0	10000.0
XMD8-92	ERBB2	100.0	10000.0
Crizotinib	DAPK1	74.0	10000.0
WZ3105	NEK1	100.0	10000.0
WH-4-023	ROCK2	88.0	10000.0
AG1478	RPS6KA4(Kin.Dom.2-C-terminal)	91.0	10000.0
ZSTK474	ITK	100.0	1000.0
BS-181	MAP4K4	86.0	10000.0
JW-7-24-1	MK11	100.0	10000.0
CP466722	YSK4	0.5	10000.0
Pictilisib	EGFR(L858R)	100.0	1000.0
NG25	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
QL-X-138	STK35	98.0	10000.0
AS-252424	PHKG1	71.7	10000.0
WYE-125132	MAP3K3	100.0	10000.0
Buparlisib	FAK1	100.0	1000.0
Torin2	ACVR2A	95.0	10000.0
QL-XI-92	EGFR(E746-A750del)	81.0	10000.0
Omipalisib	PAK6	92.0	10000.0
BI-D1870	MLCK	24.0	10000.0
ALW-II-38-3	PLK4	100.0	10000.0
BMS-536924	NEK5	100.0	1000.0
GSK1059615	NEK4	96.0	10000.0
CH5424802	PLK2	95.0	1000.0
MRT67307	DDR1	100.0	10000.0
HG-9-91-01	EPHA2	0.1	10000.0
HG-14-10-04	ICK	73.0	10000.0
BMS-536924	ABL1(Y253F)	19.0	1000.0
QL-X-138	SRPK2	96.0	10000.0
NVP-TAE684	ABL1	7.3	1000.0
BS-181	JNK3	72.0	10000.0
(s)-CR8	CDK4-cyclinD1	100.0	10000.0
Ribociclib	HASP	100.0	1000.0
PLX-4720	EGFR(L747-T751del,Sins)	75.0	10000.0
KIN001-111	ACVRL1	100.0	1000.0
PD173074	DRAK2	100.0	10000.0
Torkinib	M4K1	33.0	10000.0
XMD16-144	PIK3CD	2.2	10000.0
AZD-6482	JNK3	82.0	10000.0
XMD13-2	KPCL	100.0	10000.0
XMD13-2	STK36	88.0	10000.0
XMD11-85h	NEK2	100.0	10000.0
KIN001-220	ULK1	28.0	10000.0
CP724714	PGFRA	56.0	10000.0
KU63794	LCK	98.0	10000.0
KIN001-123	DAPK1	100.0	1000.0
Ceritinib	BMPR1A	89.0	1000.0
HG-9-91-01	MLK3	98.0	10000.0
Dabrafenib	PIP5K1A	100.0	10000.0
PD173074	PGFRA	100.0	10000.0
WH-4-023	AURKC	9.9	10000.0
WZ3105	TIE1	86.0	10000.0
OTSSP167	FGFR3	21.0	10000.0
5z-7-oxozeaenol	CAMK1	100.0	10000.0
PHA-793887	CDK7	0.5	10000.0
AZD4547	CSNK1G3	75.0	10000.0
CGP60474	BTK	100.0	10000.0
Dactolisib	ZAP70	100.0	1000.0
ZM-447439	KPCI	94.0	10000.0
Canertinib	EGFR(G719C)	0.0	1000.0
JW-7-24-1	ABL1(M351T)	12.0	10000.0
PLX-4720	EGFR(G719S)	72.0	10000.0
XMD14-99	PFCDPK1(P.falciparum)	95.0	10000.0
AZD-6482	PFCDPK1(P.falciparum)	62.0	10000.0
Lapatinib	CDK4-cyclinD3	100.0	10000.0
KIN001-220	CAMKK2	48.0	10000.0
KU63794	M4K3	85.0	10000.0
CP466722	MP2K4	3.8	10000.0
Crizotinib	CSF1R	0.2	10000.0
TGX221	KPCE	100.0	1000.0
GW843682X	CDC2L2	99.0	10000.0
ZSTK474	JAK3(Kin.Dom.2)	100.0	1000.0
XMD14-99	MAST1	24.0	10000.0
Dactolisib	TIE1	100.0	1000.0
Ibrutinib	LOK	40.0	1000.0
XMD-12	PKMYT1	100.0	1000.0
Barasertib	FLT3(K663Q)	1.0	10000.0
HG-9-91-01	NEK4	100.0	10000.0
XMD11-85h	MYLK2	100.0	10000.0
PD173074	AKT1	100.0	10000.0
PHA-793887	CDK14	0.5	10000.0
Torin2	RIOK3	100.0	10000.0
OTSSP167	CSNK1G3	3.0	10000.0
PHA-767491	MERTK	87.0	10000.0
JNK-IN-5A	SRC	81.0	10000.0
Alpelisib	MAP3K15	100.0	1000.0
KIN001-111	FAK2	100.0	1000.0
AS-252424	MKNK1	66.1	10000.0
Canertinib	SIK2	100.0	1000.0
WZ-7043	RET(V804L)	100.0	10000.0
SB590885	EGFR(L747-E749del,A750P)	92.0	10000.0
AG1478	KCC2D	61.0	10000.0
Seliciclib	KIT(A829P)	100.0	10000.0
Omipalisib	TNIK	92.0	10000.0
SB590885	MAST1	100.0	10000.0
Canertinib	EGFR(E746-A750del)	0.3	1000.0
XMD14-99	ACVR1	100.0	10000.0
XMD11-85h	MST1	100.0	10000.0
Baricitinib	TRKA	32.0	10000.0
CH5424802	AKT2	99.0	1000.0
WZ4002	WEE2	100.0	10000.0
Palbociclib	TAOK1	100.0	1000.0
Sigma A6730	TNK1	91.0	10000.0
JWE-035	BMPR1A	100.0	10000.0
PD0325901	GRK7	100.0	10000.0
SB590885	CDK11	86.0	10000.0
QL-XII-47	ERK5	100.0	1000.0
Crizotinib	EPHB4	4.8	10000.0
BMS-536924	KPCD3	100.0	1000.0
Torin1	LIMK2	4.8	10000.0
Sorafenib	PIK3CA(H1047L)	100.0	10000.0
JNK-IN-8	WEE1	100.0	1000.0
Taselisib	CDK4-cyclinD3	100.0	1000.0
Buparlisib	CDK2	95.0	1000.0
HG-6-64-01	PGFRB	0.1	10000.0
Canertinib	CSNK2A2	100.0	1000.0
XMD16-144	IKKE	100.0	10000.0
GSK429286A	NDR1	19.0	10000.0
Dactolisib	AKT1	100.0	1000.0
Taselisib	DAPK1	94.0	1000.0
Torin1	PDPK1	100.0	10000.0
Dabrafenib	JAK3(JH1domain-catalytic)	1.0	10000.0
BMX-IN-1	CDK9	95.0	10000.0
Neratinib	MAP4K4	6.2	10000.0
Lapatinib	ERK4	76.0	10000.0
GSK1059615	TXK	79.0	10000.0
KIN001-220	SIK1	28.0	10000.0
CP724714	MK09	53.0	10000.0
CH5424802	MLTK	96.0	1000.0
PHA-767491	TAOK3	1.0	10000.0
Dactolisib	MAP3K15	100.0	1000.0
GSK429286A	TAOK3	96.0	10000.0
HG-5-113-01	FLT3	2.4	10000.0
THZ1	EGFR(S752-I759del)	30.0	10000.0
Neratinib	STK39	84.0	10000.0
AZD4547	ABL1(H396P)-phosphorylated	2.3	10000.0
ALW-II-38-3	FGFR3(G697C)	100.0	10000.0
XMD8-85	AKT1	100.0	10000.0
Sigma A6730	MYLK2	86.0	10000.0
SCH772984	VGFR2	95.0	1000.0
Ibrutinib	FGR	3.2	1000.0
XMD11-85h	AKT1	100.0	10000.0
Ribociclib	ALK(C1156Y)	73.0	1000.0
MRT67307	ROCK1	2.8	10000.0
GSK1059615	LATS2	100.0	10000.0
ZM-447439	PIK3CA(I800L)	100.0	10000.0
GSK1059615	AMPK-alpha1	88.0	10000.0
THZ1	AURKA	2.8	10000.0
JWE-035	LIMK1	52.0	10000.0
OTSSP167	PIK3CA(E542K)	4.0	10000.0
GSK1059615	TLK2	87.0	10000.0
AZ-628	MERTK	100.0	10000.0
AS-252424	M4K3	99.1	10000.0
SP600125	CAMK1	15.0	10000.0
HG-14-10-04	PIK3CA(C420R)	100.0	10000.0
HG-14-8-02	EPHA5	94.0	10000.0
SB590885	CHK2	100.0	10000.0
NVP-TAE684	RET(V804M)	0.5	1000.0
Momelotinib	CDKL5	65.0	10000.0
SCH772984	SIK1	94.0	1000.0
QL-X-138	ABL1(H396P)-nonphosphorylated	20.0	10000.0
PD173074	PIP5K1A	100.0	10000.0
WZ-4-145	CDK14	100.0	10000.0
XMD14-99	KKCC1	6.3	10000.0
Sorafenib	MAP3K3	86.0	10000.0
Taselisib	SGK2	100.0	1000.0
NVP-TAE684	TAOK1	0.1	1000.0
WZ-7043	CDK9	100.0	10000.0
Dinaciclib	CAMKK2	20.0	10000.0
RO-3306	JNK3	57.0	10000.0
JNK-IN-11	FLT3(R834Q)	68.0	1000.0
BX-912	PTK6	45.0	10000.0
Sorafenib	LIMK1	30.0	10000.0
CGP74514A	PI42C	51.0	10000.0
Abemaciclib	MINK	26.0	1000.0
XMD-12	KIT(D816V)	69.0	1000.0
MRT67307	MARK3	0.3	10000.0
THZ1	MP2K5	1.8	10000.0
SCH772984	PAK1	100.0	1000.0
GSK1059615	PRKX	19.0	10000.0
Torin2	PAK1	95.0	10000.0
MRT67307	DMPK	2.0	10000.0
ALW-II-38-3	WEE2	100.0	10000.0
GSK429286A	ABL1(F317I)-nonphosphorylated	72.0	10000.0
THZ1	FLT3(K663Q)	0.1	10000.0
WZ-4-145	BRAF(V600E)	100.0	10000.0
Dabrafenib	SRPK2	92.0	10000.0
BMS-536924	PHKG2	6.4	1000.0
Dinaciclib	TAOK2	4.8	10000.0
RO-3306	GRK1	100.0	10000.0
Torin2	IRAK3	42.0	10000.0
A443654	MLK1	100.0	10000.0
Dinaciclib	NUAK1	80.0	10000.0
Abemaciclib	MP2K6	50.0	1000.0
XMD11-85h	LTK	100.0	10000.0
PHA-793887	ALK(C1156Y)	76.0	10000.0
Ibrutinib	CIT	65.0	1000.0
XMD11-85h	MRCKB	100.0	10000.0
Omipalisib	PAK4	69.0	10000.0
Ceritinib	LATS2	86.0	1000.0
ZG-10	KPCD2	100.0	10000.0
WH-4-023	ABL1(M351T)-phosphorylated	1.3	10000.0
Ribociclib	HIPK3	100.0	1000.0
WYE-125132	EIF2AK1	100.0	10000.0
Crizotinib	GRK4	14.0	10000.0
Omipalisib	PIK3CD	3.3	10000.0
Torkinib	MET(Y1235D)	88.0	10000.0
NG25	JAK3(Kin.Dom.2)	2.1	10000.0
AS-252424	BTK	77.0	10000.0
CH5424802	LIMK1	100.0	1000.0
Dinaciclib	EGFR(L858R)	75.0	10000.0
AZD 5438	PIK3CA(M1043I)	37.0	10000.0
Ibrutinib	PIK3C2G	80.0	1000.0
CG-930	TNK2	100.0	10000.0
XMD13-2	AURKC	8.6	10000.0
THZ1	FGFR1	0.0	10000.0
Dinaciclib	PAK2	80.0	10000.0
KIN001-111	MAP3K3	16.0	1000.0
GW-5074	SIK1	83.0	10000.0
QL-X-138	NIM1	89.0	10000.0
Dactolisib	PLK3	100.0	1000.0
CGP60474	CAMK2A	100.0	10000.0
AZD4547	NIM1	67.0	10000.0
WH-4-023	FGR	0.2	10000.0
BMS345541	SIK2	82.0	10000.0
Ibrutinib	FLT3(N841I)	23.0	1000.0
Momelotinib	NEK2	77.0	10000.0
Baricitinib	NEK2	76.0	10000.0
WZ4003	PCTK3	100.0	1000.0
SCH772984	NEK5	100.0	1000.0
Palbociclib	M3K13	100.0	1000.0
BX-912	SRPK1	4.2	10000.0
SP600125	HIPK1	100.0	10000.0
BI-2536	FGR	100.0	10000.0
THZ1	RSK4(Kin.Dom.1-N-terminal)	0.2	10000.0
XMD13-2	EPHB4	100.0	10000.0
CH5424802	PIK3CA(E542K)	93.0	1000.0
TGX221	MLK1	100.0	1000.0
CP724714	PLK2	100.0	10000.0
R406	FAK1	0.4	1000.0
PLX-4720	FGFR2	59.0	10000.0
XMD13-2	BIKE	3.7	10000.0
BI-2536	KIT(D816V)	100.0	10000.0
AZD4547	NEK4	59.0	10000.0
NU7441	ABL1(M351T)-phosphorylated	100.0	10000.0
Torin2	CAMK2A	83.0	10000.0
Seliciclib	GRK1	54.0	10000.0
XMD8-92	EGFR(G719C)	100.0	10000.0
JWE-035	KPCD2	25.0	10000.0
Abemaciclib	FYN	100.0	1000.0
MRT67307	BIKE	0.4	10000.0
BX-912	ULK3	0.1	10000.0
ZG-10	CDK5	100.0	10000.0
R406	TAOK1	8.7	1000.0
Sigma A6730	ULK2	88.0	10000.0
CP466722	JAK1(JH1domain-catalytic)	100.0	10000.0
XMD11-85h	ABL2	100.0	10000.0
TGX221	MK13	100.0	1000.0
AZD 5438	EGFR(S752-I759del)	100.0	10000.0
HG-14-10-04	ABL1(Q252H)-phosphorylated	0.7	10000.0
HG-9-91-01	MYLK	90.0	10000.0
BX-912	IRAK4	0.0	10000.0
ZG-10	MST4	100.0	10000.0
HG-6-64-01	MK11	0.0	10000.0
Lapatinib	CDK3	100.0	10000.0
SCH772984	AKT3	82.0	1000.0
THZ1	MARK4	0.8	10000.0
QL-XII-47	M3K5	100.0	1000.0
WZ4002	FER	11.0	10000.0
HG-9-91-01	SGK3	100.0	10000.0
GW843682X	SRC	64.0	10000.0
PD173074	DAPK1	100.0	10000.0
NU7441	VGFR1	97.0	10000.0
XMD16-144	FES	67.0	10000.0
BI-D1870	DRAK1	20.0	10000.0
Dinaciclib	TRKA	93.0	10000.0
Momelotinib	VRK2	94.0	10000.0
KIN001-220	SRC	18.0	10000.0
PD0325901	ABL1(T315I)-nonphosphorylated	82.0	10000.0
R406	DRAK1	0.1	1000.0
KIN001-123	EPHA7	100.0	1000.0
JNK-9L	PIK3CB	100.0	10000.0
THZ1	MTOR	100.0	10000.0
WZ-4-145	ACVR1	100.0	10000.0
QL-X-138	FLT4	65.0	10000.0
SB590885	PIP5K1A	100.0	10000.0
QL-XI-92	KIT(L576P)	2.3	10000.0
Canertinib	PAK6	100.0	1000.0
GSK461364	LYN	99.0	10000.0
CG-930	ABL1(T315I)-nonphosphorylated	100.0	10000.0
WZ-7043	TGFBR2	100.0	10000.0
QL-XI-92	FLT3(K663Q)	100.0	10000.0
WYE-125132	NEK11	99.0	10000.0
PHA-793887	MK13	92.0	10000.0
Abemaciclib	CDC2L2	100.0	1000.0
PHA-793887	FER	100.0	10000.0
TAK-715	RSK4(Kin.Dom.2-C-terminal)	4.3	10000.0
WH-4-023	NDR1	100.0	10000.0
5z-7-oxozeaenol	INSR	71.0	10000.0
BS-181	TIE2	100.0	10000.0
WZ3105	PGFRB	8.4	10000.0
KIN001-111	AKT3	100.0	1000.0
RO-3306	CSK	100.0	10000.0
AG1478	PIM1	49.0	10000.0
Pictilisib	DMPK	100.0	1000.0
AZD 5438	TGFBR2	1.2	10000.0
XMD8-85	KIT(V559D,T670I)	100.0	10000.0
KU63794	TESK1	98.0	10000.0
Crizotinib	DRAK2	100.0	10000.0
PLX-4720	JAK1(JH2domain-pseudokinase)	100.0	10000.0
WH-4-023	AURKA	6.8	10000.0
JNK-IN-8	TSSK1	100.0	1000.0
QL-XII-47	KPCE	87.0	1000.0
Vemurafenib	RET(V804M)	91.0	10000.0
Dinaciclib	PAK7	74.0	10000.0
BI-2536	MELK	29.0	10000.0
XMD11-50	SYK	100.0	10000.0
WZ4003	AKT1	100.0	1000.0
PD173074	RIOK3	100.0	10000.0
KIN001-127	FLT3	100.0	10000.0
Buparlisib	TESK1	78.0	1000.0
ZG-10	HCK	100.0	10000.0
Canertinib	ZAP70	100.0	1000.0
ZM-447439	AMPK-alpha2	72.0	10000.0
TGX221	FLT3(N841I)	100.0	1000.0
PD0325901	ABL1(F317L)-phosphorylated	86.0	10000.0
Taselisib	MP2K5	95.0	1000.0
BMS345541	RET(M918T)	100.0	10000.0
BS-181	EGFR(G719C)	62.0	10000.0
XMD14-99	OSR1	100.0	10000.0
NG25	RIPK1	0.1	10000.0
QL-XI-92	RET(V804M)	100.0	10000.0
KU63794	KIT(D816V)	94.0	10000.0
PHA-793887	PIK4CB	94.0	10000.0
MRT67307	RSK1(Kin.Dom.2-C-terminal)	40.0	10000.0
R406	FLT3(N841I)	0.8	1000.0
HG-14-10-04	RPS6KA4(Kin.Dom.2-C-terminal)	3.2	10000.0
WZ3105	PHKG2	44.0	10000.0
ALW-II-38-3	CLK4	100.0	10000.0
TGX221	EGFR(G719C)	100.0	1000.0
Abemaciclib	PRP4	64.0	1000.0
JNK-IN-5A	WEE1	64.0	10000.0
WZ4002	ULK2	2.0	10000.0
CGP60474	MARK4	100.0	10000.0
XMD8-85	VGFR1	100.0	10000.0
Ceritinib	DRAK2	93.0	1000.0
XMD14-99	BMPR2	90.0	10000.0
BMS-536924	PIK3CB	100.0	1000.0
KIN001-123	CDC2L1	100.0	1000.0
CG-930	BRSK1	86.0	10000.0
PLX-4720	NEK11	2.0	10000.0
5z-7-oxozeaenol	BRSK2	83.0	10000.0
WZ3105	CDC2L2	98.0	10000.0
Pictilisib	PIK3CD	0.0	1000.0
Torkinib	KCC2D	69.0	10000.0
HG-6-64-01	CDK16	98.0	10000.0
THZ1	PKN1	3.5	10000.0
NG25	EPHB1	100.0	10000.0
GSK461364	CHEK1	100.0	10000.0
Seliciclib	PAK1	85.0	10000.0
Ibrutinib	KC1G2	92.0	1000.0
ZSTK474	EPHA6	100.0	1000.0
WZ-7043	IRAK3	100.0	10000.0
QL-XI-92	RAF1	40.0	10000.0
AZD-6482	AKT1	100.0	10000.0
SCH772984	EGFR(L747-T751del,Sins)	87.0	1000.0
XMD8-85	ACVR1	100.0	10000.0
GW-5074	DAPK2	1.9	10000.0
BMX-IN-1	NEK11	100.0	10000.0
XMD13-2	MLTK	100.0	10000.0
KIN001-021	KGP1	100.0	1000.0
BMS345541	ABL1(F317L)-phosphorylated	100.0	10000.0
CP724714	PRP4	93.0	10000.0
JWE-035	EPHB4	93.0	10000.0
GW-5074	CSNK2A1	4.2	10000.0
XMD11-85h	PIK4CB	100.0	10000.0
HG-6-64-01	MP2K6	79.0	10000.0
AZD4547	M3K12	23.0	10000.0
CGP74514A	BIKE	82.0	10000.0
BMS345541	MLK1	100.0	10000.0
XMD8-85	FER	32.0	10000.0
CGP60474	MAPKAPK5	100.0	10000.0
Barasertib	KPCD3	63.0	10000.0
Palbociclib	PKN2	100.0	1000.0
XMD11-50	IGF1R	96.0	10000.0
AZD-6482	GSK3A	100.0	10000.0
MPS-1-IN-1	PIP5K1A	100.0	1000.0
AZD4547	PIK3CA(E545A)	64.0	10000.0
XMD11-85h	RIOK3	100.0	10000.0
HG-6-64-01	PCTK2	61.0	10000.0
Dinaciclib	IGF1R	100.0	10000.0
PHA-767491	PIK3CA(Q546K)	90.0	10000.0
BGJ398	TESK1	88.0	1000.0
JNK-IN-5A	YES	78.0	10000.0
Sigma A6730	PDPK1	93.0	10000.0
BI-D1870	NIM1	15.0	10000.0
KU63794	ANKK1	98.0	10000.0
NU7441	IKKA	100.0	10000.0
HG-5-113-01	LATS2	100.0	10000.0
Seliciclib	KPCD3	100.0	10000.0
BMS345541	ERBB4	100.0	10000.0
Torin2	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
KIN001-220	RSK2(Kin.Dom.1-N-terminal)	32.0	10000.0
Seliciclib	HIPK3	72.0	10000.0
BS-181	CSNK1E	0.1	10000.0
SB590885	NLK	90.0	10000.0
TGX221	MRCKB	100.0	1000.0
ERK5-IN-1	PAK2	92.0	1000.0
XMD11-85h	INSRR	100.0	10000.0
(s)-CR8	TESK1	70.0	10000.0
AG1478	EPHB2	67.0	10000.0
Ribociclib	GRK7	100.0	1000.0
Abemaciclib	NEK2	96.0	1000.0
HG-9-91-01	AKT3	100.0	10000.0
XMD14-99	RSK3(Kin.Dom.2-C-terminal)	2.9	10000.0
Sigma A6730	CSNK1D	18.0	10000.0
WZ4002	AURKB	20.0	10000.0
AZD-6482	ROCK2	91.0	10000.0
Barasertib	TYRO3	100.0	10000.0
CP724714	JNK1	66.0	10000.0
XMD8-92	TIE1	100.0	10000.0
XMD13-2	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
NVP-TAE684	LIMK1	2.2	1000.0
WZ3105	ABL1(T315I)-phosphorylated	55.0	10000.0
JNK-IN-5A	CDK5	100.0	10000.0
JNK-9L	CSNK1E	95.0	10000.0
JNK-9L	FER	99.0	10000.0
JNK-9L	PI42C	2.8	10000.0
PD0325901	IGF1R	87.0	10000.0
Sorafenib	SNRK	100.0	10000.0
Sigma A6730	FLT3(D835H)	74.0	10000.0
HG-14-8-02	CLK2	54.0	10000.0
A443654	CSNK2A1	17.0	10000.0
Dabrafenib	MAP3K14	87.0	10000.0
GW-5074	RIPK5	66.0	10000.0
QL-X-138	CDK4-cyclinD3	87.0	10000.0
HG-14-10-04	RIOK2	6.0	10000.0
GSK1059615	M4K1	26.0	10000.0
HG-5-113-01	CDKL2	100.0	10000.0
HG-14-8-02	ABL1(H396P)-nonphosphorylated	19.0	10000.0
XMD8-92	HIPK4	100.0	10000.0
KIN001-127	TRKA	20.0	10000.0
OTSSP167	ALK(C1156Y)	8.0	10000.0
RO-3306	CAMK1D	83.0	10000.0
ALW-II-38-3	NEK5	100.0	10000.0
Neratinib	CAMK2G	95.0	10000.0
NPK76-II-72-1	GAK	3.8	10000.0
WZ3105	FGFR3(G697C)	99.0	10000.0
XMD14-99	TYK2(JH2domain-pseudokinase)	60.0	10000.0
NPK76-II-72-1	ABL1(E255K)	100.0	10000.0
Torin2	KPCI	100.0	10000.0
ZM-447439	ADCK3	90.0	10000.0
Palbociclib	CDC2L2	100.0	1000.0
MPS-1-IN-1	RET(V804L)	100.0	1000.0
Neratinib	ERK3	100.0	10000.0
XMD11-50	CTK	100.0	10000.0
ZSTK474	DMPK	100.0	1000.0
GW-5074	TNK1	100.0	10000.0
HG-14-8-02	HUNK	11.0	10000.0
Taselisib	RSK4(Kin.Dom.1-N-terminal)	94.0	1000.0
XMD13-2	CLK4	100.0	10000.0
CP724714	FGFR3(G697C)	90.0	10000.0
RO-3306	FGFR4	98.0	10000.0
Canertinib	IGF1R	100.0	1000.0
Sorafenib	RSK1(Kin.Dom.1-N-terminal)	82.0	10000.0
Buparlisib	TXK	100.0	1000.0
Ceritinib	INSRR	1.3	1000.0
SCH772984	PIM2	91.0	1000.0
ALW-II-38-3	CAMK2G	100.0	10000.0
CGP74514A	TYK2(JH1domain-catalytic)	6.4	10000.0
QL-X-138	KPCD2	89.0	10000.0
MLN8054	ERBB4	52.0	10000.0
QL-X-138	MK12	98.0	10000.0
GSK429286A	PLK3	84.0	10000.0
KU63794	DAPK2	80.0	10000.0
CG-930	TYK2(JH1domain-catalytic)	81.0	10000.0
MRT67307	OSR1	71.0	10000.0
GW-5074	RET	100.0	10000.0
XMD-12	MP2K3	84.0	1000.0
NVP-TAE684	CSNK2A2	100.0	1000.0
PHA-793887	MST2	27.0	10000.0
JW-7-24-1	IKKE	100.0	10000.0
HG-9-91-01	BMPR1B	0.0	10000.0
Ceritinib	ULK1	13.0	1000.0
MRT67307	PHKG2	16.0	10000.0
JWE-035	TRKA	34.0	10000.0
Taselisib	NEK7	100.0	1000.0
CP466722	M3K2	33.0	10000.0
HG-6-64-01	MRCKB	65.0	10000.0
TAK-715	SLK	41.0	10000.0
AZD7762	KIT	0.0	10000.0
AZD7762	RSK3(Kin.Dom.1-N-terminal)	5.0	10000.0
Barasertib	TESK1	100.0	10000.0
XMD8-92	ABL1(F317I)	30.0	10000.0
BMX-IN-1	RIOK3	60.0	10000.0
HG-6-64-01	TNK1	1.4	10000.0
JNK-IN-8	ABL1(E255K)-phosphorylated	100.0	1000.0
Dinaciclib	MK09	13.0	10000.0
AZ-628	KC1G2	100.0	10000.0
AZD-6482	PDPK1	100.0	10000.0
JNK-IN-5A	SRPK3	100.0	10000.0
SCH772984	RET(V804L)	100.0	1000.0
JNK-9L	CSNK1D	86.0	10000.0
OTSSP167	FGFR2	11.0	10000.0
ALW-II-38-3	MKNK1	100.0	10000.0
GSK429286A	FGFR4	67.0	10000.0
ALW-II-38-3	ULK3	100.0	10000.0
NVP-TAE684	FYN	5.6	1000.0
XMD8-92	DCAMKL2	0.7	10000.0
HG-5-113-01	BIKE	0.6	10000.0
SB590885	M3K12	49.0	10000.0
NG25	PHKG1	100.0	10000.0
OTSSP167	M4K1	5.4	10000.0
MRT67307	RIPK1	100.0	10000.0
XMD8-85	LYN	100.0	10000.0
Neratinib	ABL1(F317I)-nonphosphorylated	96.0	10000.0
PLX-4720	PRKR	74.0	10000.0
Dabrafenib	MLTK	1.0	10000.0
CH5424802	YANK1	95.0	1000.0
JNK-IN-11	CDK11	100.0	1000.0
SCH772984	CDK9	100.0	1000.0
BI-2536	CSF1R	100.0	10000.0
WH-4-023	HUNK	9.0	10000.0
ERK5-IN-1	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	1000.0
PHA-793887	MAPKAPK2	100.0	10000.0
OTSSP167	PIK3C2G	3.0	10000.0
GSK461364	CASK	50.0	10000.0
JWE-035	YANK1	81.0	10000.0
ZSTK474	MERTK	100.0	1000.0
ALW-II-38-3	BLK	7.4	1000.0
Dinaciclib	KPCD3	88.0	10000.0
PHA-767491	TNK2	94.0	10000.0
Vemurafenib	EGFR(G719S)	50.0	10000.0
BGJ398	MLCK	85.0	1000.0
CH5424802	SRPK2	92.0	1000.0
HG-14-10-04	NUAK1	0.2	10000.0
Barasertib	KKCC1	71.0	10000.0
TGX221	MKNK2	100.0	1000.0
BGJ398	CDKL1	70.0	1000.0
AS-252424	EPHA3	100.0	10000.0
NVP-TAE684	ERBB2	8.0	1000.0
QL-XI-92	EGFR(L747-T751del,Sins)	100.0	10000.0
CP466722	SRPK3	38.0	10000.0
KU63794	MAPKAPK5	77.0	10000.0
Barasertib	EGFR(L747-E749del,A750P)	33.0	10000.0
BI-2536	MK13	100.0	10000.0
AZD 5438	HIPK2	1.9	10000.0
BMS345541	LYN	100.0	10000.0
Barasertib	YANK1	100.0	10000.0
KIN001-021	EPHA3	0.0	1000.0
JNK-9L	MK12	80.0	10000.0
PHA-767491	MINK	8.8	10000.0
PD0325901	PIM3	100.0	10000.0
SCH772984	ERN1	84.0	1000.0
ZG-10	NEK2	1.1	10000.0
Ribociclib	ERK5	99.0	1000.0
GSK429286A	MK13	98.0	10000.0
PLX-4720	RPS6KA4(Kin.Dom.2-C-terminal)	69.0	10000.0
XMD11-85h	TXK	100.0	10000.0
PD0325901	SIK3	52.0	10000.0
Baricitinib	WNK1	96.0	10000.0
XMD-12	CDK4-cyclinD3	100.0	1000.0
JNK-IN-5A	CDKL5	70.0	10000.0
XMD-12	CDKL1	89.0	1000.0
Ibrutinib	PIK3C2B	63.0	1000.0
PLX-4720	ABL1(F317I)-nonphosphorylated	5.8	10000.0
ZG-10	FGFR2	86.0	10000.0
TAK-715	PKAC-alpha	85.0	10000.0
Neratinib	RIPK5	69.0	10000.0
Neratinib	ABL1(M351T)-phosphorylated	100.0	10000.0
AZD7762	ABL1(T315I)-nonphosphorylated	0.0	10000.0
Neratinib	MST1	17.0	10000.0
Ribociclib	MELK	100.0	1000.0
Dabrafenib	SRPK3	94.0	10000.0
JNK-IN-5A	MYLK4	98.0	10000.0
SCH772984	KIT(V559D,T670I)	81.0	1000.0
Pictilisib	PIK3CA(E545A)	0.0	1000.0
ZG-10	YES	100.0	10000.0
Ribociclib	DRAK1	100.0	1000.0
Dactolisib	RPS6KA2(Kin.Dom.2)	100.0	1000.0
GW843682X	CDK16	100.0	10000.0
PHA-767491	YANK1	93.0	10000.0
Buparlisib	CAMK2B	100.0	1000.0
AG1478	EGFR(E746-A750del)	3.3	10000.0
A443654	CSNK1A1L	11.0	10000.0
KIN001-123	NEK7	100.0	1000.0
Seliciclib	CLK2	2.5	10000.0
AZD7762	ERN1	25.0	10000.0
CGP74514A	PAK3	3.2	10000.0
PHA-793887	CDK11	80.0	10000.0
Seliciclib	FAK1	83.0	10000.0
Palbociclib	CDKL3	100.0	1000.0
BGJ398	MK01	94.0	1000.0
PD0325901	ADCK3	86.0	10000.0
JWE-035	SYK	78.0	10000.0
Seliciclib	FGFR3(G697C)	100.0	10000.0
CGP74514A	CAMKK2	25.0	10000.0
KIN001-127	ERBB2	100.0	10000.0
AZD 5438	MAP3K15	55.0	10000.0
CP724714	MYO3A	75.0	10000.0
AZD4547	CLK2	1.5	10000.0
AZ-628	ERK4	100.0	10000.0
PLX-4720	MARK1	74.0	10000.0
JNK-IN-11	TAOK2	31.0	1000.0
HG-14-10-04	ANKK1	64.0	10000.0
XMD8-85	EGFR(L747-E749del,A750P)	100.0	10000.0
AS-252424	NEK1	72.7	10000.0
Ceritinib	M3K5	90.0	1000.0
WYE-125132	HIPK1	100.0	10000.0
Alpelisib	FAK2	100.0	1000.0
Dactolisib	PKN1	100.0	1000.0
Abemaciclib	RIPK5	71.0	1000.0
Abemaciclib	DDR1	56.0	1000.0
XMD-12	PCTK3	100.0	1000.0
Torkinib	PIP5K2B	55.0	10000.0
PHA-793887	ABL1-phosphorylated	82.0	10000.0
Lapatinib	RIPK1	93.0	10000.0
WZ-7043	AMPK-alpha1	100.0	10000.0
BI-D1870	BRSK2	27.0	10000.0
Torin2	BLK	98.0	10000.0
WYE-125132	TNK1	78.0	10000.0
BMX-IN-1	PI42C	3.9	10000.0
AG1478	TESK1	100.0	10000.0
XMD-12	PKN2	92.0	1000.0
QL-X-138	IRAK3	0.7	10000.0
TAK-715	SRPK1	100.0	10000.0
QL-X-138	M3K12	76.0	10000.0
Ibrutinib	MAP3K15	92.0	1000.0
JNK-IN-5A	TYK2(JH2domain-pseudokinase)	100.0	10000.0
Sigma A6730	EPHB4	100.0	10000.0
ERK5-IN-1	LRRK2(G2019S)	23.0	1000.0
XMD13-2	CDK5	60.0	10000.0
XMD16-144	ABL1(M351T)-phosphorylated	0.8	10000.0
CG-930	PIK3CA(M1043I)	100.0	10000.0
XMD8-85	ERBB2	100.0	10000.0
Ibrutinib	CAMK2B	95.0	1000.0
JNK-IN-5A	RPS6KA5(Kin.Dom.2-C-terminal)	95.0	10000.0
PD173074	RPS6KA4(Kin.Dom.2)	100.0	10000.0
Abemaciclib	CSNK1G3	97.0	1000.0
Torin2	M4K3	63.0	10000.0
GSK461364	PAK7	60.0	10000.0
JW-7-24-1	KPCL	100.0	10000.0
KIN001-127	VGFR1	100.0	10000.0
BS-181	MLK3	100.0	10000.0
KU63794	SNRK	48.0	10000.0
PHA-793887	ABL1-nonphosphorylated	82.0	10000.0
Abemaciclib	CDKL5	0.0	1000.0
JW-7-24-1	MAP4K4	8.2	10000.0
ZM-447439	MP2K1	0.1	10000.0
ALW-II-38-3	PIK3CB	100.0	10000.0
GSK429286A	RSK3(Kin.Dom.2-C-terminal)	94.0	10000.0
CP466722	PIK3CA(H1047L)	17.0	10000.0
AZ-628	LRRK2	32.0	10000.0
(s)-CR8	BRSK2	95.0	10000.0
CGP74514A	WEE2	100.0	10000.0
Pictilisib	YES	100.0	1000.0
Baricitinib	CLK4	1.9	10000.0
GSK429286A	NDR2	12.0	10000.0
CP724714	MP2K5	0.2	10000.0
THZ1	ABL1(Q252H)-nonphosphorylated	9.4	10000.0
QL-XII-47	PKAC-alpha	94.0	1000.0
NVP-TAE684	FRK	0.2	1000.0
Sigma A6730	EGFR(E746-A750del)	80.0	10000.0
Vemurafenib	PRP4	92.0	10000.0
KU63794	MYLK	57.0	10000.0
5z-7-oxozeaenol	NLK	70.0	10000.0
ZM-447439	ABL1(H396P)-nonphosphorylated	0.8	10000.0
GSK1059615	FGR	69.0	10000.0
AZ-628	PIK3CA(E545A)	89.0	10000.0
ALW-II-49-7	CAMK1D	100.0	10000.0
ERK5-IN-1	TGFBR1	100.0	1000.0
Torkinib	RSK2(Kin.Dom.1-N-terminal)	0.4	10000.0
PD0325901	STK33	79.0	10000.0
HG-14-10-04	CDC2L2	91.0	10000.0
Baricitinib	TYRO3	65.0	10000.0
SP600125	RIPK2	100.0	10000.0
HG-14-10-04	PIK3CA(H1047Y)	100.0	10000.0
XMD11-50	HCK	100.0	10000.0
MLN8054	PRKR	100.0	10000.0
WZ3105	PKMYT1	93.0	10000.0
HG-9-91-01	YSK1	7.2	10000.0
Neratinib	TNK1	100.0	10000.0
AS-252424	PAK4	100.0	10000.0
ERK5-IN-1	KC1G2	96.0	1000.0
SP600125	RIOK3	2.6	10000.0
Palbociclib	FLT3(N841I)	100.0	1000.0
JWE-035	KPCI	100.0	10000.0
KU63794	PIP5K1A	97.0	10000.0
GSK461364	PFPK5(P.falciparum)	100.0	10000.0
Dabrafenib	HIPK2	2.2	10000.0
Baricitinib	JAK3(JH1domain-catalytic)	0.0	10000.0
BGJ398	CDK4-cyclinD1	65.0	1000.0
XMD16-144	MARK2	21.0	10000.0
ALW-II-38-3	MAP3K15	100.0	10000.0
XMD-12	GRK7	100.0	1000.0
ZM-447439	MST3	46.0	10000.0
CG-930	SNARK	52.0	10000.0
BI-2536	KKCC1	1.9	10000.0
BGJ398	CAMK2B	93.0	1000.0
XMD11-85h	EPHB4	100.0	10000.0
BI-D1870	CLK2	3.6	10000.0
BX-912	BIKE	0.0	10000.0
CGP60474	MERTK	100.0	10000.0
XMD8-92	FLT3(N841I)	100.0	10000.0
XMD8-92	AURKC	100.0	10000.0
GW-5074	TBK1	95.0	10000.0
AZ-628	GRK7	91.0	10000.0
CP724714	MERTK	97.0	10000.0
TAK-715	MST4	100.0	10000.0
Ibrutinib	KIT(V559D,V654A)	96.0	1000.0
GSK461364	PIK3CA(I800L)	24.0	10000.0
SCH772984	LYN	100.0	1000.0
R406	IKKB	2.0	1000.0
Buparlisib	FLT3(ITD)	92.0	1000.0
Dabrafenib	RIPK1	100.0	10000.0
XMD11-50	PIM3	88.0	10000.0
ZSTK474	DRAK2	100.0	1000.0
HG-6-64-01	ERBB3	100.0	10000.0
XMD-12	RET	15.0	1000.0
HG-6-64-01	ABL1-nonphosphorylated	0.0	10000.0
AZD 5438	PTK6	64.0	10000.0
Seliciclib	HIPK1	6.4	10000.0
Momelotinib	FLT4	48.0	10000.0
Buparlisib	TAOK2	100.0	1000.0
ALW-II-38-3	MAST1	100.0	10000.0
ZG-10	MERTK	100.0	10000.0
(s)-CR8	TXK	96.0	10000.0
XMD8-92	IRAK3	100.0	10000.0
Taselisib	SIK2	96.0	1000.0
HG-6-64-01	KIT(V559D)	0.0	10000.0
Palbociclib	ERK3	100.0	1000.0
KIN001-220	MKNK1	100.0	10000.0
XMD11-50	CLK3	95.0	10000.0
Vemurafenib	EPHA3	44.0	10000.0
XMD16-144	BMX	71.0	10000.0
PHA-793887	MAP3K3	94.0	10000.0
GSK1059615	TAOK1	3.0	10000.0
Seliciclib	AURKB	79.0	10000.0
RO-3306	KC1G1	48.0	10000.0
RO-3306	MKNK1	92.0	10000.0
Crizotinib	HIPK1	78.0	10000.0
JWE-035	DAPK1	65.0	10000.0
AS-252424	CDK2	80.7	10000.0
Dabrafenib	KGP1	100.0	10000.0
CGP60474	INSRR	100.0	10000.0
BMX-IN-1	ACVRL1	75.0	10000.0
ERK5-IN-1	S6K1	100.0	1000.0
PLX-4720	DYRK2	100.0	10000.0
JWE-035	MAP4K2	17.0	10000.0
BMX-IN-1	EPHB1	100.0	10000.0
GSK429286A	IKKE	77.0	10000.0
CH5424802	CDK15	96.0	1000.0
BS-181	MP2K5	97.0	10000.0
JNK-IN-8	M3K12	99.0	1000.0
XMD11-85h	CLK3	100.0	10000.0
Taselisib	MAST1	69.0	1000.0
Sorafenib	NEK3	70.0	10000.0
ZSTK474	SRC	100.0	1000.0
Dabrafenib	MET	35.0	10000.0
Sorafenib	YANK2	100.0	10000.0
BX-912	KCC2D	46.0	10000.0
PHA-767491	TXK	100.0	10000.0
Alpelisib	CDK2	100.0	1000.0
XMD-12	MAP4K2	80.0	1000.0
WH-4-023	NLK	3.9	10000.0
QL-XII-47	TNNI3K	84.0	1000.0
OTSSP167	WNK1	89.0	10000.0
PD0325901	PCTK3	100.0	10000.0
GSK461364	HCK	100.0	10000.0
TAK-715	ABL1(Y253F)-phosphorylated	26.0	10000.0
ALW-II-38-3	EPHA2	1.0	1000.0
Torkinib	YSK1	53.0	10000.0
GSK1059615	PGFRB	55.0	10000.0
Taselisib	PCTK3	100.0	1000.0
XMD-12	DDR2	96.0	1000.0
TGX221	YANK2	100.0	1000.0
OTSSP167	EGFR(L747-E749del,A750P)	4.0	10000.0
NU7441	PLK3	86.0	10000.0
KIN001-123	PRKR	100.0	1000.0
MPS-1-IN-1	EGFR(E746-A750del)	100.0	1000.0
ZG-10	MARK4	26.0	10000.0
XMD16-144	EGFR(L747-T751del,Sins)	77.0	10000.0
QL-XII-47	MLK1	100.0	1000.0
Dinaciclib	SRMS	100.0	10000.0
CGP74514A	GRK1	11.0	10000.0
GSK1059615	STK36	89.0	10000.0
BX-912	RIPK1	18.0	10000.0
JNK-9L	MAST1	100.0	10000.0
CP466722	MKNK1	51.0	10000.0
AZD-6482	SIK1	100.0	10000.0
Ibrutinib	FAK2	96.0	1000.0
GSK429286A	PHKG2	92.0	10000.0
Torin2	FLT3(D835Y)	32.0	10000.0
5z-7-oxozeaenol	BMPR2	90.0	10000.0
CGP60474	AKT2	100.0	10000.0
Ibrutinib	AKT2	75.0	1000.0
AS-252424	MAP4K5	100.0	10000.0
Vemurafenib	NEK1	100.0	10000.0
R406	ABL1(H396P)	24.0	1000.0
TGX221	CIT	100.0	1000.0
GSK1059615	KIT(V559D,T670I)	76.0	10000.0
AZ-628	SRPK1	100.0	10000.0
CGP74514A	MET(Y1235D)	57.0	10000.0
XMD13-2	CDK4-cyclinD1	94.0	10000.0
HG-9-91-01	MLK2	11.0	10000.0
(s)-CR8	BLK	83.0	10000.0
Buparlisib	CSNK1G3	100.0	1000.0
Ceritinib	LRRK2(G2019S)	6.4	1000.0
AZD4547	ACVRL1	100.0	10000.0
RO-3306	CDK9	80.0	10000.0
CG-930	PIM1	100.0	10000.0
BGJ398	MAP4K5	29.0	1000.0
MLN8054	EGFR(T790M)	50.0	10000.0
Sigma A6730	FLT3(K663Q)	56.0	10000.0
NG25	FLT3(K663Q)	0.0	10000.0
Omipalisib	KIT(L576P)	76.0	10000.0
XMD11-50	ABL1(F317L)-phosphorylated	0.9	10000.0
Dabrafenib	KPCD3	11.0	10000.0
Seliciclib	KPCD2	100.0	10000.0
Torin2	MST2	63.0	10000.0
JNK-IN-11	EPHB4	43.0	1000.0
NVP-TAE684	NEK5	100.0	1000.0
PHA-767491	CDKL2	16.0	10000.0
WZ3105	BMPR2	31.0	10000.0
JNK-IN-8	ROS1	90.0	1000.0
Ribociclib	EPHB6	81.0	1000.0
JNK-IN-11	AURKA	28.0	1000.0
AZD7762	CSNK2A2	5.9	10000.0
HG-9-91-01	PKAC-alpha	2.9	10000.0
XMD13-2	BRSK2	74.0	10000.0
XMD-12	AURKA	2.4	1000.0
NG25	CDK3	10.0	10000.0
WZ4003	JNK1	16.0	1000.0
KIN001-220	LIMK2	30.0	10000.0
ALW-II-38-3	DMPK	100.0	10000.0
Torkinib	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
Abemaciclib	WNK4	96.0	1000.0
PLX-4720	KIT(D816V)	49.0	10000.0
KIN001-127	MLK3	100.0	10000.0
Crizotinib	ULK1	1.0	10000.0
CGP74514A	MLCK	73.0	10000.0
Canertinib	CAMK1D	100.0	1000.0
WH-4-023	IRAK3	19.0	10000.0
CG-930	PLK2	100.0	10000.0
CG-930	FGFR3	88.0	10000.0
PHA-793887	FLT4	100.0	10000.0
ERK5-IN-1	AURKA	100.0	1000.0
JW-7-24-1	TGFBR2	100.0	10000.0
(s)-CR8	PIK3CA(Q546K)	95.0	10000.0
ZSTK474	PLK1	25.0	1000.0
WZ-4-145	PIM2	100.0	10000.0
ZM-447439	SNRK	81.0	10000.0
Palbociclib	RSK1(Kin.Dom.2-C-terminal)	54.0	1000.0
KIN001-111	TYRO3	18.0	1000.0
HG-6-64-01	MET	40.0	10000.0
WZ4003	SIK2	19.0	1000.0
(s)-CR8	PRP4	87.0	10000.0
GW-5074	ITK	96.0	10000.0
Torin1	FLT3(D835H)	18.0	10000.0
JWE-035	RSK2(Kin.Dom.1-N-terminal)	28.0	10000.0
Torin1	CSNK2A1	94.0	10000.0
OTSSP167	PTK6	42.0	10000.0
JNK-IN-5A	MET(Y1235D)	71.0	10000.0
BMS-536924	MK14	100.0	1000.0
KIN001-127	RPS6KA1(Kin.Dom.1)	100.0	10000.0
BMS345541	PAK6	100.0	10000.0
WH-4-023	ROCK1	65.0	10000.0
NPK76-II-72-1	MAP4K5	100.0	10000.0
JNK-9L	CDK8	80.0	10000.0
BMS-536924	VGFR1	9.4	1000.0
Sorafenib	CDK11	1.4	10000.0
JNK-9L	YANK3	89.0	10000.0
NU7441	NEK4	100.0	10000.0
BI-2536	MARK4	100.0	10000.0
Vemurafenib	SLK	1.4	10000.0
THZ1	AMPK-alpha1	3.4	10000.0
XMD8-85	MP2K2	100.0	10000.0
GW-5074	TRPM6	100.0	10000.0
WZ4002	SRPK2	100.0	10000.0
CGP74514A	MK01	13.0	10000.0
JNK-IN-11	ABL1(F317L)-nonphosphorylated	22.0	1000.0
Ribociclib	BRSK2	95.0	1000.0
JNK-IN-5A	TTK	91.0	10000.0
Ribociclib	FES	100.0	1000.0
AZD-6482	KIT(L576P)	95.0	10000.0
AZD4547	MET(Y1235D)	27.0	10000.0
MRT67307	YANK2	100.0	10000.0
Vemurafenib	NDR2	100.0	10000.0
ALW-II-38-3	PIK3CA(E545K)	100.0	10000.0
Dactolisib	MAPKAPK5	100.0	1000.0
BGJ398	CASK	85.0	1000.0
HG-14-8-02	JNK1	24.0	10000.0
BMS-536924	ACVRL1	10.0	1000.0
Vemurafenib	MK13	100.0	10000.0
Sigma A6730	TRPM6	87.0	10000.0
QL-XII-47	KPCD3	100.0	1000.0
NVP-TAE684	NUAK1	0.8	1000.0
ERK5-IN-1	MK03	100.0	1000.0
GW843682X	PLK3	0.0	10000.0
ALW-II-49-7	RIOK1	100.0	10000.0
A443654	MST4	30.0	10000.0
Dabrafenib	PIK3C2B	0.1	10000.0
Alpelisib	CHK2	94.0	1000.0
JNK-IN-11	CAMK2A	100.0	1000.0
XMD16-144	SRMS	57.0	10000.0
JW-7-24-1	JAK1(Kin.Dom.2)	100.0	10000.0
GSK1059615	GRK7	5.4	10000.0
Torkinib	TGFBR1	1.1	10000.0
XMD11-85h	PCTK2	100.0	10000.0
HG-14-10-04	MARK3	0.3	10000.0
MRT67307	FGFR3(G697C)	50.0	10000.0
XMD14-99	KGP1	100.0	10000.0
JNK-IN-11	ACVR1	3.8	1000.0
ERK5-IN-1	GAK	100.0	1000.0
RO-3306	KGP2	63.0	10000.0
HG-14-8-02	RIPK5	100.0	10000.0
Lapatinib	LTK	53.0	10000.0
MPS-1-IN-1	YANK3	100.0	1000.0
CP466722	MYLK2	61.0	10000.0
TGX221	ROCK2	100.0	1000.0
RO-3306	KIT(L576P)	27.0	10000.0
MLN8054	IKKE	68.0	10000.0
XMD11-50	MUSK	99.0	10000.0
QL-X-138	TAK1	0.4	10000.0
XMD14-99	MST4	100.0	10000.0
BGJ398	MYLK4	64.0	1000.0
Pictilisib	CDKL1	84.0	1000.0
GSK461364	KCC2D	7.3	10000.0
HG-9-91-01	EGFR(G719S)	0.1	10000.0
WZ3105	PAK3	100.0	10000.0
Alpelisib	M3K2	100.0	1000.0
GSK429286A	EPHB2	100.0	10000.0
GSK461364	EGFR(T790M)	54.0	10000.0
CP466722	MK01	56.0	10000.0
AZD-6482	MARK1	100.0	10000.0
BS-181	MK01	93.0	10000.0
XMD11-50	AKT1	79.0	10000.0
XMD8-92	MST4	100.0	10000.0
Abemaciclib	KPCI	77.0	1000.0
GSK429286A	PLK2	86.0	10000.0
CGP74514A	RPS6KA4(Kin.Dom.1-N-terminal)	19.0	10000.0
PD173074	ZAP70	100.0	10000.0
CGP60474	EPHA5	100.0	10000.0
Dactolisib	MAP3K1	100.0	1000.0
CGP74514A	RPS6KA4(Kin.Dom.2-C-terminal)	68.0	10000.0
JNK-IN-5A	PIP5K1A	100.0	10000.0
WZ-4-145	DDR2	100.0	10000.0
AS-252424	BMX	93.8	10000.0
HG-5-113-01	STK36	100.0	10000.0
5z-7-oxozeaenol	MAP3K1	100.0	10000.0
AZD7762	VGFR1	0.1	10000.0
Dabrafenib	CSNK2A2	54.0	10000.0
WH-4-023	ABL1(Q252H)-phosphorylated	0.1	10000.0
MRT67307	MARK4	11.0	10000.0
A443654	VGFR2	100.0	10000.0
JWE-035	JNK1	100.0	10000.0
WZ3105	NEK11	54.0	10000.0
(s)-CR8	RIOK2	100.0	10000.0
AG1478	DCLK1	54.0	10000.0
KIN001-111	LYN	0.7	1000.0
KIN001-111	MUSK	100.0	1000.0
JNK-IN-11	FYN	49.0	1000.0
PLX-4720	FAK1	51.0	10000.0
5z-7-oxozeaenol	AKT3	95.0	10000.0
XMD-12	CDC2L5	100.0	1000.0
5z-7-oxozeaenol	SRPK2	100.0	10000.0
ZM-447439	NEK11	100.0	10000.0
SCH772984	KIT(V559D)	62.0	1000.0
Taselisib	ACVR2B	92.0	1000.0
CGP74514A	SNARK	1.4	10000.0
SP600125	MLK2	100.0	10000.0
XMD11-85h	MYLK	100.0	10000.0
TGX221	FGFR4	100.0	1000.0
Palbociclib	CSNK1G3	100.0	1000.0
Ibrutinib	KIT	44.0	1000.0
Dactolisib	IKKB	100.0	1000.0
GW-5074	CAMK1D	76.0	10000.0
XMD14-99	MARK3	100.0	10000.0
KIN001-220	MK14	97.0	10000.0
CP724714	GSK3B	68.0	10000.0
HG-14-10-04	ACVR1B	91.0	10000.0
GW843682X	IKKE	60.0	10000.0
ERK5-IN-1	CDK11	100.0	1000.0
Ibrutinib	MKNK1	100.0	1000.0
THZ1	EPHA2	4.6	10000.0
A443654	IRAK3	30.0	10000.0
GW843682X	JAK2(JH1domain-catalytic)	48.0	10000.0
5z-7-oxozeaenol	MK03	58.0	10000.0
WZ-4-145	KIT(V559D)	0.1	10000.0
Sigma A6730	MP2K4	94.0	10000.0
THZ1	EPHB1	8.2	10000.0
KIN001-111	ZAP70	100.0	1000.0
Lapatinib	KIT(D816H)	96.0	10000.0
BMS-536924	PLK1	100.0	1000.0
PD0325901	PIK3CA(I800L)	33.0	10000.0
QL-XII-47	PIK3CA(H1047Y)	42.0	1000.0
AZ-628	PKN2	100.0	10000.0
CGP60474	EGFR(G719C)	100.0	10000.0
Dinaciclib	AURKC	47.0	10000.0
JNK-IN-8	NIM1	100.0	1000.0
BMX-IN-1	DDR2	100.0	10000.0
AZD7762	JAK2(JH1domain-catalytic)	0.0	10000.0
AZD4547	IRAK3	76.0	10000.0
XMD11-50	MAP3K4	100.0	10000.0
TAK-715	STK16	74.0	10000.0
QL-XII-47	EPHB3	100.0	1000.0
SCH772984	DYRK2	12.0	1000.0
AZ-628	MAP4K5	59.0	10000.0
GSK429286A	RET(M918T)	15.0	10000.0
Abemaciclib	FLT3	69.0	1000.0
Dinaciclib	ABL1-nonphosphorylated	95.0	10000.0
KIN001-220	FLT3(ITD)	0.1	10000.0
R406	MYLK4	4.4	1000.0
MLN8054	TNK2	46.0	10000.0
PHA-793887	NEK9	100.0	10000.0
Torin2	CTK	100.0	10000.0
5z-7-oxozeaenol	KC1G1	100.0	10000.0
PHA-767491	M4K3	26.0	10000.0
XMD13-2	S6K1	100.0	10000.0
GSK1059615	SYK	62.0	10000.0
XMD13-2	CSNK1G3	98.0	10000.0
Ribociclib	TBK1	76.0	1000.0
AZD7762	LYN	0.7	10000.0
SP600125	KGP1	100.0	10000.0
Sorafenib	KC1G1	100.0	10000.0
Torin1	GRK4	90.0	10000.0
XMD14-99	PIK3CA(E545A)	100.0	10000.0
QL-XII-47	IRAK4	100.0	1000.0
CP724714	FGFR4	100.0	10000.0
Crizotinib	ERBB3	81.0	10000.0
Ceritinib	ABL1(Q252H)-phosphorylated	69.0	1000.0
XMD8-92	CDKL3	100.0	10000.0
GW-5074	FES	95.0	10000.0
HG-6-64-01	RIPK2	1.8	10000.0
WZ4003	ABL1(T315I)	100.0	1000.0
PLX-4720	ABL1(Q252H)-phosphorylated	38.0	10000.0
GSK429286A	CDKL5	45.0	10000.0
ALW-II-38-3	ICK	100.0	10000.0
Lapatinib	PDPK1	100.0	10000.0
JNK-IN-11	PAK2	88.0	1000.0
KIN001-123	DRAK2	100.0	1000.0
Torin2	KCC4	100.0	10000.0
Alpelisib	MP2K1	99.0	1000.0
HG-14-10-04	AURKC	13.0	10000.0
KIN001-220	DRAK2	13.0	10000.0
SP600125	DAPK2	4.1	10000.0
GSK461364	ABL1(Q252H)-phosphorylated	78.0	10000.0
Buparlisib	NEK10	100.0	1000.0
XMD11-50	SRMS	77.0	10000.0
PHA-767491	WNK1	80.0	10000.0
JNK-IN-8	AMPK-alpha1	100.0	1000.0
KIN001-220	ABL1(F317L)-phosphorylated	53.0	10000.0
SCH772984	BMPR1A	100.0	1000.0
JNK-IN-8	NEK7	100.0	1000.0
Pictilisib	GSK3B	100.0	1000.0
Taselisib	DDR2	83.0	1000.0
NU7441	EPHB3	100.0	10000.0
RO-3306	SLK	26.0	10000.0
ZM-447439	AMPK-alpha1	62.0	10000.0
Neratinib	PIP5K1A	100.0	10000.0
HG-9-91-01	EPHA3	0.2	10000.0
5z-7-oxozeaenol	NEK9	90.0	10000.0
Ibrutinib	EIF2AK1	81.0	1000.0
OTSSP167	IKKB	2.2	10000.0
Dabrafenib	MET(M1250T)	13.0	10000.0
ZG-10	ABL1(Q252H)-nonphosphorylated	19.0	10000.0
KU63794	ERK3	84.0	10000.0
BX-912	ABL1-phosphorylated	0.2	10000.0
WH-4-023	TIE1	5.8	10000.0
Omipalisib	DCLK1	62.0	10000.0
Sorafenib	FGFR3(G697C)	39.0	10000.0
JWE-035	AURKA	0.4	10000.0
GSK429286A	MET	51.0	10000.0
Dinaciclib	HIPK3	4.4	10000.0
Barasertib	CDKL2	18.0	10000.0
Dactolisib	MET(M1250T)	100.0	1000.0
TGX221	CSNK2A2	100.0	1000.0
RO-3306	GRK4	60.0	10000.0
TAK-715	PDPK1	89.0	10000.0
AZD4547	SRC	2.8	10000.0
GSK1059615	GCN2(Kin.Dom.2,S808G)	7.4	10000.0
BS-181	IRAK4	84.0	10000.0
Baricitinib	RPS6KA4(Kin.Dom.2-C-terminal)	0.4	10000.0
KIN001-220	MLTK	2.9	10000.0
Torkinib	ERN1	31.0	10000.0
Lapatinib	PFCDPK1(P.falciparum)	76.0	10000.0
WZ3105	ABL1(F317L)-phosphorylated	54.0	10000.0
GW843682X	PAK7	98.0	10000.0
CP724714	TNNI3K	100.0	10000.0
BI-2536	TAOK1	100.0	10000.0
JNK-IN-8	GSK3B	100.0	1000.0
JW-7-24-1	AKT2	100.0	10000.0
Vemurafenib	AMPK-alpha1	89.0	10000.0
XMD-12	SIK1	79.0	1000.0
OTSSP167	ERK8	1.5	10000.0
HG-5-88-01	ABL1(F317L)	12.0	10000.0
Seliciclib	MP2K5	75.0	10000.0
AG1478	RSK4(Kin.Dom.1-N-terminal)	46.0	10000.0
QL-XII-47	PIK3CA(M1043I)	100.0	1000.0
(s)-CR8	JAK2(JH1domain-catalytic)	98.0	10000.0
SP600125	ABL1(T315I)	100.0	10000.0
JNK-IN-11	ACVR1B	8.4	1000.0
XMD8-92	GRK1	100.0	10000.0
TAK-715	MK03	98.0	10000.0
PHA-793887	KIT(D816V)	89.0	10000.0
KIN001-127	RIOK3	100.0	10000.0
Seliciclib	PIP5K2B	95.0	10000.0
Vemurafenib	RSK3(Kin.Dom.2-C-terminal)	81.0	10000.0
CP724714	LYN	92.0	10000.0
MRT67307	HCK	100.0	10000.0
KU63794	KC1G1	94.0	10000.0
ALW-II-38-3	PIK3CA(Q546K)	100.0	10000.0
SP600125	SRC	100.0	10000.0
Seliciclib	ACVRL1	100.0	10000.0
AS-252424	MAP4K2	95.4	10000.0
CG-930	ABL1(H396P)-phosphorylated	31.0	10000.0
KIN001-220	KIT(V559D,V654A)	84.0	10000.0
XMD13-2	SIK2	91.0	10000.0
KIN001-111	EPHA3	100.0	1000.0
NVP-TAE684	SRMS	0.0	1000.0
Sorafenib	CLK4	52.0	10000.0
Lapatinib	DCAMKL3	84.0	10000.0
KIN001-127	FLT4	100.0	10000.0
AZD-6482	ACVR2B	100.0	10000.0
XMD13-2	MP2K4	66.0	10000.0
CGP60474	FLT3(D835H)	100.0	10000.0
CG-930	DCAMKL2	100.0	10000.0
XMD14-99	AKT1	100.0	10000.0
QL-XII-47	MARK2	87.0	1000.0
HG-14-10-04	MAPKAPK5	86.0	10000.0
5z-7-oxozeaenol	ERK4	100.0	10000.0
AS-252424	DCAMKL2	100.0	10000.0
BI-D1870	RIOK3	2.8	10000.0
WH-4-023	AKT2	100.0	10000.0
Baricitinib	ACVR2B	82.0	10000.0
Omipalisib	ERK5	93.0	10000.0
GSK429286A	PIM1	88.0	10000.0
QL-X-138	CDKL5	3.3	10000.0
HG-14-10-04	M3K6	100.0	10000.0
SB590885	MP2K6	100.0	10000.0
XMD11-85h	ABL1(F317L)	100.0	10000.0
MRT67307	ABL1-nonphosphorylated	24.0	10000.0
Torin1	ERK3	1.8	10000.0
GSK429286A	PIK3C2B	100.0	10000.0
WYE-125132	DAPK3	100.0	10000.0
SCH772984	EGFR(T790M)	100.0	1000.0
Torkinib	KIT(V559D,V654A)	59.0	10000.0
GSK461364	CLK4	59.0	10000.0
BMS345541	ABL2	100.0	10000.0
KIN001-123	CAMK1	100.0	1000.0
Ibrutinib	EGFR(T790M)	0.2	1000.0
KU63794	PKMYT1	84.0	10000.0
Vemurafenib	LRRK2(G2019S)	70.0	10000.0
JW-7-24-1	ACVRL1	100.0	10000.0
GW843682X	KPCD	100.0	10000.0
Canertinib	FGFR2	100.0	1000.0
Dabrafenib	RET(M918T)	27.0	10000.0
WYE-125132	BIKE	85.0	10000.0
SB590885	TNIK	12.0	10000.0
Ribociclib	ADCK4	94.0	1000.0
WZ-7043	PIM2	100.0	10000.0
SP600125	NDR2	28.0	10000.0
THZ1	DCLK1	55.0	10000.0
Momelotinib	TEC	100.0	10000.0
CP466722	MST1	61.0	10000.0
BGJ398	MAPKAPK2	74.0	1000.0
KIN001-021	BRSK2	100.0	1000.0
JNK-IN-11	VGFR1	9.3	1000.0
QL-X-138	M4K1	90.0	10000.0
ALW-II-38-3	EPHB4	13.0	1000.0
XMD14-99	LIMK2	94.0	10000.0
Torin1	MELK	50.0	10000.0
ZSTK474	TLK1	100.0	1000.0
Momelotinib	AKT3	100.0	10000.0
Torkinib	MP2K4	3.4	10000.0
Buparlisib	PIK3CA(E545A)	0.7	1000.0
AS-252424	ABL1(F317L)	92.5	10000.0
Alpelisib	NIM1	100.0	1000.0
Abemaciclib	AXL	71.0	1000.0
XMD-12	MLTK	100.0	1000.0
AZD4547	EPHA4	92.0	10000.0
AZD4547	ZAP70	7.8	10000.0
ZSTK474	GSK3A	100.0	1000.0
OTSSP167	TGFBR1	100.0	10000.0
GW-5074	RSK4(Kin.Dom.1-N-terminal)	51.0	10000.0
KIN001-123	MP2K4	2.9	1000.0
MRT67307	MLK3	3.4	10000.0
PHA-793887	PKN1	65.0	10000.0
KIN001-021	NEK6	31.0	1000.0
JWE-035	MARK2	40.0	10000.0
Alpelisib	ULK2	100.0	1000.0
Omipalisib	MKNK1	78.0	10000.0
GSK461364	DDR1	100.0	10000.0
HG-5-88-01	MK01	26.0	10000.0
HG-14-8-02	BMX	45.0	10000.0
Ribociclib	STK36	100.0	1000.0
WZ3105	TTK	51.0	10000.0
JNK-IN-11	AKT2	100.0	1000.0
WZ-4-145	VGFR2	0.5	10000.0
BI-2536	WEE2	100.0	10000.0
Lapatinib	LKB1	100.0	10000.0
WYE-125132	DMPK2	84.0	10000.0
ZG-10	RSK1(Kin.Dom.2-C-terminal)	91.0	10000.0
AS-252424	PAK1	100.0	10000.0
XMD11-85h	EPHA4	100.0	10000.0
Torin1	EPHB1	100.0	10000.0
Ibrutinib	FGFR1	36.0	1000.0
BS-181	JAK1(JH1domain-catalytic)	83.0	10000.0
XMD8-85	MYLK4	100.0	10000.0
BX-912	TNNI3K	28.0	10000.0
SCH772984	ZAP70	99.0	1000.0
XMD11-85h	M4K1	100.0	10000.0
MPS-1-IN-1	YSK1	100.0	1000.0
QL-X-138	BMX	4.6	10000.0
QL-X-138	CDC2L1	100.0	10000.0
Momelotinib	RIOK2	68.0	10000.0
Ribociclib	MP2K4	100.0	1000.0
XMD11-50	MET(M1250T)	96.0	10000.0
Neratinib	ROS1	96.0	10000.0
QL-XI-92	CLK3	100.0	10000.0
NG25	MP2K1	100.0	10000.0
Omipalisib	YES	90.0	10000.0
OTSSP167	KCC4	1.0	10000.0
WZ3105	CSNK2A2	48.0	10000.0
JNK-IN-5A	MRCKB	80.0	10000.0
JWE-035	MET	36.0	10000.0
SCH772984	PHKG2	80.0	1000.0
BI-2536	MK09	100.0	10000.0
CH5424802	ALK	0.2	1000.0
A443654	ERK4	100.0	10000.0
TAK-715	SIK2	62.0	10000.0
JNK-9L	TRKC	100.0	10000.0
CG-930	PIP5K1A	93.0	10000.0
TAK-715	MAPKAPK2	100.0	10000.0
GSK461364	M3K6	75.0	10000.0
PLX-4720	DDR1	1.6	10000.0
HG-5-88-01	CHEK1	100.0	10000.0
KIN001-123	EPHB3	100.0	1000.0
Dactolisib	HUNK	100.0	1000.0
ALW-II-49-7	DCAMKL2	100.0	10000.0
BMX-IN-1	PAK4	100.0	10000.0
BS-181	TRKC	92.0	10000.0
Abemaciclib	ERN1	35.0	1000.0
QL-XII-47	HUNK	72.0	1000.0
QL-XII-47	MERTK	78.0	1000.0
PD173074	KPCL	100.0	10000.0
KU63794	ABL1(F317I)-phosphorylated	96.0	10000.0
NG25	VGFR2	1.5	10000.0
AS-252424	DCAMKL3	50.2	10000.0
Momelotinib	MAPKAPK5	4.4	10000.0
RO-3306	CSNK1D	83.0	10000.0
Dinaciclib	BIKE	78.0	10000.0
AG1478	MYLK	18.0	10000.0
KIN001-021	INSRR	100.0	1000.0
CH5424802	ABL1(Q252H)-nonphosphorylated	81.0	1000.0
Dabrafenib	MARK1	87.0	10000.0
Dactolisib	JNK3	100.0	1000.0
CGP60474	PIP5K2B	100.0	10000.0
QL-X-138	ITK	29.0	10000.0
HG-5-88-01	PCTK3	100.0	10000.0
ERK5-IN-1	IRAK1	100.0	1000.0
JNK-9L	JNK3	0.2	10000.0
KIN001-111	MP2K4	2.0	1000.0
SB590885	ROS1	88.0	10000.0
Omipalisib	FLT3-autoinhibited	83.0	10000.0
Barasertib	DCAMKL2	100.0	10000.0
AZD-6482	DAPK1	95.0	10000.0
PD0325901	TNK2	72.0	10000.0
Lapatinib	NEK3	79.0	10000.0
KIN001-220	BMX	25.0	10000.0
SP600125	LTK	100.0	10000.0
XMD11-50	PIK3CA(I800L)	38.0	10000.0
JNK-IN-8	CDC2L2	98.0	1000.0
Vemurafenib	ABL1(Q252H)-phosphorylated	80.0	10000.0
XMD14-99	DMPK2	100.0	10000.0
XMD8-92	MST2	100.0	10000.0
QL-X-138	AKT3	100.0	10000.0
GSK1059615	ULK1	74.0	10000.0
Vemurafenib	MK03	100.0	10000.0
Dactolisib	EPHB3	100.0	1000.0
WZ-7043	PKMYT1	100.0	10000.0
Neratinib	SNARK	8.8	10000.0
JW-7-24-1	PCTK2	100.0	10000.0
RO-3306	PTK6	99.0	10000.0
XMD16-144	NEK7	100.0	10000.0
ALW-II-38-3	INSRR	100.0	10000.0
XMD11-50	ERBB2	100.0	10000.0
BX-912	SRMS	37.0	10000.0
QL-X-138	LKB1	100.0	10000.0
GSK1059615	BMPR2	3.7	10000.0
GW-5074	KPCD1	100.0	10000.0
XMD8-92	PKMYT1	100.0	10000.0
ZG-10	CIT	38.0	10000.0
BI-2536	PAK3	100.0	10000.0
Pictilisib	SGK3	100.0	1000.0
MLN8054	SRPK1	100.0	10000.0
PD173074	ABL1(Q252H)	100.0	10000.0
A443654	PAK1	6.2	10000.0
PLX-4720	PLK1	100.0	10000.0
ZSTK474	PIK3CD	2.2	1000.0
HG-14-8-02	RET(V804L)	100.0	10000.0
RO-3306	CSNK1A1	95.0	10000.0
BI-2536	PAK2	100.0	10000.0
JNK-9L	CDK2	30.0	10000.0
Neratinib	ULK1	100.0	10000.0
HG-5-88-01	RPS6KA5(Kin.Dom.2)	100.0	10000.0
GSK1059615	AURKA	69.0	10000.0
QL-XI-92	FLT3(N841I)	82.0	10000.0
Crizotinib	DCAMKL2	1.2	10000.0
HG-14-10-04	PLK2	48.0	10000.0
AG1478	ABL1(T315I)-phosphorylated	2.5	10000.0
MRT67307	STK35	97.0	10000.0
Ribociclib	PIM3	68.0	1000.0
SCH772984	RSK2(Kin.Dom.2-C-terminal)	100.0	1000.0
KIN001-021	PLK3	100.0	1000.0
HG-6-64-01	LOK	0.0	10000.0
GSK429286A	STK16	100.0	10000.0
BMS-536924	ULK3	0.1	1000.0
Momelotinib	WNK3	90.0	10000.0
KU63794	MKNK1	36.0	10000.0
BMX-IN-1	PIK3CD	100.0	10000.0
Crizotinib	GRK7	42.0	10000.0
Omipalisib	CAMK1G	71.0	10000.0
XMD13-2	ABL1(F317I)-phosphorylated	100.0	10000.0
Ibrutinib	ABL1(M351T)-phosphorylated	74.0	1000.0
KIN001-111	EGFR(L747-T751del,Sins)	26.0	1000.0
XMD8-92	IKKA	100.0	10000.0
QL-X-138	FGFR2	94.0	10000.0
BX-912	TLK1	37.0	10000.0
A443654	MAPKAPK5	100.0	10000.0
MPS-1-IN-1	SRPK2	100.0	1000.0
ALW-II-49-7	FES	100.0	10000.0
JNK-IN-8	MK14	100.0	1000.0
Abemaciclib	NDR1	74.0	1000.0
Ceritinib	YES	97.0	1000.0
HG-14-10-04	ULK3	0.0	10000.0
Dabrafenib	EPHA6	56.0	10000.0
Alpelisib	ADCK3	80.0	1000.0
Torkinib	MST2	27.0	10000.0
QL-XI-92	ERBB4	100.0	10000.0
AZ-628	BMPR1A	100.0	10000.0
HG-9-91-01	MTOR	96.0	10000.0
CGP60474	FLT3(D835Y)	19.0	10000.0
XMD14-99	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
CGP74514A	FLT4	37.0	10000.0
Barasertib	ERN1	67.0	10000.0
XMD14-99	SLK	1.6	10000.0
GSK1059615	YANK1	83.0	10000.0
Dinaciclib	KIT(A829P)	98.0	10000.0
TAK-715	GRK4	100.0	10000.0
JNK-IN-11	LATS2	78.0	1000.0
PLX-4720	SIK1	2.6	10000.0
Ribociclib	BTK	100.0	1000.0
ZM-447439	PTK6	0.8	10000.0
MLN8054	PIK3CA(H1047L)	79.0	10000.0
KIN001-111	CDK3	100.0	1000.0
MRT67307	CTK	97.0	10000.0
JNK-9L	KPCD1	66.0	10000.0
SCH772984	PIP5K1C	82.0	1000.0
A443654	MRCKB	1.0	10000.0
ALW-II-49-7	CAMKK2	100.0	10000.0
Vemurafenib	MK12	93.0	10000.0
BI-2536	MRCKB	100.0	10000.0
AG1478	RSK1(Kin.Dom.1-N-terminal)	93.0	10000.0
Omipalisib	DRAK1	87.0	10000.0
AZ-628	RET	0.2	10000.0
KIN001-021	EGFR(L747-T751del,Sins)	33.0	1000.0
RO-3306	NEK3	97.0	10000.0
BI-2536	PIP5K1A	100.0	10000.0
AG1478	MINK	37.0	10000.0
HG-14-10-04	EPHA5	100.0	10000.0
WH-4-023	NEK1	76.0	10000.0
PHA-767491	RET(V804M)	100.0	10000.0
Torin2	JAK1(JH2domain-pseudokinase)	13.0	10000.0
JNK-IN-5A	HUNK	95.0	10000.0
RO-3306	YANK2	100.0	10000.0
WZ-4-145	EPHA6	100.0	10000.0
BGJ398	PIK3CA(H1047L)	84.0	1000.0
MPS-1-IN-1	ERK5	11.0	1000.0
Baricitinib	MK12	38.0	10000.0
Momelotinib	MK01	93.0	10000.0
BMS345541	ERBB3	83.0	10000.0
XMD14-99	VRK2	100.0	10000.0
CGP74514A	TAK1	13.0	10000.0
THZ1	IKKE	100.0	10000.0
PHA-793887	CHEK1	60.0	10000.0
XMD-12	TRKA	64.0	1000.0
HG-9-91-01	MAPKAPK5	100.0	10000.0
XMD8-85	MAPKAPK2	100.0	10000.0
BMS-536924	BIKE	0.2	1000.0
BMS345541	ULK3	76.0	10000.0
QL-XI-92	DDR1	0.1	10000.0
XMD16-144	DYRK1B	100.0	10000.0
R406	RPS6KA4(Kin.Dom.1)	100.0	1000.0
WYE-125132	VRK2	100.0	10000.0
GSK429286A	HIPK1	75.0	10000.0
CP466722	PFPK5(P.falciparum)	94.0	10000.0
JW-7-24-1	SgK110	100.0	10000.0
WZ-7043	ERK5	4.1	10000.0
CH5424802	RAF1	99.0	1000.0
BGJ398	KIT(L576P)	6.8	1000.0
Barasertib	CDKL5	50.0	10000.0
BMS-536924	TRKA	0.0	1000.0
Barasertib	AURKC	19.0	10000.0
PD0325901	MP2K6	100.0	10000.0
A443654	KC1G2	0.7	10000.0
MLN8054	JAK1(JH2domain-pseudokinase)	80.0	10000.0
BS-181	MK12	88.0	10000.0
XMD13-2	OSR1	98.0	10000.0
GW-5074	DRAK1	2.5	10000.0
Sorafenib	TAOK3	0.8	10000.0
HG-9-91-01	MAP3K4	39.0	10000.0
CP466722	PIK3CA(I800L)	2.8	10000.0
AZD7762	ROCK2	0.2	10000.0
KIN001-111	AAK1	100.0	1000.0
TAK-715	CLK4	93.0	10000.0
Omipalisib	KPCT	87.0	10000.0
QL-XI-92	LIMK2	96.0	10000.0
XMD8-92	NEK9	100.0	10000.0
AZD7762	EGFR(T790M)	0.1	10000.0
AZ-628	M3K13	100.0	10000.0
Momelotinib	EPHA5	87.0	10000.0
WZ-7043	M3K6	100.0	10000.0
Neratinib	GCN2(Kin.Dom.2,S808G)	1.4	10000.0
GSK1059615	CDK9	16.0	10000.0
WZ-7043	FER	100.0	10000.0
ERK5-IN-1	TEC	100.0	1000.0
HG-9-91-01	BRAF	17.0	10000.0
Sorafenib	MK14	0.2	10000.0
KU63794	PDPK1	100.0	10000.0
KIN001-127	PDPK1	100.0	10000.0
Alpelisib	BRAF	100.0	1000.0
Sorafenib	PCTK2	17.0	10000.0
BMS-536924	RPS6KA6(Kin.Dom.1)	100.0	1000.0
Seliciclib	MLK1	100.0	10000.0
CGP74514A	KIT(V559D)	15.0	10000.0
QL-XI-92	TRPM6	100.0	10000.0
AS-252424	KIT(V559D)	87.1	10000.0
Dinaciclib	TRKC	98.0	10000.0
Neratinib	GRK7	100.0	10000.0
JNK-IN-5A	MK03	74.0	10000.0
JWE-035	CSK	93.0	10000.0
ZM-447439	TLK1	78.0	10000.0
MLN8054	LCK	1.6	10000.0
CH5424802	FRK	15.0	1000.0
Omipalisib	RPS6KA4(Kin.Dom.2-C-terminal)	94.0	10000.0
GSK429286A	MUSK	95.0	10000.0
Canertinib	TRKB	100.0	1000.0
WZ4003	AURKB	14.0	1000.0
AZ-628	PIM2	100.0	10000.0
PD0325901	TAOK1	100.0	10000.0
WYE-125132	ROCK1	100.0	10000.0
Ibrutinib	TRPM6	31.0	1000.0
HG-14-10-04	SgK110	92.0	10000.0
Taselisib	GSK3A	87.0	1000.0
Sorafenib	PIP5K1C	87.0	10000.0
JNK-IN-8	AURKC	95.0	1000.0
Pictilisib	RIPK5	100.0	1000.0
CG-930	IKKE	85.0	10000.0
HG-9-91-01	RSK3(Kin.Dom.1-N-terminal)	5.6	10000.0
KIN001-220	HIPK4	2.4	10000.0
Palbociclib	PRP4	100.0	1000.0
THZ1	BMPR1B	31.0	10000.0
SCH772984	EPHB4	98.0	1000.0
GW-5074	STK36	14.0	10000.0
ZM-447439	MARK3	96.0	10000.0
Alpelisib	ACVRL1	100.0	1000.0
THZ1	RET(V804L)	0.0	10000.0
MRT67307	TRKC	38.0	10000.0
THZ1	LCK	5.0	10000.0
WZ-4-145	NEK5	100.0	10000.0
ALW-II-49-7	MK13	100.0	10000.0
Canertinib	EPHA1	100.0	1000.0
KIN001-127	TGFBR2	100.0	10000.0
HG-14-10-04	M4K3	8.0	10000.0
Ribociclib	DCLK1	75.0	1000.0
Sigma A6730	FLT3(N841I)	61.0	10000.0
MLN8054	EGFR(S752-I759del)	34.0	10000.0
HG-9-91-01	HASP	99.0	10000.0
GSK1059615	TIE2	98.0	10000.0
MLN8054	EGFR(L747-E749del,A750P)	28.0	10000.0
ZG-10	DDR1	100.0	10000.0
PD173074	MST4	100.0	10000.0
HG-14-8-02	ULK3	97.0	10000.0
BGJ398	BRSK2	81.0	1000.0
JWE-035	EGFR(G719C)	89.0	10000.0
Omipalisib	PIK3CA(H1047Y)	0.6	10000.0
ALW-II-49-7	SRMS	100.0	10000.0
BMS-536924	TAOK1	100.0	1000.0
HG-14-8-02	LTK	1.8	10000.0
XMD16-144	ERK3	46.0	10000.0
QL-XII-47	TXK	59.0	1000.0
CGP74514A	NEK10	73.0	10000.0
BMS345541	GSK3B	68.0	10000.0
AG1478	ERBB3	18.0	10000.0
WH-4-023	ACVR1	0.0	10000.0
Alpelisib	ABL1(F317I)-phosphorylated	73.0	1000.0
KIN001-021	FGFR3	100.0	1000.0
AS-252424	MAPKAPK5	84.3	10000.0
PD0325901	SIK2	92.0	10000.0
JWE-035	ACVR2A	56.0	10000.0
HG-14-10-04	MST4	42.0	10000.0
Ribociclib	RIPK5	100.0	1000.0
AZD-6482	ABL1(F317L)-nonphosphorylated	87.0	10000.0
ZSTK474	DDR2	100.0	1000.0
XMD11-85h	ERBB2	100.0	10000.0
GW843682X	NEK11	100.0	10000.0
Canertinib	CDK7	100.0	1000.0
(s)-CR8	JAK1(JH2domain-pseudokinase)	100.0	10000.0
AG1478	GRK1	100.0	10000.0
WZ-4-145	ERK8	100.0	10000.0
KIN001-111	DAPK3	100.0	1000.0
QL-X-138	ABL1(Q252H)-nonphosphorylated	32.0	10000.0
JNK-IN-8	GAK	92.0	1000.0
TGX221	FLT3(D835H)	100.0	1000.0
Canertinib	KPCT	100.0	1000.0
MLN8054	JNK1	100.0	10000.0
GW843682X	JAK1(JH1domain-catalytic)	100.0	10000.0
MPS-1-IN-1	CSNK1G3	100.0	1000.0
CH5424802	CAMK1	77.0	1000.0
XMD16-144	MLK3	100.0	10000.0
Ceritinib	ULK3	84.0	1000.0
HG-5-113-01	PHKG1	100.0	10000.0
SP600125	LCK	100.0	10000.0
Sorafenib	CSF1R	0.1	10000.0
KIN001-127	MYO3A	100.0	10000.0
PHA-767491	MTOR	95.0	10000.0
KU63794	INSR	97.0	10000.0
Dinaciclib	SBK1	61.0	10000.0
PLX-4720	MP2K4	6.6	10000.0
HG-5-88-01	MAP3K4	100.0	10000.0
Canertinib	WEE1	100.0	1000.0
MLN8054	M4K1	71.0	10000.0
WZ3105	KIT(L576P)	33.0	10000.0
Dinaciclib	PIK3C2G	98.0	10000.0
CGP60474	DRAK2	100.0	10000.0
BMX-IN-1	CSF1R	87.0	10000.0
SB590885	ABL1(E255K)-phosphorylated	8.6	10000.0
BS-181	M3K13	87.0	10000.0
JNK-IN-5A	GSK3B	66.0	10000.0
KU63794	EPHA6	100.0	10000.0
BGJ398	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	1000.0
Canertinib	RET	100.0	1000.0
XMD8-92	CSNK2A1	100.0	10000.0
Taselisib	RSK3(Kin.Dom.1-N-terminal)	100.0	1000.0
GSK1059615	PKN1	56.0	10000.0
ZG-10	MK03	100.0	10000.0
OTSSP167	RIOK1	98.0	10000.0
Baricitinib	TRPM6	85.0	10000.0
CG-930	EPHA8	72.0	10000.0
XMD8-92	MAP4K5	100.0	10000.0
XMD14-99	NEK4	96.0	10000.0
MRT67307	PIP5K1A	1.6	10000.0
Torin1	CDK11	1.2	10000.0
XMD11-50	MST1R	98.0	10000.0
KIN001-220	PIK3CB	83.0	10000.0
CG-930	KPCL	96.0	10000.0
KIN001-111	ABL1	2.1	1000.0
Alpelisib	WNK2	100.0	1000.0
Dabrafenib	FLT3(ITD)	59.0	10000.0
KIN001-220	NDR2	60.0	10000.0
BMX-IN-1	PIK3CA(C420R)	32.0	10000.0
Torin1	MARK2	98.0	10000.0
XMD11-85h	M3K13	100.0	10000.0
JWE-035	KPCT	100.0	10000.0
GW-5074	PIK3CA(C420R)	100.0	10000.0
R406	KC1G2	100.0	1000.0
XMD8-92	ABL1(E255K)	100.0	10000.0
CP466722	MST3	56.0	10000.0
XMD14-99	EGFR(L747-T751del,Sins)	91.0	10000.0
WZ4002	KCC2D	100.0	10000.0
WH-4-023	CSNK1D	82.0	10000.0
Taselisib	S6K1	100.0	1000.0
HG-9-91-01	TAOK2	0.0	10000.0
BGJ398	ADCK3	96.0	1000.0
Dactolisib	ABL1(Y253F)	100.0	1000.0
XMD-12	TNK2	29.0	1000.0
KIN001-127	MLTK	100.0	10000.0
Canertinib	JAK2(Kin.Dom.2)	100.0	1000.0
HG-14-8-02	PIK3C2B	100.0	10000.0
Pictilisib	NEK10	85.0	1000.0
JNK-9L	PKN1	48.0	10000.0
CH5424802	EPHB1	48.0	1000.0
HG-5-88-01	CSNK2A2	100.0	10000.0
NU7441	MARK2	90.0	10000.0
BMS345541	CDK9	35.0	10000.0
Dabrafenib	HIPK3	1.6	10000.0
Omipalisib	MST3	100.0	10000.0
R406	VGFR1	0.1	1000.0
AZD4547	RPS6KA4(Kin.Dom.2-C-terminal)	81.0	10000.0
QL-XII-47	KKCC1	93.0	1000.0
KU63794	M3K12	100.0	10000.0
ZG-10	FLT4	97.0	10000.0
Abemaciclib	PKN1	26.0	1000.0
XMD11-85h	MAP3K1	100.0	10000.0
MRT67307	EGFR(T790M)	75.0	10000.0
BS-181	CAMK2G	93.0	10000.0
WZ4002	RPS6KA3(Kin.Dom.1)	100.0	10000.0
Dactolisib	EGFR(G719S)	100.0	1000.0
(s)-CR8	PKN1	100.0	10000.0
Seliciclib	MELK	97.0	10000.0
ERK5-IN-1	LTK	48.0	1000.0
Lapatinib	PIK4CB	54.0	10000.0
SCH772984	MET	100.0	1000.0
XMD-12	BRSK2	48.0	1000.0
HG-14-8-02	EGFR(E746-A750del)	0.0	10000.0
ZG-10	CSNK1A1L	100.0	10000.0
KIN001-220	MTOR	20.0	10000.0
WZ3105	DDR1	100.0	10000.0
SB590885	MAK	100.0	10000.0
JNK-IN-8	PIK3CA(Q546K)	100.0	1000.0
NVP-TAE684	CDK15	16.0	1000.0
HG-14-8-02	AXL	41.0	10000.0
SB590885	RSK2(Kin.Dom.1-N-terminal)	67.0	10000.0
SB590885	TYRO3	100.0	10000.0
PHA-767491	IKKE	83.0	10000.0
Sorafenib	MAST1	100.0	10000.0
XMD8-92	PRP4	100.0	10000.0
Baricitinib	ABL1-phosphorylated	19.0	10000.0
HG-5-88-01	MK14	100.0	10000.0
WZ4002	KC1G2	100.0	10000.0
BX-912	ACVRL1	100.0	10000.0
CH5424802	YES	40.0	1000.0
BX-912	JNK3	0.1	10000.0
TAK-715	EGFR(L747-E749del,A750P)	5.4	10000.0
XMD8-85	RPS6KA3(Kin.Dom.1)	100.0	10000.0
Baricitinib	GSK3A	94.0	10000.0
Buparlisib	CDK5	100.0	1000.0
QL-X-138	PIM1	70.0	10000.0
Baricitinib	PIK3CA(E545K)	62.0	10000.0
QL-XII-47	PAK3	100.0	1000.0
GW-5074	GRK1	92.0	10000.0
Dabrafenib	PKMYT1	100.0	10000.0
XMD11-50	EPHA7	97.0	10000.0
ERK5-IN-1	KGP2	100.0	1000.0
GSK461364	VRK2	100.0	10000.0
HG-9-91-01	SgK110	33.0	10000.0
AZD-6482	EGFR(S752-I759del)	100.0	10000.0
ERK5-IN-1	PGFRB	100.0	1000.0
R406	CIT	4.7	1000.0
Crizotinib	ABL1(H396P)-nonphosphorylated	0.0	10000.0
NU7441	DCAMKL2	100.0	10000.0
Buparlisib	SLK	100.0	1000.0
RO-3306	PRKX	3.6	10000.0
NVP-TAE684	DDR1	0.1	1000.0
TAK-715	PIK3CG	100.0	10000.0
Alpelisib	MST1	98.0	1000.0
XMD13-2	TNNI3K	92.0	10000.0
Ibrutinib	M3K5	87.0	1000.0
GSK461364	FLT3	11.0	10000.0
Sorafenib	MYLK4	100.0	10000.0
Taselisib	PAK7	96.0	1000.0
Momelotinib	DYRK1A	66.0	10000.0
R406	CDK11	100.0	1000.0
NG25	CAMK1G	20.0	10000.0
OTSSP167	CTK	22.0	10000.0
BMS345541	RSK4(Kin.Dom.1-N-terminal)	88.0	10000.0
Crizotinib	PCTK3	94.0	10000.0
ALW-II-38-3	BMPR1B	100.0	10000.0
Dactolisib	BIKE	100.0	1000.0
JNK-IN-5A	AURKB	94.0	10000.0
WH-4-023	ALK	0.4	10000.0
Seliciclib	CDKL5	100.0	10000.0
BMS-536924	ANKK1	2.5	1000.0
Sorafenib	PIK3CB	100.0	10000.0
JNK-IN-11	EPHA4	89.0	1000.0
GSK429286A	RIOK1	100.0	10000.0
PD173074	AMPK-alpha2	100.0	10000.0
KIN001-127	MST2	100.0	10000.0
BX-912	MAP3K15	50.0	10000.0
HG-5-88-01	ERK5	100.0	10000.0
HG-9-91-01	BMX	3.6	10000.0
Torin2	ICK	79.0	10000.0
TAK-715	DYRK2	99.0	10000.0
HG-5-113-01	YES	1.6	10000.0
THZ1	DRAK2	8.5	10000.0
TAK-715	RIPK4	90.0	10000.0
ERK5-IN-1	DYRK2	100.0	1000.0
GW843682X	CDKL3	100.0	10000.0
WZ4002	TGFBR1	100.0	10000.0
SCH772984	EGFR(L858R,T790M)	88.0	1000.0
JNK-IN-8	RPS6KA5(Kin.Dom.2-C-terminal)	97.0	1000.0
PHA-767491	DDR2	71.0	10000.0
WZ4002	STK16	27.0	10000.0
BGJ398	TRKB	82.0	1000.0
AS-252424	TXK	99.2	10000.0
AG1478	BUB1	0.3	10000.0
Omipalisib	BRSK2	82.0	10000.0
Torin2	IKKB	89.0	10000.0
Torin1	DCLK1	100.0	10000.0
CGP74514A	CDK5	0.1	10000.0
TGX221	NUAK1	100.0	1000.0
AZD4547	NDR1	48.0	10000.0
KIN001-127	MP2K1	100.0	10000.0
XMD11-50	CIT	99.0	10000.0
5z-7-oxozeaenol	KPCE	74.0	10000.0
Barasertib	AMPK-alpha1	64.0	10000.0
TGX221	ULK3	100.0	1000.0
Ibrutinib	PTK6	1.0	1000.0
CG-930	IRAK4	94.0	10000.0
JNK-IN-11	ERK3	71.0	1000.0
MPS-1-IN-1	KC1G2	100.0	1000.0
Buparlisib	CSNK1D	97.0	1000.0
WZ-7043	PIK3CB	100.0	10000.0
Neratinib	CSF1R	68.0	10000.0
SCH772984	MARK3	100.0	1000.0
ZM-447439	EPHA4	98.0	10000.0
JWE-035	SRPK2	81.0	10000.0
WZ-4-145	EGFR	0.4	10000.0
PD0325901	MARK4	100.0	10000.0
JNK-IN-11	INSRR	97.0	1000.0
BGJ398	PLK1	81.0	1000.0
Baricitinib	ABL1(M351T)-phosphorylated	20.0	10000.0
QL-X-138	PRKX	100.0	10000.0
Sigma A6730	PAK4	74.0	10000.0
BI-2536	LOK	100.0	10000.0
BX-912	YANK1	51.0	10000.0
(s)-CR8	RET	100.0	10000.0
Omipalisib	CSNK1A1L	93.0	10000.0
CGP60474	MET(Y1235D)	100.0	10000.0
HG-5-88-01	KC1G1	100.0	10000.0
ZG-10	HIPK1	6.0	10000.0
KIN001-127	CSNK1G3	100.0	10000.0
MLN8054	EIF2AK1	89.0	10000.0
A443654	ABL1(H396P)	100.0	10000.0
Vemurafenib	CDKL3	100.0	10000.0
PD173074	MKNK1	100.0	10000.0
SCH772984	JNK1	2.2	1000.0
Abemaciclib	CSF1R	100.0	1000.0
ZSTK474	MARK1	100.0	1000.0
Torin2	MP2K7	100.0	10000.0
SB590885	MK12	77.0	10000.0
WZ-4-145	JAK1(Kin.Dom.2)	100.0	10000.0
CH5424802	NEK5	100.0	1000.0
WZ3105	RAF1	100.0	10000.0
HG-6-64-01	CDK7	41.0	10000.0
QL-XI-92	FGFR4	100.0	10000.0
GSK1059615	KPCD1	89.0	10000.0
PLX-4720	EGFR(L858R,T790M)	90.0	10000.0
Torin2	PRKR	70.0	10000.0
Torkinib	KIT(A829P)	10.0	10000.0
JNK-IN-5A	BRSK2	100.0	10000.0
THZ1	DAPK2	54.0	10000.0
PHA-767491	VGFR1	100.0	10000.0
SB590885	ERBB3	0.7	10000.0
AZD 5438	WNK3	98.0	10000.0
Ibrutinib	IKKE	100.0	1000.0
Torin1	TAK1	47.0	10000.0
OTSSP167	CDK11	0.9	10000.0
Torin2	VGFR2	100.0	10000.0
JNK-IN-8	PLK4	58.0	1000.0
GSK429286A	DYRK1B	84.0	10000.0
ALW-II-49-7	MYLK4	100.0	10000.0
XMD14-99	RIOK3	100.0	10000.0
QL-XI-92	DAPK3	96.0	10000.0
NVP-TAE684	VGFR2	2.2	1000.0
TGX221	TNIK	100.0	1000.0
GSK429286A	SRMS	58.0	10000.0
Lapatinib	MST1	95.0	10000.0
AZD4547	DMPK	100.0	10000.0
(s)-CR8	INSR	96.0	10000.0
TAK-715	MET(M1250T)	100.0	10000.0
CGP60474	ERK5	100.0	10000.0
ZM-447439	TXK	99.0	10000.0
HG-9-91-01	NEK6	100.0	10000.0
Pictilisib	ROCK2	100.0	1000.0
WZ4002	FGR	100.0	10000.0
HG-5-88-01	MST4	100.0	10000.0
AS-252424	ANKK1	88.0	10000.0
THZ1	EPHA5	35.0	10000.0
CH5424802	PCTK3	100.0	1000.0
XMD-12	FGR	6.6	1000.0
GSK1059615	MLK2	60.0	10000.0
JWE-035	PIP5K1A	5.0	10000.0
WZ3105	MARK3	81.0	10000.0
BMX-IN-1	ZAP70	100.0	10000.0
QL-XII-47	LRRK2(G2019S)	95.0	1000.0
SCH772984	PAK7	92.0	1000.0
KIN001-021	CDK7	100.0	1000.0
NU7441	RIPK1	100.0	10000.0
CH5424802	MYLK2	96.0	1000.0
XMD11-85h	SIK1	100.0	10000.0
Torkinib	DMPK	0.6	10000.0
BI-D1870	EGFR(G719S)	32.0	10000.0
KIN001-220	TAOK1	62.0	10000.0
ZM-447439	MK13	40.0	10000.0
XMD14-99	FLT3	96.0	10000.0
NG25	PIK3CA	100.0	10000.0
WZ3105	CDK4-cyclinD1	40.0	10000.0
OTSSP167	AKT1	3.7	10000.0
JNK-IN-8	SRPK1	99.0	1000.0
XMD8-92	FLT3(D835Y)	100.0	10000.0
HG-6-64-01	PAK2	100.0	10000.0
Seliciclib	PIK3CA(M1043I)	94.0	10000.0
WZ3105	CDKL3	100.0	10000.0
NG25	SLK	3.1	10000.0
WZ4003	MAP4K2	100.0	1000.0
CP724714	MAPKAPK5	100.0	10000.0
CP466722	DDR1	88.0	10000.0
PHA-767491	HIPK1	0.9	10000.0
PHA-793887	SRPK2	90.0	10000.0
GSK461364	KC1G1	100.0	10000.0
Torin2	GRK1	100.0	10000.0
WZ-7043	HCK	100.0	10000.0
KIN001-220	GAK	5.7	10000.0
GW-5074	ACVRL1	100.0	10000.0
Palbociclib	PKNB(M.tuberculosis)	29.0	1000.0
QL-XII-47	EGFR(G719S)	67.0	1000.0
XMD-12	DMPK	100.0	1000.0
MLN8054	ALK	48.0	10000.0
KIN001-021	M3K5	100.0	1000.0
KIN001-127	BLK	100.0	10000.0
Sigma A6730	PAK1	90.0	10000.0
SP600125	PIM3	14.0	10000.0
WZ4002	MLTK	100.0	10000.0
Torkinib	CDK15	96.0	10000.0
WZ4002	BRAF(V600E)	100.0	10000.0
Ribociclib	LIMK1	100.0	1000.0
JNK-IN-11	AMPK-alpha2	90.0	1000.0
BMX-IN-1	FLT3(N841I)	86.0	10000.0
JNK-IN-8	EGFR(L747-S752del,P753S)	81.0	1000.0
QL-XI-92	NEK4	84.0	10000.0
JNK-9L	CDK5	79.0	10000.0
WZ4002	FLT4	100.0	10000.0
Alpelisib	DDR2	77.0	1000.0
JNK-IN-8	RET(M918T)	90.0	1000.0
HG-5-113-01	JAK2(Kin.Dom.2)	1.6	10000.0
Torin2	SgK110	100.0	10000.0
PHA-767491	CASK	82.0	10000.0
Dabrafenib	MST2	47.0	10000.0
Omipalisib	TBK1	63.0	10000.0
AZ-628	CDK3	100.0	10000.0
Dinaciclib	MP2K6	82.0	10000.0
XMD14-99	KGP2	74.0	10000.0
HG-14-10-04	CDK15	77.0	10000.0
CP466722	NUAK1	100.0	10000.0
Dactolisib	EPHA5	100.0	1000.0
WH-4-023	STK39	100.0	10000.0
QL-XI-92	INSR	92.0	10000.0
Dinaciclib	FLT3(R834Q)	97.0	10000.0
KIN001-127	AAK1	100.0	10000.0
PD0325901	PIK3CA(C420R)	50.0	10000.0
GW-5074	RSK1(Kin.Dom.2-C-terminal)	12.0	10000.0
Dactolisib	NEK1	100.0	1000.0
NG25	HIPK1	5.6	10000.0
Lapatinib	MET(Y1235D)	69.0	10000.0
ZSTK474	MP2K4	100.0	1000.0
BS-181	KGP2	64.0	10000.0
QL-XI-92	TYRO3	93.0	10000.0
KIN001-127	FES	100.0	10000.0
Dactolisib	CLK3	100.0	1000.0
AZ-628	JAK1(JH1domain-catalytic)	100.0	10000.0
MRT67307	M3K5	100.0	10000.0
HG-5-113-01	CSK	100.0	10000.0
Torkinib	M3K6	85.0	10000.0
BMS345541	DAPK2	65.0	10000.0
GSK429286A	ROS1	100.0	10000.0
5z-7-oxozeaenol	CSF1R	62.0	10000.0
ZG-10	ADCK3	100.0	10000.0
WZ4003	RPS6KA4(Kin.Dom.1)	100.0	1000.0
WYE-125132	SGK3	100.0	10000.0
Torin1	MINK	19.0	10000.0
Seliciclib	EPHA1	100.0	10000.0
SCH772984	SIK2	92.0	1000.0
PD173074	RET(M918T)	100.0	10000.0
Barasertib	EGFR(G719S)	1.8	10000.0
JNK-IN-11	CDK2	100.0	1000.0
XMD14-99	RSK4(Kin.Dom.1-N-terminal)	79.0	10000.0
XMD13-2	MAP4K5	24.0	10000.0
CH5424802	WEE2	100.0	1000.0
QL-XI-92	DCAMKL3	100.0	10000.0
Sorafenib	IRAK1	70.0	10000.0
Pictilisib	IKKB	100.0	1000.0
OTSSP167	PRP4	100.0	10000.0
Omipalisib	ABL1-nonphosphorylated	74.0	10000.0
Dabrafenib	BTK	13.0	10000.0
XMD11-50	CDK3	100.0	10000.0
GSK1059615	ABL2	77.0	10000.0
BMS-536924	IKKB	100.0	1000.0
Omipalisib	TNK2	89.0	10000.0
BMX-IN-1	PCTK3	88.0	10000.0
BGJ398	FGFR2	3.2	1000.0
THZ1	MAP3K3	5.8	10000.0
OTSSP167	KIT-autoinhibited	1.2	10000.0
ERK5-IN-1	KC1G1	98.0	1000.0
Vemurafenib	PIK3C2B	100.0	10000.0
HG-14-8-02	RSK3(Kin.Dom.2-C-terminal)	57.0	10000.0
WH-4-023	CSNK2A2	95.0	10000.0
HG-6-64-01	KCC4	100.0	10000.0
CGP60474	SRPK2	100.0	10000.0
Vemurafenib	CTK	100.0	10000.0
SP600125	ROCK2	25.0	10000.0
CP466722	RPS6KA5(Kin.Dom.2-C-terminal)	33.0	10000.0
QL-XII-47	MARK3	100.0	1000.0
TGX221	DCLK1	100.0	1000.0
AZD4547	KIT(V559D,T670I)	0.2	10000.0
BMS-536924	ADCK4	100.0	1000.0
AZ-628	CSNK1A1	100.0	10000.0
JNK-9L	EPHB2	89.0	10000.0
WZ3105	FLT3(D835Y)	0.9	10000.0
AZD 5438	AURKB	5.2	10000.0
AZD 5438	MTOR	0.2	10000.0
Lapatinib	MYO3A	100.0	10000.0
SCH772984	TEC	100.0	1000.0
Dabrafenib	ACVR2B	31.0	10000.0
Sigma A6730	CAMKK2	97.0	10000.0
BX-912	MET(Y1235D)	2.4	10000.0
Torin1	ABL1(F317I)-phosphorylated	78.0	10000.0
Momelotinib	VGFR1	55.0	10000.0
XMD14-99	EGFR(E746-A750del)	85.0	10000.0
MRT67307	RET	16.0	10000.0
Canertinib	LCK	25.0	1000.0
NU7441	MAP3K4	100.0	10000.0
PD0325901	ACVR1B	100.0	10000.0
PHA-793887	S6K1	100.0	10000.0
ERK5-IN-1	SBK1	99.0	1000.0
GSK429286A	PGFRA	84.0	10000.0
NPK76-II-72-1	MYO3A	100.0	10000.0
KIN001-220	PAK3	12.0	10000.0
RO-3306	IRAK4	49.0	10000.0
KIN001-021	LTK	29.0	1000.0
ALW-II-38-3	LIMK1	100.0	10000.0
GSK429286A	M3K13	83.0	10000.0
JW-7-24-1	PIM3	18.0	10000.0
WZ-4-145	PAK7	100.0	10000.0
HG-14-8-02	MAP3K1	95.0	10000.0
BMS345541	NEK1	78.0	10000.0
HG-5-88-01	RPS6KA1(Kin.Dom.1)	100.0	10000.0
XMD8-92	TYK2(JH2domain-pseudokinase)	100.0	10000.0
HG-14-8-02	PIP5K1C	100.0	10000.0
Torin1	JAK3(JH1domain-catalytic)	100.0	10000.0
WZ4003	PIK3C2B	100.0	1000.0
CG-930	FLT3	97.0	10000.0
ZG-10	PKN1	95.0	10000.0
ERK5-IN-1	MLCK	100.0	1000.0
JNK-9L	PKN2	44.0	10000.0
WZ4003	MK09	100.0	1000.0
WZ4002	YANK3	100.0	10000.0
A443654	CHEK1	100.0	10000.0
WH-4-023	STK33	28.0	10000.0
KIN001-111	HIPK1	100.0	1000.0
Seliciclib	RSK2(Kin.Dom.2-C-terminal)	84.0	10000.0
Lapatinib	PLK2	93.0	10000.0
NPK76-II-72-1	JAK1(Kin.Dom.2)	100.0	10000.0
SB590885	CSNK1G3	92.0	10000.0
JNK-IN-8	ABL1(Q252H)-phosphorylated	56.0	1000.0
BMS-536924	MST1R	100.0	1000.0
WZ-4-145	BMPR2	100.0	10000.0
SP600125	ULK2	6.4	10000.0
AZ-628	DYRK2	100.0	10000.0
KIN001-220	TIE2	48.0	10000.0
Momelotinib	PRP4	8.0	10000.0
CH5424802	IKKE	86.0	1000.0
BGJ398	ERK3	100.0	1000.0
Canertinib	KIT(V559D,V654A)	100.0	1000.0
AZD7762	ABL2	0.2	10000.0
MRT67307	MYLK4	55.0	10000.0
Ribociclib	LATS2	100.0	1000.0
PD0325901	PAK2	93.0	10000.0
GW843682X	PHKG1	88.0	10000.0
JW-7-24-1	CAMK2A	100.0	10000.0
AZD7762	NEK2	75.0	10000.0
AZD 5438	KPCD	8.4	10000.0
KIN001-127	GSK3B	100.0	10000.0
PLX-4720	MKNK2	84.0	10000.0
R406	EPHA2	5.1	1000.0
MLN8054	ACVRL1	64.0	10000.0
XMD8-85	PAK1	100.0	10000.0
Momelotinib	EGFR(S752-I759del)	72.0	10000.0
Momelotinib	TAOK1	32.0	10000.0
XMD14-99	TAOK1	52.0	10000.0
MRT67307	FLT3(ITD)	0.1	10000.0
WZ-7043	EGFR(L858R,T790M)	100.0	10000.0
Taselisib	KIT(D816H)	95.0	1000.0
PHA-793887	SRPK3	93.0	10000.0
Crizotinib	KCC4	100.0	10000.0
AZD 5438	TRPM6	75.0	10000.0
NVP-TAE684	PIK3CG	100.0	1000.0
Taselisib	PRKX	100.0	1000.0
Barasertib	TGFBR2	100.0	10000.0
KIN001-111	CAMKK2	100.0	1000.0
Sorafenib	MTOR	80.0	10000.0
GSK1059615	MELK	8.6	10000.0
Dabrafenib	FES	98.0	10000.0
CG-930	KPCT	100.0	10000.0
WH-4-023	AKT3	100.0	10000.0
Dinaciclib	CIT	94.0	10000.0
Abemaciclib	RIOK3	8.5	1000.0
Dinaciclib	INSR	42.0	10000.0
AG1478	EPHA5	55.0	10000.0
XMD11-50	KKCC1	73.0	10000.0
HG-14-10-04	DCAMKL2	3.6	10000.0
TAK-715	TRKA	100.0	10000.0
HG-5-113-01	M4K3	1.0	10000.0
JNK-IN-5A	RSK1(Kin.Dom.1-N-terminal)	100.0	10000.0
HG-14-10-04	MYLK4	1.4	10000.0
JNK-IN-11	VRK2	85.0	1000.0
GSK461364	AMPK-alpha2	80.0	10000.0
CGP74514A	EGFR(T790M)	14.0	10000.0
PHA-767491	EGFR(G719C)	74.0	10000.0
AZ-628	INSR	100.0	10000.0
AS-252424	PGFRB	97.8	10000.0
RO-3306	TNK1	75.0	10000.0
Pictilisib	SRC	90.0	1000.0
XMD11-85h	PIP5K2B	100.0	10000.0
GSK429286A	LCK	30.0	10000.0
JNK-IN-8	YANK1	78.0	1000.0
JNK-9L	JAK3(JH1domain-catalytic)	2.2	10000.0
XMD11-50	MAST1	100.0	10000.0
HG-9-91-01	TSSK1	40.0	10000.0
Taselisib	ABL2	100.0	1000.0
5z-7-oxozeaenol	ERK5	100.0	10000.0
Taselisib	ERK4	100.0	1000.0
BMS345541	PFPK5(P.falciparum)	100.0	10000.0
HG-5-88-01	DCAMKL2	100.0	10000.0
MPS-1-IN-1	EPHA1	100.0	1000.0
KIN001-123	ACVR2B	100.0	1000.0
THZ1	TBK1	2.0	10000.0
GW843682X	PFPK5(P.falciparum)	93.0	10000.0
BMX-IN-1	DMPK	100.0	10000.0
GSK461364	CSK	100.0	10000.0
QL-X-138	CAMK1D	86.0	10000.0
NG25	M4K1	1.6	10000.0
NVP-TAE684	BRSK2	0.5	1000.0
BS-181	VRK2	47.0	10000.0
XMD8-85	TAOK2	17.0	10000.0
KIN001-127	MUSK	0.2	10000.0
Torin1	FGFR2	55.0	10000.0
AZD 5438	PIK3CA(H1047L)	7.0	10000.0
KIN001-127	EPHB1	24.0	10000.0
XMD14-99	SIK3	76.0	10000.0
KIN001-123	CSNK1E	100.0	1000.0
TAK-715	AKT3	95.0	10000.0
TAK-715	MK09	0.0	10000.0
Baricitinib	ITK	84.0	10000.0
Lapatinib	MET	84.0	10000.0
XMD8-92	KKCC1	100.0	10000.0
Dactolisib	RPS6KA6(Kin.Dom.2)	100.0	1000.0
Alpelisib	FLT3(ITD)	100.0	1000.0
AZD 5438	CSNK1G3	4.5	10000.0
XMD14-99	ERN1	99.0	10000.0
BX-912	FAK2	8.2	10000.0
AG1478	MAP3K3	6.6	10000.0
ERK5-IN-1	DCAMKL2	3.6	1000.0
BGJ398	CSK	77.0	1000.0
BMS345541	FLT3(R834Q)	100.0	10000.0
BMS-536924	MERTK	0.5	1000.0
Torkinib	LRRK2(G2019S)	2.6	10000.0
Buparlisib	PIP5K2B	99.0	1000.0
Canertinib	CAMKK2	100.0	1000.0
Sigma A6730	VGFR2	86.0	10000.0
QL-XI-92	PIK3CD	100.0	10000.0
XMD-12	LIMK2	100.0	1000.0
GSK429286A	TLK2	100.0	10000.0
GSK429286A	MLTK	92.0	10000.0
HG-14-8-02	CSNK1E	71.0	10000.0
HG-9-91-01	MST1R	95.0	10000.0
XMD16-144	ACVR1B	53.0	10000.0
ALW-II-49-7	KIT(D816V)	100.0	10000.0
BGJ398	TAOK1	31.0	1000.0
Vemurafenib	MAP4K5	6.4	10000.0
Sigma A6730	MK01	100.0	10000.0
R406	PIK3CB	100.0	1000.0
CP724714	PHKG1	100.0	10000.0
HG-14-8-02	YANK2	99.0	10000.0
HG-14-8-02	PIM2	100.0	10000.0
XMD-12	KPCD2	99.0	1000.0
BMX-IN-1	KIT	89.0	10000.0
BMS345541	KPCE	100.0	10000.0
Seliciclib	LATS2	100.0	10000.0
Sigma A6730	CDC2L2	100.0	10000.0
ALW-II-49-7	KC1G2	100.0	10000.0
AZD-6482	ABL1(M351T)-phosphorylated	94.0	10000.0
AZD 5438	S6K1	18.0	10000.0
Pictilisib	TNK1	75.0	1000.0
5z-7-oxozeaenol	KGP2	82.0	10000.0
CP466722	KC1G1	33.0	10000.0
XMD-12	KIT(A829P)	76.0	1000.0
PD173074	RPS6KA6(Kin.Dom.2)	100.0	10000.0
CP466722	STK39	80.0	10000.0
PLX-4720	RET(V804M)	89.0	10000.0
AZ-628	PIK3CA	100.0	10000.0
WYE-125132	PCTK2	100.0	10000.0
BGJ398	CSNK1A1L	94.0	1000.0
Crizotinib	MAP3K3	0.2	10000.0
Neratinib	BMPR2	81.0	10000.0
(s)-CR8	MARK3	96.0	10000.0
Ribociclib	DAPK3	94.0	1000.0
RO-3306	MP2K5	64.0	10000.0
WZ4003	KPCT	100.0	1000.0
TGX221	STK33	100.0	1000.0
HG-5-113-01	PKAC-alpha	100.0	10000.0
BMS-536924	PRKR	100.0	1000.0
QL-XII-47	JAK3(JH1domain-catalytic)	60.0	1000.0
XMD8-85	M3K6	100.0	10000.0
Crizotinib	AXL	5.3	10000.0
JW-7-24-1	MAP3K4	100.0	10000.0
AZ-628	EGFR(G719C)	49.0	10000.0
Baricitinib	PCTK2	87.0	10000.0
CGP60474	PLK4	100.0	10000.0
AG1478	ABL1(F317L)-nonphosphorylated	6.8	10000.0
SB590885	PAK3	72.0	10000.0
Ibrutinib	PIK3CA(Q546K)	83.0	1000.0
XMD13-2	MKNK2	50.0	10000.0
PHA-767491	MAP3K3	61.0	10000.0
Lapatinib	CDK2	100.0	10000.0
HG-6-64-01	AURKB	16.0	10000.0
HG-9-91-01	LKB1	100.0	10000.0
AG1478	MLK1	86.0	10000.0
Omipalisib	CDC2L2	96.0	10000.0
CG-930	NUAK1	97.0	10000.0
JWE-035	ACVR1B	100.0	10000.0
Seliciclib	JNK3	46.0	10000.0
SP600125	LATS1	100.0	10000.0
JNK-IN-11	RAF1	83.0	1000.0
XMD11-50	CDK5	81.0	10000.0
OTSSP167	MAP3K1	37.0	10000.0
Alpelisib	EGFR(L747-S752del,P753S)	92.0	1000.0
TGX221	RPS6KA2(Kin.Dom.2)	100.0	1000.0
CH5424802	EPHA3	97.0	1000.0
Abemaciclib	MAPKAPK2	100.0	1000.0
MRT67307	JNK1	47.0	10000.0
Alpelisib	PGFRB	100.0	1000.0
Ibrutinib	FLT3(D835Y)	16.0	1000.0
WH-4-023	ERK5	39.0	10000.0
GW843682X	BIKE	1.0	10000.0
KU63794	M3K6	91.0	10000.0
PLX-4720	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
Crizotinib	CLK1	84.0	10000.0
(s)-CR8	MP2K1	95.0	10000.0
BX-912	GSK3B	44.0	10000.0
MLN8054	KIT(V559D)	63.0	10000.0
JW-7-24-1	CDK15	100.0	10000.0
RO-3306	CSNK1A1L	92.0	10000.0
Canertinib	ACVR1	100.0	1000.0
JNK-IN-5A	FRK	58.0	10000.0
THZ1	TNIK	5.4	10000.0
WZ3105	PIK4CB	100.0	10000.0
(s)-CR8	KIT(V559D,V654A)	100.0	10000.0
Baricitinib	PLK3	17.0	10000.0
KIN001-021	SRPK1	100.0	1000.0
XMD13-2	ERBB3	69.0	10000.0
Baricitinib	MP2K1	2.6	10000.0
QL-XI-92	NUAK1	100.0	10000.0
NVP-TAE684	MLK1	0.4	1000.0
Ibrutinib	NEK3	96.0	1000.0
QL-XII-47	RIPK1	100.0	1000.0
KIN001-021	EGFR(L747-S752del,P753S)	100.0	1000.0
AG1478	MAP4K2	36.0	10000.0
Torin1	ABL1(T315I)-nonphosphorylated	100.0	10000.0
HG-14-10-04	RAF1	100.0	10000.0
XMD8-92	CAMK2G	100.0	10000.0
Canertinib	TTK	100.0	1000.0
Canertinib	NEK5	100.0	1000.0
MLN8054	CDK14	100.0	10000.0
Dabrafenib	NEK6	0.3	10000.0
OTSSP167	TRPM6	100.0	10000.0
JNK-IN-8	PAK6	100.0	1000.0
KIN001-111	AXL	1.4	1000.0
ZM-447439	PLK4	2.0	10000.0
SP600125	MAPKAPK2	100.0	10000.0
BGJ398	ACVR1B	89.0	1000.0
5z-7-oxozeaenol	PIM2	97.0	10000.0
GW-5074	KPCL	100.0	10000.0
AZD 5438	PLK2	63.0	10000.0
QL-X-138	DDR1	67.0	10000.0
Momelotinib	BUB1	3.5	10000.0
SP600125	FGFR4	100.0	10000.0
GW843682X	PIK3CA(C420R)	100.0	10000.0
ZG-10	JAK2(JH1domain-catalytic)	8.4	10000.0
BGJ398	MKNK2	84.0	1000.0
PD0325901	ABL1(F317I)-nonphosphorylated	100.0	10000.0
QL-XI-92	PCTK3	91.0	10000.0
Taselisib	ZAP70	93.0	1000.0
BGJ398	DCAMKL2	99.0	1000.0
XMD13-2	PKN1	100.0	10000.0
JW-7-24-1	SIK1	100.0	10000.0
Momelotinib	EGFR(L861Q)	66.0	10000.0
CG-930	AKT3	100.0	10000.0
Abemaciclib	TAOK1	8.6	1000.0
WZ4003	DAPK1	14.0	1000.0
JWE-035	IGF1R	100.0	10000.0
CP724714	PAK2	87.0	10000.0
SB590885	TTK	94.0	10000.0
Sorafenib	CDC2L1	98.0	10000.0
KIN001-123	FES	100.0	1000.0
GSK461364	KIT(D816V)	16.0	10000.0
Dabrafenib	SLK	28.0	10000.0
Torin2	RIPK5	88.0	10000.0
TGX221	ZAP70	100.0	1000.0
Sigma A6730	RSK3(Kin.Dom.2-C-terminal)	100.0	10000.0
Baricitinib	TESK1	56.0	10000.0
Omipalisib	DAPK1	98.0	10000.0
Pictilisib	AAK1	93.0	1000.0
Buparlisib	PIK3CA(H1047L)	0.9	1000.0
HG-9-91-01	YSK4	3.0	10000.0
JNK-9L	IRAK3	12.0	10000.0
CGP74514A	KPCL	6.6	10000.0
GSK461364	EPHA1	94.0	10000.0
Sorafenib	DYRK1B	92.0	10000.0
BI-D1870	CDK14	15.0	10000.0
AG1478	EGFR(T790M)	1.3	10000.0
KIN001-220	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
SCH772984	IKKB	100.0	1000.0
Palbociclib	MAP3K3	96.0	1000.0
Sigma A6730	MLCK	100.0	10000.0
XMD16-144	YES	13.0	10000.0
Baricitinib	CDC2L5	90.0	10000.0
ALW-II-49-7	MLK2	100.0	10000.0
QL-X-138	CSNK2A2	1.2	10000.0
CGP60474	KKCC1	100.0	10000.0
AZD4547	PHKG2	1.2	10000.0
HG-5-113-01	ERBB4	100.0	10000.0
AZD-6482	CDK5	100.0	10000.0
Barasertib	MUSK	3.3	10000.0
Seliciclib	NEK9	100.0	10000.0
HG-6-64-01	CDKL2	1.6	10000.0
JWE-035	NEK6	64.0	10000.0
PHA-767491	LYN	84.0	10000.0
XMD8-92	PKAC-beta	100.0	10000.0
R406	ACVR1	100.0	1000.0
PD0325901	ERK5	88.0	10000.0
XMD-12	JAK2(JH1domain-catalytic)	1.3	1000.0
(s)-CR8	CHK2	92.0	10000.0
Ceritinib	SgK110	56.0	1000.0
AZD7762	NEK9	80.0	10000.0
PLX-4720	CDKL1	93.0	10000.0
WH-4-023	MST1	42.0	10000.0
XMD-12	PLK1	50.0	1000.0
CGP60474	PIK3CA(E545K)	100.0	10000.0
GSK429286A	DYRK2	100.0	10000.0
Momelotinib	SRMS	100.0	10000.0
QL-XI-92	MYO3B	100.0	10000.0
HG-14-8-02	ABL1(F317L)-nonphosphorylated	89.0	10000.0
XMD8-92	ACVR1B	100.0	10000.0
Lapatinib	PKN2	86.0	10000.0
Ceritinib	MERTK	97.0	1000.0
BI-2536	NEK7	100.0	10000.0
JNK-IN-8	BRAF	90.0	1000.0
JWE-035	CDK14	100.0	10000.0
AZD-6482	EGFR(L858R,T790M)	99.0	10000.0
ALW-II-49-7	FGFR4	100.0	10000.0
AG1478	MRCKA	77.0	10000.0
TAK-715	NLK	4.0	10000.0
Torin2	PIM1	92.0	10000.0
BMX-IN-1	LTK	100.0	10000.0
PHA-793887	EGFR(T790M)	93.0	10000.0
KU63794	FGFR2	99.0	10000.0
Palbociclib	CDK14	83.0	1000.0
THZ1	SNARK	11.0	10000.0
Ribociclib	AMPK-alpha2	100.0	1000.0
Vemurafenib	SRC	3.4	10000.0
Torin2	DCAMKL3	100.0	10000.0
GSK461364	CAMK2A	4.9	10000.0
Torin2	PGFRB	34.0	10000.0
HG-6-64-01	TYK2(JH2domain-pseudokinase)	100.0	10000.0
BMS345541	CDK8	100.0	10000.0
Omipalisib	BTK	68.0	10000.0
NPK76-II-72-1	DYRK1B	100.0	10000.0
WZ4003	RET(V804L)	28.0	1000.0
Omipalisib	MST1R	100.0	10000.0
Ceritinib	PLK2	91.0	1000.0
AZD4547	MAP3K3	0.3	10000.0
Dactolisib	PAK6	100.0	1000.0
AZD 5438	MLK2	17.0	10000.0
KIN001-127	BMPR1B	100.0	10000.0
Seliciclib	JAK3(JH1domain-catalytic)	94.0	10000.0
XMD14-99	MST2	85.0	10000.0
Abemaciclib	IKKE	96.0	1000.0
HG-9-91-01	JAK3(JH1domain-catalytic)	0.0	10000.0
Lapatinib	PGFRA	67.0	10000.0
NG25	FRK	0.3	10000.0
ALW-II-49-7	DDR2	0.0	1000.0
AZD7762	TTK	12.0	10000.0
BMS-536924	PGFRB	1.8	1000.0
Pictilisib	PIP5K2B	100.0	1000.0
BI-2536	STK36	100.0	10000.0
WH-4-023	JNK1	64.0	10000.0
AZD7762	MLCK	10.0	10000.0
XMD14-99	PAK4	100.0	10000.0
HG-14-10-04	CAMK1G	5.7	10000.0
Barasertib	CDC2L1	6.5	10000.0
CGP74514A	MINK	14.0	10000.0
AZD7762	PAK2	16.0	10000.0
PHA-767491	MET(Y1235D)	33.0	10000.0
Torin2	ITK	100.0	10000.0
JWE-035	SIK3	74.0	10000.0
PHA-767491	FLT3(D835Y)	12.0	10000.0
PLX-4720	FLT3	14.0	10000.0
ERK5-IN-1	KPCL	100.0	1000.0
Ceritinib	FLT3(ITD)	42.0	1000.0
AZD 5438	TRKB	7.2	10000.0
SCH772984	PLK3	94.0	1000.0
Neratinib	KIT	80.0	10000.0
HG-14-10-04	EPHB2	68.0	10000.0
HG-14-10-04	LCK	3.2	10000.0
GSK1059615	KPCE	38.0	10000.0
Dabrafenib	NUAK1	98.0	10000.0
SB590885	PIK3CA(E542K)	93.0	10000.0
XMD-12	PI42C	27.0	1000.0
XMD11-50	MK03	100.0	10000.0
Dinaciclib	OSR1	26.0	10000.0
Barasertib	PIP5K1A	73.0	10000.0
WH-4-023	ERK4	100.0	10000.0
ZG-10	MYLK	64.0	10000.0
Vemurafenib	MYLK2	18.0	10000.0
GSK429286A	MYLK2	99.0	10000.0
HG-5-113-01	AAK1	11.0	10000.0
BMS-536924	PIM2	100.0	1000.0
BGJ398	LRRK2	68.0	1000.0
XMD11-85h	EGFR(L861Q)	100.0	10000.0
AG1478	ROCK2	39.0	10000.0
AZD 5438	RIPK4	2.2	10000.0
TGX221	MAP4K2	100.0	1000.0
GSK1059615	ABL1(Q252H)-nonphosphorylated	71.0	10000.0
Dabrafenib	PLK4	0.0	10000.0
Neratinib	FGFR1	100.0	10000.0
BS-181	ERK5	79.0	10000.0
ZG-10	EPHB4	100.0	10000.0
GW-5074	STK33	94.0	10000.0
NG25	ACVR2B	100.0	10000.0
A443654	EGFR(S752-I759del)	100.0	10000.0
5z-7-oxozeaenol	FAK1	100.0	10000.0
JW-7-24-1	AURKA	100.0	10000.0
Ibrutinib	MST1R	100.0	1000.0
JNK-IN-11	SIK1	29.0	1000.0
Barasertib	GRK7	54.0	10000.0
Torin1	AKT1	91.0	10000.0
KIN001-220	IKKE	100.0	10000.0
THZ1	TGFBR1	54.0	10000.0
Baricitinib	CDK3	99.0	10000.0
NU7441	LRRK2	100.0	10000.0
HG-5-113-01	IRAK3	15.0	10000.0
HG-14-8-02	IKKA	65.0	10000.0
OTSSP167	MRCKB	6.4	10000.0
HG-5-113-01	JAK1(Kin.Dom.2)	2.0	10000.0
GSK429286A	KPCI	72.0	10000.0
HG-5-88-01	RPS6KA3(Kin.Dom.1)	100.0	10000.0
GW-5074	PIK3CA(Q546K)	97.0	10000.0
Crizotinib	KGP2	89.0	10000.0
Baricitinib	ZAP70	76.0	10000.0
ALW-II-49-7	BRAF	2.0	1000.0
XMD16-144	EPHA6	91.0	10000.0
(s)-CR8	ALK	81.0	10000.0
WYE-125132	NEK7	100.0	10000.0
Sorafenib	RSK3(Kin.Dom.2-C-terminal)	81.0	10000.0
Crizotinib	MLTK	100.0	10000.0
Baricitinib	RIPK2	99.0	10000.0
CGP60474	EPHB6	100.0	10000.0
Pictilisib	ERBB4	97.0	1000.0
Lapatinib	SRMS	89.0	10000.0
BS-181	ROCK2	99.0	10000.0
R406	TNIK	26.0	1000.0
PHA-767491	PIK3CG	65.0	10000.0
THZ1	PFPK5(P.falciparum)	72.0	10000.0
AZD-6482	LKB1	98.0	10000.0
Torin1	PKMYT1	52.0	10000.0
BMS345541	IRAK4	100.0	10000.0
CP466722	PAK2	37.0	10000.0
PHA-793887	RSK4(Kin.Dom.2-C-terminal)	72.0	10000.0
XMD11-85h	ITK	100.0	10000.0
AZD4547	TRPM6	58.0	10000.0
ZM-447439	RSK3(Kin.Dom.2-C-terminal)	100.0	10000.0
NVP-TAE684	WEE1	17.0	1000.0
Taselisib	M3K2	88.0	1000.0
HG-9-91-01	DDR2	6.0	10000.0
ALW-II-49-7	TLK2	100.0	10000.0
Momelotinib	KPCT	100.0	10000.0
PHA-767491	SGK2	55.0	10000.0
XMD14-99	MAPKAPK5	100.0	10000.0
HG-14-8-02	EGFR	0.1	10000.0
A443654	KPCT	0.0	10000.0
Vemurafenib	ABL1(F317I)-phosphorylated	64.0	10000.0
AZD 5438	EGFR(L858R)	73.0	10000.0
Seliciclib	DMPK2	100.0	10000.0
MLN8054	TYRO3	46.0	10000.0
GSK429286A	CDKL2	94.0	10000.0
NPK76-II-72-1	CDK7	100.0	10000.0
Dinaciclib	EGFR(E746-A750del)	100.0	10000.0
Buparlisib	GSK3B	100.0	1000.0
WH-4-023	PKAC-beta	2.5	10000.0
HG-14-10-04	ABL2	4.0	10000.0
BMS-536924	CHK2	22.0	1000.0
XMD13-2	FLT3(R834Q)	67.0	10000.0
PHA-793887	MYLK4	100.0	10000.0
NVP-TAE684	FLT3(ITD)	0.0	1000.0
XMD8-85	RIPK4	100.0	10000.0
OTSSP167	EPHB1	0.2	10000.0
Dinaciclib	RSK1(Kin.Dom.2-C-terminal)	42.0	10000.0
AZ-628	LIMK2	95.0	10000.0
Ribociclib	CDK11	98.0	1000.0
NPK76-II-72-1	DRAK2	100.0	10000.0
XMD16-144	CHK2	94.0	10000.0
Sorafenib	SRPK3	90.0	10000.0
XMD16-144	KPCD3	19.0	10000.0
GSK1059615	NDR2	100.0	10000.0
GSK461364	JNK3	100.0	10000.0
Seliciclib	HASP	96.0	10000.0
WZ-7043	NEK9	100.0	10000.0
NU7441	MK01	95.0	10000.0
CP466722	EPHB1	32.0	10000.0
MPS-1-IN-1	FLT3(D835H)	100.0	1000.0
Dabrafenib	MST1R	60.0	10000.0
JNK-IN-11	CSNK1A1	2.0	1000.0
JNK-9L	CDKL2	2.0	10000.0
HG-14-10-04	DCLK1	1.8	10000.0
JWE-035	CDK4-cyclinD1	65.0	10000.0
KIN001-021	CDC2L2	100.0	1000.0
AZD-6482	EGFR(L858R)	100.0	10000.0
GSK461364	MP2K1	92.0	10000.0
Torin2	FES	100.0	10000.0
BMS345541	M3K6	100.0	10000.0
Lapatinib	KPCI	100.0	10000.0
MRT67307	CDK11	100.0	10000.0
AZ-628	CSNK2A1	88.0	10000.0
SP600125	BMPR1B	12.0	10000.0
Abemaciclib	HASP	18.0	1000.0
NPK76-II-72-1	PKAC-beta	100.0	10000.0
Crizotinib	EPHA3	11.0	10000.0
WYE-125132	RIPK1	83.0	10000.0
PHA-767491	CDC2L2	52.0	10000.0
WZ-4-145	M3K5	100.0	10000.0
QL-X-138	NEK7	100.0	10000.0
Sigma A6730	NEK6	100.0	10000.0
Seliciclib	PIK3C2G	100.0	10000.0
ERK5-IN-1	MUSK	100.0	1000.0
CGP74514A	PKAC-beta	41.0	10000.0
ZSTK474	RET(M918T)	100.0	1000.0
Momelotinib	CAMK1	59.0	10000.0
GSK1059615	INSRR	70.0	10000.0
Abemaciclib	MP2K4	6.3	1000.0
Taselisib	LOK	85.0	1000.0
TGX221	DRAK1	100.0	1000.0
SB590885	CSNK2A2	74.0	10000.0
Lapatinib	CDKL1	100.0	10000.0
BX-912	ZAP70	7.1	10000.0
Neratinib	IRAK3	85.0	10000.0
XMD8-85	MK14	100.0	10000.0
RO-3306	PAK2	27.0	10000.0
QL-X-138	EGFR(L858R)	41.0	10000.0
OTSSP167	SGK1	0.0	10000.0
CG-930	MTOR	68.0	10000.0
GSK1059615	KGP2	56.0	10000.0
BX-912	MP2K5	0.6	10000.0
Torin2	MAP3K3	84.0	10000.0
PHA-793887	FLT3(R834Q)	84.0	10000.0
WZ4003	KIT(V559D,T670I)	100.0	1000.0
HG-5-88-01	NLK	100.0	10000.0
AS-252424	AURKC	100.0	10000.0
Omipalisib	PGFRB	65.0	10000.0
SP600125	EPHA7	100.0	10000.0
JNK-IN-5A	TIE2	100.0	10000.0
Dabrafenib	AKT1	100.0	10000.0
Dactolisib	PIK4CB	100.0	1000.0
QL-XII-47	PCTK3	98.0	1000.0
Omipalisib	FGFR4	63.0	10000.0
Palbociclib	AKT3	100.0	1000.0
GW-5074	SNRK	99.0	10000.0
CG-930	MST3	88.0	10000.0
WZ4002	AURKA	28.0	10000.0
THZ1	AKT1	100.0	10000.0
MLN8054	MLK1	70.0	10000.0
XMD-12	AKT1	100.0	1000.0
5z-7-oxozeaenol	FGFR2	82.0	10000.0
Abemaciclib	GRK1	87.0	1000.0
TAK-715	RET(M918T)	72.0	10000.0
HG-14-10-04	PIK3CA	100.0	10000.0
KU63794	RSK4(Kin.Dom.1-N-terminal)	76.0	10000.0
AS-252424	MAPKAPK2	100.0	10000.0
BMS345541	MAP4K5	96.0	10000.0
Baricitinib	NEK10	35.0	10000.0
Dinaciclib	ERK3	96.0	10000.0
WZ4002	NEK2	100.0	10000.0
AZD7762	CLK1	1.2	10000.0
GW-5074	MET	100.0	10000.0
WZ4003	MYLK	100.0	1000.0
Torin1	PIK3CA(E545A)	1.0	10000.0
HG-9-91-01	PIK3CA	100.0	10000.0
GSK1059615	CAMK2A	4.8	10000.0
Dabrafenib	CHEK1	100.0	10000.0
HG-6-64-01	TBK1	55.0	10000.0
KIN001-021	RPS6KA6(Kin.Dom.2)	100.0	1000.0
Omipalisib	SGK1	77.0	10000.0
KIN001-111	DAPK1	100.0	1000.0
Canertinib	MYLK2	100.0	1000.0
QL-XI-92	PAK7	94.0	10000.0
Seliciclib	ADCK4	55.0	10000.0
SP600125	IKKE	12.0	10000.0
NU7441	CDK2	75.0	10000.0
ZM-447439	YSK1	63.0	10000.0
HG-5-88-01	BRAF	100.0	10000.0
NVP-TAE684	SIK2	7.5	1000.0
AZD 5438	TIE2	88.0	10000.0
Crizotinib	DRAK1	100.0	10000.0
Barasertib	PKNB(M.tuberculosis)	50.0	10000.0
AS-252424	EGFR	40.8	10000.0
TAK-715	MLK1	94.0	10000.0
KU63794	DMPK2	65.0	10000.0
NG25	AMPK-alpha2	100.0	10000.0
BX-912	MARK4	0.0	10000.0
BMS345541	CSNK1A1	68.0	10000.0
5z-7-oxozeaenol	IKKA	100.0	10000.0
MPS-1-IN-1	AMPK-alpha1	100.0	1000.0
AZD4547	VRK2	97.0	10000.0
CGP60474	YES	100.0	10000.0
THZ1	M3K6	100.0	10000.0
HG-14-8-02	EPHA1	100.0	10000.0
HG-6-64-01	VGFR1	2.4	10000.0
ZSTK474	PIM3	100.0	1000.0
AZD 5438	IGF1R	96.0	10000.0
TAK-715	CASK	100.0	10000.0
XMD8-92	PAK1	100.0	10000.0
XMD16-144	NIM1	21.0	10000.0
AS-252424	CSNK1G3	99.7	10000.0
XMD16-144	STK36	100.0	10000.0
Crizotinib	FLT3	7.8	10000.0
XMD11-85h	PAK3	100.0	10000.0
XMD11-85h	TEC	100.0	10000.0
KIN001-123	M3K12	100.0	1000.0
AG1478	RET(M918T)	3.4	10000.0
RO-3306	PAK6	56.0	10000.0
JNK-IN-11	MAPKAPK5	100.0	1000.0
JNK-IN-11	DCAMKL2	100.0	1000.0
RO-3306	ERK3	81.0	10000.0
XMD8-92	PIK3CA(E542K)	100.0	10000.0
Ceritinib	ADCK4	17.0	1000.0
QL-XII-47	CDK15	100.0	1000.0
Dactolisib	VGFR2	100.0	1000.0
WYE-125132	MUSK	92.0	10000.0
BMS345541	CASK	100.0	10000.0
WYE-125132	CDK8	100.0	10000.0
AZ-628	PHKG1	100.0	10000.0
XMD16-144	FYN	6.7	10000.0
NU7441	ZAP70	100.0	10000.0
ALW-II-49-7	BMPR1A	100.0	10000.0
SP600125	TGFBR1	100.0	10000.0
BGJ398	RPS6KA4(Kin.Dom.2-C-terminal)	31.0	1000.0
Torkinib	M3K13	100.0	10000.0
PHA-793887	TIE1	100.0	10000.0
Dactolisib	AURKB	100.0	1000.0
BS-181	MKNK1	84.0	10000.0
XMD14-99	DYRK1A	72.0	10000.0
WZ-4-145	CAMKK2	100.0	10000.0
WH-4-023	JAK2(JH1domain-catalytic)	35.0	10000.0
R406	ADCK4	0.0	1000.0
ZSTK474	DCAMKL3	100.0	1000.0
HG-5-113-01	EGFR(L747-T751del,Sins)	100.0	10000.0
CGP74514A	AURKB	65.0	10000.0
HG-5-88-01	CAMK1D	100.0	10000.0
CGP74514A	MST3	35.0	10000.0
A443654	ACVR1	100.0	10000.0
HG-5-88-01	MKNK2	14.0	10000.0
CG-930	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
XMD-12	HIPK2	69.0	1000.0
XMD14-99	PIK3CA	99.0	10000.0
HG-14-8-02	ERK4	98.0	10000.0
BS-181	LCK	100.0	10000.0
AS-252424	PIK3CB	53.1	10000.0
R406	LCK	0.1	1000.0
JNK-IN-5A	FLT3-autoinhibited	87.0	10000.0
Vemurafenib	DDR1	0.3	10000.0
Lapatinib	EGFR(S752-I759del)	0.8	10000.0
BX-912	RSK3(Kin.Dom.1-N-terminal)	7.6	10000.0
HG-5-113-01	DDR1	100.0	10000.0
OTSSP167	MAP3K3	1.8	10000.0
Momelotinib	IKKB	0.2	10000.0
WZ3105	BMPR1A	84.0	10000.0
CG-930	NEK2	100.0	10000.0
Buparlisib	BMPR2	100.0	1000.0
A443654	ACVR2B	100.0	10000.0
ALW-II-38-3	RIOK1	100.0	10000.0
(s)-CR8	CDC2L5	100.0	10000.0
XMD16-144	IGF1R	100.0	10000.0
JNK-IN-8	CDKL1	88.0	1000.0
ZM-447439	MARK4	100.0	10000.0
HG-5-113-01	SRMS	100.0	10000.0
ERK5-IN-1	MAPKAPK5	100.0	1000.0
Ceritinib	ABL1-phosphorylated	86.0	1000.0
CGP60474	RPS6KA1(Kin.Dom.1)	100.0	10000.0
(s)-CR8	YANK3	96.0	10000.0
Abemaciclib	M4K3	99.0	1000.0
WH-4-023	PIK3CA(E542K)	100.0	10000.0
Omipalisib	ABL1(F317L)-nonphosphorylated	71.0	10000.0
Abemaciclib	MAP3K15	71.0	1000.0
Seliciclib	STK39	74.0	10000.0
WYE-125132	HASP	100.0	10000.0
5z-7-oxozeaenol	RSK4(Kin.Dom.1-N-terminal)	62.0	10000.0
ERK5-IN-1	MK11	81.0	1000.0
GW843682X	TRKC	93.0	10000.0
BGJ398	PIK3CA(C420R)	82.0	1000.0
QL-X-138	INSR	90.0	10000.0
AZD7762	IKKA	0.0	10000.0
XMD14-99	MARK2	90.0	10000.0
TGX221	CDK11	100.0	1000.0
XMD-12	JAK1(JH1domain-catalytic)	30.0	1000.0
HG-14-8-02	EGFR(L747-S752del,P753S)	0.0	10000.0
CGP60474	PDPK1	100.0	10000.0
(s)-CR8	CHEK1	90.0	10000.0
Crizotinib	FLT3(N841I)	2.0	10000.0
R406	EGFR(G719S)	100.0	1000.0
OTSSP167	DCAMKL3	0.4	10000.0
JWE-035	FLT3(R834Q)	69.0	10000.0
AZ-628	LATS1	100.0	10000.0
Alpelisib	YSK4	100.0	1000.0
Sorafenib	MK03	100.0	10000.0
Torin2	YES	100.0	10000.0
Abemaciclib	PAK4	79.0	1000.0
5z-7-oxozeaenol	CDK4-cyclinD3	100.0	10000.0
QL-XI-92	NEK9	100.0	10000.0
GSK429286A	ABL1-nonphosphorylated	31.0	10000.0
Dactolisib	FLT3(K663Q)	100.0	1000.0
WZ-4-145	MST2	100.0	10000.0
R406	CSF1R	0.0	1000.0
BMX-IN-1	PIK3CA(Q546K)	35.0	10000.0
5z-7-oxozeaenol	MKNK2	11.0	10000.0
JNK-9L	M3K6	88.0	10000.0
Dinaciclib	RSK1(Kin.Dom.1-N-terminal)	62.0	10000.0
JW-7-24-1	MRCKA	100.0	10000.0
Sorafenib	EPHA5	30.0	10000.0
JW-7-24-1	FGFR2	100.0	10000.0
WH-4-023	KC1G1	95.0	10000.0
CGP74514A	HIPK2	1.6	10000.0
WZ-7043	M4K1	100.0	10000.0
Torkinib	PIM2	0.6	10000.0
5z-7-oxozeaenol	RSK4(Kin.Dom.2-C-terminal)	3.0	10000.0
Abemaciclib	EGFR(L747-E749del,A750P)	85.0	1000.0
JNK-IN-5A	MAP4K2	100.0	10000.0
HG-9-91-01	EPHB3	0.0	10000.0
MRT67307	AURKA	25.0	10000.0
JWE-035	TNIK	100.0	10000.0
PD0325901	INSRR	81.0	10000.0
Momelotinib	AURKB	69.0	10000.0
ZG-10	KPCD1	100.0	10000.0
CGP74514A	EPHA8	56.0	10000.0
KIN001-220	NEK4	63.0	10000.0
AZD4547	MRCKA	100.0	10000.0
CP466722	MET	55.0	10000.0
Sigma A6730	CDK4-cyclinD3	100.0	10000.0
TAK-715	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
BMX-IN-1	NDR1	100.0	10000.0
HG-9-91-01	NDR1	64.0	10000.0
AZD4547	CAMK1G	34.0	10000.0
Momelotinib	PIP5K1A	39.0	10000.0
XMD13-2	DCAMKL3	100.0	10000.0
GW843682X	CSF1R	61.0	10000.0
Seliciclib	CLK1	7.8	10000.0
JNK-IN-5A	LOK	67.0	10000.0
(s)-CR8	KGP2	100.0	10000.0
ZSTK474	PIP5K1A	100.0	1000.0
AZD4547	ERK3	100.0	10000.0
Torin1	RET(M918T)	51.0	10000.0
KIN001-127	SRPK2	100.0	10000.0
ZM-447439	IRAK4	51.0	10000.0
BX-912	EGFR(S752-I759del)	66.0	10000.0
ZG-10	PIK3CA(E545A)	100.0	10000.0
R406	CAMK2G	100.0	1000.0
KU63794	CSNK1A1	100.0	10000.0
XMD11-85h	FGFR3(G697C)	100.0	10000.0
R406	AURKB	0.5	1000.0
HG-5-88-01	CSNK1D	100.0	10000.0
Abemaciclib	EIF2AK1	100.0	1000.0
XMD14-99	ERK4	90.0	10000.0
XMD13-2	ZAP70	90.0	10000.0
MPS-1-IN-1	CSK	100.0	1000.0
KU63794	ABL1-phosphorylated	99.0	10000.0
ZSTK474	CDC2L2	100.0	1000.0
PHA-793887	SLK	98.0	10000.0
SB590885	PAK7	100.0	10000.0
SB590885	PIK3CG	84.0	10000.0
Buparlisib	PIP5K1A	100.0	1000.0
BI-D1870	JAK3(JH1domain-catalytic)	16.0	10000.0
SB590885	SRMS	74.0	10000.0
BS-181	MYLK	49.0	10000.0
CG-930	ABL1(M351T)-phosphorylated	38.0	10000.0
Omipalisib	BRSK1	83.0	10000.0
GW843682X	FGFR3(G697C)	26.0	10000.0
XMD8-85	MP2K3	100.0	10000.0
XMD11-50	GSK3A	100.0	10000.0
HG-14-8-02	PKAC-beta	100.0	10000.0
ALW-II-38-3	FLT3	100.0	10000.0
KIN001-220	SIK3	68.0	10000.0
AZ-628	FLT4	0.2	10000.0
Seliciclib	NEK11	100.0	10000.0
Torin2	TRPM6	71.0	10000.0
CGP74514A	FGFR4	100.0	10000.0
CGP60474	ABL1(H396P)	100.0	10000.0
WZ-7043	CDK3	100.0	10000.0
JNK-IN-5A	CDK14	98.0	10000.0
PD0325901	KCC4	100.0	10000.0
QL-XII-47	CDK2	92.0	1000.0
THZ1	RSK4(Kin.Dom.2-C-terminal)	71.0	10000.0
CGP60474	PIK3CA(C420R)	100.0	10000.0
BMX-IN-1	ICK	100.0	10000.0
WZ3105	MUSK	84.0	10000.0
CGP60474	SBK1	100.0	10000.0
Sigma A6730	LIMK1	86.0	10000.0
HG-14-10-04	TIE2	2.4	10000.0
QL-XII-47	ROS1	100.0	1000.0
ERK5-IN-1	PIM3	100.0	1000.0
SB590885	ROCK2	47.0	10000.0
CG-930	FGFR1	69.0	10000.0
BMS-536924	SRC	0.1	1000.0
XMD8-85	MST1	100.0	10000.0
A443654	EPHA1	100.0	10000.0
XMD11-50	ABL1(M351T)-phosphorylated	94.0	10000.0
JNK-9L	AMPK-alpha2	94.0	10000.0
PHA-767491	PIP5K1A	32.0	10000.0
BMS345541	MARK4	100.0	10000.0
Ibrutinib	CSF1R	75.0	1000.0
WZ-7043	ERK4	100.0	10000.0
CGP60474	DRAK1	100.0	10000.0
ZG-10	HIPK4	8.6	10000.0
Torin1	HIPK3	86.0	10000.0
OTSSP167	CDK4-cyclinD1	10.0	10000.0
Barasertib	KGP1	99.0	10000.0
Pictilisib	DCLK1	100.0	1000.0
Torkinib	CLK4	9.7	10000.0
XMD-12	ICK	100.0	1000.0
ALW-II-49-7	NUAK1	100.0	10000.0
(s)-CR8	KIT	96.0	10000.0
ERK5-IN-1	STK35	96.0	1000.0
Ceritinib	LATS1	100.0	1000.0
JNK-IN-5A	WNK1	89.0	10000.0
R406	MET	1.0	1000.0
ALW-II-38-3	MARK4	100.0	10000.0
SB590885	RIPK1	72.0	10000.0
NU7441	JAK3(JH1domain-catalytic)	81.0	10000.0
Vemurafenib	MET(Y1235D)	78.0	10000.0
Dinaciclib	PAK6	100.0	10000.0
PD0325901	CSNK1A1	100.0	10000.0
Abemaciclib	IKKA	16.0	1000.0
BMS-536924	PKN2	22.0	1000.0
Dinaciclib	PKNB(M.tuberculosis)	85.0	10000.0
Sorafenib	RAF1	0.1	10000.0
BI-2536	RPS6KA6(Kin.Dom.2)	8.3	10000.0
HG-5-88-01	AURKA	100.0	10000.0
ZG-10	YSK4	0.1	10000.0
Torin1	DYRK2	86.0	10000.0
5z-7-oxozeaenol	MLK2	77.0	10000.0
Dinaciclib	CAMK2G	83.0	10000.0
Taselisib	RIOK1	75.0	1000.0
MPS-1-IN-1	SRC	100.0	1000.0
XMD8-92	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
RO-3306	ABL1-nonphosphorylated	84.0	10000.0
BMS345541	TGFBR2	93.0	10000.0
WZ4002	MP2K4	100.0	10000.0
Buparlisib	LYN	100.0	1000.0
AZD 5438	PIK3CA(I800L)	9.3	10000.0
RO-3306	PIP5K1C	55.0	10000.0
JNK-9L	LRRK2	94.0	10000.0
JWE-035	PLK1	27.0	10000.0
Palbociclib	MYLK2	100.0	1000.0
HG-6-64-01	PIK4CB	91.0	10000.0
WYE-125132	PKAC-alpha	75.0	10000.0
5z-7-oxozeaenol	DAPK3	79.0	10000.0
NU7441	CAMKK2	88.0	10000.0
Alpelisib	AURKC	98.0	1000.0
XMD14-99	PIK3C2B	98.0	10000.0
(s)-CR8	BRSK1	98.0	10000.0
KIN001-127	BMPR2	100.0	10000.0
Vemurafenib	STK36	4.6	10000.0
R406	MP2K4	6.0	1000.0
Lapatinib	FRK	100.0	10000.0
Ribociclib	M3K12	100.0	1000.0
Torin2	PAK2	100.0	10000.0
Ribociclib	NEK2	90.0	1000.0
SB590885	ABL1(F317I)-phosphorylated	81.0	10000.0
ZM-447439	KGP1	100.0	10000.0
HG-5-88-01	BMPR2	100.0	10000.0
AZD4547	MAK	100.0	10000.0
JNK-9L	MYLK	100.0	10000.0
Taselisib	CAMK2B	100.0	1000.0
ZM-447439	PCTK2	94.0	10000.0
AZD4547	RIPK2	14.0	10000.0
AZD7762	MP2K2	0.0	10000.0
Buparlisib	MKNK2	100.0	1000.0
NU7441	CSNK1D	89.0	10000.0
JW-7-24-1	ABL1(H396P)	13.0	10000.0
PHA-793887	VGFR2	92.0	10000.0
JNK-IN-5A	KPCD	100.0	10000.0
PD173074	PAK4	100.0	10000.0
SB590885	MARK1	100.0	10000.0
WZ4003	PGFRB	10.0	1000.0
JW-7-24-1	PLK3	100.0	10000.0
Torin2	ABL1(H396P)-nonphosphorylated	53.0	10000.0
R406	CSK	2.2	1000.0
JWE-035	M4K1	18.0	10000.0
Vemurafenib	PIP5K1A	100.0	10000.0
GW843682X	MP2K5	0.5	10000.0
AZD 5438	TYRO3	82.0	10000.0
GW843682X	ZAP70	95.0	10000.0
BGJ398	PCTK3	100.0	1000.0
BX-912	NDR1	35.0	10000.0
BI-D1870	FLT3(D835H)	2.6	10000.0
WZ-4-145	PTK6	100.0	10000.0
CP466722	PGFRA	57.0	10000.0
Buparlisib	ACVR1	100.0	1000.0
XMD-12	KPCD1	98.0	1000.0
Sigma A6730	AXL	45.0	10000.0
GSK1059615	MAPKAPK5	0.2	10000.0
ERK5-IN-1	SIK2	100.0	1000.0
BI-2536	CLK2	5.4	10000.0
ZG-10	STK39	58.0	10000.0
NG25	PAK3	100.0	10000.0
BMX-IN-1	BLK	4.8	10000.0
MPS-1-IN-1	CAMK1D	100.0	1000.0
Palbociclib	YSK4	32.0	1000.0
TAK-715	MK12	100.0	10000.0
ZSTK474	MARK3	100.0	1000.0
MLN8054	ABL1(F317I)-phosphorylated	72.0	10000.0
XMD11-50	MST1	100.0	10000.0
Abemaciclib	FAK2	54.0	1000.0
Alpelisib	PIK3CA(M1043I)	2.5	1000.0
KIN001-123	AURKC	100.0	1000.0
XMD13-2	CDKL3	55.0	10000.0
XMD11-85h	IKKA	100.0	10000.0
ERK5-IN-1	RIPK5	16.0	1000.0
AZD7762	CDK11	100.0	10000.0
CP466722	PKNB(M.tuberculosis)	7.1	10000.0
ZSTK474	ABL1(T315I)	100.0	1000.0
XMD-12	EPHB4	100.0	1000.0
KIN001-123	PIK3CA	21.0	1000.0
GSK429286A	MARK4	100.0	10000.0
RO-3306	MP2K2	77.0	10000.0
BMS-536924	CDK15	100.0	1000.0
PHA-767491	EGFR(L747-E749del,A750P)	54.0	10000.0
CP466722	CDK5	100.0	10000.0
Lapatinib	TTK	100.0	10000.0
Baricitinib	MYLK4	55.0	10000.0
Ribociclib	WNK3	100.0	1000.0
KIN001-123	KGP2	100.0	1000.0
AZD7762	ABL1(F317I)-nonphosphorylated	0.0	10000.0
JWE-035	YSK1	47.0	10000.0
Abemaciclib	ABL1-nonphosphorylated	65.0	1000.0
XMD11-85h	TNNI3K	100.0	10000.0
ERK5-IN-1	TNNI3K	89.0	1000.0
Ceritinib	CSNK1D	88.0	1000.0
Alpelisib	JAK3(JH1domain-catalytic)	100.0	1000.0
GSK1059615	MAP4K5	41.0	10000.0
BI-2536	PIK3CA(E545K)	100.0	10000.0
Sigma A6730	TNK2	100.0	10000.0
WZ4003	IKKE	100.0	1000.0
Torkinib	ABL1(F317I)-nonphosphorylated	19.0	10000.0
CG-930	ROCK1	91.0	10000.0
Vemurafenib	DMPK	67.0	10000.0
AZD7762	KPCL	1.4	10000.0
JNK-IN-5A	DDR2	100.0	10000.0
QL-XI-92	ABL1(H396P)-nonphosphorylated	14.0	10000.0
A443654	KKCC1	2.4	10000.0
ZM-447439	PRP4	97.0	10000.0
CP466722	STK33	6.4	10000.0
NU7441	RPS6KA5(Kin.Dom.2-C-terminal)	80.0	10000.0
WZ4002	RET(V804L)	100.0	10000.0
A443654	NUAK1	100.0	10000.0
KIN001-123	NEK2	100.0	1000.0
GSK429286A	PIM2	100.0	10000.0
GW843682X	FLT3(K663Q)	12.0	10000.0
PHA-767491	EPHB3	96.0	10000.0
ERK5-IN-1	FGFR3(G697C)	100.0	1000.0
SB590885	ABL1(T315I)-phosphorylated	1.6	10000.0
Abemaciclib	EPHA8	100.0	1000.0
5z-7-oxozeaenol	PAK3	48.0	10000.0
KIN001-220	RIPK2	19.0	10000.0
QL-XII-47	SYK	100.0	1000.0
Ceritinib	DMPK	93.0	1000.0
Buparlisib	MP2K4	100.0	1000.0
KIN001-021	FRK	100.0	1000.0
ALW-II-38-3	NEK1	100.0	10000.0
Ibrutinib	ABL1(F317I)-nonphosphorylated	30.0	1000.0
WZ4002	MAP3K3	100.0	10000.0
NPK76-II-72-1	MAPKAPK2	100.0	10000.0
CP466722	AURKA	15.0	10000.0
JNK-IN-5A	WEE2	70.0	10000.0
JNK-IN-8	M3K13	93.0	1000.0
HG-14-10-04	NEK2	39.0	10000.0
WZ3105	STK33	15.0	10000.0
GW-5074	EPHB6	24.0	10000.0
CG-930	KIT(V559D,T670I)	92.0	10000.0
PD0325901	MST3	88.0	10000.0
ERK5-IN-1	ERBB3	100.0	1000.0
JNK-IN-8	PIK3CD	95.0	1000.0
WZ3105	TRKC	28.0	10000.0
GW-5074	LIMK2	77.0	10000.0
Dabrafenib	BMX	28.0	10000.0
GSK1059615	DAPK3	0.6	10000.0
GSK1059615	EGFR(L858R,T790M)	82.0	10000.0
GSK429286A	PIK3CB	86.0	10000.0
Crizotinib	CIT	62.0	10000.0
CH5424802	IRAK1	0.4	1000.0
JNK-IN-11	MYLK2	100.0	1000.0
Omipalisib	RIPK1	100.0	10000.0
MLN8054	IRAK3	15.0	10000.0
Alpelisib	MET(M1250T)	100.0	1000.0
ZM-447439	PIK3CA(H1047L)	99.0	10000.0
Dactolisib	PIK3CA(C420R)	4.6	1000.0
HG-14-10-04	FLT3	0.0	10000.0
GSK429286A	ABL1(Q252H)-nonphosphorylated	29.0	10000.0
R406	PIM3	100.0	1000.0
Torin1	ADCK3	17.0	10000.0
BMS345541	PIK3CA(E545A)	31.0	10000.0
KIN001-111	BTK	1.4	1000.0
ALW-II-49-7	PIK3CB	100.0	10000.0
XMD16-144	CHEK1	8.5	10000.0
KIN001-021	IKKE	100.0	1000.0
KIN001-123	TTK	5.0	1000.0
Torin1	TNIK	39.0	10000.0
GSK429286A	TYRO3	100.0	10000.0
BI-2536	ABL1(Y253F)	100.0	10000.0
JW-7-24-1	BLK	16.0	10000.0
Neratinib	MYLK4	86.0	10000.0
GW843682X	BTK	86.0	10000.0
XMD8-85	PIM3	100.0	10000.0
TGX221	KPCD2	100.0	1000.0
CH5424802	MP2K5	52.0	1000.0
HG-14-8-02	NEK4	100.0	10000.0
CGP74514A	BRAF(V600E)	77.0	10000.0
MLN8054	FLT3(K663Q)	68.0	10000.0
HG-14-8-02	KPCD	93.0	10000.0
AZD4547	ACVR2B	70.0	10000.0
PD173074	MELK	100.0	10000.0
Ibrutinib	AMPK-alpha1	75.0	1000.0
HG-5-113-01	LIMK2	100.0	10000.0
HG-5-88-01	M3K5	100.0	10000.0
KIN001-220	ABL1(Y253F)-phosphorylated	16.0	10000.0
AZ-628	NEK5	33.0	10000.0
AZ-628	OSR1	96.0	10000.0
Ribociclib	ABL1(H396P)-nonphosphorylated	93.0	1000.0
CGP74514A	BLK	0.7	10000.0
ALW-II-38-3	NEK7	100.0	10000.0
TAK-715	NEK4	100.0	10000.0
JNK-9L	STK35	48.0	10000.0
SCH772984	PIM1	65.0	1000.0
A443654	AMPK-alpha1	100.0	10000.0
ALW-II-49-7	TEC	100.0	10000.0
WZ-4-145	LKB1	100.0	10000.0
AZ-628	CDKL1	100.0	10000.0
SCH772984	PFCDPK1(P.falciparum)	17.0	1000.0
AS-252424	TLK2	100.0	10000.0
Abemaciclib	KIT-autoinhibited	100.0	1000.0
Palbociclib	BRAF(V600E)	100.0	1000.0
Barasertib	TNNI3K	100.0	10000.0
5z-7-oxozeaenol	PIK3CA(H1047L)	98.0	10000.0
Torin1	RSK2(Kin.Dom.1-N-terminal)	38.0	10000.0
GSK1059615	CASK	59.0	10000.0
CH5424802	KGP1	96.0	1000.0
ALW-II-49-7	AKT2	100.0	10000.0
JNK-IN-11	PKN1	100.0	1000.0
Ibrutinib	TESK1	86.0	1000.0
ALW-II-38-3	PRP4	100.0	10000.0
HG-5-88-01	TAK1	100.0	10000.0
Dabrafenib	ABL1(T315I)-nonphosphorylated	83.0	10000.0
WYE-125132	KCC4	100.0	10000.0
Sorafenib	FLT3	0.5	10000.0
GSK1059615	MARK4	89.0	10000.0
JNK-IN-5A	KCC2D	93.0	10000.0
SCH772984	KPCD1	100.0	1000.0
JNK-IN-11	DAPK2	97.0	1000.0
BMS345541	KIT(D816H)	100.0	10000.0
PLX-4720	AURKC	100.0	10000.0
CG-930	PIK3CA(I800L)	97.0	10000.0
WZ4003	KPCD	100.0	1000.0
WZ4003	PHKG1	7.2	1000.0
CP466722	MK13	100.0	10000.0
XMD11-85h	MP2K1	100.0	10000.0
GSK461364	GRK4	16.0	10000.0
Alpelisib	MK14	100.0	1000.0
KIN001-123	EPHA4	100.0	1000.0
Ceritinib	CLK2	27.0	1000.0
BS-181	PIK4CB	99.0	10000.0
MPS-1-IN-1	RET	100.0	1000.0
Lapatinib	EGFR(L747-E749del,A750P)	0.0	10000.0
Sigma A6730	SIK2	85.0	10000.0
Torin1	FAK1	14.0	10000.0
Momelotinib	FLT3	12.0	10000.0
HG-14-8-02	ICK	100.0	10000.0
WYE-125132	CLK2	98.0	10000.0
Crizotinib	NEK9	6.2	10000.0
HG-14-8-02	DYRK2	17.0	10000.0
CP724714	EGFR(G719S)	0.0	10000.0
XMD8-85	KPCD2	0.6	10000.0
WH-4-023	ABL1(F317I)-phosphorylated	9.2	10000.0
WZ-7043	FLT3(N841I)	100.0	10000.0
AZD 5438	CSNK1A1L	0.2	10000.0
CG-930	MINK	71.0	10000.0
Sigma A6730	NIM1	71.0	10000.0
PHA-767491	S6K1	60.0	10000.0
CP724714	ABL1-nonphosphorylated	100.0	10000.0
CP724714	LIMK2	100.0	10000.0
BGJ398	FGFR1	0.1	1000.0
AZ-628	TGFBR1	100.0	10000.0
Vemurafenib	CAMKK2	100.0	10000.0
MRT67307	MK11	88.0	10000.0
Lapatinib	NUAK1	100.0	10000.0
TAK-715	NDR2	96.0	10000.0
HG-9-91-01	CHEK1	38.0	10000.0
CG-930	M4K1	83.0	10000.0
NU7441	ABL1(Q252H)-nonphosphorylated	100.0	10000.0
KIN001-111	MK12	100.0	1000.0
CP724714	TRKB	100.0	10000.0
Ibrutinib	TLK1	100.0	1000.0
MLN8054	KPCD	100.0	10000.0
MPS-1-IN-1	PLK1	100.0	1000.0
Vemurafenib	JAK1(JH2domain-pseudokinase)	100.0	10000.0
Abemaciclib	ALK(C1156Y)	64.0	1000.0
XMD16-144	PIK3CA(E545K)	100.0	10000.0
XMD14-99	MK11	77.0	10000.0
HG-14-10-04	TAK1	5.2	10000.0
NU7441	KIT	80.0	10000.0
BGJ398	AMPK-alpha2	94.0	1000.0
THZ1	DAPK1	25.0	10000.0
BS-181	PIM2	100.0	10000.0
Dinaciclib	SNARK	13.0	10000.0
AG1478	CSNK1A1L	72.0	10000.0
QL-XII-47	MST1	100.0	1000.0
NVP-TAE684	ERBB4	1.2	1000.0
RO-3306	PIM2	23.0	10000.0
MPS-1-IN-1	CDC2L1	100.0	1000.0
(s)-CR8	ADCK3	96.0	10000.0
ERK5-IN-1	KCC4	100.0	1000.0
GSK429286A	SIK2	99.0	10000.0
Ceritinib	MK01	20.0	1000.0
Alpelisib	PIM2	100.0	1000.0
BX-912	KPCD	12.0	10000.0
WZ-4-145	PIK3CG	100.0	10000.0
Momelotinib	FRK	98.0	10000.0
OTSSP167	ALK(L1196M)	4.8	10000.0
Ibrutinib	KPCE	100.0	1000.0
Lapatinib	PIK3CA(Q546K)	94.0	10000.0
Torkinib	JAK2(JH1domain-catalytic)	1.0	10000.0
QL-X-138	CDK11	100.0	10000.0
GW843682X	RIPK2	41.0	10000.0
CGP74514A	RSK4(Kin.Dom.2-C-terminal)	41.0	10000.0
Omipalisib	PCTK3	83.0	10000.0
Ibrutinib	ITK	6.5	1000.0
Ribociclib	TAOK2	72.0	1000.0
Ibrutinib	PIK3CD	71.0	1000.0
Torin1	EGFR(S752-I759del)	84.0	10000.0
THZ1	GAK	8.0	10000.0
AG1478	NEK6	100.0	10000.0
BS-181	RIPK4	93.0	10000.0
AS-252424	MRCKB	96.7	10000.0
MPS-1-IN-1	BRSK1	100.0	1000.0
Torin2	FYN	92.0	10000.0
MPS-1-IN-1	ULK2	23.0	1000.0
BMX-IN-1	STK16	28.0	10000.0
AZD4547	ERN1	58.0	10000.0
XMD11-85h	ABL1(M351T)	100.0	10000.0
HG-6-64-01	JAK1(JH1domain-catalytic)	39.0	10000.0
CH5424802	RIOK1	100.0	1000.0
AZD 5438	BMX	52.0	10000.0
WZ3105	ULK1	0.7	10000.0
JNK-IN-11	PIK3CA(I800L)	77.0	1000.0
NU7441	INSRR	100.0	10000.0
NPK76-II-72-1	FGFR4	100.0	10000.0
CH5424802	MAST1	91.0	1000.0
AZD4547	YSK4	0.0	10000.0
TAK-715	MP2K3	96.0	10000.0
QL-XII-47	EGFR(L858R)	100.0	1000.0
TAK-715	FLT3(ITD)	50.0	10000.0
BMS345541	IRAK1	78.0	10000.0
QL-XI-92	M4K3	87.0	10000.0
A443654	DRAK1	5.4	10000.0
JW-7-24-1	ABL1(F317I)	100.0	10000.0
AZ-628	KCC2D	100.0	10000.0
AZD7762	MERTK	0.1	10000.0
SCH772984	PLK4	62.0	1000.0
BGJ398	YSK1	96.0	1000.0
AZD4547	SGK1	76.0	10000.0
(s)-CR8	FLT3(D835Y)	61.0	10000.0
Crizotinib	ABL1-nonphosphorylated	0.0	10000.0
XMD-12	TGFBR1	73.0	1000.0
Neratinib	ERK5	100.0	10000.0
Crizotinib	EPHA7	0.3	10000.0
SB590885	ERBB2	40.0	10000.0
WZ-7043	STK16	100.0	10000.0
Buparlisib	FLT3(N841I)	100.0	1000.0
JNK-IN-5A	MINK	95.0	10000.0
HG-5-113-01	NLK	100.0	10000.0
JNK-IN-8	GSK3A	92.0	1000.0
GSK461364	NEK5	25.0	10000.0
5z-7-oxozeaenol	MAP4K4	84.0	10000.0
HG-5-113-01	EPHB1	100.0	10000.0
Ribociclib	PIP5K1A	100.0	1000.0
KIN001-220	KPCD	60.0	10000.0
SB590885	TRKB	75.0	10000.0
HG-6-64-01	IRAK4	48.0	10000.0
5z-7-oxozeaenol	EGFR(S752-I759del)	100.0	10000.0
Alpelisib	TTK	100.0	1000.0
Sigma A6730	PIK3CA(M1043I)	100.0	10000.0
Sigma A6730	PLK4	60.0	10000.0
JWE-035	RET(M918T)	0.6	10000.0
R406	WEE2	1.6	1000.0
HG-9-91-01	MK03	100.0	10000.0
Vemurafenib	ADCK3	100.0	10000.0
AZD4547	BIKE	7.8	10000.0
JNK-IN-5A	ZAP70	87.0	10000.0
CP466722	RET(V804M)	66.0	10000.0
WZ3105	ERBB4	76.0	10000.0
KIN001-220	EPHB1	66.0	10000.0
CP724714	SGK3	100.0	10000.0
WZ-4-145	ACVRL1	100.0	10000.0
R406	TNNI3K	1.9	1000.0
QL-X-138	M3K6	75.0	10000.0
QL-XI-92	KIT(A829P)	54.0	10000.0
WZ-4-145	ULK3	100.0	10000.0
HG-5-113-01	KIT	20.0	10000.0
Taselisib	HIPK4	99.0	1000.0
NPK76-II-72-1	LIMK2	100.0	10000.0
Dactolisib	ACVR2A	100.0	1000.0
Ribociclib	FGR	86.0	1000.0
XMD16-144	TNK1	0.4	10000.0
KU63794	FLT3(N841I)	82.0	10000.0
5z-7-oxozeaenol	MAST1	89.0	10000.0
ZSTK474	CSF1R	100.0	1000.0
Taselisib	PKN2	80.0	1000.0
HG-6-64-01	MUSK	0.0	10000.0
ZSTK474	TGFBR1	100.0	1000.0
Taselisib	ALK(L1196M)	74.0	1000.0
JWE-035	IRAK1	25.0	10000.0
ZM-447439	ACVR2A	100.0	10000.0
BMX-IN-1	PIM2	100.0	10000.0
5z-7-oxozeaenol	ERN1	77.0	10000.0
HG-14-10-04	HIPK2	3.5	10000.0
WZ-7043	MAK	100.0	10000.0
Ibrutinib	CDK2	100.0	1000.0
Dinaciclib	AKT2	100.0	10000.0
AZD-6482	PIK4CB	100.0	10000.0
Palbociclib	PHKG1	100.0	1000.0
BX-912	FGFR1	0.3	10000.0
Pictilisib	MAP4K5	90.0	1000.0
XMD16-144	M3K12	38.0	10000.0
PLX-4720	AMPK-alpha1	64.0	10000.0
CGP60474	ANKK1	100.0	10000.0
BX-912	DCLK1	35.0	10000.0
5z-7-oxozeaenol	SGK2	100.0	10000.0
Lapatinib	ALK	89.0	10000.0
Canertinib	TEC	100.0	1000.0
SB590885	EGFR(T790M)	34.0	10000.0
HG-5-88-01	FER	0.6	10000.0
NVP-TAE684	KGP1	1.3	1000.0
Sigma A6730	DYRK2	88.0	10000.0
BMX-IN-1	CSNK1A1	100.0	10000.0
XMD16-144	RET(V804M)	0.2	10000.0
GW843682X	MAP4K2	53.0	10000.0
JWE-035	DRAK2	100.0	10000.0
XMD8-92	CAMK1D	100.0	10000.0
Neratinib	EGFR(L747-T751del,Sins)	0.3	10000.0
Dabrafenib	MP2K3	51.0	10000.0
Torkinib	MARK2	11.0	10000.0
WZ-4-145	EPHA3	100.0	10000.0
BMX-IN-1	RSK4(Kin.Dom.1-N-terminal)	88.0	10000.0
MRT67307	MST2	99.0	10000.0
ZM-447439	MELK	42.0	10000.0
WH-4-023	MAP3K15	83.0	10000.0
Crizotinib	EPHA1	0.9	10000.0
XMD11-50	ACVR1	98.0	10000.0
PLX-4720	PAK7	44.0	10000.0
CGP74514A	KIT(V559D,T670I)	63.0	10000.0
JNK-9L	BIKE	0.6	10000.0
Torkinib	FAK2	100.0	10000.0
BMS345541	AKT2	100.0	10000.0
Torin2	FLT3(D835H)	16.0	10000.0
CH5424802	TESK1	93.0	1000.0
AZD7762	PIK3CA	100.0	10000.0
BS-181	CDK3	78.0	10000.0
Torkinib	EGFR(L858R)	16.0	10000.0
Torkinib	CDK3	100.0	10000.0
A443654	MUSK	100.0	10000.0
KIN001-123	MAPKAPK2	100.0	1000.0
XMD8-85	ERK4	100.0	10000.0
Momelotinib	CAMK1D	40.0	10000.0
Ribociclib	RSK4(Kin.Dom.1-N-terminal)	100.0	1000.0
XMD-12	ADCK4	78.0	1000.0
HG-6-64-01	SIK1	0.9	10000.0
BX-912	CDC2L5	0.4	10000.0
Torin1	DDR2	100.0	10000.0
SP600125	ZAP70	100.0	10000.0
XMD14-99	MLK1	100.0	10000.0
RO-3306	ULK1	47.0	10000.0
CG-930	ADCK3	35.0	10000.0
HG-14-8-02	MRCKA	100.0	10000.0
JWE-035	FES	100.0	10000.0
NPK76-II-72-1	MLK3	100.0	10000.0
JWE-035	ALK	64.0	10000.0
XMD14-99	IRAK3	90.0	10000.0
Sigma A6730	RET	76.0	10000.0
Torin2	ALK	100.0	10000.0
XMD14-99	SIK1	86.0	10000.0
TGX221	BMPR1B	100.0	1000.0
PD173074	DMPK	100.0	10000.0
THZ1	EGFR(L747-S752del,P753S)	18.0	10000.0
Ceritinib	FGFR3(G697C)	88.0	1000.0
Vemurafenib	MYLK	91.0	10000.0
ALW-II-49-7	PHKG2	100.0	10000.0
AZD-6482	DYRK2	89.0	10000.0
Vemurafenib	FGFR1	49.0	10000.0
OTSSP167	PKNB(M.tuberculosis)	0.1	10000.0
KIN001-127	MARK3	100.0	10000.0
XMD16-144	CDK11	100.0	10000.0
NPK76-II-72-1	KPCL	100.0	10000.0
ERK5-IN-1	ZAP70	90.0	1000.0
Abemaciclib	KGP2	91.0	1000.0
XMD13-2	EPHA3	64.0	10000.0
(s)-CR8	FER	96.0	10000.0
PLX-4720	CDK4-cyclinD1	64.0	10000.0
ZM-447439	NUAK1	92.0	10000.0
Torin2	ABL1(E255K)-phosphorylated	76.0	10000.0
SCH772984	M3K5	98.0	1000.0
XMD16-144	PIK3CA(M1043I)	39.0	10000.0
CGP60474	PRP4	100.0	10000.0
NU7441	TYK2(JH1domain-catalytic)	75.0	10000.0
GW843682X	FGR	63.0	10000.0
HG-14-8-02	IRAK4	90.0	10000.0
HG-14-10-04	ACVR1	100.0	10000.0
BMS345541	IKKE	100.0	10000.0
Alpelisib	FLT3(ITD,F691L)	95.0	1000.0
Torin1	NEK9	100.0	10000.0
OTSSP167	ABL1-phosphorylated	0.2	10000.0
QL-XI-92	PIK3C2B	100.0	10000.0
GSK429286A	LTK	100.0	10000.0
AS-252424	ZAP70	95.8	10000.0
CGP74514A	CSK	81.0	10000.0
HG-9-91-01	MST3	1.6	10000.0
PLX-4720	GCN2(Kin.Dom.2,S808G)	1.0	10000.0
BS-181	PCTK3	67.0	10000.0
AG1478	PHKG1	67.0	10000.0
BI-D1870	CAMK1	33.0	10000.0
CP466722	BMPR2	14.0	10000.0
WZ3105	KPCL	91.0	10000.0
KIN001-123	FER	100.0	1000.0
AG1478	MST4	84.0	10000.0
BMX-IN-1	MK09	24.0	10000.0
ZM-447439	TNIK	51.0	10000.0
Sorafenib	PAK6	91.0	10000.0
AZD-6482	VRK2	100.0	10000.0
Dactolisib	DYRK1B	100.0	1000.0
Seliciclib	MARK4	88.0	10000.0
Baricitinib	SRPK1	29.0	10000.0
5z-7-oxozeaenol	KPCD1	10.0	10000.0
CGP60474	NEK6	100.0	10000.0
GW-5074	TYRO3	88.0	10000.0
JWE-035	OSR1	59.0	10000.0
JW-7-24-1	DMPK2	100.0	10000.0
BS-181	FES	86.0	10000.0
KU63794	TLK1	94.0	10000.0
Sigma A6730	MAP4K2	71.0	10000.0
AG1478	MP2K6	95.0	10000.0
Neratinib	ACVR1	100.0	10000.0
RO-3306	ZAP70	96.0	10000.0
HG-5-113-01	CSNK1G3	22.0	10000.0
BMX-IN-1	PIK3CB	44.0	10000.0
Sigma A6730	EPHA2	100.0	10000.0
GSK429286A	KPCT	54.0	10000.0
QL-XII-47	KIT	62.0	1000.0
ZSTK474	TNK1	100.0	1000.0
TAK-715	SgK110	100.0	10000.0
QL-X-138	TBK1	100.0	10000.0
JNK-9L	ICK	2.6	10000.0
Canertinib	JAK1(Kin.Dom.1)	100.0	1000.0
Vemurafenib	LATS2	75.0	10000.0
XMD11-85h	JAK3(JH1domain-catalytic)	100.0	10000.0
Baricitinib	MINK	49.0	10000.0
Omipalisib	MLK2	68.0	10000.0
AS-252424	TGFBR2	36.1	10000.0
JNK-IN-11	PIK3C2B	100.0	1000.0
Momelotinib	EPHA7	96.0	10000.0
GSK1059615	CDK2	76.0	10000.0
GSK429286A	PIP5K1C	92.0	10000.0
Lapatinib	YSK1	71.0	10000.0
HG-14-8-02	RIOK3	33.0	10000.0
JNK-IN-11	BMPR2	100.0	1000.0
KIN001-021	FAK1	100.0	1000.0
NU7441	YANK1	100.0	10000.0
XMD11-50	HUNK	100.0	10000.0
5z-7-oxozeaenol	DCLK1	74.0	10000.0
XMD14-99	AAK1	61.0	10000.0
BMS-536924	CSNK1A1L	100.0	1000.0
MLN8054	TRKB	30.0	10000.0
AZD-6482	BTK	97.0	10000.0
KIN001-123	RET	0.4	1000.0
Sorafenib	SIK2	97.0	10000.0
GW-5074	SRPK3	7.8	10000.0
Baricitinib	MK13	100.0	10000.0
QL-XII-47	MP2K3	70.0	1000.0
TAK-715	CDK3	100.0	10000.0
NVP-TAE684	CDK5	5.2	1000.0
Ibrutinib	TRKA	79.0	1000.0
QL-XI-92	PI42C	90.0	10000.0
RO-3306	KC1G2	9.0	10000.0
RO-3306	FLT3(R834Q)	78.0	10000.0
THZ1	MAP4K5	34.0	10000.0
HG-14-8-02	NEK6	100.0	10000.0
Torin2	ULK3	100.0	10000.0
KIN001-220	ACVR2B	38.0	10000.0
ZSTK474	JAK2(Kin.Dom.2)	100.0	1000.0
PD0325901	MKNK1	100.0	10000.0
MRT67307	PTK6	100.0	10000.0
Buparlisib	ALK	93.0	1000.0
GSK461364	MINK	29.0	10000.0
ERK5-IN-1	MTOR	100.0	1000.0
MPS-1-IN-1	AURKB	100.0	1000.0
SP600125	HCK	100.0	10000.0
Alpelisib	MAP3K3	96.0	1000.0
Palbociclib	MYO3A	100.0	1000.0
Sigma A6730	PIK3CA(E545A)	95.0	10000.0
BI-2536	CHEK1	100.0	10000.0
MLN8054	GRK1	100.0	10000.0
PHA-767491	NEK7	100.0	10000.0
GSK461364	SBK1	55.0	10000.0
XMD8-92	EGFR(L858R,T790M)	100.0	10000.0
Dabrafenib	MAST1	83.0	10000.0
KIN001-111	BIKE	100.0	1000.0
THZ1	AKT2	66.0	10000.0
XMD8-85	M4K3	100.0	10000.0
Dabrafenib	TYK2(JH2domain-pseudokinase)	2.4	10000.0
HG-14-8-02	CAMK2A	22.0	10000.0
PD173074	EGFR(E746-A750del)	100.0	10000.0
Sigma A6730	MAP3K15	100.0	10000.0
JNK-9L	SIK3	100.0	10000.0
KIN001-123	JNK3	3.8	1000.0
Seliciclib	WEE1	100.0	10000.0
PHA-767491	AMPK-alpha1	100.0	10000.0
BGJ398	MST4	56.0	1000.0
BS-181	EGFR(S752-I759del)	100.0	10000.0
MRT67307	TLK2	100.0	10000.0
WZ-4-145	MAP3K4	10.0	10000.0
BX-912	FAK1	0.2	10000.0
BMX-IN-1	MAP3K15	100.0	10000.0
XMD8-85	NEK1	100.0	10000.0
Torin1	MAPKAPK2	100.0	10000.0
CP466722	CDK2	50.0	10000.0
HG-14-8-02	KPCL	100.0	10000.0
CP724714	MK11	100.0	10000.0
NVP-TAE684	MST1R	3.0	1000.0
R406	SRPK3	9.4	1000.0
Sorafenib	MK13	7.6	10000.0
XMD8-92	ABL1(H396P)	100.0	10000.0
XMD8-92	PIM3	100.0	10000.0
CG-930	RIPK2	37.0	10000.0
ERK5-IN-1	ERK4	100.0	1000.0
XMD11-50	NEK1	83.0	10000.0
CGP74514A	PKAC-alpha	42.0	10000.0
A443654	KPCD2	0.0	10000.0
HG-14-8-02	DRAK1	100.0	10000.0
Dactolisib	ABL1(E255K)	100.0	1000.0
KIN001-111	MYO3B	7.9	1000.0
PLX-4720	PKN1	85.0	10000.0
Omipalisib	WEE2	98.0	10000.0
ALW-II-49-7	EPHB4	6.9	1000.0
XMD8-92	KPCD3	100.0	10000.0
CP724714	MK03	95.0	10000.0
ZG-10	EGFR(G719C)	83.0	10000.0
HG-6-64-01	PLK4	59.0	10000.0
Neratinib	LCK	3.7	10000.0
NPK76-II-72-1	ABL1(M351T)	100.0	10000.0
XMD-12	ACVRL1	100.0	1000.0
WYE-125132	NLK	85.0	10000.0
PHA-767491	FES	100.0	10000.0
NU7441	STK33	100.0	10000.0
QL-XI-92	CTK	100.0	10000.0
AZD-6482	HIPK3	89.0	10000.0
R406	JAK1(Kin.Dom.2)	0.2	1000.0
CP466722	JNK3	1.4	10000.0
Pictilisib	AKT2	100.0	1000.0
XMD13-2	ITK	100.0	10000.0
AZD4547	PKMYT1	100.0	10000.0
ERK5-IN-1	ABL1(M351T)-phosphorylated	89.0	1000.0
PHA-793887	STK36	61.0	10000.0
PHA-793887	TYK2(JH1domain-catalytic)	97.0	10000.0
OTSSP167	PLK1	0.1	10000.0
Buparlisib	MYO3B	84.0	1000.0
Buparlisib	MAP3K4	88.0	1000.0
XMD14-99	CDC2L2	3.6	10000.0
JNK-IN-8	OSR1	89.0	1000.0
KIN001-021	RPS6KA4(Kin.Dom.2)	100.0	1000.0
(s)-CR8	MYLK4	94.0	10000.0
AZD7762	GRK7	0.2	10000.0
Crizotinib	FLT3(K663Q)	5.6	10000.0
Barasertib	MELK	47.0	10000.0
WZ4002	MP2K1	100.0	10000.0
Lapatinib	DCLK1	98.0	10000.0
RO-3306	SRMS	65.0	10000.0
Crizotinib	PRP4	48.0	10000.0
XMD11-85h	AMPK-alpha1	100.0	10000.0
HG-6-64-01	BIKE	3.0	10000.0
AS-252424	IKKB	100.0	10000.0
JNK-IN-11	ABL1(T315I)-phosphorylated	76.0	1000.0
Ceritinib	MK09	66.0	1000.0
Abemaciclib	BRSK1	98.0	1000.0
XMD11-50	ALK	13.0	10000.0
MRT67307	PCTK2	93.0	10000.0
Vemurafenib	ACVRL1	65.0	10000.0
KIN001-220	CAMK1G	39.0	10000.0
WZ4003	M4K1	100.0	1000.0
Ribociclib	SLK	52.0	1000.0
Baricitinib	CAMKK2	91.0	10000.0
Sigma A6730	MYLK	57.0	10000.0
AZD 5438	RSK3(Kin.Dom.1-N-terminal)	84.0	10000.0
JW-7-24-1	FLT3	100.0	10000.0
XMD11-50	PKNB(M.tuberculosis)	100.0	10000.0
Dinaciclib	TXK	88.0	10000.0
KIN001-220	TLK1	19.0	10000.0
AZD 5438	LATS2	41.0	10000.0
Canertinib	INSR	100.0	1000.0
OTSSP167	EGFR(T790M)	1.0	10000.0
BS-181	ABL1(F317L)-phosphorylated	87.0	10000.0
Abemaciclib	MARK2	96.0	1000.0
WZ-7043	DMPK2	100.0	10000.0
HG-14-10-04	NEK3	100.0	10000.0
XMD-12	FLT3(D835Y)	24.0	1000.0
BS-181	IRAK3	69.0	10000.0
HG-5-113-01	AMPK-alpha2	8.9	10000.0
5z-7-oxozeaenol	RSK2(Kin.Dom.2-C-terminal)	100.0	10000.0
Ceritinib	RIOK2	84.0	1000.0
Buparlisib	RET(M918T)	100.0	1000.0
JNK-IN-11	CLK3	100.0	1000.0
Momelotinib	MK03	100.0	10000.0
JNK-IN-8	DAPK3	100.0	1000.0
BMS345541	PRP4	66.0	10000.0
BMS-536924	RPS6KA6(Kin.Dom.2)	3.4	1000.0
XMD14-99	EGFR(L858R,T790M)	100.0	10000.0
AG1478	BTK	70.0	10000.0
JNK-9L	PAK1	65.0	10000.0
PLX-4720	RIPK2	8.3	10000.0
BMS345541	NIM1	100.0	10000.0
Pictilisib	PCTK3	94.0	1000.0
KIN001-220	CDC2L5	100.0	10000.0
JNK-IN-11	PCTK3	95.0	1000.0
CP466722	GSK3B	100.0	10000.0
Dactolisib	CAMK2B	100.0	1000.0
Abemaciclib	ALK(L1196M)	90.0	1000.0
NVP-TAE684	RIOK1	2.6	1000.0
HG-14-10-04	ABL1(E255K)-phosphorylated	0.6	10000.0
JW-7-24-1	CIT	100.0	10000.0
Momelotinib	CDK3	100.0	10000.0
HG-14-10-04	HIPK4	0.3	10000.0
Ceritinib	ULK2	50.0	1000.0
BI-D1870	KPCD1	22.0	10000.0
GSK429286A	ERK3	98.0	10000.0
CGP74514A	RIPK5	36.0	10000.0
Torin2	STK35	92.0	10000.0
Dabrafenib	MLK3	11.0	10000.0
A443654	EGFR(L747-E749del,A750P)	100.0	10000.0
QL-XII-47	RIPK5	100.0	1000.0
ZSTK474	CAMK1G	100.0	1000.0
WZ-7043	DCAMKL2	100.0	10000.0
AG1478	FGFR4	98.0	10000.0
HG-14-8-02	PIK4CB	54.0	10000.0
MLN8054	MLCK	100.0	10000.0
XMD11-50	TAOK1	28.0	10000.0
Taselisib	WNK4	88.0	1000.0
KIN001-021	MST3	100.0	1000.0
A443654	INSRR	100.0	10000.0
CP724714	PKNB(M.tuberculosis)	23.0	10000.0
QL-XI-92	ABL1-phosphorylated	67.0	10000.0
BMS345541	M4K1	81.0	10000.0
Torin2	ABL1(Q252H)-nonphosphorylated	100.0	10000.0
NG25	ERBB4	28.0	10000.0
PLX-4720	FES	55.0	10000.0
HG-9-91-01	LIMK2	0.0	10000.0
HG-9-91-01	TXK	1.4	10000.0
CH5424802	LATS1	88.0	1000.0
GSK461364	IGF1R	100.0	10000.0
XMD8-85	RIOK1	100.0	10000.0
TAK-715	CTK	100.0	10000.0
ZG-10	KIT(A829P)	64.0	10000.0
AZD7762	MLK3	0.0	10000.0
SB590885	TIE2	63.0	10000.0
Momelotinib	IRAK1	1.3	10000.0
WZ3105	TXK	48.0	10000.0
PHA-793887	RIPK1	98.0	10000.0
AS-252424	KIT	100.0	10000.0
TGX221	KKCC1	100.0	1000.0
QL-XII-47	DAPK2	100.0	1000.0
CGP74514A	LRRK2(G2019S)	23.0	10000.0
KIN001-220	MET(Y1235D)	23.0	10000.0
Pictilisib	NEK11	100.0	1000.0
MRT67307	CAMK1D	43.0	10000.0
XMD13-2	IRAK3	69.0	10000.0
WZ4003	CLK4	8.6	1000.0
Torkinib	HUNK	99.0	10000.0
GW843682X	CAMKK2	44.0	10000.0
AZD-6482	KPCD3	100.0	10000.0
XMD14-99	TRKC	100.0	10000.0
WZ3105	RET	73.0	10000.0
CH5424802	MAP3K3	59.0	1000.0
Omipalisib	YANK3	89.0	10000.0
KIN001-123	SRMS	4.7	1000.0
ERK5-IN-1	PLK2	97.0	1000.0
SCH772984	RAF1	100.0	1000.0
Vemurafenib	SNRK	100.0	10000.0
WZ-7043	BRAF	100.0	10000.0
HG-5-113-01	MK09	100.0	10000.0
AZD-6482	SgK110	100.0	10000.0
BMS345541	RET(V804M)	100.0	10000.0
PHA-793887	GRK7	14.0	10000.0
Barasertib	IKKE	51.0	10000.0
KIN001-021	IKKB	100.0	1000.0
Alpelisib	FER	92.0	1000.0
TAK-715	STK33	97.0	10000.0
A443654	PCTK3	28.0	10000.0
GW-5074	IRAK3	62.0	10000.0
ERK5-IN-1	EGFR(L858R)	100.0	1000.0
PD0325901	FLT3(K663Q)	85.0	10000.0
QL-XII-47	TYRO3	96.0	1000.0
CGP74514A	RSK1(Kin.Dom.1-N-terminal)	6.6	10000.0
Taselisib	PIK3CA	0.0	1000.0
ZM-447439	MST2	100.0	10000.0
NU7441	CDK16	97.0	10000.0
TGX221	CAMKK2	100.0	1000.0
JNK-9L	MST1R	100.0	10000.0
Sorafenib	DYRK2	95.0	10000.0
KIN001-127	FGFR3(G697C)	100.0	10000.0
Taselisib	PIK3CA(E542K)	0.0	1000.0
AZD-6482	PRKX	91.0	10000.0
GW843682X	DAPK1	8.6	10000.0
CGP74514A	STK36	25.0	10000.0
CG-930	CSF1R	64.0	10000.0
PD173074	TRKC	100.0	10000.0
GSK429286A	BRAF	100.0	10000.0
XMD-12	RIPK5	27.0	1000.0
Momelotinib	LIMK1	100.0	10000.0
PHA-793887	LYN	77.0	10000.0
Ibrutinib	ABL1(H396P)-nonphosphorylated	12.0	1000.0
OTSSP167	M4K3	11.0	10000.0
NPK76-II-72-1	PLK3	0.0	10000.0
Dinaciclib	FAK1	93.0	10000.0
AZD 5438	MK14	100.0	10000.0
SB590885	RIOK1	97.0	10000.0
Barasertib	CSNK2A2	86.0	10000.0
XMD13-2	CSNK1D	78.0	10000.0
Buparlisib	SRC	100.0	1000.0
MLN8054	PHKG1	100.0	10000.0
HG-9-91-01	PAK6	3.4	10000.0
KU63794	PIK3CA(E542K)	2.8	10000.0
NVP-TAE684	MK12	100.0	1000.0
ALW-II-38-3	KIT(D816V)	27.0	10000.0
CGP74514A	ACVR2A	97.0	10000.0
Dactolisib	NDR1	100.0	1000.0
WZ3105	YSK1	89.0	10000.0
JWE-035	PAK7	81.0	10000.0
Palbociclib	LCK	100.0	1000.0
Crizotinib	MST4	13.0	10000.0
QL-X-138	PLK1	80.0	10000.0
Baricitinib	PIP5K1C	97.0	10000.0
HG-5-88-01	RIOK1	100.0	10000.0
QL-XI-92	MARK2	100.0	10000.0
BMX-IN-1	SIK2	100.0	10000.0
MLN8054	EPHB1	2.2	10000.0
ZSTK474	NEK7	100.0	1000.0
TAK-715	PIK3CA	100.0	10000.0
BX-912	KGP2	4.8	10000.0
ZSTK474	TNK2	100.0	1000.0
XMD14-99	FGR	93.0	10000.0
XMD13-2	STK16	3.0	10000.0
(s)-CR8	BRAF	100.0	10000.0
ERK5-IN-1	ABL1(F317L)-nonphosphorylated	71.0	1000.0
GW843682X	PIK3CA(E542K)	100.0	10000.0
AZ-628	MKNK1	100.0	10000.0
ALW-II-49-7	MST3	100.0	10000.0
ZM-447439	ABL1-phosphorylated	35.0	10000.0
Seliciclib	ERBB3	94.0	10000.0
KIN001-021	TESK1	100.0	1000.0
JWE-035	BRSK2	42.0	10000.0
PHA-793887	DCAMKL2	4.3	10000.0
KIN001-123	MST4	100.0	1000.0
SB590885	MAP3K1	72.0	10000.0
AZD4547	FLT3(D835Y)	0.1	10000.0
Alpelisib	PRKX	100.0	1000.0
Canertinib	BMPR2	100.0	1000.0
JNK-IN-5A	KIT(A829P)	87.0	10000.0
AZD 5438	KIT(A829P)	27.0	10000.0
Palbociclib	TAOK2	97.0	1000.0
THZ1	KIT(L576P)	0.4	10000.0
Ceritinib	KPCL	100.0	1000.0
AS-252424	ULK2	72.8	10000.0
Omipalisib	JAK1(JH2domain-pseudokinase)	2.2	10000.0
Dactolisib	GSK3A	100.0	1000.0
Torin1	CLK4	49.0	10000.0
AG1478	DRAK1	19.0	10000.0
Ribociclib	KGP2	99.0	1000.0
GW-5074	TNK2	74.0	10000.0
Canertinib	KPCE	100.0	1000.0
XMD13-2	MYO3B	93.0	10000.0
ZM-447439	MLK3	20.0	10000.0
TGX221	ERK8	100.0	1000.0
HG-6-64-01	KPCD2	50.0	10000.0
NVP-TAE684	CDK9	100.0	1000.0
PLX-4720	MYLK2	64.0	10000.0
SB590885	ABL1(H396P)-nonphosphorylated	1.3	10000.0
Sigma A6730	PAK3	72.0	10000.0
Seliciclib	PIK3CD	98.0	10000.0
Vemurafenib	MYO3B	64.0	10000.0
WZ-4-145	RPS6KA1(Kin.Dom.1)	100.0	10000.0
QL-XII-47	MP2K5	85.0	1000.0
QL-XI-92	CDK9	100.0	10000.0
SB590885	TNK2	100.0	10000.0
Torin2	MLTK	65.0	10000.0
Momelotinib	EPHB6	58.0	10000.0
Sigma A6730	LTK	56.0	10000.0
Taselisib	MST3	96.0	1000.0
CP724714	FGFR2	100.0	10000.0
R406	CDK5	100.0	1000.0
BMX-IN-1	ABL1(E255K)-phosphorylated	77.0	10000.0
HG-5-88-01	IKKE	100.0	10000.0
Momelotinib	FLT3-autoinhibited	100.0	10000.0
JNK-9L	PKMYT1	65.0	10000.0
PD0325901	FLT3(D835Y)	100.0	10000.0
XMD11-85h	MK03	100.0	10000.0
QL-XII-47	YSK4	100.0	1000.0
GSK429286A	CDC2L2	96.0	10000.0
JNK-9L	NEK5	1.4	10000.0
Torkinib	SIK1	13.0	10000.0
AZD-6482	CDK4-cyclinD3	100.0	10000.0
JNK-9L	NEK7	45.0	10000.0
AZD7762	CDK7	4.9	10000.0
XMD11-85h	IRAK3	100.0	10000.0
BMS-536924	RPS6KA2(Kin.Dom.1)	29.0	1000.0
Baricitinib	ACVR1B	100.0	10000.0
WZ-7043	CDK5	100.0	10000.0
Barasertib	CDKL3	99.0	10000.0
MLN8054	CDK5	100.0	10000.0
WZ3105	LKB1	66.0	10000.0
Ribociclib	BMX	100.0	1000.0
Taselisib	ABL1(F317I)-nonphosphorylated	100.0	1000.0
THZ1	AURKC	0.7	10000.0
KU63794	RIPK5	78.0	10000.0
XMD8-85	EGFR(S752-I759del)	100.0	10000.0
AZD7762	SGK3	27.0	10000.0
JNK-IN-8	KIT(V559D,T670I)	4.4	1000.0
XMD8-85	CIT	100.0	10000.0
SB590885	EPHA3	99.0	10000.0
QL-X-138	KIT(L576P)	68.0	10000.0
NU7441	MP2K7	100.0	10000.0
GSK461364	ABL2	90.0	10000.0
XMD11-50	MAP4K4	85.0	10000.0
Neratinib	PIK3C2B	100.0	10000.0
QL-XII-47	KCC4	100.0	1000.0
GSK461364	MRCKA	95.0	10000.0
AZD-6482	RET	100.0	10000.0
SCH772984	ABL1(Q252H)-nonphosphorylated	94.0	1000.0
JNK-IN-5A	RIPK2	58.0	10000.0
Lapatinib	GAK	83.0	10000.0
Lapatinib	HCK	78.0	10000.0
Momelotinib	RSK1(Kin.Dom.1-N-terminal)	100.0	10000.0
JNK-9L	EGFR	71.0	10000.0
HG-5-88-01	EPHA3	100.0	10000.0
WH-4-023	KIT(V559D,T670I)	48.0	10000.0
OTSSP167	KCC2D	1.6	10000.0
NPK76-II-72-1	MK12	100.0	10000.0
Buparlisib	AKT2	76.0	1000.0
Pictilisib	MAPKAPK2	100.0	1000.0
Dabrafenib	MK14	73.0	10000.0
JW-7-24-1	PIM1	100.0	10000.0
JNK-IN-5A	ROCK2	100.0	10000.0
AG1478	MK11	57.0	10000.0
CH5424802	NIM1	91.0	1000.0
GW843682X	ICK	100.0	10000.0
MLN8054	MP2K2	99.0	10000.0
XMD-12	FGFR3	62.0	1000.0
Dabrafenib	MET(Y1235D)	7.4	10000.0
XMD11-50	AMPK-alpha2	66.0	10000.0
CG-930	ACVR2A	92.0	10000.0
HG-14-8-02	EPHB6	12.0	10000.0
PHA-767491	PIK3CD	65.0	10000.0
BX-912	EIF2AK1	100.0	10000.0
Lapatinib	PI42C	78.0	10000.0
Omipalisib	SBK1	77.0	10000.0
KIN001-127	SRMS	100.0	10000.0
JNK-IN-8	BTK	100.0	1000.0
OTSSP167	SgK110	100.0	10000.0
GSK1059615	ADCK4	35.0	10000.0
HG-14-8-02	CSNK1D	100.0	10000.0
WYE-125132	CDC2L2	97.0	10000.0
HG-6-64-01	M4K1	0.0	10000.0
HG-6-64-01	PLK1	100.0	10000.0
CH5424802	BUB1	80.0	1000.0
WZ-4-145	EGFR(E746-A750del)	0.6	10000.0
Dactolisib	MARK4	100.0	1000.0
RO-3306	SYK	100.0	10000.0
Pictilisib	LCK	85.0	1000.0
CG-930	FLT3(ITD)	90.0	10000.0
WZ3105	NEK5	94.0	10000.0
BGJ398	SNARK	76.0	1000.0
CG-930	INSR	98.0	10000.0
HG-9-91-01	M4K3	4.1	10000.0
HG-14-8-02	STK39	68.0	10000.0
AG1478	MK12	100.0	10000.0
JNK-IN-8	YSK4	65.0	1000.0
KIN001-127	MST1R	100.0	10000.0
Abemaciclib	MYO3B	100.0	1000.0
Torkinib	JAK1(JH1domain-catalytic)	11.0	10000.0
Sigma A6730	MTOR	100.0	10000.0
Torin2	ABL2	100.0	10000.0
AZD4547	MP2K3	79.0	10000.0
Alpelisib	WNK4	100.0	1000.0
KU63794	PTK6	100.0	10000.0
A443654	FER	100.0	10000.0
SB590885	OSR1	100.0	10000.0
BGJ398	PIP5K1A	73.0	1000.0
CP466722	PI42C	1.1	10000.0
BS-181	BRAF	92.0	10000.0
XMD16-144	AMPK-alpha2	1.4	10000.0
PLX-4720	PIK3CA(E545A)	92.0	10000.0
XMD13-2	BTK	100.0	10000.0
CP724714	STK16	78.0	10000.0
WZ3105	ABL1(H396P)-nonphosphorylated	24.0	10000.0
CG-930	TYK2(JH2domain-pseudokinase)	61.0	10000.0
WYE-125132	ULK1	100.0	10000.0
Palbociclib	OSR1	100.0	1000.0
WZ-4-145	MST4	100.0	10000.0
OTSSP167	DCAMKL2	22.0	10000.0
XMD11-50	CDKL3	83.0	10000.0
JNK-9L	ACVR2A	16.0	10000.0
SCH772984	NDR2	100.0	1000.0
XMD-12	PLK2	100.0	1000.0
Taselisib	AKT3	95.0	1000.0
GSK1059615	BRSK2	91.0	10000.0
WH-4-023	MK03	100.0	10000.0
AZD7762	AURKA	22.0	10000.0
WZ4002	EGFR(G719S)	0.3	10000.0
PD0325901	NDR2	100.0	10000.0
JNK-IN-8	ABL1(T315I)-phosphorylated	92.0	1000.0
TGX221	LTK	100.0	1000.0
ALW-II-38-3	DCAMKL2	100.0	10000.0
QL-XII-47	TBK1	93.0	1000.0
BS-181	ABL1(F317I)-nonphosphorylated	88.0	10000.0
WH-4-023	CAMK2G	100.0	10000.0
MPS-1-IN-1	KKCC1	100.0	1000.0
(s)-CR8	MP2K5	78.0	10000.0
GSK1059615	MYLK4	2.2	10000.0
Seliciclib	EPHB6	90.0	10000.0
MPS-1-IN-1	MP2K6	31.0	1000.0
CP724714	TRKC	93.0	10000.0
Barasertib	PAK7	100.0	10000.0
SP600125	MST4	2.4	10000.0
HG-14-10-04	CLK1	0.7	10000.0
BI-D1870	TAK1	1.9	10000.0
Barasertib	GAK	21.0	10000.0
CGP74514A	BUB1	38.0	10000.0
HG-14-10-04	HIPK3	4.3	10000.0
BGJ398	CDKL5	88.0	1000.0
AZD-6482	GSK3B	100.0	10000.0
Abemaciclib	CDK7	1.7	1000.0
A443654	RPS6KA4(Kin.Dom.2)	9.9	10000.0
AG1478	MYLK4	78.0	10000.0
ALW-II-38-3	MYO3A	100.0	10000.0
Barasertib	RIOK3	100.0	10000.0
XMD13-2	PAK3	60.0	10000.0
NPK76-II-72-1	CDC2L2	100.0	10000.0
Abemaciclib	AAK1	2.0	1000.0
GW-5074	GRK4	21.0	10000.0
HG-6-64-01	RIOK2	19.0	10000.0
CH5424802	AURKB	94.0	1000.0
CG-930	ACVRL1	72.0	10000.0
Dabrafenib	EGFR(T790M)	80.0	10000.0
WZ3105	IRAK3	38.0	10000.0
XMD16-144	PIM1	66.0	10000.0
JWE-035	CAMK2G	81.0	10000.0
Torin1	PLK2	85.0	10000.0
Dabrafenib	PIK3CA(Q546K)	100.0	10000.0
HG-14-10-04	CSNK2A2	0.1	10000.0
BGJ398	TSSK1	100.0	1000.0
Buparlisib	BARK1	100.0	1000.0
JNK-IN-8	DAPK1	100.0	1000.0
Ibrutinib	RIOK1	77.0	1000.0
HG-9-91-01	KKCC1	84.0	10000.0
Barasertib	MP2K1	32.0	10000.0
JNK-IN-8	FLT3(R834Q)	100.0	1000.0
AS-252424	CDK7	46.6	10000.0
NVP-TAE684	TIE2	0.0	1000.0
AG1478	MST1R	100.0	10000.0
XMD16-144	RSK3(Kin.Dom.2-C-terminal)	21.0	10000.0
SCH772984	ACVR2A	100.0	1000.0
CP724714	BMPR1A	100.0	10000.0
KIN001-123	CSNK2A1	100.0	1000.0
KIN001-127	ITK	0.3	10000.0
KIN001-220	FES	48.0	10000.0
GSK461364	RSK3(Kin.Dom.1-N-terminal)	4.0	10000.0
ERK5-IN-1	CDK16	100.0	1000.0
QL-XI-92	TRKC	100.0	10000.0
AZD-6482	MAPKAPK5	100.0	10000.0
Torin2	LOK	100.0	10000.0
PD0325901	CAMKK2	100.0	10000.0
MLN8054	PIK3CG	100.0	10000.0
JWE-035	KC1G1	7.6	10000.0
XMD11-85h	MERTK	34.0	10000.0
AZD7762	GRK1	0.6	10000.0
ALW-II-49-7	EGFR(L747-S752del,P753S)	100.0	10000.0
Pictilisib	MYLK	86.0	1000.0
Ibrutinib	CSNK2A1	57.0	1000.0
Dabrafenib	INSRR	91.0	10000.0
KIN001-021	MARK2	100.0	1000.0
QL-XI-92	PCTK2	92.0	10000.0
Pictilisib	MK09	98.0	1000.0
AZD4547	ABL1(T315I)-phosphorylated	0.3	10000.0
Ceritinib	AKT1	100.0	1000.0
HG-5-88-01	CDK5	100.0	10000.0
KIN001-220	EPHA5	92.0	10000.0
GW-5074	ERBB2	94.0	10000.0
RO-3306	ABL1(F317L)-nonphosphorylated	69.0	10000.0
WZ3105	PIK3CD	92.0	10000.0
PD0325901	SgK110	100.0	10000.0
GSK1059615	SLK	0.3	10000.0
HG-14-10-04	TGFBR1	100.0	10000.0
MRT67307	MET	11.0	10000.0
QL-X-138	PHKG2	79.0	10000.0
Dinaciclib	RET(V804M)	100.0	10000.0
CP466722	MST1R	100.0	10000.0
HG-9-91-01	KPCT	21.0	10000.0
KU63794	ABL1(T315I)-nonphosphorylated	100.0	10000.0
Torin1	HUNK	91.0	10000.0
CH5424802	YANK3	100.0	1000.0
JWE-035	PAK6	79.0	10000.0
HG-6-64-01	MERTK	9.2	10000.0
Baricitinib	IKKE	11.0	10000.0
Ribociclib	CDK14	100.0	1000.0
ZG-10	LIMK1	60.0	10000.0
BS-181	PIK3CG	84.0	10000.0
AG1478	PTK6	58.0	10000.0
Lapatinib	AKT2	96.0	10000.0
CGP74514A	IRAK4	9.8	10000.0
Vemurafenib	TLK1	95.0	10000.0
JNK-IN-8	ITK	100.0	1000.0
XMD8-85	PKMYT1	100.0	10000.0
Dabrafenib	ACVR2A	100.0	10000.0
Pictilisib	KPCD2	95.0	1000.0
Abemaciclib	CLK1	1.0	1000.0
OTSSP167	TTK	100.0	10000.0
Torin2	CDK8	100.0	10000.0
Crizotinib	ABL2	0.9	10000.0
JNK-IN-8	SRC	87.0	1000.0
QL-XI-92	LATS2	88.0	10000.0
RO-3306	CDK16	88.0	10000.0
WZ-7043	TAK1	100.0	10000.0
Dabrafenib	CASK	73.0	10000.0
XMD8-92	BMX	100.0	10000.0
ZM-447439	RSK4(Kin.Dom.2-C-terminal)	71.0	10000.0
THZ1	MET(Y1235D)	0.4	10000.0
CG-930	MK12	80.0	10000.0
PHA-793887	LKB1	100.0	10000.0
Alpelisib	FLT3(K663Q)	100.0	1000.0
GW-5074	ALK	100.0	10000.0
GW-5074	YANK2	100.0	10000.0
JNK-9L	KPCD	65.0	10000.0
GSK429286A	GAK	100.0	10000.0
GSK1059615	CDK4-cyclinD1	92.0	10000.0
BI-2536	TYK2(Kin.Dom.2)	100.0	10000.0
NU7441	PCTK2	100.0	10000.0
SCH772984	PIK3C2G	100.0	1000.0
ALW-II-49-7	MLK1	100.0	10000.0
SP600125	MYO3B	100.0	10000.0
PD173074	SIK1	100.0	10000.0
ZG-10	EPHB3	75.0	10000.0
ERK5-IN-1	PRKX	100.0	1000.0
KIN001-111	ABL1(F317I)	1.6	1000.0
Ibrutinib	RSK3(Kin.Dom.1-N-terminal)	89.0	1000.0
TGX221	DAPK1	100.0	1000.0
KU63794	CDC2L1	100.0	10000.0
Ceritinib	PIK4CB	88.0	1000.0
Omipalisib	PHKG2	70.0	10000.0
5z-7-oxozeaenol	FLT3(D835H)	11.0	10000.0
Canertinib	YANK2	100.0	1000.0
WZ-7043	CAMK2B	100.0	10000.0
Dactolisib	ADCK3	100.0	1000.0
AZ-628	EPHA8	2.1	10000.0
5z-7-oxozeaenol	HIPK2	100.0	10000.0
NVP-TAE684	NLK	100.0	1000.0
OTSSP167	NEK3	100.0	10000.0
OTSSP167	PIK3CA(H1047Y)	36.0	10000.0
Momelotinib	PAK2	100.0	10000.0
QL-XI-92	MELK	100.0	10000.0
Sorafenib	PIP5K1A	100.0	10000.0
QL-X-138	MST2	100.0	10000.0
CH5424802	KIT(V559D,T670I)	100.0	1000.0
BGJ398	MP2K4	93.0	1000.0
5z-7-oxozeaenol	ABL1(H396P)-phosphorylated	93.0	10000.0
NPK76-II-72-1	EGFR(E746-A750del)	100.0	10000.0
ALW-II-38-3	NEK6	100.0	10000.0
Torin2	CDKL3	100.0	10000.0
XMD8-85	TYRO3	100.0	10000.0
WZ4002	CSNK1E	100.0	10000.0
RO-3306	IKKE	64.0	10000.0
Buparlisib	S6K1	100.0	1000.0
AG1478	ADCK4	28.0	10000.0
TGX221	RIPK2	100.0	1000.0
BS-181	CSF1R-autoinhibited	34.0	10000.0
MRT67307	SLK	100.0	10000.0
BS-181	MK13	64.0	10000.0
BI-2536	CSNK1D	100.0	10000.0
AZD7762	FGFR2	11.0	10000.0
GW-5074	EPHA5	91.0	10000.0
WZ4002	NEK1	100.0	10000.0
TGX221	CAMK1	100.0	1000.0
BMS345541	PIK3CB	88.0	10000.0
ALW-II-38-3	PIK3CD	100.0	10000.0
5z-7-oxozeaenol	SIK3	99.0	10000.0
Palbociclib	DAPK3	31.0	1000.0
Torkinib	BMX	22.0	10000.0
BI-2536	KPCL	100.0	10000.0
5z-7-oxozeaenol	CTK	100.0	10000.0
GSK429286A	NEK5	90.0	10000.0
BX-912	CDC2L2	52.0	10000.0
Alpelisib	AURKB	91.0	1000.0
Torin1	PIK3CA(E542K)	1.0	10000.0
5z-7-oxozeaenol	TXK	85.0	10000.0
JNK-IN-11	ADCK4	0.0	1000.0
XMD-12	MARK2	51.0	1000.0
XMD13-2	CDK7	18.0	10000.0
SCH772984	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	1000.0
TAK-715	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
Alpelisib	TRKA	100.0	1000.0
Vemurafenib	KCC2D	100.0	10000.0
AZD-6482	LCK	97.0	10000.0
JNK-IN-11	IRAK1	2.0	1000.0
TGX221	CSNK1D	100.0	1000.0
A443654	RPS6KA2(Kin.Dom.1)	29.0	10000.0
SP600125	PKAC-beta	100.0	10000.0
CG-930	TRKB	79.0	10000.0
Seliciclib	CSNK1D	1.8	10000.0
Crizotinib	RSK4(Kin.Dom.1-N-terminal)	46.0	10000.0
XMD13-2	EGFR(L747-E749del,A750P)	82.0	10000.0
AG1478	CDC2L2	77.0	10000.0
XMD-12	CSNK1D	77.0	1000.0
Baricitinib	CDK7	14.0	10000.0
WYE-125132	AKT3	86.0	10000.0
QL-XI-92	SIK2	100.0	10000.0
TGX221	EGFR(E746-A750del)	100.0	1000.0
CP466722	RAF1	59.0	10000.0
WYE-125132	MAP3K4	86.0	10000.0
AG1478	PAK4	84.0	10000.0
Lapatinib	LATS2	100.0	10000.0
Crizotinib	ULK2	4.7	10000.0
JNK-IN-11	MK13	100.0	1000.0
Omipalisib	MINK	84.0	10000.0
KIN001-127	MAP4K4	100.0	10000.0
OTSSP167	SNRK	23.0	10000.0
R406	ABL1(Y253F)	23.0	1000.0
Dinaciclib	STK39	42.0	10000.0
Barasertib	DCLK1	51.0	10000.0
Palbociclib	LIMK1	100.0	1000.0
PD173074	AXL	100.0	10000.0
KIN001-111	KGP2	100.0	1000.0
BI-2536	RPS6KA2(Kin.Dom.1)	100.0	10000.0
WZ3105	PIP5K1A	36.0	10000.0
XMD11-85h	EPHB1	100.0	10000.0
Torkinib	TSSK1	83.0	10000.0
XMD13-2	EGFR(S752-I759del)	72.0	10000.0
WZ4002	MKNK2	2.0	10000.0
NVP-TAE684	PRKX	28.0	1000.0
JW-7-24-1	CDK11	100.0	10000.0
KIN001-123	MARK4	100.0	1000.0
Torkinib	FGFR4	12.0	10000.0
NPK76-II-72-1	PHKG1	100.0	10000.0
BMS345541	MP2K1	100.0	10000.0
PD0325901	LOK	82.0	10000.0
Alpelisib	ADCK4	100.0	1000.0
HG-6-64-01	ULK3	1.5	10000.0
Seliciclib	ACVR1	100.0	10000.0
KIN001-021	LCK	100.0	1000.0
BMS345541	MLCK	95.0	10000.0
Pictilisib	GRK1	100.0	1000.0
WZ3105	INSRR	64.0	10000.0
XMD14-99	JAK1(JH2domain-pseudokinase)	100.0	10000.0
HG-5-113-01	CAMK1G	100.0	10000.0
QL-X-138	FLT3	6.2	10000.0
WZ4002	DMPK2	100.0	10000.0
ZG-10	ADCK4	98.0	10000.0
A443654	BRSK1	100.0	10000.0
SP600125	DCLK1	100.0	10000.0
KU63794	MAP4K4	88.0	10000.0
TAK-715	LYN	54.0	10000.0
MLN8054	FYN	17.0	10000.0
ZG-10	CDK15	100.0	10000.0
ERK5-IN-1	SNRK	52.0	1000.0
Buparlisib	CDK8	77.0	1000.0
Omipalisib	NIM1	72.0	10000.0
(s)-CR8	KC1G2	57.0	10000.0
CH5424802	TGFBR1	99.0	1000.0
HG-14-8-02	FLT3(R834Q)	23.0	10000.0
GSK1059615	MK12	56.0	10000.0
HG-14-8-02	CLK1	28.0	10000.0
Buparlisib	MYLK2	100.0	1000.0
CP724714	EPHA7	100.0	10000.0
Sorafenib	TRKA	16.0	10000.0
SCH772984	CSNK1E	82.0	1000.0
SCH772984	TYK2(JH1domain-catalytic)	86.0	1000.0
TAK-715	KPCD2	46.0	10000.0
KIN001-123	MRCKB	100.0	1000.0
XMD8-92	ERBB3	100.0	10000.0
BMS345541	ZAP70	100.0	10000.0
JNK-IN-8	KIT(L576P)	100.0	1000.0
Canertinib	ERBB4	0.8	1000.0
GW-5074	CAMK2A	20.0	10000.0
BS-181	MK14	98.0	10000.0
Dinaciclib	MLK3	100.0	10000.0
ZG-10	NEK4	100.0	10000.0
SP600125	PLK1	100.0	10000.0
ERK5-IN-1	AURKB	100.0	1000.0
NVP-TAE684	FAK2	0.0	1000.0
QL-XI-92	MERTK	99.0	10000.0
SP600125	MARK3	100.0	10000.0
NU7441	IRAK3	41.0	10000.0
Ceritinib	JNK3	68.0	1000.0
WZ4002	ABL1(E255K)	100.0	10000.0
CP466722	TESK1	100.0	10000.0
BMS345541	TTK	100.0	10000.0
XMD8-85	CDK8	100.0	10000.0
NPK76-II-72-1	TAOK3	100.0	10000.0
Palbociclib	FGFR3(G697C)	97.0	1000.0
MRT67307	MST3	81.0	10000.0
WZ-7043	AURKC	100.0	10000.0
NVP-TAE684	LCK	0.1	1000.0
AZ-628	FAK1	100.0	10000.0
Vemurafenib	FGFR3	93.0	10000.0
AZD4547	CAMK1	17.0	10000.0
HG-6-64-01	KIT(L576P)	0.0	10000.0
MLN8054	FGFR3	9.0	10000.0
Alpelisib	PKAC-beta	90.0	1000.0
KIN001-021	MET	100.0	1000.0
GW843682X	AKT1	100.0	10000.0
ALW-II-49-7	ERK5	100.0	10000.0
Alpelisib	YANK2	100.0	1000.0
BMS345541	RIPK5	100.0	10000.0
AZD4547	MK14	100.0	10000.0
ZG-10	JNK3	1.3	10000.0
PD0325901	PIK3CA(H1047Y)	57.0	10000.0
AZD 5438	LCK	74.0	10000.0
Vemurafenib	RIPK4	91.0	10000.0
ZM-447439	MP2K3	100.0	10000.0
CH5424802	MST4	89.0	1000.0
ERK5-IN-1	PKNB(M.tuberculosis)	96.0	1000.0
JNK-9L	ACVR2B	49.0	10000.0
RO-3306	ICK	74.0	10000.0
Buparlisib	MLTK	94.0	1000.0
Lapatinib	INSRR	100.0	10000.0
Abemaciclib	RSK4(Kin.Dom.1-N-terminal)	82.0	1000.0
BMS-536924	FLT3(D835H)	0.1	1000.0
HG-5-88-01	PTK6	3.0	10000.0
CGP74514A	CSNK1E	3.2	10000.0
Torin1	MP2K1	100.0	10000.0
GW843682X	MAPKAPK2	100.0	10000.0
Vemurafenib	ZAP70	90.0	10000.0
BI-2536	PIK3C2B	100.0	10000.0
AG1478	CAMK2A	62.0	10000.0
PHA-767491	MK13	50.0	10000.0
AZ-628	KPCL	100.0	10000.0
KIN001-123	CHEK1	100.0	1000.0
KIN001-021	CSNK1A1L	100.0	1000.0
Abemaciclib	MAP4K5	76.0	1000.0
BS-181	AKT2	88.0	10000.0
Baricitinib	ERN1	20.0	10000.0
HG-14-10-04	KIT(A829P)	0.0	10000.0
PHA-793887	MTOR	95.0	10000.0
XMD8-92	KPCD	100.0	10000.0
Omipalisib	PIP5K1C	64.0	10000.0
XMD14-99	MAPKAPK2	100.0	10000.0
HG-14-10-04	LKB1	21.0	10000.0
Lapatinib	TGFBR2	75.0	10000.0
Dabrafenib	TIE1	12.0	10000.0
GSK1059615	WEE2	95.0	10000.0
Seliciclib	CDC2L2	89.0	10000.0
CGP74514A	JNK3	69.0	10000.0
Ribociclib	CSNK1A1	86.0	1000.0
Torin1	FYN	49.0	10000.0
NPK76-II-72-1	LATS1	100.0	10000.0
ALW-II-49-7	CAMK2A	100.0	10000.0
ZG-10	DRAK2	19.0	10000.0
Abemaciclib	NEK9	100.0	1000.0
JWE-035	VGFR1	100.0	10000.0
JNK-IN-11	TNIK	27.0	1000.0
KIN001-123	MYO3A	100.0	1000.0
Torin1	MAP4K2	35.0	10000.0
ALW-II-49-7	SIK2	100.0	10000.0
XMD16-144	DMPK	32.0	10000.0
SB590885	LYN	86.0	10000.0
Torin1	SIK3	89.0	10000.0
ZM-447439	GRK1	100.0	10000.0
Palbociclib	SgK110	100.0	1000.0
JNK-9L	DYRK2	39.0	10000.0
AZ-628	MST2	100.0	10000.0
KIN001-021	INSR	100.0	1000.0
Taselisib	BRAF(V600E)	88.0	1000.0
Sigma A6730	KKCC1	100.0	10000.0
NG25	AURKB	100.0	10000.0
Abemaciclib	PIM1	2.9	1000.0
KIN001-220	TXK	2.2	10000.0
KIN001-220	MK09	0.8	10000.0
RO-3306	CDK7	1.8	10000.0
AZD-6482	M3K12	85.0	10000.0
Taselisib	FLT3(ITD,D835V)	76.0	1000.0
Baricitinib	FLT3(K663Q)	57.0	10000.0
PD173074	RPS6KA5(Kin.Dom.1)	100.0	10000.0
OTSSP167	GSK3B	5.8	10000.0
AZD 5438	KCC4	100.0	10000.0
XMD14-99	IGF1R	72.0	10000.0
GW843682X	CSNK2A2	17.0	10000.0
WZ3105	M3K13	79.0	10000.0
HG-5-113-01	AKT3	100.0	10000.0
SP600125	MP2K1	7.2	10000.0
AZD 5438	HUNK	97.0	10000.0
KU63794	BMPR1A	70.0	10000.0
NG25	CSNK1G3	100.0	10000.0
CH5424802	MET	98.0	1000.0
NVP-TAE684	MP2K1	3.6	1000.0
XMD16-144	KIT(V559D,V654A)	96.0	10000.0
JNK-IN-11	PIK3CG	84.0	1000.0
HG-14-10-04	MTOR	88.0	10000.0
AZD7762	SRPK3	0.6	10000.0
MRT67307	CDKL5	0.9	10000.0
CH5424802	AXL	2.4	1000.0
XMD16-144	MYLK4	86.0	10000.0
Ribociclib	SBK1	100.0	1000.0
Seliciclib	JAK1(JH1domain-catalytic)	100.0	10000.0
WZ-7043	KPCL	100.0	10000.0
Torin2	LIMK2	89.0	10000.0
GSK461364	TEC	91.0	10000.0
KU63794	HIPK1	97.0	10000.0
CG-930	CAMK1	100.0	10000.0
GSK429286A	CAMK1	93.0	10000.0
WZ4003	MLK1	100.0	1000.0
Momelotinib	ABL2	57.0	10000.0
ZG-10	MK09	2.5	10000.0
SCH772984	ALK(L1196M)	100.0	1000.0
PD0325901	FGR	95.0	10000.0
(s)-CR8	MST4	79.0	10000.0
A443654	RPS6KA4(Kin.Dom.1)	100.0	10000.0
XMD11-85h	DMPK2	100.0	10000.0
Seliciclib	CSNK2A2	100.0	10000.0
ALW-II-38-3	PIK3CA(H1047L)	100.0	10000.0
JNK-IN-8	PIK3CA(H1047L)	100.0	1000.0
ALW-II-38-3	SIK2	100.0	10000.0
Taselisib	NEK11	100.0	1000.0
BMX-IN-1	CDK4-cyclinD3	93.0	10000.0
ZSTK474	RAF1	100.0	1000.0
WZ3105	CDKL2	100.0	10000.0
Torkinib	CAMK2A	53.0	10000.0
XMD16-144	IRAK3	44.0	10000.0
WZ-4-145	CAMK2B	100.0	10000.0
CP466722	ABL1(Q252H)-nonphosphorylated	0.0	10000.0
WZ-7043	ABL1(H396P)	100.0	10000.0
Momelotinib	ABL1(Q252H)-nonphosphorylated	26.0	10000.0
ALW-II-49-7	TNIK	100.0	10000.0
NVP-TAE684	EGFR(E746-A750del)	0.0	1000.0
Neratinib	SIK2	58.0	10000.0
CP466722	ABL1-nonphosphorylated	0.9	10000.0
GSK461364	MTOR	55.0	10000.0
HG-14-8-02	SLK	47.0	10000.0
Omipalisib	PIK3CA(Q546K)	1.0	10000.0
GSK1059615	CDKL1	61.0	10000.0
Momelotinib	CAMKK2	51.0	10000.0
WZ4003	MELK	12.0	1000.0
TAK-715	TLK2	87.0	10000.0
AZD4547	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
Abemaciclib	WEE1	94.0	1000.0
CGP60474	YSK1	100.0	10000.0
XMD13-2	PKAC-beta	100.0	10000.0
CP466722	MLK1	70.0	10000.0
ZSTK474	MYLK2	100.0	1000.0
Sigma A6730	MYO3B	100.0	10000.0
BGJ398	ITK	99.0	1000.0
WZ-4-145	KGP2	100.0	10000.0
BMS345541	CSNK2A1	33.0	10000.0
QL-XII-47	FGFR3	95.0	1000.0
SB590885	AURKB	100.0	10000.0
PLX-4720	RSK3(Kin.Dom.1-N-terminal)	67.0	10000.0
OTSSP167	KIT	2.0	10000.0
Sigma A6730	FLT3(D835Y)	51.0	10000.0
GW-5074	AKT2	90.0	10000.0
ZG-10	RET(M918T)	70.0	10000.0
WZ4003	SYK	100.0	1000.0
HG-6-64-01	FAK1	67.0	10000.0
Lapatinib	PAK2	100.0	10000.0
JNK-9L	BMX	72.0	10000.0
Sigma A6730	KPCL	69.0	10000.0
Palbociclib	PLK3	100.0	1000.0
CGP74514A	PGFRA	21.0	10000.0
Alpelisib	FLT3(N841I)	100.0	1000.0
QL-XII-47	BIKE	84.0	1000.0
JNK-IN-11	ABL1(H396P)-phosphorylated	11.0	1000.0
AZD 5438	NEK3	80.0	10000.0
JWE-035	PRP4	76.0	10000.0
HG-6-64-01	GRK7	77.0	10000.0
Baricitinib	CDK2	92.0	10000.0
WH-4-023	PFPK5(P.falciparum)	100.0	10000.0
Canertinib	VGFR1	100.0	1000.0
AZD 5438	FAK2	25.0	10000.0
NU7441	NEK7	100.0	10000.0
AZ-628	EPHA6	0.0	10000.0
Palbociclib	FAK1	100.0	1000.0
BGJ398	MRCKB	100.0	1000.0
XMD16-144	LIMK1	71.0	10000.0
TGX221	PIK3CA	100.0	1000.0
QL-XI-92	FYN	73.0	10000.0
NPK76-II-72-1	EGFR(L861Q)	100.0	10000.0
SCH772984	RET(M918T)	100.0	1000.0
SB590885	ALK	45.0	10000.0
BMS345541	MAK	100.0	10000.0
PHA-767491	YES	100.0	10000.0
GSK1059615	PIK3CA(C420R)	0.4	10000.0
Lapatinib	TNNI3K	97.0	10000.0
JWE-035	SNRK	88.0	10000.0
XMD11-50	CHK2	66.0	10000.0
JNK-9L	CASK	78.0	10000.0
MLN8054	BRSK2	100.0	10000.0
R406	DRAK2	0.9	1000.0
Dinaciclib	BTK	100.0	10000.0
MRT67307	CAMK2B	22.0	10000.0
AS-252424	CSNK2A2	4.3	10000.0
ERK5-IN-1	CSK	100.0	1000.0
BMX-IN-1	TRPM6	100.0	10000.0
WYE-125132	ACVR1B	100.0	10000.0
GW-5074	M3K6	100.0	10000.0
ZG-10	RIOK1	10.0	10000.0
AZD4547	ABL1(E255K)-phosphorylated	2.0	10000.0
XMD8-92	EPHA8	100.0	10000.0
Abemaciclib	DYRK2	0.9	1000.0
AZD7762	MYLK4	51.0	10000.0
Ibrutinib	ULK1	71.0	1000.0
Momelotinib	PKN2	47.0	10000.0
RO-3306	LOK	59.0	10000.0
R406	PGFRA	0.2	1000.0
XMD13-2	EGFR(L747-S752del,P753S)	96.0	10000.0
A443654	MKNK1	19.0	10000.0
Pictilisib	BIKE	85.0	1000.0
TAK-715	MINK	8.4	10000.0
JNK-9L	HIPK3	5.5	10000.0
KIN001-123	GCN2(Kin.Dom.2,S808G)	100.0	1000.0
Torkinib	FLT4	0.3	10000.0
5z-7-oxozeaenol	HASP	94.0	10000.0
Taselisib	CDC2L5	91.0	1000.0
WZ-7043	BMPR1B	100.0	10000.0
GSK1059615	PIK3CA(H1047L)	27.0	10000.0
PD173074	ABL1(E255K)	100.0	10000.0
Seliciclib	YES	100.0	10000.0
PD173074	M3K5	100.0	10000.0
WH-4-023	TIE2	0.3	10000.0
Torin2	MAP3K1	100.0	10000.0
AZ-628	AURKC	100.0	10000.0
AZ-628	DRAK1	100.0	10000.0
OTSSP167	GCN2(Kin.Dom.2,S808G)	35.0	10000.0
Vemurafenib	PKAC-beta	100.0	10000.0
WZ-4-145	RIPK4	100.0	10000.0
XMD11-85h	NIM1	100.0	10000.0
MRT67307	TXK	100.0	10000.0
JNK-IN-5A	RIOK1	100.0	10000.0
Neratinib	PIP5K1C	100.0	10000.0
CH5424802	ABL1(Y253F)-phosphorylated	67.0	1000.0
Abemaciclib	KIT(L576P)	94.0	1000.0
XMD14-99	WEE1	100.0	10000.0
XMD16-144	ROS1	27.0	10000.0
KIN001-123	BRAF	100.0	1000.0
Abemaciclib	RPS6KA4(Kin.Dom.2-C-terminal)	4.9	1000.0
KIN001-127	MST4	100.0	10000.0
ZM-447439	RIOK1	100.0	10000.0
PD0325901	KIT(D816H)	91.0	10000.0
Seliciclib	BIKE	94.0	10000.0
XMD14-99	JAK2(JH1domain-catalytic)	80.0	10000.0
Dabrafenib	GSK3A	44.0	10000.0
SB590885	FLT3(ITD)	78.0	10000.0
GSK429286A	EGFR(L858R,T790M)	87.0	10000.0
CGP60474	KPCD1	100.0	10000.0
WZ-4-145	KPCD1	100.0	10000.0
Pictilisib	CASK	78.0	1000.0
ALW-II-49-7	INSRR	100.0	10000.0
Ibrutinib	DRAK2	100.0	1000.0
XMD11-50	BRAF	81.0	10000.0
HG-14-10-04	LIMK1	83.0	10000.0
PD173074	MAPKAPK5	100.0	10000.0
NG25	SRPK3	100.0	10000.0
GSK461364	PKN2	6.0	10000.0
ZSTK474	CAMK2B	100.0	1000.0
WZ-7043	CSNK2A2	100.0	10000.0
XMD-12	LTK	100.0	1000.0
Momelotinib	EPHA8	83.0	10000.0
AZD-6482	CLK1	74.0	10000.0
SP600125	ABL1	100.0	10000.0
THZ1	EPHB2	43.0	10000.0
NVP-TAE684	NEK9	3.3	1000.0
Barasertib	SNARK	54.0	10000.0
XMD11-50	MYLK	8.7	10000.0
BX-912	EPHB3	100.0	10000.0
WH-4-023	MAP3K4	23.0	10000.0
Torkinib	RSK4(Kin.Dom.2-C-terminal)	47.0	10000.0
NG25	AURKC	100.0	10000.0
WZ-7043	PIK3CA(H1047L)	100.0	10000.0
HG-6-64-01	MLK1	1.4	10000.0
Dactolisib	MP2K1	100.0	1000.0
KIN001-220	BRSK1	88.0	10000.0
GSK461364	MKNK1	100.0	10000.0
HG-9-91-01	MST1	41.0	10000.0
Abemaciclib	MLK1	84.0	1000.0
5z-7-oxozeaenol	RET(V804L)	93.0	10000.0
WZ4003	KCC4	100.0	1000.0
JNK-9L	PAK2	72.0	10000.0
Seliciclib	SRPK2	100.0	10000.0
KIN001-220	EGFR(G719C)	46.0	10000.0
Dinaciclib	DAPK2	91.0	10000.0
PHA-793887	PIK3CD	98.0	10000.0
SP600125	PKN2	100.0	10000.0
Pictilisib	ABL1(Q252H)-nonphosphorylated	80.0	1000.0
BMS345541	RSK3(Kin.Dom.1-N-terminal)	100.0	10000.0
JNK-9L	MUSK	92.0	10000.0
XMD11-50	RPS6KA5(Kin.Dom.1-N-terminal)	96.0	10000.0
JNK-9L	M3K13	100.0	10000.0
NPK76-II-72-1	ERBB2	100.0	10000.0
Omipalisib	EGFR(L747-S752del,P753S)	87.0	10000.0
HG-5-113-01	CDK3	100.0	10000.0
THZ1	MK13	23.0	10000.0
SB590885	EPHA7	100.0	10000.0
AG1478	EPHA2	62.0	10000.0
AZD 5438	KPCT	50.0	10000.0
GW-5074	M4K3	100.0	10000.0
Baricitinib	RIPK1	100.0	10000.0
JNK-IN-5A	MP2K1	98.0	10000.0
A443654	RPS6KA5(Kin.Dom.1)	11.0	10000.0
Lapatinib	MYLK4	88.0	10000.0
GW-5074	MKNK2	89.0	10000.0
AZD 5438	ICK	0.9	10000.0
Ceritinib	PKN2	95.0	1000.0
R406	ERK3	32.0	1000.0
MLN8054	LRRK2(G2019S)	100.0	10000.0
Neratinib	AKT2	99.0	10000.0
Abemaciclib	MLK2	87.0	1000.0
XMD11-85h	TAK1	100.0	10000.0
BMX-IN-1	BMX	6.0	10000.0
SB590885	EPHB3	100.0	10000.0
Abemaciclib	CDK9	12.0	1000.0
Taselisib	CAMK1	97.0	1000.0
CG-930	FYN	100.0	10000.0
SCH772984	MK14	100.0	1000.0
MRT67307	EPHA5	100.0	10000.0
WZ3105	AKT1	93.0	10000.0
XMD16-144	MRCKA	100.0	10000.0
QL-XI-92	JAK2(JH1domain-catalytic)	74.0	10000.0
KIN001-220	PIP5K1A	0.0	10000.0
XMD16-144	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
Neratinib	DDR2	100.0	10000.0
JW-7-24-1	BRAF	4.1	10000.0
JNK-IN-11	INSR	100.0	1000.0
ALW-II-38-3	BRAF(V600E)	0.2	1000.0
WYE-125132	CAMK1D	95.0	10000.0
Ceritinib	PHKG1	29.0	1000.0
Taselisib	LCK	90.0	1000.0
RO-3306	M4K3	90.0	10000.0
ERK5-IN-1	FGR	99.0	1000.0
Dactolisib	MK09	100.0	1000.0
BMX-IN-1	CSNK2A2	67.0	10000.0
XMD8-85	PIK4CB	100.0	10000.0
XMD8-85	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
MLN8054	HUNK	59.0	10000.0
BMS345541	ACVR1B	97.0	10000.0
WZ3105	EIF2AK1	100.0	10000.0
PHA-767491	ERBB3	91.0	10000.0
Momelotinib	KC1G1	100.0	10000.0
WYE-125132	ABL1(H396P)-nonphosphorylated	100.0	10000.0
Ribociclib	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	1000.0
KIN001-123	KCC4	100.0	1000.0
Lapatinib	CSK	98.0	10000.0
CH5424802	EIF2AK1	94.0	1000.0
GSK461364	DAPK2	15.0	10000.0
CP466722	EPHB3	56.0	10000.0
THZ1	CSNK1E	41.0	10000.0
WZ4003	CDK2	100.0	1000.0
KIN001-220	IRAK1	22.0	10000.0
WH-4-023	KPCI	62.0	10000.0
BGJ398	WEE1	98.0	1000.0
Dinaciclib	CDC2L1	79.0	10000.0
AG1478	CLK4	37.0	10000.0
Ribociclib	ABL1(F317I)-phosphorylated	100.0	1000.0
BX-912	BLK	0.6	10000.0
XMD16-144	JAK1(JH1domain-catalytic)	2.8	10000.0
CP466722	LRRK2	41.0	10000.0
Crizotinib	EGFR(L861Q)	82.0	10000.0
Vemurafenib	PLK4	48.0	10000.0
XMD14-99	MERTK	87.0	10000.0
R406	MST4	100.0	1000.0
AS-252424	EPHA7	100.0	10000.0
Omipalisib	RIOK2	68.0	10000.0
CH5424802	M3K2	56.0	1000.0
Alpelisib	RSK3(Kin.Dom.2-C-terminal)	85.0	1000.0
TAK-715	PGFRA	84.0	10000.0
GSK461364	KIT(L576P)	54.0	10000.0
Ceritinib	IRAK4	87.0	1000.0
BMX-IN-1	YANK1	100.0	10000.0
AZD7762	DYRK1A	0.0	10000.0
NPK76-II-72-1	PKMYT1	100.0	10000.0
HG-14-10-04	LATS2	23.0	10000.0
BGJ398	MAST1	100.0	1000.0
Sorafenib	CLK1	23.0	10000.0
HG-9-91-01	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
Sorafenib	YES	69.0	10000.0
Buparlisib	FAK2	100.0	1000.0
QL-X-138	EPHA8	96.0	10000.0
Omipalisib	ABL1(T315I)-nonphosphorylated	83.0	10000.0
QL-X-138	HIPK4	51.0	10000.0
HG-14-8-02	ULK2	100.0	10000.0
Taselisib	CDC2L2	100.0	1000.0
WYE-125132	TAK1	98.0	10000.0
A443654	ABL1(E255K)	100.0	10000.0
GSK1059615	SIK2	100.0	10000.0
WZ4002	PAK2	100.0	10000.0
TGX221	PIK3C2B	100.0	1000.0
AZD7762	BMPR1B	0.4	10000.0
Alpelisib	EPHA4	100.0	1000.0
NVP-TAE684	BMPR1A	0.0	1000.0
XMD11-85h	CLK4	100.0	10000.0
JWE-035	CLK3	92.0	10000.0
Torin2	SRPK2	100.0	10000.0
Palbociclib	CDK4-cyclinD1	0.4	1000.0
XMD8-85	CHK2	30.0	10000.0
GSK1059615	ABL1(M351T)-phosphorylated	56.0	10000.0
SCH772984	LTK	95.0	1000.0
Vemurafenib	KPCE	87.0	10000.0
KIN001-111	KIT	0.2	1000.0
BS-181	EGFR(L747-T751del,Sins)	89.0	10000.0
Omipalisib	CHEK1	89.0	10000.0
TAK-715	AURKA	90.0	10000.0
AZD 5438	TEC	52.0	10000.0
JW-7-24-1	KGP1	100.0	10000.0
Dactolisib	RET	100.0	1000.0
KIN001-021	EPHA5	100.0	1000.0
JNK-IN-8	FLT3(D835Y)	58.0	1000.0
Abemaciclib	SRMS	100.0	1000.0
WH-4-023	FGFR2	0.5	10000.0
Lapatinib	SYK	100.0	10000.0
Ibrutinib	ABL1(E255K)-phosphorylated	65.0	1000.0
NG25	TNK2	100.0	10000.0
WZ4003	SIK1	100.0	1000.0
GSK1059615	DCAMKL2	91.0	10000.0
JWE-035	CHEK1	57.0	10000.0
HG-14-8-02	PGFRB	12.0	10000.0
PHA-767491	PKAC-beta	33.0	10000.0
MLN8054	CHEK1	91.0	10000.0
WZ3105	TIE2	95.0	10000.0
XMD16-144	GRK7	100.0	10000.0
OTSSP167	PIM3	75.0	10000.0
Dinaciclib	DDR1	95.0	10000.0
JNK-9L	CAMK1G	48.0	10000.0
WYE-125132	PIK3CA(I800L)	5.0	10000.0
WZ-4-145	RIOK3	100.0	10000.0
Torin1	FLT3(R834Q)	52.0	10000.0
SB590885	PGFRB	63.0	10000.0
XMD11-85h	PGFRA	100.0	10000.0
Sigma A6730	ALK	37.0	10000.0
HG-14-10-04	NEK4	61.0	10000.0
ZG-10	CDK9	90.0	10000.0
XMD8-85	NDR2	100.0	10000.0
TGX221	ABL1(F317I)	100.0	1000.0
TGX221	TLK2	100.0	1000.0
Barasertib	HIPK1	40.0	10000.0
BS-181	SGK3	100.0	10000.0
JNK-IN-11	ABL1(E255K)-phosphorylated	12.0	1000.0
JNK-9L	PIK3CD	100.0	10000.0
WZ4002	JAK1(Kin.Dom.2)	100.0	10000.0
CP724714	KIT(A829P)	68.0	10000.0
Ibrutinib	LRRK2(G2019S)	92.0	1000.0
NU7441	MAPKAPK2	100.0	10000.0
PD0325901	MP2K5	86.0	10000.0
PHA-767491	ACVRL1	74.0	10000.0
CGP60474	EPHA6	100.0	10000.0
TAK-715	MARK4	100.0	10000.0
KIN001-220	ACVR1	13.0	10000.0
GSK1059615	IRAK4	47.0	10000.0
WH-4-023	TYK2(JH1domain-catalytic)	45.0	10000.0
KIN001-021	TXK	100.0	1000.0
ALW-II-49-7	DRAK1	100.0	10000.0
BX-912	KIT(L576P)	0.0	10000.0
BMS345541	HIPK2	58.0	10000.0
Omipalisib	M3K5	77.0	10000.0
Torkinib	BIKE	33.0	10000.0
AZ-628	ANKK1	100.0	10000.0
Vemurafenib	ABL1-nonphosphorylated	6.6	10000.0
CP724714	ULK3	68.0	10000.0
Torkinib	MUSK	100.0	10000.0
XMD14-99	CDK5	88.0	10000.0
Torkinib	CSNK2A1	16.0	10000.0
Torin2	MAST1	100.0	10000.0
HG-6-64-01	MST4	18.0	10000.0
WZ4002	M4K3	29.0	10000.0
GSK461364	RET(M918T)	100.0	10000.0
XMD8-85	EGFR(G719C)	100.0	10000.0
BI-D1870	ULK2	1.0	10000.0
GSK429286A	M4K1	87.0	10000.0
HG-14-10-04	MARK2	1.2	10000.0
SP600125	RPS6KA6(Kin.Dom.2)	3.0	10000.0
Baricitinib	NEK3	14.0	10000.0
Torkinib	JNK1	89.0	10000.0
Momelotinib	CDK2	55.0	10000.0
HG-9-91-01	ABL1(M351T)-phosphorylated	0.7	10000.0
BMS-536924	DAPK1	0.5	1000.0
BMX-IN-1	HCK	100.0	10000.0
MLN8054	CSNK1G3	93.0	10000.0
OTSSP167	TAOK2	0.3	10000.0
Ceritinib	LTK	1.4	1000.0
BMX-IN-1	TNK2	100.0	10000.0
Ribociclib	TIE2	100.0	1000.0
Momelotinib	CDKL1	60.0	10000.0
CGP74514A	PIK3CA(E542K)	64.0	10000.0
WZ4002	KC1G1	100.0	10000.0
Torkinib	DYRK2	1.4	10000.0
Ibrutinib	MLTK	34.0	1000.0
AS-252424	NEK9	97.3	10000.0
XMD11-50	TYK2(JH1domain-catalytic)	52.0	10000.0
Baricitinib	DYRK2	29.0	10000.0
BI-2536	CSNK2A2	100.0	10000.0
Lapatinib	ULK2	96.0	10000.0
NG25	PIK3CD	100.0	10000.0
SP600125	FRK	100.0	10000.0
Crizotinib	MP2K3	42.0	10000.0
GSK429286A	YANK1	52.0	10000.0
ZG-10	NEK1	63.0	10000.0
ALW-II-38-3	RPS6KA2(Kin.Dom.1)	100.0	10000.0
Seliciclib	MK11	100.0	10000.0
BMX-IN-1	LKB1	100.0	10000.0
GW-5074	PKAC-beta	100.0	10000.0
MLN8054	PAK7	93.0	10000.0
HG-6-64-01	ABL1(M351T)-phosphorylated	2.2	10000.0
HG-5-113-01	CAMK2G	100.0	10000.0
CP724714	RET(M918T)	77.0	10000.0
Abemaciclib	PIK3CA(E542K)	100.0	1000.0
Seliciclib	DAPK1	95.0	10000.0
THZ1	EPHA3	23.0	10000.0
5z-7-oxozeaenol	RSK1(Kin.Dom.2-C-terminal)	27.0	10000.0
AZD7762	PKN2	38.0	10000.0
KU63794	YSK1	100.0	10000.0
Dinaciclib	STK33	81.0	10000.0
ZM-447439	FER	65.0	10000.0
AG1478	MAPKAPK2	100.0	10000.0
CP466722	GSK3A	73.0	10000.0
XMD-12	SNRK	61.0	1000.0
QL-XI-92	MKNK2	100.0	10000.0
NU7441	MP2K6	73.0	10000.0
5z-7-oxozeaenol	EGFR	99.0	10000.0
ALW-II-38-3	ABL1(F317I)	0.6	1000.0
HG-5-88-01	KCC2D	100.0	10000.0
WH-4-023	IKKB	93.0	10000.0
ZM-447439	EPHB1	100.0	10000.0
BS-181	PIK3CA(M1043I)	100.0	10000.0
KIN001-127	BRSK1	100.0	10000.0
KIN001-127	EGFR(L861Q)	100.0	10000.0
BS-181	CDK4-cyclinD3	62.0	10000.0
KIN001-111	ERK5	8.5	1000.0
CGP74514A	CSNK1A1L	15.0	10000.0
BMS345541	YANK2	100.0	10000.0
GW-5074	CDC2L1	100.0	10000.0
TGX221	ABL1(M351T)	100.0	1000.0
QL-X-138	ANKK1	82.0	10000.0
CGP60474	MP2K1	100.0	10000.0
HG-9-91-01	MK14	0.1	10000.0
QL-XI-92	IKKA	100.0	10000.0
PD173074	CSNK1A1L	100.0	10000.0
AZD4547	ULK2	1.0	10000.0
Dinaciclib	SIK2	100.0	10000.0
Ibrutinib	PLK2	77.0	1000.0
TAK-715	PIM1	87.0	10000.0
NVP-TAE684	EPHB1	0.1	1000.0
Sigma A6730	M3K13	100.0	10000.0
QL-XI-92	RSK4(Kin.Dom.1-N-terminal)	86.0	10000.0
PHA-767491	HUNK	89.0	10000.0
XMD11-50	LTK	32.0	10000.0
AZD7762	MST4	0.2	10000.0
PD0325901	M4K3	87.0	10000.0
XMD16-144	SYK	50.0	10000.0
WZ-7043	DAPK1	100.0	10000.0
(s)-CR8	CSNK1A1	85.0	10000.0
HG-14-8-02	WNK3	100.0	10000.0
ALW-II-49-7	ULK1	100.0	10000.0
AZ-628	MRCKA	100.0	10000.0
QL-X-138	FRK	99.0	10000.0
HG-5-113-01	KKCC1	100.0	10000.0
Ribociclib	KCC4	100.0	1000.0
GW843682X	MARK3	78.0	10000.0
AS-252424	YES	100.0	10000.0
PD0325901	MAP3K15	100.0	10000.0
Taselisib	JNK3	97.0	1000.0
THZ1	KGP1	93.0	10000.0
WYE-125132	AAK1	100.0	10000.0
TGX221	LCK	100.0	1000.0
Torkinib	BMPR2	0.1	10000.0
MLN8054	CSNK2A1	29.0	10000.0
Buparlisib	PFPK5(P.falciparum)	100.0	1000.0
Dinaciclib	MAP3K3	84.0	10000.0
WZ3105	MET	100.0	10000.0
TGX221	CSNK1E	100.0	1000.0
HG-14-8-02	TGFBR1	100.0	10000.0
ZSTK474	RPS6KA6(Kin.Dom.1)	100.0	1000.0
WZ4003	IRAK3	100.0	1000.0
Abemaciclib	PTK6	100.0	1000.0
Pictilisib	EGFR(E746-A750del)	82.0	1000.0
R406	DAPK3	1.2	1000.0
GW-5074	BRSK1	85.0	10000.0
ZG-10	PAK4	83.0	10000.0
Sigma A6730	FAK2	91.0	10000.0
PHA-767491	SRMS	100.0	10000.0
Torkinib	ICK	58.0	10000.0
CG-930	FLT3(N841I)	66.0	10000.0
Dinaciclib	RSK2(Kin.Dom.1-N-terminal)	25.0	10000.0
Baricitinib	MYLK2	95.0	10000.0
Sorafenib	RIPK4	92.0	10000.0
KIN001-021	CSNK2A2	100.0	1000.0
NPK76-II-72-1	ERK8	100.0	10000.0
WZ4002	VGFR2	100.0	10000.0
QL-X-138	RSK3(Kin.Dom.2-C-terminal)	92.0	10000.0
KIN001-111	PIP5K1A	100.0	1000.0
Palbociclib	FGFR2	86.0	1000.0
BMS345541	MAP4K4	100.0	10000.0
Lapatinib	TNIK	96.0	10000.0
BGJ398	CDK5	100.0	1000.0
BGJ398	WNK3	96.0	1000.0
Baricitinib	CLK3	14.0	10000.0
XMD11-85h	DCAMKL3	100.0	10000.0
ZM-447439	NEK2	51.0	10000.0
ERK5-IN-1	BMPR2	93.0	1000.0
Seliciclib	PLK4	69.0	10000.0
JNK-IN-8	DDR2	89.0	1000.0
BMS345541	MAP3K3	100.0	10000.0
HG-14-10-04	RSK3(Kin.Dom.2-C-terminal)	15.0	10000.0
HG-9-91-01	ERBB2	0.0	10000.0
XMD8-92	MET(M1250T)	100.0	10000.0
GSK1059615	MKNK1	84.0	10000.0
NVP-TAE684	PDPK1	28.0	1000.0
KIN001-111	CDK16	6.4	1000.0
Lapatinib	DAPK2	100.0	10000.0
BI-2536	IRAK3	100.0	10000.0
Abemaciclib	HIPK3	0.5	1000.0
PD0325901	RPS6KA5(Kin.Dom.1-N-terminal)	87.0	10000.0
Vemurafenib	GSK3A	54.0	10000.0
CH5424802	TNIK	21.0	1000.0
CP466722	TNNI3K	80.0	10000.0
GW843682X	CSNK1D	81.0	10000.0
Dactolisib	FGFR4	100.0	1000.0
WZ4002	CDK15	100.0	10000.0
PHA-793887	YSK1	12.0	10000.0
JNK-9L	MKNK1	100.0	10000.0
Omipalisib	CASK	44.0	10000.0
WYE-125132	CSNK1G3	48.0	10000.0
Pictilisib	MST4	100.0	1000.0
WZ-4-145	MARK3	100.0	10000.0
Abemaciclib	PRKX	100.0	1000.0
Ribociclib	FLT4	100.0	1000.0
SB590885	HIPK1	11.0	10000.0
XMD-12	CDK3	100.0	1000.0
HG-14-10-04	DYRK2	1.0	10000.0
JNK-IN-8	EIF2AK1	100.0	1000.0
CP466722	MET(Y1235D)	40.0	10000.0
PHA-793887	MYO3B	88.0	10000.0
5z-7-oxozeaenol	MRCKA	89.0	10000.0
WZ3105	PKN2	61.0	10000.0
AS-252424	BMPR1A	93.9	10000.0
AZ-628	FGFR2	55.0	10000.0
BS-181	CAMK1D	94.0	10000.0
BX-912	HIPK4	2.0	10000.0
PHA-767491	IKKA	0.0	10000.0
CH5424802	PAK2	38.0	1000.0
NVP-TAE684	TRKA	12.0	1000.0
HG-6-64-01	ZAP70	52.0	10000.0
AZD-6482	JAK2(JH1domain-catalytic)	62.0	10000.0
CP724714	M4K3	80.0	10000.0
Vemurafenib	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
Baricitinib	ACVRL1	100.0	10000.0
Abemaciclib	PHKG2	23.0	1000.0
Torin1	CAMK1D	88.0	10000.0
PD173074	CDK8	100.0	10000.0
Torkinib	RET(V804M)	12.0	10000.0
CH5424802	ACVR2A	100.0	1000.0
Ribociclib	PRKR	100.0	1000.0
HG-14-10-04	FGFR3(G697C)	1.0	10000.0
KIN001-021	YSK1	100.0	1000.0
ALW-II-38-3	TYRO3	100.0	10000.0
AZD4547	KPCL	100.0	10000.0
R406	ULK2	4.6	1000.0
KIN001-220	PHKG1	82.0	10000.0
HG-9-91-01	MAP3K15	91.0	10000.0
MRT67307	LIMK2	100.0	10000.0
RO-3306	SIK3	80.0	10000.0
THZ1	ABL1(F317L)-nonphosphorylated	10.0	10000.0
Ceritinib	KIT(V559D,V654A)	91.0	1000.0
Ibrutinib	CAMK1	77.0	1000.0
CH5424802	PCTK2	95.0	1000.0
KIN001-220	PKN2	100.0	10000.0
Omipalisib	ULK1	79.0	10000.0
JNK-IN-11	TAOK1	40.0	1000.0
HG-9-91-01	FGFR3(G697C)	0.5	10000.0
Barasertib	DYRK1B	86.0	10000.0
Neratinib	CTK	71.0	10000.0
Dabrafenib	PIK3CA	100.0	10000.0
5z-7-oxozeaenol	SgK110	100.0	10000.0
GW843682X	JNK1	100.0	10000.0
Ceritinib	YANK2	4.0	1000.0
ALW-II-38-3	YANK3	100.0	10000.0
AZD 5438	LKB1	27.0	10000.0
ZG-10	FAK2	100.0	10000.0
GSK1059615	PIP5K1C	28.0	10000.0
XMD11-85h	FER	100.0	10000.0
XMD11-85h	YSK1	100.0	10000.0
ZG-10	KCC2D	67.0	10000.0
AG1478	JNK3	9.8	10000.0
XMD8-85	SIK1	100.0	10000.0
HG-5-113-01	MYO3A	100.0	10000.0
Palbociclib	PIM2	100.0	1000.0
CGP74514A	GSK3A	97.0	10000.0
KIN001-123	MKNK2	100.0	1000.0
Ceritinib	EPHA2	92.0	1000.0
Torkinib	PDPK1	96.0	10000.0
Palbociclib	PRKR	99.0	1000.0
AZD4547	ERBB3	88.0	10000.0
CGP74514A	EGFR(L858R,T790M)	51.0	10000.0
XMD11-50	DDR2	100.0	10000.0
BMS-536924	EPHA1	100.0	1000.0
BGJ398	TTK	65.0	1000.0
Dinaciclib	MAP3K15	72.0	10000.0
CGP60474	MAP3K4	100.0	10000.0
Torin1	PLK4	100.0	10000.0
Vemurafenib	NDR1	100.0	10000.0
AZ-628	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
Palbociclib	TYK2(JH1domain-catalytic)	100.0	1000.0
BMX-IN-1	GRK1	99.0	10000.0
GSK461364	TNK2	100.0	10000.0
XMD13-2	SYK	100.0	10000.0
JNK-IN-5A	NEK6	92.0	10000.0
BMS-536924	GSK3B	100.0	1000.0
(s)-CR8	MTOR	100.0	10000.0
Sigma A6730	DAPK1	100.0	10000.0
Buparlisib	DAPK1	64.0	1000.0
Lapatinib	BRAF	100.0	10000.0
JNK-IN-11	DCLK1	93.0	1000.0
NU7441	HIPK1	93.0	10000.0
MPS-1-IN-1	FAK1	0.1	1000.0
Lapatinib	EPHA5	100.0	10000.0
CH5424802	TRKB	67.0	1000.0
Momelotinib	BRAF(V600E)	56.0	10000.0
HG-14-10-04	HUNK	3.1	10000.0
KU63794	MELK	97.0	10000.0
RO-3306	AURKB	46.0	10000.0
RO-3306	MKNK2	37.0	10000.0
XMD16-144	CAMK2G	46.0	10000.0
BI-D1870	EPHA6	19.0	10000.0
XMD11-50	CDC2L1	84.0	10000.0
CP724714	HIPK2	98.0	10000.0
JNK-IN-8	LIMK1	74.0	1000.0
BS-181	MLTK	100.0	10000.0
Torin1	PI42C	58.0	10000.0
Ribociclib	PIK3CA(C420R)	92.0	1000.0
HG-9-91-01	PIK3CA(C420R)	100.0	10000.0
KIN001-127	EGFR(G719C)	100.0	10000.0
AZD7762	CDK15	73.0	10000.0
WYE-125132	KKCC1	100.0	10000.0
GSK429286A	MAP3K3	82.0	10000.0
WH-4-023	PIM3	92.0	10000.0
XMD8-85	AXL	100.0	10000.0
KU63794	MK09	76.0	10000.0
(s)-CR8	EPHB4	88.0	10000.0
GW-5074	EPHB3	100.0	10000.0
Seliciclib	CDK3	89.0	10000.0
Sigma A6730	CASK	79.0	10000.0
Vemurafenib	CDK4-cyclinD3	82.0	10000.0
5z-7-oxozeaenol	ABL1(F317I)-phosphorylated	96.0	10000.0
WZ-7043	M3K2	6.8	10000.0
XMD13-2	PAK2	69.0	10000.0
Lapatinib	CIT	48.0	10000.0
JNK-9L	EGFR(S752-I759del)	87.0	10000.0
Lapatinib	MP2K1	100.0	10000.0
NPK76-II-72-1	LOK	29.0	10000.0
R406	LATS2	33.0	1000.0
WZ-7043	BLK	100.0	10000.0
Neratinib	JAK1(JH1domain-catalytic)	83.0	10000.0
(s)-CR8	S6K1	100.0	10000.0
CP466722	NEK9	2.2	10000.0
AZD 5438	EGFR(L747-T751del,Sins)	88.0	10000.0
AZD 5438	PAK3	11.0	10000.0
WZ3105	MST1R	100.0	10000.0
HG-14-8-02	TLK1	89.0	10000.0
KIN001-021	ERK4	100.0	1000.0
Abemaciclib	AURKB	100.0	1000.0
Baricitinib	MUSK	100.0	10000.0
NG25	DDR1	0.1	10000.0
HG-14-10-04	FAK2	0.1	10000.0
BGJ398	SGK3	90.0	1000.0
AZD7762	PIK3CD	100.0	10000.0
XMD11-50	BMX	87.0	10000.0
HG-14-10-04	NEK6	0.2	10000.0
KIN001-127	MK14	100.0	10000.0
XMD14-99	PIK4CB	100.0	10000.0
ALW-II-38-3	FLT3(K663Q)	100.0	10000.0
CG-930	LATS2	88.0	10000.0
Alpelisib	LRRK2	100.0	1000.0
XMD13-2	ACVRL1	100.0	10000.0
HG-5-88-01	PRKR	100.0	10000.0
KIN001-127	CDK15	100.0	10000.0
Crizotinib	TEC	100.0	10000.0
QL-XI-92	PLK3	100.0	10000.0
CGP60474	NEK9	100.0	10000.0
NU7441	CSNK1A1L	92.0	10000.0
RO-3306	PIK3CA(M1043I)	29.0	10000.0
AZD7762	MK03	91.0	10000.0
JNK-IN-8	YSK1	92.0	1000.0
PHA-793887	FRK	75.0	10000.0
XMD11-85h	PCTK3	100.0	10000.0
SB590885	RSK3(Kin.Dom.2-C-terminal)	100.0	10000.0
CGP74514A	PKNB(M.tuberculosis)	9.7	10000.0
TAK-715	FER	60.0	10000.0
Dactolisib	CAMK1D	100.0	1000.0
PD173074	M3K12	100.0	10000.0
NPK76-II-72-1	JAK3(Kin.Dom.2)	100.0	10000.0
BI-D1870	SYK	13.0	10000.0
Canertinib	ACVR2B	100.0	1000.0
PD0325901	ABL1(H396P)-nonphosphorylated	100.0	10000.0
GSK429286A	TBK1	82.0	10000.0
THZ1	MAP4K4	1.6	10000.0
KIN001-127	PIM3	100.0	10000.0
WZ3105	CDKL5	100.0	10000.0
Sorafenib	IGF1R	100.0	10000.0
Momelotinib	PRKX	74.0	10000.0
Omipalisib	EGFR(E746-A750del)	86.0	10000.0
XMD11-50	KIT(D816H)	100.0	10000.0
HG-14-10-04	MST1R	84.0	10000.0
Lapatinib	RIOK1	90.0	10000.0
Torin1	DCAMKL2	100.0	10000.0
Pictilisib	PCTK2	100.0	1000.0
Canertinib	TNIK	100.0	1000.0
XMD11-50	RSK4(Kin.Dom.1-N-terminal)	92.0	10000.0
JNK-IN-11	KPCE	93.0	1000.0
Omipalisib	TRKA	66.0	10000.0
GSK429286A	AKT1	76.0	10000.0
BX-912	PRKX	0.2	10000.0
WZ-7043	CDK15	100.0	10000.0
SCH772984	CASK	98.0	1000.0
TAK-715	LTK	26.0	10000.0
XMD8-85	RPS6KA2(Kin.Dom.2)	15.0	10000.0
WYE-125132	KIT(L576P)	85.0	10000.0
CG-930	PIK3CA	100.0	10000.0
AZD-6482	CHK2	100.0	10000.0
NVP-TAE684	KC1G1	100.0	1000.0
BMS345541	TYRO3	100.0	10000.0
Pictilisib	ERBB2	92.0	1000.0
R406	MYLK	100.0	1000.0
Ibrutinib	BTK	0.0	1000.0
QL-XI-92	FER	100.0	10000.0
JNK-IN-11	KIT	0.2	1000.0
(s)-CR8	IKKE	73.0	10000.0
XMD8-92	MK13	100.0	10000.0
KIN001-111	CAMK1G	100.0	1000.0
Dabrafenib	CAMK2G	78.0	10000.0
KIN001-127	KIT(D816V)	100.0	10000.0
WZ3105	PIK3CA(I800L)	100.0	10000.0
Pictilisib	KPCD1	86.0	1000.0
HG-14-8-02	AURKA	100.0	10000.0
TAK-715	M4K3	80.0	10000.0
Taselisib	PFCDPK1(P.falciparum)	72.0	1000.0
GW843682X	VGFR2	76.0	10000.0
GSK1059615	MKNK2	49.0	10000.0
Barasertib	FLT3(N841I)	0.2	10000.0
KIN001-111	JAK3(Kin.Dom.2)	100.0	1000.0
MRT67307	ZAP70	28.0	10000.0
QL-XII-47	M3K2	99.0	1000.0
NVP-TAE684	TNIK	12.0	1000.0
CGP60474	FLT3(ITD)	100.0	10000.0
GW843682X	ACVR1	60.0	10000.0
BGJ398	RSK3(Kin.Dom.1-N-terminal)	90.0	1000.0
Palbociclib	CAMK1B	100.0	1000.0
(s)-CR8	TRKB	100.0	10000.0
XMD-12	NEK3	63.0	1000.0
BMS-536924	TTK	23.0	1000.0
GSK1059615	PIK3CA(E542K)	0.2	10000.0
WZ-7043	AMPK-alpha2	100.0	10000.0
(s)-CR8	EGFR	73.0	10000.0
A443654	MYO3A	100.0	10000.0
BGJ398	KKCC1	67.0	1000.0
JNK-IN-8	CLK4	93.0	1000.0
PD0325901	KPCL	100.0	10000.0
GSK461364	ADCK3	77.0	10000.0
PHA-793887	BUB1	100.0	10000.0
XMD14-99	MARK4	82.0	10000.0
XMD-12	PIK3CA(H1047Y)	82.0	1000.0
JNK-IN-11	MARK3	75.0	1000.0
Pictilisib	ANKK1	100.0	1000.0
AZD-6482	TYK2(JH1domain-catalytic)	82.0	10000.0
BI-D1870	GAK	2.3	10000.0
NG25	CDC2L2	0.2	10000.0
WZ3105	KIT(D816H)	27.0	10000.0
RO-3306	ABL1(F317L)-phosphorylated	93.0	10000.0
AZD4547	EGFR(L747-T751del,Sins)	72.0	10000.0
CP466722	EPHA5	19.0	10000.0
Canertinib	AXL	100.0	1000.0
JNK-IN-8	RPS6KA4(Kin.Dom.2-C-terminal)	74.0	1000.0
Dactolisib	MYLK	100.0	1000.0
Crizotinib	MAP4K4	35.0	10000.0
Torin1	MST1	7.6	10000.0
AZ-628	DCAMKL3	100.0	10000.0
Crizotinib	EGFR(L747-E749del,A750P)	71.0	10000.0
KIN001-123	EPHA8	100.0	1000.0
Dactolisib	TYK2(JH1domain-catalytic)	100.0	1000.0
AS-252424	MP2K3	71.7	10000.0
Lapatinib	ERN1	100.0	10000.0
Seliciclib	INSRR	100.0	10000.0
JW-7-24-1	PIK3CA(E545K)	13.0	10000.0
XMD11-50	CDK14	81.0	10000.0
Pictilisib	PIK3CA(H1047Y)	0.0	1000.0
GW843682X	MUSK	100.0	10000.0
XMD-12	SGK3	100.0	1000.0
Sigma A6730	MYLK4	64.0	10000.0
HG-14-10-04	ERBB4	1.6	10000.0
R406	ROS1	0.2	1000.0
WZ-7043	CAMK2A	100.0	10000.0
XMD-12	DYRK1B	100.0	1000.0
XMD13-2	ABL1-nonphosphorylated	47.0	10000.0
BMS-536924	PAK6	14.0	1000.0
Dabrafenib	CSNK1G3	73.0	10000.0
BMS345541	EPHB1	100.0	10000.0
Torin1	CSNK1A1	93.0	10000.0
ERK5-IN-1	FLT3(K663Q)	100.0	1000.0
Ceritinib	MP2K2	80.0	1000.0
Crizotinib	PHKG1	100.0	10000.0
JNK-9L	CDK4-cyclinD3	12.0	10000.0
NU7441	CHK2	100.0	10000.0
RO-3306	FER	98.0	10000.0
GSK429286A	EPHA4	78.0	10000.0
CGP60474	SRPK3	100.0	10000.0
QL-XI-92	TGFBR2	93.0	10000.0
PD0325901	BTK	87.0	10000.0
Crizotinib	CDK16	96.0	10000.0
ALW-II-38-3	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
GSK429286A	EPHA3	88.0	10000.0
MRT67307	ADCK4	85.0	10000.0
XMD8-85	RPS6KA6(Kin.Dom.1)	100.0	10000.0
Sigma A6730	TYRO3	73.0	10000.0
GSK1059615	TRKC	68.0	10000.0
KIN001-111	MERTK	5.4	1000.0
A443654	PKN1	0.0	10000.0
KU63794	MP2K6	83.0	10000.0
SCH772984	TIE1	100.0	1000.0
CP724714	MP2K4	95.0	10000.0
XMD11-85h	MAP3K15	100.0	10000.0
BGJ398	FGFR3(G697C)	0.0	1000.0
WZ-4-145	EGFR(L858R)	0.2	10000.0
Momelotinib	DAPK3	11.0	10000.0
BGJ398	CAMK2G	88.0	1000.0
Torin2	JAK3(JH1domain-catalytic)	100.0	10000.0
KIN001-021	MARK4	100.0	1000.0
QL-XII-47	NDR1	67.0	1000.0
AZD-6482	PIM3	100.0	10000.0
Barasertib	MLK2	92.0	10000.0
HG-14-10-04	BMPR1B	94.0	10000.0
Lapatinib	PIK3CA(E545A)	100.0	10000.0
NPK76-II-72-1	ABL1(T315I)	100.0	10000.0
KIN001-123	MLTK	100.0	1000.0
5z-7-oxozeaenol	FGFR1	100.0	10000.0
AZD-6482	BMX	85.0	10000.0
RO-3306	RSK3(Kin.Dom.1-N-terminal)	84.0	10000.0
BX-912	ROCK1	0.6	10000.0
THZ1	PKNB(M.tuberculosis)	7.1	10000.0
ZM-447439	MYO3A	79.0	10000.0
HG-5-113-01	ABL1(T315I)	0.0	10000.0
KIN001-021	ABL1(Y253F)	100.0	1000.0
Torkinib	CDK5	100.0	10000.0
Lapatinib	RIPK5	48.0	10000.0
BI-2536	LIMK2	100.0	10000.0
ZG-10	ERN1	70.0	10000.0
Ceritinib	WNK1	100.0	1000.0
Torkinib	MP2K5	0.4	10000.0
XMD8-85	PIK3CA(E542K)	100.0	10000.0
Ceritinib	GRK7	83.0	1000.0
ZSTK474	CLK1	100.0	1000.0
GW843682X	MET(M1250T)	31.0	10000.0
CGP74514A	BRSK2	78.0	10000.0
Dinaciclib	PTK6	79.0	10000.0
Vemurafenib	LYN	16.0	10000.0
PD0325901	CASK	67.0	10000.0
Crizotinib	PKMYT1	100.0	10000.0
ZSTK474	ADCK4	100.0	1000.0
Taselisib	KKCC1	100.0	1000.0
Vemurafenib	MET(M1250T)	25.0	10000.0
PHA-793887	PIM3	100.0	10000.0
Torin1	IRAK4	90.0	10000.0
Crizotinib	KIT(V559D,V654A)	100.0	10000.0
Palbociclib	PAK1	100.0	1000.0
R406	TNK1	0.1	1000.0
Abemaciclib	RAF1	100.0	1000.0
ZM-447439	AURKC	23.0	10000.0
NU7441	PIK3CA(E545K)	24.0	10000.0
BMS-536924	NLK	100.0	1000.0
GW-5074	SgK110	100.0	10000.0
GSK1059615	KPCD3	74.0	10000.0
TGX221	NEK5	100.0	1000.0
Pictilisib	RPS6KA6(Kin.Dom.1)	100.0	10000.0
XMD14-99	PIM3	100.0	10000.0
Omipalisib	WNK1	66.0	10000.0
BS-181	PIK3CA(E545A)	65.0	10000.0
XMD11-50	KGP1	98.0	10000.0
CP466722	PIM3	7.6	10000.0
Seliciclib	PGFRB	87.0	10000.0
5z-7-oxozeaenol	JAK2(JH1domain-catalytic)	95.0	10000.0
XMD13-2	ABL1(F317I)-nonphosphorylated	92.0	10000.0
AZD 5438	KCC2D	43.0	10000.0
XMD14-99	PIP5K2B	100.0	10000.0
AZD7762	MKNK1	6.0	10000.0
Neratinib	KC1G2	84.0	10000.0
BMS345541	CDC2L5	4.7	10000.0
BMS-536924	RIOK2	23.0	1000.0
CP724714	RPS6KA5(Kin.Dom.1-N-terminal)	99.0	10000.0
QL-XI-92	IKKB	90.0	10000.0
AZD7762	MLTK	40.0	10000.0
JNK-IN-8	LTK	100.0	1000.0
ALW-II-38-3	KIT(V559D,T670I)	100.0	10000.0
Pictilisib	PLK1	91.0	1000.0
Palbociclib	M4K1	84.0	1000.0
Lapatinib	JAK3(JH1domain-catalytic)	100.0	10000.0
PLX-4720	ABL1(F317I)-phosphorylated	43.0	10000.0
XMD11-50	EGFR(L747-T751del,Sins)	100.0	10000.0
TGX221	ADCK4	100.0	1000.0
HG-5-113-01	MAPKAPK2	100.0	10000.0
Abemaciclib	JNK3	4.0	1000.0
5z-7-oxozeaenol	PRKX	100.0	10000.0
Torkinib	MK14	95.0	10000.0
WH-4-023	FAK1	32.0	10000.0
PLX-4720	TLK1	58.0	10000.0
NU7441	CDKL2	96.0	10000.0
BX-912	LRRK2	11.0	10000.0
HG-9-91-01	EGFR(L747-S752del,P753S)	1.4	10000.0
MRT67307	FRK	100.0	10000.0
BI-D1870	TTK	7.0	10000.0
BI-2536	RPS6KA6(Kin.Dom.1)	100.0	10000.0
XMD14-99	FAK1	62.0	10000.0
CGP74514A	PIK3CA(E545K)	77.0	10000.0
Pictilisib	ABL1(H396P)-nonphosphorylated	81.0	1000.0
Neratinib	FRK	100.0	10000.0
WYE-125132	JNK3	86.0	10000.0
XMD11-50	TEC	100.0	10000.0
WH-4-023	FGFR1	0.3	10000.0
AZD 5438	EPHA5	54.0	10000.0
Canertinib	DCAMKL2	100.0	1000.0
GSK461364	CSNK2A1	13.0	10000.0
(s)-CR8	RSK1(Kin.Dom.2-C-terminal)	85.0	10000.0
Ceritinib	PIP5K2B	91.0	1000.0
GSK461364	PLK2	2.6	10000.0
GW-5074	ABL1-nonphosphorylated	57.0	10000.0
HG-14-10-04	MLK2	3.6	10000.0
(s)-CR8	EGFR(G719C)	98.0	10000.0
QL-XI-92	IRAK3	100.0	10000.0
HG-14-10-04	CAMK2G	2.0	10000.0
BMX-IN-1	PIK3CA(M1043I)	24.0	10000.0
CH5424802	PIK3CB	97.0	1000.0
GSK429286A	MP2K5	71.0	10000.0
Abemaciclib	MK11	100.0	1000.0
NVP-TAE684	ERK4	100.0	1000.0
Barasertib	RSK1(Kin.Dom.1-N-terminal)	83.0	10000.0
Ibrutinib	ICK	98.0	1000.0
Omipalisib	M3K13	77.0	10000.0
BMS-536924	DAPK3	2.2	1000.0
XMD11-50	CDK8	100.0	10000.0
Ceritinib	MST3	97.0	1000.0
CG-930	DAPK2	100.0	10000.0
WYE-125132	CDK4-cyclinD1	90.0	10000.0
Buparlisib	CSK	100.0	1000.0
BS-181	PKAC-alpha	100.0	10000.0
HG-9-91-01	ABL1-phosphorylated	0.1	10000.0
CP466722	EGFR(T790M)	67.0	10000.0
SB590885	SRC	77.0	10000.0
ERK5-IN-1	YANK3	100.0	1000.0
QL-X-138	RSK1(Kin.Dom.1-N-terminal)	87.0	10000.0
XMD-12	IRAK3	82.0	1000.0
HG-5-113-01	EGFR(S752-I759del)	100.0	10000.0
ALW-II-49-7	PIM1	100.0	10000.0
5z-7-oxozeaenol	PIP5K1A	58.0	10000.0
AZ-628	MTOR	100.0	10000.0
JNK-IN-8	NEK11	99.0	1000.0
AZ-628	IRAK4	83.0	10000.0
AG1478	SIK2	67.0	10000.0
MPS-1-IN-1	CDK2	100.0	1000.0
XMD14-99	CAMK2G	17.0	10000.0
Crizotinib	MUSK	0.3	10000.0
PLX-4720	ADCK3	92.0	10000.0
ALW-II-49-7	EPHA5	1.1	1000.0
BI-D1870	CLK3	3.9	10000.0
Neratinib	ZAP70	87.0	10000.0
JNK-9L	INSR	78.0	10000.0
Dinaciclib	KCC2D	83.0	10000.0
JWE-035	EPHA1	61.0	10000.0
Dabrafenib	MELK	13.0	10000.0
XMD8-92	TXK	100.0	10000.0
JNK-IN-8	ACVR2A	100.0	1000.0
5z-7-oxozeaenol	EPHA1	62.0	10000.0
BX-912	SRPK2	5.4	10000.0
JNK-9L	EPHA5	91.0	10000.0
R406	RPS6KA4(Kin.Dom.2)	0.5	1000.0
HG-5-88-01	PHKG2	13.0	10000.0
Ibrutinib	PLK1	90.0	1000.0
GSK429286A	BMX	97.0	10000.0
HG-9-91-01	RIPK4	88.0	10000.0
BGJ398	CHEK1	100.0	1000.0
THZ1	PIM2	100.0	10000.0
WZ-7043	EPHA4	100.0	10000.0
OTSSP167	CDKL1	2.6	10000.0
PLX-4720	RSK3(Kin.Dom.2-C-terminal)	94.0	10000.0
Taselisib	NEK6	100.0	1000.0
JNK-IN-8	SIK1	100.0	1000.0
QL-XII-47	CAMK2A	95.0	1000.0
SP600125	SRPK2	100.0	10000.0
MRT67307	CDK4-cyclinD1	77.0	10000.0
ZSTK474	ULK2	100.0	1000.0
WZ4003	PAK2	100.0	1000.0
GW-5074	KGP2	83.0	10000.0
Pictilisib	PRKX	100.0	1000.0
A443654	MYLK2	100.0	10000.0
Momelotinib	CDC2L5	91.0	10000.0
AZ-628	CLK4	100.0	10000.0
ZM-447439	WEE2	100.0	10000.0
GSK1059615	NEK5	100.0	10000.0
BI-2536	LTK	24.0	10000.0
AZD-6482	WEE2	100.0	10000.0
Dabrafenib	PIK3CA(M1043I)	100.0	10000.0
Sorafenib	KCC2D	95.0	10000.0
GW843682X	PIK3CA(E545K)	90.0	10000.0
Neratinib	PIK3CA(H1047Y)	78.0	10000.0
JNK-IN-11	PIK3CA(E545A)	100.0	1000.0
Abemaciclib	ERBB3	95.0	1000.0
ZG-10	CSNK1G3	100.0	10000.0
SB590885	ZAP70	100.0	10000.0
CGP74514A	YANK1	3.0	10000.0
WH-4-023	ABL1(F317I)-nonphosphorylated	3.3	10000.0
KU63794	RIPK1	100.0	10000.0
MRT67307	PKMYT1	100.0	10000.0
PHA-767491	DCAMKL2	59.0	10000.0
GW-5074	MYLK4	14.0	10000.0
PLX-4720	KGP2	93.0	10000.0
WH-4-023	CTK	67.0	10000.0
Alpelisib	GCN2(Kin.Dom.2,S808G)	78.0	1000.0
WZ4002	CHEK1	7.0	10000.0
Neratinib	PAK7	72.0	10000.0
Alpelisib	PLK2	100.0	1000.0
Dabrafenib	FLT3-autoinhibited	100.0	10000.0
Seliciclib	KIT(V559D,V654A)	95.0	10000.0
XMD8-92	EPHB1	100.0	10000.0
RO-3306	RSK1(Kin.Dom.2-C-terminal)	65.0	10000.0
ZSTK474	MRCKA	100.0	1000.0
SCH772984	MET(Y1235D)	100.0	1000.0
Neratinib	KPCE	100.0	10000.0
THZ1	IGF1R	0.5	10000.0
TAK-715	YSK1	84.0	10000.0
Taselisib	PAK3	72.0	1000.0
PD0325901	MAPKAPK2	84.0	10000.0
CP724714	MINK	77.0	10000.0
PLX-4720	DAPK3	85.0	10000.0
Vemurafenib	MAP4K4	48.0	10000.0
XMD16-144	AKT1	100.0	10000.0
CGP74514A	FLT3(N841I)	1.8	10000.0
Buparlisib	EGFR(G719S)	87.0	1000.0
BMX-IN-1	MP2K1	65.0	10000.0
ALW-II-38-3	EPHA5	9.1	1000.0
XMD13-2	CAMK1G	75.0	10000.0
HG-5-88-01	ZAP70	100.0	10000.0
ZM-447439	NEK5	100.0	10000.0
XMD-12	AURKC	22.0	1000.0
Momelotinib	BIKE	0.8	10000.0
Ceritinib	STK36	92.0	1000.0
Dinaciclib	GAK	95.0	10000.0
MLN8054	TYK2(JH2domain-pseudokinase)	100.0	10000.0
WH-4-023	CDK15	94.0	10000.0
BMS345541	JAK3(JH1domain-catalytic)	100.0	10000.0
Taselisib	MP2K4	89.0	1000.0
ZM-447439	AAK1	94.0	10000.0
GW843682X	MLTK	74.0	10000.0
KIN001-127	EPHA8	100.0	10000.0
SCH772984	ROCK1	45.0	1000.0
NU7441	MLK1	100.0	10000.0
Sorafenib	FYN	48.0	10000.0
A443654	PAK6	16.0	10000.0
Vemurafenib	TGFBR1	53.0	10000.0
Abemaciclib	MP2K3	6.0	1000.0
JNK-IN-8	NUAK1	100.0	1000.0
BI-2536	KPCD	100.0	10000.0
BX-912	STK35	67.0	10000.0
AZD 5438	MRCKB	100.0	10000.0
HG-9-91-01	EIF2AK1	100.0	10000.0
GSK461364	RIOK2	65.0	10000.0
AG1478	ULK3	24.0	10000.0
Taselisib	KPCD	97.0	1000.0
PD0325901	ERK4	77.0	10000.0
HG-14-8-02	MK11	81.0	10000.0
HG-5-88-01	AXL	8.6	10000.0
THZ1	MST1R	73.0	10000.0
Dinaciclib	RAF1	92.0	10000.0
Dactolisib	CSF1R	100.0	1000.0
ZG-10	BTK	71.0	10000.0
NU7441	MINK	100.0	10000.0
Baricitinib	TTK	5.0	10000.0
XMD-12	MKNK2	8.4	1000.0
WZ3105	ERK4	100.0	10000.0
BI-2536	MAP4K5	100.0	10000.0
Neratinib	KPCT	100.0	10000.0
BGJ398	STK33	79.0	1000.0
HG-5-88-01	EPHB1	100.0	10000.0
Canertinib	EPHA5	100.0	1000.0
XMD11-50	PKN2	95.0	10000.0
Baricitinib	EGFR	87.0	10000.0
GSK461364	TRKA	74.0	10000.0
Canertinib	STK33	100.0	1000.0
Crizotinib	S6K1	1.8	10000.0
Buparlisib	RIPK1	100.0	1000.0
JNK-9L	RET(V804L)	100.0	10000.0
Ribociclib	SIK2	70.0	1000.0
NU7441	GRK1	100.0	10000.0
CGP60474	CDK3	100.0	10000.0
ZSTK474	MK09	100.0	1000.0
Sorafenib	MYO3B	28.0	10000.0
ZG-10	DYRK1A	28.0	10000.0
SCH772984	PKNB(M.tuberculosis)	100.0	1000.0
Abemaciclib	AKT1	100.0	1000.0
Baricitinib	NEK11	86.0	10000.0
THZ1	YSK4	0.8	10000.0
WZ4003	KIT(V559D)	25.0	1000.0
AZD 5438	FRK	74.0	10000.0
JNK-9L	CSNK2A2	11.0	10000.0
CG-930	PIK3CG	100.0	10000.0
JWE-035	EGFR(L747-T751del,Sins)	95.0	10000.0
WZ4003	ACVR1B	100.0	1000.0
Barasertib	ABL1(T315I)-nonphosphorylated	0.6	10000.0
KU63794	SRPK2	100.0	10000.0
GSK461364	HIPK3	37.0	10000.0
QL-XII-47	ABL2	100.0	1000.0
Dabrafenib	M3K13	84.0	10000.0
ZG-10	KPCD	100.0	10000.0
HG-5-88-01	PIP5K1A	100.0	10000.0
CG-930	CSNK1D	83.0	10000.0
JNK-IN-8	SYK	100.0	1000.0
PLX-4720	PLK3	96.0	10000.0
HG-14-10-04	SRPK2	6.8	10000.0
JNK-IN-8	PIK3C2G	81.0	1000.0
JWE-035	PLK3	100.0	10000.0
Ceritinib	SIK2	80.0	1000.0
QL-X-138	RET(V804L)	79.0	10000.0
Lapatinib	PAK7	86.0	10000.0
Abemaciclib	IRAK4	99.0	1000.0
Sigma A6730	CSNK2A1	96.0	10000.0
KIN001-021	EGFR(L861Q)	100.0	1000.0
WZ4002	HIPK1	100.0	10000.0
HG-5-88-01	EPHA1	15.0	10000.0
XMD16-144	CLK1	50.0	10000.0
AZD7762	CLK4	2.4	10000.0
PD173074	DDR2	100.0	10000.0
WZ-4-145	WEE1	100.0	10000.0
R406	NEK5	0.1	1000.0
5z-7-oxozeaenol	LIMK1	84.0	10000.0
PHA-793887	CDC2L2	98.0	10000.0
Dinaciclib	EPHA2	96.0	10000.0
PHA-793887	FLT3(D835Y)	58.0	10000.0
MPS-1-IN-1	BLK	100.0	1000.0
Sorafenib	PKAC-beta	100.0	10000.0
Ibrutinib	FGFR4	84.0	1000.0
WZ-7043	CDK7	100.0	10000.0
MRT67307	PIK3CG	76.0	10000.0
PLX-4720	ACVR2A	100.0	10000.0
AZD-6482	CDKL5	74.0	10000.0
ZM-447439	YSK4	23.0	10000.0
NPK76-II-72-1	EPHB3	100.0	10000.0
Baricitinib	HCK	29.0	10000.0
KIN001-123	TLK2	100.0	1000.0
Torin2	MK03	100.0	10000.0
CGP74514A	CDK7	0.1	10000.0
PHA-767491	PCTK3	96.0	10000.0
XMD13-2	ABL1(F317L)-phosphorylated	100.0	10000.0
PHA-793887	MERTK	52.0	10000.0
WH-4-023	ANKK1	100.0	10000.0
GSK429286A	TGFBR2	85.0	10000.0
(s)-CR8	EGFR(E746-A750del)	82.0	10000.0
XMD13-2	FLT3(D835Y)	15.0	10000.0
WZ-4-145	PAK2	100.0	10000.0
Dinaciclib	CAMK1G	85.0	10000.0
CGP60474	AURKC	100.0	10000.0
CH5424802	ABL1-phosphorylated	73.0	1000.0
BGJ398	RIOK1	66.0	1000.0
AZD-6482	TBK1	100.0	10000.0
PHA-767491	ERBB4	85.0	10000.0
QL-XII-47	HIPK2	66.0	1000.0
NPK76-II-72-1	MST4	100.0	10000.0
THZ1	ACVR1	65.0	10000.0
CP466722	BIKE	7.1	10000.0
WZ-4-145	DCAMKL3	100.0	10000.0
AZD 5438	NEK9	81.0	10000.0
Abemaciclib	TGFBR2	100.0	1000.0
AZ-628	GSK3A	100.0	10000.0
ZM-447439	MAPKAPK5	100.0	10000.0
Torin2	MUSK	100.0	10000.0
Dabrafenib	ROCK2	94.0	10000.0
HG-5-88-01	AKT2	100.0	10000.0
AZD4547	TRKB	0.1	10000.0
KU63794	EPHA8	80.0	10000.0
Canertinib	EGFR(S752-I759del)	0.0	1000.0
ZM-447439	CDKL3	100.0	10000.0
Dinaciclib	MK12	78.0	10000.0
TAK-715	MAPKAPK5	100.0	10000.0
WZ4002	CDK3	100.0	10000.0
Dinaciclib	EPHB1	86.0	10000.0
BI-2536	RPS6KA1(Kin.Dom.2)	21.0	10000.0
PHA-793887	CDK5	1.9	10000.0
SCH772984	DYRK1A	60.0	1000.0
PHA-793887	FGFR2	82.0	10000.0
JW-7-24-1	MP2K2	100.0	10000.0
Canertinib	NEK6	100.0	1000.0
Dinaciclib	BUB1	97.0	10000.0
CP466722	FAK1	80.0	10000.0
(s)-CR8	M3K5	74.0	10000.0
Vemurafenib	MARK4	100.0	10000.0
AZ-628	FGFR3	100.0	10000.0
Ibrutinib	ABL1(Y253F)-phosphorylated	62.0	1000.0
NVP-TAE684	TYK2(Kin.Dom.1)	11.0	1000.0
ALW-II-38-3	VGFR1	100.0	10000.0
Dactolisib	DMPK2	100.0	1000.0
JW-7-24-1	MERTK	29.0	10000.0
RO-3306	ROCK1	9.8	10000.0
QL-XII-47	PAK2	100.0	1000.0
WZ4002	PIK3CG	100.0	10000.0
R406	SYK	0.3	1000.0
GW843682X	AMPK-alpha1	68.0	10000.0
Vemurafenib	SYK	66.0	10000.0
KU63794	RIOK3	100.0	10000.0
GW-5074	ERK4	100.0	10000.0
Ceritinib	GRK4	72.0	1000.0
JNK-IN-8	STK36	91.0	1000.0
JWE-035	DYRK1B	68.0	10000.0
TGX221	CLK3	100.0	1000.0
XMD16-144	TYK2(JH2domain-pseudokinase)	18.0	10000.0
Dactolisib	MAP4K5	100.0	1000.0
HG-9-91-01	MP2K5	0.8	10000.0
Palbociclib	CASK	69.0	1000.0
XMD16-144	CDK9	100.0	10000.0
OTSSP167	PIK3CA(C420R)	3.0	10000.0
PHA-793887	PKAC-beta	100.0	10000.0
THZ1	PIK3C2G	40.0	10000.0
BMX-IN-1	AURKB	75.0	10000.0
CGP74514A	ABL1(Q252H)-nonphosphorylated	0.4	10000.0
Momelotinib	RSK3(Kin.Dom.1-N-terminal)	100.0	10000.0
Seliciclib	BMX	100.0	10000.0
Dactolisib	CDK5	100.0	1000.0
CG-930	GRK7	86.0	10000.0
GW843682X	VGFR1	58.0	10000.0
RO-3306	WEE2	100.0	10000.0
CGP74514A	RIOK1	100.0	10000.0
JNK-IN-11	CDK7	83.0	1000.0
AG1478	SNRK	71.0	10000.0
ERK5-IN-1	MK13	100.0	1000.0
ALW-II-49-7	TIE1	100.0	10000.0
Ceritinib	EGFR(L747-S752del,P753S)	55.0	1000.0
CH5424802	PIM2	12.0	1000.0
Ibrutinib	MET(M1250T)	89.0	1000.0
XMD8-85	TESK1	100.0	10000.0
JW-7-24-1	IKKA	19.0	10000.0
HG-5-88-01	ABL1(M351T)	100.0	10000.0
HG-9-91-01	LATS1	56.0	10000.0
CGP74514A	CSNK1D	14.0	10000.0
AG1478	HUNK	69.0	10000.0
WYE-125132	RSK3(Kin.Dom.2-C-terminal)	93.0	10000.0
QL-XI-92	NLK	93.0	10000.0
HG-14-8-02	MARK2	56.0	10000.0
Lapatinib	KIT(V559D)	91.0	10000.0
HG-9-91-01	FLT3	56.0	10000.0
RO-3306	DDR1	100.0	10000.0
HG-5-88-01	RIOK3	100.0	10000.0
XMD14-99	BMX	82.0	10000.0
AZD 5438	CDC2L5	13.0	10000.0
HG-14-10-04	MAPKAPK2	100.0	10000.0
Ceritinib	KC1G1	95.0	1000.0
A443654	MAP3K3	29.0	10000.0
PD173074	EPHA8	100.0	10000.0
NPK76-II-72-1	KGP2	100.0	10000.0
JW-7-24-1	MK01	100.0	10000.0
BX-912	ABL1(E255K)-phosphorylated	0.2	10000.0
THZ1	PIK3CA(E545A)	70.0	10000.0
NVP-TAE684	ABL1(E255K)	19.0	1000.0
Buparlisib	FGFR2	100.0	1000.0
PLX-4720	MAK	71.0	10000.0
WH-4-023	MP2K5	0.6	10000.0
GW843682X	EPHB2	94.0	10000.0
Omipalisib	FLT3(ITD)	93.0	10000.0
Torin2	MAP4K2	68.0	10000.0
Momelotinib	ULK2	60.0	10000.0
WZ4003	FAK2	18.0	1000.0
WZ4003	VGFR1	100.0	1000.0
CGP74514A	WNK1	72.0	10000.0
JNK-IN-11	RIPK5	80.0	1000.0
HG-9-91-01	CSF1R	0.6	10000.0
NU7441	CSF1R	100.0	10000.0
XMD8-92	RET(V804L)	100.0	10000.0
WZ4003	TYK2(Kin.Dom.2)	100.0	1000.0
JWE-035	EGFR(L861Q)	98.0	10000.0
MLN8054	TAOK2	94.0	10000.0
JNK-IN-5A	M4K3	79.0	10000.0
Ibrutinib	PIP5K1A	97.0	1000.0
AZD-6482	MLK3	100.0	10000.0
AZD7762	PFCDPK1(P.falciparum)	0.1	10000.0
Neratinib	ABL1(H396P)-nonphosphorylated	79.0	10000.0
Ibrutinib	BRSK1	100.0	1000.0
QL-XI-92	KC1G1	100.0	10000.0
QL-XII-47	CDK4-cyclinD1	94.0	1000.0
NVP-TAE684	M4K1	3.2	1000.0
Ceritinib	NEK1	90.0	1000.0
JW-7-24-1	TYK2(Kin.Dom.2)	100.0	10000.0
ALW-II-38-3	ROCK1	100.0	10000.0
JNK-IN-8	GRK7	72.0	1000.0
PD0325901	WEE2	77.0	10000.0
WZ-7043	MUSK	100.0	10000.0
Barasertib	ABL1(Y253F)-phosphorylated	28.0	10000.0
AS-252424	MARK2	100.0	10000.0
HG-14-10-04	MK03	100.0	10000.0
Vemurafenib	TNNI3K	65.0	10000.0
XMD11-85h	MYO3A	100.0	10000.0
XMD13-2	KC1G2	94.0	10000.0
Dabrafenib	GAK	1.6	10000.0
Seliciclib	MAP4K2	98.0	10000.0
BS-181	BRSK1	94.0	10000.0
Abemaciclib	EGFR(E746-A750del)	76.0	1000.0
KIN001-111	YANK2	100.0	1000.0
Omipalisib	DYRK2	100.0	10000.0
XMD16-144	STK16	8.4	10000.0
AZD 5438	TNNI3K	47.0	10000.0
CP466722	KPCD1	88.0	10000.0
Dabrafenib	RIPK4	65.0	10000.0
TGX221	SRC	100.0	1000.0
NPK76-II-72-1	TAK1	100.0	10000.0
BI-D1870	PIP5K1A	0.7	10000.0
R406	BMPR2	100.0	1000.0
Buparlisib	IKKB	100.0	1000.0
BX-912	ABL1(T315I)-nonphosphorylated	0.0	10000.0
NPK76-II-72-1	RIPK1	100.0	10000.0
WZ-4-145	CSNK1D	100.0	10000.0
AZD4547	STK33	14.0	10000.0
WH-4-023	PIK3CD	92.0	10000.0
GW843682X	MYO3A	81.0	10000.0
CP724714	TBK1	90.0	10000.0
(s)-CR8	RIPK1	87.0	10000.0
BX-912	PRP4	5.3	10000.0
Torkinib	MAP4K5	72.0	10000.0
Sigma A6730	EPHA1	100.0	10000.0
Momelotinib	PIK3CB	100.0	10000.0
PLX-4720	EPHA6	100.0	10000.0
BGJ398	PHKG1	97.0	1000.0
Alpelisib	EPHA7	100.0	1000.0
Dactolisib	PAK4	100.0	1000.0
HG-5-88-01	LATS1	100.0	10000.0
GSK1059615	PIK3CD	4.8	10000.0
CG-930	RSK2(Kin.Dom.1-N-terminal)	60.0	10000.0
Momelotinib	ABL1(E255K)-phosphorylated	29.0	10000.0
WYE-125132	EGFR(G719S)	69.0	10000.0
CGP74514A	ULK1	0.3	10000.0
GSK1059615	ANKK1	47.0	10000.0
PLX-4720	STK35	100.0	10000.0
QL-X-138	EPHA4	97.0	10000.0
ALW-II-49-7	PIK3CG	100.0	10000.0
Ceritinib	CAMKK2	15.0	1000.0
THZ1	BLK	0.5	10000.0
BS-181	DDR2	95.0	10000.0
SP600125	MST2	100.0	10000.0
WZ3105	PLK1	21.0	10000.0
GW-5074	MARK2	44.0	10000.0
CP724714	SBK1	100.0	10000.0
BGJ398	PCTK2	100.0	1000.0
BMS-536924	FLT4	1.8	1000.0
XMD11-50	MK09	94.0	10000.0
BS-181	RSK1(Kin.Dom.1-N-terminal)	64.0	10000.0
KU63794	RSK4(Kin.Dom.2-C-terminal)	93.0	10000.0
WZ-7043	ABL2	100.0	10000.0
KIN001-127	KPCE	100.0	10000.0
AZ-628	AURKA	100.0	10000.0
Momelotinib	OSR1	58.0	10000.0
ZSTK474	TESK1	100.0	1000.0
QL-X-138	HIPK1	52.0	10000.0
JNK-IN-8	PAK7	88.0	1000.0
QL-XI-92	EPHB1	79.0	10000.0
TAK-715	KKCC1	100.0	10000.0
Sorafenib	ADCK3	100.0	10000.0
OTSSP167	ZAP70	31.0	10000.0
MLN8054	PIK3C2G	16.0	10000.0
AG1478	CAMKK2	72.0	10000.0
CGP74514A	STK16	34.0	10000.0
WZ4002	EPHA1	100.0	10000.0
A443654	MLK3	100.0	10000.0
JNK-IN-5A	ABL1(F317I)-phosphorylated	100.0	10000.0
GSK429286A	EPHA8	71.0	10000.0
JNK-IN-11	RSK4(Kin.Dom.2-C-terminal)	13.0	1000.0
BGJ398	RIOK3	62.0	1000.0
BI-2536	MLK1	100.0	10000.0
HG-14-8-02	RIOK1	33.0	10000.0
AZ-628	PIP5K2B	100.0	10000.0
KU63794	PRKR	100.0	10000.0
CGP74514A	RSK2(Kin.Dom.1-N-terminal)	1.6	10000.0
CGP60474	NEK1	100.0	10000.0
HG-14-10-04	JAK3(JH1domain-catalytic)	0.0	10000.0
Torin2	YANK1	100.0	10000.0
ZSTK474	GCN2(Kin.Dom.2,S808G)	100.0	1000.0
Baricitinib	PAK2	80.0	10000.0
ERK5-IN-1	MYO3B	100.0	1000.0
SP600125	SIK1	100.0	10000.0
Palbociclib	MST3	100.0	1000.0
(s)-CR8	MST1R	98.0	10000.0
XMD8-85	ABL1(Q252H)	100.0	10000.0
CGP74514A	PIK3C2B	59.0	10000.0
MLN8054	BLK	0.7	10000.0
Alpelisib	FGFR2	97.0	1000.0
WYE-125132	CAMK2A	100.0	10000.0
BS-181	SIK2	99.0	10000.0
JNK-IN-8	MK09	0.0	1000.0
BGJ398	KIT	25.0	1000.0
(s)-CR8	AMPK-alpha2	100.0	10000.0
XMD8-92	PKN1	100.0	10000.0
Sigma A6730	SYK	84.0	10000.0
GSK461364	ACVR2B	100.0	10000.0
Neratinib	FES	37.0	10000.0
Torkinib	MLK3	79.0	10000.0
XMD11-85h	KCC4	100.0	10000.0
AZD7762	PI42C	87.0	10000.0
MLN8054	RET	59.0	10000.0
AZD7762	ADCK3	93.0	10000.0
WZ3105	PRKX	100.0	10000.0
WZ4002	LOK	100.0	10000.0
Vemurafenib	KIT(V559D,T670I)	60.0	10000.0
Vemurafenib	CDK16	96.0	10000.0
Barasertib	YSK1	66.0	10000.0
AG1478	CTK	48.0	10000.0
PHA-767491	RPS6KA5(Kin.Dom.1-N-terminal)	79.0	10000.0
Abemaciclib	YANK3	96.0	1000.0
CH5424802	FLT3(D835Y)	0.7	1000.0
HG-14-8-02	ABL1-phosphorylated	53.0	10000.0
TGX221	PLK3	100.0	1000.0
XMD11-50	GAK	16.0	10000.0
JNK-IN-11	SGK3	91.0	1000.0
ERK5-IN-1	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	1000.0
KIN001-123	ERBB2	100.0	1000.0
R406	MLTK	32.0	1000.0
QL-X-138	KPCE	100.0	10000.0
TAK-715	MAP3K3	92.0	10000.0
NVP-TAE684	ABL1(F317L)	0.7	1000.0
ZSTK474	PAK2	100.0	1000.0
QL-X-138	EPHB6	54.0	10000.0
Dabrafenib	MP2K2	47.0	10000.0
Buparlisib	AURKB	98.0	1000.0
JNK-IN-11	FLT3	1.0	1000.0
ALW-II-49-7	ABL1(T315I)	100.0	10000.0
GW843682X	YANK3	100.0	10000.0
AZD-6482	YANK1	89.0	10000.0
TGX221	KGP2	100.0	1000.0
GW843682X	ABL1(H396P)-nonphosphorylated	16.0	10000.0
TGX221	KPCD	100.0	1000.0
Neratinib	ERK4	100.0	10000.0
5z-7-oxozeaenol	HIPK4	82.0	10000.0
Barasertib	INSRR	76.0	10000.0
Baricitinib	CDK8	74.0	10000.0
HG-9-91-01	HIPK4	100.0	10000.0
XMD13-2	IKKB	78.0	10000.0
PD0325901	RSK1(Kin.Dom.1-N-terminal)	100.0	10000.0
A443654	STK16	100.0	10000.0
Ceritinib	DRAK1	100.0	1000.0
GSK429286A	PIK4CB	100.0	10000.0
HG-14-10-04	KGP1	25.0	10000.0
Ibrutinib	TAOK2	82.0	1000.0
A443654	LKB1	30.0	10000.0
Omipalisib	EPHA3	80.0	10000.0
GSK429286A	FGR	78.0	10000.0
BMS345541	CDC2L1	1.0	10000.0
XMD13-2	FGFR1	100.0	10000.0
ERK5-IN-1	CTK	89.0	1000.0
Torkinib	PIK3CA(C420R)	30.0	10000.0
Sigma A6730	MUSK	100.0	10000.0
GSK1059615	HIPK3	1.2	10000.0
ZG-10	RSK1(Kin.Dom.1-N-terminal)	91.0	10000.0
XMD8-85	MAST1	100.0	10000.0
KIN001-127	ABL2	100.0	10000.0
ALW-II-49-7	EGFR(S752-I759del)	100.0	10000.0
OTSSP167	PLK2	2.2	10000.0
Abemaciclib	EGFR(L747-S752del,P753S)	68.0	1000.0
Torin1	PIK3CA(M1043I)	8.6	10000.0
Pictilisib	RPS6KA1(Kin.Dom.2)	100.0	10000.0
KIN001-123	TLK1	100.0	1000.0
Lapatinib	MST1R	90.0	10000.0
CG-930	PIK3CA(C420R)	100.0	10000.0
XMD16-144	PAK1	91.0	10000.0
KIN001-220	MST3	32.0	10000.0
PD0325901	PKN2	100.0	10000.0
BS-181	MP2K7	100.0	10000.0
Taselisib	FGFR2	99.0	1000.0
Momelotinib	PI42C	54.0	10000.0
JNK-IN-8	SLK	100.0	1000.0
KIN001-021	FGFR2	100.0	1000.0
WH-4-023	AMPK-alpha2	7.9	10000.0
ERK5-IN-1	GRK7	100.0	1000.0
XMD8-92	MAST1	100.0	10000.0
AZD-6482	S6K1	72.0	10000.0
WZ3105	DAPK1	29.0	10000.0
5z-7-oxozeaenol	MARK2	96.0	10000.0
CH5424802	DDR1	96.0	1000.0
PD0325901	KPCD1	100.0	10000.0
Dactolisib	RET(V804L)	100.0	1000.0
CH5424802	BRSK2	100.0	1000.0
XMD11-50	FGFR4	28.0	10000.0
Barasertib	CLK4	36.0	10000.0
XMD16-144	RSK1(Kin.Dom.1-N-terminal)	67.0	10000.0
Torkinib	ABL1(M351T)-phosphorylated	1.2	10000.0
QL-X-138	ERK3	95.0	10000.0
GSK1059615	RET(V804M)	96.0	10000.0
JNK-IN-11	BRAF	43.0	1000.0
XMD-12	LIMK1	97.0	1000.0
XMD14-99	PI42C	46.0	10000.0
XMD-12	PIP5K1A	100.0	1000.0
Crizotinib	KPCL	100.0	10000.0
KIN001-111	TAOK3	100.0	1000.0
Omipalisib	JAK1(JH1domain-catalytic)	79.0	10000.0
Momelotinib	EGFR(L858R,T790M)	44.0	10000.0
Vemurafenib	MLK2	73.0	10000.0
Sorafenib	NEK9	79.0	10000.0
PLX-4720	M3K13	100.0	10000.0
KIN001-123	CDK14	100.0	1000.0
AZD4547	CSNK1E	50.0	10000.0
NU7441	FER	100.0	10000.0
ALW-II-38-3	MST1	100.0	10000.0
MLN8054	PHKG2	73.0	10000.0
BI-2536	EGFR(S752-I759del)	30.0	10000.0
XMD-12	BIKE	43.0	1000.0
RO-3306	KPCD3	36.0	10000.0
AZD4547	TTK	64.0	10000.0
JNK-IN-11	SRMS	87.0	1000.0
XMD-12	CDK9	100.0	1000.0
WH-4-023	MRCKA	16.0	10000.0
BGJ398	RSK2(Kin.Dom.1-N-terminal)	91.0	1000.0
BX-912	NEK2	6.2	10000.0
SB590885	HIPK2	19.0	10000.0
HG-9-91-01	TBK1	78.0	10000.0
GSK429286A	SLK	100.0	10000.0
Buparlisib	AMPK-alpha2	100.0	1000.0
Torin1	PAK2	100.0	10000.0
Taselisib	ULK2	97.0	1000.0
CP466722	ABL2	33.0	10000.0
PD0325901	MLTK	88.0	10000.0
GSK429286A	FES	95.0	10000.0
AZD 5438	STK36	2.5	10000.0
BX-912	MAP3K1	34.0	10000.0
BGJ398	EGFR(L858R)	82.0	1000.0
XMD11-50	LOK	100.0	10000.0
NG25	BMPR1B	100.0	10000.0
Vemurafenib	MKNK2	65.0	10000.0
QL-XII-47	KPCD1	100.0	1000.0
Barasertib	EPHB3	100.0	10000.0
ZM-447439	CDC2L2	6.9	10000.0
JNK-IN-8	EPHB2	100.0	1000.0
Ibrutinib	HASP	75.0	1000.0
Dactolisib	TNNI3K	100.0	1000.0
NVP-TAE684	MK03	0.1	1000.0
Abemaciclib	STK39	31.0	1000.0
RO-3306	RSK3(Kin.Dom.2-C-terminal)	29.0	10000.0
PHA-793887	EGFR(L858R)	80.0	10000.0
Taselisib	EGFR(G719C)	97.0	1000.0
TGX221	MYLK2	100.0	1000.0
MPS-1-IN-1	ABL1(E255K)	100.0	1000.0
AZD-6482	DMPK2	100.0	10000.0
Dinaciclib	RSK4(Kin.Dom.2-C-terminal)	68.0	10000.0
JNK-IN-5A	PKN2	81.0	10000.0
KIN001-127	AMPK-alpha1	100.0	10000.0
ZG-10	SRMS	85.0	10000.0
PHA-793887	CSF1R	97.0	10000.0
Vemurafenib	EGFR(E746-A750del)	95.0	10000.0
Lapatinib	PHKG2	100.0	10000.0
ZG-10	RET	79.0	10000.0
MRT67307	GRK4	2.0	10000.0
CG-930	TEC	100.0	10000.0
PHA-767491	EPHA6	97.0	10000.0
Ceritinib	M3K12	94.0	1000.0
A443654	EPHA3	100.0	10000.0
AG1478	CDK9	100.0	10000.0
Ibrutinib	CDK14	81.0	1000.0
QL-XI-92	PIK3CA(E545A)	86.0	10000.0
HG-5-113-01	KPCD3	100.0	10000.0
QL-X-138	LCK	64.0	10000.0
CG-930	FGFR3(G697C)	82.0	10000.0
MRT67307	BTK	83.0	10000.0
Ibrutinib	TXK	1.4	1000.0
Sigma A6730	ROS1	50.0	10000.0
ERK5-IN-1	PKN2	100.0	1000.0
HG-14-10-04	PDPK1	39.0	10000.0
MLN8054	MK13	100.0	10000.0
KU63794	MET(Y1235D)	100.0	10000.0
MPS-1-IN-1	RET(M918T)	100.0	1000.0
QL-X-138	CDK16	97.0	10000.0
HG-14-10-04	PIK3CD	95.0	10000.0
THZ1	BMPR1A	77.0	10000.0
NPK76-II-72-1	KCC2D	100.0	10000.0
Momelotinib	CSNK1A1	81.0	10000.0
BMX-IN-1	IRAK4	100.0	10000.0
HG-5-88-01	YSK1	100.0	10000.0
Torkinib	CDC2L5	100.0	10000.0
JNK-IN-5A	ABL1(E255K)-phosphorylated	100.0	10000.0
Ceritinib	PKNB(M.tuberculosis)	93.0	1000.0
NVP-TAE684	DCAMKL3	0.0	1000.0
Lapatinib	YES	74.0	10000.0
JNK-IN-5A	AMPK-alpha1	80.0	10000.0
(s)-CR8	JNK1	59.0	10000.0
TGX221	ITK	100.0	1000.0
Omipalisib	NDR2	66.0	10000.0
Alpelisib	MK03	100.0	1000.0
Seliciclib	FER	100.0	10000.0
OTSSP167	ACVR2B	70.0	10000.0
THZ1	CDK4-cyclinD3	25.0	10000.0
SCH772984	PIK4CB	100.0	1000.0
SP600125	PAK3	100.0	10000.0
Neratinib	FLT3(N841I)	64.0	10000.0
BI-D1870	CSF1R	4.8	10000.0
HG-14-8-02	LKB1	97.0	10000.0
BMS345541	CDK4-cyclinD1	58.0	10000.0
PHA-767491	CDKL5	4.5	10000.0
XMD16-144	KPCD	100.0	10000.0
Ceritinib	BTK	87.0	1000.0
XMD13-2	MELK	64.0	10000.0
QL-X-138	CSNK1G3	84.0	10000.0
Alpelisib	CSNK1A1L	99.0	1000.0
JW-7-24-1	CDK5	100.0	10000.0
HG-14-8-02	MP2K5	1.2	10000.0
XMD8-92	CDK16	100.0	10000.0
Taselisib	CAMK1B	98.0	1000.0
WZ4002	ABL1	100.0	10000.0
R406	MAP4K2	28.0	1000.0
XMD-12	SRPK1	100.0	1000.0
HG-5-88-01	MELK	100.0	10000.0
Pictilisib	HCK	99.0	1000.0
ERK5-IN-1	CDK14	100.0	1000.0
PD0325901	EGFR(L858R,T790M)	100.0	10000.0
BGJ398	KPCE	77.0	1000.0
NVP-TAE684	PIM2	100.0	1000.0
AS-252424	AKT2	100.0	10000.0
GSK1059615	CSNK2A2	1.2	10000.0
GSK429286A	TNNI3K	78.0	10000.0
Sorafenib	FLT4	0.0	10000.0
GSK1059615	CDK3	87.0	10000.0
ERK5-IN-1	KIT	100.0	1000.0
NVP-TAE684	MUSK	0.4	1000.0
AZD-6482	MST2	66.0	10000.0
WYE-125132	IGF1R	93.0	10000.0
Sigma A6730	CDKL5	86.0	10000.0
ZG-10	MP2K5	41.0	10000.0
WZ3105	MP2K5	59.0	10000.0
PD0325901	EGFR(L861Q)	62.0	10000.0
Lapatinib	FLT3(ITD)	97.0	10000.0
BMS345541	KPCD3	41.0	10000.0
CG-930	MAP4K5	100.0	10000.0
Barasertib	NEK6	99.0	10000.0
Lapatinib	MLK3	99.0	10000.0
WYE-125132	EGFR(L747-T751del,Sins)	50.0	10000.0
AZ-628	EPHB2	0.0	10000.0
SP600125	JNK3	7.2	10000.0
Alpelisib	CAMK2B	98.0	1000.0
Abemaciclib	PIM2	8.9	1000.0
TGX221	RIPK4	100.0	1000.0
BGJ398	ABL1(Q252H)-nonphosphorylated	28.0	1000.0
PHA-793887	DYRK1A	11.0	10000.0
NPK76-II-72-1	NEK9	100.0	10000.0
ALW-II-49-7	DDR1	0.1	1000.0
BMX-IN-1	FGR	79.0	10000.0
Abemaciclib	CAMK2B	0.4	1000.0
AZD7762	FGFR4	13.0	10000.0
KIN001-123	NEK9	100.0	1000.0
Seliciclib	ALK(C1156Y)	25.0	10000.0
Torin2	PIK3CA	0.6	10000.0
RO-3306	EGFR(L858R)	79.0	10000.0
QL-XII-47	FGFR3(G697C)	100.0	1000.0
XMD8-92	RPS6KA1(Kin.Dom.2)	28.0	10000.0
Neratinib	JAK2(JH1domain-catalytic)	63.0	10000.0
Dactolisib	PIK3C2B	2.8	1000.0
XMD14-99	M3K13	100.0	10000.0
Barasertib	ERK8	100.0	10000.0
Pictilisib	LYN	100.0	1000.0
KIN001-021	EPHA4	100.0	1000.0
Neratinib	PI42C	100.0	10000.0
JNK-IN-5A	EPHA5	89.0	10000.0
QL-XI-92	ULK1	100.0	10000.0
PHA-767491	NEK4	92.0	10000.0
KIN001-021	AXL	100.0	1000.0
SCH772984	ERK5	96.0	1000.0
Ceritinib	HIPK4	74.0	1000.0
Ceritinib	PLK1	68.0	1000.0
BMS345541	ABL1(M351T)-phosphorylated	100.0	10000.0
AZD7762	ERBB2	0.0	10000.0
WZ4003	BRAF	100.0	1000.0
CGP60474	CDKL5	9.4	10000.0
SCH772984	KIT(D816V)	60.0	1000.0
Sigma A6730	BMPR2	88.0	10000.0
AZD 5438	CTK	72.0	10000.0
Torkinib	TRKC	49.0	10000.0
Dabrafenib	CDC2L5	3.1	10000.0
XMD11-85h	FES	100.0	10000.0
5z-7-oxozeaenol	TESK1	86.0	10000.0
QL-XII-47	EGFR(L747-T751del,Sins)	62.0	1000.0
KIN001-220	MAPKAPK2	100.0	10000.0
Dabrafenib	MP2K5	0.3	10000.0
JNK-IN-11	CSNK1E	0.0	1000.0
MPS-1-IN-1	DCLK1	100.0	1000.0
KIN001-021	M3K12	100.0	1000.0
Dinaciclib	GRK7	68.0	10000.0
SCH772984	MAP3K3	100.0	1000.0
Palbociclib	GSK3B	100.0	1000.0
WYE-125132	WEE2	100.0	10000.0
HG-5-113-01	MARK4	4.0	10000.0
HG-5-113-01	TAOK1	0.7	10000.0
CGP74514A	JAK2(JH1domain-catalytic)	14.0	10000.0
OTSSP167	MST2	100.0	10000.0
MPS-1-IN-1	EGFR(G719C)	100.0	1000.0
ZG-10	MARK1	70.0	10000.0
GW843682X	PKN2	39.0	10000.0
JNK-9L	PIK3CA(E545K)	100.0	10000.0
XMD8-92	JAK3(JH1domain-catalytic)	100.0	10000.0
WYE-125132	CDK16	100.0	10000.0
BGJ398	YANK2	95.0	1000.0
WZ4003	FRK	31.0	1000.0
THZ1	KIT(D816H)	100.0	10000.0
WZ-7043	MAST1	100.0	10000.0
JWE-035	CSNK1A1	16.0	10000.0
Sorafenib	TAOK1	23.0	10000.0
CP466722	CSF1R	52.0	10000.0
GSK1059615	MK01	100.0	10000.0
XMD-12	PLK3	97.0	1000.0
Palbociclib	TNNI3K	100.0	1000.0
BGJ398	M3K13	51.0	1000.0
SP600125	FES	100.0	10000.0
PD173074	KC1G2	100.0	10000.0
AZD-6482	HIPK1	100.0	10000.0
ZSTK474	TYK2(Kin.Dom.2)	100.0	1000.0
AZD7762	FRK	0.7	10000.0
JNK-9L	ABL1(F317I)-phosphorylated	100.0	10000.0
Lapatinib	NEK2	80.0	10000.0
GSK461364	MET	76.0	10000.0
BI-2536	CDC2L1	100.0	10000.0
Dactolisib	RET(V804M)	100.0	1000.0
Momelotinib	ROCK1	2.9	10000.0
5z-7-oxozeaenol	PKMYT1	97.0	10000.0
ERK5-IN-1	CHEK1	100.0	1000.0
5z-7-oxozeaenol	EGFR(L747-T751del,Sins)	89.0	10000.0
MRT67307	CDK3	91.0	10000.0
WZ4002	M3K12	100.0	10000.0
AZD4547	TYK2(JH2domain-pseudokinase)	96.0	10000.0
5z-7-oxozeaenol	PIK3CA	100.0	10000.0
Torin2	MAP4K5	100.0	10000.0
KU63794	IKKA	72.0	10000.0
KIN001-111	PIP5K2B	100.0	1000.0
Pictilisib	EPHB4	96.0	1000.0
Baricitinib	JAK2(JH1domain-catalytic)	0.3	10000.0
Torin1	OSR1	100.0	10000.0
ALW-II-49-7	YES	100.0	10000.0
Seliciclib	YANK1	100.0	10000.0
ALW-II-38-3	M3K12	100.0	10000.0
XMD8-92	TGFBR2	100.0	10000.0
JNK-IN-8	EPHA6	100.0	1000.0
KIN001-127	EGFR(L747-S752del,P753S)	100.0	10000.0
GW843682X	DCAMKL2	99.0	10000.0
(s)-CR8	CSK	100.0	10000.0
Lapatinib	CDK8	75.0	10000.0
MLN8054	M3K6	99.0	10000.0
NPK76-II-72-1	FLT3(K663Q)	100.0	10000.0
WH-4-023	JAK3(JH1domain-catalytic)	0.3	10000.0
CP466722	FGFR3(G697C)	100.0	10000.0
XMD8-85	MERTK	100.0	10000.0
KIN001-127	FGFR4	100.0	10000.0
PD173074	MST2	100.0	10000.0
Alpelisib	M3K5	90.0	1000.0
HG-14-10-04	PKAC-beta	18.0	10000.0
Baricitinib	FAK2	58.0	10000.0
KU63794	PLK3	92.0	10000.0
HG-5-88-01	FAK1	0.0	10000.0
CGP74514A	CDK11	100.0	10000.0
ZSTK474	IKKE	100.0	1000.0
BGJ398	PGFRB	38.0	1000.0
SB590885	NEK2	100.0	10000.0
CP466722	ABL1(F317I)-nonphosphorylated	3.5	10000.0
Alpelisib	DRAK1	72.0	1000.0
WYE-125132	TAOK1	100.0	10000.0
SP600125	CDK2	100.0	10000.0
Lapatinib	ULK1	100.0	10000.0
GSK461364	MP2K4	86.0	10000.0
KIN001-127	M4K3	100.0	10000.0
Torin1	PIK3C2B	25.0	10000.0
TGX221	NDR2	100.0	1000.0
Dabrafenib	SRMS	0.0	10000.0
QL-X-138	CSNK1A1	81.0	10000.0
JNK-IN-5A	CAMK1G	90.0	10000.0
GW-5074	LYN	86.0	10000.0
A443654	PRKR	100.0	10000.0
HG-5-113-01	LOK	0.0	10000.0
BMX-IN-1	CDK2	100.0	10000.0
HG-14-10-04	RIOK1	3.8	10000.0
Ceritinib	NEK4	90.0	1000.0
PLX-4720	PKAC-beta	100.0	10000.0
Abemaciclib	EPHA5	100.0	1000.0
JNK-IN-11	AKT1	100.0	1000.0
Vemurafenib	GRK7	93.0	10000.0
BGJ398	PRKR	82.0	1000.0
Torkinib	AURKA	100.0	10000.0
KIN001-111	TEC	5.2	1000.0
KIN001-220	ERN1	91.0	10000.0
WYE-125132	LYN	85.0	10000.0
ALW-II-49-7	CAMK1	100.0	10000.0
Lapatinib	PKMYT1	100.0	10000.0
Seliciclib	ULK1	68.0	10000.0
MPS-1-IN-1	DYRK1B	100.0	1000.0
BMS345541	NDR1	84.0	10000.0
WH-4-023	VGFR1	11.0	10000.0
JNK-IN-5A	IKKB	72.0	10000.0
WZ3105	IKKA	82.0	10000.0
NG25	ABL1(T315I)	0.0	10000.0
NU7441	MST1	98.0	10000.0
Sorafenib	HIPK3	0.6	10000.0
Sigma A6730	MAST1	100.0	10000.0
Torkinib	PIK3C2G	3.4	10000.0
HG-9-91-01	JNK1	0.0	10000.0
R406	TGFBR2	3.6	1000.0
Dabrafenib	ADCK3	0.0	10000.0
PHA-793887	M3K5	100.0	10000.0
Ceritinib	ABL1-nonphosphorylated	90.0	1000.0
KU63794	PIK3CA(H1047Y)	3.2	10000.0
WZ4002	TTK	2.0	10000.0
Buparlisib	ICK	100.0	1000.0
KIN001-123	M4K3	100.0	1000.0
XMD8-85	FLT3(N841I)	100.0	10000.0
AZD7762	FGFR1	1.3	10000.0
BMS345541	ABL1(Y253F)-phosphorylated	100.0	10000.0
WZ4003	CSNK1A1L	100.0	1000.0
AG1478	MTOR	83.0	10000.0
PHA-767491	CSK	100.0	10000.0
ZG-10	STK35	80.0	10000.0
SP600125	EGFR(L747-E749del,A750P)	100.0	10000.0
KIN001-220	RSK1(Kin.Dom.1-N-terminal)	45.0	10000.0
HG-5-113-01	DRAK1	100.0	10000.0
RO-3306	MRCKA	46.0	10000.0
GSK1059615	KIT(D816V)	63.0	10000.0
Baricitinib	HASP	7.0	10000.0
NPK76-II-72-1	EPHA3	100.0	10000.0
Neratinib	FLT3(ITD)	86.0	10000.0
Momelotinib	PRKR	47.0	10000.0
Neratinib	SGK3	100.0	10000.0
OTSSP167	LATS2	3.2	10000.0
ERK5-IN-1	KIT(L576P)	100.0	1000.0
A443654	PLK4	100.0	10000.0
XMD13-2	WEE1	84.0	10000.0
KIN001-220	TBK1	5.6	10000.0
SP600125	CIT	100.0	10000.0
PHA-767491	DMPK2	99.0	10000.0
MRT67307	MP2K6	66.0	10000.0
AZD4547	RIOK2	82.0	10000.0
WZ3105	PAK6	47.0	10000.0
MLN8054	MK03	97.0	10000.0
KU63794	MLK1	88.0	10000.0
XMD8-85	SLK	100.0	10000.0
KIN001-021	MK03	100.0	1000.0
HG-6-64-01	JNK3	15.0	10000.0
QL-XI-92	SLK	100.0	10000.0
CH5424802	ABL1(T315I)-phosphorylated	86.0	1000.0
BI-D1870	MAP4K2	6.2	10000.0
QL-X-138	JAK3(JH1domain-catalytic)	0.0	10000.0
KIN001-123	IRAK3	100.0	1000.0
NU7441	KPCD3	100.0	10000.0
GSK429286A	MST1	100.0	10000.0
XMD-12	PAK4	97.0	1000.0
BI-D1870	MLK2	28.0	10000.0
CP466722	PIK4CB	9.8	10000.0
KIN001-021	GSK3B	100.0	1000.0
MRT67307	EPHA1	100.0	10000.0
XMD-12	MK01	100.0	1000.0
Omipalisib	FGFR2	64.0	10000.0
HG-14-8-02	TEC	11.0	10000.0
ALW-II-38-3	IKKB	100.0	10000.0
OTSSP167	RAF1	100.0	10000.0
WYE-125132	RIOK1	91.0	10000.0
GW-5074	BRAF	0.9	10000.0
TGX221	MP2K3	100.0	1000.0
AZD 5438	PKAC-beta	88.0	10000.0
NPK76-II-72-1	SLK	1.4	10000.0
TGX221	CSNK2A1	100.0	1000.0
BMX-IN-1	DYRK1B	81.0	10000.0
HG-5-88-01	RIPK1	100.0	10000.0
KU63794	EGFR(L747-S752del,P753S)	100.0	10000.0
Alpelisib	HIPK1	87.0	1000.0
(s)-CR8	MK03	100.0	10000.0
Sorafenib	MST4	100.0	10000.0
BMS-536924	MARK4	23.0	1000.0
MLN8054	PKAC-alpha	47.0	10000.0
NPK76-II-72-1	ACVR2A	100.0	10000.0
Lapatinib	MK03	100.0	10000.0
Ibrutinib	PKNB(M.tuberculosis)	68.0	1000.0
Momelotinib	CAMK2B	14.0	10000.0
JNK-IN-8	FGFR4	100.0	1000.0
Ceritinib	PAK7	96.0	1000.0
MRT67307	ABL1(F317I)-phosphorylated	100.0	10000.0
AZD-6482	RSK4(Kin.Dom.2-C-terminal)	100.0	10000.0
ERK5-IN-1	VGFR1	100.0	1000.0
ALW-II-38-3	TRKB	100.0	10000.0
Crizotinib	FGFR2	35.0	10000.0
Taselisib	FLT3(ITD)	100.0	1000.0
Taselisib	TXK	100.0	1000.0
WZ-7043	EPHA3	100.0	10000.0
BGJ398	CSF1R-autoinhibited	0.0	1000.0
Momelotinib	INSR	57.0	10000.0
JNK-IN-11	EGFR(G719S)	1.8	1000.0
CP724714	FRK	100.0	10000.0
HG-14-8-02	NEK7	89.0	10000.0
AS-252424	TESK1	100.0	10000.0
Pictilisib	FLT3(R834Q)	100.0	1000.0
Omipalisib	EPHA7	84.0	10000.0
CGP74514A	EGFR(L747-E749del,A750P)	36.0	10000.0
HG-14-8-02	PFPK5(P.falciparum)	100.0	10000.0
HG-6-64-01	OSR1	74.0	10000.0
SB590885	GRK4	100.0	10000.0
Sigma A6730	ABL1(Q252H)-phosphorylated	85.0	10000.0
ZG-10	YANK3	100.0	10000.0
ERK5-IN-1	TRPM6	94.0	1000.0
TGX221	MLTK	100.0	1000.0
THZ1	CSNK1A1L	12.0	10000.0
TAK-715	MARK1	100.0	10000.0
THZ1	MAPKAPK5	67.0	10000.0
TAK-715	ROS1	69.0	10000.0
XMD13-2	PAK4	79.0	10000.0
QL-X-138	EPHB4	100.0	10000.0
PLX-4720	AAK1	84.0	10000.0
QL-X-138	ERBB2	42.0	10000.0
XMD14-99	EPHB3	0.0	10000.0
PHA-767491	MLCK	2.6	10000.0
Torin2	DYRK1A	75.0	10000.0
R406	CDK9	100.0	1000.0
Torkinib	PRKR	48.0	10000.0
KIN001-123	JNK1	14.0	1000.0
WYE-125132	TESK1	80.0	10000.0
AZD 5438	AKT2	100.0	10000.0
JNK-9L	KIT(A829P)	51.0	10000.0
Momelotinib	TBK1	10.0	10000.0
Omipalisib	MYLK4	79.0	10000.0
CH5424802	MARK4	100.0	1000.0
QL-X-138	PI42C	2.7	10000.0
ERK5-IN-1	MAK	100.0	1000.0
A443654	ABL1(F317I)	100.0	10000.0
XMD16-144	YSK4	6.2	10000.0
Ibrutinib	MLK3	96.0	1000.0
HG-5-113-01	TYK2(Kin.Dom.1)	1.0	10000.0
XMD11-85h	RPS6KA2(Kin.Dom.1)	100.0	10000.0
SCH772984	ABL1(T315I)-nonphosphorylated	98.0	1000.0
HG-6-64-01	PCTK3	100.0	10000.0
A443654	PHKG2	23.0	10000.0
PHA-793887	PHKG2	8.1	10000.0
KIN001-021	PAK2	100.0	1000.0
ZM-447439	ALK	26.0	10000.0
GSK1059615	SIK1	96.0	10000.0
JWE-035	MAPKAPK5	100.0	10000.0
GSK1059615	KCC2D	10.0	10000.0
MLN8054	MK01	100.0	10000.0
BMX-IN-1	MET(Y1235D)	100.0	10000.0
Ribociclib	CSK	98.0	1000.0
OTSSP167	CSK	23.0	10000.0
Ribociclib	INSR	100.0	1000.0
HG-9-91-01	MAP4K2	0.4	10000.0
WZ3105	CSNK1A1	0.7	10000.0
AS-252424	JNK3	38.1	10000.0
ZM-447439	EGFR(G719C)	0.5	10000.0
A443654	DAPK3	2.3	10000.0
ZSTK474	TRKC	100.0	1000.0
JNK-IN-11	FGFR3(G697C)	93.0	1000.0
Dinaciclib	WEE1	92.0	10000.0
HG-9-91-01	CSNK1A1	39.0	10000.0
GSK1059615	PIK3CG	0.0	10000.0
XMD13-2	PKAC-alpha	100.0	10000.0
NU7441	KIT(A829P)	96.0	10000.0
Lapatinib	PIP5K1A	67.0	10000.0
BS-181	NDR2	100.0	10000.0
KIN001-127	MK13	100.0	10000.0
CG-930	CSNK1A1L	55.0	10000.0
CG-930	RIOK3	100.0	10000.0
CH5424802	CDK5	100.0	1000.0
Dinaciclib	BMPR2	86.0	10000.0
Dactolisib	NEK2	100.0	1000.0
AZ-628	CIT	0.1	10000.0
BX-912	CSNK2A2	0.0	10000.0
Torkinib	JAK1(JH2domain-pseudokinase)	0.2	10000.0
Momelotinib	TNIK	59.0	10000.0
Barasertib	M3K13	100.0	10000.0
ALW-II-38-3	PHKG2	100.0	10000.0
HG-9-91-01	RET	0.1	10000.0
Ceritinib	CLK3	73.0	1000.0
HG-6-64-01	TAOK3	0.0	10000.0
BS-181	MYLK2	96.0	10000.0
XMD8-92	KPCD2	100.0	10000.0
Ceritinib	MAST1	47.0	1000.0
WZ3105	PIK3CB	100.0	10000.0
ALW-II-38-3	CDK11	100.0	10000.0
BI-2536	EPHA2	100.0	10000.0
WYE-125132	AMPK-alpha2	93.0	10000.0
Abemaciclib	PKAC-beta	84.0	1000.0
PHA-767491	YSK4	0.0	10000.0
Seliciclib	PAK6	53.0	10000.0
AZD7762	BRSK2	2.8	10000.0
WYE-125132	FAK2	100.0	10000.0
ZSTK474	EGFR(L747-E749del,A750P)	100.0	1000.0
CP466722	EGFR(G719C)	24.0	10000.0
XMD-12	GSK3A	100.0	1000.0
GSK461364	ITK	89.0	10000.0
HG-6-64-01	EGFR(G719C)	0.1	10000.0
AG1478	KIT(D816V)	38.0	10000.0
Ceritinib	LKB1	84.0	1000.0
Palbociclib	MK09	55.0	1000.0
NG25	CHK2	100.0	10000.0
XMD-12	KPCI	79.0	1000.0
RO-3306	SgK110	74.0	10000.0
Vemurafenib	PIK3CA(H1047L)	95.0	10000.0
CH5424802	KPCL	93.0	1000.0
WZ4003	BLK	100.0	1000.0
ALW-II-38-3	FGR	23.0	10000.0
NG25	KPCE	20.0	10000.0
HG-9-91-01	PHKG2	85.0	10000.0
XMD11-85h	KIT	100.0	10000.0
BMX-IN-1	STK33	95.0	10000.0
MRT67307	KPCL	100.0	10000.0
MLN8054	SIK2	49.0	10000.0
XMD13-2	STK33	100.0	10000.0
ZM-447439	CDK14	100.0	10000.0
QL-XII-47	PIK3CA(Q546K)	81.0	1000.0
MRT67307	MP2K5	0.2	10000.0
BI-2536	MK12	100.0	10000.0
AZD-6482	CDK4-cyclinD1	100.0	10000.0
NG25	MARK4	0.0	10000.0
BI-2536	PAK1	100.0	10000.0
Sorafenib	TXK	77.0	10000.0
XMD8-85	BRAF	100.0	10000.0
WZ-7043	TRKC	100.0	10000.0
NPK76-II-72-1	RPS6KA3(Kin.Dom.1)	100.0	10000.0
Baricitinib	SRMS	85.0	10000.0
PLX-4720	EIF2AK1	32.0	10000.0
HG-9-91-01	BUB1	100.0	10000.0
HG-14-8-02	AKT2	100.0	10000.0
SB590885	M4K3	98.0	10000.0
NU7441	CAMK2A	78.0	10000.0
Sorafenib	LTK	88.0	10000.0
Momelotinib	MET(Y1235D)	100.0	10000.0
AZD4547	MLK1	10.0	10000.0
QL-XII-47	CDK4-cyclinD3	100.0	1000.0
AZ-628	ABL1(Y253F)-phosphorylated	1.4	10000.0
KU63794	STK16	93.0	10000.0
WZ3105	ERN1	96.0	10000.0
Ibrutinib	SRPK3	83.0	1000.0
XMD14-99	ACVR1B	100.0	10000.0
KIN001-021	CDK3	100.0	1000.0
(s)-CR8	EIF2AK1	97.0	10000.0
NVP-TAE684	KCC4	0.5	1000.0
Barasertib	SIK3	100.0	10000.0
Dabrafenib	IRAK4	100.0	10000.0
Torin1	EPHA3	70.0	10000.0
SB590885	FGFR3	100.0	10000.0
HG-5-113-01	KCC2D	100.0	10000.0
Seliciclib	RPS6KA4(Kin.Dom.2-C-terminal)	70.0	10000.0
MPS-1-IN-1	EPHB2	100.0	1000.0
QL-X-138	EGFR(T790M)	1.4	10000.0
KIN001-127	STK35	100.0	10000.0
JNK-IN-8	ERK3	37.0	1000.0
5z-7-oxozeaenol	BIKE	3.8	10000.0
JNK-IN-8	EPHA3	67.0	1000.0
A443654	ZAP70	100.0	10000.0
SB590885	PIK3CA(M1043I)	84.0	10000.0
(s)-CR8	STK36	95.0	10000.0
WZ4002	NDR2	100.0	10000.0
SB590885	MINK	6.0	10000.0
JWE-035	PIK3CB	68.0	10000.0
Omipalisib	MK03	88.0	10000.0
BMS345541	GRK4	100.0	10000.0
NG25	ABL1(F317L)	0.1	10000.0
QL-X-138	AURKB	97.0	10000.0
THZ1	MK09	0.1	10000.0
JW-7-24-1	STK35	100.0	10000.0
GSK1059615	PI42C	3.2	10000.0
GSK461364	GSK3B	100.0	10000.0
Torin1	RSK3(Kin.Dom.1-N-terminal)	100.0	10000.0
BS-181	ABL2	90.0	10000.0
QL-X-138	KC1G2	94.0	10000.0
JNK-IN-11	LIMK1	100.0	1000.0
QL-XII-47	PI42C	100.0	1000.0
QL-X-138	KIT(V559D,V654A)	100.0	10000.0
HG-14-8-02	DYRK1A	93.0	10000.0
SCH772984	FYN	100.0	1000.0
ALW-II-49-7	ADCK4	100.0	10000.0
CH5424802	SGK1	100.0	1000.0
TAK-715	M3K5	100.0	10000.0
PD0325901	MK01	100.0	10000.0
XMD-12	CDK14	100.0	1000.0
Ceritinib	TGFBR1	91.0	1000.0
KIN001-127	EGFR(L747-E749del,A750P)	100.0	10000.0
AZD-6482	MAP3K1	90.0	10000.0
AZ-628	MYO3A	100.0	10000.0
ERK5-IN-1	DDR2	81.0	1000.0
HG-5-113-01	TXK	33.0	10000.0
KU63794	EGFR(L861Q)	83.0	10000.0
AZD 5438	MAP4K4	15.0	10000.0
A443654	LATS1	3.8	10000.0
XMD-12	KIT(V559D,V654A)	58.0	1000.0
JW-7-24-1	PKN2	100.0	10000.0
GSK1059615	MP2K2	4.4	10000.0
PD0325901	SGK1	100.0	10000.0
ZG-10	EPHB2	100.0	10000.0
ZG-10	PLK3	35.0	10000.0
WYE-125132	M4K3	94.0	10000.0
MPS-1-IN-1	CSNK1D	100.0	1000.0
CGP60474	PTK6	100.0	10000.0
Dabrafenib	ALK	67.0	10000.0
Ceritinib	SNARK	47.0	1000.0
MRT67307	MKNK2	0.2	10000.0
AZD 5438	CDK4-cyclinD3	0.4	10000.0
Neratinib	EGFR(G719C)	0.0	10000.0
XMD11-50	CDK11	100.0	10000.0
JWE-035	AKT1	100.0	10000.0
BGJ398	ERBB3	92.0	1000.0
Abemaciclib	PKNB(M.tuberculosis)	8.2	1000.0
QL-XI-92	IGF1R	63.0	10000.0
Torkinib	RPS6KA5(Kin.Dom.2-C-terminal)	22.0	10000.0
Vemurafenib	MRCKA	80.0	10000.0
SCH772984	RPS6KA5(Kin.Dom.1-N-terminal)	76.0	1000.0
PLX-4720	KPCD2	100.0	10000.0
WZ-7043	FGFR3(G697C)	1.3	10000.0
BMX-IN-1	MET	64.0	10000.0
JNK-9L	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
BMX-IN-1	SYK	96.0	10000.0
MRT67307	PKAC-alpha	100.0	10000.0
Neratinib	PIK3C2G	100.0	10000.0
Omipalisib	SYK	70.0	10000.0
GSK429286A	MLK3	100.0	10000.0
Alpelisib	TAOK1	100.0	1000.0
MRT67307	ABL1(H396P)-phosphorylated	72.0	10000.0
AS-252424	CLK4	40.3	10000.0
Sigma A6730	ERBB3	100.0	10000.0
AS-252424	SYK	55.0	10000.0
TGX221	SNARK	100.0	1000.0
KU63794	CSNK1E	87.0	10000.0
SB590885	PAK6	100.0	10000.0
AZD-6482	CDKL2	91.0	10000.0
TAK-715	CSNK2A2	86.0	10000.0
Taselisib	DYRK1A	99.0	1000.0
SB590885	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
GW843682X	TBK1	83.0	10000.0
PD0325901	LKB1	83.0	10000.0
JNK-9L	MAP3K3	30.0	10000.0
Crizotinib	AURKA	3.2	10000.0
PHA-793887	KPCI	62.0	10000.0
KIN001-021	CAMK2G	100.0	1000.0
BX-912	MRCKA	95.0	10000.0
BX-912	MAK	100.0	10000.0
BMS345541	RSK4(Kin.Dom.2-C-terminal)	40.0	10000.0
JW-7-24-1	DCAMKL3	100.0	10000.0
WH-4-023	MK11	11.0	10000.0
HG-5-113-01	ERK3	100.0	10000.0
NU7441	MAST1	100.0	10000.0
Palbociclib	ERK4	100.0	1000.0
CH5424802	RSK2(Kin.Dom.2-C-terminal)	58.0	1000.0
ZSTK474	MP2K3	100.0	1000.0
Sigma A6730	AMPK-alpha1	72.0	10000.0
WZ3105	LATS1	100.0	10000.0
XMD8-92	MLK3	100.0	10000.0
XMD11-50	MK01	85.0	10000.0
KIN001-127	RIOK1	100.0	10000.0
Abemaciclib	RSK3(Kin.Dom.2-C-terminal)	67.0	1000.0
OTSSP167	MET(Y1235D)	18.0	10000.0
GSK1059615	CAMK2G	28.0	10000.0
WYE-125132	EPHA4	100.0	10000.0
Ribociclib	MAP4K5	100.0	1000.0
ZM-447439	EGFR(L858R,T790M)	85.0	10000.0
Sigma A6730	MKNK2	81.0	10000.0
BX-912	CAMK2B	35.0	10000.0
(s)-CR8	AURKA	84.0	10000.0
WH-4-023	MYO3A	69.0	10000.0
WZ-4-145	ABL1(F317L)	100.0	10000.0
JNK-IN-11	CIT	0.3	1000.0
GW-5074	DYRK1A	26.0	10000.0
PHA-793887	CSNK1D	100.0	10000.0
NPK76-II-72-1	AKT1	100.0	10000.0
SP600125	CDK16	5.2	10000.0
WYE-125132	KIT(V559D)	85.0	10000.0
WZ-7043	MYO3B	100.0	10000.0
MPS-1-IN-1	RPS6KA5(Kin.Dom.1)	100.0	1000.0
QL-X-138	IKKA	100.0	10000.0
Palbociclib	AURKA	100.0	1000.0
ALW-II-38-3	CHK2	100.0	10000.0
JNK-9L	DAPK1	60.0	10000.0
TGX221	EPHB4	100.0	1000.0
PD0325901	M3K6	95.0	10000.0
CGP74514A	MK14	86.0	10000.0
Dactolisib	EGFR(L747-E749del,A750P)	100.0	1000.0
JNK-IN-8	CDK3	100.0	1000.0
ALW-II-49-7	FER	100.0	10000.0
BX-912	ABL1(F317L)-phosphorylated	1.2	10000.0
ALW-II-49-7	LIMK1	100.0	10000.0
KU63794	YANK2	100.0	10000.0
KIN001-220	CAMK2G	55.0	10000.0
Vemurafenib	DDR2	35.0	10000.0
WYE-125132	CSK	100.0	10000.0
KIN001-220	RET	1.8	10000.0
TAK-715	ZAP70	100.0	10000.0
Alpelisib	EGFR(S752-I759del)	98.0	1000.0
SCH772984	ACVR2B	100.0	1000.0
Torin2	SGK3	100.0	10000.0
WZ-7043	MET(Y1235D)	100.0	10000.0
WZ-4-145	ABL1(M351T)	16.0	10000.0
Torkinib	M3K5	100.0	10000.0
XMD11-85h	FAK2	100.0	10000.0
JNK-9L	DCLK1	100.0	10000.0
KIN001-220	CAMK2A	68.0	10000.0
Pictilisib	BARK1	100.0	1000.0
AZD4547	PGFRA	2.7	10000.0
WZ4002	VGFR1	100.0	10000.0
XMD-12	DYRK2	73.0	1000.0
TAK-715	FLT3	17.0	10000.0
CGP60474	CDK16	1.9	10000.0
TGX221	KPCT	100.0	1000.0
GW-5074	FGFR1	77.0	10000.0
ZM-447439	PKAC-alpha	100.0	10000.0
CG-930	MYLK2	100.0	10000.0
KIN001-021	RIOK1	100.0	1000.0
Crizotinib	TRKB	0.2	10000.0
Torkinib	AKT2	100.0	10000.0
ERK5-IN-1	MST2	100.0	1000.0
Sorafenib	DMPK	100.0	10000.0
WZ3105	M3K12	71.0	10000.0
WZ4002	MLK1	35.0	10000.0
WZ-4-145	M4K1	16.0	10000.0
GW843682X	AURKC	27.0	10000.0
Alpelisib	IRAK4	100.0	1000.0
BI-2536	TYRO3	100.0	10000.0
XMD11-85h	PAK7	100.0	10000.0
JNK-9L	DYRK1B	10.0	10000.0
HG-6-64-01	EPHA3	4.8	10000.0
QL-XII-47	M3K6	100.0	1000.0
HG-14-10-04	PIM3	5.6	10000.0
Palbociclib	INSR	100.0	1000.0
Ribociclib	AXL	75.0	1000.0
AZD-6482	KPCD	82.0	10000.0
XMD8-92	MAP3K1	100.0	10000.0
JNK-IN-11	ERBB4	5.4	1000.0
AZ-628	IGF1R	95.0	10000.0
AZD4547	MERTK	3.6	10000.0
Neratinib	IGF1R	100.0	10000.0
XMD11-50	RIPK5	16.0	10000.0
Sigma A6730	ERN1	66.0	10000.0
BMS345541	CSK	100.0	10000.0
Seliciclib	ADCK3	100.0	10000.0
Alpelisib	PIK3CA(H1047L)	0.0	1000.0
NU7441	EGFR(G719S)	100.0	10000.0
BMX-IN-1	CTK	95.0	10000.0
TGX221	PAK3	100.0	1000.0
CG-930	FLT3(K663Q)	100.0	10000.0
SCH772984	LRRK2	55.0	1000.0
MPS-1-IN-1	TEC	100.0	1000.0
NVP-TAE684	CAMK2A	1.2	1000.0
Pictilisib	MET(M1250T)	100.0	1000.0
JW-7-24-1	CLK4	19.0	10000.0
Barasertib	MST1R	25.0	10000.0
HG-6-64-01	TYK2(JH1domain-catalytic)	12.0	10000.0
MPS-1-IN-1	ANKK1	100.0	1000.0
BMS345541	KGP1	100.0	10000.0
JW-7-24-1	LATS2	3.5	10000.0
JNK-IN-11	CLK2	90.0	1000.0
Buparlisib	FLT3(D835H)	96.0	1000.0
WYE-125132	KPCE	100.0	10000.0
BMS-536924	NEK2	16.0	1000.0
Ceritinib	NEK10	25.0	1000.0
SB590885	KPCD2	80.0	10000.0
Pictilisib	ACVR1	100.0	1000.0
JNK-IN-5A	ULK3	94.0	10000.0
AZD7762	KIT(L576P)	0.0	10000.0
SB590885	FGFR4	100.0	10000.0
BX-912	SNARK	3.8	10000.0
Canertinib	DAPK1	100.0	1000.0
R406	BRAF(V600E)	24.0	1000.0
KU63794	AURKB	73.0	10000.0
BX-912	STK16	0.6	10000.0
Palbociclib	GAK	100.0	1000.0
XMD8-92	DYRK1B	100.0	10000.0
Seliciclib	CDC2L1	100.0	10000.0
QL-XI-92	KIT(D816V)	78.0	10000.0
BGJ398	MP2K5	93.0	1000.0
Omipalisib	LYN	99.0	10000.0
BGJ398	EIF2AK1	91.0	1000.0
PHA-767491	TLK2	86.0	10000.0
Dactolisib	AAK1	100.0	1000.0
Pictilisib	ULK3	100.0	1000.0
BX-912	CDK16	40.0	10000.0
XMD16-144	M3K6	94.0	10000.0
AZD7762	SBK1	0.0	10000.0
SB590885	PIP5K1C	52.0	10000.0
SB590885	KKCC1	99.0	10000.0
MPS-1-IN-1	MKNK1	100.0	1000.0
PD0325901	ERN1	97.0	10000.0
Neratinib	M3K6	87.0	10000.0
Neratinib	NEK5	100.0	10000.0
5z-7-oxozeaenol	CDC2L5	98.0	10000.0
Seliciclib	SRPK3	100.0	10000.0
Palbociclib	JAK1(JH1domain-catalytic)	100.0	1000.0
SB590885	WEE1	100.0	10000.0
PLX-4720	KIT(D816H)	93.0	10000.0
CH5424802	EPHB2	39.0	1000.0
Ribociclib	CIT	100.0	1000.0
HG-5-88-01	ABL1(F317I)	4.8	10000.0
Vemurafenib	JAK3(JH1domain-catalytic)	83.0	10000.0
Dactolisib	MERTK	100.0	1000.0
CGP74514A	MLK2	85.0	10000.0
Alpelisib	KPCT	82.0	1000.0
BMS-536924	NDR2	21.0	1000.0
Torin2	TLK2	100.0	10000.0
MRT67307	AAK1	3.4	10000.0
QL-XI-92	MLK2	100.0	10000.0
Taselisib	CDK2	100.0	1000.0
MPS-1-IN-1	HCK	100.0	1000.0
XMD-12	TBK1	100.0	1000.0
CP724714	NLK	100.0	10000.0
WZ3105	LTK	88.0	10000.0
Dactolisib	STK16	100.0	1000.0
WYE-125132	TGFBR1	100.0	10000.0
Ibrutinib	BRAF	53.0	1000.0
WH-4-023	RSK2(Kin.Dom.1-N-terminal)	37.0	10000.0
R406	PAK3	2.2	1000.0
Barasertib	CSNK1A1	49.0	10000.0
XMD8-92	PIK3CG	100.0	10000.0
Palbociclib	NEK5	100.0	1000.0
Baricitinib	ULK3	0.2	10000.0
MPS-1-IN-1	ABL1(F317L)	100.0	1000.0
ZSTK474	SYK	100.0	1000.0
THZ1	EGFR(L858R,T790M)	36.0	10000.0
HG-14-8-02	MELK	95.0	10000.0
SB590885	MYLK	51.0	10000.0
Dactolisib	CAMK1G	100.0	1000.0
ERK5-IN-1	CLK3	100.0	1000.0
Ceritinib	MP2K4	49.0	1000.0
BMX-IN-1	CDK14	72.0	10000.0
TAK-715	EGFR(G719S)	2.9	10000.0
Momelotinib	EPHB4	100.0	10000.0
BS-181	BLK	100.0	10000.0
Dinaciclib	MAP3K14	89.0	10000.0
WH-4-023	SYK	1.4	10000.0
JNK-IN-5A	CSNK1A1	100.0	10000.0
NU7441	LOK	100.0	10000.0
Buparlisib	NEK2	100.0	1000.0
Dactolisib	MP2K6	100.0	1000.0
BMS345541	PIK4CB	100.0	10000.0
(s)-CR8	NEK5	90.0	10000.0
RO-3306	MELK	14.0	10000.0
PHA-793887	DAPK3	100.0	10000.0
XMD13-2	MET(Y1235D)	74.0	10000.0
GW843682X	FAK1	83.0	10000.0
GSK461364	TRKC	100.0	10000.0
ZM-447439	MARK2	81.0	10000.0
Omipalisib	CDKL1	73.0	10000.0
Alpelisib	PI42C	84.0	1000.0
Palbociclib	EPHB2	88.0	1000.0
Crizotinib	CAMK1	37.0	10000.0
JWE-035	JNK3	100.0	10000.0
BS-181	S6K1	89.0	10000.0
MLN8054	YANK2	38.0	10000.0
CH5424802	PAK7	97.0	1000.0
Pictilisib	EGFR(L858R,T790M)	100.0	1000.0
CG-930	PIK3CA(E545K)	100.0	10000.0
Abemaciclib	EPHB1	92.0	1000.0
QL-XII-47	KIT(D816V)	92.0	1000.0
Buparlisib	ERK3	100.0	1000.0
RO-3306	KIT(A829P)	78.0	10000.0
QL-XI-92	RSK3(Kin.Dom.1-N-terminal)	100.0	10000.0
JNK-IN-11	EGFR(G719C)	0.6	1000.0
Sorafenib	NIM1	97.0	10000.0
Seliciclib	RET(M918T)	100.0	10000.0
Baricitinib	GCN2(Kin.Dom.2,S808G)	99.0	10000.0
HG-5-88-01	CLK1	0.7	10000.0
CP466722	M3K5	100.0	10000.0
SCH772984	LRRK2(G2019S)	25.0	1000.0
Pictilisib	EPHA4	100.0	1000.0
GSK1059615	CLK1	0.0	10000.0
QL-XII-47	RSK3(Kin.Dom.1-N-terminal)	100.0	1000.0
KU63794	FLT3	71.0	10000.0
Momelotinib	HCK	100.0	10000.0
ALW-II-49-7	KKCC1	100.0	10000.0
AZD 5438	ABL1(Q252H)-phosphorylated	3.8	10000.0
Sigma A6730	CTK	70.0	10000.0
KU63794	M3K5	97.0	10000.0
SP600125	ERBB2	100.0	10000.0
Pictilisib	ITK	95.0	1000.0
KIN001-111	KGP1	100.0	1000.0
Canertinib	TLK1	100.0	1000.0
NG25	TESK1	100.0	10000.0
JNK-9L	VGFR1	48.0	10000.0
XMD8-85	ITK	100.0	10000.0
KIN001-111	TYK2(Kin.Dom.2)	7.8	1000.0
XMD-12	EPHB6	32.0	1000.0
NU7441	ERK8	100.0	10000.0
NU7441	MAP4K4	100.0	10000.0
GSK461364	BMPR2	100.0	10000.0
Crizotinib	STK36	100.0	10000.0
CP724714	ERBB3	20.0	10000.0
NVP-TAE684	DCLK1	0.0	1000.0
AZD 5438	PRKR	12.0	10000.0
GSK461364	EGFR(L747-S752del,P753S)	97.0	10000.0
XMD-12	BRSK1	56.0	1000.0
OTSSP167	RSK3(Kin.Dom.2-C-terminal)	7.5	10000.0
BI-2536	PGFRA	100.0	10000.0
WZ4002	RIPK2	100.0	10000.0
RO-3306	JNK1	61.0	10000.0
CP466722	ULK1	6.6	10000.0
WZ4002	EPHA3	100.0	10000.0
Sigma A6730	RET(V804L)	85.0	10000.0
AZD 5438	STK16	0.2	10000.0
XMD11-85h	SYK	100.0	10000.0
THZ1	RSK3(Kin.Dom.1-N-terminal)	1.6	10000.0
Palbociclib	ALK(L1196M)	100.0	1000.0
R406	ACVR1B	24.0	1000.0
GW843682X	CHEK1	100.0	10000.0
Alpelisib	BARK2	100.0	1000.0
Sigma A6730	CDK11	75.0	10000.0
WZ4002	PDPK1	100.0	10000.0
XMD11-50	TLK2	99.0	10000.0
Ribociclib	CSNK2A2	99.0	1000.0
Ribociclib	SGK3	100.0	1000.0
Torin1	NEK7	90.0	10000.0
Abemaciclib	FLT3(ITD)	100.0	1000.0
BI-D1870	MAP4K5	15.0	10000.0
XMD11-50	KPCE	100.0	10000.0
A443654	TXK	100.0	10000.0
AG1478	FAK2	86.0	10000.0
NU7441	PCTK3	100.0	10000.0
XMD14-99	CDC2L5	83.0	10000.0
Pictilisib	ABL1(F317I)-phosphorylated	100.0	1000.0
5z-7-oxozeaenol	MLTK	2.2	10000.0
MPS-1-IN-1	TRKA	100.0	1000.0
HG-6-64-01	ERK4	100.0	10000.0
AG1478	CDK14	88.0	10000.0
XMD8-92	DRAK1	100.0	10000.0
WYE-125132	TIE2	100.0	10000.0
JWE-035	BMX	91.0	10000.0
Torin1	AURKC	91.0	10000.0
AZD 5438	FLT3-autoinhibited	100.0	10000.0
Ibrutinib	CDKL3	100.0	1000.0
JWE-035	JAK2(JH1domain-catalytic)	0.0	10000.0
AG1478	MKNK1	4.6	10000.0
XMD16-144	RPS6KA4(Kin.Dom.2-C-terminal)	70.0	10000.0
ALW-II-49-7	MINK	100.0	10000.0
GSK1059615	EGFR(L747-E749del,A750P)	47.0	10000.0
SP600125	STK36	100.0	10000.0
HG-14-10-04	ABL1(F317I)-nonphosphorylated	0.4	10000.0
HG-14-10-04	GCN2(Kin.Dom.2,S808G)	0.2	10000.0
AG1478	NEK5	93.0	10000.0
KU63794	CDKL5	77.0	10000.0
Momelotinib	PIK3CA(Q546K)	100.0	10000.0
AZD 5438	SNARK	1.8	10000.0
NPK76-II-72-1	SIK1	100.0	10000.0
Dactolisib	CTK	100.0	1000.0
Vemurafenib	ABL2	32.0	10000.0
Seliciclib	M3K13	98.0	10000.0
GSK429286A	RIOK2	86.0	10000.0
HG-14-10-04	MAP4K2	39.0	10000.0
KU63794	SRC	100.0	10000.0
ERK5-IN-1	ABL1(T315I)-nonphosphorylated	95.0	1000.0
NVP-TAE684	MK01	0.3	1000.0
KIN001-127	ABL1(Y253F)	100.0	10000.0
KIN001-123	PAK3	100.0	1000.0
WZ4003	ABL1(M351T)	100.0	1000.0
ZM-447439	MAPKAPK2	100.0	10000.0
GSK1059615	MST1R	100.0	10000.0
JNK-9L	CSNK1A1	60.0	10000.0
BI-D1870	M4K1	19.0	10000.0
BI-2536	AAK1	100.0	10000.0
ERK5-IN-1	FLT3	100.0	1000.0
XMD-12	FLT3(R834Q)	100.0	1000.0
WYE-125132	MLCK	100.0	10000.0
Vemurafenib	EGFR(G719C)	28.0	10000.0
SCH772984	ERBB2	70.0	1000.0
QL-XII-47	FLT3	98.0	1000.0
NPK76-II-72-1	BRSK2	100.0	10000.0
XMD8-85	CAMK1D	100.0	10000.0
MPS-1-IN-1	M4K3	100.0	1000.0
XMD11-85h	YES	100.0	10000.0
Ibrutinib	ADCK4	96.0	1000.0
BI-2536	CAMKK2	1.9	10000.0
TGX221	PKN1	100.0	1000.0
Taselisib	GAK	97.0	1000.0
BX-912	CDK15	25.0	10000.0
HG-6-64-01	ABL1-phosphorylated	0.1	10000.0
AZD-6482	FLT3(N841I)	44.0	10000.0
AZD4547	TAOK2	29.0	10000.0
Pictilisib	STK35	100.0	1000.0
Alpelisib	MUSK	100.0	1000.0
TAK-715	CSNK1A1	2.6	10000.0
TAK-715	CHK2	80.0	10000.0
XMD13-2	ERK3	78.0	10000.0
QL-XII-47	TTK	80.0	1000.0
Dactolisib	GCN2(Kin.Dom.2,S808G)	100.0	1000.0
MLN8054	KC1G2	66.0	10000.0
BX-912	MRCKB	82.0	10000.0
Ribociclib	PDPK1	100.0	1000.0
PHA-793887	CSNK1A1	47.0	10000.0
AZD7762	JAK3(JH1domain-catalytic)	0.0	10000.0
KIN001-123	PDPK1	100.0	1000.0
Torin2	MYLK	95.0	10000.0
MRT67307	CDC2L2	83.0	10000.0
Seliciclib	RET(V804M)	100.0	10000.0
Torin1	MLCK	94.0	10000.0
XMD11-85h	FGFR4	100.0	10000.0
Omipalisib	PIP5K2B	67.0	10000.0
Omipalisib	MK01	99.0	10000.0
Momelotinib	RIOK3	0.0	10000.0
Barasertib	CASK	88.0	10000.0
ZSTK474	MKNK1	100.0	1000.0
BGJ398	NDR2	12.0	1000.0
Seliciclib	IRAK3	99.0	10000.0
5z-7-oxozeaenol	LKB1	88.0	10000.0
ALW-II-38-3	STK35	100.0	10000.0
KU63794	KKCC1	100.0	10000.0
WZ3105	CDK7	15.0	10000.0
SCH772984	BUB1	100.0	1000.0
Torin1	MLK1	84.0	10000.0
JNK-IN-8	MLTK	100.0	1000.0
WZ-4-145	PGFRB	0.0	10000.0
CGP74514A	ERBB4	81.0	10000.0
BI-2536	HIPK1	100.0	10000.0
Seliciclib	KPCI	100.0	10000.0
Neratinib	MK11	100.0	10000.0
Baricitinib	ERK3	100.0	10000.0
THZ1	TRPM6	100.0	10000.0
CGP60474	LTK	100.0	10000.0
Palbociclib	CHK2	100.0	1000.0
Neratinib	KIT(V559D)	100.0	10000.0
WZ-4-145	CSNK1A1L	100.0	10000.0
Torkinib	ROCK1	61.0	10000.0
AZD7762	ABL1(H396P)-nonphosphorylated	0.0	10000.0
Palbociclib	AXL	90.0	1000.0
Abemaciclib	LRRK2	100.0	1000.0
HG-5-88-01	PIM3	100.0	10000.0
NPK76-II-72-1	IGF1R	32.0	10000.0
THZ1	KPCD2	1.8	10000.0
Sorafenib	CTK	100.0	10000.0
PHA-793887	MAP3K1	100.0	10000.0
Seliciclib	MYO3B	85.0	10000.0
R406	EGFR(L747-T751del,Sins)	2.7	1000.0
5z-7-oxozeaenol	PCTK2	95.0	10000.0
AZD 5438	MRCKA	100.0	10000.0
BGJ398	MK12	52.0	1000.0
CGP60474	PIK3CG	100.0	10000.0
AZ-628	FLT3(ITD)	78.0	10000.0
HG-9-91-01	YANK1	5.8	10000.0
PD173074	STK16	100.0	10000.0
NG25	PIM3	100.0	10000.0
Alpelisib	MAP4K4	100.0	1000.0
MPS-1-IN-1	ROS1	12.0	1000.0
TGX221	EGFR(L747-E749del,A750P)	100.0	1000.0
PHA-793887	PIM1	100.0	10000.0
MPS-1-IN-1	INSRR	2.0	1000.0
XMD8-85	AURKC	100.0	10000.0
GW-5074	CDK7	67.0	10000.0
Sigma A6730	NEK5	97.0	10000.0
SP600125	KIT(V559D,T670I)	100.0	10000.0
Abemaciclib	MERTK	100.0	1000.0
Dinaciclib	PHKG1	57.0	10000.0
MRT67307	FLT3(D835H)	3.4	10000.0
JNK-IN-8	TLK1	98.0	1000.0
ZSTK474	MP2K6	100.0	1000.0
MLN8054	PIK3CD	88.0	10000.0
QL-X-138	IRAK1	41.0	10000.0
Omipalisib	EGFR	69.0	10000.0
QL-X-138	IKKE	100.0	10000.0
RO-3306	PFPK5(P.falciparum)	73.0	10000.0
Torin1	WEE1	42.0	10000.0
AG1478	MST2	91.0	10000.0
XMD11-50	JNK3	77.0	10000.0
R406	CLK1	1.4	1000.0
XMD8-92	BRSK1	100.0	10000.0
Palbociclib	FLT3(D835V)	44.0	1000.0
Momelotinib	EPHA3	69.0	10000.0
BMS-536924	TLK1	100.0	1000.0
JWE-035	SRMS	54.0	10000.0
Abemaciclib	HUNK	100.0	1000.0
CGP74514A	CHEK1	20.0	10000.0
KIN001-127	JAK3(Kin.Dom.2)	100.0	10000.0
XMD13-2	KIT(D816V)	97.0	10000.0
NVP-TAE684	TIE1	0.0	1000.0
MPS-1-IN-1	CSNK1E	100.0	1000.0
ZM-447439	CSF1R	16.0	10000.0
Abemaciclib	TBK1	86.0	1000.0
WZ-7043	PAK6	100.0	10000.0
QL-XI-92	TXK	93.0	10000.0
Barasertib	CAMK1	69.0	10000.0
AZD 5438	ANKK1	12.0	10000.0
QL-X-138	MLK1	86.0	10000.0
WZ4002	FYN	100.0	10000.0
PHA-767491	GAK	25.0	10000.0
SCH772984	MYO3A	100.0	1000.0
BMS345541	TLK1	82.0	10000.0
ALW-II-49-7	JAK2(Kin.Dom.2)	100.0	10000.0
R406	BLK	0.1	1000.0
MRT67307	HIPK2	35.0	10000.0
5z-7-oxozeaenol	MST1R	88.0	10000.0
Barasertib	PKMYT1	84.0	10000.0
Canertinib	TRKA	100.0	1000.0
JNK-IN-5A	LRRK2(G2019S)	94.0	10000.0
Ribociclib	KPCL	100.0	1000.0
KIN001-220	TAOK3	69.0	10000.0
RO-3306	PDPK1	95.0	10000.0
BMS-536924	CSNK1E	16.0	1000.0
JNK-IN-8	ERK8	100.0	1000.0
XMD8-85	CDKL5	100.0	10000.0
ERK5-IN-1	PIK3C2B	100.0	1000.0
AZ-628	CDK15	100.0	10000.0
CH5424802	PHKG1	1.3	1000.0
Baricitinib	IGF1R	98.0	10000.0
Omipalisib	AURKC	59.0	10000.0
JNK-9L	EPHB1	90.0	10000.0
WH-4-023	PFCDPK1(P.falciparum)	5.0	10000.0
Lapatinib	NEK11	81.0	10000.0
WZ-7043	RIPK1	100.0	10000.0
Palbociclib	HASP	92.0	1000.0
HG-6-64-01	MELK	20.0	10000.0
Torkinib	LRRK2	4.8	10000.0
BS-181	NLK	100.0	10000.0
JNK-IN-5A	KGP2	86.0	10000.0
SP600125	MKNK2	0.0	10000.0
PLX-4720	FLT3(D835Y)	31.0	10000.0
Abemaciclib	PIK3CA(H1047L)	100.0	1000.0
QL-X-138	AURKC	100.0	10000.0
QL-XI-92	CASK	83.0	10000.0
WZ3105	YSK4	15.0	10000.0
BI-2536	EGFR(G719C)	23.0	10000.0
Barasertib	DAPK1	80.0	10000.0
Barasertib	PIK3CA(M1043I)	100.0	10000.0
BI-2536	MP2K4	100.0	10000.0
Crizotinib	HUNK	74.0	10000.0
QL-X-138	IGF1R	100.0	10000.0
AZ-628	BRAF	0.0	10000.0
AZD4547	ABL1(Q252H)-phosphorylated	2.0	10000.0
BGJ398	TGFBR2	89.0	1000.0
PD0325901	MLK2	100.0	10000.0
TAK-715	VGFR1	31.0	10000.0
Dactolisib	PRKX	100.0	1000.0
XMD14-99	MELK	100.0	10000.0
Barasertib	TNK1	86.0	10000.0
XMD8-85	BRSK1	100.0	10000.0
BI-2536	RET(M918T)	100.0	10000.0
GW843682X	MAP3K1	1.6	10000.0
NPK76-II-72-1	BIKE	100.0	10000.0
GSK429286A	TEC	19.0	10000.0
HG-9-91-01	NEK10	0.0	10000.0
CGP74514A	ERBB2	78.0	10000.0
CP466722	ABL1(E255K)-phosphorylated	0.4	10000.0
XMD16-144	MRCKB	100.0	10000.0
HG-9-91-01	ABL1(Q252H)-nonphosphorylated	0.0	10000.0
Sorafenib	HIPK1	13.0	10000.0
Momelotinib	ERBB2	61.0	10000.0
BMX-IN-1	DCAMKL3	78.0	10000.0
THZ1	CAMK1D	42.0	10000.0
Vemurafenib	MAST1	100.0	10000.0
XMD8-85	MAP3K15	100.0	10000.0
KIN001-111	LCK	0.2	1000.0
CGP74514A	MAP4K4	93.0	10000.0
XMD16-144	CIT	86.0	10000.0
CG-930	SYK	100.0	10000.0
WZ-4-145	TAK1	100.0	10000.0
WYE-125132	ABL1(M351T)-phosphorylated	100.0	10000.0
CGP60474	ERK3	100.0	10000.0
BI-2536	CAMK1	100.0	10000.0
PHA-767491	FLT3(N841I)	39.0	10000.0
KU63794	ABL1(F317L)-nonphosphorylated	100.0	10000.0
HG-6-64-01	VRK2	92.0	10000.0
Neratinib	FGFR3	98.0	10000.0
JW-7-24-1	FLT3(D835Y)	4.0	10000.0
Neratinib	ABL1-nonphosphorylated	81.0	10000.0
NPK76-II-72-1	MYLK	2.8	10000.0
XMD11-85h	DAPK1	100.0	10000.0
JWE-035	FGFR3(G697C)	31.0	10000.0
XMD8-85	KC1G2	100.0	10000.0
XMD8-92	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
Palbociclib	FLT3(ITD)	87.0	1000.0
CH5424802	DMPK2	100.0	1000.0
Baricitinib	AKT2	81.0	10000.0
HG-14-8-02	CAMK2G	53.0	10000.0
JNK-IN-8	KIT(V559D)	1.0	1000.0
WZ-4-145	STK35	100.0	10000.0
Sorafenib	TSSK1	78.0	10000.0
BX-912	ERK8	1.8	10000.0
QL-XII-47	FGR	100.0	1000.0
Canertinib	BTK	100.0	1000.0
XMD8-85	MAP4K4	100.0	10000.0
Sigma A6730	NEK7	82.0	10000.0
JNK-IN-11	EPHB2	67.0	1000.0
Seliciclib	ULK2	94.0	10000.0
HG-5-113-01	PLK1	19.0	10000.0
WZ4002	DAPK2	28.0	10000.0
Seliciclib	KIT(V559D,T670I)	100.0	10000.0
JW-7-24-1	ADCK3	33.0	10000.0
QL-XII-47	PIK3CD	100.0	1000.0
HG-5-113-01	PIK3CD	100.0	10000.0
PLX-4720	KPCE	100.0	10000.0
JNK-IN-5A	DRAK2	100.0	10000.0
MLN8054	SRMS	54.0	10000.0
Sigma A6730	WNK3	95.0	10000.0
Momelotinib	NEK1	42.0	10000.0
HG-6-64-01	KGP1	100.0	10000.0
QL-XII-47	JAK1(JH1domain-catalytic)	97.0	1000.0
R406	LATS1	30.0	1000.0
WZ-4-145	LYN	5.0	10000.0
KIN001-220	CDK3	92.0	10000.0
JNK-IN-11	AXL	58.0	1000.0
AS-252424	GSK3A	64.9	10000.0
TAK-715	NEK7	100.0	10000.0
PD0325901	PGFRB	66.0	10000.0
Sigma A6730	STK35	100.0	10000.0
GW843682X	RIOK1	4.1	10000.0
JNK-IN-11	SNRK	100.0	1000.0
BMS-536924	TRKB	0.0	1000.0
WH-4-023	M3K12	73.0	10000.0
Lapatinib	ABL1(F317L)-phosphorylated	100.0	10000.0
TGX221	PAK2	100.0	1000.0
CH5424802	CSNK1G3	94.0	1000.0
Omipalisib	JNK3	54.0	10000.0
R406	KIT	0.0	1000.0
GSK461364	JAK1(JH1domain-catalytic)	100.0	10000.0
Dactolisib	KC1G1	100.0	1000.0
HG-14-10-04	MARK1	12.0	10000.0
Barasertib	IRAK1	63.0	10000.0
Torkinib	LOK	0.5	10000.0
5z-7-oxozeaenol	BTK	99.0	10000.0
AZ-628	MK14	0.0	10000.0
PD0325901	BLK	83.0	10000.0
Sigma A6730	TAK1	85.0	10000.0
MRT67307	CSNK1A1	100.0	10000.0
Crizotinib	LRRK2(G2019S)	57.0	10000.0
OTSSP167	PAK1	100.0	10000.0
XMD8-85	CSNK2A1	100.0	10000.0
WZ-7043	ACVR2B	100.0	10000.0
BX-912	CLK1	13.0	10000.0
AZD7762	ACVR2B	3.8	10000.0
BMX-IN-1	ROCK2	79.0	10000.0
GSK429286A	PAK6	90.0	10000.0
OTSSP167	MP2K3	1.0	10000.0
MLN8054	NDR2	100.0	10000.0
XMD14-99	RSK1(Kin.Dom.2-C-terminal)	58.0	10000.0
MLN8054	PIK3CA(E542K)	89.0	10000.0
Canertinib	RPS6KA1(Kin.Dom.1)	100.0	1000.0
JNK-IN-5A	FER	92.0	10000.0
Taselisib	TYK2(JH1domain-catalytic)	95.0	1000.0
Omipalisib	FYN	79.0	10000.0
JW-7-24-1	NLK	100.0	10000.0
Taselisib	WEE1	92.0	1000.0
AZD7762	GRK4	0.0	10000.0
JNK-IN-5A	CTK	100.0	10000.0
Palbociclib	BMPR1A	100.0	1000.0
Pictilisib	SGK2	100.0	1000.0
Seliciclib	VGFR2	100.0	10000.0
Buparlisib	DMPK	100.0	1000.0
WH-4-023	STK36	1.0	10000.0
QL-XI-92	SRPK2	89.0	10000.0
AZD7762	ERBB3	28.0	10000.0
Buparlisib	EPHB6	100.0	1000.0
MRT67307	LIMK1	93.0	10000.0
BI-2536	HCK	100.0	10000.0
BMX-IN-1	CAMK1G	68.0	10000.0
PLX-4720	LRRK2(G2019S)	38.0	10000.0
SB590885	MST1R	100.0	10000.0
GSK461364	CDK7	33.0	10000.0
PD0325901	EPHB2	73.0	10000.0
BI-2536	PIK3CG	100.0	10000.0
AZD4547	FGFR3	0.3	10000.0
TAK-715	NEK3	100.0	10000.0
SB590885	PIK3CA(C420R)	100.0	10000.0
SCH772984	MARK4	95.0	1000.0
ZG-10	CLK2	2.2	10000.0
Ceritinib	STK16	82.0	1000.0
ALW-II-38-3	CAMKK2	100.0	10000.0
R406	PDPK1	4.6	1000.0
Omipalisib	ERBB4	68.0	10000.0
Dabrafenib	CDK15	2.5	10000.0
PHA-767491	CDC2L5	3.1	10000.0
PD173074	IKKE	100.0	10000.0
WZ-7043	DAPK3	100.0	10000.0
Torkinib	MRCKA	74.0	10000.0
RO-3306	PIK4CB	56.0	10000.0
Momelotinib	MLK3	95.0	10000.0
BS-181	BUB1	90.0	10000.0
WZ4002	PHKG2	3.5	10000.0
Dactolisib	RPS6KA3(Kin.Dom.1)	100.0	1000.0
(s)-CR8	PIK3CA(E545A)	92.0	10000.0
Canertinib	SRPK1	100.0	1000.0
JNK-IN-5A	CSNK2A1	89.0	10000.0
HG-14-10-04	ADCK4	0.0	10000.0
THZ1	LRRK2(G2019S)	19.0	10000.0
PHA-793887	ZAP70	88.0	10000.0
WYE-125132	CDK2	92.0	10000.0
KIN001-021	IGF1R	100.0	1000.0
GSK1059615	LYN	92.0	10000.0
Crizotinib	DYRK2	9.6	10000.0
Sorafenib	EPHB2	17.0	10000.0
Pictilisib	TGFBR1	99.0	1000.0
Baricitinib	LTK	3.6	10000.0
Ceritinib	HASP	95.0	1000.0
BX-912	HUNK	73.0	10000.0
NVP-TAE684	MST2	0.3	1000.0
Pictilisib	ABL1(T315I)-phosphorylated	100.0	1000.0
JWE-035	AMPK-alpha2	5.0	10000.0
KIN001-220	PLK2	88.0	10000.0
Torin2	AURKA	100.0	10000.0
AZD7762	ABL1(Q252H)-phosphorylated	0.0	10000.0
Torin2	ACVRL1	59.0	10000.0
CP724714	FAK1	92.0	10000.0
Dinaciclib	RIPK2	84.0	10000.0
BMX-IN-1	KPCD	91.0	10000.0
WZ-4-145	MST3	18.0	10000.0
CP724714	TESK1	75.0	10000.0
ALW-II-49-7	FGR	100.0	10000.0
CGP74514A	ULK3	1.9	10000.0
ERK5-IN-1	MARK1	100.0	1000.0
JW-7-24-1	ERBB4	100.0	10000.0
Abemaciclib	FES	92.0	1000.0
(s)-CR8	TNK2	98.0	10000.0
JNK-IN-11	NEK2	93.0	1000.0
CP724714	ERBB2	0.0	10000.0
ZSTK474	MLK2	100.0	1000.0
Palbociclib	CAMK1	68.0	1000.0
MRT67307	ABL1(T315I)-phosphorylated	26.0	10000.0
XMD11-85h	PIK3CA(E542K)	100.0	10000.0
WZ-4-145	GCN2(Kin.Dom.2,S808G)	1.5	10000.0
GSK461364	PAK2	38.0	10000.0
GSK1059615	NEK11	72.0	10000.0
XMD16-144	KPCD1	15.0	10000.0
AZD7762	FYN	0.1	10000.0
Ibrutinib	ABL1-phosphorylated	54.0	1000.0
Sigma A6730	EPHA7	100.0	10000.0
SCH772984	JAK1(JH2domain-pseudokinase)	89.0	1000.0
HG-14-10-04	MK14	94.0	10000.0
Torkinib	TAK1	22.0	10000.0
HG-5-88-01	EPHB2	100.0	10000.0
MLN8054	TLK1	77.0	10000.0
GW843682X	PKAC-alpha	100.0	10000.0
WYE-125132	TSSK1	100.0	10000.0
CP466722	EGFR(E746-A750del)	50.0	10000.0
Ibrutinib	PKN1	71.0	1000.0
MRT67307	AXL	24.0	10000.0
ALW-II-38-3	MP2K4	100.0	10000.0
ZG-10	BIKE	31.0	10000.0
Dactolisib	IKKA	100.0	1000.0
A443654	MLK2	100.0	10000.0
Buparlisib	KIT-autoinhibited	100.0	1000.0
WZ4003	ADCK4	100.0	1000.0
Dactolisib	SYK	100.0	1000.0
WZ4002	KPCD2	15.0	10000.0
MLN8054	ABL1(T315I)-nonphosphorylated	0.8	10000.0
Buparlisib	EPHA8	100.0	1000.0
Taselisib	PGFRA	100.0	1000.0
XMD-12	PGFRB	61.0	1000.0
XMD14-99	EGFR(L747-E749del,A750P)	100.0	10000.0
Palbociclib	TNIK	71.0	1000.0
BI-2536	MK01	100.0	10000.0
NPK76-II-72-1	MAP3K3	100.0	10000.0
(s)-CR8	MET	89.0	10000.0
TAK-715	CDK14	99.0	10000.0
XMD11-85h	ICK	100.0	10000.0
NVP-TAE684	KPCD	28.0	1000.0
Ibrutinib	MUSK	97.0	1000.0
Buparlisib	JNK3	100.0	1000.0
Abemaciclib	STK33	32.0	1000.0
Torin2	ROCK1	79.0	10000.0
JNK-IN-11	MTOR	100.0	1000.0
Canertinib	PLK1	100.0	1000.0
XMD8-85	EPHB4	100.0	10000.0
Dinaciclib	ITK	91.0	10000.0
JNK-9L	AXL	28.0	10000.0
A443654	RET(V804M)	10.0	10000.0
PHA-793887	MK09	97.0	10000.0
NG25	EGFR(L747-S752del,P753S)	1.2	10000.0
Dinaciclib	AKT3	100.0	10000.0
MRT67307	STK33	7.1	10000.0
Canertinib	FGFR1	100.0	1000.0
Neratinib	M3K2	24.0	10000.0
Palbociclib	MP2K7	100.0	1000.0
WZ-4-145	LATS2	100.0	10000.0
AS-252424	LYN	91.0	10000.0
CH5424802	CDK4	100.0	1000.0
SCH772984	FGR	100.0	1000.0
WH-4-023	MAPKAPK5	100.0	10000.0
Sorafenib	DAPK1	99.0	10000.0
JNK-IN-8	KIT	3.5	1000.0
JNK-9L	RIOK1	3.8	10000.0
WZ-7043	CSK	100.0	10000.0
BMX-IN-1	M3K2	100.0	10000.0
PD0325901	HIPK1	91.0	10000.0
RO-3306	MYLK	13.0	10000.0
GW843682X	LATS1	100.0	10000.0
WZ4003	MAP4K5	100.0	1000.0
NG25	MK14	0.0	10000.0
RO-3306	TGFBR2	58.0	10000.0
ZG-10	MK01	77.0	10000.0
JNK-IN-8	SRMS	94.0	1000.0
WZ-7043	INSR	100.0	10000.0
CG-930	AXL	86.0	10000.0
CGP74514A	MAP3K3	4.8	10000.0
KU63794	SNARK	100.0	10000.0
Buparlisib	CSNK1E	98.0	1000.0
XMD14-99	PIK3CA(E542K)	100.0	10000.0
WYE-125132	PIM1	100.0	10000.0
CG-930	MET(Y1235D)	100.0	10000.0
Crizotinib	ERBB4	93.0	10000.0
JNK-IN-11	OSR1	100.0	1000.0
AZD 5438	KGP2	84.0	10000.0
QL-XI-92	SIK1	97.0	10000.0
XMD11-85h	GSK3B	100.0	10000.0
WZ4002	RIOK1	17.0	10000.0
AG1478	AURKB	40.0	10000.0
WZ-7043	ROS1	100.0	10000.0
AS-252424	TYK2(JH1domain-catalytic)	82.9	10000.0
AZD4547	MST3	3.6	10000.0
(s)-CR8	IKKA	98.0	10000.0
CP466722	MK11	8.2	10000.0
NPK76-II-72-1	KC1G2	100.0	10000.0
KIN001-220	AAK1	7.0	10000.0
NPK76-II-72-1	GSK3B	100.0	10000.0
KIN001-111	RPS6KA1(Kin.Dom.1)	8.4	1000.0
A443654	KPCL	1.4	10000.0
GSK429286A	ABL2	86.0	10000.0
KIN001-111	MET	8.3	1000.0
CH5424802	DYRK2	66.0	1000.0
CGP74514A	EPHA1	13.0	10000.0
SP600125	MLK3	100.0	10000.0
ZSTK474	EPHA5	100.0	1000.0
AZ-628	PAK6	84.0	10000.0
BGJ398	NEK7	81.0	1000.0
KIN001-123	CDK9	100.0	1000.0
KIN001-111	CDC2L2	100.0	1000.0
Omipalisib	GRK7	69.0	10000.0
AZD 5438	RIPK5	3.3	10000.0
HG-9-91-01	PIK4CB	98.0	10000.0
WZ-4-145	ACVR1B	100.0	10000.0
QL-X-138	PIK3C2B	53.0	10000.0
ALW-II-49-7	DMPK2	100.0	10000.0
Sorafenib	CSNK1A1L	98.0	10000.0
KU63794	MAP4K2	86.0	10000.0
CG-930	TYRO3	100.0	10000.0
BMS345541	HIPK1	21.0	10000.0
HG-5-88-01	KGP1	100.0	10000.0
HG-6-64-01	PI42C	100.0	10000.0
Pictilisib	PIK3C2B	18.0	1000.0
GW843682X	CSNK1E	77.0	10000.0
BMX-IN-1	RET	96.0	10000.0
WZ-4-145	TAOK1	0.8	10000.0
BMS-536924	MP2K2	0.0	1000.0
Ibrutinib	HCK	0.6	1000.0
AZD-6482	CDK16	100.0	10000.0
GW843682X	ERK8	46.0	10000.0
Dabrafenib	YSK1	10.0	10000.0
TGX221	TYK2(Kin.Dom.1)	100.0	1000.0
Ceritinib	CDK4-cyclinD3	81.0	1000.0
HG-9-91-01	PIK3CA(Q546K)	100.0	10000.0
ALW-II-49-7	DCLK1	100.0	10000.0
WZ4002	FLT3(K663Q)	1.1	10000.0
AZD-6482	RIOK1	100.0	10000.0
Buparlisib	DYRK1A	100.0	1000.0
CG-930	CDC2L1	91.0	10000.0
AZ-628	TAK1	17.0	10000.0
Dinaciclib	MELK	84.0	10000.0
QL-XI-92	PKNB(M.tuberculosis)	75.0	10000.0
Neratinib	PIK3CA(Q546K)	100.0	10000.0
AZD 5438	DDR2	15.0	10000.0
GSK1059615	CLK3	0.1	10000.0
Ribociclib	FGFR2	100.0	1000.0
WZ3105	FLT3(D835H)	5.4	10000.0
Torin1	ABL1(Q252H)-nonphosphorylated	89.0	10000.0
BMX-IN-1	TRKB	78.0	10000.0
Sigma A6730	BIKE	89.0	10000.0
Torkinib	AAK1	31.0	10000.0
KIN001-220	NEK6	8.4	10000.0
GW-5074	FLT3(R834Q)	100.0	10000.0
MRT67307	AMPK-alpha2	18.0	10000.0
ALW-II-38-3	DRAK1	100.0	10000.0
XMD11-50	DCAMKL2	0.5	10000.0
Lapatinib	MK14	100.0	10000.0
Torin1	TRPM6	100.0	10000.0
Torin2	FLT4	85.0	10000.0
Torin2	MP2K5	84.0	10000.0
WZ4002	KIT	34.0	10000.0
Buparlisib	MLK2	69.0	1000.0
CG-930	RPS6KA5(Kin.Dom.1-N-terminal)	68.0	10000.0
ALW-II-38-3	BRSK1	100.0	10000.0
5z-7-oxozeaenol	STK33	100.0	10000.0
Crizotinib	RSK1(Kin.Dom.2-C-terminal)	54.0	10000.0
HG-5-88-01	ERBB2	18.0	10000.0
BI-D1870	PAK6	21.0	10000.0
BMX-IN-1	RSK2(Kin.Dom.1-N-terminal)	100.0	10000.0
Alpelisib	RAF1	100.0	1000.0
XMD11-85h	MP2K2	100.0	10000.0
Sorafenib	MST1	81.0	10000.0
Barasertib	TEC	78.0	10000.0
Torin1	CDK14	99.0	10000.0
GSK1059615	FGFR3	100.0	10000.0
AG1478	EPHA6	11.0	10000.0
Torkinib	EGFR(L858R,T790M)	51.0	10000.0
Ceritinib	CSF1R	83.0	1000.0
ERK5-IN-1	TRKC	90.0	1000.0
Omipalisib	KPCL	100.0	10000.0
XMD16-144	ABL1(F317I)-phosphorylated	4.0	10000.0
TGX221	JAK2(Kin.Dom.2)	100.0	1000.0
QL-XII-47	PGFRA	69.0	1000.0
Ceritinib	PAK3	59.0	1000.0
JNK-IN-8	CDK11	62.0	1000.0
Torkinib	PIK3CD	0.0	10000.0
PHA-767491	ACVR2B	6.0	10000.0
NG25	LATS1	100.0	10000.0
KIN001-127	FYN	100.0	10000.0
ZG-10	MST3	100.0	10000.0
NPK76-II-72-1	RPS6KA4(Kin.Dom.2)	100.0	10000.0
HG-14-8-02	BMPR1A	100.0	10000.0
QL-X-138	CSNK1E	88.0	10000.0
MRT67307	NLK	100.0	10000.0
BMS-536924	PIK3CA(E545K)	100.0	1000.0
XMD8-85	DYRK1B	100.0	10000.0
Palbociclib	CDKL5	99.0	1000.0
GW843682X	CLK2	47.0	10000.0
WZ4002	CAMKK2	10.0	10000.0
5z-7-oxozeaenol	PHKG1	97.0	10000.0
QL-XII-47	ABL1(T315I)-phosphorylated	100.0	1000.0
RO-3306	MST1R	100.0	10000.0
Momelotinib	ABL1(F317I)-nonphosphorylated	95.0	10000.0
PLX-4720	SYK	100.0	10000.0
SP600125	PIK3CB	100.0	10000.0
Sorafenib	ERK3	100.0	10000.0
BMS345541	BMX	96.0	10000.0
XMD8-85	TNIK	100.0	10000.0
WZ-4-145	MLK3	10.0	10000.0
JNK-IN-5A	TLK2	100.0	10000.0
BS-181	GRK4	91.0	10000.0
PLX-4720	ULK1	44.0	10000.0
Torkinib	IKKE	70.0	10000.0
CG-930	ROS1	95.0	10000.0
ERK5-IN-1	BLK	100.0	1000.0
(s)-CR8	GRK4	94.0	10000.0
MLN8054	PGFRA	56.0	10000.0
ZG-10	YSK1	83.0	10000.0
QL-XI-92	EGFR(L747-E749del,A750P)	100.0	10000.0
R406	PCTK2	12.0	1000.0
GSK461364	NEK4	69.0	10000.0
KIN001-220	LATS1	100.0	10000.0
WZ4002	KIT(D816V)	13.0	10000.0
GSK1059615	LCK	62.0	10000.0
CH5424802	TEC	100.0	1000.0
GW-5074	IGF1R	97.0	10000.0
Ibrutinib	KPCD3	100.0	1000.0
Abemaciclib	PLK4	13.0	1000.0
AZD7762	KGP2	0.5	10000.0
AG1478	RAF1	84.0	10000.0
Seliciclib	RIPK1	100.0	10000.0
CG-930	MAP3K3	83.0	10000.0
NPK76-II-72-1	ROS1	100.0	10000.0
XMD11-85h	AURKA	100.0	10000.0
Alpelisib	IKKB	100.0	1000.0
CG-930	HIPK3	95.0	10000.0
MRT67307	IRAK3	11.0	10000.0
Dactolisib	LTK	33.0	1000.0
BS-181	FGFR1	100.0	10000.0
Baricitinib	SIK3	55.0	10000.0
NG25	MLK3	25.0	10000.0
PLX-4720	MARK2	92.0	10000.0
JNK-IN-5A	KKCC1	91.0	10000.0
XMD8-85	MYLK	13.0	10000.0
WZ3105	KIT(D816V)	10.0	10000.0
Torin1	NUAK1	100.0	10000.0
TGX221	M4K1	100.0	1000.0
AS-252424	SRMS	100.0	10000.0
PD0325901	CDC2L2	100.0	10000.0
XMD11-50	ACVRL1	100.0	10000.0
WZ4003	DAPK2	34.0	1000.0
HG-5-113-01	TNK1	4.0	10000.0
AZD-6482	CDK9	100.0	10000.0
JNK-IN-8	CDK15	100.0	1000.0
ZM-447439	DCAMKL2	100.0	10000.0
GSK461364	FAK2	82.0	10000.0
BI-D1870	NEK7	3.4	10000.0
WZ3105	LATS2	70.0	10000.0
CH5424802	MK01	100.0	1000.0
Ceritinib	JAK2(JH1domain-catalytic)	77.0	1000.0
Alpelisib	RSK1(Kin.Dom.1-N-terminal)	100.0	1000.0
JNK-IN-8	CDK4-cyclinD3	60.0	1000.0
PD0325901	BMPR1B	100.0	10000.0
CGP60474	TGFBR2	100.0	10000.0
JNK-IN-5A	CDKL1	73.0	10000.0
WZ3105	MK01	93.0	10000.0
Ceritinib	MST2	100.0	1000.0
GW-5074	GSK3A	100.0	10000.0
KIN001-220	PIK3CA(H1047Y)	62.0	10000.0
Ceritinib	RIPK4	96.0	1000.0
CGP60474	ADCK3	100.0	10000.0
JNK-IN-8	ULK2	96.0	1000.0
ZM-447439	KIT(V559D)	0.0	10000.0
ERK5-IN-1	PIP5K2B	100.0	1000.0
NU7441	PIK3CA(C420R)	19.0	10000.0
JNK-IN-11	PIK3CA	99.0	1000.0
PHA-767491	ULK2	6.4	10000.0
WZ4002	IKKA	100.0	10000.0
GSK429286A	CSNK2A2	86.0	10000.0
JNK-IN-8	PTK6	100.0	1000.0
SP600125	DAPK1	1.4	10000.0
ZM-447439	RSK4(Kin.Dom.1-N-terminal)	68.0	10000.0
TAK-715	CLK3	78.0	10000.0
AZ-628	RSK4(Kin.Dom.2-C-terminal)	3.5	10000.0
Baricitinib	DRAK1	0.5	10000.0
Omipalisib	TYRO3	100.0	10000.0
WH-4-023	RET(M918T)	0.1	10000.0
WH-4-023	CLK1	84.0	10000.0
BI-2536	KPCD2	16.0	10000.0
GSK461364	PRKX	100.0	10000.0
AZD 5438	SgK110	82.0	10000.0
PLX-4720	PIK3CA(M1043I)	76.0	10000.0
PLX-4720	PIK3CG	83.0	10000.0
Pictilisib	RIPK4	100.0	1000.0
AZD4547	MK13	100.0	10000.0
AZD 5438	ALK(L1196M)	84.0	10000.0
XMD8-92	AXL	100.0	10000.0
Ceritinib	MINK	70.0	1000.0
CP466722	PIK3CD	5.0	10000.0
AZD7762	JAK1(JH2domain-pseudokinase)	2.5	10000.0
TAK-715	FGFR3(G697C)	93.0	10000.0
GSK429286A	TIE2	83.0	10000.0
QL-X-138	KKCC1	59.0	10000.0
ZSTK474	PIK3CG	1.4	1000.0
Sorafenib	PRKX	100.0	10000.0
AZ-628	PIK3CA(Q546K)	88.0	10000.0
ALW-II-49-7	PRKR	100.0	10000.0
Momelotinib	SLK	100.0	10000.0
AZD-6482	PIK3CA(H1047Y)	4.2	10000.0
Crizotinib	MKNK2	11.0	10000.0
Buparlisib	CAMK2A	100.0	1000.0
Crizotinib	IKKB	14.0	10000.0
KIN001-123	LKB1	100.0	1000.0
XMD16-144	MAP4K2	13.0	10000.0
ERK5-IN-1	LIMK1	100.0	1000.0
HG-5-113-01	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
JNK-IN-5A	RSK1(Kin.Dom.2-C-terminal)	78.0	10000.0
AZ-628	ERBB3	100.0	10000.0
GW843682X	PIK3CA(Q546K)	96.0	10000.0
Vemurafenib	RSK1(Kin.Dom.2-C-terminal)	59.0	10000.0
JWE-035	JAK1(JH1domain-catalytic)	93.0	10000.0
HG-5-88-01	M3K12	100.0	10000.0
Neratinib	PKMYT1	84.0	10000.0
Crizotinib	ERK8	80.0	10000.0
PD0325901	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
Pictilisib	MYO3A	100.0	1000.0
WZ-4-145	ABL1(E255K)	100.0	10000.0
SB590885	TLK2	86.0	10000.0
QL-XI-92	GRK4	100.0	10000.0
Abemaciclib	VGFR1	87.0	1000.0
XMD11-85h	EPHA6	100.0	10000.0
Neratinib	EGFR(L858R)	0.0	10000.0
JNK-IN-8	HIPK2	71.0	1000.0
ZG-10	SIK3	64.0	10000.0
CH5424802	MET(M1250T)	92.0	1000.0
Sorafenib	TRKC	0.7	10000.0
QL-X-138	DCLK1	94.0	10000.0
CGP74514A	TYRO3	33.0	10000.0
NVP-TAE684	TYRO3	24.0	1000.0
R406	LIMK1	6.2	1000.0
AG1478	TYK2(JH1domain-catalytic)	52.0	10000.0
Dabrafenib	TLK1	88.0	10000.0
BX-912	DDR2	65.0	10000.0
Seliciclib	SNARK	100.0	10000.0
Alpelisib	YSK1	100.0	1000.0
Palbociclib	DCAMKL3	4.3	1000.0
GSK461364	NLK	100.0	10000.0
Canertinib	MK09	100.0	1000.0
XMD11-85h	LCK	100.0	10000.0
PD0325901	KGP2	86.0	10000.0
A443654	FAK1	100.0	10000.0
XMD14-99	FES	45.0	10000.0
AZD-6482	AMPK-alpha2	88.0	10000.0
BS-181	MAPKAPK5	97.0	10000.0
BGJ398	CSNK2A1	82.0	1000.0
CGP74514A	ALK(L1196M)	28.0	10000.0
CP466722	PIK3CA(C420R)	41.0	10000.0
AG1478	ABL1-phosphorylated	0.9	10000.0
GW-5074	MK13	100.0	10000.0
BX-912	PKAC-beta	1.0	10000.0
JNK-IN-5A	M3K12	79.0	10000.0
NU7441	CSNK1A1	78.0	10000.0
ALW-II-49-7	NLK	100.0	10000.0
AS-252424	MST1R	85.4	10000.0
RO-3306	HCK	87.0	10000.0
TAK-715	KC1G1	28.0	10000.0
PLX-4720	PIP5K1A	100.0	10000.0
JNK-9L	MAP4K2	10.0	10000.0
Pictilisib	SLK	87.0	1000.0
NG25	AURKA	100.0	10000.0
XMD8-92	DYRK2	100.0	10000.0
Ibrutinib	IKKA	91.0	1000.0
PD173074	LIMK2	100.0	10000.0
Pictilisib	BMPR1B	100.0	1000.0
CP466722	TRKC	100.0	10000.0
Dabrafenib	MARK3	97.0	10000.0
KIN001-111	TGFBR2	100.0	1000.0
WZ3105	MELK	25.0	10000.0
QL-X-138	SIK1	77.0	10000.0
NG25	BRSK2	100.0	10000.0
BS-181	FER	90.0	10000.0
Sorafenib	ULK1	100.0	10000.0
HG-5-113-01	MLK1	0.9	10000.0
Barasertib	ACVR2A	100.0	10000.0
GSK1059615	PRP4	88.0	10000.0
JNK-IN-11	YSK4	62.0	1000.0
Crizotinib	MP2K4	93.0	10000.0
Abemaciclib	KIT(D816V)	95.0	1000.0
TGX221	TXK	100.0	1000.0
XMD11-85h	AKT2	100.0	10000.0
ERK5-IN-1	PIK3CA	100.0	1000.0
NU7441	RSK3(Kin.Dom.1-N-terminal)	97.0	10000.0
CH5424802	MK03	100.0	1000.0
BMX-IN-1	YSK4	65.0	10000.0
CP724714	MYO3B	100.0	10000.0
ALW-II-38-3	MAK	100.0	10000.0
WYE-125132	NEK6	90.0	10000.0
WZ-4-145	TLK2	100.0	10000.0
Momelotinib	EGFR(E746-A750del)	100.0	10000.0
CGP60474	TAOK1	31.0	10000.0
Pictilisib	PIM1	100.0	1000.0
KIN001-220	EPHA2	51.0	10000.0
CGP74514A	CAMK2A	67.0	10000.0
XMD8-92	KC1G1	100.0	10000.0
HG-6-64-01	MST1	21.0	10000.0
Dabrafenib	PIK3CG	94.0	10000.0
Pictilisib	DMPK2	100.0	1000.0
GSK461364	KC1G2	97.0	10000.0
XMD8-85	GRK1	100.0	10000.0
Momelotinib	RET(V804L)	64.0	10000.0
JNK-9L	CDK4-cyclinD1	100.0	10000.0
Sorafenib	RPS6KA4(Kin.Dom.1-N-terminal)	85.0	10000.0
CH5424802	PHKG2	3.4	1000.0
Baricitinib	GRK1	4.1	10000.0
Vemurafenib	CDK14	100.0	10000.0
Omipalisib	DYRK1B	62.0	10000.0
GW843682X	TNIK	32.0	10000.0
Torin2	GSK3A	100.0	10000.0
CGP60474	FGFR1	100.0	10000.0
Taselisib	MST1	84.0	1000.0
SP600125	TESK1	100.0	10000.0
QL-X-138	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
HG-6-64-01	HIPK1	74.0	10000.0
XMD14-99	PIP5K1A	88.0	10000.0
TGX221	LIMK2	100.0	1000.0
NPK76-II-72-1	ABL1(F317I)	100.0	10000.0
GSK429286A	TIE1	75.0	10000.0
CH5424802	MKNK1	93.0	1000.0
MRT67307	MARK2	59.0	10000.0
KIN001-220	RIOK3	0.2	10000.0
A443654	AURKB	100.0	10000.0
AZD7762	YANK2	1.0	10000.0
HG-14-8-02	MAP4K2	98.0	10000.0
ERK5-IN-1	IKKE	100.0	1000.0
AZ-628	MP2K6	100.0	10000.0
AZD 5438	DMPK2	88.0	10000.0
KIN001-021	FLT3(N841I)	100.0	1000.0
Momelotinib	ERK5	48.0	10000.0
WZ4002	GSK3A	100.0	10000.0
MRT67307	IKKE	4.2	10000.0
MLN8054	FER	22.0	10000.0
ERK5-IN-1	EGFR(L747-S752del,P753S)	100.0	1000.0
5z-7-oxozeaenol	IGF1R	80.0	10000.0
AZD-6482	TAK1	89.0	10000.0
BX-912	PIK3CA(M1043I)	95.0	10000.0
JWE-035	SIK1	27.0	10000.0
NPK76-II-72-1	CDK2	100.0	10000.0
WH-4-023	EGFR(S752-I759del)	1.0	10000.0
BMS345541	MP2K5	96.0	10000.0
Momelotinib	MAP3K4	92.0	10000.0
HG-5-113-01	KC1G1	16.0	10000.0
WZ-7043	ABL1(T315I)	100.0	10000.0
HG-9-91-01	LOK	0.0	10000.0
Alpelisib	ABL1(T315I)-phosphorylated	100.0	1000.0
SB590885	ABL1(F317I)-nonphosphorylated	72.0	10000.0
WYE-125132	PIM3	100.0	10000.0
CGP74514A	PLK3	54.0	10000.0
XMD-12	EGFR(G719C)	100.0	1000.0
BGJ398	SIK3	83.0	1000.0
PHA-793887	MAP4K4	60.0	10000.0
Baricitinib	GAK	8.5	10000.0
XMD16-144	RSK1(Kin.Dom.2-C-terminal)	39.0	10000.0
NVP-TAE684	MET	0.0	1000.0
XMD8-85	ABL1(E255K)	100.0	10000.0
GSK1059615	M4K3	67.0	10000.0
Crizotinib	LYN	13.0	10000.0
Dinaciclib	MST3	20.0	10000.0
OTSSP167	VGFR2	0.3	10000.0
Pictilisib	EGFR(L747-E749del,A750P)	100.0	1000.0
HG-9-91-01	TGFBR1	0.0	10000.0
Taselisib	KIT	100.0	1000.0
Barasertib	TXK	100.0	10000.0
Canertinib	LIMK2	100.0	1000.0
A443654	RPS6KA6(Kin.Dom.2)	100.0	10000.0
Palbociclib	ABL1(Y253F)-phosphorylated	100.0	1000.0
THZ1	DAPK3	26.0	10000.0
Sorafenib	M3K12	57.0	10000.0
GW843682X	PIK3C2G	100.0	10000.0
Vemurafenib	CDKL5	100.0	10000.0
Dactolisib	MAP4K2	11.0	1000.0
CP724714	RSK2(Kin.Dom.1-N-terminal)	92.0	10000.0
JNK-IN-8	KPCT	100.0	1000.0
QL-XII-47	LTK	100.0	1000.0
GSK429286A	CLK4	100.0	10000.0
QL-XI-92	INSRR	100.0	10000.0
WH-4-023	EGFR(E746-A750del)	0.0	10000.0
Torkinib	ERK3	52.0	10000.0
Taselisib	DCAMKL3	100.0	1000.0
JNK-IN-11	CAMK2G	100.0	1000.0
WZ3105	LRRK2	61.0	10000.0
WZ4002	ACVR1	100.0	10000.0
Vemurafenib	RPS6KA5(Kin.Dom.1-N-terminal)	98.0	10000.0
ZG-10	MAP3K4	71.0	10000.0
RO-3306	TTK	65.0	10000.0
BI-2536	NDR2	100.0	10000.0
XMD14-99	KIT(L576P)	100.0	10000.0
ZSTK474	PDPK1	100.0	1000.0
XMD16-144	ABL1(T315I)-nonphosphorylated	0.0	10000.0
Pictilisib	KGP2	99.0	1000.0
Dinaciclib	JAK3(JH1domain-catalytic)	83.0	10000.0
BMS-536924	KIT	0.9	1000.0
OTSSP167	MLCK	2.2	10000.0
PHA-793887	EPHA4	100.0	10000.0
QL-XII-47	DYRK1B	68.0	1000.0
MLN8054	MP2K7	100.0	10000.0
THZ1	TAOK3	18.0	10000.0
ALW-II-49-7	MYLK	100.0	10000.0
SCH772984	NEK3	95.0	1000.0
Torkinib	PIK3CA(H1047Y)	23.0	10000.0
ZG-10	FGFR3	96.0	10000.0
Sorafenib	EGFR(L747-S752del,P753S)	75.0	10000.0
Sorafenib	M3K6	100.0	10000.0
Pictilisib	LIMK1	100.0	1000.0
GSK1059615	LKB1	12.0	10000.0
Omipalisib	IRAK4	67.0	10000.0
OTSSP167	LRRK2(G2019S)	100.0	10000.0
MPS-1-IN-1	MP2K4	6.2	1000.0
SB590885	VGFR2	100.0	10000.0
WZ-4-145	AURKC	100.0	10000.0
GW843682X	PCTK2	100.0	10000.0
ALW-II-49-7	PDPK1	100.0	10000.0
AZD4547	WEE2	80.0	10000.0
GW843682X	PAK4	100.0	10000.0
Momelotinib	ERBB4	100.0	10000.0
Crizotinib	FGFR1	46.0	10000.0
HG-5-113-01	ABL2	9.4	10000.0
WZ3105	EPHA2	60.0	10000.0
(s)-CR8	PKAC-beta	95.0	10000.0
HG-6-64-01	CAMK1	30.0	10000.0
AZD4547	LOK	0.0	10000.0
PHA-793887	MKNK2	99.0	10000.0
JWE-035	RIPK5	7.1	10000.0
PLX-4720	STK39	100.0	10000.0
Ibrutinib	TRKB	62.0	1000.0
WZ3105	PKAC-alpha	100.0	10000.0
CP724714	ABL1(F317L)-phosphorylated	100.0	10000.0
ERK5-IN-1	MAPKAPK2	100.0	1000.0
BI-2536	RIPK2	100.0	10000.0
PHA-767491	IGF1R	100.0	10000.0
HG-14-8-02	PRP4	67.0	10000.0
XMD16-144	PKN1	69.0	10000.0
SP600125	LIMK1	100.0	10000.0
CGP74514A	ABL1(F317I)-nonphosphorylated	35.0	10000.0
KU63794	EGFR(E746-A750del)	100.0	10000.0
JW-7-24-1	EPHA7	100.0	10000.0
BX-912	ABL1(F317I)-phosphorylated	7.3	10000.0
GW-5074	MUSK	74.0	10000.0
BMS345541	TESK1	79.0	10000.0
WZ-7043	RIOK3	100.0	10000.0
WH-4-023	KPCE	27.0	10000.0
KU63794	LATS2	89.0	10000.0
MRT67307	IGF1R	91.0	10000.0
KIN001-127	PAK6	100.0	10000.0
Seliciclib	TNIK	52.0	10000.0
JNK-IN-8	BMPR2	77.0	1000.0
Alpelisib	DAPK3	93.0	1000.0
NVP-TAE684	TGFBR2	2.7	1000.0
CGP74514A	VRK2	18.0	10000.0
WH-4-023	FLT3(D835H)	3.0	10000.0
XMD13-2	PIK3CA(H1047L)	98.0	10000.0
XMD11-50	EPHA4	89.0	10000.0
WYE-125132	CSF1R-autoinhibited	100.0	10000.0
AZD4547	ERK8	51.0	10000.0
Vemurafenib	STK39	100.0	10000.0
Torkinib	DCAMKL2	100.0	10000.0
Ceritinib	FGFR1	88.0	1000.0
Torin1	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
Vemurafenib	NUAK1	100.0	10000.0
WZ-4-145	RET(V804M)	100.0	10000.0
WYE-125132	MLK2	100.0	10000.0
CP466722	CSK	43.0	10000.0
Abemaciclib	ULK3	35.0	1000.0
Dinaciclib	EGFR(G719S)	100.0	10000.0
HG-5-113-01	ERBB2	100.0	10000.0
Torin1	TEC	99.0	10000.0
ZG-10	FLT3(K663Q)	34.0	10000.0
AZD7762	RPS6KA5(Kin.Dom.1-N-terminal)	49.0	10000.0
Crizotinib	KIT(D816H)	50.0	10000.0
XMD8-92	CDKL2	100.0	10000.0
Sorafenib	AMPK-alpha2	74.0	10000.0
R406	KIT(V559D)	0.0	1000.0
OTSSP167	CHK2	100.0	10000.0
KIN001-021	NDR2	100.0	1000.0
JW-7-24-1	PDPK1	100.0	10000.0
Crizotinib	RIPK5	1.6	10000.0
Sigma A6730	CDK5	100.0	10000.0
Seliciclib	DCAMKL2	93.0	10000.0
Momelotinib	ERK3	71.0	10000.0
KIN001-021	ABL1(H396P)	100.0	1000.0
CH5424802	BRAF	100.0	1000.0
SP600125	FER	100.0	10000.0
PHA-793887	CSNK1E	55.0	10000.0
Torin1	AURKA	100.0	10000.0
Torin1	EGFR(L858R,T790M)	100.0	10000.0
WZ-4-145	SRC	6.6	10000.0
PHA-793887	TRKA	92.0	10000.0
KIN001-111	STK33	100.0	1000.0
XMD8-92	MUSK	100.0	10000.0
GW-5074	KGP1	100.0	10000.0
PD173074	MK09	100.0	10000.0
Dactolisib	PIP5K2B	100.0	1000.0
JWE-035	MK09	57.0	10000.0
CGP60474	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
ZM-447439	ULK3	7.3	10000.0
Momelotinib	HASP	67.0	10000.0
Torin2	PIK3CG	0.2	10000.0
A443654	TYK2(Kin.Dom.2)	100.0	10000.0
KIN001-127	KPCL	100.0	10000.0
CP724714	MET	74.0	10000.0
NU7441	PIM1	62.0	10000.0
Crizotinib	FAK1	0.0	10000.0
Pictilisib	ABL1(E255K)-phosphorylated	85.0	1000.0
Crizotinib	EGFR(L747-S752del,P753S)	66.0	10000.0
Sorafenib	M3K2	100.0	10000.0
WYE-125132	FGFR4	62.0	10000.0
AZ-628	PIK3CA(I800L)	100.0	10000.0
Crizotinib	ABL1(T315I)-phosphorylated	0.6	10000.0
Crizotinib	PIM3	100.0	10000.0
NG25	ABL1	0.1	10000.0
HG-14-8-02	STK36	100.0	10000.0
AZD-6482	ABL1(F317I)-phosphorylated	100.0	10000.0
(s)-CR8	CDK3	69.0	10000.0
Torkinib	NEK2	75.0	10000.0
PHA-793887	AKT3	98.0	10000.0
Palbociclib	RIPK2	96.0	1000.0
AZD7762	AURKB	4.8	10000.0
Dinaciclib	SLK	100.0	10000.0
XMD11-50	HIPK2	88.0	10000.0
AZ-628	MAK	100.0	10000.0
Dinaciclib	M4K1	98.0	10000.0
Dactolisib	ABL1(H396P)	100.0	1000.0
PHA-767491	RAF1	100.0	10000.0
Palbociclib	TGFBR2	100.0	1000.0
Pictilisib	NDR2	100.0	1000.0
NU7441	NIM1	100.0	10000.0
AZD 5438	PAK4	27.0	10000.0
HG-14-8-02	ABL1(F317I)-phosphorylated	29.0	10000.0
KIN001-123	MAP4K4	100.0	1000.0
ZSTK474	PHKG1	100.0	1000.0
BX-912	TIE1	2.2	10000.0
BS-181	FLT3(D835Y)	70.0	10000.0
SB590885	DDR2	67.0	10000.0
Momelotinib	EPHB1	91.0	10000.0
BI-D1870	TAOK3	0.6	10000.0
CG-930	ACVR1B	99.0	10000.0
AZ-628	ADCK3	100.0	10000.0
ALW-II-49-7	LCK	1.9	1000.0
ALW-II-49-7	TGFBR2	100.0	10000.0
HG-6-64-01	PIK3CA(C420R)	100.0	10000.0
PD173074	PAK1	100.0	10000.0
JWE-035	BRAF(V600E)	100.0	10000.0
JNK-IN-11	KIT(L576P)	3.0	1000.0
Seliciclib	EIF2AK1	100.0	10000.0
JNK-IN-8	MET(Y1235D)	100.0	1000.0
Ceritinib	SRPK3	72.0	1000.0
HG-14-8-02	S6K1	100.0	10000.0
GSK461364	ABL1(M351T)-phosphorylated	93.0	10000.0
KIN001-220	FGFR3(G697C)	21.0	10000.0
HG-5-88-01	MK13	100.0	10000.0
AG1478	PIP5K1A	93.0	10000.0
Taselisib	CSNK1A1	100.0	1000.0
JNK-IN-11	CDK15	100.0	1000.0
RO-3306	ROCK2	9.9	10000.0
ALW-II-49-7	EPHB3	3.3	1000.0
GW843682X	LRRK2(G2019S)	60.0	10000.0
Seliciclib	M3K12	100.0	10000.0
JNK-IN-8	RIOK2	10.0	1000.0
AS-252424	ERK4	100.0	10000.0
Canertinib	CLK1	100.0	1000.0
PD0325901	MLK3	100.0	10000.0
BMS-536924	TXK	7.0	1000.0
Neratinib	IRAK4	96.0	10000.0
CP724714	RSK4(Kin.Dom.2-C-terminal)	88.0	10000.0
Canertinib	PGFRB	100.0	1000.0
Seliciclib	CDKL1	62.0	10000.0
JNK-IN-11	PRKR	92.0	1000.0
Omipalisib	ACVRL1	99.0	10000.0
AZD-6482	YSK4	100.0	10000.0
XMD8-85	RAF1	100.0	10000.0
A443654	PKMYT1	100.0	10000.0
JNK-9L	KCC4	100.0	10000.0
PD173074	EGFR	100.0	10000.0
Ribociclib	FLT3(ITD)	100.0	1000.0
ZSTK474	BIKE	100.0	1000.0
KU63794	FGR	100.0	10000.0
WZ3105	SIK2	69.0	10000.0
A443654	PKAC-alpha	0.9	10000.0
AZD4547	MK03	100.0	10000.0
ZG-10	BMPR2	28.0	10000.0
CH5424802	CSK	92.0	1000.0
JW-7-24-1	JAK1(Kin.Dom.1)	29.0	10000.0
BMS-536924	RIPK4	100.0	1000.0
AZD7762	RSK4(Kin.Dom.1-N-terminal)	0.3	10000.0
BX-912	PRKR	31.0	10000.0
XMD16-144	NUAK1	0.9	10000.0
WH-4-023	FLT4	16.0	10000.0
QL-XI-92	VGFR1	100.0	10000.0
CGP74514A	CTK	12.0	10000.0
PD173074	JNK1	100.0	10000.0
5z-7-oxozeaenol	ULK3	83.0	10000.0
NU7441	CAMK2B	80.0	10000.0
RO-3306	TIE2	95.0	10000.0
QL-XI-92	TNK1	85.0	10000.0
Dinaciclib	PAK4	50.0	10000.0
Dinaciclib	ABL1(Q252H)-phosphorylated	83.0	10000.0
WZ-7043	STK33	100.0	10000.0
AZD 5438	M3K5	94.0	10000.0
AZD 5438	TYK2(JH2domain-pseudokinase)	2.4	10000.0
WZ-4-145	CAMK2A	100.0	10000.0
NPK76-II-72-1	KPCD	100.0	10000.0
PHA-767491	TRPM6	100.0	10000.0
HG-5-88-01	TYRO3	100.0	10000.0
SCH772984	PIK3CA(M1043I)	100.0	1000.0
TGX221	MP2K1	100.0	1000.0
MPS-1-IN-1	SLK	100.0	1000.0
CGP74514A	PAK6	2.0	10000.0
Sigma A6730	PLK1	93.0	10000.0
HG-14-10-04	OSR1	12.0	10000.0
GW843682X	BMPR2	64.0	10000.0
Ceritinib	GRK1	82.0	1000.0
CG-930	PIK3CB	100.0	10000.0
Lapatinib	MAP4K5	89.0	10000.0
Dinaciclib	VGFR2	78.0	10000.0
SP600125	FGFR2	100.0	10000.0
PHA-793887	IKKA	85.0	10000.0
ZSTK474	LIMK1	100.0	1000.0
Lapatinib	DRAK2	86.0	10000.0
WZ3105	CDK4-cyclinD3	23.0	10000.0
SB590885	KPCL	100.0	10000.0
Barasertib	MLCK	98.0	10000.0
Sorafenib	EGFR(L747-E749del,A750P)	89.0	10000.0
(s)-CR8	PIK3CA(E545K)	100.0	10000.0
XMD8-92	ABL1(M351T)	100.0	10000.0
AS-252424	TAOK3	53.8	10000.0
GSK429286A	RSK3(Kin.Dom.1-N-terminal)	95.0	10000.0
HG-9-91-01	ACVR2A	2.8	10000.0
PHA-767491	NEK5	92.0	10000.0
CP466722	ALK	45.0	10000.0
MLN8054	M3K5	100.0	10000.0
Dactolisib	ERK3	100.0	1000.0
Crizotinib	MAST1	100.0	10000.0
Dabrafenib	TNK2	23.0	10000.0
QL-XI-92	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
ALW-II-38-3	SRPK1	100.0	10000.0
Baricitinib	CSNK1D	55.0	10000.0
JNK-IN-8	LIMK2	98.0	1000.0
KIN001-127	DRAK2	100.0	10000.0
BGJ398	PHKG2	91.0	1000.0
Vemurafenib	PRKX	100.0	10000.0
Momelotinib	M3K13	77.0	10000.0
GW843682X	ADCK4	71.0	10000.0
ZSTK474	ERBB4	100.0	1000.0
GSK429286A	TYK2(JH1domain-catalytic)	20.0	10000.0
WZ4003	RPS6KA2(Kin.Dom.1)	15.0	1000.0
HG-14-8-02	GAK	5.8	10000.0
XMD-12	MARK1	59.0	1000.0
XMD13-2	PGFRB	24.0	10000.0
BMX-IN-1	MAP4K2	89.0	10000.0
Omipalisib	CDK9	98.0	10000.0
Ibrutinib	M3K2	80.0	1000.0
Neratinib	MAPKAPK5	89.0	10000.0
AZ-628	KIT(D816H)	57.0	10000.0
R406	KPCD1	100.0	1000.0
WZ-7043	TNK1	100.0	10000.0
MPS-1-IN-1	PIK3CG	100.0	1000.0
HG-5-113-01	KCC4	100.0	10000.0
JW-7-24-1	DRAK2	100.0	10000.0
BI-2536	SRPK3	100.0	10000.0
Dinaciclib	FYN	100.0	10000.0
BI-2536	AKT3	100.0	10000.0
GSK461364	KPCD3	12.0	10000.0
Momelotinib	PLK4	15.0	10000.0
Dactolisib	IKKE	100.0	1000.0
AG1478	TYRO3	23.0	10000.0
PHA-767491	HASP	0.6	10000.0
PHA-767491	RIOK3	23.0	10000.0
Abemaciclib	MET(M1250T)	39.0	1000.0
PD173074	CDK7	100.0	10000.0
AZD 5438	MST1R	78.0	10000.0
THZ1	CAMKK2	13.0	10000.0
AS-252424	NDR2	71.7	10000.0
GSK429286A	ADCK3	76.0	10000.0
PHA-767491	PIP5K1C	81.0	10000.0
ERK5-IN-1	RSK4(Kin.Dom.1-N-terminal)	100.0	1000.0
JNK-IN-5A	CAMK1D	85.0	10000.0
R406	BMPR1B	28.0	1000.0
TGX221	JNK1	100.0	1000.0
PD0325901	LYN	72.0	10000.0
Neratinib	CDKL1	100.0	10000.0
OTSSP167	EPHB4	1.4	10000.0
NPK76-II-72-1	ABL1(Q252H)	100.0	10000.0
THZ1	ERK8	0.2	10000.0
JWE-035	VGFR2	100.0	10000.0
CGP60474	STK39	100.0	10000.0
JNK-IN-5A	SIK2	78.0	10000.0
AZD7762	SRPK1	1.4	10000.0
PLX-4720	BMX	67.0	10000.0
AS-252424	FAK2	100.0	10000.0
BS-181	SBK1	71.0	10000.0
WH-4-023	CAMK1G	73.0	10000.0
BMS345541	MRCKB	100.0	10000.0
Ceritinib	EGFR(T790M)	8.4	1000.0
Ribociclib	MST3	100.0	1000.0
ZG-10	PI42C	0.8	10000.0
JNK-9L	GRK4	37.0	10000.0
ZG-10	MET(Y1235D)	100.0	10000.0
BMS345541	NEK9	100.0	10000.0
JWE-035	STK36	82.0	10000.0
BX-912	PIM3	69.0	10000.0
MPS-1-IN-1	ITK	100.0	1000.0
JNK-IN-8	AURKA	100.0	1000.0
Barasertib	CDK15	88.0	10000.0
Sorafenib	STK33	33.0	10000.0
Ceritinib	MAPKAPK5	73.0	1000.0
KIN001-123	RPS6KA5(Kin.Dom.1)	100.0	1000.0
Torkinib	ABL1(H396P)-nonphosphorylated	0.0	10000.0
BX-912	BTK	5.2	10000.0
QL-X-138	MLTK	6.9	10000.0
Torkinib	LIMK1	73.0	10000.0
Sigma A6730	PCTK3	97.0	10000.0
XMD8-85	ABL1(M351T)	100.0	10000.0
JNK-IN-8	BMPR1A	100.0	1000.0
JNK-IN-5A	YSK4	100.0	10000.0
TGX221	INSR	100.0	1000.0
ERK5-IN-1	CDKL1	86.0	1000.0
BMS345541	PIK3C2B	100.0	10000.0
WZ3105	BRAF	81.0	10000.0
BMS345541	MELK	96.0	10000.0
SCH772984	SRPK1	62.0	1000.0
NVP-TAE684	BLK	0.1	1000.0
HG-14-8-02	CDKL3	78.0	10000.0
OTSSP167	JAK1(JH1domain-catalytic)	5.9	10000.0
WYE-125132	MRCKA	100.0	10000.0
KIN001-021	MLK2	100.0	1000.0
SCH772984	CSNK2A2	7.4	1000.0
JW-7-24-1	RPS6KA1(Kin.Dom.1)	100.0	10000.0
TAK-715	SRPK2	73.0	10000.0
KU63794	MLCK	100.0	10000.0
Dactolisib	CDC2L1	100.0	1000.0
XMD13-2	KIT(L576P)	51.0	10000.0
JWE-035	KIT(V559D,T670I)	74.0	10000.0
MRT67307	PIK3CA(I800L)	100.0	10000.0
Sorafenib	KIT(V559D)	0.1	10000.0
Torkinib	FYN	4.6	10000.0
Pictilisib	BMPR2	100.0	1000.0
KIN001-127	EPHB3	100.0	10000.0
XMD11-85h	DDR1	100.0	10000.0
WH-4-023	DRAK1	100.0	10000.0
PD173074	MARK3	100.0	10000.0
Barasertib	TAK1	16.0	10000.0
Torkinib	MYLK	0.9	10000.0
MLN8054	ABL1(Q252H)-nonphosphorylated	0.9	10000.0
Torkinib	CDKL5	100.0	10000.0
WZ3105	ZAP70	77.0	10000.0
AZ-628	ACVR1B	97.0	10000.0
BMX-IN-1	MARK3	97.0	10000.0
CP466722	NEK7	1.4	10000.0
SCH772984	MAP4K4	66.0	1000.0
OTSSP167	NEK10	14.0	10000.0
MPS-1-IN-1	ABL2	100.0	1000.0
QL-XII-47	SIK1	100.0	1000.0
XMD11-50	NUAK1	47.0	10000.0
BS-181	PAK6	100.0	10000.0
HG-5-88-01	EGFR(E746-A750del)	0.0	10000.0
Taselisib	AURKC	88.0	1000.0
GSK429286A	M3K12	69.0	10000.0
Dinaciclib	CAMK1D	100.0	10000.0
CP724714	MARK2	98.0	10000.0
Canertinib	RPS6KA5(Kin.Dom.1)	100.0	1000.0
Canertinib	CSNK1A1L	100.0	1000.0
Vemurafenib	MAP3K4	63.0	10000.0
Crizotinib	BRSK1	48.0	10000.0
Seliciclib	PLK1	58.0	10000.0
XMD16-144	RPS6KA5(Kin.Dom.2-C-terminal)	80.0	10000.0
PHA-793887	MYLK	98.0	10000.0
CP724714	GAK	84.0	10000.0
TAK-715	MYO3A	60.0	10000.0
XMD8-85	PKN1	100.0	10000.0
GSK461364	AKT3	100.0	10000.0
Lapatinib	M4K3	94.0	10000.0
KIN001-021	MAPKAPK5	100.0	1000.0
R406	TTK	20.0	1000.0
WYE-125132	RSK1(Kin.Dom.2-C-terminal)	91.0	10000.0
Sorafenib	LATS2	85.0	10000.0
Seliciclib	FLT3(N841I)	96.0	10000.0
MPS-1-IN-1	ALK	8.9	1000.0
Ceritinib	PIM1	100.0	1000.0
SCH772984	CLK4	14.0	1000.0
ALW-II-38-3	STK16	100.0	10000.0
JW-7-24-1	TRKB	100.0	10000.0
Canertinib	MK03	100.0	1000.0
HG-14-8-02	FAK1	14.0	10000.0
KIN001-021	ABL1	100.0	1000.0
KU63794	KPCD3	85.0	10000.0
Barasertib	TLK2	100.0	10000.0
THZ1	PGFRA	7.4	10000.0
Taselisib	DMPK2	100.0	1000.0
QL-X-138	RPS6KA5(Kin.Dom.2-C-terminal)	75.0	10000.0
ZM-447439	EGFR(L861Q)	6.2	10000.0
SP600125	RPS6KA6(Kin.Dom.1)	100.0	10000.0
GSK429286A	NIM1	86.0	10000.0
XMD16-144	TLK2	88.0	10000.0
KIN001-123	TXK	1.8	1000.0
XMD14-99	MET(M1250T)	100.0	10000.0
ALW-II-49-7	LTK	100.0	10000.0
WYE-125132	JAK2(JH1domain-catalytic)	100.0	10000.0
Torin2	ABL1-phosphorylated	79.0	10000.0
(s)-CR8	FGFR2	89.0	10000.0
Dabrafenib	TAOK1	50.0	10000.0
HG-6-64-01	MAP4K5	3.4	10000.0
GW843682X	RIPK4	100.0	10000.0
PHA-793887	CDK2	0.4	10000.0
Sorafenib	MARK4	100.0	10000.0
JNK-IN-8	EGFR(L747-E749del,A750P)	84.0	1000.0
Neratinib	MLK3	85.0	10000.0
Baricitinib	LATS2	40.0	10000.0
Baricitinib	YANK2	100.0	10000.0
BMS345541	TNK1	100.0	10000.0
GW-5074	PKAC-alpha	100.0	10000.0
Pictilisib	FLT3(K663Q)	100.0	1000.0
MPS-1-IN-1	RIOK2	100.0	1000.0
HG-14-10-04	BUB1	3.9	10000.0
BGJ398	KPCD	100.0	1000.0
Sigma A6730	ANKK1	73.0	10000.0
Taselisib	CDKL1	87.0	1000.0
KU63794	EPHA2	100.0	10000.0
CP724714	AURKB	100.0	10000.0
KIN001-220	SNARK	23.0	10000.0
Pictilisib	CAMK2G	100.0	1000.0
XMD13-2	CDK9	93.0	10000.0
AZD-6482	PGFRA	84.0	10000.0
WH-4-023	YES	0.1	10000.0
Ribociclib	MINK	85.0	1000.0
Torin1	CDC2L1	97.0	10000.0
RO-3306	EPHB1	90.0	10000.0
TAK-715	PLK3	98.0	10000.0
JNK-IN-5A	FGR	100.0	10000.0
AG1478	ULK1	75.0	10000.0
WZ4002	PAK4	100.0	10000.0
Dabrafenib	M3K2	18.0	10000.0
HG-5-88-01	MLTK	100.0	10000.0
CP724714	JAK2(JH1domain-catalytic)	100.0	10000.0
GSK1059615	SRPK1	100.0	10000.0
Crizotinib	TRKC	0.4	10000.0
WYE-125132	ABL1(Y253F)-phosphorylated	99.0	10000.0
OTSSP167	YSK1	12.0	10000.0
WYE-125132	MST1	100.0	10000.0
Abemaciclib	ZAP70	93.0	1000.0
BMS-536924	ABL1(M351T)	14.0	1000.0
SB590885	SNRK	89.0	10000.0
MRT67307	EPHA4	100.0	10000.0
MRT67307	RIOK3	2.2	10000.0
QL-XII-47	MET(M1250T)	92.0	1000.0
MRT67307	HIPK4	66.0	10000.0
JNK-9L	MLK3	46.0	10000.0
Sorafenib	TIE1	4.0	10000.0
CH5424802	EGFR	52.0	1000.0
Seliciclib	PIK3CB	97.0	10000.0
BS-181	FLT3(R834Q)	75.0	10000.0
HG-9-91-01	PGFRB	0.0	10000.0
Ceritinib	DAPK3	76.0	1000.0
Alpelisib	CDKL3	96.0	1000.0
XMD-12	ERBB4	100.0	1000.0
GSK461364	CSNK1E	100.0	10000.0
XMD8-85	PIK3CB	100.0	10000.0
RO-3306	PIP5K2B	42.0	10000.0
BGJ398	HIPK4	100.0	1000.0
Neratinib	EGFR(S752-I759del)	0.1	10000.0
HG-14-10-04	SNRK	31.0	10000.0
CGP74514A	MST4	12.0	10000.0
Neratinib	AAK1	68.0	10000.0
GSK461364	MAP4K4	64.0	10000.0
AZD7762	ABL1(F317L)-phosphorylated	0.0	10000.0
Sigma A6730	MINK	88.0	10000.0
NVP-TAE684	JAK1(Kin.Dom.1)	4.2	1000.0
WZ4003	BMX	100.0	1000.0
BMS345541	PKAC-alpha	100.0	10000.0
AS-252424	MUSK	84.6	10000.0
ZM-447439	ERBB4	0.7	10000.0
HG-14-8-02	NEK5	100.0	10000.0
AS-252424	SRPK2	100.0	10000.0
HG-5-88-01	AURKB	100.0	10000.0
WYE-125132	NEK4	82.0	10000.0
HG-5-113-01	PRKX	100.0	10000.0
JNK-IN-5A	ANKK1	78.0	10000.0
JW-7-24-1	RIOK2	100.0	10000.0
WZ4002	BRSK1	100.0	10000.0
QL-X-138	TTK	21.0	10000.0
AZ-628	HIPK2	73.0	10000.0
AG1478	PRKR	52.0	10000.0
Taselisib	CSF1R-autoinhibited	99.0	1000.0
Ribociclib	ABL1(Q252H)-nonphosphorylated	100.0	1000.0
Sorafenib	PFPK5(P.falciparum)	94.0	10000.0
5z-7-oxozeaenol	EPHA4	85.0	10000.0
AZD7762	ABL1(T315I)-phosphorylated	0.0	10000.0
Barasertib	M3K12	58.0	10000.0
AZD7762	MELK	1.4	10000.0
ZM-447439	CDKL2	12.0	10000.0
QL-X-138	CSK	100.0	10000.0
Ibrutinib	ACVR2A	97.0	1000.0
ZM-447439	FYN	55.0	10000.0
Palbociclib	MAP3K14	98.0	1000.0
JW-7-24-1	MYLK	30.0	10000.0
AS-252424	CSNK1A1L	97.1	10000.0
TGX221	RIOK2	100.0	1000.0
BMS345541	GCN2(Kin.Dom.2,S808G)	98.0	10000.0
WZ-4-145	NEK1	100.0	10000.0
KIN001-220	ABL1-phosphorylated	13.0	10000.0
QL-X-138	PCTK3	88.0	10000.0
Seliciclib	RAF1	100.0	10000.0
XMD13-2	TAOK1	4.5	10000.0
GSK429286A	RSK2(Kin.Dom.1-N-terminal)	53.0	10000.0
MRT67307	PIP5K2B	5.9	10000.0
Torkinib	ULK2	39.0	10000.0
AS-252424	ERK8	3.7	10000.0
ZG-10	WEE1	100.0	10000.0
HG-14-10-04	KCC4	7.2	10000.0
JNK-IN-8	AXL	77.0	1000.0
ZSTK474	DAPK3	100.0	1000.0
SP600125	TRKB	100.0	10000.0
XMD11-85h	EPHB2	100.0	10000.0
Omipalisib	MTOR	11.0	10000.0
Torin2	TEC	100.0	10000.0
XMD11-85h	LATS1	100.0	10000.0
ALW-II-38-3	CDC2L2	100.0	10000.0
PD0325901	CSNK1G3	67.0	10000.0
Momelotinib	PKMYT1	100.0	10000.0
XMD11-85h	STK35	100.0	10000.0
WH-4-023	NEK5	85.0	10000.0
BMS-536924	YANK3	100.0	1000.0
SCH772984	CTK	100.0	1000.0
XMD8-92	KPCT	100.0	10000.0
XMD16-144	M3K5	100.0	10000.0
BMS345541	TRKC	100.0	10000.0
Vemurafenib	TLK2	94.0	10000.0
BMX-IN-1	JNK3	20.0	10000.0
Vemurafenib	YES	18.0	10000.0
CP724714	PAK6	89.0	10000.0
Barasertib	NEK1	86.0	10000.0
KU63794	TBK1	100.0	10000.0
AG1478	LIMK2	100.0	10000.0
KIN001-111	PHKG1	100.0	1000.0
GSK461364	M3K13	87.0	10000.0
ALW-II-38-3	MAP4K2	100.0	10000.0
CP724714	BIKE	73.0	10000.0
WYE-125132	NEK3	100.0	10000.0
PHA-793887	TLK2	94.0	10000.0
JNK-IN-11	LRRK2	72.0	1000.0
Sorafenib	ERBB2	100.0	10000.0
Torkinib	PIK3CA	32.0	10000.0
Ibrutinib	MRCKB	100.0	1000.0
BGJ398	ROCK2	73.0	1000.0
AG1478	TGFBR2	91.0	10000.0
Torin2	GAK	56.0	10000.0
AZD4547	FGFR2	1.1	10000.0
PLX-4720	PKNB(M.tuberculosis)	46.0	10000.0
QL-XI-92	ABL1(H396P)-phosphorylated	86.0	10000.0
ZSTK474	PGFRA	100.0	1000.0
ZM-447439	NEK6	100.0	10000.0
XMD14-99	TEC	69.0	10000.0
Ibrutinib	DMPK	100.0	1000.0
NPK76-II-72-1	ABL2	100.0	10000.0
XMD13-2	MK03	95.0	10000.0
JWE-035	FLT4	100.0	10000.0
HG-6-64-01	KPCD	49.0	10000.0
XMD13-2	PIK3CA(Q546K)	98.0	10000.0
BGJ398	EGFR	97.0	1000.0
XMD14-99	IKKE	87.0	10000.0
Sigma A6730	LATS2	82.0	10000.0
OTSSP167	TRKB	1.8	10000.0
Sigma A6730	KPCT	94.0	10000.0
TGX221	FGR	100.0	1000.0
AZD7762	TNNI3K	7.3	10000.0
Alpelisib	YANK1	100.0	1000.0
Lapatinib	OSR1	100.0	10000.0
Dactolisib	PHKG1	100.0	1000.0
CGP74514A	RET(V804M)	16.0	10000.0
CH5424802	EPHA6	75.0	1000.0
Palbociclib	CIT	90.0	1000.0
GW843682X	PIP5K2B	6.6	10000.0
Crizotinib	CSNK1D	100.0	10000.0
Pictilisib	TBK1	79.0	1000.0
Neratinib	PKAC-alpha	95.0	10000.0
NPK76-II-72-1	SYK	100.0	10000.0
CGP74514A	EGFR(S752-I759del)	37.0	10000.0
OTSSP167	FYN	2.2	10000.0
PLX-4720	FLT3(ITD)	68.0	10000.0
TGX221	MLK3	100.0	1000.0
MLN8054	GRK4	100.0	10000.0
Baricitinib	TRKB	12.0	10000.0
A443654	RAF1	100.0	10000.0
AG1478	M3K5	74.0	10000.0
ALW-II-49-7	KGP2	100.0	10000.0
Torkinib	CSNK2A2	3.5	10000.0
KIN001-111	BRAF(V600E)	24.0	1000.0
RO-3306	NDR2	100.0	10000.0
NU7441	TGFBR1	100.0	10000.0
CH5424802	TRKA	8.4	1000.0
Barasertib	RET	0.3	10000.0
Dinaciclib	PIK3CA	96.0	10000.0
KIN001-111	EGFR	0.8	1000.0
PLX-4720	PAK1	11.0	10000.0
BMS-536924	MK11	100.0	1000.0
Torkinib	TNNI3K	14.0	10000.0
PD0325901	DCAMKL2	100.0	10000.0
5z-7-oxozeaenol	EGFR(E746-A750del)	91.0	10000.0
QL-XII-47	CDC2L1	100.0	1000.0
GW-5074	NUAK1	100.0	10000.0
WZ3105	EGFR(S752-I759del)	82.0	10000.0
SCH772984	JNK3	1.2	1000.0
NVP-TAE684	LKB1	100.0	1000.0
BX-912	MK09	0.3	10000.0
Taselisib	LATS2	100.0	1000.0
PLX-4720	INSR	83.0	10000.0
BS-181	ABL1(E255K)-phosphorylated	70.0	10000.0
XMD11-50	KCC4	79.0	10000.0
BX-912	PIK3CA(I800L)	100.0	10000.0
SB590885	SgK110	100.0	10000.0
Torin2	FGFR4	100.0	10000.0
KIN001-111	MK01	15.0	1000.0
WZ-4-145	MYO3B	100.0	10000.0
BX-912	MLCK	0.1	10000.0
KIN001-220	TGFBR1	57.0	10000.0
CP466722	CDKL2	2.0	10000.0
Baricitinib	CDK4-cyclinD1	86.0	10000.0
GW843682X	NIM1	88.0	10000.0
SP600125	BRAF(V600E)	100.0	10000.0
MLN8054	MST1	85.0	10000.0
WZ3105	VGFR1	100.0	10000.0
MRT67307	MYLK2	75.0	10000.0
Ibrutinib	TYK2(JH2domain-pseudokinase)	100.0	1000.0
PD0325901	CDK9	76.0	10000.0
Dactolisib	ROS1	100.0	1000.0
HG-9-91-01	CDK11	96.0	10000.0
HG-5-88-01	PIK3CA(E545K)	100.0	10000.0
MPS-1-IN-1	RPS6KA6(Kin.Dom.1)	100.0	1000.0
KIN001-127	MYLK2	100.0	10000.0
Baricitinib	KIT(V559D,V654A)	75.0	10000.0
Torin1	BMPR1A	45.0	10000.0
JNK-9L	PLK3	93.0	10000.0
Alpelisib	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	1000.0
Ceritinib	EGFR	72.0	1000.0
GW843682X	TXK	72.0	10000.0
SB590885	MST1	100.0	10000.0
XMD-12	PIK3CA(E545K)	100.0	1000.0
AG1478	DYRK1B	70.0	10000.0
Pictilisib	GSK3A	72.0	1000.0
XMD14-99	RET(M918T)	100.0	10000.0
WZ4003	BIKE	15.0	1000.0
Omipalisib	MLTK	81.0	10000.0
ERK5-IN-1	PAK4	100.0	1000.0
Palbociclib	MLK3	100.0	1000.0
GSK429286A	EPHA6	95.0	10000.0
GSK429286A	ROCK2	0.1	10000.0
AZD4547	SgK110	62.0	10000.0
TGX221	BRAF(V600E)	100.0	1000.0
(s)-CR8	RET(V804L)	92.0	10000.0
CP466722	SIK2	61.0	10000.0
WZ3105	FLT3(K663Q)	1.2	10000.0
JNK-IN-5A	PGFRA	89.0	10000.0
Neratinib	TIE2	56.0	10000.0
5z-7-oxozeaenol	TNNI3K	77.0	10000.0
Omipalisib	NEK9	85.0	10000.0
Crizotinib	CAMK2B	84.0	10000.0
THZ1	EPHA7	0.5	10000.0
Lapatinib	SIK1	76.0	10000.0
WH-4-023	PIK3CB	100.0	10000.0
KIN001-123	PKN2	100.0	1000.0
JNK-9L	MP2K6	41.0	10000.0
BMS-536924	PKAC-alpha	22.0	1000.0
HG-14-10-04	TIE1	1.4	10000.0
XMD11-50	KIT	100.0	10000.0
BGJ398	ALK	79.0	1000.0
Torin2	S6K1	86.0	10000.0
R406	MK11	100.0	1000.0
XMD13-2	MRCKB	76.0	10000.0
XMD11-50	LKB1	96.0	10000.0
WZ-7043	PHKG2	100.0	10000.0
MLN8054	EPHA4	11.0	10000.0
AG1478	EPHB3	97.0	10000.0
GSK1059615	RIOK3	1.4	10000.0
Abemaciclib	ABL1(F317I)-nonphosphorylated	100.0	1000.0
JWE-035	MERTK	48.0	10000.0
WZ3105	DYRK1B	49.0	10000.0
SP600125	RPS6KA4(Kin.Dom.2)	3.4	10000.0
JNK-9L	MP2K4	2.8	10000.0
KIN001-220	IKKB	27.0	10000.0
KIN001-123	MLK3	100.0	1000.0
Torkinib	MAP3K4	85.0	10000.0
XMD8-92	ERBB4	100.0	10000.0
XMD14-99	CDKL1	88.0	10000.0
KU63794	MRCKA	92.0	10000.0
Canertinib	TIE2	100.0	1000.0
AZD4547	EPHA5	98.0	10000.0
CGP60474	MST1	100.0	10000.0
Ibrutinib	LYN	11.0	1000.0
Ibrutinib	LTK	82.0	1000.0
SB590885	PRKX	94.0	10000.0
HG-5-88-01	MAP3K3	100.0	10000.0
KIN001-220	M3K12	71.0	10000.0
ERK5-IN-1	FES	100.0	1000.0
XMD8-92	PCTK2	100.0	10000.0
Abemaciclib	PHKG1	18.0	1000.0
Abemaciclib	ERBB4	92.0	1000.0
QL-XII-47	ABL1(T315I)-nonphosphorylated	87.0	1000.0
ZSTK474	SIK1	100.0	1000.0
KIN001-021	WEE1	100.0	1000.0
GW-5074	MST2	3.3	10000.0
XMD16-144	RIPK5	18.0	10000.0
AG1478	LCK	5.4	10000.0
ZSTK474	ABL2	100.0	1000.0
WZ-4-145	CDC2L1	100.0	10000.0
Omipalisib	KIT(V559D,T670I)	100.0	10000.0
NG25	NEK9	100.0	10000.0
XMD13-2	RIPK1	0.1	10000.0
MPS-1-IN-1	MYO3A	100.0	1000.0
XMD16-144	TRPM6	91.0	10000.0
BMX-IN-1	ROCK1	59.0	10000.0
Omipalisib	MELK	23.0	10000.0
Ibrutinib	MP2K7	1.6	1000.0
AZD 5438	AXL	14.0	10000.0
5z-7-oxozeaenol	FGFR3	95.0	10000.0
Momelotinib	ABL1(H396P)-phosphorylated	65.0	10000.0
JNK-IN-5A	MUSK	97.0	10000.0
BX-912	DRAK2	2.4	10000.0
QL-XII-47	BMPR2	100.0	1000.0
SB590885	PRKR	61.0	10000.0
Neratinib	KKCC1	100.0	10000.0
Torin1	CAMK2B	100.0	10000.0
PD173074	CSK	100.0	10000.0
KU63794	VGFR1	92.0	10000.0
ZSTK474	PHKG2	100.0	1000.0
Torin1	LCK	77.0	10000.0
NU7441	HIPK4	74.0	10000.0
PD0325901	MK12	100.0	10000.0
Dabrafenib	PIK3CB	83.0	10000.0
Torin2	EPHB4	100.0	10000.0
GSK1059615	HIPK2	0.2	10000.0
JNK-9L	GCN2(Kin.Dom.2,S808G)	3.3	10000.0
AZD 5438	TLK1	0.3	10000.0
ZSTK474	WEE2	100.0	1000.0
BGJ398	YANK1	84.0	1000.0
XMD11-50	FLT3(R834Q)	100.0	10000.0
NU7441	ABL1(H396P)-phosphorylated	100.0	10000.0
XMD8-85	BIKE	100.0	10000.0
Lapatinib	EGFR(L747-S752del,P753S)	0.0	10000.0
JNK-9L	KGP1	100.0	10000.0
(s)-CR8	SGK1	98.0	10000.0
MLN8054	KPCT	98.0	10000.0
BGJ398	IRAK1	93.0	1000.0
CGP60474	PHKG1	100.0	10000.0
SP600125	PRKX	100.0	10000.0
SP600125	AKT2	100.0	10000.0
WYE-125132	KCC2D	100.0	10000.0
HG-5-88-01	NEK9	100.0	10000.0
MPS-1-IN-1	KCC2D	100.0	1000.0
Crizotinib	DDR1	0.4	10000.0
WZ4002	RPS6KA2(Kin.Dom.2)	28.0	10000.0
Ribociclib	MAP4K4	100.0	1000.0
Momelotinib	RIOK1	1.0	10000.0
Palbociclib	SGK1	94.0	1000.0
R406	RIPK4	17.0	1000.0
HG-6-64-01	YSK1	100.0	10000.0
BI-2536	ACVR1B	100.0	10000.0
5z-7-oxozeaenol	ULK1	79.0	10000.0
Crizotinib	STK16	63.0	10000.0
HG-6-64-01	PKNB(M.tuberculosis)	89.0	10000.0
CH5424802	SBK1	92.0	1000.0
(s)-CR8	FAK1	87.0	10000.0
BX-912	WEE2	36.0	10000.0
JNK-IN-8	MP2K1	94.0	1000.0
QL-XI-92	CSNK1A1	100.0	10000.0
CH5424802	DAPK1	4.6	1000.0
AZ-628	RIOK1	100.0	10000.0
WH-4-023	ULK2	38.0	10000.0
KIN001-127	NEK5	100.0	10000.0
JNK-IN-5A	ABL1(Y253F)-phosphorylated	95.0	10000.0
SCH772984	EPHA8	100.0	1000.0
QL-XII-47	CDKL5	100.0	1000.0
OTSSP167	NDR1	4.5	10000.0
QL-X-138	OSR1	79.0	10000.0
PD173074	TXK	100.0	10000.0
WZ4002	PIM1	100.0	10000.0
SB590885	INSR	100.0	10000.0
CG-930	CAMK1G	100.0	10000.0
5z-7-oxozeaenol	SLK	34.0	10000.0
Crizotinib	VGFR2	78.0	10000.0
NVP-TAE684	AKT3	100.0	1000.0
QL-XII-47	STK35	85.0	1000.0
PD0325901	BUB1	100.0	10000.0
MRT67307	EPHA8	100.0	10000.0
Dabrafenib	KC1G2	100.0	10000.0
WZ4002	MST1R	100.0	10000.0
XMD8-85	YES	100.0	10000.0
KIN001-111	MINK	100.0	1000.0
SB590885	YANK3	100.0	10000.0
XMD8-85	PCTK2	100.0	10000.0
QL-X-138	PIK3CD	27.0	10000.0
JNK-IN-11	EPHB6	9.4	1000.0
Lapatinib	MLCK	100.0	10000.0
BI-2536	STK16	14.0	10000.0
ALW-II-38-3	ABL1(Q252H)	8.2	1000.0
Torin2	MP2K3	66.0	10000.0
HG-5-88-01	FGFR1	100.0	10000.0
Abemaciclib	TAOK2	25.0	1000.0
R406	PIK3CA(E545K)	100.0	1000.0
Barasertib	KIT(A829P)	50.0	10000.0
KIN001-021	FLT4	100.0	1000.0
Baricitinib	BRSK1	78.0	10000.0
Canertinib	NLK	100.0	1000.0
QL-XI-92	MET	100.0	10000.0
A443654	PIP5K1A	9.4	10000.0
ZM-447439	PAK2	89.0	10000.0
TAK-715	EGFR(L747-T751del,Sins)	8.9	10000.0
BGJ398	PFCDPK1(P.falciparum)	100.0	1000.0
CGP60474	MARK3	100.0	10000.0
Torkinib	NLK	10.0	10000.0
AZD-6482	NEK1	85.0	10000.0
AS-252424	NEK7	85.9	10000.0
Dabrafenib	LRRK2(G2019S)	75.0	10000.0
SCH772984	TAK1	46.0	1000.0
Sorafenib	AURKC	100.0	10000.0
5z-7-oxozeaenol	M4K3	91.0	10000.0
Ribociclib	EGFR(T790M)	78.0	1000.0
WZ-7043	LIMK1	100.0	10000.0
XMD16-144	DDR2	11.0	10000.0
Momelotinib	ABL1(Y253F)-phosphorylated	61.0	10000.0
TAK-715	KC1G2	19.0	10000.0
Neratinib	TRPM6	84.0	10000.0
Palbociclib	CSF1R	100.0	1000.0
SP600125	TEC	28.0	10000.0
Dactolisib	PIK3CA(E545K)	3.0	1000.0
HG-14-8-02	FER	34.0	10000.0
Sigma A6730	CHK2	100.0	10000.0
A443654	GAK	8.1	10000.0
WZ4003	JAK2(Kin.Dom.2)	100.0	1000.0
PHA-793887	KKCC1	32.0	10000.0
ALW-II-38-3	SLK	100.0	10000.0
Barasertib	PFCDPK1(P.falciparum)	63.0	10000.0
KIN001-021	EPHB1	100.0	1000.0
BGJ398	FER	85.0	1000.0
AZD7762	FLT3(K663Q)	0.1	10000.0
AZ-628	TYK2(JH2domain-pseudokinase)	100.0	10000.0
AZD 5438	MP2K5	1.6	10000.0
Momelotinib	KIT(V559D)	16.0	10000.0
Taselisib	TRPM6	100.0	1000.0
WH-4-023	PAK3	4.0	10000.0
Dactolisib	CSNK1G3	100.0	1000.0
HG-14-10-04	M3K13	3.2	10000.0
GW-5074	PAK1	100.0	10000.0
WZ4003	STK36	100.0	1000.0
BX-912	PIK4CB	35.0	10000.0
Alpelisib	RIOK1	78.0	1000.0
BMX-IN-1	BRAF(V600E)	100.0	10000.0
MRT67307	MAPKAPK5	100.0	10000.0
Sigma A6730	ACVR1	92.0	10000.0
ZSTK474	CIT	100.0	1000.0
AZ-628	SGK3	100.0	10000.0
XMD8-92	RIPK1	100.0	10000.0
KU63794	BRAF	81.0	10000.0
Ibrutinib	MP2K2	20.0	1000.0
CP466722	ABL1(F317L)-nonphosphorylated	2.6	10000.0
HG-6-64-01	PIK3CD	78.0	10000.0
HG-14-8-02	NDR2	100.0	10000.0
OTSSP167	CDKL2	4.0	10000.0
JNK-IN-8	ACVR1	100.0	1000.0
A443654	LCK	100.0	10000.0
XMD11-50	CAMK2B	62.0	10000.0
HG-14-10-04	ERBB3	74.0	10000.0
KIN001-111	TTK	100.0	1000.0
AZD-6482	SRPK1	100.0	10000.0
WZ3105	FYN	23.0	10000.0
PHA-767491	ITK	100.0	10000.0
Barasertib	MAP4K4	98.0	10000.0
R406	MST2	32.0	1000.0
QL-XII-47	RIOK2	96.0	1000.0
ALW-II-38-3	MELK	100.0	10000.0
AZD4547	BMPR1A	100.0	10000.0
(s)-CR8	KKCC1	72.0	10000.0
Vemurafenib	PIK3CA(M1043I)	73.0	10000.0
XMD-12	PIK3CG	4.2	1000.0
Abemaciclib	PLK3	100.0	1000.0
JNK-IN-8	FAK2	87.0	1000.0
Buparlisib	CDK4-cyclinD1	94.0	1000.0
ZG-10	ERK3	7.4	10000.0
WZ-7043	KIT(V559D,T670I)	100.0	10000.0
Buparlisib	RIOK2	100.0	1000.0
XMD16-144	NEK9	93.0	10000.0
SB590885	RIPK2	14.0	10000.0
HG-6-64-01	CDK14	72.0	10000.0
Torkinib	EPHB1	49.0	10000.0
JNK-IN-5A	AXL	88.0	10000.0
KU63794	ULK1	79.0	10000.0
KIN001-021	PHKG2	100.0	1000.0
AZD4547	ACVR2A	100.0	10000.0
5z-7-oxozeaenol	CDK4-cyclinD1	95.0	10000.0
Sigma A6730	CDK2	92.0	10000.0
Baricitinib	MST1	96.0	10000.0
QL-X-138	MET(Y1235D)	100.0	10000.0
Baricitinib	FRK	44.0	10000.0
Seliciclib	DYRK1A	1.5	10000.0
TGX221	ABL1(T315I)	100.0	1000.0
GW-5074	MAP3K4	95.0	10000.0
OTSSP167	KPCD3	100.0	10000.0
HG-14-8-02	CSF1R	41.0	10000.0
GW-5074	PIK3CA(E545K)	100.0	10000.0
BX-912	LIMK1	38.0	10000.0
ZM-447439	TBK1	66.0	10000.0
CP466722	ABL1(M351T)-phosphorylated	1.2	10000.0
(s)-CR8	TNIK	74.0	10000.0
Buparlisib	MAP3K15	100.0	1000.0
PLX-4720	MAPKAPK5	100.0	10000.0
Torin1	ABL1-phosphorylated	77.0	10000.0
XMD14-99	INSRR	100.0	10000.0
CP466722	KCC4	100.0	10000.0
Torin1	KIT(V559D)	50.0	10000.0
Dactolisib	MUSK	100.0	1000.0
HG-5-88-01	KPCD1	100.0	10000.0
AZD7762	M3K6	25.0	10000.0
Crizotinib	FGFR3(G697C)	27.0	10000.0
JWE-035	EGFR(L747-S752del,P753S)	79.0	10000.0
Vemurafenib	MP2K7	82.0	10000.0
RO-3306	S6K1	69.0	10000.0
Barasertib	EGFR(L861Q)	11.0	10000.0
BMS345541	PGFRA	96.0	10000.0
XMD11-85h	MARK2	100.0	10000.0
SCH772984	EPHB6	74.0	1000.0
NPK76-II-72-1	LYN	100.0	10000.0
(s)-CR8	MLK2	100.0	10000.0
Dinaciclib	JNK1	35.0	10000.0
Dabrafenib	RAF1	0.0	10000.0
XMD13-2	CHK2	100.0	10000.0
Baricitinib	MAPKAPK2	100.0	10000.0
PHA-767491	FAK1	100.0	10000.0
Ibrutinib	TNK1	99.0	1000.0
XMD8-92	CSNK2A2	100.0	10000.0
NPK76-II-72-1	PIP5K1A	100.0	10000.0
KIN001-111	FLT3(D835Y)	100.0	1000.0
Ceritinib	ERK4	96.0	1000.0
Pictilisib	CSF1R	100.0	1000.0
MLN8054	ERK3	92.0	10000.0
HG-5-113-01	FLT3(D835H)	0.7	10000.0
KIN001-123	RET(M918T)	0.2	1000.0
XMD16-144	DAPK3	45.0	10000.0
Torkinib	FLT3(D835H)	7.4	10000.0
Pictilisib	ABL1(F317I)-nonphosphorylated	100.0	1000.0
5z-7-oxozeaenol	NUAK1	100.0	10000.0
QL-XI-92	ABL2	32.0	10000.0
SCH772984	TAOK2	97.0	1000.0
TAK-715	TEC	100.0	10000.0
GSK461364	PIK3CA(Q546K)	29.0	10000.0
CGP74514A	SRC	0.1	10000.0
BGJ398	NDR1	82.0	1000.0
GSK1059615	DCAMKL3	11.0	10000.0
KIN001-127	CDKL2	100.0	10000.0
GW-5074	WEE2	94.0	10000.0
WZ4002	TRKB	100.0	10000.0
HG-9-91-01	MRCKA	1.1	10000.0
XMD8-92	BMPR1A	100.0	10000.0
ZSTK474	CSNK2A2	100.0	1000.0
Buparlisib	ADCK4	96.0	1000.0
XMD8-92	CAMKK2	100.0	10000.0
KU63794	CDK2	77.0	10000.0
Torkinib	KIT(D816H)	16.0	10000.0
AZD4547	PIM2	100.0	10000.0
SCH772984	AURKA	63.0	1000.0
GSK1059615	PGFRA	67.0	10000.0
WYE-125132	FYN	70.0	10000.0
Sigma A6730	PIP5K2B	88.0	10000.0
GSK429286A	TRKB	76.0	10000.0
AZ-628	MP2K4	100.0	10000.0
Ribociclib	NDR1	94.0	1000.0
MLN8054	MYO3A	80.0	10000.0
Barasertib	KPCE	100.0	10000.0
Barasertib	ABL1(H396P)-nonphosphorylated	1.2	10000.0
Ibrutinib	WEE2	100.0	1000.0
ALW-II-38-3	BRAF	1.4	1000.0
OTSSP167	ULK3	0.1	10000.0
NVP-TAE684	ULK3	0.0	1000.0
AG1478	ERK4	16.0	10000.0
CG-930	SRPK3	92.0	10000.0
WZ-4-145	AURKB	100.0	10000.0
Buparlisib	KPCT	91.0	1000.0
QL-X-138	BLK	2.4	10000.0
Taselisib	KPCD1	100.0	1000.0
CG-930	ERN1	46.0	10000.0
WZ-7043	FGFR1	0.3	10000.0
Ibrutinib	MP2K6	100.0	1000.0
MLN8054	FLT3	80.0	10000.0
GW843682X	PAK6	94.0	10000.0
PD173074	DAPK3	100.0	10000.0
Lapatinib	FGR	82.0	10000.0
Ribociclib	HIPK2	100.0	1000.0
ERK5-IN-1	EGFR(E746-A750del)	100.0	1000.0
A443654	EPHA6	100.0	10000.0
CP466722	PIK3CA(E542K)	48.0	10000.0
TAK-715	CDK11	91.0	10000.0
(s)-CR8	EPHA1	96.0	10000.0
AZD-6482	FGFR4	100.0	10000.0
ZG-10	CDK2	100.0	10000.0
Sorafenib	MERTK	5.8	10000.0
SCH772984	ITK	91.0	1000.0
JWE-035	KPCL	100.0	10000.0
BMX-IN-1	TAK1	78.0	10000.0
XMD8-92	EGFR(L747-E749del,A750P)	100.0	10000.0
Seliciclib	MYLK4	96.0	10000.0
ZSTK474	BMPR1A	100.0	1000.0
RO-3306	PIK3CD	45.0	10000.0
R406	CDK7	23.0	1000.0
XMD13-2	YANK2	100.0	10000.0
Dinaciclib	RSK3(Kin.Dom.2-C-terminal)	75.0	10000.0
Dinaciclib	KPCI	67.0	10000.0
AZD4547	RIPK5	88.0	10000.0
PLX-4720	KPCD1	31.0	10000.0
Baricitinib	CAMK1	4.4	10000.0
A443654	KIT(V559D,T670I)	100.0	10000.0
Barasertib	PLK1	100.0	10000.0
JNK-9L	LATS2	62.0	10000.0
Momelotinib	CDK5	100.0	10000.0
Torin1	AAK1	75.0	10000.0
Dactolisib	PIK3CA(H1047Y)	6.2	1000.0
GSK461364	CSNK1G3	100.0	10000.0
JNK-IN-5A	KPCI	63.0	10000.0
PHA-767491	MAPKAPK5	12.0	10000.0
5z-7-oxozeaenol	RET(V804M)	100.0	10000.0
TAK-715	JNK3	0.0	10000.0
NU7441	CDK11	100.0	10000.0
WZ-7043	NEK6	100.0	10000.0
KIN001-220	ERBB4	53.0	10000.0
GW843682X	YSK1	65.0	10000.0
XMD11-50	CASK	85.0	10000.0
BMS-536924	TIE1	1.0	1000.0
GSK461364	EPHA6	92.0	10000.0
WZ3105	HCK	27.0	10000.0
Seliciclib	PIK3CA(H1047Y)	100.0	10000.0
ALW-II-49-7	ACVRL1	100.0	10000.0
NVP-TAE684	EGFR(L747-T751del,Sins)	0.6	1000.0
JNK-IN-5A	SRPK1	100.0	10000.0
XMD8-92	BRAF	100.0	10000.0
TGX221	EPHA1	100.0	1000.0
KIN001-111	ULK3	19.0	1000.0
XMD13-2	MP2K3	33.0	10000.0
Ceritinib	PIK3CA	86.0	1000.0
XMD11-85h	CSF1R	100.0	10000.0
Palbociclib	CSNK1A1L	100.0	1000.0
GSK1059615	SRMS	67.0	10000.0
Omipalisib	LIMK2	100.0	10000.0
Pictilisib	TRKA	81.0	1000.0
TGX221	MARK4	100.0	1000.0
JW-7-24-1	CSNK1E	8.0	10000.0
HG-5-88-01	TNNI3K	100.0	10000.0
PHA-793887	NEK4	96.0	10000.0
WZ-4-145	ADCK4	100.0	10000.0
JNK-IN-5A	MP2K6	100.0	10000.0
AZ-628	MAP3K1	76.0	10000.0
NVP-TAE684	RPS6KA2(Kin.Dom.2)	6.2	1000.0
MPS-1-IN-1	JAK2(Kin.Dom.2)	100.0	1000.0
HG-6-64-01	NEK4	33.0	10000.0
HG-5-113-01	TAOK3	2.0	10000.0
ZSTK474	AKT2	100.0	1000.0
Omipalisib	STK35	100.0	10000.0
PD0325901	EPHA6	94.0	10000.0
R406	ITK	4.2	1000.0
KU63794	GSK3B	100.0	10000.0
HG-14-10-04	RSK2(Kin.Dom.1-N-terminal)	0.2	10000.0
Lapatinib	TSSK1	95.0	10000.0
THZ1	MP2K1	0.4	10000.0
XMD13-2	NIM1	100.0	10000.0
(s)-CR8	TRPM6	100.0	10000.0
AZ-628	MK03	100.0	10000.0
KIN001-127	CSNK1A1L	100.0	10000.0
QL-XII-47	M4K1	98.0	1000.0
Torin1	TYK2(JH1domain-catalytic)	70.0	10000.0
JNK-IN-5A	JAK3(JH1domain-catalytic)	98.0	10000.0
AZD-6482	KPCT	97.0	10000.0
ZSTK474	TAK1	100.0	1000.0
Pictilisib	ADCK3	91.0	1000.0
JNK-IN-11	DYRK1A	90.0	1000.0
Seliciclib	MAP3K3	98.0	10000.0
WZ4002	ABL1(F317I)	100.0	10000.0
CH5424802	WNK4	100.0	1000.0
BMX-IN-1	TEC	4.2	10000.0
5z-7-oxozeaenol	PIK3CA(E545K)	69.0	10000.0
CP466722	EPHA2	27.0	10000.0
5z-7-oxozeaenol	MP2K5	0.1	10000.0
JNK-9L	RSK4(Kin.Dom.1-N-terminal)	60.0	10000.0
Ribociclib	KIT(D816V)	100.0	1000.0
BI-D1870	MYLK2	33.0	10000.0
Lapatinib	ABL1-phosphorylated	100.0	10000.0
JNK-IN-8	FLT3(D835H)	82.0	1000.0
GSK1059615	FLT3(D835Y)	28.0	10000.0
GW843682X	PLK2	0.2	10000.0
BMS345541	TNIK	100.0	10000.0
XMD11-50	LYN	100.0	10000.0
XMD16-144	CSNK2A2	87.0	10000.0
CG-930	DAPK1	95.0	10000.0
HG-5-88-01	ABL1(E255K)	100.0	10000.0
XMD8-85	ACVR2A	100.0	10000.0
Torin1	FLT3(N841I)	8.8	10000.0
QL-XI-92	AXL	100.0	10000.0
Alpelisib	CAMK1B	100.0	1000.0
XMD13-2	FAK2	100.0	10000.0
ZSTK474	YES	100.0	1000.0
JNK-IN-11	PIK3CA(C420R)	100.0	1000.0
WZ3105	MKNK2	39.0	10000.0
HG-5-88-01	ACVR1B	100.0	10000.0
NPK76-II-72-1	CDK9	100.0	10000.0
Torin1	TSSK1	100.0	10000.0
CH5424802	EGFR(L747-E749del,A750P)	14.0	1000.0
A443654	FLT3	4.5	10000.0
CGP60474	ULK1	100.0	10000.0
PHA-793887	MARK1	77.0	10000.0
BMS345541	MK13	100.0	10000.0
THZ1	CLK2	8.3	10000.0
WZ4003	KPCE	100.0	1000.0
NU7441	MAPKAPK5	100.0	10000.0
XMD8-92	RPS6KA6(Kin.Dom.1)	100.0	10000.0
BMX-IN-1	ABL1(M351T)-phosphorylated	86.0	10000.0
BGJ398	PIK3CA(E545A)	77.0	1000.0
HG-14-8-02	DCAMKL2	94.0	10000.0
WZ-4-145	RPS6KA5(Kin.Dom.1)	100.0	10000.0
Ribociclib	YANK3	91.0	1000.0
WZ-4-145	SRPK2	100.0	10000.0
Sigma A6730	YSK4	75.0	10000.0
AZD 5438	ULK3	5.3	10000.0
Torin1	SgK110	94.0	10000.0
NVP-TAE684	EPHB4	17.0	1000.0
Barasertib	PAK2	100.0	10000.0
Barasertib	RIPK2	17.0	10000.0
Torin1	M3K6	100.0	10000.0
WZ-7043	EPHA2	100.0	10000.0
ERK5-IN-1	FLT3(R834Q)	100.0	1000.0
SB590885	CDK15	100.0	10000.0
NVP-TAE684	ACVRL1	1.7	1000.0
HG-14-10-04	AAK1	0.3	10000.0
BMX-IN-1	MK12	79.0	10000.0
BMX-IN-1	M3K13	100.0	10000.0
KU63794	NDR1	55.0	10000.0
Momelotinib	CSK	100.0	10000.0
Ibrutinib	IRAK3	100.0	1000.0
XMD8-85	CDK11	100.0	10000.0
NU7441	DRAK1	95.0	10000.0
Omipalisib	PKN2	87.0	10000.0
HG-14-8-02	ITK	59.0	10000.0
GW843682X	EPHA4	83.0	10000.0
JW-7-24-1	BRSK2	100.0	10000.0
PD0325901	CAMK1G	100.0	10000.0
HG-6-64-01	BRSK1	100.0	10000.0
Momelotinib	EIF2AK1	100.0	10000.0
MRT67307	NDR2	91.0	10000.0
AZ-628	ACVR2B	100.0	10000.0
GSK461364	MLK2	92.0	10000.0
PHA-767491	SIK2	91.0	10000.0
XMD8-85	M3K5	100.0	10000.0
XMD11-50	TGFBR1	100.0	10000.0
Buparlisib	RIPK2	98.0	1000.0
CGP74514A	RET(M918T)	11.0	10000.0
Barasertib	LATS2	52.0	10000.0
WH-4-023	CSNK1A1	71.0	10000.0
JNK-9L	KPCI	88.0	10000.0
AS-252424	CHK2	100.0	10000.0
Pictilisib	ABL1(T315I)-nonphosphorylated	96.0	1000.0
ZSTK474	PKAC-beta	100.0	1000.0
Barasertib	EPHA2	76.0	10000.0
Neratinib	KGP1	94.0	10000.0
OTSSP167	LCK	0.5	10000.0
GSK1059615	MLK1	76.0	10000.0
Alpelisib	FLT4	100.0	1000.0
GSK1059615	FAK1	100.0	10000.0
Barasertib	EPHB2	93.0	10000.0
CP724714	SYK	100.0	10000.0
GSK1059615	PIK3CA(I800L)	12.0	10000.0
ZM-447439	PIM1	100.0	10000.0
AZ-628	CSNK1G3	100.0	10000.0
A443654	ERK5	100.0	10000.0
QL-XII-47	YANK2	100.0	1000.0
ZSTK474	MAP3K4	100.0	1000.0
TAK-715	PCTK2	99.0	10000.0
Torin1	KIT(D816V)	9.3	10000.0
AZD 5438	MK11	68.0	10000.0
BGJ398	FLT3(K663Q)	71.0	1000.0
WZ4002	EPHA6	100.0	10000.0
Buparlisib	EGFR(T790M)	100.0	1000.0
Dabrafenib	M4K3	77.0	10000.0
WH-4-023	LCK	0.1	10000.0
Ibrutinib	EPHA1	61.0	1000.0
QL-XI-92	SBK1	100.0	10000.0
GSK1059615	CSF1R	88.0	10000.0
ERK5-IN-1	MET	100.0	1000.0
MPS-1-IN-1	DMPK	100.0	1000.0
CP466722	PFCDPK1(P.falciparum)	1.4	10000.0
ALW-II-49-7	RPS6KA3(Kin.Dom.1)	100.0	10000.0
KIN001-127	CDK14	100.0	10000.0
MLN8054	KCC4	66.0	10000.0
HG-14-10-04	DAPK1	0.4	10000.0
BI-D1870	STK16	4.0	10000.0
KIN001-123	KIT(D816V)	13.0	1000.0
Abemaciclib	SGK3	1.8	1000.0
MLN8054	KPCL	100.0	10000.0
PHA-767491	SRPK2	62.0	10000.0
BI-2536	LATS2	100.0	10000.0
ZG-10	CDC2L1	91.0	10000.0
MLN8054	KGP2	96.0	10000.0
SP600125	BIKE	0.6	10000.0
PD173074	IGF1R	100.0	10000.0
PHA-793887	LCK	100.0	10000.0
Abemaciclib	KPCE	4.1	1000.0
GSK461364	NEK6	95.0	10000.0
XMD11-85h	FLT3(D835Y)	100.0	10000.0
XMD14-99	KCC2D	23.0	10000.0
WZ3105	KKCC1	40.0	10000.0
GW843682X	NEK3	100.0	10000.0
XMD13-2	MET	75.0	10000.0
KU63794	MARK2	94.0	10000.0
ALW-II-49-7	ABL1(F317L)	22.0	10000.0
Omipalisib	MET	96.0	10000.0
GSK1059615	STK39	71.0	10000.0
Dinaciclib	CSNK1E	14.0	10000.0
JW-7-24-1	MKNK1	100.0	10000.0
JNK-IN-8	DYRK1A	81.0	1000.0
KIN001-123	DYRK1B	100.0	1000.0
Ibrutinib	YANK1	45.0	1000.0
JNK-IN-5A	PKAC-beta	80.0	10000.0
ERK5-IN-1	EGFR(L861Q)	100.0	1000.0
PHA-793887	BMPR2	99.0	10000.0
Dactolisib	KPCD2	100.0	1000.0
OTSSP167	NIM1	70.0	10000.0
OTSSP167	RIPK1	100.0	10000.0
XMD-12	CSK	91.0	1000.0
XMD-12	PKAC-beta	100.0	1000.0
QL-X-138	TESK1	54.0	10000.0
AZ-628	EGFR(T790M)	79.0	10000.0
Ribociclib	AKT1	100.0	1000.0
AZD4547	HIPK1	49.0	10000.0
(s)-CR8	CDC2L2	100.0	10000.0
AZD4547	KCC4	31.0	10000.0
Ceritinib	ITK	89.0	1000.0
WYE-125132	CHK2	84.0	10000.0
Crizotinib	RAF1	93.0	10000.0
GSK429286A	LATS2	10.0	10000.0
PD173074	ACVRL1	100.0	10000.0
Omipalisib	STK36	100.0	10000.0
XMD14-99	MAP3K15	51.0	10000.0
Torin2	DAPK1	91.0	10000.0
Buparlisib	MP2K6	100.0	1000.0
(s)-CR8	MAP3K14	60.0	10000.0
BGJ398	FAK2	88.0	1000.0
BMS-536924	BRSK1	100.0	1000.0
BI-2536	KPCD1	7.0	10000.0
Torkinib	MELK	10.0	10000.0
PD173074	JAK1(Kin.Dom.1)	100.0	10000.0
Dabrafenib	HUNK	86.0	10000.0
WZ-7043	CHEK1	100.0	10000.0
QL-XII-47	CLK4	95.0	1000.0
KIN001-021	MP2K3	100.0	1000.0
WZ4003	CAMK2G	100.0	1000.0
ZG-10	JNK1	1.2	10000.0
HG-6-64-01	HCK	0.5	10000.0
QL-XI-92	EGFR	79.0	10000.0
QL-XII-47	DAPK3	100.0	1000.0
XMD13-2	MST2	100.0	10000.0
Ribociclib	STK39	80.0	1000.0
MPS-1-IN-1	MK12	100.0	1000.0
Dinaciclib	KIT(D816V)	99.0	10000.0
Neratinib	PIK3CA(I800L)	99.0	10000.0
KIN001-127	LYN	100.0	10000.0
WZ4002	MAP4K5	100.0	10000.0
ZG-10	CLK4	2.2	10000.0
HG-5-113-01	DAPK1	100.0	10000.0
GSK1059615	PIK4CB	0.4	10000.0
HG-6-64-01	DRAK2	1.0	10000.0
KIN001-220	PLK3	82.0	10000.0
HG-5-113-01	DCAMKL3	2.8	10000.0
BMS345541	IKKB	0.6	10000.0
MPS-1-IN-1	SRPK3	100.0	1000.0
CGP60474	ALK	100.0	10000.0
ALW-II-38-3	NEK9	100.0	10000.0
HG-5-113-01	PIK3C2B	100.0	10000.0
GW-5074	CSNK1G3	94.0	10000.0
XMD11-85h	AAK1	100.0	10000.0
ZM-447439	NEK9	100.0	10000.0
PHA-793887	RIOK3	80.0	10000.0
OTSSP167	KPCD2	6.4	10000.0
HG-14-8-02	SGK3	100.0	10000.0
GW-5074	STK16	90.0	10000.0
PHA-793887	MAPKAPK5	93.0	10000.0
Seliciclib	EGFR(L861Q)	100.0	10000.0
AZD 5438	PIK3C2G	52.0	10000.0
JNK-IN-8	CAMK1	81.0	1000.0
JWE-035	SGK3	86.0	10000.0
AS-252424	JAK1(JH1domain-catalytic)	100.0	10000.0
KU63794	CASK	100.0	10000.0
OTSSP167	EGFR(E746-A750del)	8.4	10000.0
JNK-IN-11	NEK1	100.0	1000.0
CP724714	PIK3CA(M1043I)	100.0	10000.0
5z-7-oxozeaenol	HIPK1	71.0	10000.0
Sorafenib	DAPK2	87.0	10000.0
WH-4-023	TLK2	76.0	10000.0
Palbociclib	KGP2	100.0	1000.0
CGP74514A	CDC2L1	100.0	10000.0
Buparlisib	EPHA1	100.0	1000.0
HG-14-10-04	KGP2	46.0	10000.0
KU63794	AKT1	88.0	10000.0
WZ3105	CAMK2B	80.0	10000.0
JNK-IN-8	KPCD3	80.0	1000.0
SP600125	FGFR3(G697C)	100.0	10000.0
PHA-767491	EGFR(L747-T751del,Sins)	58.0	10000.0
QL-X-138	MP2K4	14.0	10000.0
CG-930	NEK4	100.0	10000.0
ZM-447439	SRC	32.0	10000.0
JNK-IN-11	CSK	89.0	1000.0
KU63794	MINK	100.0	10000.0
NU7441	IRAK1	96.0	10000.0
HG-9-91-01	CDK8	100.0	10000.0
GSK429286A	MP2K2	64.0	10000.0
Abemaciclib	ITK	97.0	1000.0
NVP-TAE684	MST3	24.0	1000.0
GW843682X	PIK3CA(H1047L)	73.0	10000.0
Momelotinib	IKKA	0.0	10000.0
Ceritinib	AXL	69.0	1000.0
Seliciclib	KCC2D	87.0	10000.0
KU63794	ROCK2	21.0	10000.0
ZSTK474	MAPKAPK2	100.0	1000.0
ZG-10	PRKR	50.0	10000.0
OTSSP167	PFCDPK1(P.falciparum)	2.4	10000.0
Ibrutinib	ABL1(F317L)-nonphosphorylated	16.0	1000.0
ALW-II-38-3	CLK1	100.0	10000.0
GSK461364	AURKC	100.0	10000.0
ZG-10	LYN	100.0	10000.0
HG-9-91-01	CDK4-cyclinD3	18.0	10000.0
RO-3306	MST4	83.0	10000.0
SCH772984	ERK3	93.0	1000.0
KIN001-220	MYO3B	100.0	10000.0
Torkinib	NDR1	60.0	10000.0
Baricitinib	LRRK2(G2019S)	3.7	10000.0
NU7441	DDR2	100.0	10000.0
ALW-II-38-3	PIK3CA(M1043I)	100.0	10000.0
OTSSP167	KKCC1	0.7	10000.0
NVP-TAE684	TEC	0.7	1000.0
Dactolisib	MLK3	100.0	1000.0
SCH772984	BRSK1	98.0	1000.0
MLN8054	KPCE	72.0	10000.0
NVP-TAE684	FER	0.1	1000.0
BS-181	RSK2(Kin.Dom.2-C-terminal)	79.0	10000.0
KIN001-220	SNRK	89.0	10000.0
AZD7762	PIK3CA(E542K)	100.0	10000.0
Buparlisib	TLK2	99.0	1000.0
JNK-9L	NEK6	76.0	10000.0
AZD-6482	AKT3	100.0	10000.0
TGX221	RPS6KA4(Kin.Dom.2)	100.0	1000.0
Vemurafenib	PAK6	74.0	10000.0
KIN001-220	MAP3K15	100.0	10000.0
AZD4547	NEK10	96.0	10000.0
XMD8-85	MAK	100.0	10000.0
XMD11-85h	FLT3	100.0	10000.0
WZ-7043	FGFR4	0.8	10000.0
RO-3306	LYN	89.0	10000.0
TAK-715	PAK7	90.0	10000.0
HG-14-10-04	TNIK	0.5	10000.0
XMD11-85h	INSR	100.0	10000.0
ZSTK474	WEE1	100.0	1000.0
WZ3105	CHK2	60.0	10000.0
BGJ398	LRRK2(G2019S)	61.0	1000.0
ALW-II-49-7	PIK3CA(E545K)	100.0	10000.0
Momelotinib	GSK3B	91.0	10000.0
Torin1	KIT	59.0	10000.0
Torin1	TNK2	51.0	10000.0
HG-5-113-01	MAPKAPK5	100.0	10000.0
QL-XII-47	AXL	100.0	1000.0
Barasertib	TSSK1	87.0	10000.0
KU63794	GSK3A	100.0	10000.0
Pictilisib	PHKG2	100.0	1000.0
CP466722	ZAP70	32.0	10000.0
AZD 5438	TTK	3.8	10000.0
AZ-628	RAF1	2.3	10000.0
HG-5-88-01	ABL1	100.0	10000.0
JNK-IN-5A	MKNK1	100.0	10000.0
BS-181	PAK7	89.0	10000.0
CP724714	MLK3	92.0	10000.0
HG-9-91-01	CDK9	94.0	10000.0
CP724714	NEK1	83.0	10000.0
Ibrutinib	PLK3	69.0	1000.0
BGJ398	IKKA	95.0	1000.0
NG25	RET(V804M)	1.0	10000.0
BMS345541	RIPK4	100.0	10000.0
Sigma A6730	TNIK	97.0	10000.0
ALW-II-38-3	MST1R	100.0	10000.0
Ribociclib	TRKB	100.0	1000.0
QL-X-138	MK11	89.0	10000.0
NPK76-II-72-1	ZAP70	100.0	10000.0
CGP74514A	ERK3	0.9	10000.0
MRT67307	TEC	100.0	10000.0
JNK-IN-11	MLTK	11.0	1000.0
BX-912	CDK4-cyclinD1	0.3	10000.0
CH5424802	EGFR(L858R)	28.0	1000.0
AZD 5438	YSK1	7.4	10000.0
JNK-IN-8	DRAK2	72.0	1000.0
PD173074	CDK3	100.0	10000.0
AZD4547	LRRK2(G2019S)	73.0	10000.0
NU7441	ULK2	98.0	10000.0
HG-6-64-01	BMX	6.6	10000.0
THZ1	MAP3K15	62.0	10000.0
HG-14-10-04	EPHB6	1.3	10000.0
Buparlisib	KIT(V559D,V654A)	98.0	1000.0
NG25	FLT4	0.2	10000.0
5z-7-oxozeaenol	PGFRA	1.4	10000.0
AZD-6482	ERK8	100.0	10000.0
5z-7-oxozeaenol	MK14	93.0	10000.0
QL-XII-47	ABL1(F317L)-phosphorylated	91.0	1000.0
AZ-628	MARK4	100.0	10000.0
Crizotinib	TYK2(JH2domain-pseudokinase)	2.3	10000.0
Lapatinib	ERK5	93.0	10000.0
Barasertib	CDK14	100.0	10000.0
BGJ398	MST1R	100.0	1000.0
Torin2	PI42C	21.0	10000.0
Sigma A6730	STK16	92.0	10000.0
NU7441	KC1G1	92.0	10000.0
JWE-035	TAOK3	0.1	10000.0
OTSSP167	NEK9	88.0	10000.0
HG-9-91-01	FLT3(R834Q)	60.0	10000.0
Dabrafenib	FGFR2	93.0	10000.0
TAK-715	FLT3(N841I)	28.0	10000.0
Barasertib	PIK3CG	100.0	10000.0
XMD-12	MINK	100.0	1000.0
ALW-II-38-3	MK11	0.0	1000.0
WZ3105	TRKA	15.0	10000.0
QL-XI-92	ANKK1	99.0	10000.0
HG-9-91-01	EGFR(L861Q)	0.0	10000.0
BX-912	JAK1(JH1domain-catalytic)	0.3	10000.0
NU7441	CDC2L5	100.0	10000.0
Taselisib	CAMK2G	100.0	1000.0
BMX-IN-1	ERN1	99.0	10000.0
Dactolisib	DCLK1	100.0	1000.0
WZ3105	DCLK1	30.0	10000.0
Ibrutinib	MAST1	67.0	1000.0
ERK5-IN-1	MAP4K5	95.0	1000.0
AZD-6482	MYO3B	93.0	10000.0
BGJ398	KIT-autoinhibited	72.0	1000.0
JNK-9L	GSK3A	3.5	10000.0
CH5424802	SLK	18.0	1000.0
PHA-767491	MAP3K4	100.0	10000.0
JW-7-24-1	MKNK2	100.0	10000.0
WZ-7043	KIT(V559D,V654A)	100.0	10000.0
R406	KPCE	34.0	1000.0
Canertinib	MLK1	100.0	1000.0
Barasertib	RIPK1	100.0	10000.0
Ibrutinib	EPHA2	86.0	1000.0
QL-X-138	EPHA7	99.0	10000.0
Canertinib	BMX	100.0	1000.0
MLN8054	CDK7	77.0	10000.0
CGP60474	ACVR1B	100.0	10000.0
BMS345541	FLT3(ITD)	98.0	10000.0
BX-912	EPHA7	44.0	10000.0
WZ-4-145	BTK	1.2	10000.0
PD0325901	IKKB	79.0	10000.0
Lapatinib	BLK	34.0	10000.0
Baricitinib	STK39	6.9	10000.0
AZ-628	SIK1	30.0	10000.0
CGP60474	PAK4	100.0	10000.0
XMD11-85h	TAOK3	100.0	10000.0
Torin1	PIK3CA	1.3	10000.0
KIN001-123	CAMK2A	100.0	1000.0
(s)-CR8	CDKL5	99.0	10000.0
CP466722	ABL1(T315I)-phosphorylated	12.0	10000.0
Sorafenib	CDK5	39.0	10000.0
Buparlisib	MP2K7	96.0	1000.0
Seliciclib	YSK1	83.0	10000.0
Vemurafenib	CLK1	70.0	10000.0
QL-XI-92	FES	100.0	10000.0
THZ1	MET(M1250T)	0.1	10000.0
WZ-7043	EPHA7	100.0	10000.0
ZG-10	STK36	99.0	10000.0
Torin1	NEK4	86.0	10000.0
JNK-9L	SBK1	100.0	10000.0
XMD11-85h	MP2K6	100.0	10000.0
BMX-IN-1	EGFR(L747-T751del,Sins)	57.0	10000.0
XMD13-2	FYN	79.0	10000.0
PD0325901	CTK	100.0	10000.0
TAK-715	CDK2	100.0	10000.0
RO-3306	TNK2	88.0	10000.0
WZ-7043	SRPK1	100.0	10000.0
ZSTK474	ABL1(E255K)	100.0	1000.0
XMD8-85	BRAF(V600E)	100.0	10000.0
XMD8-85	EPHA4	100.0	10000.0
WYE-125132	PIK3CA(Q546K)	11.0	10000.0
AZD4547	TSSK1	10.0	10000.0
ZSTK474	MLK1	100.0	1000.0
Omipalisib	HUNK	61.0	10000.0
Dinaciclib	PHKG2	26.0	10000.0
GSK461364	TESK1	100.0	10000.0
R406	RPS6KA2(Kin.Dom.2)	100.0	1000.0
ZG-10	CSNK2A1	12.0	10000.0
Taselisib	NEK5	100.0	1000.0
JNK-IN-8	ABL1(Q252H)-nonphosphorylated	100.0	1000.0
Dinaciclib	RIOK1	54.0	10000.0
Torkinib	BMPR1B	0.1	10000.0
AZD-6482	WEE1	100.0	10000.0
SP600125	M4K3	100.0	10000.0
XMD14-99	PDPK1	100.0	10000.0
Momelotinib	SIK3	100.0	10000.0
CG-930	PKMYT1	92.0	10000.0
HG-5-113-01	RPS6KA2(Kin.Dom.1)	1.8	10000.0
JW-7-24-1	EGFR(L861Q)	100.0	10000.0
HG-14-10-04	JNK1	0.0	10000.0
SCH772984	PRP4	67.0	1000.0
ZG-10	SRPK3	28.0	10000.0
NG25	GAK	31.0	10000.0
Sorafenib	MST1R	74.0	10000.0
BMS345541	STK33	73.0	10000.0
JNK-IN-5A	KPCD3	84.0	10000.0
Neratinib	CDKL2	100.0	10000.0
NVP-TAE684	BMX	12.0	1000.0
MPS-1-IN-1	EPHB1	100.0	1000.0
Torin1	PRP4	100.0	10000.0
Torkinib	PHKG1	50.0	10000.0
Sigma A6730	EPHB3	100.0	10000.0
ERK5-IN-1	EPHA6	100.0	1000.0
XMD8-85	DAPK3	100.0	10000.0
BS-181	PIK3CA(H1047L)	100.0	10000.0
Sigma A6730	ALK(L1196M)	64.0	10000.0
CG-930	KPCI	100.0	10000.0
PHA-767491	TBK1	65.0	10000.0
JNK-IN-5A	TGFBR1	100.0	10000.0
HG-14-10-04	YANK3	40.0	10000.0
ALW-II-38-3	CDK5	100.0	10000.0
KU63794	HUNK	90.0	10000.0
Alpelisib	MK12	90.0	1000.0
MPS-1-IN-1	MST1	100.0	1000.0
CH5424802	MYLK4	100.0	1000.0
XMD13-2	CDK3	7.2	10000.0
HG-9-91-01	PFCDPK1(P.falciparum)	0.1	10000.0
GW-5074	RSK2(Kin.Dom.1-N-terminal)	36.0	10000.0
BGJ398	ROS1	76.0	1000.0
HG-5-113-01	PIP5K2B	3.8	10000.0
ERK5-IN-1	LKB1	100.0	1000.0
Neratinib	TYK2(JH1domain-catalytic)	100.0	10000.0
Dinaciclib	CDKL3	13.0	10000.0
Baricitinib	SgK110	1.1	10000.0
Dactolisib	TYK2(JH2domain-pseudokinase)	100.0	1000.0
AG1478	SYK	54.0	10000.0
BMS-536924	ABL1	16.0	1000.0
CGP74514A	ABL1(T315I)-nonphosphorylated	41.0	10000.0
(s)-CR8	MARK1	98.0	10000.0
PHA-793887	JNK3	100.0	10000.0
TAK-715	ABL1(E255K)-phosphorylated	24.0	10000.0
R406	NEK2	6.1	1000.0
NVP-TAE684	RPS6KA1(Kin.Dom.2)	10.0	1000.0
HG-14-10-04	PIK3CB	86.0	10000.0
AZD-6482	FLT3(D835H)	27.0	10000.0
KU63794	TGFBR2	92.0	10000.0
NVP-TAE684	RPS6KA3(Kin.Dom.1)	0.6	1000.0
JW-7-24-1	MET	31.0	10000.0
XMD8-92	SIK2	100.0	10000.0
WZ4002	GAK	0.5	10000.0
Ibrutinib	MLK1	100.0	1000.0
NG25	FER	0.3	10000.0
XMD13-2	KPCD	100.0	10000.0
NU7441	LKB1	75.0	10000.0
KIN001-021	PIM3	100.0	1000.0
Barasertib	BRSK2	100.0	10000.0
WZ-4-145	RPS6KA3(Kin.Dom.1)	100.0	10000.0
Lapatinib	CSNK2A2	100.0	10000.0
Taselisib	CSK	100.0	1000.0
Baricitinib	MAP3K4	93.0	10000.0
BI-D1870	MAP3K4	6.8	10000.0
HG-14-10-04	EPHA6	44.0	10000.0
(s)-CR8	LTK	97.0	10000.0
Pictilisib	KPCE	76.0	1000.0
BX-912	CAMK2G	52.0	10000.0
JNK-IN-5A	EGFR(T790M)	74.0	10000.0
THZ1	TEC	0.2	10000.0
Lapatinib	ABL1(M351T)-phosphorylated	100.0	10000.0
QL-XII-47	IKKA	100.0	1000.0
SB590885	RSK4(Kin.Dom.1-N-terminal)	82.0	10000.0
XMD8-85	TNK2	3.2	10000.0
Baricitinib	DYRK1B	22.0	10000.0
AZD4547	CDKL2	0.2	10000.0
JNK-IN-11	KPCD2	15.0	1000.0
Omipalisib	NUAK1	96.0	10000.0
Abemaciclib	PGFRB	96.0	1000.0
SB590885	CIT	0.8	10000.0
Ibrutinib	AKT3	100.0	1000.0
THZ1	PIK3C2B	99.0	10000.0
SCH772984	GAK	19.0	1000.0
KIN001-111	ABL1(F317L)	1.8	1000.0
CP466722	KPCD	76.0	10000.0
Pictilisib	SRMS	83.0	1000.0
HG-9-91-01	KIT(A829P)	4.3	10000.0
TAK-715	JAK1(JH1domain-catalytic)	100.0	10000.0
HG-14-10-04	RIPK2	85.0	10000.0
XMD-12	IKKB	86.0	1000.0
ALW-II-49-7	SLK	100.0	10000.0
Dactolisib	DYRK2	100.0	1000.0
Baricitinib	ABL1(T315I)-nonphosphorylated	45.0	10000.0
GSK429286A	PIK3CA	80.0	10000.0
NG25	RPS6KA5(Kin.Dom.1)	4.3	10000.0
HG-5-88-01	MP2K1	100.0	10000.0
HG-14-10-04	NEK7	0.5	10000.0
Canertinib	MAP4K4	100.0	1000.0
PLX-4720	ROS1	34.0	10000.0
MLN8054	GSK3B	65.0	10000.0
NG25	MARK3	100.0	10000.0
GSK429286A	VGFR1	77.0	10000.0
Dinaciclib	PIK3CA(I800L)	83.0	10000.0
NVP-TAE684	NEK1	100.0	1000.0
Torin1	TBK1	93.0	10000.0
MPS-1-IN-1	EGFR(G719S)	100.0	1000.0
MPS-1-IN-1	STK16	100.0	1000.0
R406	ABL1(T315I)	1.4	1000.0
WZ4002	SIK2	20.0	10000.0
WYE-125132	MP2K4	90.0	10000.0
QL-XI-92	ALK	95.0	10000.0
BX-912	TAOK3	0.1	10000.0
BMS-536924	NEK7	2.0	1000.0
HG-14-8-02	CSF1R-autoinhibited	40.0	10000.0
Palbociclib	PIK3CA(H1047Y)	100.0	1000.0
PD0325901	BMPR2	81.0	10000.0
HG-14-10-04	TEC	90.0	10000.0
QL-XII-47	PIK3C2G	100.0	1000.0
CGP74514A	IRAK3	50.0	10000.0
AS-252424	JAK2(JH1domain-catalytic)	100.0	10000.0
Taselisib	ACVR1B	97.0	1000.0
ERK5-IN-1	JAK1(JH1domain-catalytic)	100.0	1000.0
KU63794	CIT	96.0	10000.0
Pictilisib	CDC2L5	99.0	1000.0
WZ4003	RPS6KA1(Kin.Dom.2)	100.0	1000.0
GW-5074	VRK2	82.0	10000.0
NVP-TAE684	MAPKAPK5	100.0	1000.0
Neratinib	ITK	52.0	10000.0
(s)-CR8	MAP3K3	92.0	10000.0
Ribociclib	CAMK1B	100.0	1000.0
QL-X-138	LTK	100.0	10000.0
QL-X-138	CDC2L2	100.0	10000.0
ERK5-IN-1	MAP4K2	92.0	1000.0
JNK-9L	TRKB	100.0	10000.0
SP600125	CDKL2	100.0	10000.0
PHA-767491	MK03	18.0	10000.0
HG-14-8-02	LCK	100.0	10000.0
GW-5074	EGFR(L858R,T790M)	98.0	10000.0
XMD13-2	LATS2	85.0	10000.0
JWE-035	ABL1(Q252H)-phosphorylated	0.1	10000.0
A443654	FLT3(ITD)	0.1	10000.0
GW-5074	EPHB1	100.0	10000.0
SCH772984	DRAK1	2.5	1000.0
R406	BRSK1	100.0	1000.0
WZ-4-145	DMPK	100.0	10000.0
Abemaciclib	PFPK5(P.falciparum)	91.0	1000.0
WZ-7043	RPS6KA2(Kin.Dom.2)	100.0	10000.0
HG-14-8-02	MAP4K4	6.6	10000.0
PD0325901	JAK1(JH1domain-catalytic)	78.0	10000.0
ZM-447439	KIT(V559D,V654A)	5.8	10000.0
Vemurafenib	M3K13	100.0	10000.0
BI-D1870	HIPK3	16.0	10000.0
PHA-793887	TNK2	100.0	10000.0
HG-14-8-02	VGFR2	76.0	10000.0
KIN001-220	LYN	46.0	10000.0
HG-6-64-01	EGFR(T790M)	9.9	10000.0
GW843682X	TYRO3	72.0	10000.0
KIN001-220	TEC	42.0	10000.0
SB590885	GSK3B	81.0	10000.0
GSK461364	TAOK2	94.0	10000.0
XMD8-85	SRPK3	100.0	10000.0
Ibrutinib	M3K12	93.0	1000.0
AS-252424	MET	97.2	10000.0
KIN001-220	EGFR(L858R)	28.0	10000.0
SB590885	ABL1(Y253F)-phosphorylated	9.1	10000.0
QL-XII-47	CDKL3	89.0	1000.0
Vemurafenib	PIK3CA(E542K)	100.0	10000.0
Buparlisib	KKCC1	100.0	1000.0
XMD11-50	MLK1	93.0	10000.0
BX-912	MAST1	58.0	10000.0
OTSSP167	EPHA4	0.0	10000.0
WZ4003	PLK3	100.0	1000.0
JNK-IN-11	DMPK	59.0	1000.0
XMD11-85h	MELK	100.0	10000.0
AS-252424	ABL1(F317I)	95.9	10000.0
Sigma A6730	FRK	100.0	10000.0
GSK1059615	BRAF	48.0	10000.0
PHA-767491	JAK3(JH1domain-catalytic)	0.0	10000.0
AS-252424	PHKG2	83.8	10000.0
AZD 5438	MYO3A	86.0	10000.0
KU63794	MARK1	100.0	10000.0
R406	KPCT	17.0	1000.0
Pictilisib	AMPK-alpha1	88.0	1000.0
JNK-IN-5A	DAPK3	88.0	10000.0
R406	ALK	0.2	1000.0
ZG-10	CAMK2G	76.0	10000.0
GSK429286A	DDR1	100.0	10000.0
JNK-IN-8	STK33	100.0	1000.0
JNK-IN-8	CSF1R	8.6	1000.0
WH-4-023	HCK	0.2	10000.0
HG-6-64-01	KCC2D	100.0	10000.0
SCH772984	KIT(V559D,V654A)	89.0	1000.0
Torin1	DRAK2	67.0	10000.0
BGJ398	SGK2	100.0	1000.0
QL-X-138	DRAK1	100.0	10000.0
KIN001-220	HIPK2	5.0	10000.0
PHA-793887	RIPK2	95.0	10000.0
QL-XII-47	EPHA4	92.0	1000.0
PD173074	ACVR1B	100.0	10000.0
GSK461364	LIMK1	100.0	10000.0
TGX221	BMPR1A	100.0	1000.0
AZD7762	CAMK2G	24.0	10000.0
Lapatinib	KPCD3	78.0	10000.0
GSK429286A	INSR	96.0	10000.0
KIN001-220	MARK2	50.0	10000.0
CGP60474	RIPK2	100.0	10000.0
AZD-6482	SIK2	100.0	10000.0
WZ4003	BRSK2	100.0	1000.0
SCH772984	MYLK	70.0	1000.0
PD0325901	EPHB6	87.0	10000.0
QL-XII-47	EPHB6	92.0	1000.0
WH-4-023	MARK1	24.0	10000.0
CP724714	PAK3	70.0	10000.0
SP600125	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
XMD11-50	DMPK	100.0	10000.0
RO-3306	PKAC-beta	28.0	10000.0
BMX-IN-1	FLT3(K663Q)	100.0	10000.0
OTSSP167	CDC2L2	3.4	10000.0
GSK429286A	ERBB2	71.0	10000.0
Ribociclib	ROCK2	100.0	1000.0
Crizotinib	TGFBR2	100.0	10000.0
ERK5-IN-1	IKKA	100.0	1000.0
Neratinib	PIK3CA(H1047L)	100.0	10000.0
Torin2	MP2K6	93.0	10000.0
XMD14-99	SRPK1	100.0	10000.0
Vemurafenib	MYLK4	0.5	10000.0
XMD13-2	TTK	42.0	10000.0
BI-2536	MK14	100.0	10000.0
SCH772984	EGFR(L858R)	94.0	1000.0
NU7441	NEK9	93.0	10000.0
Momelotinib	CLK1	9.6	10000.0
GW-5074	PIP5K1A	19.0	10000.0
SB590885	WEE2	100.0	10000.0
MLN8054	MLTK	93.0	10000.0
GSK1059615	M3K6	96.0	10000.0
KIN001-127	FGFR2	100.0	10000.0
HG-14-8-02	ALK(L1196M)	9.1	10000.0
GSK1059615	STK33	0.6	10000.0
PD0325901	EGFR(L747-T751del,Sins)	51.0	10000.0
WZ4003	DRAK1	0.8	1000.0
Palbociclib	TAK1	100.0	1000.0
QL-XII-47	KPCD2	99.0	1000.0
Lapatinib	ACVR1	100.0	10000.0
BX-912	PIP5K1C	22.0	10000.0
JW-7-24-1	TEC	100.0	10000.0
JNK-IN-5A	JAK1(JH2domain-pseudokinase)	90.0	10000.0
WH-4-023	AXL	17.0	10000.0
Seliciclib	S6K1	100.0	10000.0
KIN001-111	NEK1	100.0	1000.0
JNK-IN-11	PTK6	82.0	1000.0
QL-XII-47	RSK2(Kin.Dom.2-C-terminal)	100.0	1000.0
THZ1	PHKG2	48.0	10000.0
Taselisib	YANK3	100.0	1000.0
Momelotinib	NEK7	2.2	10000.0
JW-7-24-1	KKCC1	100.0	10000.0
GSK1059615	MARK1	74.0	10000.0
HG-9-91-01	CASK	91.0	10000.0
CGP60474	MLTK	100.0	10000.0
GSK1059615	TAK1	62.0	10000.0
ERK5-IN-1	DAPK2	99.0	1000.0
CH5424802	NEK2	88.0	1000.0
Sigma A6730	NEK11	100.0	10000.0
XMD13-2	FLT3(N841I)	33.0	10000.0
ALW-II-49-7	PIM2	100.0	10000.0
KIN001-021	ZAP70	100.0	1000.0
CP724714	AURKA	100.0	10000.0
KIN001-127	TYRO3	100.0	10000.0
Sigma A6730	LOK	65.0	10000.0
PLX-4720	DRAK1	44.0	10000.0
KIN001-220	FER	100.0	10000.0
PHA-793887	MK14	100.0	10000.0
JWE-035	AKT2	100.0	10000.0
BX-912	CDKL1	1.8	10000.0
Taselisib	AURKB	100.0	1000.0
Sigma A6730	LYN	72.0	10000.0
GSK1059615	EPHB4	74.0	10000.0
TGX221	KIT(D816V)	100.0	1000.0
JW-7-24-1	AURKC	100.0	10000.0
XMD13-2	CSK	84.0	10000.0
5z-7-oxozeaenol	MET(Y1235D)	100.0	10000.0
ALW-II-49-7	ULK3	100.0	10000.0
JNK-IN-11	RIOK2	27.0	1000.0
AZD-6482	LOK	100.0	10000.0
Dactolisib	KIT(V559D,T670I)	100.0	1000.0
Dinaciclib	KPCE	91.0	10000.0
OTSSP167	RSK4(Kin.Dom.2-C-terminal)	7.2	10000.0
NPK76-II-72-1	FGFR1	100.0	10000.0
PD173074	EPHA6	100.0	10000.0
PHA-793887	M3K6	100.0	10000.0
ZM-447439	TRKC	98.0	10000.0
BI-2536	KPCE	100.0	10000.0
SP600125	ACVR1	100.0	10000.0
PD173074	MYLK	100.0	10000.0
Abemaciclib	EGFR(L861Q)	75.0	1000.0
Omipalisib	SIK1	80.0	10000.0
XMD11-85h	PKN1	100.0	10000.0
XMD11-85h	FLT3(D835H)	100.0	10000.0
TGX221	ADCK3	100.0	1000.0
QL-X-138	DMPK2	100.0	10000.0
JWE-035	FGFR4	36.0	10000.0
Buparlisib	PHKG2	100.0	1000.0
QL-XI-92	M3K6	83.0	10000.0
Dactolisib	BMPR2	100.0	1000.0
Neratinib	PIK3CB	100.0	10000.0
AZD-6482	TRKC	98.0	10000.0
Sigma A6730	MLK1	96.0	10000.0
Crizotinib	ADCK3	53.0	10000.0
AZ-628	MK09	1.8	10000.0
RO-3306	HIPK1	20.0	10000.0
GW843682X	CLK1	36.0	10000.0
QL-XI-92	ACVRL1	100.0	10000.0
AZD 5438	VRK2	50.0	10000.0
THZ1	STK36	4.8	10000.0
BX-912	MK01	77.0	10000.0
Torin1	RIPK5	28.0	10000.0
Ribociclib	PGFRA	100.0	1000.0
NU7441	CDK5	100.0	10000.0
KIN001-220	HUNK	49.0	10000.0
GSK1059615	MLK3	98.0	10000.0
BMS345541	BRAF(V600E)	60.0	10000.0
TAK-715	CDK4-cyclinD1	84.0	10000.0
Dinaciclib	TGFBR1	88.0	10000.0
THZ1	KIT(V559D)	0.0	10000.0
WYE-125132	SRPK2	90.0	10000.0
ZG-10	AMPK-alpha1	100.0	10000.0
HG-14-8-02	RPS6KA4(Kin.Dom.2-C-terminal)	7.2	10000.0
Palbociclib	ERBB3	100.0	1000.0
THZ1	DDR1	0.7	10000.0
KIN001-127	MST3	33.0	10000.0
ZG-10	ERK4	19.0	10000.0
CGP60474	PGFRA	100.0	10000.0
XMD16-144	TESK1	100.0	10000.0
A443654	SRMS	100.0	10000.0
BMS345541	TIE2	100.0	10000.0
Dabrafenib	AKT2	91.0	10000.0
CGP60474	STK16	100.0	10000.0
HG-14-10-04	EPHA3	38.0	10000.0
KIN001-220	FYN	41.0	10000.0
PHA-793887	TRKB	75.0	10000.0
MPS-1-IN-1	TLK1	100.0	1000.0
Torin1	TTK	9.6	10000.0
WYE-125132	ROCK2	100.0	10000.0
Taselisib	FLT3(D835Y)	95.0	1000.0
QL-XII-47	NLK	100.0	1000.0
NU7441	MK13	99.0	10000.0
ZM-447439	MRCKA	85.0	10000.0
SP600125	KPCD1	100.0	10000.0
AZD-6482	RIPK4	99.0	10000.0
CP724714	ACVR2A	100.0	10000.0
KIN001-127	TXK	100.0	10000.0
KIN001-123	FGFR3	17.0	1000.0
AZD7762	KCC2D	6.7	10000.0
ALW-II-38-3	RPS6KA1(Kin.Dom.2)	100.0	10000.0
ZM-447439	SBK1	92.0	10000.0
GW-5074	IRAK4	90.0	10000.0
QL-XI-92	NEK5	100.0	10000.0
CG-930	FRK	100.0	10000.0
ZM-447439	MP2K2	0.1	10000.0
Sorafenib	CLK3	91.0	10000.0
QL-X-138	STK33	100.0	10000.0
BI-D1870	CDK15	28.0	10000.0
Lapatinib	KC1G2	91.0	10000.0
PHA-767491	KC1G1	5.9	10000.0
QL-X-138	ACVR2A	76.0	10000.0
GW-5074	AKT1	100.0	10000.0
BMX-IN-1	RSK1(Kin.Dom.2-C-terminal)	67.0	10000.0
BMX-IN-1	EGFR	25.0	10000.0
XMD14-99	PKMYT1	100.0	10000.0
5z-7-oxozeaenol	FAK2	88.0	10000.0
Torin2	CIT	100.0	10000.0
JW-7-24-1	FGFR3	100.0	10000.0
ZM-447439	TIE1	27.0	10000.0
Sorafenib	MAP3K4	98.0	10000.0
Momelotinib	GSK3A	100.0	10000.0
KIN001-111	CLK3	100.0	1000.0
BI-2536	MP2K6	100.0	10000.0
Vemurafenib	SGK3	71.0	10000.0
Crizotinib	MAP3K15	73.0	10000.0
5z-7-oxozeaenol	ABL1(H396P)-nonphosphorylated	97.0	10000.0
CH5424802	FLT3(D835V)	3.1	1000.0
AZD4547	ICK	38.0	10000.0
JNK-IN-11	ABL1(H396P)-nonphosphorylated	1.6	1000.0
GW-5074	RIPK1	85.0	10000.0
Barasertib	ROCK1	67.0	10000.0
PD0325901	STK39	96.0	10000.0
JNK-9L	PIK3CA(Q546K)	75.0	10000.0
Dinaciclib	ERK5	2.9	10000.0
SCH772984	AKT2	87.0	1000.0
HG-14-10-04	ALK	0.0	10000.0
GSK429286A	HIPK4	86.0	10000.0
XMD8-85	ERBB3	100.0	10000.0
AS-252424	PIM1	2.7	10000.0
CH5424802	FGFR2	100.0	1000.0
QL-XII-47	CSF1R-autoinhibited	85.0	1000.0
NG25	PAK2	100.0	10000.0
RO-3306	ALK(L1196M)	66.0	10000.0
BS-181	LATS1	92.0	10000.0
CGP74514A	EPHA3	14.0	10000.0
Taselisib	MP2K6	100.0	1000.0
XMD11-85h	ERBB4	100.0	10000.0
SCH772984	VRK2	83.0	1000.0
Alpelisib	RET(M918T)	100.0	1000.0
RO-3306	ACVR2B	58.0	10000.0
HG-5-88-01	CSF1R	100.0	10000.0
Dinaciclib	TEC	90.0	10000.0
JWE-035	BTK	67.0	10000.0
CGP60474	MK09	100.0	10000.0
NPK76-II-72-1	RPS6KA6(Kin.Dom.2)	12.0	10000.0
CG-930	MAST1	75.0	10000.0
AZD4547	PDPK1	100.0	10000.0
SCH772984	LATS1	60.0	1000.0
NG25	BRAF(V600E)	4.0	10000.0
(s)-CR8	RIPK5	92.0	10000.0
Torkinib	KKCC1	49.0	10000.0
OTSSP167	CDK2	2.8	10000.0
TGX221	JAK1(Kin.Dom.2)	100.0	1000.0
JNK-IN-11	MK12	94.0	1000.0
CH5424802	AKT1	100.0	1000.0
WZ-4-145	FLT3(D835Y)	100.0	10000.0
RO-3306	ERN1	72.0	10000.0
TGX221	CHEK1	100.0	1000.0
AZ-628	MYLK4	100.0	10000.0
PD173074	DYRK1B	100.0	10000.0
KIN001-021	CDK9	100.0	1000.0
(s)-CR8	FRK	92.0	10000.0
SB590885	PKAC-alpha	67.0	10000.0
QL-X-138	FGR	57.0	10000.0
JNK-IN-5A	VRK2	100.0	10000.0
QL-XII-47	WNK1	100.0	1000.0
MLN8054	EGFR	43.0	10000.0
OTSSP167	LKB1	24.0	10000.0
AZD-6482	CDK3	100.0	10000.0
Sigma A6730	CDC2L1	97.0	10000.0
NPK76-II-72-1	EPHA7	100.0	10000.0
JNK-9L	CDK14	35.0	10000.0
PHA-767491	PIM3	13.0	10000.0
JNK-9L	PIK3CA(I800L)	64.0	10000.0
HG-9-91-01	FGFR2	0.3	10000.0
CG-930	TAOK2	93.0	10000.0
Alpelisib	M3K12	100.0	1000.0
JW-7-24-1	MST3	100.0	10000.0
HG-9-91-01	SGK1	100.0	10000.0
SB590885	HIPK3	62.0	10000.0
Taselisib	PIK3C2G	74.0	1000.0
Ribociclib	MAP3K14	100.0	1000.0
CP466722	FGFR3	84.0	10000.0
HG-5-88-01	ERK4	100.0	10000.0
Buparlisib	SIK2	91.0	1000.0
Sigma A6730	TLK1	100.0	10000.0
MRT67307	DDR2	94.0	10000.0
Taselisib	KGP1	91.0	1000.0
ZSTK474	MP2K1	100.0	1000.0
CP466722	RET	20.0	10000.0
JNK-IN-5A	EPHA1	85.0	10000.0
BMX-IN-1	PFPK5(P.falciparum)	100.0	10000.0
ALW-II-49-7	TGFBR1	100.0	10000.0
PD173074	SIK2	100.0	10000.0
TGX221	SYK	100.0	1000.0
PHA-793887	DMPK	21.0	10000.0
CG-930	PIM2	100.0	10000.0
ZSTK474	MST4	100.0	1000.0
JW-7-24-1	CLK2	100.0	10000.0
PHA-793887	HIPK1	69.0	10000.0
Omipalisib	ROCK1	65.0	10000.0
Crizotinib	PAK6	72.0	10000.0
XMD8-92	ERK5	0.0	10000.0
SB590885	PIK3CB	100.0	10000.0
HG-9-91-01	TNIK	0.3	10000.0
AG1478	EPHB6	16.0	10000.0
Ceritinib	CDK11	97.0	1000.0
CH5424802	CSNK1E	47.0	1000.0
GSK429286A	JAK1(JH2domain-pseudokinase)	100.0	10000.0
BGJ398	KC1G1	74.0	1000.0
XMD8-85	AKT3	100.0	10000.0
Buparlisib	PGFRA	100.0	1000.0
ALW-II-49-7	PGFRA	0.2	1000.0
BMX-IN-1	LRRK2(G2019S)	62.0	10000.0
AZD-6482	JNK1	100.0	10000.0
Ceritinib	CDKL3	95.0	1000.0
AZD-6482	ABL1(H396P)-nonphosphorylated	61.0	10000.0
HG-5-88-01	TNK1	3.8	10000.0
Pictilisib	JAK3(JH1domain-catalytic)	84.0	1000.0
WZ3105	CTK	40.0	10000.0
BX-912	TIE2	12.0	10000.0
AZ-628	PIP5K1C	75.0	10000.0
HG-14-8-02	OSR1	100.0	10000.0
ZM-447439	FGFR1	94.0	10000.0
Vemurafenib	MLTK	7.4	10000.0
Alpelisib	MARK3	100.0	1000.0
KIN001-220	NEK2	87.0	10000.0
KU63794	TIE2	71.0	10000.0
Abemaciclib	PIK3CA(C420R)	100.0	1000.0
Torin1	MARK1	100.0	10000.0
QL-XI-92	MP2K5	80.0	10000.0
Crizotinib	ALK	8.6	10000.0
JNK-9L	LOK	39.0	10000.0
JW-7-24-1	GSK3B	31.0	10000.0
JNK-9L	IKKE	37.0	10000.0
BS-181	CDKL2	69.0	10000.0
Torin1	ACVR1B	45.0	10000.0
Crizotinib	EGFR(L858R)	67.0	10000.0
KIN001-111	ACVR1	100.0	1000.0
Vemurafenib	CSNK1G3	100.0	10000.0
Palbociclib	PIK3CB	100.0	1000.0
Momelotinib	ABL1(F317L)-phosphorylated	89.0	10000.0
AZD7762	EPHB4	6.4	10000.0
Pictilisib	MAP4K2	100.0	1000.0
Torin1	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
WYE-125132	PIM2	74.0	10000.0
QL-X-138	TIE1	100.0	10000.0
TGX221	DRAK2	100.0	1000.0
CP466722	PIK3CA(H1047Y)	24.0	10000.0
BMS-536924	BRSK2	100.0	1000.0
AZ-628	KIT(V559D)	0.1	10000.0
JNK-IN-11	TNNI3K	100.0	1000.0
A443654	MARK1	100.0	10000.0
NVP-TAE684	PCTK2	9.9	1000.0
BS-181	MAP3K14	100.0	10000.0
XMD8-85	TYK2(JH1domain-catalytic)	100.0	10000.0
GSK461364	MK12	95.0	10000.0
XMD11-85h	CSNK1G3	100.0	10000.0
Ceritinib	CDK8	88.0	1000.0
Buparlisib	GRK4	94.0	1000.0
KIN001-127	MST1	100.0	10000.0
TAK-715	RIPK5	100.0	10000.0
JNK-IN-5A	HIPK4	100.0	10000.0
MRT67307	LRRK2	10.0	10000.0
PHA-793887	ABL1(H396P)-phosphorylated	99.0	10000.0
WZ4003	ACVR1	100.0	1000.0
BMS345541	MYLK	79.0	10000.0
BI-D1870	MLK3	3.2	10000.0
Dabrafenib	CSK	0.1	10000.0
XMD11-50	MINK	77.0	10000.0
Omipalisib	FGR	76.0	10000.0
Ceritinib	PDPK1	100.0	1000.0
Canertinib	ADCK3	100.0	1000.0
Torkinib	MYLK2	43.0	10000.0
AZD 5438	NEK2	91.0	10000.0
QL-X-138	MYLK2	89.0	10000.0
Lapatinib	JNK1	100.0	10000.0
CH5424802	CDK2	100.0	1000.0
ALW-II-49-7	CSK	100.0	10000.0
XMD11-85h	EGFR(L747-S752del,P753S)	100.0	10000.0
PLX-4720	M3K12	52.0	10000.0
CH5424802	RPS6KA4(Kin.Dom.2-C-terminal)	2.1	1000.0
XMD11-50	MYO3A	94.0	10000.0
WZ4003	PHKG2	4.5	1000.0
NVP-TAE684	PAK6	13.0	1000.0
Barasertib	TNK2	100.0	10000.0
ERK5-IN-1	M3K13	92.0	1000.0
CG-930	STK16	60.0	10000.0
BMS345541	SRPK2	89.0	10000.0
JNK-IN-5A	KIT(D816V)	97.0	10000.0
Dinaciclib	FLT3(ITD)	79.0	10000.0
Abemaciclib	KPCD1	47.0	1000.0
AZD-6482	EGFR(L747-T751del,Sins)	100.0	10000.0
Vemurafenib	PIM2	96.0	10000.0
KU63794	PLK1	55.0	10000.0
A443654	HCK	100.0	10000.0
Pictilisib	EPHA5	97.0	1000.0
TAK-715	STK39	100.0	10000.0
JNK-IN-8	VGFR2	96.0	1000.0
NU7441	YANK3	54.0	10000.0
CGP60474	PAK6	100.0	10000.0
NG25	PIP5K1A	100.0	10000.0
XMD16-144	CAMK1	49.0	10000.0
HG-9-91-01	RIPK5	4.0	10000.0
Crizotinib	CLK3	68.0	10000.0
Sorafenib	SNARK	100.0	10000.0
A443654	TEC	100.0	10000.0
Lapatinib	EPHA1	100.0	10000.0
BGJ398	NEK1	100.0	1000.0
Dabrafenib	RPS6KA4(Kin.Dom.2-C-terminal)	82.0	10000.0
Dabrafenib	BUB1	1.4	10000.0
Seliciclib	TYK2(JH1domain-catalytic)	100.0	10000.0
GW843682X	ABL1(F317L)-phosphorylated	61.0	10000.0
WH-4-023	TSSK1	87.0	10000.0
MRT67307	CSF1R	24.0	10000.0
PLX-4720	M4K3	91.0	10000.0
A443654	IKKA	1.0	10000.0
SCH772984	RSK2(Kin.Dom.1-N-terminal)	84.0	1000.0
HG-5-113-01	FAK2	0.1	10000.0
GSK429286A	MRCKB	22.0	10000.0
QL-XI-92	PAK1	79.0	10000.0
CP466722	SNRK	47.0	10000.0
Sorafenib	EGFR(S752-I759del)	87.0	10000.0
HG-5-113-01	MYLK	100.0	10000.0
SCH772984	FER	100.0	1000.0
AZD 5438	PHKG2	79.0	10000.0
BGJ398	MARK2	69.0	1000.0
BGJ398	ULK2	78.0	1000.0
WZ4003	PLK1	10.0	1000.0
JNK-IN-11	KPCT	28.0	1000.0
AS-252424	EPHA5	100.0	10000.0
AZ-628	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
A443654	AURKA	100.0	10000.0
Dabrafenib	YSK4	40.0	10000.0
NG25	JNK3	12.0	10000.0
TGX221	PGFRB	100.0	1000.0
BMS-536924	RIOK3	11.0	1000.0
Dabrafenib	PRKR	53.0	10000.0
Pictilisib	WNK1	100.0	1000.0
CGP74514A	MK03	15.0	10000.0
NPK76-II-72-1	MRCKA	100.0	10000.0
JNK-IN-5A	LCK	85.0	10000.0
BGJ398	JAK1(JH2domain-pseudokinase)	97.0	1000.0
XMD-12	EIF2AK1	100.0	1000.0
HG-14-8-02	DDR2	100.0	10000.0
JNK-9L	JAK2(JH1domain-catalytic)	0.0	10000.0
Crizotinib	SLK	0.1	10000.0
AZD4547	ROS1	38.0	10000.0
Vemurafenib	EPHB3	100.0	10000.0
XMD-12	PIM2	100.0	1000.0
NVP-TAE684	CAMK1	1.4	1000.0
XMD-12	MLK3	100.0	1000.0
WZ4002	EPHB1	100.0	10000.0
AZD-6482	MYLK	70.0	10000.0
XMD11-85h	PRKX	100.0	10000.0
XMD8-85	INSRR	100.0	10000.0
Pictilisib	KCC2D	99.0	1000.0
Torin2	CLK1	12.0	10000.0
Ceritinib	JAK1(JH2domain-pseudokinase)	52.0	1000.0
PHA-767491	TLK1	74.0	10000.0
ZG-10	PGFRB	3.6	10000.0
R406	YANK3	100.0	1000.0
Torkinib	GCN2(Kin.Dom.2,S808G)	81.0	10000.0
Ibrutinib	WNK1	76.0	1000.0
JNK-IN-5A	TAK1	82.0	10000.0
Lapatinib	EPHA8	84.0	10000.0
Ibrutinib	MERTK	90.0	1000.0
Baricitinib	SNARK	1.5	10000.0
Vemurafenib	JAK1(JH1domain-catalytic)	28.0	10000.0
KIN001-127	PGFRB	100.0	10000.0
Ribociclib	RET(M918T)	100.0	1000.0
Dabrafenib	BRAF(V600E)	0.1	10000.0
ZM-447439	AKT2	100.0	10000.0
BS-181	KPCD	79.0	10000.0
Neratinib	VGFR2	94.0	10000.0
Lapatinib	MKNK1	37.0	10000.0
KIN001-021	FAK2	100.0	1000.0
SCH772984	ABL1(T315I)-phosphorylated	98.0	1000.0
ZG-10	DCAMKL2	100.0	10000.0
AZD7762	CDKL3	100.0	10000.0
Neratinib	EPHA7	97.0	10000.0
SB590885	ERBB4	73.0	10000.0
Lapatinib	KPCD1	57.0	10000.0
MLN8054	NIM1	100.0	10000.0
HG-5-88-01	PIK3CD	100.0	10000.0
XMD11-85h	EGFR(L858R)	100.0	10000.0
5z-7-oxozeaenol	NEK11	91.0	10000.0
PLX-4720	MERTK	94.0	10000.0
TGX221	ACVR1	100.0	1000.0
GW-5074	M3K12	80.0	10000.0
BI-2536	EGFR(E746-A750del)	8.4	10000.0
Omipalisib	RAF1	52.0	10000.0
GSK429286A	GSK3A	100.0	10000.0
HG-14-10-04	CDKL1	42.0	10000.0
XMD8-85	MLK1	100.0	10000.0
XMD16-144	ERK8	100.0	10000.0
CGP60474	SIK2	100.0	10000.0
Ribociclib	KIT-autoinhibited	74.0	1000.0
ZM-447439	EPHA8	83.0	10000.0
RO-3306	DCAMKL2	89.0	10000.0
PD0325901	CSNK2A2	100.0	10000.0
BI-D1870	AURKA	34.0	10000.0
Pictilisib	LOK	93.0	1000.0
QL-XI-92	JNK3	86.0	10000.0
THZ1	KCC4	100.0	10000.0
XMD8-85	ABL1(H396P)	100.0	10000.0
NPK76-II-72-1	KPCE	100.0	10000.0
WZ3105	BRSK1	88.0	10000.0
Crizotinib	SIK3	83.0	10000.0
WH-4-023	RSK3(Kin.Dom.2-C-terminal)	78.0	10000.0
Palbociclib	LRRK2	100.0	1000.0
JWE-035	ADCK4	57.0	10000.0
BGJ398	EGFR(L747-S752del,P753S)	83.0	1000.0
KIN001-111	BMX	1.2	1000.0
Neratinib	EPHA1	100.0	10000.0
TAK-715	CSK	88.0	10000.0
RO-3306	AAK1	7.6	10000.0
Torin1	ALK	80.0	10000.0
SB590885	YSK4	30.0	10000.0
HG-6-64-01	DCAMKL3	3.2	10000.0
GSK461364	M3K12	57.0	10000.0
XMD13-2	KIT(V559D)	4.8	10000.0
Pictilisib	CDK14	96.0	1000.0
Ceritinib	SRPK1	91.0	1000.0
BMS-536924	JAK1(Kin.Dom.2)	0.9	1000.0
Dabrafenib	PIK3C2G	50.0	10000.0
QL-X-138	CDK3	100.0	10000.0
Sigma A6730	PIK3C2B	54.0	10000.0
JNK-IN-5A	CDK11	88.0	10000.0
KIN001-111	PIM1	100.0	1000.0
(s)-CR8	DYRK1B	17.0	10000.0
PLX-4720	MAP3K4	92.0	10000.0
XMD11-50	KC1G2	100.0	10000.0
Ribociclib	M3K5	100.0	1000.0
WZ-7043	RPS6KA6(Kin.Dom.1)	100.0	10000.0
WZ4003	CSNK1G3	100.0	1000.0
Abemaciclib	WNK3	100.0	1000.0
SP600125	AMPK-alpha2	100.0	10000.0
BX-912	FLT3(N841I)	0.0	10000.0
RO-3306	EPHA1	91.0	10000.0
AZD4547	PIK3C2B	88.0	10000.0
JNK-IN-8	MST1	100.0	1000.0
MRT67307	KPCT	31.0	10000.0
XMD11-50	KPCD1	28.0	10000.0
GSK461364	KIT(V559D,V654A)	100.0	10000.0
Dabrafenib	AXL	10.0	10000.0
ZSTK474	LTK	100.0	1000.0
HG-9-91-01	SIK1	0.5	10000.0
HG-14-8-02	FLT4	67.0	10000.0
Sorafenib	KIT	0.0	10000.0
Seliciclib	MKNK2	100.0	10000.0
SB590885	HIPK4	18.0	10000.0
XMD11-85h	TLK1	100.0	10000.0
HG-6-64-01	CSNK2A1	90.0	10000.0
AZD7762	PRP4	7.4	10000.0
ZG-10	MP2K3	24.0	10000.0
KIN001-111	SNARK	22.0	1000.0
HG-14-10-04	EGFR(G719S)	1.8	10000.0
NU7441	NEK2	96.0	10000.0
5z-7-oxozeaenol	TGFBR1	57.0	10000.0
BS-181	PIP5K1C	100.0	10000.0
MPS-1-IN-1	DDR1	100.0	1000.0
WZ-4-145	CHEK1	100.0	10000.0
CGP60474	KGP1	100.0	10000.0
BI-D1870	FLT3(N841I)	4.2	10000.0
MLN8054	MAST1	100.0	10000.0
NG25	MK03	100.0	10000.0
(s)-CR8	EPHA8	87.0	10000.0
PHA-767491	NEK10	30.0	10000.0
KIN001-220	ERBB2	100.0	10000.0
XMD-12	TRKC	82.0	1000.0
MRT67307	CLK3	90.0	10000.0
GSK1059615	CSNK1E	2.6	10000.0
Ribociclib	YES	98.0	1000.0
WH-4-023	DYRK2	80.0	10000.0
CH5424802	LOK	7.0	1000.0
OTSSP167	SRMS	3.4	10000.0
PHA-793887	M3K2	85.0	10000.0
HG-5-88-01	KIT(V559D)	100.0	10000.0
RO-3306	PIK3CA(E545A)	62.0	10000.0
JNK-9L	IKKA	55.0	10000.0
Dabrafenib	MAP4K2	100.0	10000.0
Ceritinib	CAMK1G	83.0	1000.0
AS-252424	ERBB4	49.5	10000.0
GW-5074	ABL2	66.0	10000.0
BMS-536924	PIK3CA	100.0	1000.0
Vemurafenib	RIOK2	100.0	10000.0
Omipalisib	EPHB6	26.0	10000.0
Buparlisib	CAMK1B	100.0	1000.0
Dabrafenib	ROS1	96.0	10000.0
GW-5074	RIPK4	76.0	10000.0
GSK429286A	FER	100.0	10000.0
MRT67307	TIE2	86.0	10000.0
Dinaciclib	MST1R	86.0	10000.0
HG-14-10-04	ABL1(F317L)-nonphosphorylated	0.0	10000.0
Crizotinib	ROCK2	8.0	10000.0
XMD13-2	MAP3K4	93.0	10000.0
WYE-125132	KIT	91.0	10000.0
ERK5-IN-1	CDK8	95.0	1000.0
Alpelisib	MYLK4	100.0	1000.0
KIN001-220	FLT3(R834Q)	36.0	10000.0
GW-5074	CDKL1	84.0	10000.0
GSK429286A	PIK3C2G	52.0	10000.0
(s)-CR8	YANK2	100.0	10000.0
ZSTK474	DMPK2	100.0	1000.0
WYE-125132	NEK1	100.0	10000.0
KIN001-021	SRC	100.0	1000.0
Crizotinib	PTK6	56.0	10000.0
Ibrutinib	ERK3	100.0	1000.0
AZD-6482	KIT	91.0	10000.0
HG-5-113-01	CDC2L2	100.0	10000.0
AZ-628	TRKB	77.0	10000.0
WZ-4-145	ERK3	100.0	10000.0
Alpelisib	SIK3	100.0	1000.0
BMS-536924	YES	1.8	1000.0
PD173074	INSR	100.0	10000.0
THZ1	EIF2AK1	65.0	10000.0
WZ-7043	IKKB	100.0	10000.0
XMD13-2	ABL1(F317L)-nonphosphorylated	96.0	10000.0
WYE-125132	MRCKB	100.0	10000.0
ERK5-IN-1	FRK	87.0	1000.0
WZ3105	MAP4K2	31.0	10000.0
Pictilisib	EGFR(S752-I759del)	94.0	1000.0
Baricitinib	CSNK1G3	57.0	10000.0
JNK-IN-5A	FGFR1	99.0	10000.0
QL-XI-92	ULK3	97.0	10000.0
Crizotinib	ERBB2	97.0	10000.0
5z-7-oxozeaenol	MYO3A	93.0	10000.0
BMS-536924	DAPK2	3.0	1000.0
Palbociclib	CDK5	100.0	1000.0
BMX-IN-1	MAP3K4	100.0	10000.0
Omipalisib	CAMK1	70.0	10000.0
KIN001-127	RPS6KA2(Kin.Dom.1)	100.0	10000.0
WZ4003	RAF1	100.0	1000.0
WZ3105	ABL1(T315I)-nonphosphorylated	91.0	10000.0
PLX-4720	PIP5K1C	79.0	10000.0
Dabrafenib	PIK3CA(C420R)	100.0	10000.0
Torin2	LYN	100.0	10000.0
XMD14-99	CDC2L1	5.3	10000.0
HG-14-8-02	PLK2	100.0	10000.0
GW-5074	EGFR	56.0	10000.0
PHA-767491	PHKG1	76.0	10000.0
XMD11-85h	BRAF	100.0	10000.0
CGP60474	TIE1	100.0	10000.0
Buparlisib	LTK	99.0	1000.0
PHA-767491	IKKB	8.6	10000.0
HG-6-64-01	KPCT	31.0	10000.0
KU63794	SYK	100.0	10000.0
Torin2	GRK7	60.0	10000.0
BS-181	MST1R	75.0	10000.0
XMD14-99	CLK1	22.0	10000.0
A443654	NEK6	100.0	10000.0
Lapatinib	MARK4	87.0	10000.0
Baricitinib	MP2K7	89.0	10000.0
ALW-II-38-3	LOK	100.0	10000.0
NPK76-II-72-1	VGFR2	100.0	10000.0
Vemurafenib	CDC2L2	91.0	10000.0
R406	ACVRL1	100.0	1000.0
KIN001-021	KC1G2	100.0	1000.0
CP724714	KIT	41.0	10000.0
JNK-9L	CHEK1	100.0	10000.0
WZ-7043	PRP4	100.0	10000.0
Torin2	AAK1	71.0	10000.0
MLN8054	TYK2(JH1domain-catalytic)	100.0	10000.0
JNK-IN-11	M3K2	52.0	1000.0
BGJ398	AURKA	100.0	1000.0
XMD14-99	JNK3	100.0	10000.0
JWE-035	EGFR(S752-I759del)	98.0	10000.0
JNK-IN-11	CDC2L1	43.0	1000.0
Torin2	IGF1R	100.0	10000.0
BI-D1870	EGFR(L861Q)	22.0	10000.0
CG-930	ABL1(H396P)-nonphosphorylated	13.0	10000.0
Momelotinib	FGFR1	86.0	10000.0
GSK1059615	EPHA8	90.0	10000.0
CP724714	EGFR	0.2	10000.0
WZ3105	PIM2	100.0	10000.0
CP724714	YES	65.0	10000.0
CGP74514A	KPCD	12.0	10000.0
OTSSP167	SBK1	49.0	10000.0
Buparlisib	PIK3CA(E542K)	0.3	1000.0
BI-2536	JNK1	100.0	10000.0
ALW-II-38-3	SIK1	100.0	10000.0
XMD16-144	NEK4	87.0	10000.0
PHA-767491	ANKK1	48.0	10000.0
KU63794	KIT(V559D)	90.0	10000.0
QL-X-138	EPHA1	94.0	10000.0
GSK461364	RSK1(Kin.Dom.1-N-terminal)	29.0	10000.0
Taselisib	RET(M918T)	100.0	1000.0
BX-912	HIPK1	1.2	10000.0
SP600125	TNK2	100.0	10000.0
KIN001-021	MP2K6	100.0	1000.0
5z-7-oxozeaenol	AKT1	95.0	10000.0
Pictilisib	VGFR1	100.0	1000.0
AZD 5438	MLK3	8.0	10000.0
QL-XII-47	MAP4K2	100.0	1000.0
JNK-IN-11	MYLK4	100.0	1000.0
Dactolisib	ROCK2	100.0	1000.0
HG-14-10-04	GAK	3.0	10000.0
KIN001-127	M3K5	100.0	10000.0
Sorafenib	ICK	92.0	10000.0
GSK461364	SLK	0.3	10000.0
QL-X-138	KIT	65.0	10000.0
QL-XI-92	CAMK2B	100.0	10000.0
WZ-7043	KIT(L576P)	2.3	10000.0
Dabrafenib	KPCD1	2.0	10000.0
AZ-628	PRKX	100.0	10000.0
KIN001-111	KIT(V559D,V654A)	100.0	1000.0
BGJ398	TBK1	81.0	1000.0
RO-3306	ABL1(E255K)-phosphorylated	89.0	10000.0
XMD16-144	ABL1(F317L)-phosphorylated	0.8	10000.0
HG-9-91-01	FYN	0.0	10000.0
GSK1059615	INSR	77.0	10000.0
GW-5074	ERK3	100.0	10000.0
BMX-IN-1	EPHB6	85.0	10000.0
WZ-4-145	KPCD2	100.0	10000.0
PHA-793887	RET(V804M)	81.0	10000.0
AZD 5438	TNIK	5.8	10000.0
RO-3306	PHKG2	11.0	10000.0
KIN001-127	RPS6KA5(Kin.Dom.2)	100.0	10000.0
THZ1	KIT(V559D,T670I)	2.0	10000.0
TGX221	MK12	100.0	1000.0
KIN001-111	EPHA8	2.4	1000.0
Ceritinib	ERK8	98.0	1000.0
Torkinib	YANK3	69.0	10000.0
GSK461364	EGFR(L747-T751del,Sins)	100.0	10000.0
CP724714	RIPK2	26.0	10000.0
Lapatinib	HIPK1	75.0	10000.0
Dinaciclib	ABL1(E255K)-phosphorylated	95.0	10000.0
WZ-4-145	MYO3A	100.0	10000.0
BMS-536924	IKKA	100.0	1000.0
PLX-4720	EPHA2	100.0	10000.0
CGP74514A	PKN2	25.0	10000.0
HG-14-10-04	NEK1	68.0	10000.0
RO-3306	CIT	0.2	10000.0
AG1478	CSNK2A1	19.0	10000.0
NPK76-II-72-1	JAK1(Kin.Dom.1)	22.0	10000.0
Barasertib	ABL1(F317L)-phosphorylated	10.0	10000.0
ZG-10	EPHA6	90.0	10000.0
CH5424802	KC1G1	97.0	1000.0
PD0325901	MK03	86.0	10000.0
MPS-1-IN-1	DAPK3	100.0	1000.0
KIN001-021	FLT3(D835H)	100.0	1000.0
Buparlisib	KIT	100.0	1000.0
Palbociclib	PIK3CA(M1043I)	100.0	1000.0
GW-5074	SLK	100.0	10000.0
BMS-536924	MKNK1	100.0	1000.0
Sigma A6730	BTK	100.0	10000.0
MPS-1-IN-1	RIPK1	100.0	1000.0
Crizotinib	TESK1	3.4	10000.0
Sigma A6730	ZAP70	99.0	10000.0
XMD14-99	FLT3(R834Q)	100.0	10000.0
WZ-7043	MAP4K4	100.0	10000.0
XMD13-2	INSR	78.0	10000.0
OTSSP167	RPS6KA5(Kin.Dom.1-N-terminal)	0.4	10000.0
Dinaciclib	EPHB6	83.0	10000.0
BMS345541	KIT(D816V)	88.0	10000.0
AG1478	PIK3CA(H1047Y)	95.0	10000.0
BS-181	EGFR(L747-E749del,A750P)	70.0	10000.0
Alpelisib	FLT3-autoinhibited	100.0	1000.0
Canertinib	CIT	100.0	1000.0
XMD8-85	CAMK1	100.0	10000.0
TAK-715	MST1	74.0	10000.0
Dactolisib	EGFR(L861Q)	100.0	1000.0
WH-4-023	TAOK3	4.0	10000.0
AZD-6482	MK11	91.0	10000.0
GW843682X	FLT3(D835H)	1.4	10000.0
Canertinib	CDK16	100.0	1000.0
Pictilisib	RET(M918T)	100.0	1000.0
AG1478	EGFR	0.1	10000.0
BS-181	GSK3A	72.0	10000.0
CGP74514A	WEE1	100.0	10000.0
ZG-10	FES	99.0	10000.0
GW-5074	RIPK2	38.0	10000.0
AZD4547	ABL1(M351T)-phosphorylated	2.3	10000.0
ZM-447439	TRKA	16.0	10000.0
BS-181	PRKR	96.0	10000.0
JNK-9L	BMPR1B	28.0	10000.0
QL-XII-47	PIP5K1C	63.0	1000.0
BGJ398	MLK2	96.0	1000.0
NU7441	TAOK3	97.0	10000.0
WZ-4-145	EGFR(L747-T751del,Sins)	0.7	10000.0
Dactolisib	NEK5	100.0	1000.0
Torin1	YSK1	84.0	10000.0
AG1478	MAP3K15	34.0	10000.0
Buparlisib	MUSK	100.0	1000.0
THZ1	MARK2	12.0	10000.0
WZ-7043	GRK1	100.0	10000.0
HG-14-8-02	SRPK2	78.0	10000.0
AZD 5438	PIK4CB	1.1	10000.0
KU63794	CTK	78.0	10000.0
Canertinib	PTK6	100.0	1000.0
PHA-793887	DYRK2	100.0	10000.0
CG-930	PAK1	99.0	10000.0
(s)-CR8	RSK2(Kin.Dom.2-C-terminal)	92.0	10000.0
GW843682X	M4K3	32.0	10000.0
WH-4-023	VGFR2	15.0	10000.0
GSK429286A	PIK3CA(I800L)	100.0	10000.0
Taselisib	ERBB2	98.0	1000.0
SP600125	INSRR	100.0	10000.0
AZ-628	ULK3	97.0	10000.0
WZ3105	BMX	79.0	10000.0
PD173074	CSF1R	6.6	10000.0
Omipalisib	PKNB(M.tuberculosis)	93.0	10000.0
PHA-767491	CLK2	0.5	10000.0
WZ3105	MK13	94.0	10000.0
WH-4-023	EPHB1	0.0	10000.0
Neratinib	SIK1	31.0	10000.0
JNK-9L	CAMK1	83.0	10000.0
Omipalisib	SGK2	89.0	10000.0
Dactolisib	MYO3B	100.0	1000.0
Buparlisib	GSK3A	85.0	1000.0
GW-5074	PDPK1	100.0	10000.0
AZD 5438	IRAK1	0.3	10000.0
Neratinib	ALK	100.0	10000.0
XMD11-85h	KC1G1	100.0	10000.0
MPS-1-IN-1	PAK4	100.0	1000.0
Momelotinib	RSK2(Kin.Dom.1-N-terminal)	100.0	10000.0
Sigma A6730	WNK1	89.0	10000.0
PD0325901	CDK15	78.0	10000.0
JW-7-24-1	MAP4K2	26.0	10000.0
JNK-IN-8	EGFR(L858R)	100.0	1000.0
Canertinib	FGR	100.0	1000.0
QL-XII-47	ABL1(F317I)-phosphorylated	100.0	1000.0
WH-4-023	CDK11	100.0	10000.0
JW-7-24-1	CAMK1G	100.0	10000.0
Torin1	EPHB2	100.0	10000.0
WH-4-023	CSNK1A1L	100.0	10000.0
CGP60474	JAK1(JH1domain-catalytic)	100.0	10000.0
WZ3105	EGFR(G719C)	79.0	10000.0
XMD13-2	MAP3K1	100.0	10000.0
JNK-9L	ERK5	100.0	10000.0
PD0325901	MYLK4	100.0	10000.0
XMD16-144	NEK6	73.0	10000.0
MRT67307	MAP4K5	41.0	10000.0
WYE-125132	PIK3CA(E545K)	11.0	10000.0
AZD 5438	AURKC	3.6	10000.0
HG-5-113-01	MKNK1	100.0	10000.0
QL-XI-92	ACVR1B	100.0	10000.0
Ceritinib	ABL1(F317L)-phosphorylated	35.0	1000.0
Torin1	KPCD2	100.0	10000.0
TGX221	PIM1	100.0	1000.0
RO-3306	ADCK4	91.0	10000.0
AG1478	VRK2	35.0	10000.0
BMS-536924	AURKC	1.8	1000.0
GW843682X	CDK14	90.0	10000.0
NU7441	BMPR1B	94.0	10000.0
CGP60474	SRPK1	100.0	10000.0
CH5424802	MELK	32.0	1000.0
HG-14-8-02	TAK1	100.0	10000.0
CGP60474	M3K5	100.0	10000.0
AZD4547	PLK3	78.0	10000.0
NPK76-II-72-1	LCK	100.0	10000.0
GSK461364	KPCE	3.9	10000.0
PHA-767491	NUAK1	44.0	10000.0
PD0325901	CLK3	100.0	10000.0
PD173074	MP2K4	100.0	10000.0
WZ-4-145	PDPK1	100.0	10000.0
Dinaciclib	MKNK1	92.0	10000.0
XMD13-2	JNK3	61.0	10000.0
WYE-125132	BMPR1A	100.0	10000.0
WZ-7043	MLK1	100.0	10000.0
RO-3306	KKCC1	58.0	10000.0
Vemurafenib	NEK11	30.0	10000.0
5z-7-oxozeaenol	PAK6	98.0	10000.0
CP724714	ABL2	100.0	10000.0
AZD7762	HIPK4	38.0	10000.0
ZG-10	AMPK-alpha2	95.0	10000.0
CP724714	PIK3CA(I800L)	100.0	10000.0
KIN001-220	ACVRL1	100.0	10000.0
XMD13-2	PDPK1	81.0	10000.0
XMD8-92	ABL1(Y253F)	100.0	10000.0
Ibrutinib	TTK	73.0	1000.0
HG-5-88-01	CDK16	100.0	10000.0
Buparlisib	MET(Y1235D)	87.0	1000.0
KIN001-220	MP2K4	49.0	10000.0
PHA-767491	CDKL1	35.0	10000.0
SCH772984	PAK2	79.0	1000.0
XMD-12	NLK	74.0	1000.0
BMS345541	GAK	79.0	10000.0
Ribociclib	LKB1	100.0	1000.0
ALW-II-49-7	CDC2L2	100.0	10000.0
Canertinib	PIM1	100.0	1000.0
GW843682X	CDK4-cyclinD1	91.0	10000.0
ALW-II-38-3	EGFR(S752-I759del)	100.0	10000.0
PLX-4720	PIM2	80.0	10000.0
BMS-536924	PIM3	100.0	1000.0
CP724714	MK12	100.0	10000.0
ALW-II-49-7	HCK	100.0	10000.0
ZG-10	ABL1(Y253F)-phosphorylated	40.0	10000.0
XMD16-144	CDKL3	100.0	10000.0
PD173074	BMPR1A	100.0	10000.0
Ceritinib	ABL1(Q252H)-nonphosphorylated	80.0	1000.0
CP466722	TGFBR2	9.0	10000.0
SCH772984	IRAK1	95.0	1000.0
CGP74514A	IRAK1	6.5	10000.0
TGX221	EPHA2	100.0	1000.0
XMD16-144	NEK11	77.0	10000.0
HG-5-88-01	FLT3(K663Q)	100.0	10000.0
ALW-II-49-7	ABL1(Y253F)	100.0	10000.0
Buparlisib	MK12	100.0	1000.0
Crizotinib	FLT3(R834Q)	25.0	10000.0
Barasertib	PHKG2	81.0	10000.0
Alpelisib	MST4	100.0	1000.0
JNK-IN-5A	NEK2	65.0	10000.0
Ibrutinib	KPCI	74.0	1000.0
Abemaciclib	DDR2	54.0	1000.0
GW-5074	PIK3CB	100.0	10000.0
JWE-035	CDK3	100.0	10000.0
RO-3306	BMPR1B	49.0	10000.0
BGJ398	CAMK2A	87.0	1000.0
PHA-793887	HIPK4	83.0	10000.0
KU63794	EIF2AK1	88.0	10000.0
WYE-125132	CSNK1A1L	100.0	10000.0
QL-XII-47	RIPK4	100.0	1000.0
PLX-4720	ROCK1	77.0	10000.0
Taselisib	PDPK1	100.0	1000.0
NVP-TAE684	MST4	27.0	1000.0
XMD11-50	MERTK	100.0	10000.0
WYE-125132	MLK3	100.0	10000.0
Ibrutinib	ERN1	74.0	1000.0
NVP-TAE684	AURKB	1.0	1000.0
Seliciclib	PAK4	29.0	10000.0
HG-6-64-01	RPS6KA4(Kin.Dom.2-C-terminal)	30.0	10000.0
Barasertib	NEK5	100.0	10000.0
JNK-9L	YANK2	100.0	10000.0
RO-3306	NEK2	37.0	10000.0
GW-5074	CDKL5	92.0	10000.0
JW-7-24-1	PIP5K1A	31.0	10000.0
AZD7762	RET(V804L)	0.0	10000.0
NU7441	SNARK	100.0	10000.0
AZD-6482	EGFR(E746-A750del)	100.0	10000.0
Torkinib	TIE2	21.0	10000.0
GW843682X	DRAK2	85.0	10000.0
Lapatinib	PLK4	96.0	10000.0
XMD14-99	JAK1(JH1domain-catalytic)	100.0	10000.0
QL-XI-92	MLK3	100.0	10000.0
JNK-IN-5A	MLTK	87.0	10000.0
Dinaciclib	EPHA5	94.0	10000.0
XMD11-85h	DYRK2	100.0	10000.0
Dactolisib	TGFBR1	100.0	1000.0
PHA-793887	ACVR1	100.0	10000.0
AZD-6482	PIK3CA(M1043I)	0.0	10000.0
AZD4547	MYLK	30.0	10000.0
Canertinib	NDR2	100.0	1000.0
CP724714	PIM1	100.0	10000.0
SCH772984	M3K12	90.0	1000.0
TAK-715	FGFR3	86.0	10000.0
MRT67307	FLT3(R834Q)	9.2	10000.0
CG-930	JNK1	0.0	10000.0
AG1478	PIK3CA(Q546K)	82.0	10000.0
JWE-035	MAP3K3	0.7	10000.0
HG-9-91-01	TNK1	0.6	10000.0
Buparlisib	SRPK1	100.0	1000.0
Omipalisib	LIMK1	77.0	10000.0
R406	MST1	100.0	1000.0
JNK-IN-11	PGFRB	0.2	1000.0
XMD-12	NUAK1	17.0	1000.0
WZ4003	KPCL	100.0	1000.0
PHA-767491	RSK3(Kin.Dom.1-N-terminal)	81.0	10000.0
Pictilisib	KC1G2	95.0	1000.0
PD0325901	PIM1	100.0	10000.0
ALW-II-49-7	RPS6KA6(Kin.Dom.1)	100.0	10000.0
Taselisib	FLT3(D835H)	89.0	1000.0
QL-XI-92	PIP5K1C	100.0	10000.0
WYE-125132	SLK	100.0	10000.0
JNK-IN-5A	ACVR2A	69.0	10000.0
AZ-628	DAPK1	100.0	10000.0
XMD13-2	PIP5K1A	28.0	10000.0
JWE-035	EPHA6	90.0	10000.0
Alpelisib	CDK4-cyclinD3	100.0	1000.0
JNK-9L	MP2K2	62.0	10000.0
MRT67307	KPCD3	0.0	10000.0
HG-5-113-01	LTK	0.0	10000.0
ZG-10	PDPK1	100.0	10000.0
Sorafenib	CAMK2B	84.0	10000.0
AG1478	YSK4	3.2	10000.0
GW843682X	NLK	68.0	10000.0
5z-7-oxozeaenol	CDK11	94.0	10000.0
JNK-9L	ITK	100.0	10000.0
XMD14-99	MKNK2	77.0	10000.0
KU63794	EPHA1	96.0	10000.0
ZSTK474	ERK3	100.0	1000.0
QL-XII-47	PAK1	100.0	1000.0
KIN001-220	RIOK2	17.0	10000.0
BS-181	MLK2	88.0	10000.0
PHA-793887	RET(M918T)	99.0	10000.0
Dinaciclib	DRAK2	95.0	10000.0
NPK76-II-72-1	DDR2	100.0	10000.0
HG-9-91-01	SRC	0.0	10000.0
CGP74514A	PAK2	9.1	10000.0
PHA-767491	HIPK2	3.7	10000.0
Baricitinib	PIK3CA(I800L)	48.0	10000.0
PD0325901	ULK2	97.0	10000.0
BMS-536924	KGP1	1.8	1000.0
JNK-IN-5A	TBK1	88.0	10000.0
Torin1	PIK3CD	51.0	10000.0
MLN8054	PIK3C2B	93.0	10000.0
OTSSP167	PIK3CA(Q546K)	6.0	10000.0
Alpelisib	PLK3	100.0	1000.0
QL-XII-47	DCLK1	72.0	1000.0
SCH772984	EPHA3	80.0	1000.0
XMD11-50	SIK2	98.0	10000.0
SCH772984	GSK3A	100.0	1000.0
XMD-12	CTK	49.0	1000.0
OTSSP167	RET(V804M)	0.0	10000.0
NPK76-II-72-1	ACVR1	100.0	10000.0
NU7441	RIOK3	100.0	10000.0
ZM-447439	FGR	19.0	10000.0
XMD11-50	SgK110	62.0	10000.0
Ibrutinib	SRPK1	60.0	1000.0
KU63794	ALK	100.0	10000.0
Canertinib	PRKR	100.0	1000.0
JNK-IN-8	YANK2	90.0	1000.0
XMD-12	SgK110	5.4	1000.0
AZD 5438	CSF1R-autoinhibited	0.3	10000.0
Taselisib	PFPK5(P.falciparum)	89.0	1000.0
Vemurafenib	RPS6KA4(Kin.Dom.1-N-terminal)	90.0	10000.0
BMS345541	KPCD	100.0	10000.0
Pictilisib	PFCDPK1(P.falciparum)	90.0	1000.0
XMD11-85h	PIK3CB	100.0	10000.0
Sigma A6730	ACVRL1	100.0	10000.0
HG-14-10-04	HIPK1	2.6	10000.0
WH-4-023	ABL1(F317L)-nonphosphorylated	0.1	10000.0
Abemaciclib	MELK	64.0	1000.0
MRT67307	MERTK	20.0	10000.0
NVP-TAE684	STK16	2.8	1000.0
5z-7-oxozeaenol	IRAK3	63.0	10000.0
Omipalisib	AXL	50.0	10000.0
Vemurafenib	SgK110	100.0	10000.0
CGP74514A	MP2K2	17.0	10000.0
(s)-CR8	DYRK1A	85.0	10000.0
BMS-536924	EPHA5	14.0	1000.0
Sorafenib	GRK4	100.0	10000.0
HG-9-91-01	TNNI3K	0.0	10000.0
CGP74514A	RIPK2	96.0	10000.0
HG-6-64-01	ULK2	35.0	10000.0
WZ4002	CAMK1G	100.0	10000.0
KIN001-220	TNK2	10.0	10000.0
CGP60474	GSK3B	100.0	10000.0
GSK1059615	AKT3	100.0	10000.0
AZD-6482	FER	100.0	10000.0
SB590885	RPS6KA5(Kin.Dom.1-N-terminal)	90.0	10000.0
QL-XI-92	MAP3K3	96.0	10000.0
Buparlisib	MK01	100.0	1000.0
PLX-4720	ABL1(M351T)-phosphorylated	46.0	10000.0
XMD16-144	MP2K7	97.0	10000.0
BI-2536	FYN	100.0	10000.0
Dactolisib	DRAK2	100.0	1000.0
BI-2536	TNK2	100.0	10000.0
KIN001-127	RPS6KA6(Kin.Dom.2)	100.0	10000.0
JW-7-24-1	MAPKAPK2	100.0	10000.0
CGP60474	ULK2	100.0	10000.0
AZD-6482	PRKR	99.0	10000.0
AZD7762	FER	0.0	10000.0
SP600125	MELK	100.0	10000.0
Dinaciclib	CDK15	0.4	10000.0
ZG-10	LKB1	83.0	10000.0
Dactolisib	BRAF(V600E)	100.0	1000.0
XMD-12	CSF1R	5.8	1000.0
GW-5074	MP2K7	98.0	10000.0
CGP74514A	KCC2D	78.0	10000.0
Barasertib	LATS1	100.0	10000.0
KIN001-220	EGFR	26.0	10000.0
NU7441	EGFR(L747-E749del,A750P)	91.0	10000.0
WZ4003	TEC	100.0	1000.0
JW-7-24-1	CSK	100.0	10000.0
BS-181	EPHB4	84.0	10000.0
AS-252424	RAF1	99.2	10000.0
Dinaciclib	KGP1	71.0	10000.0
WYE-125132	AKT2	100.0	10000.0
NG25	CSNK1A1L	100.0	10000.0
ERK5-IN-1	MRCKB	100.0	1000.0
Torin1	TESK1	58.0	10000.0
Neratinib	DCAMKL2	100.0	10000.0
WZ4002	PLK3	100.0	10000.0
HG-9-91-01	LYN	0.0	10000.0
Omipalisib	FLT3(D835Y)	68.0	10000.0
ERK5-IN-1	MERTK	100.0	1000.0
CH5424802	CTK	92.0	1000.0
OTSSP167	MARK1	84.0	10000.0
Sigma A6730	RIPK1	100.0	10000.0
GSK461364	TLK1	71.0	10000.0
JWE-035	CSNK2A1	79.0	10000.0
Lapatinib	CSNK2A1	87.0	10000.0
BS-181	IKKB	86.0	10000.0
Dactolisib	SNARK	100.0	1000.0
KIN001-111	RET(M918T)	24.0	1000.0
BI-D1870	MP2K3	9.8	10000.0
Baricitinib	PI42C	100.0	10000.0
XMD8-92	STK16	100.0	10000.0
PHA-793887	NEK6	100.0	10000.0
Barasertib	TRKA	6.8	10000.0
HG-14-10-04	EPHB3	93.0	10000.0
Crizotinib	PKNB(M.tuberculosis)	30.0	10000.0
AZD7762	TAOK3	2.9	10000.0
HG-9-91-01	JAK1(JH1domain-catalytic)	97.0	10000.0
Abemaciclib	YSK1	59.0	1000.0
CP724714	DAPK2	89.0	10000.0
Taselisib	MAK	98.0	1000.0
CP724714	TAOK1	94.0	10000.0
Sorafenib	MKNK1	2.1	10000.0
GSK429286A	ZAP70	100.0	10000.0
WZ-7043	KC1G2	100.0	10000.0
BMX-IN-1	ADCK3	82.0	10000.0
Taselisib	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	1000.0
WZ3105	RSK2(Kin.Dom.1-N-terminal)	3.6	10000.0
BGJ398	DAPK2	97.0	1000.0
RO-3306	EGFR(L861Q)	64.0	10000.0
AZD-6482	TAOK1	59.0	10000.0
Neratinib	EPHA5	100.0	10000.0
NPK76-II-72-1	YES	100.0	10000.0
BMX-IN-1	PKAC-alpha	100.0	10000.0
PD173074	ERK8	100.0	10000.0
AS-252424	MLK3	65.8	10000.0
Omipalisib	MAPKAPK5	14.0	10000.0
Sigma A6730	FYN	100.0	10000.0
ZM-447439	M4K3	70.0	10000.0
SCH772984	FLT3-autoinhibited	93.0	1000.0
PHA-793887	MST3	16.0	10000.0
SP600125	KKCC1	20.0	10000.0
SP600125	JAK2(Kin.Dom.2)	100.0	10000.0
ZG-10	ACVRL1	97.0	10000.0
AZD4547	MARK1	15.0	10000.0
(s)-CR8	FGFR4	86.0	10000.0
BI-D1870	EGFR(G719C)	25.0	10000.0
Dabrafenib	DDR2	17.0	10000.0
ALW-II-49-7	WEE2	100.0	10000.0
BX-912	LCK	3.4	10000.0
TAK-715	PIP5K1A	100.0	10000.0
WZ-4-145	CDK7	100.0	10000.0
Ibrutinib	PKMYT1	100.0	1000.0
JNK-9L	CLK2	15.0	10000.0
KIN001-220	PIK3C2G	39.0	10000.0
XMD16-144	AURKB	0.1	10000.0
CG-930	JAK1(JH1domain-catalytic)	92.0	10000.0
PHA-793887	ERBB4	99.0	10000.0
WZ3105	GSK3A	100.0	10000.0
Sigma A6730	EPHA5	100.0	10000.0
AZ-628	TRKA	98.0	10000.0
Baricitinib	JNK3	58.0	10000.0
XMD13-2	PI42C	95.0	10000.0
BMS-536924	JAK3(Kin.Dom.2)	1.0	1000.0
Ceritinib	M3K2	81.0	1000.0
XMD13-2	TNIK	25.0	10000.0
CGP74514A	FGFR1	24.0	10000.0
AZD 5438	GAK	5.2	10000.0
BI-D1870	AAK1	29.0	10000.0
ALW-II-49-7	IGF1R	100.0	10000.0
Palbociclib	MP2K4	100.0	1000.0
JWE-035	MLK3	84.0	10000.0
R406	MELK	11.0	1000.0
GSK461364	TYRO3	100.0	10000.0
PHA-767491	MK01	55.0	10000.0
Seliciclib	PKMYT1	93.0	10000.0
NG25	DCLK1	100.0	10000.0
HG-9-91-01	CLK3	100.0	10000.0
MLN8054	PI42C	26.0	10000.0
XMD8-85	PIK3C2G	100.0	10000.0
PLX-4720	STK33	85.0	10000.0
JNK-IN-5A	MP2K2	100.0	10000.0
GW-5074	MAP3K1	84.0	10000.0
HG-9-91-01	FLT3(D835H)	63.0	10000.0
Neratinib	BIKE	93.0	10000.0
Palbociclib	CAMKK2	93.0	1000.0
AZD4547	TRKA	0.1	10000.0
Sigma A6730	IKKE	100.0	10000.0
QL-X-138	TRKB	51.0	10000.0
XMD13-2	SLK	100.0	10000.0
Neratinib	MAK	100.0	10000.0
AZD4547	CDK11	94.0	10000.0
XMD11-85h	SLK	100.0	10000.0
KIN001-111	BMPR2	100.0	1000.0
ZG-10	FGFR3(G697C)	84.0	10000.0
CH5424802	PIP5K2B	66.0	1000.0
Ribociclib	AURKB	51.0	1000.0
HG-5-88-01	CDC2L2	100.0	10000.0
WH-4-023	MYLK2	1.0	10000.0
GSK461364	STK33	75.0	10000.0
XMD8-92	PIK3CA(M1043I)	100.0	10000.0
Seliciclib	AURKC	98.0	10000.0
HG-5-88-01	BRSK2	100.0	10000.0
NU7441	PI42C	89.0	10000.0
KU63794	EGFR(L858R,T790M)	100.0	10000.0
PHA-793887	TTK	58.0	10000.0
TAK-715	PFCDPK1(P.falciparum)	22.0	10000.0
Ceritinib	ALK(L1196M)	0.0	1000.0
HG-9-91-01	KIT(D816V)	3.4	10000.0
Barasertib	BLK	9.6	10000.0
CH5424802	PAK6	100.0	1000.0
Crizotinib	TNNI3K	2.4	10000.0
JW-7-24-1	JNK1	34.0	10000.0
Canertinib	AKT2	100.0	1000.0
AZ-628	PRP4	100.0	10000.0
HG-5-113-01	TLK2	100.0	10000.0
Ceritinib	PLK3	74.0	1000.0
MRT67307	FAK2	46.0	10000.0
Baricitinib	PIK3CA	87.0	10000.0
XMD8-85	LCK	100.0	10000.0
OTSSP167	KIT(A829P)	100.0	10000.0
KIN001-123	MST3	100.0	1000.0
AZD-6482	PIP5K2B	100.0	10000.0
5z-7-oxozeaenol	MET(M1250T)	92.0	10000.0
MLN8054	BMPR1A	100.0	10000.0
ZSTK474	ERK5	100.0	1000.0
BMS-536924	KIT(D816V)	0.4	1000.0
WZ-4-145	ABL1(F317I)	100.0	10000.0
SB590885	STK33	88.0	10000.0
KIN001-021	IKKA	100.0	1000.0
JNK-9L	NEK11	100.0	10000.0
GW843682X	KIT(V559D)	21.0	10000.0
PHA-767491	PIM1	27.0	10000.0
Seliciclib	ABL1(E255K)-phosphorylated	64.0	10000.0
XMD11-85h	PIK3CA(H1047Y)	100.0	10000.0
CP466722	CAMK2G	56.0	10000.0
WZ4003	GAK	0.5	1000.0
GSK461364	BRSK2	52.0	10000.0
GSK1059615	DYRK1A	0.0	10000.0
BS-181	EPHB1	93.0	10000.0
BMS-536924	CDK2	100.0	1000.0
JNK-IN-11	STK16	37.0	1000.0
HG-6-64-01	SRPK3	13.0	10000.0
CP466722	ABL1(H396P)-nonphosphorylated	0.0	10000.0
(s)-CR8	SBK1	100.0	10000.0
GSK461364	INSRR	100.0	10000.0
NVP-TAE684	DDR2	14.0	1000.0
GSK461364	VGFR2	100.0	10000.0
Canertinib	LATS1	100.0	1000.0
Palbociclib	WNK3	100.0	1000.0
CH5424802	ABL1(H396P)-phosphorylated	74.0	1000.0
ZG-10	M3K13	100.0	10000.0
KIN001-021	KC1G1	100.0	1000.0
Dabrafenib	NDR1	39.0	10000.0
THZ1	TYRO3	14.0	10000.0
GSK429286A	MLK1	93.0	10000.0
MRT67307	CSNK2A2	62.0	10000.0
XMD11-85h	PKMYT1	100.0	10000.0
XMD-12	LOK	100.0	1000.0
XMD8-92	ABL2	100.0	10000.0
PLX-4720	CAMK2G	96.0	10000.0
XMD11-85h	MP2K3	100.0	10000.0
Ceritinib	NEK5	93.0	1000.0
KIN001-127	CLK2	3.7	10000.0
XMD-12	DCAMKL2	0.6	1000.0
RO-3306	MP2K7	66.0	10000.0
XMD11-85h	MAP3K3	100.0	10000.0
Torkinib	MARK1	81.0	10000.0
JNK-IN-5A	PRKX	100.0	10000.0
XMD14-99	NEK6	100.0	10000.0
CP724714	GRK1	100.0	10000.0
SCH772984	NLK	98.0	1000.0
Vemurafenib	EGFR(L747-T751del,Sins)	78.0	10000.0
(s)-CR8	PI42C	92.0	10000.0
AG1478	ABL1(F317I)-phosphorylated	26.0	10000.0
JNK-IN-8	MAP4K4	92.0	1000.0
Barasertib	KPCD1	72.0	10000.0
GSK1059615	MAP3K14	41.0	10000.0
NG25	JNK1	0.0	10000.0
KIN001-021	PCTK2	100.0	1000.0
Palbociclib	EPHA3	100.0	1000.0
Seliciclib	TRKB	100.0	10000.0
CGP74514A	FGR	9.1	10000.0
NVP-TAE684	DRAK1	5.9	1000.0
MLN8054	BTK	28.0	10000.0
AG1478	CDK5	100.0	10000.0
OTSSP167	BRAF(V600E)	1.5	10000.0
HG-9-91-01	TRKC	99.0	10000.0
JNK-IN-11	IKKA	93.0	1000.0
ZM-447439	KIT(L576P)	0.0	10000.0
BMX-IN-1	JAK3(JH1domain-catalytic)	0.6	10000.0
Alpelisib	MP2K4	100.0	1000.0
Torin2	ABL1-nonphosphorylated	73.0	10000.0
GSK1059615	KIT(A829P)	88.0	10000.0
XMD11-50	BIKE	100.0	10000.0
A443654	DCAMKL2	100.0	10000.0
Abemaciclib	RIPK2	97.0	1000.0
ZG-10	TESK1	74.0	10000.0
Baricitinib	KC1G1	69.0	10000.0
WZ-7043	AKT1	100.0	10000.0
CG-930	RIPK4	88.0	10000.0
JNK-IN-11	HCK	23.0	1000.0
JNK-9L	RAF1	91.0	10000.0
XMD-12	ABL1(F317I)-nonphosphorylated	28.0	1000.0
WZ4002	FLT3	4.6	10000.0
CGP60474	RIPK1	100.0	10000.0
XMD8-85	PRKX	100.0	10000.0
WZ4003	PRKX	100.0	1000.0
XMD11-50	TLK1	100.0	10000.0
WH-4-023	PRP4	55.0	10000.0
XMD13-2	MP2K2	82.0	10000.0
HG-14-8-02	CAMK1G	85.0	10000.0
SB590885	PDPK1	88.0	10000.0
WH-4-023	LYN	0.0	10000.0
(s)-CR8	AURKC	87.0	10000.0
Vemurafenib	SIK2	61.0	10000.0
XMD11-50	PLK2	100.0	10000.0
NU7441	CLK4	95.0	10000.0
BGJ398	RSK1(Kin.Dom.2-C-terminal)	74.0	1000.0
Neratinib	MP2K5	1.8	10000.0
XMD8-85	PLK1	9.8	10000.0
WH-4-023	LATS1	78.0	10000.0
XMD14-99	PLK2	91.0	10000.0
AZ-628	LTK	100.0	10000.0
KIN001-123	PKN1	100.0	1000.0
XMD13-2	EPHB6	1.4	10000.0
Ibrutinib	PGFRB	33.0	1000.0
CGP60474	BRSK2	100.0	10000.0
JNK-9L	PKAC-alpha	89.0	10000.0
BI-2536	ERBB2	100.0	10000.0
XMD-12	LATS1	92.0	1000.0
ERK5-IN-1	CDC2L5	100.0	1000.0
MPS-1-IN-1	CIT	100.0	1000.0
CGP74514A	EGFR(L858R)	60.0	10000.0
XMD16-144	PKNB(M.tuberculosis)	42.0	10000.0
AZD4547	NEK2	5.0	10000.0
WZ-4-145	FLT3(ITD)	100.0	10000.0
CGP74514A	HIPK4	2.3	10000.0
5z-7-oxozeaenol	ALK(L1196M)	100.0	10000.0
NVP-TAE684	MARK1	0.0	1000.0
Alpelisib	MKNK1	100.0	1000.0
Buparlisib	M3K5	100.0	1000.0
Baricitinib	EIF2AK1	66.0	10000.0
Torkinib	ERK8	54.0	10000.0
KIN001-127	GAK	100.0	10000.0
Alpelisib	MYLK2	100.0	1000.0
Seliciclib	MK13	98.0	10000.0
BMX-IN-1	NEK4	100.0	10000.0
AZD 5438	RET	42.0	10000.0
XMD14-99	BMPR1A	100.0	10000.0
Torkinib	STK16	34.0	10000.0
ZG-10	MAP4K5	59.0	10000.0
XMD11-85h	ERK5	100.0	10000.0
ZG-10	EGFR(L858R)	99.0	10000.0
ERK5-IN-1	JAK3(JH1domain-catalytic)	100.0	1000.0
KIN001-123	MELK	100.0	1000.0
SB590885	CAMK2G	94.0	10000.0
PLX-4720	SgK110	100.0	10000.0
SP600125	KIT(V559D,V654A)	100.0	10000.0
Ribociclib	FLT3(D835Y)	76.0	1000.0
XMD14-99	PIK3CB	100.0	10000.0
QL-XII-47	CSNK2A1	44.0	1000.0
Buparlisib	PIK3CB	6.9	1000.0
XMD8-85	NLK	100.0	10000.0
XMD-12	PGFRA	100.0	1000.0
PHA-767491	BMPR1A	94.0	10000.0
MRT67307	MRCKA	97.0	10000.0
Torin1	MST1R	55.0	10000.0
QL-X-138	MARK3	100.0	10000.0
Torkinib	YANK1	1.8	10000.0
GSK1059615	MP2K3	35.0	10000.0
KU63794	MST1	100.0	10000.0
Crizotinib	MELK	47.0	10000.0
NG25	SNARK	100.0	10000.0
WZ3105	MLK1	17.0	10000.0
BS-181	ABL1(H396P)-nonphosphorylated	93.0	10000.0
PHA-793887	MK03	11.0	10000.0
Lapatinib	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
Torkinib	RET(M918T)	0.0	10000.0
GSK1059615	RIOK1	1.0	10000.0
AZ-628	AKT3	100.0	10000.0
BMX-IN-1	KPCT	76.0	10000.0
NPK76-II-72-1	SRC	100.0	10000.0
HG-14-10-04	ACVRL1	100.0	10000.0
BX-912	TTK	5.0	10000.0
AS-252424	FYN	88.6	10000.0
Momelotinib	DCAMKL2	55.0	10000.0
ALW-II-38-3	ABL1(Y253F)	5.2	1000.0
Lapatinib	LYN	85.0	10000.0
Palbociclib	PGFRA	100.0	1000.0
Ceritinib	PI42C	100.0	1000.0
KIN001-111	RPS6KA4(Kin.Dom.1)	100.0	1000.0
KIN001-123	AAK1	100.0	1000.0
BI-2536	NEK1	100.0	10000.0
NVP-TAE684	AURKC	0.1	1000.0
Torin2	SRC	100.0	10000.0
ALW-II-38-3	CAMK2B	100.0	10000.0
R406	RET(V804L)	0.0	1000.0
XMD13-2	MK09	50.0	10000.0
XMD11-50	HIPK3	89.0	10000.0
Torin2	KIT(A829P)	64.0	10000.0
GW-5074	CLK1	34.0	10000.0
JNK-IN-5A	M4K1	89.0	10000.0
BS-181	LRRK2	86.0	10000.0
BGJ398	CLK1	100.0	1000.0
CG-930	DAPK3	100.0	10000.0
PD0325901	PIK3CA(E545K)	53.0	10000.0
WZ4002	ERBB4	0.3	10000.0
MPS-1-IN-1	IGF1R	0.9	1000.0
PD0325901	CAMK2G	100.0	10000.0
HG-9-91-01	CAMK2B	100.0	10000.0
Baricitinib	PIK3CA(E545A)	48.0	10000.0
Vemurafenib	M4K3	56.0	10000.0
GSK461364	PIK3CA(H1047L)	16.0	10000.0
Sigma A6730	CLK3	100.0	10000.0
Crizotinib	M3K5	100.0	10000.0
GSK461364	TLK2	94.0	10000.0
SCH772984	YANK3	98.0	1000.0
Buparlisib	TNIK	65.0	1000.0
THZ1	PKN2	14.0	10000.0
Omipalisib	ACVR1	87.0	10000.0
Barasertib	EGFR(E746-A750del)	72.0	10000.0
JNK-IN-5A	MK01	89.0	10000.0
Baricitinib	AURKA	5.7	10000.0
AZ-628	SYK	100.0	10000.0
NG25	TSSK1	100.0	10000.0
Buparlisib	MP2K5	85.0	1000.0
AS-252424	CSNK1E	62.4	10000.0
BS-181	DRAK2	96.0	10000.0
JNK-IN-5A	PIK4CB	100.0	10000.0
QL-X-138	TNK1	73.0	10000.0
AZD 5438	ACVR1	3.0	10000.0
WYE-125132	TEC	84.0	10000.0
AZ-628	KCC4	100.0	10000.0
NG25	MP2K2	100.0	10000.0
R406	SRC	0.0	1000.0
WH-4-023	KIT(V559D,V654A)	85.0	10000.0
CG-930	MARK3	97.0	10000.0
AZ-628	ABL1(F317I)-phosphorylated	26.0	10000.0
BMS345541	ERN1	88.0	10000.0
HG-5-88-01	DAPK2	100.0	10000.0
BMS345541	M3K13	74.0	10000.0
QL-XII-47	YSK1	96.0	1000.0
THZ1	CAMK1G	48.0	10000.0
PLX-4720	RSK4(Kin.Dom.2-C-terminal)	98.0	10000.0
AZ-628	RIOK3	100.0	10000.0
SB590885	MP2K3	84.0	10000.0
Sigma A6730	DCAMKL2	92.0	10000.0
Torin1	NEK1	89.0	10000.0
MPS-1-IN-1	MAP4K2	100.0	1000.0
Palbociclib	FES	100.0	1000.0
KU63794	EGFR(S752-I759del)	100.0	10000.0
Dinaciclib	SRC	100.0	10000.0
GSK461364	MAPKAPK5	89.0	10000.0
ZSTK474	RPS6KA3(Kin.Dom.1)	100.0	1000.0
Taselisib	KPCL	98.0	1000.0
(s)-CR8	NEK9	91.0	10000.0
WZ4003	CLK1	7.1	1000.0
MLN8054	CSNK1D	75.0	10000.0
R406	HCK	0.5	1000.0
XMD8-85	ERK5	0.0	10000.0
NPK76-II-72-1	KPCD3	32.0	10000.0
TAK-715	ERK8	100.0	10000.0
Torin1	KGP2	78.0	10000.0
BX-912	FLT3(D835Y)	0.1	10000.0
JNK-9L	MINK	31.0	10000.0
AZD-6482	PIK3CA(E545K)	0.6	10000.0
TAK-715	CIT	0.5	10000.0
PD0325901	KIT(V559D,V654A)	100.0	10000.0
TGX221	TYK2(Kin.Dom.2)	100.0	1000.0
WH-4-023	KPCT	21.0	10000.0
CH5424802	ABL1(F317I)-phosphorylated	5.5	1000.0
A443654	RIOK2	6.2	10000.0
AZD-6482	MLCK	100.0	10000.0
Torin1	WEE2	100.0	10000.0
XMD-12	PIK3CA(M1043I)	97.0	1000.0
AZ-628	NUAK1	100.0	10000.0
ERK5-IN-1	TYK2(JH1domain-catalytic)	81.0	1000.0
Omipalisib	PIM3	77.0	10000.0
GSK1059615	TIE1	100.0	10000.0
KU63794	MAP3K3	76.0	10000.0
Sigma A6730	YSK1	97.0	10000.0
BI-2536	RPS6KA5(Kin.Dom.1)	100.0	10000.0
JNK-IN-8	GCN2(Kin.Dom.2,S808G)	100.0	1000.0
WZ4003	CDK16	100.0	1000.0
ALW-II-38-3	MST3	100.0	10000.0
ZSTK474	MST1R	100.0	1000.0
CP466722	EPHB6	2.2	10000.0
KU63794	KC1G2	100.0	10000.0
AZD7762	BRAF	100.0	10000.0
CG-930	CLK4	100.0	10000.0
Momelotinib	AKT1	100.0	10000.0
AZD 5438	MARK4	32.0	10000.0
XMD-12	BTK	100.0	1000.0
XMD-12	JNK1	100.0	1000.0
QL-X-138	MAP3K15	56.0	10000.0
CP466722	MAP3K3	48.0	10000.0
Dabrafenib	CDKL3	100.0	10000.0
AZD-6482	ROS1	100.0	10000.0
WH-4-023	EGFR(L858R,T790M)	14.0	10000.0
ZG-10	S6K1	100.0	10000.0
Momelotinib	CDK16	21.0	10000.0
JNK-9L	AKT2	100.0	10000.0
PD0325901	AURKA	100.0	10000.0
PD0325901	DYRK1B	98.0	10000.0
CGP60474	PHKG2	100.0	10000.0
Taselisib	INSRR	100.0	1000.0
KIN001-220	ABL1-nonphosphorylated	8.8	10000.0
Crizotinib	PIK3CA(Q546K)	17.0	10000.0
ERK5-IN-1	TAOK3	82.0	1000.0
NG25	IRAK3	100.0	10000.0
AZD-6482	EGFR(L861Q)	100.0	10000.0
BMS-536924	SRMS	1.8	1000.0
CGP74514A	PGFRB	1.6	10000.0
CH5424802	TNNI3K	98.0	1000.0
CP724714	MAK	90.0	10000.0
Torkinib	PIK3CA(E545A)	25.0	10000.0
Ibrutinib	ERK5	89.0	1000.0
Ceritinib	M3K6	100.0	1000.0
SB590885	TGFBR1	17.0	10000.0
HG-14-10-04	AKT1	93.0	10000.0
Ceritinib	MAP3K3	92.0	1000.0
HG-14-8-02	MK03	100.0	10000.0
Ibrutinib	ABL2	38.0	1000.0
Taselisib	FLT3(ITD,F691L)	93.0	1000.0
Baricitinib	VGFR2	85.0	10000.0
CP724714	KPCD	87.0	10000.0
WH-4-023	KKCC1	88.0	10000.0
BI-D1870	EGFR(L747-T751del,Sins)	17.0	10000.0
(s)-CR8	CAMK1	100.0	10000.0
AS-252424	PDPK1	100.0	10000.0
Alpelisib	MET	100.0	1000.0
HG-5-88-01	BMPR1B	100.0	10000.0
AG1478	ICK	100.0	10000.0
Torin1	PKAC-alpha	79.0	10000.0
GW-5074	EGFR(G719S)	84.0	10000.0
XMD11-50	VGFR1	100.0	10000.0
CH5424802	ERBB2	87.0	1000.0
WYE-125132	RET(V804L)	85.0	10000.0
GW-5074	CDK14	95.0	10000.0
ZG-10	ABL1(F317L)-nonphosphorylated	32.0	10000.0
A443654	PAK4	13.0	10000.0
TGX221	VGFR1	100.0	1000.0
CP466722	NDR2	69.0	10000.0
TAK-715	DCAMKL2	98.0	10000.0
CP466722	SRPK2	88.0	10000.0
SB590885	ERK4	100.0	10000.0
Dabrafenib	PGFRB	14.0	10000.0
THZ1	RAF1	76.0	10000.0
Neratinib	CSNK1A1L	98.0	10000.0
PD173074	TGFBR2	100.0	10000.0
Sorafenib	EGFR(L858R)	86.0	10000.0
Palbociclib	AMPK-alpha2	100.0	1000.0
Ibrutinib	EGFR(S752-I759del)	1.8	1000.0
NPK76-II-72-1	TLK2	100.0	10000.0
CG-930	LYN	98.0	10000.0
TAK-715	ABL2	47.0	10000.0
Ceritinib	DDR1	90.0	1000.0
MLN8054	ROCK1	63.0	10000.0
KIN001-127	CSNK2A1	100.0	10000.0
JNK-IN-11	SRPK2	85.0	1000.0
AZD7762	RIPK4	0.0	10000.0
Taselisib	KPCD3	100.0	1000.0
ALW-II-49-7	ACVR2B	100.0	10000.0
NVP-TAE684	RPS6KA4(Kin.Dom.2)	100.0	1000.0
CP724714	MST3	90.0	10000.0
AS-252424	AURKB	98.9	10000.0
ERK5-IN-1	EGFR(G719S)	96.0	1000.0
Neratinib	PKAC-beta	100.0	10000.0
HG-6-64-01	MK09	0.1	10000.0
SP600125	FLT3	100.0	10000.0
HG-14-8-02	YANK1	100.0	10000.0
Dinaciclib	FGFR2	98.0	10000.0
WZ4003	M4K3	100.0	1000.0
CP466722	PIK3CA(E545K)	40.0	10000.0
KIN001-111	BRSK2	22.0	1000.0
GW843682X	CSNK1G3	100.0	10000.0
THZ1	MAPKAPK2	100.0	10000.0
Buparlisib	EPHA3	100.0	1000.0
BX-912	PCTK2	77.0	10000.0
PHA-767491	TAOK2	5.0	10000.0
Buparlisib	INSRR	100.0	1000.0
Abemaciclib	JAK1(JH1domain-catalytic)	100.0	1000.0
NU7441	ULK3	64.0	10000.0
Ibrutinib	RET(M918T)	18.0	1000.0
HG-6-64-01	CDK2	96.0	10000.0
Momelotinib	STK33	98.0	10000.0
PHA-767491	PDPK1	72.0	10000.0
Ceritinib	MP2K1	66.0	1000.0
AZD7762	GAK	2.9	10000.0
BGJ398	TEC	99.0	1000.0
GSK461364	CDK2	85.0	10000.0
AZD7762	RSK1(Kin.Dom.2-C-terminal)	1.4	10000.0
AZD4547	SBK1	39.0	10000.0
XMD14-99	TYK2(JH1domain-catalytic)	90.0	10000.0
Ribociclib	EGFR(E746-A750del)	100.0	1000.0
5z-7-oxozeaenol	IRAK1	84.0	10000.0
WH-4-023	FLT3	2.3	10000.0
WZ-7043	PCTK2	100.0	10000.0
AG1478	PLK1	92.0	10000.0
Barasertib	GSK3B	100.0	10000.0
JWE-035	EGFR(L858R,T790M)	90.0	10000.0
BGJ398	INSR	93.0	1000.0
THZ1	MLK2	0.9	10000.0
AZ-628	RSK4(Kin.Dom.1-N-terminal)	87.0	10000.0
Neratinib	EGFR	0.1	10000.0
Buparlisib	NDR2	100.0	1000.0
BMS345541	ANKK1	99.0	10000.0
CH5424802	ZAP70	88.0	1000.0
Taselisib	MK13	74.0	1000.0
ERK5-IN-1	LATS2	93.0	1000.0
SCH772984	M3K2	94.0	1000.0
WH-4-023	PIK3C2G	98.0	10000.0
Vemurafenib	KIT(L576P)	0.0	10000.0
HG-14-8-02	CSNK1G3	100.0	10000.0
Torin1	SRPK2	100.0	10000.0
ALW-II-49-7	PLK1	100.0	10000.0
XMD14-99	ABL1(T315I)-nonphosphorylated	100.0	10000.0
JNK-IN-11	NEK3	99.0	1000.0
BI-D1870	CAMKK2	28.0	10000.0
Ceritinib	FGFR3	88.0	1000.0
GSK461364	M4K3	59.0	10000.0
Taselisib	PKMYT1	88.0	1000.0
XMD11-85h	FGFR2	100.0	10000.0
5z-7-oxozeaenol	PAK2	100.0	10000.0
THZ1	PIK3CA(Q546K)	100.0	10000.0
RO-3306	M3K13	91.0	10000.0
KU63794	ERK5	100.0	10000.0
HG-5-113-01	PTK6	25.0	10000.0
Sigma A6730	ERK3	100.0	10000.0
Dabrafenib	MK09	60.0	10000.0
AZD 5438	NEK5	45.0	10000.0
Alpelisib	PIM1	100.0	1000.0
PHA-793887	EGFR(L858R,T790M)	88.0	10000.0
Omipalisib	BIKE	20.0	10000.0
AZD4547	ITK	17.0	10000.0
Lapatinib	DDR1	60.0	10000.0
MRT67307	ACVRL1	100.0	10000.0
HG-6-64-01	EPHA5	3.6	10000.0
HG-5-113-01	PHKG2	100.0	10000.0
PD173074	ERK3	100.0	10000.0
Crizotinib	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
Canertinib	KPCD2	100.0	1000.0
ERK5-IN-1	DMPK	100.0	1000.0
Buparlisib	RSK4(Kin.Dom.1-N-terminal)	100.0	1000.0
KIN001-111	CSNK1A1L	100.0	1000.0
JNK-9L	GAK	22.0	10000.0
HG-14-10-04	TLK2	92.0	10000.0
Crizotinib	RSK3(Kin.Dom.1-N-terminal)	34.0	10000.0
BX-912	MYLK2	0.4	10000.0
THZ1	M3K13	38.0	10000.0
HG-5-88-01	CDK9	100.0	10000.0
XMD14-99	CDKL3	86.0	10000.0
PD0325901	JAK3(JH1domain-catalytic)	100.0	10000.0
JNK-IN-11	PIM1	84.0	1000.0
Ceritinib	SIK3	100.0	1000.0
ERK5-IN-1	YANK1	100.0	1000.0
AZD 5438	PHKG1	67.0	10000.0
ALW-II-38-3	CDK3	100.0	10000.0
XMD13-2	KC1G1	85.0	10000.0
AZ-628	FGFR4	100.0	10000.0
Baricitinib	JAK1(JH2domain-pseudokinase)	50.0	10000.0
XMD13-2	MAPKAPK5	99.0	10000.0
GW-5074	MK11	88.0	10000.0
ERK5-IN-1	EPHA3	95.0	1000.0
Lapatinib	CTK	100.0	10000.0
Buparlisib	ERN1	100.0	1000.0
AZD 5438	JNK1	0.0	10000.0
ZM-447439	TRKB	17.0	10000.0
Dactolisib	TNK2	100.0	1000.0
(s)-CR8	TAK1	93.0	10000.0
Torkinib	EPHA3	1.5	10000.0
CGP74514A	BMPR1A	73.0	10000.0
NVP-TAE684	AURKA	0.0	1000.0
Ibrutinib	RSK1(Kin.Dom.1-N-terminal)	83.0	1000.0
AZD4547	FYN	9.6	10000.0
Baricitinib	ABL1(Y253F)-phosphorylated	33.0	10000.0
XMD16-144	ULK3	45.0	10000.0
HG-5-88-01	STK36	100.0	10000.0
XMD11-85h	TYK2(JH1domain-catalytic)	100.0	10000.0
MPS-1-IN-1	PIK3C2B	100.0	1000.0
AG1478	EPHA7	46.0	10000.0
CGP60474	KC1G1	100.0	10000.0
QL-X-138	KPCD	80.0	10000.0
SP600125	MST3	1.8	10000.0
CGP74514A	MARK2	25.0	10000.0
Barasertib	YANK2	100.0	10000.0
PLX-4720	GSK3A	100.0	10000.0
(s)-CR8	CSNK1G3	50.0	10000.0
HG-14-8-02	KCC4	100.0	10000.0
KIN001-021	PRKX	100.0	1000.0
JNK-IN-8	CIT	100.0	1000.0
Canertinib	NEK7	100.0	1000.0
Baricitinib	CSNK1A1L	100.0	10000.0
HG-9-91-01	KC1G2	100.0	10000.0
Seliciclib	MAP3K1	100.0	10000.0
JW-7-24-1	INSR	100.0	10000.0
TGX221	MARK2	100.0	1000.0
WZ-7043	INSRR	100.0	10000.0
PLX-4720	KIT(A829P)	67.0	10000.0
Torin2	EGFR(G719C)	71.0	10000.0
BGJ398	ABL1(H396P)-nonphosphorylated	19.0	1000.0
QL-XI-92	KIT	4.7	10000.0
XMD14-99	ITK	91.0	10000.0
Lapatinib	MP2K6	97.0	10000.0
WZ4002	KIT(V559D,T670I)	100.0	10000.0
BS-181	RIPK1	100.0	10000.0
BS-181	ABL1(T315I)-nonphosphorylated	93.0	10000.0
NU7441	EGFR(S752-I759del)	100.0	10000.0
NU7441	EPHA3	91.0	10000.0
JWE-035	PI42C	3.6	10000.0
JNK-IN-8	KIT(D816H)	68.0	1000.0
WZ3105	IRAK1	1.8	10000.0
JNK-IN-5A	EGFR(L858R,T790M)	100.0	10000.0
JNK-IN-8	MARK3	100.0	1000.0
XMD14-99	PHKG2	43.0	10000.0
AZD7762	KPCE	14.0	10000.0
BS-181	MAP3K15	100.0	10000.0
XMD16-144	SIK2	9.0	10000.0
XMD13-2	IRAK4	88.0	10000.0
XMD8-85	PRP4	100.0	10000.0
SCH772984	TNK1	84.0	1000.0
CP724714	GSK3A	100.0	10000.0
KIN001-021	TYK2(Kin.Dom.2)	100.0	1000.0
Dabrafenib	M4K1	73.0	10000.0
JNK-IN-8	PAK4	100.0	1000.0
AZD7762	ULK1	0.0	10000.0
WZ3105	EGFR(G719S)	98.0	10000.0
CGP60474	PIK3CA(E545A)	100.0	10000.0
BX-912	CDK14	44.0	10000.0
Torin1	CASK	100.0	10000.0
JNK-IN-8	SIK2	88.0	1000.0
WZ-7043	TSSK1	100.0	10000.0
ERK5-IN-1	TAK1	100.0	1000.0
WYE-125132	SYK	100.0	10000.0
GSK429286A	ABL1(F317I)-phosphorylated	75.0	10000.0
PD173074	CLK1	100.0	10000.0
KIN001-127	LIMK1	100.0	10000.0
BX-912	S6K1	3.2	10000.0
AZ-628	RSK3(Kin.Dom.1-N-terminal)	89.0	10000.0
WZ-4-145	ACVR2A	100.0	10000.0
OTSSP167	EPHA5	1.1	10000.0
Baricitinib	EGFR(G719S)	100.0	10000.0
NG25	MRCKA	100.0	10000.0
NVP-TAE684	YANK2	0.2	1000.0
Lapatinib	KC1G1	100.0	10000.0
Alpelisib	CDK4-cyclinD1	90.0	1000.0
Taselisib	FGFR1	96.0	1000.0
PHA-793887	EPHA1	100.0	10000.0
KIN001-021	JNK1	100.0	1000.0
WZ4003	DDR1	100.0	1000.0
BI-D1870	MAP4K4	13.0	10000.0
PHA-767491	JAK1(JH2domain-pseudokinase)	63.0	10000.0
GSK1059615	CDK4-cyclinD3	100.0	10000.0
JW-7-24-1	MARK2	100.0	10000.0
XMD13-2	M3K2	63.0	10000.0
KIN001-111	NLK	3.7	1000.0
SP600125	PLK4	0.7	10000.0
PD173074	CSNK1G3	100.0	10000.0
GSK429286A	STK33	36.0	10000.0
Barasertib	CDK7	15.0	10000.0
KIN001-111	PAK3	3.7	1000.0
HG-5-113-01	BRAF	100.0	10000.0
Torin2	TNNI3K	100.0	10000.0
SCH772984	YSK1	71.0	1000.0
PLX-4720	YSK1	53.0	10000.0
ZM-447439	S6K1	7.4	10000.0
ERK5-IN-1	LATS1	100.0	1000.0
Vemurafenib	KPCD2	95.0	10000.0
HG-5-113-01	AKT1	100.0	10000.0
Buparlisib	TAOK1	100.0	1000.0
ZM-447439	GAK	60.0	10000.0
NPK76-II-72-1	EGFR(S752-I759del)	100.0	10000.0
ALW-II-49-7	CDC2L1	100.0	10000.0
HG-9-91-01	CDK5	100.0	10000.0
Momelotinib	ALK	100.0	10000.0
Taselisib	YANK1	100.0	1000.0
BMX-IN-1	EGFR(L861Q)	45.0	10000.0
WZ-7043	MYO3A	100.0	10000.0
Baricitinib	IKKB	18.0	10000.0
PD0325901	CDK11	100.0	10000.0
PLX-4720	NDR1	78.0	10000.0
Dinaciclib	ERBB3	100.0	10000.0
Barasertib	FGFR1	85.0	10000.0
QL-X-138	PIK3CA(H1047Y)	13.0	10000.0
BX-912	INSRR	4.8	10000.0
Ibrutinib	CDKL1	72.0	1000.0
QL-XII-47	TEC	53.0	1000.0
ERK5-IN-1	TBK1	100.0	1000.0
AZ-628	MP2K2	100.0	10000.0
Torin1	PKN2	65.0	10000.0
XMD16-144	DDR1	5.4	10000.0
JNK-IN-8	M4K3	100.0	1000.0
Dinaciclib	EGFR(L747-S752del,P753S)	100.0	10000.0
PD173074	EPHA3	100.0	10000.0
JNK-IN-8	ERK4	81.0	1000.0
XMD11-85h	ROS1	100.0	10000.0
HG-6-64-01	KC1G2	39.0	10000.0
WZ3105	ABL1-nonphosphorylated	59.0	10000.0
PD0325901	PHKG2	93.0	10000.0
PD173074	PDPK1	100.0	10000.0
Neratinib	M3K13	86.0	10000.0
Torin1	HIPK4	4.6	10000.0
Abemaciclib	PCTK3	19.0	1000.0
GW-5074	BRSK2	100.0	10000.0
HG-9-91-01	PIP5K2B	28.0	10000.0
ERK5-IN-1	EGFR(L858R,T790M)	78.0	1000.0
BMS-536924	MST3	7.2	1000.0
WZ-4-145	STK33	31.0	10000.0
MLN8054	PIK3CB	100.0	10000.0
ZM-447439	MUSK	100.0	10000.0
Alpelisib	RET(V804M)	100.0	1000.0
GW-5074	M3K13	100.0	10000.0
Baricitinib	IRAK4	57.0	10000.0
BMS-536924	RPS6KA4(Kin.Dom.2)	100.0	1000.0
QL-XI-92	MTOR	97.0	10000.0
BI-2536	YANK3	100.0	10000.0
WZ4002	PIK3CA(E545K)	100.0	10000.0
Dabrafenib	JNK3	11.0	10000.0
(s)-CR8	MAP3K4	96.0	10000.0
Alpelisib	RIPK5	99.0	1000.0
QL-XII-47	TRKA	100.0	1000.0
BS-181	TBK1	92.0	10000.0
Dabrafenib	AURKB	6.2	10000.0
MRT67307	DAPK1	5.4	10000.0
JNK-IN-11	ABL2	21.0	1000.0
PHA-767491	TYK2(JH1domain-catalytic)	0.9	10000.0
Seliciclib	ERN1	100.0	10000.0
KU63794	EPHB2	100.0	10000.0
Lapatinib	TRPM6	100.0	10000.0
JW-7-24-1	PIK3CA	100.0	10000.0
NU7441	EGFR(L858R,T790M)	93.0	10000.0
NU7441	KPCD2	100.0	10000.0
SB590885	PLK1	100.0	10000.0
Torkinib	CSNK1A1	3.6	10000.0
QL-X-138	MAP3K1	97.0	10000.0
THZ1	NEK4	18.0	10000.0
HG-9-91-01	MAK	100.0	10000.0
Neratinib	TRKC	78.0	10000.0
HG-6-64-01	MLK3	3.6	10000.0
Canertinib	MST1	100.0	1000.0
AZD7762	DAPK3	2.9	10000.0
HG-6-64-01	CDC2L1	8.5	10000.0
NG25	MK11	0.0	10000.0
HG-14-10-04	PIK3CA(I800L)	100.0	10000.0
ZM-447439	PAK6	95.0	10000.0
GSK461364	PKAC-beta	89.0	10000.0
PD0325901	FLT3(D835H)	87.0	10000.0
GW-5074	CDK4-cyclinD3	99.0	10000.0
Ceritinib	RET(V804M)	98.0	1000.0
SB590885	AKT1	97.0	10000.0
ALW-II-38-3	KPCD	100.0	10000.0
MLN8054	SIK1	5.7	10000.0
Torkinib	NUAK1	86.0	10000.0
WYE-125132	EPHB3	92.0	10000.0
CH5424802	ABL1(F317L)-nonphosphorylated	24.0	1000.0
GSK1059615	KGP1	75.0	10000.0
Seliciclib	VGFR1	95.0	10000.0
MPS-1-IN-1	BTK	100.0	1000.0
Vemurafenib	CSNK1D	97.0	10000.0
MRT67307	MAP3K1	85.0	10000.0
HG-5-113-01	ULK1	7.2	10000.0
JWE-035	ACVR2B	29.0	10000.0
XMD16-144	FAK2	74.0	10000.0
Omipalisib	ERBB2	81.0	10000.0
CP466722	PIK3CB	5.0	10000.0
Seliciclib	ERBB2	100.0	10000.0
WZ-7043	FLT3(D835Y)	100.0	10000.0
Vemurafenib	TNK2	6.9	10000.0
KIN001-111	MLK2	25.0	1000.0
Dinaciclib	PKN2	86.0	10000.0
CG-930	BMPR1B	100.0	10000.0
BMX-IN-1	ERK8	100.0	10000.0
Crizotinib	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
XMD8-85	DYRK1A	100.0	10000.0
XMD16-144	MTOR	74.0	10000.0
KIN001-111	RPS6KA1(Kin.Dom.2)	100.0	1000.0
HG-6-64-01	PIK3CA(E545A)	92.0	10000.0
AZD7762	CAMK1	2.0	10000.0
WZ-7043	ZAP70	100.0	10000.0
XMD14-99	LRRK2(G2019S)	97.0	10000.0
PD0325901	PLK1	72.0	10000.0
GSK429286A	MAST1	77.0	10000.0
KIN001-127	PTK6	100.0	10000.0
Palbociclib	TRKB	100.0	1000.0
QL-XI-92	CHEK1	96.0	10000.0
Alpelisib	CSNK2A1	100.0	1000.0
HG-5-88-01	INSRR	1.2	10000.0
Neratinib	CSNK2A1	94.0	10000.0
OTSSP167	MAPKAPK5	15.0	10000.0
PHA-767491	TSSK1	90.0	10000.0
BMS-536924	FGFR3(G697C)	3.7	1000.0
ALW-II-49-7	FGFR3(G697C)	100.0	10000.0
KU63794	CAMK1	90.0	10000.0
Lapatinib	PRKX	88.0	10000.0
PD0325901	ABL1(H396P)-phosphorylated	100.0	10000.0
Baricitinib	ABL1(F317L)-phosphorylated	38.0	10000.0
GW-5074	KIT(L576P)	6.6	10000.0
Torin1	EIF2AK1	57.0	10000.0
ZG-10	FAK1	100.0	10000.0
JNK-IN-11	TESK1	99.0	1000.0
PHA-793887	DAPK1	78.0	10000.0
BX-912	EPHB1	85.0	10000.0
SB590885	EPHA2	83.0	10000.0
NU7441	PIK3CA(M1043I)	17.0	10000.0
HG-14-10-04	NLK	100.0	10000.0
KIN001-127	EPHA7	100.0	10000.0
NU7441	SgK110	100.0	10000.0
Dinaciclib	CDK3	0.3	10000.0
WH-4-023	TGFBR1	0.8	10000.0
Seliciclib	LKB1	100.0	10000.0
BI-2536	VGFR1	100.0	10000.0
AZD4547	RAF1	100.0	10000.0
Dactolisib	FLT4	100.0	1000.0
THZ1	STK35	60.0	10000.0
Sigma A6730	PRKX	100.0	10000.0
WZ-7043	FGR	100.0	10000.0
SP600125	RAF1	100.0	10000.0
Pictilisib	EGFR(L747-S752del,P753S)	66.0	1000.0
Canertinib	EGFR(L858R)	0.0	1000.0
XMD8-92	FLT3	100.0	10000.0
PD173074	MUSK	100.0	10000.0
AZD7762	CDK8	71.0	10000.0
Buparlisib	MRCKB	100.0	1000.0
BMS345541	PFCDPK1(P.falciparum)	52.0	10000.0
WYE-125132	EPHB1	90.0	10000.0
MLN8054	NEK2	73.0	10000.0
JNK-IN-11	TGFBR1	12.0	1000.0
HG-6-64-01	ERBB4	0.1	10000.0
BI-2536	JAK1(Kin.Dom.1)	100.0	10000.0
XMD8-85	MLK2	100.0	10000.0
R406	PIK3CD	29.0	1000.0
GSK429286A	MAP4K4	78.0	10000.0
ZG-10	CDK3	96.0	10000.0
KIN001-220	STK33	35.0	10000.0
Palbociclib	MST2	98.0	1000.0
CP466722	EPHA3	11.0	10000.0
Torkinib	KIT(D816V)	2.5	10000.0
XMD8-92	RIPK2	100.0	10000.0
GW-5074	HIPK4	21.0	10000.0
HG-6-64-01	CLK1	14.0	10000.0
Lapatinib	EGFR(L861Q)	0.0	10000.0
XMD14-99	PIK3CD	98.0	10000.0
XMD11-50	FLT3(N841I)	73.0	10000.0
ZM-447439	DCAMKL3	96.0	10000.0
JWE-035	YSK4	80.0	10000.0
QL-XI-92	PIP5K2B	100.0	10000.0
XMD11-85h	SRPK1	0.0	10000.0
CH5424802	MRCKA	100.0	1000.0
NVP-TAE684	M3K12	0.0	1000.0
Momelotinib	EGFR(G719S)	79.0	10000.0
GSK429286A	VRK2	87.0	10000.0
XMD11-85h	RAF1	100.0	10000.0
CGP74514A	DAPK2	36.0	10000.0
MPS-1-IN-1	ABL1(Y253F)	100.0	1000.0
Ribociclib	KIT(D816H)	87.0	1000.0
HG-6-64-01	ABL1(E255K)-phosphorylated	1.0	10000.0
XMD16-144	KPCE	67.0	10000.0
(s)-CR8	RIOK3	54.0	10000.0
AZD-6482	EPHA6	100.0	10000.0
Vemurafenib	GRK4	100.0	10000.0
JNK-IN-11	PIK3C2G	100.0	1000.0
JNK-IN-5A	FGFR4	49.0	10000.0
AG1478	DMPK2	56.0	10000.0
Dinaciclib	MAPKAPK5	93.0	10000.0
Torin2	TESK1	94.0	10000.0
XMD11-85h	RIPK1	100.0	10000.0
CGP74514A	ABL1-phosphorylated	3.4	10000.0
WH-4-023	PIP5K2B	5.4	10000.0
AZD4547	RIPK1	0.0	10000.0
BI-2536	MAP3K4	100.0	10000.0
Neratinib	CDK4-cyclinD1	71.0	10000.0
BMS-536924	MP2K6	27.0	1000.0
PHA-793887	BRAF(V600E)	97.0	10000.0
PHA-793887	PIK3CA(E545A)	83.0	10000.0
Ibrutinib	BRAF(V600E)	50.0	1000.0
Vemurafenib	IKKE	100.0	10000.0
Sigma A6730	MK11	95.0	10000.0
ZG-10	SNARK	30.0	10000.0
WH-4-023	MLK2	19.0	10000.0
AS-252424	TGFBR1	62.8	10000.0
Pictilisib	BMX	100.0	1000.0
BMX-IN-1	MAST1	94.0	10000.0
HG-9-91-01	NEK1	98.0	10000.0
XMD13-2	CIT	89.0	10000.0
5z-7-oxozeaenol	RIPK4	89.0	10000.0
JW-7-24-1	EGFR(G719S)	100.0	10000.0
Barasertib	MP2K3	98.0	10000.0
Dactolisib	AURKC	100.0	1000.0
Baricitinib	MAP3K14	27.0	10000.0
Vemurafenib	EIF2AK1	60.0	10000.0
AZD4547	SIK3	34.0	10000.0
WYE-125132	MTOR	5.7	10000.0
QL-X-138	RSK1(Kin.Dom.2-C-terminal)	94.0	10000.0
AZD-6482	MP2K3	100.0	10000.0
WZ3105	HIPK4	63.0	10000.0
CH5424802	PIM1	11.0	1000.0
WZ4002	MST2	100.0	10000.0
XMD11-50	IRAK3	100.0	10000.0
HG-5-88-01	AKT1	100.0	10000.0
XMD8-92	SRC	100.0	10000.0
JWE-035	NEK2	100.0	10000.0
MPS-1-IN-1	FLT3(D835Y)	24.0	1000.0
GSK429286A	IRAK3	85.0	10000.0
AG1478	MLK3	100.0	10000.0
5z-7-oxozeaenol	PLK3	83.0	10000.0
KIN001-127	MP2K6	100.0	10000.0
Barasertib	PIK3CA(Q546K)	15.0	10000.0
WH-4-023	TGFBR2	16.0	10000.0
CP466722	NLK	6.6	10000.0
Baricitinib	ANKK1	1.6	10000.0
TGX221	CSNK1G3	100.0	1000.0
AS-252424	DMPK2	87.4	10000.0
GW843682X	TGFBR1	86.0	10000.0
XMD13-2	DMPK	100.0	10000.0
BMS345541	ABL1(Q252H)-nonphosphorylated	68.0	10000.0
Lapatinib	TAK1	99.0	10000.0
Canertinib	TGFBR2	100.0	1000.0
KU63794	PCTK3	100.0	10000.0
NVP-TAE684	BRAF(V600E)	100.0	1000.0
AZD7762	CSNK1G3	4.6	10000.0
BMS345541	PIK3CA(I800L)	100.0	10000.0
Torkinib	VRK2	100.0	10000.0
NVP-TAE684	RPS6KA2(Kin.Dom.1)	0.1	1000.0
Pictilisib	RPS6KA2(Kin.Dom.2)	100.0	10000.0
Buparlisib	RIOK1	87.0	1000.0
XMD13-2	PAK7	67.0	10000.0
Sigma A6730	ROCK1	66.0	10000.0
Taselisib	MAP3K4	100.0	1000.0
PHA-767491	MKNK1	100.0	10000.0
WZ4003	BRAF(V600E)	100.0	1000.0
KIN001-127	ABL1(F317I)	100.0	10000.0
KIN001-127	TYK2(Kin.Dom.1)	100.0	10000.0
Canertinib	NEK1	100.0	1000.0
GSK461364	KPCD	22.0	10000.0
SB590885	MLTK	84.0	10000.0
AZD4547	RIPK4	65.0	10000.0
KIN001-127	SRPK3	100.0	10000.0
XMD11-50	BRSK2	64.0	10000.0
Buparlisib	MK09	100.0	1000.0
Baricitinib	RET(M918T)	0.6	10000.0
A443654	EPHB3	100.0	10000.0
AZD-6482	PIK3C2G	7.0	10000.0
XMD8-85	PIK3CA(M1043I)	100.0	10000.0
ALW-II-38-3	M3K13	100.0	10000.0
KIN001-127	ERK3	100.0	10000.0
AZD 5438	ABL1(H396P)-nonphosphorylated	1.0	10000.0
THZ1	PLK4	0.7	10000.0
OTSSP167	CAMK2A	81.0	10000.0
Pictilisib	PRP4	83.0	1000.0
Torin1	HIPK2	58.0	10000.0
ERK5-IN-1	RPS6KA5(Kin.Dom.2-C-terminal)	86.0	1000.0
AZD4547	HASP	51.0	10000.0
Omipalisib	ABL1(H396P)-nonphosphorylated	55.0	10000.0
Sorafenib	EPHB6	3.0	10000.0
AZD4547	FLT3-autoinhibited	60.0	10000.0
MRT67307	PFCDPK1(P.falciparum)	98.0	10000.0
AZD-6482	CDC2L5	88.0	10000.0
Pictilisib	PIK3CA(H1047L)	0.8	1000.0
Ceritinib	YSK1	93.0	1000.0
CH5424802	VRK2	87.0	1000.0
5z-7-oxozeaenol	TNK1	25.0	10000.0
XMD8-92	MST3	100.0	10000.0
NPK76-II-72-1	NEK5	100.0	10000.0
XMD16-144	LIMK2	94.0	10000.0
XMD8-92	WEE1	100.0	10000.0
5z-7-oxozeaenol	CDC2L2	77.0	10000.0
GSK429286A	SRPK2	100.0	10000.0
AZD 5438	EPHB4	42.0	10000.0
CGP74514A	ZAP70	84.0	10000.0
Ceritinib	YSK4	81.0	1000.0
WZ4002	CDK2	100.0	10000.0
Omipalisib	IKKA	69.0	10000.0
Abemaciclib	PDPK1	64.0	1000.0
HG-5-113-01	KC1G2	3.1	10000.0
Torkinib	CSNK1D	2.4	10000.0
KIN001-021	MST4	100.0	1000.0
BGJ398	HIPK1	83.0	1000.0
JNK-IN-5A	ABL1(F317I)-nonphosphorylated	100.0	10000.0
ALW-II-49-7	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
Taselisib	ROCK2	91.0	1000.0
QL-XII-47	MTOR	85.0	1000.0
HG-14-10-04	IKKA	18.0	10000.0
XMD14-99	CDKL2	93.0	10000.0
Palbociclib	DMPK2	100.0	1000.0
AZD-6482	CSK	100.0	10000.0
JNK-IN-8	PLK3	66.0	1000.0
KIN001-111	ADCK4	100.0	1000.0
ALW-II-49-7	DAPK3	100.0	10000.0
Canertinib	FYN	100.0	1000.0
ERK5-IN-1	CAMK1G	95.0	1000.0
AG1478	DAPK2	60.0	10000.0
Sigma A6730	FLT4	100.0	10000.0
Vemurafenib	CDK9	100.0	10000.0
QL-XI-92	SNRK	100.0	10000.0
CP466722	BRSK1	18.0	10000.0
Dabrafenib	CDK2	0.4	10000.0
SB590885	EPHB2	98.0	10000.0
BS-181	RSK4(Kin.Dom.1-N-terminal)	58.0	10000.0
PHA-767491	PLK1	1.4	10000.0
KIN001-111	PCTK3	100.0	1000.0
WYE-125132	ERBB2	88.0	10000.0
ALW-II-38-3	MET(M1250T)	100.0	10000.0
JNK-9L	KCC2D	24.0	10000.0
XMD8-92	FYN	100.0	10000.0
GW843682X	GSK3A	100.0	10000.0
NU7441	CDK14	100.0	10000.0
MLN8054	TBK1	100.0	10000.0
Dabrafenib	FGFR4	92.0	10000.0
Ibrutinib	RPS6KA5(Kin.Dom.2-C-terminal)	79.0	1000.0
AZD-6482	MK01	100.0	10000.0
BI-2536	MST1R	100.0	10000.0
Pictilisib	CDK2	98.0	1000.0
CG-930	BTK	100.0	10000.0
WYE-125132	STK16	98.0	10000.0
BMS-536924	PRKX	100.0	1000.0
WH-4-023	GSK3A	100.0	10000.0
HG-6-64-01	INSRR	100.0	10000.0
KIN001-220	EGFR(L747-T751del,Sins)	47.0	10000.0
CP724714	SRPK1	100.0	10000.0
Alpelisib	PIK3CA(E542K)	0.0	1000.0
5z-7-oxozeaenol	KIT(A829P)	10.0	10000.0
BMS-536924	PAK2	100.0	1000.0
XMD8-92	NLK	100.0	10000.0
KIN001-220	KKCC1	25.0	10000.0
Momelotinib	PFCDPK1(P.falciparum)	100.0	10000.0
A443654	NEK2	100.0	10000.0
Crizotinib	LIMK2	4.6	10000.0
XMD13-2	PCTK3	58.0	10000.0
WH-4-023	RSK3(Kin.Dom.1-N-terminal)	27.0	10000.0
HG-5-88-01	MLK3	100.0	10000.0
BX-912	EGFR(L747-T751del,Sins)	67.0	10000.0
Dactolisib	CDKL3	100.0	1000.0
MLN8054	LOK	6.7	10000.0
MLN8054	MET	49.0	10000.0
Crizotinib	EGFR(T790M)	100.0	10000.0
Momelotinib	MP2K3	53.0	10000.0
SCH772984	NEK6	86.0	1000.0
MPS-1-IN-1	BRAF	100.0	1000.0
WZ-4-145	LCK	0.2	10000.0
Ibrutinib	PRKX	100.0	1000.0
ERK5-IN-1	ABL1(Q252H)-phosphorylated	100.0	1000.0
SP600125	CSNK2A1	25.0	10000.0
Palbociclib	TLK1	76.0	1000.0
KIN001-021	RPS6KA5(Kin.Dom.1)	100.0	1000.0
PLX-4720	PIK3CA(I800L)	91.0	10000.0
KU63794	RET(V804L)	100.0	10000.0
TGX221	ANKK1	100.0	1000.0
JW-7-24-1	PAK4	100.0	10000.0
PHA-793887	YANK3	71.0	10000.0
Ribociclib	AKT2	94.0	1000.0
SP600125	FLT3(K663Q)	100.0	10000.0
SP600125	MST1	100.0	10000.0
JW-7-24-1	KIT(V559D)	4.4	10000.0
WH-4-023	CAMK2A	84.0	10000.0
WZ-7043	VGFR2	100.0	10000.0
XMD14-99	CDK2	79.0	10000.0
OTSSP167	BMX	2.6	10000.0
ERK5-IN-1	ABL2	100.0	1000.0
PD0325901	PIK3CG	88.0	10000.0
Torkinib	MP2K3	1.7	10000.0
KIN001-111	KIT(V559D,T670I)	100.0	1000.0
BS-181	BRAF(V600E)	94.0	10000.0
AS-252424	ABL1	100.0	10000.0
Sigma A6730	INSRR	100.0	10000.0
BX-912	TRKA	0.2	10000.0
KIN001-021	TLK1	100.0	1000.0
CG-930	TNNI3K	100.0	10000.0
XMD11-85h	CAMK1G	100.0	10000.0
PLX-4720	CLK4	51.0	10000.0
BMX-IN-1	FGFR3(G697C)	96.0	10000.0
XMD-12	RET(V804L)	1.7	1000.0
Crizotinib	RSK4(Kin.Dom.2-C-terminal)	35.0	10000.0
BGJ398	MK03	88.0	1000.0
PHA-767491	CDC2L1	76.0	10000.0
GSK429286A	CDKL1	78.0	10000.0
AZD-6482	ABL1-phosphorylated	88.0	10000.0
WYE-125132	KPCT	100.0	10000.0
HG-9-91-01	ROCK1	42.0	10000.0
WZ4003	NEK2	100.0	1000.0
Seliciclib	ABL1(M351T)-phosphorylated	99.0	10000.0
MLN8054	BMPR1B	36.0	10000.0
HG-14-10-04	ABL1(Q252H)-nonphosphorylated	0.1	10000.0
ZM-447439	DDR1	36.0	10000.0
JNK-IN-5A	STK16	89.0	10000.0
NU7441	EIF2AK1	100.0	10000.0
HG-5-113-01	ROCK2	1.0	10000.0
(s)-CR8	MP2K6	98.0	10000.0
Taselisib	CSNK1D	100.0	1000.0
AZ-628	PIK3CA(H1047L)	100.0	10000.0
AZD4547	TGFBR1	76.0	10000.0
AZD7762	PIP5K1C	27.0	10000.0
CH5424802	TGFBR2	98.0	1000.0
PHA-793887	RPS6KA5(Kin.Dom.1-N-terminal)	46.0	10000.0
BGJ398	M3K6	100.0	1000.0
XMD8-92	TNK1	7.8	10000.0
TAK-715	DYRK1A	69.0	10000.0
AG1478	MAP4K5	26.0	10000.0
Taselisib	KIT(A829P)	100.0	1000.0
QL-X-138	M3K13	84.0	10000.0
NU7441	PAK4	80.0	10000.0
ALW-II-38-3	TLK2	100.0	10000.0
AG1478	TLK1	87.0	10000.0
SB590885	EPHA4	100.0	10000.0
PD173074	KIT(V559D,V654A)	100.0	10000.0
Crizotinib	BRAF	53.0	10000.0
Torkinib	MLK2	53.0	10000.0
GW843682X	ABL1(E255K)-phosphorylated	60.0	10000.0
CH5424802	CHEK1	94.0	1000.0
Abemaciclib	DAPK1	26.0	1000.0
QL-X-138	ZAP70	48.0	10000.0
BS-181	SGK1	95.0	10000.0
5z-7-oxozeaenol	CDKL5	100.0	10000.0
Lapatinib	ACVR2B	91.0	10000.0
NG25	ACVR1B	100.0	10000.0
SP600125	EGFR(L861Q)	100.0	10000.0
KU63794	DRAK1	96.0	10000.0
CP466722	BMPR1B	0.3	10000.0
HG-14-10-04	INSRR	0.1	10000.0
JWE-035	EIF2AK1	100.0	10000.0
HG-14-10-04	CDK16	71.0	10000.0
NU7441	EPHA5	100.0	10000.0
Vemurafenib	PAK3	69.0	10000.0
BMS-536924	ABL1(H396P)	19.0	1000.0
CP466722	PAK6	55.0	10000.0
ALW-II-38-3	KPCD2	100.0	10000.0
WZ-7043	EPHB2	100.0	10000.0
KIN001-111	ACVR1B	100.0	1000.0
KIN001-127	RET	100.0	10000.0
JW-7-24-1	BTK	100.0	10000.0
RO-3306	LIMK1	81.0	10000.0
XMD16-144	GRK1	100.0	10000.0
NVP-TAE684	KIT(V559D,V654A)	7.4	1000.0
Taselisib	TLK2	100.0	1000.0
WYE-125132	NEK5	81.0	10000.0
HG-6-64-01	TGFBR1	100.0	10000.0
GW843682X	MET	15.0	10000.0
GSK1059615	BIKE	0.0	10000.0
Taselisib	TSSK3	100.0	1000.0
WZ-4-145	JNK1	100.0	10000.0
CG-930	PFCDPK1(P.falciparum)	1.5	10000.0
(s)-CR8	FLT3-autoinhibited	86.0	10000.0
Crizotinib	NEK11	98.0	10000.0
KU63794	ABL1(M351T)-phosphorylated	100.0	10000.0
R406	RIPK1	100.0	1000.0
TAK-715	PIK3CA(M1043I)	95.0	10000.0
AZ-628	ALK	93.0	10000.0
Omipalisib	CAMK2G	82.0	10000.0
HG-9-91-01	TLK1	81.0	10000.0
JNK-9L	ACVR1B	76.0	10000.0
CGP74514A	SRPK2	96.0	10000.0
Dactolisib	ULK2	100.0	1000.0
KU63794	RPS6KA4(Kin.Dom.2-C-terminal)	95.0	10000.0
(s)-CR8	CAMK1D	96.0	10000.0
OTSSP167	SRC	0.1	10000.0
GSK429286A	SYK	100.0	10000.0
Baricitinib	LCK	9.8	10000.0
WZ3105	FGFR4	98.0	10000.0
PD0325901	FGFR3	100.0	10000.0
Ribociclib	MTOR	87.0	1000.0
Buparlisib	SNARK	100.0	1000.0
WZ4002	BMX	8.6	10000.0
JWE-035	MST2	8.1	10000.0
(s)-CR8	MAK	83.0	10000.0
QL-X-138	ERK8	24.0	10000.0
NG25	NEK5	100.0	10000.0
JWE-035	MLK1	58.0	10000.0
KIN001-111	NEK2	6.4	1000.0
Neratinib	TNNI3K	100.0	10000.0
AZD7762	PTK6	1.4	10000.0
Dactolisib	STK39	100.0	1000.0
RO-3306	MARK3	98.0	10000.0
GW-5074	EGFR(S752-I759del)	35.0	10000.0
Seliciclib	RSK1(Kin.Dom.1-N-terminal)	59.0	10000.0
Ibrutinib	EPHA6	74.0	1000.0
BMX-IN-1	HIPK4	71.0	10000.0
Ibrutinib	CDC2L1	96.0	1000.0
CP724714	LRRK2	100.0	10000.0
TAK-715	AURKC	90.0	10000.0
Seliciclib	PGFRA	100.0	10000.0
AZD4547	HIPK3	63.0	10000.0
GW-5074	FLT3(ITD)	33.0	10000.0
CGP74514A	JNK1	62.0	10000.0
BX-912	DAPK3	4.0	10000.0
ERK5-IN-1	NEK9	100.0	1000.0
ALW-II-49-7	ROS1	100.0	10000.0
Pictilisib	RSK1(Kin.Dom.2-C-terminal)	71.0	1000.0
Seliciclib	MST1	100.0	10000.0
KU63794	SIK1	90.0	10000.0
KIN001-220	MST2	100.0	10000.0
GSK461364	ERBB3	100.0	10000.0
QL-XI-92	AAK1	77.0	10000.0
HG-9-91-01	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
Momelotinib	CIT	0.4	10000.0
CGP60474	FGFR3	100.0	10000.0
JWE-035	TAOK1	0.2	10000.0
SP600125	EPHB2	100.0	10000.0
ERK5-IN-1	ROCK1	77.0	1000.0
Pictilisib	ABL1-phosphorylated	99.0	1000.0
OTSSP167	AURKA	0.0	10000.0
JWE-035	MARK1	21.0	10000.0
HG-14-10-04	PIK4CB	27.0	10000.0
Dabrafenib	JAK1(JH2domain-pseudokinase)	0.3	10000.0
AG1478	LRRK2(G2019S)	67.0	10000.0
KIN001-220	YANK2	100.0	10000.0
CGP60474	EPHA3	100.0	10000.0
GW-5074	ABL1(T315I)-nonphosphorylated	88.0	10000.0
RO-3306	CAMK2B	65.0	10000.0
NVP-TAE684	LTK	0.0	1000.0
5z-7-oxozeaenol	PIK3CA(I800L)	63.0	10000.0
XMD8-92	GRK7	100.0	10000.0
WZ-7043	NEK1	100.0	10000.0
KIN001-220	CDC2L2	95.0	10000.0
Torin2	PFPK5(P.falciparum)	100.0	10000.0
JNK-9L	EGFR(G719S)	94.0	10000.0
5z-7-oxozeaenol	NEK1	100.0	10000.0
Torkinib	PCTK3	100.0	10000.0
JNK-IN-11	KPCD3	0.0	1000.0
Ceritinib	FLT3(D835H)	36.0	1000.0
NVP-TAE684	TTK	0.0	1000.0
GSK429286A	IRAK4	97.0	10000.0
JNK-IN-11	MAP3K4	80.0	1000.0
Dabrafenib	EPHA5	100.0	10000.0
Ibrutinib	CLK3	90.0	1000.0
JWE-035	ABL1(F317I)-phosphorylated	11.0	10000.0
PHA-793887	GAK	93.0	10000.0
PHA-767491	CDK2	39.0	10000.0
AZD 5438	TESK1	87.0	10000.0
THZ1	HIPK4	0.2	10000.0
Torin1	PIK3CA(C420R)	0.7	10000.0
Seliciclib	SIK1	97.0	10000.0
JNK-9L	MERTK	57.0	10000.0
Dinaciclib	MLCK	94.0	10000.0
PHA-793887	WEE2	100.0	10000.0
NG25	PKN1	100.0	10000.0
Momelotinib	PIM3	100.0	10000.0
Vemurafenib	SRPK3	100.0	10000.0
Torin1	EGFR	85.0	10000.0
Dactolisib	FYN	100.0	1000.0
PHA-767491	EPHA8	99.0	10000.0
JNK-9L	FGR	54.0	10000.0
KIN001-127	IKKB	100.0	10000.0
GW-5074	EGFR(L747-S752del,P753S)	50.0	10000.0
SP600125	BMPR2	5.0	10000.0
PHA-793887	BRSK1	100.0	10000.0
RO-3306	EPHB6	44.0	10000.0
MRT67307	IKKB	77.0	10000.0
GSK1059615	TYRO3	100.0	10000.0
JWE-035	DYRK1A	51.0	10000.0
Buparlisib	BRAF(V600E)	89.0	1000.0
HG-14-10-04	RET(V804M)	0.0	10000.0
WZ4002	PGFRB	11.0	10000.0
WZ4002	MERTK	100.0	10000.0
AG1478	ABL2	34.0	10000.0
GW-5074	PIK3CA(M1043I)	76.0	10000.0
Ribociclib	TLK1	100.0	1000.0
RO-3306	RET	84.0	10000.0
KU63794	MLTK	100.0	10000.0
PD173074	TRKB	100.0	10000.0
XMD13-2	INSRR	95.0	10000.0
WZ-7043	CDKL3	100.0	10000.0
GSK461364	TNIK	78.0	10000.0
GSK1059615	JAK1(JH1domain-catalytic)	95.0	10000.0
AZD4547	MK12	91.0	10000.0
QL-X-138	AMPK-alpha2	78.0	10000.0
Omipalisib	EPHA4	100.0	10000.0
A443654	SRPK1	17.0	10000.0
CGP60474	CLK2	0.3	10000.0
PHA-767491	PFPK5(P.falciparum)	100.0	10000.0
HG-5-88-01	MKNK1	100.0	10000.0
Lapatinib	CSNK1G3	100.0	10000.0
Dinaciclib	CDK16	0.3	10000.0
XMD13-2	RSK3(Kin.Dom.2-C-terminal)	82.0	10000.0
JNK-9L	KIT(D816H)	50.0	10000.0
GW843682X	CAMK2B	75.0	10000.0
GW843682X	RSK4(Kin.Dom.1-N-terminal)	18.0	10000.0
XMD14-99	PIM1	100.0	10000.0
GSK461364	JNK1	100.0	10000.0
Pictilisib	PLK3	81.0	1000.0
XMD13-2	FES	100.0	10000.0
XMD8-85	IKKE	100.0	10000.0
KIN001-127	PCTK3	100.0	10000.0
QL-X-138	TYK2(JH1domain-catalytic)	29.0	10000.0
WZ-7043	PAK4	100.0	10000.0
BI-D1870	PLK4	8.2	10000.0
KIN001-123	RPS6KA4(Kin.Dom.1)	100.0	1000.0
HG-9-91-01	MELK	16.0	10000.0
Canertinib	MAPKAPK2	100.0	1000.0
XMD14-99	YANK2	76.0	10000.0
RO-3306	BMX	84.0	10000.0
BMX-IN-1	PGFRA	100.0	10000.0
BGJ398	KIT(D816H)	50.0	1000.0
XMD16-144	MUSK	100.0	10000.0
Dinaciclib	FGFR3(G697C)	86.0	10000.0
Pictilisib	STK16	81.0	1000.0
Torin2	M3K6	100.0	10000.0
TAK-715	CAMK1G	97.0	10000.0
GSK461364	PDPK1	100.0	10000.0
HG-14-8-02	FGFR1	99.0	10000.0
BMS-536924	PLK4	1.8	1000.0
GW843682X	MK01	86.0	10000.0
HG-14-8-02	EPHB1	98.0	10000.0
PLX-4720	MET(Y1235D)	100.0	10000.0
NVP-TAE684	PKN2	3.2	1000.0
QL-X-138	AMPK-alpha1	96.0	10000.0
Sorafenib	TRKB	13.0	10000.0
BS-181	RET(V804L)	100.0	10000.0
Vemurafenib	BIKE	78.0	10000.0
XMD11-50	CLK4	54.0	10000.0
RO-3306	MAP3K15	26.0	10000.0
PD0325901	MKNK2	100.0	10000.0
Barasertib	EGFR(L747-T751del,Sins)	37.0	10000.0
Baricitinib	PKAC-alpha	0.4	10000.0
SP600125	IGF1R	100.0	10000.0
QL-XII-47	BRAF(V600E)	100.0	1000.0
Taselisib	WEE2	100.0	1000.0
AZD4547	JNK1	61.0	10000.0
AZD 5438	MP2K7	65.0	10000.0
Taselisib	M3K6	88.0	1000.0
ERK5-IN-1	RSK1(Kin.Dom.1-N-terminal)	100.0	1000.0
Torkinib	FGR	5.6	10000.0
JNK-IN-5A	PIK3CA(E542K)	100.0	10000.0
JW-7-24-1	MST1	100.0	10000.0
GW-5074	CDK11	63.0	10000.0
A443654	KIT	100.0	10000.0
AZD 5438	BRAF	44.0	10000.0
CP724714	PIK3CB	100.0	10000.0
ZSTK474	MST3	100.0	1000.0
PHA-767491	YANK3	96.0	10000.0
Alpelisib	EGFR	100.0	1000.0
SCH772984	CDK7	76.0	1000.0
RO-3306	MAP4K4	12.0	10000.0
Ceritinib	KIT	87.0	1000.0
KU63794	ICK	100.0	10000.0
JNK-9L	TXK	60.0	10000.0
SP600125	ABL1(E255K)	100.0	10000.0
KU63794	KPCL	100.0	10000.0
BGJ398	DMPK2	93.0	1000.0
WYE-125132	CDKL3	95.0	10000.0
NG25	KPCL	26.0	10000.0
HG-5-113-01	RIOK3	2.9	10000.0
XMD13-2	TNK1	100.0	10000.0
BGJ398	CLK3	77.0	1000.0
BMS345541	SNRK	100.0	10000.0
XMD-12	ADCK3	100.0	1000.0
XMD11-85h	STK16	100.0	10000.0
ZSTK474	NEK6	100.0	1000.0
TAK-715	ABL1(Q252H)-phosphorylated	8.7	10000.0
ERK5-IN-1	TAOK2	78.0	1000.0
A443654	PIK3CA	100.0	10000.0
Neratinib	DYRK1A	99.0	10000.0
Crizotinib	PIK3CB	99.0	10000.0
Taselisib	EPHB3	95.0	1000.0
ZM-447439	KPCL	100.0	10000.0
Neratinib	TLK2	93.0	10000.0
Buparlisib	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	1000.0
XMD8-92	ABL1(Q252H)	100.0	10000.0
BMX-IN-1	OSR1	94.0	10000.0
Torin2	SLK	100.0	10000.0
XMD16-144	IRAK4	73.0	10000.0
SCH772984	KPCL	100.0	1000.0
TAK-715	FES	97.0	10000.0
SB590885	CAMK1G	100.0	10000.0
MRT67307	PI42C	87.0	10000.0
CG-930	KPCD3	84.0	10000.0
JNK-IN-5A	ERK5	96.0	10000.0
WZ3105	TAOK1	35.0	10000.0
XMD11-85h	TAOK1	100.0	10000.0
QL-X-138	ICK	67.0	10000.0
TAK-715	NDR1	100.0	10000.0
QL-X-138	MRCKA	97.0	10000.0
QL-X-138	ABL1(Q252H)-phosphorylated	47.0	10000.0
GW843682X	M3K5	87.0	10000.0
Baricitinib	FES	100.0	10000.0
BMX-IN-1	NEK3	100.0	10000.0
XMD16-144	JNK1	91.0	10000.0
Baricitinib	RSK3(Kin.Dom.2-C-terminal)	0.5	10000.0
Torin1	TAOK3	76.0	10000.0
WH-4-023	EPHB2	0.0	10000.0
JNK-IN-11	MK03	100.0	1000.0
KU63794	SBK1	100.0	10000.0
JWE-035	TLK1	74.0	10000.0
ZG-10	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
HG-14-10-04	CSF1R	0.3	10000.0
KU63794	DAPK3	89.0	10000.0
GW-5074	LATS2	81.0	10000.0
A443654	LIMK1	100.0	10000.0
Sigma A6730	AKT2	100.0	10000.0
JNK-IN-11	ROCK1	59.0	1000.0
GW843682X	KIT(A829P)	57.0	10000.0
MPS-1-IN-1	FGFR3(G697C)	100.0	1000.0
XMD8-92	MP2K4	100.0	10000.0
XMD8-92	BLK	100.0	10000.0
CGP74514A	RIPK1	96.0	10000.0
RO-3306	ROS1	100.0	10000.0
NPK76-II-72-1	PIK3CD	100.0	10000.0
ALW-II-49-7	MAP3K4	100.0	10000.0
HG-5-113-01	FGFR2	25.0	10000.0
JNK-9L	FGFR3(G697C)	90.0	10000.0
HG-14-8-02	PIP5K1A	33.0	10000.0
Vemurafenib	PIK4CB	0.7	10000.0
(s)-CR8	MERTK	100.0	10000.0
THZ1	SIK1	10.0	10000.0
QL-XI-92	ABL1(M351T)-phosphorylated	51.0	10000.0
BMX-IN-1	TRKC	100.0	10000.0
KIN001-220	TNIK	45.0	10000.0
BMX-IN-1	EIF2AK1	100.0	10000.0
XMD13-2	IKKA	76.0	10000.0
Dactolisib	PKN2	100.0	1000.0
Taselisib	DRAK2	97.0	1000.0
XMD11-50	ABL1(H396P)-nonphosphorylated	100.0	10000.0
Ibrutinib	GAK	88.0	1000.0
BMX-IN-1	TLK1	96.0	10000.0
ZSTK474	LYN	100.0	1000.0
GSK461364	BLK	100.0	10000.0
XMD8-92	MET(Y1235D)	100.0	10000.0
Canertinib	MYLK	100.0	1000.0
SP600125	AKT3	100.0	10000.0
Buparlisib	VGFR2	100.0	1000.0
Momelotinib	ERBB3	100.0	10000.0
PD173074	TGFBR1	100.0	10000.0
MPS-1-IN-1	ERK8	100.0	1000.0
Dabrafenib	TEC	44.0	10000.0
QL-X-138	MYLK	70.0	10000.0
WZ3105	ANKK1	62.0	10000.0
RO-3306	JAK2(JH1domain-catalytic)	59.0	10000.0
MPS-1-IN-1	CDK7	100.0	1000.0
ALW-II-38-3	KIT(V559D,V654A)	5.8	1000.0
Lapatinib	KIT(D816V)	78.0	10000.0
Abemaciclib	CSNK1A1	93.0	1000.0
AZD 5438	PCTK3	1.2	10000.0
Ribociclib	MAST1	33.0	1000.0
CP724714	ACVRL1	84.0	10000.0
Baricitinib	AXL	11.0	10000.0
Baricitinib	EPHA1	71.0	10000.0
Canertinib	AMPK-alpha2	100.0	1000.0
MLN8054	TAOK1	71.0	10000.0
XMD-12	KPCT	92.0	1000.0
XMD8-85	MAP4K5	100.0	10000.0
JNK-IN-11	SRPK1	90.0	1000.0
Sigma A6730	TXK	87.0	10000.0
Alpelisib	ERK5	100.0	1000.0
Torin2	KPCD2	100.0	10000.0
Taselisib	PIK4CB	86.0	1000.0
Buparlisib	CAMKK2	81.0	1000.0
Momelotinib	PIM2	100.0	10000.0
JWE-035	RET	2.4	10000.0
Ribociclib	CDK15	84.0	1000.0
GW-5074	MYO3B	8.6	10000.0
Seliciclib	CAMK2A	77.0	10000.0
Palbociclib	KIT	100.0	1000.0
TAK-715	MK13	72.0	10000.0
TAK-715	RSK3(Kin.Dom.2-C-terminal)	86.0	10000.0
BS-181	MET	71.0	10000.0
GSK461364	ABL1(H396P)-nonphosphorylated	60.0	10000.0
Sigma A6730	PKMYT1	94.0	10000.0
CGP74514A	DYRK1B	14.0	10000.0
QL-X-138	EGFR(G719C)	100.0	10000.0
XMD8-85	AAK1	100.0	10000.0
BS-181	EPHA4	86.0	10000.0
NU7441	MK12	99.0	10000.0
AS-252424	CDC2L2	100.0	10000.0
XMD8-85	PIM1	100.0	10000.0
Dactolisib	M4K1	100.0	1000.0
JNK-IN-11	LTK	83.0	1000.0
BGJ398	VGFR1	7.8	1000.0
NPK76-II-72-1	FLT3(D835Y)	100.0	10000.0
Neratinib	ADCK4	98.0	10000.0
PLX-4720	EPHA7	99.0	10000.0
AG1478	VGFR1	75.0	10000.0
AZD4547	AKT1	100.0	10000.0
BS-181	JAK1(JH2domain-pseudokinase)	82.0	10000.0
Lapatinib	BRSK1	96.0	10000.0
XMD8-92	NDR2	100.0	10000.0
BS-181	PDPK1	100.0	10000.0
Neratinib	CAMK1	88.0	10000.0
Momelotinib	PHKG2	23.0	10000.0
BMX-IN-1	NEK7	71.0	10000.0
XMD8-92	CAMK2A	100.0	10000.0
WZ4003	KPCD3	12.0	1000.0
PHA-793887	PIK3CA	100.0	10000.0
WYE-125132	LOK	99.0	10000.0
Crizotinib	CDK3	100.0	10000.0
GSK1059615	OSR1	87.0	10000.0
Taselisib	EIF2AK1	100.0	1000.0
Sorafenib	PIK3CA(H1047Y)	94.0	10000.0
Pictilisib	LRRK2(G2019S)	100.0	1000.0
WZ3105	KPCD	83.0	10000.0
PHA-767491	INSR	70.0	10000.0
Ibrutinib	VGFR2	52.0	1000.0
AZD4547	PRKR	63.0	10000.0
SCH772984	MAK	88.0	1000.0
Crizotinib	EPHA6	0.7	10000.0
Alpelisib	FRK	94.0	1000.0
JW-7-24-1	CDK14	100.0	10000.0
NU7441	FLT3	100.0	10000.0
Dinaciclib	ABL1(M351T)-phosphorylated	100.0	10000.0
MLN8054	MYLK	95.0	10000.0
Crizotinib	HIPK4	15.0	10000.0
XMD8-92	PKAC-alpha	100.0	10000.0
OTSSP167	IRAK3	100.0	10000.0
MRT67307	RIOK1	0.6	10000.0
Dabrafenib	PDPK1	100.0	10000.0
AZD4547	SGK2	90.0	10000.0
R406	RET	0.0	1000.0
Buparlisib	ROS1	100.0	1000.0
Baricitinib	AAK1	7.6	10000.0
OTSSP167	EPHB6	2.8	10000.0
JNK-IN-11	HIPK3	100.0	1000.0
ZSTK474	ABL1	100.0	1000.0
BS-181	TYRO3	100.0	10000.0
KIN001-220	CDKL2	24.0	10000.0
CP724714	CSNK1A1L	82.0	10000.0
XMD14-99	ADCK3	93.0	10000.0
Alpelisib	DCLK1	100.0	1000.0
JW-7-24-1	RIPK1	100.0	10000.0
Ceritinib	ABL1(T315I)-phosphorylated	97.0	1000.0
Ibrutinib	DCAMKL2	90.0	1000.0
WYE-125132	EGFR(L861Q)	64.0	10000.0
HG-14-10-04	VGFR1	0.5	10000.0
TAK-715	MLK3	70.0	10000.0
Momelotinib	DYRK2	76.0	10000.0
TAK-715	AMPK-alpha1	81.0	10000.0
XMD13-2	CASK	82.0	10000.0
NVP-TAE684	EGFR(L747-S752del,P753S)	1.0	1000.0
CGP60474	MAP4K2	100.0	10000.0
Ibrutinib	CDK7	86.0	1000.0
Sorafenib	IKKE	100.0	10000.0
Buparlisib	KCC2D	100.0	1000.0
HG-14-8-02	MTOR	93.0	10000.0
CGP74514A	AKT2	90.0	10000.0
ZG-10	FYN	100.0	10000.0
KIN001-220	MP2K7	100.0	10000.0
JNK-IN-8	EPHA4	100.0	1000.0
RO-3306	RSK4(Kin.Dom.2-C-terminal)	65.0	10000.0
AZD7762	TRKC	0.2	10000.0
Lapatinib	LRRK2(G2019S)	100.0	10000.0
Ribociclib	ABL1(Q252H)-phosphorylated	100.0	1000.0
BMS-536924	BMPR1A	100.0	1000.0
BMS345541	LIMK2	100.0	10000.0
Taselisib	MAP4K4	96.0	1000.0
QL-X-138	CDK8	93.0	10000.0
Baricitinib	TYK2(JH2domain-pseudokinase)	41.0	10000.0
HG-9-91-01	WEE2	97.0	10000.0
Buparlisib	MKNK1	100.0	1000.0
PD173074	ACVR1	100.0	10000.0
XMD11-50	ITK	82.0	10000.0
ZSTK474	FLT3	100.0	1000.0
BMX-IN-1	MKNK1	100.0	10000.0
WZ-7043	BRAF(V600E)	100.0	10000.0
BMS-536924	MYLK	12.0	1000.0
WH-4-023	MAP3K1	32.0	10000.0
QL-X-138	TEC	6.0	10000.0
ALW-II-49-7	SRPK1	100.0	10000.0
Abemaciclib	ROCK1	5.2	1000.0
XMD11-85h	FAK1	100.0	10000.0
Momelotinib	YANK1	100.0	10000.0
MPS-1-IN-1	MK09	100.0	1000.0
WZ3105	FAK2	51.0	10000.0
Seliciclib	FLT3-autoinhibited	100.0	10000.0
Pictilisib	CDK7	100.0	1000.0
XMD14-99	DCLK1	3.0	10000.0
ZM-447439	LOK	0.2	10000.0
NVP-TAE684	RIPK1	18.0	1000.0
Crizotinib	CSNK1A1L	100.0	10000.0
XMD8-85	TGFBR1	100.0	10000.0
ALW-II-38-3	TIE1	100.0	10000.0
THZ1	PAK4	4.2	10000.0
CH5424802	CDKL2	96.0	1000.0
HG-5-88-01	PKN2	100.0	10000.0
AZD 5438	KKCC1	21.0	10000.0
XMD8-85	MLK3	100.0	10000.0
AZD-6482	ITK	98.0	10000.0
XMD14-99	ROS1	11.0	10000.0
Torin1	PIP5K2B	100.0	10000.0
Momelotinib	MLCK	68.0	10000.0
XMD-12	ABL1(F317L)-phosphorylated	3.3	1000.0
Baricitinib	SRC	9.4	10000.0
Seliciclib	TTK	10.0	10000.0
JNK-IN-5A	TSSK1	100.0	10000.0
PD0325901	NEK11	91.0	10000.0
MLN8054	AXL	4.4	10000.0
TGX221	MST1	100.0	1000.0
CP466722	SIK1	45.0	10000.0
Omipalisib	CSNK1D	92.0	10000.0
WYE-125132	WNK3	100.0	10000.0
KIN001-123	PHKG2	100.0	1000.0
MPS-1-IN-1	TAOK3	100.0	1000.0
WZ3105	FES	85.0	10000.0
JNK-IN-11	NEK9	100.0	1000.0
Vemurafenib	KIT(A829P)	89.0	10000.0
GSK429286A	M3K5	100.0	10000.0
AG1478	PCTK2	79.0	10000.0
Momelotinib	STK35	57.0	10000.0
TGX221	PAK4	100.0	1000.0
PD0325901	EPHA3	100.0	10000.0
PD0325901	SIK1	100.0	10000.0
XMD11-50	PLK3	51.0	10000.0
Seliciclib	EPHB1	100.0	10000.0
GSK429286A	KIT	90.0	10000.0
AG1478	KPCD3	88.0	10000.0
CH5424802	RPS6KA5(Kin.Dom.1-N-terminal)	97.0	1000.0
AG1478	MLCK	76.0	10000.0
AZD4547	KCC2D	28.0	10000.0
Taselisib	TYRO3	88.0	1000.0
R406	CAMK1	2.8	1000.0
Torin1	RSK1(Kin.Dom.1-N-terminal)	68.0	10000.0
GSK461364	TRKB	68.0	10000.0
JNK-IN-8	DCLK1	100.0	1000.0
Ibrutinib	M3K6	100.0	1000.0
GSK1059615	ALK	25.0	10000.0
A443654	JAK1(Kin.Dom.1)	100.0	10000.0
BMX-IN-1	CDKL1	58.0	10000.0
AZD-6482	CDKL1	100.0	10000.0
AZD-6482	SNARK	84.0	10000.0
Omipalisib	AKT2	100.0	10000.0
Abemaciclib	SYK	100.0	1000.0
BI-2536	FGFR3	100.0	10000.0
SB590885	EPHA5	99.0	10000.0
WZ4003	EPHB1	100.0	1000.0
GW-5074	VGFR2	100.0	10000.0
XMD-12	RSK4(Kin.Dom.2-C-terminal)	63.0	1000.0
KIN001-123	EPHB1	100.0	1000.0
THZ1	EPHA6	5.2	10000.0
Dabrafenib	TBK1	82.0	10000.0
Neratinib	TESK1	100.0	10000.0
JNK-IN-5A	CAMK2B	90.0	10000.0
WZ4002	PLK4	0.2	10000.0
Torkinib	PKNB(M.tuberculosis)	24.0	10000.0
CP724714	LRRK2(G2019S)	98.0	10000.0
Neratinib	PFPK5(P.falciparum)	100.0	10000.0
CG-930	ERK5	90.0	10000.0
R406	CSNK1A1L	100.0	1000.0
Sigma A6730	MP2K5	72.0	10000.0
NPK76-II-72-1	YANK2	100.0	10000.0
GW843682X	RET(M918T)	8.0	10000.0
PD0325901	BRSK2	100.0	10000.0
AS-252424	ABL1(H396P)	84.8	10000.0
AZD7762	MP2K1	0.0	10000.0
PD0325901	FLT3(ITD)	100.0	10000.0
AG1478	GSK3B	90.0	10000.0
MRT67307	WEE1	28.0	10000.0
5z-7-oxozeaenol	PIP5K2B	26.0	10000.0
RO-3306	M3K2	100.0	10000.0
WZ3105	CDK3	95.0	10000.0
Abemaciclib	JAK3(JH1domain-catalytic)	1.8	1000.0
AZD 5438	ERK3	55.0	10000.0
(s)-CR8	PKAC-alpha	93.0	10000.0
XMD13-2	EPHB1	100.0	10000.0
BX-912	MK12	65.0	10000.0
ALW-II-38-3	PAK3	100.0	10000.0
HG-14-8-02	KIT(D816V)	23.0	10000.0
Dactolisib	NDR2	100.0	1000.0
Dabrafenib	EGFR(G719S)	49.0	10000.0
OTSSP167	NEK6	89.0	10000.0
QL-X-138	MAP4K2	9.4	10000.0
R406	JAK1(Kin.Dom.1)	18.0	1000.0
Seliciclib	ANKK1	73.0	10000.0
CGP60474	MK13	100.0	10000.0
QL-X-138	CAMKK2	49.0	10000.0
QL-X-138	MERTK	100.0	10000.0
JWE-035	MK13	100.0	10000.0
HG-9-91-01	ADCK3	22.0	10000.0
BGJ398	PFPK5(P.falciparum)	79.0	1000.0
KIN001-021	HCK	100.0	1000.0
HG-9-91-01	PIK3CA(E545K)	100.0	10000.0
XMD13-2	NEK4	100.0	10000.0
Canertinib	CHEK1	100.0	1000.0
JNK-IN-8	JAK2(JH1domain-catalytic)	100.0	1000.0
JNK-IN-8	PIK3CG	100.0	1000.0
GW-5074	NEK4	93.0	10000.0
BMS-536924	EGFR(G719S)	5.8	1000.0
JWE-035	KCC2D	69.0	10000.0
JNK-9L	LTK	77.0	10000.0
CP724714	STK39	100.0	10000.0
QL-XI-92	KIT(D816H)	75.0	10000.0
Baricitinib	MAP4K2	28.0	10000.0
BGJ398	MP2K2	77.0	1000.0
AZD4547	MYLK4	55.0	10000.0
JNK-IN-8	MTOR	100.0	1000.0
HG-14-10-04	ROS1	0.0	10000.0
Palbociclib	PIK3CD	68.0	1000.0
AG1478	EIF2AK1	65.0	10000.0
AG1478	PIK3CA(C420R)	60.0	10000.0
GW843682X	INSR	84.0	10000.0
HG-5-88-01	ULK2	100.0	10000.0
5z-7-oxozeaenol	MAPKAPK5	47.0	10000.0
Omipalisib	RSK4(Kin.Dom.1-N-terminal)	78.0	10000.0
NU7441	STK39	100.0	10000.0
THZ1	PIK3CA(M1043I)	100.0	10000.0
JW-7-24-1	YSK1	100.0	10000.0
Baricitinib	VGFR1	82.0	10000.0
HG-5-113-01	RAF1	100.0	10000.0
Alpelisib	PKAC-alpha	90.0	1000.0
Ibrutinib	PFPK5(P.falciparum)	100.0	1000.0
WYE-125132	CDC2L5	84.0	10000.0
ZM-447439	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
XMD8-92	CIT	100.0	10000.0
KIN001-021	DRAK1	100.0	1000.0
HG-14-8-02	LIMK1	100.0	10000.0
XMD16-144	ABL2	1.4	10000.0
MRT67307	RIPK2	100.0	10000.0
WZ3105	HIPK3	26.0	10000.0
MPS-1-IN-1	FES	100.0	1000.0
XMD13-2	LYN	83.0	10000.0
Buparlisib	ALK(C1156Y)	100.0	1000.0
Pictilisib	GAK	100.0	1000.0
Sigma A6730	MST1R	100.0	10000.0
MLN8054	SRC	2.6	10000.0
AZD 5438	CLK1	2.0	10000.0
Buparlisib	FLT3-autoinhibited	100.0	1000.0
AG1478	RET(V804L)	100.0	10000.0
CG-930	FLT3(D835Y)	100.0	10000.0
Omipalisib	TGFBR2	100.0	10000.0
HG-14-10-04	PHKG2	2.2	10000.0
Buparlisib	PIK3CA(M1043I)	4.7	1000.0
THZ1	MK01	73.0	10000.0
BMS345541	DMPK	100.0	10000.0
BX-912	GSK3A	60.0	10000.0
BMX-IN-1	ABL1(F317L)-phosphorylated	100.0	10000.0
QL-XII-47	JAK1(JH2domain-pseudokinase)	100.0	1000.0
NPK76-II-72-1	AURKC	100.0	10000.0
AZD4547	PFPK5(P.falciparum)	100.0	10000.0
XMD11-50	TYK2(JH2domain-pseudokinase)	100.0	10000.0
CP466722	MAK	100.0	10000.0
Sigma A6730	EGFR(L858R,T790M)	100.0	10000.0
CP724714	YANK3	86.0	10000.0
AZ-628	NDR2	100.0	10000.0
PHA-767491	KPCL	6.4	10000.0
NG25	JAK1(Kin.Dom.2)	9.4	10000.0
Ribociclib	HIPK1	74.0	1000.0
MPS-1-IN-1	NEK5	100.0	1000.0
GSK429286A	RSK4(Kin.Dom.2-C-terminal)	85.0	10000.0
CGP74514A	ULK2	0.2	10000.0
BX-912	EGFR(G719S)	51.0	10000.0
BI-2536	MAP4K2	100.0	10000.0
Taselisib	LIMK2	100.0	1000.0
CGP60474	EPHB1	100.0	10000.0
XMD-12	CLK4	100.0	1000.0
QL-XII-47	MYLK	100.0	1000.0
BS-181	WNK3	86.0	10000.0
PD0325901	DMPK	90.0	10000.0
BX-912	AKT3	100.0	10000.0
MLN8054	JAK2(JH1domain-catalytic)	100.0	10000.0
AZ-628	FLT3	61.0	10000.0
PHA-793887	GRK1	13.0	10000.0
THZ1	MLK3	0.1	10000.0
JNK-IN-11	MAPKAPK2	84.0	1000.0
AZD4547	MP2K1	36.0	10000.0
XMD-12	STK16	59.0	1000.0
KIN001-220	PHKG2	42.0	10000.0
GSK1059615	FLT3(K663Q)	37.0	10000.0
KIN001-123	PIM2	100.0	1000.0
CGP60474	BMPR1A	100.0	10000.0
Dabrafenib	CAMK1	8.6	10000.0
HG-5-88-01	CDKL2	100.0	10000.0
HG-5-113-01	EGFR(L747-E749del,A750P)	100.0	10000.0
HG-14-10-04	FGFR2	5.2	10000.0
KIN001-021	FGR	100.0	1000.0
ZSTK474	BRSK2	100.0	1000.0
AZD 5438	SYK	15.0	10000.0
Torin2	MAP3K15	100.0	10000.0
CH5424802	DCAMKL2	94.0	1000.0
A443654	ROS1	100.0	10000.0
NPK76-II-72-1	ACVRL1	100.0	10000.0
BMX-IN-1	CDK3	100.0	10000.0
AZD4547	RET(V804L)	0.3	10000.0
Dinaciclib	KC1G2	100.0	10000.0
RO-3306	JAK3(JH1domain-catalytic)	20.0	10000.0
Sorafenib	MP2K2	86.0	10000.0
WH-4-023	PIM2	100.0	10000.0
THZ1	RPS6KA4(Kin.Dom.1-N-terminal)	17.0	10000.0
Alpelisib	DYRK1A	91.0	1000.0
AZD-6482	MELK	100.0	10000.0
PD0325901	STK16	99.0	10000.0
PHA-767491	ERK3	96.0	10000.0
Palbociclib	WNK1	100.0	1000.0
CGP60474	PIK3CB	100.0	10000.0
Alpelisib	PAK1	100.0	1000.0
ERK5-IN-1	PTK6	62.0	1000.0
QL-X-138	PAK7	95.0	10000.0
PD173074	AURKC	100.0	10000.0
Dinaciclib	FRK	76.0	10000.0
(s)-CR8	KPCD3	91.0	10000.0
WZ-4-145	CSNK1E	100.0	10000.0
MRT67307	CIT	0.0	10000.0
Sigma A6730	VRK2	76.0	10000.0
BMX-IN-1	ERK3	100.0	10000.0
CP724714	EGFR(L858R,T790M)	100.0	10000.0
BS-181	RIPK5	65.0	10000.0
TGX221	TRKA	100.0	1000.0
NU7441	STK35	80.0	10000.0
QL-XII-47	FAK2	100.0	1000.0
HG-14-10-04	STK16	0.2	10000.0
KIN001-220	LCK	6.6	10000.0
Abemaciclib	TSSK1	80.0	1000.0
PD173074	MET	100.0	10000.0
ALW-II-38-3	SNARK	100.0	10000.0
KIN001-123	MKNK1	100.0	1000.0
XMD8-85	HIPK1	100.0	10000.0
Alpelisib	TNNI3K	100.0	1000.0
ALW-II-38-3	MRCKB	100.0	10000.0
Neratinib	MP2K2	0.5	10000.0
OTSSP167	BMPR2	0.8	10000.0
Barasertib	FLT4	38.0	10000.0
Neratinib	CAMK2A	90.0	10000.0
KIN001-220	YES	60.0	10000.0
AG1478	ABL1(F317I)-nonphosphorylated	18.0	10000.0
JNK-IN-5A	PAK6	88.0	10000.0
MLN8054	EGFR(E746-A750del)	28.0	10000.0
AG1478	S6K1	63.0	10000.0
AS-252424	EGFR(G719C)	19.2	10000.0
PHA-767491	FLT3(ITD)	60.0	10000.0
WYE-125132	FLT3(R834Q)	79.0	10000.0
Abemaciclib	FGFR1	100.0	1000.0
Omipalisib	EPHB4	75.0	10000.0
PD0325901	EPHA1	91.0	10000.0
BI-2536	TAK1	100.0	10000.0
JNK-IN-8	FAK1	11.0	1000.0
JNK-IN-11	ABL1(Q252H)-nonphosphorylated	5.4	1000.0
JNK-IN-11	PKAC-alpha	99.0	1000.0
PHA-793887	EPHB2	74.0	10000.0
KIN001-220	TLK2	33.0	10000.0
Buparlisib	RIPK5	100.0	1000.0
WH-4-023	FLT3(K663Q)	3.4	10000.0
Sigma A6730	EGFR(S752-I759del)	58.0	10000.0
ZM-447439	ACVR1B	100.0	10000.0
Abemaciclib	TSSK3	82.0	1000.0
THZ1	SRPK3	3.8	10000.0
Dactolisib	YSK1	100.0	1000.0
Buparlisib	ERK5	97.0	1000.0
Ribociclib	IKKB	100.0	1000.0
HG-6-64-01	PIP5K1A	2.6	10000.0
BX-912	IRAK1	0.3	10000.0
SB590885	EGFR(G719S)	70.0	10000.0
AZD-6482	KIT(A829P)	100.0	10000.0
Abemaciclib	FGFR4	100.0	1000.0
KIN001-127	AMPK-alpha2	100.0	10000.0
AZD 5438	RET(V804M)	59.0	10000.0
KIN001-021	ERK3	100.0	1000.0
CP466722	KIT(A829P)	33.0	10000.0
KIN001-127	TNK1	100.0	10000.0
Torin2	CSK	100.0	10000.0
JWE-035	FAK2	96.0	10000.0
HG-5-113-01	MET	1.0	10000.0
Seliciclib	CASK	86.0	10000.0
Barasertib	CSNK1G3	100.0	10000.0
Dactolisib	SRPK2	100.0	1000.0
Sigma A6730	ABL1(Y253F)-phosphorylated	72.0	10000.0
JNK-IN-5A	PKMYT1	77.0	10000.0
XMD16-144	PLK3	72.0	10000.0
JWE-035	ABL1(F317L)-nonphosphorylated	0.2	10000.0
KIN001-127	FAK1	100.0	10000.0
(s)-CR8	MP2K2	94.0	10000.0
Momelotinib	PAK3	73.0	10000.0
JNK-9L	LKB1	11.0	10000.0
JNK-IN-11	HIPK2	97.0	1000.0
BGJ398	SRC	56.0	1000.0
Ibrutinib	PIK3CB	59.0	1000.0
GSK429286A	MARK3	100.0	10000.0
AZD4547	EGFR(L747-S752del,P753S)	93.0	10000.0
Torkinib	KPCD2	100.0	10000.0
ZG-10	NEK6	2.8	10000.0
JNK-IN-11	DAPK3	93.0	1000.0
Baricitinib	KIT-autoinhibited	100.0	10000.0
Buparlisib	RSK3(Kin.Dom.2-C-terminal)	62.0	1000.0
ERK5-IN-1	ADCK4	100.0	1000.0
GW843682X	CDC2L1	100.0	10000.0
HG-14-8-02	PKN2	75.0	10000.0
Baricitinib	AURKB	29.0	10000.0
HG-5-113-01	MLCK	100.0	10000.0
NVP-TAE684	DYRK1B	100.0	1000.0
NG25	LYN	0.8	10000.0
RO-3306	LTK	100.0	10000.0
JNK-9L	LYN	78.0	10000.0
TGX221	WEE2	100.0	1000.0
NU7441	JAK1(JH1domain-catalytic)	100.0	10000.0
TAK-715	KCC2D	100.0	10000.0
AZD7762	PLK4	0.0	10000.0
PLX-4720	LOK	68.0	10000.0
Ibrutinib	KPCT	100.0	1000.0
(s)-CR8	LYN	98.0	10000.0
ZM-447439	PRKR	100.0	10000.0
Ribociclib	EPHB2	99.0	1000.0
XMD13-2	PIK3CA(E542K)	100.0	10000.0
GW843682X	RSK3(Kin.Dom.2-C-terminal)	74.0	10000.0
Baricitinib	ACVR2A	82.0	10000.0
RO-3306	ABL1(Y253F)-phosphorylated	94.0	10000.0
WH-4-023	RSK1(Kin.Dom.2-C-terminal)	65.0	10000.0
AZ-628	NEK4	89.0	10000.0
AZ-628	MLK1	94.0	10000.0
XMD14-99	PRKX	93.0	10000.0
HG-9-91-01	PIK3CA(E542K)	100.0	10000.0
5z-7-oxozeaenol	CSNK1A1L	88.0	10000.0
KIN001-127	EGFR(E746-A750del)	100.0	10000.0
Ribociclib	MKNK1	100.0	1000.0
NPK76-II-72-1	DAPK3	17.0	10000.0
QL-XI-92	M3K2	100.0	10000.0
MLN8054	NEK3	100.0	10000.0
Neratinib	PKNB(M.tuberculosis)	100.0	10000.0
Baricitinib	MRCKB	81.0	10000.0
Pictilisib	MK03	100.0	1000.0
QL-XI-92	HIPK2	86.0	10000.0
KIN001-127	RET(V804L)	100.0	10000.0
(s)-CR8	PIP5K2B	75.0	10000.0
JNK-IN-5A	RIPK4	96.0	10000.0
Pictilisib	CAMK2B	87.0	1000.0
Sigma A6730	SGK3	75.0	10000.0
KIN001-127	AKT3	100.0	10000.0
QL-XII-47	PHKG2	98.0	1000.0
XMD8-92	KIT(V559D,T670I)	100.0	10000.0
WZ3105	MLK3	24.0	10000.0
SB590885	LCK	29.0	10000.0
GSK461364	FLT3(R834Q)	20.0	10000.0
Seliciclib	TEC	100.0	10000.0
AZD7762	FAK2	0.6	10000.0
AG1478	OSR1	71.0	10000.0
Palbociclib	LOK	97.0	1000.0
GW-5074	BTK	99.0	10000.0
SCH772984	DYRK1B	66.0	1000.0
XMD11-50	ABL1-nonphosphorylated	100.0	10000.0
KIN001-123	KC1G1	100.0	1000.0
KIN001-127	CAMK1	100.0	10000.0
BMX-IN-1	KPCD3	68.0	10000.0
PHA-793887	HIPK2	94.0	10000.0
QL-XII-47	WNK3	100.0	1000.0
AZD 5438	EPHB1	21.0	10000.0
KIN001-127	MAPKAPK5	100.0	10000.0
Ceritinib	WNK4	96.0	1000.0
HG-14-10-04	CSNK2A1	0.2	10000.0
Baricitinib	TLK2	29.0	10000.0
KIN001-111	CSNK1E	0.3	1000.0
AS-252424	PIK3CA(H1047R)	5.7	10000.0
AZD7762	CDK2	93.0	10000.0
GW843682X	CDK15	69.0	10000.0
ZG-10	CAMK2B	60.0	10000.0
GW-5074	FGFR3	84.0	10000.0
Ibrutinib	FLT3	18.0	1000.0
ZM-447439	RET(V804L)	9.6	10000.0
AZD4547	MAST1	51.0	10000.0
XMD11-50	NEK5	100.0	10000.0
KIN001-111	IRAK3	100.0	1000.0
XMD-12	CAMK1	100.0	1000.0
XMD8-85	M3K13	100.0	10000.0
NPK76-II-72-1	ULK2	100.0	10000.0
JNK-9L	MP2K5	8.6	10000.0
GSK461364	NEK2	2.4	10000.0
Crizotinib	NUAK1	0.7	10000.0
Buparlisib	EGFR(G719C)	94.0	1000.0
WZ3105	PKAC-beta	100.0	10000.0
R406	CSNK1E	100.0	1000.0
QL-X-138	NEK4	83.0	10000.0
PHA-767491	KCC4	100.0	10000.0
WZ-4-145	KPCD	100.0	10000.0
ZM-447439	DAPK3	100.0	10000.0
GSK461364	MK14	100.0	10000.0
Buparlisib	ABL1(F317I)-phosphorylated	100.0	1000.0
JNK-IN-11	PKMYT1	100.0	1000.0
HG-9-91-01	CSNK1E	1.0	10000.0
Momelotinib	SRPK3	18.0	10000.0
GW-5074	ERBB3	87.0	10000.0
AZ-628	PIK3CG	99.0	10000.0
CGP74514A	MP2K4	78.0	10000.0
Ibrutinib	CDK9	90.0	1000.0
Neratinib	KPCL	100.0	10000.0
CP724714	PIK3CA(E545A)	33.0	10000.0
Barasertib	PHKG1	35.0	10000.0
(s)-CR8	DMPK2	78.0	10000.0
Baricitinib	MYO3A	88.0	10000.0
AZD-6482	MARK4	100.0	10000.0
CGP60474	CDK11	100.0	10000.0
PHA-793887	LOK	100.0	10000.0
BI-2536	ERK8	100.0	10000.0
Dabrafenib	ABL1(F317I)-nonphosphorylated	30.0	10000.0
OTSSP167	CDKL3	0.2	10000.0
WYE-125132	CSF1R	100.0	10000.0
Crizotinib	ROCK1	4.0	10000.0
XMD14-99	GRK1	100.0	10000.0
AZD 5438	STK35	15.0	10000.0
ZSTK474	BTK	100.0	1000.0
Pictilisib	SIK3	100.0	1000.0
Dabrafenib	WEE2	64.0	10000.0
HG-5-113-01	DYRK1B	8.8	10000.0
ZG-10	KKCC1	52.0	10000.0
XMD14-99	MUSK	90.0	10000.0
THZ1	KPCD	8.0	10000.0
NU7441	ABL1(T315I)-nonphosphorylated	100.0	10000.0
Omipalisib	FRK	68.0	10000.0
JNK-IN-5A	MET(M1250T)	100.0	10000.0
KIN001-220	GSK3A	88.0	10000.0
HG-6-64-01	KIT(D816V)	0.7	10000.0
AS-252424	INSR	95.9	10000.0
ZG-10	PIK3CA(H1047L)	100.0	10000.0
Alpelisib	MYLK	100.0	1000.0
Barasertib	CDK2	84.0	10000.0
JNK-IN-11	TIE2	67.0	1000.0
KIN001-127	INSR	5.1	10000.0
AZD-6482	FGFR1	89.0	10000.0
THZ1	VRK2	100.0	10000.0
JNK-IN-8	EPHA5	100.0	1000.0
Neratinib	PLK2	85.0	10000.0
Ibrutinib	ABL1(H396P)-phosphorylated	87.0	1000.0
WYE-125132	RET	91.0	10000.0
BI-D1870	GSK3B	27.0	10000.0
GSK1059615	PFCDPK1(P.falciparum)	11.0	10000.0
BMX-IN-1	CDC2L1	99.0	10000.0
NU7441	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
NU7441	ANKK1	100.0	10000.0
BX-912	ANKK1	4.3	10000.0
Canertinib	ABL1(H396P)	100.0	1000.0
BMX-IN-1	DRAK1	100.0	10000.0
Lapatinib	DYRK1A	91.0	10000.0
CGP74514A	NLK	49.0	10000.0
BGJ398	NEK11	67.0	1000.0
WZ4003	FGFR4	100.0	1000.0
QL-XII-47	CIT	89.0	1000.0
XMD11-85h	MKNK1	100.0	10000.0
BI-2536	FGFR1	100.0	10000.0
Taselisib	FLT3(N841I)	100.0	1000.0
Ceritinib	PIM2	100.0	1000.0
Lapatinib	CDK7	70.0	10000.0
(s)-CR8	PIM2	88.0	10000.0
WZ4003	CDK7	30.0	1000.0
XMD-12	CDK5	100.0	1000.0
JNK-IN-5A	AURKA	100.0	10000.0
QL-XI-92	ERBB2	100.0	10000.0
BGJ398	CDK3	95.0	1000.0
Sorafenib	ABL1(E255K)-phosphorylated	47.0	10000.0
Momelotinib	PTK6	100.0	10000.0
CP724714	EGFR(L747-E749del,A750P)	3.3	10000.0
Alpelisib	MP2K6	100.0	1000.0
XMD11-50	ABL1(F317I)-phosphorylated	17.0	10000.0
Alpelisib	M4K3	94.0	1000.0
HG-14-10-04	MK12	86.0	10000.0
BMS345541	HUNK	100.0	10000.0
PHA-767491	NEK2	93.0	10000.0
KIN001-123	VGFR2	20.0	1000.0
Sigma A6730	DYRK1A	90.0	10000.0
SP600125	EPHA6	100.0	10000.0
Palbociclib	PDPK1	82.0	1000.0
WZ-7043	DYRK1B	100.0	10000.0
ZSTK474	NDR2	100.0	1000.0
Palbociclib	KPCD3	87.0	1000.0
WZ-4-145	DMPK2	100.0	10000.0
AZD 5438	DRAK2	0.0	10000.0
CH5424802	RSK4(Kin.Dom.1-N-terminal)	59.0	1000.0
CGP60474	KC1G2	100.0	10000.0
BMS-536924	KCC2D	100.0	1000.0
HG-9-91-01	CLK2	78.0	10000.0
JNK-9L	S6K1	52.0	10000.0
JWE-035	TSSK1	49.0	10000.0
GW843682X	TEC	94.0	10000.0
XMD11-85h	PIK3C2G	100.0	10000.0
BMS345541	ACVR2B	100.0	10000.0
SP600125	AURKB	100.0	10000.0
AZD4547	DCAMKL2	0.8	10000.0
KIN001-123	KC1G2	100.0	1000.0
CG-930	TGFBR1	100.0	10000.0
BGJ398	SBK1	100.0	1000.0
GW-5074	MKNK1	83.0	10000.0
Momelotinib	SBK1	46.0	10000.0
AZD4547	MST1R	100.0	10000.0
Alpelisib	LOK	90.0	1000.0
WH-4-023	MUSK	43.0	10000.0
QL-XII-47	RPS6KA5(Kin.Dom.1-N-terminal)	96.0	1000.0
Sigma A6730	TNNI3K	100.0	10000.0
JNK-9L	ERK8	2.0	10000.0
Ribociclib	KIT(V559D)	100.0	1000.0
AZD4547	ABL1(H396P)-nonphosphorylated	0.1	10000.0
QL-XII-47	MRCKA	100.0	1000.0
Torin2	CHEK1	86.0	10000.0
GW-5074	OSR1	100.0	10000.0
XMD8-92	DAPK3	100.0	10000.0
THZ1	CTK	100.0	10000.0
TGX221	EGFR(L861Q)	100.0	1000.0
JNK-IN-11	MST2	99.0	1000.0
PLX-4720	WEE2	100.0	10000.0
Ribociclib	RIOK2	100.0	1000.0
XMD11-85h	CDC2L2	100.0	10000.0
Taselisib	YANK2	93.0	1000.0
XMD11-50	STK35	100.0	10000.0
WZ4003	RIOK1	19.0	1000.0
PLX-4720	MRCKA	96.0	10000.0
KIN001-127	DAPK1	100.0	10000.0
CP466722	FLT3(N841I)	0.4	10000.0
XMD14-99	CHK2	100.0	10000.0
ALW-II-49-7	PLK4	100.0	10000.0
CP724714	VGFR2	100.0	10000.0
CP724714	TLK2	100.0	10000.0
Sigma A6730	MAP3K3	83.0	10000.0
KIN001-123	CLK2	100.0	1000.0
Omipalisib	PFPK5(P.falciparum)	100.0	10000.0
Torin1	CSNK1E	59.0	10000.0
Alpelisib	PIK3C3	88.0	1000.0
BMS345541	TAK1	100.0	10000.0
JWE-035	CIT	99.0	10000.0
XMD11-50	FGFR2	95.0	10000.0
QL-X-138	PAK1	100.0	10000.0
R406	TEC	1.4	1000.0
KIN001-127	RPS6KA4(Kin.Dom.1)	100.0	10000.0
AZ-628	MK01	100.0	10000.0
ERK5-IN-1	RSK1(Kin.Dom.2-C-terminal)	88.0	1000.0
A443654	VGFR1	100.0	10000.0
GSK461364	MP2K5	43.0	10000.0
KIN001-123	ABL1(H396P)	100.0	1000.0
PHA-793887	KIT(L576P)	87.0	10000.0
PHA-793887	CDK16	0.2	10000.0
Canertinib	RPS6KA4(Kin.Dom.1)	100.0	1000.0
JNK-IN-11	FRK	32.0	1000.0
BGJ398	PAK3	68.0	1000.0
ZG-10	ABL1(H396P)-nonphosphorylated	15.0	10000.0
Sigma A6730	TYK2(JH2domain-pseudokinase)	66.0	10000.0
XMD8-85	SRPK2	100.0	10000.0
Buparlisib	YES	100.0	1000.0
ZM-447439	NDR2	100.0	10000.0
KIN001-123	TNK2	100.0	1000.0
WZ-4-145	PKN2	100.0	10000.0
Ibrutinib	RIPK1	100.0	1000.0
JNK-IN-8	TLK2	100.0	1000.0
ZSTK474	JNK1	100.0	1000.0
ALW-II-49-7	PTK6	100.0	10000.0
MLN8054	PIK3CA	100.0	10000.0
Torin2	JNK1	60.0	10000.0
CG-930	JNK3	0.0	10000.0
JWE-035	MET(Y1235D)	86.0	10000.0
Dinaciclib	MARK3	65.0	10000.0
BS-181	PI42C	86.0	10000.0
Sigma A6730	ABL1(F317L)-nonphosphorylated	100.0	10000.0
CG-930	HIPK1	93.0	10000.0
PHA-767491	ROS1	44.0	10000.0
CGP60474	IKKE	100.0	10000.0
PD0325901	RSK2(Kin.Dom.2-C-terminal)	100.0	10000.0
BMX-IN-1	EGFR(L747-E749del,A750P)	32.0	10000.0
CGP74514A	MET(M1250T)	51.0	10000.0
HG-14-10-04	FLT3(N841I)	0.0	10000.0
ERK5-IN-1	MET(Y1235D)	100.0	1000.0
AZD7762	DCAMKL2	2.4	10000.0
WYE-125132	MAP4K5	83.0	10000.0
Ceritinib	RSK2(Kin.Dom.2-C-terminal)	12.0	1000.0
SP600125	MAP3K4	100.0	10000.0
Momelotinib	DYRK1B	90.0	10000.0
KIN001-123	ADCK4	100.0	1000.0
Vemurafenib	PIK3CG	19.0	10000.0
AZD7762	NEK4	22.0	10000.0
GSK461364	CDKL1	75.0	10000.0
AZ-628	MARK3	89.0	10000.0
R406	GAK	5.9	1000.0
TGX221	KPCD3	100.0	1000.0
JNK-IN-11	SLK	18.0	1000.0
PLX-4720	PI42C	100.0	10000.0
Ceritinib	MST4	84.0	1000.0
AZD 5438	CDK5	0.8	10000.0
CH5424802	KIT(D816H)	51.0	1000.0
BMX-IN-1	ACVR1	59.0	10000.0
BMS-536924	LIMK2	100.0	1000.0
(s)-CR8	MINK	99.0	10000.0
Seliciclib	ABL1(F317L)-nonphosphorylated	100.0	10000.0
ERK5-IN-1	BMPR1B	100.0	1000.0
TAK-715	CDK8	88.0	10000.0
ZM-447439	ABL1(T315I)-phosphorylated	18.0	10000.0
BS-181	CSNK1A1L	0.6	10000.0
PHA-767491	FLT3-autoinhibited	100.0	10000.0
JNK-IN-8	AKT2	100.0	1000.0
PD0325901	EGFR(E746-A750del)	84.0	10000.0
AG1478	FGFR3(G697C)	100.0	10000.0
Dabrafenib	TAK1	19.0	10000.0
KIN001-021	MAP3K3	100.0	1000.0
WZ3105	ROS1	99.0	10000.0
Buparlisib	NEK9	100.0	1000.0
JNK-9L	RSK3(Kin.Dom.2-C-terminal)	75.0	10000.0
Ribociclib	MK01	100.0	1000.0
Alpelisib	FLT3(ITD,D835V)	97.0	1000.0
HG-14-8-02	MAP3K3	97.0	10000.0
MRT67307	GAK	4.4	10000.0
Dabrafenib	RPS6KA5(Kin.Dom.1-N-terminal)	96.0	10000.0
CGP74514A	SgK110	18.0	10000.0
CGP74514A	TGFBR2	88.0	10000.0
ALW-II-38-3	KIT(V559D)	0.1	1000.0
Vemurafenib	ACVR1	100.0	10000.0
JW-7-24-1	MLK2	23.0	10000.0
Baricitinib	MP2K5	13.0	10000.0
XMD16-144	RSK4(Kin.Dom.2-C-terminal)	0.6	10000.0
Taselisib	HUNK	100.0	1000.0
KIN001-123	PGFRB	20.0	1000.0
BMS345541	CLK3	47.0	10000.0
Ibrutinib	PRKR	95.0	1000.0
Dactolisib	M3K13	100.0	1000.0
NPK76-II-72-1	TYK2(Kin.Dom.2)	100.0	10000.0
GW-5074	PAK3	100.0	10000.0
HG-14-10-04	DCAMKL3	0.7	10000.0
ALW-II-38-3	PKAC-beta	100.0	10000.0
BX-912	DMPK	9.1	10000.0
Buparlisib	EPHB2	100.0	1000.0
WZ3105	YANK2	100.0	10000.0
Buparlisib	AURKA	100.0	1000.0
AZ-628	TNK2	100.0	10000.0
A443654	MST3	100.0	10000.0
ZM-447439	PRKX	81.0	10000.0
NU7441	DAPK2	90.0	10000.0
Pictilisib	TLK1	71.0	1000.0
R406	PKAC-alpha	1.8	1000.0
MLN8054	TAOK3	95.0	10000.0
ALW-II-38-3	KPCL	100.0	10000.0
Sorafenib	PAK3	40.0	10000.0
TAK-715	JAK2(JH1domain-catalytic)	100.0	10000.0
ZG-10	JAK3(JH1domain-catalytic)	10.0	10000.0
KIN001-127	CAMK2G	100.0	10000.0
WZ-4-145	BMPR1B	100.0	10000.0
TGX221	MET	100.0	1000.0
OTSSP167	FLT3(N841I)	100.0	10000.0
A443654	AKT1	1.8	10000.0
Ribociclib	NIM1	100.0	1000.0
Neratinib	GRK1	84.0	10000.0
Buparlisib	WEE1	62.0	1000.0
XMD11-50	SIK3	100.0	10000.0
ERK5-IN-1	SRC	100.0	1000.0
Ceritinib	CAMK1B	0.0	1000.0
XMD13-2	DYRK1A	98.0	10000.0
PLX-4720	LTK	34.0	10000.0
XMD13-2	PRP4	53.0	10000.0
R406	STK33	1.6	1000.0
QL-XII-47	ABL1-nonphosphorylated	45.0	1000.0
AZD7762	TNK1	1.4	10000.0
PHA-793887	BMPR1A	100.0	10000.0
KIN001-123	PKAC-beta	100.0	1000.0
Alpelisib	MINK	89.0	1000.0
GSK461364	KGP1	100.0	10000.0
Buparlisib	ABL2	100.0	1000.0
AZD-6482	TIE1	100.0	10000.0
HG-14-10-04	TRPM6	100.0	10000.0
KIN001-111	FGFR3(G697C)	100.0	1000.0
(s)-CR8	CDK16	97.0	10000.0
Sigma A6730	NLK	87.0	10000.0
TAK-715	LATS2	90.0	10000.0
XMD11-85h	CDC2L1	100.0	10000.0
OTSSP167	PIP5K1C	95.0	10000.0
Torkinib	TNK1	34.0	10000.0
JWE-035	AAK1	36.0	10000.0
QL-XI-92	EGFR(G719S)	100.0	10000.0
HG-5-113-01	DMPK	10.0	10000.0
(s)-CR8	MLCK	94.0	10000.0
CH5424802	ROCK2	100.0	1000.0
ALW-II-49-7	MYO3A	100.0	10000.0
Buparlisib	CSNK1A1L	100.0	1000.0
XMD13-2	PCTK2	37.0	10000.0
BX-912	MST4	0.4	10000.0
NPK76-II-72-1	FGFR3	100.0	10000.0
QL-X-138	CASK	58.0	10000.0
ZSTK474	STK35	100.0	1000.0
MLN8054	LATS1	98.0	10000.0
CG-930	EPHB1	96.0	10000.0
HG-5-113-01	CIT	100.0	10000.0
NPK76-II-72-1	ABL1	100.0	10000.0
JNK-IN-5A	PRKR	100.0	10000.0
JNK-IN-11	ULK1	87.0	1000.0
RO-3306	EPHA8	69.0	10000.0
THZ1	PIK4CB	21.0	10000.0
WZ3105	ULK2	2.0	10000.0
CGP74514A	ABL1(F317L)-nonphosphorylated	23.0	10000.0
CG-930	KIT(D816H)	94.0	10000.0
JNK-IN-8	MP2K2	91.0	1000.0
Baricitinib	LKB1	6.9	10000.0
WZ4002	BTK	0.1	10000.0
SP600125	CAMK2A	100.0	10000.0
AZD-6482	CDK14	100.0	10000.0
SB590885	EGFR	95.0	10000.0
AS-252424	KPCL	100.0	10000.0
NPK76-II-72-1	KC1G1	100.0	10000.0
XMD-12	MST4	27.0	1000.0
PD173074	FGFR1	0.4	10000.0
XMD8-85	PHKG1	100.0	10000.0
Pictilisib	ABL1(M351T)-phosphorylated	100.0	1000.0
WZ4002	SNARK	0.3	10000.0
THZ1	JAK3(JH1domain-catalytic)	0.7	10000.0
KU63794	AAK1	93.0	10000.0
GW-5074	ABL1(Q252H)-nonphosphorylated	38.0	10000.0
HG-6-64-01	NEK6	100.0	10000.0
Neratinib	MELK	55.0	10000.0
WZ-7043	PAK3	100.0	10000.0
JNK-IN-11	M3K13	100.0	1000.0
HG-5-88-01	RET(V804L)	100.0	10000.0
Palbociclib	EGFR(G719C)	98.0	1000.0
Crizotinib	MERTK	2.1	10000.0
Sigma A6730	TYK2(JH1domain-catalytic)	66.0	10000.0
Torin1	KIT(A829P)	93.0	10000.0
Baricitinib	DAPK2	0.5	10000.0
NG25	HCK	0.9	10000.0
KIN001-111	SgK110	100.0	1000.0
MLN8054	NEK11	100.0	10000.0
Dactolisib	MET(Y1235D)	100.0	1000.0
Ribociclib	MP2K5	79.0	1000.0
Ribociclib	FLT3-autoinhibited	100.0	1000.0
BX-912	MARK3	0.3	10000.0
PLX-4720	NUAK1	100.0	10000.0
A443654	EGFR(G719C)	100.0	10000.0
NPK76-II-72-1	MP2K4	100.0	10000.0
JNK-IN-8	FGFR2	79.0	1000.0
Baricitinib	FLT3(N841I)	15.0	10000.0
THZ1	HCK	34.0	10000.0
XMD11-50	TYRO3	100.0	10000.0
Alpelisib	PIK3CB	0.0	1000.0
NG25	EGFR(E746-A750del)	8.4	10000.0
SB590885	STK39	100.0	10000.0
XMD16-144	GSK3B	82.0	10000.0
PD0325901	MP2K2	0.2	10000.0
BX-912	IGF1R	17.0	10000.0
XMD-12	TIE2	72.0	1000.0
SP600125	ABL1(F317L)	100.0	10000.0
AZD 5438	KIT	23.0	10000.0
Abemaciclib	TNIK	70.0	1000.0
BMS-536924	PAK4	5.2	1000.0
CP724714	SRPK3	100.0	10000.0
Torin1	SGK3	100.0	10000.0
TGX221	FES	100.0	1000.0
WYE-125132	FER	100.0	10000.0
Torkinib	ERBB4	49.0	10000.0
Pictilisib	M3K12	100.0	1000.0
WZ4003	MP2K3	100.0	1000.0
JNK-IN-8	BRAF(V600E)	100.0	1000.0
BX-912	DYRK1A	12.0	10000.0
MPS-1-IN-1	M3K5	100.0	1000.0
Pictilisib	IRAK1	100.0	1000.0
BS-181	M3K2	89.0	10000.0
MPS-1-IN-1	DAPK2	100.0	1000.0
PD173074	KPCD	100.0	10000.0
JNK-IN-8	TAK1	61.0	1000.0
BI-D1870	MET	8.0	10000.0
KIN001-111	KIT(V559D)	1.6	1000.0
WZ4003	TNK2	21.0	1000.0
QL-X-138	RSK2(Kin.Dom.1-N-terminal)	69.0	10000.0
KIN001-220	CDK4-cyclinD1	34.0	10000.0
WYE-125132	JNK1	91.0	10000.0
AZD4547	CDC2L5	70.0	10000.0
Taselisib	EGFR(G719S)	86.0	1000.0
ERK5-IN-1	BRAF	90.0	1000.0
Palbociclib	VGFR1	98.0	1000.0
Sorafenib	MP2K3	97.0	10000.0
KIN001-127	CAMK2A	100.0	10000.0
JNK-IN-5A	GCN2(Kin.Dom.2,S808G)	82.0	10000.0
QL-X-138	PIK3CG	4.2	10000.0
Canertinib	M3K5	100.0	1000.0
JNK-IN-8	SBK1	96.0	1000.0
WZ3105	PKNB(M.tuberculosis)	82.0	10000.0
JNK-IN-5A	MERTK	100.0	10000.0
WH-4-023	TNIK	37.0	10000.0
XMD16-144	CDK3	100.0	10000.0
MLN8054	FLT3(ITD)	87.0	10000.0
TGX221	EPHA7	100.0	1000.0
JNK-IN-8	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	1000.0
BS-181	YANK2	94.0	10000.0
5z-7-oxozeaenol	KC1G2	62.0	10000.0
Omipalisib	AURKB	54.0	10000.0
CGP60474	NEK7	100.0	10000.0
Omipalisib	KCC4	100.0	10000.0
HG-5-88-01	IKKA	100.0	10000.0
SP600125	MK03	100.0	10000.0
NG25	MAP4K4	0.0	10000.0
AZD4547	KC1G1	84.0	10000.0
JNK-IN-8	FRK	100.0	1000.0
XMD16-144	MYLK	69.0	10000.0
(s)-CR8	ERN1	98.0	10000.0
Lapatinib	SRPK1	100.0	10000.0
Ceritinib	PGFRB	89.0	1000.0
XMD13-2	SIK3	100.0	10000.0
JNK-IN-11	EGFR(E746-A750del)	0.0	1000.0
GSK429286A	FLT3(ITD)	83.0	10000.0
KIN001-127	KC1G1	100.0	10000.0
AZ-628	ABL1-nonphosphorylated	0.1	10000.0
AZD4547	TLK2	63.0	10000.0
AZ-628	TNNI3K	15.0	10000.0
Buparlisib	TLK1	61.0	1000.0
5z-7-oxozeaenol	EPHB4	85.0	10000.0
Dabrafenib	JAK2(JH1domain-catalytic)	13.0	10000.0
PHA-767491	MAP4K2	4.2	10000.0
QL-XI-92	MET(Y1235D)	100.0	10000.0
AZD4547	MUSK	8.3	10000.0
PD173074	RPS6KA3(Kin.Dom.1)	100.0	10000.0
HG-5-113-01	IKKB	100.0	10000.0
Alpelisib	AXL	100.0	1000.0
PD0325901	NDR1	100.0	10000.0
KIN001-021	NEK2	100.0	1000.0
ZG-10	ALK	100.0	10000.0
GW843682X	RIPK5	88.0	10000.0
ALW-II-38-3	GRK7	100.0	10000.0
KIN001-220	RIOK1	0.0	10000.0
Neratinib	TXK	86.0	10000.0
CP466722	RIOK1	29.0	10000.0
AZD 5438	PGFRA	66.0	10000.0
Barasertib	MLTK	63.0	10000.0
Dactolisib	LKB1	100.0	1000.0
XMD8-85	STK33	8.8	10000.0
XMD13-2	JAK2(JH1domain-catalytic)	18.0	10000.0
NU7441	FAK2	94.0	10000.0
Lapatinib	TYRO3	84.0	10000.0
Torin2	MARK2	100.0	10000.0
XMD11-85h	CAMK2G	100.0	10000.0
GSK429286A	STK35	96.0	10000.0
MRT67307	PAK6	55.0	10000.0
Ceritinib	CDK7	67.0	1000.0
NG25	RIOK3	100.0	10000.0
JNK-IN-5A	SYK	99.0	10000.0
Seliciclib	WNK3	77.0	10000.0
HG-5-113-01	ANKK1	100.0	10000.0
Momelotinib	KIT(A829P)	72.0	10000.0
RO-3306	NUAK1	92.0	10000.0
XMD16-144	RET	0.2	10000.0
PD0325901	GRK4	100.0	10000.0
QL-XII-47	MK13	96.0	1000.0
PD173074	AKT2	100.0	10000.0
GW843682X	HIPK2	89.0	10000.0
ZSTK474	TGFBR2	100.0	1000.0
ZG-10	M3K5	100.0	10000.0
XMD8-92	CDK8	100.0	10000.0
JNK-9L	HIPK4	13.0	10000.0
ERK5-IN-1	SRPK2	100.0	1000.0
A443654	BTK	100.0	10000.0
SB590885	NEK5	74.0	10000.0
JNK-9L	MAPKAPK2	100.0	10000.0
Crizotinib	MET	6.2	10000.0
GSK429286A	MAP4K2	96.0	10000.0
XMD14-99	ROCK1	79.0	10000.0
PHA-793887	CAMKK2	52.0	10000.0
A443654	M3K5	100.0	10000.0
JNK-9L	RSK1(Kin.Dom.2-C-terminal)	77.0	10000.0
BI-2536	ROS1	28.0	10000.0
ERK5-IN-1	MKNK1	96.0	1000.0
PD0325901	PAK1	100.0	10000.0
A443654	PGFRA	100.0	10000.0
JNK-9L	SIK1	73.0	10000.0
ALW-II-38-3	ABL2	1.0	1000.0
Torin2	MP2K2	100.0	10000.0
BS-181	ERK8	38.0	10000.0
JNK-IN-11	TAOK3	42.0	1000.0
Torin2	BMPR2	86.0	10000.0
BMX-IN-1	MARK4	76.0	10000.0
Ribociclib	IKKE	100.0	1000.0
Baricitinib	PFCDPK1(P.falciparum)	21.0	10000.0
(s)-CR8	JNK3	53.0	10000.0
OTSSP167	KPCT	100.0	10000.0
HG-5-113-01	PLK3	100.0	10000.0
WYE-125132	MK11	100.0	10000.0
A443654	PCTK2	25.0	10000.0
XMD11-50	CLK1	28.0	10000.0
GSK1059615	RSK1(Kin.Dom.2-C-terminal)	19.0	10000.0
Alpelisib	CLK2	45.0	1000.0
Sigma A6730	CAMK1D	76.0	10000.0
GW-5074	CTK	100.0	10000.0
AZ-628	KIT(D816V)	16.0	10000.0
Lapatinib	LCK	46.0	10000.0
Sorafenib	ACVR2A	100.0	10000.0
QL-XI-92	PIK3CA(E545K)	95.0	10000.0
WZ-7043	JNK3	100.0	10000.0
ERK5-IN-1	CAMK1	37.0	1000.0
HG-6-64-01	ABL1(Q252H)-nonphosphorylated	0.1	10000.0
PD173074	MAP4K4	100.0	10000.0
HG-5-113-01	ACVR1	100.0	10000.0
Dactolisib	KPCE	100.0	1000.0
R406	BTK	2.0	1000.0
BX-912	CIT	0.8	10000.0
Palbociclib	STK39	76.0	1000.0
Momelotinib	SRC	100.0	10000.0
Vemurafenib	TIE1	38.0	10000.0
BMS345541	PIM3	92.0	10000.0
JNK-IN-5A	MLK1	72.0	10000.0
Neratinib	AMPK-alpha1	79.0	10000.0
HG-5-88-01	FLT3	100.0	10000.0
AZD-6482	CASK	92.0	10000.0
AZD7762	AAK1	1.3	10000.0
WZ-4-145	SgK110	100.0	10000.0
BS-181	CDKL3	82.0	10000.0
RO-3306	PCTK2	93.0	10000.0
Dinaciclib	CLK1	11.0	10000.0
CGP74514A	ITK	70.0	10000.0
ZSTK474	TNNI3K	100.0	1000.0
Dinaciclib	MLTK	84.0	10000.0
ALW-II-38-3	PIK4CB	100.0	10000.0
XMD11-50	MP2K1	100.0	10000.0
JWE-035	SRPK3	57.0	10000.0
Torin1	CDK8	4.6	10000.0
XMD8-92	AAK1	100.0	10000.0
RO-3306	TRPM6	91.0	10000.0
Taselisib	RET(V804M)	100.0	1000.0
GSK1059615	RIPK1	100.0	10000.0
CG-930	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
SP600125	AXL	100.0	10000.0
Neratinib	TGFBR1	100.0	10000.0
AZD4547	CDC2L2	31.0	10000.0
SCH772984	TGFBR2	100.0	1000.0
JNK-IN-11	EPHA8	39.0	1000.0
CG-930	PLK3	100.0	10000.0
NU7441	CTK	99.0	10000.0
WYE-125132	DRAK2	100.0	10000.0
HG-5-88-01	MARK4	100.0	10000.0
Momelotinib	EPHA4	100.0	10000.0
QL-XII-47	YES	100.0	1000.0
WYE-125132	GSK3A	82.0	10000.0
GSK1059615	PIK3C2B	0.2	10000.0
CP466722	AXL	6.0	10000.0
XMD11-50	PLK1	0.7	10000.0
Sorafenib	PIK3CG	96.0	10000.0
Lapatinib	CDC2L5	66.0	10000.0
AG1478	STK16	97.0	10000.0
Pictilisib	LIMK2	99.0	1000.0
Seliciclib	BMPR1B	100.0	10000.0
Seliciclib	IRAK1	86.0	10000.0
5z-7-oxozeaenol	VRK2	100.0	10000.0
CG-930	KIT(A829P)	77.0	10000.0
XMD11-85h	LATS2	100.0	10000.0
ERK5-IN-1	DMPK2	100.0	1000.0
KIN001-021	CSK	100.0	1000.0
PD0325901	MST4	77.0	10000.0
Momelotinib	ABL1(M351T)-phosphorylated	66.0	10000.0
Baricitinib	PDPK1	23.0	10000.0
CGP74514A	MAPKAPK2	100.0	10000.0
Sorafenib	CDKL5	56.0	10000.0
SCH772984	MERTK	44.0	1000.0
AZD4547	PTK6	98.0	10000.0
AZD7762	AKT3	100.0	10000.0
WZ4002	JNK1	17.0	10000.0
HG-5-88-01	LATS2	100.0	10000.0
AZ-628	MINK	7.2	10000.0
JNK-9L	BRAF	85.0	10000.0
TGX221	EGFR(L858R)	100.0	1000.0
OTSSP167	ABL1(F317L)-phosphorylated	7.3	10000.0
Alpelisib	HIPK3	100.0	1000.0
WZ-7043	RPS6KA2(Kin.Dom.1)	100.0	10000.0
Pictilisib	BRSK1	100.0	1000.0
BS-181	WEE1	91.0	10000.0
XMD14-99	TYRO3	100.0	10000.0
PHA-793887	PIK3CA(C420R)	100.0	10000.0
GSK429286A	ACVRL1	100.0	10000.0
PHA-767491	PHKG2	14.0	10000.0
Seliciclib	SYK	100.0	10000.0
TGX221	GCN2(Kin.Dom.2,S808G)	100.0	1000.0
GW843682X	EGFR(L858R,T790M)	86.0	10000.0
QL-XI-92	YSK1	100.0	10000.0
HG-9-91-01	PKNB(M.tuberculosis)	64.0	10000.0
JWE-035	RSK4(Kin.Dom.2-C-terminal)	16.0	10000.0
KIN001-127	EGFR(L747-T751del,Sins)	100.0	10000.0
PHA-767491	MKNK2	12.0	10000.0
AZD-6482	YANK2	71.0	10000.0
Canertinib	RAF1	100.0	1000.0
CP724714	DAPK3	96.0	10000.0
THZ1	BMPR2	0.1	10000.0
JNK-IN-8	PKN1	94.0	1000.0
Ibrutinib	MAK	100.0	1000.0
NU7441	RSK4(Kin.Dom.1-N-terminal)	71.0	10000.0
JNK-IN-5A	KIT(L576P)	79.0	10000.0
Seliciclib	EGFR(S752-I759del)	82.0	10000.0
NU7441	YSK4	100.0	10000.0
KIN001-123	PIP5K1A	100.0	1000.0
NPK76-II-72-1	NEK1	100.0	10000.0
Barasertib	ABL1-phosphorylated	30.0	10000.0
QL-XII-47	CDK5	92.0	1000.0
ALW-II-38-3	AKT2	100.0	10000.0
BMX-IN-1	ABL1(Y253F)-phosphorylated	76.0	10000.0
CGP74514A	NEK1	76.0	10000.0
Ibrutinib	TGFBR1	87.0	1000.0
BS-181	M4K1	73.0	10000.0
PD173074	ERBB2	100.0	10000.0
Neratinib	TNK2	40.0	10000.0
CGP74514A	FER	37.0	10000.0
WZ4002	MK12	100.0	10000.0
GSK429286A	AURKB	42.0	10000.0
GW843682X	EGFR(L861Q)	100.0	10000.0
Omipalisib	PAK1	87.0	10000.0
Abemaciclib	STK35	91.0	1000.0
KIN001-127	MKNK1	100.0	10000.0
PD0325901	AURKC	45.0	10000.0
CGP74514A	CASK	68.0	10000.0
Neratinib	ULK2	100.0	10000.0
BMS345541	CDK11	100.0	10000.0
PLX-4720	RSK1(Kin.Dom.2-C-terminal)	75.0	10000.0
HG-5-88-01	CDC2L1	100.0	10000.0
TAK-715	AKT1	100.0	10000.0
WYE-125132	M4K1	94.0	10000.0
ZM-447439	ABL1(F317L)-nonphosphorylated	7.6	10000.0
(s)-CR8	LATS1	97.0	10000.0
ZM-447439	KKCC1	76.0	10000.0
ZM-447439	EGFR(L747-T751del,Sins)	26.0	10000.0
RO-3306	MET(M1250T)	47.0	10000.0
GSK1059615	KIT(D816H)	89.0	10000.0
Sorafenib	AMPK-alpha1	42.0	10000.0
QL-XII-47	ICK	100.0	1000.0
WH-4-023	FLT3(R834Q)	26.0	10000.0
(s)-CR8	NEK6	100.0	10000.0
JWE-035	PIK3CA	25.0	10000.0
Torkinib	BRSK1	1.6	10000.0
QL-X-138	KPCD1	100.0	10000.0
SCH772984	EPHA1	99.0	1000.0
KU63794	GCN2(Kin.Dom.2,S808G)	66.0	10000.0
XMD11-50	LRRK2(G2019S)	5.0	10000.0
Sorafenib	MAPKAPK5	100.0	10000.0
CGP60474	FES	100.0	10000.0
WZ3105	BLK	17.0	10000.0
Dactolisib	DAPK1	100.0	1000.0
Momelotinib	PAK6	100.0	10000.0
KIN001-220	DDR2	100.0	10000.0
HG-5-88-01	RPS6KA1(Kin.Dom.2)	30.0	10000.0
THZ1	RIPK2	68.0	10000.0
MRT67307	TGFBR2	100.0	10000.0
ALW-II-49-7	ADCK3	100.0	10000.0
Baricitinib	MST4	30.0	10000.0
AZD7762	DRAK1	0.6	10000.0
HG-5-113-01	RPS6KA1(Kin.Dom.1)	0.8	10000.0
QL-XI-92	NEK1	100.0	10000.0
CGP60474	TYK2(JH2domain-pseudokinase)	100.0	10000.0
BX-912	PIK3CA(E545A)	94.0	10000.0
MLN8054	ABL1(F317I)-nonphosphorylated	58.0	10000.0
MPS-1-IN-1	EGFR(L747-E749del,A750P)	100.0	1000.0
Barasertib	INSR	75.0	10000.0
KU63794	ACVR1	100.0	10000.0
SB590885	FGFR2	100.0	10000.0
MRT67307	LRRK2(G2019S)	5.0	10000.0
XMD11-50	BLK	97.0	10000.0
GSK1059615	PIK3CA(E545K)	0.8	10000.0
AZD-6482	MAP4K2	56.0	10000.0
CG-930	EIF2AK1	100.0	10000.0
Torin1	BMPR1B	100.0	10000.0
WYE-125132	ACVR1	90.0	10000.0
Momelotinib	CDK14	76.0	10000.0
MLN8054	DCAMKL2	94.0	10000.0
CGP60474	IKKB	100.0	10000.0
WH-4-023	TEC	3.7	10000.0
AZD4547	EPHA7	86.0	10000.0
TGX221	AXL	100.0	1000.0
5z-7-oxozeaenol	CHEK1	100.0	10000.0
XMD14-99	M3K6	100.0	10000.0
XMD14-99	EPHB1	87.0	10000.0
Dinaciclib	ADCK4	40.0	10000.0
CGP60474	DYRK1A	7.8	10000.0
Lapatinib	FYN	94.0	10000.0
WYE-125132	FLT3(N841I)	89.0	10000.0
A443654	CDK7	0.3	10000.0
Dactolisib	FAK2	100.0	1000.0
WZ-7043	EPHA1	100.0	10000.0
Dabrafenib	MYLK	100.0	10000.0
JNK-9L	HUNK	42.0	10000.0
XMD11-50	JAK1(JH1domain-catalytic)	100.0	10000.0
TGX221	CLK1	100.0	1000.0
GSK1059615	FER	50.0	10000.0
CGP60474	EPHB3	100.0	10000.0
XMD11-85h	BMX	100.0	10000.0
HG-14-10-04	MP2K7	100.0	10000.0
CGP74514A	PAK4	1.8	10000.0
Neratinib	SRC	82.0	10000.0
XMD13-2	RET(V804L)	96.0	10000.0
XMD11-85h	EGFR(E746-A750del)	100.0	10000.0
HG-5-88-01	NEK7	100.0	10000.0
5z-7-oxozeaenol	FGFR3(G697C)	83.0	10000.0
XMD11-50	ABL1(F317L)-nonphosphorylated	14.0	10000.0
QL-XII-47	NEK6	82.0	1000.0
JW-7-24-1	TAK1	13.0	10000.0
ALW-II-38-3	DCLK1	100.0	10000.0
GSK461364	PIK3C2G	40.0	10000.0
HG-14-10-04	PIK3CA(M1043I)	100.0	10000.0
Sigma A6730	PRKR	100.0	10000.0
HG-6-64-01	WEE2	4.8	10000.0
GW843682X	PGFRB	5.3	10000.0
BMS345541	PIK3CA(M1043I)	100.0	10000.0
WZ4002	ABL1(Q252H)	100.0	10000.0
Momelotinib	JAK2(JH1domain-catalytic)	0.1	10000.0
Sigma A6730	HIPK2	88.0	10000.0
PHA-767491	WEE2	98.0	10000.0
Palbociclib	MST4	100.0	1000.0
XMD14-99	IKKA	58.0	10000.0
CGP74514A	LCK	2.1	10000.0
XMD16-144	RET(V804L)	0.2	10000.0
Barasertib	PIK3C2G	21.0	10000.0
Sorafenib	MP2K6	76.0	10000.0
Omipalisib	MUSK	84.0	10000.0
JNK-9L	ROCK1	52.0	10000.0
AZD 5438	PAK2	44.0	10000.0
QL-X-138	EPHA2	85.0	10000.0
JWE-035	CDK5	84.0	10000.0
KIN001-123	WEE1	100.0	1000.0
THZ1	BMX	1.7	10000.0
SB590885	M3K2	69.0	10000.0
BS-181	MET(M1250T)	62.0	10000.0
Torin2	CLK2	15.0	10000.0
RO-3306	CDK4-cyclinD3	77.0	10000.0
Dinaciclib	PIK4CB	88.0	10000.0
Lapatinib	ROCK1	84.0	10000.0
HG-5-88-01	SRPK1	100.0	10000.0
PHA-793887	CASK	94.0	10000.0
Ibrutinib	KGP1	100.0	1000.0
AZD4547	DRAK2	25.0	10000.0
ERK5-IN-1	KPCI	95.0	1000.0
Ibrutinib	EGFR(L858R,T790M)	6.4	1000.0
PD173074	STK33	100.0	10000.0
XMD8-85	ACVRL1	100.0	10000.0
Barasertib	MARK2	80.0	10000.0
ZSTK474	M3K12	100.0	1000.0
Torin2	STK36	99.0	10000.0
AG1478	PIP5K2B	97.0	10000.0
NPK76-II-72-1	RPS6KA4(Kin.Dom.1)	100.0	10000.0
JWE-035	EPHB1	100.0	10000.0
Omipalisib	NEK10	64.0	10000.0
Canertinib	TYK2(Kin.Dom.2)	100.0	1000.0
WZ3105	MINK	27.0	10000.0
XMD8-85	AMPK-alpha1	100.0	10000.0
TGX221	EGFR(S752-I759del)	100.0	1000.0
Momelotinib	CDK4-cyclinD3	13.0	10000.0
BS-181	MAP4K2	95.0	10000.0
XMD11-50	TESK1	82.0	10000.0
WZ4003	LKB1	100.0	1000.0
Palbociclib	S6K1	94.0	1000.0
Seliciclib	ALK	61.0	10000.0
JWE-035	CSF1R	0.5	10000.0
WZ4003	TLK2	100.0	1000.0
Alpelisib	KPCD2	83.0	1000.0
QL-X-138	ABL1(T315I)-phosphorylated	83.0	10000.0
GSK1059615	ICK	46.0	10000.0
AS-252424	PKAC-alpha	100.0	10000.0
Alpelisib	TNK1	67.0	1000.0
Dabrafenib	MARK2	24.0	10000.0
XMD8-85	KCC2D	23.0	10000.0
ALW-II-49-7	CIT	100.0	10000.0
XMD16-144	PKN2	64.0	10000.0
ZM-447439	ACVR2B	100.0	10000.0
Buparlisib	CDK15	100.0	1000.0
XMD16-144	NEK5	58.0	10000.0
Torkinib	TYK2(JH1domain-catalytic)	8.2	10000.0
KIN001-123	PRKX	100.0	1000.0
SCH772984	HASP	14.0	1000.0
Vemurafenib	RET	43.0	10000.0
HG-9-91-01	ERBB3	0.0	10000.0
ERK5-IN-1	PHKG2	90.0	1000.0
BI-D1870	GSK3A	30.0	10000.0
HG-14-8-02	TAOK2	100.0	10000.0
CGP74514A	ABL1-nonphosphorylated	7.4	10000.0
WZ-4-145	SIK1	31.0	10000.0
KIN001-220	ULK2	77.0	10000.0
JNK-IN-11	CDC2L2	32.0	1000.0
Dabrafenib	DAPK3	26.0	10000.0
Barasertib	GRK1	100.0	10000.0
PLX-4720	GRK1	100.0	10000.0
BS-181	WNK1	81.0	10000.0
BI-2536	DCAMKL2	13.0	10000.0
CP724714	S6K1	65.0	10000.0
Dabrafenib	LKB1	92.0	10000.0
(s)-CR8	DCAMKL2	100.0	10000.0
PD0325901	MST1	100.0	10000.0
HG-9-91-01	FGR	0.1	10000.0
QL-X-138	EGFR(G719S)	79.0	10000.0
GSK461364	CSNK1D	100.0	10000.0
GW-5074	TEC	100.0	10000.0
KIN001-111	SRPK1	100.0	1000.0
XMD16-144	TIE1	5.4	10000.0
BI-2536	TLK1	100.0	10000.0
HG-5-88-01	BTK	26.0	10000.0
MLN8054	EPHB4	11.0	10000.0
Torin1	RIPK4	100.0	10000.0
MLN8054	CDK4-cyclinD1	98.0	10000.0
WYE-125132	STK39	100.0	10000.0
JNK-IN-5A	EPHA8	79.0	10000.0
KIN001-220	MAPKAPK5	100.0	10000.0
ZG-10	ABL1(E255K)-phosphorylated	29.0	10000.0
QL-XII-47	FGFR1	100.0	1000.0
WZ-4-145	KIT(V559D,T670I)	29.0	10000.0
ALW-II-38-3	NDR2	100.0	10000.0
Pictilisib	DAPK3	82.0	1000.0
ZG-10	MAPKAPK2	100.0	10000.0
Pictilisib	KIT(L576P)	95.0	1000.0
ALW-II-38-3	CSNK1E	100.0	10000.0
MRT67307	FLT3	1.2	10000.0
QL-XI-92	RSK3(Kin.Dom.2-C-terminal)	100.0	10000.0
Taselisib	RSK4(Kin.Dom.2-C-terminal)	86.0	1000.0
MPS-1-IN-1	PLK4	100.0	1000.0
NVP-TAE684	ABL1(Q252H)	2.2	1000.0
GSK461364	CDK8	95.0	10000.0
ZG-10	ULK2	99.0	10000.0
AZD7762	CDK16	79.0	10000.0
Torkinib	PAK1	52.0	10000.0
NVP-TAE684	MAP3K3	2.8	1000.0
Barasertib	LRRK2(G2019S)	100.0	10000.0
Vemurafenib	RAF1	1.0	10000.0
BI-2536	RPS6KA1(Kin.Dom.1)	100.0	10000.0
WZ4002	PIM2	100.0	10000.0
Palbociclib	JNK3	49.0	1000.0
Dabrafenib	MK01	100.0	10000.0
WZ-7043	ERBB2	100.0	10000.0
Dabrafenib	SNARK	100.0	10000.0
KIN001-111	M3K5	100.0	1000.0
R406	BMPR1A	100.0	1000.0
AZD4547	LRRK2	64.0	10000.0
(s)-CR8	ULK1	93.0	10000.0
SP600125	CSK	100.0	10000.0
CH5424802	PIK3CA(H1047Y)	95.0	1000.0
HG-9-91-01	TGFBR2	2.6	10000.0
KIN001-127	DDR1	100.0	10000.0
HG-14-8-02	GSK3A	100.0	10000.0
KIN001-123	YES	17.0	1000.0
AG1478	CDKL2	84.0	10000.0
TAK-715	KIT(D816H)	57.0	10000.0
AG1478	KGP2	82.0	10000.0
CGP60474	MKNK1	100.0	10000.0
JWE-035	ERK3	20.0	10000.0
MLN8054	LIMK2	94.0	10000.0
Abemaciclib	EPHA7	100.0	1000.0
XMD14-99	TLK1	86.0	10000.0
Sigma A6730	MLTK	92.0	10000.0
HG-14-8-02	PLK3	100.0	10000.0
HG-14-10-04	ERK3	83.0	10000.0
SCH772984	KKCC1	88.0	1000.0
Palbociclib	CDK15	100.0	1000.0
HG-14-10-04	KIT(V559D,V654A)	1.2	10000.0
GSK461364	CDK16	100.0	10000.0
BI-2536	FGFR3(G697C)	100.0	10000.0
XMD11-85h	CSNK1D	100.0	10000.0
WZ-7043	RET(M918T)	100.0	10000.0
CP724714	DCAMKL3	83.0	10000.0
(s)-CR8	IGF1R	100.0	10000.0
PHA-767491	MLK2	50.0	10000.0
HG-6-64-01	CDK8	21.0	10000.0
BI-2536	M4K1	100.0	10000.0
CP724714	MELK	92.0	10000.0
Alpelisib	ABL1(F317L)-phosphorylated	53.0	1000.0
Lapatinib	CSNK1A1	99.0	10000.0
XMD11-85h	LIMK2	100.0	10000.0
A443654	CDK14	9.8	10000.0
Dabrafenib	GRK4	100.0	10000.0
(s)-CR8	EPHB3	85.0	10000.0
XMD11-85h	DAPK3	100.0	10000.0
Sorafenib	LCK	5.2	10000.0
ZSTK474	CDK3	100.0	1000.0
XMD11-85h	SRC	100.0	10000.0
5z-7-oxozeaenol	KCC4	100.0	10000.0
MRT67307	DYRK1A	28.0	10000.0
BMX-IN-1	NEK9	65.0	10000.0
OTSSP167	DRAK2	100.0	10000.0
QL-X-138	SRPK1	39.0	10000.0
AG1478	BLK	7.1	10000.0
GSK1059615	CSF1R-autoinhibited	40.0	10000.0
Barasertib	ALK	98.0	10000.0
Lapatinib	LOK	1.4	10000.0
AZ-628	EGFR(L747-T751del,Sins)	14.0	10000.0
Taselisib	DRAK1	97.0	1000.0
ERK5-IN-1	MAP3K3	100.0	1000.0
TAK-715	TSSK1	87.0	10000.0
BS-181	GCN2(Kin.Dom.2,S808G)	93.0	10000.0
WZ3105	LIMK1	100.0	10000.0
Canertinib	MELK	100.0	1000.0
WZ3105	CDK16	100.0	10000.0
GSK1059615	DAPK2	1.7	10000.0
OTSSP167	AURKC	34.0	10000.0
BX-912	MYO3A	28.0	10000.0
XMD14-99	RIPK1	100.0	10000.0
XMD-12	EPHA5	100.0	1000.0
THZ1	PIK3CA(E542K)	73.0	10000.0
Torkinib	CAMK1G	77.0	10000.0
Abemaciclib	GAK	37.0	1000.0
OTSSP167	SYK	3.0	10000.0
XMD8-85	RET	100.0	10000.0
PHA-767491	FGFR2	100.0	10000.0
HG-14-8-02	DRAK2	99.0	10000.0
HG-6-64-01	ERK3	100.0	10000.0
XMD-12	PIP5K2B	75.0	1000.0
Seliciclib	EPHA6	100.0	10000.0
ERK5-IN-1	DRAK2	100.0	1000.0
RO-3306	ERK4	17.0	10000.0
MLN8054	FAK2	27.0	10000.0
GSK1059615	TNK1	52.0	10000.0
Ribociclib	MRCKB	100.0	1000.0
AZD4547	EGFR(G719S)	70.0	10000.0
CP466722	PLK4	0.2	10000.0
Ceritinib	PIK3CA(H1047Y)	92.0	1000.0
PD0325901	EPHA8	94.0	10000.0
CH5424802	JAK3(JH1domain-catalytic)	87.0	1000.0
Sorafenib	GSK3A	67.0	10000.0
WZ-7043	GAK	100.0	10000.0
AS-252424	RIOK1	96.6	10000.0
TGX221	FRK	100.0	1000.0
GSK461364	AXL	41.0	10000.0
WZ-4-145	FGFR1	2.2	10000.0
HG-6-64-01	FGFR1	0.1	10000.0
Ibrutinib	LKB1	100.0	1000.0
RO-3306	BIKE	1.2	10000.0
NVP-TAE684	RIPK4	100.0	1000.0
HG-6-64-01	RSK1(Kin.Dom.1-N-terminal)	31.0	10000.0
HG-5-113-01	TGFBR2	100.0	10000.0
HG-5-88-01	RPS6KA4(Kin.Dom.2)	100.0	10000.0
(s)-CR8	TYK2(JH2domain-pseudokinase)	100.0	10000.0
HG-14-8-02	MAPKAPK5	100.0	10000.0
PLX-4720	DMPK2	74.0	10000.0
CGP74514A	EGFR(L861Q)	35.0	10000.0
Taselisib	EGFR(L747-S752del,P753S)	91.0	1000.0
KIN001-220	ABL1(F317I)-nonphosphorylated	100.0	10000.0
HG-5-113-01	FYN	8.1	10000.0
ZM-447439	ABL1(Y253F)-phosphorylated	35.0	10000.0
BX-912	MK14	100.0	10000.0
BMX-IN-1	ABL1(Q252H)-nonphosphorylated	75.0	10000.0
Canertinib	MP2K3	100.0	1000.0
Torkinib	KPCD1	100.0	10000.0
MPS-1-IN-1	ACVR2B	100.0	1000.0
Ribociclib	EPHB3	89.0	1000.0
Neratinib	WEE2	98.0	10000.0
BMS345541	PRKR	100.0	10000.0
GSK429286A	ULK3	99.0	10000.0
XMD14-99	AURKC	100.0	10000.0
WZ-7043	GRK7	100.0	10000.0
Abemaciclib	WEE2	100.0	1000.0
THZ1	FLT3(D835H)	0.1	10000.0
Abemaciclib	PIK3CA(E545K)	98.0	1000.0
WH-4-023	ABL1(Q252H)-nonphosphorylated	0.0	10000.0
Abemaciclib	NDR2	92.0	1000.0
Torin2	ERK8	18.0	10000.0
Pictilisib	ABL1(Q252H)	100.0	10000.0
JW-7-24-1	YANK3	100.0	10000.0
Torin1	PKN1	92.0	10000.0
KIN001-220	BMPR1A	61.0	10000.0
Omipalisib	EGFR(S752-I759del)	88.0	10000.0
RO-3306	DDR2	64.0	10000.0
ZSTK474	YANK3	100.0	1000.0
KU63794	CAMK2A	87.0	10000.0
BS-181	CDK7	0.4	10000.0
QL-XI-92	ABL1(F317L)-nonphosphorylated	6.2	10000.0
CH5424802	SIK3	86.0	1000.0
CG-930	ITK	100.0	10000.0
Alpelisib	ABL1(H396P)-nonphosphorylated	16.0	1000.0
XMD8-92	CLK3	100.0	10000.0
Momelotinib	EGFR(L858R)	100.0	10000.0
Ceritinib	BARK1	80.0	1000.0
WYE-125132	RSK3(Kin.Dom.1-N-terminal)	100.0	10000.0
KIN001-127	CHK2	100.0	10000.0
Crizotinib	MYO3B	100.0	10000.0
ZSTK474	NEK1	100.0	1000.0
ERK5-IN-1	FER	96.0	1000.0
SCH772984	BRSK2	90.0	1000.0
WZ-7043	TIE1	10.0	10000.0
PHA-767491	EPHA4	95.0	10000.0
Alpelisib	KIT(L576P)	98.0	1000.0
Crizotinib	CSNK2A2	55.0	10000.0
Crizotinib	PGFRB	44.0	10000.0
Momelotinib	DMPK	37.0	10000.0
Baricitinib	ROCK1	0.1	10000.0
HG-6-64-01	DRAK1	1.3	10000.0
QL-XI-92	NEK3	88.0	10000.0
CGP60474	RET(V804L)	100.0	10000.0
XMD16-144	AAK1	20.0	10000.0
RO-3306	KPCL	45.0	10000.0
XMD8-92	YES	100.0	10000.0
JNK-IN-5A	GAK	67.0	10000.0
PD173074	RPS6KA1(Kin.Dom.1)	100.0	10000.0
JNK-9L	EGFR(L747-E749del,A750P)	62.0	10000.0
PHA-793887	AAK1	100.0	10000.0
GSK461364	DCLK1	40.0	10000.0
R406	FLT4	0.0	1000.0
Barasertib	ABL1(H396P)-phosphorylated	44.0	10000.0
NU7441	TTK	100.0	10000.0
JNK-IN-11	TLK2	100.0	1000.0
XMD11-50	PIK3C2B	100.0	10000.0
GW-5074	PLK4	26.0	10000.0
SCH772984	INSR	83.0	1000.0
Ribociclib	CAMKK2	92.0	1000.0
Neratinib	ABL1(H396P)-phosphorylated	100.0	10000.0
QL-XII-47	CDKL2	100.0	1000.0
Buparlisib	MARK1	81.0	1000.0
KIN001-021	PIK3C2B	100.0	1000.0
TAK-715	ANKK1	83.0	10000.0
GW-5074	MAK	100.0	10000.0
KIN001-111	FAK1	100.0	1000.0
AZD4547	EPHA8	78.0	10000.0
XMD13-2	STK39	99.0	10000.0
Pictilisib	MAP3K3	100.0	1000.0
AZD4547	SRPK1	12.0	10000.0
PD0325901	NEK7	95.0	10000.0
XMD-12	MYLK	63.0	1000.0
AZD4547	HIPK4	67.0	10000.0
MLN8054	TRKA	35.0	10000.0
Torin2	MST4	73.0	10000.0
Momelotinib	TAOK2	100.0	10000.0
BMS345541	MP2K2	77.0	10000.0
AZ-628	RSK3(Kin.Dom.2-C-terminal)	84.0	10000.0
Buparlisib	M3K12	100.0	1000.0
XMD16-144	LRRK2(G2019S)	6.1	10000.0
Torin2	FGFR1	95.0	10000.0
AZD-6482	FLT3	13.0	10000.0
WZ4002	JNK3	13.0	10000.0
SCH772984	MP2K4	3.7	1000.0
Seliciclib	AURKA	100.0	10000.0
HG-14-10-04	STK35	48.0	10000.0
ZSTK474	DAPK2	100.0	1000.0
SB590885	EGFR(L747-T751del,Sins)	54.0	10000.0
XMD-12	SYK	61.0	1000.0
KIN001-021	EPHB4	100.0	1000.0
WZ4003	JAK1(Kin.Dom.1)	100.0	1000.0
BMX-IN-1	PTK6	77.0	10000.0
Palbociclib	NEK2	100.0	1000.0
Dinaciclib	YANK1	80.0	10000.0
QL-X-138	LRRK2(G2019S)	6.4	10000.0
WZ-4-145	ABL2	9.1	10000.0
Buparlisib	KIT(V559D)	100.0	1000.0
Momelotinib	MRCKB	42.0	10000.0
Palbociclib	NEK1	100.0	1000.0
THZ1	ALK	0.2	10000.0
GSK429286A	SRC	83.0	10000.0
AZD7762	IRAK3	6.4	10000.0
NVP-TAE684	LIMK2	6.5	1000.0
MPS-1-IN-1	CHK2	100.0	1000.0
XMD-12	CDC2L2	100.0	1000.0
Ribociclib	TRKC	100.0	1000.0
Ribociclib	CHK2	96.0	1000.0
NG25	CAMK2A	100.0	10000.0
ALW-II-49-7	CDK14	100.0	10000.0
ZG-10	TNIK	36.0	10000.0
Dinaciclib	PIK3CA(M1043I)	79.0	10000.0
Barasertib	TIE1	6.6	10000.0
HG-14-10-04	BLK	2.0	10000.0
WZ-7043	FES	100.0	10000.0
Ceritinib	MP2K7	95.0	1000.0
Sigma A6730	MAK	100.0	10000.0
Neratinib	AURKC	95.0	10000.0
KIN001-220	MLCK	100.0	10000.0
AZD 5438	KGP1	93.0	10000.0
AZD-6482	BRSK2	100.0	10000.0
Ceritinib	LIMK1	93.0	1000.0
Dactolisib	PIM1	100.0	1000.0
Torin2	TLK1	90.0	10000.0
GW-5074	PKN1	89.0	10000.0
Baricitinib	S6K1	44.0	10000.0
Torin1	CDKL2	58.0	10000.0
Ribociclib	ERK4	100.0	1000.0
KIN001-111	MAP3K4	15.0	1000.0
SCH772984	PIP5K2B	25.0	1000.0
XMD11-85h	GAK	100.0	10000.0
AZD4547	MP2K5	1.4	10000.0
XMD16-144	MST3	98.0	10000.0
OTSSP167	M3K13	56.0	10000.0
HG-9-91-01	GRK4	100.0	10000.0
Torkinib	WEE2	100.0	10000.0
AG1478	BMPR1B	55.0	10000.0
WZ4003	JAK1(Kin.Dom.2)	100.0	1000.0
HG-6-64-01	S6K1	9.0	10000.0
Vemurafenib	IKKB	100.0	10000.0
SCH772984	RIOK1	5.9	1000.0
CP724714	EPHA6	96.0	10000.0
Sorafenib	PIK3CA(M1043I)	92.0	10000.0
QL-X-138	S6K1	63.0	10000.0
Torin2	PCTK2	98.0	10000.0
ALW-II-49-7	NEK1	100.0	10000.0
Pictilisib	KIT(A829P)	100.0	1000.0
CGP74514A	KIT-autoinhibited	73.0	10000.0
Sigma A6730	S6K1	84.0	10000.0
PHA-767491	CSF1R-autoinhibited	30.0	10000.0
A443654	MAP4K2	8.8	10000.0
WH-4-023	JNK3	37.0	10000.0
CH5424802	CAMK1D	80.0	1000.0
Dinaciclib	DCLK1	59.0	10000.0
ALW-II-38-3	CLK2	100.0	10000.0
CGP60474	M3K12	100.0	10000.0
WZ4002	CAMK1D	27.0	10000.0
CG-930	INSRR	100.0	10000.0
Neratinib	SBK1	100.0	10000.0
Omipalisib	CDK4-cyclinD3	100.0	10000.0
KIN001-021	AMPK-alpha1	100.0	1000.0
WZ4002	RPS6KA4(Kin.Dom.1)	100.0	10000.0
ZG-10	RIPK1	34.0	10000.0
BMX-IN-1	CLK1	86.0	10000.0
SB590885	FLT3(N841I)	81.0	10000.0
CGP74514A	MK11	100.0	10000.0
Torin2	MARK4	100.0	10000.0
MPS-1-IN-1	CDK15	100.0	1000.0
PD0325901	ROCK2	100.0	10000.0
CP724714	FLT3(R834Q)	100.0	10000.0
XMD14-99	MST3	77.0	10000.0
HG-14-10-04	CDK11	70.0	10000.0
Torkinib	EPHB4	54.0	10000.0
Baricitinib	PIM1	98.0	10000.0
TAK-715	FLT3(D835H)	55.0	10000.0
WYE-125132	KC1G1	54.0	10000.0
Omipalisib	RSK1(Kin.Dom.1-N-terminal)	95.0	10000.0
GSK461364	PIM1	3.0	10000.0
Seliciclib	RSK2(Kin.Dom.1-N-terminal)	36.0	10000.0
Canertinib	GCN2(Kin.Dom.2,S808G)	100.0	1000.0
JNK-IN-11	MAP4K4	9.8	1000.0
MRT67307	MAP3K15	27.0	10000.0
Dabrafenib	SGK2	98.0	10000.0
RO-3306	EPHA4	94.0	10000.0
AZ-628	SIK2	77.0	10000.0
AZD-6482	EPHA7	89.0	10000.0
WZ-7043	PLK1	100.0	10000.0
GSK461364	PTK6	93.0	10000.0
WYE-125132	PIK3CA(H1047Y)	9.6	10000.0
Lapatinib	CLK1	100.0	10000.0
Ibrutinib	VGFR1	60.0	1000.0
BMS345541	INSR	99.0	10000.0
TAK-715	YANK1	9.0	10000.0
ALW-II-38-3	DYRK1B	100.0	10000.0
Sigma A6730	CSF1R-autoinhibited	76.0	10000.0
SCH772984	ABL1-phosphorylated	91.0	1000.0
Pictilisib	WEE1	99.0	1000.0
GSK429286A	YSK4	50.0	10000.0
ALW-II-38-3	TNNI3K	6.0	1000.0
XMD13-2	MP2K6	55.0	10000.0
Neratinib	RSK2(Kin.Dom.1-N-terminal)	89.0	10000.0
A443654	KIT(V559D,V654A)	100.0	10000.0
QL-XI-92	NEK6	100.0	10000.0
Alpelisib	LATS1	83.0	1000.0
AZ-628	ACVR1	100.0	10000.0
HG-9-91-01	KCC4	100.0	10000.0
TAK-715	TGFBR1	1.8	10000.0
MLN8054	PCTK2	100.0	10000.0
KIN001-220	VGFR1	9.6	10000.0
AZ-628	M3K2	88.0	10000.0
Sigma A6730	BLK	76.0	10000.0
AZ-628	MAST1	100.0	10000.0
Alpelisib	PIK3C2B	98.0	1000.0
Sorafenib	KPCT	84.0	10000.0
GW-5074	KPCD3	100.0	10000.0
KIN001-220	KIT(V559D,T670I)	21.0	10000.0
MLN8054	PCTK3	100.0	10000.0
GSK1059615	LTK	22.0	10000.0
Palbociclib	MLK2	83.0	1000.0
AZD 5438	MAP4K5	22.0	10000.0
MRT67307	EPHA7	98.0	10000.0
Dinaciclib	FGR	91.0	10000.0
CGP60474	PRKX	100.0	10000.0
SP600125	MK11	100.0	10000.0
KIN001-021	EPHA2	100.0	1000.0
HG-9-91-01	ACVRL1	9.4	10000.0
QL-XI-92	NEK11	100.0	10000.0
Vemurafenib	TSSK1	99.0	10000.0
JNK-IN-5A	PRP4	100.0	10000.0
Canertinib	MST2	100.0	1000.0
KIN001-111	PTK6	0.2	1000.0
QL-XI-92	PTK6	100.0	10000.0
HG-5-88-01	IKKB	100.0	10000.0
JW-7-24-1	MLK3	100.0	10000.0
ERK5-IN-1	PKMYT1	100.0	1000.0
SP600125	FLT3(D835Y)	100.0	10000.0
GSK429286A	ABL1(H396P)-nonphosphorylated	60.0	10000.0
AZD 5438	KPCD3	12.0	10000.0
CP466722	CSNK1G3	20.0	10000.0
GW843682X	NEK6	87.0	10000.0
Ceritinib	ERK5	19.0	1000.0
JW-7-24-1	PHKG2	100.0	10000.0
KIN001-021	EGFR(L858R)	100.0	1000.0
WYE-125132	KPCL	91.0	10000.0
Taselisib	KIT(V559D,V654A)	100.0	1000.0
Alpelisib	GRK1	100.0	1000.0
MPS-1-IN-1	TNNI3K	100.0	1000.0
HG-9-91-01	NDR2	40.0	10000.0
Torin2	PKN1	100.0	10000.0
HG-14-10-04	VRK2	100.0	10000.0
MLN8054	PIP5K1A	100.0	10000.0
HG-14-8-02	PIK3CA(H1047Y)	100.0	10000.0
Dabrafenib	KIT	4.2	10000.0
Dinaciclib	NEK3	100.0	10000.0
JNK-IN-11	MAP3K3	68.0	1000.0
OTSSP167	FLT4	0.0	10000.0
AZD 5438	RSK1(Kin.Dom.2-C-terminal)	22.0	10000.0
NG25	MERTK	100.0	10000.0
KIN001-127	ACVR2B	100.0	10000.0
(s)-CR8	KIT(V559D)	76.0	10000.0
MLN8054	LKB1	92.0	10000.0
OTSSP167	KC1G2	2.2	10000.0
NPK76-II-72-1	CDK3	100.0	10000.0
SB590885	RSK3(Kin.Dom.1-N-terminal)	61.0	10000.0
TGX221	FLT3(ITD)	100.0	1000.0
Ceritinib	TAOK1	89.0	1000.0
CGP74514A	YANK2	4.8	10000.0
PLX-4720	MAST1	100.0	10000.0
QL-X-138	MLK3	100.0	10000.0
QL-XI-92	RSK4(Kin.Dom.2-C-terminal)	79.0	10000.0
GW-5074	HIPK2	7.6	10000.0
Crizotinib	NLK	93.0	10000.0
KIN001-021	CDK11	100.0	1000.0
Abemaciclib	YSK4	1.2	1000.0
BGJ398	FYN	69.0	1000.0
MRT67307	NEK9	42.0	10000.0
PHA-767491	KIT(V559D,V654A)	94.0	10000.0
BMX-IN-1	KPCL	100.0	10000.0
XMD8-85	CDK15	100.0	10000.0
WZ4003	WEE1	100.0	1000.0
Dactolisib	NIM1	100.0	1000.0
HG-14-10-04	NDR1	28.0	10000.0
WYE-125132	PIK4CB	100.0	10000.0
BMX-IN-1	WEE2	100.0	10000.0
ZG-10	FLT3(ITD)	30.0	10000.0
HG-5-113-01	IKKA	100.0	10000.0
Sigma A6730	MET	39.0	10000.0
WZ4003	TGFBR1	100.0	1000.0
Buparlisib	CTK	100.0	1000.0
XMD14-99	MP2K4	70.0	10000.0
AZ-628	KC1G1	88.0	10000.0
TAK-715	EPHB1	83.0	10000.0
XMD8-92	EGFR(L747-T751del,Sins)	100.0	10000.0
JW-7-24-1	KIT(V559D,T670I)	100.0	10000.0
WZ4002	RIOK2	12.0	10000.0
BMX-IN-1	CDKL2	93.0	10000.0
BGJ398	BIKE	83.0	1000.0
Crizotinib	KIT(L576P)	43.0	10000.0
Torin1	NLK	25.0	10000.0
Crizotinib	MLK3	81.0	10000.0
Palbociclib	BRAF	96.0	1000.0
Omipalisib	ABL1(M351T)-phosphorylated	61.0	10000.0
XMD8-92	FLT4	100.0	10000.0
Palbociclib	KIT(V559D)	100.0	1000.0
QL-X-138	KIT(V559D,T670I)	96.0	10000.0
Baricitinib	EPHB2	100.0	10000.0
Barasertib	MAP3K15	100.0	10000.0
Omipalisib	ABL2	82.0	10000.0
WZ3105	PHKG1	57.0	10000.0
WZ-7043	IRAK1	100.0	10000.0
AS-252424	PRKR	100.0	10000.0
Vemurafenib	TYRO3	100.0	10000.0
Palbociclib	KIT(V559D,T670I)	100.0	1000.0
HG-9-91-01	EGFR(L858R,T790M)	0.1	10000.0
Sorafenib	TESK1	62.0	10000.0
QL-X-138	HCK	100.0	10000.0
JWE-035	BMPR1B	8.2	10000.0
QL-X-138	VRK2	88.0	10000.0
KIN001-111	EPHB2	100.0	1000.0
GW-5074	JNK3	60.0	10000.0
Ceritinib	MK14	100.0	1000.0
MLN8054	DRAK2	8.6	10000.0
Torin1	PAK1	73.0	10000.0
Ribociclib	KCC2D	38.0	1000.0
BX-912	ERBB2	88.0	10000.0
A443654	DDR2	100.0	10000.0
Vemurafenib	NEK9	98.0	10000.0
R406	ERK5	100.0	1000.0
THZ1	GRK4	3.3	10000.0
JNK-IN-8	MAST1	97.0	1000.0
CH5424802	DAPK3	1.3	1000.0
PHA-767491	ZAP70	95.0	10000.0
SCH772984	WNK3	100.0	1000.0
SP600125	DAPK3	3.2	10000.0
Omipalisib	BMPR1B	68.0	10000.0
WZ-4-145	KKCC1	100.0	10000.0
Torin2	ANKK1	100.0	10000.0
HG-5-88-01	FGFR2	100.0	10000.0
NU7441	PIK3CA(Q546K)	16.0	10000.0
AZD4547	JAK1(JH1domain-catalytic)	59.0	10000.0
PLX-4720	CIT	66.0	10000.0
OTSSP167	MINK	1.6	10000.0
CGP74514A	AAK1	98.0	10000.0
Pictilisib	M3K13	100.0	1000.0
Ceritinib	KPCE	99.0	1000.0
PD173074	AURKA	100.0	10000.0
WYE-125132	DYRK2	90.0	10000.0
KIN001-021	TNK1	100.0	1000.0
Torkinib	PIK3CA(Q546K)	26.0	10000.0
Torkinib	ZAP70	99.0	10000.0
Torin2	PKAC-alpha	100.0	10000.0
KIN001-220	TRKB	27.0	10000.0
KIN001-127	KGP2	100.0	10000.0
WYE-125132	GRK1	100.0	10000.0
WZ4002	RIOK3	20.0	10000.0
Ceritinib	EPHB3	93.0	1000.0
HG-5-113-01	MAP3K4	100.0	10000.0
PHA-767491	ICK	24.0	10000.0
XMD13-2	TIE2	54.0	10000.0
AZD 5438	MAPKAPK2	100.0	10000.0
NG25	EGFR(G719S)	13.0	10000.0
QL-XII-47	GRK4	100.0	1000.0
SP600125	ROS1	100.0	10000.0
ALW-II-49-7	STK16	100.0	10000.0
Lapatinib	YANK3	93.0	10000.0
MRT67307	PHKG1	11.0	10000.0
Neratinib	MST1R	100.0	10000.0
NVP-TAE684	EGFR(G719C)	9.9	1000.0
XMD11-85h	KIT(D816V)	100.0	10000.0
AZD-6482	NEK9	100.0	10000.0
PHA-767491	MK11	100.0	10000.0
MRT67307	PIM1	100.0	10000.0
NU7441	RSK1(Kin.Dom.1-N-terminal)	100.0	10000.0
Torkinib	PLK3	33.0	10000.0
ALW-II-38-3	MAPKAPK5	100.0	10000.0
Buparlisib	ACVRL1	99.0	1000.0
ERK5-IN-1	DCLK1	62.0	1000.0
Abemaciclib	PIP5K1A	51.0	1000.0
BMX-IN-1	EPHA3	92.0	10000.0
WZ3105	DAPK2	37.0	10000.0
Sigma A6730	PFPK5(P.falciparum)	100.0	10000.0
THZ1	KC1G1	56.0	10000.0
PHA-767491	RET(V804L)	100.0	10000.0
MLN8054	MAP3K1	100.0	10000.0
Dabrafenib	CDK11	0.6	10000.0
ALW-II-49-7	MP2K3	100.0	10000.0
WH-4-023	HIPK2	100.0	10000.0
Ibrutinib	MYLK4	100.0	1000.0
WZ-7043	SRPK3	100.0	10000.0
JWE-035	PKN2	55.0	10000.0
AZD 5438	DRAK1	0.1	10000.0
AZD4547	TIE1	0.3	10000.0
HG-14-10-04	CLK4	0.8	10000.0
Dactolisib	RIPK1	100.0	1000.0
XMD13-2	ERN1	100.0	10000.0
Alpelisib	BRAF(V600E)	100.0	1000.0
SB590885	IKKB	100.0	10000.0
A443654	NEK7	100.0	10000.0
ALW-II-49-7	KGP1	100.0	10000.0
ZG-10	PIK3CA(Q546K)	100.0	10000.0
BI-2536	M3K12	100.0	10000.0
KIN001-220	JAK1(JH2domain-pseudokinase)	3.0	10000.0
XMD8-85	IKKB	100.0	10000.0
R406	TYK2(Kin.Dom.2)	0.0	1000.0
PLX-4720	KIT(V559D,T670I)	46.0	10000.0
CGP60474	NEK5	100.0	10000.0
CGP74514A	CSF1R	21.0	10000.0
Ibrutinib	PKAC-alpha	80.0	1000.0
AZD 5438	SGK3	25.0	10000.0
Seliciclib	FGFR1	98.0	10000.0
XMD11-50	PIK3CA(Q546K)	91.0	10000.0
PHA-767491	BRSK1	76.0	10000.0
MPS-1-IN-1	ACVRL1	100.0	1000.0
Canertinib	CSF1R	100.0	1000.0
XMD16-144	ERBB2	65.0	10000.0
XMD11-50	FLT3(D835Y)	100.0	10000.0
OTSSP167	FGFR3(G697C)	29.0	10000.0
MPS-1-IN-1	RIPK4	100.0	1000.0
PD173074	EPHB4	100.0	10000.0
(s)-CR8	PIK3CA(E542K)	100.0	10000.0
HG-14-10-04	MK09	0.0	10000.0
KIN001-123	TNK1	100.0	1000.0
NU7441	GRK7	92.0	10000.0
KIN001-021	PLK4	100.0	1000.0
AS-252424	ABL1(E255K)	100.0	10000.0
Palbociclib	M3K2	82.0	1000.0
Pictilisib	WNK4	100.0	1000.0
Alpelisib	BIKE	94.0	1000.0
Dabrafenib	TGFBR2	4.0	10000.0
AZD7762	KIT(A829P)	23.0	10000.0
THZ1	M3K12	49.0	10000.0
BGJ398	JNK3	76.0	1000.0
A443654	MK12	15.0	10000.0
QL-XII-47	FES	94.0	1000.0
Abemaciclib	PCTK2	4.3	1000.0
Seliciclib	IKKA	83.0	10000.0
Dabrafenib	FGFR1	66.0	10000.0
Palbociclib	PIK3CA(H1047L)	100.0	1000.0
Barasertib	LCK	2.2	10000.0
AS-252424	PKMYT1	90.6	10000.0
Ibrutinib	CAMK1G	73.0	1000.0
JNK-IN-5A	MST3	80.0	10000.0
QL-X-138	MKNK1	39.0	10000.0
ZG-10	CSNK1D	20.0	10000.0
KIN001-220	DMPK	100.0	10000.0
KU63794	PFPK5(P.falciparum)	90.0	10000.0
Abemaciclib	KC1G2	82.0	1000.0
Crizotinib	KIT(V559D,T670I)	7.0	10000.0
WZ3105	CSNK1A1L	1.5	10000.0
KIN001-123	IGF1R	100.0	1000.0
AZD-6482	EGFR	96.0	10000.0
JNK-IN-5A	EGFR(L747-E749del,A750P)	58.0	10000.0
ALW-II-49-7	TLK1	100.0	10000.0
Pictilisib	ERK4	100.0	1000.0
OTSSP167	DRAK1	9.6	10000.0
AZD-6482	PIK3CA(H1047L)	0.0	10000.0
ALW-II-38-3	M4K1	100.0	10000.0
BMS345541	PIK3CA(E542K)	100.0	10000.0
MLN8054	DAPK1	48.0	10000.0
Sorafenib	TNIK	27.0	10000.0
NPK76-II-72-1	BRSK1	100.0	10000.0
WZ3105	NUAK1	93.0	10000.0
HG-14-10-04	PHKG1	0.2	10000.0
CP724714	CDK7	100.0	10000.0
Ribociclib	TYK2(JH1domain-catalytic)	91.0	1000.0
PLX-4720	CDKL3	100.0	10000.0
AZD7762	FES	0.7	10000.0
Ribociclib	RIPK4	64.0	1000.0
MRT67307	AURKC	2.7	10000.0
XMD11-50	TRKC	100.0	10000.0
TGX221	BRSK2	100.0	1000.0
WZ-4-145	CDC2L2	100.0	10000.0
Taselisib	KPCE	85.0	1000.0
BMS-536924	EGFR(S752-I759del)	16.0	1000.0
Sorafenib	SIK1	100.0	10000.0
THZ1	ABL1(M351T)-phosphorylated	0.8	10000.0
XMD-12	INSRR	96.0	1000.0
WZ-4-145	ERK4	100.0	10000.0
AZ-628	CDKL2	85.0	10000.0
KU63794	FGFR1	100.0	10000.0
BI-2536	JAK1(Kin.Dom.2)	100.0	10000.0
ALW-II-49-7	FLT3(N841I)	100.0	10000.0
WZ3105	CAMK2A	34.0	10000.0
ALW-II-38-3	HIPK3	100.0	10000.0
ZG-10	ABL1(T315I)-phosphorylated	32.0	10000.0
KIN001-123	EGFR(L858R)	100.0	1000.0
WZ-4-145	MK01	100.0	10000.0
MRT67307	PIK3CA(E545K)	100.0	10000.0
R406	ERK4	100.0	1000.0
HG-6-64-01	IRAK1	26.0	10000.0
TGX221	KIT(V559D,T670I)	100.0	1000.0
QL-XII-47	NIM1	100.0	1000.0
HG-9-91-01	CDK16	100.0	10000.0
WZ-7043	KCC4	100.0	10000.0
Dinaciclib	DCAMKL2	36.0	10000.0
JNK-9L	KGP2	74.0	10000.0
KU63794	PAK1	84.0	10000.0
SCH772984	DCAMKL3	93.0	1000.0
XMD13-2	YANK1	78.0	10000.0
CGP60474	DMPK2	100.0	10000.0
Ceritinib	TYRO3	94.0	1000.0
AZD7762	YANK3	53.0	10000.0
WZ-7043	PIK3CA(H1047Y)	100.0	10000.0
CGP60474	MAP3K3	100.0	10000.0
SB590885	KIT(V559D,T670I)	93.0	10000.0
WZ4002	PAK7	100.0	10000.0
AG1478	CDK4-cyclinD1	90.0	10000.0
SB590885	RET(V804M)	92.0	10000.0
KIN001-127	M4K1	25.0	10000.0
QL-XII-47	FLT3-autoinhibited	95.0	1000.0
XMD8-92	MK12	100.0	10000.0
BX-912	PIK3CA(H1047Y)	62.0	10000.0
NU7441	DMPK2	100.0	10000.0
BI-D1870	BLK	11.0	10000.0
Torin1	BIKE	100.0	10000.0
GSK1059615	ABL1-nonphosphorylated	59.0	10000.0
ZSTK474	TLK2	100.0	1000.0
(s)-CR8	RIOK1	74.0	10000.0
PD173074	SRMS	100.0	10000.0
GW843682X	TRPM6	100.0	10000.0
Dinaciclib	BRSK1	84.0	10000.0
GSK429286A	PIK3CA(C420R)	63.0	10000.0
MPS-1-IN-1	AURKA	100.0	1000.0
AZD4547	PIK3CA(I800L)	61.0	10000.0
BX-912	IKKA	4.1	10000.0
GSK461364	CAMK1	90.0	10000.0
HG-9-91-01	SYK	54.0	10000.0
MLN8054	PLK1	100.0	10000.0
XMD-12	STK33	75.0	1000.0
QL-XI-92	PKN2	100.0	10000.0
KIN001-021	ROCK2	100.0	1000.0
Alpelisib	ABL1-phosphorylated	10.0	1000.0
Omipalisib	MAP3K3	69.0	10000.0
Canertinib	EPHA3	100.0	1000.0
ZG-10	MARK3	100.0	10000.0
JNK-IN-11	MRCKB	16.0	1000.0
ZG-10	FGFR1	89.0	10000.0
Ibrutinib	MYLK	99.0	1000.0
JNK-IN-11	PIK3CA(E545K)	100.0	1000.0
JNK-9L	PGFRA	1.2	10000.0
XMD13-2	AURKA	86.0	10000.0
CH5424802	BARK1	93.0	1000.0
WZ3105	PCTK2	100.0	10000.0
QL-XI-92	S6K1	87.0	10000.0
BX-912	MAP4K5	9.6	10000.0
AZD7762	INSR	27.0	10000.0
XMD14-99	LATS2	100.0	10000.0
OTSSP167	TNIK	5.1	10000.0
GSK1059615	EPHA7	88.0	10000.0
NVP-TAE684	MLK3	20.0	1000.0
Pictilisib	FLT3-autoinhibited	100.0	1000.0
BMS345541	ACVRL1	93.0	10000.0
OTSSP167	PIK3CA	5.4	10000.0
JNK-IN-8	TNNI3K	100.0	1000.0
PHA-793887	MP2K2	97.0	10000.0
Crizotinib	IGF1R	0.9	10000.0
ZG-10	TEC	100.0	10000.0
BI-D1870	MP2K4	0.4	10000.0
XMD16-144	SIK3	20.0	10000.0
Alpelisib	MP2K5	100.0	1000.0
Baricitinib	ABL1(E255K)-phosphorylated	6.0	10000.0
Barasertib	MST4	37.0	10000.0
JNK-IN-5A	CDK15	69.0	10000.0
MLN8054	EPHB6	41.0	10000.0
JW-7-24-1	FGFR1	100.0	10000.0
Dabrafenib	PIK3CA(E545A)	100.0	10000.0
XMD-12	ERK3	97.0	1000.0
JNK-9L	CDKL1	34.0	10000.0
Baricitinib	EGFR(L747-E749del,A750P)	70.0	10000.0
BI-D1870	MLK1	19.0	10000.0
CP466722	CSNK1E	1.6	10000.0
Dabrafenib	FLT3(D835H)	66.0	10000.0
CP724714	KPCT	100.0	10000.0
GSK1059615	ABL1(T315I)-phosphorylated	60.0	10000.0
SP600125	PAK6	100.0	10000.0
SCH772984	HCK	54.0	1000.0
JNK-IN-8	VRK2	97.0	1000.0
WH-4-023	DDR2	0.0	10000.0
CP466722	KPCI	55.0	10000.0
HG-14-8-02	MUSK	95.0	10000.0
Dactolisib	JAK1(JH2domain-pseudokinase)	100.0	1000.0
WH-4-023	PI42C	100.0	10000.0
CP724714	TYRO3	80.0	10000.0
Torin2	SRPK3	95.0	10000.0
Ibrutinib	SGK2	68.0	1000.0
KIN001-111	BLK	0.1	1000.0
OTSSP167	MARK4	31.0	10000.0
AZD-6482	EPHB4	96.0	10000.0
HG-14-10-04	KPCE	37.0	10000.0
WZ-7043	JAK1(JH2domain-pseudokinase)	100.0	10000.0
Taselisib	M4K1	72.0	1000.0
BMX-IN-1	PLK3	100.0	10000.0
BI-D1870	SRPK1	4.6	10000.0
Buparlisib	PKNB(M.tuberculosis)	100.0	1000.0
HG-6-64-01	DYRK2	78.0	10000.0
QL-XI-92	STK33	100.0	10000.0
AZD-6482	MRCKB	100.0	10000.0
Sorafenib	TYK2(JH1domain-catalytic)	70.0	10000.0
XMD16-144	KCC4	100.0	10000.0
PD0325901	DDR1	50.0	10000.0
MLN8054	ABL1-phosphorylated	8.6	10000.0
Pictilisib	IRAK3	97.0	1000.0
JNK-9L	SNRK	90.0	10000.0
AS-252424	PIK3CG	4.0	10000.0
Pictilisib	CDK11	99.0	1000.0
XMD11-50	EPHB2	100.0	10000.0
Torkinib	MST1	84.0	10000.0
KIN001-021	EGFR(G719C)	100.0	1000.0
5z-7-oxozeaenol	PLK4	55.0	10000.0
XMD-12	MTOR	75.0	1000.0
QL-XII-47	SRC	94.0	1000.0
HG-14-10-04	PAK6	17.0	10000.0
HG-5-113-01	PAK4	18.0	10000.0
Dactolisib	CSNK1A1L	100.0	1000.0
BMX-IN-1	JAK2(JH1domain-catalytic)	100.0	10000.0
(s)-CR8	CASK	81.0	10000.0
JNK-9L	EPHA7	85.0	10000.0
A443654	ITK	100.0	10000.0
KIN001-111	EGFR(L858R)	2.3	1000.0
ALW-II-38-3	CTK	100.0	10000.0
KIN001-127	ULK1	25.0	10000.0
NG25	MLTK	0.4	10000.0
ZM-447439	SRPK1	100.0	10000.0
QL-XII-47	TNK2	100.0	1000.0
ALW-II-38-3	ULK2	100.0	10000.0
PD173074	ADCK4	100.0	10000.0
GW-5074	MAPKAPK5	100.0	10000.0
Baricitinib	FGFR3	81.0	10000.0
Vemurafenib	EPHA6	100.0	10000.0
CH5424802	RET(V804M)	0.6	1000.0
Torkinib	RSK1(Kin.Dom.1-N-terminal)	32.0	10000.0
AZD-6482	BLK	99.0	10000.0
WZ3105	FGFR2	62.0	10000.0
BI-2536	TSSK1	100.0	10000.0
Ibrutinib	PIM1	94.0	1000.0
Seliciclib	BUB1	98.0	10000.0
MLN8054	JNK3	100.0	10000.0
JNK-IN-5A	RIOK3	100.0	10000.0
JNK-IN-5A	CDC2L1	95.0	10000.0
ZSTK474	PLK3	100.0	1000.0
Ceritinib	TSSK3	60.0	1000.0
Torin2	RET(V804M)	100.0	10000.0
TAK-715	GSK3A	100.0	10000.0
WZ4002	AMPK-alpha1	28.0	10000.0
OTSSP167	TAOK1	0.5	10000.0
Neratinib	WEE1	57.0	10000.0
SP600125	AKT1	100.0	10000.0
Buparlisib	JAK1(JH1domain-catalytic)	100.0	1000.0
NPK76-II-72-1	CLK2	6.2	10000.0
Seliciclib	PIM3	86.0	10000.0
Dactolisib	FGFR2	100.0	1000.0
QL-XII-47	SRPK1	100.0	1000.0
CH5424802	LIMK2	100.0	1000.0
GSK429286A	EGFR(L747-E749del,A750P)	36.0	10000.0
ZSTK474	DCAMKL2	100.0	1000.0
Alpelisib	CDKL1	97.0	1000.0
QL-X-138	IRAK4	36.0	10000.0
AZD-6482	DCAMKL3	85.0	10000.0
THZ1	ABL1(F317I)-nonphosphorylated	52.0	10000.0
HG-14-8-02	ABL1(E255K)-phosphorylated	23.0	10000.0
KIN001-021	PIK3CA(E545K)	100.0	1000.0
Palbociclib	RSK2(Kin.Dom.1-N-terminal)	62.0	1000.0
JW-7-24-1	PAK7	100.0	10000.0
JNK-9L	CAMK2G	32.0	10000.0
Palbociclib	M3K12	100.0	1000.0
Pictilisib	MLK3	66.0	1000.0
PHA-793887	RSK2(Kin.Dom.1-N-terminal)	11.0	10000.0
5z-7-oxozeaenol	DYRK1A	100.0	10000.0
KU63794	PIK3CG	23.0	10000.0
ZG-10	DCAMKL3	100.0	10000.0
GW843682X	TAK1	66.0	10000.0
WH-4-023	KIT	0.5	10000.0
ZSTK474	ULK3	100.0	1000.0
Sigma A6730	TIE2	85.0	10000.0
Ribociclib	GCN2(Kin.Dom.2,S808G)	100.0	1000.0
MPS-1-IN-1	FGFR2	100.0	1000.0
GSK429286A	CDK11	80.0	10000.0
MRT67307	INSR	100.0	10000.0
Neratinib	MP2K4	72.0	10000.0
TGX221	HIPK1	100.0	1000.0
ZM-447439	MK12	49.0	10000.0
Ribociclib	JNK3	100.0	1000.0
AZD4547	CSNK1A1L	100.0	10000.0
XMD-12	NIM1	91.0	1000.0
ZM-447439	BMX	81.0	10000.0
CH5424802	ADCK4	100.0	1000.0
TGX221	CDK9	100.0	1000.0
AZD 5438	M3K6	91.0	10000.0
WZ4003	ZAP70	100.0	1000.0
Palbociclib	TGFBR1	96.0	1000.0
Omipalisib	MKNK2	55.0	10000.0
PLX-4720	KPCT	79.0	10000.0
PHA-767491	M4K1	53.0	10000.0
KIN001-127	EPHA3	25.0	10000.0
Dactolisib	DRAK1	100.0	1000.0
HG-6-64-01	PKN2	26.0	10000.0
Canertinib	DDR2	100.0	1000.0
JNK-IN-5A	VGFR1	87.0	10000.0
XMD-12	KIT(V559D,T670I)	73.0	1000.0
CP724714	MYLK	87.0	10000.0
ZSTK474	EPHA8	100.0	1000.0
HG-14-8-02	MP2K6	99.0	10000.0
R406	AURKC	0.3	1000.0
BS-181	RAF1	100.0	10000.0
JNK-IN-5A	MARK1	100.0	10000.0
Ibrutinib	ACVRL1	100.0	1000.0
THZ1	MLCK	37.0	10000.0
JW-7-24-1	CAMKK2	100.0	10000.0
TAK-715	BRAF(V600E)	23.0	10000.0
Dabrafenib	ABL1(T315I)-phosphorylated	98.0	10000.0
GW843682X	LKB1	37.0	10000.0
AZD7762	PKAC-beta	1.8	10000.0
ZM-447439	MYLK2	100.0	10000.0
PLX-4720	CDK11	0.8	10000.0
Abemaciclib	IRAK1	0.2	1000.0
HG-9-91-01	MP2K7	100.0	10000.0
WZ-4-145	RIOK2	100.0	10000.0
WZ3105	PIK3CA(E545A)	100.0	10000.0
KIN001-021	MKNK2	100.0	1000.0
AZ-628	MP2K5	0.7	10000.0
JWE-035	MAST1	100.0	10000.0
5z-7-oxozeaenol	MST4	62.0	10000.0
KIN001-123	KPCT	100.0	1000.0
AG1478	CDKL1	90.0	10000.0
BX-912	EPHB4	78.0	10000.0
JNK-9L	M4K1	26.0	10000.0
Ibrutinib	ACVR2B	90.0	1000.0
WH-4-023	EGFR	0.4	10000.0
Abemaciclib	FGFR2	95.0	1000.0
CP466722	M3K13	96.0	10000.0
Buparlisib	BUB1	100.0	1000.0
OTSSP167	PAK6	100.0	10000.0
XMD14-99	KCC4	99.0	10000.0
Buparlisib	MYO3A	100.0	1000.0
Dinaciclib	TGFBR2	79.0	10000.0
GSK1059615	FLT3(D835H)	31.0	10000.0
JNK-9L	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
Sigma A6730	EPHB1	100.0	10000.0
AZ-628	CHK2	92.0	10000.0
NG25	EPHA3	3.4	10000.0
JWE-035	ACVR1	52.0	10000.0
JNK-9L	TNIK	26.0	10000.0
XMD16-144	ITK	58.0	10000.0
CP724714	AURKC	67.0	10000.0
BMX-IN-1	ACVR2A	88.0	10000.0
JWE-035	RET(V804L)	0.9	10000.0
HG-14-10-04	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
WH-4-023	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
BX-912	VGFR2	1.8	10000.0
BS-181	MK11	98.0	10000.0
Dinaciclib	FLT3(D835Y)	100.0	10000.0
CG-930	DRAK1	100.0	10000.0
WYE-125132	MET(Y1235D)	24.0	10000.0
Baricitinib	BMPR2	11.0	10000.0
HG-9-91-01	KPCL	100.0	10000.0
Alpelisib	FGFR3	99.0	1000.0
Seliciclib	RET	100.0	10000.0
ZG-10	PIK3CB	100.0	10000.0
Taselisib	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	1000.0
MRT67307	FGFR2	46.0	10000.0
XMD11-50	TAOK3	24.0	10000.0
XMD-12	KPCL	100.0	1000.0
SP600125	PIK3CA(E545K)	100.0	10000.0
CP724714	EGFR(L858R)	0.6	10000.0
WZ4003	KIT(D816V)	10.0	1000.0
Vemurafenib	MARK1	100.0	10000.0
AZD-6482	CDK2	93.0	10000.0
Dactolisib	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	1000.0
ERK5-IN-1	ABL1-nonphosphorylated	96.0	1000.0
Palbociclib	CSNK2A2	13.0	1000.0
TAK-715	DAPK1	72.0	10000.0
Dactolisib	FGR	100.0	1000.0
BX-912	MELK	2.2	10000.0
MRT67307	DMPK2	89.0	10000.0
SP600125	DDR1	100.0	10000.0
JNK-IN-8	PIK3C2B	100.0	1000.0
XMD14-99	SBK1	80.0	10000.0
BS-181	ROS1	92.0	10000.0
CP724714	PAK7	87.0	10000.0
Omipalisib	DAPK3	57.0	10000.0
GW-5074	PFPK5(P.falciparum)	90.0	10000.0
SCH772984	NEK2	92.0	1000.0
Ibrutinib	RIPK4	92.0	1000.0
NG25	TGFBR1	100.0	10000.0
OTSSP167	SIK1	1.3	10000.0
Baricitinib	CDKL3	99.0	10000.0
NG25	KPCD3	100.0	10000.0
MPS-1-IN-1	RPS6KA1(Kin.Dom.2)	100.0	1000.0
QL-XII-47	FLT3(K663Q)	100.0	1000.0
Torin2	PIK3CA(E545K)	0.3	10000.0
NG25	MST1R	100.0	10000.0
JW-7-24-1	DCLK1	100.0	10000.0
Ceritinib	MAP3K1	92.0	1000.0
KIN001-021	SRMS	26.0	1000.0
Barasertib	ABL1(Q252H)-phosphorylated	32.0	10000.0
BX-912	KGP1	72.0	10000.0
KIN001-123	RIPK2	100.0	1000.0
HG-14-10-04	EGFR(T790M)	0.0	10000.0
JNK-IN-8	JAK1(JH2domain-pseudokinase)	91.0	1000.0
CP466722	SBK1	100.0	10000.0
KU63794	JAK2(JH1domain-catalytic)	71.0	10000.0
OTSSP167	PGFRB	1.8	10000.0
Taselisib	MARK3	100.0	1000.0
CGP60474	FYN	100.0	10000.0
Dinaciclib	MRCKA	100.0	10000.0
QL-XII-47	CSNK1A1L	100.0	1000.0
Sigma A6730	ERK8	100.0	10000.0
Barasertib	PIK3CA(E542K)	100.0	10000.0
XMD16-144	CDK4-cyclinD1	78.0	10000.0
Lapatinib	PKN1	99.0	10000.0
R406	JNK3	11.0	1000.0
WH-4-023	MK01	87.0	10000.0
JNK-9L	PIK3CA(M1043I)	100.0	10000.0
RO-3306	TLK1	95.0	10000.0
SP600125	ERK5	100.0	10000.0
GW-5074	SRPK1	40.0	10000.0
Seliciclib	TESK1	100.0	10000.0
OTSSP167	TAOK3	0.2	10000.0
BX-912	GRK7	34.0	10000.0
AS-252424	KPCD1	72.6	10000.0
SCH772984	SIK3	100.0	1000.0
Vemurafenib	CLK4	100.0	10000.0
Ibrutinib	MLK2	91.0	1000.0
WH-4-023	FES	0.4	10000.0
WZ-7043	PRKR	100.0	10000.0
ZSTK474	PKAC-alpha	100.0	1000.0
THZ1	KPCE	100.0	10000.0
THZ1	KC1G2	45.0	10000.0
Dabrafenib	IKKB	68.0	10000.0
WZ-7043	GCN2(Kin.Dom.2,S808G)	9.5	10000.0
RO-3306	CDC2L5	95.0	10000.0
KU63794	KIT(L576P)	93.0	10000.0
PHA-793887	IKKB	72.0	10000.0
NU7441	AAK1	87.0	10000.0
Buparlisib	RPS6KA4(Kin.Dom.1-N-terminal)	76.0	1000.0
CH5424802	HASP	100.0	1000.0
TAK-715	M3K13	100.0	10000.0
XMD-12	ROS1	35.0	1000.0
Sorafenib	PAK7	100.0	10000.0
Torkinib	CTK	60.0	10000.0
XMD11-85h	CDK16	100.0	10000.0
XMD8-92	FGFR2	100.0	10000.0
NG25	MLCK	100.0	10000.0
Vemurafenib	BMX	57.0	10000.0
ZM-447439	ZAP70	100.0	10000.0
SP600125	CLK1	100.0	10000.0
OTSSP167	PRKR	61.0	10000.0
(s)-CR8	FLT3(ITD)	86.0	10000.0
Buparlisib	CDK4-cyclinD3	100.0	1000.0
OTSSP167	PIK3CA(M1043I)	42.0	10000.0
HG-6-64-01	TLK2	93.0	10000.0
HG-6-64-01	SIK2	30.0	10000.0
PLX-4720	PRP4	82.0	10000.0
HG-14-10-04	FLT3-autoinhibited	0.3	10000.0
CG-930	BRSK2	99.0	10000.0
QL-XII-47	LYN	100.0	1000.0
KU63794	NEK7	100.0	10000.0
XMD13-2	MYLK2	12.0	10000.0
CGP60474	KPCD3	100.0	10000.0
Crizotinib	PIP5K2B	3.8	10000.0
XMD8-92	EPHA6	100.0	10000.0
HG-6-64-01	MLTK	0.8	10000.0
THZ1	JAK1(JH1domain-catalytic)	0.3	10000.0
HG-5-88-01	IGF1R	0.7	10000.0
CH5424802	AURKA	99.0	1000.0
SCH772984	PRKR	23.0	1000.0
HG-5-113-01	KIT(V559D,V654A)	100.0	10000.0
GSK429286A	MST4	24.0	10000.0
GW843682X	NEK1	65.0	10000.0
Crizotinib	NEK2	81.0	10000.0
GW-5074	CDKL3	88.0	10000.0
JWE-035	MP2K3	74.0	10000.0
CP466722	CLK3	3.6	10000.0
PD0325901	TSSK1	100.0	10000.0
WH-4-023	SIK1	0.3	10000.0
HG-6-64-01	CSNK1D	38.0	10000.0
HG-9-91-01	BIKE	8.8	10000.0
BMS-536924	MLK3	0.3	1000.0
XMD11-85h	EPHA2	100.0	10000.0
XMD16-144	VGFR2	90.0	10000.0
XMD14-99	ABL1(F317L)-nonphosphorylated	80.0	10000.0
RO-3306	CLK1	0.4	10000.0
GW-5074	YSK1	100.0	10000.0
BMX-IN-1	ABL1(H396P)-phosphorylated	100.0	10000.0
JNK-IN-11	MST1R	100.0	1000.0
Torin2	CDKL5	100.0	10000.0
NVP-TAE684	CDK8	100.0	1000.0
QL-XI-92	MAP3K4	100.0	10000.0
BMX-IN-1	ULK2	92.0	10000.0
HG-5-113-01	EPHA6	29.0	10000.0
SP600125	SYK	100.0	10000.0
GW843682X	HIPK1	84.0	10000.0
BGJ398	TNK1	66.0	1000.0
RO-3306	EGFR(G719C)	42.0	10000.0
CGP74514A	RIOK2	67.0	10000.0
JNK-IN-11	PIK3CA(M1043I)	100.0	1000.0
5z-7-oxozeaenol	MK12	81.0	10000.0
(s)-CR8	M4K1	100.0	10000.0
WZ4003	FGFR2	100.0	1000.0
HG-5-113-01	DDR2	100.0	10000.0
QL-XII-47	PKAC-beta	73.0	1000.0
Alpelisib	MST3	100.0	1000.0
HG-5-88-01	STK33	4.5	10000.0
GSK461364	ABL1-nonphosphorylated	75.0	10000.0
ZG-10	EGFR	100.0	10000.0
ZM-447439	PIM3	100.0	10000.0
GSK1059615	IRAK1	0.3	10000.0
Torin2	CDK2	67.0	10000.0
XMD11-85h	PRP4	100.0	10000.0
BMS-536924	MK12	100.0	1000.0
AZ-628	GRK1	100.0	10000.0
OTSSP167	LIMK1	73.0	10000.0
SB590885	PTK6	82.0	10000.0
PHA-767491	ROCK1	0.3	10000.0
NU7441	TAK1	100.0	10000.0
BMX-IN-1	TTK	52.0	10000.0
AZD4547	NEK5	75.0	10000.0
Taselisib	LRRK2	100.0	1000.0
Ibrutinib	EGFR(G719S)	0.9	1000.0
Torin2	FGFR2	90.0	10000.0
GW-5074	EGFR(T790M)	65.0	10000.0
BGJ398	DRAK1	100.0	1000.0
Lapatinib	RSK1(Kin.Dom.1-N-terminal)	81.0	10000.0
AZD 5438	ACVR2A	19.0	10000.0
BGJ398	PRKX	100.0	1000.0
QL-X-138	FGFR1	80.0	10000.0
GSK1059615	CSK	80.0	10000.0
GSK461364	TIE1	20.0	10000.0
ALW-II-49-7	AMPK-alpha1	100.0	10000.0
XMD11-50	NLK	50.0	10000.0
HG-5-88-01	MK03	100.0	10000.0
CH5424802	INSRR	45.0	1000.0
XMD8-92	MST1R	100.0	10000.0
CG-930	GRK1	78.0	10000.0
THZ1	PIK3CA(C420R)	100.0	10000.0
GSK1059615	MYO3A	85.0	10000.0
HG-5-113-01	EPHB4	100.0	10000.0
BMS-536924	DMPK	100.0	1000.0
AS-252424	CIT	0.2	10000.0
Dinaciclib	NEK10	24.0	10000.0
WYE-125132	RET(V804M)	100.0	10000.0
Lapatinib	PAK1	90.0	10000.0
Dabrafenib	DRAK1	100.0	10000.0
BS-181	CDC2L2	92.0	10000.0
XMD16-144	MAPKAPK5	85.0	10000.0
QL-X-138	EGFR(L747-S752del,P753S)	53.0	10000.0
RO-3306	FES	85.0	10000.0
AZD-6482	ABL1(Q252H)-phosphorylated	100.0	10000.0
HG-6-64-01	CLK4	100.0	10000.0
ZM-447439	CAMK2A	85.0	10000.0
Dinaciclib	STK36	7.8	10000.0
CG-930	S6K1	80.0	10000.0
NVP-TAE684	INSRR	0.4	1000.0
QL-XII-47	DCAMKL3	100.0	1000.0
Abemaciclib	FLT3(R834Q)	100.0	1000.0
BS-181	TNK1	100.0	10000.0
Ribociclib	RSK1(Kin.Dom.2-C-terminal)	86.0	1000.0
PHA-767491	CAMK1G	74.0	10000.0
AZ-628	KIT(L576P)	0.6	10000.0
Vemurafenib	STK33	94.0	10000.0
Vemurafenib	MINK	38.0	10000.0
AZD 5438	FAK1	30.0	10000.0
Torin1	MLK3	69.0	10000.0
Torin1	NEK6	99.0	10000.0
XMD-12	EPHA6	100.0	1000.0
QL-XI-92	CSNK1D	100.0	10000.0
JNK-IN-5A	HCK	92.0	10000.0
WZ4002	FLT3(N841I)	0.3	10000.0
ERK5-IN-1	MK09	63.0	1000.0
HG-14-8-02	EPHB3	100.0	10000.0
HG-14-8-02	SRPK3	84.0	10000.0
HG-6-64-01	ABL1(H396P)-phosphorylated	0.1	10000.0
Pictilisib	MK13	99.0	1000.0
Dactolisib	HIPK4	100.0	1000.0
Taselisib	MP2K3	97.0	1000.0
XMD11-50	JNK1	95.0	10000.0
AZD7762	MK12	89.0	10000.0
MLN8054	ITK	100.0	10000.0
SP600125	FGFR3	100.0	10000.0
Dabrafenib	EPHA4	83.0	10000.0
KIN001-220	ABL1(E255K)-phosphorylated	6.2	10000.0
Dactolisib	EPHA8	100.0	1000.0
WYE-125132	IRAK3	100.0	10000.0
AZD 5438	CSF1R	16.0	10000.0
HG-6-64-01	MYO3A	28.0	10000.0
CGP74514A	M3K2	1.6	10000.0
HG-14-8-02	DAPK1	7.8	10000.0
AG1478	CDC2L5	91.0	10000.0
HG-9-91-01	GRK7	100.0	10000.0
XMD8-92	DCLK1	0.9	10000.0
GSK429286A	PLK4	86.0	10000.0
CP466722	ERK5	83.0	10000.0
5z-7-oxozeaenol	PDPK1	72.0	10000.0
Buparlisib	STK36	100.0	1000.0
Sigma A6730	SRMS	65.0	10000.0
WH-4-023	KPCD1	9.3	10000.0
NG25	EGFR(S752-I759del)	3.7	10000.0
GW-5074	KIT(V559D,T670I)	23.0	10000.0
MLN8054	BRAF(V600E)	100.0	10000.0
Sorafenib	MAP3K1	64.0	10000.0
CG-930	TRKC	100.0	10000.0
QL-XI-92	STK35	100.0	10000.0
MLN8054	MK11	99.0	10000.0
KIN001-021	BRAF(V600E)	100.0	1000.0
Crizotinib	PIK3CA(H1047Y)	18.0	10000.0
TGX221	EPHA8	100.0	1000.0
(s)-CR8	AXL	95.0	10000.0
PD173074	CAMK1G	100.0	10000.0
XMD13-2	CDK11	79.0	10000.0
XMD16-144	AKT2	99.0	10000.0
Torin2	TNK2	100.0	10000.0
XMD-12	FRK	70.0	1000.0
Lapatinib	MAP3K3	77.0	10000.0
WZ-4-145	CDK15	100.0	10000.0
NU7441	KPCD	80.0	10000.0
ALW-II-38-3	AURKB	100.0	10000.0
XMD8-85	KPCT	100.0	10000.0
OTSSP167	SGK3	1.1	10000.0
NG25	SRPK1	100.0	10000.0
AG1478	AAK1	18.0	10000.0
XMD8-85	ULK1	2.9	10000.0
CGP74514A	JAK3(JH1domain-catalytic)	25.0	10000.0
PHA-793887	KPCT	8.2	10000.0
XMD8-92	RPS6KA6(Kin.Dom.2)	31.0	10000.0
Dabrafenib	CDK3	0.2	10000.0
Baricitinib	PIK3CD	57.0	10000.0
CGP74514A	PLK2	55.0	10000.0
QL-XI-92	SRPK1	86.0	10000.0
PLX-4720	DYRK1A	76.0	10000.0
BI-2536	RIPK1	100.0	10000.0
Ribociclib	BARK1	100.0	1000.0
WZ4003	CLK3	100.0	1000.0
ALW-II-38-3	STK36	100.0	10000.0
Dinaciclib	BRAF	91.0	10000.0
XMD11-85h	CDK7	100.0	10000.0
QL-XI-92	MAK	84.0	10000.0
BS-181	KIT(D816V)	95.0	10000.0
CG-930	MARK1	100.0	10000.0
HG-9-91-01	CAMK1G	100.0	10000.0
Crizotinib	MYLK	82.0	10000.0
Taselisib	YES	100.0	1000.0
WYE-125132	MK03	97.0	10000.0
TAK-715	BLK	17.0	10000.0
CP724714	BRSK1	100.0	10000.0
Torin2	PIK4CB	1.7	10000.0
CGP60474	PGFRB	100.0	10000.0
CGP74514A	MKNK1	72.0	10000.0
XMD8-92	SRPK3	100.0	10000.0
Canertinib	KGP1	100.0	1000.0
Crizotinib	CDK15	73.0	10000.0
KIN001-021	PGFRB	100.0	1000.0
JNK-9L	PAK3	100.0	10000.0
WYE-125132	ABL1(Q252H)-phosphorylated	100.0	10000.0
BI-D1870	AURKB	7.2	10000.0
Omipalisib	MYLK	36.0	10000.0
AZD-6482	PAK7	99.0	10000.0
PD173074	TRKA	100.0	10000.0
AZ-628	MAP3K3	100.0	10000.0
Ceritinib	AURKC	76.0	1000.0
Seliciclib	CDK9	70.0	10000.0
PHA-793887	RSK3(Kin.Dom.1-N-terminal)	25.0	10000.0
NVP-TAE684	EPHA6	3.1	1000.0
Vemurafenib	TXK	59.0	10000.0
PD0325901	CDKL1	78.0	10000.0
CH5424802	KIT(A829P)	61.0	1000.0
OTSSP167	TEC	8.2	10000.0
BX-912	CDC2L1	66.0	10000.0
NVP-TAE684	MLTK	100.0	1000.0
Sigma A6730	RIPK4	87.0	10000.0
Abemaciclib	LATS2	100.0	1000.0
KIN001-111	SRPK2	100.0	1000.0
KIN001-123	PHKG1	100.0	1000.0
Seliciclib	PIK3CA(H1047L)	100.0	10000.0
BMX-IN-1	KIT(A829P)	81.0	10000.0
Buparlisib	KC1G1	100.0	1000.0
WZ3105	PFCDPK1(P.falciparum)	98.0	10000.0
Palbociclib	VRK2	96.0	1000.0
JW-7-24-1	FAK1	100.0	10000.0
Seliciclib	MAK	100.0	10000.0
HG-9-91-01	RAF1	100.0	10000.0
TGX221	FLT3(D835Y)	100.0	1000.0
BGJ398	MTOR	100.0	1000.0
BGJ398	TAOK2	1.2	1000.0
ZM-447439	TTK	40.0	10000.0
ZG-10	TRKA	60.0	10000.0
MPS-1-IN-1	GSK3B	100.0	1000.0
XMD11-85h	MK09	100.0	10000.0
JNK-9L	PLK1	99.0	10000.0
Ribociclib	M4K3	96.0	1000.0
Vemurafenib	TAOK3	74.0	10000.0
Baricitinib	BRAF(V600E)	55.0	10000.0
NU7441	JNK3	100.0	10000.0
BX-912	MP2K3	23.0	10000.0
HG-5-113-01	EPHA8	100.0	10000.0
Neratinib	RSK3(Kin.Dom.1-N-terminal)	88.0	10000.0
PD0325901	FLT3-autoinhibited	80.0	10000.0
XMD14-99	IKKB	96.0	10000.0
JNK-IN-5A	ERBB4	100.0	10000.0
GSK461364	TAK1	48.0	10000.0
Torin2	MYLK4	97.0	10000.0
Baricitinib	PAK3	73.0	10000.0
WZ4003	IKKA	100.0	1000.0
BGJ398	RIPK2	93.0	1000.0
PHA-767491	PCTK2	85.0	10000.0
SP600125	WEE1	100.0	10000.0
QL-XII-47	ROCK1	94.0	1000.0
JNK-IN-8	EGFR(G719S)	90.0	1000.0
Dabrafenib	FLT3(R834Q)	67.0	10000.0
Dabrafenib	IGF1R	100.0	10000.0
MLN8054	CASK	91.0	10000.0
5z-7-oxozeaenol	MP2K4	0.4	10000.0
NU7441	MAP3K1	100.0	10000.0
Ribociclib	PIP5K2B	99.0	1000.0
AZD7762	MP2K7	80.0	10000.0
Omipalisib	PIK3CG	0.0	10000.0
RO-3306	RSK2(Kin.Dom.1-N-terminal)	75.0	10000.0
Ceritinib	PRKX	60.0	1000.0
KIN001-220	SRPK1	1.9	10000.0
Omipalisib	STK16	3.4	10000.0
JNK-IN-8	MYLK2	13.0	1000.0
JNK-IN-8	CHK2	95.0	1000.0
KU63794	CHK2	100.0	10000.0
ZSTK474	KPCE	100.0	1000.0
TGX221	PHKG1	100.0	1000.0
Buparlisib	STK33	100.0	1000.0
NU7441	TLK2	80.0	10000.0
PD0325901	MYO3B	99.0	10000.0
AZD 5438	MK12	17.0	10000.0
BS-181	TEC	100.0	10000.0
OTSSP167	KPCD1	6.3	10000.0
PLX-4720	DDR2	15.0	10000.0
GSK461364	CLK2	69.0	10000.0
Momelotinib	MK13	100.0	10000.0
5z-7-oxozeaenol	EPHA8	96.0	10000.0
SB590885	TYK2(JH2domain-pseudokinase)	100.0	10000.0
WZ-4-145	CDK8	100.0	10000.0
KIN001-123	CSF1R	14.0	1000.0
JNK-9L	ULK2	90.0	10000.0
Sigma A6730	RSK1(Kin.Dom.1-N-terminal)	91.0	10000.0
R406	TLK1	10.0	1000.0
JNK-IN-8	LKB1	100.0	1000.0
CH5424802	LRRK2(G2019S)	2.6	1000.0
PD173074	FGFR3	0.1	10000.0
Sorafenib	PGFRA	0.0	10000.0
GSK429286A	MYO3B	100.0	10000.0
Sorafenib	RSK4(Kin.Dom.2-C-terminal)	38.0	10000.0
R406	INSRR	9.2	1000.0
Barasertib	PCTK3	62.0	10000.0
HG-14-10-04	STK36	20.0	10000.0
GW843682X	KIT(D816H)	37.0	10000.0
XMD8-85	LKB1	100.0	10000.0
QL-XI-92	JAK1(JH1domain-catalytic)	100.0	10000.0
XMD-12	M3K12	85.0	1000.0
QL-XI-92	PHKG2	95.0	10000.0
AZD7762	PAK7	0.0	10000.0
AZ-628	ADCK4	100.0	10000.0
ZSTK474	HIPK1	100.0	1000.0
KIN001-127	HCK	100.0	10000.0
Torin2	PLK1	94.0	10000.0
CP724714	PRKX	100.0	10000.0
SCH772984	DDR2	98.0	1000.0
XMD-12	KC1G1	73.0	1000.0
HG-5-88-01	HCK	24.0	10000.0
Vemurafenib	MK01	100.0	10000.0
Torin1	VGFR2	65.0	10000.0
XMD11-50	GSK3B	88.0	10000.0
PD0325901	MAP4K4	69.0	10000.0
Alpelisib	RIPK2	86.0	1000.0
KIN001-021	DDR1	100.0	1000.0
Neratinib	SRPK3	77.0	10000.0
XMD-12	MARK4	66.0	1000.0
JNK-9L	TYRO3	87.0	10000.0
GW-5074	KPCT	90.0	10000.0
A443654	PIK3CD	100.0	10000.0
AZD 5438	EPHA2	28.0	10000.0
BMS-536924	CSNK1D	100.0	1000.0
Crizotinib	JAK3(JH1domain-catalytic)	0.7	10000.0
XMD11-85h	RET(M918T)	0.0	10000.0
Abemaciclib	PIK3CA(H1047Y)	89.0	1000.0
Ibrutinib	EPHA7	78.0	1000.0
XMD13-2	LIMK2	98.0	10000.0
JNK-9L	EPHB3	88.0	10000.0
PD173074	JAK3(Kin.Dom.2)	100.0	10000.0
HG-5-88-01	RAF1	100.0	10000.0
Ibrutinib	AAK1	92.0	1000.0
AS-252424	FLT3(ITD)	91.2	10000.0
OTSSP167	BLK	0.7	10000.0
KIN001-111	CAMK2B	100.0	1000.0
5z-7-oxozeaenol	STK16	100.0	10000.0
Dabrafenib	PLK3	90.0	10000.0
BS-181	LATS2	100.0	10000.0
QL-X-138	MARK1	78.0	10000.0
5z-7-oxozeaenol	ABL1(F317L)-nonphosphorylated	95.0	10000.0
Seliciclib	EPHA7	100.0	10000.0
HG-6-64-01	ACVR1B	98.0	10000.0
JWE-035	CDC2L5	100.0	10000.0
ZG-10	MINK	50.0	10000.0
WZ3105	KPCE	52.0	10000.0
Pictilisib	CTK	100.0	1000.0
Ibrutinib	MARK3	60.0	1000.0
WYE-125132	HIPK2	100.0	10000.0
HG-9-91-01	RSK4(Kin.Dom.1-N-terminal)	4.9	10000.0
CP724714	MET(M1250T)	100.0	10000.0
CGP74514A	CDK4-cyclinD3	0.4	10000.0
SCH772984	STK33	67.0	1000.0
Torkinib	PRP4	90.0	10000.0
BX-912	MET(M1250T)	4.6	10000.0
PD0325901	LIMK1	68.0	10000.0
XMD16-144	PIP5K2B	36.0	10000.0
BS-181	FGFR4	99.0	10000.0
WZ-4-145	PHKG1	100.0	10000.0
Dinaciclib	IRAK1	87.0	10000.0
Palbociclib	SIK1	100.0	1000.0
BMS-536924	PCTK3	100.0	1000.0
Omipalisib	PAK3	41.0	10000.0
XMD-12	KIT(D816H)	66.0	1000.0
RO-3306	SIK1	74.0	10000.0
AZD7762	MINK	1.6	10000.0
CGP74514A	NEK6	62.0	10000.0
5z-7-oxozeaenol	WEE2	81.0	10000.0
JWE-035	LATS2	91.0	10000.0
XMD11-50	RIPK4	74.0	10000.0
WZ3105	CAMK1G	93.0	10000.0
QL-XI-92	PIK3CA(H1047L)	73.0	10000.0
SCH772984	CIT	67.0	1000.0
Torin1	NEK3	100.0	10000.0
JNK-IN-5A	MP2K4	94.0	10000.0
HG-6-64-01	CDK4-cyclinD1	74.0	10000.0
Barasertib	ERK3	100.0	10000.0
AG1478	FGFR1	87.0	10000.0
HG-9-91-01	PIM1	95.0	10000.0
ZG-10	MP2K7	80.0	10000.0
R406	CDC2L1	100.0	1000.0
CG-930	ACVR2B	100.0	10000.0
Torin2	CDK5	92.0	10000.0
WZ4003	MP2K2	100.0	1000.0
QL-XII-47	FLT4	95.0	1000.0
KIN001-123	TESK1	100.0	1000.0
GSK429286A	BRSK1	93.0	10000.0
TAK-715	GSK3B	60.0	10000.0
A443654	RPS6KA1(Kin.Dom.1)	100.0	10000.0
AZD 5438	CDK14	3.4	10000.0
Taselisib	EPHA7	100.0	1000.0
KIN001-127	EPHA5	100.0	10000.0
Vemurafenib	ITK	100.0	10000.0
Torin1	PAK6	77.0	10000.0
CH5424802	KIT(L576P)	66.0	1000.0
Taselisib	ULK3	97.0	1000.0
PHA-767491	FYN	99.0	10000.0
Dabrafenib	PIK3CA(H1047Y)	100.0	10000.0
WZ-7043	M3K12	100.0	10000.0
JWE-035	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
ALW-II-49-7	RPS6KA6(Kin.Dom.2)	100.0	10000.0
Barasertib	DYRK2	73.0	10000.0
CH5424802	CAMK2A	17.0	1000.0
BGJ398	EPHA4	93.0	1000.0
Dinaciclib	ROCK1	92.0	10000.0
HG-6-64-01	FGFR3	1.8	10000.0
Vemurafenib	KC1G2	88.0	10000.0
MRT67307	KIT(L576P)	20.0	10000.0
TGX221	PCTK2	100.0	1000.0
Dactolisib	CSK	100.0	1000.0
TAK-715	LATS1	100.0	10000.0
AZ-628	MLK3	91.0	10000.0
JWE-035	CSNK1G3	5.4	10000.0
XMD11-50	AKT2	100.0	10000.0
SB590885	CAMKK2	88.0	10000.0
GSK1059615	FRK	81.0	10000.0
PHA-793887	IRAK4	79.0	10000.0
JNK-IN-5A	AKT3	82.0	10000.0
AZD 5438	NIM1	100.0	10000.0
Vemurafenib	MP2K4	5.0	10000.0
Palbociclib	M4K3	100.0	1000.0
PHA-793887	SRPK1	93.0	10000.0
RO-3306	KPCE	85.0	10000.0
NPK76-II-72-1	RPS6KA1(Kin.Dom.2)	22.0	10000.0
ZM-447439	CIT	59.0	10000.0
KIN001-111	PIK3CA(E545K)	100.0	1000.0
HG-6-64-01	CDC2L5	100.0	10000.0
XMD8-85	PIK3CA(H1047Y)	100.0	10000.0
XMD8-92	CDK7	100.0	10000.0
OTSSP167	TXK	1.4	10000.0
JW-7-24-1	EGFR(L747-S752del,P753S)	100.0	10000.0
QL-XI-92	FLT3	100.0	10000.0
Canertinib	FLT3(ITD)	100.0	1000.0
RO-3306	TYK2(JH1domain-catalytic)	53.0	10000.0
AZD4547	CDK2	56.0	10000.0
AZD 5438	MARK3	30.0	10000.0
NPK76-II-72-1	CAMK2A	21.0	10000.0
GW-5074	PHKG2	92.0	10000.0
Neratinib	KPCD1	74.0	10000.0
THZ1	SIK3	92.0	10000.0
CP466722	CDK16	47.0	10000.0
Palbociclib	KIT(A829P)	100.0	1000.0
KIN001-127	PIM1	100.0	10000.0
GSK1059615	SIK3	93.0	10000.0
Dactolisib	MARK2	100.0	1000.0
HG-5-88-01	DMPK2	100.0	10000.0
JW-7-24-1	TNK2	100.0	10000.0
HG-5-88-01	IRAK3	29.0	10000.0
ALW-II-49-7	DMPK	100.0	10000.0
5z-7-oxozeaenol	MINK	89.0	10000.0
Neratinib	HIPK2	65.0	10000.0
Neratinib	LATS2	100.0	10000.0
WZ-4-145	CDK2	100.0	10000.0
ZSTK474	IGF1R	100.0	1000.0
KIN001-111	PIK3CA	100.0	1000.0
OTSSP167	JAK1(JH2domain-pseudokinase)	10.0	10000.0
AZD4547	MET(M1250T)	29.0	10000.0
WZ4003	HIPK1	100.0	1000.0
Alpelisib	EGFR(L858R)	100.0	1000.0
BS-181	KC1G1	57.0	10000.0
HG-5-88-01	DMPK	100.0	10000.0
TAK-715	HCK	31.0	10000.0
KU63794	ABL1(T315I)-phosphorylated	100.0	10000.0
AG1478	CDK11	93.0	10000.0
AZ-628	BIKE	98.0	10000.0
XMD8-85	CDK14	100.0	10000.0
ALW-II-49-7	EPHA6	100.0	10000.0
ALW-II-38-3	EGFR(G719C)	100.0	10000.0
JW-7-24-1	LKB1	100.0	10000.0
Taselisib	INSR	100.0	1000.0
BI-2536	MAP4K4	100.0	10000.0
Vemurafenib	WEE1	100.0	10000.0
CP466722	ACVR2A	66.0	10000.0
HG-14-10-04	ITK	1.8	10000.0
Torkinib	TAOK2	1.2	10000.0
Sigma A6730	RIOK1	76.0	10000.0
GW-5074	MET(M1250T)	80.0	10000.0
PHA-793887	CHK2	84.0	10000.0
WZ-4-145	CSNK2A2	100.0	10000.0
MLN8054	ULK1	40.0	10000.0
XMD13-2	TRKB	61.0	10000.0
CP724714	PIK3CA	100.0	10000.0
AZD 5438	GSK3A	0.3	10000.0
Taselisib	MRCKB	91.0	1000.0
NVP-TAE684	JNK3	2.6	1000.0
XMD14-99	NDR2	84.0	10000.0
CH5424802	CSNK1A1L	10.0	1000.0
ALW-II-49-7	ABL1(Q252H)	100.0	10000.0
WYE-125132	PIP5K2B	100.0	10000.0
Ceritinib	FYV1	100.0	1000.0
WZ4002	ANKK1	100.0	10000.0
Torin2	EGFR	100.0	10000.0
Seliciclib	AXL	100.0	10000.0
HG-5-88-01	AAK1	100.0	10000.0
GW843682X	FES	87.0	10000.0
GW-5074	FGFR3(G697C)	76.0	10000.0
JNK-9L	EGFR(L747-T751del,Sins)	79.0	10000.0
KU63794	ULK2	100.0	10000.0
PHA-793887	CAMK2A	60.0	10000.0
PHA-793887	EPHA5	96.0	10000.0
JNK-IN-5A	MARK4	97.0	10000.0
KIN001-123	MLCK	100.0	1000.0
XMD8-92	EPHB6	100.0	10000.0
XMD14-99	ABL1(F317I)-phosphorylated	51.0	10000.0
ERK5-IN-1	TTK	49.0	1000.0
ALW-II-38-3	TLK1	100.0	10000.0
AZ-628	CLK2	100.0	10000.0
Sigma A6730	MST2	100.0	10000.0
CGP60474	RIOK3	100.0	10000.0
PD0325901	BRSK1	100.0	10000.0
HG-9-91-01	IRAK4	94.0	10000.0
MLN8054	ABL1(M351T)-phosphorylated	8.6	10000.0
JW-7-24-1	FLT3(N841I)	16.0	10000.0
Crizotinib	YES	17.0	10000.0
HG-14-8-02	ROCK1	77.0	10000.0
SP600125	RIPK1	100.0	10000.0
XMD16-144	EPHA5	99.0	10000.0
Omipalisib	ROCK2	64.0	10000.0
KIN001-123	M3K5	100.0	1000.0
AZD7762	RIPK2	40.0	10000.0
ALW-II-38-3	TESK1	100.0	10000.0
AZD7762	PAK1	1.2	10000.0
GW-5074	NEK3	95.0	10000.0
Baricitinib	FAK1	64.0	10000.0
BI-D1870	CSNK1A1L	0.1	10000.0
NG25	STK16	100.0	10000.0
QL-XII-47	KC1G1	91.0	1000.0
XMD11-85h	PIP5K1A	6.4	10000.0
ERK5-IN-1	YSK1	90.0	1000.0
Torin2	MKNK1	43.0	10000.0
XMD14-99	LTK	4.2	10000.0
AZD4547	PRP4	79.0	10000.0
Neratinib	CASK	100.0	10000.0
Ceritinib	CSNK1G3	98.0	1000.0
Torin2	ROS1	82.0	10000.0
PLX-4720	EGFR	76.0	10000.0
XMD11-85h	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
Alpelisib	NEK9	100.0	1000.0
JW-7-24-1	HIPK1	100.0	10000.0
SCH772984	NEK9	95.0	1000.0
MRT67307	EPHA6	100.0	10000.0
WH-4-023	LTK	1.2	10000.0
OTSSP167	MST1R	41.0	10000.0
BX-912	MK11	90.0	10000.0
WZ-4-145	KGP1	100.0	10000.0
Dinaciclib	KPCD	85.0	10000.0
JNK-IN-5A	PIM2	69.0	10000.0
MRT67307	MP2K7	100.0	10000.0
NVP-TAE684	ITK	0.1	1000.0
NPK76-II-72-1	DMPK2	100.0	10000.0
Torin2	CSF1R	2.4	10000.0
TGX221	EGFR(G719S)	100.0	1000.0
AZD7762	DDR1	10.0	10000.0
GW843682X	MYLK	50.0	10000.0
HG-14-10-04	PRKX	70.0	10000.0
XMD11-50	MAP3K3	97.0	10000.0
CP724714	MP2K2	11.0	10000.0
QL-X-138	PAK3	81.0	10000.0
Pictilisib	PTK6	100.0	1000.0
WZ-7043	MK14	100.0	10000.0
WZ4003	ACVR2A	100.0	1000.0
CP466722	TAOK1	3.2	10000.0
JNK-9L	CDKL3	45.0	10000.0
CG-930	MYLK4	100.0	10000.0
CH5424802	PIK3CA(C420R)	95.0	1000.0
AZD4547	MLTK	2.8	10000.0
A443654	NEK1	100.0	10000.0
BMX-IN-1	TNIK	100.0	10000.0
Pictilisib	NIM1	100.0	1000.0
JW-7-24-1	RPS6KA1(Kin.Dom.2)	100.0	10000.0
CP466722	KGP2	75.0	10000.0
Barasertib	CSNK1A1L	99.0	10000.0
MLN8054	RAF1	97.0	10000.0
SCH772984	SGK1	65.0	1000.0
JNK-9L	MST1	89.0	10000.0
WZ-4-145	CHK2	100.0	10000.0
XMD11-50	ADCK3	71.0	10000.0
Momelotinib	EGFR(L747-T751del,Sins)	70.0	10000.0
Ceritinib	EGFR(G719C)	89.0	1000.0
Alpelisib	RIPK4	100.0	1000.0
JNK-IN-8	SgK110	95.0	1000.0
BMS-536924	RIOK1	0.6	1000.0
PD0325901	LTK	100.0	10000.0
HG-9-91-01	ULK1	0.2	10000.0
Dactolisib	M3K6	100.0	1000.0
KIN001-021	MST1	100.0	1000.0
SP600125	MAPKAPK5	100.0	10000.0
HG-14-10-04	PKAC-alpha	11.0	10000.0
5z-7-oxozeaenol	MARK1	83.0	10000.0
Momelotinib	EPHA2	100.0	10000.0
ERK5-IN-1	CHK2	100.0	1000.0
ERK5-IN-1	EGFR(L747-T751del,Sins)	100.0	1000.0
JNK-IN-8	EGFR(T790M)	100.0	1000.0
Torin1	EGFR(L747-T751del,Sins)	80.0	10000.0
CGP60474	GRK4	100.0	10000.0
HG-14-8-02	CDK8	100.0	10000.0
AG1478	PAK6	94.0	10000.0
JNK-IN-8	CDKL5	100.0	1000.0
PD173074	YES	100.0	10000.0
Dinaciclib	IRAK3	66.0	10000.0
HG-5-113-01	AURKA	2.7	10000.0
Abemaciclib	CDK14	11.0	1000.0
Dabrafenib	TRKC	49.0	10000.0
OTSSP167	LYN	0.5	10000.0
ZM-447439	FLT3(D835H)	13.0	10000.0
KU63794	ACVRL1	100.0	10000.0
JNK-IN-8	TRPM6	98.0	1000.0
JNK-IN-5A	ABL1-phosphorylated	98.0	10000.0
WZ-7043	EGFR(L858R)	100.0	10000.0
BMS345541	MST2	90.0	10000.0
THZ1	FLT4	0.0	10000.0
QL-XII-47	WEE1	95.0	1000.0
XMD8-85	INSR	100.0	10000.0
HG-14-8-02	YANK3	100.0	10000.0
BMX-IN-1	KKCC1	74.0	10000.0
Baricitinib	SIK1	44.0	10000.0
TGX221	KPCD1	100.0	1000.0
Torin2	FLT3(N841I)	11.0	10000.0
SB590885	DRAK1	69.0	10000.0
XMD16-144	MARK4	1.5	10000.0
R406	KGP2	6.8	1000.0
WZ4003	ERK4	100.0	1000.0
XMD13-2	ACVR2B	84.0	10000.0
OTSSP167	GRK4	50.0	10000.0
Abemaciclib	RSK1(Kin.Dom.2-C-terminal)	53.0	1000.0
5z-7-oxozeaenol	MTOR	94.0	10000.0
AZD 5438	RIOK1	5.4	10000.0
Torin1	LIMK1	15.0	10000.0
CGP74514A	BRAF	97.0	10000.0
Taselisib	STK36	100.0	1000.0
JNK-IN-5A	TLK1	76.0	10000.0
Dactolisib	M4K3	100.0	1000.0
Lapatinib	RET(M918T)	100.0	10000.0
WZ4002	HCK	100.0	10000.0
Taselisib	RIPK5	99.0	1000.0
TAK-715	DRAK1	81.0	10000.0
AZ-628	ERBB2	72.0	10000.0
GSK429286A	PKAC-beta	6.4	10000.0
Buparlisib	MELK	100.0	1000.0
PLX-4720	PIK3C2B	84.0	10000.0
WZ-7043	RIPK2	100.0	10000.0
XMD13-2	PRKX	100.0	10000.0
BMS-536924	EGFR(G719C)	2.8	1000.0
KIN001-127	BTK	2.6	10000.0
BI-2536	SNARK	100.0	10000.0
Barasertib	JNK3	41.0	10000.0
ALW-II-38-3	EPHB3	16.0	1000.0
Pictilisib	LATS2	85.0	1000.0
RO-3306	VGFR2	94.0	10000.0
PLX-4720	MK11	100.0	10000.0
XMD11-50	ADCK4	94.0	10000.0
ALW-II-49-7	MARK3	100.0	10000.0
Abemaciclib	MYLK2	97.0	1000.0
HG-5-113-01	CAMK2B	100.0	10000.0
Neratinib	DRAK2	46.0	10000.0
GW843682X	BRSK2	31.0	10000.0
SP600125	CDC2L2	100.0	10000.0
XMD11-50	PFCDPK1(P.falciparum)	100.0	10000.0
KIN001-021	CIT	100.0	1000.0
WZ4002	JAK1(Kin.Dom.1)	100.0	10000.0
BGJ398	TNK2	91.0	1000.0
QL-XII-47	SNRK	100.0	1000.0
WZ3105	MYO3A	94.0	10000.0
NU7441	LYN	95.0	10000.0
QL-XI-92	CDK2	100.0	10000.0
WZ3105	FLT3(R834Q)	8.4	10000.0
AZD 5438	MKNK1	93.0	10000.0
PLX-4720	CLK1	37.0	10000.0
Buparlisib	DYRK2	100.0	1000.0
AS-252424	MLK2	100.0	10000.0
Vemurafenib	MK14	70.0	10000.0
HG-9-91-01	RET(V804M)	100.0	10000.0
NPK76-II-72-1	NEK6	100.0	10000.0
PHA-767491	SgK110	100.0	10000.0
AZ-628	RIOK2	100.0	10000.0
OTSSP167	SLK	1.5	10000.0
Vemurafenib	MST3	77.0	10000.0
Barasertib	MET	46.0	10000.0
HG-14-8-02	EGFR(G719C)	0.1	10000.0
GW843682X	YANK1	82.0	10000.0
Torin2	VGFR1	100.0	10000.0
KIN001-220	YANK3	77.0	10000.0
XMD16-144	PRKX	100.0	10000.0
ERK5-IN-1	NEK7	100.0	1000.0
JW-7-24-1	M3K5	100.0	10000.0
XMD8-92	MLK1	100.0	10000.0
PD0325901	AMPK-alpha2	97.0	10000.0
HG-5-113-01	STK33	1.4	10000.0
BMS345541	AMPK-alpha2	100.0	10000.0
PLX-4720	TNK2	8.2	10000.0
WZ-7043	RPS6KA6(Kin.Dom.2)	100.0	10000.0
JWE-035	HCK	24.0	10000.0
Pictilisib	MAP4K4	88.0	1000.0
MRT67307	CASK	77.0	10000.0
BI-D1870	DCAMKL3	0.8	10000.0
BMS345541	SRPK3	100.0	10000.0
Ribociclib	MERTK	100.0	1000.0
GW843682X	LIMK1	79.0	10000.0
SP600125	EGFR(G719S)	100.0	10000.0
Sigma A6730	CDK3	100.0	10000.0
TGX221	AAK1	100.0	1000.0
KU63794	PIK3CA(C420R)	2.3	10000.0
Alpelisib	DYRK1B	45.0	1000.0
CGP60474	TNNI3K	100.0	10000.0
5z-7-oxozeaenol	ROCK2	96.0	10000.0
XMD8-92	ERK3	100.0	10000.0
CH5424802	FLT3(R834Q)	80.0	1000.0
CP466722	PIK3CG	3.1	10000.0
AS-252424	PIK3C2B	19.1	10000.0
HG-9-91-01	M3K2	2.8	10000.0
BGJ398	CDKL2	49.0	1000.0
Alpelisib	ULK1	100.0	1000.0
Abemaciclib	MYLK4	31.0	1000.0
JNK-IN-11	NEK5	98.0	1000.0
GW-5074	PIM2	2.1	10000.0
MRT67307	PLK2	27.0	10000.0
THZ1	KGP2	13.0	10000.0
AZD4547	PIK3CA(Q546K)	95.0	10000.0
NG25	MARK2	100.0	10000.0
Crizotinib	PFPK5(P.falciparum)	95.0	10000.0
BS-181	PLK4	95.0	10000.0
NU7441	ABL1(F317I)-nonphosphorylated	100.0	10000.0
PHA-793887	TRKC	72.0	10000.0
Omipalisib	CDK7	65.0	10000.0
HG-14-10-04	ALK(L1196M)	0.0	10000.0
GW843682X	MAP3K3	74.0	10000.0
ALW-II-38-3	TXK	8.5	1000.0
MLN8054	CDC2L2	100.0	10000.0
XMD13-2	NLK	31.0	10000.0
XMD14-99	PIK3CA(I800L)	96.0	10000.0
Buparlisib	FRK	92.0	1000.0
PHA-767491	EGFR(G719S)	97.0	10000.0
ERK5-IN-1	CSNK2A2	97.0	1000.0
WZ-7043	KC1G1	100.0	10000.0
CGP74514A	NEK9	69.0	10000.0
Seliciclib	NIM1	100.0	10000.0
CGP74514A	EPHA2	51.0	10000.0
PD173074	CAMKK2	100.0	10000.0
CP724714	DDR1	52.0	10000.0
Torkinib	KIT(L576P)	0.8	10000.0
(s)-CR8	DRAK2	99.0	10000.0
Pictilisib	FLT3(ITD,D835V)	67.0	1000.0
Crizotinib	TRPM6	79.0	10000.0
SB590885	MLK2	92.0	10000.0
Ibrutinib	TGFBR2	98.0	1000.0
Torin2	TNK1	100.0	10000.0
BS-181	ABL1-nonphosphorylated	96.0	10000.0
OTSSP167	YANK2	13.0	10000.0
AZD 5438	FYN	63.0	10000.0
WH-4-023	IKKE	78.0	10000.0
BX-912	ACVR1B	61.0	10000.0
CG-930	IRAK1	38.0	10000.0
Sigma A6730	MARK1	97.0	10000.0
WYE-125132	NEK2	72.0	10000.0
QL-X-138	MYO3A	94.0	10000.0
KIN001-127	TSSK1	100.0	10000.0
Torin1	ROCK1	53.0	10000.0
GW843682X	MST4	85.0	10000.0
PD0325901	MAP4K2	100.0	10000.0
PD0325901	EPHA4	100.0	10000.0
PHA-793887	EPHA6	100.0	10000.0
BI-D1870	MP2K2	19.0	10000.0
KIN001-127	ADCK4	100.0	10000.0
Ceritinib	ACVR1B	80.0	1000.0
Torin2	JAK2(JH1domain-catalytic)	64.0	10000.0
AZD4547	MAP3K1	60.0	10000.0
Seliciclib	CDK8	100.0	10000.0
JNK-IN-11	MP2K3	58.0	1000.0
AZD7762	MAP3K4	42.0	10000.0
JNK-IN-11	TSSK1	86.0	1000.0
GW843682X	EPHA1	84.0	10000.0
AG1478	PIK3C2B	7.6	10000.0
PD0325901	EGFR(L747-E749del,A750P)	72.0	10000.0
WZ-4-145	PIM3	100.0	10000.0
JNK-IN-11	GRK1	100.0	1000.0
XMD11-50	TIE1	100.0	10000.0
ERK5-IN-1	WEE2	100.0	1000.0
ALW-II-38-3	BRSK2	100.0	10000.0
XMD16-144	BLK	0.7	10000.0
Seliciclib	KC1G2	16.0	10000.0
AZD7762	RIPK5	1.3	10000.0
MPS-1-IN-1	EGFR(S752-I759del)	100.0	1000.0
RO-3306	EGFR(G719S)	48.0	10000.0
ALW-II-49-7	SRC	100.0	10000.0
AZD-6482	HUNK	81.0	10000.0
XMD8-85	HIPK4	100.0	10000.0
JW-7-24-1	RPS6KA2(Kin.Dom.1)	100.0	10000.0
AZD-6482	ABL1(Y253F)-phosphorylated	100.0	10000.0
PHA-767491	RPS6KA5(Kin.Dom.2-C-terminal)	7.9	10000.0
QL-XII-47	BTK	5.1	1000.0
AG1478	FLT3-autoinhibited	58.0	10000.0
HG-14-10-04	ZAP70	5.3	10000.0
THZ1	ANKK1	39.0	10000.0
JWE-035	MKNK2	0.2	10000.0
QL-XI-92	KIT(V559D)	1.4	10000.0
XMD14-99	MP2K1	100.0	10000.0
AZ-628	EPHB6	2.4	10000.0
BMS-536924	FLT3	0.2	1000.0
Taselisib	PIK3CA(C420R)	0.1	1000.0
NG25	KCC4	0.0	10000.0
AZD7762	PIK3CA(Q546K)	83.0	10000.0
Taselisib	NEK3	83.0	1000.0
BX-912	EGFR(T790M)	2.0	10000.0
Palbociclib	RIOK1	58.0	1000.0
AZD 5438	FLT3(D835H)	15.0	10000.0
BI-2536	CDK15	100.0	10000.0
Buparlisib	IKKA	100.0	1000.0
MLN8054	KIT(A829P)	100.0	10000.0
PD0325901	CDK14	100.0	10000.0
Alpelisib	ROCK2	100.0	1000.0
AS-252424	MYLK4	17.0	10000.0
BS-181	NUAK1	96.0	10000.0
JNK-9L	KPCL	83.0	10000.0
XMD8-92	EPHA4	100.0	10000.0
Alpelisib	MAST1	100.0	1000.0
WZ4002	DDR2	100.0	10000.0
WZ4003	MP2K1	100.0	1000.0
MRT67307	LYN	71.0	10000.0
Dinaciclib	MLK1	100.0	10000.0
JWE-035	LATS1	100.0	10000.0
GSK429286A	EGFR(L747-T751del,Sins)	81.0	10000.0
GSK461364	MAST1	3.1	10000.0
MRT67307	ROCK2	1.4	10000.0
(s)-CR8	CLK2	76.0	10000.0
ZSTK474	EGFR(L858R)	100.0	1000.0
PHA-793887	MLTK	100.0	10000.0
XMD11-85h	ERK4	100.0	10000.0
Ibrutinib	FGFR3(G697C)	28.0	1000.0
HG-6-64-01	CDKL1	61.0	10000.0
Vemurafenib	ULK1	93.0	10000.0
WZ-7043	MAP3K4	5.3	10000.0
JNK-9L	FGFR4	99.0	10000.0
PLX-4720	OSR1	24.0	10000.0
BMX-IN-1	DYRK1A	62.0	10000.0
Ceritinib	MYLK2	81.0	1000.0
GSK1059615	PKNB(M.tuberculosis)	36.0	10000.0
ALW-II-38-3	TAOK1	100.0	10000.0
Pictilisib	PLK2	100.0	1000.0
XMD14-99	MYO3B	94.0	10000.0
PD173074	YSK1	9.4	10000.0
AZ-628	MAP3K15	100.0	10000.0
CP724714	CLK1	90.0	10000.0
AS-252424	M3K2	99.5	10000.0
BMS-536924	CSNK1G3	100.0	1000.0
HG-6-64-01	ROCK1	43.0	10000.0
Crizotinib	PRKR	43.0	10000.0
KIN001-123	RPS6KA2(Kin.Dom.2)	100.0	1000.0
JNK-IN-8	CSNK1E	70.0	1000.0
Canertinib	CAMK1G	100.0	1000.0
XMD14-99	HIPK3	99.0	10000.0
XMD-12	WEE1	100.0	1000.0
BMX-IN-1	BIKE	39.0	10000.0
PHA-793887	DDR2	100.0	10000.0
HG-14-8-02	EGFR(T790M)	0.2	10000.0
HG-5-88-01	CAMKK2	6.5	10000.0
WZ4002	MAPKAPK5	100.0	10000.0
Abemaciclib	ULK1	48.0	1000.0
Ceritinib	RSK3(Kin.Dom.2-C-terminal)	11.0	1000.0
Torin1	ERK5	100.0	10000.0
PHA-793887	TSSK1	94.0	10000.0
KIN001-220	PIK3CD	41.0	10000.0
Taselisib	PIK3C2B	21.0	1000.0
XMD11-50	ABL1(H396P)-phosphorylated	100.0	10000.0
ZSTK474	CDKL2	100.0	1000.0
Dactolisib	FAK1	100.0	1000.0
XMD-12	DDR1	68.0	1000.0
CGP74514A	ABL1(Q252H)-phosphorylated	1.4	10000.0
Omipalisib	CDKL2	95.0	10000.0
HG-6-64-01	TAOK1	0.8	10000.0
XMD11-50	TNK2	18.0	10000.0
PHA-793887	YANK1	50.0	10000.0
XMD-12	NDR2	82.0	1000.0
MLN8054	FGFR1	14.0	10000.0
Ibrutinib	LIMK1	30.0	1000.0
HG-5-113-01	PCTK2	100.0	10000.0
PLX-4720	IRAK3	26.0	10000.0
XMD11-50	PIK3C2G	100.0	10000.0
ERK5-IN-1	TLK1	90.0	1000.0
KIN001-021	FYN	100.0	1000.0
Canertinib	ABL2	100.0	1000.0
TAK-715	ABL1(H396P)-nonphosphorylated	3.0	10000.0
TAK-715	MARK3	72.0	10000.0
AS-252424	TYRO3	94.5	10000.0
Crizotinib	MAP4K2	0.0	10000.0
GW-5074	MP2K1	68.0	10000.0
RO-3306	BTK	100.0	10000.0
PLX-4720	PIK3CB	100.0	10000.0
JNK-IN-5A	BRAF	100.0	10000.0
ERK5-IN-1	AMPK-alpha2	100.0	1000.0
Ceritinib	PGFRA	72.0	1000.0
KU63794	CAMK2B	96.0	10000.0
MRT67307	PRKX	32.0	10000.0
Dabrafenib	ERBB3	0.3	10000.0
XMD11-85h	KPCD	0.0	10000.0
WH-4-023	NIM1	100.0	10000.0
SB590885	RIOK3	82.0	10000.0
CP466722	DCAMKL2	88.0	10000.0
HG-6-64-01	TGFBR2	5.7	10000.0
KIN001-111	CDK9	100.0	1000.0
HG-5-113-01	KGP1	100.0	10000.0
BMS345541	CDK4-cyclinD3	75.0	10000.0
HG-14-8-02	NEK3	100.0	10000.0
HG-5-88-01	MAPKAPK5	100.0	10000.0
TAK-715	EGFR(L858R,T790M)	48.0	10000.0
HG-9-91-01	EGFR(S752-I759del)	1.8	10000.0
Barasertib	ERBB4	4.0	10000.0
PLX-4720	MRCKB	100.0	10000.0
XMD-12	MP2K7	100.0	1000.0
WZ4003	ULK1	1.2	1000.0
Torin1	TYK2(JH2domain-pseudokinase)	55.0	10000.0
Abemaciclib	LOK	78.0	1000.0
WZ4002	RPS6KA6(Kin.Dom.1)	100.0	10000.0
THZ1	JAK2(JH1domain-catalytic)	100.0	10000.0
BMS-536924	ABL2	2.5	1000.0
Buparlisib	KPCE	69.0	1000.0
QL-XII-47	MKNK2	74.0	1000.0
SP600125	TNNI3K	100.0	10000.0
BMX-IN-1	INSRR	100.0	10000.0
Ceritinib	IRAK3	71.0	1000.0
TGX221	ABL1(H396P)	100.0	1000.0
Ribociclib	NEK7	100.0	1000.0
BMS345541	CLK2	54.0	10000.0
OTSSP167	CSNK2A1	0.9	10000.0
QL-XII-47	PLK1	100.0	1000.0
HG-5-113-01	NEK7	100.0	10000.0
Ribociclib	FYV1	79.0	1000.0
Vemurafenib	ROCK2	77.0	10000.0
PHA-767491	DMPK	21.0	10000.0
AZ-628	FGR	12.0	10000.0
(s)-CR8	PGFRA	88.0	10000.0
XMD11-50	KPCT	100.0	10000.0
ZSTK474	RPS6KA2(Kin.Dom.1)	100.0	1000.0
PLX-4720	SRPK2	100.0	10000.0
ZSTK474	CDK7	100.0	1000.0
XMD-12	IGF1R	100.0	1000.0
XMD8-85	SRC	100.0	10000.0
AS-252424	DDR2	100.0	10000.0
KIN001-127	PIK3CA	100.0	10000.0
Sigma A6730	TAOK1	91.0	10000.0
WZ3105	PAK7	17.0	10000.0
ZSTK474	KPCD1	100.0	1000.0
AZD 5438	CLK3	3.5	10000.0
Dactolisib	MRCKA	100.0	1000.0
KU63794	TRPM6	50.0	10000.0
ALW-II-49-7	EGFR(L858R)	100.0	10000.0
Omipalisib	M3K12	88.0	10000.0
JNK-9L	PIK3CA(H1047Y)	100.0	10000.0
OTSSP167	EGFR(G719S)	46.0	10000.0
CGP74514A	KIT(A829P)	8.2	10000.0
CP466722	MP2K2	74.0	10000.0
QL-XII-47	ZAP70	90.0	1000.0
JNK-IN-11	MP2K2	88.0	1000.0
PLX-4720	PIK3CA(E545K)	100.0	10000.0
PHA-793887	EGFR(L861Q)	96.0	10000.0
HG-9-91-01	ABL1(H396P)-phosphorylated	0.0	10000.0
NU7441	MELK	100.0	10000.0
PD0325901	MAPKAPK5	100.0	10000.0
CP466722	PHKG2	36.0	10000.0
CGP74514A	SBK1	2.2	10000.0
Palbociclib	ABL1(F317I)-phosphorylated	100.0	1000.0
GSK1059615	ABL1-phosphorylated	63.0	10000.0
KIN001-111	CHK2	1.4	1000.0
WYE-125132	LIMK1	95.0	10000.0
WZ4003	MST3	100.0	1000.0
JW-7-24-1	EGFR	100.0	10000.0
AS-252424	M3K5	100.0	10000.0
AG1478	MET(M1250T)	94.0	10000.0
PHA-793887	OSR1	51.0	10000.0
Pictilisib	JNK3	93.0	1000.0
CP466722	EPHA7	18.0	10000.0
OTSSP167	JAK3(JH1domain-catalytic)	2.4	10000.0
Dinaciclib	HUNK	95.0	10000.0
GW-5074	LIMK1	100.0	10000.0
QL-XI-92	ERK3	100.0	10000.0
Canertinib	LYN	100.0	1000.0
Lapatinib	ABL1(Q252H)-nonphosphorylated	100.0	10000.0
CG-930	EGFR(L747-E749del,A750P)	21.0	10000.0
Lapatinib	ITK	92.0	10000.0
CGP74514A	MYO3A	97.0	10000.0
Crizotinib	CSK	39.0	10000.0
Lapatinib	MYO3B	91.0	10000.0
Dinaciclib	GSK3A	3.0	10000.0
Sorafenib	PIK3CA(E545A)	79.0	10000.0
HG-14-10-04	ULK2	0.2	10000.0
Barasertib	PIK3CB	81.0	10000.0
XMD8-92	ABL1	100.0	10000.0
OTSSP167	RSK1(Kin.Dom.1-N-terminal)	5.2	10000.0
BX-912	MP2K7	60.0	10000.0
WH-4-023	ACVR2A	0.8	10000.0
CGP74514A	DRAK2	5.7	10000.0
JNK-IN-8	RET(V804M)	100.0	1000.0
JNK-IN-5A	MAP4K5	65.0	10000.0
CGP74514A	EPHA4	39.0	10000.0
JNK-IN-5A	KIT(V559D)	60.0	10000.0
Sorafenib	TYRO3	80.0	10000.0
BI-2536	FLT3(K663Q)	100.0	10000.0
Omipalisib	RIOK3	55.0	10000.0
PLX-4720	SRMS	0.1	10000.0
PD173074	PKAC-alpha	100.0	10000.0
MLN8054	VGFR2	68.0	10000.0
Palbociclib	BLK	100.0	1000.0
XMD-12	MK13	100.0	1000.0
Buparlisib	MST3	100.0	1000.0
Torin2	PIK3CA(E542K)	0.3	10000.0
GSK461364	CDK15	67.0	10000.0
ALW-II-38-3	MK09	100.0	10000.0
Lapatinib	PIM3	100.0	10000.0
Vemurafenib	TAOK2	53.0	10000.0
BGJ398	EPHA3	77.0	1000.0
XMD11-50	KPCD	75.0	10000.0
ZSTK474	ACVR1	100.0	1000.0
SB590885	EPHA6	88.0	10000.0
GSK1059615	TNK2	100.0	10000.0
QL-X-138	ULK1	87.0	10000.0
AZD4547	M3K5	100.0	10000.0
WZ3105	IGF1R	87.0	10000.0
WZ-7043	EGFR(L747-S752del,P753S)	100.0	10000.0
Ibrutinib	MST3	98.0	1000.0
JNK-9L	FLT3	18.0	10000.0
Ceritinib	PIM3	85.0	1000.0
MPS-1-IN-1	GCN2(Kin.Dom.2,S808G)	100.0	1000.0
Vemurafenib	PIK3CA(C420R)	100.0	10000.0
SB590885	ACVR2B	98.0	10000.0
PHA-793887	TNK1	100.0	10000.0
OTSSP167	CDK5	1.9	10000.0
TGX221	DAPK2	100.0	1000.0
XMD11-50	MYO3B	83.0	10000.0
KU63794	YES	100.0	10000.0
AZD4547	TESK1	79.0	10000.0
TAK-715	MYLK4	100.0	10000.0
JWE-035	CDK7	4.0	10000.0
QL-XI-92	KPCD1	100.0	10000.0
HG-14-8-02	MLK3	94.0	10000.0
SP600125	CAMK2B	100.0	10000.0
GSK429286A	CDK2	79.0	10000.0
KIN001-127	IGF1R	4.1	10000.0
XMD13-2	TAOK2	20.0	10000.0
Torkinib	KGP2	16.0	10000.0
WZ-4-145	TTK	100.0	10000.0
HG-6-64-01	PIK3CA(M1043I)	84.0	10000.0
JNK-IN-8	PIM1	100.0	1000.0
JWE-035	MAP3K4	81.0	10000.0
AZD4547	GAK	60.0	10000.0
THZ1	ABL1(H396P)-nonphosphorylated	0.6	10000.0
BX-912	MYO3B	93.0	10000.0
KIN001-021	MP2K4	100.0	1000.0
PD0325901	CDK4-cyclinD3	84.0	10000.0
QL-X-138	MST4	79.0	10000.0
JW-7-24-1	TIE2	100.0	10000.0
Baricitinib	FER	75.0	10000.0
GSK429286A	LIMK2	89.0	10000.0
XMD13-2	MK14	2.0	10000.0
Taselisib	SNARK	91.0	1000.0
Buparlisib	RET(V804M)	100.0	1000.0
AS-252424	LATS2	100.0	10000.0
THZ1	MKNK2	0.2	10000.0
HG-14-8-02	PIP5K2B	66.0	10000.0
ZSTK474	KGP1	100.0	1000.0
WZ3105	VGFR2	96.0	10000.0
JNK-IN-11	IKKB	84.0	1000.0
Palbociclib	AKT2	100.0	1000.0
BMS345541	YES	100.0	10000.0
KIN001-123	GSK3B	100.0	1000.0
Dactolisib	MAPKAPK2	100.0	1000.0
BMS345541	NEK11	100.0	10000.0
GSK1059615	PRKR	20.0	10000.0
WH-4-023	IRAK1	19.0	10000.0
BI-2536	KCC4	100.0	10000.0
NPK76-II-72-1	MST3	100.0	10000.0
PHA-767491	PAK6	100.0	10000.0
XMD-12	KC1G2	80.0	1000.0
Seliciclib	DCLK1	51.0	10000.0
SB590885	MAP4K2	74.0	10000.0
BMS345541	PIP5K2B	100.0	10000.0
CGP74514A	SIK3	32.0	10000.0
OTSSP167	ULK2	0.2	10000.0
Taselisib	ALK(C1156Y)	87.0	1000.0
GW-5074	MP2K5	56.0	10000.0
THZ1	PKMYT1	84.0	10000.0
ZSTK474	MRCKB	100.0	1000.0
AZD-6482	CDC2L2	100.0	10000.0
Torin1	ABL1(F317L)-nonphosphorylated	78.0	10000.0
CG-930	TNIK	83.0	10000.0
BX-912	RIOK1	0.0	10000.0
KIN001-111	PIM2	100.0	1000.0
Buparlisib	LRRK2(G2019S)	100.0	1000.0
Torin2	KIT	55.0	10000.0
Vemurafenib	MP2K6	57.0	10000.0
ZSTK474	EPHB2	100.0	1000.0
BS-181	ANKK1	74.0	10000.0
Crizotinib	MK11	100.0	10000.0
TGX221	YSK1	100.0	1000.0
A443654	PIM1	0.4	10000.0
KIN001-123	TRKA	100.0	1000.0
AZD7762	MYO3B	8.2	10000.0
Sigma A6730	HIPK4	72.0	10000.0
ZM-447439	FGFR3(G697C)	100.0	10000.0
PD0325901	TYRO3	80.0	10000.0
BMS-536924	LOK	29.0	1000.0
BMX-IN-1	PHKG2	88.0	10000.0
CGP60474	BMPR2	100.0	10000.0
GSK461364	SRC	100.0	10000.0
Neratinib	DYRK2	64.0	10000.0
WZ-7043	ULK2	100.0	10000.0
KIN001-127	CAMK2B	100.0	10000.0
Omipalisib	PIM1	79.0	10000.0
WZ4002	MAP4K2	100.0	10000.0
Ceritinib	MKNK2	5.3	1000.0
CGP60474	MELK	100.0	10000.0
BMX-IN-1	M3K6	100.0	10000.0
Baricitinib	ABL1(F317L)-nonphosphorylated	74.0	10000.0
QL-XII-47	KGP1	88.0	1000.0
Ceritinib	CDC2L1	88.0	1000.0
NU7441	MARK3	99.0	10000.0
Ibrutinib	MK09	60.0	1000.0
ALW-II-49-7	FLT3(K663Q)	100.0	10000.0
AZD-6482	AURKA	100.0	10000.0
Torin2	MK01	100.0	10000.0
NU7441	AURKC	100.0	10000.0
XMD16-144	TRKC	16.0	10000.0
QL-XII-47	FGFR2	92.0	1000.0
R406	EPHA7	0.1	1000.0
HG-9-91-01	GSK3B	96.0	10000.0
PHA-767491	NDR2	24.0	10000.0
NU7441	PTK6	98.0	10000.0
Ibrutinib	RET(V804L)	91.0	1000.0
BS-181	MYLK4	97.0	10000.0
BX-912	RSK4(Kin.Dom.2-C-terminal)	10.0	10000.0
WH-4-023	EGFR(G719S)	0.5	10000.0
BGJ398	DDR2	49.0	1000.0
CGP74514A	JAK1(JH2domain-pseudokinase)	39.0	10000.0
5z-7-oxozeaenol	ERK3	98.0	10000.0
QL-X-138	CIT	42.0	10000.0
CH5424802	ROCK1	100.0	1000.0
XMD11-85h	KKCC1	100.0	10000.0
Taselisib	MAP4K2	99.0	1000.0
CH5424802	MAK	100.0	1000.0
Abemaciclib	CLK2	0.4	1000.0
PD0325901	RSK3(Kin.Dom.2-C-terminal)	92.0	10000.0
Ibrutinib	KIT(D816H)	82.0	1000.0
Dabrafenib	TTK	33.0	10000.0
XMD8-92	SYK	100.0	10000.0
XMD11-50	CSK	90.0	10000.0
XMD14-99	NIM1	80.0	10000.0
WZ-4-145	LATS1	100.0	10000.0
HG-6-64-01	RIPK1	0.2	10000.0
ALW-II-38-3	RPS6KA6(Kin.Dom.2)	100.0	10000.0
QL-XI-92	CAMK2A	91.0	10000.0
Pictilisib	BTK	97.0	1000.0
BMS345541	RIOK2	79.0	10000.0
XMD16-144	CASK	39.0	10000.0
KIN001-111	TRKB	100.0	1000.0
Sorafenib	KIT(V559D,V654A)	1.1	10000.0
BMX-IN-1	CDK4-cyclinD1	100.0	10000.0
MRT67307	MAPKAPK2	100.0	10000.0
(s)-CR8	ABL1(F317L)-phosphorylated	84.0	10000.0
BI-2536	LIMK1	100.0	10000.0
(s)-CR8	RIPK2	92.0	10000.0
MPS-1-IN-1	KPCD3	100.0	1000.0
XMD8-85	SYK	100.0	10000.0
AZ-628	DDR1	0.0	10000.0
Dabrafenib	MP2K7	98.0	10000.0
BI-2536	RAF1	100.0	10000.0
XMD8-92	ULK1	100.0	10000.0
JNK-IN-11	STK33	91.0	1000.0
PHA-793887	EPHA3	49.0	10000.0
WZ4003	KIT	100.0	1000.0
BS-181	DYRK2	33.0	10000.0
Taselisib	PKAC-alpha	96.0	1000.0
TAK-715	CLK2	61.0	10000.0
AZD7762	SIK2	2.6	10000.0
Sorafenib	PI42C	100.0	10000.0
Ribociclib	ACVR1B	100.0	1000.0
Dinaciclib	LYN	100.0	10000.0
PHA-793887	MINK	70.0	10000.0
CGP74514A	ERN1	40.0	10000.0
Ibrutinib	NEK7	94.0	1000.0
TGX221	CDC2L2	100.0	1000.0
Ribociclib	SRMS	100.0	1000.0
Sorafenib	PIK3CA(E542K)	100.0	10000.0
KIN001-021	RET	100.0	1000.0
Dabrafenib	RSK1(Kin.Dom.1-N-terminal)	1.6	10000.0
(s)-CR8	RSK2(Kin.Dom.1-N-terminal)	74.0	10000.0
CG-930	MAP4K2	91.0	10000.0
XMD8-85	MK09	100.0	10000.0
KU63794	MAP3K1	100.0	10000.0
CP466722	MK12	21.0	10000.0
HG-6-64-01	MK12	40.0	10000.0
BMS345541	SLK	100.0	10000.0
XMD13-2	DAPK1	91.0	10000.0
Seliciclib	TIE2	100.0	10000.0
JNK-IN-5A	DAPK1	85.0	10000.0
KIN001-123	CSNK1A1L	100.0	1000.0
MPS-1-IN-1	IRAK3	100.0	1000.0
NU7441	AMPK-alpha1	100.0	10000.0
HG-9-91-01	PIK3C2G	100.0	10000.0
WZ-7043	CLK4	100.0	10000.0
JW-7-24-1	PAK6	100.0	10000.0
AG1478	TXK	63.0	10000.0
BGJ398	PAK1	82.0	1000.0
Torin2	BTK	100.0	10000.0
MLN8054	ABL1(H396P)-nonphosphorylated	0.2	10000.0
MLN8054	NUAK1	67.0	10000.0
ZG-10	PAK3	100.0	10000.0
RO-3306	TRKA	90.0	10000.0
BMS345541	YSK4	16.0	10000.0
TGX221	ABL1(E255K)	100.0	1000.0
JNK-IN-11	ABL1-phosphorylated	24.0	1000.0
Dinaciclib	ULK1	40.0	10000.0
Torkinib	EGFR(L747-E749del,A750P)	14.0	10000.0
JWE-035	MST4	5.6	10000.0
CH5424802	GSK3B	93.0	1000.0
5z-7-oxozeaenol	MELK	92.0	10000.0
PHA-767491	ROCK2	0.5	10000.0
Seliciclib	CAMK1	100.0	10000.0
HG-14-10-04	PIK3CA(E545A)	95.0	10000.0
HG-14-8-02	CDKL2	98.0	10000.0
5z-7-oxozeaenol	TYK2(JH1domain-catalytic)	100.0	10000.0
Ibrutinib	FYN	7.8	1000.0
Torkinib	MP2K7	75.0	10000.0
PLX-4720	CHK2	64.0	10000.0
GSK1059615	TESK1	84.0	10000.0
Palbociclib	IKKE	100.0	1000.0
(s)-CR8	KIT-autoinhibited	76.0	10000.0
XMD11-85h	LKB1	100.0	10000.0
AZD-6482	PTK6	75.0	10000.0
SCH772984	BLK	86.0	1000.0
THZ1	STK39	100.0	10000.0
HG-5-113-01	ABL1(M351T)	7.9	10000.0
WZ-4-145	JAK1(Kin.Dom.1)	100.0	10000.0
BX-912	PFCDPK1(P.falciparum)	3.8	10000.0
KU63794	FRK	100.0	10000.0
HG-5-113-01	MK12	100.0	10000.0
Torin2	KCC2D	85.0	10000.0
WZ4003	MKNK1	100.0	1000.0
Barasertib	SLK	64.0	10000.0
XMD13-2	PLK4	13.0	10000.0
MPS-1-IN-1	PHKG2	100.0	1000.0
Buparlisib	HIPK2	100.0	1000.0
WZ3105	EPHA1	72.0	10000.0
Seliciclib	PAK3	100.0	10000.0
GW843682X	KGP1	100.0	10000.0
HG-5-113-01	PIK3CA	100.0	10000.0
GSK461364	MARK2	53.0	10000.0
ZM-447439	PIK3CD	100.0	10000.0
NU7441	ERBB3	72.0	10000.0
XMD8-85	MYO3A	100.0	10000.0
XMD16-144	KPCD2	36.0	10000.0
BGJ398	M3K2	8.8	1000.0
BMS345541	CDK5	100.0	10000.0
WH-4-023	CDKL2	0.5	10000.0
Neratinib	EGFR(T790M)	0.2	10000.0
AZ-628	DRAK2	100.0	10000.0
HG-9-91-01	MLTK	2.7	10000.0
RO-3306	JAK1(JH1domain-catalytic)	100.0	10000.0
Baricitinib	LATS1	100.0	10000.0
WZ3105	ERK5	100.0	10000.0
WZ3105	ABL1(F317I)-phosphorylated	78.0	10000.0
Neratinib	LIMK2	100.0	10000.0
QL-X-138	ALK	100.0	10000.0
NG25	CDC2L1	0.4	10000.0
AS-252424	PIM2	2.0	10000.0
XMD16-144	STK39	100.0	10000.0
AZD-6482	MAPKAPK2	66.0	10000.0
MRT67307	VGFR2	100.0	10000.0
Barasertib	KPCD2	80.0	10000.0
MLN8054	PGFRB	34.0	10000.0
JNK-IN-5A	TGFBR2	100.0	10000.0
MLN8054	CLK1	63.0	10000.0
Momelotinib	LIMK2	68.0	10000.0
JWE-035	FGFR1	17.0	10000.0
NU7441	VGFR2	100.0	10000.0
AZD7762	MP2K4	2.2	10000.0
PHA-767491	SGK3	16.0	10000.0
ALW-II-49-7	ABL1	100.0	10000.0
XMD-12	YSK1	96.0	1000.0
XMD16-144	OSR1	25.0	10000.0
MPS-1-IN-1	CLK1	7.3	1000.0
AZD-6482	SRPK3	100.0	10000.0
Dinaciclib	TNK2	98.0	10000.0
AZD7762	CAMK1D	0.2	10000.0
Barasertib	VGFR2	2.7	10000.0
GSK1059615	KCC4	100.0	10000.0
GSK461364	CDK11	100.0	10000.0
MRT67307	MRCKB	100.0	10000.0
KIN001-220	MUSK	11.0	10000.0
HG-6-64-01	SGK3	38.0	10000.0
MRT67307	CSK	87.0	10000.0
PHA-793887	HCK	76.0	10000.0
JNK-IN-11	JNK3	0.0	1000.0
Ceritinib	SIK1	88.0	1000.0
BI-D1870	CDK16	0.2	10000.0
JNK-IN-8	FLT4	100.0	1000.0
GSK461364	TSSK1	19.0	10000.0
XMD13-2	ERBB2	100.0	10000.0
Omipalisib	TRKB	80.0	10000.0
Torkinib	S6K1	57.0	10000.0
Sorafenib	CDK8	1.4	10000.0
Pictilisib	MST1R	100.0	1000.0
WH-4-023	CSNK1E	23.0	10000.0
XMD16-144	TEC	97.0	10000.0
Ibrutinib	FGFR3	43.0	1000.0
GW-5074	M3K2	100.0	10000.0
GSK429286A	CDK14	89.0	10000.0
GW843682X	TYK2(JH2domain-pseudokinase)	97.0	10000.0
AZ-628	ROCK1	92.0	10000.0
BI-2536	MP2K1	100.0	10000.0
NU7441	ABL1(Q252H)-phosphorylated	100.0	10000.0
NU7441	KPCE	100.0	10000.0
ALW-II-49-7	RPS6KA2(Kin.Dom.1)	100.0	10000.0
Ribociclib	PIK3CA(E542K)	100.0	1000.0
JNK-9L	RSK1(Kin.Dom.1-N-terminal)	31.0	10000.0
CGP60474	KIT(L576P)	100.0	10000.0
HG-6-64-01	TIE2	0.1	10000.0
KU63794	TRKA	72.0	10000.0
Alpelisib	FLT3(D835V)	82.0	1000.0
XMD11-50	KPCD2	59.0	10000.0
CGP60474	MP2K4	100.0	10000.0
HG-6-64-01	MP2K5	0.2	10000.0
Dactolisib	CDK7	100.0	1000.0
PHA-767491	TEC	100.0	10000.0
WZ3105	MAP3K1	100.0	10000.0
Sorafenib	TAK1	6.2	10000.0
HG-9-91-01	YANK3	16.0	10000.0
CH5424802	SRPK1	58.0	1000.0
GSK429286A	NEK4	85.0	10000.0
Abemaciclib	TAK1	4.7	1000.0
Taselisib	NUAK1	100.0	1000.0
PLX-4720	YANK3	86.0	10000.0
BMS-536924	FAK2	0.5	1000.0
WZ-7043	NEK5	100.0	10000.0
Seliciclib	EPHA4	100.0	10000.0
AZD 5438	NLK	34.0	10000.0
BGJ398	BUB1	100.0	1000.0
Neratinib	NEK1	70.0	10000.0
WYE-125132	DRAK1	100.0	10000.0
KIN001-123	BTK	3.7	1000.0
AZD-6482	CAMK1D	100.0	10000.0
Sigma A6730	TRKB	85.0	10000.0
GSK1059615	RIOK2	37.0	10000.0
PHA-793887	KCC4	84.0	10000.0
Dabrafenib	EGFR(L858R)	41.0	10000.0
Dinaciclib	STK35	100.0	10000.0
SB590885	MP2K2	91.0	10000.0
GW843682X	CIT	38.0	10000.0
Pictilisib	RIPK1	91.0	1000.0
GSK461364	ERK5	91.0	10000.0
CG-930	FAK1	100.0	10000.0
BI-D1870	DDR2	21.0	10000.0
HG-14-10-04	ERN1	16.0	10000.0
Sigma A6730	JAK3(JH1domain-catalytic)	95.0	10000.0
GW843682X	PIK3CD	78.0	10000.0
Neratinib	EPHB1	98.0	10000.0
CH5424802	PLK1	90.0	1000.0
PHA-793887	PAK2	58.0	10000.0
Dinaciclib	DCAMKL3	18.0	10000.0
BMX-IN-1	RIPK4	100.0	10000.0
HG-14-10-04	MYO3B	0.0	10000.0
WZ-4-145	PIM1	100.0	10000.0
CP466722	ABL1(F317L)-phosphorylated	0.1	10000.0
XMD14-99	PGFRA	84.0	10000.0
BMX-IN-1	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
AZD7762	VRK2	92.0	10000.0
XMD13-2	ACVR2A	92.0	10000.0
GSK429286A	CTK	68.0	10000.0
ZSTK474	MLTK	100.0	1000.0
AZD4547	RSK4(Kin.Dom.1-N-terminal)	42.0	10000.0
Abemaciclib	DAPK3	2.9	1000.0
Abemaciclib	KGP1	100.0	1000.0
NVP-TAE684	TESK1	100.0	1000.0
JNK-IN-8	IRAK1	13.0	1000.0
KIN001-021	NEK5	100.0	1000.0
GW-5074	MAP3K3	92.0	10000.0
PHA-793887	SIK1	100.0	10000.0
BMS345541	NEK5	100.0	10000.0
JNK-IN-11	EGFR	1.8	1000.0
TAK-715	KIT(V559D)	32.0	10000.0
HG-6-64-01	TTK	6.8	10000.0
NPK76-II-72-1	LTK	100.0	10000.0
CP724714	TLK1	79.0	10000.0
R406	ABL2	4.4	1000.0
Torkinib	ADCK4	13.0	10000.0
R406	TIE1	0.3	1000.0
MLN8054	MAP3K3	72.0	10000.0
KU63794	ERK8	96.0	10000.0
KIN001-127	DAPK3	100.0	10000.0
PD0325901	ICK	84.0	10000.0
Lapatinib	LRRK2	100.0	10000.0
BGJ398	CAMKK2	81.0	1000.0
RO-3306	CDK2	73.0	10000.0
AS-252424	IKKE	100.0	10000.0
KIN001-220	CSF1R	6.5	10000.0
5z-7-oxozeaenol	CSNK2A2	60.0	10000.0
Palbociclib	DRAK1	100.0	1000.0
AG1478	KIT-autoinhibited	77.0	10000.0
Ceritinib	RIPK2	93.0	1000.0
WZ-4-145	JAK3(Kin.Dom.2)	0.2	10000.0
Buparlisib	TTK	100.0	1000.0
A443654	ANKK1	100.0	10000.0
GW843682X	IRAK3	67.0	10000.0
NU7441	TXK	91.0	10000.0
GSK429286A	TRKC	100.0	10000.0
XMD11-50	FGR	84.0	10000.0
Abemaciclib	LKB1	100.0	1000.0
Abemaciclib	TYK2(JH1domain-catalytic)	92.0	1000.0
Torkinib	CLK1	14.0	10000.0
CG-930	MK09	0.0	10000.0
Torkinib	AKT1	100.0	10000.0
OTSSP167	TYK2(JH2domain-pseudokinase)	32.0	10000.0
ERK5-IN-1	YES	100.0	1000.0
ZSTK474	TIE1	100.0	1000.0
Baricitinib	MKNK2	0.4	10000.0
Seliciclib	MTOR	100.0	10000.0
WZ-4-145	TNK2	1.7	10000.0
BMS345541	SRC	100.0	10000.0
Palbociclib	MLCK	84.0	1000.0
KU63794	PIK4CB	100.0	10000.0
XMD11-50	FAK1	34.0	10000.0
MRT67307	TRKB	10.0	10000.0
PHA-767491	PIK3C2G	87.0	10000.0
NU7441	KCC4	100.0	10000.0
ZM-447439	IKKE	62.0	10000.0
AS-252424	NLK	91.3	10000.0
WZ-7043	EPHB1	100.0	10000.0
Pictilisib	RSK3(Kin.Dom.1-N-terminal)	84.0	1000.0
WZ-4-145	RAF1	100.0	10000.0
JWE-035	RSK3(Kin.Dom.2-C-terminal)	32.0	10000.0
JNK-IN-5A	KC1G2	57.0	10000.0
Abemaciclib	NEK4	87.0	1000.0
JNK-IN-8	RSK4(Kin.Dom.2-C-terminal)	76.0	1000.0
ALW-II-38-3	ANKK1	100.0	10000.0
AZ-628	FLT3(K663Q)	22.0	10000.0
JNK-IN-5A	ACVR1B	100.0	10000.0
Pictilisib	INSRR	100.0	1000.0
Seliciclib	TAK1	100.0	10000.0
AZD4547	DAPK2	46.0	10000.0
Dinaciclib	CSNK1G3	91.0	10000.0
WH-4-023	MLCK	100.0	10000.0
WYE-125132	ABL1(Q252H)-nonphosphorylated	100.0	10000.0
BGJ398	MAPKAPK5	84.0	1000.0
PD0325901	NIM1	100.0	10000.0
HG-5-113-01	M3K5	100.0	10000.0
CG-930	NIM1	100.0	10000.0
Omipalisib	CHK2	73.0	10000.0
Vemurafenib	CAMK2B	98.0	10000.0
AZ-628	CDK9	100.0	10000.0
Ibrutinib	PAK3	39.0	1000.0
PLX-4720	IRAK4	86.0	10000.0
Dabrafenib	EPHA7	94.0	10000.0
Barasertib	TTK	49.0	10000.0
KIN001-127	TNK2	100.0	10000.0
QL-X-138	VGFR1	100.0	10000.0
SP600125	MARK2	100.0	10000.0
ZM-447439	ERN1	74.0	10000.0
HG-9-91-01	DRAK2	54.0	10000.0
BI-2536	MST2	100.0	10000.0
BMS-536924	MAPKAPK5	100.0	1000.0
RO-3306	CAMK1	88.0	10000.0
QL-XII-47	MAP3K15	59.0	1000.0
AZD7762	ABL1(F317I)-phosphorylated	4.4	10000.0
Omipalisib	LRRK2	95.0	10000.0
PD0325901	FLT3(R834Q)	78.0	10000.0
GSK429286A	BIKE	69.0	10000.0
KIN001-127	TAOK3	3.6	10000.0
Ceritinib	ACVR2A	100.0	1000.0
MLN8054	AMPK-alpha2	67.0	10000.0
AZ-628	MP2K1	100.0	10000.0
Seliciclib	RSK3(Kin.Dom.2-C-terminal)	54.0	10000.0
CH5424802	CSNK1A1	17.0	1000.0
Crizotinib	KIT(V559D)	27.0	10000.0
Alpelisib	TXK	100.0	1000.0
OTSSP167	ABL1(T315I)-nonphosphorylated	12.0	10000.0
A443654	KCC4	12.0	10000.0
KU63794	MP2K1	100.0	10000.0
Crizotinib	FGR	6.8	10000.0
RO-3306	PIK3CB	41.0	10000.0
Vemurafenib	NLK	81.0	10000.0
MRT67307	CDK2	100.0	10000.0
PD173074	RIPK2	100.0	10000.0
GW843682X	KPCI	72.0	10000.0
KIN001-220	FRK	28.0	10000.0
BMS-536924	PAK7	0.8	1000.0
NG25	FYN	1.2	10000.0
MPS-1-IN-1	ULK3	100.0	1000.0
CG-930	M3K13	100.0	10000.0
ALW-II-49-7	SYK	100.0	10000.0
KIN001-127	CDK7	1.4	10000.0
Pictilisib	SGK1	100.0	1000.0
Abemaciclib	KPCT	51.0	1000.0
Seliciclib	RIOK2	49.0	10000.0
Torin2	EPHA1	93.0	10000.0
BI-D1870	TRKA	31.0	10000.0
XMD14-99	PIK3CA(E545K)	100.0	10000.0
HG-5-88-01	PAK6	100.0	10000.0
CP466722	KPCD3	42.0	10000.0
HG-14-8-02	MRCKB	95.0	10000.0
Ribociclib	ACVRL1	100.0	1000.0
5z-7-oxozeaenol	NIM1	100.0	10000.0
AZD4547	ERK4	100.0	10000.0
Sorafenib	MP2K7	88.0	10000.0
Dactolisib	TAK1	100.0	1000.0
Ribociclib	NDR2	100.0	1000.0
Buparlisib	ROCK1	100.0	1000.0
Abemaciclib	TRKC	38.0	1000.0
GSK1059615	KIT	30.0	10000.0
HG-5-88-01	RIPK4	100.0	10000.0
BMS345541	DYRK1A	39.0	10000.0
BS-181	AURKA	86.0	10000.0
ZSTK474	AMPK-alpha1	100.0	1000.0
GW843682X	EGFR	81.0	10000.0
CP466722	BLK	8.8	10000.0
Momelotinib	FGFR3(G697C)	79.0	10000.0
QL-XI-92	BMPR2	100.0	10000.0
AZD 5438	M4K1	19.0	10000.0
SP600125	PAK2	100.0	10000.0
XMD16-144	MKNK1	38.0	10000.0
Ibrutinib	ABL1-nonphosphorylated	7.2	1000.0
Torin1	KPCD1	99.0	10000.0
CGP74514A	EGFR(E746-A750del)	47.0	10000.0
CP466722	DAPK3	4.6	10000.0
Vemurafenib	KPCD	100.0	10000.0
Ribociclib	RIOK3	93.0	1000.0
QL-XII-47	CDK16	92.0	1000.0
JNK-IN-5A	SNARK	95.0	10000.0
JNK-IN-8	GRK4	96.0	1000.0
PLX-4720	PCTK2	56.0	10000.0
KIN001-127	MRCKB	100.0	10000.0
Baricitinib	PKAC-beta	1.0	10000.0
NG25	TRKC	6.8	10000.0
SP600125	TNIK	18.0	10000.0
GW843682X	DYRK2	37.0	10000.0
RO-3306	LKB1	42.0	10000.0
KIN001-111	RPS6KA6(Kin.Dom.1)	100.0	1000.0
SCH772984	BTK	64.0	1000.0
HG-14-10-04	PLK3	10.0	10000.0
WZ3105	PRP4	90.0	10000.0
HG-5-88-01	FLT3(N841I)	13.0	10000.0
SP600125	EGFR	100.0	10000.0
NU7441	EGFR(L747-S752del,P753S)	90.0	10000.0
ERK5-IN-1	EPHA5	100.0	1000.0
HG-6-64-01	BMPR1A	100.0	10000.0
Baricitinib	DAPK1	0.5	10000.0
PHA-767491	RSK4(Kin.Dom.2-C-terminal)	35.0	10000.0
GW-5074	PAK4	82.0	10000.0
BMX-IN-1	NLK	100.0	10000.0
ALW-II-49-7	YANK3	100.0	10000.0
NG25	MYLK2	6.6	10000.0
CG-930	EGFR(L858R)	17.0	10000.0
MPS-1-IN-1	PAK1	100.0	1000.0
Vemurafenib	HIPK2	66.0	10000.0
TAK-715	ABL1(M351T)-phosphorylated	22.0	10000.0
Buparlisib	INSR	100.0	1000.0
MRT67307	STK16	5.0	10000.0
Dabrafenib	WNK1	84.0	10000.0
JNK-IN-5A	EPHA3	100.0	10000.0
BGJ398	CHK2	99.0	1000.0
BS-181	RIOK3	69.0	10000.0
ALW-II-38-3	NUAK1	100.0	10000.0
AS-252424	SIK2	100.0	10000.0
Baricitinib	MRCKA	89.0	10000.0
AZD7762	TLK2	1.9	10000.0
PLX-4720	ADCK4	100.0	10000.0
Torkinib	MYO3A	12.0	10000.0
QL-X-138	EGFR(L861Q)	22.0	10000.0
XMD16-144	YSK1	66.0	10000.0
AZD-6482	ADCK4	79.0	10000.0
Lapatinib	PIK3CA(E542K)	96.0	10000.0
XMD16-144	PIK3C2G	76.0	10000.0
Dinaciclib	CDK7	0.4	10000.0
ZM-447439	MK01	72.0	10000.0
SCH772984	MK12	62.0	1000.0
5z-7-oxozeaenol	PKAC-alpha	70.0	10000.0
R406	AXL	0.4	1000.0
R406	CAMK2A	23.0	1000.0
AZD4547	FLT3(K663Q)	0.3	10000.0
CP466722	CDK7	5.4	10000.0
GSK461364	GCN2(Kin.Dom.2,S808G)	29.0	10000.0
AG1478	KPCT	100.0	10000.0
AZ-628	ERBB4	34.0	10000.0
Ceritinib	SGK3	83.0	1000.0
CH5424802	PKN1	91.0	1000.0
XMD11-85h	RIPK4	100.0	10000.0
HG-6-64-01	EPHA1	2.0	10000.0
Dinaciclib	MAST1	77.0	10000.0
KU63794	AMPK-alpha2	100.0	10000.0
ERK5-IN-1	BMX	100.0	1000.0
CG-930	CDKL1	95.0	10000.0
WYE-125132	KIT(D816V)	82.0	10000.0
SP600125	LATS2	100.0	10000.0
XMD11-85h	DCAMKL2	100.0	10000.0
Vemurafenib	ABL1(H396P)-nonphosphorylated	5.6	10000.0
NU7441	MKNK1	100.0	10000.0
Crizotinib	SIK1	24.0	10000.0
Canertinib	SNARK	100.0	1000.0
XMD13-2	PAK6	61.0	10000.0
WZ-4-145	PIP5K2B	100.0	10000.0
Palbociclib	MP2K2	89.0	1000.0
XMD16-144	SLK	7.3	10000.0
JNK-IN-5A	MYO3B	88.0	10000.0
Dabrafenib	PGFRA	100.0	10000.0
CP466722	TEC	100.0	10000.0
Torkinib	ACVRL1	6.7	10000.0
Pictilisib	TYK2(JH1domain-catalytic)	100.0	1000.0
HG-14-8-02	FGR	95.0	10000.0
PD0325901	PLK3	100.0	10000.0
R406	MYLK2	22.0	1000.0
OTSSP167	CSNK1A1L	1.0	10000.0
PD0325901	M3K13	86.0	10000.0
ALW-II-49-7	KPCT	100.0	10000.0
THZ1	TIE2	1.2	10000.0
KIN001-220	DCAMKL3	80.0	10000.0
TGX221	PLK1	100.0	1000.0
A443654	RET(V804L)	12.0	10000.0
Crizotinib	MET(Y1235D)	1.7	10000.0
XMD14-99	NEK9	100.0	10000.0
Torin1	AKT3	77.0	10000.0
PHA-793887	AURKC	100.0	10000.0
Ibrutinib	PAK4	89.0	1000.0
Sorafenib	CHEK1	91.0	10000.0
AZD 5438	YSK4	0.0	10000.0
GSK461364	PHKG1	94.0	10000.0
QL-X-138	DYRK2	0.6	10000.0
Sigma A6730	PLK3	94.0	10000.0
Ibrutinib	MTOR	89.0	1000.0
QL-XI-92	M4K1	75.0	10000.0
Barasertib	M3K6	88.0	10000.0
NG25	MYLK4	100.0	10000.0
R406	MK09	11.0	1000.0
Omipalisib	ADCK4	20.0	10000.0
QL-XI-92	BMX	100.0	10000.0
PHA-767491	YANK2	95.0	10000.0
BI-2536	PAK4	100.0	10000.0
Sorafenib	ABL1(F317I)-nonphosphorylated	5.6	10000.0
Ibrutinib	MST1	74.0	1000.0
CGP60474	AXL	100.0	10000.0
AZD7762	EGFR(E746-A750del)	4.2	10000.0
Torin1	GSK3A	93.0	10000.0
KIN001-111	CDK8	3.2	1000.0
CH5424802	PIP5K1C	74.0	1000.0
MRT67307	FLT3(N841I)	0.0	10000.0
5z-7-oxozeaenol	KPCT	100.0	10000.0
Lapatinib	IRAK1	92.0	10000.0
Alpelisib	MRCKB	96.0	1000.0
XMD11-50	RET(V804L)	89.0	10000.0
AS-252424	TRKA	100.0	10000.0
GW-5074	STK35	100.0	10000.0
WH-4-023	PHKG2	100.0	10000.0
XMD11-50	CAMK2G	47.0	10000.0
AS-252424	MISR2	84.7	10000.0
KIN001-220	NEK9	18.0	10000.0
NG25	CLK3	100.0	10000.0
Momelotinib	MLTK	100.0	10000.0
RO-3306	PGFRB	76.0	10000.0
AZD 5438	LTK	100.0	10000.0
NG25	ABL1(M351T)	0.1	10000.0
CH5424802	M3K12	100.0	1000.0
XMD13-2	AMPK-alpha2	45.0	10000.0
AZD4547	CLK1	2.0	10000.0
Torin2	KC1G1	100.0	10000.0
XMD11-85h	OSR1	100.0	10000.0
BS-181	HUNK	78.0	10000.0
XMD13-2	MARK3	75.0	10000.0
Ribociclib	PKNB(M.tuberculosis)	86.0	1000.0
ZM-447439	ABL2	82.0	10000.0
XMD8-85	MINK	100.0	10000.0
CGP60474	DDR1	100.0	10000.0
ALW-II-49-7	TXK	100.0	10000.0
HG-14-10-04	DYRK1A	0.0	10000.0
ALW-II-49-7	EGFR(L861Q)	100.0	10000.0
Neratinib	DAPK2	87.0	10000.0
NG25	TGFBR2	100.0	10000.0
Dactolisib	DDR2	100.0	1000.0
ERK5-IN-1	ULK3	100.0	1000.0
KU63794	CDK4-cyclinD3	80.0	10000.0
BGJ398	PIM3	78.0	1000.0
Alpelisib	CAMK2A	93.0	1000.0
Canertinib	KCC2D	100.0	1000.0
PLX-4720	CDC2L5	100.0	10000.0
Buparlisib	EPHA2	91.0	1000.0
ALW-II-49-7	CLK1	100.0	10000.0
HG-14-8-02	RSK1(Kin.Dom.1-N-terminal)	78.0	10000.0
PHA-767491	LIMK1	96.0	10000.0
GSK429286A	RET(V804M)	43.0	10000.0
(s)-CR8	ABL1(H396P)-phosphorylated	99.0	10000.0
HG-14-10-04	GSK3A	100.0	10000.0
NG25	FLT3(N841I)	0.0	10000.0
Alpelisib	GRK4	90.0	1000.0
XMD16-144	PIK3CG	0.0	10000.0
MLN8054	PAK1	80.0	10000.0
WYE-125132	TRKB	100.0	10000.0
ZSTK474	PRKX	100.0	1000.0
THZ1	KPCL	18.0	10000.0
Crizotinib	KC1G2	100.0	10000.0
XMD11-50	TRKB	100.0	10000.0
Dactolisib	PCTK3	100.0	1000.0
Lapatinib	TESK1	51.0	10000.0
Neratinib	RIOK3	97.0	10000.0
5z-7-oxozeaenol	SBK1	70.0	10000.0
ZG-10	EPHB6	3.9	10000.0
Seliciclib	KGP1	100.0	10000.0
Sorafenib	SRPK2	96.0	10000.0
THZ1	HUNK	31.0	10000.0
QL-X-138	NEK3	77.0	10000.0
Taselisib	CSF1R	100.0	1000.0
Dactolisib	EPHA6	100.0	1000.0
5z-7-oxozeaenol	AAK1	13.0	10000.0
(s)-CR8	BUB1	100.0	10000.0
WYE-125132	IRAK4	100.0	10000.0
PHA-767491	STK16	44.0	10000.0
WZ-7043	CLK2	100.0	10000.0
HG-9-91-01	CSNK2A2	100.0	10000.0
Ribociclib	MYLK4	100.0	1000.0
Canertinib	ACVRL1	100.0	1000.0
THZ1	TNK1	0.5	10000.0
JWE-035	MP2K1	86.0	10000.0
Buparlisib	KPCD	93.0	1000.0
Dabrafenib	TYK2(JH1domain-catalytic)	45.0	10000.0
PHA-793887	PTK6	95.0	10000.0
Torin2	BMPR1A	100.0	10000.0
JNK-IN-11	EGFR(L747-E749del,A750P)	1.6	1000.0
KIN001-021	CSNK1D	100.0	1000.0
KIN001-111	JAK2(Kin.Dom.2)	100.0	1000.0
GW843682X	LATS2	50.0	10000.0
SB590885	STK36	35.0	10000.0
PHA-793887	NEK3	100.0	10000.0
WYE-125132	MST1R	100.0	10000.0
CGP74514A	GRK7	2.0	10000.0
CP466722	DMPK	100.0	10000.0
ALW-II-38-3	ACVR2A	100.0	10000.0
ALW-II-38-3	TAOK3	100.0	10000.0
PLX-4720	RIPK5	54.0	10000.0
HG-5-88-01	GAK	2.5	10000.0
KIN001-220	PKMYT1	100.0	10000.0
SB590885	MK14	85.0	10000.0
WZ4003	MKNK2	1.8	1000.0
CG-930	CSK	98.0	10000.0
MLN8054	FLT3(D835H)	74.0	10000.0
JNK-IN-11	LCK	8.6	1000.0
OTSSP167	HIPK4	7.8	10000.0
HG-5-113-01	PGFRA	100.0	10000.0
KU63794	TYK2(JH1domain-catalytic)	100.0	10000.0
AZD-6482	MP2K4	100.0	10000.0
BGJ398	EGFR(L861Q)	100.0	1000.0
A443654	SRC	100.0	10000.0
CGP60474	EPHB2	100.0	10000.0
Sorafenib	SYK	88.0	10000.0
Lapatinib	MAP3K15	94.0	10000.0
R406	ANKK1	13.0	1000.0
OTSSP167	BRSK1	35.0	10000.0
KIN001-220	MARK3	80.0	10000.0
Baricitinib	RIOK3	44.0	10000.0
XMD11-50	PIM1	100.0	10000.0
CP724714	BRAF(V600E)	80.0	10000.0
(s)-CR8	NEK7	88.0	10000.0
AZ-628	ERK5	100.0	10000.0
GSK461364	EPHA5	100.0	10000.0
WYE-125132	MP2K2	100.0	10000.0
AZ-628	MKNK2	99.0	10000.0
Torin2	JNK3	78.0	10000.0
R406	CDKL2	24.0	1000.0
HG-14-8-02	NEK2	100.0	10000.0
QL-XI-92	TLK1	100.0	10000.0
BX-912	FGR	13.0	10000.0
BMS345541	MP2K3	95.0	10000.0
CP466722	ERK8	0.6	10000.0
SB590885	CLK3	98.0	10000.0
AS-252424	SgK110	100.0	10000.0
SB590885	EPHA1	91.0	10000.0
Vemurafenib	BRSK2	100.0	10000.0
RO-3306	SNARK	39.0	10000.0
MLN8054	PKAC-beta	58.0	10000.0
MLN8054	MUSK	93.0	10000.0
Ibrutinib	RSK4(Kin.Dom.1-N-terminal)	100.0	1000.0
BI-2536	NEK9	100.0	10000.0
KU63794	TXK	100.0	10000.0
CG-930	AMPK-alpha2	100.0	10000.0
GSK461364	MK13	100.0	10000.0
Canertinib	ABL1	100.0	1000.0
AZ-628	PAK7	100.0	10000.0
SB590885	TNNI3K	76.0	10000.0
AG1478	IKKB	66.0	10000.0
AS-252424	KPCD	100.0	10000.0
NG25	FLT3	0.2	10000.0
Dinaciclib	LRRK2(G2019S)	91.0	10000.0
GW-5074	KPCI	100.0	10000.0
Pictilisib	PKAC-beta	100.0	1000.0
NPK76-II-72-1	STK35	100.0	10000.0
WZ4003	MP2K4	100.0	1000.0
CG-930	ULK1	84.0	10000.0
Ribociclib	ACVR2B	96.0	1000.0
RO-3306	FLT4	84.0	10000.0
TAK-715	ERBB4	2.8	10000.0
CG-930	TXK	99.0	10000.0
Baricitinib	BMPR1A	100.0	10000.0
XMD8-85	TRKA	100.0	10000.0
CP466722	S6K1	2.6	10000.0
AG1478	HIPK4	6.1	10000.0
Ceritinib	PIK3C3	99.0	1000.0
5z-7-oxozeaenol	PIM3	79.0	10000.0
AZD-6482	PCTK3	100.0	10000.0
WZ-4-145	MUSK	6.2	10000.0
Neratinib	MLK1	84.0	10000.0
AZD4547	KIT(L576P)	0.0	10000.0
Abemaciclib	SRC	72.0	1000.0
HG-5-113-01	MST4	19.0	10000.0
Ibrutinib	PAK1	64.0	1000.0
RO-3306	KCC4	100.0	10000.0
NU7441	GSK3A	78.0	10000.0
KU63794	CDK3	100.0	10000.0
KIN001-123	PAK1	100.0	1000.0
KIN001-127	PLK4	100.0	10000.0
HG-5-113-01	RPS6KA3(Kin.Dom.1)	25.0	10000.0
SCH772984	KCC4	100.0	1000.0
HG-6-64-01	KIT(A829P)	64.0	10000.0
Pictilisib	PIP5K1C	71.0	1000.0
HG-5-88-01	ULK3	100.0	10000.0
Ibrutinib	HUNK	81.0	1000.0
WH-4-023	ACVR2B	1.8	10000.0
Ceritinib	MAP3K14	68.0	1000.0
CG-930	CAMK2B	100.0	10000.0
Seliciclib	KGP2	100.0	10000.0
GW843682X	INSRR	100.0	10000.0
THZ1	CDK4-cyclinD1	52.0	10000.0
Buparlisib	BARK2	100.0	1000.0
WH-4-023	KPCD2	6.4	10000.0
Dabrafenib	CSNK1E	27.0	10000.0
GSK429286A	LATS1	60.0	10000.0
SB590885	MP2K5	22.0	10000.0
XMD11-85h	ULK3	100.0	10000.0
KIN001-220	SgK110	40.0	10000.0
HG-14-8-02	ZAP70	48.0	10000.0
Baricitinib	PCTK3	100.0	10000.0
XMD13-2	EGFR(G719S)	85.0	10000.0
KIN001-220	CDK5	79.0	10000.0
JNK-IN-11	MAK	100.0	1000.0
PD0325901	EPHA5	96.0	10000.0
JNK-IN-5A	CLK2	87.0	10000.0
XMD14-99	SRMS	71.0	10000.0
Alpelisib	PLK1	83.0	1000.0
Torkinib	TEC	100.0	10000.0
PD173074	CAMK1D	100.0	10000.0
XMD14-99	HCK	100.0	10000.0
Baricitinib	ABL1(H396P)-phosphorylated	21.0	10000.0
KIN001-021	MST1R	100.0	1000.0
CGP74514A	MRCKB	100.0	10000.0
XMD11-85h	DYRK1B	100.0	10000.0
PHA-767491	ABL1(F317L)-nonphosphorylated	100.0	10000.0
TAK-715	VRK2	63.0	10000.0
XMD-12	TLK2	100.0	1000.0
KIN001-021	RPS6KA3(Kin.Dom.1)	100.0	1000.0
KIN001-021	TAOK3	100.0	1000.0
JNK-IN-5A	EGFR(L858R)	62.0	10000.0
BMX-IN-1	DDR1	75.0	10000.0
XMD16-144	ACVR1	45.0	10000.0
ZSTK474	CAMK1	100.0	1000.0
Alpelisib	PAK4	91.0	1000.0
KIN001-111	RAF1	14.0	1000.0
Ceritinib	PIK3CB	46.0	1000.0
Alpelisib	NEK4	100.0	1000.0
WZ-4-145	ABL1(Q252H)	14.0	10000.0
5z-7-oxozeaenol	KPCL	82.0	10000.0
JNK-IN-11	DDR1	0.0	1000.0
JNK-IN-5A	STK39	100.0	10000.0
WZ-7043	BMX	100.0	10000.0
ALW-II-49-7	KIT(V559D)	0.0	1000.0
BMS-536924	TRKC	0.0	1000.0
Alpelisib	JAK1(JH2domain-pseudokinase)	97.0	1000.0
ALW-II-49-7	CDK16	100.0	10000.0
BI-2536	CDKL2	100.0	10000.0
Torin1	TGFBR2	77.0	10000.0
PHA-767491	ALK(C1156Y)	67.0	10000.0
AZD4547	FER	31.0	10000.0
PHA-793887	PAK1	8.9	10000.0
GSK461364	TRPM6	100.0	10000.0
KIN001-127	KIT	100.0	10000.0
WZ-7043	SNARK	100.0	10000.0
MLN8054	CDK9	85.0	10000.0
QL-XII-47	PIK3CA(E545K)	52.0	1000.0
WZ4002	SLK	100.0	10000.0
Alpelisib	ACVR1B	93.0	1000.0
JW-7-24-1	PHKG1	100.0	10000.0
BMS-536924	KIT(V559D,T670I)	3.8	1000.0
XMD16-144	ABL1-phosphorylated	0.0	10000.0
HG-5-88-01	FGFR3(G697C)	100.0	10000.0
Ceritinib	FLT3-autoinhibited	90.0	1000.0
Abemaciclib	CDK11	100.0	1000.0
BX-912	RAF1	100.0	10000.0
CP466722	FGR	36.0	10000.0
WZ4002	DRAK2	100.0	10000.0
BMX-IN-1	VGFR1	100.0	10000.0
AZ-628	TNIK	3.4	10000.0
KU63794	PAK3	100.0	10000.0
Sigma A6730	AURKA	68.0	10000.0
Ribociclib	MAP4K2	100.0	1000.0
JW-7-24-1	TXK	100.0	10000.0
XMD11-85h	PIK3CA	100.0	10000.0
Dabrafenib	LRRK2	73.0	10000.0
AS-252424	CLK2	27.3	10000.0
ALW-II-38-3	PTK6	11.0	1000.0
MRT67307	CDC2L5	100.0	10000.0
BMS-536924	SRPK1	0.0	1000.0
Abemaciclib	ACVR1B	100.0	1000.0
HG-6-64-01	GCN2(Kin.Dom.2,S808G)	0.6	10000.0
HG-9-91-01	WNK3	97.0	10000.0
XMD14-99	RIOK2	100.0	10000.0
MPS-1-IN-1	RPS6KA2(Kin.Dom.2)	33.0	1000.0
Momelotinib	LRRK2	48.0	10000.0
JNK-9L	MK01	100.0	10000.0
QL-XII-47	TYK2(JH2domain-pseudokinase)	100.0	1000.0
WH-4-023	M3K5	100.0	10000.0
GW843682X	PAK2	96.0	10000.0
JNK-9L	RIPK1	7.8	10000.0
JW-7-24-1	FES	100.0	10000.0
XMD11-50	PIK3CB	96.0	10000.0
PHA-767491	NEK3	100.0	10000.0
XMD11-85h	TLK2	100.0	10000.0
Pictilisib	RAF1	100.0	1000.0
Ceritinib	BRAF(V600E)	85.0	1000.0
KIN001-021	PCTK3	100.0	1000.0
ZG-10	CSNK2A2	5.2	10000.0
AZ-628	KPCE	100.0	10000.0
Momelotinib	ROCK2	0.7	10000.0
THZ1	PAK1	42.0	10000.0
HG-14-10-04	M3K5	100.0	10000.0
GW-5074	HCK	81.0	10000.0
WZ-7043	PAK2	100.0	10000.0
CGP60474	TIE2	100.0	10000.0
HG-5-113-01	KIT(V559D)	18.0	10000.0
ALW-II-49-7	FGFR3	100.0	10000.0
GSK429286A	PGFRB	70.0	10000.0
CP724714	CSF1R	100.0	10000.0
XMD8-85	WEE1	100.0	10000.0
NU7441	TRPM6	100.0	10000.0
KIN001-123	BLK	3.4	1000.0
PHA-767491	BMX	100.0	10000.0
HG-9-91-01	RSK1(Kin.Dom.2-C-terminal)	13.0	10000.0
Seliciclib	PIK4CB	64.0	10000.0
RO-3306	STK36	96.0	10000.0
GW843682X	PIK3CA(I800L)	24.0	10000.0
OTSSP167	MTOR	100.0	10000.0
5z-7-oxozeaenol	EGFR(T790M)	100.0	10000.0
CH5424802	ABL1(F317L)-phosphorylated	2.2	1000.0
Neratinib	KIT(V559D,T670I)	73.0	10000.0
BMS345541	MK11	87.0	10000.0
BMS345541	SGK3	100.0	10000.0
CGP74514A	ALK	7.9	10000.0
PHA-793887	FGFR1	98.0	10000.0
Taselisib	KPCI	91.0	1000.0
PLX-4720	BIKE	100.0	10000.0
ZG-10	PIK3CA(M1043I)	100.0	10000.0
XMD8-92	ULK3	100.0	10000.0
AG1478	RIPK1	100.0	10000.0
SB590885	FLT3(K663Q)	90.0	10000.0
NVP-TAE684	IRAK3	0.2	1000.0
BI-D1870	PIK4CB	13.0	10000.0
JW-7-24-1	WEE1	100.0	10000.0
XMD8-85	YSK4	100.0	10000.0
TGX221	LOK	100.0	1000.0
ALW-II-49-7	YSK1	100.0	10000.0
JW-7-24-1	ULK1	100.0	10000.0
Baricitinib	PGFRB	17.0	10000.0
KIN001-220	S6K1	39.0	10000.0
JNK-IN-8	MK12	100.0	1000.0
QL-X-138	MARK2	83.0	10000.0
Ribociclib	PIK3CA	93.0	1000.0
MPS-1-IN-1	GSK3A	100.0	1000.0
Torin1	CSNK1G3	100.0	10000.0
PHA-767491	PFCDPK1(P.falciparum)	6.6	10000.0
Canertinib	MYLK4	100.0	1000.0
WH-4-023	AMPK-alpha1	23.0	10000.0
WZ4002	ERK5	4.0	10000.0
OTSSP167	YES	1.0	10000.0
AZD7762	EGFR(L747-S752del,P753S)	4.6	10000.0
AG1478	TIE1	71.0	10000.0
(s)-CR8	M3K6	100.0	10000.0
Palbociclib	ICK	100.0	1000.0
KIN001-220	PIK3CA	83.0	10000.0
NU7441	PAK1	71.0	10000.0
Lapatinib	M3K6	100.0	10000.0
GW843682X	PKAC-beta	100.0	10000.0
HG-14-8-02	CDK3	100.0	10000.0
QL-XII-47	SIK2	93.0	1000.0
AZD-6482	CAMKK2	100.0	10000.0
XMD16-144	DCLK1	4.0	10000.0
HG-9-91-01	CDKL5	100.0	10000.0
OTSSP167	GSK3A	31.0	10000.0
AZD 5438	PRP4	31.0	10000.0
CP466722	MARK1	86.0	10000.0
JNK-IN-11	KKCC1	100.0	1000.0
NVP-TAE684	GSK3B	100.0	1000.0
ALW-II-38-3	CSNK1G3	100.0	10000.0
KU63794	ROS1	100.0	10000.0
Pictilisib	FLT3(D835H)	79.0	1000.0
JNK-IN-11	EPHA3	65.0	1000.0
MRT67307	BMPR1B	100.0	10000.0
Momelotinib	CSNK1E	100.0	10000.0
Ibrutinib	NLK	100.0	1000.0
XMD11-85h	IGF1R	100.0	10000.0
MPS-1-IN-1	ABL1(H396P)	100.0	1000.0
Canertinib	JNK3	100.0	1000.0
KIN001-021	PHKG1	100.0	1000.0
KIN001-127	RET(V804M)	100.0	10000.0
Momelotinib	DMPK2	96.0	10000.0
TGX221	EPHB3	100.0	1000.0
KU63794	CLK4	62.0	10000.0
Baricitinib	RSK3(Kin.Dom.1-N-terminal)	74.0	10000.0
AZD 5438	PIM2	77.0	10000.0
Omipalisib	LTK	56.0	10000.0
AS-252424	ABL1(M351T)	81.5	10000.0
AZD4547	HCK	7.8	10000.0
SCH772984	ACVRL1	100.0	1000.0
Abemaciclib	MST1	100.0	1000.0
Sigma A6730	PKAC-beta	100.0	10000.0
AZD7762	HIPK3	12.0	10000.0
Abemaciclib	PIK3CA(Q546K)	100.0	1000.0
XMD14-99	PKNB(M.tuberculosis)	80.0	10000.0
KIN001-021	SIK2	100.0	1000.0
KIN001-220	RPS6KA5(Kin.Dom.2-C-terminal)	66.0	10000.0
Torkinib	CSNK1E	0.1	10000.0
TAK-715	TLK1	82.0	10000.0
R406	VGFR2	0.2	1000.0
BX-912	FGFR4	1.8	10000.0
KU63794	MLK2	98.0	10000.0
GW-5074	SIK3	100.0	10000.0
SCH772984	JAK1(JH1domain-catalytic)	100.0	1000.0
JWE-035	BIKE	10.0	10000.0
HG-9-91-01	ITK	100.0	10000.0
XMD8-85	KIT(V559D,V654A)	100.0	10000.0
PHA-767491	GCN2(Kin.Dom.2,S808G)	55.0	10000.0
NG25	RPS6KA2(Kin.Dom.2)	100.0	10000.0
QL-XII-47	CSF1R	98.0	1000.0
BMS-536924	DCAMKL3	3.5	1000.0
AZD4547	MARK4	7.2	10000.0
BS-181	EGFR(L747-S752del,P753S)	100.0	10000.0
MLN8054	MST3	76.0	10000.0
Dactolisib	LATS2	100.0	1000.0
XMD13-2	MP2K1	100.0	10000.0
THZ1	RIOK3	1.0	10000.0
XMD8-85	BTK	100.0	10000.0
XMD14-99	ABL1-phosphorylated	86.0	10000.0
OTSSP167	TRKC	0.6	10000.0
WZ4002	CDK5	100.0	10000.0
BS-181	CHK2	53.0	10000.0
PD0325901	CSNK2A1	77.0	10000.0
CGP74514A	BMX	63.0	10000.0
GW-5074	LKB1	84.0	10000.0
QL-X-138	MET(M1250T)	80.0	10000.0
CP466722	RIOK3	32.0	10000.0
BGJ398	CDK2	93.0	1000.0
XMD13-2	M4K3	60.0	10000.0
XMD11-50	KIT(D816V)	72.0	10000.0
CG-930	STK36	6.5	10000.0
JWE-035	TYK2(JH2domain-pseudokinase)	13.0	10000.0
BS-181	MERTK	56.0	10000.0
TGX221	DDR2	100.0	1000.0
Sigma A6730	NEK9	88.0	10000.0
NVP-TAE684	CDC2L1	100.0	1000.0
AZD 5438	PIK3CA(E545K)	40.0	10000.0
WZ3105	SIK3	92.0	10000.0
Dactolisib	MST4	100.0	1000.0
BMS345541	RIPK1	100.0	10000.0
XMD8-92	FES	100.0	10000.0
AZD4547	MYLK2	6.0	10000.0
KIN001-021	RIOK3	100.0	1000.0
BX-912	KIT(D816H)	11.0	10000.0
Buparlisib	MST1	100.0	1000.0
Torin2	ULK1	96.0	10000.0
Torin2	PHKG1	100.0	10000.0
BMS-536924	PKAC-beta	16.0	1000.0
BGJ398	DDR1	0.9	1000.0
Barasertib	CDC2L2	5.0	10000.0
ALW-II-49-7	IKKE	100.0	10000.0
ALW-II-49-7	BRAF(V600E)	0.2	1000.0
RO-3306	ACVRL1	100.0	10000.0
Palbociclib	AAK1	86.0	1000.0
JNK-9L	ANKK1	55.0	10000.0
PD0325901	WEE1	67.0	10000.0
Torkinib	FLT3(R834Q)	16.0	10000.0
JW-7-24-1	EPHB3	100.0	10000.0
XMD8-92	EGFR(S752-I759del)	100.0	10000.0
Palbociclib	PIK3CA(E545K)	55.0	1000.0
AZD7762	ALK	0.1	10000.0
CP724714	TRKA	89.0	10000.0
Taselisib	HIPK1	96.0	1000.0
SP600125	KC1G1	25.0	10000.0
Ceritinib	TNIK	99.0	1000.0
CGP60474	PCTK2	100.0	10000.0
Sorafenib	AAK1	100.0	10000.0
AG1478	EPHB1	67.0	10000.0
XMD11-85h	NEK5	100.0	10000.0
TAK-715	AMPK-alpha2	100.0	10000.0
Ceritinib	EGFR(S752-I759del)	94.0	1000.0
XMD8-92	TAOK1	100.0	10000.0
ALW-II-49-7	ERBB2	100.0	10000.0
AS-252424	EGFR(G719S)	28.8	10000.0
CP466722	ABL1(H396P)-phosphorylated	0.2	10000.0
AZD-6482	PKAC-beta	100.0	10000.0
NPK76-II-72-1	MELK	100.0	10000.0
Dinaciclib	PFPK5(P.falciparum)	1.2	10000.0
HG-5-88-01	PKN1	100.0	10000.0
KU63794	CDK9	98.0	10000.0
Torkinib	MRCKB	71.0	10000.0
Ribociclib	MET(Y1235D)	68.0	1000.0
(s)-CR8	PGFRB	96.0	10000.0
Alpelisib	KIT-autoinhibited	99.0	1000.0
Canertinib	CDK3	100.0	1000.0
NPK76-II-72-1	AURKB	100.0	10000.0
Abemaciclib	FLT3(K663Q)	74.0	1000.0
XMD11-85h	MYO3B	100.0	10000.0
JNK-IN-5A	PTK6	46.0	10000.0
Barasertib	MK14	100.0	10000.0
SB590885	MK09	5.1	10000.0
GSK429286A	MYLK4	88.0	10000.0
HG-9-91-01	PLK1	87.0	10000.0
GSK461364	MYLK	62.0	10000.0
OTSSP167	DAPK1	45.0	10000.0
Vemurafenib	YSK4	53.0	10000.0
Ibrutinib	MAPKAPK2	96.0	1000.0
Ceritinib	PAK6	94.0	1000.0
BMS345541	TRKA	100.0	10000.0
Torkinib	EGFR(L747-T751del,Sins)	8.8	10000.0
PD173074	WEE1	100.0	10000.0
ZM-447439	ICK	100.0	10000.0
5z-7-oxozeaenol	RIPK2	76.0	10000.0
AS-252424	DRAK1	1.5	10000.0
WZ4002	MK11	100.0	10000.0
PD0325901	ABL1-phosphorylated	97.0	10000.0
NVP-TAE684	CDK3	100.0	1000.0
PD173074	CIT	100.0	10000.0
CGP74514A	KIT(D816V)	4.1	10000.0
BGJ398	JAK1(JH1domain-catalytic)	100.0	1000.0
PHA-793887	FAK1	90.0	10000.0
QL-X-138	RET(V804M)	68.0	10000.0
BMS345541	MERTK	100.0	10000.0
PD0325901	MLCK	100.0	10000.0
XMD-12	MK14	100.0	1000.0
GW843682X	EGFR(L747-S752del,P753S)	63.0	10000.0
XMD13-2	MLK2	95.0	10000.0
MPS-1-IN-1	CAMK1G	100.0	1000.0
NU7441	S6K1	67.0	10000.0
Dactolisib	BRSK2	100.0	1000.0
HG-9-91-01	SNARK	1.8	10000.0
SB590885	DAPK2	100.0	10000.0
PLX-4720	YSK4	29.0	10000.0
MLN8054	AURKA	0.5	10000.0
BX-912	KC1G2	76.0	10000.0
Ribociclib	KPCD2	61.0	1000.0
NU7441	TRKC	74.0	10000.0
CP724714	RSK3(Kin.Dom.1-N-terminal)	78.0	10000.0
ZSTK474	MK12	100.0	1000.0
Sigma A6730	SgK110	81.0	10000.0
BX-912	ERK4	3.2	10000.0
BMS-536924	ABL1(F317I)	100.0	1000.0
AZD7762	SRC	0.1	10000.0
Barasertib	DAPK2	89.0	10000.0
WZ4002	PKN2	100.0	10000.0
ZM-447439	KPCD1	99.0	10000.0
GSK461364	NEK11	100.0	10000.0
BX-912	CAMK2A	27.0	10000.0
R406	TRKC	7.0	1000.0
A443654	CLK1	0.0	10000.0
Buparlisib	ERK8	98.0	1000.0
R406	MK01	100.0	1000.0
HG-6-64-01	EIF2AK1	78.0	10000.0
JNK-IN-11	FER	87.0	1000.0
Omipalisib	MST1	70.0	10000.0
KU63794	M3K13	100.0	10000.0
AZD-6482	MST4	100.0	10000.0
HG-9-91-01	SRPK1	51.0	10000.0
JNK-IN-5A	MELK	85.0	10000.0
WZ4002	SRC	100.0	10000.0
PHA-793887	PRKX	89.0	10000.0
GW-5074	PIM3	2.0	10000.0
Sigma A6730	NEK4	93.0	10000.0
GW-5074	RPS6KA5(Kin.Dom.1-N-terminal)	96.0	10000.0
Omipalisib	RSK4(Kin.Dom.2-C-terminal)	59.0	10000.0
XMD16-144	PIK3CA	54.0	10000.0
(s)-CR8	NEK11	92.0	10000.0
Omipalisib	MET(M1250T)	82.0	10000.0
MPS-1-IN-1	MK11	100.0	1000.0
Sorafenib	GAK	80.0	10000.0
JNK-IN-8	MAPKAPK5	74.0	1000.0
THZ1	GSK3A	1.9	10000.0
5z-7-oxozeaenol	MRCKB	100.0	10000.0
BMS-536924	ROCK2	100.0	1000.0
ALW-II-38-3	YES	5.8	1000.0
Dinaciclib	ACVR1	100.0	10000.0
XMD-12	MYO3A	85.0	1000.0
OTSSP167	WNK3	72.0	10000.0
Ceritinib	DYRK1A	85.0	1000.0
WZ4002	ABL1(Y253F)	100.0	10000.0
WH-4-023	BRSK1	68.0	10000.0
WYE-125132	DAPK2	100.0	10000.0
BX-912	EPHA4	100.0	10000.0
Crizotinib	M4K3	1.3	10000.0
BS-181	KIT(L576P)	61.0	10000.0
ALW-II-38-3	FRK	0.7	1000.0
XMD14-99	TGFBR2	92.0	10000.0
(s)-CR8	FGFR1	83.0	10000.0
NVP-TAE684	MRCKB	25.0	1000.0
WH-4-023	ABL1-phosphorylated	0.0	10000.0
A443654	LYN	100.0	10000.0
JNK-IN-8	MRCKA	100.0	1000.0
R406	SRMS	16.0	1000.0
MPS-1-IN-1	PKN2	100.0	1000.0
GW843682X	FLT4	1.4	10000.0
XMD11-50	YANK1	100.0	10000.0
ALW-II-49-7	FLT3(D835Y)	100.0	10000.0
QL-X-138	PIP5K2B	73.0	10000.0
Sorafenib	LIMK2	57.0	10000.0
PHA-767491	EGFR(L858R,T790M)	36.0	10000.0
JW-7-24-1	MK12	100.0	10000.0
JWE-035	MAP4K4	81.0	10000.0
Ribociclib	PIK3C2G	100.0	1000.0
WZ4003	RPS6KA2(Kin.Dom.2)	25.0	1000.0
WZ-7043	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
Canertinib	IRAK3	100.0	1000.0
PHA-793887	ABL2	100.0	10000.0
PHA-793887	ERBB2	100.0	10000.0
JNK-IN-8	YANK3	95.0	1000.0
WZ-4-145	CLK3	100.0	10000.0
Palbociclib	ANKK1	100.0	1000.0
GSK429286A	YANK3	48.0	10000.0
RO-3306	IKKB	42.0	10000.0
PHA-793887	MST1R	96.0	10000.0
Torin1	MERTK	53.0	10000.0
JNK-IN-5A	LYN	78.0	10000.0
JWE-035	MP2K4	100.0	10000.0
AZ-628	EPHA4	0.0	10000.0
XMD16-144	BMPR1A	78.0	10000.0
WH-4-023	ICK	100.0	10000.0
Torin2	ACVR2B	97.0	10000.0
GW843682X	MAP4K4	53.0	10000.0
XMD8-85	PIP5K2B	100.0	10000.0
BMX-IN-1	IRAK1	60.0	10000.0
MRT67307	M3K13	69.0	10000.0
WZ4003	SRPK1	23.0	1000.0
Ceritinib	RPS6KA4(Kin.Dom.2-C-terminal)	62.0	1000.0
Abemaciclib	IKKB	43.0	1000.0
Ibrutinib	NEK2	91.0	1000.0
KU63794	LRRK2(G2019S)	100.0	10000.0
Momelotinib	PAK4	100.0	10000.0
XMD11-50	PAK3	83.0	10000.0
XMD14-99	PIM2	100.0	10000.0
PLX-4720	NDR2	71.0	10000.0
CGP60474	DYRK2	100.0	10000.0
TGX221	CAMK2G	100.0	1000.0
WZ-4-145	FLT4	0.1	10000.0
XMD8-92	STK39	100.0	10000.0
R406	AKT1	100.0	1000.0
AZ-628	EPHB3	0.0	10000.0
Omipalisib	BMX	98.0	10000.0
CH5424802	RIPK1	99.0	1000.0
Ibrutinib	INSR	57.0	1000.0
WZ4002	CAMK2B	100.0	10000.0
XMD11-85h	MK11	100.0	10000.0
XMD8-92	MRCKA	100.0	10000.0
Barasertib	NLK	100.0	10000.0
Ceritinib	CDK5	74.0	1000.0
ALW-II-38-3	ROCK2	100.0	10000.0
ERK5-IN-1	GSK3A	100.0	1000.0
WZ3105	AURKA	100.0	10000.0
GW843682X	YSK4	34.0	10000.0
GSK461364	MP2K3	52.0	10000.0
GSK461364	STK35	76.0	10000.0
QL-X-138	ABL1(Y253F)-phosphorylated	71.0	10000.0
Momelotinib	BMPR2	85.0	10000.0
HG-5-113-01	YSK1	100.0	10000.0
Taselisib	MARK2	97.0	1000.0
AG1478	KC1G2	83.0	10000.0
MPS-1-IN-1	CAMK2A	100.0	1000.0
NVP-TAE684	MARK3	3.2	1000.0
KIN001-021	PKN1	100.0	1000.0
HG-6-64-01	MARK2	68.0	10000.0
GSK1059615	RIPK4	56.0	10000.0
THZ1	SgK110	7.2	10000.0
GSK461364	ERK3	100.0	10000.0
Pictilisib	PIK3C2G	17.0	1000.0
JNK-IN-11	DAPK1	94.0	1000.0
Neratinib	MP2K3	100.0	10000.0
GSK461364	ERBB2	68.0	10000.0
HG-6-64-01	NIM1	100.0	10000.0
ERK5-IN-1	FGFR1	100.0	1000.0
Vemurafenib	ABL1(E255K)-phosphorylated	58.0	10000.0
SP600125	YSK1	28.0	10000.0
Torin2	BRSK2	100.0	10000.0
BX-912	BRAF	83.0	10000.0
PLX-4720	JNK3	90.0	10000.0
GW843682X	MELK	61.0	10000.0
Taselisib	ERK5	100.0	1000.0
JWE-035	TRKC	100.0	10000.0
Palbociclib	PFCDPK1(P.falciparum)	94.0	1000.0
BS-181	NEK7	100.0	10000.0
BI-2536	SRC	100.0	10000.0
WZ3105	TAOK2	66.0	10000.0
AS-252424	PAK2	58.5	10000.0
MPS-1-IN-1	KPCD	100.0	1000.0
WH-4-023	VRK2	100.0	10000.0
WYE-125132	FGR	100.0	10000.0
JNK-9L	BRSK2	98.0	10000.0
AZD 5438	CSNK1A1	0.9	10000.0
CP724714	KPCD2	97.0	10000.0
NPK76-II-72-1	PIK3CA	100.0	10000.0
Sigma A6730	IRAK4	80.0	10000.0
MLN8054	MTOR	75.0	10000.0
CP466722	ULK3	10.0	10000.0
HG-14-8-02	DMPK2	100.0	10000.0
Taselisib	EGFR(L861Q)	79.0	1000.0
CGP60474	NDR1	100.0	10000.0
ZSTK474	KIT(D816V)	100.0	1000.0
Ibrutinib	MARK2	100.0	1000.0
Omipalisib	FGFR3(G697C)	80.0	10000.0
HG-14-8-02	KPCT	84.0	10000.0
JWE-035	PIP5K1C	24.0	10000.0
KIN001-123	PAK7	100.0	1000.0
HG-9-91-01	BRAF(V600E)	5.2	10000.0
Sorafenib	ROCK2	88.0	10000.0
JNK-IN-5A	FLT3(K663Q)	93.0	10000.0
PHA-793887	CLK2	2.6	10000.0
Alpelisib	CSNK1E	100.0	1000.0
SCH772984	SRPK3	45.0	1000.0
WZ4003	MYO3B	100.0	1000.0
JNK-IN-11	BMX	76.0	1000.0
WZ-7043	CDK8	100.0	10000.0
Palbociclib	MST1	100.0	1000.0
NPK76-II-72-1	YANK3	100.0	10000.0
WZ4003	RET(V804M)	34.0	1000.0
WZ-7043	HUNK	100.0	10000.0
Abemaciclib	CAMK2G	0.7	1000.0
ZG-10	LRRK2	100.0	10000.0
Taselisib	IRAK1	100.0	1000.0
MLN8054	KIT(V559D,T670I)	72.0	10000.0
WH-4-023	CLK2	78.0	10000.0
KIN001-220	FLT3(N841I)	0.0	10000.0
NU7441	MK11	90.0	10000.0
WYE-125132	TAOK2	100.0	10000.0
CGP60474	KPCD	100.0	10000.0
AZ-628	EPHA1	10.0	10000.0
KIN001-127	KGP1	100.0	10000.0
Torin2	PLK3	94.0	10000.0
JNK-IN-5A	RPS6KA4(Kin.Dom.1-N-terminal)	91.0	10000.0
OTSSP167	ABL1(Q252H)-nonphosphorylated	15.0	10000.0
AZ-628	PAK3	81.0	10000.0
XMD14-99	TXK	100.0	10000.0
XMD11-85h	GRK7	100.0	10000.0
Torin2	EPHA8	99.0	10000.0
KU63794	RSK1(Kin.Dom.1-N-terminal)	70.0	10000.0
ZSTK474	KIT	100.0	1000.0
CH5424802	CAMK1B	100.0	1000.0
BX-912	SIK3	7.0	10000.0
KIN001-123	ABL1(E255K)	100.0	1000.0
Canertinib	RET(M918T)	100.0	1000.0
HG-14-8-02	KC1G2	100.0	10000.0
ZM-447439	MP2K4	100.0	10000.0
SCH772984	RET	83.0	1000.0
QL-X-138	RPS6KA4(Kin.Dom.2-C-terminal)	94.0	10000.0
CGP60474	MLK1	100.0	10000.0
XMD14-99	KPCT	54.0	10000.0
XMD11-85h	ABL1(H396P)	100.0	10000.0
OTSSP167	ERBB3	1.3	10000.0
GSK1059615	PKMYT1	78.0	10000.0
OTSSP167	PRKX	100.0	10000.0
HG-6-64-01	SBK1	57.0	10000.0
Palbociclib	CLK2	18.0	1000.0
BMS-536924	FER	2.7	1000.0
Seliciclib	ERBB4	92.0	10000.0
Torin2	CHK2	100.0	10000.0
Dabrafenib	EGFR(L861Q)	26.0	10000.0
Dactolisib	BMPR1A	100.0	1000.0
ALW-II-49-7	RIOK3	100.0	10000.0
Torin2	FLT3(R834Q)	32.0	10000.0
QL-X-138	MST1R	99.0	10000.0
GW-5074	FRK	45.0	10000.0
Canertinib	AURKC	100.0	1000.0
Ribociclib	EGFR(G719S)	100.0	1000.0
HG-5-113-01	TRKC	0.4	10000.0
WYE-125132	PIK3CA(M1043I)	4.4	10000.0
ALW-II-49-7	MYO3B	100.0	10000.0
AZ-628	CAMK2G	100.0	10000.0
Omipalisib	MP2K4	5.9	10000.0
WZ3105	PIK3CA(H1047Y)	90.0	10000.0
WYE-125132	TGFBR2	100.0	10000.0
Baricitinib	CHEK1	96.0	10000.0
Seliciclib	DCAMKL3	93.0	10000.0
Dinaciclib	KPCD2	91.0	10000.0
Dabrafenib	MUSK	74.0	10000.0
JNK-9L	MARK2	73.0	10000.0
GSK461364	FLT3(D835Y)	21.0	10000.0
XMD8-92	AURKA	100.0	10000.0
XMD11-50	RAF1	100.0	10000.0
QL-X-138	ROCK1	94.0	10000.0
AZD-6482	PIK3CB	0.0	10000.0
HG-14-10-04	IKKE	13.0	10000.0
5z-7-oxozeaenol	MYLK2	80.0	10000.0
HG-14-10-04	SGK2	100.0	10000.0
KIN001-021	TGFBR2	100.0	1000.0
JNK-9L	SRC	38.0	10000.0
PHA-767491	IRAK1	0.1	10000.0
AZD 5438	PAK7	17.0	10000.0
Torin1	TIE2	19.0	10000.0
ZG-10	MKNK1	42.0	10000.0
BMX-IN-1	AKT2	100.0	10000.0
Torkinib	ABL1-nonphosphorylated	0.8	10000.0
RO-3306	BMPR1A	100.0	10000.0
ALW-II-38-3	KCC2D	100.0	10000.0
Baricitinib	KIT(L576P)	35.0	10000.0
JWE-035	ABL1(E255K)-phosphorylated	0.1	10000.0
Ibrutinib	MET	98.0	1000.0
JW-7-24-1	ABL1(E255K)	30.0	10000.0
Momelotinib	NDR2	71.0	10000.0
GW-5074	MYLK	16.0	10000.0
TGX221	RPS6KA1(Kin.Dom.1)	100.0	1000.0
ZSTK474	TNIK	100.0	1000.0
GSK1059615	MAP3K3	75.0	10000.0
XMD8-92	RET(V804M)	100.0	10000.0
XMD-12	EPHA7	100.0	1000.0
AZD4547	CDKL5	100.0	10000.0
JW-7-24-1	PTK6	100.0	10000.0
Palbociclib	TSSK1	98.0	1000.0
SB590885	PIK3CA	85.0	10000.0
5z-7-oxozeaenol	SRPK1	83.0	10000.0
AG1478	GRK7	75.0	10000.0
WZ4002	SRPK1	21.0	10000.0
RO-3306	RPS6KA4(Kin.Dom.1-N-terminal)	85.0	10000.0
CP724714	CSNK1G3	100.0	10000.0
(s)-CR8	MRCKB	14.0	10000.0
AZD-6482	FLT3(ITD)	53.0	10000.0
Baricitinib	ROS1	48.0	10000.0
KU63794	SLK	98.0	10000.0
Crizotinib	PAK2	96.0	10000.0
OTSSP167	PIK3CA(I800L)	35.0	10000.0
Ceritinib	PHKG2	34.0	1000.0
HG-14-10-04	BMX	79.0	10000.0
ZM-447439	TNK2	5.9	10000.0
MRT67307	MYO3A	100.0	10000.0
Crizotinib	CDC2L2	0.4	10000.0
OTSSP167	CASK	25.0	10000.0
OTSSP167	MST4	0.4	10000.0
CP724714	BTK	68.0	10000.0
XMD14-99	EGFR(T790M)	100.0	10000.0
PLX-4720	CLK2	10.0	10000.0
Neratinib	GRK4	68.0	10000.0
JNK-IN-8	AMPK-alpha2	84.0	1000.0
OTSSP167	MST1	3.4	10000.0
Ceritinib	LCK	89.0	1000.0
TAK-715	IGF1R	100.0	10000.0
JWE-035	M3K6	100.0	10000.0
THZ1	CSNK1G3	62.0	10000.0
GSK461364	PIK3CG	6.4	10000.0
WZ3105	EGFR	100.0	10000.0
PD173074	RIOK1	100.0	10000.0
OTSSP167	STK39	66.0	10000.0
BI-2536	CDK9	100.0	10000.0
Ibrutinib	RIOK3	69.0	1000.0
MRT67307	ABL1(F317I)-nonphosphorylated	100.0	10000.0
WYE-125132	KIT(V559D,T670I)	100.0	10000.0
XMD8-92	STK33	100.0	10000.0
ERK5-IN-1	AURKC	66.0	1000.0
Abemaciclib	MET	16.0	1000.0
NU7441	EPHA8	82.0	10000.0
BX-912	AURKC	0.0	10000.0
WH-4-023	RET	0.1	10000.0
Vemurafenib	PAK7	78.0	10000.0
Crizotinib	CSNK1G3	100.0	10000.0
TGX221	HCK	100.0	1000.0
ALW-II-49-7	EPHA8	0.4	1000.0
CP724714	BLK	62.0	10000.0
Baricitinib	PIP5K2B	3.6	10000.0
GSK461364	CDKL2	90.0	10000.0
TGX221	EPHB2	100.0	1000.0
AS-252424	PRKX	89.5	10000.0
AZD4547	FAK1	18.0	10000.0
JNK-IN-5A	M3K2	100.0	10000.0
XMD14-99	MRCKA	100.0	10000.0
BI-2536	IKKE	100.0	10000.0
Dactolisib	HIPK3	100.0	1000.0
WYE-125132	PLK3	100.0	10000.0
WZ3105	PIK3CA	100.0	10000.0
Buparlisib	CLK4	28.0	1000.0
HG-6-64-01	PIK3C2G	82.0	10000.0
KIN001-021	ACVRL1	100.0	1000.0
CH5424802	MK09	100.0	1000.0
BGJ398	KPCT	81.0	1000.0
HG-9-91-01	EGFR(G719C)	0.1	10000.0
Lapatinib	PGFRB	100.0	10000.0
WZ-7043	TTK	100.0	10000.0
TAK-715	JNK1	0.3	10000.0
BI-2536	BRSK2	100.0	10000.0
Pictilisib	CDC2L2	100.0	1000.0
GSK429286A	RSK4(Kin.Dom.1-N-terminal)	42.0	10000.0
JNK-IN-8	DMPK2	86.0	1000.0
XMD11-85h	KGP1	100.0	10000.0
XMD11-85h	MK14	100.0	10000.0
WZ4002	SRPK3	8.4	10000.0
ERK5-IN-1	TESK1	100.0	1000.0
Palbociclib	FGFR1	96.0	1000.0
Vemurafenib	CAMK1D	100.0	10000.0
NPK76-II-72-1	ULK1	100.0	10000.0
ZSTK474	KPCT	100.0	1000.0
SCH772984	RPS6KA4(Kin.Dom.1-N-terminal)	48.0	1000.0
ALW-II-38-3	EGFR(L858R,T790M)	100.0	10000.0
OTSSP167	RET	0.1	10000.0
BMS345541	RAF1	100.0	10000.0
A443654	DAPK2	1.3	10000.0
NG25	KCC2D	100.0	10000.0
Omipalisib	CSNK1G3	100.0	10000.0
AZD7762	TAOK2	35.0	10000.0
ZM-447439	TAOK3	95.0	10000.0
NG25	BLK	0.6	10000.0
Crizotinib	EGFR	82.0	10000.0
XMD13-2	ABL1(H396P)-nonphosphorylated	13.0	10000.0
JW-7-24-1	KCC2D	100.0	10000.0
KIN001-123	YANK3	100.0	1000.0
Dabrafenib	DAPK1	48.0	10000.0
CP466722	LATS1	100.0	10000.0
KIN001-021	LIMK1	100.0	1000.0
GSK1059615	MINK	49.0	10000.0
JNK-IN-5A	MET	66.0	10000.0
XMD8-85	STK36	100.0	10000.0
Pictilisib	JAK1(JH1domain-catalytic)	92.0	1000.0
XMD16-144	TGFBR1	25.0	10000.0
HG-5-88-01	MRCKB	100.0	10000.0
Neratinib	LIMK1	100.0	10000.0
Canertinib	TIE1	100.0	1000.0
KU63794	CDK7	73.0	10000.0
ZM-447439	EPHA7	84.0	10000.0
HG-5-113-01	MLK2	18.0	10000.0
MLN8054	AKT3	100.0	10000.0
Barasertib	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
QL-XII-47	CLK1	96.0	1000.0
PD173074	DMPK2	100.0	10000.0
Torin2	ACVR1	86.0	10000.0
Ribociclib	EPHA2	100.0	1000.0
Vemurafenib	IRAK1	99.0	10000.0
PLX-4720	VGFR1	28.0	10000.0
ZG-10	RSK4(Kin.Dom.2-C-terminal)	97.0	10000.0
JNK-9L	DAPK2	96.0	10000.0
HG-5-113-01	LCK	0.3	10000.0
CP724714	MST1	87.0	10000.0
(s)-CR8	BMPR2	98.0	10000.0
QL-XII-47	PLK2	83.0	1000.0
Baricitinib	EPHA4	94.0	10000.0
WZ3105	EGFR(L861Q)	100.0	10000.0
JWE-035	ABL1(H396P)-phosphorylated	0.0	10000.0
ZM-447439	CAMK2B	78.0	10000.0
ALW-II-49-7	AKT3	100.0	10000.0
XMD11-50	MKNK1	50.0	10000.0
WZ-4-145	BIKE	100.0	10000.0
Baricitinib	CIT	1.8	10000.0
GSK1059615	MARK3	100.0	10000.0
AZD-6482	DAPK3	100.0	10000.0
RO-3306	ITK	90.0	10000.0
Neratinib	OSR1	54.0	10000.0
NG25	AAK1	100.0	10000.0
Neratinib	FLT3(D835Y)	89.0	10000.0
BMS-536924	IKKE	5.4	1000.0
(s)-CR8	ACVR1	98.0	10000.0
HG-9-91-01	CSK	0.2	10000.0
MLN8054	OSR1	94.0	10000.0
Torin2	RSK1(Kin.Dom.1-N-terminal)	100.0	10000.0
Baricitinib	NEK7	3.7	10000.0
KIN001-021	DCAMKL3	100.0	1000.0
Ribociclib	MP2K2	58.0	1000.0
Crizotinib	MP2K1	64.0	10000.0
CP724714	MP2K3	100.0	10000.0
BMS345541	MARK1	100.0	10000.0
AZD4547	TEC	44.0	10000.0
JNK-IN-8	PIK3CA(E542K)	100.0	1000.0
PHA-793887	DRAK1	98.0	10000.0
WZ4002	TEC	6.6	10000.0
GW-5074	RSK3(Kin.Dom.1-N-terminal)	58.0	10000.0
Ibrutinib	ABL1(Q252H)-nonphosphorylated	5.1	1000.0
WZ-4-145	AXL	100.0	10000.0
GSK1059615	NEK1	47.0	10000.0
(s)-CR8	ADCK4	86.0	10000.0
WYE-125132	SgK110	96.0	10000.0
ZM-447439	CSNK2A2	100.0	10000.0
CH5424802	NEK6	100.0	1000.0
Sorafenib	CDC2L5	86.0	10000.0
GSK1059615	MST2	54.0	10000.0
NPK76-II-72-1	EGFR(L747-T751del,Sins)	100.0	10000.0
Taselisib	TNIK	89.0	1000.0
HG-9-91-01	MP2K6	20.0	10000.0
Crizotinib	EIF2AK1	81.0	10000.0
JWE-035	MST3	35.0	10000.0
KIN001-111	EGFR(E746-A750del)	100.0	1000.0
TAK-715	KCC4	99.0	10000.0
XMD11-85h	BTK	100.0	10000.0
XMD11-85h	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
WZ3105	GRK1	47.0	10000.0
Abemaciclib	BMPR1A	99.0	1000.0
AG1478	PRP4	84.0	10000.0
GSK1059615	CAMK2B	9.6	10000.0
R406	DMPK	6.8	1000.0
A443654	ADCK3	100.0	10000.0
ZM-447439	CDK16	64.0	10000.0
Omipalisib	PAK2	73.0	10000.0
Palbociclib	TEC	100.0	1000.0
Barasertib	RSK3(Kin.Dom.1-N-terminal)	80.0	10000.0
XMD14-99	GSK3A	67.0	10000.0
TGX221	MYO3B	100.0	1000.0
KIN001-123	ALK	100.0	1000.0
GSK429286A	GRK4	99.0	10000.0
Buparlisib	TRPM6	100.0	1000.0
JNK-9L	PIK4CB	100.0	10000.0
HG-9-91-01	MAPKAPK2	100.0	10000.0
THZ1	ICK	8.2	10000.0
NVP-TAE684	BRSK1	1.2	1000.0
WZ3105	KIT(V559D,V654A)	44.0	10000.0
PHA-767491	LKB1	100.0	10000.0
AS-252424	FES	100.0	10000.0
ALW-II-49-7	CHK2	100.0	10000.0
Vemurafenib	LOK	16.0	10000.0
BMX-IN-1	TRKA	100.0	10000.0
PD0325901	LCK	88.0	10000.0
WYE-125132	EGFR(T790M)	68.0	10000.0
HG-9-91-01	EPHB4	0.0	10000.0
Alpelisib	MELK	86.0	1000.0
Alpelisib	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	1000.0
ALW-II-49-7	TTK	100.0	10000.0
PHA-793887	ALK(L1196M)	92.0	10000.0
MPS-1-IN-1	PAK2	100.0	1000.0
Torin2	NDR2	100.0	10000.0
HG-14-8-02	EGFR(S752-I759del)	0.0	10000.0
TAK-715	FAK1	96.0	10000.0
WYE-125132	WEE1	79.0	10000.0
Crizotinib	DYRK1B	84.0	10000.0
Torin1	MK14	90.0	10000.0
ERK5-IN-1	CDKL5	100.0	1000.0
R406	EGFR(S752-I759del)	4.8	1000.0
AG1478	AMPK-alpha2	100.0	10000.0
PHA-767491	STK36	85.0	10000.0
Vemurafenib	ERK5	69.0	10000.0
QL-X-138	CDK5	84.0	10000.0
Crizotinib	KPCD3	3.0	10000.0
Ibrutinib	MST2	57.0	1000.0
GSK429286A	KPCL	35.0	10000.0
PHA-793887	ULK2	1.8	10000.0
BGJ398	MAP4K4	81.0	1000.0
ZG-10	TIE1	55.0	10000.0
(s)-CR8	AAK1	94.0	10000.0
Pictilisib	ABL1(H396P)-phosphorylated	100.0	1000.0
Baricitinib	PIK3CB	56.0	10000.0
Dinaciclib	CSF1R-autoinhibited	44.0	10000.0
Pictilisib	EPHB6	57.0	1000.0
Taselisib	FGR	90.0	1000.0
XMD13-2	KIT(D816H)	75.0	10000.0
HG-5-88-01	ACVR2B	100.0	10000.0
THZ1	CDKL3	3.4	10000.0
HG-14-8-02	CSNK1A1	73.0	10000.0
BI-2536	DMPK	100.0	10000.0
Sigma A6730	ABL1(H396P)-phosphorylated	78.0	10000.0
Dabrafenib	LIMK2	0.0	10000.0
Crizotinib	ULK3	8.8	10000.0
WYE-125132	CDK9	100.0	10000.0
JNK-IN-5A	CSK	95.0	10000.0
Dabrafenib	ABL1(F317L)-phosphorylated	48.0	10000.0
Sigma A6730	AKT3	100.0	10000.0
GSK1059615	EGFR(E746-A750del)	81.0	10000.0
XMD14-99	EIF2AK1	100.0	10000.0
NVP-TAE684	DAPK1	6.4	1000.0
THZ1	PKAC-beta	3.2	10000.0
CGP60474	STK36	100.0	10000.0
XMD16-144	NEK2	62.0	10000.0
BI-2536	ULK3	100.0	10000.0
NPK76-II-72-1	CDK16	100.0	10000.0
ZSTK474	VGFR1	100.0	1000.0
WZ-4-145	MARK4	100.0	10000.0
Ribociclib	CLK4	100.0	1000.0
CH5424802	JNK1	93.0	1000.0
Dabrafenib	CDKL2	0.7	10000.0
Barasertib	MK03	100.0	10000.0
PHA-767491	ABL1(E255K)-phosphorylated	25.0	10000.0
Palbociclib	AKT1	100.0	1000.0
QL-X-138	MET	89.0	10000.0
PD173074	DCAMKL3	100.0	10000.0
KIN001-127	TLK1	100.0	10000.0
SP600125	MAP3K3	100.0	10000.0
Crizotinib	ABL1(Q252H)-phosphorylated	0.1	10000.0
SP600125	TAOK3	22.0	10000.0
NPK76-II-72-1	KGP1	100.0	10000.0
QL-X-138	PIP5K1A	44.0	10000.0
Neratinib	MAP3K15	100.0	10000.0
WZ4003	CDK15	100.0	1000.0
XMD13-2	BMPR1A	100.0	10000.0
Abemaciclib	ERBB2	92.0	1000.0
Vemurafenib	FGFR4	100.0	10000.0
XMD13-2	NDR2	96.0	10000.0
GSK429286A	MP2K3	67.0	10000.0
WYE-125132	YES	97.0	10000.0
A443654	ERBB4	100.0	10000.0
WZ-7043	GSK3B	100.0	10000.0
KU63794	KIT(V559D,V654A)	100.0	10000.0
QL-XII-47	SRMS	95.0	1000.0
XMD8-92	JAK2(JH1domain-catalytic)	100.0	10000.0
MLN8054	MK14	93.0	10000.0
WZ4003	MST1R	100.0	1000.0
ZM-447439	EIF2AK1	20.0	10000.0
PD0325901	ABL1(M351T)-phosphorylated	94.0	10000.0
CH5424802	FAK1	45.0	1000.0
MLN8054	ULK2	100.0	10000.0
XMD11-50	PIK3CA(M1043I)	65.0	10000.0
CH5424802	PRKR	100.0	1000.0
ERK5-IN-1	EPHA1	98.0	1000.0
Dabrafenib	RSK2(Kin.Dom.2-C-terminal)	96.0	10000.0
JW-7-24-1	STK16	26.0	10000.0
WZ-7043	MAP4K2	100.0	10000.0
XMD-12	MAST1	95.0	1000.0
MRT67307	RSK1(Kin.Dom.1-N-terminal)	27.0	10000.0
PLX-4720	MTOR	58.0	10000.0
Ribociclib	MP2K7	88.0	1000.0
XMD11-85h	PIM3	100.0	10000.0
CP724714	LATS1	100.0	10000.0
KU63794	KCC4	100.0	10000.0
MLN8054	TAK1	80.0	10000.0
KIN001-123	RPS6KA6(Kin.Dom.1)	100.0	1000.0
A443654	BLK	100.0	10000.0
Alpelisib	LIMK2	100.0	1000.0
TAK-715	IRAK1	99.0	10000.0
XMD8-92	EGFR(G719S)	100.0	10000.0
BI-2536	ADCK3	100.0	10000.0
MLN8054	KIT(L576P)	60.0	10000.0
XMD-12	AKT2	100.0	1000.0
Buparlisib	PIK3CG	33.0	1000.0
JWE-035	ERK8	100.0	10000.0
NVP-TAE684	PRKR	100.0	1000.0
QL-X-138	SNRK	100.0	10000.0
Barasertib	ACVR1	81.0	10000.0
Ibrutinib	STK33	80.0	1000.0
Ribociclib	MK13	99.0	1000.0
Dactolisib	PIK3CD	7.2	1000.0
XMD11-85h	KPCT	100.0	10000.0
A443654	TLK1	100.0	10000.0
Torkinib	YANK2	8.2	10000.0
WZ3105	PIK3C2B	100.0	10000.0
Torin1	ABL1(F317L)-phosphorylated	100.0	10000.0
QL-XI-92	MLCK	91.0	10000.0
ALW-II-38-3	GSK3B	100.0	10000.0
TAK-715	PIK3CB	95.0	10000.0
WZ-7043	RIOK1	100.0	10000.0
GSK429286A	TSSK1	98.0	10000.0
Buparlisib	GRK1	100.0	1000.0
GW-5074	EGFR(L747-T751del,Sins)	50.0	10000.0
CGP60474	PIP5K1A	100.0	10000.0
Ceritinib	ABL1(F317I)-phosphorylated	47.0	1000.0
Vemurafenib	ROCK1	85.0	10000.0
SP600125	TYRO3	100.0	10000.0
XMD14-99	CDK8	100.0	10000.0
SB590885	MRCKA	78.0	10000.0
Torin2	KKCC1	94.0	10000.0
JNK-IN-5A	MAPKAPK2	93.0	10000.0
QL-XII-47	KIT(V559D,V654A)	100.0	1000.0
HG-9-91-01	PRP4	84.0	10000.0
SP600125	PIP5K1A	100.0	10000.0
5z-7-oxozeaenol	FES	88.0	10000.0
WZ4002	PIP5K2B	100.0	10000.0
KIN001-127	EGFR(L858R)	100.0	10000.0
XMD11-50	DAPK2	67.0	10000.0
PD0325901	ADCK4	100.0	10000.0
AG1478	CLK3	100.0	10000.0
BS-181	FRK	88.0	10000.0
PHA-793887	DYRK1B	2.2	10000.0
GSK1059615	ERN1	66.0	10000.0
PD173074	NEK5	100.0	10000.0
KIN001-021	EPHA7	100.0	1000.0
GW-5074	TGFBR1	10.0	10000.0
WH-4-023	MST4	33.0	10000.0
JNK-IN-5A	PIK3CA(E545K)	88.0	10000.0
CGP74514A	MKNK2	18.0	10000.0
WZ3105	BRAF(V600E)	85.0	10000.0
XMD14-99	STK35	100.0	10000.0
JNK-IN-11	GSK3B	49.0	1000.0
SP600125	PGFRB	100.0	10000.0
CP466722	SgK110	100.0	10000.0
Ceritinib	RPS6KA5(Kin.Dom.2-C-terminal)	87.0	1000.0
Vemurafenib	DRAK1	62.0	10000.0
AZD7762	EPHB1	1.6	10000.0
ZG-10	ABL1(Q252H)-phosphorylated	26.0	10000.0
KIN001-111	ERK8	100.0	1000.0
AZD-6482	CDC2L1	100.0	10000.0
JNK-IN-8	RPS6KA4(Kin.Dom.1-N-terminal)	79.0	1000.0
Taselisib	ABL1-nonphosphorylated	97.0	1000.0
GSK429286A	GRK1	78.0	10000.0
Dactolisib	HCK	100.0	1000.0
RO-3306	CHK2	40.0	10000.0
XMD16-144	RIPK1	28.0	10000.0
5z-7-oxozeaenol	CHK2	81.0	10000.0
HG-6-64-01	AMPK-alpha2	39.0	10000.0
XMD16-144	RET(M918T)	0.6	10000.0
QL-XII-47	AAK1	63.0	1000.0
ZM-447439	CHK2	100.0	10000.0
5z-7-oxozeaenol	ULK2	96.0	10000.0
WZ4002	IKKE	100.0	10000.0
BGJ398	FRK	57.0	1000.0
BMS345541	DDR1	100.0	10000.0
Lapatinib	MYLK	100.0	10000.0
KIN001-127	ROCK2	100.0	10000.0
NVP-TAE684	EGFR(L861Q)	0.2	1000.0
PD173074	ERK4	100.0	10000.0
Seliciclib	CSNK2A1	44.0	10000.0
SB590885	MAP3K15	100.0	10000.0
XMD8-92	KPCD1	100.0	10000.0
ALW-II-38-3	LIMK2	100.0	10000.0
Sigma A6730	DDR1	86.0	10000.0
Torin1	ROCK2	50.0	10000.0
GW843682X	TIE2	57.0	10000.0
Ceritinib	NEK11	100.0	1000.0
GW-5074	FER	100.0	10000.0
GSK429286A	MINK	71.0	10000.0
BS-181	ABL1(Y253F)-phosphorylated	78.0	10000.0
AZ-628	SRC	0.6	10000.0
Crizotinib	LTK	0.3	10000.0
Sorafenib	RIPK1	81.0	10000.0
TGX221	KIT(V559D)	100.0	1000.0
BMS345541	MLTK	96.0	10000.0
TAK-715	NUAK1	100.0	10000.0
AZD7762	SYK	0.1	10000.0
PD0325901	MYLK	96.0	10000.0
R406	MK13	0.0	1000.0
AS-252424	WEE2	100.0	10000.0
BMS345541	CDK14	100.0	10000.0
WZ4002	NEK5	100.0	10000.0
BX-912	RPS6KA4(Kin.Dom.2-C-terminal)	1.0	10000.0
PD0325901	RSK3(Kin.Dom.1-N-terminal)	100.0	10000.0
CGP74514A	M4K1	14.0	10000.0
PHA-793887	GSK3A	1.0	10000.0
XMD-12	CAMK1G	91.0	1000.0
WZ-4-145	EGFR(S752-I759del)	2.3	10000.0
Buparlisib	CAMK1D	100.0	1000.0
THZ1	MARK1	6.2	10000.0
BGJ398	EPHB4	89.0	1000.0
GSK1059615	EGFR(L747-S752del,P753S)	74.0	10000.0
WYE-125132	MKNK2	87.0	10000.0
NG25	BMX	2.4	10000.0
WZ-4-145	EGFR(L861Q)	0.1	10000.0
AZ-628	PHKG2	100.0	10000.0
Dinaciclib	PCTK2	0.9	10000.0
Abemaciclib	LTK	100.0	1000.0
WZ-4-145	PKMYT1	100.0	10000.0
AZD-6482	ULK3	98.0	10000.0
Vemurafenib	RSK3(Kin.Dom.1-N-terminal)	39.0	10000.0
Sorafenib	SRC	48.0	10000.0
JWE-035	TGFBR1	81.0	10000.0
Baricitinib	VRK2	48.0	10000.0
Palbociclib	PIP5K1C	62.0	1000.0
MLN8054	MAP3K4	36.0	10000.0
HG-9-91-01	SLK	0.1	10000.0
Seliciclib	CAMK1G	100.0	10000.0
JNK-IN-11	DMPK2	0.3	1000.0
PD0325901	HASP	100.0	10000.0
Ribociclib	CSF1R-autoinhibited	100.0	1000.0
CGP74514A	PIK3CA(I800L)	66.0	10000.0
Baricitinib	EPHA5	92.0	10000.0
MPS-1-IN-1	TRKC	100.0	1000.0
Canertinib	ITK	100.0	1000.0
KU63794	EPHB6	83.0	10000.0
PHA-793887	EPHA7	100.0	10000.0
KIN001-021	KGP2	100.0	1000.0
BX-912	YANK3	100.0	10000.0
THZ1	MP2K3	22.0	10000.0
KIN001-127	CDK11	100.0	10000.0
Torkinib	DAPK3	2.8	10000.0
NU7441	MST4	95.0	10000.0
QL-XII-47	LATS2	70.0	1000.0
SCH772984	NDR1	76.0	1000.0
CH5424802	JNK3	100.0	1000.0
WH-4-023	EPHB3	0.0	10000.0
QL-XII-47	CAMKK2	95.0	1000.0
SP600125	ULK3	11.0	10000.0
THZ1	AKT3	100.0	10000.0
GSK429286A	EPHA1	77.0	10000.0
GSK461364	PKNB(M.tuberculosis)	27.0	10000.0
R406	CSNK1D	100.0	1000.0
BS-181	PIK3CA(E545K)	73.0	10000.0
Torkinib	TGFBR2	2.8	10000.0
RO-3306	ABL1(T315I)-phosphorylated	62.0	10000.0
KIN001-220	CDKL1	41.0	10000.0
WZ4002	MYLK2	100.0	10000.0
WYE-125132	LTK	68.0	10000.0
PD173074	SYK	100.0	10000.0
Torin1	EGFR(E746-A750del)	91.0	10000.0
Torkinib	EPHB6	5.3	10000.0
BMX-IN-1	S6K1	76.0	10000.0
XMD11-50	MLK2	100.0	10000.0
PLX-4720	MK09	71.0	10000.0
MRT67307	NEK6	64.0	10000.0
Neratinib	EGFR(L747-S752del,P753S)	0.6	10000.0
OTSSP167	ACVR2A	100.0	10000.0
XMD8-85	MARK2	100.0	10000.0
PHA-767491	EGFR(E746-A750del)	73.0	10000.0
(s)-CR8	MKNK2	95.0	10000.0
Alpelisib	BMPR1B	98.0	1000.0
XMD11-50	PTK6	58.0	10000.0
QL-XI-92	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
ERK5-IN-1	CDKL3	99.0	1000.0
SP600125	RIOK1	10.0	10000.0
Ribociclib	PIK3CA(E545A)	65.0	1000.0
XMD8-92	PIM2	100.0	10000.0
Ibrutinib	MLCK	100.0	1000.0
GSK461364	ABL1(F317I)-nonphosphorylated	92.0	10000.0
PHA-793887	BRSK2	100.0	10000.0
PHA-767491	FER	100.0	10000.0
WZ4003	ABL2	100.0	1000.0
KIN001-123	JAK3(Kin.Dom.2)	2.8	1000.0
THZ1	CDKL1	0.0	10000.0
BS-181	FLT3	54.0	10000.0
JWE-035	MAP4K5	35.0	10000.0
Sigma A6730	PCTK2	100.0	10000.0
SB590885	KIT(D816H)	100.0	10000.0
BS-181	FLT3(ITD)	81.0	10000.0
XMD11-85h	AMPK-alpha2	100.0	10000.0
WZ-4-145	VGFR1	0.3	10000.0
A443654	EGFR(E746-A750del)	100.0	10000.0
Dactolisib	PRP4	100.0	1000.0
NU7441	PIP5K1A	100.0	10000.0
CGP60474	MK01	100.0	10000.0
Ribociclib	GSK3A	84.0	1000.0
Baricitinib	SYK	35.0	10000.0
AZ-628	SNARK	100.0	10000.0
CP466722	HIPK2	0.7	10000.0
AZD 5438	BRAF(V600E)	38.0	10000.0
WZ-7043	MAP3K1	100.0	10000.0
Lapatinib	PIP5K1C	100.0	10000.0
Buparlisib	MK14	100.0	1000.0
JNK-9L	ABL1(F317L)-phosphorylated	100.0	10000.0
BX-912	RIPK5	36.0	10000.0
5z-7-oxozeaenol	MLCK	100.0	10000.0
NG25	SYK	4.2	10000.0
XMD8-92	MYLK4	100.0	10000.0
Momelotinib	FLT3(ITD)	22.0	10000.0
JNK-IN-8	ZAP70	79.0	1000.0
5z-7-oxozeaenol	SYK	82.0	10000.0
QL-XII-47	LCK	100.0	1000.0
Dinaciclib	M3K13	100.0	10000.0
XMD8-92	TTK	19.0	10000.0
ZG-10	LCK	100.0	10000.0
5z-7-oxozeaenol	TBK1	80.0	10000.0
CP724714	KPCL	100.0	10000.0
Abemaciclib	ERK3	100.0	1000.0
Sigma A6730	CAMK1	87.0	10000.0
A443654	CDK8	9.6	10000.0
GW843682X	DDR2	81.0	10000.0
ZM-447439	VGFR1	56.0	10000.0
BMX-IN-1	EGFR(T790M)	2.1	10000.0
GSK429286A	DMPK2	83.0	10000.0
R406	MAPKAPK5	100.0	1000.0
ERK5-IN-1	TYK2(JH2domain-pseudokinase)	100.0	1000.0
Lapatinib	TNK2	100.0	10000.0
ZSTK474	RIOK2	100.0	1000.0
Neratinib	ABL2	92.0	10000.0
WYE-125132	MYLK2	100.0	10000.0
HG-5-113-01	SRPK3	12.0	10000.0
Baricitinib	CDC2L1	57.0	10000.0
JWE-035	LRRK2	15.0	10000.0
PD0325901	ABL1(Q252H)-nonphosphorylated	100.0	10000.0
Vemurafenib	PIK3CA(Q546K)	86.0	10000.0
(s)-CR8	KCC2D	98.0	10000.0
WZ4002	ZAP70	100.0	10000.0
WZ3105	PIK3CA(E542K)	100.0	10000.0
WYE-125132	ABL1(T315I)-nonphosphorylated	83.0	10000.0
NPK76-II-72-1	NEK7	100.0	10000.0
Ibrutinib	CHK2	96.0	1000.0
Baricitinib	FLT3(D835Y)	7.9	10000.0
WZ4002	ERK4	100.0	10000.0
AZD4547	CDK16	11.0	10000.0
Pictilisib	RPS6KA6(Kin.Dom.2)	100.0	10000.0
KIN001-021	TIE2	100.0	1000.0
GSK1059615	MST1	81.0	10000.0
Ribociclib	SRPK2	100.0	1000.0
HG-6-64-01	MAP3K3	1.4	10000.0
Baricitinib	NDR2	21.0	10000.0
CH5424802	DYRK1B	15.0	1000.0
Ceritinib	BMPR2	85.0	1000.0
Dinaciclib	GRK1	92.0	10000.0
WZ3105	TAOK3	28.0	10000.0
ERK5-IN-1	TYRO3	100.0	1000.0
BMX-IN-1	MP2K3	69.0	10000.0
PLX-4720	KGP1	100.0	10000.0
Barasertib	PAK1	100.0	10000.0
NU7441	PIK4CB	100.0	10000.0
XMD16-144	MELK	43.0	10000.0
Lapatinib	SRC	89.0	10000.0
KIN001-123	MET	27.0	1000.0
XMD-12	MK03	100.0	1000.0
MPS-1-IN-1	MAP3K3	100.0	1000.0
AZ-628	TXK	5.6	10000.0
AZD-6482	MK13	87.0	10000.0
TAK-715	PHKG2	76.0	10000.0
KIN001-021	MRCKA	100.0	1000.0
NPK76-II-72-1	RIOK2	100.0	10000.0
JNK-IN-11	BRSK2	100.0	1000.0
(s)-CR8	PIP5K1C	100.0	10000.0
PD173074	PAK7	100.0	10000.0
XMD13-2	MTOR	100.0	10000.0
GSK1059615	CAMK1D	57.0	10000.0
PD173074	KPCT	100.0	10000.0
BS-181	MST1	100.0	10000.0
WZ-7043	MRCKA	100.0	10000.0
CP466722	NEK5	26.0	10000.0
Torkinib	HIPK2	0.9	10000.0
NU7441	MST2	85.0	10000.0
CP724714	DCAMKL2	100.0	10000.0
HG-14-10-04	TNNI3K	55.0	10000.0
NVP-TAE684	PLK4	0.0	1000.0
Canertinib	FLT3(D835H)	100.0	1000.0
XMD13-2	MAP4K2	99.0	10000.0
QL-XII-47	STK36	100.0	1000.0
Sigma A6730	RPS6KA5(Kin.Dom.2-C-terminal)	99.0	10000.0
AZD7762	RPS6KA4(Kin.Dom.2-C-terminal)	0.4	10000.0
JNK-9L	INSRR	68.0	10000.0
RO-3306	ULK3	67.0	10000.0
Omipalisib	MAP4K2	69.0	10000.0
Alpelisib	INSR	100.0	1000.0
SB590885	YANK1	85.0	10000.0
Ibrutinib	JNK3	77.0	1000.0
A443654	CDK5	100.0	10000.0
GSK429286A	ACVR1	100.0	10000.0
AZD-6482	MST1R	80.0	10000.0
AG1478	DAPK3	35.0	10000.0
BMS345541	MUSK	100.0	10000.0
BS-181	KIT	77.0	10000.0
AZ-628	DYRK1B	100.0	10000.0
MRT67307	ACVR2A	83.0	10000.0
XMD8-92	KIT(L576P)	100.0	10000.0
RO-3306	FYN	100.0	10000.0
JWE-035	ERK4	100.0	10000.0
WYE-125132	EPHA6	98.0	10000.0
KIN001-220	CAMK1D	5.6	10000.0
TAK-715	JAK3(JH1domain-catalytic)	80.0	10000.0
SB590885	CDK3	98.0	10000.0
AS-252424	DAPK3	24.8	10000.0
PHA-767491	STK33	6.6	10000.0
BI-2536	RIPK4	100.0	10000.0
Canertinib	M4K1	100.0	1000.0
Dinaciclib	CDC2L5	0.3	10000.0
XMD-12	PRKR	100.0	1000.0
HG-6-64-01	YANK1	100.0	10000.0
Palbociclib	STK33	88.0	1000.0
Omipalisib	TGFBR1	78.0	10000.0
QL-XII-47	ERK4	100.0	1000.0
KIN001-127	JAK1(Kin.Dom.2)	100.0	10000.0
CG-930	SNRK	100.0	10000.0
TGX221	PIK3CB	5.0	1000.0
ZM-447439	TYK2(JH2domain-pseudokinase)	83.0	10000.0
HG-9-91-01	BMPR1A	0.6	10000.0
ZM-447439	FGFR2	89.0	10000.0
BX-912	CDK7	0.6	10000.0
Seliciclib	FLT3(ITD)	96.0	10000.0
WZ4002	MP2K2	100.0	10000.0
ZM-447439	MAP4K4	84.0	10000.0
WZ-4-145	AKT3	100.0	10000.0
XMD8-92	LATS2	100.0	10000.0
WH-4-023	SIK3	22.0	10000.0
ALW-II-49-7	CDKL2	100.0	10000.0
ZSTK474	NEK5	100.0	1000.0
PHA-793887	YANK2	12.0	10000.0
GSK429286A	ERBB3	92.0	10000.0
ZG-10	CDK14	98.0	10000.0
Ceritinib	FRK	61.0	1000.0
Abemaciclib	VRK2	94.0	1000.0
WZ3105	JNK1	100.0	10000.0
MRT67307	DAPK2	16.0	10000.0
CP724714	ABL1(F317I)-phosphorylated	100.0	10000.0
BMS-536924	LATS2	33.0	1000.0
Omipalisib	MET(Y1235D)	100.0	10000.0
BI-2536	TTK	6.3	10000.0
AZ-628	PFCDPK1(P.falciparum)	0.8	10000.0
XMD8-92	NUAK1	100.0	10000.0
Sigma A6730	RSK3(Kin.Dom.1-N-terminal)	51.0	10000.0
JNK-IN-8	NEK1	81.0	1000.0
PD173074	VGFR1	8.0	10000.0
ZSTK474	DAPK1	100.0	1000.0
Omipalisib	SgK110	93.0	10000.0
QL-XII-47	MP2K4	100.0	1000.0
AZD-6482	PIP5K1C	63.0	10000.0
Ribociclib	CDC2L5	98.0	1000.0
ZM-447439	CDK8	100.0	10000.0
ZG-10	MTOR	80.0	10000.0
XMD11-50	FLT3(ITD)	100.0	10000.0
MLN8054	WEE2	89.0	10000.0
CG-930	MKNK2	100.0	10000.0
Pictilisib	TRKB	100.0	1000.0
JNK-9L	MLCK	100.0	10000.0
Torin2	LATS2	100.0	10000.0
Vemurafenib	TTK	57.0	10000.0
BX-912	ERK3	5.0	10000.0
XMD11-85h	ERK3	100.0	10000.0
Neratinib	TRKB	95.0	10000.0
CG-930	MLK1	100.0	10000.0
WZ4002	ADCK3	100.0	10000.0
BMX-IN-1	CDK11	44.0	10000.0
Torin2	CDK4-cyclinD3	90.0	10000.0
AS-252424	PIK3CD	26.8	10000.0
Alpelisib	ERK3	100.0	1000.0
PHA-793887	KIT(A829P)	97.0	10000.0
HG-5-88-01	MST1	100.0	10000.0
Abemaciclib	IGF1R	98.0	1000.0
XMD11-50	MST2	71.0	10000.0
ZSTK474	TTK	100.0	1000.0
CP724714	GRK7	100.0	10000.0
BMS-536924	FRK	1.8	1000.0
ZM-447439	ERK8	100.0	10000.0
MPS-1-IN-1	MKNK2	100.0	1000.0
AZD-6482	FLT3(D835Y)	54.0	10000.0
PD173074	LKB1	100.0	10000.0
ZSTK474	KIT(V559D,T670I)	100.0	1000.0
Canertinib	PDPK1	100.0	1000.0
SCH772984	CDK14	97.0	1000.0
Torin2	CDK7	51.0	10000.0
NG25	PTK6	100.0	10000.0
THZ1	CDK9	40.0	10000.0
AZD7762	AKT2	60.0	10000.0
CG-930	EGFR(L861Q)	19.0	10000.0
TAK-715	DCLK1	96.0	10000.0
PD0325901	NEK3	100.0	10000.0
SB590885	VGFR1	79.0	10000.0
AZ-628	AKT1	100.0	10000.0
WZ-7043	MST1R	100.0	10000.0
Torin2	CDC2L1	100.0	10000.0
Dabrafenib	TLK2	90.0	10000.0
KIN001-021	CDK8	100.0	1000.0
Torin1	MAP3K3	75.0	10000.0
WZ-7043	GSK3A	100.0	10000.0
OTSSP167	FRK	2.4	10000.0
JNK-9L	CDK16	6.8	10000.0
Ribociclib	BMPR1B	100.0	1000.0
WZ4003	EGFR(L861Q)	12.0	1000.0
PD0325901	PTK6	46.0	10000.0
AS-252424	RPS6KA4(Kin.Dom.1-N-terminal)	90.3	10000.0
AZD-6482	EPHA8	96.0	10000.0
HG-14-10-04	MP2K1	3.8	10000.0
GW843682X	ABL1(H396P)-phosphorylated	65.0	10000.0
BGJ398	PTK6	100.0	1000.0
(s)-CR8	SNRK	92.0	10000.0
JNK-9L	LIMK2	60.0	10000.0
WYE-125132	MAK	100.0	10000.0
SP600125	FLT4	100.0	10000.0
Lapatinib	FGFR3(G697C)	99.0	10000.0
AG1478	MST3	87.0	10000.0
CP466722	KIT(V559D)	3.4	10000.0
Pictilisib	TYK2(JH2domain-pseudokinase)	96.0	1000.0
MLN8054	EGFR(L747-T751del,Sins)	45.0	10000.0
XMD8-92	DDR1	100.0	10000.0
NG25	EGFR(L747-T751del,Sins)	1.1	10000.0
Canertinib	CDK2	100.0	1000.0
WZ3105	ERK8	75.0	10000.0
QL-X-138	MLK2	100.0	10000.0
XMD11-85h	LOK	100.0	10000.0
Lapatinib	PIM1	100.0	10000.0
BI-2536	AURKC	100.0	10000.0
KIN001-127	SRC	1.2	10000.0
JNK-IN-5A	CASK	71.0	10000.0
XMD8-85	FLT3(D835Y)	100.0	10000.0
MPS-1-IN-1	MRCKB	100.0	1000.0
PLX-4720	MAP3K3	61.0	10000.0
Palbociclib	NUAK1	100.0	1000.0
(s)-CR8	TSSK1	100.0	10000.0
XMD11-50	BRSK1	81.0	10000.0
Pictilisib	M3K2	99.0	1000.0
AZD7762	NDR2	0.0	10000.0
PD0325901	CSF1R-autoinhibited	80.0	10000.0
Crizotinib	NDR2	95.0	10000.0
Crizotinib	MYLK4	86.0	10000.0
KIN001-220	LIMK1	9.8	10000.0
Lapatinib	CASK	100.0	10000.0
ERK5-IN-1	INSR	100.0	1000.0
A443654	TAOK1	0.1	10000.0
AZD-6482	PLK4	100.0	10000.0
CP466722	DCAMKL3	100.0	10000.0
PHA-767491	ABL1(F317L)-phosphorylated	92.0	10000.0
OTSSP167	ERK3	100.0	10000.0
CH5424802	JAK1(JH2domain-pseudokinase)	99.0	1000.0
Torkinib	MAK	99.0	10000.0
JNK-IN-5A	INSRR	100.0	10000.0
JWE-035	MK14	100.0	10000.0
Pictilisib	MERTK	100.0	1000.0
(s)-CR8	NIM1	100.0	10000.0
WZ3105	MET(Y1235D)	100.0	10000.0
Alpelisib	VRK2	100.0	1000.0
Palbociclib	KPCD1	30.0	1000.0
Alpelisib	ERK4	100.0	1000.0
Neratinib	JAK3(JH1domain-catalytic)	100.0	10000.0
THZ1	PRKR	50.0	10000.0
ZG-10	DCLK1	98.0	10000.0
NU7441	MTOR	18.0	10000.0
AZ-628	PIK3CB	100.0	10000.0
BS-181	CAMK1G	100.0	10000.0
Alpelisib	MKNK2	100.0	1000.0
Palbociclib	FAK2	100.0	1000.0
JNK-9L	LRRK2(G2019S)	53.0	10000.0
SP600125	MLK1	100.0	10000.0
AZD 5438	CDKL1	2.3	10000.0
CG-930	IKKB	100.0	10000.0
Dabrafenib	PFPK5(P.falciparum)	8.6	10000.0
ZG-10	ABL1(F317L)-phosphorylated	55.0	10000.0
GSK429286A	MAP3K15	77.0	10000.0
Seliciclib	CDKL2	97.0	10000.0
HG-6-64-01	NEK9	8.4	10000.0
Momelotinib	JAK1(JH2domain-pseudokinase)	100.0	10000.0
ALW-II-38-3	ABL1(F317L)	1.3	1000.0
5z-7-oxozeaenol	NEK6	81.0	10000.0
WH-4-023	PIP5K1C	96.0	10000.0
OTSSP167	HIPK1	0.5	10000.0
CP466722	MLTK	4.5	10000.0
BS-181	BIKE	90.0	10000.0
CGP60474	VGFR2	100.0	10000.0
Palbociclib	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	1000.0
SCH772984	ACVR1	100.0	1000.0
Seliciclib	MP2K6	84.0	10000.0
JNK-IN-11	FAK1	95.0	1000.0
HG-9-91-01	CDK7	60.0	10000.0
Vemurafenib	INSRR	73.0	10000.0
(s)-CR8	ULK2	100.0	10000.0
NPK76-II-72-1	FLT3(D835H)	100.0	10000.0
Momelotinib	EPHB2	100.0	10000.0
AZ-628	MST4	100.0	10000.0
JW-7-24-1	EGFR(G719C)	100.0	10000.0
Vemurafenib	INSR	78.0	10000.0
BGJ398	EPHB6	59.0	1000.0
HG-9-91-01	BTK	0.2	10000.0
HG-14-10-04	MINK	0.9	10000.0
HG-5-88-01	MP2K3	23.0	10000.0
Sigma A6730	KIT(L576P)	87.0	10000.0
(s)-CR8	BMPR1B	78.0	10000.0
PD173074	KCC2D	100.0	10000.0
NG25	TAOK3	0.2	10000.0
GW-5074	EPHA7	100.0	10000.0
AS-252424	ABL2	100.0	10000.0
PHA-767491	FLT4	99.0	10000.0
KIN001-123	CLK4	100.0	1000.0
CG-930	KCC4	87.0	10000.0
NG25	PAK4	100.0	10000.0
Ceritinib	AURKA	69.0	1000.0
HG-9-91-01	CDKL3	82.0	10000.0
WZ4003	MK12	100.0	1000.0
CH5424802	GRK7	62.0	1000.0
JNK-IN-5A	KPCL	87.0	10000.0
XMD13-2	TNK2	100.0	10000.0
CGP60474	ADCK4	100.0	10000.0
JWE-035	MARK3	11.0	10000.0
CG-930	FGFR4	74.0	10000.0
HG-5-113-01	MST3	100.0	10000.0
WZ4003	RPS6KA6(Kin.Dom.2)	22.0	1000.0
CH5424802	CASK	92.0	1000.0
(s)-CR8	STK39	88.0	10000.0
SP600125	KIT(D816V)	100.0	10000.0
Ribociclib	CDK4-cyclinD3	1.0	1000.0
BMS345541	FES	100.0	10000.0
Seliciclib	PRKX	100.0	10000.0
SCH772984	PAK6	100.0	1000.0
HG-9-91-01	YANK2	3.4	10000.0
Torin1	MK09	40.0	10000.0
Ibrutinib	TYRO3	41.0	1000.0
RO-3306	M4K1	73.0	10000.0
KIN001-127	PAK1	100.0	10000.0
QL-X-138	PKAC-beta	100.0	10000.0
Torin1	SRMS	92.0	10000.0
BS-181	FLT3-autoinhibited	100.0	10000.0
JNK-IN-8	IKKB	99.0	1000.0
SP600125	MK09	6.6	10000.0
PLX-4720	CLK3	80.0	10000.0
BGJ398	EPHA2	91.0	1000.0
KIN001-021	TTK	100.0	1000.0
PHA-767491	FLT3	89.0	10000.0
NVP-TAE684	PAK4	9.6	1000.0
CP724714	ABL1(T315I)-phosphorylated	77.0	10000.0
AS-252424	KGP1	100.0	10000.0
Torin2	KPCT	100.0	10000.0
CP466722	MELK	9.2	10000.0
NU7441	SLK	100.0	10000.0
Momelotinib	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
CGP60474	TNK2	100.0	10000.0
KU63794	HIPK4	88.0	10000.0
HG-14-8-02	MET(Y1235D)	53.0	10000.0
Torin1	FLT3(ITD)	29.0	10000.0
PLX-4720	MP2K7	83.0	10000.0
XMD11-85h	DCLK1	100.0	10000.0
CGP74514A	ACVR2B	100.0	10000.0
XMD13-2	KIT(V559D,T670I)	43.0	10000.0
QL-XII-47	CDK14	96.0	1000.0
HG-14-8-02	KCC2D	30.0	10000.0
AZD 5438	PRKX	93.0	10000.0
AZD-6482	DCLK1	78.0	10000.0
Dactolisib	FLT3(D835H)	21.0	1000.0
HG-14-10-04	RSK2(Kin.Dom.2-C-terminal)	100.0	10000.0
QL-X-138	ERN1	50.0	10000.0
GW843682X	SIK3	76.0	10000.0
AG1478	MAP4K4	48.0	10000.0
QL-XII-47	GCN2(Kin.Dom.2,S808G)	96.0	1000.0
Dabrafenib	KIT-autoinhibited	100.0	10000.0
SCH772984	EPHA7	90.0	1000.0
AZD 5438	LRRK2(G2019S)	2.2	10000.0
JWE-035	SBK1	6.9	10000.0
OTSSP167	EPHA7	0.6	10000.0
Alpelisib	CLK4	59.0	1000.0
XMD-12	AMPK-alpha2	31.0	1000.0
KIN001-220	PIK3CA(I800L)	88.0	10000.0
PHA-767491	MARK1	57.0	10000.0
QL-XI-92	ABL1(Q252H)-nonphosphorylated	7.4	10000.0
Neratinib	CLK3	86.0	10000.0
QL-XI-92	PIK3CA(E542K)	88.0	10000.0
JNK-9L	FYN	83.0	10000.0
CG-930	BMPR2	78.0	10000.0
Alpelisib	PIP5K1A	100.0	1000.0
GSK429286A	RIPK5	69.0	10000.0
Ibrutinib	DDR1	90.0	1000.0
Pictilisib	DCAMKL3	96.0	1000.0
PHA-767491	EGFR	100.0	10000.0
PD0325901	SRC	69.0	10000.0
Crizotinib	TAOK1	1.2	10000.0
PHA-793887	PIM2	100.0	10000.0
TAK-715	LOK	59.0	10000.0
Torkinib	EPHA8	1.2	10000.0
BX-912	CAMKK2	2.0	10000.0
GSK1059615	MST3	87.0	10000.0
XMD-12	PIK3CA(C420R)	98.0	1000.0
JNK-IN-11	CSNK2A2	100.0	1000.0
SCH772984	ABL1(F317L)-nonphosphorylated	97.0	1000.0
Sigma A6730	PRP4	81.0	10000.0
TAK-715	MAP3K15	100.0	10000.0
Dinaciclib	LATS1	84.0	10000.0
THZ1	SLK	0.0	10000.0
5z-7-oxozeaenol	NEK4	100.0	10000.0
PD0325901	HIPK2	100.0	10000.0
OTSSP167	DCLK1	4.5	10000.0
GSK1059615	RSK4(Kin.Dom.2-C-terminal)	5.2	10000.0
R406	MAP3K3	2.4	1000.0
Canertinib	FGFR3(G697C)	100.0	1000.0
CP724714	MAP3K1	100.0	10000.0
QL-XI-92	M3K13	98.0	10000.0
QL-XII-47	CAMK1G	92.0	1000.0
Ceritinib	CAMK2A	52.0	1000.0
MRT67307	AMPK-alpha1	24.0	10000.0
MLN8054	MKNK2	84.0	10000.0
Torkinib	GAK	6.2	10000.0
KIN001-127	BRSK2	100.0	10000.0
JNK-IN-5A	RSK2(Kin.Dom.2-C-terminal)	100.0	10000.0
JNK-9L	CIT	0.9	10000.0
Torin2	ABL1(F317L)-phosphorylated	100.0	10000.0
5z-7-oxozeaenol	MST3	99.0	10000.0
WH-4-023	ABL1(Y253F)-phosphorylated	0.1	10000.0
Sigma A6730	ACVR2B	100.0	10000.0
AG1478	EGFR(G719C)	0.1	10000.0
AZD 5438	EGFR(L747-S752del,P753S)	93.0	10000.0
GW-5074	RSK3(Kin.Dom.2-C-terminal)	45.0	10000.0
XMD14-99	PIK3CA(H1047Y)	100.0	10000.0
Barasertib	KIT(V559D)	0.0	10000.0
XMD8-85	TAOK3	2.0	10000.0
TAK-715	IKKB	100.0	10000.0
SB590885	ACVR1B	40.0	10000.0
MRT67307	EPHB1	100.0	10000.0
Sorafenib	RPS6KA4(Kin.Dom.2-C-terminal)	89.0	10000.0
KIN001-111	EPHA1	7.7	1000.0
PHA-767491	BLK	100.0	10000.0
CGP60474	YANK3	100.0	10000.0
JNK-IN-11	MKNK1	96.0	1000.0
NU7441	LCK	90.0	10000.0
AZD7762	JNK1	29.0	10000.0
Dabrafenib	CAMK1G	32.0	10000.0
GSK429286A	EGFR(G719S)	57.0	10000.0
AS-252424	CAMK1D	100.0	10000.0
Omipalisib	PIK3CA	0.0	10000.0
SCH772984	GRK1	95.0	1000.0
BGJ398	DYRK1B	76.0	1000.0
ALW-II-49-7	ERK3	100.0	10000.0
QL-XI-92	LRRK2(G2019S)	85.0	10000.0
BGJ398	SRPK1	55.0	1000.0
R406	RET(M918T)	0.0	1000.0
BI-2536	EPHA4	100.0	10000.0
NU7441	ABL2	92.0	10000.0
KIN001-021	BLK	100.0	1000.0
XMD8-85	FGFR1	100.0	10000.0
XMD8-85	HIPK2	100.0	10000.0
WYE-125132	MLK1	97.0	10000.0
JNK-9L	IRAK1	9.3	10000.0
BMS345541	ROCK1	100.0	10000.0
AG1478	JAK1(JH2domain-pseudokinase)	38.0	10000.0
Torin1	DRAK1	93.0	10000.0
CG-930	ACVR1	100.0	10000.0
Lapatinib	KGP1	98.0	10000.0
Canertinib	BRSK2	100.0	1000.0
HG-6-64-01	RSK4(Kin.Dom.2-C-terminal)	15.0	10000.0
CH5424802	CDKL1	98.0	1000.0
Neratinib	NEK11	64.0	10000.0
RO-3306	YES	96.0	10000.0
CP724714	CSK	59.0	10000.0
ALW-II-38-3	CAMK1G	100.0	10000.0
WZ-7043	CDKL5	100.0	10000.0
Buparlisib	PKN2	92.0	1000.0
HG-14-8-02	KPCE	100.0	10000.0
Pictilisib	ERK8	99.0	1000.0
Barasertib	TYK2(JH2domain-pseudokinase)	98.0	10000.0
JNK-IN-11	ITK	100.0	1000.0
QL-XII-47	GSK3A	100.0	1000.0
WZ4002	TYK2(Kin.Dom.1)	100.0	10000.0
PD0325901	ABL1-nonphosphorylated	77.0	10000.0
XMD16-144	CDKL5	100.0	10000.0
BS-181	MARK3	51.0	10000.0
WZ4002	MARK2	100.0	10000.0
PLX-4720	FLT3(N841I)	28.0	10000.0
AZD4547	FAK2	66.0	10000.0
5z-7-oxozeaenol	ZAP70	86.0	10000.0
Vemurafenib	KKCC1	86.0	10000.0
PD173074	ABL2	100.0	10000.0
RO-3306	KPCD1	18.0	10000.0
HG-6-64-01	PFPK5(P.falciparum)	93.0	10000.0
CGP74514A	RSK1(Kin.Dom.2-C-terminal)	31.0	10000.0
BMX-IN-1	ERK4	100.0	10000.0
AZD7762	FLT3(D835Y)	0.1	10000.0
BMS-536924	RET(V804M)	0.0	1000.0
PHA-767491	KKCC1	25.0	10000.0
Barasertib	CTK	71.0	10000.0
THZ1	ABL2	0.8	10000.0
SCH772984	PIK3CA	100.0	1000.0
TAK-715	LRRK2	100.0	10000.0
Sigma A6730	STK36	74.0	10000.0
JNK-IN-11	ACVRL1	22.0	1000.0
Torin2	PLK4	100.0	10000.0
PD0325901	PIK3CA(Q546K)	41.0	10000.0
AZD-6482	ROCK1	73.0	10000.0
Abemaciclib	PIM3	2.8	1000.0
XMD8-92	EPHA3	100.0	10000.0
Dabrafenib	PAK1	77.0	10000.0
Neratinib	JNK3	27.0	10000.0
Abemaciclib	SNARK	6.1	1000.0
Sigma A6730	GRK7	98.0	10000.0
HG-5-88-01	HIPK1	100.0	10000.0
Lapatinib	VRK2	100.0	10000.0
Sorafenib	MLK2	73.0	10000.0
HG-6-64-01	TRPM6	100.0	10000.0
AZD4547	FLT3	0.2	10000.0
Barasertib	MK01	100.0	10000.0
QL-XI-92	TTK	77.0	10000.0
AZD7762	CASK	92.0	10000.0
BS-181	MST3	100.0	10000.0
NPK76-II-72-1	PIM2	100.0	10000.0
XMD11-50	PLK4	0.0	10000.0
Torin1	PHKG1	100.0	10000.0
KIN001-220	FLT4	7.6	10000.0
Dinaciclib	IKKA	82.0	10000.0
ALW-II-38-3	RIOK3	100.0	10000.0
AZD7762	RET(V804M)	0.0	10000.0
CP466722	TRKB	47.0	10000.0
Momelotinib	EPHA6	98.0	10000.0
AZD4547	ABL1(T315I)-nonphosphorylated	0.0	10000.0
5z-7-oxozeaenol	EGFR(L747-E749del,A750P)	79.0	10000.0
KIN001-127	ROS1	100.0	10000.0
Sorafenib	PLK1	100.0	10000.0
Lapatinib	CSNK1A1L	94.0	10000.0
QL-X-138	KGP2	78.0	10000.0
JNK-IN-8	SGK3	48.0	1000.0
WYE-125132	MYLK4	100.0	10000.0
JNK-IN-11	CDC2L5	100.0	1000.0
QL-XI-92	EPHA4	48.0	10000.0
Neratinib	PAK4	93.0	10000.0
CH5424802	PFPK5(P.falciparum)	93.0	1000.0
Palbociclib	CLK1	10.0	1000.0
AZD4547	ULK3	34.0	10000.0
PLX-4720	MYO3B	47.0	10000.0
CGP74514A	MYLK2	82.0	10000.0
WH-4-023	CAMKK2	56.0	10000.0
Dinaciclib	CSF1R	95.0	10000.0
R406	EPHB1	0.2	1000.0
BI-2536	FLT4	100.0	10000.0
Pictilisib	FGR	100.0	1000.0
HG-9-91-01	AURKB	24.0	10000.0
Taselisib	RSK2(Kin.Dom.1-N-terminal)	89.0	1000.0
JNK-IN-8	IRAK4	93.0	1000.0
GSK461364	HIPK4	36.0	10000.0
PLX-4720	M3K2	62.0	10000.0
KIN001-111	CLK1	100.0	1000.0
GW843682X	SIK1	40.0	10000.0
ERK5-IN-1	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	1000.0
Torkinib	KGP1	100.0	10000.0
NPK76-II-72-1	BMPR1A	100.0	10000.0
Palbociclib	PIK3CG	93.0	1000.0
SP600125	RET(V804M)	100.0	10000.0
JW-7-24-1	KIT(V559D,V654A)	100.0	10000.0
PLX-4720	PIK3CA(C420R)	100.0	10000.0
WH-4-023	LIMK1	0.0	10000.0
AZD-6482	PAK1	100.0	10000.0
Ceritinib	TAOK2	93.0	1000.0
Ceritinib	ABL1(H396P)-phosphorylated	66.0	1000.0
SB590885	LATS1	87.0	10000.0
PLX-4720	SRPK3	100.0	10000.0
WZ3105	MP2K1	83.0	10000.0
WYE-125132	RSK2(Kin.Dom.2-C-terminal)	100.0	10000.0
XMD16-144	FGFR2	13.0	10000.0
Ibrutinib	EGFR(L858R)	2.4	1000.0
JNK-9L	AURKC	40.0	10000.0
AZD4547	PCTK2	19.0	10000.0
BMX-IN-1	TGFBR2	100.0	10000.0
XMD8-92	YSK1	100.0	10000.0
QL-XII-47	GSK3B	100.0	1000.0
ALW-II-49-7	TESK1	100.0	10000.0
Momelotinib	PKAC-alpha	96.0	10000.0
CG-930	MP2K2	100.0	10000.0
Torin1	SRPK1	100.0	10000.0
ZSTK474	PIK3C2B	0.0	1000.0
WZ4002	CDK8	100.0	10000.0
Taselisib	MYO3B	63.0	1000.0
BMS345541	STK35	90.0	10000.0
Crizotinib	ABL1(T315I)-nonphosphorylated	0.0	10000.0
ZG-10	PIK3CD	91.0	10000.0
BGJ398	EPHA5	98.0	1000.0
HG-9-91-01	CAMK2G	98.0	10000.0
Neratinib	TAOK1	83.0	10000.0
ZM-447439	ROS1	41.0	10000.0
WZ-4-145	KPCD3	100.0	10000.0
HG-14-10-04	EPHB4	68.0	10000.0
NVP-TAE684	ROCK2	1.0	1000.0
XMD8-85	MK12	100.0	10000.0
Sorafenib	CDKL2	0.3	10000.0
ZM-447439	NLK	100.0	10000.0
GW-5074	BIKE	9.7	10000.0
AZ-628	TIE2	62.0	10000.0
Seliciclib	CDC2L5	75.0	10000.0
Taselisib	PIK3CA(H1047Y)	1.4	1000.0
CP466722	PAK4	72.0	10000.0
QL-X-138	CAMK2A	21.0	10000.0
Neratinib	VRK2	67.0	10000.0
HG-14-8-02	PIK3CA(M1043I)	95.0	10000.0
ZG-10	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
KU63794	ABL1(F317I)-nonphosphorylated	91.0	10000.0
ZG-10	PIP5K2B	56.0	10000.0
HG-14-8-02	RSK1(Kin.Dom.2-C-terminal)	68.0	10000.0
Dabrafenib	CSNK1D	94.0	10000.0
GSK1059615	MK13	100.0	10000.0
Baricitinib	KPCD3	66.0	10000.0
AZD4547	ABL1(F317I)-nonphosphorylated	64.0	10000.0
5z-7-oxozeaenol	RET(M918T)	99.0	10000.0
THZ1	MK03	77.0	10000.0
XMD13-2	TLK1	51.0	10000.0
WZ4003	TAK1	100.0	1000.0
HG-5-88-01	AKT3	100.0	10000.0
TGX221	PKMYT1	100.0	1000.0
Barasertib	FLT3(D835H)	4.0	10000.0
KIN001-127	ABL1(T315I)	19.0	10000.0
XMD16-144	M3K2	0.1	10000.0
R406	CSNK1G3	100.0	1000.0
JW-7-24-1	ERBB2	100.0	10000.0
XMD14-99	SNARK	60.0	10000.0
NPK76-II-72-1	HIPK1	100.0	10000.0
BMX-IN-1	ACVR1B	100.0	10000.0
Dinaciclib	MARK2	65.0	10000.0
MPS-1-IN-1	PHKG1	100.0	1000.0
BI-2536	MARK2	100.0	10000.0
MPS-1-IN-1	MST4	100.0	1000.0
ALW-II-49-7	CLK4	100.0	10000.0
ALW-II-38-3	DDR1	0.1	1000.0
GSK1059615	RSK4(Kin.Dom.1-N-terminal)	45.0	10000.0
JNK-IN-8	CSNK1A1L	71.0	1000.0
KIN001-021	AAK1	100.0	1000.0
XMD14-99	FGFR3(G697C)	100.0	10000.0
R406	AKT2	100.0	1000.0
SCH772984	ABL1(F317L)-phosphorylated	92.0	1000.0
PHA-767491	VGFR2	100.0	10000.0
WZ-7043	PLK4	100.0	10000.0
XMD11-50	M3K2	97.0	10000.0
XMD-12	CSNK1A1	96.0	1000.0
NVP-TAE684	SRPK1	2.2	1000.0
NG25	STK36	0.6	10000.0
TGX221	M4K3	100.0	1000.0
XMD16-144	CDC2L2	100.0	10000.0
SB590885	PIM3	88.0	10000.0
GW-5074	EGFR(G719C)	80.0	10000.0
BMX-IN-1	TYRO3	100.0	10000.0
Dinaciclib	EPHA7	94.0	10000.0
Canertinib	EPHB1	100.0	1000.0
JWE-035	ULK3	7.4	10000.0
Ribociclib	KPCI	91.0	1000.0
CG-930	RET(V804M)	96.0	10000.0
BGJ398	LCK	3.6	1000.0
KIN001-021	ULK2	100.0	1000.0
5z-7-oxozeaenol	YANK1	100.0	10000.0
WZ4002	FLT3(ITD)	0.9	10000.0
Abemaciclib	CAMK1G	27.0	1000.0
HG-6-64-01	RIOK1	0.8	10000.0
OTSSP167	MET(M1250T)	33.0	10000.0
QL-X-138	NEK1	93.0	10000.0
TAK-715	CHEK1	77.0	10000.0
SB590885	PI42C	100.0	10000.0
ZSTK474	RIOK1	100.0	1000.0
ALW-II-38-3	TGFBR1	100.0	10000.0
Pictilisib	KKCC1	84.0	1000.0
BS-181	DCAMKL2	74.0	10000.0
CP724714	ERBB4	0.9	10000.0
Buparlisib	TAOK3	100.0	1000.0
GSK461364	STK36	98.0	10000.0
Crizotinib	ABL1(F317I)-phosphorylated	13.0	10000.0
PD173074	CDK2	100.0	10000.0
ALW-II-38-3	MP2K1	100.0	10000.0
TAK-715	ACVR1B	4.6	10000.0
Barasertib	CDK11	100.0	10000.0
KIN001-127	LIMK2	100.0	10000.0
TAK-715	EIF2AK1	100.0	10000.0
ZSTK474	GAK	100.0	1000.0
NVP-TAE684	MK14	100.0	1000.0
XMD8-92	AURKB	100.0	10000.0
Ribociclib	EGFR(L747-E749del,A750P)	99.0	1000.0
SCH772984	NEK7	99.0	1000.0
Vemurafenib	JAK2(JH1domain-catalytic)	84.0	10000.0
Buparlisib	TYRO3	94.0	1000.0
Omipalisib	PKAC-beta	100.0	10000.0
ZSTK474	KCC4	100.0	1000.0
Alpelisib	SgK110	100.0	1000.0
HG-14-10-04	BRSK2	88.0	10000.0
OTSSP167	PIK4CB	0.3	10000.0
SB590885	IRAK3	71.0	10000.0
GSK429286A	PLK1	96.0	10000.0
WZ-7043	MET	100.0	10000.0
Ibrutinib	ULK2	91.0	1000.0
BGJ398	NEK9	71.0	1000.0
BMS-536924	RPS6KA1(Kin.Dom.1)	5.9	1000.0
NG25	WEE1	100.0	10000.0
WH-4-023	KIT(V559D)	0.3	10000.0
BMS-536924	MELK	4.8	1000.0
WZ4003	RPS6KA5(Kin.Dom.2)	100.0	1000.0
KIN001-021	BMPR2	100.0	1000.0
ERK5-IN-1	PIK4CB	100.0	1000.0
BMX-IN-1	YANK3	100.0	10000.0
Buparlisib	AAK1	100.0	1000.0
BS-181	FAK2	66.0	10000.0
WZ4002	FGFR1	10.0	10000.0
Baricitinib	DMPK2	78.0	10000.0
MRT67307	STK39	13.0	10000.0
CH5424802	CDK9	95.0	1000.0
WZ3105	EPHA8	100.0	10000.0
CG-930	MLK2	100.0	10000.0
XMD14-99	SNRK	82.0	10000.0
XMD11-50	CSNK2A1	100.0	10000.0
KIN001-127	WEE1	100.0	10000.0
WYE-125132	PFPK5(P.falciparum)	100.0	10000.0
ERK5-IN-1	EGFR(S752-I759del)	86.0	1000.0
Torin1	DYRK1A	71.0	10000.0
Ceritinib	KPCD	87.0	1000.0
TAK-715	ADCK3	0.2	10000.0
KIN001-111	DCLK1	100.0	1000.0
RO-3306	PKN1	47.0	10000.0
Abemaciclib	KCC4	69.0	1000.0
CH5424802	FLT3(ITD)	2.1	1000.0
QL-XII-47	BLK	100.0	1000.0
HG-9-91-01	PIK3CA(E545A)	86.0	10000.0
Abemaciclib	LATS1	100.0	1000.0
CGP74514A	SGK3	17.0	10000.0
NVP-TAE684	MYLK2	100.0	1000.0
XMD13-2	MLK1	66.0	10000.0
PHA-793887	RSK1(Kin.Dom.1-N-terminal)	52.0	10000.0
Sorafenib	SLK	15.0	10000.0
PLX-4720	MYLK	79.0	10000.0
XMD13-2	CAMK1	84.0	10000.0
GSK1059615	CLK2	0.2	10000.0
BI-2536	BTK	100.0	10000.0
XMD-12	AMPK-alpha1	17.0	1000.0
AZ-628	ITK	100.0	10000.0
Sorafenib	HUNK	70.0	10000.0
NVP-TAE684	MYO3B	0.6	1000.0
Palbociclib	TRKC	100.0	1000.0
Neratinib	TBK1	100.0	10000.0
JNK-9L	FGFR3	74.0	10000.0
ALW-II-49-7	ERBB4	100.0	10000.0
XMD11-85h	RIPK2	100.0	10000.0
JW-7-24-1	CDK2	100.0	10000.0
XMD11-85h	SRPK2	100.0	10000.0
JNK-9L	BRAF(V600E)	72.0	10000.0
Torkinib	CSNK1G3	27.0	10000.0
Sorafenib	ERK4	100.0	10000.0
MLN8054	MP2K1	86.0	10000.0
Sigma A6730	STK39	100.0	10000.0
Torin2	FLT3(ITD)	45.0	10000.0
CP724714	MK14	100.0	10000.0
BS-181	DYRK1A	1.6	10000.0
QL-XII-47	DRAK1	100.0	1000.0
Torkinib	SBK1	92.0	10000.0
Torin1	TLK2	100.0	10000.0
GSK1059615	CSNK1D	3.6	10000.0
WYE-125132	CDK7	88.0	10000.0
JNK-IN-5A	MK14	100.0	10000.0
Palbociclib	RSK3(Kin.Dom.2-C-terminal)	84.0	1000.0
Taselisib	MYLK4	100.0	1000.0
BS-181	PKMYT1	100.0	10000.0
GSK429286A	RSK1(Kin.Dom.1-N-terminal)	72.0	10000.0
Taselisib	PAK1	100.0	1000.0
PD0325901	TRKC	93.0	10000.0
HG-6-64-01	MP2K2	58.0	10000.0
Dabrafenib	ABL1(F317L)-nonphosphorylated	14.0	10000.0
Dabrafenib	NIM1	99.0	10000.0
GSK461364	AMPK-alpha1	57.0	10000.0
Neratinib	CDK14	97.0	10000.0
GW-5074	ULK1	100.0	10000.0
TAK-715	YSK4	64.0	10000.0
JNK-9L	ROCK2	25.0	10000.0
AZD 5438	RSK2(Kin.Dom.2-C-terminal)	66.0	10000.0
Seliciclib	KIT(L576P)	82.0	10000.0
WZ3105	FAK1	26.0	10000.0
XMD11-85h	MYLK4	100.0	10000.0
NPK76-II-72-1	INSRR	26.0	10000.0
Lapatinib	MK11	100.0	10000.0
JNK-IN-11	TRKB	14.0	1000.0
KIN001-220	EPHA4	83.0	10000.0
Momelotinib	CDK9	55.0	10000.0
BI-2536	ANKK1	100.0	10000.0
BX-912	PLK3	20.0	10000.0
WH-4-023	CDKL1	100.0	10000.0
BS-181	ERK4	100.0	10000.0
Ribociclib	KC1G1	99.0	1000.0
R406	CLK3	5.3	1000.0
XMD8-85	PIK3CA(C420R)	100.0	10000.0
SB590885	MLK1	100.0	10000.0
BX-912	M4K3	4.6	10000.0
BI-2536	BRAF	100.0	10000.0
AZD 5438	LRRK2	0.6	10000.0
AZD7762	ABL1-nonphosphorylated	0.0	10000.0
QL-X-138	DAPK2	57.0	10000.0
Torin1	LRRK2	81.0	10000.0
Ribociclib	FAK2	95.0	1000.0
QL-XI-92	DMPK2	100.0	10000.0
SCH772984	MAPKAPK2	88.0	1000.0
NU7441	KIT(V559D,T670I)	100.0	10000.0
SCH772984	FAK1	100.0	1000.0
GW-5074	RPS6KA4(Kin.Dom.1-N-terminal)	87.0	10000.0
Barasertib	EGFR(T790M)	22.0	10000.0
5z-7-oxozeaenol	WEE1	78.0	10000.0
WYE-125132	PHKG2	96.0	10000.0
PLX-4720	DRAK2	68.0	10000.0
SB590885	PIK3C2G	55.0	10000.0
Ibrutinib	EPHA5	96.0	1000.0
WH-4-023	MARK2	87.0	10000.0
ZG-10	NDR1	90.0	10000.0
ZM-447439	FLT3(R834Q)	34.0	10000.0
AS-252424	MK12	92.5	10000.0
Alpelisib	LCK	82.0	1000.0
GSK1059615	CDC2L2	85.0	10000.0
WZ4002	SgK110	100.0	10000.0
QL-XI-92	KPCL	100.0	10000.0
Ribociclib	RSK4(Kin.Dom.2-C-terminal)	90.0	1000.0
AG1478	PIK4CB	44.0	10000.0
KIN001-021	DDR2	100.0	1000.0
GW-5074	PIK3CA(I800L)	61.0	10000.0
HG-5-88-01	EPHA4	100.0	10000.0
A443654	ULK1	22.0	10000.0
AZD 5438	MLCK	2.9	10000.0
JNK-IN-11	PRP4	100.0	1000.0
Pictilisib	TAOK2	100.0	1000.0
Ibrutinib	CDK4-cyclinD1	96.0	1000.0
JNK-IN-5A	MAP4K4	66.0	10000.0
Crizotinib	LIMK1	2.7	10000.0
KIN001-111	NDR2	14.0	1000.0
KIN001-220	RSK3(Kin.Dom.2-C-terminal)	57.0	10000.0
Ibrutinib	TYK2(JH1domain-catalytic)	80.0	1000.0
Dabrafenib	PIK3CA(E545K)	92.0	10000.0
GW843682X	MST3	87.0	10000.0
BMS345541	PIK3CA	100.0	10000.0
Crizotinib	TLK1	61.0	10000.0
WZ3105	JAK1(JH1domain-catalytic)	88.0	10000.0
PHA-793887	TGFBR2	100.0	10000.0
Taselisib	ABL1(T315I)-nonphosphorylated	100.0	1000.0
BMS-536924	PLK3	100.0	1000.0
Ibrutinib	JAK1(JH2domain-pseudokinase)	100.0	1000.0
BI-2536	KIT(V559D,T670I)	100.0	10000.0
Barasertib	EPHB1	98.0	10000.0
WZ4002	DRAK1	1.6	10000.0
Pictilisib	PKN1	100.0	1000.0
BMS-536924	ACVR2B	100.0	1000.0
BGJ398	PRP4	94.0	1000.0
PHA-767491	MLTK	78.0	10000.0
XMD-12	BMX	89.0	1000.0
THZ1	LRRK2	27.0	10000.0
Barasertib	ABL1(Q252H)-nonphosphorylated	1.7	10000.0
PLX-4720	FLT4	61.0	10000.0
JWE-035	MLK2	100.0	10000.0
Baricitinib	PLK1	20.0	10000.0
BS-181	KPCD2	49.0	10000.0
MRT67307	PKNB(M.tuberculosis)	32.0	10000.0
Torin1	CDK7	57.0	10000.0
NG25	LATS2	13.0	10000.0
KIN001-021	CDK2	100.0	1000.0
JNK-IN-8	CASK	100.0	1000.0
XMD14-99	SgK110	100.0	10000.0
KIN001-123	FLT3(D835H)	1.5	1000.0
Palbociclib	NEK3	74.0	1000.0
WZ3105	EPHA7	100.0	10000.0
ERK5-IN-1	ICK	100.0	1000.0
AZD-6482	FLT3(K663Q)	13.0	10000.0
WZ-4-145	ERK5	9.7	10000.0
CGP60474	TNK1	100.0	10000.0
A443654	RET	100.0	10000.0
XMD14-99	DDR2	100.0	10000.0
RO-3306	ANKK1	78.0	10000.0
QL-XI-92	ICK	75.0	10000.0
THZ1	TNNI3K	29.0	10000.0
Ceritinib	TRKB	92.0	1000.0
JNK-9L	TAOK3	28.0	10000.0
BMX-IN-1	TNNI3K	77.0	10000.0
PD173074	TIE1	12.0	10000.0
JNK-IN-8	LRRK2(G2019S)	67.0	1000.0
THZ1	RSK1(Kin.Dom.1-N-terminal)	0.1	10000.0
BS-181	NEK9	96.0	10000.0
GSK461364	ACVR1B	97.0	10000.0
Torkinib	RIOK3	83.0	10000.0
5z-7-oxozeaenol	TRKC	91.0	10000.0
Dabrafenib	CSNK1A1	63.0	10000.0
NPK76-II-72-1	ERBB4	100.0	10000.0
ERK5-IN-1	TXK	100.0	1000.0
XMD13-2	FLT3	63.0	10000.0
Torin1	MRCKA	0.7	10000.0
Baricitinib	TRKC	33.0	10000.0
Taselisib	CLK4	97.0	1000.0
ZG-10	FLT3(R834Q)	83.0	10000.0
CP466722	JAK3(JH1domain-catalytic)	33.0	10000.0
Dinaciclib	KIT(V559D,T670I)	97.0	10000.0
ALW-II-49-7	RPS6KA4(Kin.Dom.1)	100.0	10000.0
Baricitinib	GRK4	7.0	10000.0
Dinaciclib	PLK1	60.0	10000.0
AG1478	PCTK3	79.0	10000.0
GSK1059615	NUAK1	100.0	10000.0
CP724714	PCTK3	99.0	10000.0
KIN001-220	YSK1	35.0	10000.0
WZ3105	SLK	26.0	10000.0
KIN001-123	CSK	100.0	1000.0
Baricitinib	AMPK-alpha2	51.0	10000.0
ALW-II-38-3	RIPK4	100.0	10000.0
XMD8-85	CAMK2B	100.0	10000.0
Palbociclib	ABL1(H396P)-phosphorylated	100.0	1000.0
BMX-IN-1	NEK6	74.0	10000.0
HG-5-113-01	MARK2	33.0	10000.0
SB590885	PIK3CA(E545K)	100.0	10000.0
CP724714	FLT3(K663Q)	79.0	10000.0
Omipalisib	SIK2	100.0	10000.0
Seliciclib	MK01	100.0	10000.0
THZ1	SYK	0.5	10000.0
BS-181	SNRK	99.0	10000.0
Pictilisib	CDK3	100.0	1000.0
Sorafenib	ACVR1B	92.0	10000.0
Lapatinib	CDK4-cyclinD1	100.0	10000.0
CG-930	HUNK	89.0	10000.0
THZ1	KIT(D816V)	0.1	10000.0
XMD8-85	IKKA	100.0	10000.0
ZSTK474	FGFR3(G697C)	100.0	1000.0
Torin1	PIK3CA(H1047Y)	12.0	10000.0
AS-252424	KKCC1	65.0	10000.0
BX-912	ITK	4.5	10000.0
R406	KGP1	100.0	1000.0
Sorafenib	CDKL1	70.0	10000.0
Ibrutinib	DMPK2	97.0	1000.0
Ribociclib	ALK	100.0	1000.0
AZD4547	EGFR(L858R,T790M)	35.0	10000.0
ZSTK474	PIM2	100.0	1000.0
QL-XI-92	JAK3(JH1domain-catalytic)	100.0	10000.0
XMD8-92	CSNK1A1L	100.0	10000.0
Canertinib	MRCKA	100.0	1000.0
AZD7762	EGFR(L858R,T790M)	5.0	10000.0
HG-5-88-01	PKAC-beta	100.0	10000.0
KIN001-127	AURKA	100.0	10000.0
HG-6-64-01	GRK4	8.2	10000.0
Dinaciclib	PRP4	78.0	10000.0
XMD13-2	VGFR2	93.0	10000.0
HG-9-91-01	EPHA7	15.0	10000.0
CP724714	SNRK	71.0	10000.0
PD0325901	KPCE	100.0	10000.0
AZD4547	TAOK1	15.0	10000.0
SCH772984	KGP1	81.0	1000.0
HG-14-8-02	KKCC1	73.0	10000.0
HG-14-8-02	FAK2	16.0	10000.0
Ibrutinib	VRK2	92.0	1000.0
ZM-447439	LIMK1	100.0	10000.0
HG-5-113-01	SRPK1	2.0	10000.0
Torkinib	CHEK1	66.0	10000.0
ALW-II-38-3	PIP5K2B	100.0	10000.0
XMD13-2	EGFR(L858R,T790M)	100.0	10000.0
Abemaciclib	HIPK2	0.0	1000.0
BMS345541	TNNI3K	100.0	10000.0
ZSTK474	LOK	100.0	1000.0
HG-5-113-01	YANK2	100.0	10000.0
SP600125	MK12	21.0	10000.0
WZ4003	DRAK2	35.0	1000.0
AZD4547	MK11	96.0	10000.0
JNK-IN-11	BRSK1	86.0	1000.0
SCH772984	PIK3CB	100.0	1000.0
PHA-767491	MP2K5	31.0	10000.0
Neratinib	ULK3	100.0	10000.0
ZSTK474	SRPK1	100.0	1000.0
SCH772984	ABL1(E255K)-phosphorylated	100.0	1000.0
KIN001-220	ALK	22.0	10000.0
AG1478	DYRK1A	40.0	10000.0
Dinaciclib	EPHA6	86.0	10000.0
Momelotinib	ERK4	93.0	10000.0
Sorafenib	CAMK1	82.0	10000.0
HG-14-10-04	ACVR2B	91.0	10000.0
SB590885	AXL	78.0	10000.0
PD0325901	SBK1	100.0	10000.0
PD0325901	HIPK3	49.0	10000.0
HG-9-91-01	YES	0.0	10000.0
WZ4003	TNNI3K	100.0	1000.0
Crizotinib	EPHA5	1.8	10000.0
BS-181	ALK(C1156Y)	22.0	10000.0
BX-912	VRK2	12.0	10000.0
Vemurafenib	KIT(D816H)	98.0	10000.0
XMD13-2	RSK1(Kin.Dom.1-N-terminal)	81.0	10000.0
SP600125	RPS6KA1(Kin.Dom.2)	3.8	10000.0
BMS345541	MET(M1250T)	100.0	10000.0
BX-912	EGFR(G719C)	24.0	10000.0
KIN001-123	AMPK-alpha2	100.0	1000.0
(s)-CR8	FLT3(N841I)	100.0	10000.0
GSK461364	NUAK1	17.0	10000.0
KIN001-220	KCC4	100.0	10000.0
AZD-6482	DYRK1B	80.0	10000.0
TGX221	KC1G1	100.0	1000.0
Torin2	INSR	59.0	10000.0
WZ-7043	ACVR1B	100.0	10000.0
PHA-767491	BMPR1B	0.2	10000.0
TGX221	FER	100.0	1000.0
MLN8054	PFCDPK1(P.falciparum)	63.0	10000.0
ZG-10	SBK1	100.0	10000.0
SCH772984	CHK2	70.0	1000.0
WZ-7043	TESK1	100.0	10000.0
BMS345541	MK03	97.0	10000.0
CG-930	NEK9	100.0	10000.0
Sorafenib	FRK	6.6	10000.0
JW-7-24-1	AMPK-alpha1	100.0	10000.0
MPS-1-IN-1	M4K1	100.0	1000.0
AZD 5438	PLK4	0.6	10000.0
Neratinib	PIK3CA(C420R)	78.0	10000.0
AZD 5438	PGFRB	1.8	10000.0
Ceritinib	MRCKA	100.0	1000.0
AZ-628	PLK1	100.0	10000.0
QL-X-138	PFCDPK1(P.falciparum)	11.0	10000.0
AZD 5438	DCAMKL2	85.0	10000.0
Crizotinib	CAMK1G	76.0	10000.0
Torin2	DCLK1	97.0	10000.0
Sigma A6730	HIPK3	87.0	10000.0
Taselisib	BARK1	100.0	1000.0
Alpelisib	TEC	98.0	1000.0
GW843682X	FRK	82.0	10000.0
ALW-II-49-7	HIPK1	100.0	10000.0
BMS345541	LATS2	100.0	10000.0
ERK5-IN-1	CDKL2	99.0	1000.0
XMD16-144	MINK	29.0	10000.0
Alpelisib	AKT2	100.0	1000.0
Torkinib	MARK4	82.0	10000.0
KIN001-021	BTK	100.0	1000.0
AZD4547	RSK2(Kin.Dom.2-C-terminal)	81.0	10000.0
BX-912	AAK1	3.1	10000.0
Momelotinib	MP2K1	100.0	10000.0
AG1478	PIK3CA(E545K)	71.0	10000.0
AZ-628	MELK	100.0	10000.0
WZ-7043	YSK4	100.0	10000.0
Dabrafenib	FLT4	24.0	10000.0
PLX-4720	BRSK2	86.0	10000.0
JNK-IN-8	LOK	100.0	1000.0
ZM-447439	M3K6	100.0	10000.0
CGP74514A	PIK3CA(H1047Y)	58.0	10000.0
Sigma A6730	RSK2(Kin.Dom.2-C-terminal)	100.0	10000.0
5z-7-oxozeaenol	NEK10	96.0	10000.0
WYE-125132	LRRK2	82.0	10000.0
Canertinib	CDK14	100.0	1000.0
JNK-9L	FLT3(N841I)	12.0	10000.0
JWE-035	M3K2	0.6	10000.0
WZ4002	ALK	0.7	10000.0
ZG-10	NEK9	22.0	10000.0
BMS345541	CDKL5	46.0	10000.0
XMD14-99	CDK4-cyclinD3	0.4	10000.0
BMS-536924	MARK1	14.0	1000.0
HG-14-8-02	HIPK2	11.0	10000.0
RO-3306	MK14	97.0	10000.0
XMD13-2	BRAF(V600E)	65.0	10000.0
XMD11-85h	FGFR3	100.0	10000.0
Seliciclib	CSNK1E	0.2	10000.0
HG-9-91-01	MYO3B	4.3	10000.0
GW-5074	MST3	97.0	10000.0
Dinaciclib	MAP3K4	86.0	10000.0
RO-3306	ABL1(H396P)-phosphorylated	96.0	10000.0
BMS345541	AKT3	100.0	10000.0
JNK-IN-11	KC1G1	39.0	1000.0
AS-252424	WEE1	99.5	10000.0
Ceritinib	CAMK1	62.0	1000.0
KIN001-220	PIK3CA(E542K)	84.0	10000.0
Dabrafenib	M3K6	100.0	10000.0
Torkinib	MKNK2	4.5	10000.0
Abemaciclib	FLT3(N841I)	28.0	1000.0
Omipalisib	TRPM6	79.0	10000.0
GSK429286A	LOK	100.0	10000.0
AZD7762	DRAK2	2.0	10000.0
TGX221	TNK2	100.0	1000.0
Barasertib	M4K3	51.0	10000.0
GW843682X	PIP5K1A	3.4	10000.0
XMD8-85	MST2	100.0	10000.0
AG1478	PRKX	100.0	10000.0
JNK-IN-8	CDK14	88.0	1000.0
WZ-7043	FAK2	100.0	10000.0
CH5424802	EGFR(L747-S752del,P753S)	22.0	1000.0
CP724714	EPHA3	97.0	10000.0
JW-7-24-1	KCC4	100.0	10000.0
GSK429286A	FGFR1	73.0	10000.0
Buparlisib	FLT4	100.0	1000.0
KU63794	PIK3CA(I800L)	0.0	10000.0
BMS345541	MLK2	100.0	10000.0
GSK429286A	LKB1	100.0	10000.0
HG-14-10-04	SGK3	94.0	10000.0
GSK461364	PIK4CB	100.0	10000.0
AZD 5438	EGFR(T790M)	44.0	10000.0
Alpelisib	CSF1R	100.0	1000.0
Barasertib	KIT(D816H)	34.0	10000.0
BGJ398	MAP3K3	4.0	1000.0
AS-252424	AMPK-alpha1	98.4	10000.0
WZ4003	NDR2	100.0	1000.0
PHA-767491	MYO3A	43.0	10000.0
Torin1	ERBB4	100.0	10000.0
AS-252424	NEK5	87.7	10000.0
SB590885	SYK	100.0	10000.0
Ceritinib	SYK	84.0	1000.0
XMD14-99	CDK3	97.0	10000.0
Neratinib	TIE1	24.0	10000.0
SCH772984	GRK7	96.0	1000.0
NPK76-II-72-1	ABL1(H396P)	100.0	10000.0
AZ-628	FGFR3(G697C)	100.0	10000.0
WZ-4-145	PAK3	100.0	10000.0
HG-14-8-02	RSK2(Kin.Dom.2-C-terminal)	100.0	10000.0
Dabrafenib	MARK4	37.0	10000.0
QL-XII-47	MAP4K5	100.0	1000.0
Barasertib	FES	100.0	10000.0
Neratinib	PKN1	100.0	10000.0
HG-9-91-01	TAOK1	0.0	10000.0
Sorafenib	TEC	100.0	10000.0
BI-D1870	NEK9	8.8	10000.0
Crizotinib	MK09	82.0	10000.0
KIN001-127	BRAF(V600E)	100.0	10000.0
JNK-9L	PCTK3	43.0	10000.0
WZ-4-145	PLK4	100.0	10000.0
WYE-125132	CAMK2B	100.0	10000.0
RO-3306	PIK3CA(E545K)	69.0	10000.0
BS-181	PIK3CA(H1047Y)	88.0	10000.0
SB590885	PKMYT1	100.0	10000.0
XMD8-85	CDK16	100.0	10000.0
BGJ398	EPHA7	89.0	1000.0
TGX221	PIM2	100.0	1000.0
TGX221	MAP3K4	100.0	1000.0
ALW-II-38-3	GRK1	100.0	10000.0
XMD16-144	KGP2	81.0	10000.0
XMD13-2	HCK	100.0	10000.0
Canertinib	BRSK1	100.0	1000.0
PHA-767491	TAK1	26.0	10000.0
SP600125	FAK2	100.0	10000.0
AZD 5438	RSK4(Kin.Dom.1-N-terminal)	26.0	10000.0
KIN001-021	NUAK1	100.0	1000.0
KIN001-123	FYN	100.0	1000.0
RO-3306	FLT3-autoinhibited	55.0	10000.0
Alpelisib	KIT(D816H)	100.0	1000.0
Vemurafenib	S6K1	86.0	10000.0
Pictilisib	PFPK5(P.falciparum)	95.0	1000.0
Torin1	PIM1	80.0	10000.0
Pictilisib	CIT	98.0	1000.0
XMD16-144	AURKC	9.2	10000.0
CGP74514A	ERBB3	28.0	10000.0
Sorafenib	CSNK2A2	100.0	10000.0
Neratinib	MAP4K2	5.2	10000.0
SB590885	ERK5	97.0	10000.0
GW-5074	FGR	86.0	10000.0
PLX-4720	PGFRB	0.0	10000.0
TGX221	BRAF	100.0	1000.0
A443654	PLK3	100.0	10000.0
WZ4002	RIPK1	9.4	10000.0
XMD16-144	TSSK1	53.0	10000.0
GSK1059615	AURKB	39.0	10000.0
WZ4003	SNARK	0.3	1000.0
HG-14-8-02	MST2	99.0	10000.0
Buparlisib	CDC2L5	100.0	1000.0
GW843682X	FGFR4	77.0	10000.0
Taselisib	KPCT	90.0	1000.0
HG-14-8-02	ABL1(Q252H)-phosphorylated	37.0	10000.0
BX-912	ADCK3	100.0	10000.0
Vemurafenib	MAP4K2	59.0	10000.0
XMD8-92	ACVR2B	100.0	10000.0
Sigma A6730	PIK3CD	51.0	10000.0
HG-5-88-01	FAK2	0.2	10000.0
ZM-447439	BTK	7.3	10000.0
XMD16-144	SRC	0.7	10000.0
AZD4547	MK09	60.0	10000.0
Abemaciclib	ABL1(M351T)-phosphorylated	100.0	1000.0
Dactolisib	PTK6	100.0	1000.0
KIN001-127	MK03	100.0	10000.0
MRT67307	CDKL3	94.0	10000.0
CG-930	MLK3	100.0	10000.0
AZD 5438	RAF1	100.0	10000.0
XMD13-2	DCAMKL2	100.0	10000.0
Taselisib	MTOR	68.0	1000.0
Lapatinib	FLT3(D835Y)	97.0	10000.0
TAK-715	EGFR(S752-I759del)	4.8	10000.0
GW-5074	NEK9	100.0	10000.0
CG-930	PLK4	100.0	10000.0
HG-14-10-04	TNK2	0.2	10000.0
PD0325901	PIP5K2B	100.0	10000.0
BI-D1870	MYLK	25.0	10000.0
HG-14-8-02	PRKX	94.0	10000.0
Palbociclib	BMPR2	100.0	1000.0
MPS-1-IN-1	NEK6	100.0	1000.0
Alpelisib	TNIK	94.0	1000.0
KIN001-123	NEK6	100.0	1000.0
XMD14-99	SRC	100.0	10000.0
Torin2	ERN1	100.0	10000.0
XMD13-2	KPCI	74.0	10000.0
HG-6-64-01	MLK2	20.0	10000.0
WH-4-023	CASK	90.0	10000.0
Torin1	ROS1	71.0	10000.0
XMD16-144	SRPK1	23.0	10000.0
R406	TAOK3	100.0	1000.0
HG-5-113-01	MK01	22.0	10000.0
NPK76-II-72-1	MK14	100.0	10000.0
ERK5-IN-1	FYN	78.0	1000.0
BS-181	ABL1(Q252H)-nonphosphorylated	100.0	10000.0
ZM-447439	PGFRA	2.0	10000.0
Alpelisib	NDR2	100.0	1000.0
GW-5074	CASK	74.0	10000.0
CG-930	IKKA	86.0	10000.0
GSK461364	PIP5K1A	14.0	10000.0
SCH772984	CAMK1G	72.0	1000.0
WZ4002	MYO3B	100.0	10000.0
Lapatinib	TXK	100.0	10000.0
KIN001-127	NEK1	100.0	10000.0
KIN001-127	ACVR2A	100.0	10000.0
BS-181	ICK	61.0	10000.0
GW843682X	M3K6	84.0	10000.0
AS-252424	CSNK1D	100.0	10000.0
Alpelisib	STK39	100.0	1000.0
CGP74514A	YES	8.4	10000.0
Sorafenib	FLT3(K663Q)	0.5	10000.0
BMS-536924	AURKA	25.0	1000.0
XMD-12	PIK4CB	70.0	1000.0
PHA-793887	ROCK2	96.0	10000.0
KIN001-123	TYK2(Kin.Dom.2)	100.0	1000.0
HG-5-113-01	KPCL	100.0	10000.0
CG-930	PKAC-alpha	100.0	10000.0
PHA-767491	ABL1-nonphosphorylated	72.0	10000.0
AZD4547	JNK3	53.0	10000.0
KIN001-220	PAK6	65.0	10000.0
GSK429286A	PAK4	85.0	10000.0
ALW-II-49-7	M4K3	100.0	10000.0
QL-XII-47	ABL1(E255K)-phosphorylated	89.0	1000.0
XMD13-2	MKNK1	69.0	10000.0
RO-3306	RSK4(Kin.Dom.1-N-terminal)	64.0	10000.0
WZ4002	STK36	100.0	10000.0
Taselisib	RET	88.0	1000.0
AZD-6482	KPCL	82.0	10000.0
SP600125	ERK8	100.0	10000.0
XMD13-2	PIM2	100.0	10000.0
BMS-536924	ITK	3.6	1000.0
WZ-4-145	PKAC-alpha	100.0	10000.0
Baricitinib	PKNB(M.tuberculosis)	18.0	10000.0
WYE-125132	PIK3C2B	25.0	10000.0
GSK1059615	IKKA	44.0	10000.0
Torin2	NLK	86.0	10000.0
TGX221	CAMK2A	100.0	1000.0
Palbociclib	PAK3	100.0	1000.0
AZD4547	YANK1	34.0	10000.0
GSK429286A	PAK3	36.0	10000.0
HG-9-91-01	TRKB	100.0	10000.0
CH5424802	ERBB4	51.0	1000.0
Vemurafenib	TRPM6	100.0	10000.0
XMD14-99	KC1G2	100.0	10000.0
RO-3306	FGFR2	94.0	10000.0
Dinaciclib	ERBB2	99.0	10000.0
AZD 5438	WNK1	93.0	10000.0
AZD4547	NEK3	100.0	10000.0
Torin2	AKT3	100.0	10000.0
AG1478	TYK2(JH2domain-pseudokinase)	55.0	10000.0
HG-14-8-02	SgK110	100.0	10000.0
ZM-447439	PIK3CA(E545A)	19.0	10000.0
Sorafenib	FGFR4	65.0	10000.0
JNK-IN-8	TEC	100.0	1000.0
GW843682X	CDK3	100.0	10000.0
KIN001-021	DYRK1B	100.0	1000.0
CGP60474	TSSK1	100.0	10000.0
HG-9-91-01	MST4	0.9	10000.0
Palbociclib	CDK16	91.0	1000.0
KIN001-111	RET(V804L)	100.0	1000.0
HG-14-8-02	PIK3CA(C420R)	100.0	10000.0
HG-5-113-01	KIT(V559D,T670I)	22.0	10000.0
JNK-IN-11	NEK6	100.0	1000.0
HG-14-8-02	HIPK3	31.0	10000.0
GW-5074	MTOR	95.0	10000.0
AZ-628	PTK6	94.0	10000.0
CH5424802	NEK4	75.0	1000.0
PHA-793887	EPHB6	99.0	10000.0
AZD4547	PIP5K2B	44.0	10000.0
BI-2536	PIK3CB	100.0	10000.0
BX-912	DAPK2	22.0	10000.0
XMD8-92	TSSK1	100.0	10000.0
GSK429286A	FGFR2	95.0	10000.0
NG25	SRC	0.2	10000.0
BI-2536	FAK1	2.4	10000.0
HG-14-10-04	PFCDPK1(P.falciparum)	5.4	10000.0
XMD-12	CDK16	100.0	1000.0
AZD-6482	ANKK1	100.0	10000.0
AZD 5438	MKNK2	17.0	10000.0
QL-X-138	TGFBR1	83.0	10000.0
CP724714	PHKG2	86.0	10000.0
HG-5-113-01	ERK4	100.0	10000.0
QL-X-138	EGFR(L858R,T790M)	18.0	10000.0
AS-252424	CAMK2B	64.8	10000.0
WZ3105	MAST1	83.0	10000.0
Alpelisib	GRK7	100.0	1000.0
PD0325901	JNK3	90.0	10000.0
BMS-536924	EGFR(E746-A750del)	18.0	1000.0
AZD7762	MLK2	1.2	10000.0
XMD8-92	KCC4	100.0	10000.0
JW-7-24-1	EPHB1	100.0	10000.0
AS-252424	EPHA6	92.3	10000.0
ALW-II-38-3	TTK	100.0	10000.0
BX-912	JAK1(JH2domain-pseudokinase)	0.2	10000.0
GSK461364	CDKL5	31.0	10000.0
OTSSP167	CSNK1A1	2.8	10000.0
WZ3105	FGFR3	68.0	10000.0
WZ4002	LATS2	100.0	10000.0
Seliciclib	RIPK2	100.0	10000.0
Neratinib	ABL1(E255K)-phosphorylated	100.0	10000.0
CGP74514A	MK13	82.0	10000.0
SB590885	RET	100.0	10000.0
PLX-4720	TGFBR1	60.0	10000.0
Seliciclib	AKT3	100.0	10000.0
WZ4002	CDKL2	100.0	10000.0
BI-D1870	CDK5	14.0	10000.0
CGP74514A	KPCD1	34.0	10000.0
Torin1	HCK	77.0	10000.0
QL-X-138	KIT(V559D)	66.0	10000.0
NG25	RET(M918T)	0.1	10000.0
WH-4-023	ERBB3	0.0	10000.0
Torin1	CDK2	6.2	10000.0
HG-14-8-02	MARK4	100.0	10000.0
MPS-1-IN-1	MYLK2	100.0	1000.0
KIN001-220	YANK1	100.0	10000.0
PHA-767491	OSR1	96.0	10000.0
AZD 5438	EGFR(L861Q)	87.0	10000.0
SB590885	CAMK1D	100.0	10000.0
Barasertib	MAP3K1	99.0	10000.0
ZG-10	GRK7	98.0	10000.0
Pictilisib	NUAK1	97.0	1000.0
BS-181	PIK3CD	93.0	10000.0
Dabrafenib	CSF1R	1.8	10000.0
BMS-536924	KPCD2	100.0	1000.0
MPS-1-IN-1	CSNK2A1	100.0	1000.0
AZD4547	CAMK1D	0.4	10000.0
Vemurafenib	NEK6	100.0	10000.0
JNK-9L	PCTK2	18.0	10000.0
XMD16-144	EPHB4	83.0	10000.0
Sorafenib	PIK3C2B	92.0	10000.0
XMD8-92	FAK1	100.0	10000.0
SB590885	MAPKAPK2	100.0	10000.0
Buparlisib	PKN1	100.0	1000.0
THZ1	LYN	8.0	10000.0
Pictilisib	CSNK1E	75.0	1000.0
BI-2536	MKNK2	100.0	10000.0
AZ-628	PIK3C2G	88.0	10000.0
Torkinib	PGFRA	2.2	10000.0
Dabrafenib	ALK(C1156Y)	98.0	10000.0
RO-3306	MTOR	53.0	10000.0
AZD7762	RSK3(Kin.Dom.2-C-terminal)	1.9	10000.0
AG1478	FLT3(D835H)	15.0	10000.0
XMD13-2	FRK	89.0	10000.0
KIN001-111	TNIK	13.0	1000.0
ERK5-IN-1	BRAF(V600E)	100.0	1000.0
RO-3306	ERBB2	82.0	10000.0
Torin1	PCTK2	97.0	10000.0
GW-5074	TXK	100.0	10000.0
Neratinib	GSK3A	97.0	10000.0
XMD13-2	HIPK4	40.0	10000.0
OTSSP167	EPHA6	1.4	10000.0
JW-7-24-1	ACVR1B	100.0	10000.0
HG-5-88-01	CDK7	100.0	10000.0
QL-X-138	ACVRL1	42.0	10000.0
QL-XI-92	ABL1(F317L)-phosphorylated	53.0	10000.0
(s)-CR8	PFCDPK1(P.falciparum)	100.0	10000.0
Barasertib	ULK2	100.0	10000.0
BX-912	MYLK	34.0	10000.0
BMX-IN-1	PKMYT1	100.0	10000.0
Torin2	MK13	48.0	10000.0
(s)-CR8	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
Alpelisib	KIT(V559D)	100.0	1000.0
CP724714	RET(V804L)	100.0	10000.0
WZ3105	ROCK2	10.0	10000.0
AG1478	MERTK	71.0	10000.0
CP466722	CDK15	88.0	10000.0
KIN001-021	PIM2	100.0	1000.0
Ribociclib	EGFR(L858R)	97.0	1000.0
PHA-793887	PIK3CA(M1043I)	100.0	10000.0
(s)-CR8	EGFR(L861Q)	81.0	10000.0
CP466722	PAK1	70.0	10000.0
SB590885	JNK3	8.6	10000.0
XMD14-99	PTK6	100.0	10000.0
AZD7762	TXK	0.1	10000.0
WZ-7043	MARK1	100.0	10000.0
XMD-12	FAK2	78.0	1000.0
BI-D1870	KPCD2	22.0	10000.0
KIN001-220	CIT	27.0	10000.0
BGJ398	PIK3CA(E545K)	73.0	1000.0
Dabrafenib	IKKA	58.0	10000.0
MPS-1-IN-1	DDR2	100.0	1000.0
QL-XII-47	DRAK2	100.0	1000.0
WZ-4-145	EGFR(L747-S752del,P753S)	0.5	10000.0
XMD8-85	PAK4	100.0	10000.0
HG-14-10-04	MYO3A	0.4	10000.0
PD0325901	GRK1	100.0	10000.0
BI-2536	VGFR2	100.0	10000.0
PD0325901	PRKR	100.0	10000.0
5z-7-oxozeaenol	KPCI	100.0	10000.0
Baricitinib	CASK	10.0	10000.0
Lapatinib	ERK8	100.0	10000.0
QL-X-138	KIT(D816H)	14.0	10000.0
NPK76-II-72-1	RIOK3	100.0	10000.0
Alpelisib	ABL1(H396P)-phosphorylated	2.9	1000.0
Buparlisib	DRAK1	100.0	1000.0
KIN001-021	MELK	100.0	1000.0
AG1478	RSK1(Kin.Dom.2-C-terminal)	28.0	10000.0
Barasertib	ABL1(F317I)-phosphorylated	39.0	10000.0
CP466722	CDC2L2	100.0	10000.0
BMX-IN-1	TAOK1	79.0	10000.0
HG-9-91-01	WNK1	100.0	10000.0
JNK-IN-5A	CAMK1	73.0	10000.0
JWE-035	CLK1	86.0	10000.0
Baricitinib	CLK1	5.9	10000.0
Torin1	PIK3CG	1.2	10000.0
QL-XII-47	FAK1	95.0	1000.0
RO-3306	TRKB	95.0	10000.0
BMS345541	TBK1	100.0	10000.0
XMD13-2	FAK1	90.0	10000.0
NPK76-II-72-1	BTK	100.0	10000.0
JNK-9L	GRK7	70.0	10000.0
GSK429286A	KPCD3	81.0	10000.0
Torkinib	ABL1(Q252H)-nonphosphorylated	0.1	10000.0
JWE-035	MAP3K1	55.0	10000.0
KIN001-127	PIK3CA(E545K)	100.0	10000.0
Baricitinib	MAST1	26.0	10000.0
XMD11-85h	MLK1	100.0	10000.0
NU7441	YSK1	59.0	10000.0
XMD16-144	CDK15	84.0	10000.0
Vemurafenib	AXL	8.4	10000.0
WZ3105	GCN2(Kin.Dom.2,S808G)	59.0	10000.0
ZSTK474	FLT3(D835Y)	100.0	1000.0
Torin1	AMPK-alpha2	74.0	10000.0
HG-14-8-02	GRK1	77.0	10000.0
Baricitinib	MYO3B	100.0	10000.0
AZD 5438	EPHA7	40.0	10000.0
QL-XI-92	FGFR3	97.0	10000.0
RO-3306	RPS6KA5(Kin.Dom.2-C-terminal)	10.0	10000.0
BI-2536	GSK3A	100.0	10000.0
XMD14-99	IRAK1	92.0	10000.0
5z-7-oxozeaenol	DAPK2	86.0	10000.0
ALW-II-38-3	EGFR(L747-S752del,P753S)	100.0	10000.0
AZD 5438	CDKL5	1.4	10000.0
JW-7-24-1	ULK3	100.0	10000.0
QL-XII-47	ACVR2B	70.0	1000.0
GW843682X	KKCC1	88.0	10000.0
TAK-715	MP2K4	95.0	10000.0
PHA-767491	SIK3	92.0	10000.0
(s)-CR8	PIP5K1A	85.0	10000.0
Pictilisib	EPHA7	100.0	1000.0
5z-7-oxozeaenol	PCTK3	100.0	10000.0
JNK-9L	IRAK4	100.0	10000.0
ERK5-IN-1	PHKG1	100.0	1000.0
NU7441	IGF1R	97.0	10000.0
BGJ398	FAK1	96.0	1000.0
Buparlisib	MTOR	2.8	1000.0
PD0325901	CAMK2B	100.0	10000.0
Momelotinib	CSNK2A1	52.0	10000.0
MPS-1-IN-1	MRCKA	100.0	1000.0
Torin2	CDC2L5	100.0	10000.0
GW-5074	NLK	56.0	10000.0
XMD11-50	YANK3	100.0	10000.0
R406	FES	2.6	1000.0
XMD-12	SNARK	23.0	1000.0
ALW-II-38-3	CDK8	100.0	10000.0
Ribociclib	MRCKA	100.0	1000.0
Dinaciclib	LIMK2	100.0	10000.0
Lapatinib	MK01	100.0	10000.0
BI-2536	IKKB	100.0	10000.0
QL-XII-47	LIMK1	100.0	1000.0
HG-14-8-02	PKN1	100.0	10000.0
XMD11-50	NEK3	100.0	10000.0
AZD4547	KGP2	35.0	10000.0
TAK-715	CSNK1E	0.1	10000.0
HG-5-113-01	KGP2	25.0	10000.0
Palbociclib	TTK	59.0	1000.0
NVP-TAE684	FLT3	0.1	1000.0
JWE-035	BMPR2	53.0	10000.0
AS-252424	RIPK2	31.8	10000.0
KIN001-123	CIT	100.0	1000.0
ZG-10	ERK8	23.0	10000.0
KIN001-220	CDK9	73.0	10000.0
NU7441	KPCT	100.0	10000.0
BMS345541	NEK3	100.0	10000.0
WZ4002	YES	100.0	10000.0
Seliciclib	MLCK	100.0	10000.0
KIN001-111	ERK3	100.0	1000.0
JNK-9L	AURKB	57.0	10000.0
HG-9-91-01	MKNK2	26.0	10000.0
AZD7762	LRRK2(G2019S)	4.2	10000.0
CG-930	CHEK1	97.0	10000.0
GSK461364	MK11	100.0	10000.0
Barasertib	YSK4	39.0	10000.0
OTSSP167	KIT(V559D,T670I)	9.2	10000.0
PLX-4720	GRK4	100.0	10000.0
JW-7-24-1	RIPK2	28.0	10000.0
JW-7-24-1	SRPK1	100.0	10000.0
WZ-7043	BTK	100.0	10000.0
KIN001-111	MK13	100.0	1000.0
AZD7762	NIM1	13.0	10000.0
JW-7-24-1	LCK	0.8	10000.0
BGJ398	M4K1	55.0	1000.0
XMD11-85h	KPCE	100.0	10000.0
CG-930	ERBB2	52.0	10000.0
HG-5-113-01	RPS6KA4(Kin.Dom.2)	100.0	10000.0
AG1478	SGK1	68.0	10000.0
AZ-628	EGFR(L858R)	48.0	10000.0
CP466722	ICK	47.0	10000.0
TAK-715	TAK1	64.0	10000.0
XMD-12	ABL1(F317I)-phosphorylated	7.4	1000.0
KIN001-220	DDR1	22.0	10000.0
Sorafenib	ACVRL1	77.0	10000.0
WH-4-023	YANK1	8.2	10000.0
Seliciclib	ABL1(Q252H)-phosphorylated	100.0	10000.0
A443654	YES	100.0	10000.0
RO-3306	TEC	92.0	10000.0
Abemaciclib	FLT3(D835H)	39.0	1000.0
(s)-CR8	CIT	92.0	10000.0
Sigma A6730	CSK	93.0	10000.0
JWE-035	DAPK3	79.0	10000.0
AS-252424	CDK11	100.0	10000.0
AZ-628	DAPK3	85.0	10000.0
KIN001-111	MLK1	24.0	1000.0
Baricitinib	ABL1(F317I)-nonphosphorylated	86.0	10000.0
HG-5-113-01	BRSK1	100.0	10000.0
HG-14-10-04	PCTK3	82.0	10000.0
Sigma A6730	MAP3K4	78.0	10000.0
Sigma A6730	BRSK2	88.0	10000.0
AZD-6482	PIK3CG	0.1	10000.0
MLN8054	AURKB	0.3	10000.0
TGX221	RET(V804L)	100.0	1000.0
Lapatinib	MP2K3	94.0	10000.0
KIN001-220	SIK2	20.0	10000.0
THZ1	LTK	0.7	10000.0
Taselisib	RSK1(Kin.Dom.1-N-terminal)	100.0	1000.0
PLX-4720	CSNK2A1	18.0	10000.0
XMD-12	EPHA1	100.0	1000.0
Sigma A6730	FLT3(ITD)	60.0	10000.0
Torin2	PIK3CD	14.0	10000.0
XMD-12	PAK7	87.0	1000.0
JW-7-24-1	DAPK3	100.0	10000.0
GSK429286A	MP2K7	80.0	10000.0
JNK-IN-5A	STK33	86.0	10000.0
WH-4-023	GSK3B	72.0	10000.0
MPS-1-IN-1	ABL1(M351T)	100.0	1000.0
Ribociclib	JAK2(JH1domain-catalytic)	77.0	1000.0
PHA-793887	TAOK3	13.0	10000.0
BMX-IN-1	GSK3B	77.0	10000.0
BMS345541	PLK1	100.0	10000.0
ALW-II-38-3	ULK1	100.0	10000.0
JWE-035	EPHA8	100.0	10000.0
AZD7762	LKB1	4.8	10000.0
CH5424802	PIK3CA(M1043I)	97.0	1000.0
PD173074	RPS6KA1(Kin.Dom.2)	100.0	10000.0
Ibrutinib	FGFR2	46.0	1000.0
SB590885	CDKL3	100.0	10000.0
WZ4003	TYK2(Kin.Dom.1)	100.0	1000.0
R406	IRAK3	0.4	1000.0
Torin1	ERBB3	44.0	10000.0
KIN001-021	HIPK1	100.0	1000.0
NPK76-II-72-1	EGFR(L747-S752del,P753S)	100.0	10000.0
QL-X-138	CDKL3	33.0	10000.0
Taselisib	MAP3K15	100.0	1000.0
HG-9-91-01	CAMKK2	85.0	10000.0
Dactolisib	EPHA7	100.0	1000.0
HG-5-113-01	HCK	11.0	10000.0
WZ4003	RPS6KA6(Kin.Dom.1)	100.0	1000.0
XMD14-99	DYRK1B	42.0	10000.0
CGP60474	CDK9	10.0	10000.0
SCH772984	MST1R	95.0	1000.0
QL-XI-92	AKT2	100.0	10000.0
GSK461364	MST3	81.0	10000.0
Ibrutinib	CAMK1D	84.0	1000.0
QL-X-138	ABL1(F317L)-phosphorylated	83.0	10000.0
HG-5-88-01	AURKC	100.0	10000.0
Omipalisib	ABL1(T315I)-phosphorylated	80.0	10000.0
MLN8054	LYN	25.0	10000.0
Omipalisib	S6K1	53.0	10000.0
PD173074	SNARK	100.0	10000.0
ALW-II-38-3	EPHA6	100.0	10000.0
ZG-10	PAK6	46.0	10000.0
WZ4002	MINK	100.0	10000.0
GSK461364	MLTK	100.0	10000.0
XMD8-85	MST4	100.0	10000.0
PD0325901	LRRK2(G2019S)	100.0	10000.0
XMD16-144	CDK8	100.0	10000.0
GSK461364	PIP5K2B	5.8	10000.0
Ribociclib	VGFR2	100.0	1000.0
KIN001-220	MP2K3	57.0	10000.0
Abemaciclib	KIT(A829P)	100.0	1000.0
Dinaciclib	YES	100.0	10000.0
Taselisib	WNK3	98.0	1000.0
BI-2536	BRAF(V600E)	100.0	10000.0
Seliciclib	TYRO3	100.0	10000.0
PHA-767491	TIE1	68.0	10000.0
Palbociclib	PIK3CA(E545A)	100.0	1000.0
CGP74514A	VGFR2	55.0	10000.0
Barasertib	CDK8	75.0	10000.0
XMD8-85	FES	100.0	10000.0
SP600125	PKAC-alpha	100.0	10000.0
CP724714	CSNK1D	90.0	10000.0
(s)-CR8	TLK2	100.0	10000.0
KU63794	SgK110	98.0	10000.0
CGP60474	CLK3	100.0	10000.0
Torkinib	PAK2	31.0	10000.0
ZM-447439	MINK	33.0	10000.0
KIN001-127	EGFR(G719S)	100.0	10000.0
Palbociclib	FGR	98.0	1000.0
GW843682X	PIM3	63.0	10000.0
WZ-7043	PIM1	100.0	10000.0
Pictilisib	MYLK2	100.0	1000.0
HG-14-8-02	MET	90.0	10000.0
PD0325901	BMPR1A	100.0	10000.0
Pictilisib	SRPK2	90.0	1000.0
Seliciclib	PKAC-alpha	73.0	10000.0
XMD16-144	PIP5K1C	11.0	10000.0
HG-14-8-02	BMPR1B	94.0	10000.0
CG-930	RSK3(Kin.Dom.2-C-terminal)	91.0	10000.0
ZG-10	TRPM6	100.0	10000.0
XMD14-99	DAPK2	86.0	10000.0
Vemurafenib	GSK3B	100.0	10000.0
THZ1	DMPK	0.4	10000.0
Seliciclib	PHKG1	92.0	10000.0
PD0325901	IKKE	100.0	10000.0
JWE-035	TGFBR2	94.0	10000.0
WYE-125132	PIK3CA(H1047L)	15.0	10000.0
JW-7-24-1	KC1G2	100.0	10000.0
JW-7-24-1	YES	32.0	10000.0
WZ3105	FER	74.0	10000.0
TGX221	AMPK-alpha1	100.0	1000.0
Taselisib	STK16	96.0	1000.0
Palbociclib	EPHA2	87.0	1000.0
WH-4-023	KIT(D816H)	44.0	10000.0
JNK-IN-11	M3K5	100.0	1000.0
CH5424802	SRC	56.0	1000.0
Dactolisib	BLK	100.0	1000.0
WYE-125132	ABL1(F317L)-nonphosphorylated	100.0	10000.0
KIN001-123	ERK4	100.0	1000.0
XMD14-99	ERBB3	50.0	10000.0
CH5424802	KPCD1	38.0	1000.0
CGP74514A	RET(V804L)	24.0	10000.0
GW843682X	EPHA2	44.0	10000.0
XMD8-92	GRK4	100.0	10000.0
OTSSP167	MP2K2	0.0	10000.0
Lapatinib	RIPK2	6.1	10000.0
Alpelisib	SNRK	100.0	1000.0
XMD8-85	TTK	26.0	10000.0
BS-181	ACVR2A	92.0	10000.0
Torin1	MAP3K4	47.0	10000.0
NG25	BRSK1	100.0	10000.0
AZD-6482	DCAMKL2	100.0	10000.0
Abemaciclib	TYK2(JH2domain-pseudokinase)	91.0	1000.0
BMS345541	ADCK4	24.0	10000.0
Torkinib	IGF1R	100.0	10000.0
Alpelisib	ALK(C1156Y)	100.0	1000.0
XMD-12	RIOK1	90.0	1000.0
JNK-IN-8	MARK2	77.0	1000.0
CGP74514A	LATS2	5.0	10000.0
Buparlisib	GCN2(Kin.Dom.2,S808G)	55.0	1000.0
NVP-TAE684	JAK1(Kin.Dom.2)	4.7	1000.0
QL-XII-47	TGFBR2	100.0	1000.0
MPS-1-IN-1	RPS6KA3(Kin.Dom.1)	100.0	1000.0
BS-181	JAK3(JH1domain-catalytic)	90.0	10000.0
JWE-035	ICK	80.0	10000.0
OTSSP167	ABL1(T315I)-phosphorylated	1.5	10000.0
Omipalisib	RET	91.0	10000.0
Ceritinib	DYRK2	100.0	1000.0
SCH772984	MARK1	66.0	1000.0
GSK429286A	INSRR	99.0	10000.0
Alpelisib	TAOK2	100.0	1000.0
MLN8054	ANKK1	100.0	10000.0
Torkinib	ERK4	75.0	10000.0
BMX-IN-1	RPS6KA4(Kin.Dom.1-N-terminal)	81.0	10000.0
Pictilisib	TIE1	100.0	1000.0
BS-181	FAK1	55.0	10000.0
HG-5-88-01	MYLK4	100.0	10000.0
JWE-035	CSNK1D	32.0	10000.0
PD173074	RAF1	100.0	10000.0
Alpelisib	DMPK2	100.0	1000.0
ZG-10	ABL1(M351T)-phosphorylated	29.0	10000.0
TGX221	PIM3	100.0	1000.0
PHA-767491	PLK2	16.0	10000.0
MPS-1-IN-1	ERBB2	100.0	1000.0
SB590885	BRAF	0.0	10000.0
ZG-10	EPHA4	100.0	10000.0
KIN001-021	NLK	100.0	1000.0
AZD-6482	NEK11	100.0	10000.0
PLX-4720	MAP4K5	22.0	10000.0
Taselisib	EGFR(L747-E749del,A750P)	87.0	1000.0
Buparlisib	CAMK1G	100.0	1000.0
ZG-10	FLT3(D835H)	28.0	10000.0
Ribociclib	ACVR1	96.0	1000.0
Dactolisib	PGFRB	100.0	1000.0
Buparlisib	CSNK1A1	100.0	1000.0
XMD8-85	JAK3(JH1domain-catalytic)	100.0	10000.0
JWE-035	DMPK2	92.0	10000.0
KIN001-021	MLK1	100.0	1000.0
Torkinib	TTK	9.2	10000.0
Abemaciclib	M3K2	78.0	1000.0
Taselisib	FER	93.0	1000.0
BMX-IN-1	DAPK1	61.0	10000.0
SCH772984	VGFR1	94.0	1000.0
Dactolisib	SRPK3	100.0	1000.0
ERK5-IN-1	EGFR(G719C)	100.0	1000.0
MLN8054	RPS6KA5(Kin.Dom.2-C-terminal)	74.0	10000.0
CGP60474	EPHA2	100.0	10000.0
Torkinib	SNARK	9.2	10000.0
Ibrutinib	TNK2	27.0	1000.0
Torkinib	HIPK3	0.9	10000.0
WZ-7043	SIK2	100.0	10000.0
WYE-125132	RIPK4	98.0	10000.0
CG-930	PKN1	91.0	10000.0
HG-14-8-02	CHEK1	100.0	10000.0
HG-5-88-01	TAOK1	100.0	10000.0
OTSSP167	RPS6KA4(Kin.Dom.1-N-terminal)	1.0	10000.0
JWE-035	PIM1	86.0	10000.0
XMD8-85	TIE1	100.0	10000.0
NPK76-II-72-1	FLT3	100.0	10000.0
GSK461364	RPS6KA4(Kin.Dom.1-N-terminal)	68.0	10000.0
BS-181	BTK	94.0	10000.0
KIN001-220	EGFR(L747-E749del,A750P)	11.0	10000.0
QL-XI-92	RSK1(Kin.Dom.1-N-terminal)	99.0	10000.0
PHA-793887	M4K3	69.0	10000.0
Omipalisib	CDK4-cyclinD1	85.0	10000.0
THZ1	DMPK2	43.0	10000.0
JNK-IN-5A	ERK4	90.0	10000.0
Buparlisib	FES	97.0	1000.0
PD173074	EPHB1	100.0	10000.0
Dinaciclib	LCK	100.0	10000.0
Crizotinib	IKKA	100.0	10000.0
HG-5-113-01	MAP4K4	31.0	10000.0
JWE-035	HIPK4	100.0	10000.0
WZ4002	PTK6	100.0	10000.0
(s)-CR8	FYN	96.0	10000.0
XMD8-85	ULK2	0.5	10000.0
KIN001-021	BMPR1B	100.0	1000.0
TAK-715	KPCL	88.0	10000.0
HG-6-64-01	FAK2	0.8	10000.0
WZ3105	KCC2D	53.0	10000.0
CGP74514A	TLK1	17.0	10000.0
Canertinib	EGFR(L747-E749del,A750P)	0.0	1000.0
Abemaciclib	ABL1(F317I)-phosphorylated	100.0	1000.0
Pictilisib	MK01	98.0	1000.0
WYE-125132	KPCD2	100.0	10000.0
Alpelisib	CSK	100.0	1000.0
THZ1	TRKC	1.0	10000.0
R406	PIP5K1A	4.3	1000.0
AG1478	CSF1R-autoinhibited	91.0	10000.0
Torkinib	FGFR3(G697C)	11.0	10000.0
JNK-IN-8	ABL1(F317L)-phosphorylated	61.0	1000.0
CGP74514A	MST1R	100.0	10000.0
Taselisib	MYLK2	94.0	1000.0
Dactolisib	MP2K4	100.0	1000.0
Taselisib	RPS6KA4(Kin.Dom.1-N-terminal)	88.0	1000.0
MLN8054	DCAMKL3	92.0	10000.0
WZ3105	RIPK4	72.0	10000.0
XMD11-85h	CSNK2A2	100.0	10000.0
KIN001-127	DCAMKL2	100.0	10000.0
Ibrutinib	CAMK2G	81.0	1000.0
RO-3306	CDK11	27.0	10000.0
XMD16-144	FLT3(R834Q)	37.0	10000.0
XMD13-2	MYO3A	72.0	10000.0
PHA-767491	KC1G2	0.8	10000.0
Neratinib	FAK2	90.0	10000.0
MLN8054	PIK3CA(M1043I)	92.0	10000.0
CP466722	LIMK1	22.0	10000.0
PLX-4720	HIPK1	36.0	10000.0
WZ4002	MYO3A	28.0	10000.0
JWE-035	WEE1	91.0	10000.0
Torin1	PIP5K1A	89.0	10000.0
AZD4547	EPHA6	72.0	10000.0
HG-9-91-01	FES	0.8	10000.0
AS-252424	FGR	100.0	10000.0
ZG-10	WEE2	100.0	10000.0
ALW-II-38-3	RET(V804L)	100.0	10000.0
NPK76-II-72-1	CSNK2A1	100.0	10000.0
AZD-6482	CDK7	97.0	10000.0
Buparlisib	DMPK2	100.0	1000.0
OTSSP167	EPHA8	0.1	10000.0
AZ-628	EGFR(L747-E749del,A750P)	11.0	10000.0
PD173074	MAPKAPK2	100.0	10000.0
(s)-CR8	MELK	78.0	10000.0
PHA-767491	YSK1	66.0	10000.0
AS-252424	CDK16	65.7	10000.0
Dactolisib	NUAK1	30.0	1000.0
XMD13-2	M3K6	86.0	10000.0
BMS-536924	TGFBR2	33.0	1000.0
Canertinib	KC1G1	100.0	1000.0
XMD8-92	AKT2	100.0	10000.0
PD173074	ADCK3	100.0	10000.0
XMD8-92	MET	100.0	10000.0
TAK-715	PRKX	100.0	10000.0
HG-5-88-01	ERBB4	0.6	10000.0
Dinaciclib	DAPK1	85.0	10000.0
Sigma A6730	KGP1	88.0	10000.0
MLN8054	EPHB2	50.0	10000.0
JW-7-24-1	TESK1	100.0	10000.0
Torin2	MYO3A	100.0	10000.0
SP600125	M3K12	100.0	10000.0
AG1478	CAMK1	81.0	10000.0
GSK429286A	RSK1(Kin.Dom.2-C-terminal)	83.0	10000.0
Crizotinib	CASK	0.5	10000.0
BX-912	NLK	100.0	10000.0
CP724714	CAMK1G	96.0	10000.0
JNK-IN-11	GRK7	86.0	1000.0
AZD7762	CDK14	100.0	10000.0
WZ-7043	EGFR	100.0	10000.0
AZD-6482	SNRK	89.0	10000.0
Buparlisib	BRAF	85.0	1000.0
WZ-7043	PLK2	100.0	10000.0
XMD11-85h	PTK6	100.0	10000.0
GW843682X	CAMK2G	83.0	10000.0
JNK-9L	DRAK1	49.0	10000.0
XMD16-144	FGFR4	22.0	10000.0
Ibrutinib	ACVR1B	100.0	1000.0
JNK-IN-8	CDK9	100.0	1000.0
GSK1059615	ACVR2A	83.0	10000.0
XMD8-85	MST3	100.0	10000.0
XMD8-92	SNARK	100.0	10000.0
WZ3105	BTK	35.0	10000.0
QL-X-138	EIF2AK1	100.0	10000.0
BGJ398	RPS6KA5(Kin.Dom.1-N-terminal)	82.0	1000.0
Lapatinib	PIK3CG	89.0	10000.0
MLN8054	PKNB(M.tuberculosis)	96.0	10000.0
(s)-CR8	PTK6	90.0	10000.0
KU63794	ULK3	100.0	10000.0
Palbociclib	ROS1	100.0	1000.0
TAK-715	CSNK1A1L	1.3	10000.0
NVP-TAE684	DMPK2	23.0	1000.0
Seliciclib	CDK11	88.0	10000.0
WZ-4-145	KIT(D816V)	7.2	10000.0
Taselisib	KIT-autoinhibited	98.0	1000.0
A443654	STK36	100.0	10000.0
WZ3105	MAP3K3	2.7	10000.0
Crizotinib	SRC	0.6	10000.0
WYE-125132	KPCD1	100.0	10000.0
Sorafenib	DAPK3	88.0	10000.0
XMD13-2	TIE1	31.0	10000.0
WYE-125132	MKNK1	100.0	10000.0
ZSTK474	MK13	100.0	1000.0
MRT67307	KIT(D816V)	0.5	10000.0
GSK429286A	YES	65.0	10000.0
Alpelisib	CDK3	100.0	1000.0
SCH772984	MAST1	81.0	1000.0
AS-252424	PIP5K1A	82.0	10000.0
CGP74514A	M4K3	53.0	10000.0
XMD13-2	M3K13	64.0	10000.0
CG-930	CDK14	100.0	10000.0
PD0325901	MYO3A	47.0	10000.0
BGJ398	RET	71.0	1000.0
SB590885	GRK1	91.0	10000.0
AG1478	KIT(V559D,T670I)	49.0	10000.0
Sorafenib	MYLK	83.0	10000.0
CG-930	SIK3	22.0	10000.0
CGP60474	EPHA8	100.0	10000.0
BI-D1870	M4K3	30.0	10000.0
Torin2	ABL1(Q252H)-phosphorylated	99.0	10000.0
XMD16-144	PIK3CA(H1047L)	16.0	10000.0
SCH772984	EGFR(S752-I759del)	100.0	1000.0
XMD8-85	FGR	100.0	10000.0
Seliciclib	CAMK1D	93.0	10000.0
BMX-IN-1	PIK3CA(H1047Y)	26.0	10000.0
OTSSP167	DYRK1A	0.0	10000.0
Baricitinib	M3K12	87.0	10000.0
HG-6-64-01	PIK3CA(Q546K)	98.0	10000.0
Lapatinib	EGFR(L747-T751del,Sins)	0.5	10000.0
THZ1	MERTK	0.1	10000.0
BI-2536	PKMYT1	100.0	10000.0
GW843682X	DCAMKL3	100.0	10000.0
BMS-536924	FGFR4	1.0	1000.0
Baricitinib	RPS6KA5(Kin.Dom.1-N-terminal)	82.0	10000.0
GSK429286A	MAPKAPK2	100.0	10000.0
PD173074	TESK1	100.0	10000.0
KIN001-111	TNNI3K	0.7	1000.0
MPS-1-IN-1	FGFR1	100.0	1000.0
AS-252424	TNK1	100.0	10000.0
Dabrafenib	TAOK2	9.6	10000.0
MRT67307	BMPR2	3.9	10000.0
Barasertib	PIM2	100.0	10000.0
Neratinib	DAPK3	91.0	10000.0
Palbociclib	MYLK4	100.0	1000.0
XMD14-99	EPHA7	88.0	10000.0
HG-5-113-01	ADCK4	25.0	10000.0
XMD11-85h	PLK4	100.0	10000.0
PHA-793887	ABL1(F317L)-phosphorylated	51.0	10000.0
XMD14-99	FLT3(K663Q)	100.0	10000.0
GSK429286A	EGFR(S752-I759del)	90.0	10000.0
OTSSP167	WEE2	97.0	10000.0
XMD16-144	MP2K3	100.0	10000.0
HG-9-91-01	STK39	50.0	10000.0
Palbociclib	GRK4	91.0	1000.0
Ribociclib	M3K6	100.0	1000.0
Crizotinib	PRKX	94.0	10000.0
Abemaciclib	MK12	100.0	1000.0
GSK1059615	TNIK	36.0	10000.0
CH5424802	FYV1	99.0	1000.0
XMD16-144	AXL	7.0	10000.0
PLX-4720	RSK1(Kin.Dom.1-N-terminal)	71.0	10000.0
PD173074	STK36	100.0	10000.0
KU63794	PKAC-beta	96.0	10000.0
PD0325901	PGFRA	96.0	10000.0
ALW-II-38-3	KIT	0.0	1000.0
XMD-12	KGP1	100.0	1000.0
QL-XI-92	PKAC-alpha	100.0	10000.0
Barasertib	FGFR3(G697C)	100.0	10000.0
Ribociclib	DYRK2	100.0	1000.0
HG-6-64-01	LTK	62.0	10000.0
Palbociclib	ABL1(Q252H)-phosphorylated	100.0	1000.0
AZD7762	KIT(D816H)	7.8	10000.0
Baricitinib	FGFR2	48.0	10000.0
WZ4003	CDKL2	100.0	1000.0
CGP60474	PKAC-beta	100.0	10000.0
XMD8-92	CLK1	100.0	10000.0
Abemaciclib	AMPK-alpha2	82.0	1000.0
AZD7762	MST1	0.4	10000.0
Torin1	IKKE	87.0	10000.0
PLX-4720	PHKG1	100.0	10000.0
NU7441	PIM3	65.0	10000.0
BMS345541	MK09	44.0	10000.0
BS-181	ACVR1	100.0	10000.0
AG1478	ABL1(M351T)-phosphorylated	1.4	10000.0
QL-XI-92	PAK3	100.0	10000.0
Alpelisib	DRAK2	85.0	1000.0
BX-912	PFPK5(P.falciparum)	100.0	10000.0
PD0325901	VGFR2	84.0	10000.0
PHA-793887	AURKB	77.0	10000.0
KIN001-123	ABL1(T315I)	0.8	1000.0
PD173074	PHKG1	100.0	10000.0
WZ4003	EGFR(L747-S752del,P753S)	14.0	1000.0
PD0325901	EGFR(L858R)	79.0	10000.0
Sorafenib	GCN2(Kin.Dom.2,S808G)	77.0	10000.0
PHA-767491	SRPK1	74.0	10000.0
Ribociclib	SNARK	47.0	1000.0
Palbociclib	PLK2	100.0	1000.0
CGP60474	TAOK3	100.0	10000.0
Lapatinib	CDK16	90.0	10000.0
QL-XI-92	ACVR2A	100.0	10000.0
CG-930	KIT(V559D,V654A)	68.0	10000.0
WZ4003	AKT3	100.0	1000.0
XMD11-85h	BMPR2	100.0	10000.0
Alpelisib	VGFR2	100.0	1000.0
Sigma A6730	SRPK2	85.0	10000.0
Torin2	MARK3	100.0	10000.0
Momelotinib	PIK3CA(H1047L)	100.0	10000.0
CH5424802	MARK1	92.0	1000.0
BMX-IN-1	ADCK4	64.0	10000.0
AZD-6482	TTK	100.0	10000.0
Momelotinib	PIK3CA(I800L)	88.0	10000.0
Palbociclib	TRPM6	100.0	1000.0
Torkinib	AKT3	29.0	10000.0
5z-7-oxozeaenol	SRPK3	47.0	10000.0
KU63794	SRPK3	75.0	10000.0
JNK-IN-11	PFCDPK1(P.falciparum)	0.6	1000.0
ERK5-IN-1	YANK2	100.0	1000.0
JW-7-24-1	FER	100.0	10000.0
CGP74514A	PAK1	40.0	10000.0
BMS-536924	TESK1	26.0	1000.0
HG-14-10-04	MLTK	100.0	10000.0
HG-5-113-01	PIP5K1A	4.6	10000.0
AZD4547	KPCD1	92.0	10000.0
GW843682X	LIMK2	74.0	10000.0
JNK-IN-5A	FGFR2	100.0	10000.0
XMD-12	ERK5	0.3	1000.0
ZG-10	HIPK2	2.6	10000.0
XMD8-85	CSNK1A1L	100.0	10000.0
GW843682X	CLK3	83.0	10000.0
5z-7-oxozeaenol	CIT	87.0	10000.0
SP600125	MYLK	0.7	10000.0
Momelotinib	CSNK1A1L	100.0	10000.0
HG-5-113-01	CDK2	100.0	10000.0
HG-5-113-01	KPCD1	100.0	10000.0
ZM-447439	DYRK1B	96.0	10000.0
GW843682X	EPHB6	9.9	10000.0
XMD-12	TRKB	36.0	1000.0
NU7441	PLK1	94.0	10000.0
XMD8-85	PLK4	6.8	10000.0
CGP74514A	AKT3	100.0	10000.0
CGP74514A	PIK3CA(Q546K)	90.0	10000.0
HG-14-10-04	EPHB1	35.0	10000.0
JNK-9L	EGFR(L861Q)	92.0	10000.0
CG-930	KGP2	100.0	10000.0
Dinaciclib	CSNK2A1	90.0	10000.0
Ribociclib	LRRK2	100.0	1000.0
GSK461364	KCC4	100.0	10000.0
AZ-628	MLK2	100.0	10000.0
Pictilisib	DAPK2	100.0	1000.0
BMS345541	KIT(V559D,V654A)	100.0	10000.0
KIN001-111	TAOK1	100.0	1000.0
HG-9-91-01	KGP2	100.0	10000.0
CP724714	BMX	73.0	10000.0
AZD-6482	ABL1(F317L)-phosphorylated	89.0	10000.0
HG-9-91-01	PRKR	100.0	10000.0
Torin1	MARK3	100.0	10000.0
KIN001-220	EPHA3	62.0	10000.0
TGX221	CDK3	100.0	1000.0
XMD8-85	EGFR(E746-A750del)	100.0	10000.0
Baricitinib	FLT4	72.0	10000.0
SP600125	JAK1(Kin.Dom.1)	100.0	10000.0
AG1478	TAOK1	38.0	10000.0
NPK76-II-72-1	KKCC1	100.0	10000.0
AZD 5438	CHEK1	100.0	10000.0
MLN8054	TLK2	83.0	10000.0
CG-930	TRKA	75.0	10000.0
Lapatinib	FAK1	100.0	10000.0
Alpelisib	CDK8	100.0	1000.0
A443654	BIKE	1.2	10000.0
AG1478	EGFR(L747-E749del,A750P)	1.4	10000.0
XMD-12	ANKK1	100.0	1000.0
KIN001-021	CAMKK2	100.0	1000.0
Torkinib	ULK3	65.0	10000.0
BX-912	NIM1	0.1	10000.0
Taselisib	LKB1	100.0	1000.0
JNK-9L	PAK4	31.0	10000.0
Crizotinib	RET(V804M)	32.0	10000.0
CP724714	FGR	89.0	10000.0
XMD11-85h	CAMK2A	100.0	10000.0
HG-14-10-04	ROCK2	3.4	10000.0
NPK76-II-72-1	CLK1	18.0	10000.0
HG-5-88-01	KIT	100.0	10000.0
Abemaciclib	MP2K7	100.0	1000.0
JNK-IN-11	PIM2	100.0	1000.0
CH5424802	STK36	96.0	1000.0
CGP60474	CHK2	100.0	10000.0
BS-181	PIK3C2G	98.0	10000.0
TAK-715	MKNK1	100.0	10000.0
JNK-9L	PDPK1	100.0	10000.0
ZM-447439	GRK7	71.0	10000.0
JNK-9L	JAK1(JH1domain-catalytic)	59.0	10000.0
ZSTK474	CDC2L1	100.0	1000.0
PD0325901	RSK4(Kin.Dom.1-N-terminal)	75.0	10000.0
GW843682X	MK11	88.0	10000.0
WZ4003	FLT3(K663Q)	1.2	1000.0
AZD-6482	MAP4K4	97.0	10000.0
MPS-1-IN-1	CDK3	100.0	1000.0
KIN001-127	BMPR1A	100.0	10000.0
Torin2	FAK2	86.0	10000.0
JNK-IN-5A	ABL1(T315I)-nonphosphorylated	82.0	10000.0
JNK-IN-5A	YANK1	81.0	10000.0
NG25	RET(V804L)	0.9	10000.0
MRT67307	SRPK1	12.0	10000.0
BGJ398	ROCK1	69.0	1000.0
KU63794	PIK3CA	2.5	10000.0
XMD11-85h	KPCL	100.0	10000.0
Taselisib	DYRK1B	84.0	1000.0
XMD16-144	MST4	31.0	10000.0
THZ1	HIPK1	4.2	10000.0
Ribociclib	JAK1(JH2domain-pseudokinase)	100.0	1000.0
KIN001-123	EPHA2	100.0	1000.0
AS-252424	PAK3	100.0	10000.0
NVP-TAE684	ROS1	0.5	1000.0
XMD8-92	SIK1	100.0	10000.0
XMD11-85h	TRKB	100.0	10000.0
JNK-IN-5A	RSK2(Kin.Dom.1-N-terminal)	100.0	10000.0
AZD4547	KPCI	39.0	10000.0
SCH772984	PIK3CA(I800L)	95.0	1000.0
KU63794	MK12	100.0	10000.0
RO-3306	CDK3	52.0	10000.0
PD173074	MARK4	100.0	10000.0
KIN001-220	KPCT	74.0	10000.0
Ceritinib	TESK1	85.0	1000.0
ERK5-IN-1	TSSK1	100.0	1000.0
Baricitinib	SIK2	36.0	10000.0
MPS-1-IN-1	PGFRA	100.0	1000.0
MPS-1-IN-1	STK33	12.0	1000.0
PD173074	PAK2	100.0	10000.0
KIN001-127	RPS6KA2(Kin.Dom.2)	100.0	10000.0
HG-5-88-01	EPHA6	100.0	10000.0
KU63794	ERBB4	89.0	10000.0
NVP-TAE684	CHK2	0.0	1000.0
Ibrutinib	NEK9	88.0	1000.0
Ribociclib	MP2K1	88.0	1000.0
HG-9-91-01	M3K12	25.0	10000.0
TAK-715	CDC2L1	88.0	10000.0
PHA-793887	CDKL5	0.1	10000.0
Dactolisib	LYN	100.0	1000.0
HG-9-91-01	ABL1-nonphosphorylated	0.0	10000.0
GW-5074	TRKB	55.0	10000.0
GW843682X	TRKB	59.0	10000.0
CG-930	FER	100.0	10000.0
XMD-12	KIT	66.0	1000.0
JNK-9L	PTK6	100.0	10000.0
PHA-767491	VRK2	84.0	10000.0
CH5424802	RET	0.0	1000.0
MPS-1-IN-1	ABL1	100.0	1000.0
QL-X-138	MTOR	0.0	10000.0
AZD7762	TYRO3	3.2	10000.0
AZD4547	AXL	0.7	10000.0
JNK-9L	JAK1(JH2domain-pseudokinase)	1.0	10000.0
HG-9-91-01	ALK(C1156Y)	7.6	10000.0
SP600125	ERK4	100.0	10000.0
Ceritinib	FLT4	87.0	1000.0
BI-2536	EPHA7	100.0	10000.0
Sorafenib	ZAP70	100.0	10000.0
JNK-IN-5A	BRSK1	100.0	10000.0
HG-6-64-01	MAP4K4	4.2	10000.0
HG-9-91-01	KPCE	7.0	10000.0
HG-14-10-04	PAK7	0.2	10000.0
Ceritinib	YANK3	39.0	1000.0
AZD7762	EPHA6	8.2	10000.0
ZG-10	RSK2(Kin.Dom.1-N-terminal)	62.0	10000.0
Pictilisib	CLK3	100.0	1000.0
SCH772984	PLK2	63.0	1000.0
Ribociclib	STK33	95.0	1000.0
Omipalisib	CDK11	12.0	10000.0
MRT67307	MLCK	36.0	10000.0
Torkinib	M4K3	52.0	10000.0
Palbociclib	TRKA	30.0	1000.0
AZD4547	DMPK2	50.0	10000.0
Torin2	SNARK	46.0	10000.0
JNK-IN-11	ERK4	94.0	1000.0
KIN001-021	JAK2(Kin.Dom.2)	100.0	1000.0
WYE-125132	KIT(D816H)	86.0	10000.0
WYE-125132	FES	100.0	10000.0
AS-252424	DRAK2	3.3	10000.0
Palbociclib	ACVR2A	100.0	1000.0
XMD16-144	BRSK2	4.2	10000.0
ZM-447439	STK16	100.0	10000.0
RO-3306	PKNB(M.tuberculosis)	39.0	10000.0
ZSTK474	MAP4K2	100.0	1000.0
WYE-125132	CDKL5	79.0	10000.0
Baricitinib	PIM3	100.0	10000.0
ZG-10	EIF2AK1	100.0	10000.0
NG25	NEK1	100.0	10000.0
TAK-715	EPHA8	89.0	10000.0
A443654	TNIK	3.2	10000.0
GSK429286A	FLT4	94.0	10000.0
PLX-4720	M4K1	70.0	10000.0
R406	PRKX	100.0	1000.0
HG-9-91-01	DAPK2	99.0	10000.0
Vemurafenib	RIPK2	4.3	10000.0
Ibrutinib	WNK3	55.0	1000.0
HG-14-8-02	TRKB	99.0	10000.0
Ribociclib	MARK1	89.0	1000.0
BMX-IN-1	NEK2	85.0	10000.0
AS-252424	RSK2(Kin.Dom.1-N-terminal)	100.0	10000.0
JNK-IN-8	IRAK3	85.0	1000.0
GW843682X	MKNK1	88.0	10000.0
WZ-4-145	PRKX	100.0	10000.0
BGJ398	AURKB	95.0	1000.0
MLN8054	STK35	87.0	10000.0
AZD 5438	MAK	0.7	10000.0
GW-5074	LATS1	44.0	10000.0
AZD 5438	ALK(C1156Y)	67.0	10000.0
PD173074	MP2K2	100.0	10000.0
Crizotinib	JAK1(JH1domain-catalytic)	0.5	10000.0
NU7441	MP2K1	76.0	10000.0
ZSTK474	ADCK3	100.0	1000.0
JW-7-24-1	TSSK1	100.0	10000.0
WZ3105	EGFR(T790M)	68.0	10000.0
SCH772984	KIT	80.0	1000.0
RO-3306	KGP1	77.0	10000.0
KIN001-220	INSRR	63.0	10000.0
GSK429286A	ABL1(M351T)-phosphorylated	82.0	10000.0
XMD-12	TYRO3	100.0	1000.0
HG-5-88-01	SLK	2.6	10000.0
WZ3105	PIK3CA(C420R)	89.0	10000.0
AZD7762	PKNB(M.tuberculosis)	0.0	10000.0
BMX-IN-1	KIT(V559D)	88.0	10000.0
JNK-IN-8	CDK7	39.0	1000.0
KIN001-111	FLT3(K663Q)	100.0	1000.0
HG-5-88-01	PCTK2	100.0	10000.0
RO-3306	RAF1	89.0	10000.0
BI-2536	GAK	1.6	10000.0
ERK5-IN-1	TRKB	100.0	1000.0
Pictilisib	FGFR4	100.0	1000.0
Crizotinib	MST1	3.9	10000.0
Ibrutinib	DRAK1	100.0	1000.0
BMS-536924	EPHB3	100.0	1000.0
Canertinib	MP2K4	100.0	1000.0
PD0325901	MST1R	78.0	10000.0
NVP-TAE684	MKNK1	100.0	1000.0
Neratinib	KIT(L576P)	94.0	10000.0
NPK76-II-72-1	ERK3	100.0	10000.0
XMD8-85	TRKB	100.0	10000.0
Baricitinib	MST1R	100.0	10000.0
MPS-1-IN-1	KIT(V559D)	100.0	1000.0
MRT67307	CSNK1A1L	87.0	10000.0
BMS345541	ALK	100.0	10000.0
GSK429286A	AAK1	70.0	10000.0
KU63794	MP2K3	94.0	10000.0
QL-XI-92	SGK3	100.0	10000.0
Ibrutinib	TSSK1	82.0	1000.0
Dinaciclib	M3K12	97.0	10000.0
GSK429286A	JNK1	85.0	10000.0
Lapatinib	M3K13	100.0	10000.0
Torin1	GCN2(Kin.Dom.2,S808G)	99.0	10000.0
XMD-12	CDK8	100.0	1000.0
QL-X-138	FLT3(D835Y)	1.2	10000.0
BS-181	DDR1	100.0	10000.0
Vemurafenib	LTK	100.0	10000.0
Alpelisib	CDK7	100.0	1000.0
CGP60474	PAK1	100.0	10000.0
QL-X-138	CDK9	100.0	10000.0
ZSTK474	SIK2	100.0	1000.0
XMD16-144	PLK2	37.0	10000.0
Sigma A6730	ABL1(T315I)-nonphosphorylated	100.0	10000.0
ALW-II-49-7	MAP4K5	100.0	10000.0
SCH772984	ULK1	94.0	1000.0
AZD4547	PAK3	20.0	10000.0
ZM-447439	RSK2(Kin.Dom.1-N-terminal)	66.0	10000.0
QL-XII-47	CSNK1A1	97.0	1000.0
GSK461364	MAK	100.0	10000.0
GSK429286A	TGFBR1	100.0	10000.0
PD173074	BTK	100.0	10000.0
HG-9-91-01	EGFR(E746-A750del)	1.6	10000.0
WZ3105	TYRO3	100.0	10000.0
Seliciclib	FGFR3	100.0	10000.0
NU7441	CDKL5	100.0	10000.0
THZ1	AXL	0.5	10000.0
AZ-628	CHEK1	84.0	10000.0
XMD8-92	CDK14	100.0	10000.0
Palbociclib	PRKX	100.0	1000.0
Torin1	ABL1(H396P)-nonphosphorylated	68.0	10000.0
Dabrafenib	PIK3CA(H1047L)	94.0	10000.0
JWE-035	NEK4	80.0	10000.0
MPS-1-IN-1	CDK11	100.0	1000.0
Dinaciclib	MYO3B	67.0	10000.0
WZ4003	PKAC-beta	100.0	1000.0
JNK-IN-5A	RIOK2	91.0	10000.0
JNK-IN-8	MP2K7	59.0	1000.0
Alpelisib	BRSK2	89.0	1000.0
GW843682X	PIK3CA	77.0	10000.0
PHA-793887	PIK3C2B	99.0	10000.0
R406	FLT3	0.0	1000.0
Seliciclib	ULK3	86.0	10000.0
SB590885	ABL2	55.0	10000.0
XMD14-99	MK13	63.0	10000.0
ZG-10	KPCI	100.0	10000.0
GSK1059615	KIT(V559D)	30.0	10000.0
BMS345541	SNARK	100.0	10000.0
TAK-715	TGFBR2	82.0	10000.0
Omipalisib	KCC2D	90.0	10000.0
WYE-125132	MK13	16.0	10000.0
BMX-IN-1	ALK	100.0	10000.0
BMX-IN-1	ERBB2	26.0	10000.0
Alpelisib	CDC2L5	100.0	1000.0
CH5424802	MLK2	100.0	1000.0
KIN001-111	FES	2.4	1000.0
KIN001-220	JAK2(JH1domain-catalytic)	76.0	10000.0
AZD4547	SRMS	81.0	10000.0
Dinaciclib	SIK3	98.0	10000.0
Seliciclib	MAPKAPK5	100.0	10000.0
ZM-447439	HIPK4	4.9	10000.0
JNK-IN-5A	DDR1	71.0	10000.0
ALW-II-38-3	CDK16	100.0	10000.0
KIN001-127	MAP4K2	100.0	10000.0
CH5424802	M3K6	66.0	1000.0
JNK-IN-8	M3K2	100.0	1000.0
GSK429286A	KCC4	100.0	10000.0
TAK-715	KPCD	50.0	10000.0
BMX-IN-1	LIMK2	100.0	10000.0
GSK429286A	SgK110	59.0	10000.0
JNK-IN-8	YES	86.0	1000.0
JW-7-24-1	SRMS	100.0	10000.0
Taselisib	RIOK3	95.0	1000.0
KIN001-220	CDK4-cyclinD3	21.0	10000.0
Barasertib	MAP3K3	70.0	10000.0
XMD8-92	M3K6	100.0	10000.0
NG25	MAPKAPK2	100.0	10000.0
QL-XII-47	PIP5K1A	82.0	1000.0
NVP-TAE684	FLT3(K663Q)	0.3	1000.0
KIN001-021	LATS2	100.0	1000.0
XMD11-50	JAK2(JH1domain-catalytic)	70.0	10000.0
MRT67307	DCLK1	4.7	10000.0
Torin1	YANK2	87.0	10000.0
KIN001-021	KPCD2	100.0	1000.0
Vemurafenib	YANK1	100.0	10000.0
A443654	RET(M918T)	100.0	10000.0
Seliciclib	CIT	94.0	10000.0
Lapatinib	FLT4	100.0	10000.0
Vemurafenib	KGP1	100.0	10000.0
Ribociclib	TIE1	85.0	1000.0
BMX-IN-1	ABL1(F317L)-nonphosphorylated	75.0	10000.0
KU63794	DYRK1B	85.0	10000.0
XMD8-92	EPHB4	100.0	10000.0
Momelotinib	SIK1	62.0	10000.0
JWE-035	TNK2	24.0	10000.0
BMX-IN-1	TLK2	100.0	10000.0
SP600125	PIM2	100.0	10000.0
PLX-4720	CAMK1	14.0	10000.0
HG-5-88-01	MINK	100.0	10000.0
MLN8054	DYRK2	92.0	10000.0
JWE-035	CDKL2	80.0	10000.0
BI-D1870	NEK1	24.0	10000.0
JNK-IN-8	S6K1	100.0	1000.0
MLN8054	FRK	73.0	10000.0
KIN001-220	DAPK3	5.2	10000.0
XMD11-50	TRKA	69.0	10000.0
5z-7-oxozeaenol	CDK7	100.0	10000.0
XMD-12	CDKL5	100.0	1000.0
SP600125	MYLK4	0.3	10000.0
AZD 5438	EGFR(G719C)	61.0	10000.0
BX-912	NEK4	9.4	10000.0
CP724714	NEK11	100.0	10000.0
SB590885	CSNK1A1	38.0	10000.0
Lapatinib	ADCK4	76.0	10000.0
PD0325901	CLK4	89.0	10000.0
Torkinib	PLK4	2.6	10000.0
ERK5-IN-1	EPHB1	95.0	1000.0
AZD-6482	SYK	100.0	10000.0
Momelotinib	AURKC	18.0	10000.0
XMD14-99	MRCKB	100.0	10000.0
SCH772984	CDK15	100.0	1000.0
ERK5-IN-1	CAMK1D	61.0	1000.0
XMD8-85	RET(M918T)	100.0	10000.0
R406	GCN2(Kin.Dom.2,S808G)	0.2	1000.0
WH-4-023	YANK2	1.1	10000.0
CGP60474	RET(V804M)	100.0	10000.0
JW-7-24-1	KPCE	1.4	10000.0
Dabrafenib	EPHA2	91.0	10000.0
PHA-767491	CLK4	0.4	10000.0
WZ-7043	PIK3C2G	100.0	10000.0
Palbociclib	HUNK	100.0	1000.0
HG-6-64-01	MST1R	100.0	10000.0
BMX-IN-1	PKAC-beta	100.0	10000.0
HG-6-64-01	NDR2	35.0	10000.0
JW-7-24-1	ROCK2	100.0	10000.0
GW843682X	EGFR(L747-T751del,Sins)	100.0	10000.0
AZD 5438	CDK2	0.1	10000.0
AG1478	RIPK2	19.0	10000.0
KIN001-111	TSSK1	100.0	1000.0
ALW-II-49-7	DCAMKL3	100.0	10000.0
CGP74514A	RPS6KA5(Kin.Dom.2-C-terminal)	93.0	10000.0
BS-181	SgK110	100.0	10000.0
WZ4003	EPHA1	100.0	1000.0
HG-14-8-02	PFCDPK1(P.falciparum)	78.0	10000.0
Alpelisib	ICK	100.0	1000.0
XMD13-2	KGP1	100.0	10000.0
JNK-IN-5A	FAK2	79.0	10000.0
WZ-7043	M3K5	100.0	10000.0
Canertinib	ACVR2A	100.0	1000.0
WZ4003	FLT3(N841I)	0.1	1000.0
Sigma A6730	TRKA	100.0	10000.0
WZ-7043	PIP5K1A	100.0	10000.0
GSK429286A	PAK2	88.0	10000.0
WH-4-023	CIT	3.8	10000.0
OTSSP167	SRPK3	87.0	10000.0
JWE-035	JAK3(JH1domain-catalytic)	9.8	10000.0
GSK429286A	EPHB3	84.0	10000.0
ZSTK474	FYN	100.0	1000.0
HG-5-88-01	FGFR3	100.0	10000.0
BGJ398	MLK1	83.0	1000.0
THZ1	ZAP70	31.0	10000.0
Dinaciclib	KIT(L576P)	72.0	10000.0
JNK-9L	MARK4	78.0	10000.0
Barasertib	JAK1(JH2domain-pseudokinase)	100.0	10000.0
Torin2	DDR1	100.0	10000.0
WYE-125132	PIK3CA(E542K)	14.0	10000.0
R406	MLK2	0.0	1000.0
QL-XI-92	MK12	96.0	10000.0
AZD7762	S6K1	6.4	10000.0
SP600125	STK16	1.4	10000.0
Momelotinib	LTK	100.0	10000.0
XMD-12	RET(M918T)	4.2	1000.0
QL-XI-92	MYO3A	93.0	10000.0
MRT67307	PIK3CA	100.0	10000.0
XMD8-85	AURKA	100.0	10000.0
CG-930	RAF1	100.0	10000.0
OTSSP167	KPCE	3.7	10000.0
MRT67307	GRK1	78.0	10000.0
CP724714	MAPKAPK2	100.0	10000.0
XMD-12	EGFR(L858R,T790M)	100.0	1000.0
Dabrafenib	PI42C	27.0	10000.0
BI-2536	JNK3	100.0	10000.0
XMD11-50	PIK3CA(E542K)	77.0	10000.0
XMD11-50	FGFR3(G697C)	85.0	10000.0
Sigma A6730	TSSK1	82.0	10000.0
Vemurafenib	NEK2	71.0	10000.0
(s)-CR8	PIK3CA(M1043I)	77.0	10000.0
KIN001-111	MLK3	35.0	1000.0
KU63794	PKN2	100.0	10000.0
Sigma A6730	PIM3	100.0	10000.0
RO-3306	TESK1	85.0	10000.0
GSK429286A	BMPR1B	17.0	10000.0
XMD16-144	ERBB4	100.0	10000.0
Pictilisib	PAK4	100.0	1000.0
JNK-IN-8	TNIK	56.0	1000.0
TAK-715	KIT(A829P)	100.0	10000.0
BI-2536	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
ALW-II-38-3	CAMK2A	100.0	10000.0
AG1478	CSNK1E	32.0	10000.0
Buparlisib	PIK3CA(I800L)	0.0	1000.0
AG1478	ABL1(T315I)-nonphosphorylated	12.0	10000.0
MLN8054	SRPK3	100.0	10000.0
BI-D1870	MLTK	26.0	10000.0
AZD 5438	HIPK4	9.5	10000.0
NPK76-II-72-1	PIK3CG	100.0	10000.0
MPS-1-IN-1	TNIK	100.0	1000.0
Crizotinib	M3K12	9.0	10000.0
XMD8-92	PIK3CA(H1047L)	100.0	10000.0
GSK1059615	ACVR1B	51.0	10000.0
XMD-12	PCTK2	90.0	1000.0
XMD13-2	CDK16	5.0	10000.0
XMD8-92	SRMS	100.0	10000.0
Seliciclib	EGFR(L858R)	74.0	10000.0
WH-4-023	FLT3(ITD)	4.8	10000.0
HG-5-88-01	ABL1(H396P)	100.0	10000.0
JNK-IN-11	PHKG1	100.0	1000.0
AG1478	AKT1	100.0	10000.0
Torin1	FGFR3(G697C)	52.0	10000.0
ALW-II-49-7	EGFR	100.0	10000.0
AZD7762	CAMKK2	2.9	10000.0
Momelotinib	S6K1	100.0	10000.0
AZ-628	MRCKB	100.0	10000.0
(s)-CR8	ACVR2B	99.0	10000.0
KIN001-220	ICK	100.0	10000.0
WH-4-023	PCTK2	80.0	10000.0
PHA-767491	EPHA2	100.0	10000.0
XMD13-2	TLK2	79.0	10000.0
JW-7-24-1	TLK1	100.0	10000.0
WYE-125132	MARK1	100.0	10000.0
PD173074	CAMK2A	100.0	10000.0
Neratinib	MET	84.0	10000.0
XMD8-85	IRAK1	100.0	10000.0
AG1478	HIPK1	48.0	10000.0
XMD16-144	MK01	100.0	10000.0
Torin2	FLT3	12.0	10000.0
GSK1059615	FLT4	98.0	10000.0
NG25	YANK3	100.0	10000.0
GSK461364	MST1	100.0	10000.0
BX-912	SGK3	91.0	10000.0
PHA-793887	IRAK1	93.0	10000.0
5z-7-oxozeaenol	JAK3(JH1domain-catalytic)	77.0	10000.0
XMD-12	MP2K4	74.0	1000.0
PHA-767491	HIPK4	2.3	10000.0
NU7441	AKT2	51.0	10000.0
BS-181	INSR	53.0	10000.0
SCH772984	MP2K1	100.0	1000.0
KIN001-123	RPS6KA5(Kin.Dom.2)	100.0	1000.0
GW-5074	S6K1	81.0	10000.0
GSK429286A	PKNB(M.tuberculosis)	92.0	10000.0
KIN001-220	PCTK3	43.0	10000.0
Omipalisib	TLK2	95.0	10000.0
Sorafenib	AKT2	70.0	10000.0
BGJ398	SYK	81.0	1000.0
Canertinib	MARK4	100.0	1000.0
Lapatinib	EPHB1	100.0	10000.0
WZ3105	PLK3	100.0	10000.0
AZD7762	MAK	100.0	10000.0
BGJ398	YSK4	76.0	1000.0
QL-XII-47	PKMYT1	93.0	1000.0
OTSSP167	ABL2	0.2	10000.0
JNK-IN-8	MLK2	87.0	1000.0
CG-930	BIKE	100.0	10000.0
ZM-447439	MK14	100.0	10000.0
TAK-715	FLT3(D835Y)	67.0	10000.0
KU63794	EGFR(L858R)	100.0	10000.0
HG-6-64-01	TXK	0.7	10000.0
Lapatinib	FLT3(K663Q)	94.0	10000.0
HG-9-91-01	MP2K1	21.0	10000.0
BGJ398	MST2	100.0	1000.0
AZ-628	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
CP724714	TIE1	100.0	10000.0
CGP74514A	PIK3CB	60.0	10000.0
AZD-6482	CHEK1	100.0	10000.0
5z-7-oxozeaenol	AURKB	100.0	10000.0
NPK76-II-72-1	KPCD2	100.0	10000.0
GSK461364	PAK4	37.0	10000.0
CG-930	IGF1R	90.0	10000.0
RO-3306	EGFR(L858R,T790M)	89.0	10000.0
GSK1059615	DYRK2	5.4	10000.0
Neratinib	ABL1(T315I)-nonphosphorylated	90.0	10000.0
Momelotinib	SYK	32.0	10000.0
KIN001-111	PIK3C2B	100.0	1000.0
BX-912	PKAC-alpha	1.0	10000.0
XMD-12	FGFR1	61.0	1000.0
Barasertib	ERK4	100.0	10000.0
XMD13-2	EPHB3	100.0	10000.0
KIN001-220	NIM1	79.0	10000.0
XMD8-92	CSF1R	100.0	10000.0
HG-14-10-04	TYK2(JH2domain-pseudokinase)	53.0	10000.0
GW843682X	MLK2	98.0	10000.0
HG-6-64-01	TNK2	0.8	10000.0
PLX-4720	BTK	52.0	10000.0
BMS345541	FGFR2	100.0	10000.0
CH5424802	M3K13	91.0	1000.0
Ribociclib	TNK2	100.0	1000.0
Crizotinib	TAK1	8.2	10000.0
CGP60474	CSNK1E	100.0	10000.0
RO-3306	CDC2L1	97.0	10000.0
Sigma A6730	PAK7	58.0	10000.0
AS-252424	EPHB4	100.0	10000.0
Ceritinib	TLK2	98.0	1000.0
KIN001-123	ZAP70	100.0	1000.0
Pictilisib	HUNK	100.0	1000.0
ALW-II-38-3	EPHA4	3.4	1000.0
XMD8-92	TRKC	100.0	10000.0
ZSTK474	MST2	100.0	1000.0
Buparlisib	PIK3CA(H1047Y)	4.6	1000.0
WZ-7043	FGFR2	2.6	10000.0
KU63794	CSF1R	90.0	10000.0
JWE-035	PAK4	80.0	10000.0
BMS345541	MYO3B	100.0	10000.0
HG-14-8-02	AAK1	14.0	10000.0
BX-912	PGFRA	0.1	10000.0
NPK76-II-72-1	MYO3B	100.0	10000.0
GSK1059615	MARK2	74.0	10000.0
BGJ398	GRK1	49.0	1000.0
Seliciclib	NEK4	96.0	10000.0
NVP-TAE684	JNK1	5.2	1000.0
XMD16-144	ERK5	0.1	10000.0
PD173074	MAP3K4	100.0	10000.0
XMD14-99	RIPK2	70.0	10000.0
Palbociclib	RET(M918T)	100.0	1000.0
Alpelisib	MYO3A	99.0	1000.0
BX-912	IKKE	4.6	10000.0
ZG-10	TNK1	20.0	10000.0
TAK-715	PIK3CA(C420R)	72.0	10000.0
Barasertib	RSK4(Kin.Dom.1-N-terminal)	74.0	10000.0
Ibrutinib	ROCK1	98.0	1000.0
GSK429286A	CDK5	80.0	10000.0
NU7441	FLT3(K663Q)	86.0	10000.0
KU63794	CHEK1	99.0	10000.0
CGP60474	RPS6KA2(Kin.Dom.2)	100.0	10000.0
RO-3306	RET(V804M)	83.0	10000.0
Ribociclib	ABL1-nonphosphorylated	83.0	1000.0
Sigma A6730	ABL1(H396P)-nonphosphorylated	93.0	10000.0
ZM-447439	EGFR(L747-E749del,A750P)	22.0	10000.0
HG-9-91-01	BLK	0.1	10000.0
MRT67307	CDK9	100.0	10000.0
SP600125	CSF1R	100.0	10000.0
WZ3105	IRAK4	2.5	10000.0
CP724714	ZAP70	100.0	10000.0
BMS345541	PRKX	86.0	10000.0
XMD8-85	ABL1(F317I)	5.0	10000.0
GW843682X	MARK1	82.0	10000.0
ZSTK474	RPS6KA2(Kin.Dom.2)	100.0	1000.0
Lapatinib	RSK3(Kin.Dom.1-N-terminal)	72.0	10000.0
WZ-4-145	KCC2D	100.0	10000.0
TAK-715	GAK	4.4	10000.0
PD0325901	YANK3	100.0	10000.0
A443654	EGFR(L747-T751del,Sins)	100.0	10000.0
MLN8054	CAMKK2	72.0	10000.0
HG-14-8-02	EGFR(G719S)	0.0	10000.0
WZ-4-145	MLTK	100.0	10000.0
JNK-IN-11	ABL1-nonphosphorylated	11.0	1000.0
TGX221	MAP3K3	100.0	1000.0
5z-7-oxozeaenol	GRK4	42.0	10000.0
Omipalisib	MYO3A	100.0	10000.0
THZ1	GSK3B	14.0	10000.0
CGP74514A	MAP3K4	83.0	10000.0
KU63794	PIK3CA(H1047L)	26.0	10000.0
HG-9-91-01	PAK4	35.0	10000.0
BMS-536924	AURKB	1.2	1000.0
JNK-IN-11	EGFR(T790M)	11.0	1000.0
Torin1	ABL1(Q252H)-phosphorylated	99.0	10000.0
AZD7762	CAMK1G	6.2	10000.0
AZD7762	TIE1	7.2	10000.0
ERK5-IN-1	FAK1	57.0	1000.0
BX-912	KKCC1	8.8	10000.0
XMD8-92	MYLK	100.0	10000.0
Momelotinib	RSK2(Kin.Dom.2-C-terminal)	100.0	10000.0
CP724714	CDC2L2	100.0	10000.0
Torin2	RIOK1	65.0	10000.0
HG-14-10-04	STK39	2.6	10000.0
WZ3105	ABL1(F317L)-nonphosphorylated	89.0	10000.0
CP466722	NEK6	0.2	10000.0
TAK-715	MP2K6	79.0	10000.0
A443654	ROCK2	0.0	10000.0
AZD-6482	DYRK1A	90.0	10000.0
GW-5074	MARK4	100.0	10000.0
AZD-6482	STK36	100.0	10000.0
(s)-CR8	CAMK1G	70.0	10000.0
Palbociclib	CAMK1G	97.0	1000.0
CGP74514A	PCTK2	7.2	10000.0
XMD8-92	PRKX	100.0	10000.0
KIN001-220	JNK3	0.8	10000.0
XMD14-99	MLK2	100.0	10000.0
BX-912	ABL1-nonphosphorylated	0.6	10000.0
PD0325901	MET(M1250T)	92.0	10000.0
Dabrafenib	MAP3K1	84.0	10000.0
BS-181	ACVR2B	83.0	10000.0
CG-930	HCK	100.0	10000.0
BMS-536924	RIPK1	100.0	1000.0
XMD13-2	SNARK	24.0	10000.0
AZD4547	JAK2(JH1domain-catalytic)	0.9	10000.0
KIN001-220	ANKK1	36.0	10000.0
CP724714	ALK	100.0	10000.0
KIN001-021	MKNK1	100.0	1000.0
JWE-035	MP2K7	100.0	10000.0
Torin2	PIM3	100.0	10000.0
Canertinib	EPHA8	100.0	1000.0
ERK5-IN-1	ABL1(F317L)-phosphorylated	34.0	1000.0
AG1478	KIT(D816H)	59.0	10000.0
CH5424802	KIT(V559D)	64.0	1000.0
PD0325901	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
WZ-7043	ACVR1	100.0	10000.0
OTSSP167	TLK1	23.0	10000.0
ERK5-IN-1	RSK3(Kin.Dom.2-C-terminal)	83.0	1000.0
AZD-6482	INSR	100.0	10000.0
WH-4-023	MARK4	49.0	10000.0
TGX221	WEE1	100.0	1000.0
WZ3105	TNK1	100.0	10000.0
Baricitinib	M3K5	70.0	10000.0
AZD 5438	MST3	6.5	10000.0
CP466722	TSSK1	60.0	10000.0
Alpelisib	PAK7	97.0	1000.0
QL-XI-92	GRK7	100.0	10000.0
KU63794	HCK	100.0	10000.0
KIN001-021	MK12	100.0	1000.0
WZ4003	NEK1	100.0	1000.0
AG1478	NEK4	76.0	10000.0
WYE-125132	VGFR2	76.0	10000.0
Dactolisib	NEK6	100.0	1000.0
SB590885	KIT(V559D)	65.0	10000.0
Ibrutinib	CSNK2A2	52.0	1000.0
KIN001-021	PAK3	28.0	1000.0
Dabrafenib	TNK1	1.3	10000.0
QL-XI-92	TLK2	100.0	10000.0
JNK-IN-11	EGFR(S752-I759del)	7.8	1000.0
GSK429286A	MET(M1250T)	23.0	10000.0
PLX-4720	CDK3	98.0	10000.0
AG1478	M3K2	30.0	10000.0
WH-4-023	CSK	2.5	10000.0
CP724714	PIM2	100.0	10000.0
AZD-6482	SRMS	63.0	10000.0
KIN001-127	MKNK2	100.0	10000.0
PHA-767491	DAPK1	1.4	10000.0
WH-4-023	M4K3	1.4	10000.0
BI-D1870	NEK6	23.0	10000.0
HG-5-88-01	KC1G2	100.0	10000.0
Buparlisib	MP2K3	97.0	1000.0
HG-5-88-01	CDK15	100.0	10000.0
HG-5-88-01	TNIK	100.0	10000.0
KIN001-123	CDK3	100.0	1000.0
RO-3306	PAK4	51.0	10000.0
WZ4003	DDR2	100.0	1000.0
HG-5-88-01	EGFR(L861Q)	0.3	10000.0
NG25	RPS6KA6(Kin.Dom.2)	100.0	10000.0
XMD8-85	NEK7	100.0	10000.0
Dactolisib	ERBB4	100.0	1000.0
QL-XII-47	PFPK5(P.falciparum)	94.0	1000.0
PHA-793887	MARK4	57.0	10000.0
WH-4-023	TXK	0.5	10000.0
AG1478	PLK3	85.0	10000.0
BS-181	CASK	85.0	10000.0
JWE-035	NEK1	66.0	10000.0
Dinaciclib	AURKA	79.0	10000.0
ALW-II-49-7	PAK7	100.0	10000.0
ZM-447439	KPCD2	100.0	10000.0
Vemurafenib	CHK2	100.0	10000.0
SCH772984	TRKA	70.0	1000.0
Alpelisib	FLT3(D835H)	96.0	1000.0
Ribociclib	PTK6	100.0	1000.0
PD0325901	CDKL3	98.0	10000.0
OTSSP167	STK36	0.1	10000.0
Buparlisib	NEK7	100.0	1000.0
AZ-628	CDKL5	93.0	10000.0
Dinaciclib	ZAP70	84.0	10000.0
Seliciclib	CDK5	27.0	10000.0
BGJ398	KCC4	98.0	1000.0
5z-7-oxozeaenol	ABL1-nonphosphorylated	72.0	10000.0
Seliciclib	ICK	52.0	10000.0
PD0325901	PIM2	75.0	10000.0
QL-XI-92	PIK3CA(I800L)	93.0	10000.0
Torkinib	ACVR1B	11.0	10000.0
Dactolisib	MKNK2	100.0	1000.0
CP466722	YANK1	64.0	10000.0
BGJ398	KGP1	100.0	1000.0
Seliciclib	CAMKK2	82.0	10000.0
AZD 5438	DYRK1B	2.2	10000.0
GW-5074	EPHA8	100.0	10000.0
WZ-4-145	TYK2(Kin.Dom.1)	100.0	10000.0
Pictilisib	EPHB1	100.0	1000.0
CG-930	EGFR(L747-T751del,Sins)	5.7	10000.0
JNK-IN-8	PKAC-alpha	100.0	1000.0
XMD-12	ACVR1B	91.0	1000.0
WZ-7043	KPCD3	100.0	10000.0
XMD14-99	MP2K2	93.0	10000.0
CGP60474	MINK	100.0	10000.0
JNK-IN-11	HIPK1	100.0	1000.0
HG-9-91-01	PLK4	37.0	10000.0
BMS345541	KIT(L576P)	28.0	10000.0
BMS-536924	TNNI3K	100.0	1000.0
SCH772984	MAP4K2	58.0	1000.0
RO-3306	PLK1	86.0	10000.0
ERK5-IN-1	NEK6	100.0	1000.0
AZD7762	EGFR(S752-I759del)	2.4	10000.0
Abemaciclib	CDK4-cyclinD1	0.4	1000.0
GW843682X	CDK5	100.0	10000.0
Abemaciclib	MK03	100.0	1000.0
Barasertib	LTK	17.0	10000.0
GW-5074	MST1R	100.0	10000.0
(s)-CR8	FLT3(K663Q)	88.0	10000.0
GSK429286A	ERK8	80.0	10000.0
NVP-TAE684	PKMYT1	100.0	1000.0
JWE-035	JAK1(JH2domain-pseudokinase)	0.1	10000.0
CP466722	ROCK2	20.0	10000.0
Sigma A6730	SRPK3	87.0	10000.0
XMD-12	YANK1	100.0	1000.0
NG25	NEK2	100.0	10000.0
XMD11-50	EPHB3	100.0	10000.0
Omipalisib	DDR1	51.0	10000.0
Dabrafenib	PAK6	63.0	10000.0
CGP60474	LIMK1	100.0	10000.0
ALW-II-38-3	LATS1	100.0	10000.0
BGJ398	HIPK3	98.0	1000.0
THZ1	CSF1R	8.0	10000.0
ALW-II-49-7	STK33	100.0	10000.0
PD0325901	TIE2	100.0	10000.0
JNK-IN-11	EGFR(L861Q)	0.8	1000.0
PHA-767491	PGFRB	54.0	10000.0
KIN001-123	ADCK3	100.0	1000.0
KIN001-220	CDC2L1	87.0	10000.0
5z-7-oxozeaenol	PKN1	75.0	10000.0
WYE-125132	DMPK	83.0	10000.0
PD173074	EGFR(L747-E749del,A750P)	100.0	10000.0
QL-X-138	PCTK2	92.0	10000.0
Barasertib	YES	42.0	10000.0
Sorafenib	ERK5	85.0	10000.0
Taselisib	RIPK4	98.0	1000.0
ZG-10	ROCK2	41.0	10000.0
ZM-447439	RIPK2	2.8	10000.0
GSK429286A	YANK2	52.0	10000.0
BX-912	PAK3	2.6	10000.0
OTSSP167	FLT3(R834Q)	100.0	10000.0
KU63794	RAF1	100.0	10000.0
GSK461364	FLT3(ITD)	31.0	10000.0
Dabrafenib	SGK1	45.0	10000.0
QL-XII-47	CLK2	86.0	1000.0
KU63794	KPCD	100.0	10000.0
XMD11-85h	ANKK1	100.0	10000.0
XMD14-99	HIPK4	24.0	10000.0
Omipalisib	STK33	79.0	10000.0
Pictilisib	NEK1	92.0	1000.0
HG-6-64-01	PIK3CA(I800L)	100.0	10000.0
THZ1	NEK1	100.0	10000.0
Crizotinib	KGP1	100.0	10000.0
PLX-4720	EGFR(L747-E749del,A750P)	77.0	10000.0
NG25	CDK16	11.0	10000.0
(s)-CR8	PIK3CA(H1047Y)	100.0	10000.0
PLX-4720	KC1G1	66.0	10000.0
MPS-1-IN-1	WEE2	100.0	1000.0
Torin2	ERBB4	100.0	10000.0
KIN001-111	TLK1	100.0	1000.0
ALW-II-49-7	M3K12	100.0	10000.0
BX-912	ROS1	97.0	10000.0
BI-2536	MP2K2	100.0	10000.0
KIN001-220	MKNK2	5.6	10000.0
AZD-6482	PIK3CA(Q546K)	0.1	10000.0
Crizotinib	INSRR	0.3	10000.0
CG-930	VGFR2	100.0	10000.0
Abemaciclib	RIPK1	61.0	1000.0
CG-930	M3K2	82.0	10000.0
PHA-793887	MP2K4	26.0	10000.0
Ceritinib	ABL1(Y253F)-phosphorylated	65.0	1000.0
Dabrafenib	CSNK2A1	39.0	10000.0
5z-7-oxozeaenol	MAPKAPK2	100.0	10000.0
Seliciclib	SGK1	99.0	10000.0
SP600125	EPHA3	100.0	10000.0
KU63794	TTK	95.0	10000.0
NPK76-II-72-1	CDC2L1	100.0	10000.0
Sorafenib	HCK	27.0	10000.0
XMD16-144	KIT(A829P)	40.0	10000.0
Barasertib	STK39	100.0	10000.0
WZ-7043	MELK	100.0	10000.0
MRT67307	KPCD1	0.7	10000.0
BMX-IN-1	TBK1	77.0	10000.0
Canertinib	MYO3B	100.0	1000.0
AZD7762	MKNK2	0.0	10000.0
TGX221	PGFRA	100.0	1000.0
Canertinib	AAK1	100.0	1000.0
OTSSP167	ADCK4	85.0	10000.0
Sigma A6730	MKNK1	77.0	10000.0
XMD-12	TSSK1	100.0	1000.0
PD0325901	MET	86.0	10000.0
(s)-CR8	TTK	86.0	10000.0
WZ-7043	ERK8	100.0	10000.0
BMS345541	YANK1	100.0	10000.0
JNK-IN-11	ERN1	100.0	1000.0
NVP-TAE684	ULK2	1.1	1000.0
A443654	ALK	100.0	10000.0
Sigma A6730	MP2K3	100.0	10000.0
Momelotinib	MYLK2	23.0	10000.0
CP466722	PCTK3	62.0	10000.0
BGJ398	GCN2(Kin.Dom.2,S808G)	6.8	1000.0
WZ-7043	TNIK	100.0	10000.0
Sorafenib	CLK2	55.0	10000.0
NVP-TAE684	IKKE	25.0	1000.0
R406	PIM2	100.0	1000.0
Abemaciclib	SRPK3	24.0	1000.0
NU7441	PGFRB	76.0	10000.0
HG-14-10-04	ERK8	15.0	10000.0
GW843682X	SYK	72.0	10000.0
XMD8-85	PLK2	100.0	10000.0
AZD-6482	JAK1(JH1domain-catalytic)	100.0	10000.0
WZ3105	MYO3B	100.0	10000.0
(s)-CR8	KPCE	100.0	10000.0
BMX-IN-1	RIPK2	92.0	10000.0
TAK-715	DRAK2	91.0	10000.0
XMD11-50	ABL1(E255K)-phosphorylated	80.0	10000.0
HG-9-91-01	DDR1	0.2	10000.0
SB590885	CSK	97.0	10000.0
Abemaciclib	ABL1(Q252H)-nonphosphorylated	50.0	1000.0
ZSTK474	TSSK1	100.0	1000.0
AZD 5438	PIK3CA(C420R)	58.0	10000.0
Lapatinib	ROS1	96.0	10000.0
Dabrafenib	LIMK1	0.6	10000.0
RO-3306	EGFR(E746-A750del)	67.0	10000.0
5z-7-oxozeaenol	ERBB3	100.0	10000.0
PHA-767491	RSK2(Kin.Dom.2-C-terminal)	66.0	10000.0
KIN001-111	CDK14	100.0	1000.0
Torin1	GAK	57.0	10000.0
SB590885	ROCK1	77.0	10000.0
THZ1	CDK14	8.0	10000.0
Sorafenib	MET	69.0	10000.0
JNK-9L	MAK	49.0	10000.0
BGJ398	RIPK5	90.0	1000.0
BX-912	M3K5	24.0	10000.0
Ribociclib	TESK1	98.0	1000.0
Ribociclib	ALK(L1196M)	81.0	1000.0
PD173074	MYO3A	100.0	10000.0
XMD8-85	ZAP70	100.0	10000.0
BMS-536924	EPHA7	1.3	1000.0
WZ3105	ITK	65.0	10000.0
KIN001-123	EGFR(S752-I759del)	24.0	1000.0
CGP60474	TRKB	100.0	10000.0
Torin1	ABL1-nonphosphorylated	60.0	10000.0
THZ1	LIMK2	48.0	10000.0
BX-912	DMPK2	49.0	10000.0
BS-181	CTK	100.0	10000.0
HG-9-91-01	DRAK1	95.0	10000.0
BGJ398	AURKC	61.0	1000.0
Palbociclib	TIE2	98.0	1000.0
BMS-536924	KC1G2	100.0	1000.0
BX-912	CASK	67.0	10000.0
WZ-4-145	EGFR(G719S)	0.2	10000.0
Vemurafenib	BRSK1	100.0	10000.0
GW843682X	M4K1	44.0	10000.0
BS-181	BMPR1A	100.0	10000.0
XMD8-92	GSK3B	100.0	10000.0
Ribociclib	WEE2	96.0	1000.0
AG1478	PIM2	74.0	10000.0
XMD14-99	GRK7	100.0	10000.0
AS-252424	LIMK1	100.0	10000.0
Crizotinib	NEK1	56.0	10000.0
Palbociclib	MET	100.0	1000.0
ALW-II-49-7	RIPK1	100.0	10000.0
MRT67307	MLK2	40.0	10000.0
ZG-10	M4K3	57.0	10000.0
BI-2536	MYLK	3.6	10000.0
Abemaciclib	MAK	8.0	1000.0
R406	RPS6KA5(Kin.Dom.1)	100.0	1000.0
Pictilisib	RIOK2	67.0	1000.0
JNK-9L	ULK3	6.0	10000.0
Abemaciclib	AURKA	98.0	1000.0
Ceritinib	NLK	84.0	1000.0
Sigma A6730	BMPR1A	82.0	10000.0
NPK76-II-72-1	MP2K2	100.0	10000.0
Taselisib	CDK4-cyclinD1	81.0	1000.0
Seliciclib	CAMK2G	82.0	10000.0
JNK-IN-11	NUAK1	83.0	1000.0
NU7441	AXL	100.0	10000.0
KIN001-123	SRPK1	100.0	1000.0
RO-3306	DCLK1	75.0	10000.0
Ibrutinib	ACVR1	100.0	1000.0
Barasertib	NEK11	98.0	10000.0
PD173074	SRPK1	100.0	10000.0
SCH772984	ERBB3	89.0	1000.0
HG-5-113-01	MST2	0.2	10000.0
XMD-12	PIM1	91.0	1000.0
NU7441	FLT4	92.0	10000.0
XMD13-2	PIK3CA(I800L)	100.0	10000.0
Palbociclib	RIPK5	100.0	1000.0
ZG-10	YANK2	100.0	10000.0
Canertinib	FLT4	100.0	1000.0
MPS-1-IN-1	DCAMKL3	100.0	1000.0
Neratinib	FAK1	65.0	10000.0
XMD8-85	TAOK1	4.8	10000.0
R406	CLK2	9.1	1000.0
Ceritinib	CDK15	100.0	1000.0
HG-14-8-02	HCK	90.0	10000.0
Dactolisib	FLT3	100.0	1000.0
TAK-715	PTK6	30.0	10000.0
RO-3306	MUSK	61.0	10000.0
R406	ACVR2B	100.0	1000.0
KIN001-220	TNNI3K	24.0	10000.0
GW-5074	NEK1	87.0	10000.0
OTSSP167	FER	1.3	10000.0
Momelotinib	PIK3CG	2.4	10000.0
WZ4002	ULK1	1.6	10000.0
CP724714	EPHA4	98.0	10000.0
MRT67307	BLK	65.0	10000.0
R406	RPS6KA6(Kin.Dom.1)	28.0	1000.0
Dinaciclib	EPHB4	87.0	10000.0
Torkinib	LIMK2	77.0	10000.0
5z-7-oxozeaenol	CDK8	77.0	10000.0
A443654	PKN2	2.4	10000.0
XMD13-2	TBK1	61.0	10000.0
SB590885	PIK3CD	79.0	10000.0
JW-7-24-1	RPS6KA6(Kin.Dom.1)	100.0	10000.0
Ceritinib	KIT(L576P)	66.0	1000.0
BMS345541	MYO3A	100.0	10000.0
Neratinib	DAPK1	98.0	10000.0
WZ-4-145	TXK	16.0	10000.0
Omipalisib	MRCKA	83.0	10000.0
CH5424802	MP2K3	78.0	1000.0
HG-6-64-01	PIK3CA	100.0	10000.0
Neratinib	CDK2	58.0	10000.0
Crizotinib	EGFR(L747-T751del,Sins)	80.0	10000.0
BMS345541	DCAMKL2	100.0	10000.0
Taselisib	PIK3CB	0.0	1000.0
ZSTK474	PGFRB	100.0	1000.0
Buparlisib	LATS2	100.0	1000.0
KIN001-220	AURKA	0.5	10000.0
Alpelisib	CAMK1D	91.0	1000.0
TAK-715	CSNK2A1	100.0	10000.0
5z-7-oxozeaenol	CDKL1	82.0	10000.0
Ceritinib	STK33	20.0	1000.0
ZG-10	PLK4	29.0	10000.0
WZ3105	MP2K6	100.0	10000.0
HG-14-10-04	FGR	17.0	10000.0
KIN001-111	EPHB3	100.0	1000.0
NG25	TRKB	10.0	10000.0
WZ-7043	PIK3CA(E545K)	100.0	10000.0
Neratinib	MST4	2.0	10000.0
NU7441	PHKG2	99.0	10000.0
ZSTK474	MINK	100.0	1000.0
WYE-125132	PIK3C2G	22.0	10000.0
Torkinib	SgK110	100.0	10000.0
Torkinib	ABL1(T315I)-phosphorylated	1.0	10000.0
PHA-793887	ABL1(Q252H)-phosphorylated	97.0	10000.0
XMD11-85h	MK12	100.0	10000.0
Dactolisib	KIT(V559D,V654A)	100.0	1000.0
GSK461364	CHK2	69.0	10000.0
Palbociclib	MAP4K5	92.0	1000.0
Taselisib	TGFBR1	100.0	1000.0
MPS-1-IN-1	MAP4K5	100.0	1000.0
Ceritinib	EGFR(L861Q)	54.0	1000.0
AS-252424	PAK7	100.0	10000.0
SP600125	MAP4K5	100.0	10000.0
PHA-793887	FGR	87.0	10000.0
PHA-767491	EPHB6	91.0	10000.0
GSK429286A	MARK1	100.0	10000.0
GW-5074	BLK	41.0	10000.0
Lapatinib	DAPK1	100.0	10000.0
Pictilisib	ACVR2A	88.0	1000.0
XMD11-50	PHKG1	54.0	10000.0
HG-14-8-02	PIK3C2G	100.0	10000.0
Alpelisib	PKMYT1	90.0	1000.0
Sigma A6730	ABL1(F317I)-nonphosphorylated	100.0	10000.0
AZD-6482	MAP3K3	87.0	10000.0
Ibrutinib	SIK2	100.0	1000.0
BMX-IN-1	EPHA1	100.0	10000.0
WZ-7043	CDK11	100.0	10000.0
HG-14-10-04	EGFR(S752-I759del)	5.2	10000.0
RO-3306	BRAF	79.0	10000.0
XMD11-50	PDPK1	100.0	10000.0
Torkinib	BRSK2	1.0	10000.0
GSK1059615	RET(M918T)	93.0	10000.0
HG-6-64-01	SYK	7.2	10000.0
Sorafenib	ERBB4	100.0	10000.0
Buparlisib	ULK3	100.0	1000.0
ZSTK474	PIP5K2B	100.0	1000.0
NG25	MST2	100.0	10000.0
OTSSP167	GRK1	0.2	10000.0
Abemaciclib	EGFR(L858R)	92.0	1000.0
ZM-447439	PFCDPK1(P.falciparum)	47.0	10000.0
AS-252424	SIK1	92.2	10000.0
Dabrafenib	FAK2	58.0	10000.0
Dabrafenib	FGFR3	98.0	10000.0
Baricitinib	ERK5	79.0	10000.0
THZ1	PRKX	48.0	10000.0
KU63794	GRK4	67.0	10000.0
XMD11-85h	DMPK	100.0	10000.0
Ibrutinib	FLT3(K663Q)	22.0	1000.0
QL-X-138	YANK1	100.0	10000.0
Dabrafenib	NDR2	21.0	10000.0
KIN001-021	PDPK1	100.0	1000.0
BMS-536924	IGF1R	0.5	1000.0
KIN001-021	EGFR(S752-I759del)	100.0	1000.0
XMD8-92	AMPK-alpha1	100.0	10000.0
WZ-7043	MET(M1250T)	100.0	10000.0
Dinaciclib	AMPK-alpha1	27.0	10000.0
AG1478	EPHA8	38.0	10000.0
Alpelisib	SRC	100.0	1000.0
TAK-715	EGFR(L861Q)	5.2	10000.0
Pictilisib	PLK4	95.0	1000.0
Sorafenib	RIOK1	100.0	10000.0
BX-912	KPCL	33.0	10000.0
CH5424802	TRKC	78.0	1000.0
AZD4547	PIM1	91.0	10000.0
Palbociclib	MET(Y1235D)	53.0	1000.0
CP466722	MRCKA	99.0	10000.0
NPK76-II-72-1	M3K12	100.0	10000.0
TGX221	AMPK-alpha2	100.0	1000.0
ERK5-IN-1	PCTK2	100.0	1000.0
Palbociclib	GRK7	100.0	1000.0
XMD13-2	MAP3K3	85.0	10000.0
Torkinib	VGFR2	9.8	10000.0
HG-6-64-01	ACVR1	100.0	10000.0
KIN001-127	CLK3	19.0	10000.0
NG25	TRKA	27.0	10000.0
MLN8054	PTK6	77.0	10000.0
ZSTK474	MAPKAPK5	100.0	1000.0
BGJ398	ABL1(H396P)-phosphorylated	74.0	1000.0
Dinaciclib	MK11	87.0	10000.0
RO-3306	TNNI3K	100.0	10000.0
Torin2	FRK	100.0	10000.0
5z-7-oxozeaenol	TNK2	67.0	10000.0
BI-2536	MYO3A	100.0	10000.0
WZ-4-145	RPS6KA2(Kin.Dom.2)	100.0	10000.0
AZD-6482	ERK5	100.0	10000.0
Momelotinib	TRPM6	100.0	10000.0
GSK429286A	EGFR(E746-A750del)	96.0	10000.0
AZD4547	PIK3C2G	85.0	10000.0
SCH772984	FLT3(K663Q)	93.0	1000.0
JW-7-24-1	PCTK3	100.0	10000.0
AZD-6482	MUSK	100.0	10000.0
WZ3105	MKNK1	32.0	10000.0
Ribociclib	CDK7	87.0	1000.0
XMD16-144	TAOK3	0.0	10000.0
R406	MYO3A	100.0	1000.0
Sorafenib	PFCDPK1(P.falciparum)	1.0	10000.0
THZ1	KPCI	100.0	10000.0
AZ-628	PLK3	100.0	10000.0
Canertinib	KPCD	100.0	1000.0
GSK429286A	FAK2	100.0	10000.0
ALW-II-38-3	BMPR1A	100.0	10000.0
AZD4547	STK35	3.2	10000.0
QL-X-138	DRAK2	100.0	10000.0
NG25	KIT(V559D)	0.0	10000.0
TGX221	EPHA5	100.0	1000.0
Canertinib	KIT(V559D)	100.0	1000.0
NPK76-II-72-1	CDK5	100.0	10000.0
Barasertib	CDKL1	84.0	10000.0
Sigma A6730	FGFR1	73.0	10000.0
AZD 5438	YANK3	100.0	10000.0
CP724714	OSR1	100.0	10000.0
MRT67307	EGFR(L861Q)	95.0	10000.0
ALW-II-38-3	RET(V804M)	100.0	10000.0
XMD11-85h	LYN	100.0	10000.0
BI-D1870	MET(Y1235D)	4.8	10000.0
QL-X-138	SRMS	75.0	10000.0
Ibrutinib	PIP5K1C	13.0	1000.0
RO-3306	FLT3	1.4	10000.0
BGJ398	MARK1	84.0	1000.0
RO-3306	NEK5	69.0	10000.0
XMD8-92	INSR	100.0	10000.0
TAK-715	NEK6	100.0	10000.0
BMS-536924	KIT(V559D,V654A)	10.0	1000.0
Baricitinib	CDK9	97.0	10000.0
BGJ398	ABL1(F317L)-phosphorylated	96.0	1000.0
AZD4547	PIK3CA	93.0	10000.0
CGP60474	CSNK2A2	100.0	10000.0
CP466722	CDK3	82.0	10000.0
ZG-10	CDC2L5	86.0	10000.0
Dabrafenib	KIT(V559D,T670I)	49.0	10000.0
KIN001-123	CDK2	100.0	1000.0
Torin2	LKB1	98.0	10000.0
JNK-9L	KKCC1	48.0	10000.0
RO-3306	MAP3K1	67.0	10000.0
GSK461364	SNRK	100.0	10000.0
JNK-IN-5A	DCAMKL2	100.0	10000.0
Abemaciclib	NIM1	37.0	1000.0
KIN001-127	FLT3(D835Y)	26.0	10000.0
XMD11-85h	ACVRL1	100.0	10000.0
XMD16-144	CDK4-cyclinD3	85.0	10000.0
ERK5-IN-1	KIT(A829P)	74.0	1000.0
QL-XI-92	PIP5K1A	100.0	10000.0
KIN001-123	MERTK	27.0	1000.0
WYE-125132	CDK15	100.0	10000.0
NG25	CAMK2B	100.0	10000.0
ALW-II-49-7	AKT1	100.0	10000.0
KIN001-021	CAMK2B	100.0	1000.0
WZ4003	PCTK2	100.0	1000.0
KU63794	FLT3(K663Q)	96.0	10000.0
Pictilisib	FYN	91.0	1000.0
AG1478	LRRK2	79.0	10000.0
BMS345541	ULK2	100.0	10000.0
Taselisib	CAMK1G	100.0	1000.0
MRT67307	YSK4	0.1	10000.0
Sorafenib	NEK2	100.0	10000.0
Canertinib	FER	100.0	1000.0
BX-912	YSK1	30.0	10000.0
PLX-4720	MLK1	94.0	10000.0
GSK1059615	EGFR	58.0	10000.0
KIN001-111	EPHA2	100.0	1000.0
BI-D1870	JAK1(JH1domain-catalytic)	27.0	10000.0
TGX221	RPS6KA1(Kin.Dom.2)	100.0	1000.0
BMX-IN-1	PIK3CG	0.0	10000.0
HG-5-113-01	DAPK3	100.0	10000.0
TAK-715	WEE1	100.0	10000.0
BX-912	CDKL2	4.7	10000.0
NU7441	TESK1	72.0	10000.0
QL-XI-92	PIK3CA(M1043I)	93.0	10000.0
CP724714	EPHA2	100.0	10000.0
Crizotinib	DMPK2	48.0	10000.0
Alpelisib	PIP5K1C	83.0	1000.0
Ribociclib	CDK2	100.0	1000.0
SB590885	LATS2	45.0	10000.0
PD0325901	RIPK2	66.0	10000.0
Palbociclib	FGFR3	100.0	1000.0
CGP74514A	FYN	11.0	10000.0
SCH772984	EPHB2	100.0	1000.0
XMD13-2	ABL1(Y253F)-phosphorylated	60.0	10000.0
PLX-4720	STK36	18.0	10000.0
XMD8-85	DMPK2	100.0	10000.0
Ibrutinib	MYO3B	100.0	1000.0
XMD16-144	PIK3CA(I800L)	55.0	10000.0
Taselisib	ITK	100.0	1000.0
WZ-4-145	EPHA2	100.0	10000.0
R406	NEK1	1.2	1000.0
NU7441	HIPK2	100.0	10000.0
JNK-IN-8	PRKX	0.0	1000.0
KIN001-021	MARK3	100.0	1000.0
BMS-536924	FLT3(ITD)	0.1	1000.0
PHA-767491	AURKB	87.0	10000.0
AZD 5438	ABL1-phosphorylated	12.0	10000.0
SCH772984	NEK10	93.0	1000.0
NU7441	ROCK2	100.0	10000.0
PHA-793887	JNK1	89.0	10000.0
TGX221	TAOK3	100.0	1000.0
ZSTK474	PAK4	100.0	1000.0
TGX221	CSK	100.0	1000.0
Dinaciclib	PLK4	100.0	10000.0
KIN001-127	JAK2(Kin.Dom.2)	100.0	10000.0
Buparlisib	BLK	100.0	1000.0
Dabrafenib	DMPK	100.0	10000.0
TAK-715	RIPK1	95.0	10000.0
BMS-536924	CDK16	100.0	1000.0
JNK-9L	M4K3	6.3	10000.0
NU7441	FGFR2	82.0	10000.0
KIN001-123	LYN	100.0	1000.0
QL-X-138	BRSK1	82.0	10000.0
Canertinib	GAK	5.4	1000.0
Torkinib	IRAK1	25.0	10000.0
Torin1	GRK1	99.0	10000.0
TAK-715	BMX	90.0	10000.0
CP466722	RIPK2	2.6	10000.0
CP466722	RSK4(Kin.Dom.1-N-terminal)	20.0	10000.0
Ceritinib	CDK4-cyclinD1	100.0	1000.0
ERK5-IN-1	KPCD2	100.0	1000.0
Canertinib	ABL1(Y253F)	100.0	1000.0
AZD-6482	ALK	100.0	10000.0
MRT67307	VGFR1	66.0	10000.0
Baricitinib	RET(V804M)	0.1	10000.0
AZD 5438	HIPK3	2.0	10000.0
AS-252424	ACVR1	84.6	10000.0
HG-14-10-04	BMPR2	79.0	10000.0
WYE-125132	BTK	90.0	10000.0
Alpelisib	CDKL5	100.0	1000.0
WZ4003	VGFR2	100.0	1000.0
NVP-TAE684	BIKE	2.8	1000.0
SP600125	TLK1	100.0	10000.0
CP724714	RSK1(Kin.Dom.1-N-terminal)	100.0	10000.0
PD0325901	PIP5K1A	91.0	10000.0
AZD7762	CDKL5	100.0	10000.0
GW-5074	KIT(V559D,V654A)	5.7	10000.0
Ibrutinib	ANKK1	71.0	1000.0
HG-5-113-01	VGFR2	100.0	10000.0
QL-X-138	ACVR1B	100.0	10000.0
BS-181	CSNK1G3	20.0	10000.0
5z-7-oxozeaenol	CSF1R-autoinhibited	81.0	10000.0
WH-4-023	WEE2	100.0	10000.0
AZ-628	CSF1R	0.1	10000.0
CH5424802	ABL1(H396P)-nonphosphorylated	70.0	1000.0
Barasertib	KC1G2	76.0	10000.0
Torin2	BRSK1	88.0	10000.0
Dabrafenib	SgK110	100.0	10000.0
ERK5-IN-1	KPCD	100.0	1000.0
Abemaciclib	NLK	100.0	1000.0
Sorafenib	MP2K1	100.0	10000.0
Lapatinib	LATS1	91.0	10000.0
XMD11-50	TNNI3K	100.0	10000.0
GSK1059615	KC1G1	20.0	10000.0
SP600125	MRCKA	100.0	10000.0
AZD 5438	IKKB	2.1	10000.0
Ceritinib	ABL1(T315I)-nonphosphorylated	77.0	1000.0
BI-D1870	RPS6KA4(Kin.Dom.1-N-terminal)	1.1	10000.0
MLN8054	MELK	81.0	10000.0
MLN8054	ACVR1B	94.0	10000.0
WH-4-023	ERBB2	15.0	10000.0
AZ-628	TRKC	38.0	10000.0
CP466722	CDKL3	5.3	10000.0
XMD14-99	TGFBR1	100.0	10000.0
AZD-6482	PAK4	100.0	10000.0
HG-14-10-04	SIK1	1.5	10000.0
BI-2536	PIM3	100.0	10000.0
JNK-9L	PIM2	100.0	10000.0
XMD8-85	FGFR3(G697C)	100.0	10000.0
Dactolisib	EPHA1	100.0	1000.0
Buparlisib	SRMS	100.0	1000.0
Torkinib	MK09	70.0	10000.0
CGP74514A	HCK	0.8	10000.0
Sigma A6730	RIPK5	76.0	10000.0
XMD8-85	CAMKK2	15.0	10000.0
NG25	KGP2	100.0	10000.0
BMS345541	MTOR	87.0	10000.0
PHA-767491	PAK4	92.0	10000.0
ALW-II-49-7	MP2K1	100.0	10000.0
AZ-628	FGFR1	59.0	10000.0
PHA-793887	RPS6KA4(Kin.Dom.1-N-terminal)	69.0	10000.0
5z-7-oxozeaenol	MAK	96.0	10000.0
MLN8054	RIOK1	100.0	10000.0
KIN001-220	LRRK2(G2019S)	53.0	10000.0
JNK-IN-11	STK35	94.0	1000.0
QL-XII-47	TAOK1	100.0	1000.0
TAK-715	PAK4	86.0	10000.0
BGJ398	ABL1(T315I)-nonphosphorylated	66.0	1000.0
Neratinib	AURKA	87.0	10000.0
WZ4003	ERK5	6.8	1000.0
NU7441	MP2K2	97.0	10000.0
ALW-II-38-3	KKCC1	100.0	10000.0
WH-4-023	MAP4K2	1.6	10000.0
Abemaciclib	MAP3K1	81.0	1000.0
QL-XII-47	AURKA	100.0	1000.0
BMX-IN-1	MK13	100.0	10000.0
JNK-IN-5A	CDK9	83.0	10000.0
Taselisib	JAK2(JH1domain-catalytic)	89.0	1000.0
JWE-035	PIK3CA(E542K)	24.0	10000.0
WH-4-023	CDK4-cyclinD1	5.4	10000.0
BGJ398	RPS6KA5(Kin.Dom.2-C-terminal)	13.0	1000.0
HG-9-91-01	RIPK2	0.2	10000.0
Torkinib	EGFR(E746-A750del)	11.0	10000.0
QL-XI-92	MST4	91.0	10000.0
CGP60474	FGR	100.0	10000.0
GW-5074	MAP4K5	100.0	10000.0
PD173074	KGP2	100.0	10000.0
PHA-767491	MST1	100.0	10000.0
Taselisib	BARK2	100.0	1000.0
NVP-TAE684	YANK3	3.1	1000.0
Abemaciclib	BRAF	95.0	1000.0
PHA-793887	MARK3	32.0	10000.0
BI-2536	PRKX	100.0	10000.0
Momelotinib	VGFR2	99.0	10000.0
XMD8-85	YANK3	100.0	10000.0
ERK5-IN-1	HIPK1	100.0	1000.0
CH5424802	RPS6KA5(Kin.Dom.2-C-terminal)	92.0	1000.0
SB590885	FRK	96.0	10000.0
CP466722	ACVR1B	14.0	10000.0
AZ-628	YANK1	100.0	10000.0
AG1478	SBK1	25.0	10000.0
SB590885	CASK	82.0	10000.0
XMD11-50	CHEK1	100.0	10000.0
Torin1	RET	44.0	10000.0
WYE-125132	SBK1	100.0	10000.0
KU63794	INSRR	100.0	10000.0
SB590885	EIF2AK1	58.0	10000.0
Sorafenib	AKT3	100.0	10000.0
WZ-4-145	MAPKAPK5	100.0	10000.0
GW843682X	AAK1	28.0	10000.0
JNK-9L	MARK1	84.0	10000.0
HG-14-10-04	JAK1(JH1domain-catalytic)	5.5	10000.0
Crizotinib	ABL1(F317L)-phosphorylated	0.0	10000.0
HG-9-91-01	PAK7	1.2	10000.0
SB590885	ACVR1	51.0	10000.0
Momelotinib	FLT3(K663Q)	11.0	10000.0
CP724714	EPHB6	74.0	10000.0
CGP74514A	PLK4	30.0	10000.0
Taselisib	CLK3	89.0	1000.0
5z-7-oxozeaenol	HUNK	69.0	10000.0
Buparlisib	TNK2	100.0	1000.0
XMD13-2	DRAK1	96.0	10000.0
AZD4547	CSNK2A1	89.0	10000.0
Abemaciclib	GRK4	23.0	1000.0
JNK-IN-5A	CSNK1A1L	66.0	10000.0
Dabrafenib	MYLK2	100.0	10000.0
Torkinib	RET	0.0	10000.0
WZ3105	ERBB2	100.0	10000.0
Alpelisib	BTK	100.0	1000.0
KIN001-220	IRAK4	100.0	10000.0
(s)-CR8	MAP3K1	84.0	10000.0
HG-14-8-02	TBK1	83.0	10000.0
XMD-12	CAMK2A	86.0	1000.0
SCH772984	LCK	100.0	1000.0
Pictilisib	ALK(L1196M)	100.0	1000.0
HG-14-10-04	TXK	35.0	10000.0
Omipalisib	ERK3	95.0	10000.0
Ribociclib	MKNK2	91.0	1000.0
THZ1	KIT(A829P)	76.0	10000.0
JWE-035	HIPK1	78.0	10000.0
NG25	AXL	100.0	10000.0
QL-XI-92	BRAF(V600E)	19.0	10000.0
PLX-4720	NEK5	100.0	10000.0
HG-14-8-02	LRRK2(G2019S)	7.2	10000.0
KIN001-021	ERBB4	100.0	1000.0
Vemurafenib	IRAK3	63.0	10000.0
Palbociclib	CSK	100.0	1000.0
BS-181	PFPK5(P.falciparum)	100.0	10000.0
CG-930	CDK2	100.0	10000.0
OTSSP167	TYK2(JH1domain-catalytic)	2.4	10000.0
Palbociclib	ACVR1B	100.0	1000.0
CGP74514A	HUNK	90.0	10000.0
WYE-125132	ABL1(H396P)-phosphorylated	100.0	10000.0
(s)-CR8	ABL1(Y253F)-phosphorylated	100.0	10000.0
CP724714	PLK1	81.0	10000.0
Pictilisib	MRCKA	100.0	1000.0
BGJ398	KIT(D816V)	66.0	1000.0
AG1478	MLTK	94.0	10000.0
Torkinib	NEK11	74.0	10000.0
Dabrafenib	FYN	10.0	10000.0
5z-7-oxozeaenol	VGFR1	0.5	10000.0
JNK-9L	BMPR2	28.0	10000.0
ALW-II-38-3	FAK2	100.0	10000.0
Barasertib	EGFR	3.8	10000.0
WYE-125132	BRAF(V600E)	100.0	10000.0
KIN001-021	PAK4	100.0	1000.0
5z-7-oxozeaenol	PRKR	94.0	10000.0
CH5424802	KIT	81.0	1000.0
XMD11-50	ABL1(F317I)-nonphosphorylated	15.0	10000.0
5z-7-oxozeaenol	CDK3	94.0	10000.0
CH5424802	FAK2	17.0	1000.0
WZ4003	PKN2	100.0	1000.0
Dabrafenib	STK39	55.0	10000.0
Alpelisib	PLK4	100.0	1000.0
ERK5-IN-1	M3K6	100.0	1000.0
CH5424802	TLK2	100.0	1000.0
KU63794	TNK1	100.0	10000.0
MRT67307	PRP4	4.9	10000.0
TGX221	MRCKA	100.0	1000.0
NU7441	KIT(D816H)	100.0	10000.0
BX-912	M4K1	13.0	10000.0
Lapatinib	KIT(A829P)	87.0	10000.0
Baricitinib	CDKL1	70.0	10000.0
HG-14-10-04	CSNK1E	60.0	10000.0
OTSSP167	LTK	5.2	10000.0
WZ4003	FYN	100.0	1000.0
HG-6-64-01	MRCKA	15.0	10000.0
TAK-715	TIE1	96.0	10000.0
PD0325901	NEK1	98.0	10000.0
QL-XI-92	BTK	100.0	10000.0
NU7441	RIPK2	91.0	10000.0
Barasertib	SgK110	100.0	10000.0
JNK-IN-8	NEK4	79.0	1000.0
XMD8-92	CDK11	100.0	10000.0
Abemaciclib	FYV1	5.5	1000.0
BI-D1870	PLK2	0.6	10000.0
WZ-7043	CDK14	100.0	10000.0
KU63794	IRAK4	99.0	10000.0
XMD13-2	ROS1	100.0	10000.0
KIN001-021	ULK1	100.0	1000.0
AZD 5438	CIT	3.0	10000.0
XMD8-92	PIK3C2G	100.0	10000.0
Dabrafenib	HASP	96.0	10000.0
MLN8054	CAMK2A	69.0	10000.0
WZ4002	MK03	100.0	10000.0
(s)-CR8	HIPK2	72.0	10000.0
GW-5074	RPS6KA5(Kin.Dom.2-C-terminal)	63.0	10000.0
BI-2536	KC1G1	100.0	10000.0
KIN001-220	WEE2	12.0	10000.0
CH5424802	DRAK1	41.0	1000.0
JW-7-24-1	CAMK2B	100.0	10000.0
ZM-447439	AXL	1.8	10000.0
QL-X-138	FLT3(R834Q)	12.0	10000.0
ZG-10	NLK	82.0	10000.0
Seliciclib	ACVR2A	100.0	10000.0
NU7441	PDPK1	95.0	10000.0
Omipalisib	MLK1	81.0	10000.0
BI-D1870	DYRK1B	11.0	10000.0
Crizotinib	PIK3CA(E542K)	100.0	10000.0
CG-930	TAOK1	81.0	10000.0
QL-XII-47	MK01	100.0	1000.0
Ceritinib	NEK9	100.0	1000.0
Baricitinib	ADCK3	99.0	10000.0
HG-9-91-01	ABL1(F317I)-nonphosphorylated	0.1	10000.0
Taselisib	AAK1	97.0	1000.0
Lapatinib	CSNK1E	80.0	10000.0
PHA-767491	JAK2(JH1domain-catalytic)	0.0	10000.0
Alpelisib	KIT(A829P)	100.0	1000.0
Sigma A6730	ROCK2	73.0	10000.0
HG-5-113-01	SIK2	9.8	10000.0
CP466722	CDC2L1	93.0	10000.0
XMD13-2	ABL1(Q252H)-phosphorylated	66.0	10000.0
Torin1	TYRO3	31.0	10000.0
Pictilisib	AKT3	96.0	1000.0
KIN001-021	CLK4	100.0	1000.0
Neratinib	PRKX	100.0	10000.0
JNK-IN-8	CDK5	100.0	1000.0
ZM-447439	RET(M918T)	0.1	10000.0
AZD4547	MINK	2.0	10000.0
HG-14-10-04	CDKL5	100.0	10000.0
TAK-715	MET	94.0	10000.0
Sorafenib	CSNK1D	100.0	10000.0
AZD7762	MAPKAPK2	0.0	10000.0
AZD 5438	SRPK2	40.0	10000.0
HG-6-64-01	ABL1(F317I)-nonphosphorylated	0.9	10000.0
XMD8-92	PGFRA	100.0	10000.0
CH5424802	CAMK1G	63.0	1000.0
Taselisib	HIPK3	98.0	1000.0
CG-930	MST1R	100.0	10000.0
BMS-536924	SRPK3	5.6	1000.0
HG-14-10-04	RIPK5	1.4	10000.0
WZ3105	CDK9	100.0	10000.0
BI-2536	RPS6KA4(Kin.Dom.1)	100.0	10000.0
BI-2536	EGFR(L861Q)	100.0	10000.0
Crizotinib	AKT1	100.0	10000.0
GSK429286A	ABL1(F317L)-phosphorylated	89.0	10000.0
HG-9-91-01	KPCD	22.0	10000.0
A443654	ACVR2A	100.0	10000.0
Baricitinib	CAMK2G	3.7	10000.0
Lapatinib	RSK4(Kin.Dom.1-N-terminal)	89.0	10000.0
Baricitinib	CSNK1A1	25.0	10000.0
BI-D1870	TNK1	18.0	10000.0
WH-4-023	SRPK1	23.0	10000.0
JWE-035	RIPK1	24.0	10000.0
OTSSP167	EIF2AK1	68.0	10000.0
Omipalisib	NEK2	86.0	10000.0
JNK-IN-11	MK09	0.0	1000.0
Dabrafenib	BMPR1A	30.0	10000.0
XMD13-2	KIT(A829P)	76.0	10000.0
BS-181	BMX	100.0	10000.0
XMD-12	ERK4	100.0	1000.0
XMD11-50	FER	51.0	10000.0
ZG-10	CDK11	100.0	10000.0
RO-3306	CHEK1	33.0	10000.0
AZD7762	PIK3CA(H1047L)	100.0	10000.0
BMX-IN-1	KIT(D816H)	100.0	10000.0
TAK-715	VGFR2	38.0	10000.0
QL-X-138	MARK4	64.0	10000.0
PD173074	DRAK1	100.0	10000.0
Canertinib	DCLK1	100.0	1000.0
GW843682X	ACVR1B	76.0	10000.0
BI-D1870	CLK1	2.6	10000.0
TGX221	RIPK1	100.0	1000.0
KU63794	WEE1	98.0	10000.0
NU7441	FGFR1	93.0	10000.0
Lapatinib	EGFR(G719C)	0.1	10000.0
Dabrafenib	PIM1	100.0	10000.0
XMD8-92	PIK3CB	100.0	10000.0
KIN001-021	KIT(D816V)	100.0	1000.0
HG-6-64-01	FLT3(R834Q)	50.0	10000.0
SCH772984	PAK4	92.0	1000.0
PD173074	KKCC1	100.0	10000.0
Buparlisib	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	1000.0
Dabrafenib	BMPR1B	0.1	10000.0
AZ-628	EGFR(L747-S752del,P753S)	19.0	10000.0
KIN001-220	EPHB6	15.0	10000.0
JNK-IN-8	IKKE	91.0	1000.0
Ribociclib	MK11	100.0	1000.0
ZM-447439	CDKL1	81.0	10000.0
WZ-7043	IKKA	100.0	10000.0
ZM-447439	SIK1	82.0	10000.0
KU63794	KIT	87.0	10000.0
CGP60474	PIK3CA(H1047L)	100.0	10000.0
Torkinib	ACVR1	0.1	10000.0
BI-D1870	KIT(V559D,T670I)	7.4	10000.0
TGX221	FYN	100.0	1000.0
Vemurafenib	EGFR(L747-E749del,A750P)	74.0	10000.0
Seliciclib	MP2K1	97.0	10000.0
SCH772984	MET(M1250T)	81.0	1000.0
Lapatinib	CDKL5	100.0	10000.0
Alpelisib	MERTK	100.0	1000.0
MPS-1-IN-1	LOK	100.0	1000.0
Baricitinib	RIPK5	89.0	10000.0
AZ-628	SRPK3	100.0	10000.0
XMD16-144	RIOK2	79.0	10000.0
CGP74514A	OSR1	39.0	10000.0
QL-XII-47	TRPM6	87.0	1000.0
CH5424802	ABL2	100.0	1000.0
BI-D1870	NEK5	1.8	10000.0
WH-4-023	EPHA2	0.0	10000.0
WZ-4-145	TLK1	100.0	10000.0
JNK-IN-11	ALK	100.0	1000.0
GW843682X	CDK7	79.0	10000.0
MRT67307	SGK3	34.0	10000.0
ZG-10	MAP4K2	9.0	10000.0
WZ-7043	TYK2(JH1domain-catalytic)	100.0	10000.0
ERK5-IN-1	ABL1(Q252H)-nonphosphorylated	100.0	1000.0
PD173074	EGFR(L861Q)	100.0	10000.0
AZ-628	MUSK	92.0	10000.0
KIN001-111	MST4	24.0	1000.0
WYE-125132	ROS1	81.0	10000.0
ZG-10	PHKG1	96.0	10000.0
PHA-793887	MAP4K5	64.0	10000.0
Canertinib	DYRK1B	100.0	1000.0
ZG-10	RIPK2	84.0	10000.0
CH5424802	AMPK-alpha1	81.0	1000.0
AS-252424	KC1G2	100.0	10000.0
Dactolisib	MLTK	100.0	1000.0
HG-14-10-04	CDK2	100.0	10000.0
5z-7-oxozeaenol	CAMK2G	100.0	10000.0
SB590885	PKN1	92.0	10000.0
HG-14-10-04	TRKB	1.4	10000.0
R406	WEE1	7.8	1000.0
Alpelisib	RSK4(Kin.Dom.2-C-terminal)	61.0	1000.0
BI-D1870	EGFR(L858R)	24.0	10000.0
BMS345541	ABL1(E255K)-phosphorylated	87.0	10000.0
Palbociclib	PAK2	88.0	1000.0
CP466722	RSK1(Kin.Dom.1-N-terminal)	33.0	10000.0
QL-XI-92	RSK1(Kin.Dom.2-C-terminal)	100.0	10000.0
NPK76-II-72-1	CHK2	100.0	10000.0
Neratinib	PIK3CA(E545A)	100.0	10000.0
CGP60474	KIT	100.0	10000.0
GSK461364	KIT	47.0	10000.0
WZ-7043	EGFR(L747-E749del,A750P)	100.0	10000.0
QL-XII-47	EPHA5	100.0	1000.0
XMD13-2	TXK	77.0	10000.0
BMS345541	TNK2	100.0	10000.0
Lapatinib	KPCL	59.0	10000.0
QL-XI-92	CDKL1	100.0	10000.0
TGX221	EGFR(L747-S752del,P753S)	100.0	1000.0
JWE-035	TRPM6	100.0	10000.0
ERK5-IN-1	KPCT	100.0	1000.0
MPS-1-IN-1	TNK2	14.0	1000.0
GSK429286A	MK12	79.0	10000.0
CGP74514A	TIE1	39.0	10000.0
Neratinib	PHKG2	92.0	10000.0
CP466722	MAPKAPK5	100.0	10000.0
XMD14-99	KIT	100.0	10000.0
OTSSP167	KPCI	15.0	10000.0
JNK-9L	KIT(V559D)	1.0	10000.0
KU63794	PAK2	91.0	10000.0
GSK1059615	DRAK1	0.2	10000.0
GSK429286A	CAMK2A	100.0	10000.0
Buparlisib	M3K13	100.0	1000.0
SCH772984	TYK2(JH2domain-pseudokinase)	100.0	1000.0
Ribociclib	CSNK1D	100.0	1000.0
WZ-7043	LOK	100.0	10000.0
Momelotinib	CSF1R-autoinhibited	100.0	10000.0
Dabrafenib	ABL1(M351T)-phosphorylated	59.0	10000.0
BI-2536	MAPKAPK2	100.0	10000.0
AZD-6482	MAK	67.0	10000.0
QL-X-138	DCAMKL2	100.0	10000.0
WH-4-023	RIPK1	63.0	10000.0
JWE-035	KGP2	86.0	10000.0
Alpelisib	BRSK1	100.0	1000.0
Neratinib	MLCK	86.0	10000.0
BI-2536	EGFR(L747-S752del,P753S)	18.0	10000.0
SB590885	SIK3	100.0	10000.0
CGP74514A	WNK3	4.9	10000.0
PHA-793887	VRK2	22.0	10000.0
AZD7762	YES	0.2	10000.0
Buparlisib	ABL1(E255K)-phosphorylated	98.0	1000.0
XMD11-50	BMPR2	100.0	10000.0
NVP-TAE684	IKKB	100.0	1000.0
Sigma A6730	EGFR(L747-T751del,Sins)	92.0	10000.0
PHA-793887	RSK4(Kin.Dom.1-N-terminal)	9.8	10000.0
CGP60474	NEK2	100.0	10000.0
PLX-4720	CDK9	86.0	10000.0
ERK5-IN-1	MELK	100.0	1000.0
KU63794	RSK3(Kin.Dom.2-C-terminal)	94.0	10000.0
KIN001-220	PIM3	67.0	10000.0
(s)-CR8	EPHA4	95.0	10000.0
CP466722	GCN2(Kin.Dom.2,S808G)	1.6	10000.0
Seliciclib	VRK2	16.0	10000.0
CGP60474	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
ALW-II-38-3	MET	100.0	10000.0
KIN001-111	SYK	100.0	1000.0
BI-2536	ABL1(F317I)	100.0	10000.0
BGJ398	TYK2(JH2domain-pseudokinase)	90.0	1000.0
Taselisib	YSK4	71.0	1000.0
CGP74514A	FLT3(R834Q)	13.0	10000.0
JNK-IN-5A	PKN1	94.0	10000.0
KIN001-220	TRKC	78.0	10000.0
WZ4002	LKB1	100.0	10000.0
XMD8-92	ANKK1	100.0	10000.0
JW-7-24-1	LTK	100.0	10000.0
ERK5-IN-1	FLT4	100.0	1000.0
Torin2	MTOR	4.6	10000.0
Pictilisib	RPS6KA4(Kin.Dom.1-N-terminal)	93.0	1000.0
Crizotinib	IRAK1	0.0	10000.0
Neratinib	GSK3B	87.0	10000.0
GW843682X	FYN	48.0	10000.0
CGP74514A	EGFR(L747-T751del,Sins)	61.0	10000.0
MRT67307	ABL1(M351T)-phosphorylated	38.0	10000.0
BI-2536	EPHB3	100.0	10000.0
SCH772984	RIPK5	100.0	1000.0
BS-181	LYN	75.0	10000.0
Torkinib	ROCK2	60.0	10000.0
Barasertib	IKKB	91.0	10000.0
AG1478	SIK1	100.0	10000.0
AZD-6482	NEK7	100.0	10000.0
WZ-4-145	TIE1	0.0	10000.0
Neratinib	STK36	69.0	10000.0
PD173074	BMPR2	100.0	10000.0
Ibrutinib	IRAK4	66.0	1000.0
HG-5-113-01	RIOK1	2.0	10000.0
Barasertib	AURKB	0.2	10000.0
NG25	ABL1(Y253F)	0.7	10000.0
BMX-IN-1	MP2K7	6.1	10000.0
Canertinib	ACVR1B	100.0	1000.0
Baricitinib	TAOK3	24.0	10000.0
XMD-12	CAMK1D	98.0	1000.0
OTSSP167	ADCK3	0.1	10000.0
KIN001-123	MK03	100.0	1000.0
NU7441	CSNK2A2	100.0	10000.0
BMS345541	DYRK1B	85.0	10000.0
ZG-10	SNRK	66.0	10000.0
(s)-CR8	CAMKK2	55.0	10000.0
Ibrutinib	SRPK2	86.0	1000.0
CP724714	CDK9	100.0	10000.0
GSK461364	LATS1	100.0	10000.0
Barasertib	SRPK1	100.0	10000.0
XMD-12	YSK4	38.0	1000.0
KIN001-220	PAK4	47.0	10000.0
PLX-4720	PLK4	27.0	10000.0
Vemurafenib	ACVR2B	27.0	10000.0
NU7441	PIK3CA	22.0	10000.0
(s)-CR8	DMPK	100.0	10000.0
Neratinib	CHEK1	65.0	10000.0
WZ3105	ABL2	94.0	10000.0
QL-X-138	ABL1(T315I)-nonphosphorylated	100.0	10000.0
Lapatinib	FLT3(D835H)	91.0	10000.0
PLX-4720	BMPR1B	13.0	10000.0
HG-14-10-04	DDR2	43.0	10000.0
(s)-CR8	WEE1	97.0	10000.0
BS-181	CDKL5	100.0	10000.0
Sorafenib	KKCC1	89.0	10000.0
BMX-IN-1	CIT	53.0	10000.0
QL-XII-47	ITK	92.0	1000.0
Alpelisib	CLK1	59.0	1000.0
CP466722	MAST1	73.0	10000.0
QL-XI-92	CLK1	93.0	10000.0
BGJ398	TIE2	38.0	1000.0
KIN001-111	DCAMKL3	2.8	1000.0
GW-5074	FGFR4	100.0	10000.0
BX-912	M3K2	0.3	10000.0
HG-6-64-01	KC1G1	98.0	10000.0
Ceritinib	FLT3(D835V)	34.0	1000.0
BI-D1870	KIT(D816V)	25.0	10000.0
BGJ398	SLK	78.0	1000.0
NG25	MET	100.0	10000.0
Sorafenib	FLT3(ITD)	2.8	10000.0
BMS-536924	DRAK1	0.1	1000.0
(s)-CR8	GRK7	94.0	10000.0
XMD14-99	BRAF	94.0	10000.0
XMD8-85	KC1G1	100.0	10000.0
AG1478	PKAC-beta	100.0	10000.0
HG-5-88-01	KPCL	100.0	10000.0
ZG-10	AURKB	22.0	10000.0
HG-9-91-01	CDC2L1	74.0	10000.0
KU63794	OSR1	72.0	10000.0
AZD7762	PAK4	1.2	10000.0
NPK76-II-72-1	AKT3	100.0	10000.0
HG-14-10-04	ABL1-phosphorylated	0.2	10000.0
Alpelisib	RET	91.0	1000.0
Crizotinib	HCK	19.0	10000.0
HG-5-88-01	TRKA	100.0	10000.0
BGJ398	FLT3-autoinhibited	96.0	1000.0
RO-3306	AMPK-alpha1	96.0	10000.0
SB590885	JNK1	92.0	10000.0
Canertinib	TYRO3	100.0	1000.0
AZD 5438	DYRK2	4.0	10000.0
CG-930	M3K5	100.0	10000.0
BMS-536924	STK16	1.6	1000.0
AG1478	KPCD1	89.0	10000.0
JNK-IN-8	KPCD	100.0	1000.0
JNK-IN-11	MAP4K5	27.0	1000.0
WZ4002	PHKG1	7.7	10000.0
Vemurafenib	MERTK	60.0	10000.0
XMD16-144	KPCL	100.0	10000.0
ALW-II-49-7	CDK8	100.0	10000.0
BMX-IN-1	CDKL5	81.0	10000.0
JNK-IN-8	RSK2(Kin.Dom.1-N-terminal)	100.0	1000.0
QL-XI-92	MK01	100.0	10000.0
Buparlisib	PIK3C2G	69.0	1000.0
CP466722	MYO3B	100.0	10000.0
GW-5074	EPHB2	100.0	10000.0
CH5424802	MST3	91.0	1000.0
Seliciclib	MP2K7	100.0	10000.0
Momelotinib	ABL1(H396P)-nonphosphorylated	6.2	10000.0
XMD11-50	DMPK2	100.0	10000.0
GSK1059615	SNARK	36.0	10000.0
ZSTK474	MP2K2	100.0	1000.0
AZD-6482	PIK3C2B	0.4	10000.0
KIN001-220	NLK	98.0	10000.0
OTSSP167	STK16	46.0	10000.0
JNK-IN-8	DCAMKL2	94.0	1000.0
PHA-767491	TRKC	97.0	10000.0
ZM-447439	TGFBR2	82.0	10000.0
Seliciclib	MAP3K15	100.0	10000.0
Palbociclib	ULK3	100.0	1000.0
Alpelisib	FGR	93.0	1000.0
QL-XI-92	GRK1	86.0	10000.0
WH-4-023	PAK6	71.0	10000.0
Vemurafenib	MARK2	69.0	10000.0
WZ-7043	PGFRB	21.0	10000.0
AZD7762	TSSK1	2.6	10000.0
HG-5-113-01	EGFR(G719S)	100.0	10000.0
CGP60474	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
AS-252424	LTK	100.0	10000.0
Crizotinib	CDK2	81.0	10000.0
AG1478	PAK3	25.0	10000.0
CGP74514A	GSK3B	72.0	10000.0
HG-14-10-04	PI42C	81.0	10000.0
WZ4003	PAK7/PAK5	100.0	1000.0
KIN001-127	ABL1(M351T)	100.0	10000.0
JNK-IN-8	KCC2D	100.0	1000.0
5z-7-oxozeaenol	RET	97.0	10000.0
QL-XI-92	CSK	71.0	10000.0
HG-5-88-01	MYLK2	100.0	10000.0
GSK1059615	ULK2	65.0	10000.0
KIN001-021	FLT3	100.0	1000.0
CP466722	EGFR(L747-E749del,A750P)	44.0	10000.0
THZ1	PIK3CA(E545K)	100.0	10000.0
GW843682X	LOK	0.0	10000.0
Vemurafenib	CAMK1	25.0	10000.0
MRT67307	RSK4(Kin.Dom.2-C-terminal)	58.0	10000.0
GW843682X	ROCK2	100.0	10000.0
KIN001-127	SLK	31.0	10000.0
WZ4002	CAMK1	100.0	10000.0
WZ4003	ERBB4	17.0	1000.0
Sigma A6730	ITK	97.0	10000.0
GSK429286A	S6K1	50.0	10000.0
QL-X-138	YES	94.0	10000.0
ERK5-IN-1	CAMKK2	100.0	1000.0
GSK1059615	TAOK3	13.0	10000.0
Seliciclib	NEK7	100.0	10000.0
QL-XII-47	MST2	100.0	1000.0
WZ3105	AKT3	91.0	10000.0
WZ-7043	HIPK1	100.0	10000.0
BX-912	RPS6KA5(Kin.Dom.1-N-terminal)	57.0	10000.0
Omipalisib	TAOK1	62.0	10000.0
PHA-793887	KIT(V559D,V654A)	100.0	10000.0
JNK-9L	PIK3C2G	100.0	10000.0
CP724714	CLK4	100.0	10000.0
XMD11-85h	YANK2	100.0	10000.0
XMD11-50	PIK3CA(H1047L)	20.0	10000.0
TGX221	AURKC	100.0	1000.0
Abemaciclib	MTOR	36.0	1000.0
Pictilisib	KPCI	85.0	1000.0
CP466722	NIM1	89.0	10000.0
GSK429286A	CASK	88.0	10000.0
PD173074	PLK4	100.0	10000.0
ZSTK474	EGFR(G719S)	100.0	1000.0
QL-X-138	MUSK	93.0	10000.0
JNK-IN-8	NDR2	100.0	1000.0
XMD16-144	ABL1(Y253F)-phosphorylated	0.0	10000.0
Abemaciclib	CDK4-cyclinD3	0.7	1000.0
ZM-447439	DYRK2	91.0	10000.0
CP724714	FES	100.0	10000.0
Torin1	AMPK-alpha1	91.0	10000.0
Sorafenib	RET(V804M)	0.0	10000.0
GSK461364	KGP2	95.0	10000.0
SCH772984	MINK	21.0	1000.0
MLN8054	ROCK2	89.0	10000.0
JWE-035	DCAMKL2	1.3	10000.0
ERK5-IN-1	DAPK3	100.0	1000.0
JNK-IN-8	MAP3K15	82.0	1000.0
Dactolisib	MAP4K4	100.0	1000.0
A443654	TYK2(Kin.Dom.1)	100.0	10000.0
(s)-CR8	PAK3	94.0	10000.0
(s)-CR8	YSK4	63.0	10000.0
Taselisib	DAPK2	100.0	1000.0
WZ4003	TRKC	100.0	1000.0
Vemurafenib	FLT3(R834Q)	100.0	10000.0
CG-930	PCTK3	100.0	10000.0
XMD14-99	LCK	86.0	10000.0
Torin2	NDR1	100.0	10000.0
BMS-536924	AKT3	100.0	1000.0
MLN8054	RSK2(Kin.Dom.1-N-terminal)	28.0	10000.0
Baricitinib	NIM1	100.0	10000.0
JNK-9L	MP2K7	100.0	10000.0
CP466722	FGFR2	76.0	10000.0
RO-3306	DCAMKL3	58.0	10000.0
HG-5-88-01	CDK11	100.0	10000.0
AZD 5438	MST2	0.3	10000.0
JNK-IN-11	TYRO3	81.0	1000.0
OTSSP167	EGFR(L747-S752del,P753S)	6.6	10000.0
XMD-12	MERTK	100.0	1000.0
SP600125	NEK2	27.0	10000.0
Ceritinib	NEK7	82.0	1000.0
Ceritinib	EPHA1	88.0	1000.0
THZ1	ADCK3	78.0	10000.0
CP724714	MARK1	100.0	10000.0
GW-5074	TRKC	35.0	10000.0
PD0325901	PIK3CA(E542K)	57.0	10000.0
AS-252424	FER	95.5	10000.0
CGP74514A	MAST1	40.0	10000.0
QL-X-138	SYK	100.0	10000.0
HG-9-91-01	FLT3(ITD)	64.0	10000.0
KU63794	NEK1	100.0	10000.0
Ribociclib	EGFR	100.0	1000.0
HG-9-91-01	PIM3	94.0	10000.0
Ceritinib	MAP4K2	98.0	1000.0
Taselisib	DCAMKL2	100.0	1000.0
Ribociclib	PLK1	74.0	1000.0
XMD16-144	YANK3	93.0	10000.0
(s)-CR8	M3K12	89.0	10000.0
GW843682X	CAMK1D	100.0	10000.0
BS-181	HCK	79.0	10000.0
JNK-9L	DYRK1A	3.1	10000.0
AZD7762	ABL1(F317L)-nonphosphorylated	0.0	10000.0
TAK-715	RSK1(Kin.Dom.2-C-terminal)	28.0	10000.0
A443654	CDK11	0.5	10000.0
PHA-793887	PLK2	89.0	10000.0
JNK-IN-11	RPS6KA5(Kin.Dom.2-C-terminal)	97.0	1000.0
ALW-II-49-7	MLCK	100.0	10000.0
NPK76-II-72-1	AXL	100.0	10000.0
AZD 5438	EPHA8	70.0	10000.0
Canertinib	LIMK1	100.0	1000.0
R406	LYN	1.5	1000.0
JWE-035	STK16	15.0	10000.0
Momelotinib	SGK3	59.0	10000.0
Dinaciclib	CDK9	0.0	10000.0
GSK461364	MLK1	17.0	10000.0
KIN001-111	FYN	0.3	1000.0
Barasertib	AAK1	38.0	10000.0
KIN001-220	CDK11	76.0	10000.0
Taselisib	PGFRB	100.0	1000.0
Crizotinib	PGFRA	92.0	10000.0
WH-4-023	FLT3(N841I)	0.7	10000.0
CGP60474	JAK1(JH2domain-pseudokinase)	100.0	10000.0
HG-6-64-01	RET(M918T)	0.0	10000.0
ALW-II-38-3	SRPK3	100.0	10000.0
AZD-6482	M4K1	100.0	10000.0
AZD7762	EPHA1	1.4	10000.0
QL-XI-92	FLT3(R834Q)	100.0	10000.0
Dinaciclib	PIM3	100.0	10000.0
PHA-793887	TBK1	68.0	10000.0
Canertinib	MAP4K5	100.0	1000.0
Torin1	SBK1	88.0	10000.0
Taselisib	PIK3CA(I800L)	0.0	1000.0
HG-14-8-02	FLT3(D835Y)	7.1	10000.0
Ribociclib	MARK3	88.0	1000.0
OTSSP167	FAK1	0.4	10000.0
XMD-12	ABL1(T315I)-nonphosphorylated	3.6	1000.0
Ceritinib	EPHB2	97.0	1000.0
Lapatinib	NEK1	94.0	10000.0
Momelotinib	YANK3	100.0	10000.0
OTSSP167	MAP3K14	15.0	10000.0
AZD7762	YSK4	0.0	10000.0
XMD13-2	CSF1R	70.0	10000.0
AZD4547	PGFRB	0.0	10000.0
AS-252424	TAK1	85.7	10000.0
MRT67307	KPCD2	0.6	10000.0
JNK-IN-8	EPHA7	100.0	1000.0
XMD16-144	KIT(L576P)	33.0	10000.0
Torin1	TNNI3K	66.0	10000.0
AZD7762	TYK2(JH2domain-pseudokinase)	3.2	10000.0
MLN8054	MET(Y1235D)	51.0	10000.0
GSK1059615	ULK3	39.0	10000.0
SCH772984	CAMKK2	80.0	1000.0
QL-XII-47	LRRK2	99.0	1000.0
XMD16-144	LKB1	100.0	10000.0
R406	EPHA5	4.6	1000.0
KIN001-111	EGFR(L747-S752del,P753S)	27.0	1000.0
WYE-125132	MYO3A	52.0	10000.0
SP600125	KPCD	100.0	10000.0
Lapatinib	MARK2	91.0	10000.0
Canertinib	EPHA7	100.0	1000.0
Buparlisib	RSK2(Kin.Dom.2-C-terminal)	96.0	1000.0
Pictilisib	BMPR1A	100.0	1000.0
Barasertib	FGFR2	80.0	10000.0
CG-930	DRAK2	70.0	10000.0
Sorafenib	TBK1	100.0	10000.0
AZD4547	PIK3CG	88.0	10000.0
TGX221	MARK3	100.0	1000.0
XMD11-85h	MAP4K2	100.0	10000.0
Sorafenib	PIM2	91.0	10000.0
AZD4547	M3K6	72.0	10000.0
Ceritinib	FLT3(R834Q)	81.0	1000.0
JNK-IN-8	INSRR	100.0	1000.0
MPS-1-IN-1	KGP1	100.0	1000.0
NG25	LIMK1	100.0	10000.0
QL-XII-47	PLK4	50.0	1000.0
Vemurafenib	JNK1	18.0	10000.0
BMS345541	LTK	95.0	10000.0
Canertinib	NEK2	100.0	1000.0
KIN001-220	RET(V804L)	3.2	10000.0
NG25	MLK2	100.0	10000.0
A443654	KGP2	5.7	10000.0
PD173074	MP2K6	100.0	10000.0
CP466722	DAPK2	12.0	10000.0
CP724714	ABL1(Q252H)-phosphorylated	100.0	10000.0
PD173074	PRKR	24.0	10000.0
NPK76-II-72-1	CSNK1D	100.0	10000.0
A443654	EGFR	100.0	10000.0
ZM-447439	TAOK2	94.0	10000.0
Palbociclib	PTK6	100.0	1000.0
GW843682X	TSSK1	98.0	10000.0
WZ3105	AMPK-alpha1	78.0	10000.0
CP724714	IKKB	100.0	10000.0
AZD 5438	SLK	11.0	10000.0
AG1478	EGFR(L747-T751del,Sins)	3.2	10000.0
HG-5-113-01	EPHA7	1.7	10000.0
BMX-IN-1	BMPR1A	100.0	10000.0
ZM-447439	PLK2	100.0	10000.0
Omipalisib	RSK3(Kin.Dom.2-C-terminal)	77.0	10000.0
XMD14-99	BIKE	100.0	10000.0
NU7441	ERBB4	92.0	10000.0
ALW-II-38-3	AXL	100.0	10000.0
PLX-4720	PHKG2	52.0	10000.0
(s)-CR8	PKNB(M.tuberculosis)	100.0	10000.0
JW-7-24-1	MARK3	100.0	10000.0
WZ3105	DMPK	8.8	10000.0
Barasertib	LRRK2	100.0	10000.0
CH5424802	RSK1(Kin.Dom.1-N-terminal)	7.2	1000.0
RO-3306	ABL1(Q252H)-phosphorylated	78.0	10000.0
Barasertib	PIK3CA(C420R)	72.0	10000.0
Palbociclib	EGFR	100.0	1000.0
Alpelisib	NLK	99.0	1000.0
WZ-4-145	PAK1	100.0	10000.0
WZ4002	BRSK2	100.0	10000.0
JNK-IN-8	KKCC1	100.0	1000.0
A443654	MARK3	9.4	10000.0
CP724714	PI42C	84.0	10000.0
SP600125	MK01	100.0	10000.0
GSK429286A	FYN	82.0	10000.0
JW-7-24-1	KGP2	100.0	10000.0
KIN001-111	DRAK1	100.0	1000.0
CP466722	RSK3(Kin.Dom.1-N-terminal)	76.0	10000.0
Pictilisib	GRK7	100.0	1000.0
GSK1059615	MAST1	83.0	10000.0
Dabrafenib	TGFBR1	0.0	10000.0
Ibrutinib	SBK1	68.0	1000.0
AS-252424	VGFR2	98.4	10000.0
ALW-II-49-7	NEK5	100.0	10000.0
QL-XII-47	BMPR1B	100.0	1000.0
Torin2	DAPK2	100.0	10000.0
QL-X-138	PFPK5(P.falciparum)	100.0	10000.0
Omipalisib	ABL1(Y253F)-phosphorylated	71.0	10000.0
Torin2	EPHB3	100.0	10000.0
CP724714	MST4	90.0	10000.0
CGP74514A	ALK(C1156Y)	17.0	10000.0
BS-181	KGP1	94.0	10000.0
MPS-1-IN-1	FGR	100.0	1000.0
GSK1059615	DDR2	63.0	10000.0
PD0325901	KPCD	100.0	10000.0
GSK429286A	ICK	79.0	10000.0
WZ4003	WEE2	100.0	1000.0
Vemurafenib	ACVR2A	100.0	10000.0
BMS345541	PAK4	100.0	10000.0
Buparlisib	FLT3(ITD,D835V)	93.0	1000.0
JNK-9L	TSSK1	100.0	10000.0
AZD-6482	KPCD1	89.0	10000.0
HG-14-10-04	NIM1	15.0	10000.0
XMD11-50	PIK3CD	62.0	10000.0
OTSSP167	BIKE	3.4	10000.0
Seliciclib	ACVR1B	100.0	10000.0
QL-XII-47	NDR2	92.0	1000.0
Ibrutinib	GRK4	100.0	1000.0
GW-5074	MYLK2	85.0	10000.0
ZM-447439	EPHA3	60.0	10000.0
JNK-IN-11	ABL1(Y253F)-phosphorylated	1.6	1000.0
AZD4547	TRKC	0.1	10000.0
R406	MST1R	0.0	1000.0
ZM-447439	CDK11	100.0	10000.0
Ibrutinib	EPHA3	100.0	1000.0
WYE-125132	PLK2	100.0	10000.0
Baricitinib	AKT3	36.0	10000.0
CP466722	ERK3	85.0	10000.0
QL-XI-92	MAP4K5	100.0	10000.0
CP466722	DRAK1	1.6	10000.0
QL-X-138	GRK4	84.0	10000.0
AZD7762	PIK3CG	100.0	10000.0
WH-4-023	DAPK1	73.0	10000.0
Palbociclib	PHKG2	100.0	1000.0
Ceritinib	DAPK1	79.0	1000.0
Torin2	PIK3CB	6.6	10000.0
QL-X-138	EGFR(S752-I759del)	23.0	10000.0
PD173074	MST3	7.0	10000.0
QL-XI-92	ERBB3	100.0	10000.0
Omipalisib	MERTK	90.0	10000.0
AS-252424	DYRK1B	70.1	10000.0
THZ1	YES	9.4	10000.0
HG-14-8-02	PAK1	90.0	10000.0
Baricitinib	ULK2	0.4	10000.0
ZM-447439	FLT3(ITD)	45.0	10000.0
XMD16-144	RIOK3	16.0	10000.0
CP466722	ACVR2B	49.0	10000.0
HG-14-10-04	S6K1	58.0	10000.0
Taselisib	CSNK1A1L	100.0	1000.0
QL-X-138	PAK6	96.0	10000.0
BMX-IN-1	AKT1	100.0	10000.0
PHA-793887	LRRK2	86.0	10000.0
QL-XII-47	TNIK	83.0	1000.0
AZD-6482	KCC2D	95.0	10000.0
Torkinib	EGFR(G719S)	33.0	10000.0
Lapatinib	JNK3	100.0	10000.0
KIN001-123	RPS6KA6(Kin.Dom.2)	100.0	1000.0
TAK-715	MET(Y1235D)	81.0	10000.0
PD0325901	DRAK2	100.0	10000.0
HG-14-8-02	ACVR2B	95.0	10000.0
Vemurafenib	RSK4(Kin.Dom.1-N-terminal)	82.0	10000.0
RO-3306	ABL1-phosphorylated	97.0	10000.0
SP600125	CDC2L1	100.0	10000.0
SB590885	RIOK2	6.0	10000.0
Pictilisib	TAOK1	100.0	1000.0
HG-14-10-04	NEK10	9.6	10000.0
GW843682X	MYLK2	59.0	10000.0
JW-7-24-1	ABL1	12.0	10000.0
Taselisib	FES	87.0	1000.0
QL-X-138	TAOK3	47.0	10000.0
JWE-035	CDK4-cyclinD3	100.0	10000.0
PD173074	NEK2	100.0	10000.0
Dinaciclib	MK14	100.0	10000.0
NVP-TAE684	CSK	2.0	1000.0
WYE-125132	FLT3	75.0	10000.0
WZ4003	RIOK2	18.0	1000.0
5z-7-oxozeaenol	DYRK2	95.0	10000.0
JWE-035	RIOK2	100.0	10000.0
KIN001-123	DAPK2	100.0	1000.0
JNK-IN-11	HUNK	67.0	1000.0
KIN001-127	ANKK1	100.0	10000.0
HG-14-8-02	TYK2(JH1domain-catalytic)	56.0	10000.0
AZD-6482	RET(V804M)	100.0	10000.0
XMD8-85	SIK3	100.0	10000.0
Dabrafenib	RSK3(Kin.Dom.2-C-terminal)	78.0	10000.0
MLN8054	TRPM6	100.0	10000.0
BMS345541	CAMK1D	69.0	10000.0
Seliciclib	MARK2	53.0	10000.0
AZ-628	RSK1(Kin.Dom.1-N-terminal)	85.0	10000.0
WZ4002	RPS6KA5(Kin.Dom.1)	100.0	10000.0
AG1478	MAP3K4	83.0	10000.0
GSK429286A	CSNK2A1	81.0	10000.0
(s)-CR8	PFPK5(P.falciparum)	100.0	10000.0
KU63794	KIT(D816H)	100.0	10000.0
JNK-IN-8	EGFR	100.0	1000.0
HG-9-91-01	TIE1	29.0	10000.0
Torkinib	KPCI	52.0	10000.0
GW-5074	PLK1	100.0	10000.0
CGP74514A	CDC2L2	92.0	10000.0
Ceritinib	RSK3(Kin.Dom.1-N-terminal)	45.0	1000.0
KIN001-127	PIM2	100.0	10000.0
Taselisib	SRC	100.0	1000.0
Neratinib	MARK2	86.0	10000.0
JNK-IN-5A	PIK3CA	99.0	10000.0
Dactolisib	MET	100.0	1000.0
NU7441	PKN1	100.0	10000.0
XMD16-144	EGFR(L858R,T790M)	86.0	10000.0
Ceritinib	CHK2	3.0	1000.0
XMD-12	EGFR	100.0	1000.0
XMD11-50	VRK2	99.0	10000.0
Dactolisib	BMX	100.0	1000.0
SB590885	ABL1(H396P)-phosphorylated	6.9	10000.0
Torkinib	CAMKK2	30.0	10000.0
R406	MRCKA	100.0	1000.0
Abemaciclib	ADCK3	95.0	1000.0
OTSSP167	PI42C	100.0	10000.0
Seliciclib	CDKL3	100.0	10000.0
BX-912	NUAK1	0.0	10000.0
Momelotinib	GRK1	100.0	10000.0
Omipalisib	YSK1	82.0	10000.0
QL-XI-92	CDK3	97.0	10000.0
AZD4547	RSK3(Kin.Dom.2-C-terminal)	78.0	10000.0
ERK5-IN-1	KIT(D816V)	96.0	1000.0
Dabrafenib	MRCKA	100.0	10000.0
HG-5-88-01	ABL1(T315I)	100.0	10000.0
BMX-IN-1	MYO3B	100.0	10000.0
BMS345541	PAK2	94.0	10000.0
ZG-10	M3K12	74.0	10000.0
JW-7-24-1	DMPK	26.0	10000.0
TGX221	MAPKAPK5	100.0	1000.0
QL-XII-47	LIMK2	100.0	1000.0
Omipalisib	RSK1(Kin.Dom.2-C-terminal)	31.0	10000.0
JWE-035	SgK110	0.6	10000.0
AZD4547	RSK1(Kin.Dom.2-C-terminal)	82.0	10000.0
ZG-10	PLK2	81.0	10000.0
Sigma A6730	EIF2AK1	87.0	10000.0
PLX-4720	YANK2	100.0	10000.0
HG-5-113-01	ABL1(Q252H)	11.0	10000.0
PLX-4720	TRKA	100.0	10000.0
Taselisib	EGFR(E746-A750del)	97.0	1000.0
AZD7762	AMPK-alpha1	0.2	10000.0
MRT67307	CDK8	100.0	10000.0
Ribociclib	NEK4	100.0	1000.0
Ceritinib	PIK3CG	85.0	1000.0
GSK429286A	AMPK-alpha2	25.0	10000.0
JNK-9L	CDK11	88.0	10000.0
SB590885	JAK2(JH1domain-catalytic)	70.0	10000.0
GSK461364	MLK3	75.0	10000.0
Torin2	CDC2L2	98.0	10000.0
Abemaciclib	DYRK1B	0.8	1000.0
CG-930	STK33	100.0	10000.0
HG-14-8-02	PIK3CA(Q546K)	100.0	10000.0
QL-XII-47	TGFBR1	96.0	1000.0
Neratinib	KIT(D816V)	70.0	10000.0
AS-252424	MK11	100.0	10000.0
BMX-IN-1	PIK3C2B	40.0	10000.0
Alpelisib	PIP5K2B	76.0	1000.0
NPK76-II-72-1	RPS6KA2(Kin.Dom.1)	100.0	10000.0
Palbociclib	CDKL2	71.0	1000.0
XMD11-50	OSR1	88.0	10000.0
JNK-IN-8	TAOK2	73.0	1000.0
ALW-II-38-3	AKT3	100.0	10000.0
XMD13-2	RIPK2	72.0	10000.0
KIN001-021	AURKC	100.0	1000.0
KIN001-111	PKAC-beta	100.0	1000.0
XMD11-50	EGFR(L858R)	79.0	10000.0
XMD11-50	PIK3CA(E545A)	98.0	10000.0
Neratinib	CAMK1G	100.0	10000.0
AZ-628	LATS2	99.0	10000.0
ZM-447439	PAK1	82.0	10000.0
BGJ398	PIK3CG	87.0	1000.0
GW-5074	RET(M918T)	100.0	10000.0
HG-5-113-01	EPHB3	100.0	10000.0
ZM-447439	CAMK1D	62.0	10000.0
Sorafenib	FLT3(D835Y)	3.2	10000.0
Abemaciclib	CSNK1D	53.0	1000.0
CP466722	MET(M1250T)	44.0	10000.0
SCH772984	FLT3(D835H)	91.0	1000.0
PD173074	BRSK2	100.0	10000.0
PD173074	MK11	100.0	10000.0
Dactolisib	EGFR(S752-I759del)	100.0	1000.0
XMD16-144	PHKG2	25.0	10000.0
BI-2536	PAK6	100.0	10000.0
PHA-793887	LIMK2	100.0	10000.0
Abemaciclib	ERK4	100.0	1000.0
Torin2	RIPK4	100.0	10000.0
SCH772984	TRKB	80.0	1000.0
HG-5-88-01	BRAF(V600E)	100.0	10000.0
Dactolisib	M3K12	100.0	1000.0
(s)-CR8	LRRK2	100.0	10000.0
Ribociclib	NLK	98.0	1000.0
Abemaciclib	FAK1	69.0	1000.0
WH-4-023	SIK2	7.6	10000.0
BMS345541	EPHA3	100.0	10000.0
XMD13-2	MUSK	91.0	10000.0
Omipalisib	MAP3K15	71.0	10000.0
Dinaciclib	AMPK-alpha2	28.0	10000.0
Lapatinib	MAPKAPK2	100.0	10000.0
Torin2	KPCD1	87.0	10000.0
Ribociclib	DYRK1B	95.0	1000.0
NG25	ACVRL1	100.0	10000.0
Palbociclib	MYLK	100.0	1000.0
KIN001-021	RIPK2	100.0	1000.0
Momelotinib	BRAF	74.0	10000.0
HG-5-113-01	RET	3.8	10000.0
JNK-IN-8	TGFBR2	64.0	1000.0
NU7441	NLK	88.0	10000.0
HG-6-64-01	MARK1	94.0	10000.0
BMS345541	EGFR	100.0	10000.0
Torkinib	MYLK4	43.0	10000.0
WZ3105	FLT4	58.0	10000.0
PHA-793887	AKT2	100.0	10000.0
Lapatinib	ROCK2	88.0	10000.0
Ribociclib	FER	100.0	1000.0
Torin2	NEK5	94.0	10000.0
GW843682X	CDKL5	73.0	10000.0
PLX-4720	IRAK1	60.0	10000.0
KIN001-123	FLT3(ITD)	3.0	1000.0
JNK-IN-11	CSNK1G3	1.2	1000.0
OTSSP167	AKT3	48.0	10000.0
SB590885	ERK3	92.0	10000.0
Torin1	RSK4(Kin.Dom.1-N-terminal)	66.0	10000.0
HG-14-10-04	CDK7	23.0	10000.0
Vemurafenib	DAPK2	95.0	10000.0
Barasertib	MINK	25.0	10000.0
JNK-9L	FGFR2	91.0	10000.0
WZ-7043	MKNK2	100.0	10000.0
KU63794	JNK1	87.0	10000.0
BMX-IN-1	FAK2	92.0	10000.0
Barasertib	DYRK1A	100.0	10000.0
(s)-CR8	ACVRL1	65.0	10000.0
GSK429286A	DCAMKL3	70.0	10000.0
SCH772984	ACVR1B	99.0	1000.0
XMD-12	MAP3K1	96.0	1000.0
R406	ABL1(Q252H)	30.0	1000.0
ERK5-IN-1	ABL1(E255K)-phosphorylated	100.0	1000.0
Omipalisib	SGK3	72.0	10000.0
Palbociclib	EIF2AK1	100.0	1000.0
CG-930	BRAF(V600E)	98.0	10000.0
Dactolisib	PIK3CA(E542K)	2.8	1000.0
TAK-715	MK01	96.0	10000.0
XMD13-2	JAK1(JH1domain-catalytic)	100.0	10000.0
AZD4547	CDK4-cyclinD3	11.0	10000.0
CP724714	MET(Y1235D)	81.0	10000.0
NU7441	CAMK1	91.0	10000.0
JW-7-24-1	FLT4	18.0	10000.0
Baricitinib	NDR1	10.0	10000.0
AZ-628	CDK7	100.0	10000.0
GSK429286A	MELK	99.0	10000.0
TAK-715	CAMK1D	100.0	10000.0
CG-930	BMX	100.0	10000.0
ZSTK474	EPHA1	100.0	1000.0
XMD11-85h	CDK9	100.0	10000.0
SP600125	STK35	100.0	10000.0
Crizotinib	RET	23.0	10000.0
PLX-4720	PKAC-alpha	94.0	10000.0
Torin1	TIE1	100.0	10000.0
WH-4-023	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
XMD11-50	RIPK1	99.0	10000.0
Torin1	EPHB4	85.0	10000.0
AZD 5438	CLK2	1.4	10000.0
JWE-035	GAK	12.0	10000.0
BGJ398	CSNK1E	98.0	1000.0
HG-5-113-01	RPS6KA2(Kin.Dom.2)	100.0	10000.0
PLX-4720	EPHA5	100.0	10000.0
XMD-12	TIE1	59.0	1000.0
BMS345541	PIP5K1C	92.0	10000.0
Sorafenib	MYO3A	67.0	10000.0
Lapatinib	EPHA4	96.0	10000.0
Ceritinib	RSK4(Kin.Dom.2-C-terminal)	8.4	1000.0
QL-XII-47	CSNK1E	96.0	1000.0
SCH772984	ABL1(F317I)-phosphorylated	100.0	1000.0
CG-930	MRCKB	100.0	10000.0
THZ1	ITK	0.4	10000.0
AZ-628	PKAC-beta	100.0	10000.0
SP600125	EPHA5	100.0	10000.0
THZ1	M3K2	3.6	10000.0
JNK-IN-11	JAK2(JH1domain-catalytic)	100.0	1000.0
Vemurafenib	MARK3	61.0	10000.0
AZD 5438	CAMK1	50.0	10000.0
ZM-447439	RET	0.2	10000.0
GSK429286A	GSK3B	89.0	10000.0
BS-181	FLT3(K663Q)	43.0	10000.0
WZ-7043	PIK3CA	100.0	10000.0
Alpelisib	FLT3(D835Y)	100.0	1000.0
Palbociclib	MINK	95.0	1000.0
BMS345541	PGFRB	57.0	10000.0
SCH772984	CDKL3	92.0	1000.0
JNK-IN-5A	LTK	90.0	10000.0
JNK-IN-11	RIOK3	97.0	1000.0
Omipalisib	DMPK	100.0	10000.0
CG-930	MK01	15.0	10000.0
KIN001-123	CAMK1G	100.0	1000.0
KIN001-111	RPS6KA3(Kin.Dom.1)	100.0	1000.0
XMD14-99	YANK1	88.0	10000.0
WZ-7043	DDR2	30.0	10000.0
AS-252424	BMPR2	12.5	10000.0
Sorafenib	ABL1(M351T)-phosphorylated	21.0	10000.0
XMD11-50	MAP3K15	69.0	10000.0
OTSSP167	ROCK1	100.0	10000.0
Palbociclib	EGFR(L858R)	100.0	1000.0
GW843682X	MP2K6	85.0	10000.0
WZ4003	KC1G1	100.0	1000.0
Crizotinib	BLK	1.2	10000.0
Buparlisib	PIK3C2B	100.0	1000.0
AS-252424	NUAK1	100.0	10000.0
JNK-IN-8	ANKK1	75.0	1000.0
BI-2536	MST3	100.0	10000.0
JNK-9L	FAK2	20.0	10000.0
AZD4547	BTK	24.0	10000.0
Sigma A6730	PHKG1	100.0	10000.0
Torkinib	PAK7	8.6	10000.0
XMD11-85h	RPS6KA1(Kin.Dom.2)	100.0	10000.0
MLN8054	PIP5K2B	100.0	10000.0
CGP74514A	PDPK1	85.0	10000.0
WZ3105	NEK6	90.0	10000.0
SCH772984	S6K1	43.0	1000.0
JW-7-24-1	CDK16	100.0	10000.0
GW-5074	EPHA1	98.0	10000.0
WH-4-023	ABL1(H396P)-nonphosphorylated	0.0	10000.0
NU7441	CSNK1E	76.0	10000.0
BI-2536	AKT1	100.0	10000.0
A443654	TLK2	100.0	10000.0
Pictilisib	RPS6KA3(Kin.Dom.1)	100.0	10000.0
BMS-536924	TGFBR1	100.0	1000.0
THZ1	MET	2.8	10000.0
Palbociclib	STK36	96.0	1000.0
AZD-6482	TNK2	100.0	10000.0
WZ4002	MARK3	7.8	10000.0
WZ4003	DCAMKL2	0.3	1000.0
Torkinib	CAMK1D	22.0	10000.0
Seliciclib	KC1G1	55.0	10000.0
GW843682X	TESK1	73.0	10000.0
Crizotinib	RIOK1	3.4	10000.0
BMS345541	CDK15	100.0	10000.0
QL-XII-47	DMPK	95.0	1000.0
HG-14-8-02	IKKE	98.0	10000.0
WZ4003	TIE2	100.0	1000.0
CP466722	HUNK	41.0	10000.0
WZ4002	PRKR	100.0	10000.0
PHA-767491	CSNK2A1	3.0	10000.0
GW-5074	AAK1	5.2	10000.0
Abemaciclib	ACVRL1	100.0	1000.0
Torkinib	CSK	15.0	10000.0
Pictilisib	MARK1	86.0	1000.0
PHA-767491	MK09	92.0	10000.0
AZD-6482	NEK4	61.0	10000.0
AZ-628	PAK4	72.0	10000.0
MLN8054	ERK5	100.0	10000.0
BMX-IN-1	NDR2	95.0	10000.0
HG-14-10-04	KIT(V559D)	0.0	10000.0
Alpelisib	ABL1(F317I)-nonphosphorylated	44.0	1000.0
OTSSP167	ERBB4	24.0	10000.0
Alpelisib	WEE2	100.0	1000.0
QL-XII-47	S6K1	95.0	1000.0
JWE-035	ERN1	96.0	10000.0
CGP74514A	MST1	50.0	10000.0
BGJ398	EGFR(G719S)	88.0	1000.0
BI-2536	TNNI3K	100.0	10000.0
AZD 5438	MST1	29.0	10000.0
KIN001-127	YSK1	100.0	10000.0
BGJ398	VGFR2	27.0	1000.0
RO-3306	MAP4K2	8.8	10000.0
XMD11-50	EGFR(L747-E749del,A750P)	78.0	10000.0
ZG-10	EGFR(T790M)	65.0	10000.0
CH5424802	HUNK	96.0	1000.0
CP724714	TRPM6	100.0	10000.0
Barasertib	ABL1(F317I)-nonphosphorylated	15.0	10000.0
AG1478	DYRK2	27.0	10000.0
Ibrutinib	NIM1	100.0	1000.0
ZM-447439	SLK	1.0	10000.0
JNK-IN-11	CAMKK2	100.0	1000.0
BS-181	ABL1(M351T)-phosphorylated	100.0	10000.0
WYE-125132	AMPK-alpha1	94.0	10000.0
QL-XI-92	AURKA	95.0	10000.0
KIN001-220	ERK4	82.0	10000.0
XMD8-85	MK03	100.0	10000.0
Ibrutinib	PIK3CA(H1047L)	54.0	1000.0
WZ-7043	PIK3CA(M1043I)	100.0	10000.0
AG1478	PAK7	90.0	10000.0
Pictilisib	PHKG1	100.0	1000.0
XMD11-85h	KC1G2	100.0	10000.0
JNK-9L	ABL1(H396P)-phosphorylated	87.0	10000.0
CH5424802	GRK4	80.0	1000.0
THZ1	TESK1	90.0	10000.0
BMS345541	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
BMX-IN-1	RIPK1	100.0	10000.0
ZM-447439	RIPK5	34.0	10000.0
BS-181	JNK1	70.0	10000.0
GW843682X	GRK4	18.0	10000.0
AG1478	MAP3K14	100.0	10000.0
XMD-12	RIOK3	82.0	1000.0
Buparlisib	RSK1(Kin.Dom.1-N-terminal)	94.0	1000.0
WZ-7043	MP2K4	100.0	10000.0
GSK429286A	CLK1	72.0	10000.0
CG-930	MP2K5	75.0	10000.0
WYE-125132	PKAC-beta	87.0	10000.0
HG-9-91-01	DYRK2	99.0	10000.0
AS-252424	FLT3(N841I)	82.3	10000.0
XMD-12	TAK1	58.0	1000.0
AS-252424	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
GSK1059615	FLT3(ITD)	47.0	10000.0
GSK461364	GRK7	33.0	10000.0
Omipalisib	ACVR2A	86.0	10000.0
Dactolisib	MST1	100.0	1000.0
OTSSP167	TIE1	100.0	10000.0
QL-XI-92	TESK1	100.0	10000.0
OTSSP167	MK09	0.2	10000.0
NG25	TXK	12.0	10000.0
CP724714	CDKL1	69.0	10000.0
Seliciclib	MRCKA	100.0	10000.0
AZD4547	EPHA3	26.0	10000.0
ZM-447439	MET(M1250T)	4.0	10000.0
ZG-10	PIK4CB	51.0	10000.0
Crizotinib	ERN1	42.0	10000.0
BX-912	NEK1	30.0	10000.0
Taselisib	ACVR1	100.0	1000.0
BX-912	TAK1	1.3	10000.0
(s)-CR8	KPCT	100.0	10000.0
A443654	TTK	100.0	10000.0
QL-XII-47	KPCD	100.0	1000.0
BX-912	LOK	4.6	10000.0
Vemurafenib	CAMK2A	100.0	10000.0
TAK-715	CDK16	100.0	10000.0
XMD11-50	YANK2	100.0	10000.0
Abemaciclib	PIK3C3	12.0	1000.0
BI-D1870	FGFR3	32.0	10000.0
XMD8-92	KGP1	100.0	10000.0
JW-7-24-1	ABL1(F317L)	100.0	10000.0
Dactolisib	KGP1	100.0	1000.0
NU7441	MAP4K5	89.0	10000.0
Palbociclib	DRAK2	100.0	1000.0
BS-181	KPCT	32.0	10000.0
NPK76-II-72-1	SNARK	100.0	10000.0
HG-14-8-02	TAOK1	61.0	10000.0
Dabrafenib	DAPK2	46.0	10000.0
Palbociclib	SLK	65.0	1000.0
THZ1	NIM1	59.0	10000.0
Torin2	CSNK1D	63.0	10000.0
ZSTK474	AMPK-alpha2	100.0	1000.0
WYE-125132	CIT	100.0	10000.0
Barasertib	PIK3CA(H1047Y)	30.0	10000.0
JWE-035	CDK9	100.0	10000.0
SB590885	NEK6	100.0	10000.0
5z-7-oxozeaenol	KGP1	99.0	10000.0
ZG-10	KPCL	100.0	10000.0
PD0325901	RET	90.0	10000.0
BMX-IN-1	NEK1	81.0	10000.0
Crizotinib	MYO3A	66.0	10000.0
PHA-767491	SBK1	59.0	10000.0
TGX221	ERK4	100.0	1000.0
BGJ398	MUSK	100.0	1000.0
WZ4003	STK33	1.5	1000.0
BMS-536924	SgK110	8.6	1000.0
ALW-II-38-3	MLK1	100.0	10000.0
Torkinib	KPCD	39.0	10000.0
RO-3306	PLK2	74.0	10000.0
HG-14-8-02	CAMKK2	19.0	10000.0
CG-930	STK39	100.0	10000.0
Lapatinib	SRPK3	87.0	10000.0
KIN001-021	ACVR2B	100.0	1000.0
ZSTK474	JNK3	100.0	1000.0
PHA-793887	DAPK2	96.0	10000.0
XMD16-144	LRRK2	31.0	10000.0
WZ-7043	EGFR(L861Q)	100.0	10000.0
CGP60474	NUAK1	100.0	10000.0
WZ-7043	ALK	100.0	10000.0
CGP74514A	MAP4K5	77.0	10000.0
Momelotinib	MINK	82.0	10000.0
GSK461364	CDK4-cyclinD1	91.0	10000.0
BI-D1870	CDK2	8.4	10000.0
SB590885	IKKA	92.0	10000.0
NG25	PLK3	100.0	10000.0
AZ-628	NEK2	100.0	10000.0
Torin2	KIT(V559D,T670I)	68.0	10000.0
Torin2	CAMK1D	100.0	10000.0
AG1478	PIK3CD	71.0	10000.0
XMD11-85h	NLK	100.0	10000.0
GW-5074	MP2K3	46.0	10000.0
MPS-1-IN-1	MARK1	100.0	1000.0
BMS-536924	TYK2(Kin.Dom.1)	0.6	1000.0
HG-6-64-01	AXL	4.6	10000.0
WZ-4-145	SIK2	100.0	10000.0
Abemaciclib	PLK1	85.0	1000.0
JNK-IN-8	ACVR2B	100.0	1000.0
JNK-IN-8	ALK	85.0	1000.0
Crizotinib	MARK3	7.2	10000.0
ZSTK474	FAK2	100.0	1000.0
WZ3105	FGFR1	76.0	10000.0
Palbociclib	WNK2	100.0	1000.0
HG-9-91-01	MAP4K5	0.7	10000.0
Dabrafenib	KPCT	90.0	10000.0
TGX221	TNK1	100.0	1000.0
GW-5074	ERN1	57.0	10000.0
NPK76-II-72-1	EGFR	100.0	10000.0
ZG-10	TGFBR1	100.0	10000.0
JWE-035	ROCK2	100.0	10000.0
HG-9-91-01	CAMK1	58.0	10000.0
Dinaciclib	BMX	100.0	10000.0
OTSSP167	AMPK-alpha2	1.4	10000.0
Taselisib	EPHA1	100.0	1000.0
CP466722	PLK1	22.0	10000.0
TAK-715	ERBB3	49.0	10000.0
JNK-IN-8	ROCK2	49.0	1000.0
Palbociclib	PAK7	100.0	1000.0
Ibrutinib	TLK2	99.0	1000.0
GSK429286A	MAPKAPK5	100.0	10000.0
WYE-125132	TYK2(JH1domain-catalytic)	100.0	10000.0
JWE-035	EGFR(L747-E749del,A750P)	79.0	10000.0
BX-912	MP2K2	0.2	10000.0
Pictilisib	KIT(D816H)	83.0	1000.0
KIN001-111	RPS6KA4(Kin.Dom.2)	100.0	1000.0
PD173074	BIKE	100.0	10000.0
HG-14-10-04	TAOK2	88.0	10000.0
KIN001-127	MERTK	3.2	10000.0
Ceritinib	LYN	96.0	1000.0
Taselisib	ABL1(T315I)-phosphorylated	100.0	1000.0
A443654	RIOK1	2.8	10000.0
SB590885	RAF1	0.0	10000.0
MPS-1-IN-1	PAK6	100.0	1000.0
QL-XI-92	YANK2	100.0	10000.0
QL-XI-92	HIPK1	97.0	10000.0
QL-XI-92	KPCI	100.0	10000.0
KIN001-220	PFPK5(P.falciparum)	100.0	10000.0
Ribociclib	TLK2	100.0	1000.0
(s)-CR8	KPCI	91.0	10000.0
HG-14-8-02	CSNK2A2	0.9	10000.0
Neratinib	MUSK	100.0	10000.0
Lapatinib	AXL	33.0	10000.0
Vemurafenib	EPHB4	100.0	10000.0
SP600125	GSK3B	100.0	10000.0
CH5424802	AURKC	95.0	1000.0
QL-X-138	SBK1	90.0	10000.0
Omipalisib	M3K6	83.0	10000.0
CP466722	AKT3	100.0	10000.0
NPK76-II-72-1	NEK2	100.0	10000.0
CG-930	VRK2	100.0	10000.0
WZ-4-145	CDK9	100.0	10000.0
ALW-II-38-3	CDKL5	100.0	10000.0
AZ-628	CDKL3	100.0	10000.0
CG-930	CDK4-cyclinD3	80.0	10000.0
HG-14-8-02	MYO3A	45.0	10000.0
(s)-CR8	SRMS	97.0	10000.0
ALW-II-38-3	MINK	100.0	10000.0
ZG-10	AURKC	5.5	10000.0
SCH772984	RSK4(Kin.Dom.2-C-terminal)	89.0	1000.0
BMS345541	LCK	98.0	10000.0
NPK76-II-72-1	MET	100.0	10000.0
BMS345541	FLT4	100.0	10000.0
QL-XII-47	MK11	86.0	1000.0
AZD 5438	RPS6KA5(Kin.Dom.2-C-terminal)	72.0	10000.0
Taselisib	ULK1	100.0	1000.0
NG25	MRCKB	100.0	10000.0
MRT67307	PGFRB	3.3	10000.0
Torkinib	SYK	100.0	10000.0
CP724714	PIM3	100.0	10000.0
KU63794	MRCKB	81.0	10000.0
Pictilisib	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	1000.0
Vemurafenib	EPHA8	83.0	10000.0
Dactolisib	IGF1R	100.0	1000.0
Dabrafenib	MP2K4	1.4	10000.0
HG-14-10-04	PAK1	17.0	10000.0
Neratinib	RSK1(Kin.Dom.1-N-terminal)	57.0	10000.0
JNK-IN-5A	KIT(D816H)	85.0	10000.0
Neratinib	CLK4	100.0	10000.0
CGP74514A	KPCD3	53.0	10000.0
Buparlisib	WNK3	100.0	1000.0
QL-XII-47	MK09	79.0	1000.0
THZ1	TYK2(JH2domain-pseudokinase)	3.6	10000.0
Pictilisib	TESK1	100.0	1000.0
BMS-536924	ERK3	100.0	1000.0
WZ-7043	YSK1	100.0	10000.0
AZD 5438	M3K12	74.0	10000.0
Taselisib	MK12	100.0	1000.0
THZ1	TSSK1	53.0	10000.0
(s)-CR8	STK16	36.0	10000.0
Ibrutinib	EPHB1	86.0	1000.0
QL-XII-47	PIK3CA(C420R)	64.0	1000.0
WYE-125132	EGFR(L747-E749del,A750P)	52.0	10000.0
RO-3306	MARK2	89.0	10000.0
KIN001-220	STK36	2.1	10000.0
XMD16-144	VGFR1	83.0	10000.0
GW843682X	ERBB4	80.0	10000.0
MPS-1-IN-1	FLT4	100.0	1000.0
THZ1	CAMK2B	62.0	10000.0
Sigma A6730	CSNK1G3	93.0	10000.0
GSK1059615	MK09	39.0	10000.0
ALW-II-49-7	MK03	100.0	10000.0
Crizotinib	KKCC1	60.0	10000.0
RO-3306	TXK	74.0	10000.0
SP600125	FLT3(N841I)	100.0	10000.0
HG-9-91-01	CDK3	100.0	10000.0
THZ1	CSNK1D	83.0	10000.0
PHA-793887	ERK3	20.0	10000.0
QL-XII-47	ABL1(H396P)-phosphorylated	100.0	1000.0
WZ3105	AXL	40.0	10000.0
WH-4-023	OSR1	93.0	10000.0
AZD-6482	MLTK	100.0	10000.0
GSK429286A	CDK7	58.0	10000.0
GSK429286A	EGFR(L858R)	90.0	10000.0
Dactolisib	MAST1	100.0	1000.0
CP724714	MAP3K4	97.0	10000.0
Barasertib	LKB1	80.0	10000.0
CGP60474	TTK	100.0	10000.0
CP466722	ROS1	25.0	10000.0
XMD11-85h	TRKC	100.0	10000.0
Buparlisib	EPHA5	100.0	1000.0
(s)-CR8	TEC	90.0	10000.0
WYE-125132	TNNI3K	59.0	10000.0
Seliciclib	CDK4-cyclinD3	92.0	10000.0
ZM-447439	GSK3B	70.0	10000.0
OTSSP167	MK13	5.6	10000.0
Momelotinib	MP2K6	77.0	10000.0
Omipalisib	DDR2	66.0	10000.0
CP466722	MKNK2	8.4	10000.0
XMD13-2	FLT3(D835H)	47.0	10000.0
Barasertib	DDR2	27.0	10000.0
CH5424802	FGFR3	100.0	1000.0
QL-XII-47	CHK2	100.0	1000.0
Baricitinib	BMPR1B	3.1	10000.0
GSK429286A	TNIK	100.0	10000.0
CP466722	CAMK1D	34.0	10000.0
XMD11-50	TXK	91.0	10000.0
CGP74514A	RPS6KA5(Kin.Dom.1-N-terminal)	81.0	10000.0
WZ-4-145	FES	4.0	10000.0
NPK76-II-72-1	RPS6KA2(Kin.Dom.2)	5.8	10000.0
GSK1059615	BMX	100.0	10000.0
HG-14-10-04	ACVR2A	100.0	10000.0
JNK-IN-8	PIM2	100.0	1000.0
KU63794	MK14	99.0	10000.0
AG1478	PAK1	85.0	10000.0
XMD16-144	CSF1R	0.1	10000.0
PD173074	BRSK1	100.0	10000.0
CP466722	RSK3(Kin.Dom.2-C-terminal)	43.0	10000.0
CG-930	EGFR(G719S)	12.0	10000.0
CGP60474	PRKR	100.0	10000.0
ZM-447439	TLK2	100.0	10000.0
5z-7-oxozeaenol	EPHA5	91.0	10000.0
JNK-IN-5A	PFPK5(P.falciparum)	100.0	10000.0
Dabrafenib	TRKB	14.0	10000.0
THZ1	PHKG1	22.0	10000.0
JWE-035	ANKK1	18.0	10000.0
Baricitinib	PAK7	16.0	10000.0
Palbociclib	FLT3(R834Q)	100.0	1000.0
Ibrutinib	ERK8	91.0	1000.0
XMD-12	LYN	80.0	1000.0
Dinaciclib	NEK2	100.0	10000.0
KIN001-127	MYLK4	100.0	10000.0
CGP74514A	EPHA6	64.0	10000.0
AZ-628	CDK5	100.0	10000.0
BMX-IN-1	ABL1-nonphosphorylated	73.0	10000.0
Canertinib	TNK1	100.0	1000.0
RO-3306	BMPR2	6.4	10000.0
PD0325901	MP2K1	0.1	10000.0
Sigma A6730	IGF1R	100.0	10000.0
AZD7762	TIE2	17.0	10000.0
TAK-715	SRMS	83.0	10000.0
PLX-4720	LATS1	86.0	10000.0
ERK5-IN-1	DYRK1B	71.0	1000.0
5z-7-oxozeaenol	NEK7	81.0	10000.0
Pictilisib	KIT(V559D,V654A)	100.0	1000.0
Omipalisib	TRKC	50.0	10000.0
Ceritinib	EGFR(L747-T751del,Sins)	56.0	1000.0
Palbociclib	MERTK	98.0	1000.0
XMD11-50	SNARK	47.0	10000.0
WZ4003	EGFR(S752-I759del)	17.0	1000.0
PHA-793887	CDC2L1	100.0	10000.0
Dabrafenib	KIT(D816V)	49.0	10000.0
ALW-II-49-7	FYN	100.0	10000.0
Baricitinib	CAMK2B	0.7	10000.0
Vemurafenib	MP2K5	0.2	10000.0
WH-4-023	SGK3	100.0	10000.0
Dabrafenib	CDK4-cyclinD1	0.3	10000.0
XMD13-2	IKKE	100.0	10000.0
XMD11-85h	EPHA3	100.0	10000.0
MLN8054	NEK4	66.0	10000.0
XMD11-85h	M3K6	100.0	10000.0
WZ3105	NDR2	41.0	10000.0
XMD-12	HIPK4	91.0	1000.0
GSK461364	PIM3	11.0	10000.0
Dactolisib	LIMK2	100.0	1000.0
WZ4002	PAK1	100.0	10000.0
KIN001-123	AKT3	100.0	1000.0
MPS-1-IN-1	KIT(V559D,V654A)	100.0	1000.0
PD0325901	PKNB(M.tuberculosis)	91.0	10000.0
Buparlisib	TYK2(JH1domain-catalytic)	100.0	1000.0
BMS345541	CDK2	89.0	10000.0
GSK429286A	KIT(L576P)	93.0	10000.0
ZM-447439	PLK1	100.0	10000.0
Baricitinib	EPHB1	53.0	10000.0
HG-5-88-01	FRK	6.6	10000.0
PLX-4720	ULK2	60.0	10000.0
XMD8-92	BMPR2	100.0	10000.0
Dactolisib	ADCK4	100.0	1000.0
NG25	KC1G2	100.0	10000.0
Sigma A6730	TEC	100.0	10000.0
GSK1059615	KC1G2	0.1	10000.0
GSK461364	AURKA	100.0	10000.0
XMD13-2	AURKB	30.0	10000.0
KIN001-021	EPHA8	100.0	1000.0
Dinaciclib	TLK1	0.9	10000.0
JNK-IN-5A	FLT3	94.0	10000.0
QL-XII-47	STK33	100.0	1000.0
CP466722	RIPK1	86.0	10000.0
ZG-10	AKT1	100.0	10000.0
Palbociclib	YANK2	100.0	1000.0
HG-14-8-02	KPCD2	49.0	10000.0
Baricitinib	BMX	100.0	10000.0
ZM-447439	MYLK4	100.0	10000.0
KIN001-021	CDC2L1	100.0	1000.0
JW-7-24-1	CDK9	100.0	10000.0
GSK461364	CDK5	100.0	10000.0
BMS-536924	AMPK-alpha1	5.4	1000.0
KIN001-111	BRAF	8.9	1000.0
HG-14-8-02	EPHA6	100.0	10000.0
HG-5-88-01	JAK1(Kin.Dom.1)	100.0	10000.0
BMS-536924	CLK2	3.1	1000.0
Taselisib	ACVRL1	100.0	1000.0
BMS345541	CSNK2A2	86.0	10000.0
Baricitinib	M3K13	81.0	10000.0
CP466722	TGFBR1	14.0	10000.0
Abemaciclib	KIT(V559D,V654A)	100.0	1000.0
JNK-IN-8	EGFR(G719C)	81.0	1000.0
Vemurafenib	JNK3	91.0	10000.0
AZD4547	IGF1R	2.6	10000.0
GW-5074	ABL1(F317L)-nonphosphorylated	69.0	10000.0
Palbociclib	ABL1-nonphosphorylated	97.0	1000.0
NU7441	SNRK	73.0	10000.0
(s)-CR8	PLK4	100.0	10000.0
XMD8-92	PIP5K2B	100.0	10000.0
PD173074	PIK3CA	20.0	10000.0
NVP-TAE684	DMPK	1.8	1000.0
WZ4003	PAK4	100.0	1000.0
HG-9-91-01	AKT1	100.0	10000.0
WZ3105	TGFBR2	100.0	10000.0
XMD11-85h	EGFR(G719S)	100.0	10000.0
HG-5-88-01	WEE2	100.0	10000.0
MRT67307	AKT2	100.0	10000.0
QL-XI-92	HUNK	100.0	10000.0
KIN001-123	SRPK2	100.0	1000.0
Omipalisib	GRK1	86.0	10000.0
KIN001-111	CLK2	100.0	1000.0
Sorafenib	CDK16	72.0	10000.0
KIN001-123	CAMK2B	100.0	1000.0
XMD11-50	RIPK2	100.0	10000.0
XMD-12	DYRK1A	100.0	1000.0
5z-7-oxozeaenol	LRRK2(G2019S)	98.0	10000.0
BI-D1870	PIP5K2B	7.4	10000.0
ZG-10	SLK	98.0	10000.0
KU63794	CDK14	100.0	10000.0
XMD8-85	DAPK1	100.0	10000.0
AZD 5438	MET	13.0	10000.0
JWE-035	EGFR	73.0	10000.0
NG25	MST4	100.0	10000.0
SB590885	TAOK1	81.0	10000.0
HG-14-8-02	MP2K2	92.0	10000.0
JWE-035	CLK4	100.0	10000.0
WZ4003	JAK3(Kin.Dom.2)	21.0	1000.0
JNK-IN-11	JNK1	0.0	1000.0
A443654	ABL1	100.0	10000.0
AZD7762	PIK3C2G	64.0	10000.0
Palbociclib	CDK2	99.0	1000.0
BMS-536924	TYRO3	100.0	1000.0
Momelotinib	KKCC1	27.0	10000.0
CP466722	CTK	57.0	10000.0
WYE-125132	RSK4(Kin.Dom.2-C-terminal)	84.0	10000.0
XMD11-85h	EPHB6	100.0	10000.0
Sorafenib	PCTK3	70.0	10000.0
XMD-12	ROCK2	86.0	1000.0
WZ4002	PIK3C2B	100.0	10000.0
RO-3306	MK01	84.0	10000.0
THZ1	KPCT	0.0	10000.0
Taselisib	DDR1	97.0	1000.0
WZ3105	KPCT	3.6	10000.0
WZ4003	ABL1(F317L)	100.0	1000.0
XMD11-85h	TRKA	100.0	10000.0
KIN001-111	CSNK1D	14.0	1000.0
Ibrutinib	BIKE	84.0	1000.0
RO-3306	AKT3	100.0	10000.0
Omipalisib	ABL1(Q252H)-nonphosphorylated	77.0	10000.0
Crizotinib	ZAP70	29.0	10000.0
BMX-IN-1	TAOK2	100.0	10000.0
SP600125	KCC2D	100.0	10000.0
XMD8-85	DAPK2	100.0	10000.0
Dactolisib	CSNK1E	100.0	1000.0
GSK429286A	PIK3CD	98.0	10000.0
Seliciclib	PCTK2	82.0	10000.0
AG1478	GRK4	100.0	10000.0
KIN001-127	MK01	100.0	10000.0
Canertinib	KGP2	100.0	1000.0
Ibrutinib	RSK2(Kin.Dom.1-N-terminal)	73.0	1000.0
XMD16-144	EGFR(L747-S752del,P753S)	100.0	10000.0
XMD11-85h	EGFR	100.0	10000.0
Seliciclib	CHEK1	100.0	10000.0
AS-252424	KC1G1	64.5	10000.0
Momelotinib	TGFBR1	76.0	10000.0
KIN001-220	JNK1	1.7	10000.0
AZD-6482	CSNK1G3	100.0	10000.0
PD173074	KIT	100.0	10000.0
JW-7-24-1	MAP4K5	27.0	10000.0
Vemurafenib	CDK3	94.0	10000.0
AZD7762	FGFR3(G697C)	22.0	10000.0
Crizotinib	RSK2(Kin.Dom.1-N-terminal)	47.0	10000.0
XMD11-50	ULK2	67.0	10000.0
GSK1059615	BUB1	12.0	10000.0
ZG-10	MLTK	62.0	10000.0
XMD-12	AAK1	62.0	1000.0
Alpelisib	SBK1	100.0	1000.0
ERK5-IN-1	BRSK1	100.0	1000.0
ALW-II-49-7	EGFR(G719C)	100.0	10000.0
HG-14-10-04	MAST1	11.0	10000.0
NG25	FGFR3(G697C)	14.0	10000.0
TAK-715	KGP1	100.0	10000.0
SB590885	ABL1(F317L)-phosphorylated	37.0	10000.0
QL-XI-92	ACVR2B	100.0	10000.0
ALW-II-49-7	GAK	100.0	10000.0
Abemaciclib	RSK1(Kin.Dom.1-N-terminal)	89.0	1000.0
JNK-9L	PIK3C2B	76.0	10000.0
BX-912	GAK	1.4	10000.0
HG-14-10-04	KPCD2	0.0	10000.0
ZSTK474	KIT(V559D,V654A)	100.0	1000.0
XMD16-144	PGFRA	100.0	10000.0
Palbociclib	HCK	100.0	1000.0
SP600125	SRMS	100.0	10000.0
PHA-793887	ULK1	0.7	10000.0
XMD8-92	NEK1	100.0	10000.0
Torin1	FAK2	100.0	10000.0
Neratinib	PDPK1	88.0	10000.0
HG-6-64-01	ROS1	100.0	10000.0
SCH772984	CSNK2A1	25.0	1000.0
BGJ398	CDC2L5	58.0	1000.0
SB590885	FGR	87.0	10000.0
RO-3306	BRAF(V600E)	78.0	10000.0
CG-930	LRRK2(G2019S)	95.0	10000.0
5z-7-oxozeaenol	KPCD3	12.0	10000.0
SP600125	NLK	100.0	10000.0
JNK-9L	SNARK	57.0	10000.0
Abemaciclib	LYN	97.0	1000.0
(s)-CR8	TIE1	72.0	10000.0
JWE-035	CDK8	94.0	10000.0
BI-D1870	MARK1	22.0	10000.0
HG-5-88-01	PHKG1	12.0	10000.0
BMS345541	MINK	100.0	10000.0
AZ-628	SRMS	7.4	10000.0
RO-3306	MK11	100.0	10000.0
Neratinib	GAK	10.0	10000.0
Buparlisib	STK35	97.0	1000.0
BMS345541	DCAMKL3	76.0	10000.0
Dabrafenib	TIE2	2.2	10000.0
CG-930	FLT3(R834Q)	91.0	10000.0
MPS-1-IN-1	JAK1(Kin.Dom.2)	100.0	1000.0
CGP74514A	EPHA7	67.0	10000.0
AZ-628	AXL	75.0	10000.0
NU7441	EPHB1	100.0	10000.0
SP600125	PIP5K2B	100.0	10000.0
CH5424802	FLT4	59.0	1000.0
JNK-9L	DMPK	85.0	10000.0
KIN001-220	NDR1	70.0	10000.0
AZD4547	FLT3(D835H)	0.2	10000.0
(s)-CR8	LOK	99.0	10000.0
HG-5-88-01	M4K1	100.0	10000.0
Ibrutinib	MP2K4	100.0	1000.0
Neratinib	ERBB4	0.0	10000.0
MPS-1-IN-1	STK35	100.0	1000.0
OTSSP167	ABL1(H396P)-phosphorylated	0.2	10000.0
Abemaciclib	CAMK1D	27.0	1000.0
WZ-7043	STK36	100.0	10000.0
Ceritinib	BRSK1	75.0	1000.0
QL-X-138	MRCKB	97.0	10000.0
XMD-12	RIPK4	61.0	1000.0
SCH772984	CDC2L5	93.0	1000.0
OTSSP167	ITK	0.3	10000.0
KIN001-111	CHEK1	100.0	1000.0
TAK-715	LRRK2(G2019S)	100.0	10000.0
RO-3306	SRPK2	82.0	10000.0
Buparlisib	SBK1	100.0	1000.0
Omipalisib	LCK	64.0	10000.0
XMD8-85	GSK3A	100.0	10000.0
NVP-TAE684	FLT3(D835Y)	0.1	1000.0
AZ-628	KKCC1	34.0	10000.0
KU63794	FLT3(D835H)	100.0	10000.0
XMD8-92	EGFR(E746-A750del)	100.0	10000.0
WYE-125132	CAMK1G	100.0	10000.0
AS-252424	MP2K1	80.8	10000.0
Crizotinib	RIOK3	3.4	10000.0
Palbociclib	SIK2	98.0	1000.0
BMX-IN-1	ABL1-phosphorylated	79.0	10000.0
Dinaciclib	AKT1	100.0	10000.0
PD0325901	M4K1	77.0	10000.0
Torin2	INSRR	100.0	10000.0
XMD16-144	CSNK1G3	39.0	10000.0
Lapatinib	MARK3	100.0	10000.0
Seliciclib	WNK1	100.0	10000.0
CGP74514A	NUAK1	9.0	10000.0
CGP74514A	BMPR1B	60.0	10000.0
Crizotinib	CDK4-cyclinD3	39.0	10000.0
Crizotinib	FGFR3	22.0	10000.0
WZ3105	STK35	80.0	10000.0
AZ-628	EPHA5	1.0	10000.0
ZM-447439	ERK3	100.0	10000.0
ZM-447439	RIPK4	56.0	10000.0
GSK429286A	HIPK2	87.0	10000.0
ZG-10	FLT3	36.0	10000.0
NU7441	TYK2(JH2domain-pseudokinase)	100.0	10000.0
Dabrafenib	DMPK2	100.0	10000.0
GW843682X	MYLK4	17.0	10000.0
HG-5-88-01	FLT3(ITD)	20.0	10000.0
Abemaciclib	CLK3	82.0	1000.0
Barasertib	CDK5	100.0	10000.0
GW-5074	ACVR1B	33.0	10000.0
BMS-536924	NEK1	100.0	1000.0
Crizotinib	CDK11	100.0	10000.0
XMD-12	YANK2	100.0	1000.0
AZD4547	CDK14	57.0	10000.0
Torin1	BMX	59.0	10000.0
XMD11-50	CLK2	72.0	10000.0
JWE-035	TNK1	0.3	10000.0
ERK5-IN-1	CASK	98.0	1000.0
NU7441	RSK1(Kin.Dom.2-C-terminal)	75.0	10000.0
A443654	LTK	100.0	10000.0
PLX-4720	IGF1R	91.0	10000.0
AZD4547	ERK5	23.0	10000.0
(s)-CR8	MET(Y1235D)	94.0	10000.0
QL-XII-47	TYK2(JH1domain-catalytic)	100.0	1000.0
PD173074	ABL1(H396P)	100.0	10000.0
AZD4547	EPHA1	18.0	10000.0
Torkinib	PIM3	31.0	10000.0
CGP74514A	CDKL1	27.0	10000.0
Omipalisib	PKN1	76.0	10000.0
AZD-6482	KIT(D816V)	81.0	10000.0
OTSSP167	DYRK2	0.4	10000.0
MPS-1-IN-1	TIE1	100.0	1000.0
Momelotinib	IRAK3	22.0	10000.0
XMD14-99	TBK1	100.0	10000.0
Momelotinib	SIK2	14.0	10000.0
WH-4-023	SRPK2	42.0	10000.0
TGX221	LATS1	100.0	1000.0
WZ4002	CDK7	35.0	10000.0
WZ4002	FGFR3(G697C)	100.0	10000.0
AZD7762	MAP4K4	0.5	10000.0
KIN001-111	BMPR1A	100.0	1000.0
AZ-628	SRPK2	100.0	10000.0
ZM-447439	RSK1(Kin.Dom.1-N-terminal)	72.0	10000.0
WZ-4-145	MP2K3	100.0	10000.0
ALW-II-49-7	PIK3CA	100.0	10000.0
A443654	CAMK1	33.0	10000.0
Sorafenib	NUAK1	84.0	10000.0
A443654	NLK	100.0	10000.0
XMD16-144	BTK	42.0	10000.0
OTSSP167	EPHB3	6.6	10000.0
Omipalisib	KC1G1	89.0	10000.0
CG-930	KIT	96.0	10000.0
R406	CDK15	100.0	1000.0
BS-181	YSK4	77.0	10000.0
JNK-IN-11	FLT3(D835Y)	54.0	1000.0
(s)-CR8	ABL1(F317L)-nonphosphorylated	100.0	10000.0
Torin2	ABL1(T315I)-phosphorylated	100.0	10000.0
NVP-TAE684	LATS1	32.0	1000.0
SP600125	SNARK	5.8	10000.0
HG-6-64-01	FRK	0.6	10000.0
HG-9-91-01	MYO3A	2.2	10000.0
Torkinib	KPCD3	94.0	10000.0
PHA-767491	WEE1	95.0	10000.0
CG-930	ABL1(Q252H)-nonphosphorylated	47.0	10000.0
Dactolisib	ABL1	100.0	1000.0
Buparlisib	BRSK2	87.0	1000.0
JW-7-24-1	MLCK	100.0	10000.0
XMD14-99	CTK	61.0	10000.0
XMD-12	RSK4(Kin.Dom.1-N-terminal)	61.0	1000.0
BMS345541	MLK3	87.0	10000.0
Taselisib	SIK3	100.0	1000.0
Momelotinib	RIPK4	100.0	10000.0
GW843682X	KC1G1	86.0	10000.0
(s)-CR8	ABL1-nonphosphorylated	100.0	10000.0
(s)-CR8	PDPK1	83.0	10000.0
BI-2536	ABL1(F317L)	100.0	10000.0
AZ-628	MAP4K2	62.0	10000.0
WZ4002	MYLK	100.0	10000.0
WZ4003	KC1G2	100.0	1000.0
5z-7-oxozeaenol	AMPK-alpha1	100.0	10000.0
Baricitinib	HIPK4	25.0	10000.0
HG-5-113-01	DMPK2	100.0	10000.0
OTSSP167	CAMKK2	3.5	10000.0
Vemurafenib	FLT3(ITD)	29.0	10000.0
KU63794	FGFR4	100.0	10000.0
JNK-IN-8	CSNK1A1	73.0	1000.0
NG25	KIT(D816V)	10.0	10000.0
Omipalisib	HIPK2	72.0	10000.0
Canertinib	ABL1(T315I)	100.0	1000.0
BI-2536	KPCT	100.0	10000.0
AZD-6482	MST1	95.0	10000.0
Ibrutinib	FLT3(R834Q)	64.0	1000.0
OTSSP167	KGP2	5.1	10000.0
Neratinib	MYLK2	79.0	10000.0
Momelotinib	ABL1(T315I)-nonphosphorylated	55.0	10000.0
CP466722	MRCKB	100.0	10000.0
Dabrafenib	KIT(V559D)	1.9	10000.0
PLX-4720	MKNK1	100.0	10000.0
RO-3306	SGK2	37.0	10000.0
CP724714	TNK1	86.0	10000.0
CP466722	STK35	24.0	10000.0
WZ-4-145	MINK	100.0	10000.0
XMD8-85	MP2K4	100.0	10000.0
PHA-767491	PKN1	5.0	10000.0
PD0325901	SYK	100.0	10000.0
WYE-125132	EGFR(L858R,T790M)	100.0	10000.0
KIN001-021	EPHA6	100.0	1000.0
ERK5-IN-1	RSK3(Kin.Dom.1-N-terminal)	100.0	1000.0
NVP-TAE684	MAP3K4	13.0	1000.0
SCH772984	AURKB	33.0	1000.0
PHA-767491	MUSK	7.6	10000.0
JNK-IN-8	JAK1(JH1domain-catalytic)	98.0	1000.0
PHA-793887	MST4	5.4	10000.0
MLN8054	DYRK1A	52.0	10000.0
CP466722	M3K6	64.0	10000.0
WH-4-023	CAMK1D	100.0	10000.0
ERK5-IN-1	RAF1	100.0	1000.0
XMD8-92	BMPR1B	100.0	10000.0
Torin1	PIK3CB	65.0	10000.0
SCH772984	PIK3CA(H1047Y)	93.0	1000.0
HG-5-88-01	INSR	0.1	10000.0
GSK429286A	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
JWE-035	ABL1(Y253F)-phosphorylated	0.1	10000.0
Crizotinib	ABL1(E255K)-phosphorylated	0.2	10000.0
ALW-II-38-3	MLK3	100.0	10000.0
JNK-IN-8	PIK3CA(C420R)	99.0	1000.0
WZ3105	MYLK2	90.0	10000.0
Barasertib	ROCK2	66.0	10000.0
NU7441	DYRK2	100.0	10000.0
PD0325901	DRAK1	100.0	10000.0
JNK-9L	M3K2	31.0	10000.0
Seliciclib	LIMK2	100.0	10000.0
ERK5-IN-1	MST3	100.0	1000.0
JNK-9L	PRKX	55.0	10000.0
GSK461364	SRPK1	46.0	10000.0
GSK429286A	NEK3	100.0	10000.0
Torkinib	TESK1	17.0	10000.0
Seliciclib	PIK3CA(E545K)	88.0	10000.0
WH-4-023	DCAMKL2	44.0	10000.0
Lapatinib	FLT3(N841I)	70.0	10000.0
BMX-IN-1	CAMK1D	77.0	10000.0
XMD8-92	FGFR4	100.0	10000.0
Ceritinib	EPHB6	68.0	1000.0
PHA-767491	M3K5	7.6	10000.0
Torkinib	CDK4-cyclinD1	60.0	10000.0
ERK5-IN-1	NEK2	86.0	1000.0
MPS-1-IN-1	TLK2	100.0	1000.0
ZSTK474	ALK	100.0	1000.0
Barasertib	DMPK2	100.0	10000.0
JW-7-24-1	INSRR	100.0	10000.0
(s)-CR8	ITK	86.0	10000.0
GSK429286A	KGP1	15.0	10000.0
RO-3306	TAOK1	14.0	10000.0
CP724714	EPHB2	100.0	10000.0
BS-181	ABL1(F317L)-nonphosphorylated	96.0	10000.0
XMD-12	PLK4	1.8	1000.0
Baricitinib	PAK6	17.0	10000.0
SB590885	GCN2(Kin.Dom.2,S808G)	97.0	10000.0
PHA-767491	PAK2	30.0	10000.0
WYE-125132	LATS2	76.0	10000.0
Crizotinib	TNK2	2.8	10000.0
HG-14-8-02	EIF2AK1	100.0	10000.0
NPK76-II-72-1	LATS2	100.0	10000.0
OTSSP167	MELK	5.5	10000.0
JNK-9L	HIPK1	2.2	10000.0
ERK5-IN-1	BMPR1A	100.0	1000.0
QL-XII-47	MYO3B	100.0	1000.0
SB590885	ULK2	90.0	10000.0
XMD11-85h	GSK3A	100.0	10000.0
HG-9-91-01	TLK2	91.0	10000.0
WYE-125132	ICK	87.0	10000.0
QL-XI-92	PLK1	77.0	10000.0
GW843682X	GAK	4.1	10000.0
NG25	EGFR(L747-E749del,A750P)	1.5	10000.0
GW-5074	PI42C	100.0	10000.0
ALW-II-38-3	PIK3CA(E545A)	100.0	10000.0
Seliciclib	TRPM6	100.0	10000.0
PLX-4720	MK12	100.0	10000.0
PLX-4720	NEK6	91.0	10000.0
XMD13-2	CLK3	80.0	10000.0
NU7441	RIOK2	22.0	10000.0
Torin1	PIK3C2G	11.0	10000.0
BI-2536	ACVR1	100.0	10000.0
JW-7-24-1	LIMK1	100.0	10000.0
GSK461364	ABL1(Y253F)-phosphorylated	69.0	10000.0
ERK5-IN-1	PIK3CB	100.0	1000.0
XMD8-92	NEK5	100.0	10000.0
Vemurafenib	KIT(V559D)	0.1	10000.0
GSK461364	MET(M1250T)	93.0	10000.0
Dabrafenib	YANK2	94.0	10000.0
XMD13-2	ICK	13.0	10000.0
AZD7762	RIOK3	0.4	10000.0
NVP-TAE684	MARK4	0.0	1000.0
Vemurafenib	TRKA	90.0	10000.0
WZ-7043	ERBB3	100.0	10000.0
ZSTK474	RIPK4	100.0	1000.0
XMD13-2	SGK3	42.0	10000.0
Lapatinib	M4K1	95.0	10000.0
WZ-7043	EPHA8	100.0	10000.0
AG1478	TEC	100.0	10000.0
XMD14-99	KPCE	68.0	10000.0
Dinaciclib	EGFR(L858R,T790M)	82.0	10000.0
Pictilisib	PAK3	100.0	1000.0
JW-7-24-1	BMX	100.0	10000.0
PHA-793887	BRAF	73.0	10000.0
BMS-536924	BMPR2	3.4	1000.0
JWE-035	AURKC	8.7	10000.0
AZD4547	EPHB1	44.0	10000.0
GW843682X	PKNB(M.tuberculosis)	76.0	10000.0
PHA-793887	PKNB(M.tuberculosis)	49.0	10000.0
HG-5-113-01	WEE2	100.0	10000.0
ZG-10	FLT3(N841I)	31.0	10000.0
HG-14-10-04	WEE2	0.4	10000.0
BGJ398	NLK	86.0	1000.0
Crizotinib	PAK4	80.0	10000.0
PD0325901	FGFR1	100.0	10000.0
Dinaciclib	BRAF(V600E)	100.0	10000.0
Buparlisib	RIPK4	100.0	1000.0
JNK-IN-11	PIP5K2B	100.0	1000.0
MPS-1-IN-1	FER	16.0	1000.0
AZD7762	TNK2	0.9	10000.0
PHA-767491	TRKA	79.0	10000.0
AS-252424	MERTK	89.9	10000.0
SP600125	RET	100.0	10000.0
TAK-715	FYN	45.0	10000.0
Canertinib	DMPK	100.0	1000.0
JNK-IN-5A	EGFR(G719S)	89.0	10000.0
R406	PKN1	1.8	1000.0
NU7441	PRKR	72.0	10000.0
HG-14-8-02	TSSK1	35.0	10000.0
GSK429286A	ABL1(Y253F)-phosphorylated	72.0	10000.0
QL-XI-92	LTK	89.0	10000.0
Baricitinib	FLT3-autoinhibited	100.0	10000.0
Sigma A6730	LIMK2	100.0	10000.0
HG-9-91-01	JNK3	0.0	10000.0
PHA-767491	LRRK2	18.0	10000.0
XMD11-50	ACVR2B	100.0	10000.0
JNK-IN-8	RIPK1	51.0	1000.0
XMD-12	YANK3	100.0	1000.0
GW843682X	CAMK1G	72.0	10000.0
ALW-II-49-7	INSR	100.0	10000.0
PD173074	PIK3CA(E545K)	100.0	10000.0
Pictilisib	PIK3CG	3.5	1000.0
AZD7762	LIMK1	62.0	10000.0
AZD7762	DAPK1	0.1	10000.0
AZD7762	YANK1	1.0	10000.0
Canertinib	YANK3	100.0	1000.0
KIN001-123	MARK2	100.0	1000.0
Vemurafenib	CSNK2A2	100.0	10000.0
CG-930	MP2K7	94.0	10000.0
JNK-IN-11	CDKL2	74.0	1000.0
WZ3105	AURKB	73.0	10000.0
GSK429286A	CDK4-cyclinD3	77.0	10000.0
SCH772984	BMX	86.0	1000.0
PHA-793887	PKN2	93.0	10000.0
Buparlisib	ERK4	97.0	1000.0
Torin2	CASK	67.0	10000.0
CP466722	DYRK1A	0.1	10000.0
Ceritinib	RIOK3	70.0	1000.0
WZ4002	LYN	100.0	10000.0
JNK-IN-11	PKN2	100.0	1000.0
JNK-IN-5A	PIK3CA(Q546K)	79.0	10000.0
BS-181	HIPK4	3.4	10000.0
ZG-10	EPHA1	76.0	10000.0
BI-2536	BMPR1A	100.0	10000.0
JNK-IN-5A	FES	100.0	10000.0
Omipalisib	AKT1	83.0	10000.0
AZ-628	MAPKAPK5	100.0	10000.0
THZ1	LOK	0.1	10000.0
QL-X-138	M4K3	73.0	10000.0
Dactolisib	CIT	100.0	1000.0
SP600125	IKKA	0.1	10000.0
Dactolisib	CLK4	22.0	1000.0
R406	MP2K6	6.1	1000.0
Abemaciclib	CDKL3	3.1	1000.0
ALW-II-38-3	FLT3(ITD)	100.0	10000.0
Taselisib	SGK3	84.0	1000.0
Seliciclib	NEK6	100.0	10000.0
XMD11-85h	HIPK3	100.0	10000.0
Baricitinib	LRRK2	24.0	10000.0
THZ1	PIK3CA	77.0	10000.0
XMD8-85	KCC4	100.0	10000.0
Vemurafenib	PIK3CA(E545K)	100.0	10000.0
ALW-II-38-3	DDR2	0.7	1000.0
HG-5-113-01	RIPK1	100.0	10000.0
KU63794	STK33	95.0	10000.0
BS-181	BRSK2	100.0	10000.0
AG1478	CASK	67.0	10000.0
KIN001-111	KPCD2	100.0	1000.0
WZ-4-145	MRCKB	100.0	10000.0
JNK-IN-8	LRRK2	50.0	1000.0
AZ-628	CSNK1E	100.0	10000.0
AZ-628	PIK3C2B	100.0	10000.0
CP466722	EGFR(L747-S752del,P753S)	68.0	10000.0
ZG-10	JAK1(JH2domain-pseudokinase)	0.6	10000.0
AZD7762	DCAMKL3	56.0	10000.0
JWE-035	PFPK5(P.falciparum)	100.0	10000.0
GSK1059615	JAK2(JH1domain-catalytic)	31.0	10000.0
XMD-12	MKNK1	28.0	1000.0
BI-D1870	RET(M918T)	4.7	10000.0
ALW-II-49-7	KCC4	100.0	10000.0
XMD8-92	RPS6KA2(Kin.Dom.1)	100.0	10000.0
KIN001-220	MET	8.6	10000.0
RO-3306	MYLK4	39.0	10000.0
XMD16-144	MP2K1	82.0	10000.0
BGJ398	ANKK1	66.0	1000.0
Barasertib	BRAF(V600E)	100.0	10000.0
JNK-IN-5A	MST1	94.0	10000.0
CGP60474	PAK7	100.0	10000.0
JW-7-24-1	PIM2	34.0	10000.0
XMD14-99	PHKG1	82.0	10000.0
PLX-4720	CAMKK2	79.0	10000.0
Buparlisib	ALK(L1196M)	100.0	1000.0
5z-7-oxozeaenol	ERBB4	81.0	10000.0
KIN001-127	PIP5K1A	100.0	10000.0
XMD16-144	CLK3	82.0	10000.0
BMS-536924	LYN	2.2	1000.0
XMD11-85h	ABL1(T315I)	100.0	10000.0
PHA-767491	KIT	79.0	10000.0
QL-X-138	TNNI3K	100.0	10000.0
HG-6-64-01	DMPK	57.0	10000.0
Palbociclib	CAMK1D	81.0	1000.0
Neratinib	STK35	81.0	10000.0
ALW-II-49-7	CDK7	100.0	10000.0
XMD13-2	MAK	51.0	10000.0
BMS-536924	PKN1	2.6	1000.0
BI-D1870	TYK2(JH2domain-pseudokinase)	0.3	10000.0
HG-6-64-01	AKT1	100.0	10000.0
KIN001-220	MK12	100.0	10000.0
Dactolisib	KIT(D816V)	100.0	1000.0
TAK-715	HIPK4	97.0	10000.0
GW-5074	FLT3(D835H)	40.0	10000.0
XMD14-99	ABL1(H396P)-phosphorylated	85.0	10000.0
XMD14-99	S6K1	89.0	10000.0
CP466722	KGP1	100.0	10000.0
ZM-447439	GSK3A	100.0	10000.0
GSK1059615	SRC	69.0	10000.0
WZ4002	ROCK2	27.0	10000.0
JWE-035	TYK2(JH1domain-catalytic)	2.0	10000.0
GW843682X	KIT(D816V)	1.4	10000.0
GSK429286A	ITK	74.0	10000.0
NPK76-II-72-1	STK36	100.0	10000.0
Torkinib	EGFR(T790M)	33.0	10000.0
BMS-536924	NUAK1	0.1	1000.0
JNK-IN-8	EGFR(L858R,T790M)	81.0	1000.0
SP600125	ABL2	100.0	10000.0
AZD7762	AXL	0.0	10000.0
CG-930	MAP4K4	54.0	10000.0
Seliciclib	EGFR(T790M)	100.0	10000.0
HG-5-88-01	EPHA7	15.0	10000.0
GSK429286A	PIK3CA(H1047L)	83.0	10000.0
Palbociclib	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	1000.0
Canertinib	RPS6KA5(Kin.Dom.2)	100.0	1000.0
ZG-10	IRAK4	34.0	10000.0
Ribociclib	CDK9	78.0	1000.0
KIN001-220	PRKX	76.0	10000.0
SB590885	IRAK4	91.0	10000.0
5z-7-oxozeaenol	EPHA6	76.0	10000.0
QL-XII-47	FLT3(ITD)	92.0	1000.0
GSK461364	RIPK4	52.0	10000.0
Pictilisib	PIK3CA(C420R)	0.0	1000.0
NVP-TAE684	RPS6KA5(Kin.Dom.1)	100.0	1000.0
Abemaciclib	MLK3	100.0	1000.0
Ceritinib	NDR1	93.0	1000.0
JWE-035	CASK	15.0	10000.0
BS-181	SYK	92.0	10000.0
HG-6-64-01	CSNK2A2	95.0	10000.0
Omipalisib	PTK6	80.0	10000.0
AZD4547	SLK	0.2	10000.0
PD0325901	MAST1	100.0	10000.0
Momelotinib	ACVR2A	75.0	10000.0
GW-5074	PGFRB	5.5	10000.0
Baricitinib	ICK	98.0	10000.0
WZ4002	EPHB3	100.0	10000.0
CP466722	PKN1	100.0	10000.0
WZ4003	ABL1(Q252H)	100.0	1000.0
WH-4-023	PIK3CA(I800L)	100.0	10000.0
Ceritinib	M3K13	81.0	1000.0
SCH772984	GSK3B	99.0	1000.0
CP724714	JAK3(JH1domain-catalytic)	100.0	10000.0
GW843682X	SIK2	26.0	10000.0
Taselisib	CDK9	100.0	1000.0
GSK1059615	DCLK1	77.0	10000.0
(s)-CR8	CDKL2	63.0	10000.0
Sorafenib	CDK4-cyclinD1	65.0	10000.0
Dinaciclib	FGFR1	59.0	10000.0
MPS-1-IN-1	EGFR(L747-S752del,P753S)	100.0	1000.0
AZD7762	M3K13	7.0	10000.0
Buparlisib	MAPKAPK2	93.0	1000.0
R406	IKKE	2.7	1000.0
R406	RIOK2	16.0	1000.0
AZD-6482	ACVR1	98.0	10000.0
XMD8-92	LATS1	100.0	10000.0
Dabrafenib	KIT(D816H)	44.0	10000.0
QL-XII-47	FGFR4	95.0	1000.0
HG-9-91-01	TYRO3	21.0	10000.0
XMD16-144	RIPK2	18.0	10000.0
ALW-II-38-3	MAP3K3	100.0	10000.0
ERK5-IN-1	DCAMKL3	92.0	1000.0
QL-XII-47	INSRR	100.0	1000.0
Torkinib	ERK5	100.0	10000.0
(s)-CR8	VGFR1	92.0	10000.0
KIN001-021	RIPK4	100.0	1000.0
TAK-715	RAF1	34.0	10000.0
KIN001-127	IRAK3	100.0	10000.0
Lapatinib	PLK1	87.0	10000.0
Buparlisib	ITK	100.0	1000.0
Palbociclib	KIT-autoinhibited	100.0	1000.0
SCH772984	DMPK	86.0	1000.0
JNK-9L	TBK1	35.0	10000.0
GSK461364	IRAK3	38.0	10000.0
HG-5-113-01	TNNI3K	100.0	10000.0
TAK-715	ICK	100.0	10000.0
Torin2	ERK5	100.0	10000.0
AZD-6482	ABL1(F317I)-nonphosphorylated	94.0	10000.0
Vemurafenib	PIK3CB	100.0	10000.0
HG-9-91-01	ALK(L1196M)	19.0	10000.0
(s)-CR8	CLK4	42.0	10000.0
BS-181	MK03	100.0	10000.0
CGP74514A	INSR	19.0	10000.0
HG-6-64-01	MP2K4	76.0	10000.0
MLN8054	MAPKAPK2	100.0	10000.0
NPK76-II-72-1	RET(M918T)	100.0	10000.0
RO-3306	NEK10	67.0	10000.0
HG-9-91-01	PLK2	82.0	10000.0
PHA-793887	WEE1	100.0	10000.0
CG-930	PIK3CA(Q546K)	100.0	10000.0
AZD 5438	FLT4	26.0	10000.0
TAK-715	CDK4-cyclinD3	92.0	10000.0
ALW-II-38-3	TRKC	100.0	10000.0
Lapatinib	WEE1	100.0	10000.0
GSK461364	FAK1	99.0	10000.0
Torin1	CDKL1	100.0	10000.0
BX-912	ULK1	0.1	10000.0
QL-X-138	RIOK3	31.0	10000.0
Torin1	YANK3	100.0	10000.0
JNK-9L	TNK1	25.0	10000.0
XMD16-144	PFPK5(P.falciparum)	100.0	10000.0
ALW-II-38-3	PIK3CG	100.0	10000.0
HG-5-113-01	TNK2	1.0	10000.0
QL-XI-92	KGP2	94.0	10000.0
Pictilisib	ULK2	100.0	1000.0
XMD8-85	EGFR(L858R,T790M)	100.0	10000.0
(s)-CR8	DDR1	95.0	10000.0
AZD7762	PRKR	3.4	10000.0
BMX-IN-1	NIM1	100.0	10000.0
ALW-II-38-3	MARK1	100.0	10000.0
Crizotinib	SRMS	54.0	10000.0
5z-7-oxozeaenol	MST1	100.0	10000.0
XMD8-92	RAF1	100.0	10000.0
PD0325901	GSK3A	90.0	10000.0
CP724714	CDK4-cyclinD3	100.0	10000.0
Taselisib	IKKE	100.0	1000.0
PHA-767491	SRC	97.0	10000.0
Crizotinib	MAP3K1	4.4	10000.0
AG1478	RPS6KA5(Kin.Dom.2-C-terminal)	67.0	10000.0
XMD11-50	AKT3	100.0	10000.0
Ribociclib	PIK3CA(H1047L)	100.0	1000.0
XMD11-85h	TIE2	100.0	10000.0
HG-9-91-01	M3K13	20.0	10000.0
Seliciclib	IKKB	83.0	10000.0
AS-252424	ABL1(Y253F)	100.0	10000.0
MRT67307	ACVR1	100.0	10000.0
HG-9-91-01	MK11	0.0	10000.0
GSK1059615	CTK	50.0	10000.0
Seliciclib	MYO3A	97.0	10000.0
BMS345541	EPHA4	100.0	10000.0
Taselisib	ABL1(E255K)-phosphorylated	99.0	1000.0
Alpelisib	DYRK2	100.0	1000.0
Palbociclib	MUSK	100.0	1000.0
Dabrafenib	CDC2L2	62.0	10000.0
ALW-II-38-3	PKMYT1	100.0	10000.0
OTSSP167	PHKG1	11.0	10000.0
AG1478	SRC	9.9	10000.0
Buparlisib	CDKL5	97.0	1000.0
AZ-628	IRAK1	75.0	10000.0
CGP60474	PIK3C2G	100.0	10000.0
WZ4003	EPHA6	100.0	1000.0
XMD11-85h	MAP4K4	100.0	10000.0
ERK5-IN-1	PIK3C2G	99.0	1000.0
SB590885	YSK1	100.0	10000.0
HG-14-8-02	MK12	68.0	10000.0
GW-5074	FAK2	81.0	10000.0
GW843682X	MST1	56.0	10000.0
JNK-9L	MK03	100.0	10000.0
KIN001-220	NUAK1	18.0	10000.0
WZ3105	RPS6KA5(Kin.Dom.1-N-terminal)	93.0	10000.0
GSK461364	OSR1	98.0	10000.0
OTSSP167	EGFR	13.0	10000.0
QL-X-138	RSK4(Kin.Dom.2-C-terminal)	67.0	10000.0
GSK1059615	ZAP70	93.0	10000.0
PD0325901	PLK4	86.0	10000.0
BX-912	EGFR(E746-A750del)	62.0	10000.0
5z-7-oxozeaenol	ANKK1	66.0	10000.0
WZ-7043	SIK3	100.0	10000.0
NU7441	RET(V804L)	100.0	10000.0
WZ4003	CLK2	100.0	1000.0
Ribociclib	CSNK1E	78.0	1000.0
XMD8-85	MAPKAPK5	100.0	10000.0
GSK1059615	MET(M1250T)	40.0	10000.0
GW-5074	GCN2(Kin.Dom.2,S808G)	78.0	10000.0
Vemurafenib	RSK4(Kin.Dom.2-C-terminal)	75.0	10000.0
XMD-12	PKN1	100.0	1000.0
Abemaciclib	FLT3(ITD,F691L)	22.0	1000.0
BMS345541	ACVR2A	92.0	10000.0
GW843682X	ULK2	82.0	10000.0
Crizotinib	MAP4K5	0.6	10000.0
HG-5-88-01	TNK2	0.2	10000.0
Dinaciclib	PLK3	97.0	10000.0
WZ-7043	MARK3	100.0	10000.0
CH5424802	PLK4	100.0	1000.0
Ceritinib	CSNK2A2	85.0	1000.0
AZ-628	CDK8	22.0	10000.0
WZ4003	EPHA7	100.0	1000.0
WH-4-023	DAPK2	100.0	10000.0
KIN001-220	HIPK3	12.0	10000.0
CGP74514A	ABL1(H396P)-nonphosphorylated	0.1	10000.0
JNK-IN-8	WEE2	100.0	1000.0
XMD8-92	CDK9	100.0	10000.0
NVP-TAE684	ABL2	1.4	1000.0
CGP60474	EGFR(L747-T751del,Sins)	100.0	10000.0
Ceritinib	FGR	90.0	1000.0
KIN001-220	PIP5K1C	77.0	10000.0
BS-181	SNARK	93.0	10000.0
ZG-10	CAMK2A	54.0	10000.0
ZG-10	ABL1-nonphosphorylated	30.0	10000.0
QL-X-138	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
ZG-10	ABL2	100.0	10000.0
OTSSP167	TYRO3	100.0	10000.0
CH5424802	PKAC-alpha	100.0	1000.0
BGJ398	RET(M918T)	64.0	1000.0
MPS-1-IN-1	MUSK	100.0	1000.0
BMX-IN-1	SRPK1	100.0	10000.0
Seliciclib	TGFBR1	100.0	10000.0
Lapatinib	MST2	58.0	10000.0
Dabrafenib	SIK1	0.7	10000.0
JNK-IN-8	CSK	100.0	1000.0
Torin1	PRKR	88.0	10000.0
BI-2536	MK11	100.0	10000.0
KIN001-111	DMPK	100.0	1000.0
PD0325901	ABL1(E255K)-phosphorylated	100.0	10000.0
Vemurafenib	ERK4	100.0	10000.0
ZSTK474	CDK15	100.0	1000.0
TGX221	NEK7	100.0	1000.0
AS-252424	MARK3	100.0	10000.0
SCH772984	CDC2L2	100.0	1000.0
MPS-1-IN-1	BRSK2	100.0	1000.0
Barasertib	TYK2(JH1domain-catalytic)	85.0	10000.0
XMD-12	RAF1	100.0	1000.0
CP724714	RPS6KA5(Kin.Dom.2-C-terminal)	98.0	10000.0
KIN001-111	ALK	100.0	1000.0
XMD13-2	PFPK5(P.falciparum)	100.0	10000.0
Abemaciclib	CSNK2A2	0.1	1000.0
CGP60474	KPCD2	100.0	10000.0
WZ-7043	BRSK2	100.0	10000.0
Vemurafenib	EPHB6	5.8	10000.0
PD173074	KIT(V559D)	100.0	10000.0
MPS-1-IN-1	TIE2	100.0	1000.0
OTSSP167	KC1G1	78.0	10000.0
NPK76-II-72-1	PAK7	100.0	10000.0
PLX-4720	S6K1	58.0	10000.0
HG-5-113-01	TNIK	19.0	10000.0
XMD-12	M3K13	100.0	1000.0
GW-5074	ABL1(F317I)-nonphosphorylated	70.0	10000.0
Momelotinib	JNK1	1.0	10000.0
JNK-9L	YANK1	100.0	10000.0
WZ-4-145	ERBB4	2.2	10000.0
(s)-CR8	MLTK	85.0	10000.0
OTSSP167	EPHB2	0.0	10000.0
HG-5-88-01	EPHA5	100.0	10000.0
Taselisib	MLK3	100.0	1000.0
BGJ398	BRAF	81.0	1000.0
Dinaciclib	KIT-autoinhibited	87.0	10000.0
KIN001-220	CASK	82.0	10000.0
(s)-CR8	NDR1	100.0	10000.0
Dinaciclib	PKN1	89.0	10000.0
MPS-1-IN-1	FAK2	0.5	1000.0
HG-5-113-01	AKT2	100.0	10000.0
WZ3105	ABL1(Q252H)-nonphosphorylated	65.0	10000.0
QL-XII-47	MUSK	100.0	1000.0
Alpelisib	ABL1(F317L)-nonphosphorylated	65.0	1000.0
KIN001-127	KPCT	100.0	10000.0
XMD-12	FYN	35.0	1000.0
JW-7-24-1	AURKB	100.0	10000.0
KIN001-127	CSF1R	100.0	10000.0
R406	EGFR(L858R)	2.3	1000.0
Momelotinib	DAPK1	7.0	10000.0
HG-9-91-01	MRCKB	1.6	10000.0
KIN001-021	M4K1	100.0	1000.0
WH-4-023	NEK11	100.0	10000.0
(s)-CR8	TIE2	100.0	10000.0
Buparlisib	MST1R	100.0	1000.0
PHA-767491	JAK1(JH1domain-catalytic)	31.0	10000.0
Ribociclib	RIPK2	100.0	1000.0
Canertinib	RPS6KA2(Kin.Dom.1)	100.0	1000.0
A443654	RIPK2	100.0	10000.0
Palbociclib	PAK4	100.0	1000.0
HG-14-10-04	CDKL2	29.0	10000.0
ALW-II-38-3	MP2K2	100.0	10000.0
Dactolisib	KPCD1	100.0	1000.0
HG-14-10-04	DRAK2	6.8	10000.0
A443654	CDK16	16.0	10000.0
JNK-IN-8	ABL1(H396P)-nonphosphorylated	42.0	1000.0
JNK-IN-8	PAK2	100.0	1000.0
MPS-1-IN-1	EPHA7	100.0	1000.0
WZ4002	PRKX	100.0	10000.0
KIN001-111	RPS6KA2(Kin.Dom.1)	1.6	1000.0
CP466722	CDK4-cyclinD1	47.0	10000.0
Taselisib	KPCD2	98.0	1000.0
GSK1059615	M3K2	90.0	10000.0
Momelotinib	CDK15	58.0	10000.0
Crizotinib	PAK3	5.8	10000.0
JNK-IN-8	MK13	100.0	1000.0
Ibrutinib	TBK1	91.0	1000.0
Taselisib	AKT2	99.0	1000.0
QL-XI-92	RIPK1	100.0	10000.0
CH5424802	DCLK1	100.0	1000.0
JNK-IN-5A	CSNK1D	100.0	10000.0
BS-181	MLCK	78.0	10000.0
Ceritinib	PKMYT1	80.0	1000.0
Buparlisib	MARK4	81.0	1000.0
OTSSP167	MAP4K4	18.0	10000.0
Palbociclib	TYK2(JH2domain-pseudokinase)	100.0	1000.0
AG1478	BIKE	81.0	10000.0
AZD-6482	PLK2	99.0	10000.0
HG-5-88-01	RET(V804M)	100.0	10000.0
NVP-TAE684	JAK2(Kin.Dom.2)	2.0	1000.0
MLN8054	PFPK5(P.falciparum)	100.0	10000.0
GSK429286A	MK14	100.0	10000.0
Ceritinib	ERBB3	76.0	1000.0
QL-X-138	TYK2(JH2domain-pseudokinase)	36.0	10000.0
TAK-715	KPCI	100.0	10000.0
CP466722	KKCC1	17.0	10000.0
AZ-628	PGFRA	0.1	10000.0
GSK1059615	CLK4	0.2	10000.0
ALW-II-49-7	FAK1	100.0	10000.0
WYE-125132	ULK3	92.0	10000.0
Momelotinib	MAST1	42.0	10000.0
XMD14-99	ERK8	84.0	10000.0
SCH772984	DCAMKL2	100.0	1000.0
Omipalisib	MK11	88.0	10000.0
HG-6-64-01	ADCK3	100.0	10000.0
PHA-793887	KPCD1	2.4	10000.0
CG-930	MK11	24.0	10000.0
QL-XII-47	KIT(L576P)	88.0	1000.0
Canertinib	YES	100.0	1000.0
Alpelisib	LTK	95.0	1000.0
Dabrafenib	CAMKK2	98.0	10000.0
ZM-447439	MLK1	70.0	10000.0
NU7441	PRKX	89.0	10000.0
NU7441	BRSK1	100.0	10000.0
KIN001-111	AMPK-alpha2	7.8	1000.0
JW-7-24-1	MAP3K3	34.0	10000.0
Dinaciclib	PIP5K1C	73.0	10000.0
R406	EPHA1	1.9	1000.0
PLX-4720	GRK7	76.0	10000.0
CGP60474	PAK3	100.0	10000.0
AZD7762	JNK3	63.0	10000.0
Sigma A6730	CIT	47.0	10000.0
Baricitinib	SLK	97.0	10000.0
SP600125	TYK2(Kin.Dom.1)	100.0	10000.0
XMD14-99	ACVR2A	95.0	10000.0
XMD14-99	FLT3(N841I)	47.0	10000.0
CH5424802	KC1G2	96.0	1000.0
BMX-IN-1	MRCKA	96.0	10000.0
5z-7-oxozeaenol	BRAF	100.0	10000.0
RO-3306	NEK9	91.0	10000.0
5z-7-oxozeaenol	MK11	78.0	10000.0
MLN8054	ROS1	23.0	10000.0
AZD 5438	FLT3(K663Q)	17.0	10000.0
XMD8-92	CHK2	100.0	10000.0
JNK-9L	FLT3(D835Y)	14.0	10000.0
XMD8-85	DCAMKL3	16.0	10000.0
AZD 5438	ACVR2B	18.0	10000.0
Buparlisib	ABL1(Y253F)-phosphorylated	100.0	1000.0
WH-4-023	NEK3	100.0	10000.0
NU7441	TNK2	97.0	10000.0
CGP60474	RET	100.0	10000.0
SCH772984	SNARK	96.0	1000.0
HG-6-64-01	EGFR(L858R,T790M)	77.0	10000.0
Omipalisib	RET(V804M)	96.0	10000.0
CG-930	EPHA7	100.0	10000.0
BMX-IN-1	RSK3(Kin.Dom.1-N-terminal)	78.0	10000.0
(s)-CR8	MARK4	98.0	10000.0
CP466722	ERBB2	93.0	10000.0
NVP-TAE684	TGFBR1	0.2	1000.0
Alpelisib	CSNK1A1	100.0	1000.0
PHA-793887	MK11	91.0	10000.0
WZ-7043	TGFBR1	100.0	10000.0
CP466722	CDK8	100.0	10000.0
AS-252424	NEK6	100.0	10000.0
GW843682X	MARK4	99.0	10000.0
ALW-II-38-3	CSNK2A1	100.0	10000.0
XMD11-50	KIT(L576P)	100.0	10000.0
GSK461364	PIK3CB	0.8	10000.0
CP724714	NEK6	100.0	10000.0
WZ-7043	LATS2	100.0	10000.0
ERK5-IN-1	ABL1(F317I)-nonphosphorylated	51.0	1000.0
CP724714	PRKR	99.0	10000.0
CP466722	PKN2	79.0	10000.0
Sigma A6730	RIOK2	79.0	10000.0
Ceritinib	PIP5K1A	100.0	1000.0
MLN8054	ADCK3	88.0	10000.0
Buparlisib	CDK11	100.0	1000.0
AG1478	TIE2	97.0	10000.0
XMD14-99	ACVRL1	84.0	10000.0
Omipalisib	EGFR(L858R,T790M)	81.0	10000.0
HG-6-64-01	PRKR	80.0	10000.0
RO-3306	PIK3CA(I800L)	38.0	10000.0
RO-3306	FGR	58.0	10000.0
Lapatinib	ERBB2	0.0	10000.0
Ibrutinib	BRSK2	76.0	1000.0
XMD13-2	PIM1	70.0	10000.0
CGP74514A	CSNK2A1	1.8	10000.0
Torin2	CSNK1A1L	89.0	10000.0
XMD14-99	CDK4-cyclinD1	2.3	10000.0
PHA-793887	STK39	34.0	10000.0
XMD16-144	MAPKAPK2	100.0	10000.0
(s)-CR8	AKT3	99.0	10000.0
AS-252424	SRPK3	100.0	10000.0
JNK-IN-5A	NEK3	100.0	10000.0
JWE-035	PAK1	86.0	10000.0
MRT67307	HUNK	82.0	10000.0
Seliciclib	PRKR	100.0	10000.0
RO-3306	RIOK1	8.7	10000.0
HG-9-91-01	CDK15	96.0	10000.0
Barasertib	CDK4-cyclinD1	92.0	10000.0
BX-912	LYN	24.0	10000.0
WZ3105	MAPKAPK2	100.0	10000.0
Lapatinib	WEE2	100.0	10000.0
Baricitinib	JAK1(JH1domain-catalytic)	0.0	10000.0
Neratinib	TAOK3	75.0	10000.0
Ribociclib	LYN	100.0	1000.0
HG-5-88-01	DDR2	100.0	10000.0
PD173074	EPHA7	100.0	10000.0
Canertinib	ALK	100.0	1000.0
Baricitinib	EGFR(G719C)	66.0	10000.0
KU63794	IKKE	100.0	10000.0
Ceritinib	TGFBR2	97.0	1000.0
ZG-10	EGFR(L861Q)	56.0	10000.0
Sigma A6730	MP2K2	75.0	10000.0
Sorafenib	VRK2	100.0	10000.0
PD173074	RPS6KA5(Kin.Dom.2)	100.0	10000.0
Alpelisib	PGFRA	100.0	1000.0
ZG-10	ROS1	76.0	10000.0
Dinaciclib	EGFR(S752-I759del)	100.0	10000.0
Sigma A6730	PIK3CA(C420R)	62.0	10000.0
GW843682X	TRKA	78.0	10000.0
Ribociclib	KGP1	100.0	1000.0
ALW-II-38-3	CDK9	100.0	10000.0
TGX221	STK36	100.0	1000.0
CGP60474	RIOK2	100.0	10000.0
SCH772984	CLK2	7.7	1000.0
Crizotinib	LATS2	56.0	10000.0
NPK76-II-72-1	TTK	4.6	10000.0
RO-3306	HIPK4	8.6	10000.0
Alpelisib	KGP2	100.0	1000.0
KIN001-123	NUAK1	100.0	1000.0
BMX-IN-1	AURKA	100.0	10000.0
CP466722	HCK	12.0	10000.0
ERK5-IN-1	MET(M1250T)	100.0	1000.0
MPS-1-IN-1	FLT3(K663Q)	100.0	1000.0
JNK-IN-5A	ACVR2B	67.0	10000.0
CGP74514A	ABL1(T315I)-phosphorylated	17.0	10000.0
CP466722	MTOR	5.0	10000.0
PD173074	DAPK2	100.0	10000.0
PHA-793887	PDPK1	100.0	10000.0
GW-5074	PIK3C2B	10.0	10000.0
ZSTK474	CDK9	100.0	1000.0
NU7441	ROCK1	100.0	10000.0
Dabrafenib	CDC2L1	88.0	10000.0
OTSSP167	TNK2	1.4	10000.0
XMD16-144	M3K13	40.0	10000.0
XMD8-85	DCLK1	0.7	10000.0
A443654	TNNI3K	100.0	10000.0
Alpelisib	TLK1	76.0	1000.0
TGX221	STK16	100.0	1000.0
KIN001-220	KIT(A829P)	64.0	10000.0
WZ3105	EPHB6	74.0	10000.0
Sorafenib	EGFR(L861Q)	45.0	10000.0
CP466722	BMX	88.0	10000.0
HG-14-8-02	WEE2	100.0	10000.0
Momelotinib	YES	91.0	10000.0
JWE-035	PAK3	9.4	10000.0
KIN001-111	PDPK1	100.0	1000.0
ERK5-IN-1	SRPK3	100.0	1000.0
MRT67307	KPCE	38.0	10000.0
BMS-536924	LTK	0.3	1000.0
Lapatinib	MK12	96.0	10000.0
KIN001-123	MP2K1	100.0	1000.0
JNK-IN-5A	ALK	100.0	10000.0
Pictilisib	AXL	93.0	1000.0
BMS-536924	EGFR(L861Q)	5.2	1000.0
XMD-12	PFPK5(P.falciparum)	100.0	1000.0
Torin2	EGFR(L858R)	100.0	10000.0
HG-5-88-01	EGFR(G719C)	20.0	10000.0
GSK429286A	EGFR(L747-S752del,P753S)	100.0	10000.0
KU63794	FGFR3(G697C)	77.0	10000.0
BI-2536	CLK4	100.0	10000.0
Alpelisib	TRPM6	100.0	1000.0
HG-9-91-01	STK33	81.0	10000.0
SP600125	PIK3CA	100.0	10000.0
WH-4-023	TYK2(JH2domain-pseudokinase)	100.0	10000.0
HG-5-88-01	MP2K2	100.0	10000.0
AZD4547	PIM3	98.0	10000.0
Crizotinib	BRSK2	65.0	10000.0
QL-X-138	CDC2L5	100.0	10000.0
PD0325901	KIT(V559D)	74.0	10000.0
Buparlisib	TAK1	100.0	1000.0
GSK429286A	JAK2(JH1domain-catalytic)	12.0	10000.0
TGX221	TYRO3	100.0	1000.0
WH-4-023	RIOK2	83.0	10000.0
KIN001-220	HCK	84.0	10000.0
KU63794	PKAC-alpha	100.0	10000.0
QL-X-138	JAK1(JH2domain-pseudokinase)	34.0	10000.0
ZSTK474	TEC	100.0	1000.0
A443654	CDC2L1	100.0	10000.0
KIN001-111	NEK6	100.0	1000.0
PLX-4720	AKT3	100.0	10000.0
Buparlisib	RIOK3	95.0	1000.0
Dactolisib	JAK3(JH1domain-catalytic)	100.0	1000.0
CH5424802	ADCK3	100.0	1000.0
CP724714	PIK3CA(H1047Y)	47.0	10000.0
AS-252424	MYLK	93.5	10000.0
PHA-793887	TGFBR1	100.0	10000.0
AG1478	EGFR(L861Q)	0.1	10000.0
Palbociclib	CSNK1A1	100.0	1000.0
Pictilisib	TYRO3	95.0	1000.0
CGP74514A	ROCK2	1.8	10000.0
AZD 5438	EPHA3	6.4	10000.0
JNK-9L	BMPR1A	85.0	10000.0
WH-4-023	PKMYT1	100.0	10000.0
MLN8054	CIT	37.0	10000.0
QL-XI-92	TNK2	84.0	10000.0
ZG-10	MAP3K3	93.0	10000.0
Lapatinib	FAK2	84.0	10000.0
CP724714	ACVR1	90.0	10000.0
NPK76-II-72-1	DCAMKL2	19.0	10000.0
BGJ398	NEK2	17.0	1000.0
JNK-9L	AURKA	93.0	10000.0
CP724714	CDK4-cyclinD1	100.0	10000.0
JNK-9L	CAMK1D	87.0	10000.0
Crizotinib	PIK3CD	100.0	10000.0
QL-XI-92	TNIK	100.0	10000.0
QL-XI-92	CIT	97.0	10000.0
Baricitinib	BRAF	78.0	10000.0
Pictilisib	FLT3(ITD,F691L)	71.0	1000.0
KIN001-123	DMPK	100.0	1000.0
ZSTK474	MYO3A	100.0	1000.0
HG-14-10-04	KPCI	63.0	10000.0
R406	KPCL	100.0	1000.0
Barasertib	MAK	92.0	10000.0
ZG-10	CSK	97.0	10000.0
KIN001-021	SYK	100.0	1000.0
AZD 5438	DMPK	79.0	10000.0
MRT67307	KIT(V559D)	16.0	10000.0
BGJ398	ACVRL1	74.0	1000.0
Dinaciclib	S6K1	96.0	10000.0
AZD 5438	GSK3B	0.2	10000.0
WH-4-023	DDR1	0.3	10000.0
Crizotinib	ABL1(H396P)-phosphorylated	0.0	10000.0
XMD-12	EGFR(T790M)	99.0	1000.0
Torkinib	RSK4(Kin.Dom.1-N-terminal)	4.6	10000.0
Buparlisib	NEK1	100.0	1000.0
ERK5-IN-1	MARK2	96.0	1000.0
Dinaciclib	ABL1(Q252H)-nonphosphorylated	100.0	10000.0
GW-5074	MRCKB	100.0	10000.0
AG1478	HASP	100.0	10000.0
PHA-793887	CSNK2A1	61.0	10000.0
Pictilisib	CDKL2	92.0	1000.0
XMD8-92	MLK2	100.0	10000.0
KU63794	ERK4	100.0	10000.0
XMD16-144	BRSK1	14.0	10000.0
MLN8054	STK36	100.0	10000.0
Torin2	EGFR(E746-A750del)	92.0	10000.0
QL-X-138	RET	55.0	10000.0
CG-930	CDK3	100.0	10000.0
NU7441	EPHA1	92.0	10000.0
JWE-035	DAPK2	70.0	10000.0
Barasertib	PTK6	72.0	10000.0
Seliciclib	PTK6	100.0	10000.0
ZM-447439	TAK1	49.0	10000.0
BX-912	BMPR1B	0.8	10000.0
(s)-CR8	MYO3A	98.0	10000.0
WH-4-023	NUAK1	30.0	10000.0
BMS345541	PIK3C2G	23.0	10000.0
MLN8054	VRK2	100.0	10000.0
Ribociclib	LTK	98.0	1000.0
RO-3306	BRSK1	92.0	10000.0
NG25	MYO3B	5.8	10000.0
CH5424802	SGK3	79.0	1000.0
PD0325901	CDC2L5	84.0	10000.0
TGX221	MAPKAPK2	100.0	1000.0
Palbociclib	WEE1	97.0	1000.0
Torkinib	FGFR3	9.2	10000.0
TGX221	SRPK3	100.0	1000.0
OTSSP167	DYRK1B	5.8	10000.0
Vemurafenib	DMPK2	34.0	10000.0
Ibrutinib	ABL1(T315I)-phosphorylated	70.0	1000.0
NVP-TAE684	SYK	3.4	1000.0
ZM-447439	BMPR1A	100.0	10000.0
BMS-536924	LKB1	7.0	1000.0
XMD14-99	RIPK5	52.0	10000.0
HG-9-91-01	KIT(V559D,V654A)	52.0	10000.0
Dabrafenib	RET	17.0	10000.0
Baricitinib	SGK1	31.0	10000.0
HG-14-10-04	RIPK4	100.0	10000.0
AG1478	PIK3CA(E545A)	98.0	10000.0
HG-5-88-01	CLK2	4.6	10000.0
NVP-TAE684	CAMK2G	2.0	1000.0
HG-5-88-01	MAP4K5	100.0	10000.0
HG-5-88-01	ERK3	100.0	10000.0
AS-252424	LKB1	98.1	10000.0
HG-14-10-04	CDC2L5	72.0	10000.0
AG1478	TLK2	100.0	10000.0
Buparlisib	MET	100.0	1000.0
Ibrutinib	PIM2	89.0	1000.0
XMD-12	EGFR(L861Q)	100.0	1000.0
Ceritinib	ANKK1	72.0	1000.0
GW-5074	YANK1	91.0	10000.0
MRT67307	MYLK	57.0	10000.0
GSK461364	KPCD2	27.0	10000.0
CG-930	MERTK	17.0	10000.0
JNK-9L	ERN1	54.0	10000.0
MRT67307	CLK4	5.5	10000.0
A443654	PIK3CB	100.0	10000.0
Torkinib	LYN	12.0	10000.0
CH5424802	MYO3A	87.0	1000.0
WZ4002	ERK8	100.0	10000.0
(s)-CR8	GSK3B	97.0	10000.0
KU63794	SIK3	97.0	10000.0
JNK-IN-5A	DYRK1A	100.0	10000.0
XMD14-99	TTK	20.0	10000.0
Baricitinib	SBK1	0.6	10000.0
GW843682X	MAST1	75.0	10000.0
ALW-II-38-3	RIOK2	100.0	10000.0
ZM-447439	PIK3C2G	14.0	10000.0
MLN8054	HIPK2	100.0	10000.0
Sorafenib	PIK3CA(E545K)	100.0	10000.0
XMD8-92	RPS6KA1(Kin.Dom.1)	100.0	10000.0
AS-252424	MELK	93.6	10000.0
CGP60474	HIPK4	14.0	10000.0
(s)-CR8	EPHA7	92.0	10000.0
MPS-1-IN-1	TESK1	100.0	1000.0
Torin1	MYO3B	100.0	10000.0
HG-14-10-04	FES	3.2	10000.0
WZ-4-145	CDKL2	0.4	10000.0
HG-14-10-04	CSNK1D	92.0	10000.0
KIN001-021	FLT3(D835Y)	100.0	1000.0
JWE-035	ERBB4	95.0	10000.0
BI-2536	EPHB1	100.0	10000.0
KIN001-220	M3K6	86.0	10000.0
Lapatinib	ADCK3	68.0	10000.0
Lapatinib	CDK14	96.0	10000.0
BMS-536924	MYO3A	27.0	1000.0
GSK429286A	ULK2	85.0	10000.0
Ceritinib	PFPK5(P.falciparum)	79.0	1000.0
JNK-9L	FRK	92.0	10000.0
JNK-IN-11	SBK1	92.0	1000.0
Neratinib	DCAMKL3	100.0	10000.0
Pictilisib	ABL1(F317L)-phosphorylated	100.0	1000.0
SB590885	CAMK1	93.0	10000.0
BS-181	HIPK1	23.0	10000.0
Torin1	DCAMKL3	97.0	10000.0
CGP60474	TXK	100.0	10000.0
Torkinib	SLK	0.2	10000.0
Ribociclib	PIP5K1C	100.0	1000.0
GSK429286A	CDKL3	78.0	10000.0
GW843682X	MAP3K15	63.0	10000.0
GSK461364	PIK3C2B	14.0	10000.0
Alpelisib	ALK(L1196M)	100.0	1000.0
(s)-CR8	PCTK2	100.0	10000.0
PHA-767491	EPHA5	100.0	10000.0
JNK-IN-5A	KPCD1	100.0	10000.0
AZD-6482	ADCK3	86.0	10000.0
JWE-035	KC1G2	8.9	10000.0
KIN001-127	RPS6KA4(Kin.Dom.2)	100.0	10000.0
GSK1059615	RET(V804L)	100.0	10000.0
Dactolisib	CDK9	100.0	1000.0
MRT67307	BRAF	100.0	10000.0
PLX-4720	KIT(V559D,V654A)	19.0	10000.0
KIN001-021	KPCD1	100.0	1000.0
JWE-035	CAMK2B	58.0	10000.0
TAK-715	CDKL3	81.0	10000.0
TAK-715	FGFR2	71.0	10000.0
AG1478	DAPK1	53.0	10000.0
XMD11-50	RSK3(Kin.Dom.2-C-terminal)	7.5	10000.0
PD173074	CSNK1E	100.0	10000.0
CGP60474	MYO3B	100.0	10000.0
ZM-447439	AURKB	0.2	10000.0
GW-5074	CDK4-cyclinD1	65.0	10000.0
Sorafenib	LYN	16.0	10000.0
5z-7-oxozeaenol	MET	100.0	10000.0
TAK-715	HIPK1	94.0	10000.0
BGJ398	MAP3K1	98.0	1000.0
Taselisib	CDK15	100.0	1000.0
XMD11-50	RSK2(Kin.Dom.1-N-terminal)	77.0	10000.0
JNK-9L	ERK4	5.0	10000.0
JWE-035	KIT(D816V)	46.0	10000.0
KIN001-220	DAPK2	15.0	10000.0
Momelotinib	CLK2	7.4	10000.0
GW-5074	CAMK1	70.0	10000.0
JNK-IN-5A	MARK3	89.0	10000.0
Dinaciclib	LRRK2	58.0	10000.0
WZ4003	TIE1	31.0	1000.0
QL-XI-92	VRK2	100.0	10000.0
JWE-035	RSK3(Kin.Dom.1-N-terminal)	37.0	10000.0
KIN001-127	MLK2	100.0	10000.0
CGP74514A	CSF1R-autoinhibited	37.0	10000.0
Canertinib	MERTK	100.0	1000.0
WZ3105	PIM3	75.0	10000.0
Omipalisib	ABL1(E255K)-phosphorylated	54.0	10000.0
PD173074	MK14	100.0	10000.0
NVP-TAE684	PKAC-beta	9.9	1000.0
THZ1	DDR2	100.0	10000.0
GSK1059615	PIK3CA(H1047Y)	0.9	10000.0
ALW-II-49-7	CDK2	100.0	10000.0
AS-252424	EPHA2	100.0	10000.0
Torkinib	SRMS	61.0	10000.0
Sorafenib	BRAF	1.2	10000.0
WZ4002	EGFR(L747-S752del,P753S)	0.4	10000.0
Torin2	PIP5K1C	51.0	10000.0
CP466722	PKAC-alpha	100.0	10000.0
XMD13-2	FGFR3	100.0	10000.0
Torin2	DMPK2	86.0	10000.0
Neratinib	ABL1(T315I)-phosphorylated	100.0	10000.0
Torin1	CLK3	43.0	10000.0
CP724714	KIT(V559D,T670I)	100.0	10000.0
Baricitinib	MARK2	16.0	10000.0
MPS-1-IN-1	DRAK2	100.0	1000.0
PD173074	NEK6	100.0	10000.0
QL-XI-92	KIT(V559D,V654A)	23.0	10000.0
Lapatinib	TRKC	100.0	10000.0
KU63794	MYLK4	92.0	10000.0
NVP-TAE684	MYLK	0.5	1000.0
JNK-IN-8	PGFRB	4.7	1000.0
BMS-536924	MST1	1.8	1000.0
CP724714	PKAC-beta	100.0	10000.0
NVP-TAE684	PIK3CB	100.0	1000.0
ZG-10	MK11	88.0	10000.0
Ribociclib	MAPKAPK5	100.0	1000.0
KIN001-220	M3K5	100.0	10000.0
CP724714	FLT3	100.0	10000.0
WZ3105	RET(V804L)	80.0	10000.0
Buparlisib	CSNK2A2	100.0	1000.0
ZG-10	IRAK1	0.9	10000.0
Ceritinib	TRPM6	100.0	1000.0
Sorafenib	ACVR2B	75.0	10000.0
Torin1	EGFR(L747-E749del,A750P)	100.0	10000.0
WYE-125132	FGFR3(G697C)	74.0	10000.0
PLX-4720	EPHA8	95.0	10000.0
WH-4-023	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
BI-2536	MERTK	100.0	10000.0
JWE-035	PRKX	100.0	10000.0
ALW-II-49-7	EPHA1	100.0	10000.0
(s)-CR8	STK33	84.0	10000.0
HG-6-64-01	PIK3CA(E542K)	100.0	10000.0
Sorafenib	LATS1	79.0	10000.0
THZ1	JNK1	0.1	10000.0
KIN001-127	CDK8	100.0	10000.0
SB590885	PIK3CA(H1047L)	98.0	10000.0
Torin1	TRKB	81.0	10000.0
AZ-628	MST1	100.0	10000.0
ZG-10	BRSK1	100.0	10000.0
Alpelisib	ULK3	98.0	1000.0
Torkinib	EPHA6	5.2	10000.0
BMX-IN-1	HIPK1	56.0	10000.0
R406	EPHB4	19.0	1000.0
Ceritinib	MK12	100.0	1000.0
GSK429286A	ERN1	71.0	10000.0
Sigma A6730	LRRK2(G2019S)	100.0	10000.0
RO-3306	PIK3CA(C420R)	62.0	10000.0
NPK76-II-72-1	CHEK1	100.0	10000.0
AZ-628	AMPK-alpha2	100.0	10000.0
PD173074	KPCE	100.0	10000.0
CGP74514A	TNIK	19.0	10000.0
Seliciclib	KIT(D816H)	100.0	10000.0
WH-4-023	SRMS	8.6	10000.0
XMD11-85h	TNK1	100.0	10000.0
JNK-9L	EGFR(L858R)	54.0	10000.0
SB590885	ACVR2A	100.0	10000.0
ERK5-IN-1	ERN1	87.0	1000.0
Omipalisib	EGFR(L747-T751del,Sins)	82.0	10000.0
AZ-628	VGFR2	2.3	10000.0
AZ-628	CLK3	100.0	10000.0
ZM-447439	ABL1(T315I)-nonphosphorylated	7.8	10000.0
Baricitinib	IRAK3	46.0	10000.0
SP600125	DMPK2	100.0	10000.0
CH5424802	STK16	94.0	1000.0
Ceritinib	MLCK	98.0	1000.0
CP466722	MK09	1.5	10000.0
AZD7762	RPS6KA4(Kin.Dom.1-N-terminal)	0.2	10000.0
MRT67307	KC1G1	68.0	10000.0
Sigma A6730	PKNB(M.tuberculosis)	78.0	10000.0
KIN001-021	MP2K2	100.0	1000.0
ZSTK474	INSRR	100.0	1000.0
5z-7-oxozeaenol	ACVR2A	18.0	10000.0
ALW-II-38-3	MERTK	100.0	10000.0
Ibrutinib	RIPK2	5.0	1000.0
BGJ398	GRK4	66.0	1000.0
WYE-125132	ABL1(F317I)-nonphosphorylated	100.0	10000.0
XMD11-50	SBK1	100.0	10000.0
JNK-9L	YSK1	64.0	10000.0
JWE-035	RSK4(Kin.Dom.1-N-terminal)	19.0	10000.0
GSK461364	MAP3K15	24.0	10000.0
Taselisib	CAMK2A	100.0	1000.0
KIN001-123	FGFR4	100.0	1000.0
AZD 5438	FLT3(ITD)	17.0	10000.0
JNK-IN-11	TYK2(JH2domain-pseudokinase)	100.0	1000.0
A443654	EPHA2	100.0	10000.0
ZM-447439	ROCK2	34.0	10000.0
AZD7762	CHEK1	0.3	10000.0
GW843682X	MARK2	50.0	10000.0
HG-5-113-01	STK35	12.0	10000.0
Lapatinib	FER	84.0	10000.0
XMD11-50	TBK1	97.0	10000.0
Dactolisib	PKMYT1	100.0	1000.0
Sorafenib	TYK2(JH2domain-pseudokinase)	100.0	10000.0
BMX-IN-1	DAPK2	94.0	10000.0
Sigma A6730	CSNK1E	15.0	10000.0
JNK-IN-5A	SIK1	92.0	10000.0
XMD11-50	STK36	97.0	10000.0
Lapatinib	EPHB2	100.0	10000.0
XMD8-85	DDR2	100.0	10000.0
ALW-II-49-7	MK11	100.0	10000.0
Abemaciclib	CDK16	0.2	1000.0
Palbociclib	ABL2	100.0	1000.0
NPK76-II-72-1	RPS6KA5(Kin.Dom.1)	100.0	10000.0
WZ-7043	KPCD2	100.0	10000.0
WYE-125132	TBK1	82.0	10000.0
CG-930	DYRK2	100.0	10000.0
MLN8054	ERK8	90.0	10000.0
ZG-10	LATS2	86.0	10000.0
GSK1059615	KKCC1	12.0	10000.0
BGJ398	PDPK1	74.0	1000.0
MRT67307	MP2K4	100.0	10000.0
SP600125	NEK7	100.0	10000.0
BMS345541	ERK8	19.0	10000.0
BI-2536	CSNK1A1L	100.0	10000.0
MRT67307	YES	69.0	10000.0
NPK76-II-72-1	FGFR2	100.0	10000.0
HG-9-91-01	MARK1	3.1	10000.0
(s)-CR8	CAMK2B	91.0	10000.0
AZD4547	NDR2	73.0	10000.0
Torkinib	KPCE	0.0	10000.0
CG-930	CASK	95.0	10000.0
BMX-IN-1	PLK2	86.0	10000.0
HG-14-8-02	SYK	100.0	10000.0
AG1478	HIPK2	80.0	10000.0
CP724714	RIOK3	100.0	10000.0
AZD 5438	M3K13	95.0	10000.0
HG-9-91-01	M4K1	1.9	10000.0
JNK-IN-8	PHKG1	87.0	1000.0
SCH772984	PFPK5(P.falciparum)	100.0	1000.0
JNK-IN-8	CLK2	95.0	1000.0
XMD11-50	RIOK2	100.0	10000.0
Vemurafenib	EGFR(L747-S752del,P753S)	78.0	10000.0
KIN001-021	LIMK2	26.0	1000.0
AZ-628	STK16	83.0	10000.0
Taselisib	LYN	99.0	1000.0
AS-252424	LOK	94.2	10000.0
KU63794	ERN1	89.0	10000.0
WZ-4-145	RIPK1	100.0	10000.0
AG1478	M3K13	100.0	10000.0
Pictilisib	NEK6	98.0	1000.0
THZ1	FAK2	0.2	10000.0
OTSSP167	CDK15	1.0	10000.0
BMS-536924	AMPK-alpha2	7.8	1000.0
ZG-10	RIOK3	13.0	10000.0
NU7441	TAOK2	98.0	10000.0
MPS-1-IN-1	PCTK2	100.0	1000.0
GSK461364	FGFR3(G697C)	75.0	10000.0
MLN8054	RSK3(Kin.Dom.2-C-terminal)	64.0	10000.0
XMD14-99	EPHA2	95.0	10000.0
HG-5-113-01	BMX	7.9	10000.0
MPS-1-IN-1	RAF1	100.0	1000.0
CP466722	KIT(V559D,T670I)	47.0	10000.0
ZM-447439	YANK3	100.0	10000.0
BMX-IN-1	PRKX	74.0	10000.0
BMS345541	ABL1(T315I)-nonphosphorylated	100.0	10000.0
GSK1059615	VRK2	81.0	10000.0
HG-14-10-04	EGFR(L747-E749del,A750P)	0.2	10000.0
PLX-4720	MELK	76.0	10000.0
KU63794	LIMK1	100.0	10000.0
XMD8-85	CDK9	100.0	10000.0
WZ3105	ICK	100.0	10000.0
SCH772984	ROS1	100.0	1000.0
THZ1	ERN1	66.0	10000.0
MLN8054	MP2K5	80.0	10000.0
XMD16-144	CAMK2A	32.0	10000.0
TGX221	KPCL	100.0	1000.0
XMD13-2	SRC	100.0	10000.0
HG-9-91-01	ICK	100.0	10000.0
XMD8-92	RET(M918T)	100.0	10000.0
AZ-628	CDC2L2	5.4	10000.0
JWE-035	ABL2	3.0	10000.0
AZD-6482	KC1G1	68.0	10000.0
MRT67307	MAP3K4	100.0	10000.0
BX-912	YES	31.0	10000.0
PHA-767491	PLK3	8.8	10000.0
ZSTK474	MLCK	100.0	1000.0
CGP74514A	AKT1	99.0	10000.0
Ibrutinib	AURKA	49.0	1000.0
Crizotinib	PIK3CA(C420R)	71.0	10000.0
CG-930	DCAMKL3	98.0	10000.0
PD173074	CDK11	100.0	10000.0
GSK461364	FGFR4	100.0	10000.0
XMD16-144	CAMK1G	52.0	10000.0
CP724714	ABL1(E255K)-phosphorylated	95.0	10000.0
CP724714	BMPR1B	17.0	10000.0
Canertinib	PAK7	100.0	1000.0
NU7441	MAP3K3	92.0	10000.0
XMD13-2	JAK3(JH1domain-catalytic)	27.0	10000.0
AZD-6482	MAP3K15	87.0	10000.0
Buparlisib	ABL1(H396P)-phosphorylated	100.0	1000.0
PHA-767491	ABL1(F317I)-phosphorylated	93.0	10000.0
XMD-12	EPHA8	100.0	1000.0
ERK5-IN-1	TAOK1	79.0	1000.0
ZM-447439	MYO3B	100.0	10000.0
WYE-125132	ERK4	100.0	10000.0
BI-2536	SgK110	100.0	10000.0
WH-4-023	BMPR1B	0.1	10000.0
XMD8-85	EGFR(L747-T751del,Sins)	100.0	10000.0
JNK-9L	SGK3	100.0	10000.0
Lapatinib	TGFBR1	89.0	10000.0
Dabrafenib	FER	100.0	10000.0
Torkinib	LKB1	79.0	10000.0
JWE-035	KIT(V559D,V654A)	100.0	10000.0
Baricitinib	SGK3	29.0	10000.0
BMS345541	LKB1	84.0	10000.0
XMD8-85	NDR1	100.0	10000.0
Dactolisib	ABL1(M351T)	100.0	1000.0
Momelotinib	KC1G2	100.0	10000.0
SP600125	CAMKK2	10.0	10000.0
AZD7762	PIK3CA(M1043I)	100.0	10000.0
5z-7-oxozeaenol	MAP3K3	100.0	10000.0
Torin2	MAP3K4	100.0	10000.0
Omipalisib	FER	90.0	10000.0
Crizotinib	FES	2.7	10000.0
Baricitinib	TGFBR1	96.0	10000.0
JNK-IN-8	FGFR3(G697C)	100.0	1000.0
SP600125	ADCK3	100.0	10000.0
Seliciclib	STK33	70.0	10000.0
PLX-4720	FYN	11.0	10000.0
XMD-12	KPCD	100.0	1000.0
Seliciclib	RET(V804L)	100.0	10000.0
AZD 5438	ROCK1	9.6	10000.0
JW-7-24-1	ABL1(Q252H)	18.0	10000.0
AZD 5438	RSK1(Kin.Dom.1-N-terminal)	67.0	10000.0
CGP74514A	EPHB4	38.0	10000.0
Taselisib	CDKL2	85.0	1000.0
SB590885	MKNK1	81.0	10000.0
HG-6-64-01	PIM2	100.0	10000.0
NVP-TAE684	MK09	12.0	1000.0
XMD8-85	EGFR(G719S)	100.0	10000.0
HG-14-8-02	KIT(A829P)	70.0	10000.0
Canertinib	PAK2	100.0	1000.0
CP466722	MP2K3	27.0	10000.0
NG25	SgK110	100.0	10000.0
THZ1	IRAK4	0.7	10000.0
Pictilisib	YSK4	95.0	1000.0
Barasertib	KC1G1	63.0	10000.0
AG1478	PDPK1	80.0	10000.0
WYE-125132	WNK1	95.0	10000.0
SB590885	EGFR(L747-S752del,P753S)	81.0	10000.0
Pictilisib	MAST1	100.0	1000.0
Buparlisib	KPCI	91.0	1000.0
Torin2	TNIK	68.0	10000.0
Sorafenib	MET(M1250T)	83.0	10000.0
BMS-536924	CDKL2	100.0	1000.0
BI-2536	MAPKAPK5	100.0	10000.0
THZ1	DCAMKL2	66.0	10000.0
Baricitinib	KIT(A829P)	22.0	10000.0
Omipalisib	AMPK-alpha2	100.0	10000.0
AZD4547	CDC2L1	58.0	10000.0
WZ3105	ACVRL1	100.0	10000.0
BS-181	RET	100.0	10000.0
Dactolisib	GRK7	100.0	1000.0
WYE-125132	BUB1	52.0	10000.0
Alpelisib	AAK1	75.0	1000.0
Torkinib	CLK2	9.7	10000.0
Seliciclib	GRK7	77.0	10000.0
MLN8054	ABL1(F317L)-nonphosphorylated	21.0	10000.0
WYE-125132	FGFR2	92.0	10000.0
AZD4547	CHEK1	1.2	10000.0
CP466722	PIK3C2G	8.2	10000.0
BGJ398	PKN2	100.0	1000.0
WZ4002	RPS6KA2(Kin.Dom.1)	16.0	10000.0
GSK429286A	PIM3	92.0	10000.0
NG25	TYK2(Kin.Dom.1)	100.0	10000.0
KU63794	CLK3	90.0	10000.0
ALW-II-38-3	TNK2	100.0	10000.0
Vemurafenib	CSNK1A1	90.0	10000.0
Momelotinib	RSK4(Kin.Dom.2-C-terminal)	52.0	10000.0
THZ1	PFCDPK1(P.falciparum)	20.0	10000.0
AZ-628	MET(M1250T)	64.0	10000.0
CGP60474	PLK1	100.0	10000.0
CP724714	LATS2	100.0	10000.0
PLX-4720	KCC2D	99.0	10000.0
WH-4-023	EGFR(G719C)	0.3	10000.0
MPS-1-IN-1	AKT3	100.0	1000.0
AZD-6482	EGFR(L747-E749del,A750P)	100.0	10000.0
JNK-IN-5A	MAPKAPK5	100.0	10000.0
PHA-767491	PIK3CA(H1047L)	79.0	10000.0
Palbociclib	EPHA7	100.0	1000.0
Palbociclib	MK11	100.0	1000.0
SB590885	MYLK4	98.0	10000.0
Sigma A6730	NDR1	62.0	10000.0
Ribociclib	DDR2	100.0	1000.0
NPK76-II-72-1	FLT3(ITD)	100.0	10000.0
AZD4547	GRK4	88.0	10000.0
THZ1	PTK6	1.6	10000.0
WYE-125132	YSK4	100.0	10000.0
Ceritinib	MKNK1	93.0	1000.0
Seliciclib	ABL2	100.0	10000.0
AZD4547	LIMK2	59.0	10000.0
Momelotinib	RPS6KA5(Kin.Dom.2-C-terminal)	9.3	10000.0
QL-X-138	WEE2	95.0	10000.0
WZ-7043	PIP5K2B	100.0	10000.0
(s)-CR8	ERK4	97.0	10000.0
Alpelisib	EGFR(T790M)	100.0	1000.0
Dinaciclib	SGK1	42.0	10000.0
ERK5-IN-1	MP2K5	100.0	1000.0
ZM-447439	GRK4	100.0	10000.0
Torin1	AXL	46.0	10000.0
AZ-628	TYK2(JH1domain-catalytic)	85.0	10000.0
WZ3105	MARK1	94.0	10000.0
AZD7762	FLT3	0.0	10000.0
KIN001-127	CHEK1	100.0	10000.0
WYE-125132	BRSK1	100.0	10000.0
Momelotinib	ULK3	0.3	10000.0
MPS-1-IN-1	SIK2	100.0	1000.0
SP600125	KPCL	100.0	10000.0
RO-3306	MAP4K5	77.0	10000.0
(s)-CR8	HIPK1	87.0	10000.0
XMD13-2	PLK3	100.0	10000.0
CP466722	FLT3(R834Q)	22.0	10000.0
XMD13-2	MAPKAPK2	100.0	10000.0
Taselisib	RSK2(Kin.Dom.2-C-terminal)	78.0	1000.0
SP600125	RPS6KA3(Kin.Dom.1)	100.0	10000.0
(s)-CR8	TRKC	72.0	10000.0
Ceritinib	IRAK1	83.0	1000.0
CP466722	MINK	40.0	10000.0
ZG-10	VGFR1	46.0	10000.0
Pictilisib	WNK3	100.0	1000.0
SP600125	RPS6KA2(Kin.Dom.1)	100.0	10000.0
PD173074	RPS6KA4(Kin.Dom.1)	100.0	10000.0
SB590885	SRPK3	100.0	10000.0
XMD8-85	ACVR1B	100.0	10000.0
BS-181	SRPK1	73.0	10000.0
HG-5-113-01	YANK3	100.0	10000.0
WZ-7043	FLT3(D835H)	100.0	10000.0
HG-14-8-02	RPS6KA5(Kin.Dom.1-N-terminal)	82.0	10000.0
AZD 5438	PIK3CA(Q546K)	46.0	10000.0
NG25	NUAK1	100.0	10000.0
BI-D1870	EGFR(E746-A750del)	13.0	10000.0
CP724714	KCC4	86.0	10000.0
CG-930	CSNK1E	11.0	10000.0
AZD-6482	IKKA	100.0	10000.0
NU7441	HCK	100.0	10000.0
KIN001-111	FGFR1	100.0	1000.0
BI-D1870	FLT3(ITD)	2.6	10000.0
ALW-II-38-3	STK39	100.0	10000.0
JNK-IN-8	MLK1	100.0	1000.0
AZD 5438	SNRK	100.0	10000.0
XMD11-50	CSNK1E	95.0	10000.0
PHA-793887	KIT(D816H)	85.0	10000.0
HG-14-10-04	CIT	0.2	10000.0
SB590885	PGFRA	100.0	10000.0
CG-930	CDK16	100.0	10000.0
KIN001-220	KGP1	100.0	10000.0
Palbociclib	MAK	100.0	1000.0
HG-5-113-01	EPHA4	100.0	10000.0
BMS345541	KCC2D	100.0	10000.0
WZ3105	PCTK3	77.0	10000.0
ZG-10	SRPK1	26.0	10000.0
BMS345541	AURKA	100.0	10000.0
WYE-125132	CTK	100.0	10000.0
HG-6-64-01	RIPK5	36.0	10000.0
GSK429286A	PIK3CG	88.0	10000.0
AZD 5438	CAMKK2	9.9	10000.0
Seliciclib	SGK2	100.0	10000.0
Palbociclib	MST1R	100.0	1000.0
TAK-715	EPHB4	53.0	10000.0
Pictilisib	PIK3CA(Q546K)	0.1	1000.0
SB590885	PLK3	94.0	10000.0
MRT67307	PLK4	36.0	10000.0
ZM-447439	SRPK3	100.0	10000.0
BGJ398	PGFRA	59.0	1000.0
WYE-125132	GRK7	91.0	10000.0
Alpelisib	TYK2(JH1domain-catalytic)	100.0	1000.0
CP466722	IGF1R	100.0	10000.0
Palbociclib	TLK2	100.0	1000.0
JNK-9L	ALK	100.0	10000.0
THZ1	MELK	6.4	10000.0
AG1478	KCC4	100.0	10000.0
XMD11-50	YSK1	68.0	10000.0
BMS345541	MRCKA	85.0	10000.0
THZ1	PCTK2	3.8	10000.0
Sorafenib	ABL1(F317L)-phosphorylated	36.0	10000.0
HG-14-8-02	MAP3K14	21.0	10000.0
AS-252424	TRKC	100.0	10000.0
5z-7-oxozeaenol	STK39	100.0	10000.0
PHA-767491	CDK7	1.7	10000.0
WZ4003	PAK3	100.0	1000.0
OTSSP167	LATS1	4.6	10000.0
KIN001-220	FGFR3	20.0	10000.0
QL-XII-47	MET(Y1235D)	100.0	1000.0
AZD 5438	M4K3	6.6	10000.0
Sorafenib	PAK2	73.0	10000.0
SB590885	AURKA	90.0	10000.0
Palbociclib	TIE1	100.0	1000.0
Dabrafenib	SGK3	82.0	10000.0
XMD8-92	EPHA5	100.0	10000.0
HG-6-64-01	MK03	100.0	10000.0
AZD4547	NUAK1	2.8	10000.0
HG-9-91-01	AURKC	32.0	10000.0
AG1478	PGFRA	29.0	10000.0
ZG-10	CLK3	100.0	10000.0
QL-XI-92	NEK7	100.0	10000.0
A443654	PIK3CG	100.0	10000.0
QL-X-138	DAPK3	61.0	10000.0
CP724714	GCN2(Kin.Dom.2,S808G)	81.0	10000.0
JNK-IN-5A	JAK2(JH1domain-catalytic)	100.0	10000.0
KIN001-220	MYO3A	100.0	10000.0
Neratinib	MINK	6.8	10000.0
KIN001-220	TGFBR2	100.0	10000.0
MRT67307	FYN	11.0	10000.0
CG-930	FLT4	55.0	10000.0
MRT67307	CDKL1	0.0	10000.0
PD0325901	EPHB4	100.0	10000.0
CGP74514A	PIP5K1C	4.6	10000.0
BMX-IN-1	SGK3	100.0	10000.0
XMD13-2	KPCT	100.0	10000.0
Dactolisib	ERK4	100.0	1000.0
HG-5-88-01	DDR1	100.0	10000.0
Buparlisib	KGP2	99.0	1000.0
BMX-IN-1	HIPK3	100.0	10000.0
MRT67307	RET(V804L)	2.4	10000.0
PHA-793887	ACVR1B	100.0	10000.0
XMD16-144	PAK6	66.0	10000.0
KU63794	LTK	96.0	10000.0
HG-14-8-02	NEK9	100.0	10000.0
PLX-4720	CDK4-cyclinD3	70.0	10000.0
GSK461364	FLT3(N841I)	1.2	10000.0
WZ4002	ERBB2	1.8	10000.0
Sigma A6730	DDR2	76.0	10000.0
NPK76-II-72-1	KIT(D816V)	100.0	10000.0
MRT67307	YSK1	58.0	10000.0
Baricitinib	KKCC1	86.0	10000.0
CGP60474	SIK1	100.0	10000.0
AZD4547	LIMK1	94.0	10000.0
OTSSP167	BMPR1A	46.0	10000.0
Momelotinib	MAP4K4	85.0	10000.0
JNK-IN-8	MP2K5	67.0	1000.0
AZ-628	IKKE	100.0	10000.0
WZ-7043	EPHA6	100.0	10000.0
RO-3306	EGFR(T790M)	48.0	10000.0
CGP74514A	MYLK4	90.0	10000.0
XMD13-2	DMPK2	62.0	10000.0
KIN001-220	CSNK1A1L	100.0	10000.0
Ribociclib	MARK2	97.0	1000.0
AZD-6482	LATS2	63.0	10000.0
SB590885	DYRK1B	100.0	10000.0
AZD-6482	STK33	100.0	10000.0
GW-5074	HUNK	2.8	10000.0
Buparlisib	RSK4(Kin.Dom.2-C-terminal)	75.0	1000.0
ZSTK474	PKN1	100.0	1000.0
BGJ398	MK13	100.0	1000.0
JWE-035	PKMYT1	100.0	10000.0
ERK5-IN-1	EGFR(L747-E749del,A750P)	100.0	1000.0
WZ-7043	PKAC-alpha	100.0	10000.0
Pictilisib	PIK3CA	0.2	1000.0
WZ3105	FLT3(N841I)	0.0	10000.0
CG-930	ABL1(Y253F)-phosphorylated	29.0	10000.0
A443654	SRPK3	1.0	10000.0
NU7441	RPS6KA4(Kin.Dom.1-N-terminal)	79.0	10000.0
Vemurafenib	MK11	29.0	10000.0
Ceritinib	TXK	79.0	1000.0
KIN001-111	MAP4K4	20.0	1000.0
Torin2	MET(Y1235D)	98.0	10000.0
Ribociclib	EGFR(G719C)	100.0	1000.0
PHA-793887	PRKR	100.0	10000.0
CP466722	LATS2	11.0	10000.0
HG-9-91-01	ERBB4	2.0	10000.0
ALW-II-49-7	MK09	100.0	10000.0
AZD4547	S6K1	43.0	10000.0
CP724714	MLK2	100.0	10000.0
CGP74514A	PIP5K1A	98.0	10000.0
ZSTK474	CLK3	100.0	1000.0
PHA-793887	EGFR	90.0	10000.0
NG25	PIM1	100.0	10000.0
JNK-IN-8	ERBB4	96.0	1000.0
ZG-10	EPHA5	97.0	10000.0
CP724714	CAMK1	72.0	10000.0
AZ-628	M4K1	63.0	10000.0
Dactolisib	PGFRA	100.0	1000.0
Taselisib	FGFR4	94.0	1000.0
Ribociclib	IRAK4	100.0	1000.0
Palbociclib	NEK10	65.0	1000.0
Dinaciclib	EIF2AK1	69.0	10000.0
PHA-793887	SRMS	100.0	10000.0
Torkinib	STK36	100.0	10000.0
WZ-7043	ERBB4	100.0	10000.0
WZ3105	STK39	51.0	10000.0
Dinaciclib	FAK2	78.0	10000.0
BS-181	KPCI	89.0	10000.0
BGJ398	KIT(A829P)	32.0	1000.0
Abemaciclib	MK14	100.0	1000.0
Dabrafenib	TNNI3K	30.0	10000.0
PD0325901	PIP5K1C	100.0	10000.0
Neratinib	NUAK1	61.0	10000.0
Sigma A6730	PIK4CB	60.0	10000.0
Dabrafenib	DCLK1	3.3	10000.0
RO-3306	LIMK2	88.0	10000.0
Abemaciclib	CDK15	47.0	1000.0
NPK76-II-72-1	EPHB1	100.0	10000.0
Taselisib	GRK1	100.0	1000.0
Seliciclib	MAP4K5	100.0	10000.0
JNK-9L	RIPK2	53.0	10000.0
JNK-IN-5A	ULK2	98.0	10000.0
WZ3105	TNK2	46.0	10000.0
XMD13-2	MST3	82.0	10000.0
KIN001-127	RET(M918T)	32.0	10000.0
Torin1	M3K13	100.0	10000.0
CG-930	SRC	72.0	10000.0
AS-252424	EPHB2	74.6	10000.0
KU63794	MYO3A	97.0	10000.0
KIN001-021	TRKB	100.0	1000.0
QL-XII-47	JNK1	85.0	1000.0
OTSSP167	MAP4K2	0.4	10000.0
AS-252424	STK33	96.7	10000.0
Sorafenib	BLK	31.0	10000.0
Alpelisib	CDC2L1	100.0	1000.0
Taselisib	M3K5	100.0	1000.0
5z-7-oxozeaenol	CAMK2B	66.0	10000.0
JW-7-24-1	ADCK4	100.0	10000.0
ZM-447439	ULK2	91.0	10000.0
BGJ398	EPHA8	91.0	1000.0
Seliciclib	MAP4K4	100.0	10000.0
ZM-447439	ABL1(M351T)-phosphorylated	32.0	10000.0
WYE-125132	YANK2	86.0	10000.0
5z-7-oxozeaenol	ACVR2B	46.0	10000.0
Canertinib	JAK3(Kin.Dom.2)	100.0	1000.0
JNK-IN-5A	NEK9	70.0	10000.0
Taselisib	ERBB3	92.0	1000.0
ZG-10	RAF1	100.0	10000.0
SB590885	NUAK1	100.0	10000.0
BMS345541	BRSK2	100.0	10000.0
AZD7762	EGFR(L747-E749del,A750P)	0.7	10000.0
Baricitinib	OSR1	1.4	10000.0
Neratinib	IKKE	100.0	10000.0
Abemaciclib	PAK3	55.0	1000.0
CG-930	PDPK1	100.0	10000.0
JNK-9L	NDR2	100.0	10000.0
WZ-7043	FYN	100.0	10000.0
QL-X-138	BMPR2	73.0	10000.0
WYE-125132	BLK	96.0	10000.0
Crizotinib	ERK5	0.1	10000.0
JWE-035	SNARK	6.6	10000.0
RO-3306	MLK2	100.0	10000.0
ZM-447439	MERTK	2.4	10000.0
NU7441	INSR	66.0	10000.0
QL-XII-47	MLCK	100.0	1000.0
AG1478	IKKA	72.0	10000.0
XMD8-85	CSNK2A2	100.0	10000.0
NG25	DAPK1	100.0	10000.0
WZ4003	EGFR(L858R)	22.0	1000.0
KIN001-123	CSNK2A2	100.0	1000.0
ERK5-IN-1	NEK11	100.0	1000.0
Buparlisib	MAK	97.0	1000.0
AZD4547	TXK	36.0	10000.0
XMD16-144	SBK1	7.6	10000.0
BGJ398	HASP	32.0	1000.0
ALW-II-49-7	NDR2	100.0	10000.0
HG-6-64-01	EGFR(L861Q)	0.0	10000.0
MLN8054	PKN1	83.0	10000.0
Ibrutinib	KIT(D816V)	77.0	1000.0
AZD4547	SRPK2	52.0	10000.0
CGP74514A	DMPK2	86.0	10000.0
Baricitinib	NEK9	26.0	10000.0
HG-14-8-02	MAPKAPK2	88.0	10000.0
Omipalisib	SRMS	87.0	10000.0
OTSSP167	DDR2	22.0	10000.0
TGX221	EPHA4	100.0	1000.0
WH-4-023	NEK9	100.0	10000.0
PD173074	EPHB2	100.0	10000.0
GSK461364	ULK3	100.0	10000.0
QL-X-138	JNK3	1.8	10000.0
HG-6-64-01	FLT3(D835H)	0.2	10000.0
WZ-7043	NEK7	100.0	10000.0
KIN001-111	KPCD	100.0	1000.0
Neratinib	MERTK	8.4	10000.0
Torin2	EGFR(L861Q)	93.0	10000.0
5z-7-oxozeaenol	MAP3K15	99.0	10000.0
Ceritinib	CDK4	94.0	1000.0
Ibrutinib	CSNK1A1L	99.0	1000.0
CGP60474	IRAK3	100.0	10000.0
NG25	MYLK	100.0	10000.0
KIN001-111	PLK4	100.0	1000.0
(s)-CR8	DCAMKL3	73.0	10000.0
AZ-628	DCLK1	97.0	10000.0
BI-2536	FAK2	20.0	10000.0
Torin2	PIP5K1A	78.0	10000.0
Baricitinib	MP2K3	6.6	10000.0
PHA-793887	INSRR	100.0	10000.0
KU63794	MTOR	0.0	10000.0
Momelotinib	NEK9	9.4	10000.0
Crizotinib	KPCE	100.0	10000.0
MRT67307	ABL1(Q252H)-phosphorylated	40.0	10000.0
R406	ZAP70	0.0	1000.0
(s)-CR8	CSNK2A2	55.0	10000.0
AG1478	ALK	25.0	10000.0
HG-14-8-02	CDC2L5	87.0	10000.0
AG1478	JAK2(JH1domain-catalytic)	46.0	10000.0
XMD13-2	RIOK2	78.0	10000.0
HG-6-64-01	EPHA4	0.0	10000.0
AS-252424	MARK4	100.0	10000.0
Taselisib	SLK	91.0	1000.0
KIN001-220	MST4	43.0	10000.0
NU7441	MARK4	100.0	10000.0
PD0325901	TRKB	100.0	10000.0
ZSTK474	AURKA	100.0	1000.0
Dabrafenib	PAK2	79.0	10000.0
WH-4-023	EPHA1	0.0	10000.0
PHA-767491	RIPK4	3.7	10000.0
Torkinib	CDK9	96.0	10000.0
BX-912	MLTK	12.0	10000.0
KIN001-220	AXL	2.1	10000.0
A443654	TAOK3	0.1	10000.0
AG1478	ALK(L1196M)	63.0	10000.0
MRT67307	PAK7	50.0	10000.0
ALW-II-38-3	RPS6KA1(Kin.Dom.1)	100.0	10000.0
NPK76-II-72-1	ALK	6.2	10000.0
PD0325901	DAPK2	100.0	10000.0
Seliciclib	SBK1	99.0	10000.0
Torin2	AMPK-alpha1	100.0	10000.0
AZD7762	PIM1	48.0	10000.0
Buparlisib	TRKA	100.0	1000.0
QL-XII-47	RIPK2	75.0	1000.0
JNK-IN-8	CSNK2A2	39.0	1000.0
Alpelisib	MYO3B	93.0	1000.0
AZD 5438	EGFR(G719S)	92.0	10000.0
Torkinib	FES	100.0	10000.0
WYE-125132	ABL1(T315I)-phosphorylated	80.0	10000.0
AZD 5438	TYK2(JH1domain-catalytic)	0.0	10000.0
5z-7-oxozeaenol	ALK	73.0	10000.0
CGP74514A	FGFR3	77.0	10000.0
WZ4003	TESK1	100.0	1000.0
(s)-CR8	GRK1	77.0	10000.0
XMD13-2	AKT1	100.0	10000.0
WZ3105	RPS6KA5(Kin.Dom.2-C-terminal)	95.0	10000.0
GW843682X	MP2K3	78.0	10000.0
BX-912	MK03	76.0	10000.0
ERK5-IN-1	JNK3	74.0	1000.0
WH-4-023	KCC4	100.0	10000.0
5z-7-oxozeaenol	ABL1(Y253F)-phosphorylated	90.0	10000.0
XMD16-144	EGFR(T790M)	43.0	10000.0
KU63794	EPHA4	100.0	10000.0
HG-14-8-02	WEE1	100.0	10000.0
KIN001-111	DRAK2	100.0	1000.0
XMD11-50	ABL1(Q252H)-phosphorylated	100.0	10000.0
JW-7-24-1	SRC	7.6	10000.0
PHA-767491	AMPK-alpha2	100.0	10000.0
ALW-II-49-7	BMX	100.0	10000.0
PHA-793887	RPS6KA4(Kin.Dom.2-C-terminal)	92.0	10000.0
Pictilisib	TRPM6	100.0	1000.0
HG-5-88-01	CAMK2A	32.0	10000.0
WH-4-023	GRK7	72.0	10000.0
AZ-628	ABL1(Q252H)-nonphosphorylated	2.2	10000.0
OTSSP167	HIPK2	0.3	10000.0
AZD7762	KPCD2	0.9	10000.0
ZM-447439	MP2K6	86.0	10000.0
Ceritinib	M4K1	72.0	1000.0
ALW-II-38-3	MST2	100.0	10000.0
WYE-125132	RSK2(Kin.Dom.1-N-terminal)	100.0	10000.0
PD173074	LATS1	100.0	10000.0
MLN8054	ZAP70	100.0	10000.0
Torin2	TRKC	100.0	10000.0
BMS345541	SRMS	90.0	10000.0
XMD11-50	WEE2	100.0	10000.0
KIN001-021	CAMK2A	100.0	1000.0
BMS-536924	SYK	0.3	1000.0
XMD16-144	DAPK1	52.0	10000.0
JWE-035	VRK2	100.0	10000.0
BI-2536	CAMK2A	26.0	10000.0
BMS345541	TRPM6	87.0	10000.0
BI-D1870	CIT	22.0	10000.0
Torkinib	FLT3(N841I)	5.0	10000.0
Lapatinib	MST3	100.0	10000.0
WZ4002	JAK2(Kin.Dom.2)	100.0	10000.0
BX-912	EGFR	47.0	10000.0
XMD14-99	ABL1(F317I)-nonphosphorylated	100.0	10000.0
PD0325901	KIT(L576P)	75.0	10000.0
A443654	TGFBR1	100.0	10000.0
RO-3306	EPHA3	64.0	10000.0
AZD 5438	SRPK3	5.8	10000.0
HG-5-88-01	VGFR1	100.0	10000.0
BMX-IN-1	CSK	75.0	10000.0
ZSTK474	YANK2	100.0	1000.0
CG-930	PIK3CD	96.0	10000.0
GW843682X	MAP3K4	90.0	10000.0
Vemurafenib	SRPK1	92.0	10000.0
CG-930	FGFR2	83.0	10000.0
Alpelisib	VGFR1	94.0	1000.0
SB590885	CSNK2A1	79.0	10000.0
Palbociclib	MP2K3	87.0	1000.0
XMD-12	PRP4	100.0	1000.0
HG-5-88-01	SRMS	7.3	10000.0
GW843682X	NEK2	14.0	10000.0
OTSSP167	HIPK3	0.8	10000.0
Baricitinib	CDK5	100.0	10000.0
WZ4003	MET	17.0	1000.0
A443654	CDK3	22.0	10000.0
(s)-CR8	ERBB3	70.0	10000.0
KIN001-127	CDK2	100.0	10000.0
Lapatinib	CDKL3	100.0	10000.0
MLN8054	FLT3(D835Y)	72.0	10000.0
NPK76-II-72-1	WEE1	100.0	10000.0
Seliciclib	MARK1	92.0	10000.0
AZD 5438	HCK	67.0	10000.0
GW843682X	MK13	100.0	10000.0
Barasertib	EPHA3	62.0	10000.0
NPK76-II-72-1	TLK1	100.0	10000.0
WZ4003	PRKR	100.0	1000.0
Palbociclib	TYRO3	96.0	1000.0
PHA-793887	KPCD2	1.1	10000.0
CGP60474	KCC2D	100.0	10000.0
NPK76-II-72-1	CAMK2B	100.0	10000.0
BMS345541	FER	98.0	10000.0
Dactolisib	FES	100.0	1000.0
JNK-IN-5A	PAK2	97.0	10000.0
XMD11-50	YES	100.0	10000.0
R406	EPHB2	100.0	1000.0
KIN001-127	PKAC-beta	100.0	10000.0
MLN8054	CAMK1	78.0	10000.0
Alpelisib	BMX	95.0	1000.0
PHA-767491	PIM2	10.0	10000.0
AZD-6482	BMPR2	69.0	10000.0
Buparlisib	CSNK2A1	100.0	1000.0
CH5424802	BLK	11.0	1000.0
ZM-447439	HUNK	81.0	10000.0
XMD11-50	EPHB1	98.0	10000.0
XMD11-85h	PIK3CA(E545K)	100.0	10000.0
JNK-IN-11	IRAK4	84.0	1000.0
A443654	RIPK4	100.0	10000.0
SB590885	JAK1(JH2domain-pseudokinase)	0.5	10000.0
WH-4-023	SNARK	9.8	10000.0
ZM-447439	NEK1	81.0	10000.0
AZ-628	NEK9	100.0	10000.0
XMD8-85	KPCL	100.0	10000.0
ERK5-IN-1	BTK	100.0	1000.0
QL-XII-47	TAK1	83.0	1000.0
GSK429286A	RET	20.0	10000.0
PHA-767491	CSF1R	99.0	10000.0
WH-4-023	SRC	0.1	10000.0
Torkinib	DRAK2	40.0	10000.0
WZ-7043	CAMK1D	25.0	10000.0
AG1478	ACVRL1	100.0	10000.0
(s)-CR8	INSRR	97.0	10000.0
BI-D1870	DDR1	1.6	10000.0
TGX221	MINK	100.0	1000.0
CG-930	KPCE	98.0	10000.0
GW843682X	SBK1	96.0	10000.0
NU7441	MYLK4	100.0	10000.0
CG-930	LIMK2	29.0	10000.0
AG1478	BMPR2	62.0	10000.0
CH5424802	RSK4(Kin.Dom.2-C-terminal)	18.0	1000.0
XMD13-2	CSNK2A1	62.0	10000.0
JWE-035	CDK16	92.0	10000.0
Palbociclib	MKNK2	100.0	1000.0
XMD11-50	MP2K2	99.0	10000.0
PHA-767491	PKNB(M.tuberculosis)	36.0	10000.0
PHA-767491	ABL1(H396P)-phosphorylated	85.0	10000.0
CP724714	IKKE	100.0	10000.0
WZ-4-145	BRSK2	100.0	10000.0
MRT67307	NEK3	59.0	10000.0
NVP-TAE684	GAK	0.1	1000.0
XMD16-144	CDK5	100.0	10000.0
MRT67307	ADCK3	100.0	10000.0
CG-930	KPCD2	77.0	10000.0
WZ-7043	CHK2	100.0	10000.0
CP466722	ABL1-phosphorylated	0.3	10000.0
ZSTK474	AAK1	100.0	1000.0
Abemaciclib	CSNK2A1	1.2	1000.0
XMD16-144	LATS2	97.0	10000.0
HG-5-88-01	LIMK2	100.0	10000.0
Crizotinib	EPHB3	100.0	10000.0
TAK-715	SYK	88.0	10000.0
AZD 5438	ITK	82.0	10000.0
AZD4547	GSK3B	81.0	10000.0
Baricitinib	KPCD1	99.0	10000.0
Ribociclib	MK09	100.0	1000.0
Buparlisib	TRKB	100.0	1000.0
MRT67307	DAPK3	3.4	10000.0
SB590885	CDKL5	100.0	10000.0
TAK-715	MP2K7	100.0	10000.0
AZD 5438	ULK2	44.0	10000.0
SCH772984	FGFR3(G697C)	100.0	1000.0
CP724714	ABL1(Y253F)-phosphorylated	100.0	10000.0
Ribociclib	EPHA8	100.0	1000.0
ZSTK474	KGP2	100.0	1000.0
XMD-12	AXL	88.0	1000.0
MLN8054	CDKL3	100.0	10000.0
JNK-IN-8	M3K5	100.0	1000.0
ERK5-IN-1	TNK1	53.0	1000.0
XMD14-99	CSNK2A1	91.0	10000.0
Ribociclib	CHEK1	98.0	1000.0
JNK-IN-11	PLK3	100.0	1000.0
XMD14-99	RET	97.0	10000.0
WZ-7043	TBK1	100.0	10000.0
HG-14-8-02	SRMS	44.0	10000.0
Torkinib	MAP4K2	0.0	10000.0
JW-7-24-1	MARK4	100.0	10000.0
Buparlisib	IRAK4	100.0	1000.0
JWE-035	HIPK2	100.0	10000.0
Taselisib	NIM1	100.0	1000.0
MPS-1-IN-1	RPS6KA4(Kin.Dom.1)	100.0	1000.0
JWE-035	KPCD	100.0	10000.0
(s)-CR8	EGFR(L858R,T790M)	97.0	10000.0
BMS-536924	ZAP70	100.0	1000.0
GW843682X	IGF1R	100.0	10000.0
Dactolisib	HIPK1	100.0	1000.0
ALW-II-49-7	PAK2	100.0	10000.0
AZD4547	YSK1	4.3	10000.0
WZ4003	AURKC	3.5	1000.0
QL-X-138	ABL1(H396P)-phosphorylated	60.0	10000.0
GSK1059615	CDK11	4.2	10000.0
Baricitinib	RSK1(Kin.Dom.1-N-terminal)	50.0	10000.0
HG-5-113-01	PIM1	100.0	10000.0
XMD16-144	MAP3K3	0.1	10000.0
HG-14-10-04	PKN2	43.0	10000.0
WH-4-023	BMX	0.2	10000.0
THZ1	CDK5	1.2	10000.0
Momelotinib	PLK3	11.0	10000.0
Taselisib	SGK1	100.0	1000.0
Ceritinib	SRMS	77.0	1000.0
HG-6-64-01	ABL1(Y253F)-phosphorylated	0.3	10000.0
QL-XI-92	STK36	100.0	10000.0
Torin2	CLK4	34.0	10000.0
Torin1	RSK1(Kin.Dom.2-C-terminal)	100.0	10000.0
A443654	LOK	100.0	10000.0
HG-6-64-01	DAPK3	99.0	10000.0
WZ4003	TXK	100.0	1000.0
QL-XII-47	CDKL1	68.0	1000.0
Seliciclib	LCK	100.0	10000.0
Palbociclib	NEK9	100.0	1000.0
BS-181	RET(V804M)	100.0	10000.0
Seliciclib	TBK1	68.0	10000.0
XMD8-92	PIM1	100.0	10000.0
GW843682X	RPS6KA4(Kin.Dom.2-C-terminal)	70.0	10000.0
Sorafenib	DRAK2	59.0	10000.0
(s)-CR8	EGFR(T790M)	98.0	10000.0
PD0325901	FER	100.0	10000.0
Baricitinib	MP2K4	11.0	10000.0
BGJ398	TXK	100.0	1000.0
Crizotinib	RSK1(Kin.Dom.1-N-terminal)	84.0	10000.0
Abemaciclib	KKCC1	20.0	1000.0
BGJ398	ACVR1	90.0	1000.0
Baricitinib	RSK1(Kin.Dom.2-C-terminal)	3.8	10000.0
XMD8-85	MRCKA	100.0	10000.0
ZSTK474	RIOK3	100.0	1000.0
Pictilisib	SBK1	100.0	1000.0
XMD8-92	PIK3CA(C420R)	100.0	10000.0
Barasertib	EPHA7	74.0	10000.0
BI-D1870	AXL	7.2	10000.0
ALW-II-38-3	SRC	0.4	1000.0
Barasertib	TNIK	52.0	10000.0
WZ3105	MP2K3	77.0	10000.0
(s)-CR8	EPHA2	83.0	10000.0
HG-14-10-04	CSNK1G3	90.0	10000.0
WZ4002	EPHA8	100.0	10000.0
Pictilisib	RSK3(Kin.Dom.2-C-terminal)	79.0	1000.0
BMS345541	YANK3	94.0	10000.0
Momelotinib	PKNB(M.tuberculosis)	8.7	10000.0
HG-14-10-04	DYRK1B	0.9	10000.0
Sorafenib	FGFR3	31.0	10000.0
QL-XI-92	CDK15	93.0	10000.0
JNK-IN-5A	IRAK1	100.0	10000.0
CH5424802	FLT3(N841I)	13.0	1000.0
JW-7-24-1	M3K12	100.0	10000.0
THZ1	ABL1(Q252H)-phosphorylated	0.9	10000.0
AZD4547	IRAK1	20.0	10000.0
WZ3105	KPCD2	100.0	10000.0
HG-14-10-04	ABL1(T315I)-nonphosphorylated	0.1	10000.0
Baricitinib	CSK	99.0	10000.0
SCH772984	STK36	94.0	1000.0
NVP-TAE684	KIT(V559D)	0.1	1000.0
SB590885	IGF1R	100.0	10000.0
MLN8054	PDPK1	35.0	10000.0
XMD11-50	RSK3(Kin.Dom.1-N-terminal)	83.0	10000.0
ERK5-IN-1	CDC2L2	100.0	1000.0
Vemurafenib	TYK2(JH2domain-pseudokinase)	100.0	10000.0
CGP74514A	ABL1(F317L)-phosphorylated	5.6	10000.0
Barasertib	BMPR1B	29.0	10000.0
Torin1	CLK2	65.0	10000.0
AZ-628	RIPK5	78.0	10000.0
JWE-035	KIT	57.0	10000.0
AS-252424	IKKA	47.7	10000.0
CGP74514A	NEK7	54.0	10000.0
AZD7762	RET	0.0	10000.0
AZ-628	M3K5	100.0	10000.0
AZD4547	HUNK	33.0	10000.0
ZSTK474	BRSK1	100.0	1000.0
Barasertib	FAK1	64.0	10000.0
HG-14-8-02	CDK4-cyclinD3	100.0	10000.0
PD0325901	TESK1	98.0	10000.0
WH-4-023	MLTK	24.0	10000.0
SCH772984	MP2K6	46.0	1000.0
HG-14-10-04	ABL1(H396P)-phosphorylated	0.2	10000.0
Dinaciclib	RET	91.0	10000.0
PD173074	FLT3(ITD)	100.0	10000.0
Abemaciclib	KIT	100.0	1000.0
THZ1	MRCKB	74.0	10000.0
NU7441	MKNK2	87.0	10000.0
HG-5-113-01	EGFR	100.0	10000.0
ALW-II-38-3	MP2K3	100.0	10000.0
NU7441	PFCDPK1(P.falciparum)	98.0	10000.0
Alpelisib	WEE1	98.0	1000.0
MLN8054	PKMYT1	65.0	10000.0
HG-6-64-01	SgK110	41.0	10000.0
AZD4547	AMPK-alpha2	12.0	10000.0
ERK5-IN-1	PGFRA	100.0	1000.0
Ribociclib	MAPKAPK2	99.0	1000.0
AZD-6482	M3K13	100.0	10000.0
XMD11-85h	EPHA7	100.0	10000.0
PHA-793887	TYK2(JH2domain-pseudokinase)	100.0	10000.0
JNK-IN-8	MRCKB	68.0	1000.0
NU7441	KIT(V559D)	80.0	10000.0
Taselisib	KCC4	100.0	1000.0
Momelotinib	M3K2	100.0	10000.0
BMS345541	CLK1	72.0	10000.0
AZD 5438	ABL1(F317L)-phosphorylated	55.0	10000.0
XMD8-92	CSK	100.0	10000.0
NU7441	PIK3CD	3.3	10000.0
GSK429286A	ABL1(F317L)-nonphosphorylated	73.0	10000.0
BI-2536	CIT	100.0	10000.0
Alpelisib	MK11	97.0	1000.0
Sorafenib	ABL1(H396P)-phosphorylated	35.0	10000.0
CGP60474	DYRK1B	4.0	10000.0
KIN001-220	ITK	52.0	10000.0
PD0325901	ERBB3	100.0	10000.0
SB590885	TAK1	89.0	10000.0
BMS345541	AURKC	100.0	10000.0
ALW-II-38-3	NEK2	100.0	10000.0
MRT67307	PIK4CB	87.0	10000.0
MLN8054	JAK1(JH1domain-catalytic)	90.0	10000.0
XMD16-144	MP2K6	95.0	10000.0
BI-2536	AURKB	100.0	10000.0
XMD16-144	MAP3K15	69.0	10000.0
Torin2	NEK6	92.0	10000.0
GSK1059615	CDK15	9.6	10000.0
XMD-12	LRRK2	2.2	1000.0
WZ3105	KPCD3	80.0	10000.0
PHA-767491	CSNK1A1	1.8	10000.0
CG-930	EPHB6	7.8	10000.0
Buparlisib	TNNI3K	99.0	1000.0
Torkinib	ABL1(Y253F)-phosphorylated	0.1	10000.0
Omipalisib	KPCE	86.0	10000.0
TAK-715	TAOK1	72.0	10000.0
AZD 5438	TNK1	30.0	10000.0
Barasertib	MK13	91.0	10000.0
GW-5074	NIM1	100.0	10000.0
BI-2536	TLK2	100.0	10000.0
PHA-793887	RET(V804L)	100.0	10000.0
Buparlisib	MST2	100.0	1000.0
CP724714	LTK	88.0	10000.0
XMD11-50	PAK6	98.0	10000.0
WZ4002	EGFR(L747-T751del,Sins)	0.0	10000.0
AS-252424	CHEK1	100.0	10000.0
MLN8054	PAK6	79.0	10000.0
Buparlisib	EGFR	100.0	1000.0
RO-3306	MLK3	99.0	10000.0
HG-5-88-01	SgK110	100.0	10000.0
BMX-IN-1	DCAMKL2	100.0	10000.0
CGP74514A	FLT3(ITD)	1.0	10000.0
WZ3105	TRPM6	66.0	10000.0
XMD8-85	EPHB1	100.0	10000.0
KIN001-111	TNK1	14.0	1000.0
Crizotinib	DYRK1A	100.0	10000.0
RO-3306	SRPK1	57.0	10000.0
ZSTK474	FER	100.0	1000.0
XMD16-144	NDR1	74.0	10000.0
Omipalisib	LATS1	100.0	10000.0
CGP74514A	RSK3(Kin.Dom.1-N-terminal)	4.9	10000.0
ZG-10	PIK3CA(E542K)	100.0	10000.0
Barasertib	PIM3	100.0	10000.0
XMD8-92	M3K13	100.0	10000.0
Torin2	ERK4	75.0	10000.0
Ceritinib	DMPK2	97.0	1000.0
Sigma A6730	CAMK2A	98.0	10000.0
SCH772984	PI42C	100.0	1000.0
WZ3105	MST4	16.0	10000.0
Torin1	FGFR1	96.0	10000.0
Neratinib	BMPR1B	89.0	10000.0
JWE-035	ERBB3	75.0	10000.0
SP600125	FGFR1	100.0	10000.0
Ribociclib	ZAP70	93.0	1000.0
XMD8-85	PIK3C2B	100.0	10000.0
AZ-628	PDPK1	100.0	10000.0
OTSSP167	PIK3CG	0.4	10000.0
WZ3105	DMPK2	84.0	10000.0
KIN001-123	ACVR1B	100.0	1000.0
BGJ398	ERN1	100.0	1000.0
OTSSP167	NEK1	95.0	10000.0
WH-4-023	TRKC	100.0	10000.0
Taselisib	PIP5K1C	80.0	1000.0
KIN001-111	AKT2	100.0	1000.0
TGX221	RPS6KA6(Kin.Dom.2)	100.0	1000.0
QL-XI-92	CDC2L5	100.0	10000.0
Omipalisib	JAK2(JH1domain-catalytic)	62.0	10000.0
Palbociclib	NEK4	100.0	1000.0
GSK1059615	FLT3-autoinhibited	61.0	10000.0
CP466722	STK16	2.8	10000.0
JNK-IN-8	ROCK1	63.0	1000.0
BMX-IN-1	M3K12	59.0	10000.0
ZG-10	CAMK1	94.0	10000.0
AS-252424	PIM3	4.8	10000.0
HG-14-8-02	HIPK4	2.4	10000.0
MPS-1-IN-1	ROCK2	100.0	1000.0
WZ4002	M3K5	100.0	10000.0
PLX-4720	TAOK1	52.0	10000.0
R406	TNK2	0.3	1000.0
Neratinib	CDKL3	100.0	10000.0
WYE-125132	KC1G2	95.0	10000.0
Alpelisib	PRKR	100.0	1000.0
CP724714	SgK110	100.0	10000.0
ZSTK474	PAK6	100.0	1000.0
WZ4002	EPHB4	100.0	10000.0
Dabrafenib	RET(V804L)	100.0	10000.0
XMD-12	NEK9	100.0	1000.0
KIN001-220	FGFR1	14.0	10000.0
AS-252424	CDC2L1	100.0	10000.0
QL-XII-47	PKNB(M.tuberculosis)	99.0	1000.0
Ceritinib	PIK3CA(I800L)	74.0	1000.0
PLX-4720	RIOK2	3.0	10000.0
BMS-536924	CAMK2A	25.0	1000.0
5z-7-oxozeaenol	MYLK4	84.0	10000.0
Omipalisib	YSK4	37.0	10000.0
HG-5-113-01	DCLK1	100.0	10000.0
HG-5-88-01	CAMK2G	100.0	10000.0
Dactolisib	MINK	100.0	1000.0
Torin1	M3K12	100.0	10000.0
Momelotinib	PIK3CA(C420R)	100.0	10000.0
NU7441	AKT1	89.0	10000.0
XMD11-50	IRAK1	100.0	10000.0
ERK5-IN-1	PIK3CA(E545K)	100.0	1000.0
Lapatinib	VGFR1	100.0	10000.0
XMD8-85	MARK1	100.0	10000.0
Lapatinib	MLTK	100.0	10000.0
Torin2	EPHA5	100.0	10000.0
A443654	ABL2	100.0	10000.0
WZ-4-145	IKKA	100.0	10000.0
Alpelisib	ERBB3	100.0	1000.0
Ceritinib	HIPK1	68.0	1000.0
MPS-1-IN-1	CHEK1	100.0	1000.0
PD173074	MLK1	100.0	10000.0
AZ-628	KIT(V559D,T670I)	0.4	10000.0
SP600125	LKB1	32.0	10000.0
AS-252424	CAMK2A	64.1	10000.0
OTSSP167	NUAK1	2.5	10000.0
Dactolisib	DAPK3	100.0	1000.0
Buparlisib	ULK2	100.0	1000.0
HG-6-64-01	EPHB1	0.5	10000.0
CH5424802	BTK	96.0	1000.0
BMS-536924	MYO3B	100.0	1000.0
Taselisib	CTK	100.0	1000.0
GW-5074	TSSK1	65.0	10000.0
HG-5-113-01	INSRR	3.2	10000.0
HG-6-64-01	CIT	0.0	10000.0
CP724714	NDR1	73.0	10000.0
Canertinib	KIT	100.0	1000.0
Torin1	KIT(V559D,T670I)	67.0	10000.0
WH-4-023	EGFR(T790M)	2.2	10000.0
Crizotinib	MAP3K4	34.0	10000.0
Abemaciclib	MK13	93.0	1000.0
ALW-II-49-7	MP2K2	100.0	10000.0
Pictilisib	MAPKAPK5	100.0	1000.0
Palbociclib	GRK1	98.0	1000.0
AZD 5438	MET(Y1235D)	1.4	10000.0
NU7441	SRPK3	100.0	10000.0
KIN001-123	MRCKA	100.0	1000.0
Vemurafenib	EGFR	70.0	10000.0
KIN001-123	FGR	100.0	1000.0
JNK-IN-5A	M3K6	93.0	10000.0
Omipalisib	VGFR2	92.0	10000.0
HG-5-113-01	TIE2	1.8	10000.0
XMD-12	ERN1	100.0	1000.0
Sorafenib	NDR2	100.0	10000.0
ZG-10	PIM2	100.0	10000.0
GSK461364	FLT4	63.0	10000.0
GSK1059615	EGFR(G719S)	78.0	10000.0
Vemurafenib	DCAMKL2	100.0	10000.0
TAK-715	KIT	45.0	10000.0
WZ-4-145	DAPK3	100.0	10000.0
Neratinib	MARK3	67.0	10000.0
Crizotinib	TLK2	100.0	10000.0
(s)-CR8	CDKL3	97.0	10000.0
Dactolisib	TRKB	100.0	1000.0
Taselisib	FRK	85.0	1000.0
QL-X-138	EGFR(L747-E749del,A750P)	26.0	10000.0
Seliciclib	ABL1(F317L)-phosphorylated	100.0	10000.0
PLX-4720	M3K5	74.0	10000.0
CP466722	MAP4K5	45.0	10000.0
PD173074	SLK	100.0	10000.0
THZ1	MYLK4	0.3	10000.0
WYE-125132	TNIK	100.0	10000.0
AZD-6482	HIPK2	79.0	10000.0
Torkinib	DRAK1	81.0	10000.0
AZD 5438	FGFR4	100.0	10000.0
WH-4-023	RSK4(Kin.Dom.1-N-terminal)	40.0	10000.0
XMD11-50	MST4	95.0	10000.0
HG-5-88-01	EPHA8	100.0	10000.0
Dabrafenib	NEK11	0.2	10000.0
Torin1	ACVRL1	83.0	10000.0
WZ-7043	CSNK1G3	100.0	10000.0
BMX-IN-1	ABL1(F317I)-nonphosphorylated	100.0	10000.0
BGJ398	PAK7	83.0	1000.0
QL-X-138	KPCD3	98.0	10000.0
SCH772984	ROCK2	64.0	1000.0
WZ4003	MST2	100.0	1000.0
KIN001-123	BMX	0.3	1000.0
HG-5-88-01	LTK	0.6	10000.0
QL-X-138	RIPK5	70.0	10000.0
XMD14-99	ABL1(M351T)-phosphorylated	84.0	10000.0
ERK5-IN-1	KPCD1	100.0	1000.0
Omipalisib	SRPK1	100.0	10000.0
Palbociclib	TBK1	100.0	1000.0
Vemurafenib	FER	54.0	10000.0
Canertinib	BMPR1A	100.0	1000.0
ERK5-IN-1	MLK2	100.0	1000.0
CP724714	FLT3(D835Y)	95.0	10000.0
WYE-125132	CDK14	94.0	10000.0
Dabrafenib	CAMK2B	81.0	10000.0
ZG-10	LRRK2(G2019S)	76.0	10000.0
JWE-035	PIK4CB	100.0	10000.0
HG-14-8-02	INSRR	11.0	10000.0
SB590885	KPCE	100.0	10000.0
XMD11-85h	AURKB	100.0	10000.0
A443654	SRPK2	22.0	10000.0
ALW-II-49-7	MARK1	100.0	10000.0
Ribociclib	DMPK2	100.0	1000.0
SCH772984	MST2	65.0	1000.0
Torin2	RET	100.0	10000.0
JW-7-24-1	GSK3A	2.8	10000.0
GSK1059615	PIK3CB	7.1	10000.0
CH5424802	MET(Y1235D)	100.0	1000.0
BMX-IN-1	PIK3CA(I800L)	7.6	10000.0
NU7441	KPCI	100.0	10000.0
AG1478	FLT3(N841I)	7.2	10000.0
THZ1	HIPK3	1.6	10000.0
SCH772984	FES	86.0	1000.0
NU7441	WEE1	100.0	10000.0
PHA-793887	LATS1	99.0	10000.0
JWE-035	CAMK1G	61.0	10000.0
BX-912	FLT3(K663Q)	0.1	10000.0
R406	KKCC1	100.0	1000.0
Torin2	CDK3	100.0	10000.0
BX-912	BRAF(V600E)	62.0	10000.0
XMD-12	M4K1	64.0	1000.0
RO-3306	NDR1	82.0	10000.0
Torkinib	MYO3B	19.0	10000.0
GSK1059615	MET(Y1235D)	94.0	10000.0
HG-9-91-01	ROCK2	22.0	10000.0
Torkinib	RIOK1	100.0	10000.0
KIN001-123	JAK2(Kin.Dom.2)	2.2	1000.0
HG-14-8-02	SNARK	61.0	10000.0
R406	MLK3	0.2	1000.0
AZ-628	TAOK1	91.0	10000.0
Sorafenib	EIF2AK1	57.0	10000.0
Abemaciclib	M4K1	59.0	1000.0
BGJ398	CAMK1G	66.0	1000.0
Ribociclib	GRK4	91.0	1000.0
NG25	BMPR1A	100.0	10000.0
BMX-IN-1	ABL1(H396P)-nonphosphorylated	44.0	10000.0
XMD13-2	KIT(V559D,V654A)	90.0	10000.0
PLX-4720	BMPR1A	100.0	10000.0
OTSSP167	SIK3	0.8	10000.0
BS-181	MKNK2	84.0	10000.0
BMX-IN-1	LOK	100.0	10000.0
GW-5074	SYK	78.0	10000.0
Torin1	LYN	79.0	10000.0
GSK1059615	IKKB	34.0	10000.0
Buparlisib	ABL1(H396P)-nonphosphorylated	70.0	1000.0
ZG-10	KCC4	100.0	10000.0
HG-9-91-01	MST2	61.0	10000.0
AZ-628	IKKA	72.0	10000.0
BMS345541	ERBB2	100.0	10000.0
GSK461364	PAK1	100.0	10000.0
JW-7-24-1	CDK8	100.0	10000.0
GSK1059615	MYO3B	97.0	10000.0
QL-XI-92	PIK3CG	76.0	10000.0
KU63794	TGFBR1	100.0	10000.0
Ribociclib	BMPR1A	100.0	1000.0
JW-7-24-1	NEK2	100.0	10000.0
PHA-793887	PIP5K1C	95.0	10000.0
PHA-767491	ACVR1	21.0	10000.0
SP600125	KPCE	100.0	10000.0
XMD16-144	EGFR	69.0	10000.0
Taselisib	CDKL3	93.0	1000.0
MLN8054	ABL2	30.0	10000.0
PD0325901	YES	73.0	10000.0
BGJ398	STK35	100.0	1000.0
WZ3105	PAK1	78.0	10000.0
CP724714	YSK1	94.0	10000.0
THZ1	FRK	13.0	10000.0
PHA-793887	ABL1(Y253F)-phosphorylated	100.0	10000.0
NPK76-II-72-1	ABL1(F317L)	100.0	10000.0
XMD11-50	RSK1(Kin.Dom.1-N-terminal)	73.0	10000.0
RO-3306	LCK	64.0	10000.0
XMD8-85	KPCD1	3.8	10000.0
BS-181	CDK5	86.0	10000.0
BS-181	RSK2(Kin.Dom.1-N-terminal)	34.0	10000.0
XMD16-144	JAK1(JH2domain-pseudokinase)	0.3	10000.0
HG-14-8-02	NUAK1	44.0	10000.0
ZSTK474	IKKA	100.0	1000.0
AG1478	CHK2	6.7	10000.0
Pictilisib	LATS1	100.0	1000.0
PHA-767491	MK12	21.0	10000.0
BI-2536	MST1	100.0	10000.0
CH5424802	RET(M918T)	0.4	1000.0
GSK461364	CAMK1D	82.0	10000.0
Sorafenib	MARK1	100.0	10000.0
ALW-II-49-7	KPCD2	100.0	10000.0
BI-2536	MST4	100.0	10000.0
A443654	CDK9	1.9	10000.0
GW-5074	RET(V804L)	100.0	10000.0
CG-930	LCK	57.0	10000.0
Baricitinib	PIK3CA(M1043I)	93.0	10000.0
SP600125	MP2K3	0.7	10000.0
Palbociclib	HIPK1	40.0	1000.0
WZ-4-145	RPS6KA4(Kin.Dom.1)	100.0	10000.0
Neratinib	MAP3K3	3.8	10000.0
Sigma A6730	MAP4K5	64.0	10000.0
BI-D1870	MP2K1	24.0	10000.0
WZ4002	FAK1	0.1	10000.0
JNK-IN-5A	PGFRB	44.0	10000.0
KIN001-111	KPCD1	19.0	1000.0
PD0325901	KPCD2	100.0	10000.0
BMS345541	PHKG2	79.0	10000.0
QL-XI-92	CDK8	100.0	10000.0
JWE-035	EGFR(G719S)	99.0	10000.0
NU7441	BMPR1A	100.0	10000.0
HG-9-91-01	CDK14	100.0	10000.0
MRT67307	EIF2AK1	100.0	10000.0
Ibrutinib	MAP4K5	96.0	1000.0
Dinaciclib	MET	57.0	10000.0
Buparlisib	RSK2(Kin.Dom.1-N-terminal)	98.0	1000.0
BS-181	M3K5	100.0	10000.0
XMD11-50	KIT(V559D)	100.0	10000.0
PLX-4720	TAK1	51.0	10000.0
Dinaciclib	IRAK4	70.0	10000.0
AZD-6482	ERBB4	100.0	10000.0
PD0325901	RSK1(Kin.Dom.2-C-terminal)	84.0	10000.0
XMD14-99	FGFR1	94.0	10000.0
SP600125	FAK1	100.0	10000.0
Vemurafenib	ABL1(F317L)-nonphosphorylated	21.0	10000.0
ZSTK474	PRKR	100.0	1000.0
Omipalisib	ABL1-phosphorylated	63.0	10000.0
PD173074	TLK2	100.0	10000.0
WH-4-023	YSK4	6.0	10000.0
PD0325901	EPHB1	100.0	10000.0
Lapatinib	HIPK4	72.0	10000.0
Ceritinib	GCN2(Kin.Dom.2,S808G)	84.0	1000.0
BGJ398	MP2K1	77.0	1000.0
Lapatinib	NDR1	100.0	10000.0
ZG-10	PFCDPK1(P.falciparum)	100.0	10000.0
GSK461364	FYN	100.0	10000.0
Baricitinib	KPCD2	51.0	10000.0
Seliciclib	DYRK1B	1.2	10000.0
ZSTK474	RPS6KA5(Kin.Dom.2)	100.0	1000.0
ALW-II-49-7	KCC2D	100.0	10000.0
QL-X-138	YANK3	100.0	10000.0
NVP-TAE684	MELK	1.0	1000.0
XMD16-144	KIT(D816V)	7.4	10000.0
Dactolisib	SRPK1	100.0	1000.0
GW-5074	JAK1(JH1domain-catalytic)	100.0	10000.0
WZ-4-145	STK16	100.0	10000.0
PLX-4720	MUSK	71.0	10000.0
MLN8054	ABL1(F317L)-phosphorylated	70.0	10000.0
CGP60474	EPHA1	100.0	10000.0
WH-4-023	LKB1	60.0	10000.0
AZ-628	RET(M918T)	0.4	10000.0
Sigma A6730	CDK4-cyclinD1	100.0	10000.0
CGP60474	BLK	100.0	10000.0
R406	CSNK2A1	6.4	1000.0
Baricitinib	TNK1	15.0	10000.0
CP466722	YANK2	100.0	10000.0
HG-6-64-01	CAMK1D	100.0	10000.0
CGP74514A	TESK1	100.0	10000.0
BMS345541	EIF2AK1	87.0	10000.0
AZD7762	MP2K5	0.1	10000.0
Buparlisib	BMPR1A	81.0	1000.0
ZG-10	NEK7	9.8	10000.0
QL-XII-47	OSR1	89.0	1000.0
ZM-447439	FES	100.0	10000.0
AS-252424	PLK1	100.0	10000.0
Torin1	RET(V804M)	69.0	10000.0
WZ-7043	CAMK1G	100.0	10000.0
GSK429286A	FLT3(N841I)	75.0	10000.0
(s)-CR8	PCTK3	100.0	10000.0
BI-D1870	WEE2	17.0	10000.0
Buparlisib	DAPK2	99.0	1000.0
HG-14-8-02	TRKC	87.0	10000.0
XMD14-99	LOK	40.0	10000.0
CG-930	EGFR	29.0	10000.0
ZM-447439	NEK7	100.0	10000.0
Canertinib	STK36	100.0	1000.0
Neratinib	YANK1	77.0	10000.0
Dabrafenib	ABL1(Y253F)-phosphorylated	7.7	10000.0
AS-252424	DAPK1	10.5	10000.0
CG-930	MYO3B	95.0	10000.0
AZD 5438	STK33	82.0	10000.0
GW843682X	TNK2	54.0	10000.0
HG-6-64-01	AKT2	48.0	10000.0
HG-9-91-01	CLK1	90.0	10000.0
JNK-IN-5A	NDR2	98.0	10000.0
ERK5-IN-1	ALK	21.0	1000.0
XMD13-2	LATS1	61.0	10000.0
JWE-035	PRKR	95.0	10000.0
Dinaciclib	RIPK1	100.0	10000.0
Barasertib	AKT1	96.0	10000.0
NPK76-II-72-1	TGFBR1	100.0	10000.0
AZD4547	YANK3	100.0	10000.0
Abemaciclib	HCK	100.0	1000.0
CGP60474	EPHA4	100.0	10000.0
JW-7-24-1	CDKL2	100.0	10000.0
TAK-715	KGP2	100.0	10000.0
CP466722	TAK1	15.0	10000.0
Dabrafenib	SYK	56.0	10000.0
QL-X-138	CTK	100.0	10000.0
HG-6-64-01	MYLK4	23.0	10000.0
Ribociclib	FLT3(ITD,D835V)	100.0	1000.0
R406	PKAC-beta	1.4	1000.0
WH-4-023	CDC2L5	100.0	10000.0
THZ1	FES	2.7	10000.0
HG-5-113-01	MRCKB	100.0	10000.0
Ibrutinib	BLK	0.1	1000.0
Omipalisib	CLK2	33.0	10000.0
AZD 5438	ERBB4	100.0	10000.0
HG-14-8-02	RSK4(Kin.Dom.1-N-terminal)	85.0	10000.0
AZD4547	PAK1	32.0	10000.0
BMX-IN-1	PLK4	73.0	10000.0
NVP-TAE684	PKAC-alpha	11.0	1000.0
HG-5-88-01	SYK	100.0	10000.0
XMD8-85	MELK	100.0	10000.0
Barasertib	MP2K5	0.4	10000.0
WZ3105	ADCK3	87.0	10000.0
JNK-IN-8	MK03	100.0	1000.0
JWE-035	NEK11	100.0	10000.0
TAK-715	MRCKA	82.0	10000.0
(s)-CR8	CAMK2G	86.0	10000.0
Palbociclib	RSK3(Kin.Dom.1-N-terminal)	65.0	1000.0
GSK1059615	VGFR2	81.0	10000.0
HG-5-113-01	RIPK2	100.0	10000.0
NPK76-II-72-1	DDR1	100.0	10000.0
Ceritinib	RPS6KA4(Kin.Dom.1-N-terminal)	93.0	1000.0
KIN001-123	PTK6	23.0	1000.0
QL-XII-47	RPS6KA4(Kin.Dom.2-C-terminal)	89.0	1000.0
AZD7762	CDK3	100.0	10000.0
ERK5-IN-1	NUAK1	100.0	1000.0
ZSTK474	JAK1(Kin.Dom.1)	100.0	1000.0
Buparlisib	TGFBR2	100.0	1000.0
HG-9-91-01	ALK	0.4	10000.0
Sorafenib	GSK3B	100.0	10000.0
PHA-793887	ACVRL1	96.0	10000.0
OTSSP167	MLK1	4.2	10000.0
CGP74514A	CAMK1G	64.0	10000.0
SCH772984	KIT(D816H)	90.0	1000.0
PHA-767491	EPHA3	72.0	10000.0
AZD7762	ABL1(H396P)-phosphorylated	0.0	10000.0
MRT67307	SIK1	3.7	10000.0
ZG-10	INSRR	100.0	10000.0
NVP-TAE684	BTK	0.0	1000.0
WZ4002	TRKA	100.0	10000.0
CP466722	FLT3(ITD)	5.6	10000.0
Seliciclib	CDK16	72.0	10000.0
JNK-IN-5A	PCTK2	93.0	10000.0
ZG-10	CDK4-cyclinD3	100.0	10000.0
A443654	RPS6KA2(Kin.Dom.2)	100.0	10000.0
Vemurafenib	PCTK2	86.0	10000.0
NG25	DAPK3	100.0	10000.0
HG-6-64-01	AURKC	1.5	10000.0
Dactolisib	YSK4	29.0	1000.0
AZD-6482	PLK3	89.0	10000.0
R406	MINK	15.0	1000.0
AZ-628	MP2K7	93.0	10000.0
Lapatinib	KPCT	95.0	10000.0
JNK-IN-5A	STK35	64.0	10000.0
CP724714	ADCK4	98.0	10000.0
ALW-II-38-3	MYO3B	100.0	10000.0
CGP60474	PIK3CA(M1043I)	100.0	10000.0
Momelotinib	CDKL3	60.0	10000.0
BI-2536	ERK4	100.0	10000.0
Ibrutinib	YSK4	95.0	1000.0
Taselisib	M3K12	100.0	1000.0
WZ4003	CAMK1G	100.0	1000.0
Seliciclib	STK35	100.0	10000.0
CGP60474	SNARK	100.0	10000.0
ZSTK474	CSK	100.0	1000.0
HG-9-91-01	BMPR2	86.0	10000.0
Dinaciclib	GSK3B	36.0	10000.0
ZM-447439	MAP4K5	2.7	10000.0
Momelotinib	CAMK1G	30.0	10000.0
Vemurafenib	TYK2(JH1domain-catalytic)	47.0	10000.0
JNK-IN-8	TGFBR1	89.0	1000.0
WH-4-023	RET(V804L)	85.0	10000.0
XMD11-50	NEK11	100.0	10000.0
SCH772984	TNNI3K	86.0	1000.0
NU7441	ULK1	41.0	10000.0
XMD13-2	MINK	43.0	10000.0
Dabrafenib	ABL1(F317I)-phosphorylated	59.0	10000.0
XMD8-85	TGFBR2	100.0	10000.0
Pictilisib	CHEK1	100.0	1000.0
AZD 5438	MYLK2	62.0	10000.0
Ibrutinib	ERBB3	0.1	1000.0
GW843682X	NDR1	94.0	10000.0
AZD4547	MP2K6	69.0	10000.0
Sorafenib	RSK1(Kin.Dom.2-C-terminal)	100.0	10000.0
Crizotinib	PIK3CA(M1043I)	89.0	10000.0
JNK-IN-8	HUNK	53.0	1000.0
Sigma A6730	JAK2(JH1domain-catalytic)	67.0	10000.0
ALW-II-38-3	LATS2	100.0	10000.0
WZ-7043	MYLK2	100.0	10000.0
JNK-9L	PGFRB	8.2	10000.0
Abemaciclib	SgK110	100.0	1000.0
GW-5074	PAK2	53.0	10000.0
RO-3306	YANK1	67.0	10000.0
PD173074	EGFR(G719C)	100.0	10000.0
QL-X-138	TLK2	100.0	10000.0
CG-930	NLK	5.2	10000.0
PHA-767491	DYRK2	2.0	10000.0
Ribociclib	MK12	93.0	1000.0
SB590885	CTK	100.0	10000.0
WH-4-023	PIK3C2B	11.0	10000.0
R406	SIK2	5.5	1000.0
Taselisib	NEK4	100.0	1000.0
Palbociclib	PI42C	9.4	1000.0
BMS345541	MAP3K4	100.0	10000.0
BX-912	MAP3K4	47.0	10000.0
Ibrutinib	DAPK2	92.0	1000.0
TGX221	MYLK4	100.0	1000.0
KIN001-123	KIT(V559D,T670I)	100.0	1000.0
Pictilisib	BRSK2	88.0	1000.0
BMX-IN-1	TSSK1	74.0	10000.0
BMX-IN-1	MLCK	100.0	10000.0
HG-5-88-01	KIT(V559D,T670I)	100.0	10000.0
Ceritinib	FGFR4	77.0	1000.0
KIN001-111	NEK5	100.0	1000.0
WZ-4-145	DCLK1	100.0	10000.0
MLN8054	MAP4K2	88.0	10000.0
ALW-II-38-3	MET(Y1235D)	100.0	10000.0
JNK-IN-11	CHK2	100.0	1000.0
HG-9-91-01	CIT	2.9	10000.0
5z-7-oxozeaenol	PAK7	79.0	10000.0
HG-14-8-02	DAPK3	10.0	10000.0
XMD11-85h	MRCKA	100.0	10000.0
WZ3105	AMPK-alpha2	100.0	10000.0
Torin2	MST1R	90.0	10000.0
Barasertib	NDR1	56.0	10000.0
CGP74514A	CDK8	71.0	10000.0
BS-181	ULK2	80.0	10000.0
XMD11-85h	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
HG-14-10-04	EGFR(L858R)	0.1	10000.0
JW-7-24-1	AKT3	100.0	10000.0
CP466722	TIE1	93.0	10000.0
Ibrutinib	CLK4	97.0	1000.0
A443654	TYRO3	100.0	10000.0
XMD13-2	YES	92.0	10000.0
THZ1	ROS1	0.5	10000.0
WZ4002	PGFRA	100.0	10000.0
BMS345541	EPHB2	100.0	10000.0
Seliciclib	PFCDPK1(P.falciparum)	100.0	10000.0
ZSTK474	MAP4K4	100.0	1000.0
NG25	RIOK2	100.0	10000.0
AZD 5438	NDR2	46.0	10000.0
BGJ398	MELK	70.0	1000.0
ZM-447439	BLK	0.5	10000.0
JNK-9L	DDR1	100.0	10000.0
NG25	CSNK2A1	100.0	10000.0
BMX-IN-1	CAMK2A	69.0	10000.0
KIN001-111	PAK7	13.0	1000.0
Palbociclib	KC1G2	100.0	1000.0
ALW-II-38-3	KPCT	100.0	10000.0
MRT67307	FGFR3	53.0	10000.0
KIN001-021	STK16	100.0	1000.0
QL-X-138	CAMK1G	79.0	10000.0
WZ-7043	SRC	100.0	10000.0
QL-XII-47	ALK	100.0	1000.0
GSK1059615	CDC2L5	95.0	10000.0
AZD-6482	MERTK	100.0	10000.0
HG-14-10-04	ABL1(F317I)-phosphorylated	4.2	10000.0
MRT67307	PAK3	50.0	10000.0
HG-6-64-01	MET(Y1235D)	79.0	10000.0
THZ1	EGFR(L861Q)	15.0	10000.0
AZD7762	ABL1-phosphorylated	0.0	10000.0
BMS345541	PLK2	100.0	10000.0
AZD-6482	IRAK1	90.0	10000.0
SCH772984	CSF1R-autoinhibited	69.0	1000.0
KIN001-127	PKN1	100.0	10000.0
BX-912	DCAMKL3	48.0	10000.0
NVP-TAE684	CLK3	3.0	1000.0
Ribociclib	SRPK1	100.0	1000.0
MPS-1-IN-1	MLK3	100.0	1000.0
KIN001-123	PAK4	30.0	1000.0
BI-2536	TESK1	100.0	10000.0
Lapatinib	BRAF(V600E)	100.0	10000.0
XMD11-85h	PLK2	100.0	10000.0
WH-4-023	EPHA5	0.2	10000.0
ALW-II-49-7	TNNI3K	12.0	1000.0
(s)-CR8	RSK3(Kin.Dom.2-C-terminal)	100.0	10000.0
PD173074	TEC	100.0	10000.0
PD173074	MLCK	100.0	10000.0
BX-912	EGFR(L747-S752del,P753S)	63.0	10000.0
MPS-1-IN-1	AURKC	100.0	1000.0
Dinaciclib	ABL1(F317L)-nonphosphorylated	91.0	10000.0
PD173074	PAK3	100.0	10000.0
XMD13-2	ABL1(E255K)-phosphorylated	55.0	10000.0
KU63794	MARK4	84.0	10000.0
XMD14-99	ABL1(Q252H)-nonphosphorylated	100.0	10000.0
Omipalisib	PRKX	87.0	10000.0
Dactolisib	MLCK	100.0	1000.0
BGJ398	DCLK1	72.0	1000.0
PLX-4720	RSK2(Kin.Dom.1-N-terminal)	56.0	10000.0
XMD16-144	IRAK1	19.0	10000.0
XMD16-144	FGFR3(G697C)	12.0	10000.0
NU7441	JAK1(JH2domain-pseudokinase)	72.0	10000.0
ALW-II-49-7	SNARK	100.0	10000.0
Torin2	DMPK	95.0	10000.0
QL-X-138	NLK	63.0	10000.0
Seliciclib	RSK1(Kin.Dom.2-C-terminal)	56.0	10000.0
Seliciclib	PIK3CA(E542K)	100.0	10000.0
XMD13-2	PIK4CB	84.0	10000.0
XMD13-2	MARK1	96.0	10000.0
AZD4547	LTK	25.0	10000.0
HG-9-91-01	EPHA4	0.0	10000.0
GSK1059615	FAK2	86.0	10000.0
AG1478	LYN	11.0	10000.0
NPK76-II-72-1	PAK2	100.0	10000.0
Neratinib	CDK15	98.0	10000.0
XMD11-50	EGFR(L858R,T790M)	84.0	10000.0
Buparlisib	KC1G2	100.0	1000.0
SCH772984	OSR1	96.0	1000.0
BMS345541	EPHA2	93.0	10000.0
Sorafenib	EGFR(L747-T751del,Sins)	77.0	10000.0
Pictilisib	EPHB2	98.0	1000.0
Lapatinib	MET(M1250T)	96.0	10000.0
Barasertib	RIOK1	100.0	10000.0
Torkinib	KPCL	10.0	10000.0
GSK1059615	TEC	73.0	10000.0
MPS-1-IN-1	VGFR2	100.0	1000.0
CP466722	MERTK	29.0	10000.0
Alpelisib	FLT3(R834Q)	100.0	1000.0
AZ-628	NEK6	100.0	10000.0
Abemaciclib	MARK4	99.0	1000.0
PHA-793887	IGF1R	100.0	10000.0
SP600125	BMX	100.0	10000.0
BMS345541	MYLK2	71.0	10000.0
PHA-767491	AURKC	87.0	10000.0
HG-9-91-01	HUNK	2.4	10000.0
PLX-4720	CSNK1D	91.0	10000.0
Sigma A6730	KIT(D816H)	100.0	10000.0
MRT67307	NEK4	73.0	10000.0
CG-930	ADCK4	87.0	10000.0
Sorafenib	EPHB1	30.0	10000.0
Vemurafenib	LIMK2	24.0	10000.0
Canertinib	BLK	10.0	1000.0
KIN001-220	ABL1(T315I)-phosphorylated	7.4	10000.0
HG-14-10-04	EGFR	0.1	10000.0
AZ-628	JAK1(JH2domain-pseudokinase)	82.0	10000.0
XMD8-85	EGFR(L858R)	100.0	10000.0
AZ-628	BTK	66.0	10000.0
WZ4002	KIT(V559D)	26.0	10000.0
ALW-II-38-3	DRAK2	100.0	10000.0
BMX-IN-1	MLK2	100.0	10000.0
KIN001-111	LOK	0.0	1000.0
HG-14-8-02	KIT(V559D,T670I)	30.0	10000.0
QL-XI-92	MARK1	100.0	10000.0
GSK461364	FLT3(K663Q)	14.0	10000.0
GSK461364	AURKB	80.0	10000.0
XMD8-85	DRAK1	100.0	10000.0
Sorafenib	CAMK1G	99.0	10000.0
Abemaciclib	PKMYT1	98.0	1000.0
Buparlisib	PHKG1	100.0	1000.0
THZ1	PIP5K2B	2.6	10000.0
AZD7762	KC1G1	7.6	10000.0
Palbociclib	RET(V804L)	100.0	1000.0
Alpelisib	BUB1	100.0	1000.0
Neratinib	PIP5K2B	95.0	10000.0
HG-6-64-01	DYRK1A	63.0	10000.0
NVP-TAE684	TAOK3	0.1	1000.0
PHA-767491	MP2K2	81.0	10000.0
WZ-7043	EPHB3	100.0	10000.0
MRT67307	SNARK	2.8	10000.0
ZSTK474	INSR	100.0	1000.0
Abemaciclib	M3K13	100.0	1000.0
GSK461364	MST1R	100.0	10000.0
WZ-4-145	FGFR4	0.1	10000.0
Sorafenib	PAK1	62.0	10000.0
HG-5-113-01	TLK1	100.0	10000.0
Torin2	CSNK1G3	63.0	10000.0
Torin2	MLK2	100.0	10000.0
Barasertib	MERTK	77.0	10000.0
XMD8-85	FGFR2	100.0	10000.0
AG1478	M3K6	43.0	10000.0
NVP-TAE684	TLK2	100.0	1000.0
Seliciclib	NUAK1	100.0	10000.0
QL-XI-92	MKNK1	100.0	10000.0
QL-X-138	IKKB	73.0	10000.0
JNK-IN-11	DYRK2	100.0	1000.0
Sorafenib	YSK1	80.0	10000.0
Lapatinib	KPCD	90.0	10000.0
Dinaciclib	ACVR1B	100.0	10000.0
XMD11-85h	STK33	32.0	10000.0
(s)-CR8	SLK	100.0	10000.0
HG-14-10-04	PIK3C2B	100.0	10000.0
Pictilisib	MTOR	13.0	1000.0
Omipalisib	ABL1(F317L)-phosphorylated	70.0	10000.0
Momelotinib	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
Dinaciclib	TRKB	97.0	10000.0
HG-14-10-04	FER	0.0	10000.0
BI-D1870	KIT	0.2	10000.0
Alpelisib	NDR1	85.0	1000.0
GSK461364	TNNI3K	92.0	10000.0
XMD16-144	ABL1(H396P)-nonphosphorylated	0.0	10000.0
Torkinib	GRK1	16.0	10000.0
Torin2	EIF2AK1	91.0	10000.0
QL-XI-92	TGFBR1	96.0	10000.0
ERK5-IN-1	SgK110	81.0	1000.0
Torin1	EPHB6	80.0	10000.0
GSK1059615	MP2K6	69.0	10000.0
OTSSP167	AAK1	2.3	10000.0
CG-930	CLK3	93.0	10000.0
Dactolisib	FGFR3(G697C)	100.0	1000.0
JWE-035	LOK	28.0	10000.0
MPS-1-IN-1	ERK4	100.0	1000.0
AZD-6482	CDKL3	90.0	10000.0
Ibrutinib	TAOK3	81.0	1000.0
QL-XII-47	EPHB2	100.0	1000.0
QL-XI-92	PDPK1	94.0	10000.0
JNK-9L	TGFBR1	73.0	10000.0
AZ-628	PIM3	98.0	10000.0
Dabrafenib	PIM2	100.0	10000.0
BMS-536924	FGFR1	0.5	1000.0
PD0325901	AKT2	100.0	10000.0
XMD8-92	TAOK3	100.0	10000.0
OTSSP167	TLK2	3.2	10000.0
QL-XII-47	MAP3K14	73.0	1000.0
Torin1	FLT4	74.0	10000.0
XMD8-85	MET(M1250T)	100.0	10000.0
AZ-628	BMX	58.0	10000.0
XMD-12	NDR1	87.0	1000.0
SCH772984	KPCD	95.0	1000.0
ALW-II-38-3	CAMK1	100.0	10000.0
Buparlisib	DCAMKL2	99.0	1000.0
Torin2	DDR2	99.0	10000.0
Taselisib	DCLK1	100.0	1000.0
Lapatinib	CDC2L1	99.0	10000.0
XMD8-92	ABL1(T315I)	100.0	10000.0
ZG-10	FER	100.0	10000.0
WZ4003	MK11	100.0	1000.0
Palbociclib	YES	100.0	1000.0
BMS345541	PLK4	90.0	10000.0
BX-912	SgK110	1.0	10000.0
KIN001-127	CSK	100.0	10000.0
ERK5-IN-1	LRRK2	28.0	1000.0
PD0325901	PRP4	77.0	10000.0
BX-912	EGFR(L747-E749del,A750P)	41.0	10000.0
GSK461364	ERBB4	88.0	10000.0
Torin1	DMPK	77.0	10000.0
KIN001-220	MELK	55.0	10000.0
Dabrafenib	PCTK3	0.0	10000.0
RO-3306	KIT	29.0	10000.0
CP466722	BRSK2	14.0	10000.0
GW843682X	YANK2	100.0	10000.0
HG-14-10-04	ABL1(T315I)-phosphorylated	0.2	10000.0
SP600125	NEK1	15.0	10000.0
BMX-IN-1	LCK	80.0	10000.0
AZD 5438	M3K2	2.2	10000.0
HG-14-10-04	PIK3CG	100.0	10000.0
XMD14-99	EPHB4	97.0	10000.0
Torin2	RIPK1	100.0	10000.0
TGX221	LYN	100.0	1000.0
Crizotinib	SRPK3	15.0	10000.0
JNK-9L	EPHA8	93.0	10000.0
Pictilisib	MAP3K15	100.0	1000.0
GW-5074	CHEK1	100.0	10000.0
HG-9-91-01	RIPK1	97.0	10000.0
QL-X-138	BRAF	66.0	10000.0
Ribociclib	RAF1	100.0	1000.0
AG1478	FGR	32.0	10000.0
Ibrutinib	KCC2D	79.0	1000.0
THZ1	RSK1(Kin.Dom.2-C-terminal)	71.0	10000.0
Dinaciclib	ABL1(T315I)-nonphosphorylated	91.0	10000.0
PD173074	FLT3(D835H)	100.0	10000.0
Pictilisib	RPS6KA1(Kin.Dom.1)	100.0	10000.0
Lapatinib	IKKA	55.0	10000.0
WZ3105	RPS6KA4(Kin.Dom.2-C-terminal)	52.0	10000.0
Omipalisib	RIPK5	32.0	10000.0
Seliciclib	PHKG2	50.0	10000.0
QL-XI-92	RET(M918T)	100.0	10000.0
Dabrafenib	SBK1	68.0	10000.0
SCH772984	IKKA	100.0	1000.0
SB590885	KC1G1	81.0	10000.0
NVP-TAE684	KKCC1	0.2	1000.0
AG1478	NUAK1	98.0	10000.0
THZ1	PIM1	62.0	10000.0
BI-2536	PIM2	100.0	10000.0
WYE-125132	ABL1(E255K)-phosphorylated	100.0	10000.0
KIN001-127	KC1G2	100.0	10000.0
JNK-IN-11	MLK3	71.0	1000.0
CG-930	LRRK2	83.0	10000.0
CGP74514A	TIE2	95.0	10000.0
Dinaciclib	AAK1	93.0	10000.0
JWE-035	DDR1	14.0	10000.0
Vemurafenib	EPHA1	82.0	10000.0
AZ-628	MLCK	100.0	10000.0
BMX-IN-1	TESK1	98.0	10000.0
Crizotinib	MLK1	80.0	10000.0
ZSTK474	KIT(V559D)	100.0	1000.0
TAK-715	SRPK3	100.0	10000.0
NU7441	FGFR4	99.0	10000.0
TAK-715	MTOR	100.0	10000.0
TAK-715	PIK3CA(H1047Y)	50.0	10000.0
PHA-767491	DYRK1A	0.1	10000.0
XMD11-50	LCK	100.0	10000.0
XMD13-2	WEE2	100.0	10000.0
MLN8054	MLK3	84.0	10000.0
PHA-767491	MARK2	33.0	10000.0
Pictilisib	CSK	100.0	1000.0
WZ4003	PIM2	100.0	1000.0
JNK-IN-11	PIK3CB	100.0	1000.0
ERK5-IN-1	CAMK2G	94.0	1000.0
NU7441	EGFR(T790M)	100.0	10000.0
Vemurafenib	CLK2	46.0	10000.0
KIN001-127	KCC2D	100.0	10000.0
AZD-6482	PAK6	93.0	10000.0
Dinaciclib	ABL1(H396P)-phosphorylated	87.0	10000.0
WZ-7043	ROCK2	100.0	10000.0
BMS345541	MKNK2	90.0	10000.0
SB590885	MUSK	98.0	10000.0
WZ-7043	MLCK	100.0	10000.0
XMD8-85	TBK1	100.0	10000.0
Abemaciclib	TEC	94.0	1000.0
Palbociclib	DYRK1B	48.0	1000.0
GSK429286A	NEK7	78.0	10000.0
WZ3105	JAK1(JH2domain-pseudokinase)	76.0	10000.0
Dactolisib	ULK1	100.0	1000.0
Torin2	KIT(V559D)	55.0	10000.0
Torkinib	CIT	66.0	10000.0
AS-252424	NEK2	90.0	10000.0
AZD-6482	CDK8	79.0	10000.0
Ceritinib	FAK1	0.4	1000.0
XMD-12	PRKX	93.0	1000.0
JNK-IN-8	NEK5	92.0	1000.0
ZG-10	GRK4	29.0	10000.0
JNK-IN-11	KGP1	90.0	1000.0
SP600125	TAOK1	14.0	10000.0
BMX-IN-1	MK14	100.0	10000.0
BMS-536924	SRPK2	23.0	1000.0
Dactolisib	CAMK1	100.0	1000.0
KIN001-021	MERTK	100.0	1000.0
JNK-IN-5A	TAOK3	87.0	10000.0
KIN001-123	PKAC-alpha	100.0	1000.0
PLX-4720	EPHA3	65.0	10000.0
XMD8-85	CDC2L1	100.0	10000.0
JNK-IN-5A	BMPR1B	96.0	10000.0
SP600125	MK13	100.0	10000.0
BMS345541	PKAC-beta	100.0	10000.0
QL-XI-92	LRRK2	89.0	10000.0
JNK-IN-5A	GRK1	100.0	10000.0
NU7441	ACVR2B	98.0	10000.0
HG-5-88-01	TRKC	100.0	10000.0
KIN001-123	CDK7	100.0	1000.0
Dinaciclib	EGFR(L861Q)	100.0	10000.0
Pictilisib	BLK	100.0	1000.0
ERK5-IN-1	NEK5	100.0	1000.0
PHA-793887	MUSK	100.0	10000.0
CGP74514A	M3K12	100.0	10000.0
HG-5-88-01	TIE2	100.0	10000.0
OTSSP167	JNK1	0.1	10000.0
AZD-6482	EPHA1	100.0	10000.0
Torin2	DYRK1B	97.0	10000.0
KIN001-111	MYLK4	100.0	1000.0
Abemaciclib	EGFR(G719S)	84.0	1000.0
XMD16-144	PKAC-beta	100.0	10000.0
THZ1	DYRK1B	2.6	10000.0
Taselisib	CDK11	100.0	1000.0
Dinaciclib	TAOK1	3.1	10000.0
KIN001-127	IKKE	100.0	10000.0
NU7441	BMX	83.0	10000.0
JNK-IN-11	MLK2	100.0	1000.0
ALW-II-49-7	ABL1(E255K)	100.0	10000.0
A443654	KPCD3	1.6	10000.0
NG25	DCAMKL3	100.0	10000.0
Dinaciclib	CAMK2B	93.0	10000.0
MLN8054	MYO3B	100.0	10000.0
Lapatinib	RET(V804M)	100.0	10000.0
KIN001-123	STK33	100.0	1000.0
Omipalisib	CSNK2A2	82.0	10000.0
Ceritinib	NEK6	97.0	1000.0
SB590885	HUNK	84.0	10000.0
XMD14-99	CDK11	93.0	10000.0
GSK1059615	PKN2	31.0	10000.0
BMS-536924	IRAK3	4.6	1000.0
JNK-9L	CLK4	7.2	10000.0
Ceritinib	BMX	93.0	1000.0
XMD11-50	DAPK3	67.0	10000.0
GW843682X	CAMK2A	76.0	10000.0
Taselisib	EGFR(S752-I759del)	99.0	1000.0
AZ-628	AKT2	100.0	10000.0
Taselisib	PAK4	100.0	1000.0
HG-6-64-01	CASK	77.0	10000.0
WZ4003	CSNK1D	100.0	1000.0
CH5424802	ACVR1	98.0	1000.0
CP724714	MP2K6	93.0	10000.0
Seliciclib	ABL1(H396P)-phosphorylated	99.0	10000.0
GW843682X	SNARK	6.0	10000.0
KIN001-220	KIT	1.0	10000.0
CP466722	DYRK1B	2.0	10000.0
Palbociclib	AMPK-alpha1	96.0	1000.0
BMX-IN-1	SRC	100.0	10000.0
MRT67307	DYRK1B	26.0	10000.0
CH5424802	MAPKAPK5	100.0	1000.0
BGJ398	LATS2	89.0	1000.0
Dactolisib	MST1R	100.0	1000.0
XMD8-92	DDR2	100.0	10000.0
BMS345541	DDR2	100.0	10000.0
Dabrafenib	MAP3K3	33.0	10000.0
AZD 5438	ERK4	100.0	10000.0
JNK-IN-5A	HIPK1	91.0	10000.0
Vemurafenib	ABL1(M351T)-phosphorylated	55.0	10000.0
Palbociclib	SIK3	90.0	1000.0
PD0325901	CDKL2	87.0	10000.0
SB590885	VRK2	94.0	10000.0
Alpelisib	CDK15	100.0	1000.0
BI-2536	NEK6	100.0	10000.0
Barasertib	CHEK1	98.0	10000.0
AS-252424	EPHA4	93.1	10000.0
BX-912	CLK3	74.0	10000.0
BI-2536	LCK	100.0	10000.0
SP600125	LIMK2	100.0	10000.0
(s)-CR8	CDKL1	97.0	10000.0
KIN001-021	TAK1	100.0	1000.0
JNK-IN-11	FAK2	85.0	1000.0
WZ4002	GCN2(Kin.Dom.2,S808G)	0.4	10000.0
GSK461364	EPHA4	100.0	10000.0
(s)-CR8	AKT2	98.0	10000.0
WZ3105	VRK2	11.0	10000.0
KIN001-123	EPHA1	100.0	1000.0
KU63794	TNK2	100.0	10000.0
XMD8-85	ROCK1	100.0	10000.0
WZ4003	INSRR	14.0	1000.0
TAK-715	RIOK3	100.0	10000.0
QL-X-138	YANK2	100.0	10000.0
WH-4-023	FGFR3	1.0	10000.0
AZD-6482	RIOK3	100.0	10000.0
WH-4-023	PIK3CG	100.0	10000.0
ZM-447439	PIK3CA(E545K)	98.0	10000.0
Ibrutinib	JNK1	72.0	1000.0
XMD13-2	TGFBR2	100.0	10000.0
QL-X-138	AXL	100.0	10000.0
Lapatinib	TAOK3	87.0	10000.0
Torin1	MLK2	99.0	10000.0
KIN001-111	EGFR(S752-I759del)	7.3	1000.0
HG-14-8-02	KC1G1	100.0	10000.0
WH-4-023	PIK3CA(E545A)	45.0	10000.0
Vemurafenib	EPHA4	100.0	10000.0
QL-XI-92	RIOK2	92.0	10000.0
NVP-TAE684	ACVR2B	22.0	1000.0
HG-14-8-02	NIM1	20.0	10000.0
PHA-793887	FES	100.0	10000.0
AZ-628	TBK1	100.0	10000.0
KIN001-220	KPCD2	100.0	10000.0
AS-252424	MYO3A	84.9	10000.0
Dinaciclib	WNK1	92.0	10000.0
Crizotinib	MTOR	100.0	10000.0
Ribociclib	NEK6	100.0	1000.0
ZM-447439	PLK3	99.0	10000.0
Momelotinib	CHEK1	100.0	10000.0
ALW-II-49-7	FLT3(D835H)	100.0	10000.0
PHA-767491	PKN2	3.6	10000.0
KIN001-111	ULK1	8.4	1000.0
KIN001-111	KPCD3	100.0	1000.0
Lapatinib	MAP3K1	100.0	10000.0
PLX-4720	BRAF	0.0	10000.0
BS-181	ULK1	69.0	10000.0
XMD13-2	ACVR1	48.0	10000.0
Taselisib	EPHB4	89.0	1000.0
XMD11-85h	ABL1(F317I)	100.0	10000.0
KIN001-021	FLT3(K663Q)	100.0	1000.0
SP600125	GSK3A	100.0	10000.0
ALW-II-38-3	CDK14	100.0	10000.0
QL-XII-47	ERN1	94.0	1000.0
SCH772984	CDK4-cyclinD1	91.0	1000.0
ALW-II-49-7	TNK1	100.0	10000.0
CGP60474	EPHA7	100.0	10000.0
Buparlisib	M4K3	96.0	1000.0
JNK-IN-5A	ERBB2	87.0	10000.0
KIN001-021	MYLK2	100.0	1000.0
GW-5074	TESK1	100.0	10000.0
AZD7762	PAK6	0.4	10000.0
CP466722	FES	99.0	10000.0
AZD7762	PGFRA	0.0	10000.0
PLX-4720	MST3	77.0	10000.0
AZD7762	CSNK1E	11.0	10000.0
PHA-793887	CAMK2B	66.0	10000.0
KIN001-021	DAPK3	100.0	1000.0
OTSSP167	RET(M918T)	0.1	10000.0
BGJ398	MAP3K4	9.4	1000.0
AZD 5438	CASK	50.0	10000.0
HG-9-91-01	BRSK2	76.0	10000.0
CGP60474	RPS6KA1(Kin.Dom.2)	100.0	10000.0
NG25	CLK2	100.0	10000.0
PD173074	VGFR2	21.0	10000.0
PD173074	FLT3(N841I)	100.0	10000.0
BGJ398	HIPK2	88.0	1000.0
CG-930	NEK1	97.0	10000.0
Momelotinib	FAK1	85.0	10000.0
Buparlisib	LRRK2	100.0	1000.0
Abemaciclib	RSK2(Kin.Dom.2-C-terminal)	58.0	1000.0
PD0325901	MP2K4	83.0	10000.0
QL-XII-47	CSNK2A2	64.0	1000.0
BMS345541	TRKB	89.0	10000.0
Torkinib	KIT(V559D,T670I)	30.0	10000.0
GSK1059615	CSNK1G3	2.4	10000.0
WZ-4-145	MRCKA	100.0	10000.0
AZ-628	TAOK2	72.0	10000.0
PLX-4720	BRAF(V600E)	0.0	10000.0
(s)-CR8	KIT(D816V)	77.0	10000.0
WZ-4-145	IKKE	100.0	10000.0
JNK-9L	CSF1R	14.0	10000.0
KIN001-220	CSK	73.0	10000.0
Canertinib	ABL1(Q252H)	100.0	1000.0
KIN001-123	CAMKK2	100.0	1000.0
HG-9-91-01	KIT	0.0	10000.0
BGJ398	YES	68.0	1000.0
MRT67307	SgK110	60.0	10000.0
BI-2536	AMPK-alpha1	100.0	10000.0
Lapatinib	EGFR(L858R,T790M)	97.0	10000.0
Neratinib	CDK3	100.0	10000.0
R406	PIK3CG	100.0	1000.0
A443654	FGFR4	100.0	10000.0
CGP60474	TLK2	100.0	10000.0
BGJ398	CDK14	76.0	1000.0
WZ3105	NIM1	66.0	10000.0
HG-14-8-02	ACVR2A	100.0	10000.0
AZD7762	MAP4K2	0.0	10000.0
BX-912	BMPR2	0.0	10000.0
BMS-536924	KCC4	6.6	1000.0
CGP60474	MUSK	100.0	10000.0
XMD11-50	JAK1(JH2domain-pseudokinase)	92.0	10000.0
Ribociclib	EPHA1	100.0	1000.0
Dabrafenib	NEK1	14.0	10000.0
WZ4002	TYRO3	100.0	10000.0
BGJ398	NIM1	86.0	1000.0
XMD-12	EGFR(L747-S752del,P753S)	100.0	1000.0
QL-X-138	KCC4	100.0	10000.0
CGP74514A	NDR1	13.0	10000.0
HG-14-10-04	MAP3K1	95.0	10000.0
CP466722	SRMS	27.0	10000.0
RO-3306	MLK1	100.0	10000.0
CP724714	ROCK1	100.0	10000.0
BS-181	EGFR(E746-A750del)	94.0	10000.0
XMD13-2	EPHA1	98.0	10000.0
BI-D1870	CSNK2A2	22.0	10000.0
GW843682X	RET(V804L)	24.0	10000.0
(s)-CR8	CDK4-cyclinD3	88.0	10000.0
JNK-9L	ABL1-phosphorylated	65.0	10000.0
PD0325901	MLK1	95.0	10000.0
Ribociclib	ABL1(F317I)-nonphosphorylated	98.0	1000.0
RO-3306	FGFR3(G697C)	77.0	10000.0
KIN001-127	TEC	25.0	10000.0
MLN8054	MST1R	92.0	10000.0
ALW-II-49-7	NEK7	100.0	10000.0
HG-14-8-02	PIK3CA	100.0	10000.0
Torkinib	MST4	31.0	10000.0
KIN001-111	SRC	0.0	1000.0
XMD8-92	SgK110	100.0	10000.0
XMD11-50	DCLK1	4.2	10000.0
NG25	MK09	0.0	10000.0
JNK-IN-11	PAK7	92.0	1000.0
AZD-6482	MET(M1250T)	87.0	10000.0
MRT67307	MST1R	100.0	10000.0
Dinaciclib	PIP5K2B	84.0	10000.0
BS-181	MAP3K1	88.0	10000.0
BS-181	RSK3(Kin.Dom.1-N-terminal)	86.0	10000.0
JNK-IN-11	NLK	12.0	1000.0
CGP60474	SYK	100.0	10000.0
WZ-7043	MLK2	100.0	10000.0
5z-7-oxozeaenol	CAMK1D	100.0	10000.0
ZG-10	CAMKK2	16.0	10000.0
WZ-7043	EGFR(L747-T751del,Sins)	100.0	10000.0
GW843682X	MKNK2	76.0	10000.0
MPS-1-IN-1	BMX	100.0	1000.0
MRT67307	CDK16	74.0	10000.0
JW-7-24-1	EPHA2	100.0	10000.0
Abemaciclib	KPCD	9.9	1000.0
BX-912	CDK3	62.0	10000.0
5z-7-oxozeaenol	DAPK1	74.0	10000.0
PHA-793887	TNIK	51.0	10000.0
WZ-7043	NIM1	100.0	10000.0
Abemaciclib	GSK3A	0.2	1000.0
MLN8054	PRP4	100.0	10000.0
Momelotinib	MARK2	43.0	10000.0
(s)-CR8	PAK1	100.0	10000.0
HG-14-8-02	RIOK2	46.0	10000.0
JW-7-24-1	MST2	100.0	10000.0
SB590885	KIT	75.0	10000.0
XMD8-85	FLT3	100.0	10000.0
Torin1	CDC2L5	80.0	10000.0
RO-3306	MAPKAPK5	84.0	10000.0
QL-XI-92	LKB1	100.0	10000.0
XMD16-144	AMPK-alpha1	0.5	10000.0
PD0325901	ACVR2A	80.0	10000.0
AZD7762	SNRK	2.6	10000.0
Torin2	CAMK1	82.0	10000.0
(s)-CR8	PIM3	100.0	10000.0
OTSSP167	MARK3	5.2	10000.0
WZ3105	MYLK4	88.0	10000.0
NVP-TAE684	PIK3CA	100.0	1000.0
Torin1	LATS1	100.0	10000.0
BI-2536	CAMK2G	100.0	10000.0
RO-3306	ABL1(F317I)-phosphorylated	60.0	10000.0
Vemurafenib	KPCT	43.0	10000.0
Dinaciclib	KIT(V559D)	84.0	10000.0
ALW-II-49-7	FLT3	100.0	10000.0
AZD4547	TNIK	0.9	10000.0
TGX221	JNK3	100.0	1000.0
XMD13-2	PGFRA	29.0	10000.0
WYE-125132	ADCK4	100.0	10000.0
Crizotinib	CDKL1	81.0	10000.0
AZ-628	PGFRB	0.0	10000.0
CP724714	PFCDPK1(P.falciparum)	25.0	10000.0
JWE-035	ABL1(F317L)-phosphorylated	0.4	10000.0
THZ1	PIK3CA(H1047Y)	100.0	10000.0
BMX-IN-1	CSNK1E	100.0	10000.0
BGJ398	MYLK2	96.0	1000.0
AZD4547	PLK2	49.0	10000.0
CH5424802	ALK(C1156Y)	0.3	1000.0
BS-181	PTK6	94.0	10000.0
HG-9-91-01	CDKL1	69.0	10000.0
JWE-035	MYLK	64.0	10000.0
Palbociclib	PIK3CA(C420R)	100.0	1000.0
NU7441	LIMK1	100.0	10000.0
SB590885	ABL1(Q252H)-phosphorylated	3.8	10000.0
GSK1059615	DDR1	62.0	10000.0
(s)-CR8	MAPKAPK2	95.0	10000.0
Neratinib	TAOK2	92.0	10000.0
HG-5-88-01	ABL2	100.0	10000.0
GW-5074	PIK3C2G	44.0	10000.0
CP724714	AKT2	100.0	10000.0
BMS345541	CSF1R	16.0	10000.0
Vemurafenib	PIP5K1C	44.0	10000.0
AZD4547	EGFR(L861Q)	62.0	10000.0
JNK-IN-5A	GRK7	88.0	10000.0
QL-XI-92	FLT4	100.0	10000.0
JW-7-24-1	RPS6KA5(Kin.Dom.1)	100.0	10000.0
KU63794	MAP3K15	97.0	10000.0
GSK1059615	EPHA2	95.0	10000.0
THZ1	PIK3CA(H1047L)	100.0	10000.0
Torkinib	TAOK1	0.2	10000.0
KIN001-111	AKT1	100.0	1000.0
ZG-10	SRC	100.0	10000.0
Canertinib	EPHA4	100.0	1000.0
XMD14-99	MK09	100.0	10000.0
CP466722	OSR1	42.0	10000.0
QL-X-138	PLK4	66.0	10000.0
XMD-12	EPHA4	97.0	1000.0
XMD14-99	MK03	100.0	10000.0
THZ1	AAK1	9.0	10000.0
WZ-7043	EGFR(S752-I759del)	100.0	10000.0
BS-181	PIK3CA(Q546K)	100.0	10000.0
ALW-II-49-7	PIP5K1A	100.0	10000.0
TAK-715	CDK7	100.0	10000.0
WH-4-023	FLT3(D835Y)	5.2	10000.0
HG-9-91-01	CDC2L2	78.0	10000.0
BS-181	PLK1	73.0	10000.0
Abemaciclib	MUSK	91.0	1000.0
Dabrafenib	MLK1	12.0	10000.0
XMD14-99	KIT(A829P)	81.0	10000.0
ERK5-IN-1	CDK4-cyclinD3	100.0	1000.0
GW843682X	BRSK1	38.0	10000.0
AZD4547	HIPK2	46.0	10000.0
Torkinib	PIM1	26.0	10000.0
OTSSP167	MLK2	52.0	10000.0
CP466722	TNK1	11.0	10000.0
MLN8054	VGFR1	12.0	10000.0
Dabrafenib	NEK2	7.0	10000.0
OTSSP167	GAK	32.0	10000.0
Dabrafenib	ADCK4	0.0	10000.0
AZD7762	ACVR1	4.0	10000.0
MLN8054	IKKA	100.0	10000.0
XMD16-144	ALK	51.0	10000.0
A443654	FGFR3(G697C)	100.0	10000.0
QL-XII-47	MARK1	95.0	1000.0
BI-2536	DRAK2	100.0	10000.0
WZ-7043	DYRK2	100.0	10000.0
XMD8-85	PIK3CG	31.0	10000.0
ALW-II-38-3	JNK1	100.0	10000.0
WZ-4-145	EPHB2	100.0	10000.0
Neratinib	KIT(V559D,V654A)	83.0	10000.0
RO-3306	DYRK1B	0.0	10000.0
MRT67307	NEK11	100.0	10000.0
Taselisib	ADCK4	100.0	1000.0
KU63794	TYK2(JH2domain-pseudokinase)	86.0	10000.0
AZD 5438	RIPK1	2.4	10000.0
GSK1059615	ALK(C1156Y)	42.0	10000.0
JW-7-24-1	ANKK1	100.0	10000.0
BX-912	TYRO3	85.0	10000.0
GW843682X	PIK3C2B	63.0	10000.0
JWE-035	PDPK1	100.0	10000.0
Abemaciclib	ACVR2A	97.0	1000.0
GW-5074	TYK2(JH2domain-pseudokinase)	100.0	10000.0
WZ-4-145	CLK4	100.0	10000.0
TGX221	PCTK3	100.0	1000.0
CH5424802	PIK3CD	100.0	1000.0
Buparlisib	EGFR(S752-I759del)	89.0	1000.0
Lapatinib	EPHA3	90.0	10000.0
NPK76-II-72-1	IKKE	100.0	10000.0
KU63794	STK35	96.0	10000.0
GW-5074	ROCK1	80.0	10000.0
TAK-715	MELK	95.0	10000.0
KU63794	FAK1	95.0	10000.0
OTSSP167	FLT3(ITD)	2.1	10000.0
GW843682X	AKT3	100.0	10000.0
WZ-7043	SIK1	100.0	10000.0
QL-XII-47	KIT(V559D,T670I)	84.0	1000.0
GSK461364	TYK2(JH1domain-catalytic)	81.0	10000.0
HG-6-64-01	MARK4	100.0	10000.0
PHA-767491	STK39	59.0	10000.0
KIN001-127	MARK2	100.0	10000.0
KIN001-123	CDK8	100.0	1000.0
AG1478	PIK3CA(I800L)	46.0	10000.0
KU63794	MP2K4	88.0	10000.0
KU63794	MAP3K4	100.0	10000.0
JW-7-24-1	JAK3(Kin.Dom.2)	100.0	10000.0
Momelotinib	CDC2L2	58.0	10000.0
Ibrutinib	ABL1(T315I)-nonphosphorylated	96.0	1000.0
KIN001-127	EPHA1	100.0	10000.0
Ribociclib	FYN	100.0	1000.0
Momelotinib	TSSK1	100.0	10000.0
XMD8-85	DYRK2	100.0	10000.0
AG1478	NEK11	99.0	10000.0
XMD11-85h	EPHA1	100.0	10000.0
QL-XII-47	NEK5	100.0	1000.0
HG-5-88-01	PGFRA	100.0	10000.0
JWE-035	PCTK3	97.0	10000.0
R406	AMPK-alpha1	2.6	1000.0
AS-252424	ULK3	100.0	10000.0
GW843682X	ABL1(F317I)-phosphorylated	100.0	10000.0
Omipalisib	PIK3CA(H1047L)	44.0	10000.0
WYE-125132	TYRO3	100.0	10000.0
XMD-12	MP2K5	100.0	1000.0
Sorafenib	MLTK	4.2	10000.0
MLN8054	BIKE	85.0	10000.0
Dabrafenib	AURKC	32.0	10000.0
JW-7-24-1	TYK2(Kin.Dom.1)	8.8	10000.0
ERK5-IN-1	ABL1(F317I)-phosphorylated	64.0	1000.0
AZD 5438	ERBB3	53.0	10000.0
ALW-II-38-3	ALK	100.0	10000.0
ZM-447439	MET	8.4	10000.0
XMD14-99	MAK	26.0	10000.0
Torin2	NEK9	100.0	10000.0
Lapatinib	PIK3CA(I800L)	82.0	10000.0
RO-3306	PIK3CA	73.0	10000.0
GSK461364	FGFR2	75.0	10000.0
AZ-628	RSK2(Kin.Dom.1-N-terminal)	90.0	10000.0
QL-XI-92	GAK	100.0	10000.0
WZ-7043	MARK2	100.0	10000.0
SP600125	PHKG1	100.0	10000.0
Momelotinib	MELK	100.0	10000.0
WZ-7043	HIPK3	100.0	10000.0
Sigma A6730	GSK3A	100.0	10000.0
BMX-IN-1	MAP3K1	100.0	10000.0
ZG-10	PIP5K1C	20.0	10000.0
Alpelisib	LRRK2(G2019S)	100.0	1000.0
JNK-IN-8	TXK	96.0	1000.0
SP600125	CSNK1D	13.0	10000.0
Barasertib	EIF2AK1	5.2	10000.0
5z-7-oxozeaenol	RSK3(Kin.Dom.1-N-terminal)	100.0	10000.0
Baricitinib	ABL1(H396P)-nonphosphorylated	2.4	10000.0
TGX221	TRKC	100.0	1000.0
Ceritinib	MET(Y1235D)	87.0	1000.0
SB590885	MARK2	100.0	10000.0
JWE-035	PIM2	30.0	10000.0
Ribociclib	BRSK1	100.0	1000.0
OTSSP167	HUNK	6.2	10000.0
KIN001-220	SGK3	100.0	10000.0
Torkinib	SIK3	20.0	10000.0
HG-14-10-04	MARK4	5.2	10000.0
BI-2536	MAP3K3	100.0	10000.0
Palbociclib	CDK8	93.0	1000.0
WZ3105	MTOR	100.0	10000.0
KIN001-111	WEE2	100.0	1000.0
Buparlisib	PIM2	93.0	1000.0
ALW-II-49-7	MAPKAPK2	100.0	10000.0
GW843682X	PI42C	26.0	10000.0
CP724714	EGFR(T790M)	7.8	10000.0
QL-XI-92	PIM3	100.0	10000.0
OTSSP167	PCTK3	2.7	10000.0
GW843682X	IKKA	86.0	10000.0
HG-14-8-02	PIK3CA(H1047L)	100.0	10000.0
CG-930	RET(M918T)	84.0	10000.0
Omipalisib	MAK	100.0	10000.0
Pictilisib	MKNK2	100.0	1000.0
GSK461364	AKT2	100.0	10000.0
XMD-12	DAPK3	100.0	1000.0
AZD4547	PLK4	5.2	10000.0
GW-5074	EPHA6	100.0	10000.0
TAK-715	PIK3CA(E542K)	100.0	10000.0
Canertinib	ABL1(E255K)	100.0	1000.0
SB590885	MST3	100.0	10000.0
ALW-II-38-3	BIKE	100.0	10000.0
Torkinib	MP2K6	70.0	10000.0
AS-252424	ULK1	100.0	10000.0
HG-14-10-04	WNK3	100.0	10000.0
SB590885	TAOK3	75.0	10000.0
Ibrutinib	NEK4	84.0	1000.0
Pictilisib	EGFR(L861Q)	77.0	1000.0
OTSSP167	MP2K6	67.0	10000.0
XMD14-99	CSNK1G3	79.0	10000.0
AZD 5438	ABL1(F317I)-phosphorylated	78.0	10000.0
R406	SNARK	3.0	1000.0
Buparlisib	HUNK	100.0	1000.0
GSK1059615	PIK3C2G	3.8	10000.0
(s)-CR8	ACVR1B	98.0	10000.0
AZD7762	CDKL2	60.0	10000.0
Dactolisib	PIK3CA(Q546K)	3.8	1000.0
MRT67307	ABL2	83.0	10000.0
XMD8-92	DCAMKL3	100.0	10000.0
CG-930	RET(V804L)	100.0	10000.0
KIN001-123	M4K1	100.0	1000.0
XMD14-99	KIT(D816H)	86.0	10000.0
GSK429286A	EPHA2	84.0	10000.0
AZD-6482	NIM1	100.0	10000.0
AZD 5438	NEK10	2.2	10000.0
JNK-IN-11	RIOK1	100.0	1000.0
GSK1059615	PAK4	75.0	10000.0
XMD11-85h	CSK	100.0	10000.0
Dinaciclib	FER	100.0	10000.0
Dactolisib	SRC	100.0	1000.0
CH5424802	KPCE	90.0	1000.0
Ribociclib	MAP3K3	89.0	1000.0
HG-6-64-01	MAP3K1	71.0	10000.0
MLN8054	FLT3(N841I)	54.0	10000.0
HG-9-91-01	MP2K4	6.6	10000.0
XMD11-85h	CIT	100.0	10000.0
SCH772984	ABL1(M351T)-phosphorylated	94.0	1000.0
PD0325901	TNNI3K	51.0	10000.0
Seliciclib	MET(Y1235D)	40.0	10000.0
BGJ398	CSNK1A1	93.0	1000.0
XMD11-85h	GRK1	100.0	10000.0
ZM-447439	KPCE	100.0	10000.0
CGP74514A	PIK3CA	73.0	10000.0
GSK1059615	HCK	75.0	10000.0
PHA-767491	MAST1	62.0	10000.0
HG-9-91-01	ULK3	8.4	10000.0
SCH772984	FLT3	82.0	1000.0
Dinaciclib	MUSK	100.0	10000.0
KIN001-220	CDK15	64.0	10000.0
Lapatinib	PRP4	92.0	10000.0
CP466722	ABL1(Q252H)-phosphorylated	0.2	10000.0
Dabrafenib	ANKK1	46.0	10000.0
BMS345541	IRAK3	72.0	10000.0
BMX-IN-1	MAPKAPK2	100.0	10000.0
JNK-IN-5A	MAP3K1	59.0	10000.0
XMD14-99	CSNK1E	56.0	10000.0
Ceritinib	LOK	80.0	1000.0
GSK429286A	RET(V804L)	39.0	10000.0
WZ4002	TSSK1	100.0	10000.0
GSK429286A	EGFR(L861Q)	91.0	10000.0
Dinaciclib	RIOK2	20.0	10000.0
KIN001-021	NEK7	15.0	1000.0
WZ-4-145	KC1G2	100.0	10000.0
Momelotinib	PIK3C2G	100.0	10000.0
ZM-447439	BRSK2	100.0	10000.0
CP466722	VRK2	9.8	10000.0
JNK-IN-5A	ITK	89.0	10000.0
Abemaciclib	CAMKK2	4.7	1000.0
Seliciclib	KPCD	90.0	10000.0
PD0325901	MAP3K3	98.0	10000.0
CGP60474	FGFR2	100.0	10000.0
JNK-IN-5A	TESK1	83.0	10000.0
ZM-447439	SIK3	100.0	10000.0
JNK-IN-11	PIK3CA(E542K)	91.0	1000.0
GSK1059615	AURKC	56.0	10000.0
Ceritinib	TEC	92.0	1000.0
BI-2536	FGFR2	100.0	10000.0
WZ4003	HCK	100.0	1000.0
JNK-IN-8	PIK3CB	79.0	1000.0
AZD-6482	TYRO3	100.0	10000.0
KIN001-021	TNNI3K	100.0	1000.0
Palbociclib	ROCK2	100.0	1000.0
JNK-9L	ABL1(F317L)-nonphosphorylated	80.0	10000.0
QL-XII-47	MLTK	95.0	1000.0
BGJ398	ERK4	100.0	1000.0
PHA-793887	TLK1	76.0	10000.0
NU7441	FLT3(N841I)	100.0	10000.0
AZ-628	WEE1	100.0	10000.0
ZG-10	AKT2	100.0	10000.0
R406	DAPK2	2.2	1000.0
Ibrutinib	RSK1(Kin.Dom.2-C-terminal)	91.0	1000.0
Barasertib	MAP4K2	29.0	10000.0
Abemaciclib	ROCK2	3.0	1000.0
Torin1	MYO3A	100.0	10000.0
R406	AMPK-alpha2	2.4	1000.0
Abemaciclib	LRRK2(G2019S)	35.0	1000.0
PHA-767491	CLK1	0.1	10000.0
MPS-1-IN-1	AAK1	100.0	1000.0
GW-5074	MP2K6	71.0	10000.0
KU63794	PIK3CA(Q546K)	2.8	10000.0
BS-181	CIT	89.0	10000.0
NG25	EPHA5	11.0	10000.0
ZG-10	MLCK	87.0	10000.0
Dabrafenib	CIT	0.8	10000.0
GSK1059615	SRPK2	86.0	10000.0
BI-D1870	PCTK2	3.1	10000.0
BI-2536	EPHA5	100.0	10000.0
Buparlisib	CDK3	100.0	1000.0
QL-X-138	INSRR	100.0	10000.0
JW-7-24-1	JNK3	100.0	10000.0
JNK-IN-11	ERBB2	0.4	1000.0
RO-3306	FLT3(D835Y)	11.0	10000.0
SCH772984	MRCKA	100.0	1000.0
HG-14-8-02	ROS1	11.0	10000.0
Ceritinib	WNK2	90.0	1000.0
KIN001-123	EPHA3	100.0	1000.0
ZM-447439	KCC2D	100.0	10000.0
Alpelisib	LIMK1	100.0	1000.0
TGX221	YES	100.0	1000.0
AZD 5438	PIK3C2B	67.0	10000.0
TAK-715	PIP5K1C	100.0	10000.0
SB590885	PIP5K2B	94.0	10000.0
(s)-CR8	JAK3(JH1domain-catalytic)	100.0	10000.0
Barasertib	NDR2	100.0	10000.0
PD173074	NDR2	100.0	10000.0
HG-6-64-01	KGP2	91.0	10000.0
QL-X-138	PGFRB	5.6	10000.0
RO-3306	MST3	100.0	10000.0
ZM-447439	SGK3	100.0	10000.0
Ceritinib	EPHA4	100.0	1000.0
Ibrutinib	TNNI3K	73.0	1000.0
HG-14-8-02	M4K3	34.0	10000.0
ZG-10	SYK	23.0	10000.0
AZ-628	FER	100.0	10000.0
Alpelisib	EPHB4	94.0	1000.0
WZ4003	RPS6KA5(Kin.Dom.1)	100.0	1000.0
GSK461364	ROCK1	7.9	10000.0
Dactolisib	RAF1	100.0	1000.0
GW-5074	MLK3	38.0	10000.0
Sorafenib	EGFR(G719C)	76.0	10000.0
Dactolisib	TLK1	100.0	1000.0
XMD8-85	FAK1	16.0	10000.0
R406	MP2K1	15.0	1000.0
JNK-IN-8	RIPK2	99.0	1000.0
WYE-125132	MAST1	95.0	10000.0
XMD-12	RIPK1	100.0	1000.0
GW-5074	EPHA3	66.0	10000.0
Seliciclib	TLK2	89.0	10000.0
KIN001-123	AKT1	100.0	1000.0
GW843682X	S6K1	65.0	10000.0
PHA-767491	RIPK1	96.0	10000.0
BGJ398	PIK3C2G	90.0	1000.0
PHA-793887	CAMK1D	100.0	10000.0
Crizotinib	CAMK2A	100.0	10000.0
PD173074	NEK1	100.0	10000.0
GW843682X	KGP2	86.0	10000.0
JWE-035	PKN1	76.0	10000.0
ERK5-IN-1	KIT(V559D,V654A)	100.0	1000.0
Torin2	HIPK3	92.0	10000.0
CP724714	CDK8	3.0	10000.0
BMS345541	NEK7	100.0	10000.0
KIN001-220	MYLK	57.0	10000.0
CGP60474	DDR2	100.0	10000.0
Canertinib	YSK1	100.0	1000.0
Neratinib	RSK3(Kin.Dom.2-C-terminal)	100.0	10000.0
BX-912	SNRK	100.0	10000.0
BS-181	ADCK3	100.0	10000.0
JWE-035	STK33	36.0	10000.0
Seliciclib	CLK3	45.0	10000.0
Seliciclib	CTK	100.0	10000.0
Seliciclib	LATS1	100.0	10000.0
PHA-793887	PIK3CA(I800L)	90.0	10000.0
Dactolisib	ABL2	100.0	1000.0
NVP-TAE684	TNK2	0.0	1000.0
Momelotinib	MK09	26.0	10000.0
Alpelisib	CDKL2	100.0	1000.0
SB590885	MET(Y1235D)	64.0	10000.0
ERK5-IN-1	MAP3K4	100.0	1000.0
Vemurafenib	MST4	100.0	10000.0
WZ-7043	FGFR3	3.3	10000.0
AZD-6482	FGR	95.0	10000.0
Abemaciclib	SRPK2	99.0	1000.0
HG-9-91-01	HCK	0.2	10000.0
HG-9-91-01	IKKB	81.0	10000.0
Omipalisib	SIK3	85.0	10000.0
PD0325901	EGFR(G719S)	66.0	10000.0
PD0325901	ERBB2	100.0	10000.0
BMX-IN-1	PIK3CA(E545K)	74.0	10000.0
QL-XI-92	BRSK1	100.0	10000.0
XMD8-92	ALK	29.0	10000.0
Sigma A6730	TGFBR1	100.0	10000.0
Ribociclib	NEK9	89.0	1000.0
THZ1	BRAF	72.0	10000.0
XMD11-50	INSR	84.0	10000.0
Ceritinib	MARK2	100.0	1000.0
HG-9-91-01	EPHA8	0.1	10000.0
NVP-TAE684	VGFR1	2.8	1000.0
CP466722	STK36	7.4	10000.0
5z-7-oxozeaenol	PRP4	95.0	10000.0
Dinaciclib	TIE1	84.0	10000.0
Neratinib	LYN	34.0	10000.0
CGP60474	STK33	100.0	10000.0
AZD7762	TNIK	0.1	10000.0
XMD14-99	PIK3CA(Q546K)	78.0	10000.0
PHA-767491	ADCK3	49.0	10000.0
QL-X-138	PIK3CA	24.0	10000.0
ZG-10	ABL1(F317I)-nonphosphorylated	77.0	10000.0
HG-5-88-01	MUSK	100.0	10000.0
WZ3105	MK12	96.0	10000.0
CG-930	MST4	82.0	10000.0
JNK-IN-8	MAP3K4	100.0	1000.0
JNK-9L	PAK7	21.0	10000.0
HG-14-10-04	TYRO3	100.0	10000.0
Momelotinib	ADCK4	33.0	10000.0
MLN8054	PIM2	36.0	10000.0
BS-181	ERBB2	93.0	10000.0
Ribociclib	MLK1	100.0	1000.0
Alpelisib	DCAMKL3	95.0	1000.0
GW-5074	CIT	5.6	10000.0
JW-7-24-1	RET	100.0	10000.0
AG1478	NDR2	87.0	10000.0
Neratinib	DRAK1	37.0	10000.0
WYE-125132	EGFR	62.0	10000.0
CG-930	YANK3	100.0	10000.0
BX-912	CHK2	24.0	10000.0
GSK461364	ABL1(F317L)-nonphosphorylated	85.0	10000.0
ALW-II-38-3	PAK1	100.0	10000.0
AZD4547	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
CP724714	PDPK1	100.0	10000.0
Lapatinib	JAK2(JH1domain-catalytic)	85.0	10000.0
WZ3105	MET(M1250T)	100.0	10000.0
JWE-035	MST1R	100.0	10000.0
CGP74514A	ABL1(H396P)-phosphorylated	1.8	10000.0
AZ-628	BRSK2	100.0	10000.0
KIN001-220	TYK2(JH2domain-pseudokinase)	12.0	10000.0
OTSSP167	CSNK1E	0.2	10000.0
AZ-628	FES	43.0	10000.0
THZ1	MAP3K4	54.0	10000.0
Neratinib	RSK4(Kin.Dom.2-C-terminal)	97.0	10000.0
JWE-035	KIT(V559D)	56.0	10000.0
AG1478	ADCK3	56.0	10000.0
KIN001-111	GCN2(Kin.Dom.2,S808G)	100.0	1000.0
AG1478	TTK	61.0	10000.0
GSK1059615	NIM1	71.0	10000.0
Canertinib	MP2K6	100.0	1000.0
BMS-536924	CAMK1G	100.0	1000.0
XMD-12	MST1	80.0	1000.0
WH-4-023	PIK4CB	100.0	10000.0
ZM-447439	EGFR(T790M)	42.0	10000.0
WYE-125132	TNK2	84.0	10000.0
AZD-6482	DAPK2	92.0	10000.0
AG1478	MUSK	100.0	10000.0
WZ3105	RSK4(Kin.Dom.1-N-terminal)	8.2	10000.0
AS-252424	DDR1	81.5	10000.0
MPS-1-IN-1	PIK3CA(E545K)	100.0	1000.0
AZD7762	PIK3CA(H1047Y)	36.0	10000.0
WH-4-023	MST1R	16.0	10000.0
Taselisib	TAK1	100.0	1000.0
ALW-II-38-3	KGP2	100.0	10000.0
JNK-IN-11	CAMK1D	100.0	1000.0
Barasertib	EPHA1	100.0	10000.0
QL-X-138	MAPKAPK2	100.0	10000.0
Seliciclib	PIM1	94.0	10000.0
HG-14-8-02	M3K13	91.0	10000.0
KIN001-123	KIT	100.0	1000.0
BMX-IN-1	FES	100.0	10000.0
NVP-TAE684	FES	0.3	1000.0
Momelotinib	FLT3(R834Q)	100.0	10000.0
WZ-4-145	CSF1R	0.0	10000.0
SP600125	MKNK1	100.0	10000.0
KU63794	CSK	77.0	10000.0
KIN001-021	PIK3CG	100.0	1000.0
SP600125	CHK2	26.0	10000.0
HG-5-88-01	MYLK	5.0	10000.0
KIN001-111	TNK2	1.6	1000.0
PD0325901	MK09	88.0	10000.0
NG25	MAP3K4	100.0	10000.0
Alpelisib	M4K1	100.0	1000.0
ERK5-IN-1	CAMK2B	78.0	1000.0
TGX221	TEC	100.0	1000.0
AS-252424	BRSK2	100.0	10000.0
MRT67307	ABL1(F317L)-phosphorylated	61.0	10000.0
HG-14-8-02	KPCD3	51.0	10000.0
Torin2	PGFRA	62.0	10000.0
KIN001-021	PKMYT1	100.0	1000.0
Sorafenib	STK39	100.0	10000.0
QL-XI-92	AMPK-alpha2	100.0	10000.0
PD0325901	CSNK1E	100.0	10000.0
XMD8-92	CDC2L2	100.0	10000.0
Palbociclib	JNK1	69.0	1000.0
Pictilisib	PRKR	100.0	1000.0
QL-XII-47	EGFR(T790M)	99.0	1000.0
Dinaciclib	IKKB	63.0	10000.0
Crizotinib	AURKB	0.3	10000.0
WZ-4-145	STK36	100.0	10000.0
Torkinib	SRPK1	100.0	10000.0
WZ-7043	RET(V804M)	100.0	10000.0
KU63794	ZAP70	83.0	10000.0
Ibrutinib	HIPK2	91.0	1000.0
MRT67307	ERBB3	99.0	10000.0
BGJ398	PI42C	69.0	1000.0
JW-7-24-1	SLK	3.7	10000.0
HG-5-113-01	PAK1	100.0	10000.0
CP724714	ABL1(M351T)-phosphorylated	100.0	10000.0
Pictilisib	DDR2	80.0	1000.0
GSK461364	PAK3	96.0	10000.0
Palbociclib	HIPK4	72.0	1000.0
WYE-125132	EGFR(S752-I759del)	55.0	10000.0
(s)-CR8	FLT4	98.0	10000.0
GSK1059615	NEK10	0.0	10000.0
ZG-10	DAPK3	62.0	10000.0
WYE-125132	HUNK	100.0	10000.0
Omipalisib	CSK	68.0	10000.0
Pictilisib	JAK1(JH2domain-pseudokinase)	18.0	1000.0
Sorafenib	CDK3	52.0	10000.0
CG-930	MRCKA	100.0	10000.0
NPK76-II-72-1	MK03	100.0	10000.0
XMD14-99	MINK	61.0	10000.0
Pictilisib	HASP	59.0	1000.0
KIN001-127	BMX	100.0	10000.0
MRT67307	JAK1(JH1domain-catalytic)	28.0	10000.0
AS-252424	AURKA	100.0	10000.0
WZ3105	M4K1	74.0	10000.0
QL-X-138	GRK7	52.0	10000.0
ALW-II-49-7	DAPK1	100.0	10000.0
Ribociclib	EPHA5	100.0	1000.0
Sigma A6730	ERBB2	86.0	10000.0
HG-14-10-04	PAK2	12.0	10000.0
MRT67307	MAP4K2	3.8	10000.0
BMS345541	BIKE	91.0	10000.0
KIN001-111	RPS6KA6(Kin.Dom.2)	100.0	1000.0
Dinaciclib	PAK3	7.8	10000.0
ZG-10	DMPK	64.0	10000.0
GW843682X	CAMK1	100.0	10000.0
PHA-767491	M3K2	59.0	10000.0
AZD-6482	GAK	75.0	10000.0
TGX221	PHKG2	100.0	1000.0
Seliciclib	CDK2	46.0	10000.0
MRT67307	CLK2	2.6	10000.0
Lapatinib	ICK	100.0	10000.0
Dabrafenib	SIK3	19.0	10000.0
Taselisib	M4K3	98.0	1000.0
SB590885	KC1G2	72.0	10000.0
GSK429286A	KIT(D816V)	49.0	10000.0
XMD-12	PFCDPK1(P.falciparum)	100.0	1000.0
BGJ398	MINK	61.0	1000.0
MRT67307	ERBB2	83.0	10000.0
KIN001-220	CDK14	53.0	10000.0
QL-XI-92	FGFR1	100.0	10000.0
KIN001-220	STK16	1.6	10000.0
Torin1	KPCL	92.0	10000.0
GW843682X	EGFR(L858R)	47.0	10000.0
ALW-II-38-3	RAF1	3.0	1000.0
XMD11-50	ACVR2A	100.0	10000.0
Neratinib	PCTK3	96.0	10000.0
Palbociclib	EPHA5	100.0	1000.0
Crizotinib	MST2	0.0	10000.0
SCH772984	PIK3CA(E542K)	100.0	1000.0
BS-181	PIK3C2B	86.0	10000.0
ERK5-IN-1	AKT3	84.0	1000.0
QL-XI-92	CAMKK2	69.0	10000.0
XMD14-99	M4K3	100.0	10000.0
Alpelisib	LKB1	100.0	1000.0
ZSTK474	M4K1	100.0	1000.0
XMD11-85h	MP2K4	100.0	10000.0
NU7441	PKNB(M.tuberculosis)	6.6	10000.0
XMD-12	ERBB3	92.0	1000.0
JW-7-24-1	EGFR(E746-A750del)	28.0	10000.0
WZ3105	LCK	38.0	10000.0
WH-4-023	FYN	0.0	10000.0
WZ4003	ROS1	6.8	1000.0
CG-930	PRKR	100.0	10000.0
KIN001-220	ABL1(F317I)-phosphorylated	85.0	10000.0
NPK76-II-72-1	MK09	100.0	10000.0
JNK-IN-8	RIPK5	100.0	1000.0
RO-3306	EPHA5	98.0	10000.0
NG25	ZAP70	11.0	10000.0
XMD11-50	MP2K3	75.0	10000.0
Vemurafenib	VGFR1	43.0	10000.0
GSK461364	DCAMKL3	72.0	10000.0
AZD4547	SNRK	98.0	10000.0
SP600125	PTK6	100.0	10000.0
HG-9-91-01	MK09	0.0	10000.0
CGP74514A	KIT(L576P)	18.0	10000.0
XMD16-144	CDKL2	92.0	10000.0
Vemurafenib	ABL1(Y253F)-phosphorylated	45.0	10000.0
Crizotinib	GAK	79.0	10000.0
XMD13-2	MK13	5.0	10000.0
ERK5-IN-1	PIK3CA(H1047Y)	76.0	1000.0
HG-9-91-01	TRPM6	87.0	10000.0
KIN001-127	AKT2	100.0	10000.0
(s)-CR8	ACVR2A	100.0	10000.0
Sorafenib	PRKR	73.0	10000.0
XMD13-2	TYK2(JH2domain-pseudokinase)	32.0	10000.0
QL-X-138	FGFR4	100.0	10000.0
XMD-12	SLK	100.0	1000.0
AZD-6482	KGP1	100.0	10000.0
MRT67307	ACVR1B	93.0	10000.0
JNK-IN-5A	EPHB3	98.0	10000.0
XMD14-99	PLK1	72.0	10000.0
GSK429286A	KIT(A829P)	58.0	10000.0
ERK5-IN-1	STK16	99.0	1000.0
Canertinib	TSSK1	100.0	1000.0
(s)-CR8	HCK	100.0	10000.0
Abemaciclib	CSNK1E	84.0	1000.0
XMD-12	ERBB2	99.0	1000.0
Palbociclib	KCC2D	77.0	1000.0
TGX221	CDK7	100.0	1000.0
NU7441	ERK5	100.0	10000.0
Neratinib	MK14	91.0	10000.0
GSK1059615	EGFR(L747-T751del,Sins)	84.0	10000.0
MRT67307	EGFR(L858R,T790M)	100.0	10000.0
JW-7-24-1	CDC2L1	100.0	10000.0
QL-X-138	SNARK	46.0	10000.0
(s)-CR8	AKT1	88.0	10000.0
XMD11-50	MELK	100.0	10000.0
MLN8054	BRAF	100.0	10000.0
Torkinib	GRK7	2.9	10000.0
AZD-6482	ABL1(T315I)-nonphosphorylated	100.0	10000.0
HG-14-8-02	TAOK3	68.0	10000.0
Sigma A6730	M3K2	100.0	10000.0
PHA-767491	ALK	92.0	10000.0
JNK-IN-11	BMPR1B	47.0	1000.0
Omipalisib	CLK4	32.0	10000.0
Dabrafenib	PTK6	1.1	10000.0
KIN001-127	PIP5K2B	100.0	10000.0
Ceritinib	FLT3(K663Q)	33.0	1000.0
XMD-12	NEK5	100.0	1000.0
HG-6-64-01	CDKL5	78.0	10000.0
JNK-IN-11	ANKK1	73.0	1000.0
AZD-6482	NEK6	100.0	10000.0
GW-5074	NDR2	31.0	10000.0
CGP74514A	EPHA5	25.0	10000.0
(s)-CR8	IKKB	100.0	10000.0
QL-X-138	PIK3CA(M1043I)	15.0	10000.0
Palbociclib	BARK1	100.0	1000.0
BX-912	STK33	0.8	10000.0
BMS-536924	HIPK1	100.0	1000.0
Lapatinib	CAMK2A	100.0	10000.0
HG-14-10-04	ADCK3	100.0	10000.0
(s)-CR8	NEK2	100.0	10000.0
HG-14-10-04	CDK4-cyclinD1	19.0	10000.0
ERK5-IN-1	EPHA4	100.0	1000.0
QL-X-138	TIE2	100.0	10000.0
CH5424802	RIPK2	37.0	1000.0
Alpelisib	SRMS	100.0	1000.0
XMD8-92	PIK4CB	100.0	10000.0
R406	GSK3B	100.0	1000.0
Sorafenib	ABL1(T315I)-phosphorylated	28.0	10000.0
Omipalisib	TTK	4.0	10000.0
RO-3306	ULK2	81.0	10000.0
GW843682X	ABL1-nonphosphorylated	60.0	10000.0
AZD 5438	NEK7	14.0	10000.0
Dinaciclib	KPCT	88.0	10000.0
PHA-793887	CSNK2A2	100.0	10000.0
ZSTK474	CHK2	100.0	1000.0
GSK461364	EPHB4	100.0	10000.0
GSK1059615	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
NU7441	PIK3CG	1.3	10000.0
Torin1	TAOK1	58.0	10000.0
BMS345541	AAK1	78.0	10000.0
5z-7-oxozeaenol	ACVR1	1.9	10000.0
XMD8-92	IRAK1	100.0	10000.0
HG-5-88-01	TYK2(Kin.Dom.1)	100.0	10000.0
BMS345541	FLT3(N841I)	41.0	10000.0
A443654	STK35	100.0	10000.0
5z-7-oxozeaenol	DDR1	100.0	10000.0
Alpelisib	STK16	100.0	1000.0
HG-5-113-01	MP2K2	5.2	10000.0
Dabrafenib	CDK7	3.4	10000.0
XMD8-92	MYO3A	100.0	10000.0
WYE-125132	CLK4	88.0	10000.0
MPS-1-IN-1	MAPKAPK2	100.0	1000.0
RO-3306	DAPK1	23.0	10000.0
GW-5074	ANKK1	12.0	10000.0
Dactolisib	ABL1(F317L)	100.0	1000.0
PLX-4720	NEK1	72.0	10000.0
ALW-II-49-7	LATS1	100.0	10000.0
CH5424802	BIKE	99.0	1000.0
GW843682X	KIT(L576P)	30.0	10000.0
NG25	LOK	0.1	10000.0
GSK429286A	VGFR2	88.0	10000.0
GSK1059615	IKKE	45.0	10000.0
Taselisib	TYK2(JH2domain-pseudokinase)	92.0	1000.0
Ribociclib	TNIK	82.0	1000.0
ALW-II-38-3	JAK2(JH1domain-catalytic)	100.0	10000.0
CG-930	SRPK2	100.0	10000.0
MLN8054	LIMK1	85.0	10000.0
XMD14-99	HIPK2	66.0	10000.0
QL-X-138	DAPK1	70.0	10000.0
Seliciclib	YANK3	93.0	10000.0
JW-7-24-1	AXL	26.0	10000.0
JNK-IN-11	SNARK	89.0	1000.0
JNK-IN-8	NEK6	100.0	1000.0
Neratinib	MARK1	94.0	10000.0
JNK-IN-5A	SIK3	65.0	10000.0
WZ4002	LATS1	100.0	10000.0
Seliciclib	INSR	55.0	10000.0
Ceritinib	KIT(D816H)	77.0	1000.0
Neratinib	BRAF(V600E)	100.0	10000.0
Taselisib	BRSK1	100.0	1000.0
Torkinib	FAK1	100.0	10000.0
Pictilisib	EPHA6	100.0	1000.0
GSK429286A	BMPR2	65.0	10000.0
NG25	PHKG2	100.0	10000.0
XMD11-50	MK13	72.0	10000.0
KIN001-220	MK03	100.0	10000.0
Ibrutinib	SRMS	0.0	1000.0
ALW-II-38-3	PAK7	100.0	10000.0
XMD11-50	ROCK1	100.0	10000.0
OTSSP167	LOK	0.1	10000.0
5z-7-oxozeaenol	ADCK3	97.0	10000.0
THZ1	BTK	1.2	10000.0
Dinaciclib	FLT4	100.0	10000.0
Ceritinib	PLK4	16.0	1000.0
XMD11-50	IKKE	96.0	10000.0
BMS345541	PIK3CA(Q546K)	38.0	10000.0
BMS345541	CDK7	6.3	10000.0
QL-XII-47	MYLK4	93.0	1000.0
AZD-6482	EPHA4	93.0	10000.0
HG-6-64-01	EGFR(L858R)	0.1	10000.0
Palbociclib	BRSK2	99.0	1000.0
KU63794	MAP4K5	96.0	10000.0
TGX221	AURKA	100.0	1000.0
CH5424802	MERTK	5.7	1000.0
Palbociclib	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	1000.0
Crizotinib	BMPR1A	28.0	10000.0
QL-X-138	FGFR3	89.0	10000.0
PD0325901	RSK4(Kin.Dom.2-C-terminal)	80.0	10000.0
MPS-1-IN-1	EGFR(L858R)	100.0	1000.0
SCH772984	CAMK1	83.0	1000.0
PLX-4720	RAF1	3.4	10000.0
Torin2	RSK4(Kin.Dom.1-N-terminal)	80.0	10000.0
BS-181	ALK(L1196M)	27.0	10000.0
GSK1059615	SGK1	43.0	10000.0
WZ4003	NEK5	100.0	1000.0
BMX-IN-1	CAMKK2	92.0	10000.0
PHA-793887	BMX	98.0	10000.0
HG-5-113-01	CSF1R	30.0	10000.0
BS-181	SGK2	100.0	10000.0
XMD13-2	PIK3CA(M1043I)	92.0	10000.0
CGP60474	MKNK2	100.0	10000.0
PLX-4720	ABL1(T315I)-phosphorylated	88.0	10000.0
AS-252424	BLK	76.7	10000.0
XMD16-144	M4K1	38.0	10000.0
AZD7762	KIT(V559D,V654A)	0.4	10000.0
WZ-4-145	AMPK-alpha1	100.0	10000.0
KIN001-123	SIK2	100.0	1000.0
CG-930	CDK5	100.0	10000.0
AZ-628	BMPR2	82.0	10000.0
Torin2	SIK1	79.0	10000.0
Vemurafenib	MST1	11.0	10000.0
BMS-536924	EPHA4	100.0	1000.0
BMS-536924	RPS6KA5(Kin.Dom.2)	100.0	1000.0
Barasertib	HIPK2	31.0	10000.0
Baricitinib	TAOK1	4.5	10000.0
JNK-IN-11	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	1000.0
AZD-6482	IGF1R	100.0	10000.0
Ceritinib	EPHB1	97.0	1000.0
WZ-4-145	EPHA5	100.0	10000.0
TGX221	ABL1(Y253F)	100.0	1000.0
TGX221	CHK2	100.0	1000.0
CG-930	PHKG1	100.0	10000.0
PHA-767491	PIK3CA(M1043I)	95.0	10000.0
AZD 5438	MUSK	88.0	10000.0
HG-9-91-01	EGFR(L747-E749del,A750P)	0.1	10000.0
MPS-1-IN-1	BMPR1A	100.0	1000.0
JNK-IN-5A	ADCK4	100.0	10000.0
A443654	KPCE	0.0	10000.0
XMD11-50	CSNK1A1	100.0	10000.0
NU7441	MLK2	100.0	10000.0
HG-6-64-01	PRKX	75.0	10000.0
Buparlisib	RAF1	88.0	1000.0
Barasertib	MET(Y1235D)	30.0	10000.0
SCH772984	ERBB4	100.0	1000.0
ALW-II-49-7	MLTK	6.9	1000.0
Ceritinib	ACVRL1	84.0	1000.0
Seliciclib	FLT4	100.0	10000.0
BX-912	RIOK2	36.0	10000.0
Torkinib	DYRK1B	59.0	10000.0
WZ-7043	PIK3CG	100.0	10000.0
THZ1	IRAK3	4.6	10000.0
Dactolisib	EPHA3	100.0	1000.0
PHA-793887	NDR2	100.0	10000.0
XMD11-50	KGP2	74.0	10000.0
JWE-035	MK12	97.0	10000.0
ZG-10	PRP4	100.0	10000.0
HG-5-88-01	CIT	100.0	10000.0
KIN001-123	CDK5	100.0	1000.0
AZD4547	DDR1	0.1	10000.0
Omipalisib	ERK4	100.0	10000.0
PD0325901	HUNK	100.0	10000.0
Sigma A6730	RSK4(Kin.Dom.1-N-terminal)	75.0	10000.0
HG-5-113-01	CSNK2A2	18.0	10000.0
AZD-6482	LTK	95.0	10000.0
Ribociclib	FAK1	100.0	1000.0
R406	GSK3A	13.0	1000.0
MLN8054	CSNK1E	100.0	10000.0
WZ3105	ABL1(H396P)-phosphorylated	67.0	10000.0
Dactolisib	CSNK2A2	100.0	1000.0
Omipalisib	EGFR(L747-E749del,A750P)	60.0	10000.0
CP466722	MLCK	100.0	10000.0
ZG-10	M3K2	79.0	10000.0
Crizotinib	CAMK2G	100.0	10000.0
AG1478	KPCD2	86.0	10000.0
(s)-CR8	LCK	98.0	10000.0
BS-181	KPCD3	30.0	10000.0
CP466722	PKAC-beta	100.0	10000.0
PHA-793887	EIF2AK1	100.0	10000.0
ZM-447439	M4K1	60.0	10000.0
Crizotinib	TRKA	0.1	10000.0
JWE-035	NLK	56.0	10000.0
Ibrutinib	EPHA4	94.0	1000.0
Dactolisib	MK01	100.0	1000.0
HG-14-10-04	KPCL	100.0	10000.0
THZ1	PLK3	1.0	10000.0
Torin2	MK14	100.0	10000.0
Torin1	PIK4CB	96.0	10000.0
SB590885	DRAK2	87.0	10000.0
Seliciclib	BRSK1	100.0	10000.0
JNK-IN-11	NIM1	100.0	1000.0
JNK-IN-5A	CSNK1G3	68.0	10000.0
WH-4-023	BRAF(V600E)	38.0	10000.0
KIN001-220	TNK1	1.3	10000.0
CGP74514A	DCAMKL2	69.0	10000.0
XMD16-144	PIK3CA(Q546K)	30.0	10000.0
BGJ398	BRAF(V600E)	59.0	1000.0
Momelotinib	MAK	100.0	10000.0
Vemurafenib	LRRK2	59.0	10000.0
JW-7-24-1	DAPK2	100.0	10000.0
GW-5074	CSK	92.0	10000.0
PHA-767491	LATS1	29.0	10000.0
HG-6-64-01	MLCK	100.0	10000.0
Taselisib	ABL1(F317I)-phosphorylated	96.0	1000.0
ERK5-IN-1	PLK3	84.0	1000.0
NU7441	AURKB	100.0	10000.0
XMD8-85	NIM1	100.0	10000.0
CG-930	KC1G1	100.0	10000.0
AZD 5438	PIM3	53.0	10000.0
Momelotinib	JAK1(JH1domain-catalytic)	13.0	10000.0
AS-252424	MST3	81.5	10000.0
WZ4002	FGFR4	100.0	10000.0
NU7441	CDK7	100.0	10000.0
PLX-4720	NEK9	66.0	10000.0
Palbociclib	PIP5K1A	100.0	1000.0
SB590885	INSRR	100.0	10000.0
BMX-IN-1	DCLK1	84.0	10000.0
AZD4547	AURKC	1.8	10000.0
PD173074	YANK3	100.0	10000.0
MPS-1-IN-1	KIT(D816V)	100.0	1000.0
KIN001-021	RIOK2	100.0	1000.0
ALW-II-38-3	GSK3A	100.0	10000.0
PLX-4720	CAMK2B	63.0	10000.0
QL-XII-47	NEK2	92.0	1000.0
GW-5074	CSNK1A1L	100.0	10000.0
Ibrutinib	RAF1	70.0	1000.0
CG-930	KIT(V559D)	87.0	10000.0
GSK1059615	ABL1(H396P)-phosphorylated	57.0	10000.0
NVP-TAE684	RET(V804L)	0.3	1000.0
HG-9-91-01	VGFR1	5.3	10000.0
ALW-II-49-7	JAK3(Kin.Dom.2)	100.0	10000.0
BMX-IN-1	SIK3	100.0	10000.0
WYE-125132	PI42C	100.0	10000.0
Palbociclib	EGFR(L861Q)	78.0	1000.0
ALW-II-38-3	RPS6KA6(Kin.Dom.1)	100.0	10000.0
XMD11-85h	BRSK2	0.0	10000.0
XMD16-144	FRK	18.0	10000.0
Crizotinib	PCTK2	62.0	10000.0
Palbociclib	BMX	100.0	1000.0
Sigma A6730	KIT(V559D,T670I)	100.0	10000.0
BGJ398	SIK1	94.0	1000.0
BGJ398	PIK3CA(M1043I)	76.0	1000.0
TGX221	ALK	100.0	1000.0
5z-7-oxozeaenol	DYRK1B	86.0	10000.0
PLX-4720	FGFR3	71.0	10000.0
ZM-447439	MST1	78.0	10000.0
XMD-12	MLCK	100.0	1000.0
Taselisib	PLK1	97.0	1000.0
Dinaciclib	ABL1(F317I)-phosphorylated	76.0	10000.0
JNK-9L	ABL1(T315I)-phosphorylated	39.0	10000.0
Dinaciclib	LKB1	100.0	10000.0
HG-5-88-01	EPHB4	100.0	10000.0
RO-3306	TYRO3	71.0	10000.0
NVP-TAE684	MLCK	100.0	1000.0
AZD7762	EPHA5	4.8	10000.0
XMD8-92	MAPKAPK2	100.0	10000.0
OTSSP167	NEK4	100.0	10000.0
XMD16-144	PKAC-alpha	100.0	10000.0
Torkinib	IRAK4	44.0	10000.0
Neratinib	MTOR	100.0	10000.0
THZ1	TLK2	61.0	10000.0
SP600125	DMPK	100.0	10000.0
ZG-10	ZAP70	85.0	10000.0
BGJ398	TLK2	100.0	1000.0
TAK-715	PIM2	82.0	10000.0
ERK5-IN-1	RET(V804L)	100.0	1000.0
XMD8-85	AKT2	100.0	10000.0
Dactolisib	TRKA	100.0	1000.0
Dinaciclib	MKNK2	83.0	10000.0
Abemaciclib	DYRK1A	0.0	1000.0
HG-5-88-01	RET(M918T)	100.0	10000.0
GSK461364	MP2K7	80.0	10000.0
A443654	FLT3(K663Q)	3.8	10000.0
CGP60474	EPHB4	100.0	10000.0
Canertinib	INSRR	100.0	1000.0
Vemurafenib	PKNB(M.tuberculosis)	78.0	10000.0
XMD11-50	ICK	90.0	10000.0
AZD-6482	MYLK2	100.0	10000.0
HG-14-10-04	CHK2	0.1	10000.0
Canertinib	FES	100.0	1000.0
PHA-793887	PCTK3	0.5	10000.0
AZD4547	SRPK3	88.0	10000.0
Momelotinib	ICK	100.0	10000.0
XMD-12	ABL2	33.0	1000.0
Momelotinib	IRAK4	64.0	10000.0
CH5424802	MK11	97.0	1000.0
HG-9-91-01	DAPK3	100.0	10000.0
GW843682X	PRP4	20.0	10000.0
ZM-447439	JAK1(JH1domain-catalytic)	100.0	10000.0
CP466722	PTK6	51.0	10000.0
XMD8-85	MARK4	100.0	10000.0
OTSSP167	MK01	100.0	10000.0
AZ-628	ACVRL1	100.0	10000.0
BGJ398	ABL1-nonphosphorylated	55.0	1000.0
WYE-125132	PIK3CG	72.0	10000.0
QL-XI-92	ADCK3	100.0	10000.0
GSK429286A	SIK1	77.0	10000.0
CG-930	EPHB4	100.0	10000.0
WZ4002	CDK9	100.0	10000.0
QL-X-138	RIOK1	53.0	10000.0
JNK-IN-8	CDK2	77.0	1000.0
QL-XI-92	ABL1(Q252H)-phosphorylated	89.0	10000.0
PHA-767491	FLT3(K663Q)	78.0	10000.0
XMD-12	CHK2	81.0	1000.0
RO-3306	DMPK	0.9	10000.0
CP466722	ADCK4	14.0	10000.0
Neratinib	HCK	35.0	10000.0
JNK-IN-5A	RIPK5	100.0	10000.0
WZ-7043	NUAK1	100.0	10000.0
TGX221	DDR1	100.0	1000.0
JNK-IN-11	NEK11	100.0	1000.0
CP466722	CSNK2A2	5.2	10000.0
CGP74514A	CDK2	1.2	10000.0
THZ1	NEK5	1.4	10000.0
BGJ398	STK16	71.0	1000.0
Dactolisib	FRK	100.0	1000.0
Barasertib	ERBB2	13.0	10000.0
Ribociclib	KPCE	79.0	1000.0
Momelotinib	PIK3CA(E542K)	100.0	10000.0
CH5424802	RSK3(Kin.Dom.1-N-terminal)	54.0	1000.0
Palbociclib	EPHB6	100.0	1000.0
ALW-II-49-7	JNK3	100.0	10000.0
Sorafenib	ITK	100.0	10000.0
RO-3306	SRPK3	37.0	10000.0
Momelotinib	FGFR3	86.0	10000.0
A443654	HIPK1	0.1	10000.0
AG1478	CLK2	53.0	10000.0
MPS-1-IN-1	M3K12	100.0	1000.0
THZ1	RIPK5	47.0	10000.0
CP466722	CDK9	76.0	10000.0
Dinaciclib	MK13	69.0	10000.0
GW-5074	PIK4CB	0.5	10000.0
(s)-CR8	ABL1(Q252H)-phosphorylated	89.0	10000.0
Abemaciclib	BUB1	60.0	1000.0
Omipalisib	TYK2(JH2domain-pseudokinase)	68.0	10000.0
PHA-793887	KPCD	23.0	10000.0
XMD16-144	AURKA	0.7	10000.0
ZM-447439	EGFR	0.7	10000.0
KIN001-123	AMPK-alpha1	100.0	1000.0
BMS345541	PKN2	71.0	10000.0
MRT67307	MINK	29.0	10000.0
MLN8054	SLK	80.0	10000.0
GSK429286A	PHKG1	100.0	10000.0
BMS-536924	CSNK2A1	4.8	1000.0
Barasertib	NEK4	40.0	10000.0
Seliciclib	EGFR	85.0	10000.0
Palbociclib	MK12	100.0	1000.0
Ribociclib	SIK1	100.0	1000.0
ZSTK474	MYLK4	100.0	1000.0
CGP74514A	CSNK1G3	0.9	10000.0
(s)-CR8	PIK3CB	87.0	10000.0
OTSSP167	ABL1(Q252H)-phosphorylated	0.9	10000.0
PHA-767491	CDK15	84.0	10000.0
KIN001-111	MK09	100.0	1000.0
BGJ398	CDK9	89.0	1000.0
ALW-II-49-7	MLK3	100.0	10000.0
Sorafenib	ABL1(Q252H)-phosphorylated	39.0	10000.0
BS-181	ADCK4	86.0	10000.0
Momelotinib	NEK4	100.0	10000.0
CGP74514A	CDKL5	100.0	10000.0
WZ4003	LIMK1	100.0	1000.0
R406	SIK1	0.1	1000.0
MRT67307	RSK4(Kin.Dom.1-N-terminal)	0.6	10000.0
ZM-447439	CTK	100.0	10000.0
KIN001-127	VGFR2	100.0	10000.0
Taselisib	RSK1(Kin.Dom.2-C-terminal)	95.0	1000.0
SCH772984	STK39	86.0	1000.0
Pictilisib	LRRK2	100.0	1000.0
Momelotinib	KCC2D	34.0	10000.0
CH5424802	MYLK	7.8	1000.0
TAK-715	EPHA3	69.0	10000.0
Buparlisib	DCAMKL3	100.0	1000.0
AZD4547	KPCD	58.0	10000.0
AZD 5438	MINK	6.9	10000.0
Sorafenib	NEK7	100.0	10000.0
(s)-CR8	PAK7	52.0	10000.0
XMD-12	PIP5K1C	62.0	1000.0
Lapatinib	KIT	88.0	10000.0
BMX-IN-1	KPCI	64.0	10000.0
Barasertib	ULK3	69.0	10000.0
Momelotinib	PIK3CA(H1047Y)	100.0	10000.0
HG-14-8-02	CDK11	72.0	10000.0
KIN001-220	M3K2	31.0	10000.0
TAK-715	PAK6	98.0	10000.0
ZM-447439	CASK	100.0	10000.0
BGJ398	CSNK1D	95.0	1000.0
WYE-125132	M3K13	82.0	10000.0
KU63794	BTK	100.0	10000.0
Sorafenib	EPHA8	3.9	10000.0
BMS345541	HIPK4	41.0	10000.0
A443654	KIT(V559D)	100.0	10000.0
THZ1	MARK3	2.4	10000.0
OTSSP167	CDK3	1.4	10000.0
AZD 5438	KIT(V559D,T670I)	39.0	10000.0
Neratinib	PRKR	100.0	10000.0
CP724714	EGFR(L861Q)	0.4	10000.0
Barasertib	MP2K2	21.0	10000.0
KU63794	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
A443654	MLCK	2.8	10000.0
Torin1	MUSK	100.0	10000.0
Buparlisib	CSF1R	92.0	1000.0
NVP-TAE684	NEK7	3.8	1000.0
CG-930	IRAK3	100.0	10000.0
HG-14-8-02	EGFR(L747-T751del,Sins)	0.3	10000.0
KIN001-111	PIK3CG	100.0	1000.0
Abemaciclib	MAP3K14	74.0	1000.0
CGP60474	DCAMKL2	100.0	10000.0
QL-XII-47	MST1R	100.0	1000.0
PD173074	MAP4K5	100.0	10000.0
BMX-IN-1	PIK3CA(E545A)	17.0	10000.0
WZ-4-145	KPCL	100.0	10000.0
Momelotinib	DRAK1	0.2	10000.0
JNK-9L	NEK2	94.0	10000.0
Seliciclib	TLK1	97.0	10000.0
Sorafenib	EGFR(L858R,T790M)	100.0	10000.0
KIN001-123	LCK	32.0	1000.0
Buparlisib	CDK14	100.0	1000.0
Dabrafenib	OSR1	92.0	10000.0
Ribociclib	DAPK2	100.0	1000.0
Ceritinib	KGP2	74.0	1000.0
ZG-10	BRAF	80.0	10000.0
BMX-IN-1	EPHA6	87.0	10000.0
KIN001-220	SLK	0.2	10000.0
KIN001-123	PCTK2	100.0	1000.0
SB590885	PLK4	83.0	10000.0
WZ-7043	LCK	3.0	10000.0
HG-5-88-01	TTK	7.0	10000.0
SCH772984	HIPK3	59.0	1000.0
SB590885	BMPR2	47.0	10000.0
AZD7762	TYK2(JH1domain-catalytic)	0.0	10000.0
BX-912	TGFBR1	77.0	10000.0
BMS345541	EGFR(L747-E749del,A750P)	100.0	10000.0
KIN001-021	FER	100.0	1000.0
KIN001-021	MLTK	100.0	1000.0
AZ-628	DMPK	90.0	10000.0
Seliciclib	SRPK1	100.0	10000.0
Ibrutinib	ABL1(F317I)-phosphorylated	39.0	1000.0
HG-5-113-01	PIM2	100.0	10000.0
ALW-II-49-7	CSNK1D	100.0	10000.0
WYE-125132	PIK3CB	46.0	10000.0
WZ-7043	AXL	100.0	10000.0
Lapatinib	ZAP70	100.0	10000.0
PLX-4720	CSK	2.7	10000.0
Alpelisib	GSK3B	100.0	1000.0
ZG-10	AXL	80.0	10000.0
WZ3105	CDC2L1	100.0	10000.0
BMS345541	FRK	100.0	10000.0
Torin2	LCK	100.0	10000.0
SB590885	PFCDPK1(P.falciparum)	15.0	10000.0
XMD16-144	EPHB2	100.0	10000.0
PHA-793887	HASP	91.0	10000.0
Canertinib	KC1G2	100.0	1000.0
CGP74514A	YSK4	49.0	10000.0
SP600125	LOK	100.0	10000.0
WZ-7043	ACVR2A	100.0	10000.0
Pictilisib	ALK(C1156Y)	100.0	1000.0
JW-7-24-1	VGFR1	100.0	10000.0
AS-252424	PAK6	80.2	10000.0
PD0325901	EGFR(T790M)	77.0	10000.0
A443654	JAK1(Kin.Dom.2)	100.0	10000.0
CGP60474	ABL1(T315I)	100.0	10000.0
NG25	ACVR1	100.0	10000.0
PHA-793887	TNNI3K	98.0	10000.0
PLX-4720	PIK3CA(H1047L)	100.0	10000.0
ZSTK474	SRMS	100.0	1000.0
WZ-4-145	CSK	100.0	10000.0
Ribociclib	YANK2	100.0	1000.0
KIN001-111	RIPK2	0.6	1000.0
Ceritinib	MK11	88.0	1000.0
SCH772984	BMPR2	99.0	1000.0
CP724714	PIP5K2B	100.0	10000.0
XMD11-50	STK39	39.0	10000.0
Torin2	AURKB	89.0	10000.0
BX-912	ACVR2A	6.4	10000.0
WZ4003	MUSK	100.0	1000.0
WZ-7043	EGFR(G719S)	100.0	10000.0
PLX-4720	TYRO3	100.0	10000.0
KIN001-123	MYO3B	100.0	1000.0
XMD-12	MYO3B	73.0	1000.0
ZM-447439	EGFR(S752-I759del)	14.0	10000.0
PHA-767491	DYRK1B	0.5	10000.0
Ribociclib	TTK	36.0	1000.0
Seliciclib	KKCC1	43.0	10000.0
Omipalisib	INSRR	93.0	10000.0
KIN001-123	FGFR3(G697C)	100.0	1000.0
Ceritinib	TLK1	93.0	1000.0
KIN001-111	TAK1	100.0	1000.0
WZ-4-145	TNNI3K	100.0	10000.0
XMD8-92	PRKR	100.0	10000.0
Dactolisib	EGFR(L747-S752del,P753S)	100.0	1000.0
BMX-IN-1	ABL1(Q252H)-phosphorylated	100.0	10000.0
MLN8054	EPHA8	99.0	10000.0
5z-7-oxozeaenol	EGFR(L747-S752del,P753S)	71.0	10000.0
XMD11-85h	TIE1	100.0	10000.0
NVP-TAE684	MINK	100.0	1000.0
Ceritinib	VRK2	76.0	1000.0
Dinaciclib	RIOK3	58.0	10000.0
R406	LIMK2	9.6	1000.0
Buparlisib	MLCK	93.0	1000.0
QL-X-138	RIPK4	67.0	10000.0
KU63794	CSNK1A1L	97.0	10000.0
WYE-125132	PAK7	100.0	10000.0
Pictilisib	ABL1(H396P)	100.0	10000.0
Dabrafenib	MP2K1	49.0	10000.0
TGX221	ERBB2	100.0	1000.0
Pictilisib	MAK	90.0	1000.0
HG-14-10-04	AKT3	100.0	10000.0
R406	RPS6KA1(Kin.Dom.2)	35.0	1000.0
GW-5074	PCTK2	87.0	10000.0
SCH772984	PHKG1	86.0	1000.0
Dinaciclib	PKAC-beta	83.0	10000.0
KIN001-123	ABL1(M351T)	30.0	1000.0
Palbociclib	CLK4	22.0	1000.0
XMD16-144	INSRR	100.0	10000.0
XMD13-2	ABL1(H396P)-phosphorylated	44.0	10000.0
Torkinib	CDKL1	100.0	10000.0
Momelotinib	MAP4K5	100.0	10000.0
Dabrafenib	DYRK1B	14.0	10000.0
HG-14-8-02	LYN	88.0	10000.0
Dabrafenib	MAP4K4	73.0	10000.0
CH5424802	EPHB3	90.0	1000.0
THZ1	EPHB3	97.0	10000.0
GW843682X	FGFR3	20.0	10000.0
Taselisib	AMPK-alpha2	99.0	1000.0
BI-2536	KGP2	100.0	10000.0
SP600125	PLK3	100.0	10000.0
Sorafenib	FGFR2	14.0	10000.0
Pictilisib	S6K1	93.0	1000.0
CP724714	PCTK2	100.0	10000.0
5z-7-oxozeaenol	MKNK1	100.0	10000.0
QL-XII-47	EGFR(G719C)	64.0	1000.0
Torin1	ABL1(Y253F)-phosphorylated	83.0	10000.0
SB590885	FES	100.0	10000.0
RO-3306	CDK8	45.0	10000.0
AZD4547	ABL1-phosphorylated	2.6	10000.0
ERK5-IN-1	FLT3(N841I)	100.0	1000.0
Palbociclib	ALK(C1156Y)	90.0	1000.0
AS-252424	RSK1(Kin.Dom.1-N-terminal)	81.6	10000.0
JWE-035	PIK3CA(H1047L)	1.8	10000.0
CH5424802	NDR1	100.0	1000.0
WZ4003	DMPK2	100.0	1000.0
HG-9-91-01	RIOK2	66.0	10000.0
XMD13-2	ABL1-phosphorylated	45.0	10000.0
AZ-628	LOK	0.1	10000.0
Barasertib	PIK4CB	100.0	10000.0
GSK461364	JAK3(JH1domain-catalytic)	10.0	10000.0
A443654	CSF1R	100.0	10000.0
GSK1059615	EPHA5	91.0	10000.0
HG-14-8-02	SNRK	100.0	10000.0
CGP60474	MK12	100.0	10000.0
ALW-II-38-3	CDKL2	100.0	10000.0
WZ3105	SgK110	88.0	10000.0
HG-14-8-02	MP2K7	100.0	10000.0
PHA-767491	CDK3	41.0	10000.0
GW-5074	YANK3	98.0	10000.0
AZ-628	EPHA7	84.0	10000.0
ZM-447439	HIPK1	14.0	10000.0
TGX221	FLT3	100.0	1000.0
BMS-536924	CLK4	4.6	1000.0
NVP-TAE684	CSNK1A1L	100.0	1000.0
Sorafenib	CDC2L2	85.0	10000.0
HG-9-91-01	MK12	58.0	10000.0
JNK-IN-5A	CAMK2G	94.0	10000.0
AS-252424	SNARK	89.1	10000.0
NU7441	EPHB4	87.0	10000.0
QL-XI-92	BMPR1A	100.0	10000.0
JWE-035	NIM1	57.0	10000.0
Vemurafenib	MAPKAPK2	100.0	10000.0
JNK-9L	RSK2(Kin.Dom.1-N-terminal)	69.0	10000.0
AZD7762	NEK1	24.0	10000.0
HG-14-8-02	PCTK3	99.0	10000.0
HG-5-88-01	MYO3A	15.0	10000.0
Barasertib	SRMS	29.0	10000.0
PHA-793887	NIM1	100.0	10000.0
KIN001-021	SIK1	100.0	1000.0
Sorafenib	GRK7	100.0	10000.0
AG1478	PKN1	94.0	10000.0
NU7441	EPHB6	100.0	10000.0
Torin2	IRAK1	84.0	10000.0
WZ4002	FLT3(D835H)	4.0	10000.0
HG-5-88-01	EGFR(G719S)	21.0	10000.0
HG-9-91-01	PKN1	47.0	10000.0
Neratinib	EGFR(G719S)	0.0	10000.0
TGX221	RPS6KA6(Kin.Dom.1)	100.0	1000.0
XMD11-85h	PIK3CA(E545A)	100.0	10000.0
Palbociclib	M3K5	100.0	1000.0
AZD 5438	YES	64.0	10000.0
Neratinib	KCC4	100.0	10000.0
KIN001-127	RIPK2	100.0	10000.0
JNK-IN-8	RAF1	93.0	1000.0
HG-5-113-01	KIT(D816V)	4.5	10000.0
PHA-793887	PKMYT1	77.0	10000.0
Canertinib	MLCK	100.0	1000.0
Barasertib	M4K1	76.0	10000.0
HG-6-64-01	MKNK1	68.0	10000.0
PD173074	DCAMKL2	100.0	10000.0
Dactolisib	MP2K3	100.0	1000.0
HG-6-64-01	YANK2	100.0	10000.0
Seliciclib	ITK	100.0	10000.0
BMS-536924	CDK11	100.0	1000.0
TAK-715	ULK2	100.0	10000.0
BS-181	CLK2	2.0	10000.0
ERK5-IN-1	ERK5	0.1	1000.0
XMD13-2	YSK1	76.0	10000.0
ZSTK474	NLK	100.0	1000.0
JNK-9L	PIM3	78.0	10000.0
Taselisib	MYLK	100.0	1000.0
ZG-10	PKMYT1	100.0	10000.0
Alpelisib	M3K13	100.0	1000.0
MRT67307	ERN1	30.0	10000.0
JWE-035	PGFRA	100.0	10000.0
CP466722	FAK2	75.0	10000.0
PHA-793887	PIK3CG	100.0	10000.0
XMD11-85h	ABL1(Y253F)	100.0	10000.0
ALW-II-38-3	PKN1	100.0	10000.0
AZD7762	NEK3	43.0	10000.0
XMD8-92	KIT	100.0	10000.0
Torin2	ZAP70	100.0	10000.0
QL-XI-92	HCK	60.0	10000.0
XMD14-99	VGFR2	97.0	10000.0
JNK-IN-11	MLK1	59.0	1000.0
Palbociclib	MP2K1	93.0	1000.0
AZD7762	BTK	0.2	10000.0
AZD 5438	FGFR3(G697C)	100.0	10000.0
XMD14-99	MAP4K5	78.0	10000.0
Lapatinib	MLK2	84.0	10000.0
XMD11-85h	BRSK1	100.0	10000.0
XMD11-50	STK33	10.0	10000.0
ZG-10	PFPK5(P.falciparum)	100.0	10000.0
GSK461364	MARK1	100.0	10000.0
WZ-7043	MST4	11.0	10000.0
Momelotinib	TRKB	67.0	10000.0
Ibrutinib	CTK	40.0	1000.0
QL-XI-92	BRAF	35.0	10000.0
WZ4003	LCK	100.0	1000.0
AG1478	FAK1	100.0	10000.0
AZD7762	IKKE	3.6	10000.0
XMD11-50	NEK6	76.0	10000.0
CG-930	EGFR(L747-S752del,P753S)	7.4	10000.0
ALW-II-38-3	EPHB6	100.0	10000.0
WZ4003	DCLK1	0.4	1000.0
XMD11-85h	VGFR1	100.0	10000.0
5z-7-oxozeaenol	TYK2(JH2domain-pseudokinase)	100.0	10000.0
ALW-II-38-3	AMPK-alpha2	100.0	10000.0
XMD13-2	MAST1	94.0	10000.0
Buparlisib	CIT	100.0	1000.0
A443654	TRKB	100.0	10000.0
BGJ398	KPCD2	100.0	1000.0
PHA-767491	AKT2	92.0	10000.0
THZ1	ROCK1	35.0	10000.0
NG25	ERK4	100.0	10000.0
R406	LKB1	100.0	1000.0
XMD-12	PIK3CA(E542K)	100.0	1000.0
Momelotinib	NDR1	59.0	10000.0
R406	NEK7	0.8	1000.0
MPS-1-IN-1	YES	100.0	1000.0
Palbociclib	PIK3C3	21.0	1000.0
Dactolisib	PIM2	100.0	1000.0
Seliciclib	EGFR(L747-E749del,A750P)	72.0	10000.0
KIN001-220	AURKB	14.0	10000.0
GSK1059615	EPHA4	96.0	10000.0
QL-XI-92	MUSK	100.0	10000.0
Vemurafenib	PGFRB	0.2	10000.0
ZSTK474	ZAP70	100.0	1000.0
HG-14-10-04	HASP	43.0	10000.0
RO-3306	PCTK3	91.0	10000.0
BMS345541	TIE1	100.0	10000.0
WZ-4-145	ANKK1	100.0	10000.0
(s)-CR8	ZAP70	93.0	10000.0
KIN001-111	VGFR2	100.0	1000.0
BI-2536	PLK4	100.0	10000.0
Vemurafenib	CDK8	4.6	10000.0
Vemurafenib	TIE2	62.0	10000.0
ZM-447439	CDKL5	46.0	10000.0
ALW-II-49-7	VGFR2	100.0	10000.0
Dactolisib	TGFBR2	100.0	1000.0
KIN001-123	AURKA	100.0	1000.0
XMD8-92	PIK3CA	100.0	10000.0
GW-5074	PAK7	87.0	10000.0
AZD4547	ROCK2	82.0	10000.0
AG1478	MAK	100.0	10000.0
CGP74514A	EGFR(G719C)	63.0	10000.0
KIN001-123	RPS6KA1(Kin.Dom.2)	100.0	1000.0
KIN001-111	MYLK2	100.0	1000.0
TAK-715	NEK5	100.0	10000.0
BMX-IN-1	YANK2	100.0	10000.0
ALW-II-38-3	KIT(L576P)	0.0	10000.0
KIN001-127	ADCK3	100.0	10000.0
Sigma A6730	PHKG2	100.0	10000.0
HG-6-64-01	KIT(V559D,T670I)	0.1	10000.0
XMD8-92	MLTK	100.0	10000.0
NU7441	EPHA6	89.0	10000.0
(s)-CR8	EPHA3	73.0	10000.0
Lapatinib	MLK1	91.0	10000.0
HG-6-64-01	MK13	22.0	10000.0
Sorafenib	MP2K5	0.3	10000.0
JW-7-24-1	BMPR2	100.0	10000.0
CP724714	CAMKK2	85.0	10000.0
Dinaciclib	PLK2	100.0	10000.0
HG-5-88-01	EGFR(L747-E749del,A750P)	0.2	10000.0
XMD8-85	ULK3	100.0	10000.0
XMD11-85h	RIOK2	100.0	10000.0
JW-7-24-1	LYN	22.0	10000.0
Palbociclib	CDK11	100.0	1000.0
GSK1059615	LRRK2	62.0	10000.0
WZ4003	KPCD1	10.0	1000.0
BI-D1870	FAK2	2.3	10000.0
GSK429286A	ACVR2B	96.0	10000.0
Torkinib	EGFR(L861Q)	11.0	10000.0
Abemaciclib	MP2K2	83.0	1000.0
JNK-IN-5A	EGFR	65.0	10000.0
RO-3306	MINK	29.0	10000.0
WYE-125132	MERTK	87.0	10000.0
CP724714	RET	87.0	10000.0
Dinaciclib	KGP2	71.0	10000.0
CP724714	SNARK	100.0	10000.0
(s)-CR8	SRC	81.0	10000.0
Barasertib	MARK4	100.0	10000.0
HG-6-64-01	FYN	1.2	10000.0
BMS-536924	CAMK2B	100.0	1000.0
KIN001-123	SRC	9.8	1000.0
QL-XI-92	PRKX	84.0	10000.0
PHA-767491	RET	100.0	10000.0
HG-5-113-01	PCTK3	100.0	10000.0
NPK76-II-72-1	PIK3CA(E545K)	100.0	10000.0
GSK1059615	KIT-autoinhibited	71.0	10000.0
ERK5-IN-1	M4K3	98.0	1000.0
Momelotinib	FER	100.0	10000.0
HG-14-8-02	SIK3	100.0	10000.0
MRT67307	PKN1	0.3	10000.0
Omipalisib	KKCC1	61.0	10000.0
Baricitinib	PFPK5(P.falciparum)	100.0	10000.0
HG-5-113-01	ACVR2B	100.0	10000.0
XMD14-99	TNIK	69.0	10000.0
NU7441	AMPK-alpha2	100.0	10000.0
NPK76-II-72-1	MKNK1	100.0	10000.0
XMD-12	LCK	50.0	1000.0
KIN001-111	ACVR2B	100.0	1000.0
KU63794	CSNK2A1	96.0	10000.0
TAK-715	PIK3CA(I800L)	99.0	10000.0
WZ4002	AMPK-alpha2	100.0	10000.0
NG25	PIK3CB	100.0	10000.0
CGP60474	NLK	100.0	10000.0
Dinaciclib	DAPK3	100.0	10000.0
HG-14-8-02	KIT-autoinhibited	92.0	10000.0
SB590885	MERTK	87.0	10000.0
XMD8-85	TEC	100.0	10000.0
HG-5-113-01	ULK3	3.7	10000.0
Dabrafenib	SRC	4.1	10000.0
Omipalisib	MK14	93.0	10000.0
Sigma A6730	MST1	77.0	10000.0
Palbociclib	KIT(V559D,V654A)	100.0	1000.0
THZ1	PRP4	4.1	10000.0
KIN001-220	EGFR(G719S)	78.0	10000.0
BX-912	ULK2	0.3	10000.0
Buparlisib	PIK3CA(Q546K)	0.7	1000.0
Neratinib	CAMK2B	100.0	10000.0
ERK5-IN-1	RIOK1	100.0	1000.0
XMD16-144	TXK	11.0	10000.0
JNK-IN-5A	CHK2	84.0	10000.0
Vemurafenib	TAOK1	72.0	10000.0
HG-14-10-04	HCK	3.2	10000.0
Alpelisib	MARK4	95.0	1000.0
XMD-12	MET	77.0	1000.0
JNK-IN-5A	PAK1	100.0	10000.0
HG-5-113-01	FGFR1	11.0	10000.0
Abemaciclib	ACVR2B	100.0	1000.0
XMD8-85	GRK4	100.0	10000.0
Vemurafenib	DYRK2	100.0	10000.0
AZD7762	HUNK	68.0	10000.0
NVP-TAE684	ABL1(F317I)	0.5	1000.0
BGJ398	CDK16	76.0	1000.0
SP600125	TTK	1.0	10000.0
AZD4547	KPCD3	82.0	10000.0
MLN8054	EGFR(G719S)	88.0	10000.0
Torkinib	TLK1	75.0	10000.0
Sigma A6730	RAF1	99.0	10000.0
OTSSP167	TESK1	43.0	10000.0
HG-5-88-01	DAPK3	100.0	10000.0
WZ-7043	ADCK4	100.0	10000.0
SB590885	DDR1	43.0	10000.0
XMD11-50	SLK	100.0	10000.0
XMD11-50	PI42C	40.0	10000.0
BI-D1870	TIE2	34.0	10000.0
MPS-1-IN-1	KPCE	100.0	1000.0
JNK-9L	OSR1	96.0	10000.0
XMD8-92	PHKG1	100.0	10000.0
Buparlisib	ABL1-phosphorylated	100.0	1000.0
JW-7-24-1	CSNK2A1	26.0	10000.0
Torin1	PIP5K1C	80.0	10000.0
BMS-536924	JNK3	100.0	1000.0
Dactolisib	VGFR1	100.0	1000.0
KIN001-021	KPCD	100.0	1000.0
Crizotinib	PLK2	73.0	10000.0
Abemaciclib	MK09	21.0	1000.0
ZG-10	DDR2	64.0	10000.0
CGP60474	PIK3CA(E542K)	100.0	10000.0
CP466722	RET(V804L)	54.0	10000.0
AZD7762	MYO3A	4.2	10000.0
BMS345541	TAOK1	66.0	10000.0
Ceritinib	ABL1(E255K)-phosphorylated	70.0	1000.0
Dinaciclib	MST1	98.0	10000.0
MRT67307	SRC	51.0	10000.0
NVP-TAE684	RPS6KA1(Kin.Dom.1)	0.3	1000.0
BMS345541	MAP4K2	92.0	10000.0
QL-X-138	RAF1	100.0	10000.0
XMD8-92	MK09	100.0	10000.0
CGP60474	M3K6	100.0	10000.0
GSK429286A	MST2	63.0	10000.0
SCH772984	CDKL2	76.0	1000.0
Abemaciclib	STK36	80.0	1000.0
Alpelisib	PIK3CG	0.3	1000.0
HG-14-8-02	BRSK1	100.0	10000.0
WYE-125132	DYRK1A	100.0	10000.0
SB590885	CLK1	77.0	10000.0
Baricitinib	KC1G2	21.0	10000.0
Crizotinib	MST1R	0.3	10000.0
KIN001-111	TRKA	100.0	1000.0
CH5424802	TAOK2	93.0	1000.0
QL-X-138	CSNK1D	47.0	10000.0
HG-5-88-01	MAP4K2	100.0	10000.0
Dinaciclib	FES	99.0	10000.0
Taselisib	AKT1	100.0	1000.0
HG-14-10-04	AMPK-alpha1	6.9	10000.0
GW-5074	IKKE	86.0	10000.0
AZ-628	TESK1	100.0	10000.0
HG-6-64-01	NUAK1	100.0	10000.0
BX-912	PAK1	36.0	10000.0
KIN001-127	RIPK1	100.0	10000.0
Ceritinib	PCTK3	88.0	1000.0
Neratinib	ACVRL1	100.0	10000.0
Crizotinib	DCLK1	2.0	10000.0
Canertinib	JNK1	100.0	1000.0
Abemaciclib	CSNK1A1L	100.0	1000.0
Taselisib	JAK1(JH2domain-pseudokinase)	94.0	1000.0
QL-X-138	HUNK	86.0	10000.0
Seliciclib	PIP5K1A	100.0	10000.0
Ribociclib	DAPK1	96.0	1000.0
BMX-IN-1	STK35	100.0	10000.0
Torin1	FLT3(K663Q)	23.0	10000.0
GSK1059615	EPHB1	90.0	10000.0
Ceritinib	ERN1	57.0	1000.0
JNK-9L	BRSK1	85.0	10000.0
Ibrutinib	PHKG2	84.0	1000.0
KIN001-111	AURKB	0.8	1000.0
KIN001-127	LOK	13.0	10000.0
SP600125	PAK7	100.0	10000.0
Seliciclib	WEE2	100.0	10000.0
BMS-536924	RPS6KA2(Kin.Dom.2)	100.0	1000.0
Buparlisib	PGFRB	100.0	1000.0
Barasertib	HIPK4	4.5	10000.0
ZM-447439	ITK	100.0	10000.0
ZM-447439	MAP3K3	18.0	10000.0
AZD7762	MRCKB	74.0	10000.0
MRT67307	CDC2L1	100.0	10000.0
NPK76-II-72-1	MP2K1	100.0	10000.0
MPS-1-IN-1	PRKX	100.0	1000.0
Barasertib	MYLK4	89.0	10000.0
XMD14-99	MAP3K1	100.0	10000.0
JNK-9L	EPHB4	70.0	10000.0
Sorafenib	TAOK2	1.6	10000.0
GW843682X	PHKG2	100.0	10000.0
WZ4003	CAMK2B	100.0	1000.0
Ibrutinib	SRC	4.0	1000.0
Barasertib	PIK3CA(E545A)	31.0	10000.0
XMD-12	BMPR2	78.0	1000.0
XMD13-2	TAOK3	33.0	10000.0
MPS-1-IN-1	ADCK4	100.0	1000.0
BMX-IN-1	MP2K2	66.0	10000.0
XMD13-2	YSK4	5.9	10000.0
Vemurafenib	MLK1	52.0	10000.0
Barasertib	JAK1(JH1domain-catalytic)	100.0	10000.0
AZ-628	KPCT	98.0	10000.0
ZM-447439	CSNK1G3	100.0	10000.0
CGP74514A	INSRR	62.0	10000.0
WZ-4-145	MK14	100.0	10000.0
Baricitinib	BLK	12.0	10000.0
Taselisib	ERK3	100.0	1000.0
AZD4547	EPHB2	90.0	10000.0
Ibrutinib	IKKB	72.0	1000.0
BMS-536924	RPS6KA1(Kin.Dom.2)	21.0	1000.0
ALW-II-49-7	TYK2(Kin.Dom.2)	100.0	10000.0
5z-7-oxozeaenol	ERBB2	100.0	10000.0
XMD11-85h	ULK2	100.0	10000.0
NU7441	DAPK3	92.0	10000.0
HG-9-91-01	EGFR	0.4	10000.0
PD0325901	FLT4	94.0	10000.0
BMS345541	EPHA6	100.0	10000.0
THZ1	NEK6	0.1	10000.0
BI-2536	BIKE	100.0	10000.0
QL-XII-47	MAPKAPK2	100.0	1000.0
XMD16-144	BIKE	12.0	10000.0
BMS-536924	TAOK3	100.0	1000.0
BMX-IN-1	KPCD2	82.0	10000.0
JNK-IN-5A	HIPK2	100.0	10000.0
AZ-628	ABL1(T315I)-nonphosphorylated	49.0	10000.0
JNK-IN-11	CDK14	100.0	1000.0
GSK461364	CDK9	93.0	10000.0
MRT67307	MLK1	0.5	10000.0
ALW-II-38-3	MRCKA	100.0	10000.0
PLX-4720	RIOK3	100.0	10000.0
Seliciclib	GRK4	99.0	10000.0
WZ4003	MYLK4	23.0	1000.0
Canertinib	TRKC	100.0	1000.0
XMD8-85	FGFR3	100.0	10000.0
Barasertib	MARK3	88.0	10000.0
ALW-II-49-7	DRAK2	100.0	10000.0
Buparlisib	EPHA6	86.0	1000.0
GSK1059615	TAOK2	50.0	10000.0
MRT67307	ERK4	100.0	10000.0
AZ-628	FLT3(D835Y)	100.0	10000.0
Lapatinib	CAMK1D	96.0	10000.0
WZ3105	EPHB2	87.0	10000.0
Ribociclib	DCAMKL3	97.0	1000.0
HG-5-88-01	MLK1	100.0	10000.0
SP600125	MK14	100.0	10000.0
CP724714	PIK3C2B	88.0	10000.0
PHA-767491	PIK3CA(C420R)	94.0	10000.0
A443654	M3K12	100.0	10000.0
Lapatinib	SIK2	77.0	10000.0
BMX-IN-1	MRCKB	100.0	10000.0
TGX221	BLK	100.0	1000.0
Torkinib	AXL	21.0	10000.0
XMD-12	DCAMKL3	68.0	1000.0
CP724714	MAP4K2	100.0	10000.0
AZD 5438	ABL1(E255K)-phosphorylated	6.3	10000.0
R406	M3K12	100.0	1000.0
Baricitinib	EPHA7	75.0	10000.0
TGX221	MP2K4	100.0	1000.0
(s)-CR8	PLK2	99.0	10000.0
Abemaciclib	EPHB2	100.0	1000.0
XMD11-50	GRK4	86.0	10000.0
KIN001-220	LRRK2	73.0	10000.0
XMD-12	CSNK1G3	67.0	1000.0
JNK-IN-8	ERK5	100.0	1000.0
JWE-035	PFCDPK1(P.falciparum)	74.0	10000.0
BS-181	LIMK2	100.0	10000.0
KIN001-220	BMPR1B	3.3	10000.0
NG25	JAK2(Kin.Dom.2)	11.0	10000.0
JNK-IN-11	MAP3K1	96.0	1000.0
MPS-1-IN-1	INSR	0.2	1000.0
HG-14-10-04	PAK4	0.9	10000.0
AG1478	YANK1	63.0	10000.0
Abemaciclib	SGK1	0.8	1000.0
CH5424802	BMPR2	95.0	1000.0
WZ4003	MST1	100.0	1000.0
MPS-1-IN-1	DRAK1	100.0	1000.0
WZ4003	LOK	100.0	1000.0
Palbociclib	PKMYT1	100.0	1000.0
WZ4002	FLT3(D835Y)	0.8	10000.0
ZSTK474	RPS6KA1(Kin.Dom.1)	100.0	1000.0
NPK76-II-72-1	STK33	3.6	10000.0
QL-XII-47	SRPK3	95.0	1000.0
Sigma A6730	MARK3	72.0	10000.0
BX-912	HIPK2	1.6	10000.0
SCH772984	AMPK-alpha1	100.0	1000.0
MLN8054	LTK	62.0	10000.0
AG1478	NDR1	61.0	10000.0
Neratinib	LKB1	94.0	10000.0
Buparlisib	M3K6	100.0	1000.0
BS-181	EPHA2	96.0	10000.0
WZ-7043	PKN2	100.0	10000.0
OTSSP167	PKAC-beta	1.7	10000.0
GW843682X	TAOK2	100.0	10000.0
CP724714	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
JNK-IN-11	SgK110	100.0	1000.0
Dabrafenib	MAP3K15	98.0	10000.0
Pictilisib	PKAC-alpha	93.0	1000.0
JNK-IN-5A	IGF1R	76.0	10000.0
Vemurafenib	EGFR(L858R,T790M)	100.0	10000.0
KIN001-220	PIP5K2B	1.6	10000.0
AZD 5438	ADCK4	42.0	10000.0
HG-14-10-04	MRCKA	100.0	10000.0
QL-XII-47	ACVR2A	81.0	1000.0
HG-6-64-01	MAP3K4	66.0	10000.0
BS-181	EPHA8	89.0	10000.0
Baricitinib	TYK2(JH1domain-catalytic)	0.2	10000.0
KU63794	SRPK1	100.0	10000.0
Torin2	FGR	100.0	10000.0
TAK-715	RIOK1	100.0	10000.0
BMS-536924	PGFRA	18.0	1000.0
QL-XI-92	MET(M1250T)	86.0	10000.0
XMD-12	FGFR3(G697C)	81.0	1000.0
XMD16-144	AKT3	100.0	10000.0
Palbociclib	CTK	100.0	1000.0
JNK-IN-11	ERK5	100.0	1000.0
Buparlisib	CDK9	91.0	1000.0
WZ-4-145	DRAK2	100.0	10000.0
Dabrafenib	MERTK	67.0	10000.0
Lapatinib	MTOR	100.0	10000.0
NVP-TAE684	NEK6	1.8	1000.0
Momelotinib	JNK3	2.4	10000.0
Taselisib	NEK2	94.0	1000.0
GW-5074	ABL1(Y253F)-phosphorylated	81.0	10000.0
Lapatinib	YSK4	100.0	10000.0
AZD-6482	TRKB	80.0	10000.0
Sigma A6730	ABL1(T315I)-phosphorylated	67.0	10000.0
Baricitinib	EGFR(T790M)	68.0	10000.0
BI-2536	CSK	100.0	10000.0
CP724714	CSNK1E	100.0	10000.0
MLN8054	EPHA5	1.5	10000.0
WZ-7043	KIT(V559D)	6.1	10000.0
RO-3306	CDKL3	73.0	10000.0
QL-XII-47	TRKB	97.0	1000.0
XMD11-85h	BMPR1A	100.0	10000.0
Taselisib	PIK3CA(E545A)	0.0	1000.0
MPS-1-IN-1	MP2K1	100.0	1000.0
CGP60474	CAMK1	100.0	10000.0
THZ1	PIK3CG	45.0	10000.0
BGJ398	PIK3CB	91.0	1000.0
ALW-II-49-7	MRCKA	100.0	10000.0
XMD16-144	MST1	49.0	10000.0
NG25	SIK2	100.0	10000.0
XMD16-144	PIP5K1A	9.9	10000.0
PD173074	CAMK1	100.0	10000.0
PD173074	PIM3	100.0	10000.0
QL-XII-47	MAPKAPK5	98.0	1000.0
HG-14-10-04	EPHA8	100.0	10000.0
Abemaciclib	MST4	98.0	1000.0
Buparlisib	EIF2AK1	95.0	1000.0
ALW-II-38-3	MARK2	100.0	10000.0
PHA-767491	PRKR	92.0	10000.0
XMD16-144	TAOK2	0.0	10000.0
SP600125	MLCK	100.0	10000.0
SP600125	RIPK4	2.2	10000.0
KIN001-111	MST3	4.8	1000.0
XMD8-85	NEK6	100.0	10000.0
XMD11-85h	YSK4	100.0	10000.0
ZSTK474	JAK1(Kin.Dom.2)	100.0	1000.0
Torin2	PFCDPK1(P.falciparum)	52.0	10000.0
PLX-4720	CDC2L1	99.0	10000.0
KIN001-021	SgK110	100.0	1000.0
Sigma A6730	ERBB4	66.0	10000.0
XMD-12	PAK3	37.0	1000.0
Seliciclib	BLK	100.0	10000.0
GW-5074	ERK5	5.0	10000.0
Baricitinib	PKN1	2.4	10000.0
CP724714	EPHA5	100.0	10000.0
KIN001-220	MK01	100.0	10000.0
CGP74514A	MYLK	26.0	10000.0
NG25	CHEK1	100.0	10000.0
TAK-715	NEK1	90.0	10000.0
NPK76-II-72-1	FRK	100.0	10000.0
CG-930	DMPK	100.0	10000.0
XMD13-2	MYLK4	42.0	10000.0
Seliciclib	TAOK1	99.0	10000.0
Alpelisib	HASP	90.0	1000.0
Dinaciclib	RPS6KA5(Kin.Dom.2-C-terminal)	91.0	10000.0
GW-5074	SNARK	75.0	10000.0
Ibrutinib	MK01	90.0	1000.0
QL-XI-92	KIT(V559D,T670I)	77.0	10000.0
KU63794	RIOK1	51.0	10000.0
Ceritinib	MP2K5	89.0	1000.0
GSK1059615	TTK	19.0	10000.0
SCH772984	MLK1	100.0	1000.0
BMS345541	INSRR	100.0	10000.0
Alpelisib	CDC2L2	100.0	1000.0
Abemaciclib	FGFR3(G697C)	100.0	1000.0
NU7441	MYO3A	89.0	10000.0
JNK-9L	AAK1	5.4	10000.0
HG-6-64-01	FLT3(K663Q)	0.1	10000.0
Dactolisib	EPHB6	100.0	1000.0
Torin2	RIOK2	70.0	10000.0
A443654	KPCD	0.9	10000.0
ALW-II-49-7	KPCD	100.0	10000.0
QL-XI-92	FGFR2	99.0	10000.0
Sigma A6730	ABL1(F317I)-phosphorylated	91.0	10000.0
Ibrutinib	CDK5	90.0	1000.0
HG-5-88-01	BMPR1A	100.0	10000.0
Momelotinib	MP2K5	100.0	10000.0
Sigma A6730	PGFRA	83.0	10000.0
Buparlisib	CDKL1	88.0	1000.0
XMD8-92	CSNK1D	100.0	10000.0
GSK1059615	ABL1(F317I)-phosphorylated	79.0	10000.0
MLN8054	MKNK1	100.0	10000.0
JNK-IN-5A	PHKG2	83.0	10000.0
AZ-628	FRK	2.8	10000.0
XMD11-50	RPS6KA4(Kin.Dom.2-C-terminal)	46.0	10000.0
GSK1059615	FES	100.0	10000.0
R406	PLK4	1.5	1000.0
BMX-IN-1	GCN2(Kin.Dom.2,S808G)	84.0	10000.0
CH5424802	CAMKK2	3.8	1000.0
MRT67307	KC1G2	69.0	10000.0
5z-7-oxozeaenol	ERK8	13.0	10000.0
Torin2	NEK2	100.0	10000.0
MPS-1-IN-1	JAK1(Kin.Dom.1)	100.0	1000.0
BMS345541	ROS1	77.0	10000.0
XMD11-50	MAPKAPK5	97.0	10000.0
Abemaciclib	NUAK1	99.0	1000.0
MPS-1-IN-1	KPCT	100.0	1000.0
ZG-10	KIT(V559D)	0.5	10000.0
BX-912	SIK1	0.4	10000.0
WZ-7043	DRAK2	100.0	10000.0
CH5424802	MARK3	99.0	1000.0
RO-3306	PKN2	9.9	10000.0
PLX-4720	CDK5	57.0	10000.0
NG25	PKN2	100.0	10000.0
HG-6-64-01	FGFR4	0.5	10000.0
MLN8054	NDR1	100.0	10000.0
A443654	RPS6KA3(Kin.Dom.1)	100.0	10000.0
KIN001-111	DDR2	100.0	1000.0
MLN8054	KKCC1	89.0	10000.0
SB590885	FLT3(R834Q)	100.0	10000.0
QL-XII-47	KGP2	87.0	1000.0
WZ3105	TEC	100.0	10000.0
NVP-TAE684	MST1	4.1	1000.0
Seliciclib	TAOK2	93.0	10000.0
XMD11-50	FES	84.0	10000.0
KIN001-111	PGFRB	0.1	1000.0
BI-2536	AXL	100.0	10000.0
SP600125	ABL1(Q252H)	100.0	10000.0
Canertinib	RIPK1	100.0	1000.0
XMD-12	DAPK1	98.0	1000.0
NPK76-II-72-1	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
HG-14-10-04	CASK	95.0	10000.0
AZD-6482	KIT(V559D,T670I)	91.0	10000.0
ALW-II-38-3	MK12	100.0	10000.0
HG-6-64-01	BMPR2	14.0	10000.0
Abemaciclib	MP2K5	96.0	1000.0
OTSSP167	FLT3(D835Y)	1.6	10000.0
KIN001-111	MARK2	100.0	1000.0
SCH772984	MAPKAPK5	96.0	1000.0
Pictilisib	ACVRL1	100.0	1000.0
XMD13-2	RET(V804M)	84.0	10000.0
XMD13-2	TRKC	44.0	10000.0
AZ-628	SNRK	100.0	10000.0
ZM-447439	M3K2	28.0	10000.0
TAK-715	BTK	94.0	10000.0
Dactolisib	MRCKB	100.0	1000.0
XMD16-144	ABL1(Q252H)-nonphosphorylated	0.2	10000.0
BS-181	MRCKB	100.0	10000.0
RO-3306	MP2K3	20.0	10000.0
HG-5-88-01	SRPK3	100.0	10000.0
JW-7-24-1	FGR	21.0	10000.0
BI-D1870	LOK	4.6	10000.0
TAK-715	PLK2	100.0	10000.0
GSK1059615	MK03	100.0	10000.0
PHA-793887	ERK4	60.0	10000.0
BS-181	ERN1	92.0	10000.0
BX-912	FGFR3(G697C)	0.8	10000.0
BI-D1870	FGR	27.0	10000.0
BMX-IN-1	BMPR1B	80.0	10000.0
PD0325901	RET(V804L)	93.0	10000.0
Torkinib	NDR2	63.0	10000.0
SCH772984	EGFR(E746-A750del)	100.0	1000.0
BX-912	ERBB3	41.0	10000.0
TAK-715	ERK4	90.0	10000.0
BGJ398	CSF1R	0.2	1000.0
BMS-536924	EGFR(L747-E749del,A750P)	10.0	1000.0
Sigma A6730	AMPK-alpha2	95.0	10000.0
QL-X-138	RSK3(Kin.Dom.1-N-terminal)	72.0	10000.0
Canertinib	MKNK2	100.0	1000.0
XMD14-99	NDR1	100.0	10000.0
KIN001-220	DCLK1	74.0	10000.0
HG-6-64-01	IKKA	0.0	10000.0
CGP74514A	PFCDPK1(P.falciparum)	1.6	10000.0
ZSTK474	MKNK2	100.0	1000.0
Ceritinib	PTK6	39.0	1000.0
Dabrafenib	HCK	2.8	10000.0
PLX-4720	CASK	51.0	10000.0
MRT67307	CSNK2A1	38.0	10000.0
Dabrafenib	IRAK1	52.0	10000.0
Omipalisib	YANK2	100.0	10000.0
AZD7762	IRAK4	0.0	10000.0
XMD14-99	CLK2	13.0	10000.0
MLN8054	CDC2L5	100.0	10000.0
THZ1	EGFR(G719C)	53.0	10000.0
AZD 5438	GRK7	29.0	10000.0
R406	FER	1.7	1000.0
QL-X-138	CSNK2A1	4.6	10000.0
BI-D1870	PGFRB	5.9	10000.0
ZM-447439	CSNK1A1	63.0	10000.0
ZSTK474	PIK3CA	0.5	1000.0
Palbociclib	EPHA1	97.0	1000.0
MRT67307	ITK	18.0	10000.0
BMS-536924	ADCK3	100.0	1000.0
GSK461364	MELK	49.0	10000.0
SB590885	CDK7	93.0	10000.0
XMD-12	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	1000.0
BI-D1870	SNARK	10.0	10000.0
Dactolisib	LOK	100.0	1000.0
KIN001-111	PKN2	24.0	1000.0
Sigma A6730	CDKL1	84.0	10000.0
ZM-447439	TESK1	59.0	10000.0
RO-3306	CSNK1E	36.0	10000.0
GSK429286A	JNK3	88.0	10000.0
RO-3306	M3K6	80.0	10000.0
CH5424802	CDK8	97.0	1000.0
KIN001-127	PCTK2	100.0	10000.0
QL-X-138	MAP4K4	60.0	10000.0
JWE-035	HIPK3	76.0	10000.0
PLX-4720	HIPK2	20.0	10000.0
Sorafenib	ULK2	89.0	10000.0
BMS345541	ERK5	0.7	10000.0
XMD16-144	PHKG1	69.0	10000.0
WZ-7043	OSR1	100.0	10000.0
Sorafenib	MAP4K4	18.0	10000.0
TAK-715	YES	5.6	10000.0
BGJ398	ULK3	87.0	1000.0
KIN001-021	PAK6	100.0	1000.0
KIN001-220	EGFR(E746-A750del)	48.0	10000.0
SB590885	DMPK2	32.0	10000.0
NPK76-II-72-1	RIPK2	100.0	10000.0
BMS-536924	DCAMKL2	100.0	1000.0
GSK1059615	PHKG2	6.0	10000.0
CGP60474	M3K2	100.0	10000.0
Lapatinib	ABL1(E255K)-phosphorylated	100.0	10000.0
KIN001-127	TLK2	100.0	10000.0
Ribociclib	EGFR(L747-T751del,Sins)	100.0	1000.0
Pictilisib	KIT(V559D,T670I)	99.0	1000.0
QL-XII-47	EPHB1	100.0	1000.0
BGJ398	MARK4	82.0	1000.0
JWE-035	CDKL3	100.0	10000.0
WZ-4-145	SRPK3	100.0	10000.0
Torkinib	FRK	12.0	10000.0
Lapatinib	MELK	100.0	10000.0
JNK-IN-5A	EGFR(L861Q)	86.0	10000.0
Neratinib	CLK2	100.0	10000.0
KIN001-220	PIK3C2B	93.0	10000.0
CP466722	LYN	48.0	10000.0
ALW-II-38-3	DAPK2	100.0	10000.0
Momelotinib	MAPKAPK2	100.0	10000.0
RO-3306	MP2K4	70.0	10000.0
SCH772984	DDR1	100.0	1000.0
WH-4-023	ABL1(T315I)-phosphorylated	0.8	10000.0
Barasertib	HCK	31.0	10000.0
BGJ398	RET(V804M)	82.0	1000.0
Lapatinib	PFPK5(P.falciparum)	100.0	10000.0
HG-5-88-01	LKB1	100.0	10000.0
XMD11-50	PKN1	100.0	10000.0
ALW-II-38-3	NIM1	100.0	10000.0
NVP-TAE684	PHKG1	0.1	1000.0
Dinaciclib	DMPK2	100.0	10000.0
THZ1	CDC2L5	1.2	10000.0
KIN001-127	YANK3	100.0	10000.0
Ribociclib	FGFR1	100.0	1000.0
Omipalisib	FES	96.0	10000.0
TAK-715	DYRK1B	90.0	10000.0
ALW-II-38-3	MYLK4	100.0	10000.0
JWE-035	TAK1	17.0	10000.0
Vemurafenib	PIM3	100.0	10000.0
ZG-10	CDKL1	41.0	10000.0
GSK461364	KIT(A829P)	29.0	10000.0
AG1478	RSK3(Kin.Dom.2-C-terminal)	90.0	10000.0
QL-X-138	ERBB3	94.0	10000.0
MRT67307	KGP1	100.0	10000.0
AZD 5438	CDK15	5.2	10000.0
Abemaciclib	FGFR3	100.0	1000.0
CG-930	CDK8	100.0	10000.0
NVP-TAE684	PIM3	100.0	1000.0
GSK1059615	MK14	100.0	10000.0
Ribociclib	JNK1	100.0	1000.0
WZ-7043	SYK	100.0	10000.0
HG-9-91-01	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
Buparlisib	KPCL	95.0	1000.0
GW-5074	ACVR1	31.0	10000.0
Palbociclib	RSK2(Kin.Dom.2-C-terminal)	86.0	1000.0
ALW-II-49-7	PLK3	100.0	10000.0
XMD11-85h	EPHA8	100.0	10000.0
AZ-628	SIK3	100.0	10000.0
Alpelisib	IKKE	100.0	1000.0
PHA-767491	KGP1	2.2	10000.0
PHA-793887	BTK	97.0	10000.0
Palbociclib	RIPK1	100.0	1000.0
Ceritinib	ZAP70	98.0	1000.0
OTSSP167	CHEK1	37.0	10000.0
JW-7-24-1	CHK2	100.0	10000.0
BMS345541	FGFR3	99.0	10000.0
XMD8-85	CLK1	100.0	10000.0
NU7441	M3K13	100.0	10000.0
HG-14-8-02	MP2K3	94.0	10000.0
WH-4-023	TYRO3	18.0	10000.0
CH5424802	KGP2	94.0	1000.0
Sorafenib	ABL1(Y253F)-phosphorylated	22.0	10000.0
KIN001-220	CDK16	40.0	10000.0
CGP60474	ACVR2B	100.0	10000.0
Sigma A6730	MERTK	95.0	10000.0
XMD-12	CLK2	100.0	1000.0
Ceritinib	LIMK2	88.0	1000.0
Dabrafenib	CDKL5	0.3	10000.0
PHA-767491	MAP4K5	82.0	10000.0
PHA-793887	PGFRA	100.0	10000.0
NU7441	SGK3	100.0	10000.0
AZD-6482	PHKG1	93.0	10000.0
PD173074	MST1	100.0	10000.0
AZD7762	NEK11	100.0	10000.0
KIN001-123	TNNI3K	100.0	1000.0
Torkinib	MK01	100.0	10000.0
XMD14-99	FYN	89.0	10000.0
PLX-4720	ERBB3	28.0	10000.0
WZ-7043	MERTK	100.0	10000.0
XMD11-50	CSNK1G3	93.0	10000.0
KU63794	NUAK1	76.0	10000.0
HG-14-8-02	YSK1	98.0	10000.0
GSK1059615	EPHA6	83.0	10000.0
ZM-447439	ABL1(Q252H)-nonphosphorylated	1.8	10000.0
Taselisib	EPHA8	100.0	1000.0
MPS-1-IN-1	LYN	100.0	1000.0
Canertinib	ERBB2	9.6	1000.0
HG-5-113-01	MARK3	13.0	10000.0
QL-XII-47	FLT3(R834Q)	99.0	1000.0
Crizotinib	EPHA4	6.0	10000.0
HG-14-10-04	ERBB2	0.0	10000.0
AZD7762	NEK7	72.0	10000.0
MRT67307	ERK8	17.0	10000.0
GSK461364	AKT1	100.0	10000.0
HG-9-91-01	CSNK1G3	76.0	10000.0
GSK461364	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
CP466722	FYN	25.0	10000.0
CG-930	MAP3K1	91.0	10000.0
QL-XI-92	EPHA3	9.8	10000.0
AZD 5438	TAK1	1.6	10000.0
GW843682X	PIK3CA(M1043I)	85.0	10000.0
PHA-793887	RIOK1	57.0	10000.0
AG1478	CAMK2B	95.0	10000.0
XMD13-2	PRKR	85.0	10000.0
Sigma A6730	CSNK1A1	50.0	10000.0
Canertinib	VGFR2	100.0	1000.0
JNK-IN-11	MET(M1250T)	70.0	1000.0
CG-930	CTK	95.0	10000.0
MLN8054	PRKX	75.0	10000.0
ERK5-IN-1	EPHB4	100.0	1000.0
SCH772984	CLK1	13.0	1000.0
CGP60474	FLT3(N841I)	100.0	10000.0
Ribociclib	YSK4	100.0	1000.0
AG1478	MET	62.0	10000.0
WZ4002	AXL	100.0	10000.0
PHA-767491	MP2K6	72.0	10000.0
JNK-9L	KIT(V559D,T670I)	4.2	10000.0
XMD-12	CSNK2A2	58.0	1000.0
KIN001-220	PTK6	16.0	10000.0
JNK-IN-8	ACVR1B	88.0	1000.0
Omipalisib	ERN1	95.0	10000.0
HG-6-64-01	KPCD1	3.5	10000.0
Ceritinib	MK03	21.0	1000.0
TAK-715	ALK	35.0	10000.0
AS-252424	JNK1	100.0	10000.0
BI-2536	MARK3	100.0	10000.0
CH5424802	CDK16	100.0	1000.0
Palbociclib	DYRK2	89.0	1000.0
SB590885	PRP4	84.0	10000.0
XMD11-85h	KPCD2	100.0	10000.0
WYE-125132	FLT3(D835Y)	99.0	10000.0
AZD 5438	MYLK4	6.7	10000.0
HG-14-10-04	ERK5	8.0	10000.0
SCH772984	TNK2	100.0	1000.0
Alpelisib	ERBB4	100.0	1000.0
AZD4547	MLCK	3.9	10000.0
QL-XI-92	PIK3CA(Q546K)	78.0	10000.0
SCH772984	CAMK2G	85.0	1000.0
Omipalisib	PCTK2	94.0	10000.0
Buparlisib	PI42C	79.0	1000.0
NG25	PRKR	100.0	10000.0
Alpelisib	CTK	100.0	1000.0
GW843682X	CDK2	73.0	10000.0
JWE-035	MP2K2	89.0	10000.0
QL-X-138	CDK7	3.8	10000.0
Ibrutinib	STK35	50.0	1000.0
Sigma A6730	SRC	81.0	10000.0
GSK461364	CDK3	100.0	10000.0
Barasertib	PAK6	98.0	10000.0
Canertinib	PIM3	100.0	1000.0
AZD4547	MP2K7	98.0	10000.0
XMD13-2	PLK2	88.0	10000.0
KU63794	FLT3(ITD)	100.0	10000.0
Crizotinib	YSK1	65.0	10000.0
Dabrafenib	ACVRL1	35.0	10000.0
GSK429286A	BMPR1A	97.0	10000.0
Torin2	AMPK-alpha2	95.0	10000.0
CGP60474	TESK1	100.0	10000.0
ZG-10	MYO3B	100.0	10000.0
ZM-447439	EGFR(L747-S752del,P753S)	41.0	10000.0
THZ1	VGFR1	0.2	10000.0
BS-181	STK36	77.0	10000.0
Lapatinib	KGP2	90.0	10000.0
XMD16-144	CSNK1E	75.0	10000.0
WZ4002	LIMK1	100.0	10000.0
WZ3105	CSF1R	52.0	10000.0
QL-XII-47	RAF1	89.0	1000.0
WYE-125132	ERK3	85.0	10000.0
Alpelisib	KPCI	100.0	1000.0
ALW-II-49-7	RET(V804M)	100.0	10000.0
BGJ398	IGF1R	68.0	1000.0
KU63794	CDK8	100.0	10000.0
BMS-536924	LIMK1	100.0	1000.0
JNK-9L	MLK2	72.0	10000.0
SB590885	BRAF(V600E)	0.0	10000.0
QL-X-138	ULK3	97.0	10000.0
QL-XI-92	CDKL2	100.0	10000.0
BI-2536	EPHB4	100.0	10000.0
BGJ398	CDK4-cyclinD3	45.0	1000.0
SB590885	PIK3CA(H1047Y)	88.0	10000.0
Neratinib	CLK1	84.0	10000.0
Ribociclib	TAOK3	100.0	1000.0
Alpelisib	CSF1R-autoinhibited	86.0	1000.0
CP466722	SGK3	74.0	10000.0
CGP74514A	BRSK1	91.0	10000.0
GW-5074	CLK2	15.0	10000.0
Torin1	NEK2	90.0	10000.0
AZD4547	CAMKK2	2.6	10000.0
TAK-715	ACVR1	9.6	10000.0
Abemaciclib	MAP3K4	89.0	1000.0
HG-14-8-02	CTK	100.0	10000.0
GW-5074	MLTK	84.0	10000.0
CGP74514A	DAPK1	12.0	10000.0
XMD8-85	MP2K1	100.0	10000.0
Buparlisib	MYLK4	100.0	1000.0
AZD-6482	LRRK2(G2019S)	100.0	10000.0
ERK5-IN-1	NDR1	100.0	1000.0
HG-14-10-04	CDK5	77.0	10000.0
NU7441	M4K3	76.0	10000.0
WZ-4-145	DYRK1B	100.0	10000.0
Torin2	M4K1	100.0	10000.0
PHA-793887	CDKL1	13.0	10000.0
NPK76-II-72-1	TAOK1	100.0	10000.0
XMD11-85h	ERK8	100.0	10000.0
GSK1059615	AMPK-alpha2	93.0	10000.0
MPS-1-IN-1	MLTK	100.0	1000.0
OTSSP167	ACVRL1	38.0	10000.0
Torin2	RSK1(Kin.Dom.2-C-terminal)	100.0	10000.0
QL-XII-47	CHEK1	100.0	1000.0
GSK461364	EGFR(L861Q)	100.0	10000.0
GW-5074	DYRK2	54.0	10000.0
KIN001-111	FGFR3	100.0	1000.0
Omipalisib	SRC	74.0	10000.0
XMD14-99	MLCK	100.0	10000.0
NG25	EPHA4	5.8	10000.0
NG25	YSK1	100.0	10000.0
GW-5074	M3K5	100.0	10000.0
ZSTK474	NUAK1	100.0	1000.0
WZ-7043	KIT(D816V)	100.0	10000.0
A443654	TESK1	100.0	10000.0
NPK76-II-72-1	NLK	100.0	10000.0
A443654	MARK2	13.0	10000.0
HG-14-8-02	EGFR(L747-E749del,A750P)	0.2	10000.0
CH5424802	FER	3.1	1000.0
Ceritinib	GSK3A	87.0	1000.0
Neratinib	TGFBR2	100.0	10000.0
HG-5-88-01	RPS6KA2(Kin.Dom.1)	100.0	10000.0
XMD8-92	CHEK1	100.0	10000.0
PD173074	FGFR3(G697C)	3.7	10000.0
Ibrutinib	PLK4	44.0	1000.0
HG-9-91-01	FLT3(D835Y)	62.0	10000.0
CG-930	EGFR(E746-A750del)	14.0	10000.0
JNK-9L	MLTK	17.0	10000.0
BGJ398	DMPK	100.0	1000.0
HG-5-88-01	TSSK1	100.0	10000.0
A443654	RIOK3	2.7	10000.0
AZD4547	M3K13	53.0	10000.0
CG-930	AURKB	100.0	10000.0
TGX221	MK14	100.0	1000.0
PHA-793887	BIKE	95.0	10000.0
5z-7-oxozeaenol	PIK3CA(Q546K)	96.0	10000.0
ZM-447439	BRSK1	79.0	10000.0
CP724714	ULK2	100.0	10000.0
Alpelisib	OSR1	100.0	1000.0
KIN001-111	GAK	100.0	1000.0
Torin1	CSNK1D	4.3	10000.0
TAK-715	HIPK3	100.0	10000.0
KU63794	TAOK3	90.0	10000.0
Pictilisib	MLTK	100.0	1000.0
Alpelisib	PKN2	91.0	1000.0
Buparlisib	MAP4K4	76.0	1000.0
R406	MAP4K4	100.0	1000.0
NG25	ABL1(F317I)	0.1	10000.0
Baricitinib	ALK(L1196M)	24.0	10000.0
GSK1059615	CDK5	82.0	10000.0
CH5424802	IKKB	100.0	1000.0
CGP60474	DAPK2	100.0	10000.0
Canertinib	TXK	30.0	1000.0
HG-9-91-01	EPHB1	0.1	10000.0
WZ3105	KIT(V559D,T670I)	86.0	10000.0
Abemaciclib	INSRR	97.0	1000.0
AS-252424	CDK8	100.0	10000.0
Palbociclib	NIM1	100.0	1000.0
GSK429286A	KIT(V559D)	82.0	10000.0
BGJ398	DCAMKL3	78.0	1000.0
PD173074	PHKG2	100.0	10000.0
XMD14-99	CDKL5	100.0	10000.0
GSK461364	MERTK	24.0	10000.0
Barasertib	STK16	100.0	10000.0
Torkinib	CHK2	19.0	10000.0
BI-2536	EGFR(L747-T751del,Sins)	19.0	10000.0
Ibrutinib	MARK4	81.0	1000.0
Taselisib	PHKG2	100.0	1000.0
NPK76-II-72-1	MLCK	100.0	10000.0
KIN001-021	RAF1	100.0	1000.0
TAK-715	IRAK4	100.0	10000.0
HG-14-8-02	VRK2	100.0	10000.0
TAK-715	RSK1(Kin.Dom.1-N-terminal)	89.0	10000.0
JWE-035	LRRK2(G2019S)	18.0	10000.0
ALW-II-38-3	MK14	0.3	1000.0
HG-6-64-01	CAMK1G	100.0	10000.0
ZM-447439	MKNK1	100.0	10000.0
BMS345541	DMPK2	94.0	10000.0
A443654	MST1R	100.0	10000.0
AZ-628	TIE1	11.0	10000.0
TAK-715	STK36	4.8	10000.0
JNK-IN-8	FGR	100.0	1000.0
XMD11-85h	MET(M1250T)	100.0	10000.0
ZSTK474	FLT4	100.0	1000.0
(s)-CR8	RET(V804M)	82.0	10000.0
CP724714	ERK3	100.0	10000.0
THZ1	SIK2	5.2	10000.0
QL-X-138	GSK3A	13.0	10000.0
Torkinib	OSR1	80.0	10000.0
XMD14-99	MAP3K3	76.0	10000.0
AZ-628	RIPK1	83.0	10000.0
KIN001-021	BMX	100.0	1000.0
Pictilisib	LKB1	100.0	1000.0
Vemurafenib	PFCDPK1(P.falciparum)	0.0	10000.0
Pictilisib	KC1G1	100.0	1000.0
AG1478	EGFR(L858R)	0.1	10000.0
AZ-628	MK11	0.0	10000.0
AZD7762	BRSK1	4.9	10000.0
WZ3105	CIT	50.0	10000.0
Ribociclib	NEK10	47.0	1000.0
MRT67307	TESK1	100.0	10000.0
Seliciclib	TNK2	96.0	10000.0
BS-181	PIM1	100.0	10000.0
AZD-6482	TRKA	88.0	10000.0
WYE-125132	PKNB(M.tuberculosis)	94.0	10000.0
ALW-II-49-7	CDK3	100.0	10000.0
HG-6-64-01	MK14	0.0	10000.0
GSK429286A	CHK2	78.0	10000.0
AZD 5438	CDK3	0.3	10000.0
Vemurafenib	CDKL1	100.0	10000.0
Omipalisib	AAK1	13.0	10000.0
XMD8-92	M4K3	100.0	10000.0
Palbociclib	ERN1	100.0	1000.0
WYE-125132	YANK1	99.0	10000.0
NG25	PKMYT1	100.0	10000.0
TAK-715	GRK7	100.0	10000.0
AZD-6482	PIK3CA(E545A)	0.1	10000.0
Vemurafenib	NEK7	100.0	10000.0
XMD11-85h	RIOK1	100.0	10000.0
AG1478	SRPK3	93.0	10000.0
XMD8-92	EGFR(L861Q)	100.0	10000.0
Lapatinib	CHEK1	90.0	10000.0
Ibrutinib	MK12	71.0	1000.0
HG-5-113-01	INSR	0.4	10000.0
Sorafenib	FLT3(N841I)	0.3	10000.0
WYE-125132	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
WH-4-023	MK09	2.6	10000.0
MLN8054	EGFR(G719C)	77.0	10000.0
SB590885	EPHB4	100.0	10000.0
AS-252424	KPCD3	73.3	10000.0
CP724714	KIT(V559D)	17.0	10000.0
XMD-12	ACVR2A	90.0	1000.0
JNK-IN-5A	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
GW843682X	STK39	89.0	10000.0
Ibrutinib	FLT3(ITD)	43.0	1000.0
HG-5-113-01	SYK	2.6	10000.0
Omipalisib	HIPK3	79.0	10000.0
HG-14-8-02	CDK2	100.0	10000.0
XMD8-92	MINK	100.0	10000.0
AG1478	HCK	6.8	10000.0
Alpelisib	RSK4(Kin.Dom.1-N-terminal)	100.0	1000.0
JW-7-24-1	EGFR(L747-T751del,Sins)	100.0	10000.0
CGP60474	DAPK3	100.0	10000.0
OTSSP167	TGFBR2	0.6	10000.0
ERK5-IN-1	PIK3CA(H1047L)	90.0	1000.0
WZ3105	MAK	100.0	10000.0
XMD16-144	RIOK1	18.0	10000.0
Seliciclib	MYLK2	100.0	10000.0
Torkinib	IKKB	84.0	10000.0
Ribociclib	FRK	100.0	1000.0
MRT67307	ULK2	0.0	10000.0
BMX-IN-1	ABL1(T315I)-phosphorylated	100.0	10000.0
BS-181	MARK1	98.0	10000.0
CGP74514A	AURKC	11.0	10000.0
CGP74514A	RSK2(Kin.Dom.2-C-terminal)	28.0	10000.0
NPK76-II-72-1	ACVR2B	100.0	10000.0
HG-6-64-01	ERBB2	0.0	10000.0
Torin2	PHKG2	100.0	10000.0
Taselisib	FAK2	100.0	1000.0
Sigma A6730	RSK4(Kin.Dom.2-C-terminal)	100.0	10000.0
ZM-447439	KIT	0.0	10000.0
Lapatinib	ANKK1	100.0	10000.0
Ribociclib	SRC	100.0	1000.0
XMD16-144	ULK2	0.2	10000.0
WZ-4-145	ADCK3	100.0	10000.0
AG1478	PIK3CB	47.0	10000.0
Crizotinib	IRAK4	24.0	10000.0
PLX-4720	ERBB2	78.0	10000.0
WZ4002	CLK2	100.0	10000.0
AS-252424	ERK3	80.2	10000.0
BX-912	SYK	1.0	10000.0
NVP-TAE684	ABL1(Y253F)	4.2	1000.0
QL-XII-47	CDK8	93.0	1000.0
XMD13-2	SNRK	100.0	10000.0
XMD14-99	DCAMKL3	14.0	10000.0
BMS345541	AKT1	100.0	10000.0
BI-D1870	AMPK-alpha2	17.0	10000.0
Ceritinib	SRC	90.0	1000.0
GW843682X	DAPK3	19.0	10000.0
HG-5-88-01	KGP2	100.0	10000.0
JWE-035	PIK3CD	0.0	10000.0
HG-5-113-01	PKAC-beta	13.0	10000.0
Torin1	KKCC1	80.0	10000.0
XMD11-85h	TNIK	100.0	10000.0
Alpelisib	TBK1	100.0	1000.0
GW-5074	CSF1R	71.0	10000.0
Dactolisib	SIK2	100.0	1000.0
GSK429286A	M3K2	79.0	10000.0
KIN001-111	PHKG2	100.0	1000.0
WZ3105	NEK2	94.0	10000.0
CG-930	MAK	97.0	10000.0
CG-930	MP2K6	88.0	10000.0
Baricitinib	MST3	52.0	10000.0
KIN001-021	KPCE	100.0	1000.0
BMS345541	KC1G1	94.0	10000.0
ZG-10	KIT(V559D,V654A)	56.0	10000.0
WYE-125132	DAPK1	12.0	10000.0
JNK-IN-5A	BLK	91.0	10000.0
BMX-IN-1	MKNK2	52.0	10000.0
JWE-035	DYRK2	97.0	10000.0
XMD14-99	INSR	94.0	10000.0
CH5424802	FGFR4	70.0	1000.0
NU7441	CDK4-cyclinD3	100.0	10000.0
CGP74514A	CAMK1	31.0	10000.0
Ceritinib	ICK	98.0	1000.0
CP724714	AMPK-alpha1	89.0	10000.0
Dabrafenib	CDKL1	54.0	10000.0
NPK76-II-72-1	CDK14	100.0	10000.0
GSK1059615	EGFR(L861Q)	87.0	10000.0
QL-X-138	BIKE	62.0	10000.0
HG-5-88-01	VGFR2	100.0	10000.0
Torkinib	TAOK3	4.7	10000.0
Vemurafenib	DCLK1	88.0	10000.0
GW843682X	ACVR2A	79.0	10000.0
PHA-767491	PIK3CA(H1047Y)	96.0	10000.0
5z-7-oxozeaenol	EPHA2	74.0	10000.0
Neratinib	NEK7	100.0	10000.0
BMS345541	JNK1	66.0	10000.0
AZD7762	ANKK1	1.2	10000.0
Neratinib	EPHB6	83.0	10000.0
Taselisib	PI42C	92.0	1000.0
BI-2536	LKB1	100.0	10000.0
BS-181	CSNK1D	0.5	10000.0
OTSSP167	PCTK2	13.0	10000.0
BGJ398	RET(V804L)	100.0	1000.0
AZD7762	TGFBR1	47.0	10000.0
BX-912	IKKB	8.4	10000.0
NG25	CLK4	100.0	10000.0
Torkinib	EPHB2	32.0	10000.0
NPK76-II-72-1	MAP4K4	100.0	10000.0
Vemurafenib	RPS6KA4(Kin.Dom.2-C-terminal)	96.0	10000.0
CGP74514A	PIM3	0.7	10000.0
XMD11-85h	HUNK	100.0	10000.0
CG-930	TAOK3	81.0	10000.0
WH-4-023	MP2K1	38.0	10000.0
PD0325901	SRPK2	100.0	10000.0
SB590885	LOK	0.6	10000.0
GW-5074	SBK1	85.0	10000.0
NU7441	FLT3(D835Y)	79.0	10000.0
CGP60474	MLCK	100.0	10000.0
HG-14-8-02	FYN	100.0	10000.0
CG-930	EGFR(L858R,T790M)	85.0	10000.0
AZD4547	LCK	3.0	10000.0
AZD7762	HCK	0.0	10000.0
Torkinib	MLK1	32.0	10000.0
Ibrutinib	ABL1(Q252H)-phosphorylated	76.0	1000.0
Seliciclib	FES	100.0	10000.0
ZM-447439	ERBB3	1.0	10000.0
Abemaciclib	CDC2L5	8.0	1000.0
Torin2	M3K5	100.0	10000.0
MPS-1-IN-1	PIM3	100.0	1000.0
Seliciclib	IKKE	100.0	10000.0
ALW-II-38-3	PDPK1	100.0	10000.0
WZ-7043	PAK1	100.0	10000.0
KIN001-220	BRSK2	82.0	10000.0
GW843682X	ERBB3	100.0	10000.0
Barasertib	SYK	95.0	10000.0
A443654	EPHA8	100.0	10000.0
HG-5-113-01	MLK3	7.2	10000.0
CP724714	KC1G2	100.0	10000.0
CP724714	NEK5	100.0	10000.0
AZD-6482	EGFR(T790M)	100.0	10000.0
Ceritinib	EGFR(E746-A750del)	52.0	1000.0
HG-14-8-02	CSNK2A1	1.1	10000.0
BMS345541	RPS6KA4(Kin.Dom.2-C-terminal)	15.0	10000.0
BMS345541	MST1	100.0	10000.0
CH5424802	PIP5K1A	97.0	1000.0
Taselisib	PCTK2	100.0	1000.0
XMD11-50	RPS6KA5(Kin.Dom.2-C-terminal)	92.0	10000.0
PD0325901	GAK	71.0	10000.0
Buparlisib	KPCD1	77.0	1000.0
XMD11-85h	EPHA5	100.0	10000.0
TAK-715	DAPK2	88.0	10000.0
JNK-IN-11	MP2K1	100.0	1000.0
Alpelisib	MP2K3	100.0	1000.0
WZ4002	PKAC-beta	100.0	10000.0
JNK-IN-5A	MYO3A	42.0	10000.0
AZD-6482	TYK2(JH2domain-pseudokinase)	100.0	10000.0
PD173074	PKAC-beta	100.0	10000.0
GSK461364	PIM2	77.0	10000.0
JWE-035	RAF1	100.0	10000.0
HG-6-64-01	PGFRA	0.2	10000.0
XMD16-144	RAF1	96.0	10000.0
NU7441	DYRK1A	61.0	10000.0
WZ3105	RSK3(Kin.Dom.2-C-terminal)	81.0	10000.0
KIN001-123	EGFR(E746-A750del)	17.0	1000.0
SCH772984	FLT4	99.0	1000.0
Momelotinib	PIK4CB	17.0	10000.0
PHA-767491	MET(M1250T)	7.8	10000.0
ERK5-IN-1	PAK1	100.0	1000.0
Momelotinib	CAMK2A	26.0	10000.0
NG25	CAMKK2	27.0	10000.0
ALW-II-38-3	PIM1	100.0	10000.0
AZD 5438	PIK3CA	52.0	10000.0
Torkinib	LCK	1.0	10000.0
ALW-II-49-7	CAMK2G	100.0	10000.0
XMD8-92	IGF1R	100.0	10000.0
Sigma A6730	GAK	88.0	10000.0
Vemurafenib	PAK2	80.0	10000.0
GW-5074	MK14	36.0	10000.0
JNK-9L	SgK110	78.0	10000.0
Torkinib	PIK3CA(I800L)	1.6	10000.0
SB590885	AKT2	100.0	10000.0
Lapatinib	AMPK-alpha2	91.0	10000.0
Ribociclib	IKKA	100.0	1000.0
Torin2	AKT1	100.0	10000.0
Dabrafenib	EIF2AK1	4.6	10000.0
PHA-767491	RIOK1	33.0	10000.0
Dactolisib	DDR1	100.0	1000.0
HG-14-10-04	RSK1(Kin.Dom.2-C-terminal)	30.0	10000.0
Sigma A6730	CDKL3	100.0	10000.0
KIN001-111	LIMK1	0.3	1000.0
ALW-II-38-3	SRMS	26.0	10000.0
Taselisib	MRCKA	100.0	1000.0
WZ4002	CSK	100.0	10000.0
XMD13-2	CLK1	77.0	10000.0
Baricitinib	KPCI	40.0	10000.0
JNK-IN-11	CDKL1	100.0	1000.0
RO-3306	KIT(D816H)	75.0	10000.0
HG-9-91-01	ERK3	63.0	10000.0
BX-912	RSK3(Kin.Dom.2-C-terminal)	4.8	10000.0
RO-3306	PRKR	77.0	10000.0
BMS345541	MYLK4	8.8	10000.0
CG-930	RSK3(Kin.Dom.1-N-terminal)	78.0	10000.0
AZD4547	PLK1	67.0	10000.0
XMD14-99	NLK	85.0	10000.0
THZ1	AMPK-alpha2	2.0	10000.0
AZD4547	AURKB	0.4	10000.0
CH5424802	BMPR1B	87.0	1000.0
Torin2	TIE2	100.0	10000.0
AZD 5438	BTK	19.0	10000.0
Crizotinib	MK13	100.0	10000.0
JNK-IN-5A	EPHB4	100.0	10000.0
BMS-536924	EGFR	7.4	1000.0
NG25	PGFRA	0.4	10000.0
MPS-1-IN-1	EPHA4	100.0	1000.0
BMS345541	EPHB3	100.0	10000.0
CGP60474	MST2	100.0	10000.0
Ibrutinib	RET(V804M)	90.0	1000.0
BMS345541	ABL1(F317L)-nonphosphorylated	100.0	10000.0
HG-6-64-01	STK16	54.0	10000.0
CGP60474	ABL1(M351T)	100.0	10000.0
PHA-767491	MP2K1	68.0	10000.0
PD173074	KGP1	100.0	10000.0
JW-7-24-1	ABL1(Y253F)	13.0	10000.0
AS-252424	AMPK-alpha2	99.5	10000.0
GSK461364	YANK3	100.0	10000.0
Taselisib	VGFR1	85.0	1000.0
SB590885	PIM1	86.0	10000.0
Canertinib	MK12	100.0	1000.0
MPS-1-IN-1	MST2	100.0	1000.0
ALW-II-38-3	PAK2	100.0	10000.0
Ibrutinib	CDKL5	97.0	1000.0
ALW-II-38-3	SYK	100.0	10000.0
Neratinib	MP2K7	49.0	10000.0
XMD13-2	EPHA7	96.0	10000.0
HG-5-88-01	BLK	22.0	10000.0
PD173074	MKNK2	100.0	10000.0
JNK-IN-5A	PIK3CD	100.0	10000.0
XMD16-144	MARK3	10.0	10000.0
ZM-447439	PIM2	100.0	10000.0
CH5424802	IRAK4	60.0	1000.0
MPS-1-IN-1	SYK	100.0	1000.0
Seliciclib	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
MRT67307	TSSK1	26.0	10000.0
AG1478	ALK(C1156Y)	31.0	10000.0
GSK429286A	RIPK4	98.0	10000.0
Neratinib	MKNK2	99.0	10000.0
WZ4003	KPCD2	15.0	1000.0
Pictilisib	AURKB	100.0	1000.0
OTSSP167	WEE1	100.0	10000.0
AZD 5438	TLK2	0.2	10000.0
WYE-125132	MP2K1	100.0	10000.0
Buparlisib	SRPK3	88.0	1000.0
Ceritinib	OSR1	13.0	1000.0
HG-14-10-04	MP2K6	15.0	10000.0
MLN8054	M4K3	97.0	10000.0
Pictilisib	RET(V804M)	100.0	1000.0
BMS345541	NEK6	100.0	10000.0
XMD8-92	AKT1	100.0	10000.0
CH5424802	RSK2(Kin.Dom.1-N-terminal)	35.0	1000.0
ZG-10	PTK6	100.0	10000.0
ERK5-IN-1	AKT2	100.0	1000.0
XMD8-92	YANK3	100.0	10000.0
KIN001-123	TEC	2.0	1000.0
XMD-12	KKCC1	98.0	1000.0
CG-930	MAPKAPK5	100.0	10000.0
Dinaciclib	M4K3	98.0	10000.0
Torkinib	ABL1(Q252H)-phosphorylated	0.2	10000.0
QL-XI-92	ABL1(F317I)-nonphosphorylated	12.0	10000.0
PD173074	CDK16	100.0	10000.0
Seliciclib	CSNK1A1L	4.1	10000.0
PD173074	EPHB3	100.0	10000.0
Dinaciclib	BMPR1B	99.0	10000.0
AZ-628	CDK4-cyclinD3	90.0	10000.0
Dinaciclib	NDR1	74.0	10000.0
QL-XII-47	ROCK2	100.0	1000.0
Taselisib	TNK2	100.0	1000.0
CP724714	MLK1	74.0	10000.0
Momelotinib	NLK	86.0	10000.0
CH5424802	CSF1R	100.0	1000.0
ALW-II-49-7	PIM3	100.0	10000.0
R406	CAMK1G	19.0	1000.0
CGP74514A	MP2K5	0.2	10000.0
PD0325901	DAPK3	100.0	10000.0
WZ4002	DYRK1B	17.0	10000.0
NG25	KIT	0.0	10000.0
Momelotinib	PCTK3	89.0	10000.0
Barasertib	PIM1	100.0	10000.0
TGX221	LKB1	100.0	1000.0
Ibrutinib	MAP3K3	63.0	1000.0
CGP60474	MYLK2	100.0	10000.0
BMS345541	M3K2	100.0	10000.0
WH-4-023	EGFR(L861Q)	0.1	10000.0
HG-5-88-01	PAK4	100.0	10000.0
Seliciclib	OSR1	54.0	10000.0
CGP60474	LATS1	100.0	10000.0
Ribociclib	M3K2	100.0	1000.0
AS-252424	EGFR(L858R)	20.1	10000.0
GW843682X	ABL1(Q252H)-nonphosphorylated	45.0	10000.0
BMS-536924	LATS1	100.0	1000.0
QL-XI-92	MAPKAPK2	100.0	10000.0
GSK461364	SRPK3	9.6	10000.0
KIN001-021	DCLK1	100.0	1000.0
WH-4-023	CHK2	78.0	10000.0
Ibrutinib	EGFR(E746-A750del)	5.8	1000.0
Crizotinib	JAK2(JH1domain-catalytic)	1.4	10000.0
CP466722	IKKB	45.0	10000.0
CH5424802	PIK3CA(Q546K)	96.0	1000.0
HG-6-64-01	PIK3CA(H1047L)	100.0	10000.0
XMD16-144	YANK1	100.0	10000.0
GSK461364	MLCK	100.0	10000.0
5z-7-oxozeaenol	KIT(V559D)	0.3	10000.0
NVP-TAE684	KPCL	100.0	1000.0
NVP-TAE684	TXK	6.9	1000.0
BGJ398	PAK4	93.0	1000.0
Baricitinib	DDR2	97.0	10000.0
GW-5074	MINK	2.8	10000.0
HG-14-8-02	CIT	20.0	10000.0
AG1478	YANK3	100.0	10000.0
GW-5074	ERK8	61.0	10000.0
Abemaciclib	EPHA1	97.0	1000.0
Neratinib	MAPKAPK2	89.0	10000.0
AZ-628	PIM1	100.0	10000.0
NG25	MP2K3	100.0	10000.0
XMD11-50	ABL1(Q252H)-nonphosphorylated	100.0	10000.0
NPK76-II-72-1	CDK11	100.0	10000.0
KU63794	DDR1	85.0	10000.0
Dactolisib	FER	100.0	1000.0
JWE-035	ROS1	11.0	10000.0
BX-912	MKNK2	0.1	10000.0
XMD8-92	HCK	100.0	10000.0
Taselisib	TAOK3	100.0	1000.0
BS-181	DAPK3	89.0	10000.0
WYE-125132	KIT(V559D,V654A)	100.0	10000.0
MPS-1-IN-1	AXL	19.0	1000.0
CH5424802	CDK3	100.0	1000.0
BI-D1870	ERK5	5.5	10000.0
Barasertib	MAST1	90.0	10000.0
Crizotinib	BMX	28.0	10000.0
CH5424802	MK12	98.0	1000.0
OTSSP167	ERBB2	40.0	10000.0
XMD8-85	PKAC-beta	100.0	10000.0
KIN001-123	LOK	15.0	1000.0
Neratinib	AKT3	100.0	10000.0
Barasertib	SIK2	70.0	10000.0
Dabrafenib	RET(V804M)	92.0	10000.0
WZ3105	MST2	57.0	10000.0
HG-14-8-02	ERK3	100.0	10000.0
Taselisib	TESK1	95.0	1000.0
KIN001-021	SNARK	100.0	1000.0
QL-XI-92	ERK8	100.0	10000.0
NVP-TAE684	KPCT	13.0	1000.0
WZ3105	KC1G2	7.9	10000.0
WYE-125132	PDPK1	76.0	10000.0
RO-3306	ABL1(F317I)-nonphosphorylated	65.0	10000.0
BMX-IN-1	PIK3CA(E542K)	23.0	10000.0
MRT67307	MK03	87.0	10000.0
R406	KIT(D816V)	0.2	1000.0
GSK461364	MKNK2	23.0	10000.0
Torin1	MET	84.0	10000.0
GSK1059615	NEK2	64.0	10000.0
WYE-125132	NEK9	100.0	10000.0
JNK-IN-5A	MP2K3	88.0	10000.0
AZD-6482	IRAK3	58.0	10000.0
CP724714	TYK2(JH2domain-pseudokinase)	24.0	10000.0
BS-181	TXK	100.0	10000.0
Torkinib	ERBB3	0.0	10000.0
A443654	BMPR1A	100.0	10000.0
HG-9-91-01	DCAMKL3	0.2	10000.0
CP724714	KIT(D816V)	89.0	10000.0
WZ-4-145	IKKB	100.0	10000.0
JNK-IN-8	ERBB2	82.0	1000.0
BMS345541	MAPKAPK2	100.0	10000.0
GW-5074	INSR	100.0	10000.0
Seliciclib	BRAF	96.0	10000.0
XMD8-92	LOK	100.0	10000.0
Palbociclib	NDR1	92.0	1000.0
CP466722	TRPM6	61.0	10000.0
JW-7-24-1	RPS6KA5(Kin.Dom.2)	100.0	10000.0
PD173074	SRC	100.0	10000.0
GSK461364	EGFR	87.0	10000.0
JWE-035	ADCK3	78.0	10000.0
A443654	ABL1(M351T)	100.0	10000.0
CGP74514A	NEK4	33.0	10000.0
KIN001-127	TNIK	100.0	10000.0
Taselisib	EPHA6	92.0	1000.0
GSK461364	PIK3CA(M1043I)	63.0	10000.0
AS-252424	CDK3	94.0	10000.0
KIN001-021	RET(V804L)	100.0	1000.0
BMX-IN-1	CLK3	98.0	10000.0
AZD-6482	RIPK5	100.0	10000.0
ALW-II-38-3	EGFR(E746-A750del)	100.0	10000.0
JW-7-24-1	EPHA4	100.0	10000.0
ZG-10	ERK5	100.0	10000.0
QL-XII-47	KPCI	97.0	1000.0
Ibrutinib	STK36	65.0	1000.0
Taselisib	CDK7	96.0	1000.0
NVP-TAE684	EPHA3	100.0	1000.0
Pictilisib	PGFRA	100.0	1000.0
BMX-IN-1	PGFRB	63.0	10000.0
WZ4002	AKT3	100.0	10000.0
A443654	CAMK2G	5.4	10000.0
Alpelisib	FYN	96.0	1000.0
Baricitinib	MK14	96.0	10000.0
Pictilisib	CDK5	94.0	1000.0
XMD11-50	EPHA5	95.0	10000.0
GW-5074	ICK	88.0	10000.0
XMD-12	PAK1	100.0	1000.0
HG-5-88-01	MK09	100.0	10000.0
A443654	M4K1	23.0	10000.0
Dactolisib	EGFR(E746-A750del)	100.0	1000.0
XMD-12	INSR	80.0	1000.0
AZD-6482	CDK15	100.0	10000.0
Buparlisib	SGK3	100.0	1000.0
XMD8-92	ACVR1	100.0	10000.0
KIN001-021	JNK3	100.0	1000.0
PHA-767491	ERN1	88.0	10000.0
KIN001-123	KPCD2	100.0	1000.0
Neratinib	KGP2	92.0	10000.0
OTSSP167	FGFR4	81.0	10000.0
XMD-12	RET(V804M)	3.0	1000.0
BMX-IN-1	SRPK2	81.0	10000.0
HG-5-113-01	FLT4	29.0	10000.0
Baricitinib	MARK4	17.0	10000.0
SCH772984	TGFBR1	100.0	1000.0
Dactolisib	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	1000.0
Seliciclib	FLT3(D835Y)	100.0	10000.0
Torin2	HIPK2	53.0	10000.0
AZD4547	CDK7	11.0	10000.0
QL-XII-47	EIF2AK1	100.0	1000.0
BI-D1870	EGFR(S752-I759del)	30.0	10000.0
XMD8-92	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
Sorafenib	MLK3	99.0	10000.0
WZ-7043	FLT3(ITD)	100.0	10000.0
BI-D1870	KC1G1	8.1	10000.0
HG-6-64-01	PIK3CA(H1047Y)	90.0	10000.0
BX-912	NEK11	85.0	10000.0
WZ4002	FES	11.0	10000.0
KIN001-220	RSK4(Kin.Dom.1-N-terminal)	37.0	10000.0
Torin2	ERK3	62.0	10000.0
TGX221	MKNK1	100.0	1000.0
RO-3306	LATS1	97.0	10000.0
Ceritinib	HCK	86.0	1000.0
Dinaciclib	FLT3(K663Q)	100.0	10000.0
CGP74514A	CLK4	0.3	10000.0
Dactolisib	JAK2(JH1domain-catalytic)	20.0	1000.0
CP466722	DRAK2	9.4	10000.0
SB590885	ERK8	100.0	10000.0
HG-14-10-04	LRRK2(G2019S)	0.0	10000.0
5z-7-oxozeaenol	JAK1(JH2domain-pseudokinase)	99.0	10000.0
Taselisib	GRK7	100.0	1000.0
BS-181	AURKB	81.0	10000.0
GSK429286A	PIK3CA(H1047Y)	43.0	10000.0
XMD11-50	STK16	62.0	10000.0
CG-930	ANKK1	100.0	10000.0
Canertinib	FLT3(D835Y)	100.0	1000.0
MPS-1-IN-1	MLK2	100.0	1000.0
AZD7762	MAP3K15	28.0	10000.0
QL-XI-92	MK14	0.5	10000.0
Sorafenib	PDPK1	76.0	10000.0
(s)-CR8	ULK3	95.0	10000.0
CH5424802	VGFR2	72.0	1000.0
Torkinib	PIK4CB	2.4	10000.0
JWE-035	TEC	99.0	10000.0
Seliciclib	NEK1	92.0	10000.0
Sigma A6730	KPCE	100.0	10000.0
JNK-IN-11	ABL1(Q252H)-phosphorylated	7.5	1000.0
BI-D1870	CSNK1E	0.0	10000.0
AZD7762	CSK	0.1	10000.0
BMS-536924	DCLK1	27.0	1000.0
Momelotinib	LRRK2(G2019S)	41.0	10000.0
Baricitinib	EGFR(L747-T751del,Sins)	74.0	10000.0
PHA-767491	EGFR(L858R)	90.0	10000.0
TGX221	FGFR2	100.0	1000.0
TAK-715	PFPK5(P.falciparum)	100.0	10000.0
AZ-628	S6K1	100.0	10000.0
Omipalisib	EIF2AK1	79.0	10000.0
MRT67307	MK13	100.0	10000.0
MRT67307	CDK14	100.0	10000.0
R406	RPS6KA2(Kin.Dom.1)	26.0	1000.0
WZ-4-145	DAPK2	100.0	10000.0
WZ4002	PIP5K1A	11.0	10000.0
HG-5-113-01	NEK5	100.0	10000.0
ZG-10	TLK1	92.0	10000.0
HG-5-113-01	TYK2(Kin.Dom.2)	0.3	10000.0
JWE-035	IRAK3	69.0	10000.0
BS-181	MAP4K5	88.0	10000.0
XMD8-92	CDK5	100.0	10000.0
Dactolisib	AURKA	100.0	1000.0
Dactolisib	SIK1	100.0	1000.0
KIN001-021	CDK14	100.0	1000.0
XMD13-2	KPCD2	100.0	10000.0
Taselisib	GCN2(Kin.Dom.2,S808G)	91.0	1000.0
XMD-12	DMPK2	100.0	1000.0
CG-930	KPCD1	46.0	10000.0
5z-7-oxozeaenol	RSK2(Kin.Dom.1-N-terminal)	69.0	10000.0
BMS-536924	MP2K1	0.1	1000.0
CGP60474	JNK3	100.0	10000.0
XMD13-2	STK35	16.0	10000.0
AZD4547	DDR2	0.0	10000.0
QL-XI-92	MP2K3	100.0	10000.0
TAK-715	PIK3C2G	40.0	10000.0
AG1478	TRKA	88.0	10000.0
WZ-4-145	EPHB4	100.0	10000.0
PHA-793887	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
KU63794	JAK3(JH1domain-catalytic)	100.0	10000.0
NVP-TAE684	WEE2	100.0	1000.0
Torkinib	YES	3.2	10000.0
GSK461364	LTK	100.0	10000.0
QL-X-138	ABL1(F317I)-nonphosphorylated	100.0	10000.0
WYE-125132	JAK1(JH1domain-catalytic)	82.0	10000.0
XMD16-144	PI42C	6.0	10000.0
KIN001-123	NEK5	100.0	1000.0
HG-14-10-04	AURKB	29.0	10000.0
BMS345541	M4K3	80.0	10000.0
(s)-CR8	KCC4	76.0	10000.0
ERK5-IN-1	PAK7	100.0	1000.0
SP600125	CDK11	100.0	10000.0
MRT67307	MAK	100.0	10000.0
BMS345541	PIK3CD	99.0	10000.0
GSK461364	KIT(D816H)	40.0	10000.0
HG-14-8-02	PCTK2	83.0	10000.0
HG-5-113-01	JAK1(Kin.Dom.1)	0.1	10000.0
Sorafenib	PLK4	28.0	10000.0
GW843682X	SRPK2	34.0	10000.0
Canertinib	KIT(V559D,T670I)	100.0	1000.0
Lapatinib	CHK2	100.0	10000.0
THZ1	EPHA1	0.9	10000.0
BS-181	DCLK1	51.0	10000.0
Alpelisib	RET(V804L)	100.0	1000.0
WH-4-023	EGFR(L747-E749del,A750P)	1.0	10000.0
Neratinib	BRSK2	100.0	10000.0
JNK-9L	EPHA2	56.0	10000.0
AZD-6482	PKAC-alpha	100.0	10000.0
ZG-10	ERBB4	100.0	10000.0
SCH772984	DAPK3	69.0	1000.0
Taselisib	DMPK	100.0	1000.0
Ibrutinib	TRKC	88.0	1000.0
GSK1059615	STK16	4.9	10000.0
CG-930	PRP4	100.0	10000.0
KU63794	MP2K5	100.0	10000.0
Palbociclib	ULK1	100.0	1000.0
SCH772984	SLK	100.0	1000.0
WZ-4-145	INSR	24.0	10000.0
5z-7-oxozeaenol	FGFR4	93.0	10000.0
KIN001-220	KIT(L576P)	3.2	10000.0
Sorafenib	MAP3K15	100.0	10000.0
Neratinib	TEC	73.0	10000.0
WZ3105	RIOK1	31.0	10000.0
GW-5074	KIT(D816H)	99.0	10000.0
Momelotinib	RET	50.0	10000.0
Baricitinib	FLT3(D835H)	18.0	10000.0
JW-7-24-1	EPHB4	100.0	10000.0
PD0325901	PKN1	100.0	10000.0
Sorafenib	CSNK1A1	100.0	10000.0
JNK-IN-5A	MST1R	95.0	10000.0
XMD13-2	LOK	57.0	10000.0
ZM-447439	EPHB6	2.0	10000.0
ALW-II-49-7	PKN2	100.0	10000.0
WZ4003	BMPR1A	100.0	1000.0
NPK76-II-72-1	CSK	100.0	10000.0
Alpelisib	FGFR4	100.0	1000.0
PHA-767491	MST2	21.0	10000.0
ERK5-IN-1	EGFR(T790M)	100.0	1000.0
Sorafenib	EPHB3	100.0	10000.0
Abemaciclib	CDKL1	18.0	1000.0
TGX221	RPS6KA5(Kin.Dom.1)	100.0	1000.0
JNK-9L	TRPM6	100.0	10000.0
Taselisib	TIE1	100.0	1000.0
BMX-IN-1	CHK2	100.0	10000.0
Torkinib	ABL1(H396P)-phosphorylated	0.1	10000.0
ALW-II-38-3	AAK1	100.0	10000.0
BS-181	TTK	15.0	10000.0
WH-4-023	CSNK2A1	66.0	10000.0
JNK-IN-11	RPS6KA4(Kin.Dom.2-C-terminal)	91.0	1000.0
Dinaciclib	EPHA1	89.0	10000.0
MLN8054	FGFR2	7.7	10000.0
XMD16-144	KC1G1	47.0	10000.0
Vemurafenib	PHKG1	100.0	10000.0
AZD 5438	GCN2(Kin.Dom.2,S808G)	92.0	10000.0
Ibrutinib	MST4	62.0	1000.0
CGP60474	CDKL2	14.0	10000.0
CG-930	MP2K1	100.0	10000.0
Momelotinib	DRAK2	2.6	10000.0
SP600125	KIT(V559D)	100.0	10000.0
Sigma A6730	MRCKA	85.0	10000.0
KIN001-123	MYLK	100.0	1000.0
Ceritinib	ROCK1	44.0	1000.0
AZD7762	MP2K6	3.8	10000.0
WZ-4-145	ERBB2	16.0	10000.0
CGP74514A	TNK2	54.0	10000.0
CP466722	ABL1(T315I)-nonphosphorylated	34.0	10000.0
Neratinib	CDC2L5	100.0	10000.0
Pictilisib	PIK3CB	0.0	1000.0
AZD4547	TBK1	8.6	10000.0
TGX221	TSSK1	100.0	1000.0
MRT67307	MK09	27.0	10000.0
QL-X-138	MP2K5	0.3	10000.0
JNK-IN-11	PFPK5(P.falciparum)	100.0	1000.0
BI-2536	MUSK	100.0	10000.0
Alpelisib	ERN1	100.0	1000.0
CGP74514A	FGFR3(G697C)	87.0	10000.0
ZG-10	EPHA3	73.0	10000.0
QL-XI-92	ROCK2	85.0	10000.0
Dinaciclib	SRPK2	94.0	10000.0
GSK461364	YANK1	66.0	10000.0
ALW-II-49-7	AXL	100.0	10000.0
XMD13-2	PKNB(M.tuberculosis)	15.0	10000.0
PLX-4720	LIMK2	24.0	10000.0
BMX-IN-1	MARK2	100.0	10000.0
Torkinib	EGFR	31.0	10000.0
CP466722	EPHA4	34.0	10000.0
PHA-767491	ERK8	0.1	10000.0
AZD 5438	BRSK2	29.0	10000.0
BGJ398	FLT3(R834Q)	50.0	1000.0
NG25	YANK2	100.0	10000.0
Momelotinib	TIE2	100.0	10000.0
XMD13-2	GCN2(Kin.Dom.2,S808G)	96.0	10000.0
WZ4003	M3K12	100.0	1000.0
AZD7762	PHKG2	1.6	10000.0
Vemurafenib	MP2K2	5.4	10000.0
Dinaciclib	PCTK3	0.2	10000.0
R406	CDK14	100.0	1000.0
SP600125	NEK6	100.0	10000.0
QL-XII-47	CASK	89.0	1000.0
TAK-715	TRKC	96.0	10000.0
Momelotinib	HIPK2	15.0	10000.0
JNK-9L	GSK3B	3.1	10000.0
JNK-IN-5A	RSK3(Kin.Dom.1-N-terminal)	93.0	10000.0
CGP74514A	TSSK1	50.0	10000.0
HG-14-10-04	PIP5K1C	40.0	10000.0
Dabrafenib	ALK(L1196M)	68.0	10000.0
Ceritinib	MET	82.0	1000.0
Seliciclib	KPCE	89.0	10000.0
NPK76-II-72-1	FER	31.0	10000.0
QL-XII-47	CDK7	56.0	1000.0
HG-9-91-01	PKAC-beta	2.1	10000.0
KU63794	CDK4-cyclinD1	70.0	10000.0
BMX-IN-1	PKN2	100.0	10000.0
Vemurafenib	RIPK1	63.0	10000.0
HG-14-8-02	PTK6	6.6	10000.0
WZ3105	LIMK2	100.0	10000.0
PHA-793887	DCAMKL3	6.2	10000.0
Buparlisib	MP2K2	100.0	1000.0
A443654	ERK8	0.0	10000.0
GW-5074	AURKB	9.4	10000.0
Omipalisib	PHKG1	73.0	10000.0
OTSSP167	M3K5	1.0	10000.0
AZD 5438	EGFR(L747-E749del,A750P)	56.0	10000.0
NVP-TAE684	EPHA8	100.0	1000.0
Baricitinib	MAP3K15	5.2	10000.0
XMD16-144	MAP3K1	72.0	10000.0
Taselisib	BMPR1B	100.0	1000.0
ZM-447439	DDR2	100.0	10000.0
WH-4-023	CDK16	98.0	10000.0
Canertinib	DRAK2	100.0	1000.0
CGP74514A	KGP2	20.0	10000.0
Momelotinib	TLK2	88.0	10000.0
AZD4547	BRAF(V600E)	94.0	10000.0
HG-5-113-01	MKNK2	100.0	10000.0
Baricitinib	ULK1	0.5	10000.0
QL-XII-47	ABL1(Y253F)-phosphorylated	100.0	1000.0
AG1478	CDK16	90.0	10000.0
OTSSP167	PLK3	32.0	10000.0
Palbociclib	PAK6	100.0	1000.0
Alpelisib	MAP4K2	100.0	1000.0
WZ-7043	MLTK	100.0	10000.0
Seliciclib	M4K3	100.0	10000.0
Vemurafenib	FLT3(N841I)	35.0	10000.0
WYE-125132	AURKA	100.0	10000.0
MLN8054	EPHA7	8.8	10000.0
NU7441	SRPK2	78.0	10000.0
JNK-9L	TRKA	53.0	10000.0
ZG-10	NUAK1	61.0	10000.0
CP724714	STK35	65.0	10000.0
Canertinib	PIP5K2B	100.0	1000.0
Momelotinib	HIPK1	8.9	10000.0
Dabrafenib	HIPK1	1.0	10000.0
MLN8054	CDKL1	100.0	10000.0
NPK76-II-72-1	PDPK1	100.0	10000.0
Dabrafenib	YES	14.0	10000.0
A443654	JNK1	100.0	10000.0
NU7441	MAK	43.0	10000.0
Torkinib	FER	64.0	10000.0
Seliciclib	GSK3A	86.0	10000.0
JNK-9L	GRK1	100.0	10000.0
SP600125	KPCD3	100.0	10000.0
AZD4547	EGFR(G719C)	65.0	10000.0
XMD14-99	PAK7	63.0	10000.0
MLN8054	GRK7	31.0	10000.0
XMD8-92	LIMK2	100.0	10000.0
Barasertib	MLK3	100.0	10000.0
ALW-II-49-7	SgK110	100.0	10000.0
PHA-767491	BRAF(V600E)	23.0	10000.0
KIN001-220	NEK7	2.6	10000.0
NPK76-II-72-1	LKB1	100.0	10000.0
PHA-767491	MYO3B	53.0	10000.0
PHA-793887	PAK3	20.0	10000.0
ZM-447439	FGFR3	67.0	10000.0
SB590885	MAPKAPK5	100.0	10000.0
Ibrutinib	HIPK4	91.0	1000.0
NU7441	TNNI3K	86.0	10000.0
GSK429286A	ADCK4	94.0	10000.0
CGP74514A	RIOK3	84.0	10000.0
TAK-715	TYK2(JH2domain-pseudokinase)	57.0	10000.0
CP466722	JAK2(JH1domain-catalytic)	26.0	10000.0
Omipalisib	WNK3	65.0	10000.0
Barasertib	ABL2	79.0	10000.0
HG-6-64-01	BLK	0.2	10000.0
ALW-II-38-3	FES	100.0	10000.0
ZM-447439	NEK3	100.0	10000.0
Abemaciclib	MAP3K3	100.0	1000.0
WZ3105	CDC2L5	40.0	10000.0
CH5424802	YSK4	72.0	1000.0
Dabrafenib	AMPK-alpha1	1.9	10000.0
WYE-125132	CASK	64.0	10000.0
KIN001-127	MLK1	100.0	10000.0
CP724714	AAK1	100.0	10000.0
BMS-536924	FLT3(N841I)	0.3	1000.0
CP466722	ANKK1	12.0	10000.0
TAK-715	PKMYT1	64.0	10000.0
JNK-IN-5A	NEK7	84.0	10000.0
Torin1	MARK4	100.0	10000.0
Ibrutinib	BMPR1A	100.0	1000.0
WZ-4-145	TGFBR1	100.0	10000.0
Ibrutinib	PDPK1	71.0	1000.0
Vemurafenib	M3K12	62.0	10000.0
HG-14-8-02	FGFR3	100.0	10000.0
WYE-125132	M3K5	85.0	10000.0
AZD 5438	MERTK	7.6	10000.0
AG1478	CDC2L1	86.0	10000.0
NPK76-II-72-1	EPHA8	100.0	10000.0
TGX221	M3K12	100.0	1000.0
Dinaciclib	JAK2(JH1domain-catalytic)	81.0	10000.0
AS-252424	ABL1(T315I)	69.6	10000.0
Crizotinib	RPS6KA5(Kin.Dom.2-C-terminal)	95.0	10000.0
BMX-IN-1	RPS6KA5(Kin.Dom.2-C-terminal)	80.0	10000.0
HG-5-113-01	EGFR(E746-A750del)	100.0	10000.0
(s)-CR8	BMX	94.0	10000.0
Alpelisib	CAMK1	88.0	1000.0
CP724714	DMPK2	90.0	10000.0
PHA-767491	M3K12	91.0	10000.0
Ceritinib	VGFR1	76.0	1000.0
GSK429286A	WEE2	66.0	10000.0
AZD 5438	ULK1	58.0	10000.0
Dinaciclib	HIPK1	11.0	10000.0
CGP60474	MET(M1250T)	100.0	10000.0
TGX221	FGFR1	100.0	1000.0
AG1478	MK13	100.0	10000.0
Neratinib	FGR	40.0	10000.0
Torin2	M3K12	100.0	10000.0
JW-7-24-1	NEK7	100.0	10000.0
KIN001-123	MP2K6	100.0	1000.0
Neratinib	CSNK1A1	100.0	10000.0
Torkinib	ABL1(F317L)-nonphosphorylated	12.0	10000.0
CGP74514A	TNNI3K	86.0	10000.0
Baricitinib	PIK3CA(H1047L)	65.0	10000.0
Ceritinib	KKCC1	62.0	1000.0
MPS-1-IN-1	LIMK1	100.0	1000.0
AZD 5438	TGFBR1	44.0	10000.0
GW843682X	STK35	56.0	10000.0
OTSSP167	IRAK4	1.2	10000.0
BGJ398	AKT2	100.0	1000.0
Seliciclib	EPHB4	100.0	10000.0
CP466722	MAP3K15	54.0	10000.0
BS-181	CLK3	27.0	10000.0
ERK5-IN-1	INSRR	100.0	1000.0
Canertinib	MAPKAPK5	100.0	1000.0
WZ4003	STK35	100.0	1000.0
CP466722	PIM2	78.0	10000.0
Torin2	WEE1	100.0	10000.0
AZD 5438	PCTK2	0.3	10000.0
ZM-447439	BMPR1B	37.0	10000.0
GSK429286A	SRPK3	98.0	10000.0
SCH772984	MELK	41.0	1000.0
ZG-10	EPHA2	97.0	10000.0
BS-181	AKT3	100.0	10000.0
QL-X-138	CHEK1	100.0	10000.0
XMD16-144	PDPK1	86.0	10000.0
ZM-447439	FRK	82.0	10000.0
CP724714	CTK	100.0	10000.0
CH5424802	EPHA2	100.0	1000.0
WYE-125132	SIK1	86.0	10000.0
CH5424802	MP2K6	100.0	1000.0
QL-XII-47	ABL1(F317L)-nonphosphorylated	99.0	1000.0
WYE-125132	PRKR	100.0	10000.0
QL-X-138	FGFR3(G697C)	74.0	10000.0
HG-14-10-04	CSK	22.0	10000.0
WYE-125132	NDR2	100.0	10000.0
Vemurafenib	EGFR(T790M)	75.0	10000.0
NU7441	CHEK1	100.0	10000.0
Dinaciclib	ABL1(Y253F)-phosphorylated	79.0	10000.0
PHA-793887	PIK3C2G	100.0	10000.0
Ribociclib	VGFR1	100.0	1000.0
Sigma A6730	M4K1	51.0	10000.0
Dactolisib	CLK2	100.0	1000.0
GSK1059615	EGFR(L858R)	43.0	10000.0
Lapatinib	M3K12	100.0	10000.0
ZM-447439	DMPK2	72.0	10000.0
BMS345541	ULK1	86.0	10000.0
XMD8-85	PAK2	100.0	10000.0
HG-6-64-01	MST3	20.0	10000.0
Omipalisib	JNK1	41.0	10000.0
Abemaciclib	PIK3CA	100.0	1000.0
AZD-6482	PGFRB	100.0	10000.0
ALW-II-38-3	OSR1	100.0	10000.0
Pictilisib	JNK1	71.0	1000.0
AZD-6482	RSK3(Kin.Dom.2-C-terminal)	98.0	10000.0
XMD8-85	MKNK1	100.0	10000.0
SP600125	BRAF	100.0	10000.0
JNK-IN-11	CSF1R	6.0	1000.0
HG-6-64-01	LATS1	32.0	10000.0
BX-912	FER	47.0	10000.0
(s)-CR8	EGFR(L858R)	77.0	10000.0
SCH772984	BIKE	1.7	1000.0
CGP74514A	SIK1	9.7	10000.0
JW-7-24-1	CAMK2G	100.0	10000.0
Lapatinib	KCC4	100.0	10000.0
Dactolisib	YANK3	100.0	1000.0
WZ3105	SRMS	88.0	10000.0
AZD7762	EPHA3	0.2	10000.0
HG-14-8-02	CLK4	22.0	10000.0
KIN001-220	KPCL	100.0	10000.0
KU63794	PIM3	100.0	10000.0
MRT67307	CAMKK2	5.6	10000.0
QL-X-138	SIK3	78.0	10000.0
Vemurafenib	PIK3CA	94.0	10000.0
GW843682X	CSNK1A1	60.0	10000.0
Dinaciclib	ABL1(H396P)-nonphosphorylated	80.0	10000.0
Ribociclib	NUAK1	92.0	1000.0
Torkinib	ABL1-phosphorylated	0.1	10000.0
JNK-IN-11	FLT3(K663Q)	12.0	1000.0
Dactolisib	WEE1	100.0	1000.0
Torin1	EGFR(L747-S752del,P753S)	92.0	10000.0
XMD14-99	ABL1(F317L)-phosphorylated	70.0	10000.0
CGP74514A	MAP3K1	46.0	10000.0
KU63794	BMPR2	79.0	10000.0
AZD-6482	AKT2	86.0	10000.0
Baricitinib	SRPK3	7.6	10000.0
BGJ398	BRSK1	83.0	1000.0
PLX-4720	EPHA4	100.0	10000.0
KIN001-021	KIT(V559D)	100.0	1000.0
BI-D1870	MARK4	17.0	10000.0
HG-14-8-02	MKNK2	0.2	10000.0
GSK429286A	BTK	14.0	10000.0
GW-5074	NDR1	64.0	10000.0
PD173074	KPCD1	100.0	10000.0
PHA-793887	CSNK1A1L	94.0	10000.0
OTSSP167	VRK2	9.2	10000.0
HG-6-64-01	IRAK3	65.0	10000.0
PLX-4720	RIPK4	89.0	10000.0
HG-5-113-01	FAK1	0.0	10000.0
TAK-715	INSRR	100.0	10000.0
WH-4-023	PHKG1	12.0	10000.0
Torin2	HCK	100.0	10000.0
XMD11-85h	M4K3	100.0	10000.0
XMD8-85	ABL1	100.0	10000.0
XMD8-92	PAK7	100.0	10000.0
PD0325901	KC1G2	95.0	10000.0
WZ4003	TRKA	100.0	1000.0
RO-3306	PIK3C2B	29.0	10000.0
WH-4-023	RSK4(Kin.Dom.2-C-terminal)	67.0	10000.0
Torkinib	RSK1(Kin.Dom.2-C-terminal)	46.0	10000.0
Crizotinib	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
Torin1	JNK1	22.0	10000.0
GSK461364	CTK	52.0	10000.0
KIN001-111	EGFR(G719S)	5.2	1000.0
BGJ398	ERBB4	93.0	1000.0
Taselisib	TBK1	100.0	1000.0
HG-5-88-01	NDR2	100.0	10000.0
KU63794	MAPKAPK2	92.0	10000.0
NPK76-II-72-1	MERTK	100.0	10000.0
ERK5-IN-1	PLK1	95.0	1000.0
XMD11-50	EGFR(S752-I759del)	99.0	10000.0
XMD14-99	ERK5	14.0	10000.0
XMD16-144	MK12	83.0	10000.0
Alpelisib	FES	95.0	1000.0
MRT67307	KIT(A829P)	21.0	10000.0
WYE-125132	ACVR2B	77.0	10000.0
Torin1	BRSK1	78.0	10000.0
5z-7-oxozeaenol	PKNB(M.tuberculosis)	99.0	10000.0
Torin1	CDK3	100.0	10000.0
HG-14-10-04	BMPR1A	68.0	10000.0
HG-14-8-02	FGFR4	91.0	10000.0
WH-4-023	STK16	15.0	10000.0
PD0325901	TGFBR2	100.0	10000.0
BMX-IN-1	FLT3	81.0	10000.0
OTSSP167	ABL1(F317I)-nonphosphorylated	14.0	10000.0
HG-5-88-01	FGFR4	100.0	10000.0
Omipalisib	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
JNK-IN-5A	PIK3CA(C420R)	92.0	10000.0
JNK-IN-11	PGFRA	4.4	1000.0
KIN001-127	DYRK1B	100.0	10000.0
OTSSP167	EPHA2	1.8	10000.0
JNK-IN-8	ERBB3	93.0	1000.0
XMD14-99	LYN	100.0	10000.0
CGP60474	EGFR(L858R)	100.0	10000.0
GW843682X	DMPK2	64.0	10000.0
JNK-IN-11	EPHA7	100.0	1000.0
XMD8-92	ULK2	100.0	10000.0
ZG-10	PIK3C2G	100.0	10000.0
XMD14-99	BRSK2	87.0	10000.0
BGJ398	PKNB(M.tuberculosis)	97.0	1000.0
Canertinib	CSNK2A1	100.0	1000.0
Lapatinib	CAMK1G	100.0	10000.0
RO-3306	RIOK2	17.0	10000.0
BI-2536	EPHA8	100.0	10000.0
Canertinib	MP2K1	100.0	1000.0
RO-3306	CAMK1G	57.0	10000.0
Alpelisib	MARK2	100.0	1000.0
TAK-715	PCTK3	96.0	10000.0
KIN001-111	VGFR1	26.0	1000.0
TAK-715	RET(V804M)	94.0	10000.0
AZD-6482	RPS6KA5(Kin.Dom.1-N-terminal)	81.0	10000.0
AG1478	CSF1R	72.0	10000.0
Abemaciclib	RET(M918T)	93.0	1000.0
XMD11-50	LIMK2	100.0	10000.0
XMD16-144	TYRO3	100.0	10000.0
SP600125	GAK	1.2	10000.0
Barasertib	LIMK2	100.0	10000.0
THZ1	MKNK1	59.0	10000.0
GSK461364	NEK7	66.0	10000.0
Omipalisib	STK39	82.0	10000.0
CGP74514A	SGK1	9.7	10000.0
Torin1	S6K1	66.0	10000.0
JNK-IN-11	NDR1	97.0	1000.0
BMS345541	S6K1	96.0	10000.0
Crizotinib	CDC2L5	24.0	10000.0
KIN001-021	NEK9	100.0	1000.0
JW-7-24-1	MYO3A	100.0	10000.0
BX-912	SIK2	8.0	10000.0
CGP74514A	NDR2	28.0	10000.0
KIN001-127	TGFBR1	100.0	10000.0
BMX-IN-1	ROS1	83.0	10000.0
ZM-447439	ADCK4	66.0	10000.0
BGJ398	KPCD1	97.0	1000.0
BGJ398	INSRR	78.0	1000.0
PD173074	PIM1	100.0	10000.0
5z-7-oxozeaenol	CLK4	100.0	10000.0
Dactolisib	PIP5K1A	100.0	1000.0
GSK1059615	MST4	90.0	10000.0
Omipalisib	PLK1	69.0	10000.0
HG-14-10-04	RSK3(Kin.Dom.1-N-terminal)	1.2	10000.0
(s)-CR8	DCLK1	85.0	10000.0
Canertinib	EPHA2	100.0	1000.0
GSK461364	CDC2L1	100.0	10000.0
Barasertib	DMPK	93.0	10000.0
GSK1059615	TYK2(JH2domain-pseudokinase)	51.0	10000.0
Momelotinib	ABL1(F317L)-nonphosphorylated	100.0	10000.0
ALW-II-38-3	JAK3(JH1domain-catalytic)	100.0	10000.0
NU7441	ACVR1B	91.0	10000.0
A443654	FGFR1	100.0	10000.0
CGP74514A	RSK4(Kin.Dom.1-N-terminal)	4.8	10000.0
RO-3306	ALK(C1156Y)	76.0	10000.0
Sigma A6730	CDK15	76.0	10000.0
BX-912	FLT3(ITD)	0.0	10000.0
(s)-CR8	NEK3	100.0	10000.0
HG-6-64-01	CDK3	100.0	10000.0
HG-9-91-01	STK36	0.0	10000.0
KIN001-220	PIM2	100.0	10000.0
(s)-CR8	TNK1	100.0	10000.0
HG-14-10-04	SRPK1	0.6	10000.0
Torin2	NEK11	80.0	10000.0
Omipalisib	PAK7	85.0	10000.0
SCH772984	RSK3(Kin.Dom.1-N-terminal)	100.0	1000.0
Sorafenib	RET(V804L)	0.1	10000.0
AS-252424	LATS1	100.0	10000.0
GSK461364	CSF1R	77.0	10000.0
Torkinib	BTK	22.0	10000.0
ZSTK474	KPCD2	100.0	1000.0
CH5424802	BRAF(V600E)	93.0	1000.0
QL-XII-47	MK03	100.0	1000.0
Barasertib	CSNK2A1	84.0	10000.0
JNK-9L	STK39	100.0	10000.0
JNK-9L	TAOK2	37.0	10000.0
HG-14-10-04	MP2K2	1.4	10000.0
Barasertib	BMPR1A	100.0	10000.0
BGJ398	TYRO3	97.0	1000.0
XMD-12	BRAF(V600E)	100.0	1000.0
ERK5-IN-1	DRAK1	100.0	1000.0
Ibrutinib	JAK3(JH1domain-catalytic)	0.0	1000.0
QL-X-138	SIK2	62.0	10000.0
(s)-CR8	FES	96.0	10000.0
Neratinib	RSK1(Kin.Dom.2-C-terminal)	85.0	10000.0
Ribociclib	BIKE	94.0	1000.0
HG-9-91-01	PTK6	0.0	10000.0
TGX221	MAP4K5	100.0	1000.0
(s)-CR8	PAK4	91.0	10000.0
Canertinib	RIPK2	29.0	1000.0
Palbociclib	MET(M1250T)	97.0	1000.0
Vemurafenib	RET(V804L)	90.0	10000.0
XMD11-50	MARK1	87.0	10000.0
Crizotinib	TAOK3	1.4	10000.0
TGX221	KGP1	100.0	1000.0
RO-3306	CDKL1	95.0	10000.0
BMS345541	RSK1(Kin.Dom.1-N-terminal)	79.0	10000.0
JNK-IN-5A	TRPM6	100.0	10000.0
BS-181	VGFR1	98.0	10000.0
PLX-4720	KPCL	100.0	10000.0
AZD-6482	KGP2	98.0	10000.0
Ceritinib	FGFR2	87.0	1000.0
BMS345541	KPCT	99.0	10000.0
Barasertib	NEK9	100.0	10000.0
BMS-536924	WEE1	100.0	1000.0
CGP60474	PKN2	100.0	10000.0
HG-14-8-02	PIK3CA(I800L)	100.0	10000.0
Alpelisib	PIK4CB	7.7	1000.0
Torkinib	MAP3K1	45.0	10000.0
MPS-1-IN-1	FLT3(ITD)	100.0	1000.0
Palbociclib	GSK3A	78.0	1000.0
PLX-4720	CSNK1G3	79.0	10000.0
5z-7-oxozeaenol	HIPK3	100.0	10000.0
JNK-IN-11	STK39	82.0	1000.0
CP466722	M3K12	52.0	10000.0
KIN001-021	BRSK1	100.0	1000.0
WH-4-023	MP2K3	66.0	10000.0
Ceritinib	PIK3CA(H1047L)	70.0	1000.0
KIN001-021	CLK2	100.0	1000.0
XMD16-144	KGP1	100.0	10000.0
Vemurafenib	DYRK1B	100.0	10000.0
XMD11-50	PAK1	95.0	10000.0
QL-XII-47	MK12	98.0	1000.0
MRT67307	RAF1	100.0	10000.0
KIN001-220	M3K13	44.0	10000.0
THZ1	GRK1	28.0	10000.0
Dactolisib	MP2K2	100.0	1000.0
MLN8054	MYLK2	100.0	10000.0
BX-912	ABL1(Q252H)-nonphosphorylated	0.0	10000.0
CP466722	SLK	28.0	10000.0
Ceritinib	RSK4(Kin.Dom.1-N-terminal)	59.0	1000.0
HG-9-91-01	MINK	4.8	10000.0
BS-181	SLK	97.0	10000.0
JNK-IN-5A	CLK3	72.0	10000.0
PD0325901	RPS6KA4(Kin.Dom.1-N-terminal)	86.0	10000.0
(s)-CR8	TGFBR1	99.0	10000.0
Dinaciclib	WEE2	82.0	10000.0
CH5424802	NUAK1	95.0	1000.0
SP600125	NEK5	100.0	10000.0
TGX221	RPS6KA3(Kin.Dom.1)	100.0	1000.0
CGP60474	ERBB3	100.0	10000.0
AZD4547	PIP5K1C	18.0	10000.0
CGP60474	PIK4CB	100.0	10000.0
THZ1	INSR	0.0	10000.0
CG-930	GAK	13.0	10000.0
HG-14-10-04	YSK1	62.0	10000.0
Buparlisib	DDR1	100.0	1000.0
KIN001-220	DCAMKL2	88.0	10000.0
XMD13-2	KCC4	100.0	10000.0
XMD16-144	ADCK3	74.0	10000.0
ALW-II-38-3	PHKG1	100.0	10000.0
AZD4547	CIT	84.0	10000.0
XMD13-2	CLK2	37.0	10000.0
ZG-10	EGFR(G719S)	97.0	10000.0
Taselisib	IKKB	97.0	1000.0
TAK-715	KIT(V559D,V654A)	83.0	10000.0
(s)-CR8	RIPK4	83.0	10000.0
AZD-6482	ABL1(E255K)-phosphorylated	94.0	10000.0
NVP-TAE684	PGFRA	0.9	1000.0
MRT67307	FGR	43.0	10000.0
JWE-035	EGFR(E746-A750del)	74.0	10000.0
Ceritinib	MLK2	92.0	1000.0
ALW-II-38-3	ACVRL1	100.0	10000.0
AZD-6482	PKN1	100.0	10000.0
Crizotinib	KPCD1	2.4	10000.0
SCH772984	PGFRB	71.0	1000.0
Sorafenib	LRRK2(G2019S)	89.0	10000.0
BS-181	CSNK2A2	88.0	10000.0
NPK76-II-72-1	VGFR1	100.0	10000.0
XMD11-85h	PHKG2	100.0	10000.0
NPK76-II-72-1	PHKG2	100.0	10000.0
Momelotinib	M4K1	11.0	10000.0
XMD11-50	MAK	72.0	10000.0
KU63794	FGFR3	100.0	10000.0
Ceritinib	IKKB	92.0	1000.0
SCH772984	TIE2	85.0	1000.0
WZ-4-145	NEK7	100.0	10000.0
Torkinib	CAMK1	45.0	10000.0
MPS-1-IN-1	EPHB4	100.0	1000.0
WZ4003	IKKB	100.0	1000.0
MPS-1-IN-1	NEK7	100.0	1000.0
Momelotinib	MARK3	16.0	10000.0
XMD16-144	ABL1(T315I)-phosphorylated	0.3	10000.0
SCH772984	MKNK2	82.0	1000.0
Pictilisib	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	1000.0
XMD8-85	ADCK3	100.0	10000.0
HG-9-91-01	CDK4-cyclinD1	2.0	10000.0
XMD11-85h	TNK2	100.0	10000.0
KIN001-021	SRPK2	100.0	1000.0
GSK429286A	DRAK1	95.0	10000.0
BGJ398	PLK3	92.0	1000.0
R406	TESK1	19.0	1000.0
ALW-II-49-7	ZAP70	100.0	10000.0
SP600125	RET(V804L)	100.0	10000.0
ZG-10	PCTK3	95.0	10000.0
GSK461364	RPS6KA5(Kin.Dom.2-C-terminal)	34.0	10000.0
HG-6-64-01	ABL1(H396P)-nonphosphorylated	0.1	10000.0
BS-181	M3K12	99.0	10000.0
A443654	MAP4K4	2.2	10000.0
Momelotinib	RAF1	100.0	10000.0
Baricitinib	EPHB3	100.0	10000.0
JWE-035	FGR	26.0	10000.0
BS-181	SRC	100.0	10000.0
Vemurafenib	SNARK	98.0	10000.0
BMS345541	EPHB4	100.0	10000.0
AZD4547	EGFR(L858R)	79.0	10000.0
KIN001-220	RSK1(Kin.Dom.2-C-terminal)	45.0	10000.0
NU7441	MLK3	97.0	10000.0
SB590885	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
HG-14-10-04	CLK2	0.1	10000.0
SP600125	JAK1(Kin.Dom.2)	100.0	10000.0
BMS-536924	SLK	1.6	1000.0
WZ-7043	MARK4	100.0	10000.0
GSK429286A	TESK1	92.0	10000.0
Ibrutinib	TAOK1	84.0	1000.0
Dinaciclib	CDK8	93.0	10000.0
Alpelisib	DCAMKL2	98.0	1000.0
MLN8054	SGK3	100.0	10000.0
ZG-10	ABL1-phosphorylated	43.0	10000.0
BMS-536924	MK09	100.0	1000.0
WZ4003	LIMK2	100.0	1000.0
ZM-447439	ACVR1	100.0	10000.0
PD0325901	FAK2	98.0	10000.0
QL-XII-47	MAK	100.0	1000.0
HG-14-8-02	PKAC-alpha	100.0	10000.0
WZ4003	EPHA5	100.0	1000.0
JWE-035	EGFR(T790M)	100.0	10000.0
XMD11-85h	EGFR(S752-I759del)	100.0	10000.0
Buparlisib	AXL	99.0	1000.0
XMD11-85h	SgK110	100.0	10000.0
5z-7-oxozeaenol	PHKG2	82.0	10000.0
GW-5074	BMPR1A	88.0	10000.0
Palbociclib	RAF1	99.0	1000.0
KU63794	NEK11	72.0	10000.0
HG-14-8-02	TRPM6	100.0	10000.0
BX-912	PIK3CA(C420R)	81.0	10000.0
HG-6-64-01	HIPK2	41.0	10000.0
Torin1	EPHA1	62.0	10000.0
THZ1	NEK3	57.0	10000.0
MRT67307	FLT3(K663Q)	0.2	10000.0
SP600125	WEE2	100.0	10000.0
HG-14-8-02	TNIK	7.6	10000.0
SB590885	S6K1	85.0	10000.0
XMD16-144	EPHA7	100.0	10000.0
Sigma A6730	AURKB	91.0	10000.0
BI-D1870	KC1G2	4.2	10000.0
NU7441	CDK9	98.0	10000.0
GSK429286A	EGFR	40.0	10000.0
R406	PGFRB	0.0	1000.0
AZ-628	PRKR	75.0	10000.0
XMD8-92	KGP2	100.0	10000.0
Abemaciclib	NEK7	100.0	1000.0
HG-6-64-01	RSK1(Kin.Dom.2-C-terminal)	20.0	10000.0
A443654	CDC2L2	100.0	10000.0
SB590885	PCTK3	100.0	10000.0
ZM-447439	TSSK1	100.0	10000.0
Torin1	CDK16	91.0	10000.0
RO-3306	TSSK1	38.0	10000.0
NPK76-II-72-1	ACVR1B	100.0	10000.0
THZ1	MK14	71.0	10000.0
JNK-IN-8	NDR1	97.0	1000.0
Torin1	STK33	90.0	10000.0
ERK5-IN-1	FGFR4	100.0	1000.0
SP600125	PIK3C2B	100.0	10000.0
GSK429286A	OSR1	92.0	10000.0
A443654	JAK2(Kin.Dom.2)	100.0	10000.0
RO-3306	GSK3A	85.0	10000.0
HG-14-10-04	KIT(V559D,T670I)	0.1	10000.0
Vemurafenib	FGFR3(G697C)	100.0	10000.0
PHA-767491	LRRK2(G2019S)	16.0	10000.0
RO-3306	GAK	4.0	10000.0
AZD 5438	STK39	47.0	10000.0
JW-7-24-1	ALK	100.0	10000.0
WH-4-023	CDKL3	0.1	10000.0
WZ4003	CIT	100.0	1000.0
XMD8-85	AMPK-alpha2	100.0	10000.0
XMD11-50	MP2K4	100.0	10000.0
PLX-4720	CSF1R	2.2	10000.0
KIN001-123	EGFR(G719C)	100.0	1000.0
5z-7-oxozeaenol	TAK1	3.6	10000.0
Momelotinib	HIPK4	12.0	10000.0
CGP60474	AAK1	21.0	10000.0
PD173074	SRPK2	100.0	10000.0
OTSSP167	ERK5	1.4	10000.0
Ibrutinib	ERK4	100.0	1000.0
WYE-125132	KPCI	67.0	10000.0
XMD11-85h	EGFR(L747-T751del,Sins)	100.0	10000.0
XMD13-2	CSNK1E	80.0	10000.0
KIN001-220	MLK1	17.0	10000.0
HG-6-64-01	CDK9	96.0	10000.0
ALW-II-49-7	CAMK1G	100.0	10000.0
PD0325901	PIK3C2G	48.0	10000.0
Sorafenib	PHKG2	100.0	10000.0
KIN001-111	CDC2L1	100.0	1000.0
KIN001-220	RET(V804M)	4.6	10000.0
BX-912	LIMK2	59.0	10000.0
R406	RPS6KA6(Kin.Dom.2)	30.0	1000.0
HG-9-91-01	EPHA5	1.4	10000.0
HG-5-88-01	ITK	100.0	10000.0
WZ-4-145	ITK	16.0	10000.0
ALW-II-49-7	CAMK2B	100.0	10000.0
XMD8-85	BMPR1B	100.0	10000.0
WYE-125132	MST2	97.0	10000.0
ZM-447439	MK03	100.0	10000.0
JNK-IN-11	ADCK3	0.0	1000.0
WZ3105	ABL1(F317I)-nonphosphorylated	90.0	10000.0
WZ3105	ABL1-phosphorylated	49.0	10000.0
Abemaciclib	MYO3A	90.0	1000.0
KIN001-220	RSK4(Kin.Dom.2-C-terminal)	62.0	10000.0
Momelotinib	PIK3CA	74.0	10000.0
XMD14-99	PRP4	100.0	10000.0
Abemaciclib	KPCL	33.0	1000.0
XMD-12	BRAF	94.0	1000.0
XMD-12	SIK3	91.0	1000.0
GSK429286A	MKNK2	62.0	10000.0
PD173074	MYO3B	100.0	10000.0
GW843682X	KIT(V559D,V654A)	100.0	10000.0
MPS-1-IN-1	RIOK3	0.0	1000.0
XMD11-50	SIK1	77.0	10000.0
KIN001-021	RPS6KA1(Kin.Dom.1)	100.0	1000.0
BX-912	MK13	11.0	10000.0
QL-X-138	VGFR2	50.0	10000.0
WZ4003	CDK8	100.0	1000.0
PLX-4720	SBK1	92.0	10000.0
AZD 5438	KIT(L576P)	8.1	10000.0
KU63794	FES	99.0	10000.0
WZ-4-145	CDK5	100.0	10000.0
Alpelisib	DAPK2	83.0	1000.0
NU7441	EPHA2	72.0	10000.0
XMD16-144	WEE2	97.0	10000.0
XMD8-92	TIE2	100.0	10000.0
HG-6-64-01	CDK4-cyclinD3	73.0	10000.0
CH5424802	NDR2	97.0	1000.0
ALW-II-49-7	RPS6KA5(Kin.Dom.2)	100.0	10000.0
Buparlisib	FGFR1	86.0	1000.0
JW-7-24-1	TIE1	100.0	10000.0
KIN001-123	MK14	100.0	1000.0
PHA-767491	EGFR(L861Q)	88.0	10000.0
HG-6-64-01	KIT(V559D,V654A)	2.6	10000.0
BX-912	PKN2	4.6	10000.0
AZD 5438	EIF2AK1	100.0	10000.0
BI-2536	EPHA6	100.0	10000.0
WZ-4-145	MK11	100.0	10000.0
QL-X-138	MK01	100.0	10000.0
BS-181	EPHA5	91.0	10000.0
MRT67307	LKB1	2.2	10000.0
Seliciclib	FGFR4	100.0	10000.0
Pictilisib	DYRK1A	100.0	1000.0
WZ-4-145	FLT3	6.0	10000.0
GSK461364	RPS6KA4(Kin.Dom.2-C-terminal)	0.6	10000.0
Neratinib	INSRR	94.0	10000.0
GW-5074	SRMS	65.0	10000.0
JNK-IN-11	CAMK1	100.0	1000.0
HG-9-91-01	EGFR(L747-T751del,Sins)	1.2	10000.0
Ribociclib	MST1	100.0	1000.0
NG25	ABL2	0.3	10000.0
KU63794	LOK	92.0	10000.0
NPK76-II-72-1	CIT	100.0	10000.0
HG-14-8-02	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
WZ4002	TNIK	100.0	10000.0
GSK429286A	MLCK	92.0	10000.0
XMD16-144	FLT3(D835H)	5.3	10000.0
SB590885	CHEK1	80.0	10000.0
Vemurafenib	CAMK1G	92.0	10000.0
CGP74514A	PIM2	1.2	10000.0
WZ3105	PIP5K1C	100.0	10000.0
QL-X-138	ABL1-phosphorylated	68.0	10000.0
GW-5074	ABL1(H396P)-phosphorylated	77.0	10000.0
A443654	MYLK4	3.0	10000.0
Alpelisib	RSK2(Kin.Dom.1-N-terminal)	97.0	1000.0
Momelotinib	FES	100.0	10000.0
AZD 5438	MP2K6	0.3	10000.0
Ribociclib	PAK7	93.0	1000.0
GSK429286A	PFPK5(P.falciparum)	100.0	10000.0
A443654	TAK1	3.2	10000.0
GSK429286A	TAOK1	53.0	10000.0
HG-14-10-04	MP2K3	1.3	10000.0
HG-14-10-04	SRC	0.7	10000.0
Sorafenib	SGK3	82.0	10000.0
BMS-536924	EPHB1	28.0	1000.0
KIN001-123	MLK1	100.0	1000.0
Seliciclib	M3K5	100.0	10000.0
AZD7762	BLK	0.0	10000.0
WH-4-023	PRKR	92.0	10000.0
KIN001-220	BMPR2	22.0	10000.0
GW843682X	TNNI3K	81.0	10000.0
SB590885	NIM1	91.0	10000.0
R406	MAP3K4	13.0	1000.0
Barasertib	MET(M1250T)	52.0	10000.0
GW843682X	PRKX	98.0	10000.0
HG-14-8-02	PIK3CA(E542K)	100.0	10000.0
AZD-6482	ABL1(Q252H)-nonphosphorylated	100.0	10000.0
Pictilisib	KCC4	94.0	1000.0
Lapatinib	CDC2L2	91.0	10000.0
WZ4003	PIK3CB	100.0	1000.0
KIN001-220	JAK1(JH1domain-catalytic)	6.9	10000.0
ALW-II-49-7	PRKX	100.0	10000.0
Torin1	MK03	91.0	10000.0
HG-9-91-01	OSR1	80.0	10000.0
KIN001-111	CDK7	100.0	1000.0
Omipalisib	FGFR1	63.0	10000.0
Ceritinib	PFCDPK1(P.falciparum)	80.0	1000.0
Ceritinib	AURKB	96.0	1000.0
Dactolisib	AXL	100.0	1000.0
Torin2	TXK	100.0	10000.0
WH-4-023	MET(M1250T)	5.4	10000.0
SCH772984	FLT3(R834Q)	82.0	1000.0
XMD-12	TLK1	69.0	1000.0
XMD14-99	ALK	0.4	10000.0
HG-14-8-02	ERK5	86.0	10000.0
JNK-9L	TNK2	61.0	10000.0
Crizotinib	MP2K5	54.0	10000.0
WZ4003	KGP1	100.0	1000.0
NVP-TAE684	MP2K6	100.0	1000.0
HG-9-91-01	ACVR1B	2.2	10000.0
5z-7-oxozeaenol	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
QL-XII-47	ALK(C1156Y)	100.0	1000.0
AZD-6482	CIT	89.0	10000.0
NVP-TAE684	KIT	0.1	1000.0
XMD8-92	FGFR3(G697C)	100.0	10000.0
JNK-9L	NIM1	58.0	10000.0
AG1478	NIM1	77.0	10000.0
ZG-10	TAOK2	70.0	10000.0
Dactolisib	PIK3CB	22.0	1000.0
WZ-4-145	RET(M918T)	0.4	10000.0
HG-5-88-01	AMPK-alpha2	100.0	10000.0
(s)-CR8	ABL1(Q252H)-nonphosphorylated	100.0	10000.0
Pictilisib	TNNI3K	100.0	1000.0
JWE-035	MYLK2	88.0	10000.0
NPK76-II-72-1	MKNK2	100.0	10000.0
Ribociclib	EGFR(L747-S752del,P753S)	99.0	1000.0
R406	YANK2	29.0	1000.0
JNK-9L	DRAK2	56.0	10000.0
PD0325901	TNK1	68.0	10000.0
JNK-IN-11	BTK	100.0	1000.0
BMX-IN-1	FER	89.0	10000.0
HG-5-88-01	PIM1	100.0	10000.0
KU63794	PHKG1	93.0	10000.0
SB590885	CAMK2B	98.0	10000.0
XMD8-85	PKAC-alpha	100.0	10000.0
ZM-447439	DYRK1A	58.0	10000.0
XMD16-144	BMPR1B	0.7	10000.0
CGP74514A	PAK7	0.4	10000.0
WZ-4-145	MK09	100.0	10000.0
HG-14-10-04	FYN	22.0	10000.0
Ceritinib	CSNK2A1	61.0	1000.0
(s)-CR8	MK13	93.0	10000.0
XMD14-99	MST1R	96.0	10000.0
CP466722	EGFR(L858R,T790M)	84.0	10000.0
BMS345541	TAOK2	70.0	10000.0
HG-14-10-04	MUSK	3.3	10000.0
PHA-767491	CHK2	14.0	10000.0
AZ-628	CDK4-cyclinD1	61.0	10000.0
AZD-6482	TESK1	100.0	10000.0
NVP-TAE684	JAK3(Kin.Dom.2)	0.0	1000.0
Ceritinib	YANK1	5.1	1000.0
BS-181	RIPK2	84.0	10000.0
KIN001-127	TAOK1	16.0	10000.0
Sigma A6730	CAMK2B	86.0	10000.0
OTSSP167	MARK2	57.0	10000.0
QL-X-138	MAPKAPK5	78.0	10000.0
Palbociclib	KGP1	100.0	1000.0
AG1478	PAK2	53.0	10000.0
AZ-628	HIPK1	100.0	10000.0
BI-2536	FRK	100.0	10000.0
AZD 5438	CDC2L1	11.0	10000.0
GW843682X	CTK	85.0	10000.0
PD173074	FES	100.0	10000.0
Ceritinib	PIK3CA(C420R)	86.0	1000.0
ZG-10	SgK110	100.0	10000.0
Alpelisib	PIK3CA	0.0	1000.0
XMD-12	MAPKAPK2	100.0	1000.0
BI-D1870	DRAK2	9.8	10000.0
ERK5-IN-1	RET	100.0	1000.0
Lapatinib	GSK3B	100.0	10000.0
CG-930	SRPK1	100.0	10000.0
ZG-10	EGFR(L747-S752del,P753S)	96.0	10000.0
Omipalisib	GRK4	100.0	10000.0
R406	DMPK2	100.0	1000.0
AZD7762	ERK3	54.0	10000.0
XMD13-2	DRAK2	100.0	10000.0
KIN001-021	MK01	100.0	1000.0
JNK-IN-11	EGFR(L747-T751del,Sins)	3.4	1000.0
Momelotinib	AMPK-alpha1	42.0	10000.0
AZD4547	DYRK2	44.0	10000.0
KIN001-021	FLT3(ITD)	100.0	1000.0
Ribociclib	CAMK1G	79.0	1000.0
Buparlisib	NIM1	100.0	1000.0
XMD16-144	PAK2	67.0	10000.0
5z-7-oxozeaenol	IKKB	79.0	10000.0
AZD4547	BUB1	56.0	10000.0
CGP74514A	MARK4	41.0	10000.0
Palbociclib	FER	92.0	1000.0
Baricitinib	MARK3	1.4	10000.0
BI-2536	ERK5	19.0	10000.0
KIN001-123	RIPK1	100.0	1000.0
BMX-IN-1	EPHB4	100.0	10000.0
Buparlisib	IRAK3	100.0	1000.0
Sigma A6730	NDR2	82.0	10000.0
Baricitinib	CSNK2A2	23.0	10000.0
Momelotinib	SgK110	83.0	10000.0
ALW-II-38-3	STK33	100.0	10000.0
MLN8054	ADCK4	95.0	10000.0
Baricitinib	AMPK-alpha1	42.0	10000.0
Torin1	M3K5	100.0	10000.0
GSK1059615	RET	98.0	10000.0
Lapatinib	PLK3	91.0	10000.0
BI-2536	M3K5	100.0	10000.0
Dactolisib	TAOK2	100.0	1000.0
WZ-4-145	ULK2	100.0	10000.0
NVP-TAE684	PAK1	4.8	1000.0
AZ-628	MST3	79.0	10000.0
AZ-628	BMPR1B	100.0	10000.0
CP466722	KIT(D816V)	0.2	10000.0
Dactolisib	PLK2	100.0	1000.0
Seliciclib	PIM2	73.0	10000.0
XMD16-144	PTK6	37.0	10000.0
Seliciclib	EGFR(L858R,T790M)	98.0	10000.0
PLX-4720	ANKK1	98.0	10000.0
HG-14-8-02	AMPK-alpha2	97.0	10000.0
PHA-793887	MAP3K4	100.0	10000.0
Barasertib	PRP4	67.0	10000.0
GSK461364	FRK	100.0	10000.0
Ceritinib	KC1G2	88.0	1000.0
NPK76-II-72-1	SIK2	100.0	10000.0
Sigma A6730	CDK16	97.0	10000.0
AZD7762	CDKL1	46.0	10000.0
Omipalisib	MP2K1	80.0	10000.0
ZG-10	MYLK4	36.0	10000.0
KIN001-111	PLK1	100.0	1000.0
XMD8-92	FLT3(ITD)	100.0	10000.0
GSK429286A	PRKX	14.0	10000.0
Dinaciclib	NLK	100.0	10000.0
Dabrafenib	EGFR	76.0	10000.0
WZ3105	CDK8	100.0	10000.0
HG-5-113-01	CSNK1D	100.0	10000.0
KIN001-127	MARK4	100.0	10000.0
HG-5-113-01	EGFR(G719C)	100.0	10000.0
TAK-715	FLT4	27.0	10000.0
QL-XII-47	EGFR(L858R,T790M)	72.0	1000.0
SP600125	SLK	100.0	10000.0
KIN001-123	LIMK1	100.0	1000.0
AZD 5438	MK09	0.0	10000.0
SB590885	KIT(D816V)	79.0	10000.0
AG1478	JAK1(JH1domain-catalytic)	84.0	10000.0
WZ3105	MAPKAPK5	87.0	10000.0
Momelotinib	NUAK1	45.0	10000.0
AS-252424	MK03	100.0	10000.0
KIN001-123	DMPK2	100.0	1000.0
BI-2536	ITK	100.0	10000.0
5z-7-oxozeaenol	GRK7	100.0	10000.0
WZ-7043	KIT	6.7	10000.0
HG-6-64-01	SNRK	95.0	10000.0
QL-XI-92	PKAC-beta	100.0	10000.0
KIN001-123	CLK3	100.0	1000.0
WZ-7043	PIK3CA(Q546K)	100.0	10000.0
GSK429286A	PIK3CA(M1043I)	93.0	10000.0
PLX-4720	ERK5	65.0	10000.0
GSK429286A	RIOK3	100.0	10000.0
PHA-793887	EPHA2	98.0	10000.0
ZM-447439	KC1G2	100.0	10000.0
Taselisib	FLT3(D835V)	87.0	1000.0
Pictilisib	BARK2	100.0	1000.0
CP466722	BRAF	36.0	10000.0
ZG-10	MAST1	100.0	10000.0
MRT67307	TTK	51.0	10000.0
GW-5074	ADCK3	100.0	10000.0
JNK-IN-8	IKKA	100.0	1000.0
KU63794	FLT3(D835Y)	86.0	10000.0
ALW-II-38-3	MK13	100.0	10000.0
Sorafenib	STK36	23.0	10000.0
SCH772984	PKMYT1	97.0	1000.0
PLX-4720	MAP3K1	73.0	10000.0
WZ3105	SIK1	85.0	10000.0
JNK-IN-5A	MK13	46.0	10000.0
A443654	LIMK2	100.0	10000.0
QL-XI-92	DCAMKL2	100.0	10000.0
PD173074	TSSK1	100.0	10000.0
XMD11-50	NDR1	96.0	10000.0
SP600125	FYN	100.0	10000.0
WZ4002	BMPR2	100.0	10000.0
WZ3105	EPHA5	76.0	10000.0
Ibrutinib	MINK	88.0	1000.0
AZD7762	MUSK	18.0	10000.0
BS-181	MYO3A	100.0	10000.0
NPK76-II-72-1	BMX	100.0	10000.0
R406	MKNK2	0.0	1000.0
TGX221	DCAMKL3	100.0	1000.0
Seliciclib	MK12	60.0	10000.0
Neratinib	MYLK	73.0	10000.0
HG-14-10-04	MP2K5	0.4	10000.0
Vemurafenib	PLK1	100.0	10000.0
KIN001-220	NEK3	60.0	10000.0
HG-5-113-01	BRAF(V600E)	100.0	10000.0
BX-912	CSNK2A1	0.3	10000.0
PHA-767491	PRP4	84.0	10000.0
SCH772984	PIK3CG	96.0	1000.0
BGJ398	FLT4	35.0	1000.0
JWE-035	ITK	100.0	10000.0
BX-912	RET(V804L)	0.2	10000.0
Palbociclib	YSK1	100.0	1000.0
Seliciclib	MINK	61.0	10000.0
XMD8-85	KIT(L576P)	100.0	10000.0
KIN001-111	FLT4	100.0	1000.0
GW843682X	KIT(V559D,T670I)	21.0	10000.0
AZ-628	PKN1	100.0	10000.0
QL-XII-47	PIM1	100.0	1000.0
BMS345541	TAOK3	59.0	10000.0
MLN8054	ACVR2A	95.0	10000.0
Momelotinib	SNARK	8.9	10000.0
JNK-IN-5A	CLK4	84.0	10000.0
Taselisib	STK39	77.0	1000.0
PLX-4720	ABL1(F317L)-nonphosphorylated	7.0	10000.0
Abemaciclib	GCN2(Kin.Dom.2,S808G)	1.9	1000.0
Neratinib	CSNK1D	60.0	10000.0
AZD7762	PIK3CA(C420R)	62.0	10000.0
MRT67307	PIK3CA(E545A)	99.0	10000.0
Dabrafenib	CDK8	3.2	10000.0
XMD14-99	AKT3	100.0	10000.0
Buparlisib	AMPK-alpha1	97.0	1000.0
KIN001-123	FRK	100.0	1000.0
QL-XII-47	CDK9	100.0	1000.0
HG-14-10-04	KIT-autoinhibited	17.0	10000.0
Sorafenib	M4K1	41.0	10000.0
AZD4547	ADCK3	95.0	10000.0
Dinaciclib	PIK3CA(E545A)	89.0	10000.0
WZ3105	NEK3	60.0	10000.0
AZD 5438	KPCL	38.0	10000.0
GW843682X	PCTK3	83.0	10000.0
Ibrutinib	PCTK3	78.0	1000.0
WYE-125132	ALK	42.0	10000.0
BMS345541	MST1R	100.0	10000.0
Torkinib	ERBB2	29.0	10000.0
THZ1	WEE1	17.0	10000.0
SB590885	NEK11	81.0	10000.0
WYE-125132	LKB1	80.0	10000.0
AZD 5438	BIKE	0.3	10000.0
QL-X-138	MYO3B	100.0	10000.0
AZD 5438	MYO3B	100.0	10000.0
RO-3306	PIK3CA(Q546K)	78.0	10000.0
WH-4-023	PKN2	19.0	10000.0
GSK1059615	RSK3(Kin.Dom.1-N-terminal)	100.0	10000.0
BGJ398	EGFR(L858R,T790M)	81.0	1000.0
Abemaciclib	GSK3B	1.2	1000.0
Omipalisib	SNARK	75.0	10000.0
AZD 5438	SIK3	100.0	10000.0
BS-181	EGFR(L858R,T790M)	90.0	10000.0
WYE-125132	CDK11	100.0	10000.0
HG-14-8-02	MK13	100.0	10000.0
WH-4-023	FGFR3(G697C)	2.6	10000.0
GSK1059615	MTOR	5.0	10000.0
HG-9-91-01	HIPK3	100.0	10000.0
HG-5-113-01	FGFR3	18.0	10000.0
HG-5-113-01	CLK3	2.8	10000.0
WZ-7043	IKKE	100.0	10000.0
JNK-IN-11	PKAC-beta	83.0	1000.0
MLN8054	RET(M918T)	54.0	10000.0
XMD13-2	FGFR2	100.0	10000.0
NPK76-II-72-1	DCAMKL3	100.0	10000.0
Seliciclib	RIPK4	80.0	10000.0
XMD11-85h	EGFR(L747-E749del,A750P)	100.0	10000.0
AZD4547	SNARK	0.4	10000.0
NU7441	FYN	100.0	10000.0
ERK5-IN-1	STK39	100.0	1000.0
Ibrutinib	PFCDPK1(P.falciparum)	0.0	1000.0
NPK76-II-72-1	EPHB4	100.0	10000.0
KIN001-220	KCC2D	71.0	10000.0
JNK-IN-11	SRPK3	100.0	1000.0
MPS-1-IN-1	EPHB3	100.0	1000.0
KIN001-111	MELK	31.0	1000.0
GSK461364	RSK1(Kin.Dom.2-C-terminal)	71.0	10000.0
SP600125	SRPK1	32.0	10000.0
JNK-IN-5A	KPCT	86.0	10000.0
MLN8054	SRPK2	80.0	10000.0
BMS-536924	MRCKB	13.0	1000.0
HG-9-91-01	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
GSK429286A	CLK3	65.0	10000.0
Ribociclib	TSSK3	99.0	1000.0
JW-7-24-1	SRPK2	100.0	10000.0
Sigma A6730	ABL1-nonphosphorylated	100.0	10000.0
JNK-IN-11	MK11	6.6	1000.0
Lapatinib	RIPK4	100.0	10000.0
Taselisib	BLK	100.0	1000.0
Dactolisib	INSRR	100.0	1000.0
BMS345541	BMPR2	71.0	10000.0
NG25	MAPKAPK5	100.0	10000.0
HG-5-113-01	IKKE	100.0	10000.0
CGP60474	ULK3	100.0	10000.0
WYE-125132	PAK3	99.0	10000.0
HG-9-91-01	INSR	89.0	10000.0
HG-9-91-01	MYLK4	100.0	10000.0
Dinaciclib	KC1G1	94.0	10000.0
GSK461364	SIK3	69.0	10000.0
JNK-IN-5A	PKNB(M.tuberculosis)	100.0	10000.0
SB590885	BIKE	82.0	10000.0
WH-4-023	MK12	75.0	10000.0
OTSSP167	IRAK1	3.0	10000.0
PD173074	ABL1(Y253F)	100.0	10000.0
THZ1	MP2K2	1.0	10000.0
WYE-125132	STK35	95.0	10000.0
Ceritinib	MARK3	100.0	1000.0
THZ1	ACVR1B	46.0	10000.0
AZ-628	ABL1(F317L)-phosphorylated	6.4	10000.0
JNK-IN-8	PDPK1	61.0	1000.0
GSK1059615	PAK3	20.0	10000.0
Baricitinib	MK03	97.0	10000.0
Alpelisib	CDK5	100.0	1000.0
XMD16-144	MK03	100.0	10000.0
Barasertib	IRAK4	76.0	10000.0
Torin2	MLK3	96.0	10000.0
Crizotinib	AURKC	3.4	10000.0
AZ-628	LIMK1	100.0	10000.0
TGX221	KIT(V559D,V654A)	100.0	1000.0
XMD-12	FLT3	100.0	1000.0
WZ-4-145	LIMK2	100.0	10000.0
Dinaciclib	LIMK1	100.0	10000.0
XMD13-2	BMX	91.0	10000.0
GSK1059615	PFPK5(P.falciparum)	93.0	10000.0
BS-181	SRPK3	95.0	10000.0
A443654	FGFR3	100.0	10000.0
SCH772984	EGFR(G719S)	98.0	1000.0
Dactolisib	ACVR2B	100.0	1000.0
SP600125	ACVR2A	100.0	10000.0
GW-5074	AMPK-alpha1	100.0	10000.0
PD173074	ACVR2A	100.0	10000.0
Baricitinib	AURKC	21.0	10000.0
WZ-7043	PKAC-beta	100.0	10000.0
AZD 5438	EPHB2	50.0	10000.0
JNK-IN-8	ABL1(Y253F)-phosphorylated	71.0	1000.0
XMD11-85h	CDKL2	100.0	10000.0
NU7441	PFPK5(P.falciparum)	100.0	10000.0
WZ3105	MRCKA	82.0	10000.0
5z-7-oxozeaenol	CSNK1G3	94.0	10000.0
ZSTK474	CAMK2A	100.0	1000.0
HG-9-91-01	WEE1	100.0	10000.0
ERK5-IN-1	EPHB3	100.0	1000.0
JNK-IN-11	RET(V804L)	89.0	1000.0
WZ4002	CHK2	8.8	10000.0
WZ-7043	CLK1	100.0	10000.0
ERK5-IN-1	AAK1	100.0	1000.0
GSK1059615	NEK9	95.0	10000.0
GSK461364	CDK4-cyclinD3	70.0	10000.0
Palbociclib	SNRK	100.0	1000.0
R406	MUSK	0.2	1000.0
Baricitinib	TAK1	13.0	10000.0
SCH772984	MRCKB	78.0	1000.0
Lapatinib	MAPKAPK5	100.0	10000.0
ALW-II-38-3	M3K2	100.0	10000.0
Dinaciclib	MYO3A	95.0	10000.0
PD0325901	DYRK1A	100.0	10000.0
5z-7-oxozeaenol	PIK3CA(M1043I)	100.0	10000.0
AZ-628	KPCD1	67.0	10000.0
HG-9-91-01	M3K5	100.0	10000.0
QL-XII-47	ERK8	100.0	1000.0
TGX221	SLK	100.0	1000.0
NVP-TAE684	AMPK-alpha2	0.2	1000.0
KIN001-123	KPCD	100.0	1000.0
KIN001-111	BRSK1	35.0	1000.0
CH5424802	PAK3	56.0	1000.0
Crizotinib	IRAK3	1.0	10000.0
JNK-IN-8	KC1G1	100.0	1000.0
AZD-6482	MTOR	11.0	10000.0
GSK461364	IRAK4	43.0	10000.0
WZ4003	RET	100.0	1000.0
ZG-10	PIK3CG	13.0	10000.0
ALW-II-38-3	IRAK3	100.0	10000.0
Dabrafenib	MINK	46.0	10000.0
QL-XI-92	RPS6KA5(Kin.Dom.1-N-terminal)	82.0	10000.0
OTSSP167	DDR1	2.6	10000.0
Pictilisib	ABL1(F317I)	100.0	10000.0
Buparlisib	FLT3(D835V)	70.0	1000.0
Neratinib	RIOK2	53.0	10000.0
BI-2536	PHKG2	20.0	10000.0
QL-XII-47	RSK3(Kin.Dom.2-C-terminal)	68.0	1000.0
Dactolisib	FGFR3	100.0	1000.0
CGP60474	CSNK1G3	100.0	10000.0
THZ1	MLK1	0.2	10000.0
KU63794	EGFR	100.0	10000.0
BS-181	CDK15	45.0	10000.0
Torkinib	NEK1	61.0	10000.0
R406	FLT3(D835Y)	0.0	1000.0
Ribociclib	CDK8	100.0	1000.0
ZG-10	ITK	100.0	10000.0
NG25	CDK5	19.0	10000.0
HG-9-91-01	ANKK1	61.0	10000.0
Seliciclib	RPS6KA4(Kin.Dom.1-N-terminal)	89.0	10000.0
XMD13-2	FER	78.0	10000.0
CH5424802	MP2K1	100.0	1000.0
AZD4547	MLK2	14.0	10000.0
WZ-4-145	ROCK2	100.0	10000.0
Alpelisib	MST1R	100.0	1000.0
MRT67307	M3K2	3.7	10000.0
HG-14-8-02	NEK10	62.0	10000.0
XMD13-2	KGP2	72.0	10000.0
RO-3306	PIK3CA(H1047L)	26.0	10000.0
KU63794	NEK6	96.0	10000.0
CP724714	DRAK1	84.0	10000.0
Sorafenib	DCAMKL3	75.0	10000.0
JWE-035	AXL	11.0	10000.0
BI-2536	PLK3	0.0	10000.0
GSK1059615	MP2K4	9.6	10000.0
NU7441	IKKE	100.0	10000.0
Pictilisib	MKNK1	86.0	1000.0
MRT67307	EGFR	98.0	10000.0
R406	PAK6	4.1	1000.0
GW843682X	KPCT	92.0	10000.0
CP466722	TYK2(JH2domain-pseudokinase)	0.0	10000.0
PLX-4720	TNNI3K	75.0	10000.0
Baricitinib	MK11	93.0	10000.0
WYE-125132	HIPK4	100.0	10000.0
WZ4003	EPHB2	100.0	1000.0
QL-XI-92	RPS6KA4(Kin.Dom.2-C-terminal)	94.0	10000.0
XMD16-144	PKMYT1	100.0	10000.0
SB590885	DCAMKL3	89.0	10000.0
XMD11-50	CSNK1D	81.0	10000.0
HG-9-91-01	TYK2(JH1domain-catalytic)	48.0	10000.0
KU63794	CDK16	100.0	10000.0
AZD 5438	PIM1	75.0	10000.0
WZ4003	CDK9	100.0	1000.0
HG-9-91-01	EPHB2	0.0	10000.0
AS-252424	KCC4	100.0	10000.0
Pictilisib	YSK1	100.0	1000.0
WZ-7043	JAK3(JH1domain-catalytic)	100.0	10000.0
XMD13-2	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
NU7441	FLT3(ITD)	93.0	10000.0
Torin2	EGFR(G719S)	88.0	10000.0
WH-4-023	TAK1	57.0	10000.0
Ibrutinib	MAP4K2	79.0	1000.0
CH5424802	SNARK	82.0	1000.0
Crizotinib	SRPK2	46.0	10000.0
AZD-6482	DRAK1	98.0	10000.0
GSK1059615	BMPR1A	91.0	10000.0
XMD11-85h	PAK1	100.0	10000.0
ZM-447439	CDK5	100.0	10000.0
JNK-IN-5A	CHEK1	82.0	10000.0
QL-XI-92	YANK1	100.0	10000.0
JNK-9L	KC1G1	92.0	10000.0
AZD 5438	ABL1(Q252H)-nonphosphorylated	2.4	10000.0
Sorafenib	CSK	70.0	10000.0
JWE-035	ULK2	0.0	10000.0
CGP60474	GRK7	100.0	10000.0
THZ1	ACVRL1	100.0	10000.0
XMD8-85	KGP1	100.0	10000.0
XMD8-92	RPS6KA3(Kin.Dom.1)	100.0	10000.0
ZG-10	M3K6	86.0	10000.0
PD0325901	PKAC-beta	98.0	10000.0
JWE-035	TNNI3K	78.0	10000.0
XMD16-144	PAK4	61.0	10000.0
Crizotinib	AMPK-alpha1	8.0	10000.0
XMD-12	ULK2	6.2	1000.0
KU63794	CDC2L5	100.0	10000.0
Crizotinib	LCK	0.2	10000.0
GSK461364	PCTK2	90.0	10000.0
XMD13-2	CSNK1A1	100.0	10000.0
Taselisib	PIK3CA(H1047L)	0.0	1000.0
GW843682X	KPCD2	100.0	10000.0
HG-5-88-01	TYK2(Kin.Dom.2)	100.0	10000.0
HG-9-91-01	SRPK3	93.0	10000.0
Neratinib	NLK	95.0	10000.0
JNK-IN-5A	TEC	91.0	10000.0
PD0325901	TAOK3	89.0	10000.0
THZ1	IRAK1	0.5	10000.0
BMS345541	KIT	37.0	10000.0
JNK-IN-5A	RPS6KA5(Kin.Dom.1-N-terminal)	85.0	10000.0
Barasertib	EGFR(S752-I759del)	30.0	10000.0
AZD 5438	ABL1(T315I)-phosphorylated	7.2	10000.0
ZSTK474	PAK7/PAK5	100.0	1000.0
QL-XI-92	ERN1	90.0	10000.0
HG-14-8-02	STK35	100.0	10000.0
AZD 5438	FGFR1	64.0	10000.0
KIN001-220	CDK8	46.0	10000.0
ZSTK474	PLK4	100.0	1000.0
CGP60474	PIK3C2B	100.0	10000.0
GW843682X	ANKK1	80.0	10000.0
PLX-4720	HUNK	24.0	10000.0
GSK1059615	TNNI3K	79.0	10000.0
AS-252424	CSK	100.0	10000.0
HG-14-10-04	EPHA2	100.0	10000.0
Vemurafenib	DCAMKL3	47.0	10000.0
SB590885	MYO3A	94.0	10000.0
KIN001-021	TNK2	100.0	1000.0
AZD4547	KIT(D816H)	3.2	10000.0
R406	NUAK1	0.9	1000.0
XMD-12	PHKG2	100.0	1000.0
BMX-IN-1	MARK1	89.0	10000.0
Buparlisib	OSR1	100.0	1000.0
JWE-035	CDK15	76.0	10000.0
Buparlisib	ABL1-nonphosphorylated	68.0	1000.0
XMD8-85	DMPK	100.0	10000.0
KIN001-123	GAK	100.0	1000.0
WZ-7043	ACVRL1	100.0	10000.0
WZ-4-145	MK13	4.9	10000.0
Ceritinib	ADCK3	86.0	1000.0
BMX-IN-1	M4K3	100.0	10000.0
OTSSP167	MKNK2	2.2	10000.0
ALW-II-49-7	KIT(V559D,T670I)	100.0	10000.0
XMD14-99	ULK3	100.0	10000.0
AZD-6482	EPHA5	99.0	10000.0
Crizotinib	DAPK2	97.0	10000.0
CP724714	CAMK2B	88.0	10000.0
A443654	BRAF	100.0	10000.0
ZSTK474	PIM1	100.0	1000.0
Dactolisib	TRKC	100.0	1000.0
PHA-767491	ABL1(H396P)-nonphosphorylated	45.0	10000.0
Torin2	MK12	87.0	10000.0
HG-5-113-01	JAK3(Kin.Dom.2)	1.8	10000.0
ZM-447439	DAPK2	90.0	10000.0
AG1478	PFPK5(P.falciparum)	100.0	10000.0
Baricitinib	TXK	70.0	10000.0
HG-9-91-01	FRK	0.0	10000.0
Momelotinib	KCC4	100.0	10000.0
(s)-CR8	RET(M918T)	94.0	10000.0
MLN8054	FLT3(R834Q)	100.0	10000.0
BI-2536	MLTK	100.0	10000.0
Seliciclib	GAK	81.0	10000.0
GW-5074	PIK3CA(E542K)	84.0	10000.0
HG-9-91-01	KIT(V559D,T670I)	94.0	10000.0
PHA-767491	ABL2	100.0	10000.0
Seliciclib	SNRK	100.0	10000.0
BMS-536924	EPHB4	30.0	1000.0
NU7441	MRCKB	88.0	10000.0
WYE-125132	M3K12	93.0	10000.0
WYE-125132	STK33	82.0	10000.0
BI-D1870	KIT(L576P)	0.4	10000.0
ZSTK474	MAP4K5	100.0	1000.0
GW843682X	AKT2	100.0	10000.0
BGJ398	GSK3B	82.0	1000.0
MLN8054	LRRK2	82.0	10000.0
Alpelisib	KCC4	98.0	1000.0
PLX-4720	CDKL5	92.0	10000.0
Palbociclib	SRPK3	87.0	1000.0
HG-5-113-01	EGFR(L747-S752del,P753S)	100.0	10000.0
NG25	RPS6KA4(Kin.Dom.1)	4.0	10000.0
Ceritinib	MAK	94.0	1000.0
Taselisib	NEK1	100.0	1000.0
WZ3105	MARK2	57.0	10000.0
ZG-10	EPHA8	91.0	10000.0
ALW-II-49-7	STK35	100.0	10000.0
HG-14-10-04	SYK	3.1	10000.0
ERK5-IN-1	MP2K7	88.0	1000.0
GSK461364	BMX	97.0	10000.0
XMD16-144	SRPK3	63.0	10000.0
Momelotinib	PLK2	51.0	10000.0
KIN001-021	JAK1(Kin.Dom.2)	100.0	1000.0
5z-7-oxozeaenol	SGK1	100.0	10000.0
TGX221	ACVR1B	100.0	1000.0
KIN001-123	ACVR1	100.0	1000.0
AZD 5438	CSK	65.0	10000.0
KIN001-220	ABL2	20.0	10000.0
BMS345541	RET(V804L)	100.0	10000.0
GSK461364	PLK3	3.6	10000.0
JNK-9L	MKNK2	34.0	10000.0
KIN001-220	PRKR	15.0	10000.0
SP600125	ADCK4	100.0	10000.0
CGP60474	ABL2	100.0	10000.0
Dinaciclib	EPHA3	99.0	10000.0
Alpelisib	HIPK4	39.0	1000.0
JNK-IN-5A	LIMK1	76.0	10000.0
PHA-793887	NEK7	100.0	10000.0
HG-5-88-01	KIT(V559D,V654A)	100.0	10000.0
OTSSP167	CSNK1D	9.4	10000.0
WZ4002	ABL1(H396P)	100.0	10000.0
Barasertib	SGK3	100.0	10000.0
ERK5-IN-1	MST1	100.0	1000.0
PHA-793887	ADCK4	100.0	10000.0
WZ-7043	FRK	100.0	10000.0
BI-D1870	CDK9	25.0	10000.0
Dabrafenib	BLK	3.0	10000.0
A443654	PIM2	1.2	10000.0
XMD11-50	ABL1(T315I)-nonphosphorylated	100.0	10000.0
Taselisib	PIK3CA(E545K)	0.0	1000.0
HG-6-64-01	EPHA8	0.2	10000.0
Vemurafenib	M4K1	20.0	10000.0
WZ-4-145	ABL1(H396P)	20.0	10000.0
Barasertib	KIT(V559D,V654A)	6.2	10000.0
XMD8-92	FGR	100.0	10000.0
BI-D1870	AMPK-alpha1	9.0	10000.0
Omipalisib	EPHA8	77.0	10000.0
CP466722	NEK11	80.0	10000.0
KIN001-127	SYK	100.0	10000.0
WYE-125132	RSK1(Kin.Dom.1-N-terminal)	100.0	10000.0
CP466722	PIK3CA(M1043I)	36.0	10000.0
JNK-IN-8	FLT3(K663Q)	75.0	1000.0
JW-7-24-1	RPS6KA4(Kin.Dom.2)	100.0	10000.0
JNK-IN-5A	RET	94.0	10000.0
XMD8-92	TGFBR1	100.0	10000.0
BS-181	NEK10	90.0	10000.0
XMD13-2	CDK4-cyclinD3	82.0	10000.0
SB590885	MLK3	100.0	10000.0
GSK461364	TAOK3	19.0	10000.0
MRT67307	PIM3	91.0	10000.0
WZ4003	FES	12.0	1000.0
HG-5-113-01	SgK110	7.4	10000.0
TGX221	CLK2	100.0	1000.0
CGP60474	ERN1	100.0	10000.0
GSK1059615	ABL1(Y253F)-phosphorylated	68.0	10000.0
NG25	IGF1R	100.0	10000.0
BS-181	HIPK3	64.0	10000.0
SCH772984	CAMK2B	97.0	1000.0
R406	MAPKAPK2	100.0	1000.0
KU63794	FYN	96.0	10000.0
KU63794	PIM1	94.0	10000.0
GSK1059615	PIK3CA(E545A)	0.1	10000.0
HG-14-8-02	ACVR1B	88.0	10000.0
Lapatinib	KCC2D	100.0	10000.0
ZM-447439	FLT4	83.0	10000.0
Palbociclib	PKN1	77.0	1000.0
CH5424802	CDKL3	97.0	1000.0
WZ-4-145	LIMK1	100.0	10000.0
SB590885	ABL1(Q252H)-nonphosphorylated	3.0	10000.0
Dabrafenib	PIK4CB	0.7	10000.0
CH5424802	CDK11	100.0	1000.0
BMX-IN-1	PIM3	82.0	10000.0
AZD7762	ERK4	61.0	10000.0
WYE-125132	CSNK1E	39.0	10000.0
Torkinib	PIK3C2B	5.6	10000.0
GSK429286A	LYN	72.0	10000.0
Vemurafenib	TGFBR2	2.5	10000.0
AZD 5438	MP2K2	15.0	10000.0
WZ4002	MK13	100.0	10000.0
CGP74514A	MP2K7	57.0	10000.0
JNK-IN-8	LCK	100.0	1000.0
SP600125	DCAMKL2	100.0	10000.0
PLX-4720	FGFR3(G697C)	100.0	10000.0
BMX-IN-1	EGFR(E746-A750del)	75.0	10000.0
QL-X-138	PKAC-alpha	100.0	10000.0
KU63794	CDKL2	95.0	10000.0
SCH772984	FLT3(N841I)	34.0	1000.0
MPS-1-IN-1	CAMK2G	100.0	1000.0
AZD-6482	FES	94.0	10000.0
JNK-9L	NEK4	100.0	10000.0
WZ4003	EPHB3	100.0	1000.0
CGP60474	ABL1(Q252H)	100.0	10000.0
WZ-4-145	BRAF	100.0	10000.0
CG-930	CSNK2A1	100.0	10000.0
Seliciclib	EGFR(E746-A750del)	89.0	10000.0
JW-7-24-1	ABL1(T315I)	100.0	10000.0
WZ3105	FRK	53.0	10000.0
GW-5074	SRPK2	87.0	10000.0
AZD7762	PCTK2	84.0	10000.0
THZ1	JAK1(JH2domain-pseudokinase)	5.3	10000.0
Baricitinib	MAP4K5	70.0	10000.0
BMS-536924	CSF1R	0.4	1000.0
Omipalisib	NEK6	96.0	10000.0
HG-14-10-04	DMPK2	99.0	10000.0
BMX-IN-1	CAMK1	88.0	10000.0
TAK-715	BRSK1	93.0	10000.0
BS-181	PGFRB	70.0	10000.0
JNK-9L	AKT3	100.0	10000.0
WYE-125132	MAPKAPK5	100.0	10000.0
GW-5074	JNK1	86.0	10000.0
Torin2	ABL1(F317L)-nonphosphorylated	99.0	10000.0
PLX-4720	MAP4K4	64.0	10000.0
WZ-4-145	PHKG2	100.0	10000.0
BX-912	PIK3CA	100.0	10000.0
XMD14-99	VGFR1	100.0	10000.0
Ceritinib	AAK1	89.0	1000.0
Momelotinib	GAK	3.4	10000.0
XMD8-92	MP2K6	100.0	10000.0
WYE-125132	IRAK1	100.0	10000.0
(s)-CR8	MRCKA	96.0	10000.0
GSK429286A	BLK	12.0	10000.0
Torin2	OSR1	100.0	10000.0
JNK-IN-5A	NDR1	100.0	10000.0
BI-2536	FER	100.0	10000.0
Ceritinib	KCC4	14.0	1000.0
JNK-9L	MET	24.0	10000.0
Momelotinib	CDK4-cyclinD1	13.0	10000.0
WZ3105	CDK5	80.0	10000.0
JNK-9L	EPHA1	42.0	10000.0
TGX221	JAK1(Kin.Dom.1)	100.0	1000.0
CGP60474	ERK8	2.0	10000.0
JNK-IN-5A	EPHB1	91.0	10000.0
QL-XII-47	CAMK1D	100.0	1000.0
GSK1059615	KPCI	67.0	10000.0
Torin2	BMX	100.0	10000.0
PD173074	PKN1	100.0	10000.0
Ceritinib	SGK1	89.0	1000.0
Dinaciclib	EPHB2	100.0	10000.0
ERK5-IN-1	ANKK1	84.0	1000.0
Baricitinib	STK33	21.0	10000.0
MRT67307	RET(V804M)	0.8	10000.0
HG-14-10-04	FLT3(ITD)	0.1	10000.0
AS-252424	EPHB1	100.0	10000.0
Abemaciclib	DAPK2	15.0	1000.0
XMD8-85	PIK3CA(Q546K)	100.0	10000.0
XMD11-50	PIP5K1C	96.0	10000.0
MPS-1-IN-1	MET	100.0	1000.0
ERK5-IN-1	PIK3CA(E545A)	91.0	1000.0
KIN001-127	EGFR	100.0	10000.0
PHA-767491	NEK11	86.0	10000.0
PD173074	FRK	100.0	10000.0
QL-XII-47	RET(V804M)	100.0	1000.0
5z-7-oxozeaenol	KCC2D	97.0	10000.0
BX-912	MAP4K4	2.4	10000.0
QL-X-138	ERK5	98.0	10000.0
Sorafenib	JAK3(JH1domain-catalytic)	58.0	10000.0
Seliciclib	SgK110	100.0	10000.0
Ibrutinib	PIK3CA(M1043I)	65.0	1000.0
SB590885	CDK16	100.0	10000.0
THZ1	MYLK2	16.0	10000.0
XMD-12	SRPK2	100.0	1000.0
WYE-125132	EPHA5	92.0	10000.0
Baricitinib	BIKE	0.1	10000.0
Ceritinib	CSNK1A1L	92.0	1000.0
WYE-125132	EGFR(L858R)	53.0	10000.0
QL-X-138	PRP4	84.0	10000.0
BI-2536	RPS6KA3(Kin.Dom.1)	100.0	10000.0
GW-5074	MK03	100.0	10000.0
Omipalisib	ACVR2B	97.0	10000.0
AZD-6482	VGFR1	83.0	10000.0
Abemaciclib	YANK2	100.0	1000.0
XMD-12	MELK	100.0	1000.0
Ribociclib	BRAF	100.0	1000.0
Ribociclib	PGFRB	94.0	1000.0
CGP60474	CSF1R	100.0	10000.0
QL-XI-92	CDKL5	100.0	10000.0
Ceritinib	SNRK	53.0	1000.0
Abemaciclib	PIK3C2B	100.0	1000.0
GW843682X	RIPK1	74.0	10000.0
GSK429286A	MK01	50.0	10000.0
WZ4003	STK16	16.0	1000.0
(s)-CR8	TAOK3	98.0	10000.0
SCH772984	MK03	0.1	1000.0
Lapatinib	EGFR(L858R)	0.0	10000.0
RO-3306	MP2K6	91.0	10000.0
KU63794	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
BI-2536	RPS6KA4(Kin.Dom.2)	0.0	10000.0
JNK-9L	PRP4	57.0	10000.0
AZD-6482	TAOK3	100.0	10000.0
KU63794	NEK3	61.0	10000.0
GW-5074	M4K1	71.0	10000.0
CGP60474	INSR	100.0	10000.0
Buparlisib	SRPK2	84.0	1000.0
Vemurafenib	FLT4	82.0	10000.0
XMD11-50	CSNK1A1L	100.0	10000.0
HG-14-8-02	CSNK1A1L	100.0	10000.0
AS-252424	PKN1	71.9	10000.0
HG-14-10-04	KPCT	93.0	10000.0
Lapatinib	PCTK2	97.0	10000.0
XMD11-50	SGK3	95.0	10000.0
GW-5074	TIE1	86.0	10000.0
SB590885	MK01	100.0	10000.0
WZ4002	DCLK1	1.0	10000.0
QL-XI-92	PIK3C2G	100.0	10000.0
(s)-CR8	PLK3	96.0	10000.0
SCH772984	ADCK3	84.0	1000.0
XMD8-85	PKN2	100.0	10000.0
PHA-767491	RIPK2	41.0	10000.0
Lapatinib	PTK6	78.0	10000.0
BMS345541	ABL1(F317I)-nonphosphorylated	100.0	10000.0
PHA-767491	CDK14	71.0	10000.0
AZ-628	KIT(V559D,V654A)	1.2	10000.0
Seliciclib	TNK1	100.0	10000.0
MPS-1-IN-1	GAK	5.4	1000.0
AZD4547	TNK2	11.0	10000.0
JNK-IN-11	MK14	2.1	1000.0
Ceritinib	EGFR(L747-E749del,A750P)	46.0	1000.0
GW-5074	DDR2	73.0	10000.0
NVP-TAE684	TYK2(Kin.Dom.2)	0.5	1000.0
Neratinib	KCC2D	100.0	10000.0
Torkinib	PIK3CA(M1043I)	22.0	10000.0
Dabrafenib	PAK3	3.0	10000.0
A443654	MP2K1	100.0	10000.0
Torin2	KIT(L576P)	51.0	10000.0
KU63794	M3K2	78.0	10000.0
CG-930	GSK3B	95.0	10000.0
SCH772984	TESK1	96.0	1000.0
CGP74514A	IKKA	57.0	10000.0
WZ-7043	EGFR(G719C)	100.0	10000.0
Sorafenib	SBK1	89.0	10000.0
ZM-447439	PAK3	87.0	10000.0
Sorafenib	WEE2	87.0	10000.0
Crizotinib	CAMKK2	8.8	10000.0
XMD16-144	ABL1-nonphosphorylated	0.1	10000.0
JNK-IN-11	LKB1	93.0	1000.0
WZ4003	MAPKAPK2	100.0	1000.0
HG-9-91-01	TAOK3	0.1	10000.0
ZG-10	PKAC-alpha	100.0	10000.0
Torin1	FLT3(D835Y)	16.0	10000.0
5z-7-oxozeaenol	LATS1	100.0	10000.0
Torkinib	ULK1	86.0	10000.0
KIN001-123	KIT(V559D,V654A)	100.0	1000.0
KU63794	TNIK	100.0	10000.0
AZD7762	MARK4	2.2	10000.0
TAK-715	FGR	52.0	10000.0
KIN001-127	CDK16	100.0	10000.0
HG-14-10-04	RSK1(Kin.Dom.1-N-terminal)	0.0	10000.0
AZD4547	ALK(L1196M)	8.6	10000.0
BI-2536	TEC	100.0	10000.0
BI-D1870	TNIK	8.7	10000.0
XMD11-85h	CDKL3	100.0	10000.0
HG-14-8-02	CAMK1D	21.0	10000.0
BMS-536924	VGFR2	21.0	1000.0
TGX221	FAK1	100.0	1000.0
AZD7762	SIK3	6.2	10000.0
MRT67307	PIK3CA(Q546K)	100.0	10000.0
Abemaciclib	MKNK2	94.0	1000.0
5z-7-oxozeaenol	NEK3	85.0	10000.0
NG25	ACVR2A	100.0	10000.0
Abemaciclib	SBK1	73.0	1000.0
GSK429286A	HIPK3	85.0	10000.0
HG-5-113-01	RPS6KA5(Kin.Dom.2)	100.0	10000.0
Baricitinib	IRAK1	0.4	10000.0
BGJ398	NUAK1	97.0	1000.0
CGP74514A	M3K6	55.0	10000.0
HG-5-88-01	ROS1	3.2	10000.0
JNK-IN-11	MP2K4	100.0	1000.0
Palbociclib	RSK4(Kin.Dom.2-C-terminal)	95.0	1000.0
Canertinib	ADCK4	100.0	1000.0
CP724714	EGFR(L747-S752del,P753S)	3.7	10000.0
Crizotinib	KPCD2	3.3	10000.0
Vemurafenib	CDK11	0.8	10000.0
KIN001-127	DCLK1	31.0	10000.0
A443654	DMPK2	0.8	10000.0
SCH772984	STK35	72.0	1000.0
THZ1	ERBB2	100.0	10000.0
Pictilisib	MUSK	100.0	1000.0
BI-D1870	TYRO3	34.0	10000.0
AZD-6482	IRAK4	100.0	10000.0
AZD 5438	MST4	9.4	10000.0
BS-181	FGR	86.0	10000.0
THZ1	S6K1	13.0	10000.0
BI-2536	AKT2	100.0	10000.0
QL-X-138	NDR2	100.0	10000.0
CGP74514A	PLK1	14.0	10000.0
KIN001-021	KIT(V559D,T670I)	100.0	1000.0
Ribociclib	PCTK2	94.0	1000.0
XMD14-99	TLK2	93.0	10000.0
Dinaciclib	MST2	65.0	10000.0
HG-14-8-02	BIKE	78.0	10000.0
ZG-10	DYRK1B	24.0	10000.0
CGP60474	MP2K3	100.0	10000.0
R406	MARK3	7.2	1000.0
WZ-7043	KGP1	100.0	10000.0
BX-912	STK36	18.0	10000.0
Neratinib	PLK1	57.0	10000.0
Momelotinib	KIT(V559D,V654A)	100.0	10000.0
Dabrafenib	NLK	15.0	10000.0
Vemurafenib	BRAF(V600E)	0.2	10000.0
Neratinib	EPHA4	96.0	10000.0
XMD8-85	PDPK1	100.0	10000.0
XMD13-2	PHKG1	76.0	10000.0
KU63794	IKKB	100.0	10000.0
PHA-793887	MAST1	98.0	10000.0
BMS345541	TSSK1	100.0	10000.0
Seliciclib	DRAK2	90.0	10000.0
HG-9-91-01	RIOK1	16.0	10000.0
5z-7-oxozeaenol	CSNK1E	99.0	10000.0
Buparlisib	IKKE	100.0	1000.0
XMD11-85h	ACVR1	100.0	10000.0
CP466722	MYLK	0.8	10000.0
AG1478	MARK3	100.0	10000.0
JNK-IN-5A	MAP3K15	100.0	10000.0
PLX-4720	FGFR1	34.0	10000.0
KIN001-111	NEK7	100.0	1000.0
CGP60474	AURKA	100.0	10000.0
KIN001-123	SYK	100.0	1000.0
Buparlisib	FGFR3(G697C)	100.0	1000.0
Taselisib	CSNK2A2	96.0	1000.0
JNK-9L	STK36	15.0	10000.0
ZM-447439	EGFR(G719S)	0.5	10000.0
CGP60474	MRCKB	100.0	10000.0
AZD 5438	AURKA	0.3	10000.0
BGJ398	NEK5	100.0	1000.0
WH-4-023	FRK	0.0	10000.0
Torkinib	TBK1	84.0	10000.0
Seliciclib	PIK3CA(Q546K)	100.0	10000.0
XMD13-2	ULK2	77.0	10000.0
Dactolisib	INSR	100.0	1000.0
Torin1	PIK3CA(E545K)	0.6	10000.0
NU7441	PIK3CA(H1047Y)	11.0	10000.0
WZ-7043	ITK	100.0	10000.0
BI-D1870	GRK4	11.0	10000.0
GSK461364	RSK2(Kin.Dom.1-N-terminal)	0.5	10000.0
HG-9-91-01	PIP5K1C	20.0	10000.0
THZ1	TGFBR2	34.0	10000.0
ALW-II-38-3	FGFR1	100.0	10000.0
Ibrutinib	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	1000.0
BX-912	PKNB(M.tuberculosis)	6.6	10000.0
5z-7-oxozeaenol	EPHA3	68.0	10000.0
JWE-035	PIK3CA(E545K)	24.0	10000.0
XMD16-144	STK33	8.9	10000.0
BS-181	SIK3	100.0	10000.0
PHA-767491	GRK7	28.0	10000.0
HG-5-113-01	CSNK1E	29.0	10000.0
Taselisib	STK33	92.0	1000.0
JNK-IN-11	CAMK1G	94.0	1000.0
KIN001-220	EPHA8	63.0	10000.0
Omipalisib	CDC2L1	91.0	10000.0
NG25	BTK	100.0	10000.0
XMD11-50	INSRR	97.0	10000.0
WZ4002	KCC4	100.0	10000.0
R406	KCC4	100.0	1000.0
KIN001-127	MK11	100.0	10000.0
Dactolisib	ERN1	100.0	1000.0
Torkinib	FLT3(K663Q)	27.0	10000.0
KU63794	PIK3CA(M1043I)	2.0	10000.0
XMD14-99	MST1	100.0	10000.0
XMD11-85h	CDK3	100.0	10000.0
(s)-CR8	GAK	99.0	10000.0
Abemaciclib	RET(V804M)	100.0	1000.0
NVP-TAE684	SIK1	0.0	1000.0
WZ3105	ERBB3	94.0	10000.0
Ibrutinib	PI42C	92.0	1000.0
AG1478	MYO3B	100.0	10000.0
Dactolisib	CDC2L2	100.0	1000.0
NU7441	FLT3(D835H)	92.0	10000.0
Ceritinib	CDC2L2	85.0	1000.0
Seliciclib	EPHA2	100.0	10000.0
PLX-4720	TIE2	100.0	10000.0
XMD13-2	PTK6	97.0	10000.0
XMD-12	FES	100.0	1000.0
PD0325901	RET(V804M)	100.0	10000.0
Vemurafenib	CSK	7.4	10000.0
HG-14-10-04	ABL1(M351T)-phosphorylated	0.7	10000.0
ZG-10	PIK3CA(I800L)	60.0	10000.0
Lapatinib	MAK	92.0	10000.0
ZM-447439	PFPK5(P.falciparum)	100.0	10000.0
BMX-IN-1	EGFR(L858R)	50.0	10000.0
Dinaciclib	FLT3(D835H)	94.0	10000.0
XMD16-144	GRK4	66.0	10000.0
Buparlisib	CDK7	100.0	1000.0
Torkinib	PTK6	32.0	10000.0
XMD14-99	GRK4	85.0	10000.0
NG25	LKB1	100.0	10000.0
XMD11-50	HIPK4	100.0	10000.0
AZD4547	FLT3(N841I)	0.0	10000.0
(s)-CR8	FAK2	88.0	10000.0
Ibrutinib	MK03	94.0	1000.0
(s)-CR8	CLK1	46.0	10000.0
GW843682X	EGFR(T790M)	100.0	10000.0
HG-9-91-01	MET	46.0	10000.0
CGP74514A	FAK1	41.0	10000.0
KU63794	M4K1	88.0	10000.0
AS-252424	FGFR3	100.0	10000.0
XMD8-92	RIPK4	100.0	10000.0
OTSSP167	ABL1(Y253F)-phosphorylated	0.6	10000.0
Ribociclib	CAMK2B	36.0	1000.0
Palbociclib	RSK4(Kin.Dom.1-N-terminal)	87.0	1000.0
GSK1059615	RAF1	47.0	10000.0
AZD 5438	CDC2L2	11.0	10000.0
WZ-7043	CDK16	100.0	10000.0
CGP60474	TEC	100.0	10000.0
Palbociclib	RET	100.0	1000.0
XMD-12	ABL1(Q252H)-phosphorylated	0.4	1000.0
JNK-9L	ERBB2	100.0	10000.0
Palbociclib	EGFR(G719S)	92.0	1000.0
CP724714	RPS6KA4(Kin.Dom.1-N-terminal)	97.0	10000.0
Dabrafenib	EPHA3	6.0	10000.0
Alpelisib	EPHB3	92.0	1000.0
WZ-7043	TAOK2	0.3	10000.0
Canertinib	MET	100.0	1000.0
WZ4003	MK13	100.0	1000.0
XMD-12	VGFR2	97.0	1000.0
PHA-767491	CDK4-cyclinD3	7.2	10000.0
CP724714	ABL1-phosphorylated	78.0	10000.0
5z-7-oxozeaenol	VGFR2	5.2	10000.0
Ceritinib	PKAC-alpha	88.0	1000.0
SB590885	FLT3(D835Y)	64.0	10000.0
Canertinib	RIOK1	100.0	1000.0
PHA-767491	EGFR(S752-I759del)	85.0	10000.0
AS-252424	BRAF	46.8	10000.0
CG-930	RIOK2	94.0	10000.0
PLX-4720	CSNK1A1	84.0	10000.0
Momelotinib	CLK4	15.0	10000.0
BS-181	MAK	90.0	10000.0
AZ-628	KIT	0.0	10000.0
GSK1059615	MAP3K4	96.0	10000.0
Ceritinib	VGFR2	90.0	1000.0
Torin2	STK16	59.0	10000.0
PHA-793887	KC1G2	100.0	10000.0
Dabrafenib	PIK3CD	100.0	10000.0
Pictilisib	MELK	100.0	1000.0
XMD11-50	TNK1	2.8	10000.0
(s)-CR8	PKMYT1	14.0	10000.0
WZ4002	DMPK	17.0	10000.0
AZD 5438	ABL1(H396P)-phosphorylated	12.0	10000.0
ALW-II-38-3	CAMK1D	100.0	10000.0
Alpelisib	KPCE	85.0	1000.0
Dactolisib	MKNK1	100.0	1000.0
A443654	MP2K6	100.0	10000.0
Baricitinib	PAK1	86.0	10000.0
JNK-IN-5A	TAOK2	100.0	10000.0
BMS345541	EPHA7	100.0	10000.0
JNK-IN-5A	CDK2	95.0	10000.0
XMD13-2	FLT4	100.0	10000.0
QL-XI-92	FGFR3(G697C)	91.0	10000.0
KU63794	PRP4	100.0	10000.0
ALW-II-49-7	SRPK2	100.0	10000.0
Momelotinib	CDC2L1	66.0	10000.0
NG25	EPHA7	100.0	10000.0
(s)-CR8	MST2	90.0	10000.0
Torin1	PTK6	51.0	10000.0
BS-181	RIOK2	97.0	10000.0
KU63794	MP2K2	92.0	10000.0
XMD13-2	EPHA2	100.0	10000.0
TGX221	ABL1	100.0	1000.0
TAK-715	STK35	76.0	10000.0
Taselisib	PTK6	96.0	1000.0
Pictilisib	MLK1	100.0	1000.0
NPK76-II-72-1	JAK2(Kin.Dom.2)	100.0	10000.0
CP466722	SRC	6.7	10000.0
JW-7-24-1	NEK9	100.0	10000.0
JNK-IN-11	CDK9	100.0	1000.0
(s)-CR8	CDC2L1	95.0	10000.0
MLN8054	EPHA3	15.0	10000.0
Abemaciclib	PAK1	88.0	1000.0
Torin1	ERBB2	91.0	10000.0
GW843682X	PLK4	29.0	10000.0
WZ4003	PIK3CG	100.0	1000.0
BX-912	AKT1	100.0	10000.0
QL-XI-92	CAMK2G	89.0	10000.0
HG-14-10-04	CDK9	86.0	10000.0
OTSSP167	CAMK2B	100.0	10000.0
Alpelisib	INSRR	100.0	1000.0
R406	BIKE	1.8	1000.0
PHA-767491	SIK1	99.0	10000.0
BMX-IN-1	TXK	2.6	10000.0
Torin2	MELK	50.0	10000.0
Seliciclib	PIK3CG	100.0	10000.0
ZG-10	MST1R	100.0	10000.0
KU63794	MST2	85.0	10000.0
CP724714	PIK3CA(E542K)	100.0	10000.0
PD0325901	CDK3	69.0	10000.0
TAK-715	TAOK3	86.0	10000.0
GW-5074	TLK1	100.0	10000.0
SCH772984	YANK2	89.0	1000.0
5z-7-oxozeaenol	PIK3CA(E545A)	67.0	10000.0
KU63794	EPHA5	94.0	10000.0
XMD-12	MAP3K15	95.0	1000.0
MRT67307	ABL1(Q252H)-nonphosphorylated	20.0	10000.0
BGJ398	TRKC	82.0	1000.0
JNK-9L	PIK3CA(E545A)	58.0	10000.0
WZ3105	CLK4	5.1	10000.0
BI-D1870	MST3	13.0	10000.0
Neratinib	EPHA8	78.0	10000.0
Torin1	ABL1(M351T)-phosphorylated	100.0	10000.0
ALW-II-38-3	ERBB2	100.0	10000.0
Dabrafenib	MK11	100.0	10000.0
TGX221	MUSK	100.0	1000.0
CGP60474	CAMK2G	100.0	10000.0
WZ4003	AXL	30.0	1000.0
CGP74514A	ACVRL1	100.0	10000.0
Crizotinib	ABL1(Q252H)-nonphosphorylated	0.0	10000.0
ZSTK474	ULK1	100.0	1000.0
SCH772984	ALK	100.0	1000.0
BI-D1870	MST1	4.8	10000.0
Ibrutinib	SIK3	98.0	1000.0
NU7441	EGFR(L858R)	89.0	10000.0
PD0325901	BIKE	91.0	10000.0
Omipalisib	EPHB2	88.0	10000.0
XMD16-144	CDK7	9.6	10000.0
Pictilisib	HIPK2	61.0	1000.0
WYE-125132	ITK	88.0	10000.0
WZ-7043	MINK	100.0	10000.0
JWE-035	M3K5	100.0	10000.0
XMD8-92	MAP3K4	100.0	10000.0
XMD11-50	PIK3CA	74.0	10000.0
Sorafenib	FAK2	100.0	10000.0
PD173074	TNNI3K	100.0	10000.0
WZ-4-145	EPHA8	100.0	10000.0
Palbociclib	MAP4K2	100.0	1000.0
BI-D1870	DYRK1A	6.0	10000.0
XMD11-50	LATS2	95.0	10000.0
Dabrafenib	KGP2	91.0	10000.0
Dactolisib	FLT3(D835Y)	12.0	1000.0
KIN001-220	EGFR(S752-I759del)	56.0	10000.0
AZD 5438	FLT3	17.0	10000.0
Buparlisib	KIT(D816V)	100.0	1000.0
Seliciclib	MET(M1250T)	100.0	10000.0
Dactolisib	PIK3CA(M1043I)	11.0	1000.0
GSK429286A	MLK2	92.0	10000.0
NPK76-II-72-1	MARK1	100.0	10000.0
SCH772984	TXK	100.0	1000.0
WZ4002	NEK6	9.0	10000.0
NU7441	PKAC-alpha	87.0	10000.0
HG-14-8-02	MARK3	100.0	10000.0
HG-5-113-01	STK16	2.8	10000.0
JNK-IN-11	MP2K6	56.0	1000.0
HG-14-10-04	SIK3	100.0	10000.0
XMD8-85	IGF1R	100.0	10000.0
KU63794	EGFR(G719S)	100.0	10000.0
Abemaciclib	MST3	84.0	1000.0
JNK-IN-5A	ERK8	64.0	10000.0
BI-D1870	KPCT	19.0	10000.0
ZM-447439	ERK5	89.0	10000.0
BX-912	AXL	1.2	10000.0
Ribociclib	MYO3A	100.0	1000.0
CG-930	DMPK2	81.0	10000.0
KIN001-127	STK36	100.0	10000.0
Torin2	SRPK1	100.0	10000.0
GW843682X	EPHA5	90.0	10000.0
WZ-4-145	IRAK3	100.0	10000.0
5z-7-oxozeaenol	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
XMD11-50	SRPK3	72.0	10000.0
WYE-125132	RIOK3	100.0	10000.0
XMD8-85	PAK7	100.0	10000.0
Torin1	EPHA7	98.0	10000.0
NVP-TAE684	CAMK1G	31.0	1000.0
XMD13-2	EPHA8	92.0	10000.0
Sigma A6730	FAK1	95.0	10000.0
Sorafenib	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
RO-3306	PAK1	68.0	10000.0
XMD13-2	CDC2L1	97.0	10000.0
Vemurafenib	ULK3	46.0	10000.0
CH5424802	ABL1(T315I)-nonphosphorylated	98.0	1000.0
AZD4547	CSF1R-autoinhibited	0.0	10000.0
ZM-447439	PIP5K2B	100.0	10000.0
XMD13-2	PIK3CD	85.0	10000.0
WZ-4-145	TSSK1	100.0	10000.0
Palbociclib	MRCKA	100.0	1000.0
Vemurafenib	DRAK2	88.0	10000.0
WH-4-023	ABL2	0.1	10000.0
KIN001-123	ABL1	23.0	1000.0
XMD13-2	MP2K7	100.0	10000.0
Torin1	ABL1(E255K)-phosphorylated	85.0	10000.0
Ceritinib	ERK3	100.0	1000.0
ZM-447439	ANKK1	17.0	10000.0
ALW-II-38-3	PIK3CA(H1047Y)	100.0	10000.0
Taselisib	CDK5	100.0	1000.0
Palbociclib	RIPK4	100.0	1000.0
R406	EPHA4	12.0	1000.0
GSK461364	PAK6	98.0	10000.0
KIN001-127	AURKB	100.0	10000.0
HG-5-113-01	MRCKA	100.0	10000.0
HG-14-8-02	BRSK2	100.0	10000.0
XMD8-92	MARK2	100.0	10000.0
Dabrafenib	RPS6KA4(Kin.Dom.1-N-terminal)	62.0	10000.0
Lapatinib	MP2K2	94.0	10000.0
Torin1	MP2K3	80.0	10000.0
BS-181	STK33	13.0	10000.0
HG-5-113-01	ZAP70	100.0	10000.0
PHA-767491	FLT3(R834Q)	64.0	10000.0
XMD11-85h	KCC2D	100.0	10000.0
AZD-6482	YANK3	82.0	10000.0
Canertinib	M4K3	100.0	1000.0
JNK-IN-5A	JNK1	60.0	10000.0
Pictilisib	FAK2	100.0	1000.0
THZ1	BRAF(V600E)	38.0	10000.0
JW-7-24-1	MRCKB	100.0	10000.0
CGP60474	LIMK2	100.0	10000.0
ALW-II-49-7	AURKB	100.0	10000.0
QL-XII-47	GAK	76.0	1000.0
KU63794	PAK4	86.0	10000.0
BX-912	ICK	10.0	10000.0
HG-14-10-04	TSSK1	0.1	10000.0
Alpelisib	SIK1	98.0	1000.0
XMD16-144	MP2K5	45.0	10000.0
PHA-793887	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
JW-7-24-1	CLK3	4.4	10000.0
MRT67307	DRAK1	0.8	10000.0
Torin1	RET(V804L)	66.0	10000.0
WZ-7043	KGP2	100.0	10000.0
TGX221	NEK2	100.0	1000.0
BI-2536	AMPK-alpha2	100.0	10000.0
AZD7762	SLK	0.1	10000.0
Ibrutinib	MP2K5	0.2	1000.0
ALW-II-38-3	ERBB4	100.0	10000.0
KIN001-021	CDKL2	100.0	1000.0
MRT67307	ANKK1	2.1	10000.0
HG-14-10-04	FGFR3	1.6	10000.0
QL-XII-47	CTK	100.0	1000.0
WYE-125132	ANKK1	77.0	10000.0
CP724714	CDK14	100.0	10000.0
PD173074	LCK	22.0	10000.0
Dinaciclib	FLT3-autoinhibited	99.0	10000.0
GSK1059615	KPCD2	90.0	10000.0
XMD16-144	BRAF(V600E)	59.0	10000.0
Taselisib	TLK1	100.0	1000.0
BX-912	YANK2	100.0	10000.0
BMS345541	ADCK3	61.0	10000.0
JNK-IN-5A	PHKG1	100.0	10000.0
AG1478	TAK1	39.0	10000.0
BMS-536924	MARK3	1.2	1000.0
PHA-767491	IRAK3	55.0	10000.0
OTSSP167	ANKK1	2.3	10000.0
NU7441	SIK2	75.0	10000.0
SB590885	TGFBR2	44.0	10000.0
WH-4-023	EPHA3	9.4	10000.0
Torkinib	ABL1(F317L)-phosphorylated	2.2	10000.0
HG-5-113-01	EPHA1	100.0	10000.0
KIN001-220	LTK	32.0	10000.0
KIN001-220	MP2K1	76.0	10000.0
OTSSP167	RSK3(Kin.Dom.1-N-terminal)	7.7	10000.0
AZD4547	ALK(C1156Y)	2.0	10000.0
Buparlisib	PRP4	91.0	1000.0
NG25	RIPK2	9.8	10000.0
ZM-447439	MAP3K4	62.0	10000.0
Buparlisib	ERBB4	100.0	1000.0
WZ3105	MERTK	16.0	10000.0
JNK-IN-8	STK39	95.0	1000.0
AZD4547	TNNI3K	52.0	10000.0
ZG-10	MRCKA	100.0	10000.0
HG-5-88-01	CSNK1E	34.0	10000.0
HG-5-113-01	LIMK1	100.0	10000.0
Crizotinib	NEK3	100.0	10000.0
HG-6-64-01	PIK3C2B	100.0	10000.0
JNK-IN-8	EGFR(L747-T751del,Sins)	95.0	1000.0
CGP60474	HCK	100.0	10000.0
GSK429286A	TLK1	90.0	10000.0
Barasertib	DAPK3	82.0	10000.0
CGP74514A	ABL1(Y253F)-phosphorylated	1.6	10000.0
JNK-9L	PIK3CA(H1047L)	100.0	10000.0
BGJ398	ADCK4	99.0	1000.0
ALW-II-38-3	EPHA7	100.0	10000.0
Sorafenib	EGFR(E746-A750del)	84.0	10000.0
SCH772984	AMPK-alpha2	86.0	1000.0
GSK461364	RSK4(Kin.Dom.1-N-terminal)	0.6	10000.0
KIN001-127	TYK2(Kin.Dom.2)	100.0	10000.0
SCH772984	PTK6	87.0	1000.0
BI-2536	RET(V804L)	100.0	10000.0
NU7441	LATS2	100.0	10000.0
A443654	KCC2D	2.5	10000.0
BS-181	KC1G2	41.0	10000.0
SP600125	ACVRL1	100.0	10000.0
SP600125	KC1G2	100.0	10000.0
CGP60474	KPCT	100.0	10000.0
OTSSP167	JAK2(JH1domain-catalytic)	4.0	10000.0
MLN8054	AURKC	20.0	10000.0
Torin2	PKAC-beta	85.0	10000.0
BMS-536924	JAK2(Kin.Dom.2)	0.8	1000.0
WZ4003	NEK6	9.9	1000.0
ALW-II-38-3	ERK3	100.0	10000.0
Abemaciclib	BLK	99.0	1000.0
Torin1	CDC2L2	100.0	10000.0
Torkinib	KIT(V559D)	0.3	10000.0
HG-14-10-04	KPCD3	0.0	10000.0
Crizotinib	M4K1	4.6	10000.0
JNK-IN-8	CAMK2A	100.0	1000.0
WH-4-023	IGF1R	100.0	10000.0
WZ4002	BLK	0.8	10000.0
ZG-10	TYRO3	100.0	10000.0
RO-3306	ALK	84.0	10000.0
CP466722	FLT4	14.0	10000.0
NU7441	ITK	100.0	10000.0
KIN001-021	STK35	100.0	1000.0
WH-4-023	CLK3	88.0	10000.0
BGJ398	TAK1	75.0	1000.0
XMD-12	ITK	96.0	1000.0
NPK76-II-72-1	MK13	100.0	10000.0
GSK429286A	TXK	83.0	10000.0
CP466722	TTK	20.0	10000.0
KU63794	RET	91.0	10000.0
BI-2536	DCLK1	5.4	10000.0
Dactolisib	STK33	100.0	1000.0
CGP74514A	SYK	43.0	10000.0
AZ-628	PIK3CA(C420R)	100.0	10000.0
AS-252424	VGFR1	68.7	10000.0
CH5424802	EGFR(G719S)	46.0	1000.0
BMX-IN-1	CSNK1G3	84.0	10000.0
THZ1	CHK2	100.0	10000.0
MRT67307	MK12	71.0	10000.0
MRT67307	RIPK4	89.0	10000.0
AG1478	FES	96.0	10000.0
AZD 5438	CLK4	1.9	10000.0
GSK1059615	ABL1(F317L)-nonphosphorylated	80.0	10000.0
Sigma A6730	HUNK	72.0	10000.0
Ceritinib	EPHA8	97.0	1000.0
XMD16-144	ABL1(H396P)-phosphorylated	0.0	10000.0
JNK-IN-8	PAK1	100.0	1000.0
MPS-1-IN-1	ACVR2A	100.0	1000.0
ZG-10	RET(V804M)	74.0	10000.0
Omipalisib	PIK3CA(E545K)	0.8	10000.0
WZ3105	LRRK2(G2019S)	45.0	10000.0
PLX-4720	EGFR(T790M)	48.0	10000.0
XMD-12	ABL1-phosphorylated	3.6	1000.0
NPK76-II-72-1	MLK2	100.0	10000.0
AZD4547	CAMK2G	23.0	10000.0
TAK-715	CAMK2A	89.0	10000.0
HG-5-88-01	GSK3B	100.0	10000.0
NPK76-II-72-1	FES	100.0	10000.0
GSK1059615	CDK14	37.0	10000.0
XMD-12	JNK3	100.0	1000.0
Pictilisib	ABL1(Q252H)-phosphorylated	100.0	1000.0
HG-5-113-01	MERTK	0.3	10000.0
KIN001-127	CSNK1E	100.0	10000.0
Vemurafenib	PLK2	97.0	10000.0
HG-14-8-02	ANKK1	82.0	10000.0
Pictilisib	PDPK1	73.0	1000.0
XMD8-92	VGFR2	100.0	10000.0
XMD8-92	M3K5	100.0	10000.0
HG-6-64-01	PKAC-beta	100.0	10000.0
AZD4547	PIK3CB	82.0	10000.0
Seliciclib	ABL1(Q252H)-nonphosphorylated	70.0	10000.0
Vemurafenib	KCC4	100.0	10000.0
ERK5-IN-1	CDK4-cyclinD1	91.0	1000.0
XMD8-92	AKT3	100.0	10000.0
WZ3105	PLK4	85.0	10000.0
WZ4002	CSNK2A1	100.0	10000.0
PHA-793887	AURKA	100.0	10000.0
NU7441	KCC2D	80.0	10000.0
HG-14-8-02	TYRO3	100.0	10000.0
QL-X-138	CDK2	84.0	10000.0
JW-7-24-1	MAPKAPK5	100.0	10000.0
HG-5-88-01	DRAK1	100.0	10000.0
MPS-1-IN-1	KGP2	100.0	1000.0
BMX-IN-1	MST1R	100.0	10000.0
Dabrafenib	EGFR(S752-I759del)	77.0	10000.0
AG1478	IRAK3	30.0	10000.0
BMS345541	PIK3CA(C420R)	52.0	10000.0
XMD16-144	PIK3CA(C420R)	72.0	10000.0
AZD4547	FLT3(R834Q)	7.9	10000.0
Ribociclib	CSNK2A1	100.0	1000.0
ERK5-IN-1	JAK1(JH2domain-pseudokinase)	98.0	1000.0
Ibrutinib	JAK1(JH1domain-catalytic)	100.0	1000.0
ZSTK474	FLT3(ITD)	100.0	1000.0
ZSTK474	RPS6KA6(Kin.Dom.2)	100.0	1000.0
QL-XI-92	CSF1R	38.0	10000.0
JNK-IN-11	EPHB3	86.0	1000.0
AZD4547	ALK	0.0	10000.0
BS-181	BMPR2	100.0	10000.0
NPK76-II-72-1	MARK2	100.0	10000.0
CP466722	CSNK2A1	4.4	10000.0
Neratinib	EGFR(L861Q)	0.1	10000.0
AZD 5438	BMPR1A	32.0	10000.0
Pictilisib	IKKE	95.0	1000.0
KIN001-220	CLK3	23.0	10000.0
WZ4003	CDK11	100.0	1000.0
RO-3306	KPCD	2.4	10000.0
Dabrafenib	BRSK2	5.8	10000.0
JNK-IN-11	CDK8	100.0	1000.0
BMS-536924	MLK2	8.8	1000.0
XMD13-2	KKCC1	37.0	10000.0
Crizotinib	FLT3(ITD)	31.0	10000.0
WZ4002	CSNK1G3	100.0	10000.0
Abemaciclib	EPHA2	94.0	1000.0
SCH772984	EPHB3	92.0	1000.0
KIN001-220	AKT3	100.0	10000.0
THZ1	CDK15	1.5	10000.0
Sorafenib	MINK	46.0	10000.0
(s)-CR8	PHKG1	90.0	10000.0
XMD11-85h	ADCK4	100.0	10000.0
Dinaciclib	AURKB	82.0	10000.0
PHA-767491	KIT(D816V)	31.0	10000.0
PLX-4720	TTK	60.0	10000.0
ZM-447439	PKMYT1	89.0	10000.0
NVP-TAE684	CSF1R	0.0	1000.0
Taselisib	KIT(V559D)	97.0	1000.0
TAK-715	TRPM6	100.0	10000.0
SCH772984	EGFR(L747-S752del,P753S)	95.0	1000.0
HG-5-88-01	RPS6KA5(Kin.Dom.1)	100.0	10000.0
Dabrafenib	RSK1(Kin.Dom.2-C-terminal)	46.0	10000.0
HG-6-64-01	TRKC	1.0	10000.0
HG-9-91-01	RSK1(Kin.Dom.1-N-terminal)	13.0	10000.0
CH5424802	CSNK2A2	75.0	1000.0
AZD7762	MAP3K1	51.0	10000.0
ZG-10	DMPK2	76.0	10000.0
Crizotinib	PIM1	100.0	10000.0
WZ4003	CSF1R	14.0	1000.0
KIN001-127	PLK3	100.0	10000.0
HG-6-64-01	RSK3(Kin.Dom.2-C-terminal)	42.0	10000.0
PD0325901	SNARK	99.0	10000.0
AZD7762	CSNK1D	15.0	10000.0
CGP74514A	YANK3	32.0	10000.0
NG25	NEK7	100.0	10000.0
MPS-1-IN-1	AKT1	100.0	1000.0
CP724714	M4K1	91.0	10000.0
XMD14-99	JNK1	81.0	10000.0
ZG-10	ROCK1	48.0	10000.0
AS-252424	TIE2	2.1	10000.0
XMD11-50	MTOR	97.0	10000.0
NU7441	PAK2	61.0	10000.0
Alpelisib	FLT3	82.0	1000.0
QL-XII-47	ABL1(F317I)-nonphosphorylated	100.0	1000.0
OTSSP167	PHKG2	100.0	10000.0
HG-14-10-04	CDKL3	81.0	10000.0
Barasertib	CAMKK2	100.0	10000.0
5z-7-oxozeaenol	ROS1	83.0	10000.0
HG-14-10-04	YES	5.2	10000.0
XMD11-85h	FGR	100.0	10000.0
CP466722	MP2K7	77.0	10000.0
GSK461364	RET(V804L)	100.0	10000.0
KU63794	ROCK1	89.0	10000.0
XMD8-85	CDK2	100.0	10000.0
(s)-CR8	SRPK1	79.0	10000.0
MLN8054	ACVR1	100.0	10000.0
NG25	PKAC-alpha	26.0	10000.0
TGX221	SRPK1	100.0	1000.0
BI-2536	KIT(V559D)	100.0	10000.0
MLN8054	KC1G1	37.0	10000.0
AG1478	M4K3	100.0	10000.0
GW-5074	TAK1	67.0	10000.0
ZM-447439	FLT3(D835Y)	44.0	10000.0
CGP74514A	KC1G1	10.0	10000.0
Buparlisib	RSK3(Kin.Dom.1-N-terminal)	100.0	1000.0
AG1478	GCN2(Kin.Dom.2,S808G)	56.0	10000.0
ZM-447439	STK39	100.0	10000.0
ZSTK474	PKMYT1	100.0	1000.0
NU7441	DYRK1B	85.0	10000.0
A443654	EGFR(L858R)	100.0	10000.0
PLX-4720	TRKB	82.0	10000.0
AZ-628	M3K12	74.0	10000.0
Lapatinib	DRAK1	85.0	10000.0
TAK-715	MK11	0.0	10000.0
XMD14-99	CAMK1	0.8	10000.0
XMD13-2	SBK1	100.0	10000.0
NPK76-II-72-1	FAK2	13.0	10000.0
Baricitinib	MP2K2	6.2	10000.0
Dactolisib	YANK2	100.0	1000.0
Momelotinib	MLK2	62.0	10000.0
AZD7762	EPHB2	9.6	10000.0
BMS345541	MP2K4	100.0	10000.0
AG1478	NEK2	92.0	10000.0
WZ4003	RPS6KA1(Kin.Dom.1)	11.0	1000.0
BI-2536	CLK3	29.0	10000.0
HG-5-88-01	MK11	100.0	10000.0
QL-XII-47	PKN2	94.0	1000.0
NPK76-II-72-1	TRKA	100.0	10000.0
PHA-793887	M4K1	34.0	10000.0
GW-5074	FLT4	100.0	10000.0
GW843682X	FLT3(ITD)	26.0	10000.0
WZ4002	PCTK3	100.0	10000.0
PLX-4720	AURKB	29.0	10000.0
ZG-10	NEK3	17.0	10000.0
AZ-628	PKMYT1	98.0	10000.0
PLX-4720	EPHB1	100.0	10000.0
Pictilisib	RSK1(Kin.Dom.1-N-terminal)	94.0	1000.0
OTSSP167	ULK1	3.8	10000.0
MPS-1-IN-1	TAOK1	27.0	1000.0
PD173074	EGFR(L747-S752del,P753S)	100.0	10000.0
BGJ398	BMPR1B	72.0	1000.0
GSK1059615	HUNK	59.0	10000.0
Canertinib	PIM2	100.0	1000.0
Vemurafenib	BLK	2.2	10000.0
HG-5-113-01	PLK4	4.5	10000.0
GW843682X	MST2	1.8	10000.0
XMD8-85	CAMK2A	32.0	10000.0
Dabrafenib	FAK1	96.0	10000.0
SP600125	MUSK	100.0	10000.0
CP466722	JAK1(JH2domain-pseudokinase)	0.4	10000.0
AZD4547	KPCT	69.0	10000.0
XMD11-85h	CAMK2B	100.0	10000.0
Pictilisib	KPCD3	100.0	1000.0
ZM-447439	LATS2	82.0	10000.0
PHA-767491	PKAC-alpha	13.0	10000.0
BMX-IN-1	CDK8	62.0	10000.0
MPS-1-IN-1	MYO3B	28.0	1000.0
KIN001-111	M4K1	8.3	1000.0
Dabrafenib	TESK1	0.0	10000.0
QL-XII-47	MP2K1	99.0	1000.0
BGJ398	CDC2L2	93.0	1000.0
WH-4-023	KPCD3	11.0	10000.0
RO-3306	ERK8	2.0	10000.0
TAK-715	TYRO3	83.0	10000.0
Torkinib	VGFR1	25.0	10000.0
GSK461364	BRSK1	42.0	10000.0
HG-9-91-01	ABL1(T315I)-nonphosphorylated	0.1	10000.0
OTSSP167	NLK	36.0	10000.0
HG-6-64-01	AKT3	100.0	10000.0
Taselisib	CHK2	100.0	1000.0
WZ-7043	KPCT	100.0	10000.0
HG-6-64-01	EPHB2	0.0	10000.0
XMD16-144	PIK3CB	32.0	10000.0
RO-3306	DAPK2	16.0	10000.0
AZD4547	LYN	16.0	10000.0
QL-X-138	TLK1	100.0	10000.0
MPS-1-IN-1	RIOK1	100.0	1000.0
XMD8-85	ERN1	100.0	10000.0
Neratinib	ABL1(Y253F)-phosphorylated	98.0	10000.0
Ribociclib	MK03	100.0	1000.0
Ribociclib	MAP3K15	100.0	1000.0
BX-912	FLT3(R834Q)	7.0	10000.0
AZ-628	PIK3CA(M1043I)	89.0	10000.0
KIN001-127	DDR2	100.0	10000.0
ERK5-IN-1	YSK4	100.0	1000.0
AS-252424	YANK2	100.0	10000.0
A443654	MKNK2	13.0	10000.0
BI-2536	CLK1	100.0	10000.0
Crizotinib	M3K6	87.0	10000.0
AG1478	MARK4	100.0	10000.0
HG-14-10-04	PIK3CA(E545K)	94.0	10000.0
Canertinib	TGFBR1	100.0	1000.0
JW-7-24-1	RIPK4	100.0	10000.0
Pictilisib	EGFR(G719C)	100.0	1000.0
BS-181	KIT(D816H)	93.0	10000.0
NU7441	NDR1	100.0	10000.0
Abemaciclib	SNRK	100.0	1000.0
Pictilisib	MAP3K1	100.0	1000.0
Palbociclib	ERBB2	88.0	1000.0
BGJ398	SGK1	100.0	1000.0
RO-3306	NEK1	43.0	10000.0
JNK-IN-5A	PAK3	94.0	10000.0
ZG-10	RSK3(Kin.Dom.2-C-terminal)	100.0	10000.0
AZD7762	LIMK2	88.0	10000.0
XMD11-85h	MAP3K4	100.0	10000.0
Ribociclib	KPCD1	100.0	1000.0
Torin2	PIK3C2B	37.0	10000.0
MLN8054	MYLK4	89.0	10000.0
WZ-7043	CDC2L1	100.0	10000.0
JNK-IN-8	RSK1(Kin.Dom.1-N-terminal)	99.0	1000.0
OTSSP167	EPHA1	0.3	10000.0
A443654	IGF1R	100.0	10000.0
GSK429286A	MTOR	89.0	10000.0
AZ-628	STK39	100.0	10000.0
ALW-II-38-3	MK01	100.0	10000.0
XMD13-2	LTK	100.0	10000.0
PHA-767491	EGFR(T790M)	89.0	10000.0
BI-D1870	TAOK1	0.3	10000.0
AG1478	MELK	74.0	10000.0
Momelotinib	MARK1	66.0	10000.0
PD0325901	PI42C	100.0	10000.0
Buparlisib	MST4	100.0	1000.0
Taselisib	MAP3K3	98.0	1000.0
CG-930	TIE1	100.0	10000.0
WH-4-023	MLK1	0.6	10000.0
Palbociclib	KIT(D816H)	100.0	1000.0
GW843682X	MP2K4	100.0	10000.0
XMD11-85h	NEK6	100.0	10000.0
KIN001-111	MP2K2	0.1	1000.0
PLX-4720	PKN2	100.0	10000.0
JNK-9L	MLK1	22.0	10000.0
BS-181	KPCD1	23.0	10000.0
Lapatinib	ULK3	84.0	10000.0
XMD-12	MP2K1	100.0	1000.0
HG-14-10-04	FGFR1	0.1	10000.0
Ribociclib	DCAMKL2	100.0	1000.0
NU7441	PIK3C2B	20.0	10000.0
WZ-4-145	FER	100.0	10000.0
Taselisib	OSR1	100.0	1000.0
Torkinib	CLK3	66.0	10000.0
WZ4002	AAK1	7.0	10000.0
Torkinib	PAK4	13.0	10000.0
Torin1	PGFRA	63.0	10000.0
AZD7762	FLT3(D835H)	0.0	10000.0
Alpelisib	JAK2(JH1domain-catalytic)	96.0	1000.0
BGJ398	ABL1(F317I)-nonphosphorylated	87.0	1000.0
(s)-CR8	LIMK1	100.0	10000.0
KIN001-111	MAP4K2	17.0	1000.0
ERK5-IN-1	IKKB	99.0	1000.0
XMD16-144	EGFR(G719S)	67.0	10000.0
XMD16-144	HIPK4	76.0	10000.0
PLX-4720	CDK2	78.0	10000.0
AZD4547	CHK2	16.0	10000.0
SCH772984	KPCE	80.0	1000.0
KIN001-220	GRK4	8.8	10000.0
QL-XII-47	AMPK-alpha2	87.0	1000.0
WZ3105	LOK	72.0	10000.0
Seliciclib	LRRK2	95.0	10000.0
Ceritinib	PIK3CA(E542K)	83.0	1000.0
AS-252424	DMPK	94.3	10000.0
XMD8-85	MST1R	100.0	10000.0
Seliciclib	CSF1R-autoinhibited	44.0	10000.0
Sigma A6730	ABL1(M351T)-phosphorylated	78.0	10000.0
AZD7762	MST2	0.0	10000.0
ERK5-IN-1	KIT(D816H)	100.0	1000.0
XMD11-50	CAMKK2	31.0	10000.0
KIN001-127	AXL	4.0	10000.0
Alpelisib	BMPR1A	97.0	1000.0
BI-D1870	HIPK1	17.0	10000.0
XMD11-85h	AURKC	100.0	10000.0
BS-181	DMPK	100.0	10000.0
AG1478	CIT	7.4	10000.0
BS-181	CAMK2B	91.0	10000.0
HG-14-10-04	M3K2	19.0	10000.0
WYE-125132	CSNK2A1	80.0	10000.0
OTSSP167	FGFR1	4.6	10000.0
XMD14-99	HIPK1	69.0	10000.0
WZ3105	YANK1	89.0	10000.0
CGP60474	MST1R	100.0	10000.0
TGX221	IGF1R	100.0	1000.0
BX-912	BRSK2	5.8	10000.0
XMD8-92	ADCK3	100.0	10000.0
XMD-12	GRK4	81.0	1000.0
ZG-10	CDK7	3.2	10000.0
HG-5-88-01	TAOK3	100.0	10000.0
Dinaciclib	BRSK2	94.0	10000.0
Alpelisib	KC1G1	100.0	1000.0
BI-2536	TNIK	100.0	10000.0
A443654	EPHA7	100.0	10000.0
CG-930	CDK9	78.0	10000.0
Vemurafenib	HIPK3	100.0	10000.0
HG-5-88-01	KCC4	13.0	10000.0
XMD11-85h	KPCD1	100.0	10000.0
Seliciclib	DAPK3	100.0	10000.0
BX-912	VGFR1	0.6	10000.0
BS-181	MARK4	97.0	10000.0
WZ3105	RSK3(Kin.Dom.1-N-terminal)	4.4	10000.0
QL-X-138	FYN	90.0	10000.0
HG-6-64-01	MTOR	100.0	10000.0
ZM-447439	PIK3C2B	100.0	10000.0
A443654	AMPK-alpha2	100.0	10000.0
QL-XI-92	DYRK1B	95.0	10000.0
Sigma A6730	FLT3	44.0	10000.0
WZ-4-145	FGFR2	1.9	10000.0
NVP-TAE684	PIM1	100.0	1000.0
AZD7762	WEE2	91.0	10000.0
Alpelisib	NEK2	100.0	1000.0
WZ-7043	AAK1	100.0	10000.0
GSK429286A	DAPK3	77.0	10000.0
ERK5-IN-1	GCN2(Kin.Dom.2,S808G)	95.0	1000.0
CH5424802	TRPM6	71.0	1000.0
HG-5-113-01	CAMK1	100.0	10000.0
PHA-793887	MLK2	86.0	10000.0
CGP60474	PKMYT1	100.0	10000.0
WH-4-023	MET	3.9	10000.0
CGP74514A	PIK3CA(H1047L)	60.0	10000.0
TAK-715	PIK3CA(E545K)	98.0	10000.0
XMD14-99	PFPK5(P.falciparum)	87.0	10000.0
AS-252424	EPHA1	100.0	10000.0
CGP74514A	NEK11	54.0	10000.0
Neratinib	YANK2	73.0	10000.0
HG-5-88-01	DRAK2	100.0	10000.0
SCH772984	MP2K5	34.0	1000.0
HG-6-64-01	MP2K7	1.4	10000.0
MLN8054	ERK4	66.0	10000.0
WH-4-023	PLK1	100.0	10000.0
JNK-IN-11	S6K1	83.0	1000.0
TGX221	FGFR3(G697C)	100.0	1000.0
Ribociclib	DYRK1A	99.0	1000.0
WZ3105	MAP4K5	60.0	10000.0
Buparlisib	NEK11	100.0	1000.0
AZD7762	NDR1	4.0	10000.0
BI-2536	PDPK1	100.0	10000.0
ZSTK474	PIK3CB	0.1	1000.0
AZD7762	LRRK2	4.0	10000.0
CGP60474	CDKL3	5.4	10000.0
Vemurafenib	PLK3	93.0	10000.0
WH-4-023	BTK	1.3	10000.0
Palbociclib	MKNK1	100.0	1000.0
SB590885	YANK2	85.0	10000.0
Lapatinib	CLK4	83.0	10000.0
WZ4002	INSR	17.0	10000.0
BMS-536924	FGFR2	4.3	1000.0
GSK429286A	ACVR1B	94.0	10000.0
KIN001-123	DCAMKL3	100.0	1000.0
XMD13-2	CDKL5	42.0	10000.0
PHA-767491	MAP3K14	24.0	10000.0
WZ4002	DDR1	100.0	10000.0
Sigma A6730	CHEK1	100.0	10000.0
SP600125	ULK1	4.2	10000.0
WZ-4-145	FGFR3(G697C)	1.4	10000.0
A443654	AAK1	1.8	10000.0
AZD 5438	MARK2	14.0	10000.0
AZD4547	ACVR1	41.0	10000.0
AZ-628	ABL1-phosphorylated	1.4	10000.0
HG-9-91-01	GAK	4.0	10000.0
KIN001-123	RPS6KA4(Kin.Dom.2)	100.0	1000.0
MRT67307	TAOK3	11.0	10000.0
XMD13-2	CTK	68.0	10000.0
WYE-125132	KIT(A829P)	89.0	10000.0
Seliciclib	KIT(D816V)	100.0	10000.0
JNK-IN-8	KPCE	81.0	1000.0
CP466722	AMPK-alpha1	19.0	10000.0
WZ-7043	TNNI3K	100.0	10000.0
Palbociclib	NDR2	100.0	1000.0
GW843682X	MRCKA	68.0	10000.0
Neratinib	NEK6	88.0	10000.0
JNK-IN-5A	AKT2	100.0	10000.0
GW-5074	SGK3	73.0	10000.0
KIN001-123	SLK	0.6	1000.0
BMX-IN-1	KPCE	75.0	10000.0
AZ-628	MK12	45.0	10000.0
MPS-1-IN-1	BMPR2	100.0	1000.0
BMX-IN-1	YES	100.0	10000.0
GW-5074	PRKR	75.0	10000.0
CGP60474	ERK4	100.0	10000.0
BMS-536924	NEK6	0.1	1000.0
BX-912	KIT(V559D,V654A)	15.0	10000.0
BS-181	CDK9	76.0	10000.0
KIN001-127	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
Vemurafenib	CSNK1E	68.0	10000.0
BMS345541	DYRK2	8.8	10000.0
ZSTK474	MARK4	100.0	1000.0
(s)-CR8	MYO3B	87.0	10000.0
Ibrutinib	KC1G1	86.0	1000.0
PLX-4720	TNK1	96.0	10000.0
NG25	DDR2	5.1	10000.0
BMS345541	EGFR(G719S)	100.0	10000.0
Omipalisib	CSNK1A1	72.0	10000.0
Taselisib	TTK	100.0	1000.0
QL-X-138	KGP1	91.0	10000.0
HG-6-64-01	HUNK	18.0	10000.0
PLX-4720	EPHB2	100.0	10000.0
Crizotinib	OSR1	72.0	10000.0
QL-XII-47	CSNK1G3	99.0	1000.0
BI-D1870	TRKB	18.0	10000.0
CP724714	NDR2	100.0	10000.0
MRT67307	WEE2	22.0	10000.0
XMD16-144	MET(M1250T)	43.0	10000.0
WZ-7043	BMPR1A	100.0	10000.0
AZD7762	M3K2	0.0	10000.0
Momelotinib	MAP3K15	68.0	10000.0
XMD13-2	FGR	100.0	10000.0
(s)-CR8	IRAK3	98.0	10000.0
WZ3105	MAP3K15	66.0	10000.0
BMS-536924	AAK1	5.7	1000.0
WZ-7043	WEE2	100.0	10000.0
QL-XI-92	RET	96.0	10000.0
NPK76-II-72-1	KIT(V559D,V654A)	100.0	10000.0
Ribociclib	MST2	98.0	1000.0
PHA-793887	CLK3	4.2	10000.0
BI-D1870	STK35	12.0	10000.0
BGJ398	EGFR(T790M)	93.0	1000.0
AZD-6482	EGFR(L747-S752del,P753S)	100.0	10000.0
Pictilisib	EPHB3	100.0	1000.0
Crizotinib	CDK5	100.0	10000.0
KIN001-111	INSRR	100.0	1000.0
XMD11-85h	MST2	100.0	10000.0
WH-4-023	ABL1-nonphosphorylated	0.0	10000.0
Taselisib	YSK1	100.0	1000.0
XMD14-99	MKNK1	51.0	10000.0
ERK5-IN-1	NEK3	83.0	1000.0
KIN001-123	NEK1	100.0	1000.0
ALW-II-38-3	DAPK3	100.0	10000.0
NU7441	RSK4(Kin.Dom.2-C-terminal)	79.0	10000.0
QL-XII-47	JAK2(JH1domain-catalytic)	100.0	1000.0
HG-6-64-01	MAPKAPK5	90.0	10000.0
Torkinib	DDR1	6.4	10000.0
Torin1	YANK1	100.0	10000.0
NU7441	JNK1	88.0	10000.0
GW-5074	FLT3(K663Q)	11.0	10000.0
Buparlisib	DYRK1B	74.0	1000.0
ZG-10	YANK1	95.0	10000.0
CP466722	CDK14	62.0	10000.0
Dactolisib	MK03	100.0	1000.0
Sigma A6730	GSK3B	89.0	10000.0
XMD8-85	LATS1	100.0	10000.0
SB590885	DAPK3	89.0	10000.0
TAK-715	ITK	100.0	10000.0
KIN001-220	EGFR(T790M)	13.0	10000.0
BMS345541	HCK	100.0	10000.0
ZG-10	GRK1	98.0	10000.0
BS-181	MST4	77.0	10000.0
WZ3105	MLTK	100.0	10000.0
GSK1059615	CDK8	7.3	10000.0
KU63794	HIPK3	76.0	10000.0
Ceritinib	KPCI	65.0	1000.0
JNK-IN-8	TAOK3	66.0	1000.0
NPK76-II-72-1	MK11	100.0	10000.0
AZD4547	MAP4K2	0.2	10000.0
GW843682X	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
Sorafenib	BRAF(V600E)	0.1	10000.0
XMD11-85h	PDPK1	100.0	10000.0
Baricitinib	PRKX	9.0	10000.0
XMD16-144	LOK	30.0	10000.0
Baricitinib	MP2K6	37.0	10000.0
NU7441	MARK1	100.0	10000.0
TGX221	PAK7/PAK5	100.0	1000.0
RO-3306	RIPK4	87.0	10000.0
SCH772984	KPCT	100.0	1000.0
ERK5-IN-1	FLT3(D835Y)	100.0	1000.0
XMD11-85h	MAPKAPK2	100.0	10000.0
Crizotinib	MKNK1	100.0	10000.0
Baricitinib	FLT3(ITD)	49.0	10000.0
WZ4003	MLCK	100.0	1000.0
JNK-IN-8	PIP5K1C	93.0	1000.0
Lapatinib	PAK3	100.0	10000.0
XMD8-92	DYRK1A	100.0	10000.0
Ribociclib	PAK4	100.0	1000.0
AS-252424	PKN2	93.3	10000.0
MLN8054	SgK110	58.0	10000.0
WZ-4-145	FAK2	100.0	10000.0
OTSSP167	SGK2	1.8	10000.0
CGP60474	KIT(V559D,T670I)	100.0	10000.0
BI-2536	INSRR	100.0	10000.0
JNK-9L	SRPK2	34.0	10000.0
MRT67307	TNK1	20.0	10000.0
A443654	JNK3	25.0	10000.0
AZ-628	DYRK1A	79.0	10000.0
AZD 5438	AAK1	3.8	10000.0
TGX221	CDK5	100.0	1000.0
BMX-IN-1	CLK2	50.0	10000.0
Canertinib	LKB1	100.0	1000.0
RO-3306	MLCK	1.0	10000.0
ZG-10	CDK16	91.0	10000.0
PD0325901	RIOK1	95.0	10000.0
WZ3105	MK11	89.0	10000.0
Buparlisib	SGK2	94.0	1000.0
AZD7762	CIT	0.2	10000.0
MLN8054	CAMK1G	79.0	10000.0
XMD-12	KPCD3	69.0	1000.0
WZ4002	RPS6KA5(Kin.Dom.2)	100.0	10000.0
MLN8054	PIK3CA(H1047Y)	27.0	10000.0
QL-XI-92	EPHA5	80.0	10000.0
GW843682X	EGFR(S752-I759del)	100.0	10000.0
Barasertib	CLK3	100.0	10000.0
Ibrutinib	PIK3CA(E545K)	76.0	1000.0
MLN8054	MERTK	3.0	10000.0
QL-XI-92	CLK4	100.0	10000.0
ZM-447439	CDK15	68.0	10000.0
SP600125	CDK9	100.0	10000.0
(s)-CR8	ICK	85.0	10000.0
GSK1059615	ACVR2B	20.0	10000.0
XMD16-144	EGFR(L858R)	73.0	10000.0
ALW-II-38-3	PLK3	100.0	10000.0
BMX-IN-1	DMPK2	90.0	10000.0
AZD-6482	EGFR(G719S)	98.0	10000.0
BS-181	PGFRA	97.0	10000.0
WYE-125132	EPHA7	87.0	10000.0
AZ-628	GAK	99.0	10000.0
PHA-793887	PFPK5(P.falciparum)	1.4	10000.0
PHA-793887	CSF1R-autoinhibited	36.0	10000.0
CH5424802	RSK3(Kin.Dom.2-C-terminal)	17.0	1000.0
JNK-IN-5A	KIT	68.0	10000.0
NVP-TAE684	EPHA1	0.2	1000.0
Pictilisib	MET	95.0	1000.0
XMD8-85	PLK3	100.0	10000.0
AG1478	FRK	29.0	10000.0
XMD11-50	EIF2AK1	100.0	10000.0
KIN001-111	ABL1(Q252H)	2.6	1000.0
BI-2536	MLK3	100.0	10000.0
ALW-II-49-7	ERK4	100.0	10000.0
Dinaciclib	ABL1(F317L)-phosphorylated	77.0	10000.0
Torin1	IGF1R	94.0	10000.0
HG-9-91-01	LRRK2(G2019S)	5.8	10000.0
Dinaciclib	YSK4	78.0	10000.0
WZ-4-145	ULK1	100.0	10000.0
WZ4003	TLK1	100.0	1000.0
Canertinib	MST4	100.0	1000.0
HG-14-10-04	CLK3	4.7	10000.0
GW843682X	ALK	100.0	10000.0
HG-5-113-01	NUAK1	1.0	10000.0
XMD-12	MST1R	94.0	1000.0
CG-930	YSK4	47.0	10000.0
AZD4547	MYO3A	33.0	10000.0
JNK-9L	ULK1	37.0	10000.0
BS-181	ABL1-phosphorylated	84.0	10000.0
PLX-4720	TESK1	13.0	10000.0
Crizotinib	CDK14	92.0	10000.0
Ribociclib	PIK3CA(I800L)	40.0	1000.0
Omipalisib	MK09	51.0	10000.0
TAK-715	CAMK2B	81.0	10000.0
BS-181	PIM3	86.0	10000.0
OTSSP167	MERTK	1.8	10000.0
XMD11-85h	MAPKAPK5	100.0	10000.0
Momelotinib	FAK2	86.0	10000.0
PHA-793887	PKAC-alpha	99.0	10000.0
Torin2	PLK2	100.0	10000.0
ZM-447439	MLTK	34.0	10000.0
BMX-IN-1	SBK1	100.0	10000.0
NPK76-II-72-1	ITK	100.0	10000.0
XMD-12	EGFR(G719S)	100.0	1000.0
SP600125	VGFR1	100.0	10000.0
PLX-4720	HIPK4	34.0	10000.0
XMD8-92	PGFRB	100.0	10000.0
NU7441	PIK3CA(E542K)	27.0	10000.0
QL-XI-92	MP2K7	100.0	10000.0
JWE-035	ZAP70	90.0	10000.0
GSK461364	DAPK1	8.4	10000.0
WZ-4-145	TIE2	1.0	10000.0
Dinaciclib	MET(M1250T)	52.0	10000.0
CG-930	PIK3CA(H1047L)	100.0	10000.0
CH5424802	PRP4	88.0	1000.0
AZ-628	VRK2	100.0	10000.0
CP724714	INSRR	100.0	10000.0
QL-XII-47	AURKB	97.0	1000.0
CGP60474	MK11	100.0	10000.0
Neratinib	ROCK1	100.0	10000.0
GSK429286A	MAK	100.0	10000.0
OTSSP167	FLT3(K663Q)	5.1	10000.0
Lapatinib	CLK2	80.0	10000.0
Dinaciclib	MARK1	91.0	10000.0
Dabrafenib	PAK4	15.0	10000.0
HG-6-64-01	LKB1	7.9	10000.0
AZD-6482	MKNK2	92.0	10000.0
Alpelisib	PIK3CA(I800L)	0.0	1000.0
HG-14-10-04	PIM1	7.5	10000.0
GSK1059615	PCTK3	56.0	10000.0
KIN001-021	RET(V804M)	100.0	1000.0
WZ-4-145	ROS1	100.0	10000.0
KU63794	STK36	92.0	10000.0
PHA-793887	CSK	100.0	10000.0
NVP-TAE684	ZAP70	10.0	1000.0
TAK-715	TAOK2	86.0	10000.0
AZD 5438	LIMK1	26.0	10000.0
Ibrutinib	NDR1	70.0	1000.0
KIN001-111	PAK6	100.0	1000.0
TGX221	PDPK1	100.0	1000.0
Dinaciclib	CDK4-cyclinD3	2.0	10000.0
Torkinib	PLK1	87.0	10000.0
BMX-IN-1	AMPK-alpha1	100.0	10000.0
HG-14-8-02	PIM3	100.0	10000.0
THZ1	CSK	60.0	10000.0
GSK461364	RIPK1	100.0	10000.0
XMD11-85h	FLT3(K663Q)	100.0	10000.0
AZ-628	VGFR1	4.4	10000.0
MPS-1-IN-1	FLT3	100.0	1000.0
CGP60474	MRCKA	100.0	10000.0
GSK429286A	AKT3	40.0	10000.0
PHA-793887	BLK	100.0	10000.0
GSK1059615	TRKB	73.0	10000.0
Baricitinib	DCLK1	1.6	10000.0
KIN001-111	MKNK1	100.0	1000.0
Barasertib	PRKX	66.0	10000.0
HG-5-113-01	MAP4K5	1.8	10000.0
KIN001-111	FGR	1.3	1000.0
ZM-447439	MST4	44.0	10000.0
HG-14-8-02	MLTK	100.0	10000.0
BMX-IN-1	CDC2L5	100.0	10000.0
SCH772984	NUAK1	100.0	1000.0
Sorafenib	PIK3CA(I800L)	100.0	10000.0
Neratinib	AXL	5.4	10000.0
Taselisib	MLK2	79.0	1000.0
MRT67307	EGFR(L747-E749del,A750P)	95.0	10000.0
HG-14-10-04	CDK14	94.0	10000.0
Seliciclib	DAPK2	91.0	10000.0
Lapatinib	PKNB(M.tuberculosis)	85.0	10000.0
JNK-IN-8	TRKC	79.0	1000.0
BX-912	GRK4	5.6	10000.0
MPS-1-IN-1	EGFR	100.0	1000.0
JNK-IN-11	MYLK	77.0	1000.0
WZ4002	RAF1	100.0	10000.0
Seliciclib	MAP3K4	100.0	10000.0
AZD4547	FGFR3(G697C)	0.0	10000.0
Torin2	RSK3(Kin.Dom.2-C-terminal)	86.0	10000.0
OTSSP167	PAK4	100.0	10000.0
WZ3105	PLK2	52.0	10000.0
NG25	CDK7	2.4	10000.0
NG25	ABL1(E255K)	1.2	10000.0
JNK-IN-11	ACVR2A	5.1	1000.0
NU7441	PIM2	84.0	10000.0
MRT67307	AKT3	100.0	10000.0
XMD16-144	BRAF	66.0	10000.0
GSK429286A	PCTK2	91.0	10000.0
Barasertib	EGFR(L858R,T790M)	83.0	10000.0
XMD8-92	PIK3CD	100.0	10000.0
AZD4547	CDK5	80.0	10000.0
CGP74514A	TAOK3	12.0	10000.0
HG-14-10-04	TAOK3	62.0	10000.0
TAK-715	EPHB2	80.0	10000.0
Pictilisib	WNK2	100.0	1000.0
MLN8054	RIOK2	99.0	10000.0
BI-D1870	PCTK3	8.4	10000.0
PLX-4720	PTK6	0.5	10000.0
BMS-536924	ABL1(F317L)	100.0	1000.0
JNK-9L	PLK4	22.0	10000.0
WH-4-023	BMPR1A	0.1	10000.0
Seliciclib	KIT-autoinhibited	89.0	10000.0
Dabrafenib	KIT(L576P)	1.8	10000.0
CG-930	MAP3K15	100.0	10000.0
BS-181	AURKC	84.0	10000.0
CH5424802	TYRO3	65.0	1000.0
Palbociclib	MAP4K4	98.0	1000.0
GSK429286A	TTK	100.0	10000.0
Pictilisib	CLK1	59.0	1000.0
JW-7-24-1	PRKR	100.0	10000.0
SB590885	YES	100.0	10000.0
PD173074	CDK14	100.0	10000.0
Buparlisib	CDC2L2	100.0	1000.0
XMD8-92	HIPK1	100.0	10000.0
Alpelisib	MP2K7	100.0	1000.0
XMD8-85	BMX	100.0	10000.0
Ibrutinib	KGP2	54.0	1000.0
Torkinib	MAP4K4	38.0	10000.0
QL-X-138	PIK4CB	2.3	10000.0
HG-14-10-04	CTK	55.0	10000.0
Buparlisib	MAP3K1	100.0	1000.0
Abemaciclib	MKNK1	85.0	1000.0
WZ4002	MLCK	100.0	10000.0
AS-252424	DCLK1	100.0	10000.0
HG-5-113-01	MP2K3	10.0	10000.0
AZD7762	MK13	100.0	10000.0
KIN001-127	JNK3	100.0	10000.0
GSK461364	WEE2	83.0	10000.0
ZM-447439	EGFR(E746-A750del)	36.0	10000.0
AS-252424	M3K12	100.0	10000.0
CP724714	IKKA	100.0	10000.0
CP466722	ULK2	3.0	10000.0
KU63794	MYLK2	78.0	10000.0
GW-5074	EPHA2	83.0	10000.0
Crizotinib	WEE1	100.0	10000.0
Vemurafenib	SRMS	0.1	10000.0
NVP-TAE684	RPS6KA6(Kin.Dom.2)	1.8	1000.0
PD173074	LYN	100.0	10000.0
ZG-10	BRAF(V600E)	63.0	10000.0
JNK-IN-11	AKT3	80.0	1000.0
Seliciclib	FLT3	96.0	10000.0
AZD 5438	YANK1	87.0	10000.0
BI-2536	MYLK2	100.0	10000.0
GSK1059615	AKT1	90.0	10000.0
JNK-9L	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
Omipalisib	FLT3(D835H)	85.0	10000.0
XMD16-144	FGFR3	12.0	10000.0
WH-4-023	PRKX	41.0	10000.0
Buparlisib	PIK3CA(C420R)	0.6	1000.0
ALW-II-38-3	EPHA8	0.6	1000.0
NVP-TAE684	KPCE	16.0	1000.0
Torin1	EPHA5	100.0	10000.0
GW-5074	CDC2L2	73.0	10000.0
BMS345541	FLT3(D835H)	100.0	10000.0
Torkinib	DDR2	11.0	10000.0
WZ4003	PKN1	100.0	1000.0
Dabrafenib	PHKG1	89.0	10000.0
XMD14-99	ABL1-nonphosphorylated	100.0	10000.0
Baricitinib	MTOR	88.0	10000.0
Neratinib	ERK8	100.0	10000.0
WZ4002	YANK2	100.0	10000.0
GSK461364	RSK3(Kin.Dom.2-C-terminal)	74.0	10000.0
Abemaciclib	SIK2	98.0	1000.0
HG-5-88-01	NEK1	100.0	10000.0
Torin2	MLK1	100.0	10000.0
Omipalisib	SNRK	82.0	10000.0
Palbociclib	AURKC	99.0	1000.0
WYE-125132	VGFR1	92.0	10000.0
XMD16-144	CSNK1D	52.0	10000.0
(s)-CR8	AMPK-alpha1	90.0	10000.0
SCH772984	PIK3CA(Q546K)	100.0	1000.0
PLX-4720	ACVR2B	28.0	10000.0
Sigma A6730	STK33	100.0	10000.0
CG-930	STK35	100.0	10000.0
XMD13-2	MARK2	45.0	10000.0
XMD8-92	MKNK1	100.0	10000.0
Omipalisib	CSF1R	91.0	10000.0
XMD16-144	INSR	100.0	10000.0
GW-5074	ABL1-phosphorylated	68.0	10000.0
AG1478	RSK2(Kin.Dom.2-C-terminal)	71.0	10000.0
BGJ398	ABL1(F317L)-nonphosphorylated	73.0	1000.0
WZ3105	SYK	72.0	10000.0
JWE-035	INSRR	100.0	10000.0
XMD8-92	DMPK2	100.0	10000.0
NU7441	ALK	100.0	10000.0
Ibrutinib	SNARK	78.0	1000.0
MRT67307	SIK2	9.9	10000.0
AZD-6482	TEC	91.0	10000.0
HG-14-10-04	LRRK2	0.4	10000.0
ZG-10	PIP5K1A	34.0	10000.0
Buparlisib	MLK1	100.0	1000.0
KIN001-111	JNK3	100.0	1000.0
Vemurafenib	CHEK1	94.0	10000.0
HG-14-10-04	PRP4	16.0	10000.0
Vemurafenib	RSK2(Kin.Dom.1-N-terminal)	76.0	10000.0
Torin1	RSK4(Kin.Dom.2-C-terminal)	86.0	10000.0
JNK-IN-8	SNRK	100.0	1000.0
HG-14-8-02	LIMK2	100.0	10000.0
TGX221	GSK3B	100.0	1000.0
JNK-9L	EGFR(E746-A750del)	67.0	10000.0
WZ4002	CSNK2A2	100.0	10000.0
PD173074	INSRR	100.0	10000.0
Neratinib	ICK	100.0	10000.0
MLN8054	BMX	26.0	10000.0
QL-XI-92	CDC2L1	86.0	10000.0
Ribociclib	AMPK-alpha1	100.0	1000.0
Alpelisib	SRPK2	100.0	1000.0
BX-912	KPCI	45.0	10000.0
XMD8-92	CSNK1G3	100.0	10000.0
XMD-12	YES	38.0	1000.0
Pictilisib	RSK4(Kin.Dom.1-N-terminal)	100.0	1000.0
ZM-447439	YANK1	96.0	10000.0
CGP60474	BMX	100.0	10000.0
SCH772984	BMPR1B	100.0	1000.0
SCH772984	TBK1	72.0	1000.0
BS-181	TESK1	97.0	10000.0
Abemaciclib	CDK8	86.0	1000.0
THZ1	DYRK2	4.8	10000.0
HG-14-8-02	RIPK1	100.0	10000.0
BI-2536	KPCD3	10.0	10000.0
ERK5-IN-1	EPHA7	100.0	1000.0
NPK76-II-72-1	EPHA1	100.0	10000.0
CH5424802	KCC4	41.0	1000.0
HG-14-8-02	AURKB	87.0	10000.0
Seliciclib	HUNK	100.0	10000.0
XMD13-2	ADCK4	88.0	10000.0
JWE-035	SIK2	24.0	10000.0
KIN001-111	MK14	100.0	1000.0
AZD4547	PIK3CA(C420R)	69.0	10000.0
PLX-4720	PIK3C2G	55.0	10000.0
ZG-10	NEK5	2.2	10000.0
KIN001-220	KPCD1	100.0	10000.0
BMX-IN-1	LATS2	81.0	10000.0
GSK1059615	BLK	77.0	10000.0
HG-5-113-01	ABL1	11.0	10000.0
JNK-9L	MST2	100.0	10000.0
Taselisib	RIPK1	100.0	1000.0
NPK76-II-72-1	EPHA4	100.0	10000.0
XMD-12	NEK7	100.0	1000.0
Abemaciclib	SIK1	100.0	1000.0
Lapatinib	LIMK1	100.0	10000.0
KIN001-127	PKMYT1	100.0	10000.0
Dactolisib	EPHA4	100.0	1000.0
GSK1059615	ABL1(E255K)-phosphorylated	71.0	10000.0
Torkinib	FLT3	40.0	10000.0
ZG-10	ULK3	88.0	10000.0
ZG-10	MP2K4	9.8	10000.0
NU7441	AURKA	98.0	10000.0
XMD8-92	MST1	100.0	10000.0
Ibrutinib	PIP5K2B	83.0	1000.0
Abemaciclib	INSR	99.0	1000.0
PD173074	ITK	100.0	10000.0
KIN001-220	WEE1	31.0	10000.0
CGP60474	PLK3	100.0	10000.0
WZ-4-145	ABL1(Y253F)	13.0	10000.0
JWE-035	BRSK1	41.0	10000.0
BX-912	EPHA6	54.0	10000.0
HG-5-88-01	FYN	100.0	10000.0
AZD 5438	LATS1	66.0	10000.0
Barasertib	PKAC-alpha	100.0	10000.0
QL-XII-47	KIT(V559D)	68.0	1000.0
WZ4002	BRAF	100.0	10000.0
MLN8054	CLK4	100.0	10000.0
BMX-IN-1	MK11	95.0	10000.0
AG1478	EGFR(G719S)	0.9	10000.0
Torin1	RIOK3	90.0	10000.0
KU63794	NEK2	100.0	10000.0
WH-4-023	ERK3	100.0	10000.0
PHA-793887	INSR	98.0	10000.0
KIN001-021	DAPK2	100.0	1000.0
GW843682X	PIK4CB	100.0	10000.0
ERK5-IN-1	CSNK1G3	91.0	1000.0
Palbociclib	PIK3CA(E542K)	100.0	1000.0
XMD14-99	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
Crizotinib	STK33	26.0	10000.0
WZ-4-145	CDK3	100.0	10000.0
SCH772984	ERK8	59.0	1000.0
PHA-793887	MLK1	100.0	10000.0
SCH772984	ALK(C1156Y)	100.0	1000.0
Sorafenib	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
Ribociclib	EPHA4	96.0	1000.0
BI-D1870	CSNK1G3	1.2	10000.0
CP466722	CHK2	78.0	10000.0
NU7441	PIK3CB	0.0	10000.0
Sorafenib	ERK8	0.9	10000.0
JNK-IN-11	KIT(V559D)	0.6	1000.0
MRT67307	CDK7	7.2	10000.0
SCH772984	RIPK4	100.0	1000.0
WYE-125132	MAPKAPK2	82.0	10000.0
XMD8-92	MK01	100.0	10000.0
GSK461364	CIT	87.0	10000.0
WZ4003	ABL1(H396P)	100.0	1000.0
XMD11-85h	CAMK1	100.0	10000.0
PHA-793887	EPHB3	100.0	10000.0
XMD13-2	CHEK1	100.0	10000.0
Palbociclib	CDK7	100.0	1000.0
JNK-IN-11	PLK2	81.0	1000.0
Lapatinib	TNK1	100.0	10000.0
BX-912	MST3	2.0	10000.0
HG-14-10-04	RSK4(Kin.Dom.2-C-terminal)	41.0	10000.0
PHA-767491	PAK1	43.0	10000.0
Pictilisib	FYV1	4.5	1000.0
THZ1	KIT	0.2	10000.0
Taselisib	WNK1	100.0	1000.0
Alpelisib	AMPK-alpha1	91.0	1000.0
HG-6-64-01	ERN1	72.0	10000.0
GW843682X	SNRK	83.0	10000.0
CH5424802	EGFR(L858R,T790M)	38.0	1000.0
HG-5-113-01	MK03	100.0	10000.0
WZ4003	FLT4	100.0	1000.0
Sorafenib	TTK	15.0	10000.0
QL-X-138	CDK4-cyclinD1	100.0	10000.0
CH5424802	MAP3K14	66.0	1000.0
Palbociclib	LATS1	100.0	1000.0
BI-2536	CAMK1D	100.0	10000.0
NG25	TNNI3K	4.8	10000.0
QL-XII-47	SLK	100.0	1000.0
Alpelisib	PFCDPK1(P.falciparum)	90.0	1000.0
CGP74514A	VGFR1	61.0	10000.0
HG-5-88-01	CDK3	100.0	10000.0
5z-7-oxozeaenol	ABL1(T315I)-phosphorylated	92.0	10000.0
AZD7762	KC1G2	1.0	10000.0
Alpelisib	MAK	100.0	1000.0
SP600125	PHKG2	3.6	10000.0
BMS-536924	TNK1	0.6	1000.0
ERK5-IN-1	M3K5	100.0	1000.0
SCH772984	IGF1R	100.0	1000.0
CP466722	AURKC	6.2	10000.0
WZ4002	PIM3	100.0	10000.0
CH5424802	MST2	100.0	1000.0
CP466722	MARK4	75.0	10000.0
CGP74514A	HIPK3	3.0	10000.0
Barasertib	CAMK2G	100.0	10000.0
WYE-125132	DCAMKL3	100.0	10000.0
MPS-1-IN-1	JNK1	5.2	1000.0
KIN001-220	EPHA7	55.0	10000.0
Lapatinib	IKKB	88.0	10000.0
XMD14-99	MAP3K4	100.0	10000.0
Palbociclib	EPHB1	100.0	1000.0
Momelotinib	TRKC	63.0	10000.0
Sigma A6730	PIM2	91.0	10000.0
XMD-12	ABL1(T315I)-phosphorylated	1.0	1000.0
HG-5-113-01	ACVR1B	100.0	10000.0
SCH772984	EPHA2	91.0	1000.0
WYE-125132	LRRK2(G2019S)	65.0	10000.0
XMD-12	ABL1(F317L)-nonphosphorylated	20.0	1000.0
AZ-628	JNK1	100.0	10000.0
JW-7-24-1	MELK	100.0	10000.0
R406	EPHA3	12.0	1000.0
A443654	NEK5	100.0	10000.0
Ribociclib	M3K13	100.0	1000.0
BX-912	DYRK2	3.4	10000.0
RO-3306	TLK2	90.0	10000.0
WZ4002	STK35	100.0	10000.0
WZ3105	CASK	92.0	10000.0
Torin1	LOK	79.0	10000.0
PHA-793887	MP2K5	90.0	10000.0
JNK-IN-8	PIK4CB	82.0	1000.0
QL-XII-47	EPHA6	100.0	1000.0
Dactolisib	PIK3CA(H1047L)	4.8	1000.0
QL-XII-47	MINK	63.0	1000.0
AG1478	TRKB	80.0	10000.0
Palbociclib	PIM3	100.0	1000.0
AZ-628	EGFR(G719S)	37.0	10000.0
Vemurafenib	FES	41.0	10000.0
THZ1	TTK	33.0	10000.0
ZM-447439	CAMK1	55.0	10000.0
BS-181	KCC2D	88.0	10000.0
KIN001-123	FLT3	28.0	1000.0
Alpelisib	CLK3	80.0	1000.0
5z-7-oxozeaenol	ACVRL1	24.0	10000.0
ZSTK474	MELK	100.0	1000.0
XMD11-85h	CDK5	100.0	10000.0
CH5424802	EGFR(E746-A750del)	21.0	1000.0
(s)-CR8	EPHA5	100.0	10000.0
Vemurafenib	GCN2(Kin.Dom.2,S808G)	0.6	10000.0
R406	ROCK2	6.8	1000.0
BMX-IN-1	M4K1	94.0	10000.0
BMX-IN-1	SNRK	58.0	10000.0
KIN001-220	ROCK1	81.0	10000.0
Momelotinib	KPCL	98.0	10000.0
XMD14-99	KPCD1	44.0	10000.0
HG-9-91-01	JAK1(JH2domain-pseudokinase)	45.0	10000.0
CP466722	PAK7	63.0	10000.0
WZ-4-145	AAK1	100.0	10000.0
GSK461364	MARK4	100.0	10000.0
(s)-CR8	SRPK2	100.0	10000.0
NVP-TAE684	PAK2	30.0	1000.0
QL-XI-92	ABL1(T315I)-nonphosphorylated	89.0	10000.0
Dinaciclib	NIM1	88.0	10000.0
AZD7762	IKKB	2.5	10000.0
Dactolisib	CSNK1D	100.0	1000.0
KIN001-127	CAMKK2	24.0	10000.0
Torin2	MST3	98.0	10000.0
XMD11-50	M3K13	100.0	10000.0
Momelotinib	MAP3K3	51.0	10000.0
BMS-536924	M4K3	2.0	1000.0
Ribociclib	EGFR(L858R,T790M)	100.0	1000.0
HG-5-113-01	RET(V804L)	0.2	10000.0
Dabrafenib	WNK3	85.0	10000.0
Sigma A6730	PIK3CA(H1047Y)	100.0	10000.0
JNK-IN-8	FGFR1	94.0	1000.0
Abemaciclib	TGFBR1	100.0	1000.0
AG1478	MP2K3	57.0	10000.0
ERK5-IN-1	FLT3(ITD)	100.0	1000.0
Lapatinib	MKNK2	85.0	10000.0
AZD-6482	KIT(D816H)	88.0	10000.0
GSK1059615	ERBB3	88.0	10000.0
CH5424802	PIK3C3	90.0	1000.0
Crizotinib	YSK4	2.4	10000.0
Taselisib	PIP5K2B	58.0	1000.0
5z-7-oxozeaenol	ABL1(E255K)-phosphorylated	85.0	10000.0
KIN001-220	MINK	57.0	10000.0
Dactolisib	MYLK4	100.0	1000.0
PHA-793887	TIE2	100.0	10000.0
HG-6-64-01	YANK3	100.0	10000.0
TGX221	KC1G2	100.0	1000.0
AZD4547	WNK1	8.0	10000.0
Dabrafenib	FRK	4.6	10000.0
BX-912	M3K6	49.0	10000.0
5z-7-oxozeaenol	AMPK-alpha2	90.0	10000.0
PD173074	ERBB4	100.0	10000.0
Lapatinib	FGFR3	96.0	10000.0
JNK-IN-11	FLT4	7.8	1000.0
CH5424802	BARK2	94.0	1000.0
QL-X-138	PLK3	99.0	10000.0
AZ-628	NDR1	100.0	10000.0
Torin2	CAMK2G	95.0	10000.0
Buparlisib	PAK1	100.0	1000.0
CP724714	CHEK1	90.0	10000.0
Pictilisib	NEK3	81.0	1000.0
Barasertib	JNK1	59.0	10000.0
OTSSP167	PIM1	87.0	10000.0
HG-6-64-01	EPHA2	1.7	10000.0
Momelotinib	MYLK	100.0	10000.0
PLX-4720	ACVR1B	98.0	10000.0
KIN001-021	MYLK	100.0	1000.0
QL-X-138	PAK4	100.0	10000.0
RO-3306	PIP5K1A	18.0	10000.0
QL-XII-47	PIM3	100.0	1000.0
NPK76-II-72-1	AURKA	100.0	10000.0
TAK-715	MARK2	100.0	10000.0
GSK1059615	TRKA	78.0	10000.0
Abemaciclib	ABL1(F317L)-nonphosphorylated	86.0	1000.0
MRT67307	PIK3CA(M1043I)	100.0	10000.0
CP466722	CDK11	100.0	10000.0
Dabrafenib	BRSK1	7.2	10000.0
CH5424802	HIPK2	40.0	1000.0
ALW-II-49-7	TRKC	15.0	1000.0
GW843682X	MLK3	81.0	10000.0
Torin1	KC1G2	100.0	10000.0
JNK-9L	TAOK1	20.0	10000.0
WYE-125132	RIPK2	71.0	10000.0
GW843682X	KPCD1	100.0	10000.0
WZ4003	MINK	100.0	1000.0
NU7441	MP2K4	100.0	10000.0
Lapatinib	PIK3CA(E545K)	100.0	10000.0
BS-181	STK39	74.0	10000.0
ALW-II-49-7	CLK3	100.0	10000.0
Dactolisib	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	1000.0
WH-4-023	MP2K6	66.0	10000.0
Ibrutinib	PAK7	100.0	1000.0
WZ-7043	RPS6KA3(Kin.Dom.1)	100.0	10000.0
XMD16-144	CAMK1D	59.0	10000.0
BGJ398	MERTK	70.0	1000.0
ZM-447439	MK09	27.0	10000.0
5z-7-oxozeaenol	PFPK5(P.falciparum)	100.0	10000.0
QL-XI-92	MAST1	100.0	10000.0
RO-3306	EPHB3	72.0	10000.0
JNK-IN-11	CAMK2B	100.0	1000.0
ALW-II-38-3	CDK2	100.0	10000.0
RO-3306	LATS2	77.0	10000.0
GSK1059615	RSK2(Kin.Dom.2-C-terminal)	70.0	10000.0
AZ-628	PCTK3	100.0	10000.0
BMS345541	AURKB	67.0	10000.0
BI-D1870	CSNK1D	1.9	10000.0
MLN8054	M3K12	100.0	10000.0
CP724714	DDR2	100.0	10000.0
SCH772984	M4K3	40.0	1000.0
PD0325901	TXK	100.0	10000.0
Neratinib	PIK3CD	83.0	10000.0
Sigma A6730	PIK3CG	25.0	10000.0
MPS-1-IN-1	VGFR1	100.0	1000.0
BMS-536924	ERBB4	31.0	1000.0
Sigma A6730	HIPK1	69.0	10000.0
JNK-IN-8	EPHB6	71.0	1000.0
5z-7-oxozeaenol	ADCK4	54.0	10000.0
PD0325901	TAK1	75.0	10000.0
HG-14-8-02	RET(M918T)	100.0	10000.0
BI-2536	TXK	100.0	10000.0
AZD7762	RPS6KA5(Kin.Dom.2-C-terminal)	9.0	10000.0
Dinaciclib	MP2K1	83.0	10000.0
Alpelisib	ACVR1	100.0	1000.0
AZD4547	IKKE	20.0	10000.0
XMD11-50	CDC2L5	100.0	10000.0
WZ-7043	TIE2	100.0	10000.0
NVP-TAE684	SLK	0.1	1000.0
Sorafenib	KC1G2	94.0	10000.0
R406	FGFR3	1.0	1000.0
Dactolisib	PKAC-beta	100.0	1000.0
CG-930	ABL1(F317I)-phosphorylated	51.0	10000.0
XMD-12	ACVR2B	45.0	1000.0
WZ4003	MP2K6	100.0	1000.0
Alpelisib	WNK1	100.0	1000.0
SP600125	MP2K6	12.0	10000.0
MLN8054	RIOK3	100.0	10000.0
Sigma A6730	BRAF	87.0	10000.0
BX-912	WEE1	52.0	10000.0
CH5424802	PKN2	100.0	1000.0
SB590885	KPCD1	3.8	10000.0
BX-912	PIK3CA(H1047L)	59.0	10000.0
CGP74514A	LTK	63.0	10000.0
A443654	YANK2	100.0	10000.0
JNK-9L	AKT1	100.0	10000.0
AG1478	PIK3CA(M1043I)	76.0	10000.0
(s)-CR8	MKNK1	92.0	10000.0
XMD8-92	FER	100.0	10000.0
NVP-TAE684	KC1G2	100.0	1000.0
CG-930	ULK2	89.0	10000.0
XMD11-85h	RPS6KA3(Kin.Dom.1)	100.0	10000.0
KU63794	LKB1	95.0	10000.0
Palbociclib	WEE2	100.0	1000.0
HG-14-10-04	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
AS-252424	CDK5	77.6	10000.0
(s)-CR8	LIMK2	100.0	10000.0
Momelotinib	ABL1(Q252H)-phosphorylated	41.0	10000.0
Omipalisib	TESK1	80.0	10000.0
MPS-1-IN-1	MAPKAPK5	100.0	1000.0
HG-5-113-01	ACVR2A	100.0	10000.0
GW-5074	ZAP70	84.0	10000.0
QL-XI-92	BIKE	100.0	10000.0
AS-252424	MRCKA	81.8	10000.0
JW-7-24-1	BIKE	28.0	10000.0
WZ4002	CSF1R	14.0	10000.0
5z-7-oxozeaenol	DCAMKL3	100.0	10000.0
OTSSP167	ACVR1	0.7	10000.0
A443654	AURKC	34.0	10000.0
NU7441	TGFBR2	89.0	10000.0
CG-930	ERBB3	4.6	10000.0
GSK461364	CDK14	94.0	10000.0
Dactolisib	EGFR	100.0	1000.0
Palbociclib	FLT3(K663Q)	100.0	1000.0
AZD 5438	DAPK3	40.0	10000.0
Lapatinib	FGFR4	94.0	10000.0
JNK-IN-5A	MST4	79.0	10000.0
Crizotinib	FYN	10.0	10000.0
OTSSP167	PIK3CA(H1047L)	84.0	10000.0
BMS345541	FLT3(K663Q)	92.0	10000.0
WZ4002	CLK1	13.0	10000.0
BMX-IN-1	FYN	98.0	10000.0
KIN001-127	RIPK4	100.0	10000.0
HG-5-113-01	FLT3(K663Q)	2.6	10000.0
Sigma A6730	BUB1	64.0	10000.0
RO-3306	MET	50.0	10000.0
XMD-12	ACVR1	88.0	1000.0
WZ4002	PAK6	100.0	10000.0
JWE-035	FLT3(K663Q)	62.0	10000.0
HG-14-8-02	RPS6KA5(Kin.Dom.2-C-terminal)	85.0	10000.0
CGP74514A	KIT(D816H)	31.0	10000.0
GSK429286A	NLK	92.0	10000.0
AG1478	LIMK1	100.0	10000.0
Torin1	STK35	18.0	10000.0
Barasertib	PIK3CA	100.0	10000.0
Crizotinib	MLCK	100.0	10000.0
XMD-12	MAP3K4	100.0	1000.0
BI-2536	PAK7	100.0	10000.0
XMD-12	MYLK2	80.0	1000.0
JNK-IN-11	KIT(V559D,V654A)	49.0	1000.0
SCH772984	NIM1	100.0	1000.0
Lapatinib	PRKR	93.0	10000.0
BI-2536	ACVR2B	100.0	10000.0
PLX-4720	CDK16	68.0	10000.0
QL-XII-47	TESK1	100.0	1000.0
HG-14-10-04	MAP4K4	0.6	10000.0
BMS-536924	KPCE	100.0	1000.0
KIN001-111	M4K3	1.0	1000.0
GW-5074	PIK3CA(H1047Y)	76.0	10000.0
Sigma A6730	FES	100.0	10000.0
AZD7762	CHK2	3.8	10000.0
CGP60474	WEE1	100.0	10000.0
Torin1	ADCK4	15.0	10000.0
XMD11-85h	M3K5	100.0	10000.0
QL-XI-92	MP2K1	87.0	10000.0
HG-14-8-02	MST1R	100.0	10000.0
GSK461364	DYRK2	54.0	10000.0
HG-6-64-01	M3K5	35.0	10000.0
Lapatinib	ACVR2A	99.0	10000.0
QL-X-138	MINK	31.0	10000.0
JNK-IN-5A	EGFR(E746-A750del)	89.0	10000.0
JNK-9L	ABL1-nonphosphorylated	61.0	10000.0
WZ-7043	DYRK1A	100.0	10000.0
SCH772984	LKB1	98.0	1000.0
QL-X-138	MP2K6	53.0	10000.0
Ribociclib	RET	87.0	1000.0
HG-6-64-01	ABL1(T315I)-nonphosphorylated	0.0	10000.0
CP724714	CDKL3	100.0	10000.0
WH-4-023	CDK7	100.0	10000.0
BMX-IN-1	FLT3(R834Q)	100.0	10000.0
JNK-9L	ABL1(Q252H)-nonphosphorylated	42.0	10000.0
HG-6-64-01	JAK3(JH1domain-catalytic)	1.1	10000.0
MLN8054	PIK4CB	100.0	10000.0
GSK461364	BRAF	79.0	10000.0
BX-912	AKT2	100.0	10000.0
KIN001-127	CLK4	33.0	10000.0
PHA-767491	ABL1(T315I)-phosphorylated	30.0	10000.0
XMD11-50	PGFRA	100.0	10000.0
KIN001-127	TNNI3K	100.0	10000.0
HG-14-10-04	PKNB(M.tuberculosis)	0.2	10000.0
NVP-TAE684	EPHA7	0.4	1000.0
ALW-II-38-3	PAK6	100.0	10000.0
Seliciclib	EGFR(G719C)	99.0	10000.0
Ribociclib	PLK2	100.0	1000.0
AS-252424	PCTK2	91.2	10000.0
Vemurafenib	PKN2	92.0	10000.0
SCH772984	EPHB1	96.0	1000.0
QL-X-138	JAK2(JH1domain-catalytic)	16.0	10000.0
Alpelisib	MRCKA	100.0	1000.0
BX-912	DYRK1B	35.0	10000.0
ALW-II-49-7	KC1G1	100.0	10000.0
THZ1	DRAK1	1.6	10000.0
HG-5-113-01	SRPK2	24.0	10000.0
HG-6-64-01	STK33	31.0	10000.0
CP466722	TAOK3	39.0	10000.0
Canertinib	CDK11	100.0	1000.0
Torin1	TRKA	64.0	10000.0
XMD8-92	PIK3CA(H1047Y)	100.0	10000.0
Alpelisib	EPHA6	91.0	1000.0
Baricitinib	ABL2	65.0	10000.0
GSK461364	CSNK1A1L	84.0	10000.0
KIN001-127	ABL1(E255K)	100.0	10000.0
PHA-767491	GSK3A	0.0	10000.0
BMS345541	BTK	100.0	10000.0
GSK429286A	MAP3K4	97.0	10000.0
THZ1	CDK3	5.8	10000.0
NVP-TAE684	CDC2L2	100.0	1000.0
NU7441	SIK1	100.0	10000.0
AZD7762	MET(M1250T)	4.7	10000.0
Alpelisib	HIPK2	100.0	1000.0
AS-252424	BIKE	70.3	10000.0
AZD-6482	NDR2	94.0	10000.0
MRT67307	MK01	100.0	10000.0
MRT67307	KIT	28.0	10000.0
TGX221	CAMK2B	100.0	1000.0
HG-6-64-01	CDK15	36.0	10000.0
Sigma A6730	PIM1	93.0	10000.0
KIN001-111	DYRK1B	100.0	1000.0
KIN001-127	JAK1(Kin.Dom.1)	100.0	10000.0
Dactolisib	MST2	100.0	1000.0
QL-XI-92	YANK3	100.0	10000.0
AS-252424	SRPK1	100.0	10000.0
THZ1	RPS6KA5(Kin.Dom.1-N-terminal)	50.0	10000.0
Dinaciclib	ROS1	82.0	10000.0
ZM-447439	IKKB	100.0	10000.0
AZD7762	CDC2L2	100.0	10000.0
QL-XI-92	PAK4	93.0	10000.0
GW843682X	HIPK3	77.0	10000.0
HG-9-91-01	NEK7	100.0	10000.0
Vemurafenib	HCK	13.0	10000.0
HG-14-8-02	PGFRA	98.0	10000.0
GSK461364	EGFR(S752-I759del)	100.0	10000.0
HG-5-88-01	YANK2	3.7	10000.0
TGX221	PRKR	100.0	1000.0
MLN8054	MST4	100.0	10000.0
WZ-7043	TYK2(JH2domain-pseudokinase)	100.0	10000.0
CH5424802	LKB1	97.0	1000.0
AZD4547	CDK8	96.0	10000.0
Pictilisib	EGFR(G719S)	93.0	1000.0
(s)-CR8	TYRO3	86.0	10000.0
OTSSP167	TSSK1	100.0	10000.0
WH-4-023	PCTK3	100.0	10000.0
BMS345541	LRRK2(G2019S)	93.0	10000.0
Ribociclib	MARK4	93.0	1000.0
BX-912	PAK2	45.0	10000.0
NVP-TAE684	SRPK2	12.0	1000.0
Buparlisib	SGK1	100.0	1000.0
XMD-12	M4K3	45.0	1000.0
AZ-628	PKNB(M.tuberculosis)	100.0	10000.0
Canertinib	KPCL	100.0	1000.0
BI-2536	CDK8	100.0	10000.0
QL-XII-47	DAPK1	66.0	1000.0
QL-XII-47	SIK3	100.0	1000.0
SB590885	HCK	84.0	10000.0
Pictilisib	PIP5K1A	100.0	1000.0
MLN8054	MP2K4	100.0	10000.0
JNK-IN-5A	IRAK3	100.0	10000.0
RO-3306	MK12	91.0	10000.0
Buparlisib	PKAC-beta	99.0	1000.0
Sigma A6730	ADCK3	100.0	10000.0
MPS-1-IN-1	PIK3CB	100.0	1000.0
ALW-II-49-7	ANKK1	100.0	10000.0
BGJ398	EPHB2	100.0	1000.0
ZG-10	MLK3	100.0	10000.0
MRT67307	JAK2(JH1domain-catalytic)	0.5	10000.0
QL-X-138	CAMK2G	45.0	10000.0
Momelotinib	CLK3	91.0	10000.0
WZ-7043	PKN1	100.0	10000.0
ZSTK474	KPCD	100.0	1000.0
JNK-IN-5A	TAOK1	100.0	10000.0
WZ4002	ULK3	12.0	10000.0
JWE-035	KPCD3	8.0	10000.0
SP600125	CAMK1D	13.0	10000.0
AG1478	FLT3(K663Q)	35.0	10000.0
5z-7-oxozeaenol	TEC	98.0	10000.0
KIN001-127	KPCD2	100.0	10000.0
WZ3105	JAK3(JH1domain-catalytic)	89.0	10000.0
JNK-IN-8	KC1G2	73.0	1000.0
GSK429286A	MP2K1	73.0	10000.0
OTSSP167	MLTK	3.8	10000.0
BMS345541	JNK3	100.0	10000.0
ZG-10	BMPR1B	36.0	10000.0
Barasertib	TRPM6	100.0	10000.0
PHA-767491	LTK	100.0	10000.0
GSK461364	MST2	74.0	10000.0
XMD13-2	GAK	49.0	10000.0
A443654	EPHA5	100.0	10000.0
BI-2536	RET(V804M)	100.0	10000.0
Omipalisib	KPCD3	94.0	10000.0
Torkinib	CDK4-cyclinD3	57.0	10000.0
GSK1059615	CDKL3	99.0	10000.0
XMD-12	FLT3(N841I)	80.0	1000.0
WZ-7043	RIPK4	100.0	10000.0
CG-930	ICK	100.0	10000.0
AG1478	ERK8	100.0	10000.0
GSK1059615	CDK7	1.7	10000.0
ZM-447439	WEE1	100.0	10000.0
Palbociclib	JAK2(JH1domain-catalytic)	61.0	1000.0
Vemurafenib	CDK15	96.0	10000.0
Torkinib	AMPK-alpha1	43.0	10000.0
GSK461364	PIK3CA(E545A)	40.0	10000.0
KIN001-021	SLK	100.0	1000.0
JNK-IN-8	BRSK2	99.0	1000.0
CGP74514A	PHKG1	12.0	10000.0
(s)-CR8	MLK3	97.0	10000.0
ALW-II-38-3	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
AZ-628	YSK1	100.0	10000.0
XMD14-99	MAP4K4	76.0	10000.0
SCH772984	WNK1	100.0	1000.0
Neratinib	FLT3(K663Q)	77.0	10000.0
TAK-715	YANK2	7.0	10000.0
XMD11-50	BRAF(V600E)	100.0	10000.0
WYE-125132	RPS6KA5(Kin.Dom.2-C-terminal)	90.0	10000.0
CP466722	MYLK4	25.0	10000.0
PLX-4720	RET(M918T)	40.0	10000.0
KU63794	PI42C	87.0	10000.0
Abemaciclib	PKAC-alpha	17.0	1000.0
XMD-12	JAK3(JH1domain-catalytic)	93.0	1000.0
Ibrutinib	RIOK2	95.0	1000.0
TAK-715	CDK9	95.0	10000.0
Baricitinib	MK09	76.0	10000.0
HG-14-10-04	EGFR(L747-T751del,Sins)	0.0	10000.0
AZD 5438	CDKL3	0.6	10000.0
BMS345541	HIPK3	32.0	10000.0
XMD13-2	CSNK1A1L	100.0	10000.0
BX-912	MYLK4	6.8	10000.0
THZ1	FYN	7.0	10000.0
ALW-II-38-3	TSSK1	100.0	10000.0
QL-X-138	ABL2	86.0	10000.0
JNK-IN-5A	RSK4(Kin.Dom.2-C-terminal)	77.0	10000.0
A443654	CLK3	0.0	10000.0
CP724714	M3K5	90.0	10000.0
CP724714	M3K12	92.0	10000.0
WH-4-023	MKNK2	90.0	10000.0
JWE-035	STK35	76.0	10000.0
KIN001-111	EGFR(L861Q)	2.9	1000.0
BX-912	KCC4	100.0	10000.0
PLX-4720	MP2K5	0.2	10000.0
WZ4002	MRCKB	100.0	10000.0
KIN001-111	CSK	1.0	1000.0
QL-XI-92	TIE2	100.0	10000.0
XMD-12	DRAK1	100.0	1000.0
Pictilisib	MP2K2	96.0	1000.0
WZ-4-145	ZAP70	100.0	10000.0
HG-5-88-01	EGFR	0.6	10000.0
CP724714	CHK2	55.0	10000.0
5z-7-oxozeaenol	FRK	97.0	10000.0
JNK-IN-5A	EPHA6	94.0	10000.0
Sigma A6730	RPS6KA4(Kin.Dom.2-C-terminal)	82.0	10000.0
XMD14-99	ABL1(H396P)-nonphosphorylated	99.0	10000.0
WZ4002	TNK1	1.8	10000.0
Baricitinib	SRPK2	6.4	10000.0
RO-3306	CSNK2A2	1.2	10000.0
CP724714	CDK11	0.5	10000.0
SCH772984	MAP3K4	100.0	1000.0
Torin2	MAPKAPK2	100.0	10000.0
AS-252424	FAK1	100.0	10000.0
AZ-628	HCK	3.1	10000.0
AS-252424	FGFR4	68.0	10000.0
WYE-125132	TIE1	98.0	10000.0
AZD-6482	MKNK1	92.0	10000.0
MRT67307	IRAK1	7.0	10000.0
5z-7-oxozeaenol	MYLK	84.0	10000.0
ALW-II-38-3	FLT3(D835Y)	100.0	10000.0
BS-181	LOK	92.0	10000.0
JNK-IN-5A	KGP1	88.0	10000.0
BMX-IN-1	EPHA4	100.0	10000.0
NVP-TAE684	ADCK4	0.0	1000.0
Baricitinib	KCC4	18.0	10000.0
ZG-10	KC1G1	0.5	10000.0
ZM-447439	CDK9	100.0	10000.0
PLX-4720	ABL1(H396P)-nonphosphorylated	1.4	10000.0
CG-930	MYO3A	100.0	10000.0
NU7441	TEC	89.0	10000.0
CGP74514A	PIK3CA(E545A)	59.0	10000.0
Canertinib	BIKE	100.0	1000.0
BI-2536	ABL1(Q252H)	100.0	10000.0
Barasertib	PIK3C2B	58.0	10000.0
XMD8-85	CSF1R	16.0	10000.0
QL-XI-92	SRMS	77.0	10000.0
WZ3105	EPHB3	83.0	10000.0
BS-181	VGFR2	87.0	10000.0
JNK-IN-5A	AKT1	94.0	10000.0
XMD16-144	NDR2	54.0	10000.0
SB590885	KPCI	80.0	10000.0
HG-9-91-01	PI42C	17.0	10000.0
MLN8054	MARK4	100.0	10000.0
Abemaciclib	TIE1	86.0	1000.0
Dactolisib	DYRK1A	100.0	1000.0
ZM-447439	ABL1-nonphosphorylated	3.5	10000.0
Ribociclib	RIOK1	100.0	1000.0
ALW-II-49-7	MST2	100.0	10000.0
WZ4003	PIK3CA	100.0	1000.0
HG-5-88-01	CDK8	100.0	10000.0
CP466722	YANK3	44.0	10000.0
PHA-793887	CTK	100.0	10000.0
Ibrutinib	CDK16	98.0	1000.0
Omipalisib	PLK3	67.0	10000.0
BS-181	CAMKK2	79.0	10000.0
GW-5074	FAK1	98.0	10000.0
XMD8-92	JNK3	100.0	10000.0
XMD-12	PIM3	100.0	1000.0
BI-2536	YSK1	100.0	10000.0
AG1478	MYO3A	83.0	10000.0
BX-912	PLK4	0.7	10000.0
CP466722	MARK2	53.0	10000.0
BMS-536924	GCN2(Kin.Dom.2,S808G)	11.0	1000.0
RO-3306	EPHB2	93.0	10000.0
PHA-767491	RSK1(Kin.Dom.2-C-terminal)	52.0	10000.0
QL-XI-92	DYRK1A	99.0	10000.0
ZM-447439	CSK	7.9	10000.0
WH-4-023	CDK14	93.0	10000.0
THZ1	M4K1	14.0	10000.0
PD0325901	MRCKA	100.0	10000.0
Neratinib	ACVR2A	100.0	10000.0
CH5424802	ERK8	100.0	1000.0
BS-181	ABL1(H396P)-phosphorylated	88.0	10000.0
AZD-6482	SBK1	100.0	10000.0
A443654	MINK	6.2	10000.0
WZ3105	BMPR1B	100.0	10000.0
Dabrafenib	PIM3	96.0	10000.0
NVP-TAE684	GCN2(Kin.Dom.2,S808G)	4.5	1000.0
BMX-IN-1	EPHA7	85.0	10000.0
CP724714	RSK4(Kin.Dom.1-N-terminal)	96.0	10000.0
Ceritinib	MLTK	96.0	1000.0
ZG-10	PKN2	79.0	10000.0
BX-912	MAP4K2	0.2	10000.0
Alpelisib	CIT	100.0	1000.0
CH5424802	RIOK3	100.0	1000.0
BS-181	PRP4	70.0	10000.0
CG-930	ERK3	24.0	10000.0
JWE-035	FLT3(ITD)	19.0	10000.0
Pictilisib	FRK	95.0	1000.0
PHA-767491	PLK4	43.0	10000.0
BI-2536	CDK2	100.0	10000.0
KIN001-111	RIOK3	100.0	1000.0
XMD11-50	FGFR1	86.0	10000.0
Crizotinib	ACVR2B	38.0	10000.0
AZD4547	EGFR(L747-E749del,A750P)	67.0	10000.0
(s)-CR8	TYK2(JH1domain-catalytic)	99.0	10000.0
Sigma A6730	TAOK3	84.0	10000.0
GSK429286A	CDK15	84.0	10000.0
AZD7762	RIPK1	100.0	10000.0
5z-7-oxozeaenol	EPHA7	92.0	10000.0
Baricitinib	M4K3	44.0	10000.0
XMD16-144	MET	48.0	10000.0
BGJ398	MAK	95.0	1000.0
WZ3105	KIT(A829P)	23.0	10000.0
QL-XI-92	CSNK1A1L	90.0	10000.0
WZ-7043	AKT3	100.0	10000.0
Vemurafenib	EGFR(S752-I759del)	71.0	10000.0
JNK-IN-11	BMPR1A	66.0	1000.0
CH5424802	ABL1-nonphosphorylated	65.0	1000.0
WZ3105	NDR1	19.0	10000.0
HG-14-10-04	MK11	100.0	10000.0
WZ4003	SRMS	100.0	1000.0
CP724714	TGFBR1	100.0	10000.0
Ibrutinib	SgK110	95.0	1000.0
5z-7-oxozeaenol	RSK3(Kin.Dom.2-C-terminal)	18.0	10000.0
KIN001-123	ABL1(Q252H)	19.0	1000.0
Sorafenib	BTK	83.0	10000.0
Abemaciclib	DRAK2	15.0	1000.0
JNK-IN-8	TTK	46.0	1000.0
CH5424802	MLK3	70.0	1000.0
XMD8-85	ACVR2B	100.0	10000.0
BX-912	PKN1	0.3	10000.0
CGP74514A	PCTK3	3.8	10000.0
ALW-II-49-7	MST1R	100.0	10000.0
BS-181	RSK1(Kin.Dom.2-C-terminal)	85.0	10000.0
Alpelisib	MLCK	95.0	1000.0
AZD7762	KCC4	0.2	10000.0
WZ4002	MARK4	16.0	10000.0
Neratinib	PAK2	34.0	10000.0
Pictilisib	SNRK	100.0	1000.0
SCH772984	PKN2	62.0	1000.0
GSK1059615	MK11	86.0	10000.0
Momelotinib	PDPK1	100.0	10000.0
WZ4003	CDC2L1	100.0	1000.0
CG-930	RSK4(Kin.Dom.2-C-terminal)	13.0	10000.0
PD0325901	EPHB3	89.0	10000.0
CG-930	MAP3K4	100.0	10000.0
CG-930	HIPK2	86.0	10000.0
WZ-7043	NDR1	100.0	10000.0
JWE-035	GCN2(Kin.Dom.2,S808G)	88.0	10000.0
CP466722	DCLK1	36.0	10000.0
Torin1	SRC	95.0	10000.0
WZ4003	RPS6KA4(Kin.Dom.2)	9.8	1000.0
SB590885	FLT3	62.0	10000.0
AG1478	WEE1	93.0	10000.0
OTSSP167	CDK14	1.0	10000.0
R406	TLK2	7.4	1000.0
WZ3105	KGP1	100.0	10000.0
Alpelisib	CAMKK2	88.0	1000.0
CH5424802	WNK3	94.0	1000.0
Palbociclib	YANK1	100.0	1000.0
KIN001-123	KPCD1	100.0	1000.0
HG-6-64-01	RSK2(Kin.Dom.1-N-terminal)	14.0	10000.0
Vemurafenib	M3K5	100.0	10000.0
XMD11-50	MAP3K1	95.0	10000.0
HG-6-64-01	TAOK2	0.5	10000.0
ZG-10	PGFRA	4.0	10000.0
Taselisib	CSNK1G3	97.0	1000.0
PD0325901	JNK1	92.0	10000.0
CH5424802	PTK6	85.0	1000.0
PD173074	CDC2L2	100.0	10000.0
KIN001-220	TSSK1	100.0	10000.0
AZD7762	ABL1(Y253F)-phosphorylated	0.0	10000.0
Vemurafenib	HIPK4	57.0	10000.0
CH5424802	DAPK2	3.0	1000.0
AG1478	CAMK1G	64.0	10000.0
Palbociclib	PCTK2	63.0	1000.0
Lapatinib	PIK3CA(H1047L)	87.0	10000.0
JWE-035	TLK2	89.0	10000.0
XMD8-85	JAK1(JH2domain-pseudokinase)	100.0	10000.0
SCH772984	M4K1	65.0	1000.0
SP600125	TSSK1	100.0	10000.0
JNK-9L	CLK1	2.5	10000.0
CG-930	M3K12	100.0	10000.0
WZ-7043	PAK7	100.0	10000.0
AZD-6482	NEK2	71.0	10000.0
XMD11-50	MLCK	100.0	10000.0
GW-5074	KC1G2	100.0	10000.0
JNK-IN-8	EGFR(S752-I759del)	79.0	1000.0
Omipalisib	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
Palbociclib	KKCC1	99.0	1000.0
AZD 5438	YANK2	100.0	10000.0
AG1478	ERN1	41.0	10000.0
XMD-12	MARK3	60.0	1000.0
Dabrafenib	ACVR1	7.2	10000.0
GSK461364	DYRK1B	89.0	10000.0
HG-14-10-04	PLK4	0.0	10000.0
AZ-628	CSK	1.2	10000.0
AS-252424	FGFR1	100.0	10000.0
TAK-715	IKKE	100.0	10000.0
AS-252424	ACVR1B	69.5	10000.0
ZSTK474	RPS6KA4(Kin.Dom.2)	100.0	1000.0
HG-14-10-04	FLT3(D835Y)	0.0	10000.0
TAK-715	ERBB2	43.0	10000.0
Dactolisib	ITK	100.0	1000.0
Ceritinib	MARK1	93.0	1000.0
CP724714	PGFRB	46.0	10000.0
GSK429286A	CSNK1E	79.0	10000.0
JNK-9L	AMPK-alpha1	84.0	10000.0
CP466722	KPCT	100.0	10000.0
Ibrutinib	CLK2	99.0	1000.0
GSK461364	MAP4K5	68.0	10000.0
AZD7762	MST1R	12.0	10000.0
Neratinib	PCTK2	100.0	10000.0
SB590885	PHKG1	94.0	10000.0
KIN001-021	ABL1(T315I)	100.0	1000.0
Momelotinib	TAK1	49.0	10000.0
CH5424802	PIK4CB	72.0	1000.0
BMS-536924	MLCK	24.0	1000.0
QL-XII-47	VGFR2	100.0	1000.0
Taselisib	MELK	100.0	1000.0
Taselisib	RIOK2	99.0	1000.0
Torin2	PDPK1	100.0	10000.0
QL-X-138	ADCK4	86.0	10000.0
Barasertib	ABL1(E255K)-phosphorylated	31.0	10000.0
Ceritinib	RAF1	83.0	1000.0
KIN001-127	PIK3CB	100.0	10000.0
PHA-793887	CDK9	4.7	10000.0
XMD-12	TAOK3	1.2	1000.0
PLX-4720	VGFR2	30.0	10000.0
Torin2	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
HG-5-88-01	ADCK4	0.0	10000.0
RO-3306	FGFR1	92.0	10000.0
WZ-7043	AURKA	100.0	10000.0
AS-252424	PIK3CA	38.0	10000.0
NVP-TAE684	BMPR2	100.0	1000.0
Torin2	EPHA6	100.0	10000.0
Momelotinib	PIK3CD	45.0	10000.0
HG-14-8-02	SRPK1	86.0	10000.0
PHA-767491	MAP3K1	88.0	10000.0
ZM-447439	CAMK2G	100.0	10000.0
CH5424802	NEK9	100.0	1000.0
Ibrutinib	TAK1	64.0	1000.0
JWE-035	CLK2	39.0	10000.0
Sorafenib	EGFR(T790M)	60.0	10000.0
AZD-6482	GRK1	100.0	10000.0
HG-5-113-01	CDK5	28.0	10000.0
PD0325901	LATS2	74.0	10000.0
Sorafenib	RIOK2	97.0	10000.0
AS-252424	ERBB2	100.0	10000.0
Lapatinib	KIT(V559D,V654A)	100.0	10000.0
GW-5074	KPCD2	100.0	10000.0
XMD16-144	EGFR(L861Q)	73.0	10000.0
MPS-1-IN-1	CDK14	100.0	1000.0
WZ-7043	MK11	100.0	10000.0
JNK-IN-11	AMPK-alpha1	100.0	1000.0
NVP-TAE684	RPS6KA5(Kin.Dom.2)	100.0	1000.0
GW-5074	KC1G1	69.0	10000.0
QL-XII-47	PIK3CA(I800L)	56.0	1000.0
Taselisib	DYRK2	64.0	1000.0
XMD16-144	ZAP70	60.0	10000.0
KIN001-021	MYLK4	100.0	1000.0
WZ-7043	WEE1	100.0	10000.0
Alpelisib	SYK	98.0	1000.0
AZD-6482	FGFR3(G697C)	100.0	10000.0
Sorafenib	BMPR2	98.0	10000.0
MLN8054	EPHB3	29.0	10000.0
Dabrafenib	LATS2	100.0	10000.0
KIN001-021	GAK	100.0	1000.0
Torin2	PCTK3	100.0	10000.0
NG25	PAK6	100.0	10000.0
SB590885	SBK1	83.0	10000.0
A443654	MST2	0.4	10000.0
XMD13-2	AAK1	10.0	10000.0
SP600125	BMPR1A	100.0	10000.0
Vemurafenib	FAK1	63.0	10000.0
R406	CHEK1	14.0	1000.0
Torin2	PIM2	100.0	10000.0
Vemurafenib	ANKK1	91.0	10000.0
Torin2	ROCK2	81.0	10000.0
ERK5-IN-1	SGK3	83.0	1000.0
QL-XII-47	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	1000.0
Lapatinib	NIM1	94.0	10000.0
MPS-1-IN-1	RPS6KA4(Kin.Dom.2)	100.0	1000.0
ZSTK474	EPHB1	100.0	1000.0
TAK-715	WEE2	100.0	10000.0
BX-912	CSNK1E	70.0	10000.0
BMS345541	EGFR(L858R)	98.0	10000.0
GSK1059615	EGFR(G719C)	54.0	10000.0
GSK429286A	CSNK1A1L	98.0	10000.0
THZ1	MP2K7	30.0	10000.0
HG-9-91-01	LATS2	100.0	10000.0
HG-6-64-01	ERK8	67.0	10000.0
Sigma A6730	RET(M918T)	79.0	10000.0
ERK5-IN-1	MAP4K4	96.0	1000.0
AZD 5438	KIT(D816H)	7.4	10000.0
NU7441	PIK3C2G	16.0	10000.0
SCH772984	EGFR(L861Q)	100.0	1000.0
GW-5074	STK39	100.0	10000.0
Buparlisib	WEE2	100.0	1000.0
SCH772984	MK11	94.0	1000.0
GSK1059615	YES	84.0	10000.0
WH-4-023	EPHB4	0.0	10000.0
XMD14-99	JAK3(JH1domain-catalytic)	100.0	10000.0
GSK1059615	PIK3CA(M1043I)	0.0	10000.0
Canertinib	SLK	100.0	1000.0
XMD11-85h	CDK11	100.0	10000.0
BS-181	CSK	100.0	10000.0
QL-X-138	MAP4K5	93.0	10000.0
NVP-TAE684	EPHB3	18.0	1000.0
BI-2536	RIOK1	100.0	10000.0
ALW-II-38-3	CHEK1	100.0	10000.0
BMS-536924	BMX	24.0	1000.0
Omipalisib	KGP2	72.0	10000.0
NVP-TAE684	EPHA4	30.0	1000.0
KIN001-220	ABL1(F317L)-nonphosphorylated	58.0	10000.0
ERK5-IN-1	ERK3	100.0	1000.0
AZD 5438	SGK2	22.0	10000.0
XMD16-144	CSNK1A1L	100.0	10000.0
XMD8-92	TNNI3K	100.0	10000.0
BX-912	FGFR2	4.6	10000.0
HG-14-10-04	PKN1	31.0	10000.0
JW-7-24-1	DYRK1B	34.0	10000.0
Sigma A6730	ABL1(E255K)-phosphorylated	93.0	10000.0
JNK-IN-5A	MYLK	99.0	10000.0
HG-5-113-01	PIK3CG	100.0	10000.0
BMS-536924	PIK3CG	100.0	1000.0
Barasertib	ULK1	76.0	10000.0
AS-252424	EPHA8	100.0	10000.0
Vemurafenib	RIOK3	100.0	10000.0
ALW-II-49-7	SRPK3	100.0	10000.0
QL-X-138	NUAK1	11.0	10000.0
PHA-793887	PLK4	68.0	10000.0
Sigma A6730	PTK6	100.0	10000.0
CH5424802	PIK3C2B	94.0	1000.0
PD173074	ABL1(T315I)	100.0	10000.0
ZG-10	TBK1	38.0	10000.0
Canertinib	PAK4	100.0	1000.0
Barasertib	RET(V804L)	2.0	10000.0
CH5424802	ABL1(M351T)-phosphorylated	62.0	1000.0
Abemaciclib	KCC2D	0.5	1000.0
KIN001-127	RPS6KA1(Kin.Dom.2)	100.0	10000.0
WZ-4-145	PKN1	100.0	10000.0
XMD8-92	MP2K2	100.0	10000.0
SP600125	MRCKB	100.0	10000.0
R406	CAMKK2	100.0	1000.0
CH5424802	TYK2(JH2domain-pseudokinase)	88.0	1000.0
Baricitinib	ALK	7.8	10000.0
JWE-035	DMPK	91.0	10000.0
Sigma A6730	EGFR	65.0	10000.0
CG-930	LATS1	100.0	10000.0
CP724714	LOK	4.2	10000.0
JNK-IN-5A	TRKB	100.0	10000.0
WZ3105	M3K5	100.0	10000.0
WZ4003	RIPK4	100.0	1000.0
MPS-1-IN-1	MLCK	100.0	1000.0
QL-XI-92	MAP3K1	94.0	10000.0
XMD8-85	M3K12	100.0	10000.0
SP600125	MYO3A	100.0	10000.0
HG-6-64-01	DDR1	0.2	10000.0
AZD7762	LATS2	2.0	10000.0
Sorafenib	MST3	97.0	10000.0
MRT67307	PIP5K1C	100.0	10000.0
KIN001-127	GSK3A	100.0	10000.0
XMD13-2	AKT2	91.0	10000.0
Dactolisib	PAK1	100.0	1000.0
XMD11-50	ERK5	0.1	10000.0
QL-X-138	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
KIN001-220	PLK4	0.3	10000.0
BGJ398	STK39	83.0	1000.0
AZD-6482	RPS6KA4(Kin.Dom.1-N-terminal)	94.0	10000.0
HG-14-10-04	JAK1(JH2domain-pseudokinase)	19.0	10000.0
BGJ398	MK14	97.0	1000.0
CGP74514A	FES	60.0	10000.0
BMX-IN-1	RET(V804M)	100.0	10000.0
BS-181	CDC2L1	93.0	10000.0
Ibrutinib	ERBB4	0.0	1000.0
BX-912	TRKB	0.5	10000.0
XMD-12	DRAK2	79.0	1000.0
GW-5074	ACVR2A	100.0	10000.0
AG1478	ABL1(H396P)-phosphorylated	0.7	10000.0
CG-930	DDR1	27.0	10000.0
NVP-TAE684	TRKB	8.4	1000.0
OTSSP167	RPS6KA4(Kin.Dom.2-C-terminal)	0.0	10000.0
PHA-793887	DCLK1	4.7	10000.0
MRT67307	EGFR(L747-S752del,P753S)	100.0	10000.0
Sorafenib	MET(Y1235D)	70.0	10000.0
Crizotinib	BMPR1B	0.2	10000.0
Sigma A6730	EGFR(L747-E749del,A750P)	77.0	10000.0
ERK5-IN-1	CSNK1E	100.0	1000.0
MRT67307	EGFR(S752-I759del)	100.0	10000.0
XMD8-85	EPHA2	100.0	10000.0
Omipalisib	MAPKAPK2	100.0	10000.0
CGP74514A	MP2K3	24.0	10000.0
NPK76-II-72-1	MYLK2	100.0	10000.0
Abemaciclib	AKT3	100.0	1000.0
WZ4002	KPCD3	10.0	10000.0
WYE-125132	INSRR	100.0	10000.0
HG-5-113-01	CDK7	1.8	10000.0
Torin1	MAP3K1	92.0	10000.0
Neratinib	TTK	100.0	10000.0
JW-7-24-1	TTK	100.0	10000.0
Neratinib	PIK3CA(E545K)	88.0	10000.0
GW843682X	PIM1	89.0	10000.0
Torkinib	SRC	1.8	10000.0
Dactolisib	PIK3CA(E545A)	5.1	1000.0
CG-930	YSK1	64.0	10000.0
JNK-IN-5A	MAP3K3	96.0	10000.0
Seliciclib	ROCK2	100.0	10000.0
Palbociclib	STK35	100.0	1000.0
AZD 5438	KIT(D816V)	2.8	10000.0
Ribociclib	KPCD	95.0	1000.0
KU63794	EPHB4	100.0	10000.0
WH-4-023	CDK5	98.0	10000.0
WZ4003	TSSK1	100.0	1000.0
GSK461364	EGFR(L858R,T790M)	78.0	10000.0
Barasertib	PIK3CA(I800L)	100.0	10000.0
(s)-CR8	KPCD	88.0	10000.0
QL-X-138	SGK3	96.0	10000.0
JWE-035	CDKL5	100.0	10000.0
AS-252424	YANK3	89.4	10000.0
ZM-447439	VGFR2	26.0	10000.0
Baricitinib	TEC	100.0	10000.0
NPK76-II-72-1	ERK5	100.0	10000.0
CG-930	AKT1	72.0	10000.0
GSK461364	ABL1(T315I)-nonphosphorylated	62.0	10000.0
XMD8-92	PDPK1	100.0	10000.0
Dabrafenib	MST1	77.0	10000.0
JNK-9L	RIPK5	76.0	10000.0
XMD8-92	IKKB	100.0	10000.0
TAK-715	BMPR1A	74.0	10000.0
Torkinib	RIPK2	0.8	10000.0
GSK461364	EGFR(E746-A750del)	100.0	10000.0
XMD8-85	MKNK2	0.0	10000.0
Torin1	MAP3K15	100.0	10000.0
A443654	BMPR2	100.0	10000.0
HG-5-113-01	CSNK2A1	4.4	10000.0
WZ-7043	SgK110	100.0	10000.0
WZ4002	ERK3	100.0	10000.0
MPS-1-IN-1	ERK3	100.0	1000.0
KIN001-220	ULK3	1.5	10000.0
CH5424802	SRMS	52.0	1000.0
Ibrutinib	GRK7	69.0	1000.0
XMD8-92	PCTK3	100.0	10000.0
ZG-10	RET(V804L)	84.0	10000.0
HG-9-91-01	EPHA6	0.0	10000.0
BGJ398	HUNK	100.0	1000.0
Torkinib	RPS6KA4(Kin.Dom.2-C-terminal)	0.0	10000.0
OTSSP167	DAPK3	100.0	10000.0
HG-14-8-02	JAK2(JH1domain-catalytic)	75.0	10000.0
Crizotinib	ADCK4	3.4	10000.0
TGX221	MK09	100.0	1000.0
BMX-IN-1	MYLK4	97.0	10000.0
RO-3306	OSR1	60.0	10000.0
WZ-7043	ABL1(M351T)	100.0	10000.0
XMD16-144	JAK2(JH1domain-catalytic)	0.8	10000.0
Torkinib	PAK6	23.0	10000.0
WZ-4-145	CAMK2G	100.0	10000.0
Buparlisib	ACVR1B	82.0	1000.0
GSK1059615	M3K5	58.0	10000.0
JNK-IN-8	PIK3CA(E545K)	100.0	1000.0
AZ-628	ABL1(T315I)-phosphorylated	79.0	10000.0
ZM-447439	PIK3CB	81.0	10000.0
THZ1	DYRK1A	0.5	10000.0
AZD7762	CDK4-cyclinD3	92.0	10000.0
Omipalisib	CDK8	27.0	10000.0
BX-912	NEK6	0.5	10000.0
Torin2	ABL1(M351T)-phosphorylated	100.0	10000.0
JNK-IN-8	RIOK1	100.0	1000.0
CG-930	RIPK5	91.0	10000.0
OTSSP167	PKMYT1	40.0	10000.0
BMX-IN-1	TNK1	100.0	10000.0
AZD7762	FGR	0.2	10000.0
CH5424802	BMPR1A	88.0	1000.0
HG-14-8-02	SRC	100.0	10000.0
TAK-715	ABL1(F317L)-nonphosphorylated	26.0	10000.0
Abemaciclib	AMPK-alpha1	65.0	1000.0
PHA-767491	CAMK2B	10.0	10000.0
CP724714	MP2K7	100.0	10000.0
Barasertib	KGP2	92.0	10000.0
BGJ398	FGFR3	1.2	1000.0
BI-2536	EGFR	100.0	10000.0
Pictilisib	FLT3(D835V)	62.0	1000.0
CG-930	EPHA5	100.0	10000.0
(s)-CR8	EGFR(L747-T751del,Sins)	71.0	10000.0
Dactolisib	EGFR(L747-T751del,Sins)	100.0	1000.0
Barasertib	CAMK2A	78.0	10000.0
THZ1	GRK7	5.4	10000.0
BGJ398	CAMK1	76.0	1000.0
NVP-TAE684	YES	0.1	1000.0
Lapatinib	STK39	100.0	10000.0
RO-3306	EGFR(S752-I759del)	58.0	10000.0
AZD4547	PRKX	85.0	10000.0
NVP-TAE684	FLT3(N841I)	0.5	1000.0
BMS-536924	CDK5	100.0	1000.0
AS-252424	KIT(D816V)	100.0	10000.0
XMD11-50	SRC	100.0	10000.0
WYE-125132	ACVR2A	78.0	10000.0
Palbociclib	CDK3	100.0	1000.0
Abemaciclib	CAMK1	52.0	1000.0
R406	MARK2	5.5	1000.0
Ceritinib	CSNK1A1	93.0	1000.0
BS-181	PIK3CB	79.0	10000.0
WZ4003	MERTK	100.0	1000.0
(s)-CR8	MK09	65.0	10000.0
Ceritinib	MST1	98.0	1000.0
ALW-II-38-3	FER	100.0	10000.0
Omipalisib	NDR1	65.0	10000.0
KIN001-111	FER	0.4	1000.0
GSK429286A	HUNK	100.0	10000.0
AZD7762	SIK1	0.3	10000.0
JNK-IN-11	FGFR2	49.0	1000.0
Sigma A6730	TLK2	100.0	10000.0
XMD14-99	BTK	100.0	10000.0
Palbociclib	TNK1	62.0	1000.0
KIN001-021	IRAK3	100.0	1000.0
HG-14-10-04	EPHA4	91.0	10000.0
GSK461364	MARK3	63.0	10000.0
5z-7-oxozeaenol	SGK3	98.0	10000.0
Palbociclib	LRRK2(G2019S)	100.0	1000.0
Dinaciclib	RPS6KA4(Kin.Dom.1-N-terminal)	71.0	10000.0
Taselisib	SIK1	96.0	1000.0
GSK1059615	AAK1	1.0	10000.0
(s)-CR8	SIK3	74.0	10000.0
PLX-4720	MLK2	87.0	10000.0
SP600125	EPHB4	100.0	10000.0
WZ4003	CHEK1	6.4	1000.0
ALW-II-38-3	GAK	100.0	10000.0
KU63794	RET(M918T)	100.0	10000.0
HG-5-113-01	PAK6	100.0	10000.0
5z-7-oxozeaenol	BRAF(V600E)	100.0	10000.0
PLX-4720	MK13	85.0	10000.0
AG1478	MP2K7	73.0	10000.0
JWE-035	RSK1(Kin.Dom.1-N-terminal)	100.0	10000.0
QL-X-138	ADCK3	91.0	10000.0
PHA-793887	MST1	90.0	10000.0
GW-5074	ERBB4	50.0	10000.0
KIN001-123	DCLK1	100.0	1000.0
BMS345541	CSNK1D	45.0	10000.0
NU7441	SIK3	92.0	10000.0
SP600125	AAK1	2.6	10000.0
Abemaciclib	KPCD2	18.0	1000.0
KIN001-111	SIK1	2.4	1000.0
PHA-767491	RET(M918T)	100.0	10000.0
Neratinib	KIT(D816H)	88.0	10000.0
JNK-9L	PAK6	58.0	10000.0
XMD14-99	PKAC-beta	100.0	10000.0
Dabrafenib	ERK3	100.0	10000.0
NU7441	ABL1(E255K)-phosphorylated	100.0	10000.0
AZD 5438	MARK1	45.0	10000.0
Barasertib	PKN2	86.0	10000.0
GW-5074	ABL1(H396P)-nonphosphorylated	24.0	10000.0
CGP60474	EGFR(S752-I759del)	100.0	10000.0
XMD14-99	FRK	43.0	10000.0
ZM-447439	IRAK1	66.0	10000.0
QL-XII-47	NEK9	100.0	1000.0
AZD-6482	RPS6KA5(Kin.Dom.2-C-terminal)	91.0	10000.0
KU63794	DYRK1A	94.0	10000.0
ALW-II-38-3	JNK3	100.0	10000.0
Canertinib	PHKG2	100.0	1000.0
Buparlisib	EGFR(E746-A750del)	79.0	1000.0
GW-5074	AXL	100.0	10000.0
PHA-767491	DAPK2	2.2	10000.0
JWE-035	CSNK2A2	100.0	10000.0
AZD4547	MST4	1.8	10000.0
KIN001-111	PKMYT1	100.0	1000.0
AZ-628	KPCD	89.0	10000.0
Dinaciclib	CTK	81.0	10000.0
KIN001-111	CLK4	100.0	1000.0
ERK5-IN-1	RSK2(Kin.Dom.1-N-terminal)	100.0	1000.0
Torin2	TAOK2	92.0	10000.0
AZD4547	MAP3K15	24.0	10000.0
HG-9-91-01	ERK4	85.0	10000.0
Lapatinib	BMPR2	100.0	10000.0
XMD11-85h	SRPK3	100.0	10000.0
Sigma A6730	CLK4	95.0	10000.0
JWE-035	LIMK2	85.0	10000.0
ERK5-IN-1	CLK4	100.0	1000.0
AZD 5438	KC1G1	17.0	10000.0
XMD-12	ABL1(H396P)-phosphorylated	2.4	1000.0
JNK-9L	ERBB3	69.0	10000.0
KIN001-127	NLK	100.0	10000.0
Neratinib	KC1G1	96.0	10000.0
WZ-4-145	KC1G1	100.0	10000.0
XMD-12	KIT(L576P)	89.0	1000.0
XMD-12	ABL1(Q252H)-nonphosphorylated	2.1	1000.0
MRT67307	TAOK1	2.0	10000.0
HG-5-113-01	FGFR4	100.0	10000.0
Baricitinib	PIK3C2G	61.0	10000.0
CGP60474	SRC	100.0	10000.0
A443654	DCLK1	100.0	10000.0
Vemurafenib	PAK1	95.0	10000.0
GSK1059615	ABL1(Q252H)-phosphorylated	63.0	10000.0
THZ1	MK12	71.0	10000.0
ERK5-IN-1	PIP5K1A	78.0	1000.0
XMD11-85h	PLK1	17.0	10000.0
KU63794	GRK7	100.0	10000.0
BMS345541	CAMK2G	100.0	10000.0
JNK-IN-11	CDK3	100.0	1000.0
XMD8-92	NEK7	100.0	10000.0
HG-6-64-01	TNIK	3.2	10000.0
Torin1	YES	74.0	10000.0
WYE-125132	RPS6KA5(Kin.Dom.1-N-terminal)	86.0	10000.0
BGJ398	M4K3	68.0	1000.0
Taselisib	SRPK2	100.0	1000.0
A443654	FLT3(D835H)	5.0	10000.0
Torin2	EPHB2	98.0	10000.0
CG-930	ZAP70	100.0	10000.0
AZD 5438	DDR1	7.0	10000.0
Abemaciclib	BRSK2	91.0	1000.0
THZ1	LIMK1	6.8	10000.0
HG-5-88-01	KPCT	100.0	10000.0
ZSTK474	MUSK	100.0	1000.0
WH-4-023	KIT(D816V)	3.4	10000.0
Barasertib	PIK3CA(H1047L)	73.0	10000.0
CP724714	PTK6	100.0	10000.0
AZD-6482	KPCI	100.0	10000.0
TAK-715	SBK1	100.0	10000.0
BS-181	NDR1	68.0	10000.0
Buparlisib	CHEK1	100.0	1000.0
AG1478	KPCI	80.0	10000.0
AZD 5438	PIK3CA(H1047Y)	60.0	10000.0
CG-930	NDR1	100.0	10000.0
Sorafenib	CHK2	100.0	10000.0
OTSSP167	MYLK	5.5	10000.0
ERK5-IN-1	TNK2	80.0	1000.0
Sorafenib	CDK2	33.0	10000.0
AZD 5438	RIOK2	3.4	10000.0
Buparlisib	PTK6	98.0	1000.0
Sorafenib	LRRK2	77.0	10000.0
AG1478	MRCKB	98.0	10000.0
MPS-1-IN-1	AMPK-alpha2	100.0	1000.0
A443654	CLK2	0.1	10000.0
KIN001-021	CSNK2A1	100.0	1000.0
KIN001-021	TRKC	100.0	1000.0
XMD16-144	KCC2D	62.0	10000.0
KU63794	EPHB1	100.0	10000.0
TAK-715	PLK1	100.0	10000.0
(s)-CR8	ERBB2	76.0	10000.0
WYE-125132	OSR1	100.0	10000.0
Ceritinib	EPHB4	94.0	1000.0
JNK-9L	CAMKK2	52.0	10000.0
ZSTK474	TIE2	100.0	1000.0
NVP-TAE684	IGF1R	0.0	1000.0
GSK1059615	DYRK1B	1.2	10000.0
JNK-IN-5A	ERN1	90.0	10000.0
PD0325901	NEK5	78.0	10000.0
SB590885	AMPK-alpha2	94.0	10000.0
NVP-TAE684	TNK1	0.5	1000.0
A443654	KGP1	0.7	10000.0
PD0325901	MARK3	91.0	10000.0
PLX-4720	FRK	19.0	10000.0
WH-4-023	RIPK5	49.0	10000.0
GSK429286A	ULK1	74.0	10000.0
PHA-793887	CDKL3	10.0	10000.0
Omipalisib	MYLK2	100.0	10000.0
Vemurafenib	STK16	84.0	10000.0
Palbociclib	SGK2	100.0	1000.0
NPK76-II-72-1	NUAK1	100.0	10000.0
Palbociclib	CDK4-cyclinD3	1.2	1000.0
AZD7762	IGF1R	44.0	10000.0
Torin2	PIK3CA(Q546K)	0.4	10000.0
Taselisib	MINK	100.0	1000.0
Torin1	CAMK2A	93.0	10000.0
RO-3306	AKT1	85.0	10000.0
GW843682X	SRPK1	8.9	10000.0
BMS-536924	INSRR	0.0	1000.0
AZD-6482	CLK4	68.0	10000.0
HG-14-8-02	ULK1	100.0	10000.0
GW-5074	MAP4K4	4.2	10000.0
XMD14-99	MP2K6	85.0	10000.0
XMD-12	CDK7	60.0	1000.0
Neratinib	LOK	0.0	10000.0
CGP74514A	DMPK	20.0	10000.0
XMD8-92	M3K12	100.0	10000.0
WZ4003	ERK3	100.0	1000.0
GSK461364	SIK2	61.0	10000.0
NVP-TAE684	MK11	100.0	1000.0
JNK-IN-11	M3K12	84.0	1000.0
Sorafenib	RET	0.1	10000.0
AS-252424	MINK	57.3	10000.0
CP466722	PRKR	21.0	10000.0
SCH772984	CDKL1	66.0	1000.0
Torin1	CDK5	100.0	10000.0
XMD14-99	PCTK3	78.0	10000.0
BS-181	ERBB3	94.0	10000.0
AG1478	SGK3	65.0	10000.0
AZD 5438	GRK1	56.0	10000.0
PLX-4720	EPHB6	3.6	10000.0
CP466722	ERN1	46.0	10000.0
JNK-IN-11	JAK1(JH1domain-catalytic)	89.0	1000.0
SB590885	TEC	91.0	10000.0
JWE-035	MAPKAPK2	100.0	10000.0
GSK461364	DAPK3	15.0	10000.0
XMD16-144	ACVRL1	100.0	10000.0
KIN001-220	VRK2	100.0	10000.0
AS-252424	TNK2	100.0	10000.0
R406	CSNK2A2	1.9	1000.0
BGJ398	PIK3C2B	49.0	1000.0
XMD8-85	SIK2	100.0	10000.0
GW-5074	EGFR(E746-A750del)	36.0	10000.0
CH5424802	M4K1	29.0	1000.0
QL-XII-47	ERBB4	78.0	1000.0
Lapatinib	AURKA	89.0	10000.0
KIN001-021	MK11	100.0	1000.0
GW-5074	ABL1(E255K)-phosphorylated	54.0	10000.0
AZD-6482	KKCC1	98.0	10000.0
XMD11-50	MAPKAPK2	100.0	10000.0
ALW-II-38-3	TAK1	100.0	10000.0
KU63794	ABL1-nonphosphorylated	98.0	10000.0
A443654	MST1	100.0	10000.0
Barasertib	IKKA	100.0	10000.0
Ribociclib	CDK4	56.0	1000.0
PD173074	KIT(V559D,T670I)	100.0	10000.0
Dinaciclib	RSK3(Kin.Dom.1-N-terminal)	72.0	10000.0
BI-2536	MLCK	100.0	10000.0
WH-4-023	ERN1	62.0	10000.0
Seliciclib	MK14	100.0	10000.0
TAK-715	HIPK2	100.0	10000.0
Vemurafenib	PI42C	100.0	10000.0
Pictilisib	FAK1	95.0	1000.0
MRT67307	ROS1	100.0	10000.0
XMD8-92	MELK	100.0	10000.0
CGP74514A	KPCI	35.0	10000.0
NG25	KPCD	100.0	10000.0
A443654	ABL1(Y253F)	100.0	10000.0
KIN001-123	RAF1	100.0	1000.0
CP724714	MUSK	100.0	10000.0
NPK76-II-72-1	PAK3	100.0	10000.0
GSK1059615	IGF1R	100.0	10000.0
XMD13-2	PIP5K1C	12.0	10000.0
Torin1	FES	41.0	10000.0
QL-XI-92	AMPK-alpha1	100.0	10000.0
HG-14-8-02	HASP	95.0	10000.0
Torkinib	SIK2	9.4	10000.0
(s)-CR8	WNK1	78.0	10000.0
JWE-035	BRAF	100.0	10000.0
Torkinib	AMPK-alpha2	67.0	10000.0
Alpelisib	KIT(D816V)	100.0	1000.0
Ribociclib	ABL1(F317L)-phosphorylated	100.0	1000.0
AZD-6482	GRK7	57.0	10000.0
AZD7762	MTOR	72.0	10000.0
WZ-7043	YES	100.0	10000.0
QL-XII-47	LATS1	100.0	1000.0
PHA-793887	KPCL	78.0	10000.0
HG-5-88-01	TLK2	100.0	10000.0
Sorafenib	KPCD2	96.0	10000.0
MLN8054	PIK3CA(E545K)	100.0	10000.0
KIN001-111	TXK	1.0	1000.0
BMS345541	PIM1	100.0	10000.0
XMD14-99	NEK11	65.0	10000.0
SCH772984	IRAK3	75.0	1000.0
WZ4003	BTK	27.0	1000.0
Dabrafenib	ERK8	69.0	10000.0
TGX221	GAK	100.0	1000.0
Taselisib	ABL1(H396P)-phosphorylated	100.0	1000.0
KIN001-220	FAK1	28.0	10000.0
MRT67307	TYK2(JH2domain-pseudokinase)	95.0	10000.0
Abemaciclib	EGFR(S752-I759del)	100.0	1000.0
(s)-CR8	MLK1	100.0	10000.0
BX-912	CSNK1A1L	32.0	10000.0
TGX221	IKKB	100.0	1000.0
GW-5074	ROCK2	55.0	10000.0
Sorafenib	KIT(V559D,T670I)	0.1	10000.0
Dinaciclib	PIK3C2B	81.0	10000.0
QL-XI-92	LOK	100.0	10000.0
R406	FLT3(ITD)	0.0	1000.0
Buparlisib	CAMK2G	82.0	1000.0
KIN001-123	RIOK1	100.0	1000.0
Abemaciclib	TXK	100.0	1000.0
MPS-1-IN-1	PIM2	100.0	1000.0
ERK5-IN-1	ERBB2	100.0	1000.0
JNK-IN-11	PI42C	86.0	1000.0
KIN001-127	M3K12	30.0	10000.0
(s)-CR8	CDK14	83.0	10000.0
Torkinib	CASK	15.0	10000.0
HG-9-91-01	MARK3	1.0	10000.0
Vemurafenib	OSR1	95.0	10000.0
JNK-IN-5A	KCC4	100.0	10000.0
BGJ398	GAK	32.0	1000.0
HG-5-113-01	PKMYT1	100.0	10000.0
JNK-IN-8	ABL1-phosphorylated	100.0	1000.0
CGP74514A	MET	39.0	10000.0
(s)-CR8	CDK5	63.0	10000.0
SCH772984	KC1G1	90.0	1000.0
Ceritinib	WEE1	98.0	1000.0
GSK461364	RIOK3	6.6	10000.0
TAK-715	CDKL2	80.0	10000.0
Canertinib	RPS6KA1(Kin.Dom.2)	100.0	1000.0
CP466722	FRK	19.0	10000.0
SCH772984	FRK	83.0	1000.0
Omipalisib	BRAF	46.0	10000.0
CH5424802	PGFRA	58.0	1000.0
HG-6-64-01	PIM1	100.0	10000.0
WZ-7043	CDKL2	100.0	10000.0
Dinaciclib	FGFR3	100.0	10000.0
PD173074	GSK3A	100.0	10000.0
BS-181	HIPK2	55.0	10000.0
Omipalisib	NEK1	69.0	10000.0
ALW-II-49-7	ACVR1	100.0	10000.0
XMD16-144	PCTK3	100.0	10000.0
NVP-TAE684	INSR	0.0	1000.0
XMD11-85h	PRKR	100.0	10000.0
5z-7-oxozeaenol	EGFR(L858R,T790M)	100.0	10000.0
BI-D1870	KKCC1	9.4	10000.0
XMD8-92	TLK2	100.0	10000.0
NU7441	KPCL	100.0	10000.0
HG-5-88-01	CAMK1G	100.0	10000.0
HG-14-10-04	PFPK5(P.falciparum)	100.0	10000.0
MLN8054	MARK1	100.0	10000.0
MLN8054	EGFR(L861Q)	58.0	10000.0
HG-5-113-01	TGFBR1	100.0	10000.0
WZ3105	FGR	14.0	10000.0
Palbociclib	IKKB	100.0	1000.0
BMS345541	PIP5K1A	92.0	10000.0
SP600125	FLT3(D835H)	100.0	10000.0
ERK5-IN-1	KKCC1	100.0	1000.0
CP466722	MP2K5	1.1	10000.0
QL-XII-47	SGK3	67.0	1000.0
KIN001-021	CSF1R	100.0	1000.0
Palbociclib	KPCT	60.0	1000.0
HG-5-88-01	LYN	100.0	10000.0
KIN001-127	STK33	7.0	10000.0
Pictilisib	ABL1-nonphosphorylated	85.0	1000.0
Baricitinib	HIPK3	11.0	10000.0
Torkinib	CAMK2B	63.0	10000.0
ALW-II-49-7	PKMYT1	100.0	10000.0
XMD16-144	S6K1	63.0	10000.0
HG-14-10-04	TRKA	1.0	10000.0
R406	EPHA6	5.2	1000.0
HG-5-113-01	RET(V804M)	1.2	10000.0
Dinaciclib	LATS2	89.0	10000.0
Ribociclib	PI42C	97.0	1000.0
CH5424802	INSR	50.0	1000.0
Baricitinib	FLT3	81.0	10000.0
Ribociclib	BRAF(V600E)	100.0	1000.0
XMD8-92	TAOK2	100.0	10000.0
NU7441	ERN1	93.0	10000.0
BMS-536924	EPHA8	3.2	1000.0
OTSSP167	CAMK1D	60.0	10000.0
ZG-10	TSSK1	100.0	10000.0
HG-5-88-01	SNARK	100.0	10000.0
QL-XI-92	SNARK	97.0	10000.0
AG1478	ROCK1	41.0	10000.0
Taselisib	JAK1(JH1domain-catalytic)	94.0	1000.0
ERK5-IN-1	CDK2	100.0	1000.0
AS-252424	ERK5	100.0	10000.0
Omipalisib	CDK3	95.0	10000.0
QL-XII-47	KPCL	90.0	1000.0
Crizotinib	ABL1(F317I)-nonphosphorylated	0.0	10000.0
PHA-793887	BMPR1B	94.0	10000.0
Ribociclib	ULK1	100.0	1000.0
SCH772984	HIPK2	100.0	1000.0
Dinaciclib	LTK	100.0	10000.0
Barasertib	FLT3(R834Q)	14.0	10000.0
KIN001-127	PGFRA	100.0	10000.0
AG1478	MP2K4	85.0	10000.0
BMS345541	RSK3(Kin.Dom.2-C-terminal)	97.0	10000.0
Buparlisib	PRKR	100.0	1000.0
ZSTK474	AURKB	100.0	1000.0
CP724714	ABL1(F317L)-nonphosphorylated	100.0	10000.0
Pictilisib	PAK6	90.0	1000.0
ERK5-IN-1	PIM1	100.0	1000.0
Palbociclib	MYO3B	87.0	1000.0
Vemurafenib	ABL1(F317L)-phosphorylated	46.0	10000.0
KIN001-127	PIK3CD	100.0	10000.0
Ribociclib	ROS1	100.0	1000.0
Seliciclib	MAST1	85.0	10000.0
ZM-447439	RIPK1	100.0	10000.0
ZM-447439	JAK1(JH2domain-pseudokinase)	32.0	10000.0
Baricitinib	FGR	67.0	10000.0
AZ-628	PIK4CB	82.0	10000.0
R406	STK35	12.0	1000.0
GW-5074	TRKA	82.0	10000.0
THZ1	EGFR(G719S)	67.0	10000.0
QL-XI-92	EGFR(S752-I759del)	100.0	10000.0
Momelotinib	PHKG1	78.0	10000.0
QL-XII-47	DMPK2	100.0	1000.0
Barasertib	LOK	11.0	10000.0
CP724714	CDKL5	100.0	10000.0
Barasertib	TRKC	56.0	10000.0
HG-14-8-02	DMPK	100.0	10000.0
XMD-12	PDPK1	97.0	1000.0
QL-XII-47	RSK1(Kin.Dom.2-C-terminal)	73.0	1000.0
QL-X-138	MLCK	100.0	10000.0
Alpelisib	ABL1-nonphosphorylated	53.0	1000.0
Alpelisib	ERK8	100.0	1000.0
Crizotinib	HIPK3	92.0	10000.0
TGX221	RPS6KA5(Kin.Dom.2)	100.0	1000.0
WYE-125132	SIK3	35.0	10000.0
Momelotinib	PIM1	100.0	10000.0
XMD11-50	IRAK4	83.0	10000.0
JNK-9L	PFCDPK1(P.falciparum)	48.0	10000.0
QL-XI-92	MST1	99.0	10000.0
SP600125	IKKB	13.0	10000.0
CG-930	NEK11	90.0	10000.0
GSK1059615	MAK	100.0	10000.0
RO-3306	KPCD2	16.0	10000.0
JNK-9L	TNNI3K	80.0	10000.0
Palbociclib	KPCD2	61.0	1000.0
Lapatinib	MK13	72.0	10000.0
JWE-035	FLT3(D835H)	8.8	10000.0
Dabrafenib	NEK7	1.6	10000.0
Alpelisib	KIT	96.0	1000.0
Torin2	PAK7	69.0	10000.0
NPK76-II-72-1	DAPK1	26.0	10000.0
GSK1059615	ITK	81.0	10000.0
BI-D1870	ULK1	8.2	10000.0
QL-X-138	STK39	64.0	10000.0
NPK76-II-72-1	RET(V804L)	100.0	10000.0
BMS345541	VGFR1	98.0	10000.0
PD0325901	FES	100.0	10000.0
MPS-1-IN-1	KCC4	100.0	1000.0
TAK-715	PKN1	98.0	10000.0
MLN8054	CDK2	84.0	10000.0
Torkinib	ABL1(F317I)-phosphorylated	17.0	10000.0
Buparlisib	PFCDPK1(P.falciparum)	95.0	1000.0
AZD-6482	SLK	100.0	10000.0
MRT67307	LTK	100.0	10000.0
Seliciclib	KIT(V559D)	98.0	10000.0
CP466722	RPS6KA4(Kin.Dom.2-C-terminal)	0.6	10000.0
JW-7-24-1	RPS6KA6(Kin.Dom.2)	100.0	10000.0
Pictilisib	SgK110	99.0	1000.0
NU7441	LIMK2	100.0	10000.0
Dabrafenib	CSF1R-autoinhibited	16.0	10000.0
CP466722	MLK3	63.0	10000.0
Torin2	MRCKA	99.0	10000.0
(s)-CR8	DAPK1	89.0	10000.0
XMD8-85	TAK1	100.0	10000.0
Ceritinib	ROS1	2.9	1000.0
Alpelisib	EGFR(G719C)	100.0	1000.0
CH5424802	CAMK2B	56.0	1000.0
HG-9-91-01	DCAMKL2	9.7	10000.0
XMD14-99	ICK	7.4	10000.0
A443654	DRAK2	20.0	10000.0
GW843682X	CASK	93.0	10000.0
Sigma A6730	OSR1	81.0	10000.0
KIN001-111	MP2K3	24.0	1000.0
THZ1	SRC	0.1	10000.0
Crizotinib	CDKL3	68.0	10000.0
XMD8-85	SNARK	14.0	10000.0
HG-5-113-01	LYN	22.0	10000.0
NVP-TAE684	CDKL2	100.0	1000.0
GSK1059615	RPS6KA4(Kin.Dom.2-C-terminal)	63.0	10000.0
HG-5-88-01	MLCK	100.0	10000.0
Seliciclib	ABL1(Y253F)-phosphorylated	100.0	10000.0
AZD 5438	EGFR(E746-A750del)	88.0	10000.0
BMS345541	EGFR(L747-T751del,Sins)	100.0	10000.0
WYE-125132	EPHB4	100.0	10000.0
ZM-447439	STK36	98.0	10000.0
HG-9-91-01	PIK3CG	100.0	10000.0
PD0325901	OSR1	100.0	10000.0
PD173074	FGFR4	17.0	10000.0
SCH772984	ADCK4	100.0	1000.0
SB590885	GSK3A	100.0	10000.0
ZG-10	NEK11	100.0	10000.0
Lapatinib	NEK6	94.0	10000.0
Ibrutinib	DDR2	83.0	1000.0
Dabrafenib	TYRO3	79.0	10000.0
KIN001-021	CHEK1	100.0	1000.0
Torkinib	BLK	1.2	10000.0
BMS345541	KPCL	94.0	10000.0
WYE-125132	ERN1	93.0	10000.0
Ceritinib	ABL1(H396P)-nonphosphorylated	87.0	1000.0
SCH772984	KPCD2	87.0	1000.0
RO-3306	STK16	51.0	10000.0
SB590885	KPCD	89.0	10000.0
PD0325901	DAPK1	100.0	10000.0
JNK-IN-5A	MST2	91.0	10000.0
Omipalisib	KGP1	100.0	10000.0
XMD14-99	TESK1	100.0	10000.0
Sigma A6730	CDK9	100.0	10000.0
MLN8054	FGFR4	58.0	10000.0
JNK-IN-8	PIK3CA(M1043I)	94.0	1000.0
Lapatinib	EPHB3	99.0	10000.0
GW-5074	BMPR2	27.0	10000.0
GSK429286A	TNK2	88.0	10000.0
NG25	MK01	0.0	10000.0
NG25	RPS6KA5(Kin.Dom.2)	100.0	10000.0
WYE-125132	PIK3CD	5.7	10000.0
Dabrafenib	EPHA8	28.0	10000.0
AZD-6482	RSK2(Kin.Dom.1-N-terminal)	91.0	10000.0
Torin1	BRAF	59.0	10000.0
XMD-12	JAK1(JH2domain-pseudokinase)	4.8	1000.0
Crizotinib	PIK3CA	100.0	10000.0
Abemaciclib	CAMK1B	42.0	1000.0
WZ-7043	FLT4	100.0	10000.0
Palbociclib	CHEK1	100.0	1000.0
Baricitinib	PIK3CG	48.0	10000.0
BX-912	MARK1	0.5	10000.0
WZ-4-145	GSK3A	100.0	10000.0
ZSTK474	TXK	100.0	1000.0
SCH772984	WEE2	100.0	1000.0
SB590885	MLCK	98.0	10000.0
Taselisib	MKNK2	100.0	1000.0
BX-912	CDK8	97.0	10000.0
PD0325901	KPCT	100.0	10000.0
SB590885	MYO3B	81.0	10000.0
AG1478	EPHA3	28.0	10000.0
HG-9-91-01	CTK	94.0	10000.0
RO-3306	MYO3A	91.0	10000.0
PHA-793887	ROCK1	88.0	10000.0
TAK-715	CAMK1	85.0	10000.0
BX-912	PIP5K2B	0.6	10000.0
KIN001-220	RET(M918T)	0.6	10000.0
JNK-IN-11	PLK1	100.0	1000.0
CH5424802	EPHB4	57.0	1000.0
Pictilisib	TRKC	100.0	1000.0
KU63794	BRAF(V600E)	92.0	10000.0
Barasertib	STK35	85.0	10000.0
KIN001-111	RIPK1	100.0	1000.0
NG25	FES	1.5	10000.0
HG-6-64-01	DAPK1	100.0	10000.0
THZ1	PAK6	3.4	10000.0
MRT67307	CAMK2A	7.2	10000.0
WH-4-023	JAK1(JH1domain-catalytic)	36.0	10000.0
CH5424802	DYRK1A	27.0	1000.0
SB590885	TIE1	44.0	10000.0
BS-181	CAMK2A	65.0	10000.0
Crizotinib	M3K2	0.1	10000.0
XMD11-85h	TGFBR2	100.0	10000.0
BMS345541	MET	100.0	10000.0
ALW-II-38-3	DAPK1	100.0	10000.0
Dactolisib	PLK4	100.0	1000.0
WZ3105	WEE1	51.0	10000.0
GSK1059615	PCTK2	59.0	10000.0
GSK429286A	NEK1	91.0	10000.0
BS-181	GRK1	56.0	10000.0
HG-6-64-01	RET	0.1	10000.0
Palbociclib	DDR1	100.0	1000.0
WZ-4-145	BLK	0.1	10000.0
JW-7-24-1	MYO3B	100.0	10000.0
HG-14-10-04	IRAK4	11.0	10000.0
KIN001-123	EGFR(L861Q)	26.0	1000.0
JW-7-24-1	PKAC-alpha	100.0	10000.0
AZ-628	FAK2	100.0	10000.0
ALW-II-38-3	FYN	7.0	1000.0
PD173074	ERK5	36.0	10000.0
Alpelisib	CSNK1G3	100.0	1000.0
WZ3105	MARK4	94.0	10000.0
CG-930	MP2K3	43.0	10000.0
ALW-II-38-3	ABL1(E255K)	8.6	1000.0
Torin1	KPCD3	100.0	10000.0
BMX-IN-1	EGFR(L747-S752del,P753S)	62.0	10000.0
NPK76-II-72-1	CAMK1D	17.0	10000.0
HG-5-88-01	PAK1	100.0	10000.0
HG-9-91-01	FGFR4	0.1	10000.0
AZD-6482	LIMK2	100.0	10000.0
HG-14-10-04	PIK3C2G	100.0	10000.0
PD0325901	M3K5	91.0	10000.0
WZ4003	FLT3(D835Y)	0.6	1000.0
KIN001-111	RPS6KA5(Kin.Dom.1)	100.0	1000.0
Vemurafenib	EGFR(L861Q)	56.0	10000.0
Sigma A6730	MST3	100.0	10000.0
CH5424802	CDC2L5	97.0	1000.0
Palbociclib	MP2K6	100.0	1000.0
CH5424802	IKKA	100.0	1000.0
AZ-628	BRSK1	91.0	10000.0
Crizotinib	MAPKAPK2	100.0	10000.0
WZ4003	CAMK2A	100.0	1000.0
Canertinib	CDK8	100.0	1000.0
PHA-793887	EGFR(E746-A750del)	84.0	10000.0
ALW-II-38-3	INSR	100.0	10000.0
CG-930	MKNK1	94.0	10000.0
QL-X-138	CDK14	60.0	10000.0
WZ4002	CIT	100.0	10000.0
PD0325901	KGP1	100.0	10000.0
XMD11-85h	KIT(V559D,V654A)	100.0	10000.0
AZD-6482	CLK3	100.0	10000.0
NG25	ULK2	100.0	10000.0
Neratinib	YSK1	13.0	10000.0
NVP-TAE684	FGFR1	0.0	1000.0
Ibrutinib	CSNK1A1	87.0	1000.0
PHA-767491	ULK1	22.0	10000.0
XMD11-85h	RET(V804L)	0.0	10000.0
HG-5-113-01	CDK9	100.0	10000.0
Omipalisib	TSSK1	57.0	10000.0
Palbociclib	EGFR(L747-E749del,A750P)	100.0	1000.0
GSK1059615	PIK3CA(Q546K)	1.3	10000.0
CP724714	RIPK4	100.0	10000.0
BMS345541	YSK1	79.0	10000.0
Barasertib	PRKR	100.0	10000.0
JNK-9L	STK33	88.0	10000.0
GW843682X	JAK1(JH2domain-pseudokinase)	100.0	10000.0
JNK-9L	MK14	100.0	10000.0
ZM-447439	ERK4	100.0	10000.0
WZ4002	ROS1	5.0	10000.0
THZ1	PCTK3	6.2	10000.0
Seliciclib	MST2	100.0	10000.0
PHA-793887	YES	100.0	10000.0
BI-D1870	MELK	4.8	10000.0
ZG-10	PAK2	76.0	10000.0
ERK5-IN-1	MINK	100.0	1000.0
GSK461364	PIK3CA(E542K)	91.0	10000.0
QL-XII-47	CSK	100.0	1000.0
GSK429286A	RPS6KA4(Kin.Dom.1-N-terminal)	98.0	10000.0
KIN001-123	KPCD3	100.0	1000.0
A443654	BRSK2	100.0	10000.0
HG-14-10-04	SNARK	0.6	10000.0
(s)-CR8	IRAK1	100.0	10000.0
ZSTK474	RET	100.0	1000.0
CP724714	MYLK4	100.0	10000.0
ERK5-IN-1	ACVR2A	95.0	1000.0
XMD13-2	PIK3CA(C420R)	100.0	10000.0
AZ-628	RET(V804M)	0.2	10000.0
Sorafenib	VGFR2	0.8	10000.0
A443654	MK14	100.0	10000.0
Sigma A6730	M3K6	100.0	10000.0
Torkinib	SRPK2	100.0	10000.0
Taselisib	NDR2	96.0	1000.0
XMD-12	CSNK1E	100.0	1000.0
XMD11-50	RET(V804M)	80.0	10000.0
NG25	GSK3A	100.0	10000.0
AS-252424	FLT4	96.5	10000.0
HG-9-91-01	IKKA	47.0	10000.0
HG-6-64-01	TESK1	15.0	10000.0
MRT67307	MST1	100.0	10000.0
Ibrutinib	YES	2.0	1000.0
Vemurafenib	ULK2	100.0	10000.0
JW-7-24-1	MK03	100.0	10000.0
BX-912	PIP5K1A	1.0	10000.0
Alpelisib	ABL1(M351T)-phosphorylated	100.0	1000.0
WYE-125132	ABL1-phosphorylated	100.0	10000.0
XMD14-99	PCTK2	42.0	10000.0
TAK-715	EPHA4	94.0	10000.0
Sorafenib	SIK3	100.0	10000.0
AG1478	JNK1	38.0	10000.0
Vemurafenib	CDK7	82.0	10000.0
HG-14-10-04	LOK	0.1	10000.0
Ibrutinib	ROCK2	86.0	1000.0
NPK76-II-72-1	M4K1	100.0	10000.0
CP724714	MKNK2	1.4	10000.0
Momelotinib	M4K3	57.0	10000.0
ERK5-IN-1	PAK3	95.0	1000.0
NVP-TAE684	PIK3C2B	100.0	1000.0
KIN001-127	RAF1	100.0	10000.0
Palbociclib	DCAMKL2	67.0	1000.0
XMD8-92	MARK1	100.0	10000.0
HG-9-91-01	TAK1	15.0	10000.0
Baricitinib	CLK2	3.8	10000.0
WZ4003	PGFRA	100.0	1000.0
TGX221	IKKE	100.0	1000.0
KU63794	EGFR(G719C)	100.0	10000.0
KIN001-220	CSNK2A2	7.8	10000.0
JNK-IN-11	RIPK4	100.0	1000.0
XMD16-144	TYK2(JH1domain-catalytic)	5.0	10000.0
Ibrutinib	IRAK1	74.0	1000.0
PHA-793887	PAK4	5.4	10000.0
Ibrutinib	ULK3	73.0	1000.0
Torin2	ABL1(F317I)-nonphosphorylated	100.0	10000.0
AZD4547	CSNK2A2	76.0	10000.0
CP466722	RPS6KA5(Kin.Dom.1-N-terminal)	84.0	10000.0
ALW-II-38-3	CSF1R	0.1	1000.0
PHA-767491	CSNK1A1L	0.7	10000.0
QL-XI-92	EGFR(L858R)	100.0	10000.0
Canertinib	KPCD1	100.0	1000.0
Ceritinib	RSK1(Kin.Dom.1-N-terminal)	67.0	1000.0
XMD8-85	PIK3CA(H1047L)	100.0	10000.0
GSK1059615	FGFR3(G697C)	100.0	10000.0
XMD11-85h	ULK1	100.0	10000.0
JNK-IN-11	SIK2	42.0	1000.0
WZ-4-145	MARK1	100.0	10000.0
AZD4547	PIK3CA(E545K)	90.0	10000.0
Sorafenib	PKN2	100.0	10000.0
5z-7-oxozeaenol	JNK1	92.0	10000.0
Ribociclib	TXK	100.0	1000.0
ZM-447439	BRAF	100.0	10000.0
HG-6-64-01	GSK3A	100.0	10000.0
5z-7-oxozeaenol	LTK	70.0	10000.0
HG-6-64-01	TYRO3	100.0	10000.0
TAK-715	EPHA5	90.0	10000.0
KIN001-220	PIK3CG	65.0	10000.0
Dinaciclib	EPHA8	86.0	10000.0
TAK-715	ABL1(F317I)-phosphorylated	27.0	10000.0
BMS-536924	BTK	0.6	1000.0
GSK429286A	CAMK1G	81.0	10000.0
XMD8-85	TSSK1	100.0	10000.0
Ceritinib	FLT3(D835Y)	43.0	1000.0
(s)-CR8	PHKG2	85.0	10000.0
SP600125	PAK1	100.0	10000.0
ZG-10	CDK8	78.0	10000.0
AZD 5438	CAMK1D	48.0	10000.0
(s)-CR8	FLT3(D835H)	93.0	10000.0
JNK-IN-8	MST4	82.0	1000.0
Dinaciclib	MAP3K1	79.0	10000.0
WZ4003	ALK	0.7	1000.0
Barasertib	MKNK2	6.4	10000.0
Sorafenib	CDK7	4.2	10000.0
KIN001-111	TLK2	100.0	1000.0
BS-181	NEK6	93.0	10000.0
Sigma A6730	TBK1	70.0	10000.0
BX-912	CTK	40.0	10000.0
QL-X-138	KPCL	100.0	10000.0
GSK1059615	RSK1(Kin.Dom.1-N-terminal)	51.0	10000.0
NG25	PCTK3	1.2	10000.0
PD0325901	RET(M918T)	79.0	10000.0
KIN001-021	JAK1(Kin.Dom.1)	100.0	1000.0
JNK-IN-8	PIK3CA(H1047Y)	96.0	1000.0
GW843682X	M3K13	100.0	10000.0
AS-252424	PIK3CA(E545K)	42.3	10000.0
CGP60474	AURKB	100.0	10000.0
Sorafenib	MLCK	40.0	10000.0
Omipalisib	EPHB3	88.0	10000.0
CP466722	NEK4	41.0	10000.0
JNK-IN-11	MARK1	100.0	1000.0
CP466722	EPHA8	59.0	10000.0
PD173074	LATS2	100.0	10000.0
Torkinib	NEK7	100.0	10000.0
ALW-II-49-7	TAOK1	100.0	10000.0
Dinaciclib	EGFR(L747-T751del,Sins)	90.0	10000.0
Ribociclib	ERBB4	100.0	1000.0
GSK461364	PKMYT1	100.0	10000.0
WZ-4-145	MELK	100.0	10000.0
Pictilisib	GRK4	100.0	1000.0
BI-2536	KC1G2	100.0	10000.0
CH5424802	GAK	10.0	1000.0
Dactolisib	CDK11	100.0	1000.0
THZ1	TRKA	0.2	10000.0
CGP60474	AKT1	100.0	10000.0
Omipalisib	PIK3C2G	4.4	10000.0
XMD16-144	TRKA	18.0	10000.0
BS-181	PLK3	92.0	10000.0
KIN001-111	MAPKAPK2	100.0	1000.0
Sorafenib	JNK3	100.0	10000.0
GSK461364	M4K1	83.0	10000.0
XMD11-50	EPHB4	100.0	10000.0
Alpelisib	EGFR(L858R,T790M)	100.0	1000.0
WZ3105	DCAMKL2	89.0	10000.0
SP600125	TRKC	100.0	10000.0
AS-252424	FLT3(K663Q)	96.2	10000.0
BI-D1870	MST2	1.7	10000.0
SCH772984	CLK3	57.0	1000.0
Lapatinib	CSF1R	85.0	10000.0
Taselisib	PIK3CD	0.0	1000.0
JNK-IN-8	HCK	100.0	1000.0
PD173074	PLK1	100.0	10000.0
PD173074	EPHA1	100.0	10000.0
CP466722	TRKA	48.0	10000.0
QL-XII-47	FER	100.0	1000.0
JW-7-24-1	EPHA1	100.0	10000.0
XMD8-92	PAK4	100.0	10000.0
SCH772984	AURKC	7.9	1000.0
KIN001-111	MYO3A	4.8	1000.0
HG-5-113-01	CHEK1	100.0	10000.0
JW-7-24-1	TAOK3	0.5	10000.0
BX-912	MLK2	0.0	10000.0
XMD14-99	SRPK2	100.0	10000.0
GSK461364	CDC2L2	100.0	10000.0
XMD8-85	MK13	100.0	10000.0
Torkinib	ACVR2B	2.0	10000.0
MRT67307	FER	100.0	10000.0
PD0325901	WNK3	100.0	10000.0
XMD16-144	PIK3CA(E545A)	67.0	10000.0
Alpelisib	DAPK1	81.0	1000.0
JNK-IN-8	M4K1	89.0	1000.0
Abemaciclib	PIK3CA(E545A)	100.0	1000.0
WYE-125132	SRMS	97.0	10000.0
KIN001-021	CLK3	100.0	1000.0
GW-5074	PRP4	50.0	10000.0
Momelotinib	NEK5	2.4	10000.0
NG25	WEE2	100.0	10000.0
CG-930	ABL1-nonphosphorylated	39.0	10000.0
BI-2536	DAPK2	16.0	10000.0
Alpelisib	TIE2	89.0	1000.0
XMD11-50	ABL1(Y253F)-phosphorylated	89.0	10000.0
WZ-4-145	GAK	100.0	10000.0
PHA-793887	FLT3	100.0	10000.0
MLN8054	AMPK-alpha1	38.0	10000.0
KIN001-220	ROCK2	75.0	10000.0
XMD8-92	VGFR1	100.0	10000.0
WZ-4-145	FAK1	100.0	10000.0
Ceritinib	TIE2	90.0	1000.0
Baricitinib	PIK3C2B	100.0	10000.0
Ceritinib	PRKR	87.0	1000.0
CH5424802	MLCK	93.0	1000.0
AZD4547	ULK1	13.0	10000.0
Ribociclib	PIK3CA(Q546K)	100.0	1000.0
WH-4-023	BLK	0.1	10000.0
QL-XI-92	MP2K6	100.0	10000.0
SCH772984	CHEK1	100.0	1000.0
HG-9-91-01	ERK8	100.0	10000.0
PHA-767491	HCK	100.0	10000.0
WZ3105	CHEK1	87.0	10000.0
Taselisib	CLK1	94.0	1000.0
ZM-447439	PIK3CA	100.0	10000.0
BS-181	M4K3	96.0	10000.0
XMD14-99	ULK2	72.0	10000.0
XMD8-85	TLK2	100.0	10000.0
OTSSP167	NEK11	100.0	10000.0
WZ-7043	KCC2D	100.0	10000.0
OTSSP167	FGR	0.8	10000.0
WZ4002	EPHB2	100.0	10000.0
XMD14-99	PLK4	100.0	10000.0
Buparlisib	PIP5K1C	73.0	1000.0
XMD11-85h	WEE1	100.0	10000.0
BMS345541	WEE2	100.0	10000.0
WH-4-023	TRKA	78.0	10000.0
PLX-4720	JAK2(JH1domain-catalytic)	44.0	10000.0
Lapatinib	SNARK	100.0	10000.0
AZD4547	ADCK4	100.0	10000.0
R406	PAK7	0.7	1000.0
MLN8054	DCLK1	58.0	10000.0
Ceritinib	INSR	1.8	1000.0
Barasertib	EPHA4	92.0	10000.0
WZ-7043	BIKE	100.0	10000.0
PLX-4720	PDPK1	85.0	10000.0
JNK-IN-5A	CIT	100.0	10000.0
Ribociclib	ULK3	100.0	1000.0
Abemaciclib	MARK1	100.0	1000.0
HG-5-113-01	TESK1	30.0	10000.0
AZD4547	GSK3A	92.0	10000.0
MRT67307	KGP2	64.0	10000.0
AZD 5438	ABL1(F317L)-nonphosphorylated	96.0	10000.0
CP724714	KGP2	100.0	10000.0
HG-5-113-01	EPHA3	100.0	10000.0
JW-7-24-1	MP2K6	100.0	10000.0
Crizotinib	PLK3	85.0	10000.0
NPK76-II-72-1	FLT4	100.0	10000.0
Pictilisib	IKKA	100.0	1000.0
Baricitinib	YSK1	22.0	10000.0
Ribociclib	DMPK	94.0	1000.0
Sorafenib	MLK1	88.0	10000.0
MRT67307	EPHB6	64.0	10000.0
Ribociclib	FLT3(N841I)	61.0	1000.0
WZ-4-145	ABL1	16.0	10000.0
XMD8-85	EPHA3	100.0	10000.0
WZ4002	DAPK1	22.0	10000.0
Neratinib	EGFR(L747-E749del,A750P)	0.2	10000.0
HG-9-91-01	IGF1R	100.0	10000.0
BS-181	RET(M918T)	95.0	10000.0
BS-181	HASP	69.0	10000.0
XMD11-50	PKMYT1	80.0	10000.0
PHA-793887	SNARK	16.0	10000.0
Momelotinib	EGFR(L747-S752del,P753S)	100.0	10000.0
BI-2536	MET	34.0	10000.0
Lapatinib	MERTK	68.0	10000.0
Alpelisib	PIK3CA(C420R)	0.2	1000.0
SB590885	SRPK1	86.0	10000.0
MRT67307	ALK	100.0	10000.0
AG1478	NEK1	77.0	10000.0
Torkinib	PLK2	13.0	10000.0
Palbociclib	SRPK1	100.0	1000.0
Buparlisib	ANKK1	100.0	1000.0
BS-181	NEK2	100.0	10000.0
HG-5-113-01	M3K12	0.4	10000.0
GW-5074	PKN2	99.0	10000.0
AZD-6482	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
CGP60474	MAP3K1	100.0	10000.0
HG-14-10-04	LYN	9.6	10000.0
Dinaciclib	MST4	30.0	10000.0
ZSTK474	SgK110	100.0	1000.0
BX-912	BMX	13.0	10000.0
Ceritinib	WEE2	97.0	1000.0
KIN001-127	PHKG1	100.0	10000.0
SCH772984	MK13	83.0	1000.0
BS-181	EGFR(L861Q)	73.0	10000.0
Torin2	NUAK1	83.0	10000.0
Palbociclib	BUB1	100.0	1000.0
KIN001-127	PKAC-alpha	100.0	10000.0
CP724714	ADCK3	100.0	10000.0
BMX-IN-1	MP2K4	4.9	10000.0
Torin2	MET	100.0	10000.0
Taselisib	NLK	100.0	1000.0
JNK-IN-8	EPHA8	100.0	1000.0
5z-7-oxozeaenol	M3K12	96.0	10000.0
BMS-536924	DYRK1B	100.0	1000.0
Abemaciclib	EGFR	98.0	1000.0
QL-XII-47	PCTK2	100.0	1000.0
Abemaciclib	DCLK1	70.0	1000.0
Torin2	KPCE	69.0	10000.0
Sigma A6730	IKKA	75.0	10000.0
HG-14-8-02	RSK2(Kin.Dom.1-N-terminal)	52.0	10000.0
ERK5-IN-1	DYRK1A	88.0	1000.0
BMS-536924	DRAK2	0.5	1000.0
Taselisib	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	1000.0
WYE-125132	RIPK5	100.0	10000.0
Torkinib	STK33	45.0	10000.0
Taselisib	IKKA	100.0	1000.0
KIN001-220	MST1	98.0	10000.0
Sigma A6730	GRK4	100.0	10000.0
Abemaciclib	TNK1	65.0	1000.0
JNK-IN-11	RSK1(Kin.Dom.1-N-terminal)	100.0	1000.0
(s)-CR8	SRPK3	88.0	10000.0
GSK461364	M3K5	100.0	10000.0
XMD16-144	SRPK2	100.0	10000.0
BMS-536924	RAF1	100.0	1000.0
OTSSP167	BUB1	13.0	10000.0
Dinaciclib	ALK	70.0	10000.0
AZD-6482	PCTK2	100.0	10000.0
GSK429286A	EPHB1	91.0	10000.0
GW843682X	KCC2D	75.0	10000.0
HG-14-10-04	GRK4	16.0	10000.0
PD0325901	EPHA2	88.0	10000.0
Seliciclib	ERK8	49.0	10000.0
Sorafenib	CDKL3	0.6	10000.0
MLN8054	CDK8	100.0	10000.0
XMD13-2	EPHB2	98.0	10000.0
Dactolisib	TIE2	100.0	1000.0
WH-4-023	ERK8	76.0	10000.0
Lapatinib	NLK	73.0	10000.0
PLX-4720	ABL1(F317L)-phosphorylated	32.0	10000.0
JNK-9L	CDK7	1.2	10000.0
PLX-4720	NEK4	71.0	10000.0
BMS345541	MP2K7	100.0	10000.0
SP600125	PGFRA	100.0	10000.0
SP600125	PRKR	20.0	10000.0
Omipalisib	BLK	87.0	10000.0
AZD 5438	VGFR2	55.0	10000.0
AZD4547	RET(M918T)	0.0	10000.0
JNK-IN-5A	MKNK2	92.0	10000.0
XMD13-2	ALK	100.0	10000.0
ZG-10	M4K1	100.0	10000.0
QL-X-138	SRPK3	68.0	10000.0
AS-252424	ACVR2A	85.7	10000.0
PD173074	DCLK1	100.0	10000.0
MRT67307	PCTK3	73.0	10000.0
Pictilisib	ABL2	99.0	1000.0
AG1478	TNNI3K	38.0	10000.0
XMD11-50	TGFBR2	100.0	10000.0
XMD11-50	YSK4	99.0	10000.0
Torkinib	DAPK2	3.8	10000.0
GSK429286A	CDK8	79.0	10000.0
WH-4-023	YSK1	61.0	10000.0
XMD14-99	HUNK	100.0	10000.0
Dinaciclib	MAP4K5	84.0	10000.0
BS-181	SIK1	94.0	10000.0
XMD-12	CDC2L1	100.0	1000.0
HG-5-113-01	MARK1	26.0	10000.0
BMX-IN-1	CSNK1D	90.0	10000.0
QL-XI-92	RIPK2	100.0	10000.0
HG-14-8-02	LRRK2	11.0	10000.0
RO-3306	AURKA	46.0	10000.0
Omipalisib	MARK2	73.0	10000.0
CGP60474	ROS1	100.0	10000.0
Canertinib	RPS6KA3(Kin.Dom.1)	100.0	1000.0
WZ3105	ABL1(E255K)-phosphorylated	70.0	10000.0
WH-4-023	ULK3	59.0	10000.0
AZ-628	PIK3CA(E545K)	100.0	10000.0
GSK429286A	JAK3(JH1domain-catalytic)	3.2	10000.0
(s)-CR8	MAP4K5	99.0	10000.0
TGX221	EPHA6	100.0	1000.0
Crizotinib	SNARK	5.5	10000.0
ZSTK474	SRPK3	100.0	1000.0
XMD16-144	RSK3(Kin.Dom.1-N-terminal)	50.0	10000.0
NU7441	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
XMD8-85	LOK	100.0	10000.0
WZ-4-145	CDK11	100.0	10000.0
JWE-035	GSK3A	100.0	10000.0
A443654	PDPK1	100.0	10000.0
KIN001-220	PI42C	38.0	10000.0
AZD 5438	FGR	37.0	10000.0
QL-XII-47	ERBB2	89.0	1000.0
NG25	AMPK-alpha1	100.0	10000.0
OTSSP167	EGFR(L861Q)	2.2	10000.0
Omipalisib	EPHA6	83.0	10000.0
QL-X-138	BRAF(V600E)	91.0	10000.0
JNK-IN-5A	CSNK1E	70.0	10000.0
AG1478	PIK3CA	76.0	10000.0
5z-7-oxozeaenol	M3K6	100.0	10000.0
BS-181	MAPKAPK2	76.0	10000.0
PHA-767491	MARK3	44.0	10000.0
JNK-IN-8	KPCL	94.0	1000.0
KIN001-220	CSNK1E	100.0	10000.0
Seliciclib	MAP3K14	98.0	10000.0
Taselisib	PLK3	100.0	1000.0
Dabrafenib	EGFR(L747-E749del,A750P)	65.0	10000.0
SB590885	MRCKB	89.0	10000.0
WZ4003	FLT3(D835H)	4.2	1000.0
SP600125	CLK3	100.0	10000.0
Sigma A6730	KPCD	81.0	10000.0
TAK-715	BMPR1B	14.0	10000.0
AS-252424	ADCK4	79.6	10000.0
AS-252424	TLK1	62.8	10000.0
Vemurafenib	AAK1	100.0	10000.0
WZ3105	EPHB4	60.0	10000.0
JNK-9L	CAMK2B	37.0	10000.0
HG-6-64-01	PHKG1	100.0	10000.0
XMD14-99	FGFR3	99.0	10000.0
BS-181	IKKE	100.0	10000.0
Seliciclib	RSK4(Kin.Dom.1-N-terminal)	53.0	10000.0
5z-7-oxozeaenol	LRRK2	96.0	10000.0
PD173074	MARK1	100.0	10000.0
AZD 5438	AKT3	100.0	10000.0
(s)-CR8	SGK3	62.0	10000.0
Canertinib	ERK3	100.0	1000.0
Sorafenib	JAK2(JH1domain-catalytic)	80.0	10000.0
BMS345541	SYK	100.0	10000.0
(s)-CR8	YANK1	86.0	10000.0
AZD7762	ADCK4	55.0	10000.0
BGJ398	MP2K7	100.0	1000.0
WZ3105	SNRK	68.0	10000.0
AZD7762	TBK1	4.8	10000.0
Buparlisib	ULK1	100.0	1000.0
A443654	MYLK	0.1	10000.0
AZD4547	NEK7	71.0	10000.0
XMD11-50	LIMK1	95.0	10000.0
THZ1	FLT3(N841I)	0.0	10000.0
AZD 5438	RSK2(Kin.Dom.1-N-terminal)	30.0	10000.0
JW-7-24-1	LIMK2	100.0	10000.0
SB590885	MYLK2	100.0	10000.0
MRT67307	EPHB3	100.0	10000.0
QL-XII-47	EPHA2	100.0	1000.0
JNK-IN-8	PKMYT1	69.0	1000.0
BX-912	NEK7	0.5	10000.0
BMS-536924	GSK3A	100.0	1000.0
Ceritinib	FER	0.4	1000.0
PHA-767491	INSRR	86.0	10000.0
5z-7-oxozeaenol	BMPR1B	76.0	10000.0
Dactolisib	HIPK2	100.0	1000.0
KIN001-021	RPS6KA6(Kin.Dom.1)	100.0	1000.0
XMD-12	PKAC-alpha	100.0	1000.0
CH5424802	PIM3	4.5	1000.0
MPS-1-IN-1	CDK8	100.0	1000.0
WZ-4-145	MK03	100.0	10000.0
JNK-IN-11	RSK3(Kin.Dom.1-N-terminal)	86.0	1000.0
WH-4-023	KCC2D	100.0	10000.0
KIN001-220	EPHB3	78.0	10000.0
Omipalisib	AURKA	53.0	10000.0
ZM-447439	LRRK2	73.0	10000.0
JW-7-24-1	NEK1	100.0	10000.0
Neratinib	AKT1	98.0	10000.0
Barasertib	TAOK3	100.0	10000.0
GSK461364	ABL1(E255K)-phosphorylated	55.0	10000.0
GSK461364	ULK2	11.0	10000.0
Crizotinib	GSK3B	100.0	10000.0
5z-7-oxozeaenol	INSRR	71.0	10000.0
CP724714	CSNK2A1	87.0	10000.0
THZ1	FGFR3(G697C)	0.2	10000.0
QL-XI-92	ZAP70	54.0	10000.0
Taselisib	CSNK2A1	100.0	1000.0
Omipalisib	RIOK1	40.0	10000.0
HG-6-64-01	LRRK2	12.0	10000.0
CP466722	EGFR(L747-T751del,Sins)	77.0	10000.0
CGP74514A	AMPK-alpha2	28.0	10000.0
WZ4002	KPCD1	12.0	10000.0
JNK-9L	KIT	0.7	10000.0
Buparlisib	YSK1	100.0	1000.0
MLN8054	SBK1	100.0	10000.0
NPK76-II-72-1	BMPR2	100.0	10000.0
HG-14-10-04	GRK1	45.0	10000.0
JW-7-24-1	CSNK1A1L	100.0	10000.0
WH-4-023	TLK1	45.0	10000.0
Alpelisib	MK13	86.0	1000.0
WH-4-023	ZAP70	79.0	10000.0
WYE-125132	ERK8	25.0	10000.0
ZG-10	ICK	62.0	10000.0
CH5424802	FYN	89.0	1000.0
CGP60474	FGFR3(G697C)	100.0	10000.0
QL-X-138	PIK3CA(H1047L)	4.6	10000.0
GSK1059615	FGFR1	81.0	10000.0
R406	ACVR2A	100.0	1000.0
JNK-IN-11	LYN	58.0	1000.0
AZD4547	NEK9	94.0	10000.0
THZ1	MUSK	0.4	10000.0
BGJ398	EPHB1	93.0	1000.0
KIN001-111	KC1G1	100.0	1000.0
PD0325901	MST2	90.0	10000.0
KIN001-220	EGFR(L858R,T790M)	76.0	10000.0
CGP74514A	TBK1	62.0	10000.0
Ceritinib	TNK1	71.0	1000.0
Sigma A6730	CSNK1A1L	80.0	10000.0
Crizotinib	TAOK2	0.9	10000.0
GSK1059615	ROS1	78.0	10000.0
WZ4003	PAK6	100.0	1000.0
Barasertib	NEK3	100.0	10000.0
Torin1	AURKB	82.0	10000.0
R406	M4K1	14.0	1000.0
Neratinib	MYO3B	100.0	10000.0
Abemaciclib	MRCKB	80.0	1000.0
MRT67307	BMX	94.0	10000.0
GSK429286A	IGF1R	98.0	10000.0
CH5424802	LCK	22.0	1000.0
BI-2536	EPHA1	100.0	10000.0
Vemurafenib	MAP3K15	100.0	10000.0
XMD11-50	NEK4	95.0	10000.0
KIN001-021	BRAF	100.0	1000.0
AS-252424	TYK2(JH2domain-pseudokinase)	33.1	10000.0
ZG-10	IKKE	76.0	10000.0
GW843682X	ABL1(T315I)-phosphorylated	58.0	10000.0
JNK-9L	KIT(L576P)	17.0	10000.0
WZ-7043	MP2K1	100.0	10000.0
BGJ398	ABL2	62.0	1000.0
Barasertib	DRAK2	93.0	10000.0
Vemurafenib	ERBB2	100.0	10000.0
AS-252424	PLK3	100.0	10000.0
MRT67307	ICK	77.0	10000.0
ALW-II-38-3	ERK5	100.0	10000.0
XMD11-50	EPHA3	100.0	10000.0
WH-4-023	MLK3	8.8	10000.0
PD0325901	RSK2(Kin.Dom.1-N-terminal)	100.0	10000.0
GW-5074	DMPK2	91.0	10000.0
Lapatinib	TBK1	100.0	10000.0
Sigma A6730	EGFR(L747-S752del,P753S)	73.0	10000.0
WYE-125132	KPCD3	100.0	10000.0
RO-3306	HIPK3	12.0	10000.0
XMD-12	VGFR1	94.0	1000.0
MPS-1-IN-1	TYK2(Kin.Dom.2)	100.0	1000.0
MPS-1-IN-1	SRPK1	100.0	1000.0
WZ-7043	MK12	100.0	10000.0
TAK-715	ACVRL1	85.0	10000.0
QL-XI-92	MAPKAPK5	83.0	10000.0
Ribociclib	IRAK3	100.0	1000.0
OTSSP167	RSK1(Kin.Dom.2-C-terminal)	34.0	10000.0
ALW-II-49-7	MARK2	100.0	10000.0
HG-14-8-02	EGFR(L858R)	0.0	10000.0
ALW-II-38-3	PKN2	100.0	10000.0
BX-912	MST1	12.0	10000.0
MLN8054	ABL1(Q252H)-phosphorylated	7.8	10000.0
Sorafenib	PKMYT1	94.0	10000.0
Abemaciclib	IRAK3	46.0	1000.0
AZ-628	MET(Y1235D)	100.0	10000.0
Palbociclib	DMPK	100.0	1000.0
A443654	SgK110	100.0	10000.0
Canertinib	PAK3	100.0	1000.0
XMD-12	STK36	100.0	1000.0
Abemaciclib	NEK3	42.0	1000.0
QL-XI-92	RIPK5	100.0	10000.0
Palbociclib	DAPK2	75.0	1000.0
RO-3306	TYK2(JH2domain-pseudokinase)	86.0	10000.0
AZD4547	AAK1	14.0	10000.0
AZD4547	PKAC-beta	100.0	10000.0
QL-XI-92	CAMK1	88.0	10000.0
CP466722	YSK1	33.0	10000.0
NG25	SRPK2	100.0	10000.0
SB590885	EGFR(L861Q)	34.0	10000.0
MRT67307	TLK1	72.0	10000.0
CG-930	CDK4-cyclinD1	100.0	10000.0
BS-181	EGFR(L858R)	81.0	10000.0
XMD-12	PAK2	81.0	1000.0
Ceritinib	TRKC	94.0	1000.0
TAK-715	ABL1(F317L)-phosphorylated	27.0	10000.0
BX-912	FYN	8.2	10000.0
(s)-CR8	HASP	94.0	10000.0
QL-X-138	HIPK3	48.0	10000.0
QL-X-138	EPHB2	100.0	10000.0
Torin1	TXK	54.0	10000.0
CGP60474	PLK2	100.0	10000.0
XMD8-85	FGFR4	5.6	10000.0
Dabrafenib	PKAC-beta	100.0	10000.0
JNK-IN-8	AKT1	100.0	1000.0
Buparlisib	KIT(L576P)	92.0	1000.0
GW-5074	TAOK3	87.0	10000.0
PHA-767491	CSNK2A2	1.8	10000.0
HG-5-88-01	FLT3(D835Y)	5.2	10000.0
ZM-447439	ULK1	48.0	10000.0
QL-XII-47	IRAK3	65.0	1000.0
GSK429286A	FAK1	79.0	10000.0
A443654	CIT	0.2	10000.0
NVP-TAE684	EGFR(L858R)	0.1	1000.0
AZD-6482	CAMK1	100.0	10000.0
KIN001-021	AURKB	100.0	1000.0
HG-9-91-01	AKT2	100.0	10000.0
THZ1	FLT3(ITD)	0.0	10000.0
HG-9-91-01	CDC2L5	97.0	10000.0
TGX221	MK11	100.0	1000.0
5z-7-oxozeaenol	TNIK	74.0	10000.0
GSK1059615	MAP3K1	60.0	10000.0
Torin1	LATS2	100.0	10000.0
XMD8-92	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
XMD13-2	AKT3	100.0	10000.0
PHA-767491	CDK11	12.0	10000.0
JNK-IN-11	MYO3A	100.0	1000.0
KIN001-220	SRPK2	11.0	10000.0
AZD7762	BIKE	0.1	10000.0
QL-XII-47	EGFR(E746-A750del)	100.0	1000.0
QL-XI-92	ABL1(T315I)-phosphorylated	98.0	10000.0
ZSTK474	STK16	100.0	1000.0
AZ-628	PFPK5(P.falciparum)	94.0	10000.0
JNK-IN-8	BMPR1B	92.0	1000.0
RO-3306	MP2K1	74.0	10000.0
AG1478	ABL1(Q252H)-nonphosphorylated	6.7	10000.0
QL-X-138	CAMK1	96.0	10000.0
QL-XI-92	PIK3CB	100.0	10000.0
Torin1	STK16	18.0	10000.0
WZ4002	EPHA2	100.0	10000.0
BS-181	PHKG2	13.0	10000.0
Neratinib	MET(M1250T)	47.0	10000.0
TAK-715	CSF1R	76.0	10000.0
AZD7762	DMPK2	72.0	10000.0
PD0325901	VRK2	100.0	10000.0
NG25	LIMK2	100.0	10000.0
Ceritinib	PCTK2	87.0	1000.0
KIN001-021	ERK5	100.0	1000.0
BX-912	FRK	46.0	10000.0
CG-930	PFPK5(P.falciparum)	100.0	10000.0
Torin1	RSK3(Kin.Dom.2-C-terminal)	85.0	10000.0
XMD8-85	EGFR(L747-S752del,P753S)	100.0	10000.0
XMD13-2	NEK5	60.0	10000.0
CP724714	RET(V804M)	96.0	10000.0
CP724714	IRAK1	100.0	10000.0
CP724714	HIPK4	95.0	10000.0
Dinaciclib	CSNK1D	35.0	10000.0
KIN001-127	DRAK1	100.0	10000.0
Momelotinib	FGFR2	58.0	10000.0
BGJ398	EPHB3	75.0	1000.0
GSK429286A	PDPK1	100.0	10000.0
Neratinib	CIT	95.0	10000.0
WZ4002	FGFR2	100.0	10000.0
Taselisib	CLK2	100.0	1000.0
TAK-715	ABL1-phosphorylated	30.0	10000.0
PHA-767491	MLK1	96.0	10000.0
Dabrafenib	PLK2	94.0	10000.0
XMD11-50	AURKB	38.0	10000.0
ZG-10	PIK3CA(E545K)	100.0	10000.0
QL-X-138	PRKR	94.0	10000.0
5z-7-oxozeaenol	CDK5	96.0	10000.0
XMD8-92	MAP3K3	100.0	10000.0
NU7441	BTK	100.0	10000.0
Taselisib	FYV1	94.0	1000.0
SP600125	TNK1	15.0	10000.0
AZD-6482	BMPR1A	98.0	10000.0
AZD7762	MK01	65.0	10000.0
SCH772984	IRAK4	100.0	1000.0
ERK5-IN-1	KCC2D	96.0	1000.0
Crizotinib	ACVR1B	9.0	10000.0
TAK-715	KIT(V559D,T670I)	69.0	10000.0
BGJ398	ALK(C1156Y)	100.0	1000.0
5z-7-oxozeaenol	LIMK2	86.0	10000.0
CH5424802	TIE2	92.0	1000.0
CH5424802	MP2K2	100.0	1000.0
PD0325901	MAP3K4	100.0	10000.0
Momelotinib	MST1R	100.0	10000.0
WH-4-023	INSR	100.0	10000.0
CP724714	RAF1	100.0	10000.0
RO-3306	NEK11	82.0	10000.0
Crizotinib	LRRK2	97.0	10000.0
MLN8054	FLT4	18.0	10000.0
HG-5-88-01	MERTK	32.0	10000.0
XMD11-85h	PIM1	100.0	10000.0
WYE-125132	MP2K5	93.0	10000.0
Pictilisib	ERBB3	100.0	1000.0
Pictilisib	STK39	98.0	1000.0
BMS-536924	ACVR2A	100.0	1000.0
WYE-125132	FLT3(K663Q)	69.0	10000.0
KIN001-127	CDK3	100.0	10000.0
Palbociclib	SRMS	100.0	1000.0
QL-XII-47	MLK2	100.0	1000.0
KIN001-127	FRK	100.0	10000.0
SCH772984	PAK3	87.0	1000.0
KIN001-220	BRAF(V600E)	43.0	10000.0
SB590885	CDC2L5	100.0	10000.0
Momelotinib	TESK1	100.0	10000.0
ZM-447439	MK11	84.0	10000.0
Crizotinib	NEK7	6.7	10000.0
R406	TRKB	4.8	1000.0
AZD-6482	EPHA3	79.0	10000.0
KIN001-021	MYO3A	100.0	1000.0
NPK76-II-72-1	DMPK	100.0	10000.0
OTSSP167	RIOK3	90.0	10000.0
Momelotinib	CSNK1D	100.0	10000.0
NPK76-II-72-1	DCLK1	4.0	10000.0
KIN001-111	STK16	100.0	1000.0
Dinaciclib	EGFR(L747-E749del,A750P)	61.0	10000.0
Abemaciclib	S6K1	56.0	1000.0
Ceritinib	HIPK3	73.0	1000.0
XMD14-99	DAPK3	78.0	10000.0
JNK-IN-5A	GRK4	100.0	10000.0
BMS-536924	AKT2	100.0	1000.0
Dactolisib	MLK1	100.0	1000.0
5z-7-oxozeaenol	FLT3	0.6	10000.0
Ceritinib	PAK2	88.0	1000.0
BGJ398	DYRK2	87.0	1000.0
Palbociclib	HIPK2	9.3	1000.0
THZ1	MRCKA	69.0	10000.0
ZG-10	MUSK	61.0	10000.0
XMD8-85	ERBB4	100.0	10000.0
BI-2536	PKAC-beta	100.0	10000.0
Buparlisib	CDC2L1	92.0	1000.0
Barasertib	MRCKB	100.0	10000.0
XMD16-144	CDC2L1	100.0	10000.0
GSK461364	ADCK4	58.0	10000.0
NG25	RPS6KA2(Kin.Dom.1)	100.0	10000.0
JNK-IN-5A	ABL1(T315I)-phosphorylated	82.0	10000.0
JW-7-24-1	IKKB	100.0	10000.0
CP724714	RIOK1	91.0	10000.0
BI-2536	FLT3(ITD)	100.0	10000.0
AZD4547	ACVR1B	88.0	10000.0
HG-14-10-04	DAPK3	0.4	10000.0
CP724714	MKNK1	100.0	10000.0
CH5424802	FGR	18.0	1000.0
BX-912	KC1G1	54.0	10000.0
CP724714	EPHB4	95.0	10000.0
WZ-4-145	NEK6	100.0	10000.0
XMD11-85h	CHEK1	100.0	10000.0
ZSTK474	CSNK1A1L	100.0	1000.0
JNK-IN-8	PLK1	100.0	1000.0
5z-7-oxozeaenol	TTK	100.0	10000.0
XMD13-2	AXL	54.0	10000.0
MRT67307	EGFR(L858R)	100.0	10000.0
BX-912	JAK2(JH1domain-catalytic)	0.0	10000.0
BS-181	TGFBR2	79.0	10000.0
Ibrutinib	M4K1	100.0	1000.0
ZG-10	KIT(V559D,T670I)	10.0	10000.0
AZD7762	MK14	100.0	10000.0
XMD11-85h	PIK3CA(M1043I)	100.0	10000.0
AZD 5438	RPS6KA4(Kin.Dom.1-N-terminal)	50.0	10000.0
Abemaciclib	PAK6	100.0	1000.0
BMX-IN-1	EPHA5	97.0	10000.0
GW843682X	EGFR(L747-E749del,A750P)	50.0	10000.0
TAK-715	EGFR(L858R)	2.6	10000.0
Pictilisib	PAK2	87.0	1000.0
Momelotinib	PAK1	100.0	10000.0
TAK-715	M3K12	100.0	10000.0
PHA-793887	MET(M1250T)	96.0	10000.0
Abemaciclib	ABL1(T315I)-nonphosphorylated	0.0	1000.0
KIN001-127	PAK3	100.0	10000.0
NG25	INSR	28.0	10000.0
Pictilisib	TSSK3	100.0	1000.0
BI-2536	PCTK2	100.0	10000.0
XMD11-50	SNRK	94.0	10000.0
A443654	CSK	100.0	10000.0
Sorafenib	TIE2	15.0	10000.0
NG25	CAMK1	0.0	10000.0
Alpelisib	PHKG1	20.0	1000.0
WZ-4-145	CIT	100.0	10000.0
PLX-4720	BRSK1	55.0	10000.0
Pictilisib	TNK2	100.0	1000.0
QL-X-138	CLK2	1.6	10000.0
Baricitinib	INSR	67.0	10000.0
WZ-4-145	MP2K6	100.0	10000.0
XMD14-99	MP2K3	79.0	10000.0
Dinaciclib	KCC4	24.0	10000.0
AZ-628	BRAF(V600E)	0.0	10000.0
MRT67307	TBK1	0.0	10000.0
XMD8-85	CAMK2G	31.0	10000.0
ZG-10	EPHA7	100.0	10000.0
XMD-12	HUNK	89.0	1000.0
TGX221	ABL1(Q252H)	100.0	1000.0
HG-14-8-02	M3K5	100.0	10000.0
MRT67307	CDK15	37.0	10000.0
WZ4003	PAK1	100.0	1000.0
THZ1	FGFR2	1.4	10000.0
BI-2536	TRKA	100.0	10000.0
Ibrutinib	AURKB	91.0	1000.0
THZ1	CAMK1	40.0	10000.0
CGP60474	SLK	100.0	10000.0
Palbociclib	ERK8	76.0	1000.0
PD0325901	NLK	77.0	10000.0
JWE-035	PIK3CA(M1043I)	15.0	10000.0
THZ1	CDK11	100.0	10000.0
CG-930	KC1G2	100.0	10000.0
Sigma A6730	HASP	100.0	10000.0
BGJ398	EGFR(L747-T751del,Sins)	78.0	1000.0
ERK5-IN-1	OSR1	99.0	1000.0
PHA-767491	TNIK	15.0	10000.0
PHA-793887	PIK3CA(E545K)	90.0	10000.0
PD0325901	SRMS	95.0	10000.0
BS-181	PRKX	100.0	10000.0
JNK-9L	RSK3(Kin.Dom.1-N-terminal)	73.0	10000.0
(s)-CR8	RSK3(Kin.Dom.1-N-terminal)	100.0	10000.0
Dactolisib	PHKG2	100.0	1000.0
RO-3306	STK33	1.6	10000.0
QL-XII-47	PKN1	100.0	1000.0
GSK1059615	ADCK3	93.0	10000.0
GW843682X	FGFR2	25.0	10000.0
Dactolisib	DMPK	100.0	1000.0
Sigma A6730	EPHA8	95.0	10000.0
WZ-4-145	LOK	0.1	10000.0
JNK-IN-5A	PIK3CB	100.0	10000.0
JNK-IN-5A	BMPR1A	100.0	10000.0
CP466722	ACVR1	0.2	10000.0
Pictilisib	PI42C	70.0	1000.0
PD173074	CSNK2A2	100.0	10000.0
HG-6-64-01	PAK7	100.0	10000.0
PD0325901	PIK4CB	100.0	10000.0
Torin1	ZAP70	100.0	10000.0
KU63794	STK39	100.0	10000.0
ZM-447439	TRPM6	98.0	10000.0
JNK-IN-5A	PIK3CG	99.0	10000.0
SCH772984	NEK1	63.0	1000.0
BX-912	KPCE	0.0	10000.0
KIN001-111	MRCKA	0.0	1000.0
CGP74514A	LYN	16.0	10000.0
Momelotinib	MP2K7	100.0	10000.0
GSK1059615	CSNK2A1	7.9	10000.0
TAK-715	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
Ibrutinib	CDK8	76.0	1000.0
PLX-4720	AMPK-alpha2	46.0	10000.0
AG1478	ACVR2A	92.0	10000.0
MRT67307	FAK1	58.0	10000.0
ZM-447439	MLK2	86.0	10000.0
Buparlisib	MARK3	100.0	1000.0
Torin1	LTK	77.0	10000.0
Sigma A6730	NUAK1	100.0	10000.0
Omipalisib	PKMYT1	95.0	10000.0
AG1478	TSSK1	100.0	10000.0
XMD11-50	ERK8	100.0	10000.0
Lapatinib	TLK2	98.0	10000.0
ZG-10	TXK	67.0	10000.0
Momelotinib	TIE1	87.0	10000.0
JNK-IN-11	PAK1	98.0	1000.0
AZD4547	NEK1	40.0	10000.0
BMS345541	MAPKAPK5	100.0	10000.0
JNK-IN-11	MINK	46.0	1000.0
AZD 5438	KIT(V559D,V654A)	78.0	10000.0
Dabrafenib	MK03	100.0	10000.0
HG-5-88-01	STK35	100.0	10000.0
XMD8-85	LIMK2	100.0	10000.0
XMD8-92	PIK3C2B	100.0	10000.0
WZ4002	NLK	100.0	10000.0
MPS-1-IN-1	PKN1	100.0	1000.0
CP724714	IRAK3	82.0	10000.0
Ceritinib	MST1R	82.0	1000.0
PD0325901	HIPK4	100.0	10000.0
BMS-536924	TNIK	1.0	1000.0
MLN8054	SNRK	74.0	10000.0
HG-14-10-04	YANK1	10.0	10000.0
CP466722	PRKX	79.0	10000.0
AG1478	ACVR2B	54.0	10000.0
PLX-4720	MST2	21.0	10000.0
BI-D1870	LCK	13.0	10000.0
HG-14-10-04	MLCK	62.0	10000.0
ZM-447439	MST1R	3.9	10000.0
JW-7-24-1	CDK7	0.1	10000.0
CH5424802	EPHA7	99.0	1000.0
GW843682X	RAF1	87.0	10000.0
Pictilisib	RIOK1	98.0	1000.0
KU63794	DCAMKL3	100.0	10000.0
BI-2536	KGP1	100.0	10000.0
PHA-767491	FAK2	68.0	10000.0
KU63794	KPCT	100.0	10000.0
MRT67307	PIK3CD	100.0	10000.0
AG1478	EPHA1	43.0	10000.0
BMX-IN-1	MTOR	0.0	10000.0
ZG-10	MK14	99.0	10000.0
CGP74514A	RAF1	86.0	10000.0
Dactolisib	TSSK1	100.0	1000.0
CH5424802	NEK1	100.0	1000.0
Buparlisib	SNRK	99.0	1000.0
WZ4003	MAP3K4	100.0	1000.0
AZD4547	ABL1(F317L)-nonphosphorylated	19.0	10000.0
BMS345541	EPHA5	100.0	10000.0
QL-XII-47	IRAK1	100.0	1000.0
NG25	IKKE	100.0	10000.0
GSK429286A	CDK3	77.0	10000.0
XMD8-85	EGFR(L861Q)	100.0	10000.0
Momelotinib	BMPR1A	35.0	10000.0
Barasertib	NUAK1	60.0	10000.0
PHA-793887	PLK1	72.0	10000.0
HG-14-8-02	AMPK-alpha1	100.0	10000.0
Torkinib	CDKL2	75.0	10000.0
SCH772984	CDK4-cyclinD3	100.0	1000.0
Abemaciclib	AKT2	100.0	1000.0
JNK-IN-11	CDK4-cyclinD3	81.0	1000.0
Ibrutinib	M4K3	91.0	1000.0
Abemaciclib	CAMK2A	0.1	1000.0
QL-XII-47	CDC2L2	100.0	1000.0
HG-14-10-04	RIOK3	4.8	10000.0
HG-6-64-01	ABL1(F317L)-phosphorylated	2.2	10000.0
WZ4003	LATS2	100.0	1000.0
Palbociclib	IRAK3	100.0	1000.0
WZ-4-145	MERTK	100.0	10000.0
MPS-1-IN-1	FLT3(N841I)	100.0	1000.0
Torin2	TIE1	100.0	10000.0
OTSSP167	CDC2L1	0.6	10000.0
WZ-7043	CDK2	100.0	10000.0
AZD-6482	CSNK1A1	63.0	10000.0
CP466722	SIK3	83.0	10000.0
Sorafenib	S6K1	63.0	10000.0
Torin2	TSSK1	100.0	10000.0
KIN001-127	MET	29.0	10000.0
HG-9-91-01	RIOK3	18.0	10000.0
Sigma A6730	DYRK1B	88.0	10000.0
HG-14-10-04	MST2	33.0	10000.0
ERK5-IN-1	CDK15	100.0	1000.0
XMD13-2	ACVR1B	59.0	10000.0
KIN001-021	TRKA	100.0	1000.0
JNK-IN-8	ERN1	73.0	1000.0
WH-4-023	EPHA4	0.0	10000.0
QL-X-138	FLT3(N841I)	1.6	10000.0
5z-7-oxozeaenol	LYN	88.0	10000.0
THZ1	SRPK1	0.6	10000.0
Dabrafenib	MYO3A	57.0	10000.0
Taselisib	KIT(D816V)	100.0	1000.0
GW-5074	IRAK1	100.0	10000.0
Seliciclib	TIE1	100.0	10000.0
ALW-II-38-3	MLK2	100.0	10000.0
XMD8-92	CLK2	100.0	10000.0
WZ4002	SRMS	100.0	10000.0
Momelotinib	TRKA	82.0	10000.0
QL-X-138	RIPK1	100.0	10000.0
THZ1	STK33	2.8	10000.0
AZD7762	EPHA4	3.4	10000.0
Ribociclib	MLCK	96.0	1000.0
WZ4003	LTK	4.4	1000.0
Torin1	DAPK2	93.0	10000.0
BI-D1870	CDKL3	11.0	10000.0
XMD14-99	MK12	100.0	10000.0
BMS345541	FAK2	100.0	10000.0
CGP60474	M3K13	100.0	10000.0
SCH772984	RIOK3	20.0	1000.0
PHA-793887	KIT	76.0	10000.0
Canertinib	EPHB3	100.0	1000.0
Dabrafenib	S6K1	8.4	10000.0
THZ1	CDKL5	0.8	10000.0
JNK-IN-5A	NUAK1	77.0	10000.0
Pictilisib	MINK	72.0	1000.0
XMD13-2	NEK2	80.0	10000.0
Neratinib	ERN1	80.0	10000.0
MLN8054	STK16	30.0	10000.0
Dactolisib	EGFR(L858R)	100.0	1000.0
Palbociclib	KPCE	76.0	1000.0
GSK461364	LKB1	90.0	10000.0
Vemurafenib	MAP3K3	82.0	10000.0
Barasertib	MP2K4	100.0	10000.0
AG1478	FYN	81.0	10000.0
XMD8-85	ALK	16.0	10000.0
WZ3105	CSNK2A1	54.0	10000.0
WZ-7043	GRK4	100.0	10000.0
GW-5074	CAMKK2	9.0	10000.0
NG25	TIE2	0.0	10000.0
GSK429286A	ERK5	82.0	10000.0
Lapatinib	CDK11	82.0	10000.0
WZ-7043	ABL1(E255K)	100.0	10000.0
Dabrafenib	STK36	0.4	10000.0
BMS345541	M3K12	84.0	10000.0
GSK429286A	CHEK1	100.0	10000.0
Buparlisib	PIK3CA(E545K)	0.1	1000.0
ZG-10	MLK1	78.0	10000.0
OTSSP167	MST3	2.3	10000.0
Sigma A6730	LKB1	94.0	10000.0
Omipalisib	DCAMKL2	78.0	10000.0
HG-14-8-02	MAP3K4	100.0	10000.0
XMD8-92	PHKG2	100.0	10000.0
AZD7762	DYRK2	26.0	10000.0
JNK-IN-5A	LATS1	93.0	10000.0
Omipalisib	ICK	78.0	10000.0
TAK-715	DMPK2	15.0	10000.0
PHA-767491	FRK	78.0	10000.0
QL-XI-92	CDK11	96.0	10000.0
PLX-4720	LKB1	79.0	10000.0
Neratinib	BMX	78.0	10000.0
CH5424802	ERK3	100.0	1000.0
Torin1	SIK2	23.0	10000.0
HG-14-10-04	KIT(L576P)	0.3	10000.0
AZ-628	ABL1(H396P)-nonphosphorylated	0.4	10000.0
KIN001-220	FLT3(D835H)	0.6	10000.0
5z-7-oxozeaenol	FLT3-autoinhibited	100.0	10000.0
BMX-IN-1	TAOK3	100.0	10000.0
A443654	NDR2	100.0	10000.0
AZD4547	M4K3	2.0	10000.0
Ibrutinib	NUAK1	100.0	1000.0
WZ4003	RIPK2	100.0	1000.0
Seliciclib	MAPKAPK2	100.0	10000.0
Alpelisib	S6K1	96.0	1000.0
WZ3105	ACVR2A	97.0	10000.0
PHA-793887	NEK1	100.0	10000.0
NVP-TAE684	MP2K4	1.6	1000.0
BMX-IN-1	MYLK2	100.0	10000.0
Seliciclib	TXK	100.0	10000.0
JNK-IN-11	JAK1(JH2domain-pseudokinase)	79.0	1000.0
ERK5-IN-1	HIPK3	92.0	1000.0
Dinaciclib	PIM2	99.0	10000.0
A443654	MK01	100.0	10000.0
Ceritinib	PIK3CA(E545K)	85.0	1000.0
Torkinib	BRAF	5.8	10000.0
TAK-715	SRC	14.0	10000.0
BMS345541	DAPK3	53.0	10000.0
WYE-125132	PHKG1	100.0	10000.0
KU63794	MK01	100.0	10000.0
PLX-4720	ALK	14.0	10000.0
NVP-TAE684	SRPK3	1.7	1000.0
AZ-628	TAOK3	100.0	10000.0
Vemurafenib	STK35	100.0	10000.0
Dactolisib	BRAF	100.0	1000.0
Baricitinib	RSK4(Kin.Dom.2-C-terminal)	0.9	10000.0
AZ-628	PIK3CA(E542K)	100.0	10000.0
AZD7762	CDC2L5	100.0	10000.0
Sigma A6730	CSF1R	99.0	10000.0
BS-181	CDC2L5	91.0	10000.0
XMD-12	PIK3CA(E545A)	100.0	1000.0
CGP60474	ACVR2A	100.0	10000.0
Omipalisib	KPCD1	100.0	10000.0
HG-6-64-01	MP2K1	74.0	10000.0
WZ4003	EPHA3	100.0	1000.0
Lapatinib	MP2K5	12.0	10000.0
Baricitinib	STK16	4.3	10000.0
R406	DDR2	2.3	1000.0
GSK461364	TTK	95.0	10000.0
SB590885	MK03	100.0	10000.0
BGJ398	ABL1(Y253F)-phosphorylated	72.0	1000.0
MPS-1-IN-1	TNK1	16.0	1000.0
KIN001-123	INSR	100.0	1000.0
(s)-CR8	PLK1	74.0	10000.0
Baricitinib	KIT(V559D)	40.0	10000.0
CGP60474	FER	100.0	10000.0
ZG-10	PAK1	90.0	10000.0
A443654	SIK2	100.0	10000.0
AZD 5438	PLK1	70.0	10000.0
AG1478	HIPK3	54.0	10000.0
TAK-715	TYK2(JH1domain-catalytic)	100.0	10000.0
SB590885	LIMK2	79.0	10000.0
XMD13-2	ULK1	100.0	10000.0
XMD11-50	CDK15	100.0	10000.0
Torin2	CLK3	71.0	10000.0
AZ-628	EPHB1	1.0	10000.0
PD173074	RPS6KA6(Kin.Dom.1)	100.0	10000.0
RO-3306	RPS6KA5(Kin.Dom.1-N-terminal)	93.0	10000.0
JNK-IN-8	CDKL2	82.0	1000.0
Alpelisib	MAPKAPK2	100.0	1000.0
SB590885	BRSK2	88.0	10000.0
MPS-1-IN-1	MP2K2	100.0	1000.0
MPS-1-IN-1	DCAMKL2	100.0	1000.0
OTSSP167	CDC2L5	52.0	10000.0
Torin1	CTK	97.0	10000.0
Vemurafenib	PFPK5(P.falciparum)	97.0	10000.0
GSK461364	ERK4	100.0	10000.0
Ibrutinib	KKCC1	90.0	1000.0
CP466722	MK03	67.0	10000.0
CP724714	SIK2	84.0	10000.0
Baricitinib	NEK1	41.0	10000.0
(s)-CR8	TNNI3K	81.0	10000.0
SCH772984	HIPK1	79.0	1000.0
Dactolisib	ABL1(T315I)	100.0	1000.0
Taselisib	PKNB(M.tuberculosis)	74.0	1000.0
Pictilisib	SRPK3	94.0	1000.0
CG-930	KGP1	100.0	10000.0
CP724714	DYRK1A	59.0	10000.0
Torin2	TYK2(JH2domain-pseudokinase)	6.3	10000.0
Taselisib	JNK1	88.0	1000.0
PD173074	MP2K3	100.0	10000.0
Canertinib	PIK3CA(E545K)	100.0	1000.0
ALW-II-38-3	KPCE	100.0	10000.0
CH5424802	MAP4K4	24.0	1000.0
SP600125	RIOK2	100.0	10000.0
ZSTK474	DDR1	100.0	1000.0
Lapatinib	TYK2(JH2domain-pseudokinase)	71.0	10000.0
WYE-125132	SNARK	100.0	10000.0
PLX-4720	CAMK1G	76.0	10000.0
XMD11-50	EPHA1	100.0	10000.0
Sigma A6730	LRRK2	100.0	10000.0
Momelotinib	KIT(D816H)	65.0	10000.0
RO-3306	MAP3K14	60.0	10000.0
PHA-793887	MP2K6	69.0	10000.0
Lapatinib	SIK3	69.0	10000.0
CP466722	MUSK	71.0	10000.0
QL-X-138	PIK3CB	62.0	10000.0
GW-5074	CDK8	62.0	10000.0
GW843682X	NEK5	36.0	10000.0
Taselisib	SgK110	97.0	1000.0
XMD8-85	TNNI3K	100.0	10000.0
Torin1	MAK	68.0	10000.0
QL-XI-92	MK03	97.0	10000.0
Seliciclib	ERK5	100.0	10000.0
Torin1	M4K1	30.0	10000.0
BGJ398	MYO3A	51.0	1000.0
Ceritinib	CDC2L5	92.0	1000.0
JWE-035	MKNK1	100.0	10000.0
XMD8-85	KGP2	100.0	10000.0
HG-5-113-01	CAMKK2	100.0	10000.0
NPK76-II-72-1	PAK4	100.0	10000.0
XMD16-144	MAP4K5	75.0	10000.0
AZD-6482	IKKE	85.0	10000.0
CP466722	IRAK4	5.8	10000.0
Ceritinib	MP2K3	58.0	1000.0
HG-14-8-02	KGP2	100.0	10000.0
Torkinib	EIF2AK1	93.0	10000.0
KU63794	BRSK2	98.0	10000.0
BMS-536924	EPHA3	6.4	1000.0
SP600125	CAMK1G	17.0	10000.0
KU63794	NIM1	97.0	10000.0
HG-6-64-01	MAPKAPK2	100.0	10000.0
XMD11-85h	IKKE	100.0	10000.0
XMD16-144	SGK3	90.0	10000.0
AZD7762	KIT(V559D)	0.0	10000.0
SB590885	CDK9	100.0	10000.0
KU63794	KPCD1	91.0	10000.0
CP466722	CSNK1D	2.8	10000.0
JWE-035	M3K12	49.0	10000.0
Dabrafenib	PIP5K2B	94.0	10000.0
AZD 5438	EGFR	67.0	10000.0
Alpelisib	CDK14	97.0	1000.0
PLX-4720	EGFR(S752-I759del)	73.0	10000.0
AZD4547	EGFR(S752-I759del)	100.0	10000.0
CGP60474	CIT	100.0	10000.0
HG-9-91-01	IKKE	100.0	10000.0
GW-5074	TGFBR2	56.0	10000.0
Sorafenib	ABL1(Q252H)-nonphosphorylated	1.3	10000.0
Dabrafenib	DYRK1A	52.0	10000.0
Ribociclib	TYRO3	100.0	1000.0
Torin2	GSK3B	100.0	10000.0
AS-252424	CDK9	96.0	10000.0
5z-7-oxozeaenol	PIK3C2G	93.0	10000.0
PHA-793887	LTK	100.0	10000.0
Pictilisib	STK33	93.0	1000.0
CG-930	M3K6	88.0	10000.0
AG1478	CSK	62.0	10000.0
Buparlisib	KIT(V559D,T670I)	100.0	1000.0
JW-7-24-1	ACVR2B	100.0	10000.0
Sigma A6730	EGFR(G719S)	83.0	10000.0
GSK429286A	MKNK1	100.0	10000.0
WH-4-023	PAK7	82.0	10000.0
PLX-4720	KIT	0.1	10000.0
ZM-447439	CLK3	100.0	10000.0
AG1478	KIT	31.0	10000.0
XMD11-50	TAOK2	65.0	10000.0
BX-912	RSK4(Kin.Dom.1-N-terminal)	0.6	10000.0
WZ4003	RIPK1	14.0	1000.0
Seliciclib	M4K1	96.0	10000.0
QL-XI-92	MST1R	99.0	10000.0
ALW-II-49-7	LIMK2	100.0	10000.0
HG-9-91-01	MYLK2	67.0	10000.0
Dinaciclib	CDK4-cyclinD1	0.1	10000.0
SB590885	ABL1(T315I)-nonphosphorylated	5.4	10000.0
SP600125	JAK3(Kin.Dom.2)	100.0	10000.0
WZ-4-145	RPS6KA1(Kin.Dom.2)	100.0	10000.0
JNK-9L	LATS1	100.0	10000.0
Torin2	SBK1	100.0	10000.0
BS-181	MINK	47.0	10000.0
Canertinib	PAK1	100.0	1000.0
Baricitinib	PIK3CA(H1047Y)	60.0	10000.0
PLX-4720	CDK7	69.0	10000.0
PHA-793887	DDR1	100.0	10000.0
WZ3105	KGP2	96.0	10000.0
Momelotinib	WEE2	100.0	10000.0
XMD11-85h	NEK9	100.0	10000.0
HG-14-10-04	NEK9	2.6	10000.0
XMD11-50	DRAK1	100.0	10000.0
Palbociclib	BRSK1	98.0	1000.0
HG-6-64-01	CHK2	66.0	10000.0
JWE-035	NUAK1	3.0	10000.0
MPS-1-IN-1	MYLK4	100.0	1000.0
HG-5-88-01	MK12	100.0	10000.0
XMD16-144	KIT(V559D,T670I)	65.0	10000.0
KU63794	GAK	95.0	10000.0
Ibrutinib	WEE1	93.0	1000.0
BS-181	DYRK1B	2.2	10000.0
WYE-125132	AURKC	86.0	10000.0
TAK-715	LIMK2	94.0	10000.0
JNK-IN-11	TXK	24.0	1000.0
Ceritinib	CDK9	88.0	1000.0
HG-14-10-04	CSNK1A1	32.0	10000.0
MPS-1-IN-1	SIK1	100.0	1000.0
KIN001-111	RIOK2	100.0	1000.0
KIN001-021	M4K3	100.0	1000.0
MPS-1-IN-1	YANK2	100.0	1000.0
PLX-4720	DAPK2	80.0	10000.0
PD173074	M4K3	100.0	10000.0
JW-7-24-1	PIK3C2B	0.4	10000.0
CH5424802	MINK	36.0	1000.0
XMD11-50	MAP4K5	100.0	10000.0
HG-5-113-01	ACVRL1	100.0	10000.0
Dabrafenib	BRAF	0.0	10000.0
XMD8-92	ABL1(F317L)	100.0	10000.0
NG25	TNK1	0.5	10000.0
Baricitinib	RET	0.7	10000.0
Barasertib	CDK4-cyclinD3	100.0	10000.0
XMD11-50	PIK3CA(E545K)	100.0	10000.0
CH5424802	PIK3CA(E545A)	100.0	1000.0
XMD-12	MRCKB	100.0	1000.0
Taselisib	TGFBR2	100.0	1000.0
Dactolisib	RIOK1	100.0	1000.0
KIN001-021	MAP3K4	100.0	1000.0
ZM-447439	TNK1	69.0	10000.0
TAK-715	EPHB3	81.0	10000.0
OTSSP167	BMPR1B	0.1	10000.0
XMD11-50	ERBB4	100.0	10000.0
RO-3306	MST2	84.0	10000.0
Torin1	PAK7	87.0	10000.0
5z-7-oxozeaenol	ABL1(M351T)-phosphorylated	100.0	10000.0
Barasertib	PLK2	93.0	10000.0
HG-14-8-02	BRAF(V600E)	90.0	10000.0
MRT67307	PIK3CA(H1047L)	100.0	10000.0
WZ-7043	CAMK1	100.0	10000.0
ZSTK474	BRAF	34.0	1000.0
Sigma A6730	MK09	91.0	10000.0
CGP74514A	CDK4-cyclinD1	0.3	10000.0
PLX-4720	MP2K1	0.8	10000.0
JNK-IN-5A	CDKL3	82.0	10000.0
Crizotinib	ITK	33.0	10000.0
Ribociclib	INSRR	85.0	1000.0
Sigma A6730	CDK14	100.0	10000.0
R406	NEK9	0.7	1000.0
NU7441	CDK15	85.0	10000.0
WYE-125132	JAK1(JH2domain-pseudokinase)	83.0	10000.0
THZ1	INSRR	0.0	10000.0
AZD-6482	ULK1	91.0	10000.0
Barasertib	KPCL	100.0	10000.0
KIN001-111	ABL2	0.8	1000.0
KIN001-220	BIKE	0.1	10000.0
NVP-TAE684	EGFR(L747-E749del,A750P)	0.0	1000.0
AZD7762	EGFR(G719S)	0.0	10000.0
ZG-10	MAP3K15	56.0	10000.0
ALW-II-49-7	BMPR1B	100.0	10000.0
QL-XII-47	ACVRL1	100.0	1000.0
GSK429286A	DCAMKL2	87.0	10000.0
GW-5074	DCAMKL3	100.0	10000.0
BMS345541	WEE1	100.0	10000.0
R406	EGFR(G719C)	100.0	1000.0
HG-5-88-01	MAPKAPK2	100.0	10000.0
Canertinib	SRMS	100.0	1000.0
A443654	TNK2	100.0	10000.0
Torin2	HIPK1	79.0	10000.0
HG-6-64-01	PRP4	12.0	10000.0
Crizotinib	EGFR(S752-I759del)	73.0	10000.0
WZ3105	ACVR1	100.0	10000.0
Momelotinib	PKAC-beta	36.0	10000.0
KIN001-220	RIPK1	96.0	10000.0
PD0325901	KC1G1	61.0	10000.0
NU7441	RIOK1	100.0	10000.0
BS-181	TAOK2	95.0	10000.0
Torin1	MAST1	93.0	10000.0
5z-7-oxozeaenol	M3K13	100.0	10000.0
MRT67307	MK14	100.0	10000.0
JWE-035	GRK4	56.0	10000.0
KIN001-220	MRCKB	100.0	10000.0
A443654	FYN	100.0	10000.0
NU7441	FES	93.0	10000.0
AZD7762	INSRR	22.0	10000.0
HG-14-8-02	ABL1(F317I)-nonphosphorylated	71.0	10000.0
ZM-447439	JAK2(JH1domain-catalytic)	72.0	10000.0
Palbociclib	MARK4	98.0	1000.0
R406	CAMK2B	33.0	1000.0
AZD-6482	PIP5K1A	100.0	10000.0
Ibrutinib	PIK3CA(E545A)	65.0	1000.0
(s)-CR8	PIK4CB	88.0	10000.0
ERK5-IN-1	TGFBR2	100.0	1000.0
HG-9-91-01	GCN2(Kin.Dom.2,S808G)	96.0	10000.0
BS-181	CSNK2A1	75.0	10000.0
Ibrutinib	CSK	0.5	1000.0
JNK-IN-5A	MTOR	100.0	10000.0
BS-181	PIP5K2B	100.0	10000.0
AZ-628	JAK2(JH1domain-catalytic)	100.0	10000.0
ERK5-IN-1	KPCD3	100.0	1000.0
XMD11-50	MET(Y1235D)	100.0	10000.0
WH-4-023	HIPK4	8.8	10000.0
THZ1	CDC2L2	72.0	10000.0
Torin1	MYLK4	83.0	10000.0
KIN001-111	SLK	6.8	1000.0
GSK1059615	STK35	49.0	10000.0
Dabrafenib	STK33	27.0	10000.0
SCH772984	CDKL5	100.0	1000.0
CGP74514A	FLT3-autoinhibited	5.4	10000.0
AZ-628	ICK	100.0	10000.0
HG-14-8-02	SGK1	43.0	10000.0
HG-14-8-02	PIK3CA(E545A)	83.0	10000.0
(s)-CR8	MST1	93.0	10000.0
XMD16-144	MK09	100.0	10000.0
JNK-9L	RIOK3	3.2	10000.0
Neratinib	JNK1	16.0	10000.0
Taselisib	LIMK1	100.0	1000.0
Buparlisib	GAK	100.0	1000.0
XMD-12	TESK1	97.0	1000.0
PD0325901	CDK8	100.0	10000.0
AZD7762	PFPK5(P.falciparum)	100.0	10000.0
HG-9-91-01	KPCD1	1.2	10000.0
SCH772984	ABL1(F317I)-nonphosphorylated	100.0	1000.0
QL-XI-92	CDK4-cyclinD1	100.0	10000.0
KIN001-111	DDR1	27.0	1000.0
NVP-TAE684	DAPK2	12.0	1000.0
BMS-536924	ROS1	0.9	1000.0
KIN001-111	NUAK1	100.0	1000.0
AZ-628	PAK2	100.0	10000.0
TGX221	MST2	100.0	1000.0
BGJ398	AMPK-alpha1	83.0	1000.0
Alpelisib	EPHB2	97.0	1000.0
ALW-II-49-7	RET(V804L)	100.0	10000.0
Crizotinib	TNIK	51.0	10000.0
CH5424802	PGFRB	37.0	1000.0
PHA-793887	SNRK	100.0	10000.0
AZD-6482	EGFR(G719C)	95.0	10000.0
WYE-125132	ADCK3	86.0	10000.0
Ceritinib	GAK	87.0	1000.0
WZ3105	TLK1	100.0	10000.0
Torin1	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
Dactolisib	RIPK4	100.0	1000.0
Torin1	PFCDPK1(P.falciparum)	36.0	10000.0
Dinaciclib	M3K6	90.0	10000.0
XMD14-99	CIT	94.0	10000.0
Lapatinib	YANK1	100.0	10000.0
MPS-1-IN-1	MLK1	100.0	1000.0
Buparlisib	ABL1(F317L)-phosphorylated	100.0	1000.0
OTSSP167	MK03	100.0	10000.0
QL-XI-92	MARK3	67.0	10000.0
CGP60474	PIK3CA	100.0	10000.0
QL-XII-47	INSR	75.0	1000.0
CP724714	FER	100.0	10000.0
XMD8-85	TNK1	0.4	10000.0
NPK76-II-72-1	PTK6	100.0	10000.0
WH-4-023	TRPM6	100.0	10000.0
JNK-9L	FLT3(K663Q)	17.0	10000.0
CGP74514A	PKN1	9.4	10000.0
KIN001-220	EPHB2	93.0	10000.0
WZ-7043	CAMKK2	100.0	10000.0
HG-6-64-01	FGFR3(G697C)	2.5	10000.0
XMD14-99	MLTK	100.0	10000.0
HG-6-64-01	FLT3(ITD)	0.4	10000.0
Omipalisib	ANKK1	76.0	10000.0
XMD13-2	HIPK3	62.0	10000.0
WYE-125132	CAMKK2	100.0	10000.0
WZ4002	M4K1	34.0	10000.0
Neratinib	CDC2L1	97.0	10000.0
CGP74514A	DAPK3	9.0	10000.0
GSK461364	NEK1	41.0	10000.0
JW-7-24-1	BMPR1A	4.8	10000.0
Taselisib	BMX	100.0	1000.0
Momelotinib	BMPR1B	3.6	10000.0
Dinaciclib	ACVR2B	82.0	10000.0
AG1478	DDR2	42.0	10000.0
AZ-628	ABL1(F317I)-nonphosphorylated	7.3	10000.0
HG-6-64-01	MYLK	90.0	10000.0
WYE-125132	EGFR(L747-S752del,P753S)	62.0	10000.0
Palbociclib	FLT3-autoinhibited	100.0	1000.0
MPS-1-IN-1	WEE1	100.0	1000.0
BMS345541	MAP3K15	100.0	10000.0
QL-XI-92	CDK16	95.0	10000.0
Vemurafenib	ALK	62.0	10000.0
GSK1059615	MYLK	19.0	10000.0
QL-XII-47	FRK	100.0	1000.0
PD173074	TNK2	100.0	10000.0
RO-3306	CAMK2G	75.0	10000.0
TAK-715	PIK3CA(Q546K)	32.0	10000.0
XMD16-144	BMPR2	84.0	10000.0
Sorafenib	MAPKAPK2	100.0	10000.0
KIN001-021	RPS6KA2(Kin.Dom.2)	100.0	1000.0
MLN8054	YSK4	62.0	10000.0
AZD-6482	MK12	94.0	10000.0
TGX221	INSRR	100.0	1000.0
BGJ398	LIMK1	92.0	1000.0
BS-181	SRPK2	93.0	10000.0
KU63794	CSNK1D	79.0	10000.0
Ribociclib	PLK3	81.0	1000.0
Momelotinib	KGP1	100.0	10000.0
PHA-767491	MYLK4	22.0	10000.0
Ibrutinib	CDK3	95.0	1000.0
Torin1	ICK	100.0	10000.0
ZM-447439	GCN2(Kin.Dom.2,S808G)	43.0	10000.0
Buparlisib	TIE2	100.0	1000.0
BI-2536	PGFRB	100.0	10000.0
AZ-628	LCK	0.7	10000.0
PD0325901	PIK3CA(M1043I)	42.0	10000.0
Torin2	MAPKAPK5	100.0	10000.0
Sigma A6730	KPCI	79.0	10000.0
AS-252424	ACVRL1	100.0	10000.0
WZ-4-145	KPCE	100.0	10000.0
QL-XII-47	RET	100.0	1000.0
ERK5-IN-1	ACVR1	100.0	1000.0
R406	KPCD2	100.0	1000.0
BX-912	RSK2(Kin.Dom.1-N-terminal)	0.5	10000.0
WZ3105	IKKB	76.0	10000.0
Baricitinib	PTK6	77.0	10000.0
Sorafenib	MYLK2	43.0	10000.0
QL-XII-47	KPCT	100.0	1000.0
Ibrutinib	CHEK1	100.0	1000.0
ERK5-IN-1	IRAK4	100.0	1000.0
HG-14-10-04	FAK1	0.0	10000.0
WYE-125132	M3K6	80.0	10000.0
QL-X-138	GSK3B	84.0	10000.0
GW-5074	RPS6KA4(Kin.Dom.2-C-terminal)	47.0	10000.0
Ceritinib	MET(M1250T)	77.0	1000.0
Barasertib	FER	100.0	10000.0
XMD14-99	GAK	73.0	10000.0
Vemurafenib	PRKR	81.0	10000.0
ZG-10	TYK2(JH2domain-pseudokinase)	0.2	10000.0
KIN001-111	ERBB4	1.2	1000.0
(s)-CR8	HIPK4	77.0	10000.0
AG1478	CSNK1A1	35.0	10000.0
BMX-IN-1	MAPKAPK5	100.0	10000.0
HG-5-88-01	FES	2.3	10000.0
JNK-9L	KPCE	100.0	10000.0
ZSTK474	FLT3(N841I)	100.0	1000.0
ZG-10	EGFR(S752-I759del)	88.0	10000.0
Ribociclib	MAP3K1	100.0	1000.0
WZ-4-145	YES	5.2	10000.0
PHA-767491	AKT1	56.0	10000.0
SCH772984	MST3	100.0	1000.0
WH-4-023	LOK	0.0	10000.0
WZ4003	CSNK2A1	100.0	1000.0
WH-4-023	PLK4	37.0	10000.0
KU63794	PIK3CA(E545A)	2.4	10000.0
CG-930	EPHB2	72.0	10000.0
PD0325901	LIMK2	100.0	10000.0
WZ-7043	SLK	100.0	10000.0
Ibrutinib	PIM3	94.0	1000.0
JNK-IN-8	MAK	100.0	1000.0
XMD11-85h	ACVR1B	100.0	10000.0
Palbociclib	BTK	100.0	1000.0
AZD4547	TNK1	12.0	10000.0
CG-930	LIMK1	35.0	10000.0
NVP-TAE684	CDK14	100.0	1000.0
Sigma A6730	PLK2	88.0	10000.0
AS-252424	SRC	100.0	10000.0
AZD4547	KPCE	100.0	10000.0
PHA-767491	RPS6KA4(Kin.Dom.2-C-terminal)	0.2	10000.0
JNK-IN-11	KIT(V559D,T670I)	4.0	1000.0
JNK-IN-5A	EIF2AK1	100.0	10000.0
PHA-793887	EPHA8	100.0	10000.0
PHA-793887	MARK2	18.0	10000.0
XMD11-50	PGFRB	100.0	10000.0
CG-930	ABL1(Q252H)-phosphorylated	36.0	10000.0
JWE-035	YES	6.6	10000.0
AZD 5438	DCAMKL3	2.4	10000.0
Palbociclib	LATS2	100.0	1000.0
BX-912	YSK4	0.0	10000.0
Sorafenib	CAMK1D	96.0	10000.0
PLX-4720	HIPK3	46.0	10000.0
ALW-II-49-7	JAK1(Kin.Dom.2)	100.0	10000.0
Momelotinib	CTK	85.0	10000.0
THZ1	RIPK4	2.4	10000.0
JNK-IN-11	NEK7	100.0	1000.0
ZSTK474	M4K3	100.0	1000.0
CGP60474	FLT3	100.0	10000.0
Neratinib	KIT(A829P)	100.0	10000.0
Torin2	PTK6	100.0	10000.0
ALW-II-38-3	TYK2(JH2domain-pseudokinase)	100.0	10000.0
RO-3306	KPCT	100.0	10000.0
KIN001-021	PAK7/PAK5	100.0	1000.0
Baricitinib	INSRR	93.0	10000.0
WZ4003	TAOK1	100.0	1000.0
WZ3105	DAPK3	23.0	10000.0
QL-XI-92	LIMK1	100.0	10000.0
Taselisib	ABL1(Y253F)-phosphorylated	100.0	1000.0
TAK-715	RIOK2	92.0	10000.0
AS-252424	TEC	100.0	10000.0
PLX-4720	VRK2	77.0	10000.0
Omipalisib	PIK3CA(I800L)	17.0	10000.0
WH-4-023	CLK4	100.0	10000.0
Sorafenib	PKNB(M.tuberculosis)	100.0	10000.0
JNK-9L	TTK	73.0	10000.0
Dactolisib	ACVRL1	100.0	1000.0
XMD14-99	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
NU7441	EPHA7	85.0	10000.0
AZD4547	KKCC1	2.0	10000.0
CP724714	EGFR(E746-A750del)	4.6	10000.0
BGJ398	MRCKA	91.0	1000.0
XMD-12	ABL1(M351T)-phosphorylated	3.0	1000.0
HG-14-8-02	FLT3	18.0	10000.0
PHA-767491	CSNK1E	0.1	10000.0
GW-5074	DAPK3	2.6	10000.0
ERK5-IN-1	MK14	94.0	1000.0
NU7441	RSK2(Kin.Dom.1-N-terminal)	84.0	10000.0
XMD16-144	PIK3CA(E542K)	39.0	10000.0
WZ3105	RSK1(Kin.Dom.2-C-terminal)	67.0	10000.0
Sorafenib	SgK110	94.0	10000.0
GW843682X	KPCE	100.0	10000.0
Buparlisib	PKMYT1	100.0	1000.0
Palbociclib	KIT(L576P)	100.0	1000.0
JW-7-24-1	RPS6KA3(Kin.Dom.1)	100.0	10000.0
CGP60474	MAST1	100.0	10000.0
JW-7-24-1	CAMK1	100.0	10000.0
SB590885	GAK	25.0	10000.0
WYE-125132	TXK	94.0	10000.0
CP466722	FGFR1	65.0	10000.0
(s)-CR8	BMPR1A	97.0	10000.0
AZD4547	SIK2	15.0	10000.0
Dabrafenib	RPS6KA5(Kin.Dom.2-C-terminal)	92.0	10000.0
JNK-9L	CDC2L5	100.0	10000.0
CP724714	CLK2	75.0	10000.0
MLN8054	PIM1	71.0	10000.0
KIN001-021	VGFR2	100.0	1000.0
PD0325901	MYLK2	100.0	10000.0
Abemaciclib	PKN2	38.0	1000.0
5z-7-oxozeaenol	NDR1	75.0	10000.0
R406	FYN	1.0	1000.0
TGX221	PAK1	100.0	1000.0
ZG-10	PHKG2	56.0	10000.0
KU63794	MAK	100.0	10000.0
JWE-035	MYO3B	100.0	10000.0
KIN001-127	KIT(V559D,V654A)	100.0	10000.0
AZD4547	FES	8.6	10000.0
R406	AURKA	3.6	1000.0
Torin1	NEK5	5.8	10000.0
GSK1059615	GSK3A	71.0	10000.0
Sorafenib	PIK3CA(Q546K)	100.0	10000.0
Torin2	STK39	100.0	10000.0
JNK-9L	TESK1	54.0	10000.0
JWE-035	EPHA2	83.0	10000.0
(s)-CR8	NUAK1	85.0	10000.0
THZ1	KKCC1	22.0	10000.0
HG-5-113-01	NEK1	100.0	10000.0
ZSTK474	MK01	100.0	1000.0
Crizotinib	CDK8	100.0	10000.0
JNK-9L	ACVR1	23.0	10000.0
CH5424802	HCK	7.8	1000.0
Baricitinib	RSK4(Kin.Dom.1-N-terminal)	15.0	10000.0
KU63794	SRMS	98.0	10000.0
JNK-IN-11	ERK8	93.0	1000.0
JNK-9L	TLK2	65.0	10000.0
JNK-IN-5A	CSF1R-autoinhibited	84.0	10000.0
MRT67307	NEK2	55.0	10000.0
XMD11-50	KPCI	100.0	10000.0
MPS-1-IN-1	MP2K3	14.0	1000.0
NG25	EPHB2	11.0	10000.0
HG-14-8-02	MKNK1	6.8	10000.0
ERK5-IN-1	ABL1(H396P)-nonphosphorylated	86.0	1000.0
BMS-536924	MST4	3.6	1000.0
BI-D1870	SRPK3	7.1	10000.0
NU7441	SYK	100.0	10000.0
Torkinib	TXK	3.0	10000.0
AZD-6482	CSNK1A1L	100.0	10000.0
AZD 5438	ABL1(M351T)-phosphorylated	18.0	10000.0
HG-9-91-01	NLK	26.0	10000.0
KU63794	CAMK2G	87.0	10000.0
AZD7762	TAOK1	4.8	10000.0
BGJ398	IKKE	77.0	1000.0
Neratinib	TRKA	77.0	10000.0
BS-181	MLK1	100.0	10000.0
BGJ398	PKAC-alpha	91.0	1000.0
Ceritinib	EGFR(L858R)	50.0	1000.0
Palbociclib	DCLK1	80.0	1000.0
JNK-IN-11	GSK3A	38.0	1000.0
HG-5-88-01	ACVR1	100.0	10000.0
Abemaciclib	MRCKA	76.0	1000.0
Momelotinib	RET(M918T)	78.0	10000.0
XMD14-99	PAK6	55.0	10000.0
KIN001-021	LOK	100.0	1000.0
A443654	MAP3K4	100.0	10000.0
WZ3105	CDKL1	100.0	10000.0
BMX-IN-1	PDPK1	100.0	10000.0
BMX-IN-1	PAK1	62.0	10000.0
Sorafenib	TLK2	91.0	10000.0
R406	MKNK1	0.2	1000.0
HG-14-10-04	KCC2D	3.0	10000.0
ALW-II-49-7	MELK	100.0	10000.0
SP600125	YES	100.0	10000.0
HG-14-8-02	MERTK	70.0	10000.0
XMD13-2	CAMK2B	84.0	10000.0
XMD8-92	PLK1	100.0	10000.0
NU7441	MK09	39.0	10000.0
Dinaciclib	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
Abemaciclib	ERK8	0.1	1000.0
KIN001-127	PLK1	100.0	10000.0
Sigma A6730	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
BMX-IN-1	RET(V804L)	100.0	10000.0
AZD-6482	MYO3A	97.0	10000.0
JNK-IN-8	MLCK	100.0	1000.0
CG-930	CDC2L5	90.0	10000.0
CGP60474	DMPK	100.0	10000.0
NG25	ANKK1	23.0	10000.0
Seliciclib	CSNK1G3	22.0	10000.0
AG1478	PIM3	54.0	10000.0
OTSSP167	AMPK-alpha1	0.5	10000.0
XMD-12	TYK2(JH2domain-pseudokinase)	71.0	1000.0
PD0325901	NEK2	70.0	10000.0
JNK-9L	ERK3	1.0	10000.0
Ribociclib	MYLK2	100.0	1000.0
ERK5-IN-1	NDR2	100.0	1000.0
NU7441	CDC2L1	95.0	10000.0
SP600125	CDK5	100.0	10000.0
XMD11-85h	CAMK1D	100.0	10000.0
GSK1059615	FLT3(N841I)	39.0	10000.0
AZD-6482	AURKC	93.0	10000.0
Pictilisib	PIK3CA(E545K)	0.0	1000.0
Crizotinib	NEK6	27.0	10000.0
Ceritinib	RSK2(Kin.Dom.1-N-terminal)	29.0	1000.0
KIN001-021	CSNK1E	100.0	1000.0
Taselisib	TIE2	92.0	1000.0
Torin1	BRSK2	76.0	10000.0
Sigma A6730	INSR	64.0	10000.0
Barasertib	JAK3(JH1domain-catalytic)	87.0	10000.0
Omipalisib	NEK11	62.0	10000.0
AS-252424	RIPK1	95.9	10000.0
AS-252424	GCN2(Kin.Dom.2,S808G)	76.5	10000.0
PHA-793887	NEK10	90.0	10000.0
Vemurafenib	AKT3	100.0	10000.0
CG-930	GRK4	98.0	10000.0
ZM-447439	EPHA5	100.0	10000.0
Dactolisib	PLK1	100.0	1000.0
AZ-628	M3K6	100.0	10000.0
BX-912	PAK4	4.0	10000.0
ZM-447439	PAK7	94.0	10000.0
AS-252424	MK09	79.7	10000.0
HG-9-91-01	NEK2	62.0	10000.0
Dinaciclib	PIK3CD	92.0	10000.0
HG-14-8-02	EPHB4	100.0	10000.0
XMD14-99	FLT4	100.0	10000.0
JNK-IN-5A	DYRK1B	89.0	10000.0
Barasertib	FLT3	0.4	10000.0
Crizotinib	PIP5K1A	0.1	10000.0
SB590885	ITK	98.0	10000.0
MLN8054	CSNK1A1L	97.0	10000.0
Torkinib	PIP5K1C	9.8	10000.0
ALW-II-38-3	M3K6	100.0	10000.0
A443654	YANK3	100.0	10000.0
XMD14-99	RSK4(Kin.Dom.2-C-terminal)	28.0	10000.0
AZ-628	TSSK1	79.0	10000.0
QL-XII-47	PHKG1	100.0	1000.0
CG-930	AURKC	100.0	10000.0
WH-4-023	AKT1	100.0	10000.0
JNK-IN-8	CAMKK2	93.0	1000.0
Omipalisib	FLT3(R834Q)	88.0	10000.0
Alpelisib	RPS6KA4(Kin.Dom.1-N-terminal)	81.0	1000.0
XMD8-92	TRKB	100.0	10000.0
XMD14-99	STK39	66.0	10000.0
WZ4002	CLK4	12.0	10000.0
ZG-10	CSF1R	100.0	10000.0
KIN001-127	PAK2	100.0	10000.0
QL-X-138	EPHA5	100.0	10000.0
JNK-9L	EGFR(T790M)	86.0	10000.0
HG-14-8-02	TRKA	92.0	10000.0
Pictilisib	KGP1	65.0	1000.0
Baricitinib	STK36	66.0	10000.0
HG-5-113-01	SIK1	11.0	10000.0
Canertinib	SYK	100.0	1000.0
A443654	CDKL2	5.2	10000.0
HG-9-91-01	FGFR1	0.2	10000.0
KIN001-123	PIP5K2B	100.0	1000.0
Ribociclib	PFCDPK1(P.falciparum)	100.0	1000.0
ALW-II-38-3	ACVR1B	100.0	10000.0
WZ-4-145	M4K3	7.4	10000.0
OTSSP167	ABL1(H396P)-nonphosphorylated	5.6	10000.0
WH-4-023	MYLK4	100.0	10000.0
QL-XI-92	STK16	100.0	10000.0
QL-XII-47	PDPK1	94.0	1000.0
PHA-793887	AMPK-alpha1	58.0	10000.0
Sigma A6730	MAP3K14	80.0	10000.0
Ibrutinib	YSK1	96.0	1000.0
AZ-628	GCN2(Kin.Dom.2,S808G)	85.0	10000.0
AZD7762	RIOK2	48.0	10000.0
Pictilisib	FLT3(ITD)	79.0	1000.0
Buparlisib	EPHA7	100.0	1000.0
Crizotinib	CSNK1E	100.0	10000.0
Lapatinib	CDK5	100.0	10000.0
Sigma A6730	M3K12	100.0	10000.0
PHA-793887	PIK3CA(E542K)	100.0	10000.0
Neratinib	FGFR2	96.0	10000.0
Canertinib	DAPK2	100.0	1000.0
BMX-IN-1	PKNB(M.tuberculosis)	90.0	10000.0
PD0325901	JAK1(JH2domain-pseudokinase)	100.0	10000.0
Torin1	CDK4-cyclinD1	100.0	10000.0
QL-X-138	PGFRA	21.0	10000.0
RO-3306	PIK3CG	15.0	10000.0
THZ1	STK16	5.3	10000.0
RO-3306	MK03	98.0	10000.0
Ceritinib	ERBB2	100.0	1000.0
Seliciclib	DRAK1	92.0	10000.0
CP466722	LIMK2	20.0	10000.0
HG-5-88-01	EPHB3	100.0	10000.0
XMD14-99	PIP5K1C	85.0	10000.0
Ceritinib	MLK3	87.0	1000.0
Dinaciclib	CAMK2A	88.0	10000.0
Dactolisib	CDKL5	100.0	1000.0
Ibrutinib	CSNK1E	42.0	1000.0
WZ3105	NEK4	100.0	10000.0
GSK429286A	PIK3CA(E545A)	38.0	10000.0
KIN001-127	MAP3K3	100.0	10000.0
Torkinib	MK12	59.0	10000.0
OTSSP167	KIT(D816V)	1.0	10000.0
MLN8054	FGR	7.6	10000.0
Neratinib	EPHA6	99.0	10000.0
PD173074	CAMK2B	100.0	10000.0
JNK-IN-8	SNARK	70.0	1000.0
KIN001-127	KPCD3	100.0	10000.0
WZ-7043	M3K13	100.0	10000.0
Torin1	CSNK1A1L	81.0	10000.0
WZ4002	LCK	100.0	10000.0
NG25	MLK1	100.0	10000.0
Canertinib	PRKX	100.0	1000.0
Barasertib	ABL1-nonphosphorylated	3.4	10000.0
Torkinib	MP2K2	0.4	10000.0
GSK461364	PIK3CD	14.0	10000.0
Torin1	GRK7	100.0	10000.0
QL-XII-47	PRP4	79.0	1000.0
CG-930	BLK	98.0	10000.0
NG25	KKCC1	100.0	10000.0
BGJ398	LIMK2	100.0	1000.0
GW843682X	MK09	78.0	10000.0
XMD8-85	FLT3(K663Q)	100.0	10000.0
ZG-10	IRAK3	6.8	10000.0
BGJ398	GSK3A	100.0	1000.0
ZG-10	MET	100.0	10000.0
AS-252424	PTK6	100.0	10000.0
WYE-125132	IKKB	79.0	10000.0
KIN001-220	LATS2	100.0	10000.0
AS-252424	ROS1	99.8	10000.0
ALW-II-38-3	RPS6KA2(Kin.Dom.2)	100.0	10000.0
Seliciclib	BRAF(V600E)	100.0	10000.0
HG-14-10-04	SRMS	0.6	10000.0
HG-14-8-02	RAF1	100.0	10000.0
Omipalisib	TYK2(JH1domain-catalytic)	80.0	10000.0
AZD7762	LTK	0.3	10000.0
XMD16-144	TBK1	58.0	10000.0
AS-252424	ABL1(Q252H)	98.7	10000.0
Taselisib	TEC	100.0	1000.0
XMD11-85h	CLK1	100.0	10000.0
ZG-10	RIOK2	9.6	10000.0
WZ4003	ERK8	100.0	1000.0
BS-181	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
THZ1	M3K5	100.0	10000.0
Abemaciclib	STK16	2.6	1000.0
Baricitinib	CDK14	66.0	10000.0
OTSSP167	SRPK1	15.0	10000.0
Omipalisib	EPHA1	86.0	10000.0
CGP74514A	RIPK4	61.0	10000.0
AZD7762	NLK	81.0	10000.0
BI-2536	RPS6KA5(Kin.Dom.2)	14.0	10000.0
RO-3306	HIPK2	19.0	10000.0
Baricitinib	EGFR(L858R)	85.0	10000.0
Ribociclib	PIK3CA(H1047Y)	86.0	1000.0
SP600125	TLK2	30.0	10000.0
Seliciclib	PKAC-beta	100.0	10000.0
HG-9-91-01	KCC2D	100.0	10000.0
Torin1	JNK3	31.0	10000.0
WZ4003	PKMYT1	100.0	1000.0
Torkinib	BMPR1A	2.8	10000.0
CGP60474	CDK5	100.0	10000.0
HG-6-64-01	RIOK3	0.4	10000.0
WZ-4-145	MKNK1	100.0	10000.0
Palbociclib	TSSK3	100.0	1000.0
NG25	ROCK2	100.0	10000.0
SCH772984	KCC2D	82.0	1000.0
WH-4-023	LRRK2	78.0	10000.0
NG25	MARK1	100.0	10000.0
NG25	PIK3CA(E545K)	100.0	10000.0
Buparlisib	TRKC	100.0	1000.0
PD173074	CSNK2A1	100.0	10000.0
XMD8-92	TNIK	100.0	10000.0
BMS345541	LRRK2	97.0	10000.0
Lapatinib	STK36	83.0	10000.0
Barasertib	MST1	40.0	10000.0
JNK-IN-8	PGFRA	71.0	1000.0
AZD7762	TESK1	11.0	10000.0
Palbociclib	CDC2L1	99.0	1000.0
CP724714	ROCK2	100.0	10000.0
Lapatinib	PCTK3	100.0	10000.0
CP724714	CDK2	92.0	10000.0
AG1478	ERK3	33.0	10000.0
WH-4-023	NEK6	96.0	10000.0
Ribociclib	PLK4	99.0	1000.0
MPS-1-IN-1	NEK9	100.0	1000.0
RO-3306	EGFR	77.0	10000.0
AZD4547	STK36	70.0	10000.0
AS-252424	FRK	90.9	10000.0
HG-5-113-01	ROS1	0.9	10000.0
JNK-IN-5A	EPHB2	75.0	10000.0
WH-4-023	CDK9	33.0	10000.0
HG-6-64-01	FES	0.2	10000.0
Alpelisib	MAP4K5	94.0	1000.0
AZ-628	ABL2	12.0	10000.0
XMD8-92	PTK6	100.0	10000.0
JWE-035	ERK5	0.1	10000.0
HG-6-64-01	CDKL3	4.0	10000.0
XMD-12	FGFR2	63.0	1000.0
ERK5-IN-1	WEE1	100.0	1000.0
HG-5-113-01	FLT3(D835Y)	0.1	10000.0
HG-14-10-04	MKNK1	3.0	10000.0
Torin1	PHKG2	100.0	10000.0
JNK-IN-11	DDR2	9.0	1000.0
CH5424802	EGFR(L861Q)	37.0	1000.0
CG-930	PAK7	100.0	10000.0
HG-5-113-01	ABL1(Y253F)	12.0	10000.0
NPK76-II-72-1	FYN	100.0	10000.0
Taselisib	MST2	98.0	1000.0
JWE-035	CDC2L1	99.0	10000.0
XMD14-99	ABL1(Q252H)-phosphorylated	100.0	10000.0
Lapatinib	PIP5K2B	79.0	10000.0
SCH772984	FGFR3	79.0	1000.0
HG-5-113-01	MLTK	100.0	10000.0
JNK-9L	NEK1	57.0	10000.0
TGX221	KCC4	100.0	1000.0
PD0325901	PIK3CA(H1047L)	45.0	10000.0
Palbociclib	BIKE	70.0	1000.0
XMD14-99	CAMK2B	20.0	10000.0
XMD8-92	MYO3B	100.0	10000.0
XMD13-2	PIK3CA(E545K)	95.0	10000.0
Abemaciclib	EGFR(L747-T751del,Sins)	80.0	1000.0
CH5424802	OSR1	44.0	1000.0
Dabrafenib	RIOK2	56.0	10000.0
GSK429286A	TNK1	33.0	10000.0
HG-14-8-02	EPHB2	85.0	10000.0
ZG-10	ANKK1	8.1	10000.0
Dabrafenib	DDR1	4.0	10000.0
XMD11-50	MK12	76.0	10000.0
WH-4-023	TBK1	74.0	10000.0
Ribociclib	MET(M1250T)	100.0	1000.0
JWE-035	ABL1(F317I)-nonphosphorylated	1.2	10000.0
HG-5-88-01	DYRK1B	100.0	10000.0
ALW-II-49-7	YANK2	100.0	10000.0
GSK1059615	EPHB3	71.0	10000.0
XMD11-50	EGFR(L747-S752del,P753S)	84.0	10000.0
BI-2536	MK03	100.0	10000.0
BS-181	LIMK1	100.0	10000.0
WZ4002	IKKB	100.0	10000.0
PHA-793887	WNK1	100.0	10000.0
ALW-II-49-7	RIOK2	100.0	10000.0
CP724714	RIPK1	100.0	10000.0
BGJ398	ABL1(F317I)-phosphorylated	100.0	1000.0
AZD 5438	FES	80.0	10000.0
R406	MK14	100.0	1000.0
Dabrafenib	EGFR(G719C)	14.0	10000.0
ALW-II-38-3	FAK1	100.0	10000.0
SB590885	NEK9	100.0	10000.0
PHA-793887	TAK1	60.0	10000.0
Baricitinib	PGFRA	90.0	10000.0
Alpelisib	EPHA5	100.0	1000.0
Crizotinib	TNK1	7.1	10000.0
Taselisib	PRKR	100.0	1000.0
CP724714	LKB1	98.0	10000.0
WH-4-023	MKNK1	98.0	10000.0
PLX-4720	RSK4(Kin.Dom.1-N-terminal)	80.0	10000.0
JWE-035	EPHA3	100.0	10000.0
NG25	FGFR1	1.2	10000.0
JNK-IN-5A	BMX	100.0	10000.0
ERK5-IN-1	CDK5	100.0	1000.0
CGP60474	CTK	100.0	10000.0
HG-6-64-01	KPCD3	52.0	10000.0
ZSTK474	PIK3CA(E545K)	0.0	1000.0
PLX-4720	PFCDPK1(P.falciparum)	0.0	10000.0
BMS-536924	ERBB2	100.0	1000.0
ZG-10	TNK2	100.0	10000.0
Omipalisib	PDPK1	73.0	10000.0
NG25	CDK14	0.7	10000.0
PHA-767491	DCLK1	32.0	10000.0
HG-14-8-02	M3K2	100.0	10000.0
SB590885	CLK2	52.0	10000.0
BX-912	CLK4	28.0	10000.0
RO-3306	EGFR(L747-E749del,A750P)	83.0	10000.0
KIN001-127	ABL1(Q252H)	100.0	10000.0
CP466722	MYO3A	72.0	10000.0
HG-9-91-01	TTK	1.4	10000.0
Torkinib	MAPKAPK2	100.0	10000.0
AG1478	BMPR1A	100.0	10000.0
WZ3105	RET(V804M)	71.0	10000.0
Omipalisib	CLK1	34.0	10000.0
Torin1	SIK1	80.0	10000.0
ZSTK474	AKT1	100.0	1000.0
MPS-1-IN-1	PIK3CD	100.0	1000.0
HG-5-113-01	CDC2L1	100.0	10000.0
JNK-IN-5A	ABL1(Q252H)-nonphosphorylated	100.0	10000.0
CG-930	NEK5	100.0	10000.0
Pictilisib	AKT1	100.0	1000.0
MLN8054	CDK15	100.0	10000.0
ERK5-IN-1	LCK	100.0	1000.0
HG-14-10-04	PIP5K1A	1.8	10000.0
HG-5-88-01	MLK2	100.0	10000.0
PLX-4720	TSSK1	83.0	10000.0
Omipalisib	MAP4K4	93.0	10000.0
CH5424802	ACVR1B	97.0	1000.0
PHA-767491	PIK3CB	23.0	10000.0
AS-252424	M4K1	95.4	10000.0
Lapatinib	TRKB	87.0	10000.0
XMD8-85	KIT(V559D)	100.0	10000.0
HG-6-64-01	LYN	0.0	10000.0
Alpelisib	PFPK5(P.falciparum)	99.0	1000.0
WYE-125132	EGFR(G719C)	80.0	10000.0
PHA-793887	EGFR(G719C)	77.0	10000.0
THZ1	FGR	8.7	10000.0
KIN001-127	MLCK	100.0	10000.0
ALW-II-38-3	MK03	100.0	10000.0
PLX-4720	RET	76.0	10000.0
AZD-6482	ABL1(T315I)-phosphorylated	70.0	10000.0
(s)-CR8	BIKE	100.0	10000.0
JNK-IN-5A	ABL1(F317L)-phosphorylated	96.0	10000.0
GW843682X	CDKL1	72.0	10000.0
NPK76-II-72-1	TNK1	100.0	10000.0
Lapatinib	MRCKA	79.0	10000.0
Sigma A6730	PKN1	100.0	10000.0
5z-7-oxozeaenol	TIE2	82.0	10000.0
Baricitinib	KGP2	36.0	10000.0
BS-181	ABL1(F317I)-phosphorylated	77.0	10000.0
GSK429286A	TYK2(JH2domain-pseudokinase)	100.0	10000.0
BMS-536924	TSSK1	31.0	1000.0
NPK76-II-72-1	CDKL2	100.0	10000.0
Momelotinib	KGP2	100.0	10000.0
CP466722	PIK3CA(Q546K)	38.0	10000.0
AZD7762	PIP5K1A	0.0	10000.0
Dinaciclib	CDC2L2	60.0	10000.0
AZD7762	AKT1	3.2	10000.0
XMD14-99	CDK7	2.8	10000.0
BMX-IN-1	TIE2	99.0	10000.0
Abemaciclib	RSK2(Kin.Dom.1-N-terminal)	52.0	1000.0
XMD-12	PIK3CA	98.0	1000.0
WZ-7043	TXK	100.0	10000.0
NG25	KIT(V559D,T670I)	0.1	10000.0
THZ1	ABL1(T315I)-phosphorylated	0.8	10000.0
Crizotinib	MAK	63.0	10000.0
XMD13-2	FLT3(ITD)	30.0	10000.0
Ribociclib	VRK2	82.0	1000.0
BMS345541	MKNK1	100.0	10000.0
BMS-536924	BMPR1B	100.0	1000.0
ZSTK474	ACVR1B	100.0	1000.0
Ribociclib	FLT3(ITD,F691L)	100.0	1000.0
KIN001-123	PLK3	100.0	1000.0
HG-6-64-01	IKKE	94.0	10000.0
(s)-CR8	CDK8	90.0	10000.0
XMD11-50	PIM2	100.0	10000.0
GW-5074	AMPK-alpha2	100.0	10000.0
NVP-TAE684	KPCD3	0.0	1000.0
JNK-IN-5A	CDK8	100.0	10000.0
QL-X-138	SLK	100.0	10000.0
Torin2	NEK4	100.0	10000.0
BMS-536924	MYLK4	100.0	1000.0
Torin2	RAF1	100.0	10000.0
AZD-6482	TNK1	100.0	10000.0
WZ3105	RET(M918T)	100.0	10000.0
WH-4-023	JAK1(JH2domain-pseudokinase)	84.0	10000.0
ZM-447439	CAMKK2	81.0	10000.0
ZM-447439	KPCD	100.0	10000.0
AS-252424	RIOK2	100.0	10000.0
PD173074	ALK	100.0	10000.0
AG1478	PIK3CA(H1047L)	56.0	10000.0
CP724714	PIP5K1A	88.0	10000.0
XMD11-85h	MK13	100.0	10000.0
CGP60474	GRK1	100.0	10000.0
AZ-628	RPS6KA4(Kin.Dom.2-C-terminal)	94.0	10000.0
HG-9-91-01	ABL1(F317L)-phosphorylated	4.8	10000.0
BMS-536924	MK01	100.0	1000.0
WH-4-023	PLK3	100.0	10000.0
XMD11-85h	TAOK2	100.0	10000.0
A443654	SIK1	100.0	10000.0
Alpelisib	TYRO3	86.0	1000.0
KIN001-220	STK35	91.0	10000.0
A443654	CSNK1D	3.6	10000.0
AZ-628	MP2K3	80.0	10000.0
THZ1	FLT3(D835Y)	0.1	10000.0
CH5424802	DRAK2	43.0	1000.0
Palbociclib	PGFRB	100.0	1000.0
QL-XII-47	MLK3	100.0	1000.0
BX-912	PIK3CA(E545K)	100.0	10000.0
Sorafenib	IRAK4	95.0	10000.0
Dactolisib	MLK2	100.0	1000.0
KIN001-021	MRCKB	100.0	1000.0
WZ4002	MKNK1	100.0	10000.0
NU7441	BLK	100.0	10000.0
BMS345541	EGFR(L747-S752del,P753S)	100.0	10000.0
CP724714	TXK	84.0	10000.0
WZ-4-145	PIK3CA(E545K)	100.0	10000.0
Palbociclib	MLTK	100.0	1000.0
BS-181	MK09	61.0	10000.0
Taselisib	CDK8	89.0	1000.0
GSK1059615	HIPK4	3.8	10000.0
Buparlisib	SIK1	95.0	1000.0
PHA-767491	PIK3CA(I800L)	100.0	10000.0
GSK429286A	MK09	92.0	10000.0
SB590885	LKB1	88.0	10000.0
BMS-536924	PCTK2	100.0	1000.0
KIN001-220	KC1G2	58.0	10000.0
Torin2	MAP4K4	71.0	10000.0
Dinaciclib	NEK1	95.0	10000.0
Torkinib	HCK	2.5	10000.0
ERK5-IN-1	NIM1	100.0	1000.0
Sorafenib	PKAC-alpha	63.0	10000.0
Alpelisib	LATS2	100.0	1000.0
GW-5074	KIT(D816V)	79.0	10000.0
HG-14-10-04	M4K1	25.0	10000.0
GSK429286A	PRP4	86.0	10000.0
JW-7-24-1	MLTK	19.0	10000.0
NU7441	ERK3	100.0	10000.0
Dinaciclib	VRK2	80.0	10000.0
XMD8-92	MLCK	100.0	10000.0
HG-14-8-02	IRAK3	57.0	10000.0
CP466722	AKT2	42.0	10000.0
Lapatinib	AURKC	56.0	10000.0
XMD8-92	SRPK2	100.0	10000.0
Neratinib	PLK4	82.0	10000.0
RO-3306	ABL1(M351T)-phosphorylated	72.0	10000.0
GW-5074	MLCK	10.0	10000.0
MPS-1-IN-1	PKMYT1	100.0	1000.0
BI-2536	TRKC	100.0	10000.0
RO-3306	CSF1R-autoinhibited	62.0	10000.0
KU63794	RSK1(Kin.Dom.2-C-terminal)	100.0	10000.0
BMS345541	MARK3	100.0	10000.0
JWE-035	RIPK2	6.4	10000.0
HG-9-91-01	KPCI	19.0	10000.0
QL-XII-47	MAST1	100.0	1000.0
Pictilisib	MRCKB	100.0	1000.0
Sigma A6730	IRAK3	100.0	10000.0
TGX221	NLK	100.0	1000.0
Ribociclib	KKCC1	99.0	1000.0
AZD4547	BRAF	92.0	10000.0
OTSSP167	RSK2(Kin.Dom.1-N-terminal)	0.1	10000.0
NU7441	YES	94.0	10000.0
Torkinib	NEK9	100.0	10000.0
WZ-7043	TAOK1	2.9	10000.0
Buparlisib	LOK	95.0	1000.0
JNK-IN-8	FYN	78.0	1000.0
R406	FGFR1	0.0	1000.0
Taselisib	MK01	100.0	1000.0
GSK429286A	CSK	100.0	10000.0
Abemaciclib	PGFRA	100.0	1000.0
PD0325901	AAK1	100.0	10000.0
CGP74514A	PIK3C2G	62.0	10000.0
Sorafenib	KPCI	100.0	10000.0
Momelotinib	TNNI3K	100.0	10000.0
WYE-125132	EPHB6	83.0	10000.0
KIN001-123	ERBB4	1.6	1000.0
ALW-II-49-7	EPHA4	6.8	1000.0
CG-930	MET(M1250T)	100.0	10000.0
GSK461364	NIM1	30.0	10000.0
JWE-035	MYO3A	88.0	10000.0
MRT67307	PIM2	100.0	10000.0
QL-X-138	BMPR1B	12.0	10000.0
Barasertib	ADCK3	85.0	10000.0
NVP-TAE684	FAK1	0.0	1000.0
Momelotinib	LCK	90.0	10000.0
JNK-9L	ERBB4	91.0	10000.0
AG1478	BRSK2	45.0	10000.0
Omipalisib	KIT(V559D,V654A)	100.0	10000.0
(s)-CR8	FLT3	93.0	10000.0
HG-6-64-01	HIPK4	5.5	10000.0
HG-14-10-04	MST1	42.0	10000.0
KU63794	CDK11	73.0	10000.0
R406	PAK2	26.0	1000.0
XMD8-85	LATS2	100.0	10000.0
WZ-4-145	RET(V804L)	100.0	10000.0
QL-XII-47	STK16	97.0	1000.0
Momelotinib	AAK1	3.9	10000.0
WYE-125132	TAOK3	90.0	10000.0
CGP60474	BRAF(V600E)	100.0	10000.0
PD0325901	IRAK1	100.0	10000.0
GW-5074	EGFR(L858R)	32.0	10000.0
GSK1059615	HASP	6.2	10000.0
ALW-II-38-3	KGP1	100.0	10000.0
BGJ398	AAK1	76.0	1000.0
XMD13-2	HIPK1	28.0	10000.0
CG-930	SLK	88.0	10000.0
R406	MP2K2	20.0	1000.0
ERK5-IN-1	M3K2	100.0	1000.0
BX-912	CAMK1	11.0	10000.0
BI-2536	EGFR(G719S)	29.0	10000.0
Ribociclib	MYLK	100.0	1000.0
CH5424802	ICK	72.0	1000.0
Omipalisib	MARK3	79.0	10000.0
BS-181	MP2K3	94.0	10000.0
(s)-CR8	ALK(L1196M)	92.0	10000.0
WZ4002	TIE2	100.0	10000.0
Baricitinib	CAMK1G	24.0	10000.0
Pictilisib	ABL1	100.0	10000.0
QL-XII-47	KIT-autoinhibited	98.0	1000.0
GSK1059615	SRPK3	31.0	10000.0
WZ-4-145	DAPK1	100.0	10000.0
Alpelisib	MLK2	96.0	1000.0
AZD 5438	BUB1	0.3	10000.0
AS-252424	PIP5K2B	100.0	10000.0
BI-D1870	CDK7	8.7	10000.0
PD0325901	CHEK1	74.0	10000.0
JNK-IN-8	PFCDPK1(P.falciparum)	100.0	1000.0
WYE-125132	PIK3CA(C420R)	11.0	10000.0
BGJ398	CTK	96.0	1000.0
Torin2	DCAMKL2	98.0	10000.0
SB590885	M4K1	97.0	10000.0
SB590885	MET(M1250T)	64.0	10000.0
TGX221	MELK	100.0	1000.0
CP466722	CAMK1G	34.0	10000.0
CGP60474	FAK1	100.0	10000.0
GW843682X	MK14	100.0	10000.0
A443654	EPHB1	100.0	10000.0
AG1478	ERBB4	3.5	10000.0
JNK-IN-5A	PIP5K2B	100.0	10000.0
JWE-035	FER	100.0	10000.0
XMD14-99	PRKR	75.0	10000.0
BI-D1870	RPS6KA2(Kin.Dom.1-N-terminal)	0.0	10000.0
XMD8-92	PIK3CA(E545K)	100.0	10000.0
BI-2536	RET	100.0	10000.0
Sigma A6730	FGFR3(G697C)	89.0	10000.0
5z-7-oxozeaenol	MAP4K5	76.0	10000.0
ALW-II-49-7	MK01	100.0	10000.0
PLX-4720	NIM1	92.0	10000.0
Palbociclib	SRC	97.0	1000.0
XMD-12	FGFR4	73.0	1000.0
Abemaciclib	KIT(V559D,T670I)	100.0	1000.0
AZD-6482	FRK	83.0	10000.0
AZD 5438	EGFR(L858R,T790M)	27.0	10000.0
CP724714	KIT(D816H)	100.0	10000.0
Lapatinib	GRK1	100.0	10000.0
ALW-II-38-3	PRKX	100.0	10000.0
Sorafenib	MAK	41.0	10000.0
TAK-715	MAK	70.0	10000.0
Dinaciclib	ADCK3	77.0	10000.0
Torin1	KIT(D816H)	91.0	10000.0
A443654	TGFBR2	100.0	10000.0
WZ-7043	SBK1	100.0	10000.0
AZD 5438	FLT3(D835Y)	2.7	10000.0
HG-14-10-04	CAMK2A	2.9	10000.0
Torkinib	NEK3	55.0	10000.0
BX-912	RSK1(Kin.Dom.1-N-terminal)	4.3	10000.0
JNK-IN-5A	TYK2(JH1domain-catalytic)	100.0	10000.0
BMS345541	PDPK1	100.0	10000.0
QL-XI-92	EPHB2	77.0	10000.0
PHA-767491	PIK3CA(E542K)	98.0	10000.0
Taselisib	SRPK1	100.0	1000.0
ZG-10	MRCKB	100.0	10000.0
GSK461364	MAP3K1	3.7	10000.0
Omipalisib	PI42C	13.0	10000.0
ALW-II-38-3	TNIK	100.0	10000.0
GSK461364	RIPK5	34.0	10000.0
Ribociclib	ADCK3	100.0	1000.0
RO-3306	ERK5	100.0	10000.0
Dactolisib	KIT(L576P)	100.0	1000.0
XMD8-85	NUAK1	7.6	10000.0
XMD8-85	MRCKB	100.0	10000.0
Dinaciclib	MET(Y1235D)	35.0	10000.0
CP724714	CASK	100.0	10000.0
Crizotinib	BMPR2	61.0	10000.0
Dinaciclib	PRKR	69.0	10000.0
NU7441	CLK3	100.0	10000.0
KIN001-111	EGFR(G719C)	3.3	1000.0
PHA-767491	MST1R	16.0	10000.0
WYE-125132	STK36	96.0	10000.0
QL-XII-47	BRAF	100.0	1000.0
MLN8054	GAK	49.0	10000.0
JW-7-24-1	MP2K1	100.0	10000.0
NU7441	TIE1	100.0	10000.0
Taselisib	LATS1	66.0	1000.0
5z-7-oxozeaenol	GSK3A	100.0	10000.0
Baricitinib	TIE2	86.0	10000.0
Omipalisib	ALK	84.0	10000.0
PHA-793887	JAK1(JH2domain-pseudokinase)	78.0	10000.0
XMD16-144	EPHB6	4.3	10000.0
AG1478	TNK1	26.0	10000.0
CH5424802	MAPKAPK2	96.0	1000.0
AZD-6482	EPHB1	98.0	10000.0
WH-4-023	ADCK4	20.0	10000.0
QL-XI-92	CDK4-cyclinD3	95.0	10000.0
AS-252424	CLK3	53.4	10000.0
CGP74514A	MLTK	95.0	10000.0
AZD 5438	PAK6	65.0	10000.0
XMD11-50	CAMK1D	69.0	10000.0
GSK461364	FES	88.0	10000.0
QL-XII-47	AMPK-alpha1	84.0	1000.0
NG25	CAMK2G	100.0	10000.0
WYE-125132	RSK4(Kin.Dom.1-N-terminal)	87.0	10000.0
XMD8-85	CSNK1G3	100.0	10000.0
Ribociclib	RSK1(Kin.Dom.1-N-terminal)	100.0	1000.0
AZD-6482	MK14	97.0	10000.0
GSK461364	PIK3CA(E545K)	71.0	10000.0
WZ4002	MST4	100.0	10000.0
WZ-7043	MK03	100.0	10000.0
Omipalisib	MK12	67.0	10000.0
OTSSP167	AKT2	1.2	10000.0
5z-7-oxozeaenol	PIK3CB	77.0	10000.0
XMD-12	TNIK	83.0	1000.0
CH5424802	KIT-autoinhibited	100.0	1000.0
KU63794	KPCE	82.0	10000.0
Pictilisib	YANK1	100.0	1000.0
NU7441	LATS1	100.0	10000.0
Pictilisib	MK14	100.0	1000.0
Seliciclib	PIK3C2B	100.0	10000.0
JNK-IN-8	PIK3CA(E545A)	95.0	1000.0
WZ4003	EPHA8	100.0	1000.0
Neratinib	CDC2L2	100.0	10000.0
Barasertib	MLK1	98.0	10000.0
WZ3105	RPS6KA4(Kin.Dom.1-N-terminal)	59.0	10000.0
Baricitinib	KCC2D	1.7	10000.0
QL-XI-92	PRP4	100.0	10000.0
XMD14-99	BRSK1	91.0	10000.0
XMD14-99	KIT(D816V)	92.0	10000.0
Dabrafenib	EGFR(E746-A750del)	96.0	10000.0
MRT67307	KKCC1	37.0	10000.0
PHA-793887	NLK	48.0	10000.0
ALW-II-38-3	TIE2	100.0	10000.0
THZ1	TIE1	0.7	10000.0
Lapatinib	ABL1(Q252H)-phosphorylated	100.0	10000.0
BMS345541	PIK3CA(E545K)	100.0	10000.0
WZ4003	CAMK1D	22.0	1000.0
ZM-447439	SYK	69.0	10000.0
Ribociclib	PIM1	100.0	1000.0
KIN001-111	ABL1(M351T)	4.8	1000.0
BS-181	YES	100.0	10000.0
XMD16-144	CDC2L5	96.0	10000.0
BMS345541	EPHA8	100.0	10000.0
GSK429286A	KPCD	39.0	10000.0
BGJ398	WNK1	88.0	1000.0
Omipalisib	EGFR(L861Q)	93.0	10000.0
GW-5074	PAK6	73.0	10000.0
HG-14-10-04	FLT3(K663Q)	0.0	10000.0
HG-5-113-01	KPCD	15.0	10000.0
TGX221	PKN2	100.0	1000.0
MLN8054	MAK	78.0	10000.0
Alpelisib	MAP3K14	97.0	1000.0
Lapatinib	KPCE	74.0	10000.0
Crizotinib	DDR2	0.0	10000.0
WZ3105	MYLK	55.0	10000.0
JNK-IN-11	RSK4(Kin.Dom.1-N-terminal)	91.0	1000.0
GW843682X	TTK	87.0	10000.0
MLN8054	FES	100.0	10000.0
HG-14-8-02	DYRK1B	18.0	10000.0
HG-6-64-01	PLK2	60.0	10000.0
CG-930	PIM3	100.0	10000.0
Palbociclib	CAMK2A	76.0	1000.0
Abemaciclib	BTK	100.0	1000.0
NU7441	M4K1	90.0	10000.0
XMD11-50	MP2K6	83.0	10000.0
Dinaciclib	IKKE	61.0	10000.0
Canertinib	PCTK2	100.0	1000.0
THZ1	ULK1	1.4	10000.0
SB590885	RIPK5	83.0	10000.0
NG25	FGFR3	9.4	10000.0
KIN001-127	AKT1	100.0	10000.0
Vemurafenib	YANK3	100.0	10000.0
CGP74514A	CDK9	15.0	10000.0
KIN001-123	NLK	100.0	1000.0
MPS-1-IN-1	PIK3CA	100.0	1000.0
CGP74514A	CIT	53.0	10000.0
Canertinib	PKAC-alpha	100.0	1000.0
JWE-035	YANK3	100.0	10000.0
BMX-IN-1	MK03	79.0	10000.0
PHA-767491	EGFR(L747-S752del,P753S)	71.0	10000.0
XMD11-85h	VGFR2	100.0	10000.0
KIN001-220	IKKA	84.0	10000.0
WZ3105	MST1	78.0	10000.0
RO-3306	CSF1R	60.0	10000.0
Torin1	EGFR(L858R)	100.0	10000.0
PD0325901	ITK	97.0	10000.0
Buparlisib	DRAK2	93.0	1000.0
Momelotinib	CDK7	3.8	10000.0
SCH772984	KIT(A829P)	84.0	1000.0
Dinaciclib	ERN1	71.0	10000.0
ZG-10	BLK	100.0	10000.0
Vemurafenib	PIK3CD	89.0	10000.0
QL-XII-47	AKT3	90.0	1000.0
CP466722	PIP5K2B	44.0	10000.0
XMD14-99	PIK3CG	86.0	10000.0
CGP60474	DCLK1	100.0	10000.0
AZD-6482	NEK5	100.0	10000.0
CGP74514A	FRK	28.0	10000.0
Momelotinib	PGFRA	100.0	10000.0
Sigma A6730	EPHA3	82.0	10000.0
Sigma A6730	ULK1	78.0	10000.0
Barasertib	SRC	43.0	10000.0
QL-XI-92	TAK1	98.0	10000.0
JNK-IN-11	PKNB(M.tuberculosis)	100.0	1000.0
BX-912	FLT3	0.0	10000.0
AZD 5438	ABL1(F317I)-nonphosphorylated	100.0	10000.0
XMD8-92	KIT(V559D)	100.0	10000.0
Taselisib	AMPK-alpha1	90.0	1000.0
JWE-035	MRCKB	99.0	10000.0
RO-3306	AXL	34.0	10000.0
Seliciclib	EPHA5	100.0	10000.0
ZSTK474	EGFR	100.0	1000.0
Neratinib	ABL1(Q252H)-nonphosphorylated	71.0	10000.0
XMD14-99	KIT(V559D)	100.0	10000.0
CP724714	BRAF	100.0	10000.0
BS-181	CSNK1A1	7.6	10000.0
NPK76-II-72-1	SgK110	100.0	10000.0
5z-7-oxozeaenol	IRAK4	70.0	10000.0
Vemurafenib	IKKA	87.0	10000.0
CP466722	SNARK	37.0	10000.0
Momelotinib	KIT(V559D,T670I)	45.0	10000.0
HG-5-113-01	BRSK2	100.0	10000.0
Ribociclib	ABL2	5.8	1000.0
PD0325901	ULK3	89.0	10000.0
GSK461364	BMPR1B	28.0	10000.0
CGP60474	YSK4	100.0	10000.0
JNK-IN-8	RSK3(Kin.Dom.2-C-terminal)	100.0	1000.0
GW843682X	HIPK4	15.0	10000.0
JNK-IN-8	ULK3	40.0	1000.0
CGP60474	CDK15	100.0	10000.0
XMD13-2	MAP3K15	100.0	10000.0
Dactolisib	CDK2	100.0	1000.0
GSK461364	EPHA2	92.0	10000.0
XMD11-85h	WEE2	100.0	10000.0
PD0325901	EGFR(S752-I759del)	70.0	10000.0
Seliciclib	PLK2	83.0	10000.0
CP466722	EGFR(L861Q)	64.0	10000.0
BGJ398	DAPK3	90.0	1000.0
ZM-447439	MAST1	100.0	10000.0
QL-XII-47	HCK	100.0	1000.0
PLX-4720	TLK2	75.0	10000.0
XMD13-2	SRPK1	43.0	10000.0
KIN001-220	KPCD3	100.0	10000.0
PHA-767491	CLK3	1.2	10000.0
ZM-447439	PAK4	100.0	10000.0
XMD14-99	ANKK1	96.0	10000.0
BGJ398	IRAK4	100.0	1000.0
XMD11-85h	CDK2	100.0	10000.0
MPS-1-IN-1	EPHA2	100.0	1000.0
XMD14-99	TNK1	100.0	10000.0
QL-XII-47	MAP3K4	100.0	1000.0
TAK-715	AAK1	96.0	10000.0
JNK-IN-5A	ADCK3	100.0	10000.0
JNK-IN-5A	ABL1(H396P)-nonphosphorylated	100.0	10000.0
GW843682X	NEK4	52.0	10000.0
AZD 5438	CAMK2A	35.0	10000.0
SCH772984	FLT3(ITD)	82.0	1000.0
A443654	INSR	100.0	10000.0
SCH772984	TLK2	81.0	1000.0
GW-5074	PRKX	100.0	10000.0
(s)-CR8	TGFBR2	89.0	10000.0
NVP-TAE684	HCK	0.4	1000.0
Neratinib	CDKL5	100.0	10000.0
Ribociclib	GRK1	60.0	1000.0
Palbociclib	ABL1(Q252H)-nonphosphorylated	96.0	1000.0
Abemaciclib	RIOK1	7.3	1000.0
BS-181	SRMS	90.0	10000.0
BS-181	TRKB	96.0	10000.0
Abemaciclib	EPHB6	64.0	1000.0
PHA-793887	MLCK	100.0	10000.0
Taselisib	TAOK2	100.0	1000.0
BI-D1870	RPS6KA6(Kin.Dom.1-N-terminal)	9.2	10000.0
KIN001-127	DAPK2	28.0	10000.0
Momelotinib	STK39	47.0	10000.0
KU63794	ITK	88.0	10000.0
BI-2536	TGFBR2	100.0	10000.0
GSK1059615	KIT(V559D,V654A)	100.0	10000.0
AZD 5438	ROCK2	5.0	10000.0
KIN001-123	PAK2	100.0	1000.0
XMD8-92	MAP4K2	100.0	10000.0
PHA-767491	PTK6	96.0	10000.0
Ribociclib	RSK3(Kin.Dom.1-N-terminal)	92.0	1000.0
CG-930	MELK	92.0	10000.0
Ribociclib	ABL1(E255K)-phosphorylated	89.0	1000.0
OTSSP167	EPHA3	40.0	10000.0
XMD8-85	CDK7	100.0	10000.0
Dabrafenib	AURKA	19.0	10000.0
KIN001-220	BRAF	70.0	10000.0
BMS345541	TYK2(JH2domain-pseudokinase)	15.0	10000.0
TGX221	BMPR2	100.0	1000.0
MLN8054	PAK3	52.0	10000.0
Neratinib	RET(M918T)	100.0	10000.0
Canertinib	MAP3K4	100.0	1000.0
NPK76-II-72-1	PLK4	100.0	10000.0
PLX-4720	DCAMKL2	61.0	10000.0
WZ-4-145	MAP4K4	100.0	10000.0
AZ-628	DCAMKL2	100.0	10000.0
KIN001-123	KGP1	100.0	1000.0
R406	IKKA	2.2	1000.0
BI-D1870	ROCK1	26.0	10000.0
HG-14-8-02	ERK8	91.0	10000.0
Momelotinib	MST1	100.0	10000.0
XMD-12	RPS6KA4(Kin.Dom.2-C-terminal)	89.0	1000.0
R406	ERBB2	100.0	1000.0
JNK-IN-8	PIP5K1A	75.0	1000.0
AZ-628	NLK	48.0	10000.0
(s)-CR8	PAK2	97.0	10000.0
HG-9-91-01	MAP3K1	62.0	10000.0
ZSTK474	MST1	100.0	1000.0
ZG-10	ACVR1B	86.0	10000.0
XMD11-85h	IRAK1	100.0	10000.0
PD0325901	PHKG1	100.0	10000.0
Omipalisib	LKB1	74.0	10000.0
SP600125	CAMK2G	100.0	10000.0
AZD-6482	KCC4	100.0	10000.0
BGJ398	CLK4	90.0	1000.0
Torin1	DAPK3	82.0	10000.0
WZ3105	PIK3C2G	100.0	10000.0
MLN8054	RIPK2	97.0	10000.0
WZ3105	GSK3B	94.0	10000.0
BI-2536	STK35	100.0	10000.0
GW-5074	EIF2AK1	57.0	10000.0
Pictilisib	RIOK3	95.0	1000.0
KIN001-123	MST1	100.0	1000.0
BGJ398	NEK6	100.0	1000.0
WH-4-023	PGFRB	0.0	10000.0
JNK-IN-5A	MLCK	100.0	10000.0
NVP-TAE684	M4K3	2.5	1000.0
Sorafenib	ABL1(F317L)-nonphosphorylated	5.4	10000.0
AZD4547	ABL1(F317I)-phosphorylated	25.0	10000.0
Momelotinib	YSK1	71.0	10000.0
KIN001-220	GRK1	100.0	10000.0
WZ4003	DMPK	17.0	1000.0
THZ1	PIP5K1C	100.0	10000.0
AZD7762	GSK3A	100.0	10000.0
Canertinib	KPCD3	100.0	1000.0
Torin2	SIK2	73.0	10000.0
CG-930	AKT2	100.0	10000.0
HG-9-91-01	EGFR(L858R)	0.1	10000.0
GSK461364	DMPK2	100.0	10000.0
WZ3105	MLK2	84.0	10000.0
JNK-IN-11	MST4	85.0	1000.0
Neratinib	LRRK2(G2019S)	85.0	10000.0
XMD16-144	MK14	100.0	10000.0
WZ4002	DCAMKL3	0.4	10000.0
SB590885	ANKK1	100.0	10000.0
ZSTK474	EPHA3	100.0	1000.0
HG-6-64-01	MYO3B	40.0	10000.0
XMD-12	ULK1	16.0	1000.0
NVP-TAE684	MERTK	0.0	1000.0
5z-7-oxozeaenol	MLK1	100.0	10000.0
NU7441	EGFR(G719C)	100.0	10000.0
MRT67307	CSNK1E	100.0	10000.0
Seliciclib	PAK7	28.0	10000.0
KIN001-111	CAMK1D	100.0	1000.0
Baricitinib	LOK	100.0	10000.0
MLN8054	CLK3	14.0	10000.0
NG25	DMPK2	100.0	10000.0
Vemurafenib	EPHB1	100.0	10000.0
BMS345541	MAP3K1	74.0	10000.0
JNK-IN-11	PDPK1	100.0	1000.0
PLX-4720	AKT2	68.0	10000.0
RO-3306	FLT3(K663Q)	6.6	10000.0
JNK-IN-5A	DYRK2	100.0	10000.0
AZD 5438	BMPR2	0.2	10000.0
JNK-9L	EPHA6	72.0	10000.0
(s)-CR8	KPCD1	78.0	10000.0
Ceritinib	IKKE	75.0	1000.0
BI-2536	ULK2	100.0	10000.0
TAK-715	CDKL1	100.0	10000.0
HG-5-88-01	ABL1(Q252H)	100.0	10000.0
CP466722	MLK2	62.0	10000.0
Momelotinib	PIP5K1C	54.0	10000.0
Dabrafenib	MK12	32.0	10000.0
XMD11-50	PIK3CA(H1047Y)	71.0	10000.0
AZD7762	TGFBR2	2.4	10000.0
PLX-4720	YES	18.0	10000.0
TAK-715	PIK3CD	100.0	10000.0
ZG-10	PRKX	100.0	10000.0
Torkinib	PKAC-beta	65.0	10000.0
XMD11-50	MLTK	99.0	10000.0
SCH772984	RSK1(Kin.Dom.1-N-terminal)	55.0	1000.0
BX-912	EPHB2	100.0	10000.0
Vemurafenib	MLCK	24.0	10000.0
BGJ398	MST1	73.0	1000.0
Ceritinib	HUNK	82.0	1000.0
GSK461364	SGK3	28.0	10000.0
KU63794	PIK3CB	30.0	10000.0
ZM-447439	INSR	77.0	10000.0
TAK-715	MST3	69.0	10000.0
XMD13-2	PIK3CA(H1047Y)	89.0	10000.0
Momelotinib	BRSK1	100.0	10000.0
XMD8-92	IKKE	100.0	10000.0
RO-3306	YSK4	0.6	10000.0
TGX221	TNNI3K	100.0	1000.0
XMD-12	LRRK2(G2019S)	0.9	1000.0
NU7441	VRK2	100.0	10000.0
PD0325901	RIPK5	100.0	10000.0
XMD11-85h	PKN2	100.0	10000.0
XMD-12	GCN2(Kin.Dom.2,S808G)	98.0	1000.0
AZD 5438	TRKC	17.0	10000.0
R406	MK03	100.0	1000.0
KIN001-127	JNK1	100.0	10000.0
QL-XI-92	WEE1	100.0	10000.0
Torin1	IKKB	61.0	10000.0
AZD 5438	ACVRL1	23.0	10000.0
OTSSP167	KIT(V559D)	3.6	10000.0
PHA-793887	RIOK2	97.0	10000.0
BGJ398	FES	85.0	1000.0
A443654	TNK1	100.0	10000.0
BGJ398	FGFR4	2.0	1000.0
TAK-715	KIT(D816V)	5.6	10000.0
Sigma A6730	SGK1	71.0	10000.0
Torkinib	MP2K1	0.3	10000.0
HG-14-10-04	SBK1	5.4	10000.0
BMX-IN-1	DAPK3	60.0	10000.0
Taselisib	NDR1	95.0	1000.0
KIN001-220	KIT(V559D)	0.5	10000.0
HG-14-10-04	NEK5	81.0	10000.0
BS-181	TNK2	98.0	10000.0
WZ-4-145	LTK	27.0	10000.0
SCH772984	MYLK2	70.0	1000.0
BGJ398	FLT3(D835Y)	60.0	1000.0
BS-181	MP2K4	100.0	10000.0
XMD11-85h	MARK4	0.0	10000.0
XMD13-2	RIPK4	84.0	10000.0
OTSSP167	MLK3	0.6	10000.0
WZ-7043	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
BX-912	KPCT	3.6	10000.0
NU7441	PKN2	86.0	10000.0
JW-7-24-1	FLT3(D835H)	26.0	10000.0
XMD16-144	HUNK	47.0	10000.0
XMD8-85	HIPK3	100.0	10000.0
XMD8-85	PIK3CA	100.0	10000.0
BI-2536	ULK1	100.0	10000.0
Omipalisib	IRAK3	13.0	10000.0
A443654	MAPKAPK2	100.0	10000.0
AG1478	STK33	73.0	10000.0
AZD7762	EGFR(L861Q)	1.5	10000.0
TAK-715	MAP3K4	85.0	10000.0
JNK-IN-5A	TNNI3K	52.0	10000.0
JWE-035	EPHA7	100.0	10000.0
KIN001-021	TGFBR1	100.0	1000.0
Dabrafenib	TXK	30.0	10000.0
XMD11-50	VGFR2	84.0	10000.0
AZ-628	GRK4	100.0	10000.0
HG-5-88-01	CAMK2B	100.0	10000.0
Lapatinib	YANK2	74.0	10000.0
Ibrutinib	MYLK2	85.0	1000.0
GW-5074	LRRK2	11.0	10000.0
HG-14-10-04	KIT	0.0	10000.0
JNK-IN-5A	DMPK	83.0	10000.0
ZM-447439	PGFRB	1.1	10000.0
Alpelisib	KPCD1	99.0	1000.0
JNK-9L	PHKG1	65.0	10000.0
ALW-II-38-3	PCTK3	100.0	10000.0
WZ4002	MK14	100.0	10000.0
JNK-IN-11	SIK3	100.0	1000.0
Momelotinib	MYO3B	100.0	10000.0
MLN8054	KIT(D816V)	74.0	10000.0
GW-5074	NEK5	87.0	10000.0
SCH772984	CAMK2A	100.0	1000.0
Palbociclib	KPCI	93.0	1000.0
Torin2	MP2K4	44.0	10000.0
NPK76-II-72-1	CLK4	100.0	10000.0
WH-4-023	PIK3CA(H1047Y)	94.0	10000.0
SCH772984	MLK2	80.0	1000.0
JW-7-24-1	PIK3CD	8.6	10000.0
GSK461364	KKCC1	99.0	10000.0
RO-3306	KIT-autoinhibited	84.0	10000.0
Barasertib	ITK	96.0	10000.0
XMD11-50	MST3	87.0	10000.0
Pictilisib	TAK1	100.0	1000.0
AZD-6482	CSNK1D	86.0	10000.0
NPK76-II-72-1	FGR	100.0	10000.0
WZ4003	MLTK	100.0	1000.0
Ceritinib	TNNI3K	100.0	1000.0
Dactolisib	LATS1	100.0	1000.0
WZ-4-145	PAK6	100.0	10000.0
WZ-4-145	TYRO3	100.0	10000.0
BS-181	PKN1	92.0	10000.0
Barasertib	EPHA8	90.0	10000.0
Pictilisib	DYRK2	100.0	1000.0
ZSTK474	CDK2	100.0	1000.0
HG-5-88-01	NEK2	100.0	10000.0
Sorafenib	FER	87.0	10000.0
SP600125	MARK4	34.0	10000.0
SB590885	PLK2	92.0	10000.0
Vemurafenib	CDC2L1	100.0	10000.0
Sigma A6730	YANK3	87.0	10000.0
Sorafenib	KCC4	100.0	10000.0
XMD11-50	IKKB	89.0	10000.0
WZ-7043	BRSK1	100.0	10000.0
WZ-7043	STK35	100.0	10000.0
XMD8-85	GRK7	100.0	10000.0
(s)-CR8	TBK1	90.0	10000.0
HG-6-64-01	SRC	0.2	10000.0
AS-252424	EGFR(L861Q)	27.6	10000.0
ALW-II-38-3	PGFRA	0.7	1000.0
Seliciclib	TSSK1	99.0	10000.0
WYE-125132	GAK	75.0	10000.0
CGP74514A	LKB1	100.0	10000.0
Alpelisib	NEK5	100.0	1000.0
Taselisib	MST4	96.0	1000.0
Crizotinib	TXK	5.9	10000.0
HG-14-8-02	PHKG1	35.0	10000.0
CP466722	EGFR(G719S)	57.0	10000.0
WH-4-023	ERBB4	0.8	10000.0
AS-252424	FGFR2	100.0	10000.0
Omipalisib	IRAK1	20.0	10000.0
Sorafenib	KPCD1	32.0	10000.0
GW-5074	LOK	100.0	10000.0
Crizotinib	MP2K2	54.0	10000.0
WYE-125132	MARK2	100.0	10000.0
Omipalisib	PKAC-alpha	82.0	10000.0
AZ-628	PIP5K1A	100.0	10000.0
AZD4547	MAP3K4	30.0	10000.0
HG-9-91-01	MAP4K4	1.8	10000.0
AG1478	CLK1	59.0	10000.0
WZ4003	EPHB4	100.0	1000.0
CG-930	FES	100.0	10000.0
GSK429286A	PRKR	76.0	10000.0
AG1478	STK36	54.0	10000.0
AS-252424	GAK	9.3	10000.0
WZ-7043	YANK2	100.0	10000.0
AZD7762	PIM3	15.0	10000.0
Torin1	NIM1	84.0	10000.0
HG-5-88-01	RPS6KA2(Kin.Dom.2)	18.0	10000.0
HG-14-10-04	ABL1(F317L)-phosphorylated	4.7	10000.0
OTSSP167	EGFR(L858R,T790M)	1.8	10000.0
SB590885	RET(M918T)	88.0	10000.0
WZ4003	ABL1(Y253F)	100.0	1000.0
XMD16-144	ROCK2	58.0	10000.0
XMD-12	SRC	21.0	1000.0
HG-9-91-01	SBK1	3.2	10000.0
KIN001-021	PKN2	100.0	1000.0
BI-2536	CDK16	100.0	10000.0
Abemaciclib	DRAK1	1.4	1000.0
SP600125	MAP4K2	100.0	10000.0
Ibrutinib	CLK1	100.0	1000.0
XMD16-144	HIPK1	76.0	10000.0
PLX-4720	CDK8	2.2	10000.0
KIN001-127	FGFR1	100.0	10000.0
BX-912	TLK2	56.0	10000.0
CP724714	JAK1(JH1domain-catalytic)	100.0	10000.0
CGP60474	MST4	100.0	10000.0
JNK-IN-11	TTK	94.0	1000.0
QL-X-138	MK09	9.6	10000.0
QL-X-138	FAK2	96.0	10000.0
GW843682X	LTK	100.0	10000.0
Pictilisib	AURKA	100.0	1000.0
TGX221	RIOK3	100.0	1000.0
Buparlisib	FLT3(ITD,F691L)	99.0	1000.0
CP724714	TIE2	100.0	10000.0
WZ-7043	PTK6	100.0	10000.0
Dactolisib	RPS6KA6(Kin.Dom.1)	100.0	1000.0
Dabrafenib	CDK5	2.8	10000.0
GW-5074	MST1	52.0	10000.0
JNK-9L	DAPK3	73.0	10000.0
KIN001-123	SNARK	9.0	1000.0
Palbociclib	LIMK2	100.0	1000.0
KIN001-021	GCN2(Kin.Dom.2,S808G)	100.0	1000.0
AZD7762	ROCK1	0.2	10000.0
WZ4003	NLK	100.0	1000.0
WZ3105	CSNK1D	0.8	10000.0
JWE-035	RSK1(Kin.Dom.2-C-terminal)	23.0	10000.0
JNK-IN-8	BLK	65.0	1000.0
XMD13-2	PKN2	78.0	10000.0
BI-2536	DMPK2	100.0	10000.0
JNK-9L	CHK2	100.0	10000.0
WZ-7043	KPCD1	100.0	10000.0
QL-XI-92	IRAK1	100.0	10000.0
BMS345541	SBK1	100.0	10000.0
Torin2	IRAK4	85.0	10000.0
BS-181	MP2K1	79.0	10000.0
WYE-125132	TLK2	100.0	10000.0
XMD14-99	CDK9	60.0	10000.0
SP600125	CDK8	100.0	10000.0
GW-5074	DRAK2	40.0	10000.0
BMS345541	MET(Y1235D)	100.0	10000.0
ZG-10	PCTK2	92.0	10000.0
Buparlisib	CLK2	98.0	1000.0
KIN001-111	MK11	100.0	1000.0
BMS-536924	CDK9	100.0	1000.0
CGP74514A	CDKL2	38.0	10000.0
XMD11-50	MLK3	100.0	10000.0
NG25	PDPK1	100.0	10000.0
JW-7-24-1	PAK1	100.0	10000.0
SP600125	MYLK2	100.0	10000.0
Baricitinib	CDK4-cyclinD3	98.0	10000.0
XMD13-2	PKMYT1	77.0	10000.0
Baricitinib	PLK4	0.9	10000.0
Ibrutinib	CDC2L5	89.0	1000.0
HG-5-88-01	AMPK-alpha1	100.0	10000.0
Vemurafenib	PKAC-alpha	100.0	10000.0
Buparlisib	FGFR4	99.0	1000.0
Taselisib	PIK3C3	3.0	1000.0
CG-930	RIOK1	100.0	10000.0
Buparlisib	YSK4	100.0	1000.0
KIN001-021	MARK1	100.0	1000.0
RO-3306	TNIK	25.0	10000.0
ZM-447439	DRAK2	100.0	10000.0
Vemurafenib	ERN1	82.0	10000.0
Ceritinib	WNK3	100.0	1000.0
GSK429286A	ABL1(E255K)-phosphorylated	77.0	10000.0
BGJ398	AXL	71.0	1000.0
Ceritinib	STK35	73.0	1000.0
Torkinib	CDC2L2	100.0	10000.0
AZD7762	HIPK2	13.0	10000.0
RO-3306	MET(Y1235D)	84.0	10000.0
Ribociclib	SGK1	97.0	1000.0
TAK-715	M3K2	100.0	10000.0
Pictilisib	CDKL5	100.0	1000.0
Taselisib	FLT3-autoinhibited	89.0	1000.0
Dabrafenib	PLK1	94.0	10000.0
PLX-4720	MARK4	72.0	10000.0
Ibrutinib	MAP3K14	72.0	1000.0
JNK-9L	EPHA4	79.0	10000.0
JWE-035	MRCKA	70.0	10000.0
BI-D1870	TYK2(JH1domain-catalytic)	14.0	10000.0
MPS-1-IN-1	TGFBR2	100.0	1000.0
SCH772984	MP2K3	4.2	1000.0
HG-14-8-02	KIT(V559D,V654A)	100.0	10000.0
BMS-536924	YSK1	100.0	1000.0
RO-3306	ABL1(T315I)-nonphosphorylated	90.0	10000.0
AS-252424	MAP4K4	86.1	10000.0
KU63794	ACVR2B	100.0	10000.0
XMD13-2	PIK3CB	100.0	10000.0
JWE-035	M4K3	11.0	10000.0
Neratinib	YANK3	100.0	10000.0
SB590885	CSF1R	86.0	10000.0
Momelotinib	ACVR1B	38.0	10000.0
Seliciclib	CHK2	89.0	10000.0
ALW-II-49-7	FRK	1.3	1000.0
BS-181	KPCE	95.0	10000.0
Sorafenib	ABL1-phosphorylated	25.0	10000.0
Pictilisib	EGFR(T790M)	100.0	1000.0
Dactolisib	ABL1(F317I)	100.0	1000.0
QL-X-138	FLT3(ITD)	2.4	10000.0
Sigma A6730	CAMK1G	90.0	10000.0
ALW-II-38-3	NLK	100.0	10000.0
XMD-12	HCK	35.0	1000.0
MLN8054	CTK	84.0	10000.0
XMD8-85	PTK6	7.6	10000.0
KIN001-111	EPHA5	100.0	1000.0
Ibrutinib	EPHB2	100.0	1000.0
Barasertib	KIT	0.0	10000.0
Sigma A6730	PIK3CA(E545K)	69.0	10000.0
NPK76-II-72-1	PAK6	100.0	10000.0
GW843682X	DDR1	100.0	10000.0
Ceritinib	LRRK2	0.0	1000.0
BGJ398	ERK5	48.0	1000.0
ALW-II-38-3	FGFR4	100.0	10000.0
QL-X-138	PIK3CA(E545A)	23.0	10000.0
ZG-10	MK13	100.0	10000.0
HG-14-10-04	SGK1	69.0	10000.0
GW-5074	KPCD	70.0	10000.0
RO-3306	MAST1	66.0	10000.0
Dactolisib	RIOK2	100.0	1000.0
WZ-4-145	AKT2	100.0	10000.0
RO-3306	MAK	100.0	10000.0
CP724714	KIT(V559D,V654A)	88.0	10000.0
WZ4002	ADCK4	100.0	10000.0
WZ-7043	JAK1(JH1domain-catalytic)	100.0	10000.0
CH5424802	EPHA4	82.0	1000.0
XMD14-99	TRPM6	5.2	10000.0
ERK5-IN-1	HIPK4	100.0	1000.0
Omipalisib	ABL1(F317I)-nonphosphorylated	100.0	10000.0
ALW-II-49-7	IKKA	100.0	10000.0
ALW-II-38-3	SBK1	100.0	10000.0
THZ1	RSK2(Kin.Dom.1-N-terminal)	1.8	10000.0
Pictilisib	CSNK1A1L	98.0	1000.0
PLX-4720	TGFBR2	6.6	10000.0
HG-5-113-01	DCAMKL2	100.0	10000.0
Taselisib	KC1G1	99.0	1000.0
ALW-II-49-7	AMPK-alpha2	100.0	10000.0
SB590885	PIK4CB	88.0	10000.0
Dactolisib	WEE2	100.0	1000.0
GW-5074	SIK2	84.0	10000.0
NVP-TAE684	DRAK2	100.0	1000.0
XMD11-85h	NUAK1	100.0	10000.0
PHA-793887	TXK	100.0	10000.0
MPS-1-IN-1	MARK2	100.0	1000.0
Dactolisib	MAK	100.0	1000.0
HG-14-8-02	MYLK2	43.0	10000.0
WZ-4-145	MLCK	100.0	10000.0
Sigma A6730	FGFR3	92.0	10000.0
Torin1	KCC2D	72.0	10000.0
KU63794	FLT4	100.0	10000.0
Ceritinib	EGFR(L858R,T790M)	13.0	1000.0
SCH772984	JAK3(JH1domain-catalytic)	42.0	1000.0
Ribociclib	PIK3C3	96.0	1000.0
XMD11-50	PRKR	84.0	10000.0
XMD11-50	NIM1	100.0	10000.0
NU7441	TBK1	84.0	10000.0
HG-14-10-04	RSK4(Kin.Dom.1-N-terminal)	2.6	10000.0
Seliciclib	MST4	53.0	10000.0
PHA-767491	PI42C	100.0	10000.0
WZ3105	CSNK1E	0.1	10000.0
PLX-4720	CDK14	100.0	10000.0
GSK1059615	PAK1	86.0	10000.0
Vemurafenib	ERK3	100.0	10000.0
Dabrafenib	CLK1	67.0	10000.0
A443654	EPHA4	100.0	10000.0
HG-6-64-01	SIK3	100.0	10000.0
RO-3306	KPCI	100.0	10000.0
NPK76-II-72-1	CSNK2A2	100.0	10000.0
JNK-IN-8	TAOK1	67.0	1000.0
CGP74514A	CDK15	3.1	10000.0
BX-912	ROCK2	0.6	10000.0
WYE-125132	BMPR2	83.0	10000.0
HG-6-64-01	MKNK2	2.7	10000.0
NU7441	ABL1(F317L)-nonphosphorylated	100.0	10000.0
KIN001-123	BRAF(V600E)	100.0	1000.0
PD0325901	MARK1	100.0	10000.0
WH-4-023	MAP3K3	0.8	10000.0
WZ3105	MP2K2	100.0	10000.0
AZD4547	DAPK3	13.0	10000.0
XMD11-85h	TGFBR1	100.0	10000.0
XMD13-2	GRK1	100.0	10000.0
GSK1059615	MAP4K4	47.0	10000.0
AZ-628	MYLK2	100.0	10000.0
Omipalisib	ADCK3	100.0	10000.0
HG-14-8-02	FRK	57.0	10000.0
JNK-IN-5A	STK36	66.0	10000.0
Palbociclib	EPHA8	100.0	1000.0
(s)-CR8	KIT(V559D,T670I)	92.0	10000.0
BS-181	KIT(V559D)	68.0	10000.0
Sigma A6730	CDKL2	77.0	10000.0
AZ-628	SLK	68.0	10000.0
XMD11-50	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
JWE-035	MP2K6	75.0	10000.0
MPS-1-IN-1	MARK3	100.0	1000.0
XMD16-144	SNRK	58.0	10000.0
Taselisib	ABL1(F317L)-phosphorylated	100.0	1000.0
XMD11-85h	NEK1	100.0	10000.0
JNK-IN-8	FES	89.0	1000.0
Canertinib	PKN2	100.0	1000.0
SP600125	DDR2	100.0	10000.0
TGX221	ERK3	100.0	1000.0
KIN001-123	TGFBR2	100.0	1000.0
GSK429286A	M4K3	77.0	10000.0
HG-5-113-01	GSK3B	100.0	10000.0
Ceritinib	KPCT	81.0	1000.0
WZ-7043	LTK	100.0	10000.0
Dinaciclib	BLK	97.0	10000.0
XMD11-50	PAK2	65.0	10000.0
CG-930	ABL2	100.0	10000.0
WH-4-023	ABL1(E255K)-phosphorylated	0.3	10000.0
GW-5074	FLT3(D835Y)	13.0	10000.0
JNK-IN-11	FES	100.0	1000.0
AZD 5438	ROS1	25.0	10000.0
ALW-II-38-3	MLCK	100.0	10000.0
GSK461364	RSK4(Kin.Dom.2-C-terminal)	73.0	10000.0
JNK-IN-8	MAP4K5	100.0	1000.0
XMD14-99	RIPK4	96.0	10000.0
JNK-IN-11	MERTK	49.0	1000.0
WZ-4-145	PLK1	100.0	10000.0
Torin2	TGFBR1	100.0	10000.0
KIN001-220	MARK1	51.0	10000.0
GSK461364	M3K2	100.0	10000.0
Omipalisib	KC1G2	63.0	10000.0
TAK-715	EGFR(L747-S752del,P753S)	28.0	10000.0
Ribociclib	TYK2(JH2domain-pseudokinase)	100.0	1000.0
WZ-4-145	PRKR	100.0	10000.0
XMD8-85	MYO3B	100.0	10000.0
Dactolisib	ABL1(Q252H)	100.0	1000.0
HG-6-64-01	HIPK3	44.0	10000.0
Palbociclib	ACVR1	100.0	1000.0
AZD-6482	PRP4	71.0	10000.0
CGP74514A	NEK5	43.0	10000.0
Sorafenib	RSK3(Kin.Dom.1-N-terminal)	55.0	10000.0
BX-912	TRPM6	76.0	10000.0
ALW-II-49-7	ULK2	100.0	10000.0
ERK5-IN-1	MYLK	98.0	1000.0
Alpelisib	ACVR2B	93.0	1000.0
PHA-793887	NEK2	99.0	10000.0
Sorafenib	TGFBR1	100.0	10000.0
AZD-6482	ERN1	91.0	10000.0
Barasertib	CHK2	100.0	10000.0
SCH772984	M3K6	100.0	1000.0
SP600125	MARK1	100.0	10000.0
AG1478	DCAMKL2	88.0	10000.0
CGP60474	PIK3CA(Q546K)	100.0	10000.0
KIN001-127	CDK9	100.0	10000.0
HG-5-113-01	NDR2	15.0	10000.0
WYE-125132	EPHA1	81.0	10000.0
MLN8054	NEK5	46.0	10000.0
ERK5-IN-1	STK36	99.0	1000.0
AG1478	EGFR(S752-I759del)	2.5	10000.0
JNK-IN-11	CLK1	95.0	1000.0
Taselisib	ERBB4	73.0	1000.0
Lapatinib	AKT1	83.0	10000.0
CG-930	NEK6	100.0	10000.0
Ceritinib	BRAF	99.0	1000.0
XMD-12	TXK	85.0	1000.0
GW843682X	PTK6	84.0	10000.0
XMD11-85h	ADCK3	100.0	10000.0
Neratinib	BMPR1A	78.0	10000.0
Ibrutinib	IGF1R	83.0	1000.0
BMS345541	KIT(A829P)	74.0	10000.0
OTSSP167	KIT(V559D,V654A)	47.0	10000.0
KIN001-111	ADCK3	100.0	1000.0
Dinaciclib	DMPK	79.0	10000.0
WYE-125132	MARK3	92.0	10000.0
Palbociclib	PKAC-alpha	95.0	1000.0
Barasertib	VRK2	100.0	10000.0
XMD8-85	RPS6KA2(Kin.Dom.1)	100.0	10000.0
(s)-CR8	MAP3K15	95.0	10000.0
WZ-4-145	MST1	100.0	10000.0
Ribociclib	CSNK1A1L	100.0	1000.0
XMD14-99	NUAK1	100.0	10000.0
ZM-447439	PDPK1	100.0	10000.0
Torin1	MLTK	22.0	10000.0
HG-5-88-01	ERK8	100.0	10000.0
AZD 5438	ABL1-nonphosphorylated	15.0	10000.0
MRT67307	PIK3CA(H1047Y)	100.0	10000.0
HG-14-8-02	NEK1	98.0	10000.0
HG-14-10-04	TTK	1.2	10000.0
WH-4-023	MRCKB	2.9	10000.0
Sorafenib	MARK2	98.0	10000.0
KIN001-021	DMPK	100.0	1000.0
GSK429286A	CAMK2B	94.0	10000.0
XMD16-144	FLT3(K663Q)	37.0	10000.0
MLN8054	KPCD3	96.0	10000.0
Dabrafenib	MAK	97.0	10000.0
(s)-CR8	M3K2	94.0	10000.0
QL-XI-92	EGFR(L858R,T790M)	97.0	10000.0
BGJ398	TNNI3K	95.0	1000.0
XMD8-85	EPHB2	100.0	10000.0
XMD16-144	CAMK2B	40.0	10000.0
Ceritinib	CDK14	92.0	1000.0
XMD-12	CDK4-cyclinD1	47.0	1000.0
WZ3105	CLK1	1.0	10000.0
XMD11-85h	RPS6KA2(Kin.Dom.2)	100.0	10000.0
AG1478	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
Torin1	MK13	39.0	10000.0
NU7441	PAK3	100.0	10000.0
Lapatinib	BIKE	92.0	10000.0
AS-252424	TNIK	65.3	10000.0
AZD-6482	BMPR1B	97.0	10000.0
BMX-IN-1	RET(M918T)	74.0	10000.0
PHA-793887	CSNK1G3	100.0	10000.0
PHA-793887	CDK15	3.4	10000.0
OTSSP167	PIK3C2B	2.6	10000.0
JNK-IN-8	DYRK1B	100.0	1000.0
Sigma A6730	MRCKB	83.0	10000.0
OTSSP167	BRAF	3.6	10000.0
ZG-10	NIM1	94.0	10000.0
CGP60474	HIPK2	15.0	10000.0
Palbociclib	NLK	97.0	1000.0
MLN8054	TSSK1	90.0	10000.0
Dactolisib	FGFR1	100.0	1000.0
WZ4002	JAK3(Kin.Dom.2)	0.4	10000.0
AZ-628	STK36	88.0	10000.0
KU63794	NEK4	76.0	10000.0
PD0325901	ANKK1	64.0	10000.0
QL-XII-47	NEK7	100.0	1000.0
OTSSP167	CLK4	3.4	10000.0
SP600125	KPCD2	100.0	10000.0
THZ1	CLK4	2.5	10000.0
KIN001-127	CAMK1G	100.0	10000.0
Vemurafenib	NEK3	68.0	10000.0
PHA-767491	BIKE	12.0	10000.0
QL-XI-92	MAP3K15	77.0	10000.0
AZD 5438	RIPK2	41.0	10000.0
GSK1059615	MRCKB	66.0	10000.0
NPK76-II-72-1	SRPK1	100.0	10000.0
CP466722	MP2K6	46.0	10000.0
AG1478	PFCDPK1(P.falciparum)	34.0	10000.0
WZ3105	PIK3CA(E545K)	100.0	10000.0
BMS345541	BLK	100.0	10000.0
JNK-IN-8	BRSK1	100.0	1000.0
GW-5074	DMPK	100.0	10000.0
AZD 5438	HASP	4.8	10000.0
KU63794	AKT2	83.0	10000.0
THZ1	TAK1	4.6	10000.0
MRT67307	SYK	9.6	10000.0
HG-14-8-02	CDK16	97.0	10000.0
XMD8-85	NEK9	100.0	10000.0
Sorafenib	CSNK1G3	91.0	10000.0
CH5424802	STK35	99.0	1000.0
JNK-IN-8	PIP5K2B	99.0	1000.0
ZG-10	MK12	76.0	10000.0
WZ4003	ERBB2	100.0	1000.0
Sorafenib	M3K5	90.0	10000.0
SB590885	LRRK2	79.0	10000.0
Lapatinib	MST4	87.0	10000.0
XMD16-144	MAP3K4	73.0	10000.0
BS-181	ITK	93.0	10000.0
WZ3105	PTK6	100.0	10000.0
Ceritinib	TNK2	2.2	1000.0
JNK-9L	PIK3CA	100.0	10000.0
BX-912	PAK7	1.6	10000.0
WZ4003	KKCC1	14.0	1000.0
Ibrutinib	PAK6	96.0	1000.0
Neratinib	JAK1(JH2domain-pseudokinase)	100.0	10000.0
Torkinib	MAST1	87.0	10000.0
ALW-II-38-3	AURKC	100.0	10000.0
CH5424802	ERK5	92.0	1000.0
JNK-9L	RIOK2	1.4	10000.0
KIN001-220	FLT3(K663Q)	0.4	10000.0
Ribociclib	WEE1	91.0	1000.0
PHA-767491	PGFRA	100.0	10000.0
QL-XI-92	PIK4CB	88.0	10000.0
BI-2536	BMX	100.0	10000.0
KIN001-021	FGFR1	100.0	1000.0
GSK429286A	ABL1(T315I)-nonphosphorylated	70.0	10000.0
CP724714	CDC2L5	100.0	10000.0
BI-2536	PIP5K2B	100.0	10000.0
GSK1059615	DMPK2	90.0	10000.0
JNK-IN-8	ABL1(F317I)-nonphosphorylated	87.0	1000.0
JNK-9L	SRMS	62.0	10000.0
CGP74514A	ABL1(M351T)-phosphorylated	3.8	10000.0
Dinaciclib	CDKL5	1.6	10000.0
Crizotinib	RET(M918T)	17.0	10000.0
CP724714	BMPR2	74.0	10000.0
Abemaciclib	HIPK4	12.0	1000.0
Vemurafenib	BRAF	0.0	10000.0
Ibrutinib	AKT1	100.0	1000.0
Sorafenib	HIPK4	12.0	10000.0
XMD14-99	YSK4	98.0	10000.0
BI-2536	CDK7	100.0	10000.0
WZ4002	PCTK2	100.0	10000.0
CP724714	CIT	76.0	10000.0
AZD 5438	CAMK1G	53.0	10000.0
Momelotinib	TLK1	59.0	10000.0
NU7441	TYRO3	100.0	10000.0
KIN001-123	STK16	22.0	1000.0
WZ4003	EGFR(G719C)	100.0	1000.0
ALW-II-38-3	TYK2(JH1domain-catalytic)	100.0	10000.0
R406	PLK1	6.4	1000.0
WZ-7043	DRAK1	100.0	10000.0
XMD8-85	FLT3(ITD)	100.0	10000.0
AZD-6482	MARK2	90.0	10000.0
Canertinib	ERK4	100.0	1000.0
Momelotinib	MYLK4	0.0	10000.0
XMD-12	GSK3B	88.0	1000.0
Ribociclib	GAK	25.0	1000.0
KIN001-127	FER	15.0	10000.0
BMX-IN-1	PIK3C2G	8.7	10000.0
PHA-767491	TTK	26.0	10000.0
KIN001-123	ACVRL1	100.0	1000.0
Dinaciclib	CLK2	4.2	10000.0
Alpelisib	KGP1	100.0	1000.0
XMD11-50	RET	100.0	10000.0
HG-14-8-02	ALK(C1156Y)	2.5	10000.0
MLN8054	IRAK1	93.0	10000.0
GW843682X	ABL1(F317L)-nonphosphorylated	70.0	10000.0
AZ-628	CDC2L5	100.0	10000.0
BGJ398	RIPK1	94.0	1000.0
Baricitinib	CDK15	100.0	10000.0
XMD13-2	DCLK1	96.0	10000.0
Torkinib	MLTK	29.0	10000.0
Sorafenib	CAMK2A	94.0	10000.0
QL-X-138	ERBB4	22.0	10000.0
CGP74514A	MST2	21.0	10000.0
GSK1059615	CAMK1G	32.0	10000.0
SB590885	MARK4	100.0	10000.0
ALW-II-49-7	LOK	100.0	10000.0
WZ-7043	MK01	100.0	10000.0
NU7441	CASK	100.0	10000.0
Ceritinib	BUB1	100.0	1000.0
ALW-II-38-3	ROS1	100.0	10000.0
HG-14-10-04	IRAK1	0.0	10000.0
XMD14-99	AKT2	100.0	10000.0
PHA-767491	CAMK2G	42.0	10000.0
HG-5-88-01	TXK	100.0	10000.0
CP466722	GRK7	11.0	10000.0
GSK1059615	JAK1(JH2domain-pseudokinase)	57.0	10000.0
ZG-10	HIPK3	4.2	10000.0
BMS-536924	ALK	0.3	1000.0
PHA-767491	CDK8	7.8	10000.0
Omipalisib	NLK	86.0	10000.0
JNK-IN-5A	ICK	81.0	10000.0
Dactolisib	SBK1	100.0	1000.0
JW-7-24-1	MK14	100.0	10000.0
JNK-IN-5A	SGK1	100.0	10000.0
HG-6-64-01	AAK1	26.0	10000.0
CP466722	ERBB4	59.0	10000.0
BX-912	TYK2(JH1domain-catalytic)	0.0	10000.0
Neratinib	CSNK2A2	72.0	10000.0
PHA-793887	ABL1(T315I)-phosphorylated	100.0	10000.0
MRT67307	VRK2	31.0	10000.0
QL-XI-92	FAK1	91.0	10000.0
Omipalisib	ALK(L1196M)	62.0	10000.0
PLX-4720	YANK1	85.0	10000.0
Crizotinib	BIKE	0.5	10000.0
WZ4003	CDK5	100.0	1000.0
Baricitinib	ACVR1	40.0	10000.0
WYE-125132	ZAP70	83.0	10000.0
Alpelisib	AMPK-alpha2	100.0	1000.0
AZD-6482	PIK3CA(C420R)	0.1	10000.0
XMD16-144	LTK	100.0	10000.0
Crizotinib	SYK	10.0	10000.0
GW-5074	CLK3	84.0	10000.0
XMD8-85	MAP3K4	100.0	10000.0
ZG-10	KIT	3.8	10000.0
Ribociclib	TEC	100.0	1000.0
OTSSP167	PIK3CA(E545A)	2.2	10000.0
MRT67307	CSNK1D	100.0	10000.0
QL-XI-92	RIPK4	86.0	10000.0
NG25	TLK2	100.0	10000.0
MPS-1-IN-1	LIMK2	100.0	1000.0
PHA-793887	EGFR(L747-E749del,A750P)	80.0	10000.0
Pictilisib	KIT(D816V)	97.0	1000.0
NG25	CSF1R	0.0	10000.0
TGX221	CAMK1D	100.0	1000.0
CGP60474	CDC2L2	100.0	10000.0
GSK461364	CAMKK2	66.0	10000.0
Sorafenib	KGP2	96.0	10000.0
CP724714	LIMK1	93.0	10000.0
Torin1	AKT2	100.0	10000.0
Pictilisib	M4K3	100.0	1000.0
JNK-IN-8	ADCK3	100.0	1000.0
Pictilisib	CLK4	56.0	1000.0
5z-7-oxozeaenol	DRAK2	100.0	10000.0
(s)-CR8	CSNK1D	17.0	10000.0
Lapatinib	EPHA7	100.0	10000.0
Lapatinib	MARK1	88.0	10000.0
WZ3105	YES	23.0	10000.0
HG-5-88-01	NEK6	100.0	10000.0
Palbociclib	PFPK5(P.falciparum)	96.0	1000.0
Ceritinib	DYRK1B	92.0	1000.0
AZD4547	RET	0.0	10000.0
5z-7-oxozeaenol	CAMK1G	100.0	10000.0
ERK5-IN-1	ROS1	20.0	1000.0
CGP60474	EGFR(L861Q)	100.0	10000.0
Lapatinib	ABL1(T315I)-nonphosphorylated	100.0	10000.0
(s)-CR8	LRRK2(G2019S)	94.0	10000.0
AG1478	TGFBR1	88.0	10000.0
GW-5074	MLK2	93.0	10000.0
WZ4002	PIK3CB	100.0	10000.0
JNK-IN-8	DYRK2	20.0	1000.0
CP466722	KCC2D	55.0	10000.0
A443654	MARK4	100.0	10000.0
PLX-4720	LATS2	86.0	10000.0
Buparlisib	PLK2	100.0	1000.0
OTSSP167	VGFR1	2.2	10000.0
JNK-IN-8	CTK	81.0	1000.0
JNK-IN-11	ABL1(F317I)-phosphorylated	65.0	1000.0
Torin2	EGFR(S752-I759del)	70.0	10000.0
Lapatinib	RSK3(Kin.Dom.2-C-terminal)	100.0	10000.0
WYE-125132	MK01	87.0	10000.0
HG-14-8-02	ERBB2	0.0	10000.0
KIN001-021	PGFRA	100.0	1000.0
BGJ398	MLK3	99.0	1000.0
5z-7-oxozeaenol	FLT3(D835Y)	16.0	10000.0
JWE-035	FLT3(N841I)	21.0	10000.0
KIN001-220	NEK1	17.0	10000.0
ERK5-IN-1	PI42C	93.0	1000.0
HG-14-10-04	ROCK1	2.8	10000.0
Dinaciclib	JAK1(JH2domain-pseudokinase)	61.0	10000.0
HG-14-8-02	FLT3-autoinhibited	100.0	10000.0
BMX-IN-1	KGP2	95.0	10000.0
WZ3105	LYN	50.0	10000.0
AZD 5438	SRPK1	21.0	10000.0
Ribociclib	NEK3	75.0	1000.0
WYE-125132	MST4	70.0	10000.0
Omipalisib	RSK2(Kin.Dom.2-C-terminal)	90.0	10000.0
Crizotinib	ABL1(F317L)-nonphosphorylated	0.0	10000.0
JW-7-24-1	PIK3CG	0.0	10000.0
PHA-767491	TRKB	82.0	10000.0
TAK-715	ADCK4	2.2	10000.0
Barasertib	BRSK1	64.0	10000.0
Crizotinib	CTK	64.0	10000.0
HG-9-91-01	CAMK2A	100.0	10000.0
Torin1	FLT3	16.0	10000.0
WYE-125132	GRK4	100.0	10000.0
GSK461364	YES	71.0	10000.0
ERK5-IN-1	MRCKA	100.0	1000.0
Neratinib	FGFR3(G697C)	100.0	10000.0
NPK76-II-72-1	CSF1R	100.0	10000.0
KU63794	ERBB2	94.0	10000.0
BMS-536924	HCK	0.8	1000.0
NPK76-II-72-1	TNIK	100.0	10000.0
Crizotinib	EGFR(G719S)	86.0	10000.0
ZSTK474	RIPK1	100.0	1000.0
OTSSP167	PDPK1	10.0	10000.0
ERK5-IN-1	RSK4(Kin.Dom.2-C-terminal)	98.0	1000.0
AZD7762	PIK3CA(E545K)	100.0	10000.0
TAK-715	CAMKK2	100.0	10000.0
JWE-035	CAMKK2	47.0	10000.0
CGP60474	RPS6KA6(Kin.Dom.1)	100.0	10000.0
CG-930	DDR2	89.0	10000.0
Sorafenib	TNNI3K	19.0	10000.0
XMD8-92	JAK1(JH1domain-catalytic)	100.0	10000.0
XMD8-85	CDKL2	100.0	10000.0
HG-5-88-01	EPHA2	100.0	10000.0
HG-14-10-04	BIKE	0.4	10000.0
JNK-IN-5A	CDK16	100.0	10000.0
HG-5-88-01	RET	100.0	10000.0
JW-7-24-1	M4K3	100.0	10000.0
CH5424802	TLK1	100.0	1000.0
WZ3105	DYRK1A	20.0	10000.0
AZD7762	GCN2(Kin.Dom.2,S808G)	0.3	10000.0
MPS-1-IN-1	SgK110	100.0	1000.0
HG-9-91-01	ABL1(F317I)-phosphorylated	5.2	10000.0
THZ1	SRPK2	6.8	10000.0
HG-14-8-02	CDK9	100.0	10000.0
BMS-536924	EGFR(L747-T751del,Sins)	8.0	1000.0
CP724714	HUNK	70.0	10000.0
BX-912	MAPKAPK2	100.0	10000.0
5z-7-oxozeaenol	RIPK5	95.0	10000.0
GW843682X	PIK3CB	54.0	10000.0
ALW-II-38-3	ABL1(T315I)	100.0	10000.0
CP724714	IRAK4	100.0	10000.0
HG-5-113-01	GSK3A	18.0	10000.0
AZD4547	DYRK1B	92.0	10000.0
BI-2536	MLK2	100.0	10000.0
AZD4547	MP2K4	100.0	10000.0
Neratinib	MAP4K5	0.9	10000.0
XMD14-99	TNK2	97.0	10000.0
SB590885	ADCK3	7.0	10000.0
GW843682X	PIM2	100.0	10000.0
Sigma A6730	NEK3	84.0	10000.0
PLX-4720	ULK3	60.0	10000.0
CG-930	FGR	84.0	10000.0
MLN8054	ABL1(Y253F)-phosphorylated	8.2	10000.0
PD0325901	FAK1	85.0	10000.0
RO-3306	HUNK	83.0	10000.0
BGJ398	NEK10	93.0	1000.0
AZD 5438	TIE1	22.0	10000.0
BGJ398	BTK	68.0	1000.0
WZ4002	PKN1	100.0	10000.0
R406	PKN2	12.0	1000.0
PD173074	CDK5	100.0	10000.0
ZSTK474	LCK	100.0	1000.0
XMD8-85	CTK	100.0	10000.0
PD0325901	IKKA	100.0	10000.0
Crizotinib	M3K13	10.0	10000.0
Torin2	KGP2	89.0	10000.0
CGP74514A	ANKK1	64.0	10000.0
HG-5-88-01	ALK	4.5	10000.0
KIN001-111	YSK1	100.0	1000.0
KIN001-123	KCC2D	100.0	1000.0
BI-2536	ROCK2	100.0	10000.0
BS-181	CDK11	86.0	10000.0
Seliciclib	PLK3	97.0	10000.0
NU7441	MST3	86.0	10000.0
Barasertib	PI42C	51.0	10000.0
Momelotinib	PIP5K2B	89.0	10000.0
JNK-IN-5A	NEK1	100.0	10000.0
BS-181	ULK3	90.0	10000.0
BMX-IN-1	ITK	43.0	10000.0
JNK-IN-8	CSNK2A1	57.0	1000.0
HG-5-113-01	PAK3	1.0	10000.0
XMD-12	RIPK2	66.0	1000.0
Vemurafenib	AKT2	76.0	10000.0
ALW-II-38-3	AMPK-alpha1	100.0	10000.0
TAK-715	MYO3B	48.0	10000.0
TGX221	AKT2	100.0	1000.0
KIN001-220	ERK5	100.0	10000.0
KIN001-123	EPHB4	100.0	1000.0
JW-7-24-1	EGFR(L858R)	100.0	10000.0
WZ-7043	YANK3	100.0	10000.0
XMD11-85h	YANK3	100.0	10000.0
JNK-IN-5A	KIT(V559D,V654A)	100.0	10000.0
JNK-IN-11	CTK	100.0	1000.0
QL-XII-47	PRKX	100.0	1000.0
ALW-II-38-3	PIK3CA	100.0	10000.0
AZ-628	SBK1	79.0	10000.0
TAK-715	CSNK1D	2.0	10000.0
HG-14-10-04	ABL1-nonphosphorylated	1.0	10000.0
MRT67307	MST4	8.2	10000.0
HG-6-64-01	STK36	0.3	10000.0
AG1478	KGP1	100.0	10000.0
GSK1059615	ROCK2	53.0	10000.0
Torin1	PRKX	83.0	10000.0
HG-6-64-01	KIT	0.0	10000.0
QL-XI-92	TAOK1	76.0	10000.0
KU63794	PAK7	76.0	10000.0
BMX-IN-1	AAK1	58.0	10000.0
Taselisib	EGFR(L858R,T790M)	98.0	1000.0
Baricitinib	ERBB4	94.0	10000.0
XMD8-85	STK35	100.0	10000.0
CGP74514A	CDK16	2.3	10000.0
Neratinib	ANKK1	100.0	10000.0
Canertinib	NEK9	100.0	1000.0
Sigma A6730	KC1G1	100.0	10000.0
MRT67307	STK36	100.0	10000.0
HG-5-113-01	LATS1	100.0	10000.0
BGJ398	ABL1(T315I)-phosphorylated	92.0	1000.0
JNK-9L	MYLK4	26.0	10000.0
Seliciclib	FAK2	87.0	10000.0
AZD4547	PCTK3	12.0	10000.0
Alpelisib	RSK1(Kin.Dom.2-C-terminal)	78.0	1000.0
GW-5074	DDR1	85.0	10000.0
RO-3306	KIT(V559D,V654A)	40.0	10000.0
HG-9-91-01	IRAK3	47.0	10000.0
AZ-628	EGFR	37.0	10000.0
NVP-TAE684	STK36	5.8	1000.0
ERK5-IN-1	MST4	100.0	1000.0
NG25	CDK9	5.8	10000.0
Seliciclib	YANK2	100.0	10000.0
Ribociclib	FLT3(D835H)	100.0	1000.0
QL-XII-47	CLK3	100.0	1000.0
KIN001-127	MYLK	100.0	10000.0
JWE-035	RIOK1	33.0	10000.0
AZD4547	PHKG1	11.0	10000.0
Crizotinib	AKT2	100.0	10000.0
ZG-10	ABL1(H396P)-phosphorylated	54.0	10000.0
R406	PTK6	5.6	1000.0
(s)-CR8	PIK3CA(I800L)	94.0	10000.0
HG-14-8-02	DCAMKL3	100.0	10000.0
Lapatinib	SGK3	100.0	10000.0
KIN001-123	MARK1	100.0	1000.0
Vemurafenib	VGFR2	31.0	10000.0
Ceritinib	TAOK3	96.0	1000.0
ALW-II-49-7	MAP4K2	100.0	10000.0
BMS-536924	CDK8	100.0	1000.0
NU7441	CLK1	89.0	10000.0
XMD16-144	MYLK2	46.0	10000.0
Taselisib	ABL1(Q252H)-phosphorylated	100.0	1000.0
XMD-12	EPHB3	100.0	1000.0
Lapatinib	HIPK2	89.0	10000.0
Crizotinib	MINK	18.0	10000.0
Omipalisib	AKT3	100.0	10000.0
Dinaciclib	SgK110	83.0	10000.0
BMS345541	MST3	81.0	10000.0
SP600125	BRSK2	100.0	10000.0
Barasertib	PIP5K1C	75.0	10000.0
GSK461364	CDC2L5	26.0	10000.0
HG-5-113-01	JNK3	17.0	10000.0
KIN001-021	PIK3CD	100.0	1000.0
TGX221	TLK1	100.0	1000.0
MPS-1-IN-1	MST1R	100.0	1000.0
(s)-CR8	WEE2	93.0	10000.0
KIN001-111	EPHB1	100.0	1000.0
Ribociclib	PRP4	100.0	1000.0
KIN001-111	MAPKAPK5	100.0	1000.0
CGP60474	CSK	100.0	10000.0
BX-912	PHKG1	2.3	10000.0
JNK-9L	KPCD2	93.0	10000.0
AZD7762	OSR1	0.5	10000.0
AZD7762	FLT3(N841I)	0.0	10000.0
Alpelisib	NEK1	100.0	1000.0
A443654	KPCD1	2.0	10000.0
HG-14-8-02	VGFR1	100.0	10000.0
XMD13-2	EGFR(L858R)	93.0	10000.0
KIN001-021	MAP4K2	100.0	1000.0
Abemaciclib	MAP4K4	44.0	1000.0
HG-6-64-01	PFCDPK1(P.falciparum)	0.2	10000.0
XMD14-99	KPCD2	78.0	10000.0
CH5424802	PKMYT1	100.0	1000.0
ALW-II-49-7	VGFR1	33.0	10000.0
KIN001-021	PLK1	100.0	1000.0
Dactolisib	ERBB2	100.0	1000.0
JNK-IN-8	LATS2	74.0	1000.0
WZ-7043	TEC	100.0	10000.0
Abemaciclib	CDKL2	0.9	1000.0
Ceritinib	DAPK2	87.0	1000.0
CG-930	CAMKK2	94.0	10000.0
AZD4547	KIT(A829P)	7.3	10000.0
KIN001-111	TESK1	0.0	1000.0
WZ-4-145	FLT3(K663Q)	21.0	10000.0
Taselisib	SNRK	100.0	1000.0
HG-14-10-04	GRK7	8.4	10000.0
GSK1059615	BRAF(V600E)	41.0	10000.0
SCH772984	SRMS	99.0	1000.0
QL-XII-47	MRCKB	96.0	1000.0
JNK-IN-8	KPCI	93.0	1000.0
TGX221	BRSK1	100.0	1000.0
XMD-12	ERK8	100.0	1000.0
Neratinib	ABL1(F317L)-nonphosphorylated	100.0	10000.0
QL-X-138	CSF1R	90.0	10000.0
PHA-793887	KIT-autoinhibited	92.0	10000.0
Ceritinib	MAP4K4	66.0	1000.0
AZD7762	ABL1(Q252H)-nonphosphorylated	0.0	10000.0
NG25	AKT2	100.0	10000.0
MLN8054	SYK	78.0	10000.0
WZ-4-145	KIT(V559D,V654A)	100.0	10000.0
Barasertib	ADCK4	83.0	10000.0
GW-5074	MERTK	100.0	10000.0
Torin2	TYK2(JH1domain-catalytic)	85.0	10000.0
HG-6-64-01	ABL1(T315I)-phosphorylated	1.8	10000.0
Dactolisib	KCC2D	100.0	1000.0
CGP60474	CAMKK2	100.0	10000.0
PLX-4720	PLK2	83.0	10000.0
XMD14-99	ABL1(T315I)-phosphorylated	100.0	10000.0
CH5424802	RIPK4	79.0	1000.0
JNK-IN-8	MK11	20.0	1000.0
KIN001-123	LIMK2	100.0	1000.0
JWE-035	PAK2	78.0	10000.0
CP724714	ITK	92.0	10000.0
KIN001-021	AMPK-alpha2	100.0	1000.0
Torin2	PRP4	100.0	10000.0
CG-930	VGFR1	86.0	10000.0
ALW-II-49-7	PKAC-beta	100.0	10000.0
HG-9-91-01	PRKX	100.0	10000.0
AZD-6482	FGFR2	80.0	10000.0
BMS345541	CAMK1G	88.0	10000.0
NG25	CAMK1D	7.1	10000.0
NPK76-II-72-1	RIOK1	100.0	10000.0
Dabrafenib	ABL1(H396P)-phosphorylated	46.0	10000.0
RO-3306	CSNK1G3	10.0	10000.0
AZD4547	TLK1	93.0	10000.0
QL-XI-92	CHK2	96.0	10000.0
Ibrutinib	CSNK1D	97.0	1000.0
XMD-12	TAOK1	0.9	1000.0
Sigma A6730	SGK2	100.0	10000.0
GSK429286A	PKAC-alpha	4.2	10000.0
AZD7762	GSK3B	41.0	10000.0
JWE-035	PHKG1	100.0	10000.0
HG-9-91-01	CAMK1D	46.0	10000.0
Lapatinib	TYK2(JH1domain-catalytic)	100.0	10000.0
Canertinib	DRAK1	100.0	1000.0
QL-XI-92	RSK2(Kin.Dom.1-N-terminal)	96.0	10000.0
CGP60474	SIK3	100.0	10000.0
Dinaciclib	HASP	71.0	10000.0
THZ1	NEK2	75.0	10000.0
NU7441	PIP5K1C	61.0	10000.0
MRT67307	RPS6KA4(Kin.Dom.2-C-terminal)	24.0	10000.0
Seliciclib	ERK3	100.0	10000.0
XMD14-99	EPHB2	100.0	10000.0
PHA-793887	ROS1	100.0	10000.0
HG-6-64-01	DAPK2	100.0	10000.0
GSK429286A	KGP2	29.0	10000.0
KIN001-021	RPS6KA1(Kin.Dom.2)	100.0	1000.0
Torin2	CDK9	93.0	10000.0
Vemurafenib	KGP2	94.0	10000.0
JWE-035	RIPK4	12.0	10000.0
SB590885	SRPK2	100.0	10000.0
PHA-767491	GSK3B	0.6	10000.0
AZD 5438	LOK	40.0	10000.0
Ribociclib	KPCD3	60.0	1000.0
GSK1059615	PLK2	29.0	10000.0
NU7441	M3K5	100.0	10000.0
JNK-IN-8	PKNB(M.tuberculosis)	100.0	1000.0
WYE-125132	AXL	88.0	10000.0
JNK-IN-5A	DAPK2	91.0	10000.0
Seliciclib	TRKC	88.0	10000.0
Omipalisib	CTK	75.0	10000.0
KU63794	FER	100.0	10000.0
Dinaciclib	PIK3CG	98.0	10000.0
MLN8054	IKKB	100.0	10000.0
MLN8054	NEK1	56.0	10000.0
WYE-125132	CAMK1	93.0	10000.0
XMD8-92	LCK	100.0	10000.0
AG1478	CSNK2A2	16.0	10000.0
SB590885	BTK	92.0	10000.0
HG-6-64-01	NEK2	100.0	10000.0
R406	BRAF	24.0	1000.0
OTSSP167	TAK1	6.0	10000.0
KIN001-111	CSF1R	2.2	1000.0
JWE-035	DCAMKL3	68.0	10000.0
ALW-II-49-7	ACVR2A	100.0	10000.0
ALW-II-49-7	CSNK2A1	100.0	10000.0
Dabrafenib	ULK1	10.0	10000.0
TAK-715	ABL1(H396P)-phosphorylated	22.0	10000.0
Neratinib	PIK3CA(E542K)	100.0	10000.0
Pictilisib	CDC2L1	100.0	1000.0
Buparlisib	NEK3	84.0	1000.0
HG-14-8-02	BLK	5.2	10000.0
BMS345541	KGP2	100.0	10000.0
Dabrafenib	MAPKAPK5	98.0	10000.0
PD173074	NEK7	100.0	10000.0
XMD8-85	MARK3	100.0	10000.0
JNK-IN-8	NEK2	100.0	1000.0
XMD11-50	TTK	28.0	10000.0
Ibrutinib	AURKC	77.0	1000.0
XMD16-144	JNK3	80.0	10000.0
GSK1059615	CHEK1	57.0	10000.0
Pictilisib	PKNB(M.tuberculosis)	100.0	1000.0
CGP60474	MK03	100.0	10000.0
RO-3306	DRAK2	0.2	10000.0
THZ1	ERK4	1.7	10000.0
Seliciclib	EPHA3	69.0	10000.0
ZSTK474	CAMK2G	100.0	1000.0
GSK461364	ABL1(Q252H)-nonphosphorylated	52.0	10000.0
Torin2	PKN2	72.0	10000.0
XMD8-85	CSNK1E	100.0	10000.0
SB590885	MET	50.0	10000.0
Dabrafenib	IKKE	29.0	10000.0
JNK-IN-8	PFPK5(P.falciparum)	90.0	1000.0
XMD-12	FAK1	75.0	1000.0
Neratinib	RIPK2	98.0	10000.0
AZD4547	GRK1	56.0	10000.0
AZD4547	MAP4K4	1.1	10000.0
ALW-II-49-7	CSNK1G3	100.0	10000.0
THZ1	FLT3	0.1	10000.0
Dabrafenib	EPHB3	98.0	10000.0
Torin2	SNRK	100.0	10000.0
Omipalisib	MARK4	78.0	10000.0
JNK-IN-11	GAK	2.4	1000.0
Omipalisib	RPS6KA5(Kin.Dom.2-C-terminal)	47.0	10000.0
CP724714	NEK2	100.0	10000.0
ZM-447439	EPHA2	84.0	10000.0
NU7441	PLK2	100.0	10000.0
R406	CLK4	1.9	1000.0
XMD8-85	PIM2	100.0	10000.0
KIN001-127	KCC4	100.0	10000.0
HG-5-88-01	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
Dinaciclib	GRK4	87.0	10000.0
BMS345541	GSK3A	100.0	10000.0
AZD4547	KIT(V559D)	0.0	10000.0
TGX221	RAF1	100.0	1000.0
GSK461364	FGR	82.0	10000.0
NPK76-II-72-1	PGFRA	100.0	10000.0
Taselisib	MK03	100.0	1000.0
Taselisib	IRAK3	99.0	1000.0
5z-7-oxozeaenol	CLK3	93.0	10000.0
CH5424802	EPHA5	95.0	1000.0
Sigma A6730	CDK7	82.0	10000.0
NVP-TAE684	AMPK-alpha1	0.1	1000.0
BX-912	AMPK-alpha1	0.4	10000.0
Abemaciclib	FLT3(ITD,D835V)	5.1	1000.0
GW843682X	DCLK1	49.0	10000.0
WZ4003	MRCKA	100.0	1000.0
XMD8-92	FAK2	100.0	10000.0
CGP74514A	ABL1(F317I)-phosphorylated	14.0	10000.0
KIN001-220	CSNK1G3	100.0	10000.0
BX-912	OSR1	25.0	10000.0
THZ1	NEK7	0.1	10000.0
HG-14-8-02	YES	100.0	10000.0
AZD 5438	ADCK3	56.0	10000.0
Lapatinib	SBK1	94.0	10000.0
Torin1	CSK	71.0	10000.0
ZSTK474	PCTK2	100.0	1000.0
HG-5-113-01	KPCT	24.0	10000.0
Seliciclib	MLK2	100.0	10000.0
XMD14-99	M3K2	79.0	10000.0
GW843682X	AURKB	34.0	10000.0
ALW-II-38-3	NDR1	100.0	10000.0
CP466722	M4K1	56.0	10000.0
JNK-9L	FLT4	84.0	10000.0
AZD 5438	AKT1	100.0	10000.0
KIN001-220	TAK1	2.9	10000.0
PHA-767491	KIT-autoinhibited	100.0	10000.0
KIN001-123	TRKC	100.0	1000.0
Palbociclib	ABL1(F317I)-nonphosphorylated	100.0	1000.0
SB590885	GRK7	100.0	10000.0
SB590885	IKKE	85.0	10000.0
Pictilisib	FGFR1	78.0	1000.0
PHA-767491	TGFBR2	9.4	10000.0
RO-3306	MK13	100.0	10000.0
JNK-IN-5A	ERK3	86.0	10000.0
Buparlisib	CDKL3	99.0	1000.0
Barasertib	VGFR1	1.0	10000.0
SCH772984	PCTK2	100.0	1000.0
Ribociclib	WNK4	100.0	1000.0
OTSSP167	FAK2	4.0	10000.0
BS-181	PAK3	58.0	10000.0
JNK-IN-8	M3K6	92.0	1000.0
OTSSP167	LRRK2	99.0	10000.0
KIN001-127	EPHA2	25.0	10000.0
WZ-7043	ABL1(F317I)	100.0	10000.0
OTSSP167	BRSK2	24.0	10000.0
Barasertib	SIK1	88.0	10000.0
Lapatinib	NEK9	100.0	10000.0
NVP-TAE684	BMPR1B	1.2	1000.0
Seliciclib	AAK1	100.0	10000.0
KU63794	ADCK3	87.0	10000.0
WZ4003	KIT(V559D,V654A)	100.0	1000.0
MLN8054	HIPK1	14.0	10000.0
JNK-IN-11	KC1G2	0.9	1000.0
Alpelisib	EIF2AK1	100.0	1000.0
KIN001-123	PIM1	100.0	1000.0
JNK-IN-5A	ABL1(Q252H)-phosphorylated	100.0	10000.0
Buparlisib	TIE1	100.0	1000.0
R406	SLK	0.1	1000.0
PHA-793887	ERK8	0.2	10000.0
JNK-IN-8	RIOK3	72.0	1000.0
Neratinib	KPCI	90.0	10000.0
KIN001-220	ABL1(M351T)-phosphorylated	19.0	10000.0
THZ1	SRMS	15.0	10000.0
JNK-IN-8	NEK3	73.0	1000.0
Ribociclib	TRKA	100.0	1000.0
Taselisib	ERK8	100.0	1000.0
KU63794	AKT3	97.0	10000.0
HG-14-8-02	CASK	99.0	10000.0
ERK5-IN-1	FLT3(D835H)	100.0	1000.0
HG-6-64-01	TLK1	100.0	10000.0
THZ1	TLK1	67.0	10000.0
WZ3105	JNK3	100.0	10000.0
HG-14-10-04	EPHA1	7.0	10000.0
Omipalisib	RIPK2	30.0	10000.0
PHA-793887	TAOK1	9.0	10000.0
WZ4003	DAPK3	6.7	1000.0
HG-14-8-02	TNNI3K	92.0	10000.0
CG-930	EGFR(G719C)	20.0	10000.0
XMD-12	EGFR(S752-I759del)	92.0	1000.0
ZG-10	KIT(D816H)	51.0	10000.0
TGX221	CAMK1G	100.0	1000.0
JW-7-24-1	NUAK1	100.0	10000.0
Crizotinib	PIK3CA(E545A)	21.0	10000.0
THZ1	PKAC-alpha	2.2	10000.0
JNK-IN-8	FER	100.0	1000.0
GSK461364	ABL1-phosphorylated	70.0	10000.0
Seliciclib	KPCT	100.0	10000.0
HG-14-10-04	AKT2	100.0	10000.0
Crizotinib	CDK9	88.0	10000.0
Ceritinib	CDKL2	90.0	1000.0
KIN001-123	ACVR2A	100.0	1000.0
(s)-CR8	TLK1	89.0	10000.0
CH5424802	TXK	86.0	1000.0
CH5424802	FLT3-autoinhibited	68.0	1000.0
JNK-IN-5A	ABL1(H396P)-phosphorylated	99.0	10000.0
Alpelisib	STK36	99.0	1000.0
WH-4-023	PKN1	15.0	10000.0
WH-4-023	TNNI3K	0.0	10000.0
WZ4002	RET(M918T)	100.0	10000.0
ERK5-IN-1	CSNK1A1	100.0	1000.0
Torin2	LRRK2	80.0	10000.0
Taselisib	EGFR(L747-T751del,Sins)	84.0	1000.0
NG25	MKNK2	4.2	10000.0
ZM-447439	RIOK3	100.0	10000.0
BGJ398	PKN1	71.0	1000.0
GSK429286A	KIT(V559D,V654A)	92.0	10000.0
HG-9-91-01	KC1G1	89.0	10000.0
NG25	JAK1(Kin.Dom.1)	100.0	10000.0
HG-5-113-01	GAK	2.5	10000.0
(s)-CR8	ABL1(M351T)-phosphorylated	88.0	10000.0
Pictilisib	CAMKK2	97.0	1000.0
CP466722	ADCK3	10.0	10000.0
5z-7-oxozeaenol	GAK	10.0	10000.0
Baricitinib	TNIK	50.0	10000.0
Baricitinib	MAP3K3	0.4	10000.0
PD0325901	ABL1(F317L)-nonphosphorylated	100.0	10000.0
BMS345541	ICK	100.0	10000.0
BGJ398	KPCD3	100.0	1000.0
BI-2536	ERBB4	100.0	10000.0
GSK1059615	ACVR1	36.0	10000.0
XMD16-144	ABL1(F317I)-nonphosphorylated	3.0	10000.0
HG-14-8-02	ABL1(F317L)-phosphorylated	26.0	10000.0
Torkinib	PFCDPK1(P.falciparum)	4.2	10000.0
NU7441	STK16	98.0	10000.0
PHA-767491	TYRO3	100.0	10000.0
CGP74514A	HASP	0.9	10000.0
KIN001-123	MLK2	100.0	1000.0
Ribociclib	MLTK	100.0	1000.0
PLX-4720	MLCK	41.0	10000.0
Buparlisib	MERTK	99.0	1000.0
SCH772984	RPS6KA4(Kin.Dom.2-C-terminal)	51.0	1000.0
JNK-IN-5A	SNRK	100.0	10000.0
XMD14-99	CSNK1A1	84.0	10000.0
AZD 5438	ERN1	30.0	10000.0
XMD14-99	AURKA	100.0	10000.0
BMS345541	FGFR3(G697C)	100.0	10000.0
NPK76-II-72-1	MAP3K4	100.0	10000.0
Torkinib	INSRR	100.0	10000.0
Abemaciclib	MK01	100.0	1000.0
PLX-4720	MP2K2	1.0	10000.0
WZ3105	MP2K7	100.0	10000.0
PHA-793887	RET	100.0	10000.0
WZ3105	TRKB	5.3	10000.0
XMD11-50	CSF1R	98.0	10000.0
CP724714	EPHB3	86.0	10000.0
GSK429286A	KPCD2	76.0	10000.0
MPS-1-IN-1	PIP5K2B	100.0	1000.0
CGP74514A	GAK	36.0	10000.0
Barasertib	BTK	7.2	10000.0
BX-912	RIPK4	0.3	10000.0
XMD14-99	AMPK-alpha2	68.0	10000.0
Buparlisib	JAK1(JH2domain-pseudokinase)	88.0	1000.0
Pictilisib	NEK9	100.0	1000.0
Crizotinib	TGFBR1	4.0	10000.0
ALW-II-49-7	ABL1(H396P)	100.0	10000.0
XMD13-2	ERK8	2.9	10000.0
AZ-628	TTK	95.0	10000.0
ALW-II-49-7	BIKE	100.0	10000.0
HG-14-10-04	MAP4K5	47.0	10000.0
Crizotinib	BTK	22.0	10000.0
Seliciclib	MP2K3	89.0	10000.0
Vemurafenib	MP2K1	10.0	10000.0
Buparlisib	YANK3	97.0	1000.0
AZD-6482	STK39	100.0	10000.0
HG-14-8-02	MK14	100.0	10000.0
AZD4547	MK01	98.0	10000.0
MPS-1-IN-1	JAK3(Kin.Dom.2)	100.0	1000.0
XMD11-85h	M3K2	100.0	10000.0
Torkinib	CDK16	98.0	10000.0
BI-D1870	AURKC	4.0	10000.0
Sigma A6730	KIT(V559D,V654A)	92.0	10000.0
PLX-4720	MYLK4	15.0	10000.0
Momelotinib	TXK	100.0	10000.0
GW843682X	MTOR	78.0	10000.0
GSK1059615	FYN	94.0	10000.0
CP466722	MAP4K2	43.0	10000.0
ZG-10	LTK	100.0	10000.0
5z-7-oxozeaenol	M3K5	96.0	10000.0
XMD16-144	DRAK1	97.0	10000.0
SP600125	PDPK1	100.0	10000.0
ALW-II-49-7	PAK6	100.0	10000.0
MRT67307	SBK1	2.3	10000.0
XMD13-2	PFCDPK1(P.falciparum)	18.0	10000.0
JNK-IN-5A	GSK3A	72.0	10000.0
MPS-1-IN-1	MAP3K4	100.0	1000.0
Sorafenib	MK11	0.2	10000.0
JNK-IN-11	EPHA6	32.0	1000.0
NVP-TAE684	DCAMKL2	0.0	1000.0
Lapatinib	TIE2	84.0	10000.0
Dactolisib	NLK	100.0	1000.0
MPS-1-IN-1	TXK	100.0	1000.0
BS-181	JAK2(JH1domain-catalytic)	86.0	10000.0
CP724714	PIK3C2G	24.0	10000.0
XMD14-99	CAMK1G	42.0	10000.0
TAK-715	ABL1(T315I)-phosphorylated	59.0	10000.0
AS-252424	CAMKK2	70.0	10000.0
Crizotinib	MLK2	79.0	10000.0
Barasertib	CDC2L5	66.0	10000.0
AZ-628	MYO3B	100.0	10000.0
Barasertib	ABL1(T315I)-phosphorylated	31.0	10000.0
Dinaciclib	PFCDPK1(P.falciparum)	59.0	10000.0
SB590885	MAP3K4	83.0	10000.0
QL-X-138	EPHB3	100.0	10000.0
CP724714	MLTK	76.0	10000.0
KIN001-021	ABL2	100.0	1000.0
ERK5-IN-1	AXL	93.0	1000.0
BS-181	KIT(V559D,T670I)	94.0	10000.0
HG-14-10-04	PRKR	41.0	10000.0
GW843682X	DRAK1	100.0	10000.0
Palbociclib	SNARK	16.0	1000.0
ALW-II-38-3	TNK1	100.0	10000.0
Crizotinib	KIT(A829P)	35.0	10000.0
JW-7-24-1	KPCD2	100.0	10000.0
GSK1059615	MP2K5	46.0	10000.0
XMD14-99	TIE2	88.0	10000.0
KIN001-127	PKN2	100.0	10000.0
Omipalisib	MST4	88.0	10000.0
NG25	RPS6KA3(Kin.Dom.1)	100.0	10000.0
A443654	KC1G1	3.7	10000.0
Alpelisib	SLK	85.0	1000.0
CG-930	GSK3A	90.0	10000.0
XMD13-2	SRMS	93.0	10000.0
NU7441	DDR1	100.0	10000.0
CGP60474	EGFR(G719S)	100.0	10000.0
Baricitinib	ADCK4	90.0	10000.0
Sigma A6730	EPHA4	100.0	10000.0
QL-XI-92	KCC2D	83.0	10000.0
AZD4547	MKNK1	87.0	10000.0
Seliciclib	BTK	99.0	10000.0
BI-2536	FES	100.0	10000.0
XMD8-85	YSK1	100.0	10000.0
Ribociclib	PKAC-alpha	100.0	1000.0
Abemaciclib	DMPK2	91.0	1000.0
CGP74514A	CHK2	16.0	10000.0
ZM-447439	TIE2	33.0	10000.0
GSK461364	ABL1(T315I)-phosphorylated	58.0	10000.0
Buparlisib	PAK2	96.0	1000.0
CGP60474	TBK1	100.0	10000.0
NG25	CDK2	11.0	10000.0
NPK76-II-72-1	MLTK	100.0	10000.0
OTSSP167	RIPK2	28.0	10000.0
BX-912	MUSK	9.4	10000.0
Pictilisib	MYLK4	52.0	1000.0
KIN001-220	VGFR2	16.0	10000.0
ZG-10	LATS1	100.0	10000.0
ZM-447439	ROCK1	98.0	10000.0
QL-XI-92	NEK2	100.0	10000.0
Abemaciclib	TLK2	27.0	1000.0
TAK-715	CDC2L2	90.0	10000.0
XMD-12	FER	100.0	1000.0
JNK-IN-8	KIT(V559D,V654A)	81.0	1000.0
Torin1	MAPKAPK5	100.0	10000.0
Ceritinib	TYK2(JH1domain-catalytic)	95.0	1000.0
Pictilisib	DAPK1	77.0	1000.0
PD173074	NEK9	100.0	10000.0
TAK-715	TXK	75.0	10000.0
RO-3306	FLT3(ITD)	6.6	10000.0
SCH772984	ABL1(Y253F)-phosphorylated	100.0	1000.0
AG1478	ABL1(F317L)-phosphorylated	9.2	10000.0
SP600125	YANK3	100.0	10000.0
JNK-IN-8	DCAMKL3	100.0	1000.0
RO-3306	WNK3	45.0	10000.0
TAK-715	ULK3	88.0	10000.0
HG-5-113-01	ABL1(H396P)	10.0	10000.0
Seliciclib	LRRK2(G2019S)	98.0	10000.0
KIN001-111	ITK	100.0	1000.0
CGP74514A	MUSK	38.0	10000.0
HG-6-64-01	BMPR1B	76.0	10000.0
KIN001-123	FAK2	22.0	1000.0
TAK-715	NEK11	100.0	10000.0
HG-9-91-01	LTK	2.4	10000.0
XMD8-92	BTK	100.0	10000.0
AZD 5438	MAP3K14	5.3	10000.0
CGP74514A	ROCK1	5.7	10000.0
R406	MARK4	0.7	1000.0
KIN001-220	CHEK1	100.0	10000.0
Dactolisib	MELK	100.0	1000.0
BX-912	EPHA2	60.0	10000.0
ZG-10	MP2K6	47.0	10000.0
WZ-4-145	ABL1(T315I)	6.4	10000.0
AZD7762	CAMK2A	3.6	10000.0
HG-5-88-01	MP2K6	100.0	10000.0
NU7441	CAMK1D	68.0	10000.0
XMD16-144	RPS6KA4(Kin.Dom.1-N-terminal)	59.0	10000.0
Momelotinib	KPCD3	65.0	10000.0
GW-5074	CSNK1D	72.0	10000.0
Dabrafenib	ABL2	9.3	10000.0
Torkinib	PHKG2	12.0	10000.0
CGP60474	NDR2	100.0	10000.0
THZ1	CLK3	3.0	10000.0
Ribociclib	PHKG1	100.0	1000.0
XMD14-99	KIT(V559D,V654A)	94.0	10000.0
BI-2536	DAPK3	3.6	10000.0
ZM-447439	LATS1	100.0	10000.0
JNK-IN-8	RET(V804L)	100.0	1000.0
Omipalisib	ACVR1B	85.0	10000.0
ALW-II-38-3	PGFRB	0.0	1000.0
BGJ398	MP2K3	98.0	1000.0
Sigma A6730	TESK1	74.0	10000.0
PHA-793887	ICK	0.6	10000.0
Buparlisib	MK11	84.0	1000.0
SB590885	M3K5	94.0	10000.0
RO-3306	EPHA7	84.0	10000.0
SCH772984	MST4	100.0	1000.0
HG-14-10-04	PTK6	0.5	10000.0
Barasertib	JAK2(JH1domain-catalytic)	58.0	10000.0
AZD 5438	PKN1	34.0	10000.0
CGP74514A	TRPM6	51.0	10000.0
CGP60474	AKT3	100.0	10000.0
WZ4002	MLK3	100.0	10000.0
ALW-II-38-3	ZAP70	100.0	10000.0
BMS345541	MAST1	100.0	10000.0
BI-D1870	ALK	26.0	10000.0
BMS345541	NEK2	100.0	10000.0
MRT67307	PLK1	16.0	10000.0
SCH772984	ULK3	81.0	1000.0
Pictilisib	FLT3(D835Y)	89.0	1000.0
HG-9-91-01	AURKA	0.4	10000.0
NPK76-II-72-1	ERK4	100.0	10000.0
Barasertib	AKT3	88.0	10000.0
Sorafenib	TNK1	37.0	10000.0
KIN001-111	CDK5	100.0	1000.0
Dactolisib	RPS6KA1(Kin.Dom.1)	100.0	1000.0
CGP60474	CHEK1	100.0	10000.0
AS-252424	SLK	85.9	10000.0
HG-5-113-01	AURKC	0.7	10000.0
R406	AKT3	100.0	1000.0
Abemaciclib	TLK1	21.0	1000.0
BMS345541	KKCC1	100.0	10000.0
XMD8-92	RIOK1	100.0	10000.0
Pictilisib	EPHA2	83.0	1000.0
Neratinib	CDK7	68.0	10000.0
MLN8054	CAMK2B	71.0	10000.0
Canertinib	MK11	100.0	1000.0
BX-912	KIT(V559D,T670I)	2.3	10000.0
BI-2536	PKN1	100.0	10000.0
Momelotinib	CSNK2A2	6.2	10000.0
Torin2	MINK	56.0	10000.0
Dactolisib	JAK1(JH1domain-catalytic)	16.0	1000.0
Lapatinib	STK33	99.0	10000.0
KIN001-220	MP2K2	57.0	10000.0
Torin2	EPHA3	86.0	10000.0
Ibrutinib	CAMKK2	73.0	1000.0
HG-5-88-01	SIK2	100.0	10000.0
GSK1059615	ABL1(H396P)-nonphosphorylated	53.0	10000.0
XMD11-85h	PIK3CA(Q546K)	100.0	10000.0
GSK429286A	MARK2	99.0	10000.0
ZSTK474	SLK	100.0	1000.0
XMD14-99	LATS1	100.0	10000.0
WZ-4-145	MK12	100.0	10000.0
ALW-II-38-3	PIP5K1A	100.0	10000.0
JWE-035	FRK	19.0	10000.0
BMS-536924	CDK7	100.0	1000.0
WZ-7043	SRPK2	100.0	10000.0
XMD13-2	ROCK1	57.0	10000.0
KU63794	TAOK1	83.0	10000.0
Barasertib	RET(V804M)	5.5	10000.0
Sigma A6730	NEK10	78.0	10000.0
WZ3105	MP2K4	76.0	10000.0
JWE-035	TIE1	22.0	10000.0
Sorafenib	MAP4K5	7.2	10000.0
CG-930	KCC2D	76.0	10000.0
NU7441	NDR2	95.0	10000.0
JNK-9L	CSNK2A1	2.2	10000.0
Vemurafenib	FLT3	2.4	10000.0
HG-6-64-01	M3K12	22.0	10000.0
(s)-CR8	PRKR	94.0	10000.0
PHA-767491	BRAF	22.0	10000.0
XMD13-2	RSK3(Kin.Dom.1-N-terminal)	96.0	10000.0
AZD7762	M4K3	0.4	10000.0
Neratinib	IKKB	100.0	10000.0
Sorafenib	TNK2	96.0	10000.0
KIN001-123	ERK3	100.0	1000.0
QL-XII-47	PIP5K2B	100.0	1000.0
BI-D1870	CLK4	3.6	10000.0
SB590885	STK16	94.0	10000.0
Abemaciclib	PIP5K1C	67.0	1000.0
TAK-715	SIK1	100.0	10000.0
KU63794	KCC2D	100.0	10000.0
GSK1059615	ERBB2	66.0	10000.0
BMS345541	LATS1	100.0	10000.0
BX-912	ABL2	7.8	10000.0
JNK-9L	KIT(D816V)	5.3	10000.0
WYE-125132	PAK6	100.0	10000.0
PD0325901	MERTK	100.0	10000.0
Pictilisib	DDR1	100.0	1000.0
AZD 5438	IKKE	46.0	10000.0
CGP74514A	TGFBR1	91.0	10000.0
R406	FLT3(K663Q)	0.1	1000.0
CGP74514A	ICK	15.0	10000.0
BI-2536	CAMK1G	100.0	10000.0
BX-912	ABL1(H396P)-nonphosphorylated	0.1	10000.0
Palbociclib	ROCK1	100.0	1000.0
QL-XII-47	IKKE	100.0	1000.0
HG-14-10-04	TESK1	90.0	10000.0
AZD 5438	LYN	63.0	10000.0
NU7441	RIPK5	99.0	10000.0
BMX-IN-1	IGF1R	80.0	10000.0
WZ4003	KGP2	100.0	1000.0
HG-5-88-01	CSNK2A1	100.0	10000.0
Lapatinib	EIF2AK1	100.0	10000.0
SB590885	MST4	91.0	10000.0
Sorafenib	NEK1	88.0	10000.0
XMD8-85	ABL1(T315I)	100.0	10000.0
(s)-CR8	CTK	95.0	10000.0
AG1478	MARK2	74.0	10000.0
HG-9-91-01	PIP5K1A	16.0	10000.0
AZD-6482	EIF2AK1	97.0	10000.0
GW843682X	BMX	69.0	10000.0
NG25	BIKE	100.0	10000.0
GSK1059615	TBK1	29.0	10000.0
WZ4002	TAK1	100.0	10000.0
TAK-715	MST1R	88.0	10000.0
Dinaciclib	EGFR(T790M)	77.0	10000.0
BMS345541	DRAK1	68.0	10000.0
JNK-IN-5A	KC1G1	50.0	10000.0
AZD-6482	DDR1	100.0	10000.0
Sigma A6730	DRAK2	89.0	10000.0
JNK-IN-11	TIE1	23.0	1000.0
AZD4547	BRSK2	50.0	10000.0
KIN001-127	MP2K2	100.0	10000.0
Sorafenib	NEK5	90.0	10000.0
NPK76-II-72-1	ANKK1	100.0	10000.0
JWE-035	TBK1	60.0	10000.0
NU7441	ABL1(T315I)-phosphorylated	42.0	10000.0
MRT67307	IRAK4	45.0	10000.0
TGX221	IKKA	100.0	1000.0
HG-6-64-01	MAK	100.0	10000.0
Dabrafenib	RIPK5	17.0	10000.0
XMD-12	CHEK1	76.0	1000.0
Taselisib	NEK9	100.0	1000.0
GSK1059615	MP2K1	1.8	10000.0
WZ4003	PKAC-alpha	100.0	1000.0
Omipalisib	TEC	81.0	10000.0
ALW-II-49-7	EPHB1	1.8	1000.0
Palbociclib	SBK1	100.0	1000.0
JNK-9L	TGFBR2	100.0	10000.0
ALW-II-38-3	HIPK4	100.0	10000.0
PD0325901	ABL1(Y253F)-phosphorylated	92.0	10000.0
AZD-6482	FLT3(R834Q)	94.0	10000.0
Torkinib	LATS1	55.0	10000.0
TAK-715	TNNI3K	86.0	10000.0
BMS-536924	MAPKAPK2	100.0	1000.0
CGP60474	M4K1	100.0	10000.0
Canertinib	AKT3	100.0	1000.0
WZ4002	AKT1	100.0	10000.0
AZD4547	WEE1	49.0	10000.0
Dabrafenib	MRCKB	93.0	10000.0
OTSSP167	OSR1	36.0	10000.0
JWE-035	CSNK1E	45.0	10000.0
BMX-IN-1	CDC2L2	100.0	10000.0
MRT67307	TAOK2	21.0	10000.0
SB590885	NEK3	71.0	10000.0
WZ-7043	TNK2	100.0	10000.0
Abemaciclib	EGFR(G719C)	83.0	1000.0
Baricitinib	TAOK2	1.8	10000.0
QL-X-138	FES	100.0	10000.0
BMS-536924	FES	100.0	1000.0
Ribociclib	YSK1	100.0	1000.0
Crizotinib	MK03	100.0	10000.0
HG-5-88-01	PLK4	2.8	10000.0
THZ1	YANK1	26.0	10000.0
HG-9-91-01	SIK3	1.0	10000.0
HG-5-88-01	PAK3	100.0	10000.0
Dactolisib	MK11	100.0	1000.0
AZD4547	KIT(V559D,V654A)	2.8	10000.0
Barasertib	NIM1	97.0	10000.0
AZD7762	ABL1(E255K)-phosphorylated	0.0	10000.0
5z-7-oxozeaenol	CAMK2A	72.0	10000.0
Neratinib	KPCD	100.0	10000.0
Vemurafenib	RIPK5	22.0	10000.0
BGJ398	BMPR1A	100.0	1000.0
KIN001-220	ERK8	54.0	10000.0
NPK76-II-72-1	FAK1	0.4	10000.0
WYE-125132	BMPR1B	93.0	10000.0
HG-5-88-01	EGFR(S752-I759del)	1.2	10000.0
JNK-IN-8	MAP4K2	67.0	1000.0
PLX-4720	NEK7	59.0	10000.0
Taselisib	TNNI3K	81.0	1000.0
R406	DCAMKL2	33.0	1000.0
PD173074	ABL1	100.0	10000.0
MPS-1-IN-1	RIPK2	100.0	1000.0
ALW-II-38-3	CSNK1A1L	100.0	10000.0
ZSTK474	ACVRL1	100.0	1000.0
ALW-II-49-7	RIPK4	100.0	10000.0
CP466722	EPHA6	23.0	10000.0
Palbociclib	MELK	84.0	1000.0
Buparlisib	PIM3	100.0	1000.0
NPK76-II-72-1	CLK3	100.0	10000.0
MRT67307	ABL1(E255K)-phosphorylated	19.0	10000.0
WH-4-023	DRAK2	100.0	10000.0
PD0325901	MAK	100.0	10000.0
NPK76-II-72-1	TNK2	100.0	10000.0
QL-XI-92	NIM1	98.0	10000.0
CGP74514A	JAK1(JH1domain-catalytic)	83.0	10000.0
QL-X-138	KCC2D	36.0	10000.0
HG-9-91-01	CSNK1D	65.0	10000.0
Ibrutinib	SIK1	93.0	1000.0
Ribociclib	PIK3CD	100.0	1000.0
GSK461364	STK39	11.0	10000.0
ALW-II-38-3	TRKA	100.0	10000.0
QL-XII-47	MET	100.0	1000.0
CP724714	TGFBR2	94.0	10000.0
Abemaciclib	ERK5	78.0	1000.0
Taselisib	CDK3	99.0	1000.0
BMS345541	TGFBR1	100.0	10000.0
CP466722	TNIK	40.0	10000.0
Barasertib	OSR1	100.0	10000.0
JNK-9L	RSK4(Kin.Dom.2-C-terminal)	88.0	10000.0
Sigma A6730	DRAK1	100.0	10000.0
Taselisib	EPHA5	95.0	1000.0
Abemaciclib	BIKE	14.0	1000.0
5z-7-oxozeaenol	DCAMKL2	100.0	10000.0
5z-7-oxozeaenol	EGFR(L858R)	80.0	10000.0
PHA-793887	DRAK2	93.0	10000.0
ZG-10	IGF1R	100.0	10000.0
THZ1	IKKA	17.0	10000.0
Palbociclib	GCN2(Kin.Dom.2,S808G)	59.0	1000.0
HG-9-91-01	DMPK	0.5	10000.0
BMS-536924	EGFR(L858R)	6.1	1000.0
ZG-10	FLT3(D835Y)	18.0	10000.0
JWE-035	RET(V804M)	1.2	10000.0
GW843682X	M3K12	68.0	10000.0
AG1478	AKT2	100.0	10000.0
MRT67307	RIOK2	93.0	10000.0
KIN001-021	DRAK2	100.0	1000.0
GW843682X	EPHB3	76.0	10000.0
WH-4-023	MK14	52.0	10000.0
JWE-035	SRC	2.0	10000.0
PD173074	MARK2	100.0	10000.0
JWE-035	MLCK	100.0	10000.0
AG1478	ULK2	87.0	10000.0
SB590885	LTK	67.0	10000.0
GW843682X	EGFR(G719S)	98.0	10000.0
Dabrafenib	RIOK3	40.0	10000.0
XMD8-92	ROCK1	100.0	10000.0
XMD13-2	ROCK2	53.0	10000.0
Abemaciclib	CSF1R-autoinhibited	88.0	1000.0
AZ-628	RET(V804L)	31.0	10000.0
AZD4547	TIE2	4.8	10000.0
Baricitinib	FLT3(R834Q)	85.0	10000.0
HG-14-8-02	ERBB3	87.0	10000.0
Barasertib	ABL1(M351T)-phosphorylated	39.0	10000.0
SP600125	AMPK-alpha1	100.0	10000.0
CGP60474	PKAC-alpha	100.0	10000.0
QL-XI-92	CSNK2A2	81.0	10000.0
HG-14-10-04	EIF2AK1	20.0	10000.0
Ceritinib	PIP5K1C	95.0	1000.0
Sorafenib	BMPR1A	100.0	10000.0
Momelotinib	BMX	100.0	10000.0
Palbociclib	FLT3(ITD,D835V)	24.0	1000.0
Torin2	NEK3	95.0	10000.0
AZ-628	TEC	100.0	10000.0
GSK429286A	ANKK1	97.0	10000.0
Palbociclib	MAPKAPK5	100.0	1000.0
MLN8054	EPHA1	15.0	10000.0
HG-14-10-04	TRKC	42.0	10000.0
MRT67307	GCN2(Kin.Dom.2,S808G)	27.0	10000.0
JWE-035	LCK	5.0	10000.0
KIN001-111	KPCE	100.0	1000.0
CG-930	MK14	3.4	10000.0
Vemurafenib	PIK3CA(I800L)	93.0	10000.0
NG25	MK13	0.6	10000.0
TAK-715	MUSK	100.0	10000.0
Crizotinib	RIOK2	56.0	10000.0
Sigma A6730	RSK1(Kin.Dom.2-C-terminal)	100.0	10000.0
R406	ABL1(F317L)	100.0	1000.0
BMS-536924	FGR	1.8	1000.0
BMX-IN-1	BMPR2	50.0	10000.0
SP600125	ABL1(F317I)	100.0	10000.0
KIN001-220	MERTK	2.0	10000.0
Dactolisib	RIPK2	100.0	1000.0
WZ4002	ACVRL1	100.0	10000.0
WZ4003	ADCK3	100.0	1000.0
ZM-447439	ABL1(Q252H)-phosphorylated	36.0	10000.0
ALW-II-38-3	YSK1	100.0	10000.0
ZG-10	KPCD3	94.0	10000.0
CP724714	TNK2	78.0	10000.0
BMS-536924	DDR2	100.0	1000.0
JNK-IN-5A	ABL2	86.0	10000.0
GSK461364	DMPK	63.0	10000.0
WZ-4-145	PAK4	100.0	10000.0
JW-7-24-1	CSNK1D	19.0	10000.0
GW-5074	CAMK2B	17.0	10000.0
Taselisib	ROS1	100.0	1000.0
Ibrutinib	KCC4	100.0	1000.0
XMD16-144	STK35	89.0	10000.0
PD173074	PGFRB	38.0	10000.0
HG-6-64-01	KPCE	75.0	10000.0
ERK5-IN-1	MYLK4	100.0	1000.0
AZD-6482	ERK4	98.0	10000.0
WZ4002	CAMK2A	100.0	10000.0
Dinaciclib	TLK2	0.5	10000.0
Dactolisib	PKAC-alpha	100.0	1000.0
Torin2	CDK11	100.0	10000.0
WZ4002	MK01	100.0	10000.0
AS-252424	EGFR(E746-A750del)	14.6	10000.0
ERK5-IN-1	PKN1	100.0	1000.0
KIN001-111	FRK	0.2	1000.0
QL-XI-92	MARK4	100.0	10000.0
A443654	EGFR(L747-S752del,P753S)	100.0	10000.0
SP600125	KPCT	100.0	10000.0
Dinaciclib	DYRK2	50.0	10000.0
PHA-793887	CAMK2G	80.0	10000.0
PD0325901	NEK4	78.0	10000.0
ZG-10	LOK	100.0	10000.0
TAK-715	BIKE	78.0	10000.0
Crizotinib	NIM1	12.0	10000.0
Ibrutinib	ERBB2	0.0	1000.0
NU7441	JAK2(JH1domain-catalytic)	67.0	10000.0
Buparlisib	ERBB2	75.0	1000.0
HG-6-64-01	FGR	0.2	10000.0
PD0325901	CDK2	91.0	10000.0
MPS-1-IN-1	CDK5	100.0	1000.0
Crizotinib	MARK2	20.0	10000.0
RO-3306	IGF1R	100.0	10000.0
ZSTK474	DYRK1B	100.0	1000.0
HG-9-91-01	CSF1R-autoinhibited	0.5	10000.0
Dabrafenib	LTK	90.0	10000.0
Torkinib	CDK8	43.0	10000.0
Ribociclib	EPHB4	100.0	1000.0
JNK-IN-11	RET(M918T)	10.0	1000.0
GSK461364	BTK	100.0	10000.0
WZ-7043	CIT	100.0	10000.0
SP600125	MST1R	100.0	10000.0
JNK-9L	RIPK4	53.0	10000.0
Taselisib	CAMKK2	96.0	1000.0
Omipalisib	CDC2L5	97.0	10000.0
ERK5-IN-1	CDC2L1	100.0	1000.0
BMS-536924	RPS6KA4(Kin.Dom.1)	24.0	1000.0
HG-5-113-01	PKN2	5.4	10000.0
Sorafenib	MK12	51.0	10000.0
Torin2	TYRO3	100.0	10000.0
HG-14-10-04	FGFR4	0.0	10000.0
XMD8-85	FLT4	100.0	10000.0
CG-930	MLTK	100.0	10000.0
Ibrutinib	GSK3B	72.0	1000.0
Ibrutinib	CAMK2A	100.0	1000.0
KIN001-127	CSNK1D	100.0	10000.0
QL-XII-47	NEK1	95.0	1000.0
Torkinib	NEK6	100.0	10000.0
JNK-IN-11	DRAK2	100.0	1000.0
Sorafenib	GRK1	100.0	10000.0
PLX-4720	AXL	40.0	10000.0
Buparlisib	MRCKA	100.0	1000.0
Dactolisib	GSK3B	100.0	1000.0
QL-XI-92	TYK2(JH2domain-pseudokinase)	100.0	10000.0
ERK5-IN-1	NEK4	89.0	1000.0
AS-252424	AKT1	100.0	10000.0
KIN001-123	DDR2	100.0	1000.0
ZM-447439	PIP5K1A	100.0	10000.0
OTSSP167	SNARK	0.4	10000.0
JNK-IN-8	CLK1	100.0	1000.0
Seliciclib	TGFBR2	100.0	10000.0
Ibrutinib	LRRK2	85.0	1000.0
Sorafenib	NLK	32.0	10000.0
BI-2536	SIK2	100.0	10000.0
QL-XI-92	TIE1	100.0	10000.0
JNK-IN-8	ADCK4	93.0	1000.0
HG-9-91-01	MKNK1	85.0	10000.0
QL-X-138	AKT1	89.0	10000.0
TAK-715	M4K1	86.0	10000.0
KIN001-111	MARK4	100.0	1000.0
AZD7762	BMPR1A	19.0	10000.0
JNK-IN-5A	PLK3	100.0	10000.0
TAK-715	CDK15	95.0	10000.0
XMD11-85h	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
AZD7762	CLK2	0.7	10000.0
HG-5-113-01	RPS6KA6(Kin.Dom.1)	29.0	10000.0
KIN001-127	CSNK2A2	100.0	10000.0
MRT67307	MYO3B	100.0	10000.0
XMD11-85h	MET	100.0	10000.0
BS-181	WEE2	84.0	10000.0
Sigma A6730	MYO3A	100.0	10000.0
WZ4002	ACVR2A	100.0	10000.0
GW-5074	ABL1(F317I)-phosphorylated	85.0	10000.0
HG-14-10-04	MAP3K4	20.0	10000.0
Dabrafenib	EPHA1	13.0	10000.0
THZ1	MP2K4	1.9	10000.0
WZ3105	EGFR(E746-A750del)	88.0	10000.0
Momelotinib	INSRR	100.0	10000.0
GSK429286A	EPHB6	68.0	10000.0
HG-9-91-01	INSRR	100.0	10000.0
Sigma A6730	EPHA6	98.0	10000.0
JNK-9L	KPCT	100.0	10000.0
PLX-4720	SIK2	84.0	10000.0
NPK76-II-72-1	MP2K6	100.0	10000.0
MRT67307	NEK1	67.0	10000.0
Crizotinib	PHKG2	32.0	10000.0
KU63794	HIPK2	58.0	10000.0
BS-181	PAK4	74.0	10000.0
MLN8054	RET(V804L)	88.0	10000.0
Pictilisib	DRAK1	98.0	1000.0
JNK-IN-5A	CDK4-cyclinD3	84.0	10000.0
HG-5-113-01	RIOK2	13.0	10000.0
WYE-125132	EPHA2	81.0	10000.0
MRT67307	TAK1	4.8	10000.0
AS-252424	BRAF(V600E)	45.6	10000.0
Taselisib	PIM2	93.0	1000.0
PHA-793887	SIK2	90.0	10000.0
Sigma A6730	IRAK1	76.0	10000.0
ZG-10	CSNK1E	56.0	10000.0
NG25	RPS6KA6(Kin.Dom.1)	100.0	10000.0
QL-XI-92	KPCD	91.0	10000.0
MRT67307	PKAC-beta	100.0	10000.0
TGX221	NEK6	100.0	1000.0
Alpelisib	DDR1	100.0	1000.0
WYE-125132	PGFRB	89.0	10000.0
KIN001-220	PIK3CA(H1047L)	100.0	10000.0
XMD11-85h	MST3	100.0	10000.0
XMD14-99	CSNK2A2	88.0	10000.0
BMX-IN-1	MUSK	82.0	10000.0
THZ1	RIOK1	0.7	10000.0
GW-5074	NEK6	96.0	10000.0
JW-7-24-1	ERK8	6.4	10000.0
Torkinib	RIPK4	6.3	10000.0
AZ-628	ROCK2	80.0	10000.0
Neratinib	LRRK2	99.0	10000.0
Ribociclib	BLK	100.0	1000.0
AZD4547	FLT4	0.6	10000.0
Taselisib	MAPKAPK5	100.0	1000.0
BGJ398	DAPK1	84.0	1000.0
JNK-IN-5A	ABL1(F317L)-nonphosphorylated	100.0	10000.0
XMD16-144	SNARK	2.6	10000.0
XMD-12	TEC	100.0	1000.0
NPK76-II-72-1	BLK	100.0	10000.0
Omipalisib	CAMK2A	72.0	10000.0
Canertinib	KCC4	100.0	1000.0
ZG-10	KIT(D816V)	30.0	10000.0
BMX-IN-1	SRPK3	67.0	10000.0
AG1478	CDK2	100.0	10000.0
HG-14-10-04	YSK4	0.4	10000.0
Buparlisib	MET(M1250T)	98.0	1000.0
XMD13-2	LCK	100.0	10000.0
JWE-035	LTK	100.0	10000.0
JNK-IN-11	PAK3	52.0	1000.0
XMD16-144	MERTK	46.0	10000.0
JNK-IN-5A	INSR	100.0	10000.0
Vemurafenib	HIPK1	90.0	10000.0
Lapatinib	TAOK2	100.0	10000.0
QL-XI-92	M3K5	100.0	10000.0
ZM-447439	M3K13	27.0	10000.0
QL-XII-47	RSK4(Kin.Dom.2-C-terminal)	66.0	1000.0
KIN001-220	IRAK3	1.8	10000.0
MLN8054	CSF1R	38.0	10000.0
KIN001-111	MP2K6	34.0	1000.0
NU7441	ABL1(F317L)-phosphorylated	100.0	10000.0
JNK-IN-5A	PIK3C2G	87.0	10000.0
(s)-CR8	SIK1	100.0	10000.0
AZD7762	PIP5K2B	0.2	10000.0
KIN001-127	EGFR(S752-I759del)	100.0	10000.0
Torkinib	MK03	100.0	10000.0
NPK76-II-72-1	CDK8	100.0	10000.0
Abemaciclib	TNNI3K	100.0	1000.0
TAK-715	MLTK	9.4	10000.0
Torin1	PKAC-beta	100.0	10000.0
KIN001-220	CLK1	22.0	10000.0
AZD-6482	MARK3	89.0	10000.0
Torin2	PIP5K2B	100.0	10000.0
WZ4002	MST1	100.0	10000.0
KU63794	TEC	92.0	10000.0
NU7441	PAK7	96.0	10000.0
XMD-12	PIK3C2G	100.0	1000.0
WZ3105	ACVR1B	87.0	10000.0
JNK-IN-5A	BMPR2	84.0	10000.0
Pictilisib	EPHA8	100.0	1000.0
Omipalisib	IGF1R	100.0	10000.0
KIN001-021	SRPK3	100.0	1000.0
WH-4-023	CAMK2B	98.0	10000.0
AZD 5438	ALK	42.0	10000.0
KU63794	CLK2	64.0	10000.0
WZ4002	MAP3K4	100.0	10000.0
KIN001-123	RPS6KA1(Kin.Dom.1)	100.0	1000.0
ZSTK474	EGFR(E746-A750del)	100.0	1000.0
HG-14-10-04	KPCD1	0.3	10000.0
AZD-6482	NLK	94.0	10000.0
Ribociclib	RSK2(Kin.Dom.2-C-terminal)	100.0	1000.0
AS-252424	RET(V804L)	90.7	10000.0
JWE-035	GSK3B	47.0	10000.0
BGJ398	FGR	63.0	1000.0
Vemurafenib	TEC	100.0	10000.0
Palbociclib	MARK2	100.0	1000.0
Ribociclib	PFPK5(P.falciparum)	100.0	1000.0
Dactolisib	CDK15	100.0	1000.0
Baricitinib	BRSK2	70.0	10000.0
SP600125	EPHB3	100.0	10000.0
JNK-IN-8	TYK2(JH2domain-pseudokinase)	80.0	1000.0
CGP74514A	SRPK1	32.0	10000.0
CG-930	ERK4	42.0	10000.0
Seliciclib	TAOK3	95.0	10000.0
Ceritinib	EPHA3	98.0	1000.0
Torin2	PIK3CA(M1043I)	1.0	10000.0
Seliciclib	EGFR(L747-T751del,Sins)	100.0	10000.0
JNK-IN-5A	SBK1	100.0	10000.0
KIN001-111	LKB1	100.0	1000.0
Dabrafenib	CDK14	4.6	10000.0
Barasertib	KIT(V559D,T670I)	0.0	10000.0
R406	CDK8	100.0	1000.0
Dabrafenib	NEK5	75.0	10000.0
BGJ398	SgK110	83.0	1000.0
Dactolisib	CHEK1	100.0	1000.0
RO-3306	CASK	79.0	10000.0
Baricitinib	MYLK	7.4	10000.0
ZG-10	MET(M1250T)	100.0	10000.0
CGP74514A	PIK3CA(C420R)	63.0	10000.0
ZSTK474	SNARK	100.0	1000.0
WZ4002	LTK	3.6	10000.0
AZD 5438	PFCDPK1(P.falciparum)	1.5	10000.0
XMD8-85	SRPK1	100.0	10000.0
KIN001-123	DCAMKL2	100.0	1000.0
BS-181	AMPK-alpha1	84.0	10000.0
5z-7-oxozeaenol	LCK	60.0	10000.0
QL-XI-92	RIOK1	100.0	10000.0
XMD11-50	ERBB3	100.0	10000.0
AS-252424	MST4	58.5	10000.0
PLX-4720	JAK1(JH1domain-catalytic)	77.0	10000.0
Canertinib	CAMK2G	100.0	1000.0
GSK1059615	CIT	4.4	10000.0
KIN001-021	ERBB2	100.0	1000.0
AG1478	KIT(V559D,V654A)	82.0	10000.0
A443654	CHK2	100.0	10000.0
AZD-6482	MP2K7	90.0	10000.0
PLX-4720	PIK3CA(E542K)	100.0	10000.0
BX-912	EGFR(L861Q)	75.0	10000.0
GW-5074	JAK3(JH1domain-catalytic)	14.0	10000.0
Ribociclib	ERN1	100.0	1000.0
GSK429286A	SIK3	94.0	10000.0
AZD4547	CTK	36.0	10000.0
GW843682X	KPCL	100.0	10000.0
AZD-6482	CSNK2A1	100.0	10000.0
Dinaciclib	HCK	88.0	10000.0
KIN001-123	CAMK2G	100.0	1000.0
SB590885	TNK1	100.0	10000.0
ZM-447439	MAP3K15	100.0	10000.0
TAK-715	TNK2	78.0	10000.0
Sigma A6730	ABL1(F317L)-phosphorylated	69.0	10000.0
(s)-CR8	CSNK1E	15.0	10000.0
Torin2	DYRK2	88.0	10000.0
JWE-035	MYLK4	99.0	10000.0
KU63794	ACVR1B	91.0	10000.0
AZD4547	EGFR(E746-A750del)	86.0	10000.0
BMX-IN-1	SIK1	69.0	10000.0
NU7441	OSR1	100.0	10000.0
Alpelisib	SGK1	100.0	1000.0
CG-930	CDKL3	86.0	10000.0
THZ1	CSNK1A1	47.0	10000.0
JNK-9L	NEK3	0.8	10000.0
RO-3306	STK35	69.0	10000.0
Torin1	MST2	24.0	10000.0
QL-XI-92	TNNI3K	54.0	10000.0
HG-9-91-01	KGP1	100.0	10000.0
XMD8-85	ADCK4	100.0	10000.0
KU63794	AMPK-alpha1	97.0	10000.0
CP466722	PLK3	33.0	10000.0
PD173074	PAK6	100.0	10000.0
CH5424802	ABL1(Q252H)-phosphorylated	52.0	1000.0
KIN001-021	TSSK1	100.0	1000.0
Alpelisib	FGFR1	85.0	1000.0
(s)-CR8	ANKK1	94.0	10000.0
AZD7762	EPHB3	95.0	10000.0
AZD-6482	INSRR	100.0	10000.0
AZD7762	KGP1	0.8	10000.0
BX-912	PIM2	100.0	10000.0
Lapatinib	IRAK3	79.0	10000.0
JWE-035	ABL1-nonphosphorylated	0.0	10000.0
KIN001-220	BLK	28.0	10000.0
RO-3306	SNRK	80.0	10000.0
ZSTK474	STK33	100.0	1000.0
KIN001-123	ROS1	100.0	1000.0
ZG-10	RPS6KA4(Kin.Dom.2-C-terminal)	80.0	10000.0
ZM-447439	ERBB2	0.0	10000.0
BX-912	CHEK1	0.4	10000.0
WZ4003	PIP5K1A	11.0	1000.0
XMD16-144	PIK3C2B	56.0	10000.0
Alpelisib	AKT3	95.0	1000.0
Sorafenib	PIP5K2B	94.0	10000.0
QL-XII-47	EPHA1	100.0	1000.0
BS-181	EGFR	91.0	10000.0
Sigma A6730	ACVR2A	88.0	10000.0
XMD13-2	MST1R	90.0	10000.0
AZ-628	CAMK1	87.0	10000.0
Sorafenib	YSK4	0.4	10000.0
BMX-IN-1	EGFR(S752-I759del)	65.0	10000.0
AS-252424	KPCT	84.7	10000.0
GW-5074	KPCE	100.0	10000.0
Barasertib	PAK4	100.0	10000.0
Ribociclib	KPCT	58.0	1000.0
ALW-II-49-7	MK12	100.0	10000.0
HG-14-8-02	LATS1	100.0	10000.0
Dabrafenib	VGFR2	88.0	10000.0
ZSTK474	ANKK1	100.0	1000.0
Dactolisib	TYRO3	100.0	1000.0
Buparlisib	MAP3K3	100.0	1000.0
(s)-CR8	STK35	15.0	10000.0
WZ-4-145	AKT1	100.0	10000.0
GW843682X	JNK3	89.0	10000.0
NVP-TAE684	PIK3CA(E545K)	100.0	1000.0
XMD13-2	PIK3CA	99.0	10000.0
R406	JNK1	0.0	1000.0
Abemaciclib	WNK1	100.0	1000.0
Lapatinib	ACVR1B	96.0	10000.0
AZD4547	PKN1	42.0	10000.0
PD173074	BRAF(V600E)	100.0	10000.0
NPK76-II-72-1	PRKR	100.0	10000.0
Torkinib	ABL1(E255K)-phosphorylated	0.1	10000.0
TAK-715	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
ALW-II-38-3	HUNK	100.0	10000.0
R406	ABL1(M351T)	23.0	1000.0
Barasertib	KCC4	100.0	10000.0
NG25	DRAK1	100.0	10000.0
ZG-10	TAK1	9.2	10000.0
XMD-12	PIK3CA(H1047L)	100.0	1000.0
HG-14-8-02	EGFR(L858R,T790M)	0.0	10000.0
Canertinib	PCTK3	100.0	1000.0
Barasertib	IGF1R	100.0	10000.0
KIN001-220	KPCE	100.0	10000.0
KIN001-123	EGFR(L747-E749del,A750P)	14.0	1000.0
Taselisib	ABL1-phosphorylated	100.0	1000.0
AZD7762	PKMYT1	33.0	10000.0
MLN8054	CDK4-cyclinD3	100.0	10000.0
KIN001-127	CIT	100.0	10000.0
WZ3105	CLK3	9.0	10000.0
OTSSP167	INSRR	23.0	10000.0
KIN001-021	YANK3	100.0	1000.0
WYE-125132	ERBB3	100.0	10000.0
TGX221	EGFR	100.0	1000.0
JNK-9L	DDR2	100.0	10000.0
BI-2536	PTK6	100.0	10000.0
AZD-6482	PLK1	100.0	10000.0
AZD4547	TYK2(JH1domain-catalytic)	0.2	10000.0
R406	PKMYT1	100.0	1000.0
MPS-1-IN-1	FYN	100.0	1000.0
Palbociclib	ABL1(T315I)-nonphosphorylated	100.0	1000.0
QL-XII-47	PAK6	100.0	1000.0
ERK5-IN-1	MAST1	100.0	1000.0
MPS-1-IN-1	CDK16	100.0	1000.0
HG-6-64-01	BRAF	0.6	10000.0
WZ3105	CAMK2G	76.0	10000.0
KIN001-127	PIK3C2B	100.0	10000.0
Torin2	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
Palbociclib	CDC2L5	100.0	1000.0
OTSSP167	CAMK1	100.0	10000.0
BX-912	DDR1	100.0	10000.0
MPS-1-IN-1	FGFR3	100.0	1000.0
Vemurafenib	ADCK4	100.0	10000.0
OTSSP167	AURKB	0.1	10000.0
Dactolisib	CAMK2A	100.0	1000.0
Baricitinib	RIOK2	65.0	10000.0
CGP74514A	PIK3CG	57.0	10000.0
GW-5074	DCLK1	86.0	10000.0
CP466722	PHKG1	55.0	10000.0
Dinaciclib	PIK3CB	83.0	10000.0
JNK-IN-5A	NEK5	79.0	10000.0
CGP60474	FRK	100.0	10000.0
BMX-IN-1	EGFR(L858R,T790M)	44.0	10000.0
RO-3306	MERTK	72.0	10000.0
OTSSP167	MAP4K5	13.0	10000.0
ZG-10	MYO3A	73.0	10000.0
AZD4547	MLK3	7.4	10000.0
ZG-10	MKNK2	7.3	10000.0
QL-XI-92	TAOK3	77.0	10000.0
BMS-536924	MAP3K4	100.0	1000.0
ZG-10	RSK3(Kin.Dom.1-N-terminal)	83.0	10000.0
ALW-II-38-3	ACVR1	100.0	10000.0
CGP74514A	LIMK1	100.0	10000.0
QL-X-138	TXK	7.0	10000.0
BI-D1870	RET(V804L)	13.0	10000.0
XMD16-144	TNNI3K	28.0	10000.0
PD173074	TLK1	100.0	10000.0
JW-7-24-1	PLK1	100.0	10000.0
KIN001-127	DMPK2	100.0	10000.0
Dabrafenib	DYRK2	92.0	10000.0
PHA-767491	DRAK1	0.3	10000.0
NU7441	LRRK2(G2019S)	100.0	10000.0
BGJ398	DRAK2	54.0	1000.0
Alpelisib	SIK2	89.0	1000.0
JNK-9L	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
BI-D1870	M3K2	13.0	10000.0
MRT67307	PAK2	76.0	10000.0
XMD8-92	ADCK4	100.0	10000.0
OTSSP167	FLT3-autoinhibited	2.8	10000.0
WH-4-023	DAPK3	88.0	10000.0
XMD16-144	M4K3	28.0	10000.0
SP600125	CSNK1E	100.0	10000.0
Vemurafenib	ICK	73.0	10000.0
GSK429286A	DAPK2	92.0	10000.0
Neratinib	STK16	96.0	10000.0
Torin1	PIK3CA(H1047L)	2.6	10000.0
Ibrutinib	MET(Y1235D)	84.0	1000.0
Momelotinib	GRK7	100.0	10000.0
PHA-767491	FGFR4	97.0	10000.0
Vemurafenib	CSNK1A1L	100.0	10000.0
AZD4547	MET	42.0	10000.0
Abemaciclib	RSK4(Kin.Dom.2-C-terminal)	61.0	1000.0
5z-7-oxozeaenol	KIT(L576P)	0.7	10000.0
JNK-IN-11	MET	55.0	1000.0
RO-3306	IRAK1	7.1	10000.0
5z-7-oxozeaenol	WNK1	97.0	10000.0
SP600125	MP2K4	0.0	10000.0
Vemurafenib	SBK1	92.0	10000.0
HG-5-88-01	PIP5K2B	100.0	10000.0
OTSSP167	PKN1	81.0	10000.0
Ceritinib	IGF1R	1.0	1000.0
ALW-II-38-3	LTK	100.0	10000.0
Dactolisib	MAP3K4	100.0	1000.0
Torin2	SIK3	79.0	10000.0
Momelotinib	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
ZM-447439	IGF1R	100.0	10000.0
A443654	FLT3(D835Y)	0.2	10000.0
XMD16-144	CLK2	41.0	10000.0
THZ1	ABL1(T315I)-nonphosphorylated	2.6	10000.0
SB590885	CDK4-cyclinD1	58.0	10000.0
KIN001-123	TGFBR1	100.0	1000.0
TAK-715	BMPR2	100.0	10000.0
AZD-6482	FAK1	88.0	10000.0
ZSTK474	KPCD3	100.0	1000.0
Dabrafenib	ERN1	32.0	10000.0
XMD16-144	DYRK1A	73.0	10000.0
AG1478	IRAK1	5.6	10000.0
A443654	SYK	100.0	10000.0
AZD-6482	DMPK	100.0	10000.0
Crizotinib	DMPK	1.6	10000.0
KIN001-021	ABL1(Q252H)	100.0	1000.0
AS-252424	CLK1	52.5	10000.0
CG-930	PIK3CA(E542K)	100.0	10000.0
QL-XI-92	ERK4	100.0	10000.0
BGJ398	AKT1	98.0	1000.0
MRT67307	PGFRA	96.0	10000.0
WZ4002	TGFBR2	100.0	10000.0
HG-14-8-02	RET	100.0	10000.0
GSK1059615	PKAC-alpha	35.0	10000.0
MLN8054	PIP5K1C	49.0	10000.0
PLX-4720	PIK4CB	25.0	10000.0
ZG-10	EGFR(E746-A750del)	100.0	10000.0
ERK5-IN-1	NEK1	84.0	1000.0
XMD11-85h	EGFR(G719C)	100.0	10000.0
BS-181	LKB1	100.0	10000.0
WZ3105	GRK4	43.0	10000.0
Canertinib	MK01	100.0	1000.0
Lapatinib	EGFR	0.0	10000.0
HG-9-91-01	PIK3CA(I800L)	99.0	10000.0
MRT67307	KIT(V559D,T670I)	70.0	10000.0
Pictilisib	MST2	100.0	1000.0
HG-14-10-04	PGFRB	0.0	10000.0
WZ-4-145	PCTK3	100.0	10000.0
WYE-125132	MET(M1250T)	87.0	10000.0
QL-XII-47	STK39	100.0	1000.0
CGP60474	LCK	100.0	10000.0
MRT67307	EGFR(G719S)	94.0	10000.0
HG-14-10-04	MYLK2	21.0	10000.0
Abemaciclib	SRPK1	31.0	1000.0
HG-9-91-01	LRRK2	25.0	10000.0
AZD7762	MARK2	0.9	10000.0
AG1478	ZAP70	78.0	10000.0
AS-252424	HIPK1	5.0	10000.0
GSK461364	IKKE	58.0	10000.0
PHA-767491	ACVR2A	3.4	10000.0
Dactolisib	MYLK2	100.0	1000.0
WZ-7043	KKCC1	100.0	10000.0
Dinaciclib	HIPK4	16.0	10000.0
A443654	MERTK	33.0	10000.0
QL-X-138	DDR2	75.0	10000.0
BMS345541	KIT(V559D)	23.0	10000.0
Ribociclib	ICK	82.0	1000.0
QL-XII-47	TAOK2	88.0	1000.0
JWE-035	IKKB	100.0	10000.0
(s)-CR8	PIK3C2G	56.0	10000.0
WH-4-023	PAK1	6.8	10000.0
SCH772984	IKKE	100.0	1000.0
MPS-1-IN-1	EGFR(L747-T751del,Sins)	100.0	1000.0
SB590885	LRRK2(G2019S)	76.0	10000.0
Seliciclib	PKNB(M.tuberculosis)	87.0	10000.0
SB590885	EGFR(L858R,T790M)	93.0	10000.0
HG-5-113-01	FLT3(ITD)	0.3	10000.0
GW-5074	RSK1(Kin.Dom.1-N-terminal)	42.0	10000.0
HG-5-113-01	FGFR3(G697C)	20.0	10000.0
Taselisib	MP2K7	100.0	1000.0
XMD8-92	OSR1	100.0	10000.0
QL-XI-92	ACVR1	84.0	10000.0
Pictilisib	ABL1(F317L)-nonphosphorylated	100.0	1000.0
KIN001-111	CSNK2A1	100.0	1000.0
ALW-II-49-7	ERK8	100.0	10000.0
AZD 5438	TNK2	70.0	10000.0
Canertinib	CAMK2A	100.0	1000.0
AZD7762	EGFR(L858R)	2.2	10000.0
HG-14-8-02	NLK	100.0	10000.0
XMD8-92	CDKL5	100.0	10000.0
WH-4-023	BIKE	1.8	10000.0
QL-X-138	KC1G1	86.0	10000.0
NPK76-II-72-1	MRCKB	100.0	10000.0
WH-4-023	BRSK2	81.0	10000.0
Torkinib	AURKC	68.0	10000.0
Torin1	EGFR(L861Q)	90.0	10000.0
JWE-035	ABL1(Q252H)-nonphosphorylated	0.0	10000.0
JNK-IN-11	GCN2(Kin.Dom.2,S808G)	76.0	1000.0
KIN001-220	M4K1	38.0	10000.0
CP466722	NEK1	36.0	10000.0
AZ-628	ULK2	100.0	10000.0
JNK-IN-8	MUSK	100.0	1000.0
TGX221	STK35	100.0	1000.0
AZD7762	HIPK1	7.2	10000.0
KIN001-220	ACVR2A	2.2	10000.0
Neratinib	ERBB3	0.1	10000.0
QL-XI-92	FRK	12.0	10000.0
ALW-II-38-3	YSK4	100.0	10000.0
BS-181	PHKG1	49.0	10000.0
Palbociclib	CAMK2G	98.0	1000.0
Vemurafenib	ABL1(T315I)-nonphosphorylated	79.0	10000.0
BGJ398	AKT3	99.0	1000.0
Momelotinib	MTOR	100.0	10000.0
GSK429286A	PAK7	79.0	10000.0
Alpelisib	WNK3	100.0	1000.0
ZM-447439	PIK4CB	100.0	10000.0
MLN8054	ACVR2B	100.0	10000.0
HG-14-8-02	MYLK	8.2	10000.0
CP724714	MST1R	100.0	10000.0
(s)-CR8	DAPK2	91.0	10000.0
KIN001-021	EPHB3	100.0	1000.0
Baricitinib	KPCL	12.0	10000.0
Abemaciclib	CASK	49.0	1000.0
Omipalisib	CSF1R-autoinhibited	100.0	10000.0
ZG-10	PIM3	78.0	10000.0
Dactolisib	TTK	100.0	1000.0
BMS345541	CSNK1G3	100.0	10000.0
KU63794	MYO3B	100.0	10000.0
XMD16-144	FER	100.0	10000.0
XMD13-2	RIOK1	10.0	10000.0
Baricitinib	MET(Y1235D)	100.0	10000.0
BI-D1870	BMPR2	0.1	10000.0
CH5424802	EPHB6	98.0	1000.0
HG-5-113-01	MK13	100.0	10000.0
TAK-715	ABL1(F317I)-nonphosphorylated	31.0	10000.0
Abemaciclib	NEK5	80.0	1000.0
Sorafenib	RIOK3	100.0	10000.0
QL-X-138	LATS2	53.0	10000.0
XMD13-2	DYRK1B	89.0	10000.0
WH-4-023	ABL1(H396P)-phosphorylated	0.0	10000.0
BGJ398	EPHA6	87.0	1000.0
JWE-035	CAMK1D	76.0	10000.0
BMX-IN-1	RSK4(Kin.Dom.2-C-terminal)	56.0	10000.0
WH-4-023	KGP2	92.0	10000.0
Momelotinib	MKNK2	1.2	10000.0
TGX221	SgK110	100.0	1000.0
A443654	SLK	100.0	10000.0
XMD13-2	CSNK2A2	16.0	10000.0
BX-912	AMPK-alpha2	0.5	10000.0
TGX221	ROS1	100.0	1000.0
Ibrutinib	OSR1	78.0	1000.0
JNK-IN-11	TRKC	84.0	1000.0
HG-14-10-04	IGF1R	0.9	10000.0
Vemurafenib	FRK	16.0	10000.0
Omipalisib	NEK7	100.0	10000.0
Lapatinib	BRSK2	83.0	10000.0
Ibrutinib	BMX	14.0	1000.0
Ibrutinib	DYRK1B	93.0	1000.0
Torin2	NEK7	82.0	10000.0
Ibrutinib	INSRR	90.0	1000.0
Sigma A6730	DCLK1	86.0	10000.0
QL-X-138	DYRK1A	0.1	10000.0
Palbociclib	ABL1(F317L)-phosphorylated	100.0	1000.0
Palbociclib	LTK	100.0	1000.0
ZSTK474	CLK2	100.0	1000.0
HG-14-8-02	MK01	78.0	10000.0
MRT67307	M4K3	41.0	10000.0
KIN001-021	RPS6KA5(Kin.Dom.2)	100.0	1000.0
Omipalisib	MAP4K5	54.0	10000.0
OTSSP167	CDK4-cyclinD3	0.7	10000.0
Momelotinib	EGFR(L747-E749del,A750P)	100.0	10000.0
Omipalisib	WEE1	100.0	10000.0
GSK461364	KPCT	47.0	10000.0
ZG-10	FGFR4	100.0	10000.0
CH5424802	SIK2	80.0	1000.0
KU63794	KGP1	91.0	10000.0
JNK-IN-5A	BRAF(V600E)	93.0	10000.0
HG-14-8-02	FES	69.0	10000.0
CG-930	MARK4	100.0	10000.0
HG-6-64-01	MST2	5.2	10000.0
Taselisib	EPHA3	98.0	1000.0
Neratinib	SRPK2	85.0	10000.0
XMD14-99	DRAK2	73.0	10000.0
THZ1	ROCK2	25.0	10000.0
Barasertib	PFPK5(P.falciparum)	100.0	10000.0
AZD4547	RPS6KA5(Kin.Dom.2-C-terminal)	89.0	10000.0
Torin1	CDKL3	92.0	10000.0
XMD8-92	NEK2	100.0	10000.0
HG-5-113-01	MAP3K3	4.8	10000.0
XMD16-144	DMPK2	100.0	10000.0
MLN8054	DMPK2	92.0	10000.0
Taselisib	BUB1	97.0	1000.0
BX-912	CDK4-cyclinD3	0.4	10000.0
PLX-4720	TRPM6	99.0	10000.0
JNK-IN-8	DRAK1	24.0	1000.0
ALW-II-38-3	FLT4	100.0	10000.0
AZD 5438	WEE2	100.0	10000.0
BMX-IN-1	ULK3	100.0	10000.0
Sorafenib	IKKB	100.0	10000.0
GSK429286A	STK36	96.0	10000.0
GW-5074	HIPK1	11.0	10000.0
5z-7-oxozeaenol	KIT(D816H)	7.6	10000.0
XMD13-2	TSSK1	69.0	10000.0
KIN001-220	PCTK2	35.0	10000.0
ALW-II-38-3	MAP3K1	100.0	10000.0
AZD-6482	RIPK1	100.0	10000.0
QL-XI-92	KPCD3	100.0	10000.0
SB590885	ULK1	98.0	10000.0
Dinaciclib	SRPK3	93.0	10000.0
Sorafenib	DMPK2	89.0	10000.0
MPS-1-IN-1	PIM1	100.0	1000.0
Palbociclib	SYK	100.0	1000.0
AZD-6482	PIK3CA(I800L)	0.4	10000.0
(s)-CR8	TRKA	100.0	10000.0
Sigma A6730	BMX	100.0	10000.0
XMD16-144	ACVR2A	57.0	10000.0
XMD13-2	PHKG2	84.0	10000.0
KIN001-127	FAK2	100.0	10000.0
Vemurafenib	MST1R	100.0	10000.0
AZ-628	KPCD3	88.0	10000.0
CP466722	M4K3	53.0	10000.0
Neratinib	RET	97.0	10000.0
KU63794	MK11	98.0	10000.0
BX-912	RIOK3	0.5	10000.0
QL-XII-47	ERK3	100.0	1000.0
QL-XI-92	EGFR(L861Q)	100.0	10000.0
HG-14-8-02	NDR1	83.0	10000.0
Alpelisib	PKN1	93.0	1000.0
WZ4003	FGFR3	100.0	1000.0
HG-14-10-04	MST3	16.0	10000.0
QL-X-138	AAK1	18.0	10000.0
Torin1	MK11	53.0	10000.0
ZM-447439	CDK3	100.0	10000.0
Seliciclib	MP2K4	100.0	10000.0
THZ1	TYK2(JH1domain-catalytic)	25.0	10000.0
Sorafenib	KPCD	100.0	10000.0
NG25	ABL1(Q252H)	0.7	10000.0
WZ4002	CDK14	100.0	10000.0
Sorafenib	IKKA	81.0	10000.0
Dabrafenib	PRKX	96.0	10000.0
XMD-12	TRPM6	56.0	1000.0
BMS345541	CLK4	53.0	10000.0
KIN001-127	ACVR1B	100.0	10000.0
OTSSP167	AXL	16.0	10000.0
NPK76-II-72-1	M4K3	100.0	10000.0
JNK-IN-8	SRPK2	100.0	1000.0
Torin1	LKB1	100.0	10000.0
ZG-10	CDKL3	20.0	10000.0
CG-930	DYRK1A	98.0	10000.0
MRT67307	PIK3CB	100.0	10000.0
SB590885	ADCK4	45.0	10000.0
Dabrafenib	RSK2(Kin.Dom.1-N-terminal)	34.0	10000.0
BS-181	FGFR2	99.0	10000.0
ALW-II-38-3	EPHB1	11.0	1000.0
CGP74514A	LOK	0.5	10000.0
BX-912	CSF1R	1.4	10000.0
HG-14-8-02	FLT3(K663Q)	16.0	10000.0
Baricitinib	EPHA8	71.0	10000.0
KIN001-127	KIT(V559D,T670I)	100.0	10000.0
Buparlisib	AKT3	94.0	1000.0
Canertinib	RPS6KA2(Kin.Dom.2)	100.0	1000.0
NU7441	MET	63.0	10000.0
BGJ398	S6K1	84.0	1000.0
Barasertib	MK11	100.0	10000.0
CH5424802	SGK2	100.0	1000.0
AZD7762	NEK6	89.0	10000.0
WZ-4-145	SRPK1	100.0	10000.0
ERK5-IN-1	RIPK4	100.0	1000.0
ALW-II-38-3	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
Ibrutinib	KIT(A829P)	56.0	1000.0
CGP60474	BMPR1B	100.0	10000.0
Pictilisib	ROCK1	100.0	1000.0
BS-181	TIE1	85.0	10000.0
WZ3105	SBK1	20.0	10000.0
Crizotinib	FAK2	1.1	10000.0
AZD4547	MP2K2	8.5	10000.0
WZ3105	EPHA4	64.0	10000.0
AZD4547	MST1	2.2	10000.0
CGP74514A	IKKE	55.0	10000.0
Baricitinib	PIP5K1A	18.0	10000.0
HG-14-8-02	KIT	45.0	10000.0
Ibrutinib	BMPR2	89.0	1000.0
Torin1	PFPK5(P.falciparum)	97.0	10000.0
JNK-IN-5A	CAMKK2	94.0	10000.0
WZ4002	FGFR3	100.0	10000.0
GSK429286A	KIT(D816H)	69.0	10000.0
AZD-6482	SIK3	95.0	10000.0
WZ-7043	FLT3	100.0	10000.0
BMS-536924	KPCD1	100.0	1000.0
GW-5074	TTK	17.0	10000.0
NU7441	RET(M918T)	98.0	10000.0
JW-7-24-1	ERK3	100.0	10000.0
KIN001-111	STK35	2.8	1000.0
TGX221	TGFBR1	100.0	1000.0
GSK1059615	PIK3CA	0.1	10000.0
BI-2536	KCC2D	100.0	10000.0
AZD7762	M3K12	9.7	10000.0
KIN001-123	MYLK2	100.0	1000.0
HG-5-88-01	TIE1	29.0	10000.0
MRT67307	ERK3	100.0	10000.0
JWE-035	RIOK3	38.0	10000.0
AZD7762	EGFR(L747-T751del,Sins)	2.4	10000.0
Canertinib	NUAK1	100.0	1000.0
Dactolisib	PRKR	100.0	1000.0
ZSTK474	TYK2(Kin.Dom.1)	100.0	1000.0
JNK-IN-5A	AMPK-alpha2	84.0	10000.0
NPK76-II-72-1	TSSK1	100.0	10000.0
Palbociclib	BARK2	100.0	1000.0
JNK-IN-5A	HIPK3	43.0	10000.0
BS-181	STK16	100.0	10000.0
PHA-793887	LATS2	100.0	10000.0
OTSSP167	TBK1	5.0	10000.0
Dabrafenib	BIKE	56.0	10000.0
BMS345541	ABL1(H396P)-nonphosphorylated	100.0	10000.0
QL-XI-92	PAK2	71.0	10000.0
NVP-TAE684	LYN	5.0	1000.0
NVP-TAE684	MKNK2	1.4	1000.0
Baricitinib	TBK1	15.0	10000.0
Seliciclib	HIPK2	72.0	10000.0
XMD8-92	DMPK	100.0	10000.0
JNK-9L	MAP4K5	27.0	10000.0
A443654	RPS6KA5(Kin.Dom.2)	17.0	10000.0
PLX-4720	EPHB3	100.0	10000.0
KU63794	FLT3(R834Q)	100.0	10000.0
AZD-6482	HCK	100.0	10000.0
PD0325901	DCAMKL3	100.0	10000.0
AG1478	ANKK1	63.0	10000.0
Baricitinib	RPS6KA4(Kin.Dom.1-N-terminal)	98.0	10000.0
HG-5-88-01	DCLK1	18.0	10000.0
Palbociclib	PCTK3	91.0	1000.0
XMD16-144	RSK4(Kin.Dom.1-N-terminal)	9.2	10000.0
Seliciclib	PIK3CA(I800L)	100.0	10000.0
XMD11-50	MARK4	78.0	10000.0
MPS-1-IN-1	NDR2	100.0	1000.0
HG-14-8-02	ABL1-nonphosphorylated	57.0	10000.0
Seliciclib	MYLK	82.0	10000.0
XMD11-50	AMPK-alpha1	51.0	10000.0
ZM-447439	PHKG1	53.0	10000.0
Dinaciclib	NEK7	80.0	10000.0
XMD8-92	KIT(D816V)	100.0	10000.0
AZD4547	PAK6	80.0	10000.0
ALW-II-49-7	KIT(V559D,V654A)	18.0	1000.0
QL-XII-47	HASP	100.0	1000.0
Baricitinib	YSK4	0.5	10000.0
Lapatinib	DDR2	100.0	10000.0
NPK76-II-72-1	PGFRB	100.0	10000.0
NPK76-II-72-1	TRKB	100.0	10000.0
PHA-793887	PIP5K1A	94.0	10000.0
CGP74514A	TAOK2	5.7	10000.0
XMD8-85	KPCD	100.0	10000.0
HG-14-8-02	RIPK2	23.0	10000.0
Neratinib	HIPK1	71.0	10000.0
NU7441	CLK2	65.0	10000.0
CGP74514A	RET	16.0	10000.0
BMS-536924	MLK1	0.2	1000.0
ZM-447439	TNNI3K	94.0	10000.0
KIN001-220	PFCDPK1(P.falciparum)	29.0	10000.0
ALW-II-49-7	KPCD3	100.0	10000.0
TAK-715	PAK2	85.0	10000.0
KU63794	CAMK1G	94.0	10000.0
JNK-IN-11	MAP4K2	90.0	1000.0
THZ1	CIT	1.0	10000.0
Lapatinib	TLK1	100.0	10000.0
Ribociclib	PKN2	97.0	1000.0
Ibrutinib	DCAMKL3	82.0	1000.0
Sorafenib	PIM1	98.0	10000.0
AZD 5438	INSR	15.0	10000.0
CG-930	RIPK1	100.0	10000.0
TAK-715	CSNK1G3	17.0	10000.0
JW-7-24-1	ULK2	100.0	10000.0
PD173074	PIM2	100.0	10000.0
KIN001-111	RIOK1	100.0	1000.0
QL-X-138	AKT2	87.0	10000.0
XMD11-85h	MLTK	100.0	10000.0
Barasertib	LIMK1	100.0	10000.0
XMD16-144	FLT3	73.0	10000.0
R406	TSSK1	3.0	1000.0
5z-7-oxozeaenol	RPS6KA4(Kin.Dom.2-C-terminal)	85.0	10000.0
PD0325901	RIOK2	89.0	10000.0
ALW-II-49-7	BMPR2	100.0	10000.0
ALW-II-49-7	BTK	100.0	10000.0
XMD13-2	TYK2(JH1domain-catalytic)	40.0	10000.0
NU7441	KPCD1	98.0	10000.0
CH5424802	PIK3CA(I800L)	100.0	1000.0
QL-XI-92	CSNK1E	100.0	10000.0
Barasertib	PGFRA	0.0	10000.0
AZD-6482	RSK1(Kin.Dom.2-C-terminal)	84.0	10000.0
ALW-II-38-3	IKKE	100.0	10000.0
WZ-7043	LIMK2	100.0	10000.0
TAK-715	GRK1	100.0	10000.0
CP724714	EPHB1	100.0	10000.0
Torkinib	EPHA2	9.4	10000.0
KIN001-220	AMPK-alpha1	32.0	10000.0
BI-2536	KIT(V559D,V654A)	100.0	10000.0
GSK461364	FLT3(D835H)	10.0	10000.0
Taselisib	PIK3CG	0.0	1000.0
KIN001-220	KIT(D816V)	0.8	10000.0
AZD7762	PKN1	0.0	10000.0
XMD-12	FLT4	100.0	1000.0
WZ4003	AMPK-alpha1	29.0	1000.0
ERK5-IN-1	PCTK3	100.0	1000.0
MRT67307	PKN2	20.0	10000.0
Alpelisib	MK09	100.0	1000.0
PLX-4720	MYO3A	35.0	10000.0
WZ-7043	MAP3K3	3.8	10000.0
Buparlisib	STK16	100.0	1000.0
AZD7762	BMX	3.4	10000.0
WZ4003	TGFBR2	100.0	1000.0
MPS-1-IN-1	CAMK2B	100.0	1000.0
AZD-6482	TXK	90.0	10000.0
Torin2	M3K13	100.0	10000.0
JNK-IN-11	TGFBR2	10.0	1000.0
Omipalisib	M4K3	100.0	10000.0
Neratinib	ABL1(F317L)-phosphorylated	72.0	10000.0
PLX-4720	MINK	28.0	10000.0
Palbociclib	PIK3CA(Q546K)	100.0	1000.0
XMD11-85h	ZAP70	100.0	10000.0
HG-14-8-02	ABL1(Q252H)-nonphosphorylated	16.0	10000.0
KIN001-127	ULK2	24.0	10000.0
QL-X-138	ABL1(E255K)-phosphorylated	39.0	10000.0
Crizotinib	CHK2	100.0	10000.0
Sorafenib	AURKA	80.0	10000.0
ALW-II-49-7	DAPK2	100.0	10000.0
WZ-4-145	MP2K1	100.0	10000.0
XMD11-50	EGFR(T790M)	88.0	10000.0
XMD11-50	CAMK1	55.0	10000.0
QL-X-138	TNIK	47.0	10000.0
CP466722	CDKL5	0.3	10000.0
XMD8-85	BMPR1A	100.0	10000.0
Abemaciclib	CTK	100.0	1000.0
WZ-7043	DMPK	100.0	10000.0
HG-5-113-01	MELK	100.0	10000.0
HG-5-88-01	PKMYT1	100.0	10000.0
Dabrafenib	CDK9	16.0	10000.0
CGP74514A	SLK	0.1	10000.0
Dinaciclib	MYLK4	98.0	10000.0
Dinaciclib	PIK3CA(Q546K)	87.0	10000.0
Sigma A6730	FGFR4	100.0	10000.0
Sorafenib	LKB1	76.0	10000.0
QL-XI-92	CDC2L2	94.0	10000.0
Lapatinib	LIMK2	88.0	10000.0
Dabrafenib	KIT(V559D,V654A)	84.0	10000.0
Neratinib	RIOK1	68.0	10000.0
BS-181	BMPR1B	100.0	10000.0
JWE-035	PKAC-beta	100.0	10000.0
WZ-4-145	MP2K4	100.0	10000.0
MLN8054	MAP4K5	96.0	10000.0
WZ-7043	PIK3C2B	100.0	10000.0
NG25	CSK	0.5	10000.0
WZ-4-145	EPHB1	100.0	10000.0
JWE-035	STK39	100.0	10000.0
PD0325901	BMX	92.0	10000.0
TAK-715	PRP4	80.0	10000.0
R406	ERBB4	6.3	1000.0
RO-3306	MAP3K4	95.0	10000.0
CG-930	MARK2	100.0	10000.0
Palbociclib	ZAP70	100.0	1000.0
PHA-767491	EPHA1	100.0	10000.0
Sorafenib	CASK	90.0	10000.0
XMD13-2	ANKK1	8.0	10000.0
Pictilisib	AMPK-alpha2	100.0	1000.0
PD0325901	SRPK1	100.0	10000.0
XMD16-144	PIK4CB	87.0	10000.0
GSK429286A	SRPK1	100.0	10000.0
GSK1059615	WNK1	57.0	10000.0
Torin2	PAK3	100.0	10000.0
XMD8-92	MRCKB	100.0	10000.0
KIN001-220	LOK	3.4	10000.0
AG1478	FER	82.0	10000.0
RO-3306	MAP3K3	86.0	10000.0
Dinaciclib	EGFR(G719C)	95.0	10000.0
QL-XI-92	RPS6KA5(Kin.Dom.2-C-terminal)	90.0	10000.0
Pictilisib	NEK5	99.0	1000.0
AS-252424	MK01	100.0	10000.0
KIN001-123	FGFR1	100.0	1000.0
SB590885	DAPK1	99.0	10000.0
ZG-10	TRKC	65.0	10000.0
GW843682X	ERK4	100.0	10000.0
MRT67307	MAP3K3	4.7	10000.0
Pictilisib	PKN2	100.0	1000.0
BGJ398	ABL1-phosphorylated	64.0	1000.0
HG-14-8-02	KIT(V559D)	40.0	10000.0
GW-5074	AURKC	71.0	10000.0
JW-7-24-1	TGFBR1	100.0	10000.0
KU63794	JAK1(JH1domain-catalytic)	84.0	10000.0
WYE-125132	CDC2L1	100.0	10000.0
Ibrutinib	KPCD1	70.0	1000.0
5z-7-oxozeaenol	YANK3	82.0	10000.0
THZ1	ABL1(H396P)-phosphorylated	0.5	10000.0
PD0325901	TEC	100.0	10000.0
BMS-536924	STK36	100.0	1000.0
PHA-767491	MAK	100.0	10000.0
Baricitinib	CHK2	22.0	10000.0
BMX-IN-1	NUAK1	76.0	10000.0
Pictilisib	TIE2	100.0	1000.0
Dinaciclib	TYK2(JH2domain-pseudokinase)	92.0	10000.0
PHA-767491	MP2K4	74.0	10000.0
PHA-767491	PRKX	12.0	10000.0
CGP60474	M4K3	100.0	10000.0
Momelotinib	ABL1(F317I)-phosphorylated	55.0	10000.0
GSK461364	EPHB3	100.0	10000.0
CP724714	MAP3K15	100.0	10000.0
Dabrafenib	FLT3(K663Q)	55.0	10000.0
Momelotinib	AKT2	76.0	10000.0
Sorafenib	DRAK1	45.0	10000.0
(s)-CR8	BTK	100.0	10000.0
WZ-7043	DCLK1	100.0	10000.0
AZD-6482	ABL1-nonphosphorylated	100.0	10000.0
KIN001-123	RPS6KA3(Kin.Dom.1)	100.0	1000.0
AZD-6482	CSNK2A2	100.0	10000.0
KIN001-111	FLT3	100.0	1000.0
KIN001-021	CDK5	100.0	1000.0
AS-252424	CDK14	89.1	10000.0
PLX-4720	WEE1	100.0	10000.0
WZ-4-145	EGFR(G719C)	0.1	10000.0
Dabrafenib	RSK3(Kin.Dom.1-N-terminal)	54.0	10000.0
BS-181	PIK3CA	79.0	10000.0
Buparlisib	FLT3	76.0	1000.0
SB590885	PHKG2	100.0	10000.0
CP466722	TLK1	46.0	10000.0
Sigma A6730	BMPR1B	77.0	10000.0
BMS-536924	MYLK2	100.0	1000.0
Ibrutinib	S6K1	63.0	1000.0
PLX-4720	PIK3CA	82.0	10000.0
AG1478	BRSK1	37.0	10000.0
XMD11-50	CDK4-cyclinD3	100.0	10000.0
JNK-9L	CSNK1A1L	80.0	10000.0
ZM-447439	DCLK1	73.0	10000.0
CH5424802	FLT3(ITD,F691L)	16.0	1000.0
JNK-9L	FLT3(ITD)	28.0	10000.0
BGJ398	RSK3(Kin.Dom.2-C-terminal)	94.0	1000.0
HG-5-113-01	PAK7	100.0	10000.0
5z-7-oxozeaenol	MARK3	100.0	10000.0
Ribociclib	EPHA3	99.0	1000.0
XMD8-85	PIP5K1A	100.0	10000.0
MPS-1-IN-1	ERBB4	100.0	1000.0
XMD11-50	AAK1	84.0	10000.0
XMD11-50	CDK16	96.0	10000.0
ZG-10	HUNK	69.0	10000.0
XMD13-2	ABL2	100.0	10000.0
SB590885	RET(V804L)	100.0	10000.0
WH-4-023	MAP4K4	3.7	10000.0
XMD14-99	YANK3	99.0	10000.0
BMS345541	ABL1(Q252H)-phosphorylated	100.0	10000.0
Torin1	CDK4-cyclinD3	87.0	10000.0
BMS345541	SRPK1	100.0	10000.0
CH5424802	SgK110	100.0	1000.0
Abemaciclib	ADCK4	12.0	1000.0
KIN001-021	RET(M918T)	100.0	1000.0
Momelotinib	FLT3(D835Y)	6.3	10000.0
KIN001-021	PIK3CA	100.0	1000.0
Torin2	ERBB3	50.0	10000.0
Alpelisib	NEK11	100.0	1000.0
RO-3306	CSNK2A1	8.0	10000.0
GW843682X	TIE1	31.0	10000.0
Omipalisib	FLT3(K663Q)	85.0	10000.0
WZ4002	DCAMKL2	0.5	10000.0
CP724714	BRSK2	100.0	10000.0
A443654	DMPK	0.8	10000.0
Ibrutinib	BUB1	100.0	1000.0
XMD13-2	DDR1	71.0	10000.0
Abemaciclib	ABL2	91.0	1000.0
Torin1	ULK2	75.0	10000.0
PD0325901	CLK2	96.0	10000.0
ALW-II-38-3	HCK	1.8	1000.0
MLN8054	MRCKB	69.0	10000.0
Vemurafenib	TRKC	65.0	10000.0
WZ4003	EGFR(L747-T751del,Sins)	15.0	1000.0
(s)-CR8	PIK3CA(C420R)	92.0	10000.0
Dinaciclib	SYK	99.0	10000.0
ZG-10	BMX	100.0	10000.0
Crizotinib	KCC2D	100.0	10000.0
MRT67307	TRKA	8.4	10000.0
XMD13-2	CDK15	84.0	10000.0
CGP74514A	IKKB	66.0	10000.0
NU7441	MP2K3	91.0	10000.0
Barasertib	RPS6KA4(Kin.Dom.1-N-terminal)	73.0	10000.0
WH-4-023	SRPK3	11.0	10000.0
CGP60474	LATS2	100.0	10000.0
Dactolisib	SLK	100.0	1000.0
CP724714	PIK3CA(H1047L)	100.0	10000.0
JNK-9L	KPCD3	100.0	10000.0
GSK1059615	LOK	0.1	10000.0
SCH772984	SYK	98.0	1000.0
BMX-IN-1	CDK7	26.0	10000.0
GSK1059615	ERK3	100.0	10000.0
Abemaciclib	MAP4K2	53.0	1000.0
HG-9-91-01	FLT3(K663Q)	54.0	10000.0
Pictilisib	CDK4-cyclinD1	98.0	1000.0
WZ3105	TBK1	84.0	10000.0
PD0325901	CDK16	100.0	10000.0
Seliciclib	ABL1(T315I)-nonphosphorylated	100.0	10000.0
Ribociclib	CTK	100.0	1000.0
MPS-1-IN-1	LKB1	100.0	1000.0
AZD4547	CDKL3	17.0	10000.0
AG1478	MK14	63.0	10000.0
Torin2	EPHB6	82.0	10000.0
AZD4547	FLT3(ITD)	0.4	10000.0
HG-14-8-02	KIT(L576P)	18.0	10000.0
WZ4003	MAP4K4	100.0	1000.0
ERK5-IN-1	PLK4	5.1	1000.0
HG-6-64-01	PIP5K1C	84.0	10000.0
XMD14-99	RSK1(Kin.Dom.1-N-terminal)	100.0	10000.0
Pictilisib	MP2K6	100.0	1000.0
Ceritinib	DCAMKL3	77.0	1000.0
JW-7-24-1	CSNK1G3	100.0	10000.0
CGP74514A	EPHB3	91.0	10000.0
ZM-447439	IKKA	100.0	10000.0
Ribociclib	ABL1(H396P)-phosphorylated	83.0	1000.0
Buparlisib	HASP	96.0	1000.0
KIN001-021	KKCC1	100.0	1000.0
XMD14-99	FGFR2	91.0	10000.0
Sigma A6730	TAOK2	85.0	10000.0
Lapatinib	EPHB6	61.0	10000.0
XMD11-85h	NDR2	100.0	10000.0
JNK-IN-5A	CLK1	69.0	10000.0
XMD11-50	SRPK2	100.0	10000.0
Baricitinib	TNNI3K	33.0	10000.0
HG-6-64-01	ABL1(F317L)-nonphosphorylated	0.0	10000.0
KIN001-021	TAOK1	100.0	1000.0
Neratinib	ADCK3	95.0	10000.0
HG-5-113-01	ABL1(E255K)	20.0	10000.0
QL-XI-92	KCC4	100.0	10000.0
QL-X-138	CLK4	3.0	10000.0
Torin1	MP2K4	30.0	10000.0
WZ3105	PAK2	61.0	10000.0
TGX221	AKT3	100.0	1000.0
MRT67307	LATS1	81.0	10000.0
OTSSP167	MYO3A	56.0	10000.0
Sorafenib	FAK1	99.0	10000.0
Barasertib	BMPR2	77.0	10000.0
Palbociclib	M3K6	100.0	1000.0
Torkinib	M3K2	4.8	10000.0
Ibrutinib	PIK3CG	73.0	1000.0
KIN001-111	ANKK1	34.0	1000.0
QL-XII-47	AKT1	100.0	1000.0
Abemaciclib	CLK4	6.7	1000.0
PHA-767491	EPHA7	100.0	10000.0
Torin1	STK36	17.0	10000.0
HG-14-10-04	YANK2	5.4	10000.0
QL-XI-92	AURKC	100.0	10000.0
Buparlisib	ACVR2A	75.0	1000.0
CG-930	TGFBR2	71.0	10000.0
AZD7762	KIT(D816V)	0.1	10000.0
SCH772984	PIK3C2B	100.0	1000.0
BX-912	MKNK1	100.0	10000.0
XMD11-50	MK11	60.0	10000.0
SCH772984	HIPK4	78.0	1000.0
Abemaciclib	EPHA3	100.0	1000.0
HG-14-8-02	TTK	63.0	10000.0
XMD16-144	EPHA1	55.0	10000.0
R406	LTK	1.4	1000.0
Ceritinib	AKT2	100.0	1000.0
RO-3306	FRK	95.0	10000.0
Torin1	IRAK1	100.0	10000.0
WZ4002	RET(V804M)	100.0	10000.0
Sorafenib	DDR1	0.0	10000.0
(s)-CR8	MK14	99.0	10000.0
Alpelisib	ABL1(Q252H)-phosphorylated	100.0	1000.0
GSK461364	DCAMKL2	100.0	10000.0
Neratinib	M4K3	2.1	10000.0
Vemurafenib	WEE2	100.0	10000.0
Buparlisib	CLK1	47.0	1000.0
ALW-II-49-7	TAK1	100.0	10000.0
GW843682X	MERTK	7.0	10000.0
AS-252424	MARK1	100.0	10000.0
WYE-125132	TLK1	86.0	10000.0
XMD-12	NEK4	95.0	1000.0
WYE-125132	KPCD	100.0	10000.0
CP466722	WEE1	80.0	10000.0
Dabrafenib	MLK2	9.6	10000.0
CH5424802	PIK3CA(E545K)	100.0	1000.0
Palbociclib	FLT3(D835Y)	66.0	1000.0
SCH772984	LATS2	28.0	1000.0
Palbociclib	MARK3	100.0	1000.0
XMD8-92	LYN	100.0	10000.0
RO-3306	CDK14	69.0	10000.0
R406	CHK2	100.0	1000.0
PHA-793887	STK16	100.0	10000.0
Ibrutinib	EPHB6	14.0	1000.0
Baricitinib	CDK11	90.0	10000.0
KU63794	PAK6	90.0	10000.0
R406	TYK2(Kin.Dom.1)	100.0	1000.0
MLN8054	ULK3	57.0	10000.0
CGP74514A	FLT3(D835H)	2.3	10000.0
MRT67307	PAK4	96.0	10000.0
WZ-7043	EGFR(E746-A750del)	100.0	10000.0
NU7441	DCAMKL3	100.0	10000.0
RO-3306	ACVR1B	95.0	10000.0
HG-6-64-01	RAF1	0.9	10000.0
WH-4-023	GRK1	100.0	10000.0
KIN001-220	ROS1	34.0	10000.0
Ceritinib	SLK	37.0	1000.0
Momelotinib	KIT(L576P)	39.0	10000.0
Neratinib	EPHB4	91.0	10000.0
R406	KPCD	28.0	1000.0
Alpelisib	PAK6	100.0	1000.0
KIN001-220	ZAP70	100.0	10000.0
Pictilisib	PIM3	100.0	1000.0
PD0325901	FGFR2	100.0	10000.0
CP724714	ACVR2B	100.0	10000.0
WYE-125132	CDKL2	100.0	10000.0
WYE-125132	ULK2	90.0	10000.0
JNK-9L	MAPKAPK5	100.0	10000.0
CH5424802	PRKX	97.0	1000.0
CG-930	CAMK2A	95.0	10000.0
Ribociclib	ERK3	100.0	1000.0
Ribociclib	S6K1	78.0	1000.0
Palbociclib	PIK3C2G	100.0	1000.0
CH5424802	IGF1R	91.0	1000.0
Crizotinib	TSSK1	40.0	10000.0
GSK429286A	CAMKK2	55.0	10000.0
Torin1	TNK1	6.8	10000.0
TGX221	DAPK3	100.0	1000.0
XMD8-85	PGFRB	100.0	10000.0
Torin1	TLK1	100.0	10000.0
HG-6-64-01	IGF1R	100.0	10000.0
BX-912	EPHA1	35.0	10000.0
Omipalisib	MAP3K4	99.0	10000.0
Neratinib	RPS6KA5(Kin.Dom.2-C-terminal)	77.0	10000.0
PLX-4720	KPCD	100.0	10000.0
NPK76-II-72-1	PLK1	19.0	10000.0
HG-14-8-02	FLT3(N841I)	6.2	10000.0
5z-7-oxozeaenol	BMPR1A	19.0	10000.0
BX-912	CAMK1D	4.6	10000.0
Crizotinib	SGK3	100.0	10000.0
CGP60474	CSNK2A1	100.0	10000.0
JNK-IN-11	MARK2	98.0	1000.0
Omipalisib	MAST1	77.0	10000.0
Taselisib	FLT3(R834Q)	100.0	1000.0
HG-9-91-01	MARK2	1.2	10000.0
OTSSP167	PFPK5(P.falciparum)	100.0	10000.0
JWE-035	NEK7	88.0	10000.0
Ribociclib	ROCK1	100.0	1000.0
XMD11-85h	MST4	100.0	10000.0
WH-4-023	PIK3CA	100.0	10000.0
Torin1	IRAK3	27.0	10000.0
WZ-4-145	PIK3CA	100.0	10000.0
BI-2536	RIOK3	100.0	10000.0
Lapatinib	KPCD2	99.0	10000.0
XMD11-85h	DYRK1A	100.0	10000.0
XMD16-144	PFCDPK1(P.falciparum)	74.0	10000.0
Baricitinib	MKNK1	100.0	10000.0
Palbociclib	FYV1	79.0	1000.0
PD0325901	WNK1	92.0	10000.0
WZ3105	HUNK	85.0	10000.0
AZ-628	INSRR	100.0	10000.0
CGP60474	PCTK3	100.0	10000.0
WZ4002	PAK3	100.0	10000.0
ZG-10	MELK	58.0	10000.0
BMX-IN-1	MP2K5	64.0	10000.0
CG-930	NEK7	95.0	10000.0
XMD8-92	RET	100.0	10000.0
Torin1	EPHA8	71.0	10000.0
PD0325901	HCK	100.0	10000.0
A443654	GSK3A	1.0	10000.0
BI-2536	IGF1R	100.0	10000.0
XMD8-92	GSK3A	100.0	10000.0
AZD4547	KPCD2	100.0	10000.0
HG-5-88-01	LIMK1	100.0	10000.0
BS-181	MAP3K3	85.0	10000.0
CGP74514A	TNK1	99.0	10000.0
QL-XI-92	CDK5	90.0	10000.0
ERK5-IN-1	EPHA8	100.0	1000.0
JNK-IN-8	TRKA	87.0	1000.0
SCH772984	ICK	100.0	1000.0
OTSSP167	ACVR1B	31.0	10000.0
Dactolisib	MK12	100.0	1000.0
GW843682X	MLK1	71.0	10000.0
XMD11-85h	MAST1	100.0	10000.0
WZ-7043	PLK3	100.0	10000.0
QL-XI-92	BMPR1B	100.0	10000.0
Torin1	KGP1	86.0	10000.0
RO-3306	NEK7	97.0	10000.0
Alpelisib	ALK	98.0	1000.0
MLN8054	AKT1	100.0	10000.0
Baricitinib	ERBB2	100.0	10000.0
WZ4002	MP2K3	100.0	10000.0
(s)-CR8	ERK3	97.0	10000.0
ZSTK474	AXL	100.0	1000.0
HG-5-88-01	FLT3(D835H)	11.0	10000.0
QL-XII-47	EGFR(L861Q)	67.0	1000.0
Lapatinib	HIPK3	100.0	10000.0
AZD4547	DCLK1	2.0	10000.0
Barasertib	EPHA6	69.0	10000.0
Sorafenib	RET(M918T)	0.1	10000.0
BMX-IN-1	MST2	95.0	10000.0
PD173074	FGFR2	2.9	10000.0
QL-XII-47	CDK11	83.0	1000.0
PD173074	GSK3B	100.0	10000.0
CP724714	FLT3(N841I)	79.0	10000.0
CGP74514A	EPHB2	35.0	10000.0
CP466722	NDR1	51.0	10000.0
GW843682X	LCK	34.0	10000.0
Ceritinib	RIPK5	46.0	1000.0
Ceritinib	SGK2	74.0	1000.0
HG-14-8-02	ACVRL1	100.0	10000.0
ZG-10	BRSK2	88.0	10000.0
BX-912	CLK2	2.2	10000.0
HG-14-10-04	KPCD	16.0	10000.0
AZD-6482	RET(M918T)	100.0	10000.0
Crizotinib	MRCKB	62.0	10000.0
XMD8-85	NEK5	100.0	10000.0
SB590885	MARK3	95.0	10000.0
AG1478	CDK3	100.0	10000.0
Torkinib	LATS2	41.0	10000.0
Abemaciclib	ACVR1	61.0	1000.0
AZD-6482	ULK2	100.0	10000.0
Baricitinib	ERBB3	100.0	10000.0
PD0325901	PIK3CB	100.0	10000.0
Neratinib	FER	37.0	10000.0
WZ3105	JAK2(JH1domain-catalytic)	9.1	10000.0
XMD-12	EPHB2	100.0	1000.0
AS-252424	EGFR(L747-E749del,A750P)	5.8	10000.0
OTSSP167	SRPK2	74.0	10000.0
AZ-628	LKB1	100.0	10000.0
XMD11-50	PIP5K1A	90.0	10000.0
PHA-767491	CSNK1D	0.5	10000.0
BI-D1870	BIKE	2.5	10000.0
JW-7-24-1	AKT1	100.0	10000.0
NG25	MAP3K3	6.2	10000.0
AZD4547	LKB1	92.0	10000.0
XMD13-2	CAMKK2	94.0	10000.0
R406	STK16	0.2	1000.0
MLN8054	BMPR2	86.0	10000.0
AG1478	ACVR1B	100.0	10000.0
KIN001-127	CLK1	4.9	10000.0
Buparlisib	STK39	92.0	1000.0
SCH772984	MTOR	95.0	1000.0
QL-XII-47	PIK3CG	100.0	1000.0
ZM-447439	LIMK2	78.0	10000.0
Abemaciclib	RIPK4	100.0	1000.0
AZD 5438	PIK3CB	44.0	10000.0
AZD4547	DAPK1	43.0	10000.0
CGP60474	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
KIN001-220	MAP4K5	64.0	10000.0
ZSTK474	EPHB3	100.0	1000.0
BMX-IN-1	KIT(D816V)	73.0	10000.0
WZ3105	INSR	69.0	10000.0
BMS345541	GRK7	100.0	10000.0
XMD11-85h	PIK3CG	100.0	10000.0
Ribociclib	CDK5	100.0	1000.0
CGP60474	ABL1	100.0	10000.0
CGP60474	JAK3(JH1domain-catalytic)	100.0	10000.0
WZ-7043	RPS6KA1(Kin.Dom.1)	100.0	10000.0
BI-D1870	GCN2(Kin.Dom.2,S808G)	0.6	10000.0
QL-X-138	EPHB1	94.0	10000.0
QL-XI-92	MRCKA	100.0	10000.0
Abemaciclib	JAK2(JH1domain-catalytic)	50.0	1000.0
BI-2536	TAOK3	100.0	10000.0
NVP-TAE684	RET	0.0	1000.0
CP466722	PIK3C2B	0.4	10000.0
Neratinib	CDK9	94.0	10000.0
NVP-TAE684	PHKG2	0.0	1000.0
WZ4003	PDPK1	100.0	1000.0
CP724714	LCK	59.0	10000.0
XMD8-92	KCC2D	100.0	10000.0
KIN001-220	FLT3(D835Y)	0.2	10000.0
CGP74514A	TTK	43.0	10000.0
Buparlisib	CASK	86.0	1000.0
ZG-10	DAPK2	81.0	10000.0
KIN001-220	AMPK-alpha2	39.0	10000.0
XMD16-144	ERN1	69.0	10000.0
QL-XII-47	FLT3(N841I)	99.0	1000.0
Ibrutinib	FRK	14.0	1000.0
ZG-10	TAOK3	37.0	10000.0
GW-5074	PLK3	86.0	10000.0
RO-3306	MRCKB	9.6	10000.0
CH5424802	JAK1(JH1domain-catalytic)	100.0	1000.0
PLX-4720	MAPKAPK2	100.0	10000.0
KIN001-111	ROS1	19.0	1000.0
WZ4003	MLK3	100.0	1000.0
CG-930	CDK15	100.0	10000.0
5z-7-oxozeaenol	CDK14	100.0	10000.0
WZ-7043	MAP4K5	23.0	10000.0
SB590885	CSNK1E	14.0	10000.0
JWE-035	TTK	77.0	10000.0
HG-5-88-01	JAK3(Kin.Dom.2)	100.0	10000.0
SCH772984	CSNK1A1L	71.0	1000.0
KU63794	BMPR1B	99.0	10000.0
Ribociclib	CAMK1	98.0	1000.0
5z-7-oxozeaenol	TSSK1	79.0	10000.0
CP466722	PIM1	15.0	10000.0
Ceritinib	KPCD3	76.0	1000.0
BMS345541	EGFR(S752-I759del)	100.0	10000.0
WZ-4-145	PGFRA	2.2	10000.0
QL-XI-92	KKCC1	96.0	10000.0
NPK76-II-72-1	GSK3A	100.0	10000.0
JWE-035	PLK4	0.1	10000.0
Baricitinib	KPCT	38.0	10000.0
MRT67307	HIPK3	34.0	10000.0
Crizotinib	KC1G1	100.0	10000.0
Torin1	MST3	100.0	10000.0
Lapatinib	IKKE	74.0	10000.0
Barasertib	ICK	74.0	10000.0
Neratinib	IKKA	81.0	10000.0
Dabrafenib	LCK	1.8	10000.0
CP724714	AMPK-alpha2	100.0	10000.0
SCH772984	CDK5	94.0	1000.0
XMD8-92	TRKA	100.0	10000.0
Torin1	ABL1(F317I)-nonphosphorylated	100.0	10000.0
Sorafenib	PIM3	80.0	10000.0
XMD13-2	MRCKA	87.0	10000.0
KIN001-220	PIK3CA(E545A)	25.0	10000.0
BS-181	DAPK2	82.0	10000.0
AZ-628	DDR2	21.0	10000.0
HG-5-113-01	ERK5	100.0	10000.0
SB590885	TYK2(JH1domain-catalytic)	52.0	10000.0
GW-5074	RET(V804M)	100.0	10000.0
Ribociclib	CDC2L1	97.0	1000.0
BGJ398	MK09	62.0	1000.0
XMD8-85	ABL2	100.0	10000.0
XMD13-2	NEK11	95.0	10000.0
Torin1	INSR	7.6	10000.0
Palbociclib	ADCK4	100.0	1000.0
CP466722	EGFR(S752-I759del)	58.0	10000.0
AZD4547	BMPR2	83.0	10000.0
GW843682X	OSR1	100.0	10000.0
TAK-715	BRSK2	95.0	10000.0
Dabrafenib	KPCL	97.0	10000.0
QL-XI-92	PFPK5(P.falciparum)	98.0	10000.0
HG-6-64-01	PHKG2	100.0	10000.0
XMD16-144	EPHB3	88.0	10000.0
ALW-II-49-7	EPHA2	2.2	1000.0
SP600125	EGFR(E746-A750del)	100.0	10000.0
KIN001-220	PGFRB	0.2	10000.0
OTSSP167	INSR	8.8	10000.0
QL-XI-92	EGFR(G719C)	94.0	10000.0
PD0325901	GCN2(Kin.Dom.2,S808G)	84.0	10000.0
Palbociclib	FLT3	77.0	1000.0
ZM-447439	RET(V804M)	12.0	10000.0
Torin1	RIPK1	1.9	10000.0
AZD-6482	MAP4K5	96.0	10000.0
KIN001-111	CDKL2	100.0	1000.0
XMD11-85h	M3K12	100.0	10000.0
PHA-793887	YSK4	100.0	10000.0
XMD-12	MAP4K5	85.0	1000.0
KIN001-123	MYLK4	100.0	1000.0
Palbociclib	INSRR	100.0	1000.0
JNK-9L	MRCKA	68.0	10000.0
QL-XII-47	FYN	99.0	1000.0
Torin2	KIT(D816H)	80.0	10000.0
JW-7-24-1	DDR1	100.0	10000.0
Dabrafenib	ERBB4	74.0	10000.0
ZG-10	RIPK5	100.0	10000.0
MRT67307	SRMS	100.0	10000.0
Baricitinib	KGP1	36.0	10000.0
R406	PIK3CA	100.0	1000.0
MLN8054	MET(M1250T)	58.0	10000.0
GW-5074	TAOK1	54.0	10000.0
SB590885	ERN1	62.0	10000.0
XMD11-85h	FLT4	0.0	10000.0
HG-5-88-01	ULK1	100.0	10000.0
AZD 5438	MLK1	2.0	10000.0
BMS-536924	CAMK1D	22.0	1000.0
ALW-II-49-7	MK14	5.0	1000.0
Canertinib	FAK1	100.0	1000.0
XMD-12	CSNK2A1	86.0	1000.0
ZSTK474	LATS1	100.0	1000.0
BS-181	FGFR3	100.0	10000.0
PHA-793887	FLT3-autoinhibited	100.0	10000.0
XMD13-2	DDR2	90.0	10000.0
WZ-4-145	RPS6KA6(Kin.Dom.2)	100.0	10000.0
Momelotinib	MST4	83.0	10000.0
CGP74514A	KCC4	1.2	10000.0
CH5424802	M3K5	100.0	1000.0
XMD-12	M3K6	97.0	1000.0
JNK-IN-11	PAK6	100.0	1000.0
BGJ398	DYRK1A	85.0	1000.0
XMD16-144	KC1G2	69.0	10000.0
HG-6-64-01	M3K2	0.7	10000.0
CGP74514A	PRKX	76.0	10000.0
Baricitinib	ROCK2	0.1	10000.0
NU7441	ACVRL1	94.0	10000.0
AG1478	LATS1	100.0	10000.0
JNK-IN-5A	M3K5	94.0	10000.0
Omipalisib	VRK2	88.0	10000.0
KIN001-127	CDC2L2	100.0	10000.0
Crizotinib	FGFR4	98.0	10000.0
Lapatinib	BMPR1A	100.0	10000.0
AZD 5438	CAMK2B	42.0	10000.0
XMD13-2	BMPR1B	76.0	10000.0
XMD11-85h	TSSK1	100.0	10000.0
XMD16-144	RIPK4	1.0	10000.0
WZ-7043	TLK1	100.0	10000.0
CP724714	SRPK2	92.0	10000.0
PHA-767491	CIT	0.1	10000.0
Crizotinib	MK01	100.0	10000.0
CP466722	LCK	5.2	10000.0
Alpelisib	NUAK1	100.0	1000.0
XMD13-2	PIK3C2B	83.0	10000.0
Dactolisib	ACVR1	100.0	1000.0
Sigma A6730	ABL1(Q252H)-nonphosphorylated	100.0	10000.0
Lapatinib	EGFR(T790M)	18.0	10000.0
Seliciclib	GSK3B	96.0	10000.0
Crizotinib	PKN2	26.0	10000.0
BMX-IN-1	PIP5K1C	29.0	10000.0
AZD 5438	PKNB(M.tuberculosis)	0.4	10000.0
JW-7-24-1	PKMYT1	100.0	10000.0
Canertinib	RPS6KA6(Kin.Dom.2)	100.0	1000.0
SP600125	TXK	100.0	10000.0
CH5424802	VGFR1	79.0	1000.0
PD173074	ACVR2B	100.0	10000.0
PD0325901	BRAF(V600E)	100.0	10000.0
HG-14-8-02	PIM1	100.0	10000.0
AZD7762	RSK4(Kin.Dom.2-C-terminal)	1.2	10000.0
XMD8-85	EPHA1	100.0	10000.0
XMD-12	MST3	82.0	1000.0
AG1478	PGFRB	30.0	10000.0
PHA-767491	GRK1	40.0	10000.0
ZSTK474	KC1G2	100.0	1000.0
JNK-IN-5A	YANK3	97.0	10000.0
GSK461364	VGFR1	100.0	10000.0
(s)-CR8	CSF1R-autoinhibited	49.0	10000.0
GSK461364	MP2K2	79.0	10000.0
CP466722	RIPK4	12.0	10000.0
5z-7-oxozeaenol	ABL1-phosphorylated	82.0	10000.0
Sigma A6730	WEE2	96.0	10000.0
Ribociclib	LATS1	96.0	1000.0
HG-6-64-01	KKCC1	100.0	10000.0
SP600125	RPS6KA1(Kin.Dom.1)	100.0	10000.0
GSK429286A	CIT	87.0	10000.0
KIN001-111	DMPK2	0.0	1000.0
HG-14-10-04	ABL1(H396P)-nonphosphorylated	0.0	10000.0
XMD13-2	DAPK2	87.0	10000.0
KIN001-111	KKCC1	100.0	1000.0
BMX-IN-1	MAP4K5	74.0	10000.0
Dactolisib	PAK7	100.0	1000.0
Omipalisib	CSNK2A1	50.0	10000.0
XMD-12	GRK1	86.0	1000.0
XMD-12	VRK2	89.0	1000.0
TAK-715	LCK	41.0	10000.0
HG-5-113-01	ABL1(F317I)	30.0	10000.0
RO-3306	CDKL2	65.0	10000.0
KIN001-111	ABL1(H396P)	4.6	1000.0
CP466722	CLK1	0.6	10000.0
XMD13-2	M3K5	100.0	10000.0
MRT67307	EGFR(L747-T751del,Sins)	89.0	10000.0
BI-D1870	PIK3CG	4.3	10000.0
KIN001-111	EPHA6	100.0	1000.0
XMD8-92	ICK	100.0	10000.0
Baricitinib	PKN2	6.2	10000.0
Abemaciclib	PIK4CB	100.0	1000.0
PHA-767491	MAP4K4	22.0	10000.0
PHA-767491	KPCD3	12.0	10000.0
AZD7762	MET	3.1	10000.0
HG-6-64-01	LIMK2	2.9	10000.0
KIN001-220	DYRK1B	46.0	10000.0
XMD8-92	KIT(V559D,V654A)	100.0	10000.0
WYE-125132	ACVRL1	100.0	10000.0
ZG-10	MAP4K4	18.0	10000.0
BS-181	CLK4	3.6	10000.0
XMD11-50	PAK7	96.0	10000.0
JW-7-24-1	LATS1	100.0	10000.0
JNK-IN-5A	CDK4-cyclinD1	100.0	10000.0
QL-XII-47	DCAMKL2	94.0	1000.0
XMD11-50	MARK2	100.0	10000.0
5z-7-oxozeaenol	ITK	100.0	10000.0
SCH772984	PGFRA	78.0	1000.0
AZ-628	RSK1(Kin.Dom.2-C-terminal)	87.0	10000.0
JNK-9L	MST3	70.0	10000.0
CGP60474	MAP3K15	100.0	10000.0
HG-14-10-04	ABL1(Y253F)-phosphorylated	0.2	10000.0
TGX221	PIK3CG	100.0	1000.0
R406	TRKA	4.5	1000.0
NVP-TAE684	M3K5	100.0	1000.0
Ibrutinib	EPHB3	88.0	1000.0
PLX-4720	ERK3	100.0	10000.0
KIN001-220	AKT2	95.0	10000.0
JNK-IN-11	RSK2(Kin.Dom.1-N-terminal)	50.0	1000.0
KU63794	KGP2	100.0	10000.0
BGJ398	MLTK	97.0	1000.0
PD0325901	KPCD3	70.0	10000.0
Ibrutinib	MK14	100.0	1000.0
ZG-10	MAK	100.0	10000.0
Sigma A6730	VGFR1	89.0	10000.0
QL-X-138	PKNB(M.tuberculosis)	12.0	10000.0
NVP-TAE684	EGFR(S752-I759del)	1.4	1000.0
Ribociclib	FGFR4	100.0	1000.0
HG-14-10-04	BRAF	97.0	10000.0
Momelotinib	DCLK1	52.0	10000.0
CP724714	INSR	94.0	10000.0
ZM-447439	KGP2	91.0	10000.0
WZ-4-145	CSNK2A1	100.0	10000.0
Ribociclib	TSSK1	86.0	1000.0
Ribociclib	BUB1	100.0	1000.0
Seliciclib	FLT3(K663Q)	100.0	10000.0
Omipalisib	SRPK2	83.0	10000.0
RO-3306	DRAK1	0.1	10000.0
R406	YES	1.2	1000.0
RO-3306	RET(V804L)	76.0	10000.0
CP724714	ERN1	82.0	10000.0
KIN001-021	MINK	100.0	1000.0
XMD16-144	WEE1	100.0	10000.0
BX-912	MP2K4	0.3	10000.0
HG-6-64-01	BTK	0.3	10000.0
ZM-447439	NEK4	57.0	10000.0
JNK-IN-11	PIK4CB	69.0	1000.0
GW843682X	KPCD3	100.0	10000.0
QL-XII-47	ADCK3	98.0	1000.0
BMS-536924	TAK1	5.8	1000.0
Alpelisib	RSK3(Kin.Dom.1-N-terminal)	95.0	1000.0
GSK461364	PFCDPK1(P.falciparum)	62.0	10000.0
AS-252424	YSK1	100.0	10000.0
NG25	M3K5	100.0	10000.0
AZD-6482	RET(V804L)	99.0	10000.0
Buparlisib	WNK4	100.0	1000.0
XMD11-50	KIT(V559D,T670I)	81.0	10000.0
Seliciclib	PIK3CA(C420R)	100.0	10000.0
Dinaciclib	DRAK1	100.0	10000.0
Torin1	ACVR2B	42.0	10000.0
GSK1059615	M3K13	82.0	10000.0
XMD-12	MYLK4	89.0	1000.0
GSK1059615	BMPR1B	2.0	10000.0
XMD16-144	MP2K2	78.0	10000.0
Alpelisib	AKT1	96.0	1000.0
Ribociclib	PIM2	100.0	1000.0
JWE-035	CTK	94.0	10000.0
PD0325901	ERK8	100.0	10000.0
Vemurafenib	EGFR(L858R)	64.0	10000.0
QL-X-138	CHK2	87.0	10000.0
WZ4002	EGFR(E746-A750del)	0.2	10000.0
PLX-4720	SRC	9.2	10000.0
QL-XI-92	CAMK1G	91.0	10000.0
AZD4547	CSK	29.0	10000.0
XMD8-85	IRAK3	100.0	10000.0
GW-5074	MELK	99.0	10000.0
Neratinib	ACVR1B	100.0	10000.0
XMD11-85h	JNK1	100.0	10000.0
WH-4-023	ABL1(T315I)-nonphosphorylated	1.4	10000.0
ZM-447439	BRAF(V600E)	100.0	10000.0
AZD 5438	PIP5K1A	6.2	10000.0
Neratinib	MLTK	70.0	10000.0
R406	DCLK1	7.2	1000.0
PHA-767491	DCAMKL3	0.7	10000.0
Ribociclib	HCK	98.0	1000.0
Ibrutinib	FLT3-autoinhibited	67.0	1000.0
Seliciclib	MLK3	100.0	10000.0
Palbociclib	MTOR	81.0	1000.0
AG1478	KC1G1	100.0	10000.0
AZ-628	KGP2	100.0	10000.0
Dactolisib	EGFR(G719C)	100.0	1000.0
ALW-II-38-3	LKB1	100.0	10000.0
Momelotinib	MAP3K1	92.0	10000.0
Crizotinib	DAPK3	94.0	10000.0
BMX-IN-1	PIP5K2B	63.0	10000.0
Omipalisib	LATS2	54.0	10000.0
Pictilisib	M4K1	85.0	1000.0
TGX221	YANK3	100.0	1000.0
Alpelisib	TIE1	100.0	1000.0
KIN001-220	PIK3CA(C420R)	57.0	10000.0
Omipalisib	RIPK4	68.0	10000.0
XMD8-85	FLT3(D835H)	100.0	10000.0
KIN001-111	ROCK2	12.0	1000.0
Torin2	LATS1	100.0	10000.0
XMD-12	TYK2(JH1domain-catalytic)	1.9	1000.0
PHA-793887	TYRO3	96.0	10000.0
Torin2	LRRK2(G2019S)	81.0	10000.0
WH-4-023	PIK3CA(E545K)	100.0	10000.0
AS-252424	EGFR(S752-I759del)	9.9	10000.0
GSK461364	SgK110	100.0	10000.0
CG-930	ABL1(F317L)-nonphosphorylated	55.0	10000.0
Omipalisib	DCAMKL3	100.0	10000.0
CGP60474	CDC2L1	100.0	10000.0
AZD 5438	KPCI	36.0	10000.0
ALW-II-49-7	BLK	100.0	10000.0
AG1478	INSR	62.0	10000.0
KU63794	KPCD2	96.0	10000.0
Dinaciclib	PIK3CA(H1047L)	84.0	10000.0
SB590885	SGK3	88.0	10000.0
MLN8054	MAP4K4	86.0	10000.0
Dactolisib	TESK1	100.0	1000.0
Baricitinib	YANK3	74.0	10000.0
CGP74514A	BMPR2	21.0	10000.0
OTSSP167	PLK4	0.0	10000.0
NU7441	RET	100.0	10000.0
Dinaciclib	MYLK	75.0	10000.0
KIN001-111	TIE1	11.0	1000.0
KIN001-111	IKKA	100.0	1000.0
Momelotinib	RSK1(Kin.Dom.2-C-terminal)	80.0	10000.0
JNK-IN-11	PIK3CA(Q546K)	100.0	1000.0
Pictilisib	TSSK1	100.0	1000.0
Momelotinib	RIPK2	88.0	10000.0
BI-2536	CDK3	100.0	10000.0
WZ4003	NEK9	100.0	1000.0
Neratinib	PLK3	94.0	10000.0
KIN001-021	MLCK	100.0	1000.0
Ribociclib	CAMK2G	48.0	1000.0
BI-D1870	ROCK2	33.0	10000.0
PD0325901	S6K1	100.0	10000.0
MLN8054	RPS6KA5(Kin.Dom.1-N-terminal)	99.0	10000.0
Torin1	VRK2	100.0	10000.0
HG-9-91-01	PIM2	100.0	10000.0
NPK76-II-72-1	STK16	100.0	10000.0
Omipalisib	CDK2	91.0	10000.0
TAK-715	IKKA	100.0	10000.0
Canertinib	CAMK2B	100.0	1000.0
Lapatinib	CSNK1D	88.0	10000.0
Neratinib	MK09	52.0	10000.0
AZD7762	CDK4-cyclinD1	75.0	10000.0
5z-7-oxozeaenol	NEK2	94.0	10000.0
GSK429286A	DAPK1	81.0	10000.0
MRT67307	MKNK1	100.0	10000.0
5z-7-oxozeaenol	S6K1	100.0	10000.0
KIN001-127	STK16	100.0	10000.0
BMS-536924	PDPK1	100.0	1000.0
SB590885	PKNB(M.tuberculosis)	65.0	10000.0
AZD4547	SYK	16.0	10000.0
XMD8-85	TIE2	100.0	10000.0
AZD4547	AURKA	0.1	10000.0
Dactolisib	PIK3CG	23.0	1000.0
ERK5-IN-1	PRKR	97.0	1000.0
AZD7762	PIM2	57.0	10000.0
AZD-6482	PKNB(M.tuberculosis)	98.0	10000.0
ERK5-IN-1	ACVR1B	100.0	1000.0
PLX-4720	FER	58.0	10000.0
BI-2536	EPHB2	100.0	10000.0
BMS-536924	ERK5	100.0	1000.0
A443654	WEE1	100.0	10000.0
JNK-9L	RET(M918T)	100.0	10000.0
XMD11-85h	TBK1	100.0	10000.0
Abemaciclib	ABL1(Q252H)-phosphorylated	100.0	1000.0
GSK461364	PKN1	46.0	10000.0
HG-5-88-01	CSK	100.0	10000.0
Ibrutinib	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	1000.0
ZG-10	ULK1	97.0	10000.0
XMD11-85h	RPS6KA6(Kin.Dom.1)	100.0	10000.0
Pictilisib	DCAMKL2	100.0	1000.0
5z-7-oxozeaenol	MST2	52.0	10000.0
Momelotinib	RET(V804M)	95.0	10000.0
AZ-628	AMPK-alpha1	73.0	10000.0
AZD4547	M3K2	0.1	10000.0
JNK-IN-8	FLT3(ITD)	50.0	1000.0
CG-930	ABL1(E255K)-phosphorylated	31.0	10000.0
Momelotinib	ROS1	100.0	10000.0
Omipalisib	HIPK4	76.0	10000.0
QL-XII-47	DYRK1A	90.0	1000.0
Crizotinib	JNK3	80.0	10000.0
Dabrafenib	STK16	5.8	10000.0
AG1478	FLT3	42.0	10000.0
JWE-035	AURKB	1.0	10000.0
KU63794	PIP5K2B	100.0	10000.0
SB590885	KGP1	89.0	10000.0
KIN001-123	EGFR(L747-T751del,Sins)	25.0	1000.0
XMD8-85	DCAMKL2	0.5	10000.0
BX-912	KIT(V559D)	0.1	10000.0
Momelotinib	MET(M1250T)	100.0	10000.0
JNK-IN-5A	KPCD2	88.0	10000.0
WYE-125132	LATS1	95.0	10000.0
XMD11-85h	PHKG1	100.0	10000.0
Omipalisib	MYO3B	100.0	10000.0
SCH772984	ABL1(H396P)-phosphorylated	100.0	1000.0
QL-XI-92	TSSK1	93.0	10000.0
WZ4002	ABL1(M351T)	100.0	10000.0
Torin1	MP2K6	100.0	10000.0
BMS-536924	KPCT	30.0	1000.0
Omipalisib	EPHA2	77.0	10000.0
XMD11-50	MK14	87.0	10000.0
XMD11-50	DYRK1B	94.0	10000.0
THZ1	PDPK1	34.0	10000.0
SB590885	M3K13	100.0	10000.0
Dabrafenib	ULK2	1.6	10000.0
Momelotinib	YANK2	93.0	10000.0
Buparlisib	EGFR(L858R,T790M)	100.0	1000.0
ZM-447439	EPHB3	100.0	10000.0
Momelotinib	ANKK1	100.0	10000.0
KIN001-021	ULK3	100.0	1000.0
Sigma A6730	FGFR2	100.0	10000.0
(s)-CR8	KPCD2	81.0	10000.0
ZSTK474	ACVR2A	100.0	1000.0
KIN001-127	MP2K3	100.0	10000.0
SB590885	PAK2	85.0	10000.0
Ceritinib	HIPK2	94.0	1000.0
SB590885	MAP4K5	97.0	10000.0
BMS345541	STK16	100.0	10000.0
HG-14-8-02	EPHA4	100.0	10000.0
JNK-9L	CTK	62.0	10000.0
Seliciclib	MST1R	100.0	10000.0
GSK461364	LIMK2	100.0	10000.0
JNK-IN-8	PKN2	58.0	1000.0
AZD4547	RSK4(Kin.Dom.2-C-terminal)	77.0	10000.0
GSK461364	JAK2(JH1domain-catalytic)	87.0	10000.0
Torkinib	STK35	3.0	10000.0
ALW-II-38-3	MAPKAPK2	100.0	10000.0
OTSSP167	CSF1R-autoinhibited	3.2	10000.0
Sigma A6730	FER	83.0	10000.0
NVP-TAE684	CSNK1D	100.0	1000.0
Buparlisib	NEK6	100.0	1000.0
PLX-4720	CAMK1D	78.0	10000.0
Vemurafenib	AKT1	100.0	10000.0
WYE-125132	AURKB	92.0	10000.0
BMX-IN-1	PAK2	92.0	10000.0
JNK-IN-11	ZAP70	96.0	1000.0
GSK1059615	BTK	58.0	10000.0
Sigma A6730	MET(M1250T)	28.0	10000.0
TAK-715	PKNB(M.tuberculosis)	100.0	10000.0
JNK-IN-5A	FLT3(D835H)	84.0	10000.0
AZD7762	KPCI	11.0	10000.0
Taselisib	AURKA	100.0	1000.0
BX-912	RIPK2	58.0	10000.0
(s)-CR8	ERK5	97.0	10000.0
5z-7-oxozeaenol	LOK	62.0	10000.0
WZ4002	PLK1	16.0	10000.0
Seliciclib	CDK15	52.0	10000.0
KU63794	ABL1(Q252H)-phosphorylated	71.0	10000.0
Torin1	DMPK2	1.6	10000.0
MRT67307	FGFR4	100.0	10000.0
(s)-CR8	PIK3CA	77.0	10000.0
KIN001-127	MK12	100.0	10000.0
QL-X-138	FAK1	96.0	10000.0
GW-5074	PIP5K2B	10.0	10000.0
Dactolisib	OSR1	100.0	1000.0
NVP-TAE684	EPHA5	21.0	1000.0
Ceritinib	KIT(A829P)	62.0	1000.0
CP724714	TYK2(JH1domain-catalytic)	100.0	10000.0
AS-252424	JAK1(JH2domain-pseudokinase)	51.1	10000.0
Abemaciclib	YANK1	100.0	1000.0
Momelotinib	MARK4	42.0	10000.0
CG-930	CHK2	100.0	10000.0
AZD-6482	LRRK2	100.0	10000.0
WZ-4-145	DDR1	0.0	10000.0
Taselisib	CDK16	100.0	1000.0
TGX221	CDK2	100.0	1000.0
ZM-447439	ABL1(F317L)-phosphorylated	60.0	10000.0
CH5424802	PIK3CA(H1047L)	96.0	1000.0
Omipalisib	DMPK2	76.0	10000.0
Omipalisib	DRAK2	100.0	10000.0
Crizotinib	KIT(D816V)	32.0	10000.0
GW843682X	MP2K2	85.0	10000.0
KU63794	BIKE	98.0	10000.0
BI-2536	IKKA	100.0	10000.0
SCH772984	ULK2	99.0	1000.0
Alpelisib	CASK	71.0	1000.0
KIN001-021	ANKK1	100.0	1000.0
ZM-447439	MTOR	70.0	10000.0
R406	FAK2	0.3	1000.0
GW843682X	SRPK3	16.0	10000.0
AZD 5438	EPHA4	60.0	10000.0
WZ-7043	ULK1	100.0	10000.0
MPS-1-IN-1	KIT(V559D,T670I)	100.0	1000.0
XMD8-85	CLK4	100.0	10000.0
BX-912	PIK3CG	58.0	10000.0
ALW-II-49-7	LYN	9.4	1000.0
ZSTK474	RET(V804M)	100.0	1000.0
Ceritinib	NIM1	95.0	1000.0
THZ1	RIPK1	11.0	10000.0
GW843682X	BRAF(V600E)	92.0	10000.0
AZD 5438	FGFR3	89.0	10000.0
Taselisib	MYO3A	86.0	1000.0
WZ-7043	FAK1	100.0	10000.0
BGJ398	PIK3CA(E542K)	83.0	1000.0
Pictilisib	MST3	100.0	1000.0
JNK-9L	ABL1(M351T)-phosphorylated	69.0	10000.0
PHA-793887	SGK3	100.0	10000.0
Alpelisib	KPCD	81.0	1000.0
WH-4-023	BRAF	88.0	10000.0
WZ-4-145	TGFBR2	100.0	10000.0
HG-5-113-01	KPCE	18.0	10000.0
PHA-767491	CDK4-cyclinD1	12.0	10000.0
MRT67307	MUSK	97.0	10000.0
MPS-1-IN-1	LATS1	100.0	1000.0
Abemaciclib	ABL1(H396P)-nonphosphorylated	56.0	1000.0
AZD-6482	CLK2	70.0	10000.0
QL-X-138	CLK1	0.4	10000.0
A443654	YSK1	100.0	10000.0
CP466722	TBK1	24.0	10000.0
Buparlisib	KPCD2	90.0	1000.0
NPK76-II-72-1	TGFBR2	100.0	10000.0
KIN001-123	MUSK	100.0	1000.0
Dinaciclib	M3K2	66.0	10000.0
Vemurafenib	FAK2	100.0	10000.0
XMD11-85h	PIK3CD	100.0	10000.0
AZD7762	MST3	0.3	10000.0
OTSSP167	PAK7	2.4	10000.0
GSK461364	EPHA8	90.0	10000.0
Torin1	MKNK1	44.0	10000.0
HG-14-8-02	EPHA3	77.0	10000.0
CGP60474	ROCK1	100.0	10000.0
GW843682X	GCN2(Kin.Dom.2,S808G)	16.0	10000.0
Torin2	BRAF	73.0	10000.0
JNK-9L	ROS1	17.0	10000.0
HG-9-91-01	PAK1	1.0	10000.0
JNK-IN-8	KGP1	72.0	1000.0
WZ3105	PKN1	22.0	10000.0
XMD8-92	KC1G2	100.0	10000.0
BMX-IN-1	MINK	73.0	10000.0
ERK5-IN-1	PAK6	100.0	1000.0
Momelotinib	TYK2(JH1domain-catalytic)	0.3	10000.0
WZ4003	DCAMKL3	0.3	1000.0
AZD-6482	KIT(V559D,V654A)	96.0	10000.0
CP724714	CDK16	74.0	10000.0
Ribociclib	ABL1(F317L)-nonphosphorylated	97.0	1000.0
XMD11-85h	DDR2	100.0	10000.0
A443654	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
XMD11-50	WEE1	100.0	10000.0
Alpelisib	MAP3K4	100.0	1000.0
MRT67307	M3K6	58.0	10000.0
SCH772984	GRK4	32.0	1000.0
JNK-IN-8	ICK	92.0	1000.0
JNK-IN-11	ABL1(F317I)-nonphosphorylated	60.0	1000.0
Ribociclib	MP2K6	100.0	1000.0
PHA-767491	MP2K7	100.0	10000.0
ZSTK474	TYRO3	100.0	1000.0
XMD16-144	MAK	100.0	10000.0
PHA-793887	EGFR(L747-T751del,Sins)	100.0	10000.0
Dactolisib	ERK5	100.0	1000.0
Sorafenib	JNK1	100.0	10000.0
JWE-035	S6K1	48.0	10000.0
QL-XI-92	DRAK1	100.0	10000.0
JW-7-24-1	MLK1	27.0	10000.0
KU63794	PCTK2	100.0	10000.0
AZ-628	EIF2AK1	84.0	10000.0
Alpelisib	KPCD3	100.0	1000.0
HG-6-64-01	PIM3	100.0	10000.0
XMD16-144	FLT3(ITD)	9.4	10000.0
Buparlisib	ZAP70	100.0	1000.0
MRT67307	TRPM6	100.0	10000.0
HG-6-64-01	EPHB3	4.7	10000.0
TGX221	GSK3A	100.0	1000.0
KIN001-123	CAMK1D	100.0	1000.0
Abemaciclib	EPHB4	93.0	1000.0
WH-4-023	FER	0.9	10000.0
WZ4002	INSRR	13.0	10000.0
Ribociclib	PIK3CA(M1043I)	100.0	1000.0
HG-14-8-02	JAK1(JH1domain-catalytic)	100.0	10000.0
AZD7762	ULK2	0.0	10000.0
QL-XI-92	PIK3CA(C420R)	82.0	10000.0
JNK-IN-11	VGFR2	17.0	1000.0
WH-4-023	CDK4-cyclinD3	26.0	10000.0
CGP60474	LKB1	100.0	10000.0
HG-5-88-01	YES	100.0	10000.0
SB590885	MP2K1	99.0	10000.0
HG-6-64-01	KIT(D816H)	36.0	10000.0
BMS345541	DAPK1	47.0	10000.0
Barasertib	RSK1(Kin.Dom.2-C-terminal)	69.0	10000.0
OTSSP167	TRKA	0.6	10000.0
A443654	ACVR1B	100.0	10000.0
Sigma A6730	CAMK2G	100.0	10000.0
QL-XII-47	CAMK1	100.0	1000.0
BS-181	NEK1	98.0	10000.0
JW-7-24-1	RIOK3	20.0	10000.0
Torin1	NDR2	94.0	10000.0
JNK-9L	JNK1	0.1	10000.0
Dinaciclib	PIK3CA(H1047Y)	82.0	10000.0
GSK429286A	NEK9	89.0	10000.0
AZ-628	CAMK2B	100.0	10000.0
Baricitinib	ABL1(F317I)-phosphorylated	63.0	10000.0
Ribociclib	TNK1	100.0	1000.0
Sorafenib	ADCK4	100.0	10000.0
CP724714	ERK5	100.0	10000.0
Alpelisib	CSNK1D	100.0	1000.0
GW-5074	MST4	100.0	10000.0
Abemaciclib	FER	66.0	1000.0
BMS345541	M3K5	80.0	10000.0
PD0325901	NEK9	82.0	10000.0
5z-7-oxozeaenol	RIOK3	0.0	10000.0
SCH772984	KIT(L576P)	72.0	1000.0
AZD-6482	ZAP70	100.0	10000.0
HG-14-8-02	RET(V804M)	100.0	10000.0
SP600125	CSNK2A2	100.0	10000.0
CP724714	EGFR(G719C)	0.0	10000.0
WZ3105	PIK3CA(Q546K)	100.0	10000.0
HG-14-8-02	RSK4(Kin.Dom.2-C-terminal)	76.0	10000.0
GSK429286A	DMPK	100.0	10000.0
Palbociclib	PIK3C2B	100.0	1000.0
CP724714	RSK3(Kin.Dom.2-C-terminal)	97.0	10000.0
BGJ398	SRPK3	63.0	1000.0
BX-912	TAOK1	0.3	10000.0
Taselisib	MK11	100.0	1000.0
TGX221	ABL1(F317L)	100.0	1000.0
GW843682X	TYK2(JH1domain-catalytic)	59.0	10000.0
BX-912	MINK	4.2	10000.0
Buparlisib	EPHA4	91.0	1000.0
PHA-793887	FLT3(N841I)	93.0	10000.0
GSK461364	GSK3A	100.0	10000.0
BMS-536924	STK33	1.0	1000.0
CGP74514A	MRCKA	100.0	10000.0
CG-930	ERBB4	56.0	10000.0
ERK5-IN-1	ABL1-phosphorylated	100.0	1000.0
Taselisib	EGFR	93.0	1000.0
Baricitinib	MAK	100.0	10000.0
ZM-447439	AKT3	100.0	10000.0
CP724714	SIK1	100.0	10000.0
KIN001-021	DMPK2	34.0	1000.0
BI-D1870	NUAK1	23.0	10000.0
HG-9-91-01	PHKG1	80.0	10000.0
QL-XII-47	NEK11	100.0	1000.0
GW843682X	TGFBR2	100.0	10000.0
AZD 5438	NDR1	30.0	10000.0
BMX-IN-1	STK39	100.0	10000.0
NVP-TAE684	MYO3A	0.3	1000.0
SCH772984	PIK3CA(E545K)	87.0	1000.0
SP600125	LYN	100.0	10000.0
Vemurafenib	TAK1	69.0	10000.0
HG-9-91-01	ADCK4	11.0	10000.0
Torin1	TGFBR1	70.0	10000.0
GSK1059615	MUSK	92.0	10000.0
ZM-447439	CDK4-cyclinD3	100.0	10000.0
PLX-4720	KCC4	100.0	10000.0
Lapatinib	RIOK2	87.0	10000.0
KIN001-111	TGFBR1	34.0	1000.0
Torkinib	ROS1	100.0	10000.0
AZD7762	KPCD	0.7	10000.0
Lapatinib	MUSK	100.0	10000.0
JNK-IN-8	AAK1	69.0	1000.0
Dinaciclib	TNK1	100.0	10000.0
BI-2536	PKN2	100.0	10000.0
MLN8054	CDK3	100.0	10000.0
Abemaciclib	BMPR1B	95.0	1000.0
KIN001-123	MP2K3	100.0	1000.0
SCH772984	SGK2	100.0	1000.0
QL-XI-92	MAP4K2	100.0	10000.0
CG-930	KIT(L576P)	95.0	10000.0
ALW-II-49-7	IRAK3	100.0	10000.0
QL-XI-92	BLK	97.0	10000.0
ALW-II-38-3	GRK4	100.0	10000.0
5z-7-oxozeaenol	TLK2	100.0	10000.0
WH-4-023	MAP4K5	0.7	10000.0
HG-5-88-01	JAK1(Kin.Dom.2)	100.0	10000.0
Seliciclib	M3K2	100.0	10000.0
GW843682X	EPHB1	96.0	10000.0
Dinaciclib	MP2K2	100.0	10000.0
Crizotinib	LKB1	57.0	10000.0
TGX221	PLK4	100.0	1000.0
PD0325901	EGFR	85.0	10000.0
GSK1059615	YSK4	0.1	10000.0
Palbociclib	ABL1-phosphorylated	100.0	1000.0
SP600125	DRAK2	100.0	10000.0
HG-14-10-04	MRCKB	75.0	10000.0
Torkinib	PCTK2	100.0	10000.0
AZD7762	TRPM6	74.0	10000.0
Dabrafenib	HIPK4	5.1	10000.0
Momelotinib	WEE1	100.0	10000.0
Ibrutinib	EGFR(L747-T751del,Sins)	1.1	1000.0
HG-6-64-01	CDK11	4.2	10000.0
5z-7-oxozeaenol	KIT(D816V)	0.4	10000.0
KU63794	NEK9	89.0	10000.0
OTSSP167	ERN1	16.0	10000.0
AZD4547	PI42C	16.0	10000.0
GSK1059615	SGK2	84.0	10000.0
Sigma A6730	WEE1	99.0	10000.0
ALW-II-38-3	AURKA	100.0	10000.0
XMD-12	ABL1(E255K)-phosphorylated	0.6	1000.0
XMD11-85h	JAK1(JH2domain-pseudokinase)	100.0	10000.0
R406	CDK3	100.0	1000.0
WZ4003	TRKB	100.0	1000.0
Dinaciclib	YANK3	100.0	10000.0
Dinaciclib	ERK8	1.0	10000.0
Crizotinib	EGFR(L858R,T790M)	82.0	10000.0
XMD11-50	FYN	100.0	10000.0
5z-7-oxozeaenol	PLK2	69.0	10000.0
WZ4002	EPHA5	100.0	10000.0
(s)-CR8	SNARK	88.0	10000.0
MRT67307	SNRK	5.9	10000.0
AG1478	SgK110	65.0	10000.0
AZD-6482	CTK	96.0	10000.0
NU7441	CDK3	100.0	10000.0
GW-5074	EGFR(L747-E749del,A750P)	36.0	10000.0
PLX-4720	ICK	63.0	10000.0
HG-5-113-01	NEK2	100.0	10000.0
R406	RAF1	17.0	1000.0
ERK5-IN-1	DAPK1	100.0	1000.0
TGX221	MERTK	100.0	1000.0
BGJ398	MET(Y1235D)	100.0	1000.0
JW-7-24-1	NEK6	100.0	10000.0
AZD7762	FGFR3	16.0	10000.0
WYE-125132	DCAMKL2	97.0	10000.0
BGJ398	CSNK2A2	99.0	1000.0
Sigma A6730	YES	100.0	10000.0
WZ-4-145	MAP4K5	2.3	10000.0
PHA-767491	KCC2D	28.0	10000.0
A443654	MET	100.0	10000.0
CGP74514A	CLK2	2.0	10000.0
PHA-793887	PI42C	92.0	10000.0
PHA-767491	MRCKA	100.0	10000.0
Neratinib	AMPK-alpha2	80.0	10000.0
Ribociclib	MAK	100.0	1000.0
BS-181	CDK8	100.0	10000.0
BS-181	KCC4	40.0	10000.0
CP724714	ANKK1	60.0	10000.0
XMD14-99	TRKA	62.0	10000.0
R406	FRK	1.6	1000.0
Ribociclib	EPHA6	93.0	1000.0
Torkinib	MK13	97.0	10000.0
Omipalisib	YANK1	73.0	10000.0
NG25	EPHA6	100.0	10000.0
Sigma A6730	ERK4	100.0	10000.0
KIN001-220	CSNK1D	100.0	10000.0
Ceritinib	MYO3B	81.0	1000.0
AG1478	ABL1(Q252H)-phosphorylated	7.1	10000.0
ZM-447439	YES	16.0	10000.0
CP724714	PLK4	74.0	10000.0
GSK429286A	KIT(V559D,T670I)	88.0	10000.0
Pictilisib	MLK2	75.0	1000.0
XMD11-50	ABL1-phosphorylated	82.0	10000.0
SCH772984	FAK2	100.0	1000.0
Lapatinib	STK16	100.0	10000.0
JNK-9L	PIK3CG	0.8	10000.0
Seliciclib	SGK3	100.0	10000.0
PD0325901	FGFR3(G697C)	88.0	10000.0
ALW-II-49-7	RPS6KA5(Kin.Dom.1)	100.0	10000.0
WH-4-023	TRKB	82.0	10000.0
QL-X-138	FLT3(D835H)	14.0	10000.0
JNK-IN-11	GRK4	93.0	1000.0
PHA-767491	TAOK1	0.8	10000.0
PD173074	PLK3	100.0	10000.0
KIN001-111	MYLK	100.0	1000.0
R406	FGFR3(G697C)	0.6	1000.0
AZD 5438	EPHB3	96.0	10000.0
BS-181	FLT4	95.0	10000.0
MRT67307	MTOR	92.0	10000.0
PHA-767491	TYK2(JH2domain-pseudokinase)	8.4	10000.0
Taselisib	HIPK2	96.0	1000.0
Momelotinib	ABL1-nonphosphorylated	38.0	10000.0
Dinaciclib	TNNI3K	83.0	10000.0
MLN8054	RSK4(Kin.Dom.2-C-terminal)	58.0	10000.0
BMS-536924	RPS6KA5(Kin.Dom.1)	100.0	1000.0
TAK-715	MAP4K2	93.0	10000.0
CGP60474	EGFR(L747-E749del,A750P)	100.0	10000.0
JNK-IN-11	ULK3	84.0	1000.0
JW-7-24-1	PKAC-beta	100.0	10000.0
XMD-12	DAPK2	100.0	1000.0
SB590885	FAK2	100.0	10000.0
PLX-4720	PAK4	57.0	10000.0
KIN001-123	AURKB	100.0	1000.0
HG-9-91-01	PCTK2	76.0	10000.0
QL-XI-92	ROS1	100.0	10000.0
BGJ398	EGFR(L747-E749del,A750P)	89.0	1000.0
NU7441	MRCKA	94.0	10000.0
AZD4547	LATS1	100.0	10000.0
HG-6-64-01	DMPK2	16.0	10000.0
Abemaciclib	RSK3(Kin.Dom.1-N-terminal)	83.0	1000.0
CP466722	AAK1	6.9	10000.0
Sigma A6730	BRAF(V600E)	84.0	10000.0
AZD 5438	CDKL2	0.2	10000.0
BS-181	PKAC-beta	96.0	10000.0
CG-930	PIK3CA(H1047Y)	100.0	10000.0
KIN001-127	AURKC	100.0	10000.0
HG-14-8-02	INSR	3.0	10000.0
QL-X-138	ROS1	100.0	10000.0
ERK5-IN-1	ERBB4	100.0	1000.0
Sigma A6730	MK14	88.0	10000.0
Ceritinib	CHEK1	87.0	1000.0
Sigma A6730	RIPK2	64.0	10000.0
CP724714	MLCK	100.0	10000.0
MLN8054	KPCD1	92.0	10000.0
Barasertib	ZAP70	84.0	10000.0
JWE-035	ERBB2	100.0	10000.0
PD173074	DDR1	1.1	10000.0
HG-6-64-01	NEK11	32.0	10000.0
AZD4547	VGFR2	0.0	10000.0
TAK-715	RET(V804L)	99.0	10000.0
CP724714	KPCD3	83.0	10000.0
Lapatinib	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
GW843682X	AURKA	100.0	10000.0
BI-D1870	RPS6KA3(Kin.Dom.1-N-terminal)	22.0	10000.0
NG25	FLT3(D835Y)	14.0	10000.0
MLN8054	CSNK1A1	73.0	10000.0
KIN001-111	SIK2	100.0	1000.0
BMS-536924	CIT	100.0	1000.0
GSK1059615	VGFR1	73.0	10000.0
KU63794	TRKC	77.0	10000.0
XMD-12	TGFBR2	100.0	1000.0
AZD4547	RSK3(Kin.Dom.1-N-terminal)	49.0	10000.0
KU63794	PIK3CD	1.0	10000.0
XMD11-85h	TESK1	100.0	10000.0
RO-3306	PFCDPK1(P.falciparum)	65.0	10000.0
Ibrutinib	MAP4K4	93.0	1000.0
Seliciclib	ALK(L1196M)	34.0	10000.0
KIN001-111	YES	0.0	1000.0
Torin1	CAMK2G	79.0	10000.0
WYE-125132	MAP4K2	100.0	10000.0
THZ1	SBK1	10.0	10000.0
WZ3105	PIK3CG	100.0	10000.0
Seliciclib	CDK14	88.0	10000.0
Neratinib	RET(V804L)	100.0	10000.0
XMD16-144	MLK2	89.0	10000.0
PHA-793887	AKT1	100.0	10000.0
Seliciclib	AKT1	78.0	10000.0
NVP-TAE684	MAP4K5	0.3	1000.0
KU63794	MAST1	100.0	10000.0
GW843682X	CSK	97.0	10000.0
HG-14-8-02	BTK	0.9	10000.0
Alpelisib	IGF1R	100.0	1000.0
WH-4-023	CDK3	100.0	10000.0
Sigma A6730	PIK3CA(H1047L)	69.0	10000.0
KIN001-127	ERK5	100.0	10000.0
Crizotinib	FLT4	100.0	10000.0
WYE-125132	BRAF	100.0	10000.0
HG-14-8-02	PDPK1	100.0	10000.0
MRT67307	IKKA	36.0	10000.0
Torin1	BMPR2	85.0	10000.0
XMD14-99	STK36	100.0	10000.0
Torin1	MET(M1250T)	79.0	10000.0
PLX-4720	STK16	18.0	10000.0
PLX-4720	TYK2(JH2domain-pseudokinase)	100.0	10000.0
Buparlisib	PIK3CA	1.4	1000.0
Sigma A6730	EGFR(G719C)	53.0	10000.0
WZ-7043	TAOK3	0.4	10000.0
Vemurafenib	PIK3CA(E545A)	95.0	10000.0
THZ1	EPHA8	56.0	10000.0
MRT67307	TYRO3	91.0	10000.0
NVP-TAE684	PTK6	0.2	1000.0
BMS-536924	FAK1	0.0	1000.0
JNK-IN-5A	LKB1	81.0	10000.0
XMD14-99	PAK3	94.0	10000.0
Torkinib	EGFR(L747-S752del,P753S)	25.0	10000.0
Neratinib	EPHA2	94.0	10000.0
Alpelisib	EGFR(L747-T751del,Sins)	78.0	1000.0
GSK461364	CLK3	91.0	10000.0
RO-3306	YSK1	98.0	10000.0
XMD8-92	PAK3	100.0	10000.0
Torin1	RAF1	48.0	10000.0
KIN001-021	DAPK1	100.0	1000.0
GSK429286A	PIK3CA(Q546K)	32.0	10000.0
ALW-II-38-3	KC1G1	100.0	10000.0
JNK-9L	MAP4K4	24.0	10000.0
Buparlisib	CAMK1	93.0	1000.0
KIN001-021	KPCL	100.0	1000.0
GW-5074	BRAF(V600E)	0.1	10000.0
Seliciclib	NEK10	80.0	10000.0
Seliciclib	CSK	100.0	10000.0
Dabrafenib	MST4	33.0	10000.0
GSK1059615	NEK6	81.0	10000.0
KU63794	TRKB	73.0	10000.0
Pictilisib	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	1000.0
Taselisib	CIT	97.0	1000.0
ZM-447439	PIK3CG	100.0	10000.0
SB590885	TXK	97.0	10000.0
Baricitinib	EGFR(E746-A750del)	67.0	10000.0
MPS-1-IN-1	PRKR	100.0	1000.0
CGP74514A	CSNK1A1	2.0	10000.0
WZ-4-145	JAK2(Kin.Dom.2)	100.0	10000.0
SB590885	MST2	88.0	10000.0
HG-6-64-01	PIP5K2B	0.4	10000.0
GSK1059615	EPHB2	86.0	10000.0
MPS-1-IN-1	NLK	100.0	1000.0
AG1478	SIK3	53.0	10000.0
CP724714	PIK3CG	100.0	10000.0
XMD8-92	PIK3CA(Q546K)	100.0	10000.0
Vemurafenib	RET(M918T)	28.0	10000.0
JNK-IN-5A	FLT4	91.0	10000.0
Ribociclib	ABL1(T315I)-nonphosphorylated	100.0	1000.0
XMD11-85h	EGFR(L858R,T790M)	100.0	10000.0
KIN001-111	ABL1(T315I)	100.0	1000.0
Momelotinib	GRK4	10.0	10000.0
ZSTK474	CHEK1	100.0	1000.0
Alpelisib	SGK3	100.0	1000.0
PHA-793887	MK12	50.0	10000.0
XMD16-144	MP2K4	100.0	10000.0
GW-5074	TYK2(JH1domain-catalytic)	8.2	10000.0
Ribociclib	JAK1(JH1domain-catalytic)	65.0	1000.0
RO-3306	MYLK2	31.0	10000.0
RO-3306	PHKG1	85.0	10000.0
KIN001-127	PAK7	100.0	10000.0
CGP74514A	M3K5	100.0	10000.0
Neratinib	SgK110	100.0	10000.0
TGX221	PTK6	100.0	1000.0
BMS345541	LOK	100.0	10000.0
PD0325901	SNRK	100.0	10000.0
PLX-4720	ABL1-nonphosphorylated	1.2	10000.0
XMD8-85	MUSK	100.0	10000.0
ZG-10	PLK1	100.0	10000.0
CP724714	FLT4	98.0	10000.0
Sigma A6730	AKT1	77.0	10000.0
Omipalisib	PRP4	80.0	10000.0
Alpelisib	CDK11	81.0	1000.0
Neratinib	ABL1(F317I)-phosphorylated	89.0	10000.0
Momelotinib	TAOK3	100.0	10000.0
JNK-IN-5A	PDPK1	81.0	10000.0
SB590885	M3K6	100.0	10000.0
PLX-4720	MST4	96.0	10000.0
XMD8-92	JAK1(JH2domain-pseudokinase)	100.0	10000.0
XMD-12	SIK2	61.0	1000.0
CP466722	TLK2	40.0	10000.0
NPK76-II-72-1	EPHA5	100.0	10000.0
PLX-4720	GAK	40.0	10000.0
Pictilisib	ERN1	100.0	1000.0
Palbociclib	PIK4CB	100.0	1000.0
Momelotinib	KPCD	54.0	10000.0
Pictilisib	ABL1(M351T)	100.0	10000.0
Sorafenib	VGFR1	6.6	10000.0
JW-7-24-1	RET(M918T)	100.0	10000.0
Ceritinib	NEK3	74.0	1000.0
GSK429286A	ROCK1	0.3	10000.0
CP466722	INSR	91.0	10000.0
RO-3306	INSRR	89.0	10000.0
OTSSP167	ABL1(F317I)-phosphorylated	3.2	10000.0
Alpelisib	EGFR(G719S)	96.0	1000.0
XMD14-99	MYLK4	100.0	10000.0
XMD8-85	CSNK1D	100.0	10000.0
JNK-IN-5A	CSNK2A2	94.0	10000.0
GSK429286A	FLT3(R834Q)	77.0	10000.0
JNK-IN-8	MARK4	97.0	1000.0
Torkinib	CDK11	24.0	10000.0
Abemaciclib	KPCD3	7.5	1000.0
GW-5074	PIK3CA(H1047L)	97.0	10000.0
AZD 5438	PIK3CD	30.0	10000.0
Omipalisib	HASP	49.0	10000.0
KIN001-111	WEE1	100.0	1000.0
Ibrutinib	EGFR	1.8	1000.0
Ceritinib	PKN1	80.0	1000.0
AS-252424	MAP3K4	100.0	10000.0
MPS-1-IN-1	MK01	6.0	1000.0
SP600125	CSNK1A1L	100.0	10000.0
JNK-IN-11	M3K6	100.0	1000.0
SB590885	EPHB6	34.0	10000.0
CH5424802	CAMK2G	46.0	1000.0
SB590885	FER	100.0	10000.0
XMD13-2	MLCK	46.0	10000.0
WYE-125132	INSR	84.0	10000.0
TGX221	MLCK	100.0	1000.0
Dabrafenib	PKN1	100.0	10000.0
BGJ398	PIM1	91.0	1000.0
WZ4002	EGFR(L861Q)	0.1	10000.0
BGJ398	KIT(V559D,V654A)	86.0	1000.0
HG-6-64-01	SLK	0.6	10000.0
XMD16-144	DCAMKL2	0.5	10000.0
Baricitinib	GRK7	2.8	10000.0
HG-14-8-02	IRAK1	96.0	10000.0
Barasertib	MAP4K5	1.0	10000.0
Dinaciclib	EGFR	90.0	10000.0
AZD4547	FRK	13.0	10000.0
Torin2	TAK1	48.0	10000.0
WZ3105	CAMKK2	25.0	10000.0
WYE-125132	EGFR(E746-A750del)	38.0	10000.0
Ceritinib	JAK3(JH1domain-catalytic)	91.0	1000.0
NPK76-II-72-1	KIT(V559D)	100.0	10000.0
WZ3105	DDR2	100.0	10000.0
KIN001-123	MAPKAPK5	100.0	1000.0
XMD14-99	PIK3CA(H1047L)	100.0	10000.0
Neratinib	YES	26.0	10000.0
CP724714	MRCKA	100.0	10000.0
5z-7-oxozeaenol	ABL2	100.0	10000.0
JW-7-24-1	KPCT	20.0	10000.0
Sigma A6730	SNRK	91.0	10000.0
CGP74514A	NEK3	71.0	10000.0
PD173074	MYLK4	100.0	10000.0
XMD11-50	FLT4	100.0	10000.0
SCH772984	DAPK2	58.0	1000.0
HG-14-10-04	CAMKK2	0.3	10000.0
KIN001-111	GSK3B	100.0	1000.0
KIN001-021	MP2K1	100.0	1000.0
Alpelisib	TGFBR2	100.0	1000.0
HG-14-10-04	VGFR2	1.4	10000.0
ALW-II-38-3	PIK3C2G	100.0	10000.0
AZD4547	ERBB2	100.0	10000.0
WYE-125132	BMX	83.0	10000.0
ALW-II-38-3	CSK	13.0	1000.0
AG1478	AKT3	100.0	10000.0
JNK-IN-11	MK01	100.0	1000.0
Crizotinib	MET(M1250T)	0.1	10000.0
GW-5074	MAST1	100.0	10000.0
BX-912	TSSK1	48.0	10000.0
WZ-7043	JNK1	100.0	10000.0
OTSSP167	EGFR(L858R)	1.0	10000.0
Sorafenib	FLT3(D835H)	2.6	10000.0
WZ4002	KPCT	100.0	10000.0
HG-9-91-01	MK13	100.0	10000.0
Lapatinib	PIK3CB	100.0	10000.0
WYE-125132	DYRK1B	100.0	10000.0
JNK-9L	MYLK2	56.0	10000.0
Neratinib	CDK5	100.0	10000.0
XMD8-92	PIP5K1A	100.0	10000.0
Omipalisib	ULK3	67.0	10000.0
WZ-4-145	CAMK1	100.0	10000.0
XMD14-99	ERBB4	100.0	10000.0
SP600125	DYRK1B	100.0	10000.0
XMD11-85h	PAK4	100.0	10000.0
BS-181	MAP3K4	96.0	10000.0
Ibrutinib	EPHB4	86.0	1000.0
Crizotinib	PFCDPK1(P.falciparum)	79.0	10000.0
BS-181	MTOR	99.0	10000.0
(s)-CR8	RSK4(Kin.Dom.2-C-terminal)	84.0	10000.0
AZ-628	FLT3(N841I)	62.0	10000.0
BMS345541	DCLK1	84.0	10000.0
ALW-II-49-7	STK36	100.0	10000.0
XMD14-99	EPHA4	90.0	10000.0
WZ-4-145	FYN	5.6	10000.0
PHA-767491	ABL1(F317I)-nonphosphorylated	100.0	10000.0
AZD 5438	KPCD2	10.0	10000.0
ALW-II-38-3	PIM3	100.0	10000.0
Pictilisib	PAK7	100.0	1000.0
CH5424802	KPCD	100.0	1000.0
XMD8-92	MAP3K15	100.0	10000.0
Dinaciclib	SGK3	99.0	10000.0
JW-7-24-1	RET(V804L)	100.0	10000.0
Sorafenib	KIT(L576P)	0.0	10000.0
PLX-4720	TYK2(JH1domain-catalytic)	24.0	10000.0
JNK-IN-8	AKT3	100.0	1000.0
PHA-793887	VGFR1	97.0	10000.0
PHA-793887	ABL1(T315I)-nonphosphorylated	100.0	10000.0
5z-7-oxozeaenol	TAOK2	97.0	10000.0
Barasertib	ERBB3	35.0	10000.0
PHA-767491	PAK7	81.0	10000.0
WZ4002	PIK3CD	100.0	10000.0
Vemurafenib	CDC2L5	100.0	10000.0
JNK-IN-8	CAMK2B	100.0	1000.0
ZG-10	ERBB3	57.0	10000.0
CGP74514A	CDKL3	94.0	10000.0
Buparlisib	ABL1(T315I)-nonphosphorylated	100.0	1000.0
Dabrafenib	ABL1(H396P)-nonphosphorylated	0.1	10000.0
XMD11-50	FLT3	100.0	10000.0
XMD8-92	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
QL-XI-92	HIPK3	100.0	10000.0
Lapatinib	EGFR(E746-A750del)	0.0	10000.0
Taselisib	MERTK	75.0	1000.0
XMD-12	EGFR(L747-T751del,Sins)	100.0	1000.0
KIN001-123	MK11	100.0	1000.0
AZD-6482	PIK3CA	0.1	10000.0
SP600125	CDK15	100.0	10000.0
AZD 5438	RPS6KA5(Kin.Dom.1-N-terminal)	59.0	10000.0
BI-2536	JAK3(Kin.Dom.2)	100.0	10000.0
Ceritinib	PAK1	91.0	1000.0
WH-4-023	BMPR2	80.0	10000.0
Torin1	STK39	100.0	10000.0
XMD11-50	ANKK1	100.0	10000.0
Dactolisib	KIT	100.0	1000.0
Taselisib	AXL	93.0	1000.0
HG-9-91-01	MARK4	19.0	10000.0
Sorafenib	ABL1(H396P)-nonphosphorylated	1.1	10000.0
Torkinib	KIT	0.8	10000.0
BX-912	PDPK1	2.4	10000.0
Pictilisib	FGFR3	100.0	1000.0
5z-7-oxozeaenol	MP2K1	0.1	10000.0
WZ4002	IGF1R	7.4	10000.0
GSK429286A	KPCE	100.0	10000.0
PLX-4720	ROCK2	81.0	10000.0
Ceritinib	ACVR1	97.0	1000.0
ALW-II-49-7	CDK15	100.0	10000.0
ZSTK474	NEK2	100.0	1000.0
JNK-9L	STK16	12.0	10000.0
AS-252424	MP2K4	68.9	10000.0
BMS-536924	MUSK	16.0	1000.0
NU7441	KIT(V559D,V654A)	100.0	10000.0
HG-14-8-02	PLK4	9.3	10000.0
Crizotinib	JNK1	100.0	10000.0
ZM-447439	CSNK1E	80.0	10000.0
Omipalisib	MK13	100.0	10000.0
Seliciclib	NEK2	100.0	10000.0
BMS-536924	KKCC1	16.0	1000.0
GW843682X	GSK3B	100.0	10000.0
XMD8-92	STK36	100.0	10000.0
TGX221	RPS6KA4(Kin.Dom.1)	100.0	1000.0
5z-7-oxozeaenol	KKCC1	92.0	10000.0
BI-2536	EGFR(L747-E749del,A750P)	20.0	10000.0
5z-7-oxozeaenol	NEK5	92.0	10000.0
(s)-CR8	MK12	79.0	10000.0
CP466722	IKKA	44.0	10000.0
GW843682X	CDK4-cyclinD3	100.0	10000.0
BGJ398	KC1G2	94.0	1000.0
KU63794	EGFR(L747-T751del,Sins)	82.0	10000.0
ZM-447439	CSNK1D	71.0	10000.0
CGP74514A	MK12	68.0	10000.0
AG1478	AURKA	43.0	10000.0
BX-912	TRKC	2.6	10000.0
THZ1	ABL1-phosphorylated	0.3	10000.0
HG-6-64-01	SRPK1	1.8	10000.0
ZM-447439	DAPK1	84.0	10000.0
ERK5-IN-1	MP2K6	84.0	1000.0
CP724714	DYRK2	100.0	10000.0
CP466722	INSRR	100.0	10000.0
Dinaciclib	PIK3CA(E545K)	93.0	10000.0
XMD13-2	PLK1	78.0	10000.0
CGP60474	MAP4K5	100.0	10000.0
XMD-12	EPHB1	100.0	1000.0
Dinaciclib	PAK1	86.0	10000.0
BMS345541	CDKL2	82.0	10000.0
JNK-9L	IGF1R	51.0	10000.0
AZD7762	MYLK	3.3	10000.0
GW843682X	ABL1(M351T)-phosphorylated	81.0	10000.0
XMD8-85	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
NU7441	DCLK1	84.0	10000.0
PLX-4720	RET(V804L)	96.0	10000.0
Barasertib	MYO3B	100.0	10000.0
JNK-IN-5A	MK12	82.0	10000.0
PD173074	LTK	100.0	10000.0
ZSTK474	PTK6	100.0	1000.0
KIN001-127	YANK2	100.0	10000.0
XMD11-85h	CSNK2A1	100.0	10000.0
Ibrutinib	FLT4	35.0	1000.0
GW-5074	JAK2(JH1domain-catalytic)	57.0	10000.0
HG-14-8-02	CLK3	98.0	10000.0
Baricitinib	MARK1	15.0	10000.0
BI-D1870	RPS6KA5(Kin.Dom.1-N-terminal)	8.4	10000.0
AS-252424	MLTK	93.9	10000.0
KIN001-123	KIT(V559D)	28.0	1000.0
Sorafenib	NDR1	85.0	10000.0
WZ4003	YES	100.0	1000.0
AZD-6482	NEK3	100.0	10000.0
WZ-7043	MK13	100.0	10000.0
Dinaciclib	CLK4	5.1	10000.0
HG-5-113-01	VGFR1	100.0	10000.0
GSK1059615	PLK4	40.0	10000.0
CP724714	KPCI	93.0	10000.0
HG-9-91-01	DYRK1B	22.0	10000.0
Sorafenib	MK01	100.0	10000.0
Sorafenib	SRMS	72.0	10000.0
BGJ398	PAK2	87.0	1000.0
Ibrutinib	PKAC-beta	97.0	1000.0
QL-X-138	DYRK1B	1.8	10000.0
OTSSP167	PGFRA	0.3	10000.0
HG-14-10-04	CDK3	100.0	10000.0
Sigma A6730	MP2K7	80.0	10000.0
WZ-7043	ABL1(Q252H)	100.0	10000.0
AS-252424	PKAC-beta	95.7	10000.0
WZ-4-145	AMPK-alpha2	100.0	10000.0
AZD 5438	TAOK1	0.8	10000.0
Ceritinib	ALK(C1156Y)	0.8	1000.0
XMD13-2	YANK3	89.0	10000.0
XMD8-85	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
CH5424802	EPHA1	75.0	1000.0
AZD-6482	MET	86.0	10000.0
JW-7-24-1	MYLK2	32.0	10000.0
GW-5074	RAF1	0.7	10000.0
5z-7-oxozeaenol	IKKE	95.0	10000.0
BMS-536924	MRCKA	6.5	1000.0
WH-4-023	IKKA	92.0	10000.0
PLX-4720	SIK3	100.0	10000.0
Sigma A6730	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
TAK-715	FGFR4	100.0	10000.0
ZSTK474	FAK1	100.0	1000.0
BGJ398	PIK3CA(Q546K)	80.0	1000.0
BI-2536	CSNK1E	100.0	10000.0
XMD8-92	CLK4	100.0	10000.0
Palbociclib	EGFR(L747-T751del,Sins)	86.0	1000.0
BMS-536924	YANK2	100.0	1000.0
Palbociclib	ABL1(F317L)-nonphosphorylated	100.0	1000.0
Ribociclib	PAK2	53.0	1000.0
Ribociclib	MAP3K4	100.0	1000.0
HG-14-10-04	PLK1	0.7	10000.0
MLN8054	MP2K3	85.0	10000.0
Baricitinib	KIT(D816H)	29.0	10000.0
QL-X-138	RET(M918T)	51.0	10000.0
Torin1	CLK1	49.0	10000.0
PD0325901	ALK	100.0	10000.0
GW843682X	RET	39.0	10000.0
AZ-628	JNK3	73.0	10000.0
QL-XII-47	NEK10	84.0	1000.0
XMD14-99	RSK2(Kin.Dom.1-N-terminal)	66.0	10000.0
SP600125	JNK1	0.0	10000.0
TAK-715	KIT(L576P)	51.0	10000.0
CG-930	AMPK-alpha1	99.0	10000.0
ALW-II-38-3	M3K5	100.0	10000.0
Ibrutinib	MP2K3	76.0	1000.0
BMS345541	GRK1	100.0	10000.0
ALW-II-38-3	DMPK2	100.0	10000.0
(s)-CR8	SGK2	100.0	10000.0
XMD11-50	SRPK1	94.0	10000.0
Lapatinib	RAF1	0.0	10000.0
JWE-035	ABL1(M351T)-phosphorylated	0.7	10000.0
TGX221	ERBB4	100.0	1000.0
CGP60474	FLT3(K663Q)	100.0	10000.0
SCH772984	YES	100.0	1000.0
Alpelisib	KIT(V559D,V654A)	100.0	1000.0
NU7441	MAP4K2	100.0	10000.0
Sigma A6730	CLK1	100.0	10000.0
NG25	KC1G1	100.0	10000.0
WZ-4-145	CAMK1G	100.0	10000.0
KIN001-220	MAP4K2	51.0	10000.0
MLN8054	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
Alpelisib	ABL2	96.0	1000.0
Dinaciclib	ICK	0.9	10000.0
Dinaciclib	RSK4(Kin.Dom.1-N-terminal)	28.0	10000.0
TGX221	TRKB	100.0	1000.0
HG-14-10-04	MYLK	0.6	10000.0
WZ4003	SgK110	100.0	1000.0
SCH772984	FLT3(D835Y)	56.0	1000.0
CGP74514A	STK35	89.0	10000.0
PHA-793887	DMPK2	100.0	10000.0
WZ3105	KC1G1	28.0	10000.0
OTSSP167	YANK1	19.0	10000.0
BMS345541	CDKL3	98.0	10000.0
GSK461364	CSNK2A2	4.6	10000.0
5z-7-oxozeaenol	CDK2	83.0	10000.0
BMX-IN-1	EPHA8	76.0	10000.0
CG-930	JAK2(JH1domain-catalytic)	97.0	10000.0
A443654	MK03	100.0	10000.0
HG-5-113-01	CAMK2A	100.0	10000.0
WZ3105	RIOK2	66.0	10000.0
PLX-4720	ZAP70	85.0	10000.0
TGX221	CDKL2	100.0	1000.0
BI-D1870	FLT3(D835Y)	1.4	10000.0
MRT67307	MP2K1	40.0	10000.0
Palbociclib	CSNK1E	81.0	1000.0
GW843682X	TAOK3	89.0	10000.0
JW-7-24-1	IGF1R	100.0	10000.0
Torin2	ADCK4	77.0	10000.0
WH-4-023	PGFRA	9.9	10000.0
QL-XII-47	MST4	99.0	1000.0
BX-912	ACVR2B	4.9	10000.0
TGX221	MYLK	100.0	1000.0
Ribociclib	KIT(V559D,V654A)	100.0	1000.0
QL-XI-92	FGR	63.0	10000.0
SB590885	MK11	91.0	10000.0
HG-6-64-01	STK35	23.0	10000.0
(s)-CR8	DRAK1	100.0	10000.0
ERK5-IN-1	PIM2	100.0	1000.0
Ribociclib	CASK	90.0	1000.0
Baricitinib	FGFR1	21.0	10000.0
WZ-7043	KPCE	100.0	10000.0
XMD16-144	TAK1	6.2	10000.0
Ibrutinib	GRK1	100.0	1000.0
AZD7762	M4K1	2.0	10000.0
HG-5-113-01	CDK14	100.0	10000.0
QL-XI-92	FLT3(ITD)	99.0	10000.0
Taselisib	FLT3	78.0	1000.0
Torin1	MAP4K5	8.1	10000.0
XMD-12	OSR1	71.0	1000.0
WH-4-023	CAMK1	83.0	10000.0
AS-252424	KPCD2	100.0	10000.0
THZ1	PLK1	5.8	10000.0
Torkinib	PIK3CA(E542K)	25.0	10000.0
KIN001-111	FLT3(D835H)	100.0	1000.0
KU63794	RSK2(Kin.Dom.1-N-terminal)	99.0	10000.0
Canertinib	PHKG1	100.0	1000.0
Torin1	PLK1	85.0	10000.0
CP724714	PIP5K1C	93.0	10000.0
GW-5074	PIM1	2.8	10000.0
TAK-715	RSK3(Kin.Dom.1-N-terminal)	100.0	10000.0
CP724714	KC1G1	100.0	10000.0
Sorafenib	RIPK2	18.0	10000.0
XMD11-85h	STK36	100.0	10000.0
Barasertib	CSNK1E	100.0	10000.0
Lapatinib	ABL1(F317I)-phosphorylated	85.0	10000.0
BI-2536	FLT3(D835Y)	100.0	10000.0
JNK-IN-5A	RSK4(Kin.Dom.1-N-terminal)	70.0	10000.0
Omipalisib	MAP3K14	57.0	10000.0
XMD14-99	CDK16	62.0	10000.0
TAK-715	ULK1	69.0	10000.0
Baricitinib	RIOK1	2.9	10000.0
Sigma A6730	PKAC-alpha	100.0	10000.0
BX-912	PIK3C2B	89.0	10000.0
Momelotinib	M3K12	100.0	10000.0
Abemaciclib	ABL1(Y253F)-phosphorylated	100.0	1000.0
HG-5-113-01	CLK4	0.4	10000.0
AZD7762	STK39	4.4	10000.0
JNK-9L	ABL1(Y253F)-phosphorylated	84.0	10000.0
Ribociclib	PHKG2	78.0	1000.0
GSK1059615	GRK4	47.0	10000.0
AG1478	M4K1	93.0	10000.0
KIN001-021	EGFR(L747-E749del,A750P)	100.0	1000.0
Torin2	HIPK4	44.0	10000.0
Buparlisib	EGFR(L861Q)	69.0	1000.0
Dactolisib	KPCD	100.0	1000.0
Torin1	ULK3	100.0	10000.0
AZD7762	IRAK1	0.0	10000.0
Dabrafenib	STK35	88.0	10000.0
Sigma A6730	EPHB2	72.0	10000.0
5z-7-oxozeaenol	FYN	99.0	10000.0
GSK429286A	FLT3	100.0	10000.0
GSK429286A	PKN2	52.0	10000.0
HG-5-113-01	ITK	0.2	10000.0
XMD11-85h	JAK2(JH1domain-catalytic)	100.0	10000.0
AZD7762	PIK3CA(E545A)	16.0	10000.0
WZ-7043	PIK3CA(E545A)	100.0	10000.0
RO-3306	BRSK2	68.0	10000.0
JNK-IN-5A	PIK3C2B	100.0	10000.0
ZG-10	FGR	86.0	10000.0
NPK76-II-72-1	PCTK2	100.0	10000.0
Taselisib	EGFR(L858R)	90.0	1000.0
Barasertib	MST3	43.0	10000.0
RO-3306	ABL2	92.0	10000.0
SCH772984	DRAK2	3.0	1000.0
KIN001-220	MST1R	100.0	10000.0
NPK76-II-72-1	TIE1	100.0	10000.0
GSK429286A	FRK	53.0	10000.0
AZD4547	AMPK-alpha1	16.0	10000.0
QL-XI-92	ERK5	92.0	10000.0
JWE-035	KKCC1	79.0	10000.0
Vemurafenib	MET	53.0	10000.0
ZG-10	LIMK2	92.0	10000.0
Momelotinib	SRPK2	30.0	10000.0
PD0325901	CDK7	83.0	10000.0
Torin2	NIM1	100.0	10000.0
NU7441	NUAK1	100.0	10000.0
CG-930	MYLK	65.0	10000.0
WZ4003	SRPK2	100.0	1000.0
ALW-II-49-7	TYRO3	100.0	10000.0
Neratinib	SIK3	73.0	10000.0
BMX-IN-1	DYRK2	91.0	10000.0
Torkinib	KC1G1	35.0	10000.0
Barasertib	SNRK	100.0	10000.0
AZ-628	STK33	99.0	10000.0
XMD16-144	PCTK2	80.0	10000.0
Ceritinib	PIK3CA(E545A)	92.0	1000.0
SB590885	PIK3C2B	64.0	10000.0
JNK-IN-11	KGP2	83.0	1000.0
GSK1059615	NDR1	61.0	10000.0
GSK461364	LCK	70.0	10000.0
AZD 5438	SRC	21.0	10000.0
Dabrafenib	SRPK1	42.0	10000.0
XMD16-144	PAK7	36.0	10000.0
Sigma A6730	MARK2	83.0	10000.0
Barasertib	MYLK2	87.0	10000.0
Torin1	MET(Y1235D)	100.0	10000.0
PD0325901	TYK2(JH2domain-pseudokinase)	100.0	10000.0
TAK-715	PKN2	76.0	10000.0
NG25	EPHA8	0.1	10000.0
XMD14-99	SYK	59.0	10000.0
Lapatinib	RPS6KA4(Kin.Dom.1-N-terminal)	36.0	10000.0
Abemaciclib	VGFR2	100.0	1000.0
Torin1	KPCI	85.0	10000.0
ERK5-IN-1	MLTK	100.0	1000.0
A443654	PIM3	0.8	10000.0
ERK5-IN-1	STK33	100.0	1000.0
Palbociclib	TXK	100.0	1000.0
GSK461364	YSK1	83.0	10000.0
MLN8054	TRKC	65.0	10000.0
JNK-IN-11	WEE1	100.0	1000.0
ERK5-IN-1	CSNK1D	100.0	1000.0
MLN8054	MRCKA	84.0	10000.0
NVP-TAE684	EGFR(G719S)	9.6	1000.0
Lapatinib	PIM2	91.0	10000.0
HG-14-10-04	DRAK1	0.8	10000.0
KIN001-220	CAMK2B	72.0	10000.0
WH-4-023	NEK4	74.0	10000.0
GSK461364	LRRK2	60.0	10000.0
WZ4002	MLK2	100.0	10000.0
Ribociclib	TGFBR2	100.0	1000.0
AS-252424	FLT3	100.0	10000.0
AS-252424	FLT3(D835H)	88.4	10000.0
5z-7-oxozeaenol	FLT3(R834Q)	23.0	10000.0
MRT67307	RPS6KA5(Kin.Dom.2-C-terminal)	18.0	10000.0
ERK5-IN-1	CIT	98.0	1000.0
PD0325901	KKCC1	100.0	10000.0
GSK429286A	EGFR(G719C)	37.0	10000.0
JNK-IN-5A	FLT3(R834Q)	88.0	10000.0
QL-X-138	MP2K2	83.0	10000.0
SP600125	RET(M918T)	100.0	10000.0
Torin1	MP2K7	100.0	10000.0
BMS-536924	BLK	0.2	1000.0
JW-7-24-1	DCAMKL2	100.0	10000.0
RO-3306	IRAK3	60.0	10000.0
BX-912	RSK1(Kin.Dom.2-C-terminal)	13.0	10000.0
THZ1	EPHB6	2.2	10000.0
PHA-793887	LRRK2(G2019S)	92.0	10000.0
MRT67307	FLT3(D835Y)	0.0	10000.0
Sorafenib	EPHA1	20.0	10000.0
AZD 5438	IRAK4	69.0	10000.0
Ribociclib	SGK2	85.0	1000.0
Sorafenib	MUSK	0.1	10000.0
Pictilisib	CDK16	100.0	1000.0
HG-14-10-04	TAOK1	48.0	10000.0
GSK1059615	PKAC-beta	31.0	10000.0
Ribociclib	KIT(L576P)	99.0	1000.0
XMD16-144	ERBB3	89.0	10000.0
HG-5-113-01	NEK6	100.0	10000.0
NPK76-II-72-1	RPS6KA1(Kin.Dom.1)	100.0	10000.0
JWE-035	TIE2	85.0	10000.0
Torin1	JAK1(JH2domain-pseudokinase)	76.0	10000.0
AS-252424	BMPR1B	80.6	10000.0
GSK461364	CLK1	36.0	10000.0
BMX-IN-1	MERTK	100.0	10000.0
NPK76-II-72-1	PIK3C2B	100.0	10000.0
NVP-TAE684	ABL1(M351T)	5.0	1000.0
Lapatinib	PAK4	100.0	10000.0
BX-912	ALK	14.0	10000.0
Ibrutinib	YANK2	77.0	1000.0
XMD-12	RIOK2	63.0	1000.0
5z-7-oxozeaenol	RIPK1	96.0	10000.0
AZD4547	TYRO3	67.0	10000.0
HG-9-91-01	ABL1(H396P)-nonphosphorylated	0.0	10000.0
ZM-447439	MP2K7	100.0	10000.0
PLX-4720	LRRK2	37.0	10000.0
XMD13-2	RSK2(Kin.Dom.1-N-terminal)	86.0	10000.0
XMD14-99	MP2K7	100.0	10000.0
RO-3306	TGFBR1	83.0	10000.0
CH5424802	MAP3K4	100.0	1000.0
CH5424802	S6K1	91.0	1000.0
BS-181	TNIK	65.0	10000.0
Buparlisib	ABL1(M351T)-phosphorylated	100.0	1000.0
Ibrutinib	ALK	51.0	1000.0
MRT67307	SRPK3	0.0	10000.0
XMD14-99	ACVR2B	92.0	10000.0
CGP60474	IKKA	100.0	10000.0
JNK-IN-8	PRKR	82.0	1000.0
ALW-II-49-7	FLT4	100.0	10000.0
JNK-IN-5A	RSK3(Kin.Dom.2-C-terminal)	79.0	10000.0
WH-4-023	PKAC-alpha	1.6	10000.0
Crizotinib	JAK1(JH2domain-pseudokinase)	1.8	10000.0
XMD13-2	PIM3	70.0	10000.0
CGP74514A	KGP1	88.0	10000.0
KIN001-127	EPHB4	100.0	10000.0
HG-6-64-01	LIMK1	7.7	10000.0
PHA-767491	CAMK2A	22.0	10000.0
AZ-628	ERK8	100.0	10000.0
Neratinib	EPHB3	100.0	10000.0
AZD4547	EGFR	54.0	10000.0
HG-5-113-01	RPS6KA5(Kin.Dom.1)	100.0	10000.0
Sigma A6730	TRKC	98.0	10000.0
SP600125	DCAMKL3	100.0	10000.0
HG-9-91-01	MAST1	100.0	10000.0
CP466722	CDKL1	21.0	10000.0
JNK-IN-11	PIP5K1A	67.0	1000.0
XMD13-2	CDKL1	58.0	10000.0
CGP74514A	MP2K6	86.0	10000.0
CGP74514A	ROS1	31.0	10000.0
KIN001-220	PKNB(M.tuberculosis)	5.0	10000.0
CG-930	NDR2	100.0	10000.0
BX-912	IRAK3	0.7	10000.0
JNK-IN-8	INSR	14.0	1000.0
CH5424802	KIT(D816V)	20.0	1000.0
XMD-12	M3K2	0.2	1000.0
JNK-IN-8	CSNK1D	18.0	1000.0
BMX-IN-1	FGFR2	92.0	10000.0
AZD 5438	MAP3K1	64.0	10000.0
Pictilisib	MET(Y1235D)	85.0	1000.0
MLN8054	CAMK2G	98.0	10000.0
BMS-536924	MINK	7.2	1000.0
WH-4-023	DYRK1A	75.0	10000.0
CP466722	VGFR1	48.0	10000.0
WZ4003	EGFR	15.0	1000.0
HG-14-10-04	KIT(D816H)	0.6	10000.0
AZD7762	ROS1	2.0	10000.0
Torkinib	CDK2	69.0	10000.0
KIN001-111	FGFR2	100.0	1000.0
Pictilisib	BUB1	100.0	1000.0
PHA-793887	RSK3(Kin.Dom.2-C-terminal)	66.0	10000.0
Omipalisib	GSK3A	84.0	10000.0
AS-252424	LIMK2	81.9	10000.0
XMD8-92	CDK15	100.0	10000.0
CP724714	KCC2D	100.0	10000.0
JNK-IN-5A	DRAK1	100.0	10000.0
NVP-TAE684	RIOK3	3.2	1000.0
XMD13-2	ULK3	13.0	10000.0
WZ-4-145	KPCT	100.0	10000.0
AG1478	ERBB2	0.3	10000.0
AZ-628	MAP3K4	100.0	10000.0
Crizotinib	STK35	3.2	10000.0
ALW-II-49-7	SIK1	100.0	10000.0
PHA-793887	PIP5K2B	100.0	10000.0
XMD11-85h	SBK1	100.0	10000.0
CGP60474	CSNK1A1L	100.0	10000.0
ZG-10	CHEK1	100.0	10000.0
XMD-12	IKKA	79.0	1000.0
MPS-1-IN-1	EPHA5	100.0	1000.0
AG1478	TNK2	61.0	10000.0
XMD-12	CIT	95.0	1000.0
Ribociclib	PCTK3	100.0	1000.0
Lapatinib	AAK1	78.0	10000.0
CG-930	KKCC1	100.0	10000.0
Neratinib	EPHB2	86.0	10000.0
WZ-7043	MLK3	100.0	10000.0
BMX-IN-1	LIMK1	95.0	10000.0
XMD13-2	VRK2	100.0	10000.0
XMD11-85h	PKAC-alpha	100.0	10000.0
GSK429286A	EPHB4	88.0	10000.0
AZD 5438	TSSK1	100.0	10000.0
JNK-IN-8	MAP3K1	100.0	1000.0
GW843682X	MLCK	100.0	10000.0
TGX221	ACVR2B	100.0	1000.0
PHA-793887	ABL1(F317I)-nonphosphorylated	100.0	10000.0
JWE-035	DDR2	50.0	10000.0
Torin1	YSK4	38.0	10000.0
Taselisib	MLK1	92.0	1000.0
Torin2	FAK1	75.0	10000.0
BX-912	JAK3(JH1domain-catalytic)	0.0	10000.0
Seliciclib	YSK4	92.0	10000.0
Neratinib	ROCK2	86.0	10000.0
MLN8054	TNNI3K	85.0	10000.0
GW-5074	MRCKA	100.0	10000.0
WH-4-023	MK13	100.0	10000.0
CP466722	GAK	2.6	10000.0
Taselisib	PAK2	99.0	1000.0
XMD11-85h	ACVR2A	100.0	10000.0
BX-912	LATS2	0.0	10000.0
MPS-1-IN-1	RPS6KA2(Kin.Dom.1)	100.0	1000.0
WZ-4-145	TNIK	100.0	10000.0
AZD-6482	KC1G2	88.0	10000.0
BGJ398	ERBB2	80.0	1000.0
KU63794	DCLK1	100.0	10000.0
ALW-II-38-3	FLT3(N841I)	100.0	10000.0
Ceritinib	ERBB4	73.0	1000.0
Ceritinib	KPCD2	73.0	1000.0
HG-6-64-01	TEC	0.5	10000.0
PLX-4720	FAK2	83.0	10000.0
ZG-10	PIK3CA(C420R)	100.0	10000.0
SB590885	FGFR3(G697C)	100.0	10000.0
NVP-TAE684	CIT	100.0	1000.0
HG-5-88-01	CDK14	100.0	10000.0
NU7441	PIP5K2B	100.0	10000.0
WZ4003	EGFR(L747-E749del,A750P)	6.0	1000.0
KIN001-127	NEK9	100.0	10000.0
WZ4002	MST3	100.0	10000.0
HG-5-113-01	TYRO3	29.0	10000.0
BMS-536924	MAP3K3	6.0	1000.0
Ribociclib	FLT3(D835V)	100.0	1000.0
BGJ398	LKB1	95.0	1000.0
Neratinib	PGFRB	69.0	10000.0
Dabrafenib	NEK9	3.2	10000.0
Taselisib	FGFR3	100.0	1000.0
BX-912	MET	4.4	10000.0
ERK5-IN-1	ACVRL1	100.0	1000.0
Momelotinib	AXL	57.0	10000.0
Canertinib	IKKE	100.0	1000.0
JNK-IN-8	KIT(D816V)	54.0	1000.0
CH5424802	ERN1	61.0	1000.0
JNK-IN-5A	TYRO3	76.0	10000.0
JNK-IN-11	AURKC	84.0	1000.0
AZD4547	STK39	24.0	10000.0
BX-912	CAMK1G	28.0	10000.0
Crizotinib	MP2K6	54.0	10000.0
BS-181	CLK1	3.8	10000.0
A443654	TSSK1	100.0	10000.0
MLN8054	EGFR(L858R,T790M)	67.0	10000.0
ALW-II-38-3	PKAC-alpha	100.0	10000.0
Buparlisib	TNK1	65.0	1000.0
ERK5-IN-1	PFPK5(P.falciparum)	100.0	1000.0
JNK-IN-8	PIK3CA(I800L)	88.0	1000.0
Dinaciclib	GCN2(Kin.Dom.2,S808G)	94.0	10000.0
CG-930	PIP5K1C	76.0	10000.0
MRT67307	CHK2	100.0	10000.0
HG-5-113-01	FLT3(N841I)	0.4	10000.0
OTSSP167	DMPK	7.2	10000.0
MPS-1-IN-1	EGFR(L861Q)	100.0	1000.0
Omipalisib	NEK5	62.0	10000.0
AG1478	CDK7	26.0	10000.0
Dabrafenib	KIT(A829P)	8.4	10000.0
GW-5074	WEE1	100.0	10000.0
Ibrutinib	PIK3CA(I800L)	75.0	1000.0
MLN8054	NEK9	100.0	10000.0
JNK-9L	PIM1	78.0	10000.0
MPS-1-IN-1	MAP4K4	100.0	1000.0
HG-14-8-02	AURKC	100.0	10000.0
MRT67307	AURKB	1.4	10000.0
ALW-II-38-3	SIK3	100.0	10000.0
RO-3306	M3K12	91.0	10000.0
Sorafenib	MK09	19.0	10000.0
CGP60474	RPS6KA2(Kin.Dom.1)	100.0	10000.0
Sigma A6730	KPCD3	100.0	10000.0
WZ3105	TSSK1	97.0	10000.0
Buparlisib	HCK	92.0	1000.0
XMD13-2	BLK	100.0	10000.0
JNK-IN-11	AAK1	100.0	1000.0
Vemurafenib	FLT3(D835H)	54.0	10000.0
Lapatinib	DAPK3	100.0	10000.0
GSK1059615	DMPK	2.9	10000.0
PHA-767491	NEK9	100.0	10000.0
SB590885	PFPK5(P.falciparum)	86.0	10000.0
PD0325901	RIPK4	100.0	10000.0
PD0325901	PAK4	100.0	10000.0
XMD16-144	KPCI	97.0	10000.0
CP724714	WEE2	81.0	10000.0
WH-4-023	CSNK1G3	87.0	10000.0
5z-7-oxozeaenol	ICK	100.0	10000.0
Ceritinib	PIK3C2G	75.0	1000.0
Taselisib	ANKK1	89.0	1000.0
TGX221	TAOK1	100.0	1000.0
PHA-793887	ACVR2A	100.0	10000.0
AZD7762	CLK3	62.0	10000.0
PHA-767491	CAMKK2	12.0	10000.0
WZ-4-145	NEK9	100.0	10000.0
Buparlisib	VRK2	88.0	1000.0
QL-XII-47	MARK4	100.0	1000.0
R406	PCTK3	100.0	1000.0
Buparlisib	NEK5	100.0	1000.0
AG1478	TRKC	87.0	10000.0
Torin2	FLT3(K663Q)	18.0	10000.0
JWE-035	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
GSK461364	BMPR1A	100.0	10000.0
HG-9-91-01	TIE2	0.2	10000.0
ZSTK474	IRAK3	100.0	1000.0
XMD11-50	PRP4	93.0	10000.0
BMS-536924	SIK2	33.0	1000.0
Palbociclib	TESK1	88.0	1000.0
Ibrutinib	NEK5	100.0	1000.0
PD173074	PCTK2	100.0	10000.0
PD0325901	BRAF	98.0	10000.0
AZD-6482	PHKG2	100.0	10000.0
HG-6-64-01	GSK3B	99.0	10000.0
Buparlisib	PDPK1	89.0	1000.0
BMS-536924	INSR	0.0	1000.0
GSK429286A	ERK4	100.0	10000.0
Alpelisib	SRPK3	95.0	1000.0
THZ1	EGFR(L747-E749del,A750P)	11.0	10000.0
GSK461364	MAP3K4	100.0	10000.0
ERK5-IN-1	IRAK3	100.0	1000.0
HG-14-8-02	ALK	20.0	10000.0
SB590885	BLK	59.0	10000.0
Sigma A6730	SBK1	92.0	10000.0
Sigma A6730	PI42C	83.0	10000.0
HG-5-113-01	MP2K1	3.0	10000.0
AZD-6482	MST3	100.0	10000.0
TAK-715	AURKB	100.0	10000.0
AG1478	TAOK2	76.0	10000.0
BS-181	GRK7	34.0	10000.0
NG25	CIT	0.1	10000.0
ALW-II-49-7	WEE1	100.0	10000.0
CGP60474	RIOK1	100.0	10000.0
Sigma A6730	MP2K6	100.0	10000.0
AZD-6482	VGFR2	100.0	10000.0
BMX-IN-1	JNK1	14.0	10000.0
PD173074	MK12	100.0	10000.0
HG-6-64-01	RET(V804L)	0.1	10000.0
CP724714	SRMS	71.0	10000.0
CGP74514A	SNRK	49.0	10000.0
SCH772984	INSRR	100.0	1000.0
Baricitinib	STK35	72.0	10000.0
HG-5-88-01	STK16	100.0	10000.0
Dinaciclib	MYLK2	100.0	10000.0
Vemurafenib	FGFR2	64.0	10000.0
Lapatinib	BMX	77.0	10000.0
Seliciclib	DMPK	100.0	10000.0
CH5424802	AMPK-alpha2	86.0	1000.0
CH5424802	FLT3(D835H)	8.3	1000.0
AZD7762	KIT(V559D,T670I)	0.0	10000.0
MLN8054	PLK2	29.0	10000.0
PD0325901	DDR2	100.0	10000.0
Vemurafenib	DYRK1A	100.0	10000.0
GSK1059615	GSK3B	66.0	10000.0
Ceritinib	CDKL1	71.0	1000.0
Dactolisib	STK36	100.0	1000.0
Momelotinib	PIK3CA(E545K)	100.0	10000.0
CP724714	TAOK3	100.0	10000.0
GSK429286A	RAF1	100.0	10000.0
MLN8054	ABL1(T315I)-phosphorylated	11.0	10000.0
ERK5-IN-1	KGP1	100.0	1000.0
A443654	MK11	100.0	10000.0
NG25	CDK8	3.9	10000.0
TAK-715	EGFR(E746-A750del)	0.0	10000.0
ZM-447439	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
QL-X-138	PDPK1	100.0	10000.0
Seliciclib	RPS6KA5(Kin.Dom.1-N-terminal)	96.0	10000.0
WZ3105	RSK4(Kin.Dom.2-C-terminal)	100.0	10000.0
XMD8-92	SRPK1	100.0	10000.0
CG-930	PLK1	100.0	10000.0
Baricitinib	RET(V804L)	0.2	10000.0
AZD-6482	STK35	95.0	10000.0
Lapatinib	DMPK	93.0	10000.0
AZD-6482	MET(Y1235D)	78.0	10000.0
KIN001-111	CAMK2G	100.0	1000.0
HG-5-113-01	RPS6KA6(Kin.Dom.2)	100.0	10000.0
WYE-125132	MYO3B	91.0	10000.0
Sigma A6730	KIT-autoinhibited	89.0	10000.0
5z-7-oxozeaenol	JAK1(JH1domain-catalytic)	100.0	10000.0
Dinaciclib	MK01	79.0	10000.0
BI-2536	GSK3B	100.0	10000.0
PD0325901	CDKL5	67.0	10000.0
OTSSP167	CIT	3.1	10000.0
Canertinib	MARK2	100.0	1000.0
AG1478	SRPK2	62.0	10000.0
TAK-715	PRKR	94.0	10000.0
Pictilisib	TGFBR2	100.0	1000.0
JNK-9L	M3K12	63.0	10000.0
KIN001-111	HCK	0.0	1000.0
KIN001-220	EIF2AK1	66.0	10000.0
BX-912	STK39	63.0	10000.0
PLX-4720	PIK3CD	84.0	10000.0
Crizotinib	PIK3C2G	22.0	10000.0
HG-6-64-01	PIK3CA(E545K)	100.0	10000.0
QL-XI-92	JAK1(JH2domain-pseudokinase)	92.0	10000.0
KIN001-123	MAP4K5	100.0	1000.0
BMX-IN-1	GSK3A	100.0	10000.0
Torkinib	NEK5	86.0	10000.0
AZD7762	LCK	0.0	10000.0
Dactolisib	PCTK2	100.0	1000.0
Barasertib	MK09	46.0	10000.0
GSK429286A	MRCKA	79.0	10000.0
JW-7-24-1	CDK3	100.0	10000.0
WZ-4-145	MARK2	100.0	10000.0
Ibrutinib	KIT-autoinhibited	73.0	1000.0
Buparlisib	JAK2(JH1domain-catalytic)	93.0	1000.0
Torin2	PAK6	100.0	10000.0
WYE-125132	SNRK	100.0	10000.0
Buparlisib	MAP3K14	92.0	1000.0
GSK461364	EPHB6	59.0	10000.0
XMD11-50	ULK1	80.0	10000.0
Ribociclib	RIPK1	100.0	1000.0
Buparlisib	YANK2	100.0	1000.0
5z-7-oxozeaenol	ALK(C1156Y)	97.0	10000.0
JNK-IN-11	EPHA2	76.0	1000.0
CGP60474	CSNK1D	100.0	10000.0
HG-5-88-01	ACVR2A	100.0	10000.0
SCH772984	FGFR1	92.0	1000.0
SB590885	MELK	100.0	10000.0
BMS345541	EGFR(G719C)	93.0	10000.0
Buparlisib	MAP4K2	100.0	1000.0
KIN001-220	RIPK5	71.0	10000.0
CP466722	PAK3	12.0	10000.0
NU7441	CAMK1G	85.0	10000.0
Pictilisib	SNARK	100.0	1000.0
Dactolisib	CAMK2G	100.0	1000.0
Seliciclib	PKN1	100.0	10000.0
AS-252424	RPS6KA4(Kin.Dom.2-C-terminal)	21.6	10000.0
ALW-II-49-7	EPHB2	1.6	1000.0
SB590885	FLT4	100.0	10000.0
PLX-4720	PAK6	45.0	10000.0
ZM-447439	KIT(D816H)	69.0	10000.0
Ceritinib	MAP3K4	87.0	1000.0
PLX-4720	EGFR(L858R)	72.0	10000.0
Dinaciclib	AXL	74.0	10000.0
BX-912	GRK1	47.0	10000.0
KIN001-127	KIT(V559D)	100.0	10000.0
AZD7762	PIK3C2B	16.0	10000.0
QL-XII-47	RIOK1	64.0	1000.0
HG-14-8-02	ACVR1	99.0	10000.0
Ibrutinib	PIK3CA(H1047Y)	65.0	1000.0
WZ-7043	ICK	100.0	10000.0
Lapatinib	JAK1(JH1domain-catalytic)	97.0	10000.0
OTSSP167	KPCL	3.2	10000.0
GW-5074	BMPR1B	8.8	10000.0
Crizotinib	PKAC-alpha	100.0	10000.0
HG-9-91-01	NIM1	100.0	10000.0
ALW-II-38-3	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
Crizotinib	PIK3CG	100.0	10000.0
WH-4-023	KIT(L576P)	1.0	10000.0
MPS-1-IN-1	MARK4	17.0	1000.0
Barasertib	TBK1	90.0	10000.0
Torin2	FER	95.0	10000.0
KIN001-123	CDC2L2	100.0	1000.0
XMD16-144	ROCK1	49.0	10000.0
SP600125	AURKC	23.0	10000.0
GSK429286A	MST3	52.0	10000.0
KIN001-220	PIK3CA(Q546K)	23.0	10000.0
Neratinib	BLK	3.0	10000.0
CP724714	CAMK2G	94.0	10000.0
PD173074	RET	26.0	10000.0
SCH772984	WEE1	86.0	1000.0
NVP-TAE684	MRCKA	100.0	1000.0
JNK-IN-11	NDR2	100.0	1000.0
SP600125	PCTK2	100.0	10000.0
HG-6-64-01	CHEK1	28.0	10000.0
RO-3306	KIT(D816V)	19.0	10000.0
KU63794	DAPK1	95.0	10000.0
GSK461364	DRAK1	100.0	10000.0
R406	MRCKB	100.0	1000.0
OTSSP167	MAP3K15	25.0	10000.0
CP724714	KIT(L576P)	54.0	10000.0
XMD14-99	ZAP70	95.0	10000.0
ZSTK474	BMX	100.0	1000.0
R406	KIT(V559D,V654A)	3.0	1000.0
Lapatinib	VGFR2	83.0	10000.0
Ribociclib	ABL1-phosphorylated	85.0	1000.0
ZG-10	OSR1	100.0	10000.0
ERK5-IN-1	BIKE	100.0	1000.0
THZ1	GCN2(Kin.Dom.2,S808G)	0.2	10000.0
BMX-IN-1	PRKR	71.0	10000.0
SB590885	RSK1(Kin.Dom.1-N-terminal)	81.0	10000.0
Canertinib	CLK2	100.0	1000.0
WH-4-023	CSF1R	0.1	10000.0
PD173074	EGFR(G719S)	100.0	10000.0
HG-5-113-01	DRAK2	33.0	10000.0
Dactolisib	NEK9	100.0	1000.0
BMX-IN-1	EPHB2	95.0	10000.0
QL-XII-47	PIK3CA	95.0	1000.0
ALW-II-38-3	KPCD3	100.0	10000.0
ZG-10	TTK	77.0	10000.0
GW843682X	BLK	25.0	10000.0
GSK461364	RIPK2	92.0	10000.0
Torin2	CDKL2	91.0	10000.0
BS-181	EPHB6	80.0	10000.0
ALW-II-49-7	MUSK	100.0	10000.0
OTSSP167	ROCK2	100.0	10000.0
XMD13-2	GSK3B	97.0	10000.0
Omipalisib	TNNI3K	75.0	10000.0
TAK-715	PI42C	59.0	10000.0
RO-3306	PIM3	20.0	10000.0
GW-5074	PKMYT1	79.0	10000.0
BS-181	LTK	71.0	10000.0
Ribociclib	RET(V804L)	100.0	1000.0
BS-181	TAOK3	89.0	10000.0
BX-912	MLK1	0.5	10000.0
Alpelisib	MAP3K1	100.0	1000.0
KIN001-220	STK39	100.0	10000.0
QL-XII-47	LOK	93.0	1000.0
GW-5074	CLK4	36.0	10000.0
CG-930	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
WH-4-023	SNRK	100.0	10000.0
ZM-447439	CDC2L5	100.0	10000.0
Lapatinib	PIK3C2G	100.0	10000.0
Taselisib	ROCK1	98.0	1000.0
ERK5-IN-1	PIK3CA(I800L)	75.0	1000.0
KIN001-021	MLK3	100.0	1000.0
BI-D1870	RET	18.0	10000.0
NPK76-II-72-1	AMPK-alpha1	100.0	10000.0
Lapatinib	DMPK2	68.0	10000.0
WH-4-023	TAOK1	11.0	10000.0
Canertinib	MP2K2	100.0	1000.0
XMD14-99	CSK	90.0	10000.0
AZD 5438	JAK3(JH1domain-catalytic)	0.0	10000.0
BI-2536	BMPR2	100.0	10000.0
GSK1059615	JAK3(JH1domain-catalytic)	0.0	10000.0
5z-7-oxozeaenol	PIK3CA(C420R)	79.0	10000.0
Buparlisib	ADCK3	88.0	1000.0
XMD-12	CLK3	97.0	1000.0
BMS345541	CDKL1	74.0	10000.0
PD0325901	TNIK	100.0	10000.0
MRT67307	CAMK1	86.0	10000.0
PLX-4720	IKKB	75.0	10000.0
Abemaciclib	NEK11	100.0	1000.0
HG-6-64-01	RSK3(Kin.Dom.1-N-terminal)	2.7	10000.0
Vemurafenib	FYN	9.1	10000.0
JNK-IN-11	IRAK3	64.0	1000.0
Ribociclib	PIK3CA(E545K)	78.0	1000.0
WZ4002	PKAC-alpha	100.0	10000.0
TGX221	CSNK1A1L	100.0	1000.0
BS-181	DAPK1	88.0	10000.0
GSK429286A	DYRK1A	100.0	10000.0
PHA-793887	FGFR3(G697C)	100.0	10000.0
HG-5-113-01	PIK3CA(E545K)	4.7	10000.0
Lapatinib	MINK	93.0	10000.0
BS-181	NEK11	100.0	10000.0
Ibrutinib	FES	88.0	1000.0
Sorafenib	RIPK5	100.0	10000.0
XMD13-2	RAF1	78.0	10000.0
OTSSP167	MET	28.0	10000.0
KIN001-021	AKT1	100.0	1000.0
HG-6-64-01	MARK3	38.0	10000.0
BMS345541	CDC2L2	1.0	10000.0
XMD11-85h	BMPR1B	100.0	10000.0
Lapatinib	RET	92.0	10000.0
KIN001-127	ERK4	100.0	10000.0
Vemurafenib	YANK2	100.0	10000.0
XMD14-99	CAMKK2	14.0	10000.0
NG25	ERK3	100.0	10000.0
MRT67307	KCC4	100.0	10000.0
Torin1	EGFR(G719S)	93.0	10000.0
PLX-4720	ABL2	36.0	10000.0
OTSSP167	LIMK2	100.0	10000.0
BMS345541	RET	100.0	10000.0
Torin2	RET(V804L)	100.0	10000.0
Lapatinib	PAK6	100.0	10000.0
QL-X-138	BTK	0.2	10000.0
XMD11-50	PRKX	99.0	10000.0
ALW-II-49-7	AAK1	100.0	10000.0
AZD-6482	ERK3	100.0	10000.0
QL-X-138	PKN2	82.0	10000.0
MLN8054	YSK1	56.0	10000.0
AG1478	GSK3A	84.0	10000.0
Pictilisib	KPCL	100.0	1000.0
ALW-II-49-7	PCTK2	100.0	10000.0
HG-14-10-04	TYK2(JH1domain-catalytic)	1.3	10000.0
QL-XI-92	PRKR	100.0	10000.0
HG-14-10-04	CHEK1	0.1	10000.0
Alpelisib	TYK2(JH2domain-pseudokinase)	100.0	1000.0
Abemaciclib	FLT3(D835Y)	31.0	1000.0
Torkinib	MK11	100.0	10000.0
TAK-715	LIMK1	90.0	10000.0
WZ4003	PIP5K2B	100.0	1000.0
XMD11-50	PCTK2	83.0	10000.0
HG-5-113-01	CSNK1A1L	26.0	10000.0
ZSTK474	RIPK2	100.0	1000.0
BX-912	PIK3CA(Q546K)	46.0	10000.0
Alpelisib	CSNK2A2	100.0	1000.0
RO-3306	MYO3B	100.0	10000.0
Neratinib	MAST1	100.0	10000.0
WH-4-023	PKNB(M.tuberculosis)	90.0	10000.0
PHA-793887	SIK3	100.0	10000.0
PLX-4720	SLK	15.0	10000.0
AZD 5438	IRAK3	4.7	10000.0
AS-252424	EGFR(L747-T751del,Sins)	1.9	10000.0
KIN001-127	FGR	100.0	10000.0
AZD-6482	FLT4	95.0	10000.0
Torkinib	PIP5K1A	62.0	10000.0
TGX221	MARK1	100.0	1000.0
Torin2	ERBB2	97.0	10000.0
Dabrafenib	ABL1-phosphorylated	21.0	10000.0
WH-4-023	KPCL	35.0	10000.0
Buparlisib	PAK7	98.0	1000.0
BMS-536924	CLK3	100.0	1000.0
BMX-IN-1	YSK1	65.0	10000.0
CH5424802	MLK1	95.0	1000.0
PHA-767491	EIF2AK1	88.0	10000.0
BMS345541	RPS6KA5(Kin.Dom.2-C-terminal)	85.0	10000.0
Dinaciclib	VGFR1	77.0	10000.0
HG-6-64-01	PAK1	100.0	10000.0
ERK5-IN-1	ULK2	98.0	1000.0
KU63794	PKN1	94.0	10000.0
(s)-CR8	FLT3(R834Q)	100.0	10000.0
Barasertib	KCC2D	93.0	10000.0
KIN001-220	YSK4	7.2	10000.0
XMD16-144	MK13	61.0	10000.0
Alpelisib	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	1000.0
WZ-7043	PIK3CA(C420R)	100.0	10000.0
KIN001-111	PRKR	100.0	1000.0
Palbociclib	KPCL	100.0	1000.0
WZ-7043	PIK3CA(E542K)	100.0	10000.0
Canertinib	EGFR(G719S)	0.0	1000.0
AZD7762	MAPKAPK5	0.1	10000.0
KIN001-127	PRKR	100.0	10000.0
Palbociclib	MARK1	91.0	1000.0
GW-5074	MARK1	99.0	10000.0
Crizotinib	PAK1	95.0	10000.0
PLX-4720	INSRR	89.0	10000.0
GSK461364	HIPK2	36.0	10000.0
ZSTK474	ERBB2	100.0	1000.0
GSK1059615	PLK3	49.0	10000.0
HG-6-64-01	AURKA	97.0	10000.0
MRT67307	DCAMKL3	4.6	10000.0
Sorafenib	DCLK1	98.0	10000.0
Torkinib	ALK	41.0	10000.0
NPK76-II-72-1	CAMK1	100.0	10000.0
WZ4003	ANKK1	100.0	1000.0
R406	NDR2	100.0	1000.0
AS-252424	MAP3K3	100.0	10000.0
HG-5-113-01	CHK2	100.0	10000.0
Vemurafenib	LIMK1	27.0	10000.0
AZD-6482	DRAK2	100.0	10000.0
WZ4003	EGFR(G719S)	100.0	1000.0
Dabrafenib	ABL1(Q252H)-nonphosphorylated	0.2	10000.0
NG25	CDK11	0.1	10000.0
SCH772984	PIK3CA(H1047L)	85.0	1000.0
MLN8054	KIT(V559D,V654A)	60.0	10000.0
Alpelisib	ERBB2	89.0	1000.0
BMS345541	STK39	100.0	10000.0
GW843682X	MAK	100.0	10000.0
Buparlisib	TEC	100.0	1000.0
TAK-715	JAK1(JH2domain-pseudokinase)	70.0	10000.0
NVP-TAE684	SNARK	0.0	1000.0
QL-XII-47	BUB1	100.0	1000.0
CH5424802	MAP4K5	55.0	1000.0
HG-5-113-01	MK11	100.0	10000.0
HG-5-113-01	MP2K4	100.0	10000.0
GW-5074	NEK2	100.0	10000.0
QL-XI-92	MAP4K4	88.0	10000.0
Sigma A6730	MP2K1	83.0	10000.0
TGX221	PKAC-beta	100.0	1000.0
BX-912	KIT(D816V)	0.2	10000.0
KIN001-123	FAK1	100.0	1000.0
JW-7-24-1	MUSK	100.0	10000.0
AZD4547	PIK3CA(E542K)	88.0	10000.0
WZ-4-145	GSK3B	100.0	10000.0
Torkinib	DMPK2	86.0	10000.0
R406	RPS6KA3(Kin.Dom.1)	100.0	1000.0
BMS-536924	PHKG1	7.4	1000.0
AZD-6482	YES	100.0	10000.0
Abemaciclib	LIMK1	100.0	1000.0
NU7441	TLK1	71.0	10000.0
Ribociclib	CSNK1G3	93.0	1000.0
ZSTK474	FLT3(K663Q)	100.0	1000.0
Ceritinib	CTK	76.0	1000.0
KIN001-111	ACVR2A	100.0	1000.0
Omipalisib	KIT-autoinhibited	79.0	10000.0
SCH772984	KPCI	64.0	1000.0
Buparlisib	LCK	91.0	1000.0
QL-XII-47	TLK1	77.0	1000.0
Lapatinib	NEK7	82.0	10000.0
OTSSP167	STK35	10.0	10000.0
XMD13-2	TYRO3	100.0	10000.0
Dinaciclib	CDKL2	10.0	10000.0
CP466722	FLT3(K663Q)	21.0	10000.0
XMD13-2	TAK1	56.0	10000.0
RO-3306	EGFR(L747-T751del,Sins)	76.0	10000.0
PD0325901	EIF2AK1	100.0	10000.0
MLN8054	M3K2	100.0	10000.0
XMD13-2	KPCD3	100.0	10000.0
Torkinib	TRKB	25.0	10000.0
ZSTK474	CSNK1G3	100.0	1000.0
Barasertib	PLK3	89.0	10000.0
Crizotinib	PKN1	38.0	10000.0
TGX221	BMX	100.0	1000.0
ALW-II-38-3	ERBB3	100.0	10000.0
CP724714	DYRK1B	92.0	10000.0
PLX-4720	MST1	38.0	10000.0
WH-4-023	PAK4	97.0	10000.0
WH-4-023	WEE1	85.0	10000.0
ZG-10	ERBB2	97.0	10000.0
AZD 5438	KIT(V559D)	13.0	10000.0
BGJ398	CDK7	70.0	1000.0
Pictilisib	ULK1	100.0	1000.0
Dactolisib	ERK8	100.0	1000.0
CG-930	EGFR(T790M)	72.0	10000.0
Vemurafenib	SIK3	100.0	10000.0
NU7441	ERK4	100.0	10000.0
JNK-IN-8	PIK3CA	100.0	1000.0
Ceritinib	MAP4K5	88.0	1000.0
Dabrafenib	GCN2(Kin.Dom.2,S808G)	0.7	10000.0
JNK-IN-11	M4K1	69.0	1000.0
AZD7762	FAK1	0.1	10000.0
GSK1059615	SgK110	100.0	10000.0
AZD-6482	PI42C	58.0	10000.0
Dactolisib	CHK2	100.0	1000.0
NPK76-II-72-1	HCK	100.0	10000.0
Vemurafenib	M3K2	100.0	10000.0
Neratinib	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
GSK461364	S6K1	52.0	10000.0
ZM-447439	PIK3CA(C420R)	68.0	10000.0
Taselisib	ABL1(H396P)-nonphosphorylated	95.0	1000.0
NPK76-II-72-1	DAPK2	100.0	10000.0
ZM-447439	CSNK1A1L	99.0	10000.0
GSK429286A	FGFR3	81.0	10000.0
PHA-767491	PIK3CA(E545K)	77.0	10000.0
HG-9-91-01	AMPK-alpha1	48.0	10000.0
BI-2536	CSNK1G3	100.0	10000.0
AS-252424	EPHB3	75.4	10000.0
KIN001-111	MKNK2	100.0	1000.0
Buparlisib	GRK7	100.0	1000.0
WZ3105	ABL1(Q252H)-phosphorylated	58.0	10000.0
Sorafenib	PIK3C2G	80.0	10000.0
R406	DDR1	0.0	1000.0
Ibrutinib	CDKL2	100.0	1000.0
HG-5-88-01	CLK4	5.5	10000.0
KIN001-220	TAOK2	56.0	10000.0
ALW-II-49-7	MAPKAPK5	100.0	10000.0
AZD7762	KPCT	0.0	10000.0
JNK-IN-11	YANK2	30.0	1000.0
WH-4-023	PDPK1	82.0	10000.0
NPK76-II-72-1	AMPK-alpha2	100.0	10000.0
XMD11-85h	CDKL5	100.0	10000.0
GW843682X	HCK	72.0	10000.0
CG-930	CSNK2A2	96.0	10000.0
GW843682X	IRAK1	54.0	10000.0
Vemurafenib	PKN1	78.0	10000.0
HG-9-91-01	ROS1	79.0	10000.0
PHA-793887	CIT	87.0	10000.0
QL-XI-92	MST3	100.0	10000.0
Torin1	FGFR4	21.0	10000.0
Lapatinib	MAP4K2	86.0	10000.0
MRT67307	PIK3C2B	100.0	10000.0
Lapatinib	EGFR(G719S)	0.0	10000.0
XMD8-92	MP2K3	100.0	10000.0
MPS-1-IN-1	MYLK	100.0	1000.0
JNK-9L	DCAMKL3	100.0	10000.0
Alpelisib	CDK9	100.0	1000.0
RO-3306	PIK3CA(H1047Y)	48.0	10000.0
AZD 5438	TBK1	12.0	10000.0
CP724714	MRCKB	96.0	10000.0
WZ-7043	PIK3CD	100.0	10000.0
SP600125	RPS6KA2(Kin.Dom.2)	3.2	10000.0
CGP74514A	KIT	27.0	10000.0
JNK-9L	PFPK5(P.falciparum)	100.0	10000.0
Baricitinib	MET(M1250T)	82.0	10000.0
BS-181	DRAK1	100.0	10000.0
WZ-7043	ULK3	100.0	10000.0
JNK-IN-5A	MAST1	100.0	10000.0
HG-6-64-01	DDR2	9.0	10000.0
CH5424802	DDR2	100.0	1000.0
SP600125	PKN1	100.0	10000.0
HG-9-91-01	ABL1(T315I)-phosphorylated	1.6	10000.0
WZ-7043	HIPK4	100.0	10000.0
WZ-4-145	EPHA1	100.0	10000.0
XMD14-99	EGFR(L858R)	100.0	10000.0
PLX-4720	DCAMKL3	26.0	10000.0
HG-14-8-02	PKMYT1	94.0	10000.0
Baricitinib	NUAK1	53.0	10000.0
HG-14-8-02	CAMK2B	14.0	10000.0
HG-5-113-01	LKB1	18.0	10000.0
SCH772984	RSK4(Kin.Dom.1-N-terminal)	79.0	1000.0
RO-3306	TIE1	80.0	10000.0
Ribociclib	STK16	100.0	1000.0
ERK5-IN-1	VGFR2	100.0	1000.0
Dabrafenib	PKAC-alpha	100.0	10000.0
Canertinib	CSNK1E	100.0	1000.0
XMD13-2	LRRK2	100.0	10000.0
KIN001-127	PHKG2	11.0	10000.0
5z-7-oxozeaenol	PIP5K1C	100.0	10000.0
NU7441	ACVR1	91.0	10000.0
AZD 5438	MP2K1	14.0	10000.0
Sigma A6730	TGFBR2	100.0	10000.0
ALW-II-49-7	PAK4	100.0	10000.0
HG-6-64-01	CTK	100.0	10000.0
NG25	CSNK1D	100.0	10000.0
Ceritinib	SBK1	48.0	1000.0
Torkinib	DCLK1	70.0	10000.0
JNK-9L	PIP5K2B	6.9	10000.0
CP466722	GRK1	41.0	10000.0
NU7441	BMPR2	35.0	10000.0
BX-912	JNK1	0.2	10000.0
Dactolisib	TNK1	100.0	1000.0
KIN001-127	FLT3(ITD)	100.0	10000.0
HG-14-8-02	IKKB	79.0	10000.0
ZG-10	PKNB(M.tuberculosis)	84.0	10000.0
JNK-IN-5A	PIK3CA(H1047L)	70.0	10000.0
XMD14-99	RET(V804L)	100.0	10000.0
Seliciclib	PRP4	81.0	10000.0
Neratinib	DCLK1	100.0	10000.0
Dactolisib	ACVR1B	100.0	1000.0
JNK-IN-11	KIT(D816H)	86.0	1000.0
Abemaciclib	M3K6	73.0	1000.0
Torkinib	MKNK1	19.0	10000.0
JNK-9L	MP2K1	50.0	10000.0
XMD14-99	PAK1	91.0	10000.0
Torin2	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
AZ-628	DAPK2	100.0	10000.0
WZ3105	TAK1	21.0	10000.0
Omipalisib	RPS6KA4(Kin.Dom.1-N-terminal)	100.0	10000.0
GSK429286A	BRAF(V600E)	87.0	10000.0
HG-14-8-02	JAK1(JH2domain-pseudokinase)	78.0	10000.0
WH-4-023	AAK1	13.0	10000.0
KIN001-123	LATS1	100.0	1000.0
KIN001-021	VGFR1	100.0	1000.0
JNK-IN-11	MLCK	91.0	1000.0
Dabrafenib	TNIK	10.0	10000.0
GW-5074	ULK2	90.0	10000.0
Seliciclib	MK03	100.0	10000.0
CG-930	FLT3(D835H)	67.0	10000.0
XMD8-85	PAK6	100.0	10000.0
JWE-035	FAK1	57.0	10000.0
NU7441	PAK6	94.0	10000.0
RO-3306	LRRK2(G2019S)	46.0	10000.0
CP724714	MAST1	100.0	10000.0
Ceritinib	FLT3(ITD,F691L)	43.0	1000.0
Pictilisib	MP2K5	72.0	1000.0
JNK-IN-11	ABL1(M351T)-phosphorylated	14.0	1000.0
AZD 5438	DAPK1	44.0	10000.0
PD173074	MYLK2	100.0	10000.0
JNK-IN-11	KPCD	100.0	1000.0
ZSTK474	TRKA	100.0	1000.0
Canertinib	MARK3	100.0	1000.0
Buparlisib	PAK3	100.0	1000.0
Baricitinib	YANK1	76.0	10000.0
KIN001-021	ROS1	100.0	1000.0
Canertinib	EPHB4	100.0	1000.0
MPS-1-IN-1	RPS6KA1(Kin.Dom.1)	29.0	1000.0
AZD-6482	PAK3	98.0	10000.0
CP724714	VRK2	100.0	10000.0
XMD8-92	AMPK-alpha2	100.0	10000.0
A443654	MP2K2	100.0	10000.0
NPK76-II-72-1	EGFR(L858R)	100.0	10000.0
CP466722	MST2	54.0	10000.0
HG-5-88-01	LOK	100.0	10000.0
NU7441	WEE2	100.0	10000.0
CH5424802	RPS6KA4(Kin.Dom.1-N-terminal)	90.0	1000.0
XMD8-85	NEK2	100.0	10000.0
Sigma A6730	PIK3CA(I800L)	51.0	10000.0
PHA-767491	ACVR1B	34.0	10000.0
JNK-IN-11	PHKG2	100.0	1000.0
QL-XII-47	LKB1	100.0	1000.0
MRT67307	MET(Y1235D)	49.0	10000.0
GW-5074	ULK3	12.0	10000.0
WH-4-023	ROS1	0.8	10000.0
Ribociclib	CAMK2A	44.0	1000.0
KU63794	MET	88.0	10000.0
Neratinib	SRMS	91.0	10000.0
GW-5074	PIK3CA(E545A)	86.0	10000.0
XMD16-144	PIM2	100.0	10000.0
AZD7762	ULK3	0.0	10000.0
ERK5-IN-1	KIT(V559D,T670I)	100.0	1000.0
OTSSP167	GRK7	3.1	10000.0
AZD-6482	MP2K5	100.0	10000.0
AZD-6482	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
Lapatinib	PIK3C2B	39.0	10000.0
HG-9-91-01	STK35	6.0	10000.0
CH5424802	HIPK1	58.0	1000.0
BI-2536	INSR	100.0	10000.0
XMD16-144	MLCK	100.0	10000.0
JNK-IN-8	MP2K6	95.0	1000.0
JNK-IN-8	RSK1(Kin.Dom.2-C-terminal)	88.0	1000.0
JNK-IN-11	MUSK	100.0	1000.0
NU7441	KC1G2	85.0	10000.0
THZ1	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
WYE-125132	HCK	100.0	10000.0
AZD4547	EPHB4	56.0	10000.0
PD0325901	RIPK1	85.0	10000.0
NG25	RPS6KA1(Kin.Dom.1)	100.0	10000.0
BMS345541	PHKG1	95.0	10000.0
JNK-IN-8	CDK8	51.0	1000.0
CP466722	TIE2	45.0	10000.0
SCH772984	CDK8	100.0	1000.0
Buparlisib	KIT(A829P)	84.0	1000.0
OTSSP167	S6K1	1.6	10000.0
SP600125	ACVR2B	100.0	10000.0
RO-3306	NEK6	100.0	10000.0
CGP60474	CDK2	100.0	10000.0
Momelotinib	TYK2(JH2domain-pseudokinase)	100.0	10000.0
WZ4002	MELK	14.0	10000.0
NU7441	NEK1	58.0	10000.0
KIN001-220	GSK3B	61.0	10000.0
PHA-767491	PAK3	100.0	10000.0
TAK-715	PGFRB	34.0	10000.0
QL-XII-47	EPHA3	100.0	1000.0
AZ-628	MYLK	98.0	10000.0
A443654	TIE1	31.0	10000.0
Torin1	PGFRB	24.0	10000.0
PD0325901	EPHA7	94.0	10000.0
Taselisib	PIK3CA(M1043I)	0.5	1000.0
THZ1	KIT(V559D,V654A)	12.0	10000.0
Ibrutinib	AMPK-alpha2	100.0	1000.0
Torin1	TAOK2	84.0	10000.0
QL-X-138	TYRO3	100.0	10000.0
Ibrutinib	HIPK1	72.0	1000.0
Omipalisib	MP2K5	47.0	10000.0
KIN001-123	JAK1(Kin.Dom.1)	100.0	1000.0
CGP60474	TRKA	100.0	10000.0
Alpelisib	JAK1(JH1domain-catalytic)	97.0	1000.0
ZM-447439	DRAK1	100.0	10000.0
BS-181	FGFR3(G697C)	96.0	10000.0
Dactolisib	ALK	100.0	1000.0
Dinaciclib	NEK4	93.0	10000.0
CH5424802	CDK14	95.0	1000.0
Ribociclib	AAK1	79.0	1000.0
PD0325901	ABL1(F317I)-phosphorylated	100.0	10000.0
SP600125	EGFR(G719C)	100.0	10000.0
XMD-12	CDK2	91.0	1000.0
JNK-9L	EGFR(L858R,T790M)	97.0	10000.0
WZ-4-145	IGF1R	16.0	10000.0
WYE-125132	PIK3CA(E545A)	8.8	10000.0
KIN001-021	CSNK1G3	100.0	1000.0
QL-XII-47	M3K12	100.0	1000.0
HG-9-91-01	RSK2(Kin.Dom.1-N-terminal)	1.6	10000.0
GSK461364	KIT(V559D,T670I)	37.0	10000.0
XMD8-85	RPS6KA1(Kin.Dom.1)	100.0	10000.0
MRT67307	JAK1(JH2domain-pseudokinase)	10.0	10000.0
PD173074	TTK	100.0	10000.0
OTSSP167	RIPK4	0.1	10000.0
HG-14-10-04	MAP3K15	39.0	10000.0
ZM-447439	BIKE	100.0	10000.0
BGJ398	TRKA	95.0	1000.0
CGP74514A	MAP3K15	99.0	10000.0
AZD 5438	CDK9	1.7	10000.0
BX-912	PIK3CA(E542K)	100.0	10000.0
PD173074	RIPK1	100.0	10000.0
Barasertib	PGFRB	0.0	10000.0
A443654	RIPK1	100.0	10000.0
ERK5-IN-1	HCK	100.0	1000.0
PD0325901	CIT	100.0	10000.0
AZD7762	MAP4K5	0.4	10000.0
Momelotinib	LYN	94.0	10000.0
WZ-7043	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
CGP74514A	KIT(V559D,V654A)	45.0	10000.0
MLN8054	KPCD2	92.0	10000.0
Ceritinib	FLT3(ITD,D835V)	62.0	1000.0
AG1478	ABL1-nonphosphorylated	3.4	10000.0
Alpelisib	BARK1	100.0	1000.0
JNK-IN-11	PIK3CA(H1047Y)	93.0	1000.0
CP466722	CAMKK2	9.1	10000.0
Ribociclib	CDKL1	79.0	1000.0
ZM-447439	JNK1	67.0	10000.0
Barasertib	MAPKAPK5	100.0	10000.0
CP466722	PRP4	93.0	10000.0
QL-X-138	MELK	43.0	10000.0
Dactolisib	AMPK-alpha2	100.0	1000.0
Ribociclib	NEK1	93.0	1000.0
Torkinib	DCAMKL3	10.0	10000.0
THZ1	OSR1	39.0	10000.0
GW843682X	IRAK4	58.0	10000.0
Ibrutinib	RSK2(Kin.Dom.2-C-terminal)	100.0	1000.0
ZG-10	DAPK1	58.0	10000.0
Torin2	RSK2(Kin.Dom.1-N-terminal)	80.0	10000.0
Lapatinib	RSK4(Kin.Dom.2-C-terminal)	94.0	10000.0
Barasertib	CAMK1D	83.0	10000.0
SP600125	CLK4	100.0	10000.0
Abemaciclib	JNK1	4.0	1000.0
ALW-II-38-3	LCK	1.2	1000.0
PD173074	HCK	100.0	10000.0
Sorafenib	NEK6	100.0	10000.0
HG-5-88-01	SRC	23.0	10000.0
WZ-7043	PRKX	100.0	10000.0
Buparlisib	ACVR2B	72.0	1000.0
AZ-628	JAK3(JH1domain-catalytic)	87.0	10000.0
Palbociclib	RIOK2	100.0	1000.0
Momelotinib	RSK4(Kin.Dom.1-N-terminal)	78.0	10000.0
HG-6-64-01	MINK	2.8	10000.0
ZG-10	MST1	100.0	10000.0
GSK1059615	ERBB4	65.0	10000.0
NVP-TAE684	PAK7	2.7	1000.0
5z-7-oxozeaenol	ABL1(Q252H)-phosphorylated	95.0	10000.0
Omipalisib	ALK(C1156Y)	79.0	10000.0
Omipalisib	MLK3	100.0	10000.0
Torin2	DRAK2	89.0	10000.0
R406	ABL1	26.0	1000.0
SB590885	BMPR1B	26.0	10000.0
CP724714	MARK4	100.0	10000.0
PHA-793887	KIT(V559D)	93.0	10000.0
KIN001-111	IKKE	100.0	1000.0
Torin2	YSK4	37.0	10000.0
XMD14-99	RIOK1	100.0	10000.0
Seliciclib	ABL1-phosphorylated	71.0	10000.0
BS-181	YANK3	87.0	10000.0
AG1478	DDR1	1.9	10000.0
JW-7-24-1	RIOK1	17.0	10000.0
Alpelisib	ABL1(T315I)-nonphosphorylated	100.0	1000.0
BS-181	NEK3	100.0	10000.0
GW-5074	IKKA	100.0	10000.0
XMD11-50	LRRK2	0.0	10000.0
BGJ398	EGFR(E746-A750del)	89.0	1000.0
XMD13-2	PIP5K2B	5.6	10000.0
OTSSP167	ROS1	12.0	10000.0
GW843682X	FLT3	12.0	10000.0
WZ-4-145	RPS6KA5(Kin.Dom.2)	100.0	10000.0
Dinaciclib	WNK3	92.0	10000.0
KIN001-123	EGFR(L747-S752del,P753S)	31.0	1000.0
JWE-035	PIK3CA(Q546K)	3.2	10000.0
HG-5-88-01	JNK1	4.1	10000.0
THZ1	PAK2	58.0	10000.0
KIN001-220	M4K3	42.0	10000.0
HG-5-88-01	KPCE	100.0	10000.0
XMD11-50	BTK	100.0	10000.0
Alpelisib	EPHB6	100.0	1000.0
Buparlisib	EGFR(L747-T751del,Sins)	80.0	1000.0
SCH772984	JAK2(JH1domain-catalytic)	12.0	1000.0
SP600125	ERBB4	100.0	10000.0
QL-X-138	ABL1(F317I)-phosphorylated	86.0	10000.0
Buparlisib	PIK3C3	14.0	1000.0
XMD8-92	ROCK2	100.0	10000.0
Barasertib	SRPK2	92.0	10000.0
Ibrutinib	PKN2	100.0	1000.0
NG25	EPHB4	100.0	10000.0
Ibrutinib	ZAP70	100.0	1000.0
PD173074	ANKK1	100.0	10000.0
GW843682X	MAP4K5	3.0	10000.0
ZM-447439	CDK7	6.5	10000.0
CP466722	KC1G2	1.1	10000.0
AZD7762	PLK2	40.0	10000.0
CP724714	HIPK3	100.0	10000.0
JNK-9L	HCK	100.0	10000.0
Torin2	ADCK3	88.0	10000.0
CG-930	PI42C	32.0	10000.0
Torin1	EGFR(T790M)	100.0	10000.0
SP600125	PIK3CD	100.0	10000.0
XMD-12	MLK1	91.0	1000.0
GSK429286A	MERTK	91.0	10000.0
JNK-IN-8	JNK3	0.0	1000.0
KIN001-127	IKKA	100.0	10000.0
OTSSP167	CDK7	0.3	10000.0
WZ3105	HIPK1	25.0	10000.0
OTSSP167	MK11	44.0	10000.0
RO-3306	PKMYT1	100.0	10000.0
Crizotinib	BRAF(V600E)	30.0	10000.0
AZD 5438	JAK1(JH2domain-pseudokinase)	0.1	10000.0
Canertinib	BRAF	100.0	1000.0
AG1478	BMX	100.0	10000.0
AZD 5438	PFPK5(P.falciparum)	100.0	10000.0
GW843682X	PAK3	77.0	10000.0
Sorafenib	EPHA6	9.2	10000.0
ZG-10	IKKB	65.0	10000.0
XMD8-92	INSRR	100.0	10000.0
BS-181	CDKL1	60.0	10000.0
GSK1059615	CHK2	57.0	10000.0
RO-3306	VGFR1	87.0	10000.0
KIN001-111	PIK3CB	100.0	1000.0
Dactolisib	EPHA2	100.0	1000.0
HG-5-113-01	MYO3B	100.0	10000.0
JNK-IN-5A	PLK1	81.0	10000.0
GSK461364	PLK1	0.1	10000.0
AG1478	RIOK1	65.0	10000.0
GW-5074	ACVR2B	83.0	10000.0
Torin2	IKKA	55.0	10000.0
Alpelisib	SRPK1	100.0	1000.0
JWE-035	KPCE	81.0	10000.0
CP724714	MST2	82.0	10000.0
Taselisib	MAP3K1	93.0	1000.0
SB590885	AAK1	76.0	10000.0
Buparlisib	EPHB3	87.0	1000.0
QL-X-138	PIK3CA(C420R)	18.0	10000.0
(s)-CR8	MST3	88.0	10000.0
WZ3105	EPHB1	84.0	10000.0
HG-6-64-01	VGFR2	2.6	10000.0
XMD14-99	EPHA1	100.0	10000.0
ALW-II-49-7	DYRK1B	100.0	10000.0
BMS-536924	WEE2	100.0	1000.0
GW843682X	AXL	65.0	10000.0
XMD11-85h	MAP4K5	100.0	10000.0
BX-912	CSNK1G3	88.0	10000.0
Torkinib	TNIK	2.4	10000.0
Dinaciclib	MRCKB	100.0	10000.0
NPK76-II-72-1	TEC	100.0	10000.0
ZSTK474	NEK9	100.0	1000.0
JNK-IN-11	ROS1	100.0	1000.0
KIN001-123	PAK6	100.0	1000.0
GSK461364	IRAK1	23.0	10000.0
OTSSP167	RPS6KA5(Kin.Dom.2-C-terminal)	18.0	10000.0
R406	FGFR2	1.4	1000.0
JW-7-24-1	ABL2	34.0	10000.0
WZ3105	ABL1(Y253F)-phosphorylated	62.0	10000.0
MLN8054	RSK4(Kin.Dom.1-N-terminal)	36.0	10000.0
GSK1059615	FGFR4	59.0	10000.0
ZG-10	VRK2	90.0	10000.0
AZD-6482	HIPK4	100.0	10000.0
ALW-II-49-7	GSK3A	100.0	10000.0
Seliciclib	PIP5K1C	92.0	10000.0
QL-XII-47	EPHA8	96.0	1000.0
KIN001-123	BRSK2	100.0	1000.0
JNK-IN-8	RSK4(Kin.Dom.1-N-terminal)	100.0	1000.0
PHA-793887	RIPK5	28.0	10000.0
BMS345541	CAMK2A	78.0	10000.0
Taselisib	MK09	97.0	1000.0
JNK-IN-11	PIM3	94.0	1000.0
HG-14-8-02	IGF1R	7.6	10000.0
BI-2536	RIOK2	100.0	10000.0
BI-2536	ABL1(M351T)	100.0	10000.0
JWE-035	CDC2L2	97.0	10000.0
PHA-767491	CAMK1	100.0	10000.0
HG-6-64-01	ABL1(F317I)-phosphorylated	19.0	10000.0
Palbociclib	CSNK1D	100.0	1000.0
Sorafenib	PLK2	71.0	10000.0
CP724714	MAP4K4	97.0	10000.0
Dactolisib	CDKL2	28.0	1000.0
Torin1	EPHA6	75.0	10000.0
CH5424802	HIPK3	28.0	1000.0
CGP60474	PIM1	100.0	10000.0
AZD-6482	IKKB	90.0	10000.0
CP724714	PLK3	99.0	10000.0
XMD11-50	M3K6	100.0	10000.0
CG-930	CAMK1D	93.0	10000.0
GW843682X	LRRK2	80.0	10000.0
CH5424802	KPCD2	74.0	1000.0
WYE-125132	PKN2	83.0	10000.0
HG-9-91-01	LIMK1	0.0	10000.0
AG1478	NLK	43.0	10000.0
PHA-767491	NEK1	50.0	10000.0
PHA-767491	M3K6	75.0	10000.0
KIN001-111	RIPK4	100.0	1000.0
KIN001-220	MP2K6	44.0	10000.0
Crizotinib	TYRO3	4.6	10000.0
WZ-7043	LATS1	100.0	10000.0
BMX-IN-1	PIK4CB	20.0	10000.0
XMD14-99	MYLK	18.0	10000.0
PD0325901	PKAC-alpha	72.0	10000.0
GW843682X	KIT	30.0	10000.0
WH-4-023	KPCD	9.8	10000.0
AZD 5438	RSK3(Kin.Dom.2-C-terminal)	58.0	10000.0
PHA-793887	SYK	100.0	10000.0
HG-5-113-01	PKN1	0.0	10000.0
KIN001-123	RPS6KA2(Kin.Dom.1)	100.0	1000.0
CP466722	DDR2	22.0	10000.0
Torin1	GSK3B	100.0	10000.0
XMD8-85	CLK2	100.0	10000.0
CP724714	RIOK2	100.0	10000.0
Buparlisib	CDKL2	89.0	1000.0
Abemaciclib	NEK6	100.0	1000.0
KIN001-220	EPHB4	76.0	10000.0
Dinaciclib	CLK3	86.0	10000.0
WZ-4-145	FLT3(D835H)	16.0	10000.0
Dactolisib	ERBB3	100.0	1000.0
Omipalisib	EGFR(G719S)	67.0	10000.0
Torin2	CAMK2B	100.0	10000.0
WH-4-023	EPHA7	26.0	10000.0
JNK-IN-11	RPS6KA4(Kin.Dom.1-N-terminal)	88.0	1000.0
PD173074	BLK	100.0	10000.0
NVP-TAE684	PKN1	0.5	1000.0
PLX-4720	LIMK1	46.0	10000.0
HG-14-8-02	EPHA8	100.0	10000.0
CP466722	DMPK2	96.0	10000.0
GSK429286A	JAK1(JH1domain-catalytic)	28.0	10000.0
JNK-IN-11	DCAMKL3	86.0	1000.0
Seliciclib	HIPK4	6.6	10000.0
HG-5-88-01	KPCD	100.0	10000.0
BS-181	RPS6KA4(Kin.Dom.1-N-terminal)	98.0	10000.0
MLN8054	FGFR3(G697C)	12.0	10000.0
AZD4547	BRSK1	78.0	10000.0
Momelotinib	EPHA1	100.0	10000.0
XMD8-85	DRAK2	100.0	10000.0
PD0325901	AXL	83.0	10000.0
Alpelisib	CHEK1	100.0	1000.0
XMD-12	SRPK3	84.0	1000.0
KU63794	ABL1(Q252H)-nonphosphorylated	83.0	10000.0
HG-6-64-01	YSK4	0.2	10000.0
WZ3105	M3K2	0.2	10000.0
GSK461364	ABL1(F317I)-phosphorylated	78.0	10000.0
KIN001-220	TESK1	44.0	10000.0
AZD-6482	M3K5	100.0	10000.0
XMD16-144	HIPK3	85.0	10000.0
JWE-035	TYRO3	92.0	10000.0
Dinaciclib	PDPK1	99.0	10000.0
GSK461364	KPCL	90.0	10000.0
Dactolisib	TAOK3	100.0	1000.0
Vemurafenib	MTOR	100.0	10000.0
ZSTK474	M3K5	100.0	1000.0
Canertinib	TNNI3K	100.0	1000.0
QL-X-138	PIM3	42.0	10000.0
Baricitinib	GSK3B	72.0	10000.0
WZ-4-145	PLK3	100.0	10000.0
PLX-4720	FGR	8.4	10000.0
JWE-035	FGFR3	43.0	10000.0
CP466722	NEK3	87.0	10000.0
ZSTK474	FRK	100.0	1000.0
CGP74514A	PHKG2	16.0	10000.0
HG-5-113-01	EGFR(L858R)	100.0	10000.0
ERK5-IN-1	SLK	100.0	1000.0
Dabrafenib	EGFR(L747-T751del,Sins)	89.0	10000.0
GW-5074	RSK4(Kin.Dom.2-C-terminal)	1.7	10000.0
BI-D1870	HIPK2	21.0	10000.0
Ibrutinib	PRP4	80.0	1000.0
CGP60474	ZAP70	100.0	10000.0
Ceritinib	MAP3K15	69.0	1000.0
NU7441	GSK3B	44.0	10000.0
Buparlisib	PKAC-alpha	100.0	1000.0
BS-181	IRAK1	92.0	10000.0
Taselisib	WNK2	100.0	1000.0
NVP-TAE684	ERK3	100.0	1000.0
XMD11-50	ACVR1B	100.0	10000.0
XMD16-144	CSNK2A1	100.0	10000.0
Barasertib	CDK9	82.0	10000.0
GW843682X	SgK110	100.0	10000.0
XMD11-50	MARK3	98.0	10000.0
Barasertib	KIT(D816V)	23.0	10000.0
BX-912	NEK3	6.8	10000.0
Vemurafenib	YSK1	100.0	10000.0
ZM-447439	JAK3(JH1domain-catalytic)	62.0	10000.0
Pictilisib	ERK5	93.0	1000.0
GW843682X	VRK2	87.0	10000.0
PLX-4720	PIP5K2B	100.0	10000.0
KIN001-220	CDKL5	100.0	10000.0
XMD11-50	EGFR(L861Q)	100.0	10000.0
KIN001-220	TTK	18.0	10000.0
Sorafenib	FGR	53.0	10000.0
HG-14-8-02	EPHA7	100.0	10000.0
GSK1059615	YANK3	96.0	10000.0
Torkinib	WEE1	72.0	10000.0
5z-7-oxozeaenol	M3K2	79.0	10000.0
XMD14-99	CAMK1D	24.0	10000.0
XMD8-85	RIOK3	100.0	10000.0
CG-930	ULK3	94.0	10000.0
TAK-715	ABL1(T315I)-nonphosphorylated	84.0	10000.0
PD0325901	PIK3C2B	100.0	10000.0
PHA-793887	PIK3CA(Q546K)	100.0	10000.0
BX-912	BRSK1	7.6	10000.0
A443654	MLTK	100.0	10000.0
TAK-715	MP2K1	86.0	10000.0
WZ3105	ERK3	100.0	10000.0
KU63794	RSK3(Kin.Dom.1-N-terminal)	100.0	10000.0
KIN001-123	ITK	0.9	1000.0
GSK429286A	CDC2L1	89.0	10000.0
MRT67307	SIK3	14.0	10000.0
Pictilisib	PIK3C3	84.0	1000.0
GW843682X	ERK3	64.0	10000.0
NPK76-II-72-1	PIM3	100.0	10000.0
MRT67307	KPCD	77.0	10000.0
SCH772984	CDK2	100.0	1000.0
GSK461364	MUSK	100.0	10000.0
BMS-536924	PAK3	5.1	1000.0
WZ4002	MET	20.0	10000.0
CP724714	MAP3K3	100.0	10000.0
JNK-IN-8	PKAC-beta	76.0	1000.0
JWE-035	MK11	82.0	10000.0
GSK1059615	PIP5K2B	4.0	10000.0
ALW-II-49-7	CHEK1	100.0	10000.0
Torkinib	GSK3B	91.0	10000.0
MRT67307	ABL1(T315I)-nonphosphorylated	40.0	10000.0
HG-9-91-01	PAK2	67.0	10000.0
CP724714	STK36	100.0	10000.0
Crizotinib	ROS1	1.1	10000.0
Dabrafenib	SIK2	18.0	10000.0
ALW-II-38-3	MAP4K5	100.0	10000.0
Torkinib	PKMYT1	37.0	10000.0
ERK5-IN-1	MK01	100.0	1000.0
BMX-IN-1	KCC2D	92.0	10000.0
BMX-IN-1	TYK2(JH1domain-catalytic)	100.0	10000.0
NG25	AKT1	100.0	10000.0
Torkinib	ADCK3	57.0	10000.0
NU7441	KIT(L576P)	66.0	10000.0
THZ1	SNRK	100.0	10000.0
GW843682X	EPHA8	74.0	10000.0
GSK1059615	NLK	84.0	10000.0
AZD4547	IKKB	62.0	10000.0
WZ-4-145	MLK2	13.0	10000.0
Momelotinib	MLK1	45.0	10000.0
Neratinib	TLK1	86.0	10000.0
A443654	PRKX	12.0	10000.0
GSK429286A	PIK3CA(E542K)	92.0	10000.0
CP466722	FLT3(D835Y)	3.4	10000.0
MRT67307	JNK3	20.0	10000.0
WZ4002	NEK9	100.0	10000.0
XMD8-85	TYK2(JH2domain-pseudokinase)	100.0	10000.0
Momelotinib	PCTK2	55.0	10000.0
AZD-6482	LYN	99.0	10000.0
NPK76-II-72-1	MLK1	100.0	10000.0
XMD11-85h	KGP2	100.0	10000.0
MRT67307	DCAMKL2	45.0	10000.0
BMS345541	DRAK2	100.0	10000.0
BS-181	CAMK1	100.0	10000.0
ALW-II-49-7	CLK2	100.0	10000.0
PD173074	EPHA2	100.0	10000.0
PLX-4720	TRKC	77.0	10000.0
GW-5074	MAPKAPK2	100.0	10000.0
GSK461364	KPCD1	20.0	10000.0
WH-4-023	RPS6KA5(Kin.Dom.2-C-terminal)	93.0	10000.0
ERK5-IN-1	CDK9	100.0	1000.0
QL-XII-47	YANK3	93.0	1000.0
WZ4003	RPS6KA3(Kin.Dom.1)	100.0	1000.0
JW-7-24-1	CSF1R	20.0	10000.0
Vemurafenib	AURKA	81.0	10000.0
QL-X-138	EGFR	30.0	10000.0
XMD14-99	WEE2	100.0	10000.0
SCH772984	TAOK3	96.0	1000.0
GSK1059615	NEK7	88.0	10000.0
Alpelisib	M3K6	100.0	1000.0
Crizotinib	GRK1	92.0	10000.0
Dactolisib	DCAMKL2	100.0	1000.0
SB590885	TRKC	45.0	10000.0
BI-2536	CSNK2A1	100.0	10000.0
MLN8054	CSK	15.0	10000.0
PD0325901	KIT(D816V)	87.0	10000.0
Dinaciclib	MAK	15.0	10000.0
AZD4547	AKT2	98.0	10000.0
XMD11-85h	CHK2	100.0	10000.0
SCH772984	PIK3CD	100.0	1000.0
MRT67307	RSK3(Kin.Dom.1-N-terminal)	6.6	10000.0
ZSTK474	EGFR(S752-I759del)	100.0	1000.0
Ibrutinib	PIK3CA	61.0	1000.0
Lapatinib	ABL2	100.0	10000.0
GSK461364	EIF2AK1	94.0	10000.0
WZ3105	CDK2	100.0	10000.0
Neratinib	SNRK	51.0	10000.0
GSK429286A	RPS6KA5(Kin.Dom.1-N-terminal)	88.0	10000.0
QL-X-138	NEK6	92.0	10000.0
AZD4547	BMX	71.0	10000.0
Baricitinib	CSNK2A1	25.0	10000.0
SCH772984	MST1	82.0	1000.0
Dinaciclib	TAK1	74.0	10000.0
Sorafenib	KIT(A829P)	59.0	10000.0
Taselisib	JAK3(JH1domain-catalytic)	100.0	1000.0
PD0325901	CSF1R	100.0	10000.0
Torkinib	KCC4	100.0	10000.0
HG-6-64-01	EGFR(L747-T751del,Sins)	0.0	10000.0
MLN8054	IRAK4	100.0	10000.0
PD173074	TNK1	100.0	10000.0
NPK76-II-72-1	ROCK2	100.0	10000.0
BGJ398	EPHA1	100.0	1000.0
JWE-035	PKNB(M.tuberculosis)	22.0	10000.0
RO-3306	ADCK3	22.0	10000.0
Alpelisib	EGFR(E746-A750del)	93.0	1000.0
CGP74514A	ACVR1	100.0	10000.0
Omipalisib	CIT	54.0	10000.0
Dabrafenib	GRK7	81.0	10000.0
JNK-IN-8	TYRO3	85.0	1000.0
TGX221	RET(V804M)	100.0	1000.0
BMS-536924	CSNK2A2	16.0	1000.0
Alpelisib	HUNK	100.0	1000.0
PD0325901	TIE1	54.0	10000.0
CGP60474	RAF1	100.0	10000.0
Alpelisib	TGFBR1	100.0	1000.0
JW-7-24-1	HCK	16.0	10000.0
JW-7-24-1	KIT	13.0	10000.0
XMD13-2	VGFR1	100.0	10000.0
XMD13-2	SRPK3	10.0	10000.0
PD0325901	MK14	100.0	10000.0
NU7441	MET(Y1235D)	59.0	10000.0
CGP60474	MYO3A	100.0	10000.0
(s)-CR8	GCN2(Kin.Dom.2,S808G)	61.0	10000.0
Buparlisib	CDK16	100.0	1000.0
Sorafenib	BMX	78.0	10000.0
AG1478	LATS2	40.0	10000.0
HG-5-88-01	ROCK2	100.0	10000.0
MRT67307	KPCI	70.0	10000.0
HG-6-64-01	YES	0.7	10000.0
KIN001-123	AKT2	100.0	1000.0
HG-14-10-04	KC1G1	86.0	10000.0
XMD8-85	MAP4K2	100.0	10000.0
Dactolisib	DCAMKL3	100.0	1000.0
Neratinib	PIK3CG	91.0	10000.0
XMD11-50	BMPR1B	76.0	10000.0
KIN001-127	FGFR3	100.0	10000.0
WYE-125132	FRK	68.0	10000.0
5z-7-oxozeaenol	FLT3(K663Q)	6.4	10000.0
ZM-447439	PIP5K1C	69.0	10000.0
KIN001-220	CAMK1	14.0	10000.0
CP724714	ERK8	100.0	10000.0
Ceritinib	MARK4	93.0	1000.0
GW843682X	ABL1-phosphorylated	66.0	10000.0
CGP74514A	STK33	4.7	10000.0
Buparlisib	DCLK1	100.0	1000.0
QL-X-138	ULK2	81.0	10000.0
PHA-767491	FGFR3(G697C)	100.0	10000.0
NPK76-II-72-1	EPHA2	100.0	10000.0
ZG-10	PIK3CA(H1047Y)	100.0	10000.0
Baricitinib	KPCD	12.0	10000.0
ALW-II-49-7	MAP3K3	100.0	10000.0
CP466722	AURKB	0.4	10000.0
Dinaciclib	TNIK	84.0	10000.0
Buparlisib	FGFR3	100.0	1000.0
BGJ398	PKMYT1	100.0	1000.0
Abemaciclib	ABL1-phosphorylated	94.0	1000.0
GSK429286A	SGK3	100.0	10000.0
AZD7762	TAK1	0.0	10000.0
Abemaciclib	CHK2	54.0	1000.0
SCH772984	AKT1	100.0	1000.0
Neratinib	KPCD2	50.0	10000.0
PHA-793887	ABL1(F317L)-nonphosphorylated	100.0	10000.0
GW-5074	HIPK3	8.0	10000.0
5z-7-oxozeaenol	MP2K2	0.1	10000.0
JNK-IN-8	MP2K3	95.0	1000.0
MLN8054	CDKL5	100.0	10000.0
Torin2	SYK	100.0	10000.0
GSK461364	MYLK2	61.0	10000.0
JNK-IN-8	CDC2L1	100.0	1000.0
XMD11-85h	SRMS	100.0	10000.0
Omipalisib	ZAP70	74.0	10000.0
Vemurafenib	MP2K3	57.0	10000.0
Barasertib	RSK2(Kin.Dom.1-N-terminal)	80.0	10000.0
AZD7762	NEK5	90.0	10000.0
Lapatinib	ABL1(Y253F)-phosphorylated	100.0	10000.0
Barasertib	AXL	1.4	10000.0
Sigma A6730	JAK1(JH1domain-catalytic)	100.0	10000.0
QL-XI-92	EPHB6	81.0	10000.0
CGP74514A	FLT3	2.8	10000.0
XMD11-85h	CSNK1A1L	100.0	10000.0
QL-X-138	MST1	83.0	10000.0
Palbociclib	EGFR(S752-I759del)	93.0	1000.0
BI-D1870	JAK1(JH2domain-pseudokinase)	0.0	10000.0
AZD 5438	FGFR2	69.0	10000.0
XMD13-2	ABL1(T315I)-phosphorylated	34.0	10000.0
Dactolisib	KCC4	100.0	1000.0
ZSTK474	DRAK1	100.0	1000.0
AS-252424	ACVR2B	9.9	10000.0
XMD16-144	JAK3(JH1domain-catalytic)	1.2	10000.0
HG-14-10-04	MAK	100.0	10000.0
MRT67307	RSK2(Kin.Dom.1-N-terminal)	4.3	10000.0
Canertinib	GSK3B	100.0	1000.0
HG-6-64-01	NEK5	4.3	10000.0
GSK461364	EPHB2	99.0	10000.0
BMS345541	PAK1	100.0	10000.0
5z-7-oxozeaenol	YSK1	100.0	10000.0
JNK-9L	NDR1	92.0	10000.0
CG-930	CDK7	100.0	10000.0
MLN8054	GCN2(Kin.Dom.2,S808G)	79.0	10000.0
QL-XII-47	CAMK2B	91.0	1000.0
MRT67307	YANK3	100.0	10000.0
JNK-IN-8	CSNK1G3	100.0	1000.0
Crizotinib	KIT	43.0	10000.0
KIN001-021	PKAC-beta	100.0	1000.0
ZG-10	TAOK1	28.0	10000.0
BMX-IN-1	CSNK1A1L	100.0	10000.0
KIN001-220	MAK	100.0	10000.0
AZD4547	MYO3B	54.0	10000.0
SB590885	ABL1(M351T)-phosphorylated	11.0	10000.0
JNK-IN-5A	PIM1	100.0	10000.0
BI-D1870	VGFR2	26.0	10000.0
Buparlisib	LATS1	100.0	1000.0
QL-XII-47	MYO3A	100.0	1000.0
SCH772984	ANKK1	24.0	1000.0
MLN8054	MST2	48.0	10000.0
Canertinib	FGFR3	100.0	1000.0
KU63794	CDK15	95.0	10000.0
WZ-7043	FLT3(K663Q)	100.0	10000.0
XMD8-85	OSR1	100.0	10000.0
GW843682X	MST1R	100.0	10000.0
HG-9-91-01	PLK3	92.0	10000.0
PD0325901	DCLK1	100.0	10000.0
TAK-715	MRCKB	63.0	10000.0
NVP-TAE684	RAF1	100.0	1000.0
JW-7-24-1	AAK1	100.0	10000.0
ALW-II-49-7	EGFR(L747-T751del,Sins)	100.0	10000.0
Sigma A6730	IKKB	79.0	10000.0
Dinaciclib	RSK2(Kin.Dom.2-C-terminal)	70.0	10000.0
KIN001-127	LCK	6.2	10000.0
CGP74514A	EGFR	63.0	10000.0
CG-930	PIK3CA(E545A)	100.0	10000.0
PHA-767491	ABL1-phosphorylated	80.0	10000.0
WZ4002	KGP2	100.0	10000.0
QL-XI-92	IRAK4	99.0	10000.0
Lapatinib	PIK3CA	91.0	10000.0
ALW-II-38-3	DYRK1A	100.0	10000.0
R406	EGFR(L861Q)	0.8	1000.0
ZM-447439	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
HG-5-88-01	PIK3CB	100.0	10000.0
PHA-767491	LOK	63.0	10000.0
Torkinib	PIK3CG	0.6	10000.0
KIN001-123	YANK2	100.0	1000.0
SCH772984	MKNK1	100.0	1000.0
KIN001-127	BIKE	100.0	10000.0
BMS345541	RIOK1	100.0	10000.0
OTSSP167	NDR2	14.0	10000.0
PHA-767491	KPCI	24.0	10000.0
Lapatinib	NEK5	83.0	10000.0
5z-7-oxozeaenol	FLT3(ITD)	0.3	10000.0
MLN8054	DYRK1B	91.0	10000.0
SCH772984	EGFR(G719C)	79.0	1000.0
BMX-IN-1	PRP4	89.0	10000.0
5z-7-oxozeaenol	STK35	82.0	10000.0
PHA-793887	PHKG1	10.0	10000.0
CP724714	MAP4K5	86.0	10000.0
Barasertib	FYN	79.0	10000.0
AZD4547	CSNK1A1	94.0	10000.0
BS-181	TLK1	97.0	10000.0
JNK-IN-11	PRKX	94.0	1000.0
Pictilisib	JAK2(JH1domain-catalytic)	88.0	1000.0
Barasertib	MYLK	80.0	10000.0
GW843682X	KC1G2	100.0	10000.0
QL-X-138	TRKA	65.0	10000.0
AZD-6482	RAF1	100.0	10000.0
Vemurafenib	PIK3C2G	62.0	10000.0
XMD14-99	MET	100.0	10000.0
Ibrutinib	KPCL	95.0	1000.0
PD0325901	PFCDPK1(P.falciparum)	78.0	10000.0
SP600125	RPS6KA4(Kin.Dom.1)	0.0	10000.0
XMD-12	MAP3K3	0.4	1000.0
Neratinib	MRCKB	100.0	10000.0
SP600125	TAK1	100.0	10000.0
(s)-CR8	KIT(A829P)	100.0	10000.0
WYE-125132	IKKE	100.0	10000.0
Crizotinib	MP2K7	83.0	10000.0
QL-XII-47	TIE2	73.0	1000.0
HG-14-8-02	AKT3	100.0	10000.0
GSK461364	MYO3A	78.0	10000.0
XMD13-2	BRSK1	64.0	10000.0
XMD16-144	KIT	66.0	10000.0
Taselisib	PKN1	99.0	1000.0
AZD-6482	KPCD2	100.0	10000.0
XMD16-144	ADCK4	100.0	10000.0
BS-181	KKCC1	71.0	10000.0
Baricitinib	MLTK	74.0	10000.0
KIN001-220	NEK11	100.0	10000.0
JNK-IN-8	NLK	70.0	1000.0
AZD4547	AKT3	100.0	10000.0
Omipalisib	ERK8	100.0	10000.0
THZ1	ACVR2A	72.0	10000.0
WZ-4-145	KCC4	100.0	10000.0
WZ-4-145	MYLK4	100.0	10000.0
AZD 5438	BRSK1	48.0	10000.0
CG-930	PIP5K2B	98.0	10000.0
KIN001-111	LATS1	26.0	1000.0
Dactolisib	TAOK1	100.0	1000.0
Baricitinib	PRP4	0.0	10000.0
PD173074	RPS6KA2(Kin.Dom.1)	100.0	10000.0
JW-7-24-1	SIK2	100.0	10000.0
KIN001-111	MAP4K5	0.1	1000.0
CGP74514A	ABL2	21.0	10000.0
TAK-715	MYLK2	96.0	10000.0
GW-5074	GAK	1.6	10000.0
GW843682X	FLT3(D835Y)	26.0	10000.0
BI-2536	EPHA3	100.0	10000.0
(s)-CR8	MP2K7	98.0	10000.0
JNK-IN-8	KGP2	97.0	1000.0
Crizotinib	IKKE	60.0	10000.0
HG-6-64-01	ITK	18.0	10000.0
JNK-IN-11	PIK3CD	95.0	1000.0
NU7441	PIK3CA(I800L)	2.2	10000.0
Alpelisib	KC1G2	100.0	1000.0
XMD11-85h	AXL	100.0	10000.0
KIN001-021	KIT	100.0	1000.0
Sorafenib	ERN1	74.0	10000.0
SB590885	SLK	1.3	10000.0
ALW-II-49-7	CDK9	100.0	10000.0
XMD14-99	ABL1(Y253F)-phosphorylated	98.0	10000.0
Torin1	EPHA2	59.0	10000.0
Seliciclib	LIMK1	100.0	10000.0
PD173074	PIP5K2B	100.0	10000.0
PD0325901	KIT	77.0	10000.0
ERK5-IN-1	MARK4	100.0	1000.0
WYE-125132	ERBB4	100.0	10000.0
AZD-6482	KIT(V559D)	91.0	10000.0
Canertinib	AKT1	100.0	1000.0
XMD8-92	NDR1	100.0	10000.0
TGX221	DMPK	100.0	1000.0
KIN001-123	DDR1	100.0	1000.0
NU7441	CDC2L2	100.0	10000.0
AZD 5438	LIMK2	33.0	10000.0
AZD-6482	NUAK1	100.0	10000.0
GSK1059615	YSK1	75.0	10000.0
XMD11-50	LATS1	100.0	10000.0
SB590885	EPHB1	100.0	10000.0
QL-X-138	WEE1	100.0	10000.0
JW-7-24-1	MST1R	28.0	10000.0
A443654	TRKC	100.0	10000.0
Torkinib	IRAK3	12.0	10000.0
WZ-7043	ABL1(Y253F)	100.0	10000.0
HG-6-64-01	M4K3	14.0	10000.0
ZM-447439	ABL1(H396P)-phosphorylated	45.0	10000.0
R406	RIOK3	0.9	1000.0
HG-14-10-04	ERK4	92.0	10000.0
SCH772984	PCTK3	100.0	1000.0
HG-9-91-01	HIPK1	94.0	10000.0
XMD16-144	CSK	82.0	10000.0
QL-XII-47	DDR1	100.0	1000.0
XMD14-99	BMPR1B	100.0	10000.0
XMD11-85h	DRAK2	100.0	10000.0
QL-XI-92	DDR2	40.0	10000.0
HG-9-91-01	EGFR(T790M)	0.2	10000.0
KIN001-220	SYK	33.0	10000.0
5z-7-oxozeaenol	AURKC	99.0	10000.0
Crizotinib	PKAC-beta	100.0	10000.0
ZM-447439	PCTK3	75.0	10000.0
BX-912	FLT4	0.1	10000.0
CG-930	ERK8	100.0	10000.0
WZ4002	FRK	28.0	10000.0
AS-252424	AAK1	35.0	10000.0
HG-5-113-01	RET(M918T)	1.4	10000.0
HG-5-88-01	KIT(D816V)	24.0	10000.0
Omipalisib	KPCD	83.0	10000.0
JNK-IN-5A	TIE1	95.0	10000.0
CGP74514A	MLK3	15.0	10000.0
Taselisib	HASP	84.0	1000.0
RO-3306	RIPK1	100.0	10000.0
BGJ398	JAK2(JH1domain-catalytic)	85.0	1000.0
AG1478	MAP3K1	16.0	10000.0
WYE-125132	SRPK1	100.0	10000.0
Dinaciclib	NEK11	100.0	10000.0
JW-7-24-1	DAPK1	100.0	10000.0
5z-7-oxozeaenol	LATS2	100.0	10000.0
Dabrafenib	ERBB2	6.0	10000.0
WZ3105	RSK1(Kin.Dom.1-N-terminal)	9.4	10000.0
Lapatinib	NEK4	100.0	10000.0
WZ-7043	EPHB4	100.0	10000.0
MLN8054	CDK16	100.0	10000.0
XMD13-2	PAK1	70.0	10000.0
BX-912	HCK	42.0	10000.0
Seliciclib	MKNK1	100.0	10000.0
CGP60474	MARK1	100.0	10000.0
AZD4547	JAK3(JH1domain-catalytic)	0.0	10000.0
ALW-II-38-3	MAP3K4	100.0	10000.0
A443654	BMX	100.0	10000.0
WZ4003	MAP3K3	100.0	1000.0
Ribociclib	GSK3B	92.0	1000.0
HG-6-64-01	CDK5	100.0	10000.0
AS-252424	KIT(V559D,V654A)	84.2	10000.0
Pictilisib	PKMYT1	97.0	1000.0
BMS345541	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
XMD13-2	EGFR(L861Q)	69.0	10000.0
HG-6-64-01	RPS6KA4(Kin.Dom.1-N-terminal)	50.0	10000.0
Palbociclib	ABL1(T315I)-phosphorylated	100.0	1000.0
WZ4002	ACVR1B	100.0	10000.0
PLX-4720	LYN	24.0	10000.0
PLX-4720	SGK3	49.0	10000.0
HG-14-8-02	CDK14	98.0	10000.0
JNK-IN-5A	PIP5K1C	100.0	10000.0
HG-6-64-01	LRRK2(G2019S)	18.0	10000.0
CP466722	TYK2(JH1domain-catalytic)	22.0	10000.0
HG-9-91-01	RSK2(Kin.Dom.2-C-terminal)	21.0	10000.0
ZG-10	MP2K1	92.0	10000.0
CP466722	RIOK2	2.0	10000.0
Buparlisib	PAK6	100.0	1000.0
NPK76-II-72-1	LIMK1	100.0	10000.0
MPS-1-IN-1	DMPK2	100.0	1000.0
RO-3306	MST1	100.0	10000.0
KU63794	PFCDPK1(P.falciparum)	100.0	10000.0
GW843682X	MAPKAPK5	91.0	10000.0
PHA-767491	RSK4(Kin.Dom.1-N-terminal)	26.0	10000.0
Crizotinib	TYK2(JH1domain-catalytic)	14.0	10000.0
BGJ398	PIK3CD	84.0	1000.0
GSK1059615	M3K12	96.0	10000.0
GSK1059615	RSK3(Kin.Dom.2-C-terminal)	12.0	10000.0
Neratinib	ABL1-phosphorylated	100.0	10000.0
GW-5074	KIT(A829P)	93.0	10000.0
WH-4-023	RAF1	95.0	10000.0
Barasertib	M3K2	87.0	10000.0
JWE-035	ROCK1	94.0	10000.0
NU7441	GRK4	100.0	10000.0
MPS-1-IN-1	IKKA	100.0	1000.0
Crizotinib	ERK4	84.0	10000.0
PLX-4720	MP2K6	47.0	10000.0
CG-930	PKNB(M.tuberculosis)	92.0	10000.0
WZ4002	WEE1	100.0	10000.0
Dinaciclib	TIE2	100.0	10000.0
Taselisib	FLT4	100.0	1000.0
NU7441	TRKB	100.0	10000.0
CH5424802	PAK1	97.0	1000.0
Ibrutinib	CSF1R-autoinhibited	58.0	1000.0
Crizotinib	LOK	0.0	10000.0
HG-5-113-01	MYLK4	100.0	10000.0
A443654	PIP5K2B	5.4	10000.0
SCH772984	TRPM6	90.0	1000.0
BX-912	DCAMKL2	70.0	10000.0
XMD16-144	TTK	28.0	10000.0
Dactolisib	MST3	100.0	1000.0
THZ1	FAK1	0.0	10000.0
SP600125	KIT	100.0	10000.0
XMD11-85h	KIT(L576P)	100.0	10000.0
XMD11-50	EPHA8	80.0	10000.0
QL-XII-47	MKNK1	100.0	1000.0
Neratinib	CSNK1G3	81.0	10000.0
WYE-125132	LIMK2	88.0	10000.0
XMD11-85h	MK01	100.0	10000.0
TAK-715	OSR1	100.0	10000.0
OTSSP167	YSK4	0.2	10000.0
WZ-7043	MKNK1	100.0	10000.0
AG1478	ERK5	100.0	10000.0
OTSSP167	PAK2	100.0	10000.0
HG-5-88-01	MST1R	100.0	10000.0
XMD14-99	KPCI	93.0	10000.0
JNK-IN-8	MET(M1250T)	6.2	1000.0
Torin2	PIK3CA(C420R)	0.1	10000.0
BMS-536924	ACVR1B	100.0	1000.0
BGJ398	MAP4K2	79.0	1000.0
ZSTK474	ABL1(M351T)	100.0	1000.0
GSK1059615	LIMK2	100.0	10000.0
KIN001-111	RET	31.0	1000.0
JW-7-24-1	CAMK1D	100.0	10000.0
RO-3306	CAMK2A	67.0	10000.0
ALW-II-49-7	MARK4	100.0	10000.0
JW-7-24-1	IRAK3	24.0	10000.0
SB590885	KIT(L576P)	58.0	10000.0
QL-X-138	DMPK	59.0	10000.0
WYE-125132	FGFR3	83.0	10000.0
AG1478	KPCD	97.0	10000.0
NU7441	SRC	90.0	10000.0
AZD7762	AMPK-alpha2	0.4	10000.0
PD0325901	FGFR4	54.0	10000.0
Lapatinib	ERBB4	0.2	10000.0
KIN001-111	ERBB2	0.3	1000.0
QL-XII-47	RPS6KA4(Kin.Dom.1-N-terminal)	87.0	1000.0
Seliciclib	BRSK2	93.0	10000.0
JWE-035	DRAK1	100.0	10000.0
Lapatinib	SLK	18.0	10000.0
5z-7-oxozeaenol	KIT-autoinhibited	100.0	10000.0
PD0325901	FLT3(N841I)	78.0	10000.0
XMD-12	AURKB	1.4	1000.0
KIN001-123	TIE1	36.0	1000.0
GW-5074	MYO3A	2.5	10000.0
RO-3306	DYRK1A	0.0	10000.0
GW843682X	HUNK	82.0	10000.0
JWE-035	INSR	92.0	10000.0
AZD7762	CDK5	100.0	10000.0
XMD11-50	ERK4	100.0	10000.0
KIN001-111	PKN1	100.0	1000.0
HG-14-10-04	FLT4	0.0	10000.0
Neratinib	RAF1	100.0	10000.0
Momelotinib	CDK11	100.0	10000.0
Dinaciclib	ERK4	81.0	10000.0
MRT67307	TIE1	27.0	10000.0
AZD-6482	ERBB3	100.0	10000.0
Dinaciclib	CDK11	53.0	10000.0
NU7441	PKMYT1	92.0	10000.0
Crizotinib	YANK1	86.0	10000.0
JW-7-24-1	MYLK4	100.0	10000.0
KIN001-111	DCAMKL2	100.0	1000.0
CH5424802	ABL1(F317I)-nonphosphorylated	20.0	1000.0
KU63794	KIT(A829P)	100.0	10000.0
THZ1	MYO3A	46.0	10000.0
NU7441	RAF1	97.0	10000.0
Crizotinib	EPHB1	0.2	10000.0
WZ-4-145	KIT	0.3	10000.0
PHA-793887	MRCKA	100.0	10000.0
GW-5074	RIOK3	17.0	10000.0
MLN8054	CDC2L1	89.0	10000.0
Dabrafenib	PIP5K1C	17.0	10000.0
PD0325901	CAMK1D	89.0	10000.0
PD0325901	ZAP70	89.0	10000.0
Abemaciclib	TRKA	12.0	1000.0
BI-2536	PIM1	100.0	10000.0
NVP-TAE684	ADCK3	9.2	1000.0
Palbociclib	PIM1	100.0	1000.0
Torin1	MP2K2	100.0	10000.0
SB590885	ACVRL1	67.0	10000.0
WZ4002	BIKE	18.0	10000.0
PHA-767491	KPCD	4.4	10000.0
SB590885	DMPK	100.0	10000.0
BMS-536924	M4K1	6.0	1000.0
WZ4003	CDK3	100.0	1000.0
ZG-10	FRK	100.0	10000.0
PHA-767491	ULK3	88.0	10000.0
BMS345541	TXK	90.0	10000.0
OTSSP167	MP2K4	3.2	10000.0
HG-14-10-04	PIP5K2B	5.6	10000.0
KIN001-123	PIK3CA(E545K)	100.0	1000.0
JW-7-24-1	ACVR2A	100.0	10000.0
Taselisib	TSSK1	92.0	1000.0
Torin2	PIK3CA(E545A)	0.4	10000.0
BI-2536	CHK2	100.0	10000.0
ALW-II-49-7	JAK1(Kin.Dom.1)	100.0	10000.0
QL-XII-47	ADCK4	100.0	1000.0
Vemurafenib	RIOK1	100.0	10000.0
ZG-10	EGFR(L747-T751del,Sins)	87.0	10000.0
ZM-447439	PIK3CA(H1047Y)	24.0	10000.0
Taselisib	EPHB6	100.0	1000.0
GSK429286A	CAMK1D	97.0	10000.0
HG-5-113-01	CLK2	4.7	10000.0
BMS345541	JAK1(JH1domain-catalytic)	100.0	10000.0
JNK-IN-5A	PLK2	100.0	10000.0
GSK461364	MAPKAPK2	100.0	10000.0
PHA-767491	BTK	63.0	10000.0
AZD-6482	SRPK2	85.0	10000.0
AZ-628	FLT3(D835H)	60.0	10000.0
A443654	MK09	100.0	10000.0
JNK-IN-8	ABL1-nonphosphorylated	97.0	1000.0
MPS-1-IN-1	PCTK3	100.0	1000.0
BX-912	NEK9	4.6	10000.0
Alpelisib	TAK1	100.0	1000.0
PHA-793887	SgK110	100.0	10000.0
KIN001-123	AXL	16.0	1000.0
BMS345541	ABL1(T315I)-phosphorylated	84.0	10000.0
Alpelisib	ROS1	99.0	1000.0
Pictilisib	RSK2(Kin.Dom.1-N-terminal)	80.0	1000.0
WYE-125132	MK09	85.0	10000.0
HG-14-8-02	MYO3B	7.8	10000.0
Sorafenib	INSRR	97.0	10000.0
JNK-9L	MK09	0.1	10000.0
BMS345541	VRK2	100.0	10000.0
CP724714	EGFR(S752-I759del)	2.6	10000.0
AG1478	MST1	100.0	10000.0
PD0325901	TRKA	100.0	10000.0
AS-252424	STK35	92.4	10000.0
HG-14-8-02	PI42C	8.1	10000.0
AS-252424	KCC2D	91.0	10000.0
5z-7-oxozeaenol	CLK1	93.0	10000.0
ZSTK474	ROCK2	100.0	1000.0
JNK-IN-5A	ACVR1	64.0	10000.0
MLN8054	YANK1	54.0	10000.0
JNK-IN-8	STK16	61.0	1000.0
SP600125	ERK3	100.0	10000.0
Crizotinib	FLT3(D835H)	6.8	10000.0
CH5424802	CDC2L1	97.0	1000.0
ALW-II-38-3	MARK3	100.0	10000.0
Barasertib	PKAC-beta	100.0	10000.0
WZ4002	EGFR(L858R)	0.1	10000.0
HG-9-91-01	SGK2	100.0	10000.0
MPS-1-IN-1	LCK	100.0	1000.0
HG-9-91-01	MUSK	100.0	10000.0
Taselisib	STK35	98.0	1000.0
CP724714	MARK3	100.0	10000.0
NVP-TAE684	KGP2	7.6	1000.0
WYE-125132	GCN2(Kin.Dom.2,S808G)	83.0	10000.0
XMD11-50	GRK7	100.0	10000.0
AZD-6482	MAP3K4	100.0	10000.0
QL-X-138	LYN	100.0	10000.0
Pictilisib	HIPK1	79.0	1000.0
THZ1	CAMK2G	76.0	10000.0
Lapatinib	PHKG1	100.0	10000.0
BMS-536924	MST2	0.1	1000.0
Seliciclib	IRAK4	59.0	10000.0
Momelotinib	KPCD2	43.0	10000.0
BS-181	AXL	83.0	10000.0
TGX221	ABL2	100.0	1000.0
Pictilisib	ABL1(Y253F)	100.0	10000.0
KIN001-021	ABL1(M351T)	100.0	1000.0
AS-252424	RSK3(Kin.Dom.1-N-terminal)	100.0	10000.0
BMX-IN-1	KC1G1	75.0	10000.0
THZ1	TNK2	2.8	10000.0
PHA-767491	EPHB4	97.0	10000.0
GW-5074	MP2K2	74.0	10000.0
MRT67307	CDKL2	88.0	10000.0
Dabrafenib	TAOK3	60.0	10000.0
CP466722	KIT	10.0	10000.0
Torin2	AKT2	100.0	10000.0
SP600125	MERTK	100.0	10000.0
BX-912	NDR2	69.0	10000.0
SB590885	MKNK2	95.0	10000.0
Sigma A6730	YANK1	66.0	10000.0
BX-912	ABL1(T315I)-phosphorylated	0.2	10000.0
CGP60474	MYLK	100.0	10000.0
HG-9-91-01	FLT3-autoinhibited	100.0	10000.0
Lapatinib	SRPK2	98.0	10000.0
QL-XI-92	PFCDPK1(P.falciparum)	94.0	10000.0
Ribociclib	NEK11	100.0	1000.0
ZSTK474	MK11	100.0	1000.0
BMS345541	ABL1-phosphorylated	90.0	10000.0
Alpelisib	GSK3A	82.0	1000.0
Taselisib	MARK4	92.0	1000.0
BGJ398	MST3	64.0	1000.0
CGP60474	EGFR(L747-S752del,P753S)	100.0	10000.0
NPK76-II-72-1	TESK1	100.0	10000.0
HG-14-8-02	MP2K1	97.0	10000.0
NPK76-II-72-1	MARK4	100.0	10000.0
Torin2	EGFR(L747-T751del,Sins)	67.0	10000.0
KIN001-127	FLT3(N841I)	16.0	10000.0
PD0325901	ABL1(Q252H)-phosphorylated	100.0	10000.0
Seliciclib	DDR2	100.0	10000.0
HG-6-64-01	TAK1	4.8	10000.0
WZ-7043	IGF1R	100.0	10000.0
XMD-12	TTK	78.0	1000.0
CGP60474	MET	100.0	10000.0
Barasertib	MRCKA	100.0	10000.0
GW843682X	BMPR1A	81.0	10000.0
PD173074	TIE2	100.0	10000.0
AZD7762	CSNK2A1	0.4	10000.0
GSK429286A	EPHA5	86.0	10000.0
WYE-125132	PAK4	100.0	10000.0
HG-14-8-02	CSK	100.0	10000.0
Palbociclib	EGFR(T790M)	100.0	1000.0
ZSTK474	FGFR1	100.0	1000.0
Abemaciclib	TIE2	92.0	1000.0
ERK5-IN-1	EGFR	100.0	1000.0
Omipalisib	ABL1(Q252H)-phosphorylated	59.0	10000.0
Omipalisib	PIK3CA(E542K)	0.3	10000.0
AZD4547	BMPR1B	15.0	10000.0
Ceritinib	RIPK1	96.0	1000.0
Crizotinib	MAPKAPK5	68.0	10000.0
AG1478	MP2K5	3.5	10000.0
WYE-125132	FGFR1	100.0	10000.0
NU7441	NEK3	100.0	10000.0
HG-14-10-04	DAPK2	0.5	10000.0
WZ-7043	PIK4CB	100.0	10000.0
Ceritinib	ABL1(F317L)-nonphosphorylated	50.0	1000.0
BMX-IN-1	M3K5	100.0	10000.0
AZD 5438	RET(M918T)	46.0	10000.0
PD0325901	CDK5	100.0	10000.0
RO-3306	CDC2L2	100.0	10000.0
XMD14-99	CDK15	26.0	10000.0
CP466722	PKMYT1	63.0	10000.0
AZD7762	PRKX	0.7	10000.0
Dabrafenib	NEK10	56.0	10000.0
Crizotinib	EGFR(E746-A750del)	70.0	10000.0
HG-14-8-02	EPHA2	100.0	10000.0
GSK461364	EGFR(G719C)	100.0	10000.0
Momelotinib	NEK6	6.2	10000.0
KIN001-220	MK11	81.0	10000.0
NPK76-II-72-1	RPS6KA6(Kin.Dom.1)	100.0	10000.0
AS-252424	FGFR3(G697C)	92.3	10000.0
WH-4-023	RIOK3	5.1	10000.0
AZD 5438	MAP3K3	2.0	10000.0
WZ-7043	STK39	100.0	10000.0
Alpelisib	AURKA	100.0	1000.0
5z-7-oxozeaenol	FLT4	0.3	10000.0
WZ4002	CDC2L1	100.0	10000.0
JW-7-24-1	JAK2(Kin.Dom.2)	100.0	10000.0
ZSTK474	ROS1	100.0	1000.0
NU7441	BIKE	98.0	10000.0
GSK461364	TYK2(JH2domain-pseudokinase)	100.0	10000.0
Omipalisib	KIT(D816H)	97.0	10000.0
WYE-125132	CDK4-cyclinD3	92.0	10000.0
GSK461364	IKKA	65.0	10000.0
Barasertib	MAPKAPK2	100.0	10000.0
PD0325901	ERBB4	100.0	10000.0
XMD-12	CDK15	100.0	1000.0
GSK461364	RET(V804M)	100.0	10000.0
BX-912	NEK5	0.5	10000.0
Torin2	BMPR1B	100.0	10000.0
SCH772984	RIOK2	27.0	1000.0
BS-181	STK35	100.0	10000.0
Sorafenib	EPHA2	18.0	10000.0
OTSSP167	KGP1	5.4	10000.0
Alpelisib	PAK3	100.0	1000.0
GSK1059615	SGK3	66.0	10000.0
XMD13-2	MP2K5	5.0	10000.0
Palbociclib	EPHA4	100.0	1000.0
KU63794	CAMK1D	89.0	10000.0
Omipalisib	IKKE	64.0	10000.0
Pictilisib	MST1	99.0	1000.0
SCH772984	PKAC-beta	71.0	1000.0
NU7441	MYLK	91.0	10000.0
AZD4547	MKNK2	51.0	10000.0
Torkinib	EGFR(G719C)	28.0	10000.0
NPK76-II-72-1	PRKX	100.0	10000.0
WZ4002	PIK3CA	100.0	10000.0
XMD14-99	MP2K5	100.0	10000.0
JNK-IN-8	SRPK3	70.0	1000.0
XMD11-85h	ALK	100.0	10000.0
NVP-TAE684	ACVR1	0.0	1000.0
Ibrutinib	PIK4CB	100.0	1000.0
CG-930	PGFRB	64.0	10000.0
WH-4-023	RET(V804M)	66.0	10000.0
JNK-IN-11	KIT(D816V)	33.0	1000.0
WZ3105	DCAMKL3	86.0	10000.0
RO-3306	KIT(V559D,T670I)	17.0	10000.0
HG-9-91-01	AAK1	28.0	10000.0
HG-14-8-02	M3K6	100.0	10000.0
CG-930	EPHB3	84.0	10000.0
Pictilisib	MARK2	100.0	1000.0
KIN001-111	MST1	1.9	1000.0
Momelotinib	RSK3(Kin.Dom.2-C-terminal)	71.0	10000.0
NG25	DRAK2	100.0	10000.0
XMD11-85h	MARK1	100.0	10000.0
NG25	FLT3(D835H)	1.2	10000.0
XMD11-85h	DAPK2	100.0	10000.0
Dabrafenib	CDK4-cyclinD3	44.0	10000.0
TGX221	MK01	100.0	1000.0
A443654	EGFR(G719S)	100.0	10000.0
BS-181	FYN	100.0	10000.0
CGP60474	KPCL	100.0	10000.0
BMS345541	KPCD2	72.0	10000.0
CGP60474	RPS6KA3(Kin.Dom.1)	100.0	10000.0
CP466722	ITK	100.0	10000.0
TAK-715	INSR	100.0	10000.0
QL-XI-92	IKKE	100.0	10000.0
RO-3306	CLK3	1.2	10000.0
GW843682X	CHK2	100.0	10000.0
Momelotinib	TNK2	93.0	10000.0
Pictilisib	CSNK1A1	88.0	1000.0
MRT67307	FGFR1	71.0	10000.0
HG-9-91-01	MLK1	38.0	10000.0
ALW-II-38-3	ABL1	3.6	1000.0
PHA-767491	NDR1	13.0	10000.0
Palbociclib	MK13	93.0	1000.0
HG-14-8-02	MET(M1250T)	74.0	10000.0
AZD-6482	TNIK	98.0	10000.0
BMS-536924	TLK2	100.0	1000.0
SB590885	PIK3CA(E545A)	83.0	10000.0
Sorafenib	MST2	85.0	10000.0
OTSSP167	FES	1.2	10000.0
BI-2536	PKAC-alpha	100.0	10000.0
JNK-IN-11	DYRK1B	100.0	1000.0
JNK-IN-11	PLK4	92.0	1000.0
ERK5-IN-1	VRK2	82.0	1000.0
JW-7-24-1	CLK1	9.3	10000.0
Lapatinib	FLT3	81.0	10000.0
XMD8-85	EPHA7	100.0	10000.0
JNK-9L	NLK	76.0	10000.0
ALW-II-38-3	CDKL3	100.0	10000.0
Torin1	FGR	78.0	10000.0
AZ-628	RIPK4	98.0	10000.0
WH-4-023	MERTK	20.0	10000.0
KIN001-111	ERK4	100.0	1000.0
GSK429286A	CDK9	96.0	10000.0
JWE-035	PIK3CA(E545A)	6.2	10000.0
AS-252424	RSK1(Kin.Dom.2-C-terminal)	35.1	10000.0
XMD11-50	KPCL	100.0	10000.0
BMS-536924	CLK1	3.2	1000.0
BX-912	AURKB	0.0	10000.0
CGP60474	ACVRL1	100.0	10000.0
AZD 5438	MP2K3	1.0	10000.0
AZD-6482	CSF1R	94.0	10000.0
TGX221	CDK14	100.0	1000.0
ALW-II-38-3	CSNK1D	100.0	10000.0
OTSSP167	MAPKAPK2	3.6	10000.0
GSK461364	GRK1	50.0	10000.0
XMD11-50	EGFR(E746-A750del)	72.0	10000.0
PD173074	CLK2	100.0	10000.0
NG25	FGFR4	0.5	10000.0
Taselisib	MARK1	91.0	1000.0
CH5424802	KPCD3	61.0	1000.0
HG-14-8-02	SGK2	100.0	10000.0
Seliciclib	RIPK5	44.0	10000.0
Lapatinib	EPHA2	98.0	10000.0
Barasertib	TGFBR1	98.0	10000.0
KIN001-127	ALK	4.6	10000.0
AZ-628	FYN	3.6	10000.0
MLN8054	TTK	63.0	10000.0
Dinaciclib	TRPM6	100.0	10000.0
Ibrutinib	FLT3(D835H)	14.0	1000.0
KIN001-111	FGFR4	100.0	1000.0
MLN8054	IGF1R	73.0	10000.0
CP724714	AXL	68.0	10000.0
Ibrutinib	KIT(L576P)	23.0	1000.0
Sigma A6730	EPHB6	69.0	10000.0
Seliciclib	ACVR2B	89.0	10000.0
Ceritinib	CIT	94.0	1000.0
AZ-628	HIPK4	92.0	10000.0
Barasertib	LYN	18.0	10000.0
HG-14-8-02	PRKR	92.0	10000.0
CGP74514A	TEC	76.0	10000.0
HG-14-10-04	PCTK2	44.0	10000.0
Canertinib	EGFR	0.0	1000.0
KIN001-127	LTK	34.0	10000.0
WZ4003	MARK4	16.0	1000.0
AG1478	MYLK2	40.0	10000.0
Abemaciclib	TNK2	100.0	1000.0
JNK-IN-5A	EGFR(L747-S752del,P753S)	93.0	10000.0
ZG-10	PIK3C2B	100.0	10000.0
CP466722	EIF2AK1	51.0	10000.0
KIN001-021	MAPKAPK2	100.0	1000.0
Pictilisib	EPHA3	100.0	1000.0
XMD8-85	CDKL3	100.0	10000.0
PLX-4720	RPS6KA4(Kin.Dom.1-N-terminal)	85.0	10000.0
XMD-12	PIK3CA(I800L)	95.0	1000.0
WZ4002	MRCKA	100.0	10000.0
Vemurafenib	NEK4	95.0	10000.0
PD173074	KPCD3	100.0	10000.0
Dinaciclib	ROCK2	100.0	10000.0
AS-252424	IGF1R	100.0	10000.0
GW843682X	ROS1	78.0	10000.0
QL-XI-92	TAOK2	87.0	10000.0
MPS-1-IN-1	CLK4	18.0	1000.0
XMD16-144	EPHA8	90.0	10000.0
CP724714	STK33	96.0	10000.0
OTSSP167	CDK9	7.5	10000.0
HG-14-10-04	AMPK-alpha2	12.0	10000.0
RO-3306	MLTK	58.0	10000.0
KIN001-127	MAP4K5	100.0	10000.0
OTSSP167	ERK4	100.0	10000.0
JNK-9L	MET(Y1235D)	14.0	10000.0
WZ-4-145	FGFR3	4.5	10000.0
HG-14-8-02	CDC2L1	100.0	10000.0
JNK-9L	MST4	62.0	10000.0
NU7441	FRK	91.0	10000.0
XMD13-2	MERTK	71.0	10000.0
Dabrafenib	DCAMKL3	1.8	10000.0
AZD7762	EPHA2	7.4	10000.0
BMS-536924	ABL1(E255K)	100.0	1000.0
CP724714	FLT3(D835H)	94.0	10000.0
Torin1	CDK9	94.0	10000.0
WZ4002	CSNK1A1L	100.0	10000.0
CH5424802	M4K3	14.0	1000.0
AZD4547	GRK7	56.0	10000.0
BS-181	TAOK1	100.0	10000.0
Lapatinib	ABL1(F317L)-nonphosphorylated	100.0	10000.0
NG25	GSK3B	100.0	10000.0
JNK-IN-11	KCC2D	100.0	1000.0
KU63794	CSNK2A2	98.0	10000.0
XMD13-2	KPCE	100.0	10000.0
WZ-7043	CLK3	100.0	10000.0
KU63794	MST1R	99.0	10000.0
Torin2	MARK1	100.0	10000.0
AZD7762	SRMS	0.0	10000.0
JWE-035	MLTK	65.0	10000.0
PD0325901	AKT1	81.0	10000.0
Crizotinib	GSK3A	100.0	10000.0
Momelotinib	MERTK	100.0	10000.0
Torkinib	RSK3(Kin.Dom.1-N-terminal)	48.0	10000.0
BMS345541	NLK	100.0	10000.0
Pictilisib	ABL1(Y253F)-phosphorylated	100.0	1000.0
NPK76-II-72-1	RET(V804M)	100.0	10000.0
MPS-1-IN-1	MK13	100.0	1000.0
XMD16-144	GAK	13.0	10000.0
Dabrafenib	AMPK-alpha2	1.2	10000.0
QL-XII-47	FLT3(D835Y)	100.0	1000.0
PHA-767491	MAPKAPK2	0.0	10000.0
NG25	PKAC-beta	18.0	10000.0
WZ3105	SRPK3	47.0	10000.0
PD0325901	ACVRL1	100.0	10000.0
SB590885	NEK1	87.0	10000.0
Torin2	TGFBR2	84.0	10000.0
GSK429286A	PFCDPK1(P.falciparum)	82.0	10000.0
Barasertib	M3K5	100.0	10000.0
Crizotinib	CDKL2	5.4	10000.0
WYE-125132	BRSK2	100.0	10000.0
Dabrafenib	EPHB6	1.0	10000.0
SP600125	CDK3	100.0	10000.0
SP600125	SRPK3	32.0	10000.0
QL-XI-92	PHKG1	92.0	10000.0
Dinaciclib	BMPR1A	100.0	10000.0
(s)-CR8	RAF1	100.0	10000.0
A443654	FGFR2	100.0	10000.0
PHA-793887	CDK8	61.0	10000.0
Palbociclib	MP2K5	94.0	1000.0
BX-912	MST1R	70.0	10000.0
PHA-793887	M3K13	94.0	10000.0
BMX-IN-1	IKKA	100.0	10000.0
HG-6-64-01	CSK	0.8	10000.0
NPK76-II-72-1	RPS6KA5(Kin.Dom.2)	100.0	10000.0
Ibrutinib	NDR2	72.0	1000.0
MLN8054	HIPK4	31.0	10000.0
ALW-II-38-3	FLT3(D835H)	100.0	10000.0
ALW-II-38-3	MP2K6	100.0	10000.0
SB590885	CDC2L1	100.0	10000.0
Sigma A6730	RET(V804M)	91.0	10000.0
PLX-4720	SNRK	100.0	10000.0
JNK-IN-11	FGFR4	100.0	1000.0
RO-3306	GCN2(Kin.Dom.2,S808G)	75.0	10000.0
Alpelisib	MLK3	100.0	1000.0
Crizotinib	MYLK2	73.0	10000.0
Seliciclib	IGF1R	100.0	10000.0
TGX221	TAK1	100.0	1000.0
Neratinib	MRCKA	91.0	10000.0
JWE-035	PKAC-alpha	100.0	10000.0
KIN001-220	MET(M1250T)	11.0	10000.0
Seliciclib	FGFR2	100.0	10000.0
AZD-6482	MP2K6	92.0	10000.0
HG-9-91-01	CSNK1A1L	44.0	10000.0
WZ3105	PAK4	17.0	10000.0
OTSSP167	RIPK5	1.8	10000.0
WZ4003	YSK1	100.0	1000.0
CP724714	FGFR1	100.0	10000.0
KIN001-111	JAK1(Kin.Dom.1)	100.0	1000.0
KIN001-111	CAMK2A	100.0	1000.0
CP466722	EPHB4	22.0	10000.0
Ceritinib	M4K3	67.0	1000.0
JWE-035	EPHB3	80.0	10000.0
HG-6-64-01	KPCI	100.0	10000.0
WZ4002	DAPK3	7.4	10000.0
Pictilisib	PIK3CA(I800L)	0.0	1000.0
WH-4-023	MAPKAPK2	100.0	10000.0
NG25	PIM2	100.0	10000.0
Alpelisib	PCTK2	100.0	1000.0
Vemurafenib	ABL1(Q252H)-nonphosphorylated	4.4	10000.0
HG-9-91-01	ZAP70	82.0	10000.0
GSK429286A	AURKC	33.0	10000.0
NU7441	ICK	100.0	10000.0
KIN001-111	INSR	100.0	1000.0
KIN001-127	ABL1(F317L)	100.0	10000.0
KIN001-123	LTK	100.0	1000.0
MRT67307	S6K1	62.0	10000.0
WH-4-023	TTK	42.0	10000.0
CGP74514A	EPHB1	15.0	10000.0
Buparlisib	TBK1	87.0	1000.0
JNK-9L	MAP3K15	66.0	10000.0
Ribociclib	ANKK1	100.0	1000.0
BS-181	PIK3CA(I800L)	94.0	10000.0
Crizotinib	CHEK1	91.0	10000.0
Lapatinib	M3K2	84.0	10000.0
XMD-12	CDKL3	100.0	1000.0
GW843682X	LYN	60.0	10000.0
WYE-125132	EPHB2	78.0	10000.0
A443654	AKT3	2.9	10000.0
Neratinib	TYRO3	100.0	10000.0
Barasertib	RIPK4	41.0	10000.0
Barasertib	ACVR1B	88.0	10000.0
RO-3306	RIPK5	66.0	10000.0
CG-930	YES	98.0	10000.0
GW843682X	EPHA6	59.0	10000.0
JWE-035	CHK2	100.0	10000.0
KU63794	IRAK1	100.0	10000.0
Ibrutinib	KPCD2	100.0	1000.0
GW843682X	ACVR2B	58.0	10000.0
GSK429286A	EIF2AK1	89.0	10000.0
ZM-447439	LYN	7.2	10000.0
WZ4002	RPS6KA4(Kin.Dom.2)	16.0	10000.0
Palbociclib	FLT4	100.0	1000.0
CGP60474	JNK1	100.0	10000.0
NPK76-II-72-1	CSNK1G3	100.0	10000.0
CP466722	SYK	24.0	10000.0
Torin2	CAMKK2	99.0	10000.0
Crizotinib	RPS6KA4(Kin.Dom.2-C-terminal)	50.0	10000.0
GSK461364	MAP3K3	88.0	10000.0
JW-7-24-1	EGFR(L747-E749del,A750P)	19.0	10000.0
AZD7762	ACVRL1	76.0	10000.0
Lapatinib	ABL1(H396P)-nonphosphorylated	100.0	10000.0
BMS345541	STK36	28.0	10000.0
HG-5-113-01	KPCD2	100.0	10000.0
Taselisib	MAP4K5	93.0	1000.0
Ribociclib	EPHB1	100.0	1000.0
HG-6-64-01	PTK6	9.6	10000.0
WH-4-023	MAK	69.0	10000.0
NU7441	KGP2	93.0	10000.0
JNK-IN-8	MKNK2	6.8	1000.0
ALW-II-38-3	MYLK	100.0	10000.0
(s)-CR8	VRK2	91.0	10000.0
TAK-715	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
CP466722	KPCD2	65.0	10000.0
GSK461364	RET	100.0	10000.0
Sigma A6730	FLT3-autoinhibited	70.0	10000.0
XMD-12	PIK3C2B	89.0	1000.0
Ceritinib	NUAK1	82.0	1000.0
JWE-035	BLK	8.3	10000.0
KIN001-123	EPHB2	100.0	1000.0
CP724714	AKT3	100.0	10000.0
XMD11-85h	BLK	100.0	10000.0
XMD11-50	FLT3(K663Q)	97.0	10000.0
Torin1	LRRK2(G2019S)	99.0	10000.0
WH-4-023	DMPK2	0.5	10000.0
XMD16-144	SIK1	2.7	10000.0
JNK-IN-8	JNK1	0.0	1000.0
XMD14-99	DRAK1	100.0	10000.0
AZD7762	PGFRB	0.0	10000.0
AG1478	PKN2	59.0	10000.0
BS-181	MAST1	100.0	10000.0
WZ4003	MARK2	100.0	1000.0
ZG-10	CTK	91.0	10000.0
MLN8054	RSK1(Kin.Dom.2-C-terminal)	74.0	10000.0
XMD11-50	S6K1	100.0	10000.0
Palbociclib	HIPK3	33.0	1000.0
Canertinib	SIK1	100.0	1000.0
Barasertib	EPHA5	95.0	10000.0
Palbociclib	CLK3	75.0	1000.0
Abemaciclib	MLCK	100.0	1000.0
JNK-IN-8	KPCD2	100.0	1000.0
CG-930	PIK4CB	100.0	10000.0
PLX-4720	TIE1	61.0	10000.0
Ibrutinib	GSK3A	100.0	1000.0
AZD 5438	DAPK2	71.0	10000.0
CGP74514A	TRKC	6.3	10000.0
AZD7762	ZAP70	0.0	10000.0
BGJ398	ZAP70	85.0	1000.0
Barasertib	S6K1	13.0	10000.0
NPK76-II-72-1	FLT3(N841I)	100.0	10000.0
KIN001-220	FGFR2	25.0	10000.0
WZ-4-145	YANK2	100.0	10000.0
JNK-9L	WEE2	100.0	10000.0
HG-5-113-01	EPHA2	100.0	10000.0
HG-5-88-01	ABL1(Y253F)	100.0	10000.0
Alpelisib	GAK	81.0	1000.0
Pictilisib	MP2K3	79.0	1000.0
MLN8054	DAPK2	41.0	10000.0
Abemaciclib	PAK7	100.0	1000.0
WH-4-023	MINK	14.0	10000.0
JW-7-24-1	EPHB2	100.0	10000.0
(s)-CR8	SYK	95.0	10000.0
Sorafenib	PIK3CD	100.0	10000.0
NVP-TAE684	EPHB2	33.0	1000.0
AZD7762	PIK3CB	68.0	10000.0
A443654	GSK3B	1.0	10000.0
Baricitinib	LIMK1	66.0	10000.0
CG-930	MAPKAPK2	71.0	10000.0
Buparlisib	EPHB4	97.0	1000.0
Pictilisib	IRAK4	100.0	1000.0
Buparlisib	FYV1	68.0	1000.0
JWE-035	PIK3CA(C420R)	18.0	10000.0
GSK1059615	ERK8	0.1	10000.0
BMX-IN-1	PAK7	100.0	10000.0
XMD13-2	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
Sigma A6730	FGR	100.0	10000.0
GSK1059615	S6K1	53.0	10000.0
KIN001-220	PKAC-alpha	42.0	10000.0
Torin1	ERK8	79.0	10000.0
TAK-715	MAP3K1	90.0	10000.0
WZ-4-145	NUAK1	100.0	10000.0
AZD4547	DCAMKL3	0.2	10000.0
Barasertib	TLK1	60.0	10000.0
TGX221	LIMK1	100.0	1000.0
CH5424802	DMPK	100.0	1000.0
KIN001-123	BIKE	27.0	1000.0
PLX-4720	MST1R	100.0	10000.0
AS-252424	TNNI3K	92.5	10000.0
JNK-IN-5A	EGFR(S752-I759del)	79.0	10000.0
JNK-IN-11	MP2K5	23.0	1000.0
GSK429286A	KC1G2	100.0	10000.0
Alpelisib	PIK3CA(H1047Y)	15.0	1000.0
R406	MERTK	0.3	1000.0
BMS345541	CAMK2B	73.0	10000.0
KIN001-021	MK14	100.0	1000.0
KIN001-127	SIK1	100.0	10000.0
SP600125	PCTK3	100.0	10000.0
GSK461364	PGFRB	9.8	10000.0
Torin1	MST4	89.0	10000.0
WZ-4-145	TRKB	100.0	10000.0
WZ3105	AKT2	84.0	10000.0
GSK461364	ERK8	52.0	10000.0
Taselisib	RAF1	100.0	1000.0
XMD11-85h	ABL1(E255K)	100.0	10000.0
NG25	PAK7/PAK5	100.0	10000.0
Omipalisib	MLCK	100.0	10000.0
Baricitinib	TLK1	13.0	10000.0
ALW-II-49-7	RIPK2	100.0	10000.0
ZSTK474	EGFR(L747-T751del,Sins)	100.0	1000.0
PHA-793887	MK01	27.0	10000.0
QL-X-138	PKMYT1	81.0	10000.0
Dinaciclib	PGFRA	90.0	10000.0
HG-5-88-01	PGFRB	100.0	10000.0
BGJ398	CDK15	65.0	1000.0
JWE-035	MET(M1250T)	71.0	10000.0
AS-252424	CAMK1	100.0	10000.0
(s)-CR8	MAPKAPK5	100.0	10000.0
Barasertib	ACVR2B	100.0	10000.0
Sorafenib	EPHA4	42.0	10000.0
CGP74514A	EGFR(L747-S752del,P753S)	50.0	10000.0
HG-5-88-01	EGFR(L747-T751del,Sins)	0.8	10000.0
JWE-035	SRPK1	82.0	10000.0
XMD8-92	MYLK2	100.0	10000.0
JNK-IN-11	LRRK2(G2019S)	100.0	1000.0
NG25	ADCK3	100.0	10000.0
BMS345541	CIT	100.0	10000.0
WZ4003	PTK6	100.0	1000.0
BX-912	GCN2(Kin.Dom.2,S808G)	0.7	10000.0
KU63794	MLK3	100.0	10000.0
Ibrutinib	KIT(V559D,T670I)	98.0	1000.0
AZ-628	TGFBR2	94.0	10000.0
Ibrutinib	AXL	65.0	1000.0
XMD16-144	TGFBR2	55.0	10000.0
AZD7762	KPCD3	2.2	10000.0
MLN8054	TNK1	16.0	10000.0
WZ3105	PIK3CA(H1047L)	100.0	10000.0
KIN001-220	CDK7	22.0	10000.0
ZM-447439	PKNB(M.tuberculosis)	37.0	10000.0
A443654	CAMK1G	100.0	10000.0
Alpelisib	ANKK1	100.0	1000.0
Dinaciclib	MAP4K2	77.0	10000.0
Lapatinib	DCAMKL2	100.0	10000.0
Dinaciclib	SNRK	88.0	10000.0
Baricitinib	NLK	100.0	10000.0
BS-181	IGF1R	100.0	10000.0
CG-930	KIT(D816V)	84.0	10000.0
Torin1	M4K3	1.9	10000.0
WZ4002	MAP4K4	100.0	10000.0
JNK-IN-11	FLT3(ITD)	11.0	1000.0
CH5424802	HIPK4	5.5	1000.0
PD173074	KC1G1	100.0	10000.0
Sorafenib	PHKG1	90.0	10000.0
Sorafenib	PIK3CA(C420R)	100.0	10000.0
THZ1	MAST1	98.0	10000.0
RO-3306	GRK7	26.0	10000.0
XMD13-2	PIK3CA(E545A)	93.0	10000.0
BGJ398	ABL1(M351T)-phosphorylated	81.0	1000.0
GSK429286A	IRAK1	90.0	10000.0
BX-912	MAP3K3	0.3	10000.0
Crizotinib	TBK1	8.7	10000.0
5z-7-oxozeaenol	AURKA	100.0	10000.0
BMS-536924	ERK4	100.0	1000.0
Pictilisib	BRAF(V600E)	99.0	1000.0
BI-D1870	EGFR(L747-S752del,P753S)	17.0	10000.0
CH5424802	TAOK1	79.0	1000.0
Ibrutinib	EGFR(L747-S752del,P753S)	3.6	1000.0
XMD14-99	LIMK1	74.0	10000.0
Dinaciclib	CASK	18.0	10000.0
KU63794	NLK	96.0	10000.0
SCH772984	YSK4	28.0	1000.0
5z-7-oxozeaenol	STK36	1.0	10000.0
Crizotinib	FLT3(D835Y)	11.0	10000.0
KIN001-127	TRKC	100.0	10000.0
JNK-IN-5A	PIK3CA(I800L)	98.0	10000.0
R406	PIK3C2B	100.0	1000.0
GSK461364	PKAC-alpha	100.0	10000.0
Dactolisib	KIT(V559D)	100.0	1000.0
KIN001-220	KC1G1	100.0	10000.0
JNK-IN-11	LATS1	95.0	1000.0
Ibrutinib	MAPKAPK5	88.0	1000.0
XMD16-144	FLT4	100.0	10000.0
JNK-IN-11	TNK1	100.0	1000.0
GSK429286A	FLT3(D835Y)	74.0	10000.0
PLX-4720	RPS6KA5(Kin.Dom.2-C-terminal)	86.0	10000.0
NU7441	PLK4	90.0	10000.0
PHA-793887	IRAK3	100.0	10000.0
XMD11-50	EGFR(G719C)	100.0	10000.0
BMX-IN-1	AXL	100.0	10000.0
CH5424802	YSK1	99.0	1000.0
XMD-12	EPHA3	83.0	1000.0
TAK-715	NEK2	95.0	10000.0
BI-2536	MYO3B	100.0	10000.0
BMX-IN-1	FGFR3	100.0	10000.0
SP600125	RPS6KA5(Kin.Dom.2)	12.0	10000.0
SB590885	IRAK1	16.0	10000.0
TGX221	ACVR2A	100.0	1000.0
WZ4003	M3K5	100.0	1000.0
Torin2	KPCD	88.0	10000.0
R406	PIM1	100.0	1000.0
Dabrafenib	JAK1(JH1domain-catalytic)	99.0	10000.0
ZM-447439	PI42C	53.0	10000.0
JW-7-24-1	SYK	100.0	10000.0
Ceritinib	MK13	91.0	1000.0
AS-252424	EGFR(L747-S752del,P753S)	14.5	10000.0
Lapatinib	S6K1	80.0	10000.0
TGX221	MK03	100.0	1000.0
HG-5-113-01	AXL	1.3	10000.0
MPS-1-IN-1	EPHA6	100.0	1000.0
GW843682X	ABL1(Y253F)-phosphorylated	88.0	10000.0
QL-X-138	PHKG1	58.0	10000.0
KIN001-111	KPCT	100.0	1000.0
GSK429286A	MST1R	55.0	10000.0
ZSTK474	LATS2	100.0	1000.0
ALW-II-38-3	AKT1	100.0	10000.0
Neratinib	MYO3A	98.0	10000.0
Crizotinib	EPHA8	0.2	10000.0
Alpelisib	PDPK1	96.0	1000.0
GSK1059615	PAK2	21.0	10000.0
CGP60474	FGFR4	100.0	10000.0
XMD13-2	MST1	76.0	10000.0
Omipalisib	ROS1	92.0	10000.0
XMD13-2	LKB1	45.0	10000.0
XMD13-2	SRPK2	58.0	10000.0
CGP60474	KIT(V559D)	100.0	10000.0
SB590885	RIPK4	100.0	10000.0
BI-2536	FLT3(D835H)	100.0	10000.0
NG25	CSNK1E	100.0	10000.0
PD0325901	AMPK-alpha1	100.0	10000.0
Ibrutinib	PIK3CA(E542K)	72.0	1000.0
Omipalisib	CAMK2B	79.0	10000.0
TAK-715	NEK9	100.0	10000.0
WYE-125132	KIT-autoinhibited	93.0	10000.0
AZD4547	KIT	0.0	10000.0
Baricitinib	MAPKAPK5	62.0	10000.0
Lapatinib	KIT(L576P)	71.0	10000.0
QL-XII-47	ACVR1B	98.0	1000.0
Torin1	VGFR1	79.0	10000.0
NVP-TAE684	ALK	0.3	1000.0
AZ-628	TYRO3	100.0	10000.0
Palbociclib	MAP3K15	100.0	1000.0
KIN001-111	FLT3(N841I)	100.0	1000.0
HG-9-91-01	PKMYT1	100.0	10000.0
WYE-125132	CAMK2G	100.0	10000.0
QL-XI-92	VGFR2	87.0	10000.0
SCH772984	KC1G2	100.0	1000.0
Barasertib	TAOK2	98.0	10000.0
JW-7-24-1	EPHA6	100.0	10000.0
NVP-TAE684	RPS6KA4(Kin.Dom.1)	4.4	1000.0
NPK76-II-72-1	PKAC-alpha	100.0	10000.0
Baricitinib	CSF1R-autoinhibited	42.0	10000.0
JNK-IN-5A	VGFR2	96.0	10000.0
JNK-IN-5A	ABL1(M351T)-phosphorylated	98.0	10000.0
THZ1	CSNK2A1	0.9	10000.0
WZ4003	MST4	100.0	1000.0
XMD8-85	DDR1	100.0	10000.0
MRT67307	MET(M1250T)	27.0	10000.0
GSK461364	MP2K6	98.0	10000.0
AZD 5438	PKMYT1	100.0	10000.0
JWE-035	KIT(D816H)	65.0	10000.0
ALW-II-38-3	DYRK2	100.0	10000.0
NU7441	KGP1	100.0	10000.0
HG-5-113-01	IGF1R	2.2	10000.0
Crizotinib	KPCD	100.0	10000.0
(s)-CR8	ABL1(H396P)-nonphosphorylated	100.0	10000.0
AS-252424	MP2K6	77.6	10000.0
SCH772984	EPHA6	99.0	1000.0
BMX-IN-1	JAK1(JH1domain-catalytic)	76.0	10000.0
Torin1	MYLK2	40.0	10000.0
AG1478	SRMS	60.0	10000.0
Alpelisib	HCK	100.0	1000.0
A443654	EPHB4	100.0	10000.0
QL-XII-47	MP2K6	92.0	1000.0
CH5424802	MARK2	100.0	1000.0
THZ1	HIPK2	7.0	10000.0
ALW-II-38-3	PIK3CA(E542K)	100.0	10000.0
BMS-536924	RET	0.0	1000.0
Baricitinib	SGK2	70.0	10000.0
WZ3105	MLCK	100.0	10000.0
CP466722	NEK2	57.0	10000.0
JNK-9L	TEC	93.0	10000.0
Omipalisib	M3K2	94.0	10000.0
NVP-TAE684	FLT3(D835H)	0.1	1000.0
XMD13-2	EGFR	96.0	10000.0
BX-912	ADCK4	33.0	10000.0
KU63794	MST4	100.0	10000.0
Dabrafenib	RSK4(Kin.Dom.1-N-terminal)	84.0	10000.0
JNK-9L	WEE1	82.0	10000.0
Barasertib	AURKA	6.5	10000.0
Omipalisib	MP2K3	35.0	10000.0
Omipalisib	ITK	80.0	10000.0
Ibrutinib	MK13	100.0	1000.0
HG-6-64-01	ABL2	0.0	10000.0
BX-912	TGFBR2	100.0	10000.0
BMS345541	MST4	95.0	10000.0
Torin2	LIMK1	100.0	10000.0
XMD-12	RSK1(Kin.Dom.1-N-terminal)	66.0	1000.0
NVP-TAE684	CSNK1G3	100.0	1000.0
JNK-IN-5A	NEK11	100.0	10000.0
Sorafenib	PLK3	94.0	10000.0
AG1478	LOK	1.5	10000.0
A443654	ABL1(T315I)	100.0	10000.0
TAK-715	RSK4(Kin.Dom.1-N-terminal)	94.0	10000.0
BMX-IN-1	FLT3(ITD)	100.0	10000.0
BMX-IN-1	EPHB3	88.0	10000.0
XMD14-99	EPHB6	63.0	10000.0
PHA-793887	MYO3A	59.0	10000.0
Seliciclib	KPCD1	71.0	10000.0
XMD14-99	RSK3(Kin.Dom.1-N-terminal)	84.0	10000.0
Torkinib	ANKK1	8.8	10000.0
XMD11-50	PCTK3	100.0	10000.0
Omipalisib	CLK3	50.0	10000.0
CP466722	EGFR	52.0	10000.0
Torin2	PRKX	100.0	10000.0
ALW-II-38-3	JAK1(JH1domain-catalytic)	100.0	10000.0
PD173074	FER	100.0	10000.0
Ceritinib	MRCKB	92.0	1000.0
THZ1	NDR2	100.0	10000.0
HG-9-91-01	KIT(V559D)	0.1	10000.0
WZ4003	BMPR1B	100.0	1000.0
ZM-447439	RIOK2	100.0	10000.0
BS-181	ACVRL1	75.0	10000.0
QL-X-138	MK13	76.0	10000.0
WH-4-023	CDC2L2	42.0	10000.0
XMD11-85h	CSNK1E	100.0	10000.0
GSK1059615	GRK1	22.0	10000.0
RO-3306	SIK2	89.0	10000.0
SCH772984	MK01	0.3	1000.0
JW-7-24-1	EPHA5	100.0	10000.0
KIN001-123	EGFR	5.6	1000.0
XMD8-92	TYK2(JH1domain-catalytic)	100.0	10000.0
Torkinib	TIE1	49.0	10000.0
SB590885	CDK14	100.0	10000.0
XMD14-99	LRRK2	81.0	10000.0
QL-XI-92	KPCE	100.0	10000.0
Lapatinib	PIK3CA(C420R)	100.0	10000.0
Palbociclib	CDKL1	91.0	1000.0
NG25	AKT3	100.0	10000.0
Palbociclib	MK01	100.0	1000.0
GSK1059615	PHKG1	31.0	10000.0
HG-14-10-04	KKCC1	0.3	10000.0
WH-4-023	TAOK2	2.4	10000.0
Omipalisib	PLK4	17.0	10000.0
ZSTK474	TRKB	100.0	1000.0
JNK-IN-5A	TNK2	77.0	10000.0
PLX-4720	ITK	99.0	10000.0
WZ-7043	MAPKAPK5	100.0	10000.0
AZD-6482	SRC	100.0	10000.0
Ceritinib	MAPKAPK2	84.0	1000.0
Barasertib	CLK2	67.0	10000.0
HG-9-91-01	NEK3	87.0	10000.0
WZ4002	YSK1	100.0	10000.0
WZ3105	ULK3	52.0	10000.0
AG1478	KPCE	75.0	10000.0
AZD 5438	NUAK1	4.0	10000.0
Baricitinib	TNK2	14.0	10000.0
Lapatinib	STK35	100.0	10000.0
WZ4003	PIM3	100.0	1000.0
(s)-CR8	PIK3CA(H1047L)	92.0	10000.0
Canertinib	FLT3	100.0	1000.0
Dabrafenib	CAMK2A	72.0	10000.0
CGP74514A	ABL1(E255K)-phosphorylated	2.5	10000.0
Buparlisib	LKB1	95.0	1000.0
Torin1	PAK4	100.0	10000.0
Dinaciclib	ALK(C1156Y)	60.0	10000.0
Ribociclib	AURKC	92.0	1000.0
PHA-767491	MARK4	55.0	10000.0
XMD8-85	PIK3CD	33.0	10000.0
Vemurafenib	PKMYT1	100.0	10000.0
WZ-4-145	MET	100.0	10000.0
THZ1	CDK7	1.1	10000.0
CP466722	GRK4	39.0	10000.0
XMD11-50	ERN1	59.0	10000.0
XMD11-50	CDKL5	100.0	10000.0
GSK1059615	PAK6	83.0	10000.0
OTSSP167	M3K2	0.3	10000.0
NPK76-II-72-1	MST1	100.0	10000.0
WYE-125132	ABL2	84.0	10000.0
TAK-715	SIK3	94.0	10000.0
XMD14-99	PIK3C2G	100.0	10000.0
GSK429286A	KPCD1	76.0	10000.0
Dabrafenib	JNK1	6.1	10000.0
MPS-1-IN-1	PAK7/PAK5	100.0	1000.0
CG-930	CDKL5	100.0	10000.0
JNK-IN-5A	ERBB3	100.0	10000.0
Sigma A6730	ABL2	100.0	10000.0
AZ-628	CSNK2A2	100.0	10000.0
HG-6-64-01	PAK4	86.0	10000.0
ALW-II-38-3	MLTK	5.4	1000.0
GSK429286A	LIMK1	100.0	10000.0
GSK461364	WEE1	100.0	10000.0
Taselisib	MET	100.0	1000.0
CG-930	EPHA3	85.0	10000.0
KIN001-220	HIPK1	3.2	10000.0
XMD16-144	LATS1	100.0	10000.0
PHA-793887	FGFR4	100.0	10000.0
HG-5-113-01	M4K1	7.9	10000.0
PHA-767491	CSNK1G3	0.4	10000.0
CH5424802	ULK2	52.0	1000.0
SP600125	ITK	100.0	10000.0
JWE-035	SLK	2.4	10000.0
SCH772984	BRAF(V600E)	100.0	1000.0
GW-5074	ADCK4	65.0	10000.0
QL-X-138	LIMK1	100.0	10000.0
JNK-9L	ABL1(T315I)-nonphosphorylated	44.0	10000.0
Dinaciclib	MK03	83.0	10000.0
Barasertib	KPCD	91.0	10000.0
Sorafenib	ROS1	83.0	10000.0
BX-912	PIK3CB	100.0	10000.0
ERK5-IN-1	TIE1	100.0	1000.0
BI-D1870	PIK3C2G	28.0	10000.0
HG-5-88-01	EGFR(L747-S752del,P753S)	2.9	10000.0
QL-X-138	PIK3C2G	5.9	10000.0
OTSSP167	BTK	7.6	10000.0
NVP-TAE684	TLK1	100.0	1000.0
KIN001-220	ABL1(Q252H)-phosphorylated	9.6	10000.0
Vemurafenib	ERBB3	73.0	10000.0
KIN001-111	PRKX	100.0	1000.0
PD0325901	CDK4-cyclinD1	93.0	10000.0
CP466722	PDPK1	90.0	10000.0
Torin2	MKNK2	0.9	10000.0
CP724714	PIK3CA(C420R)	69.0	10000.0
KIN001-123	MK09	100.0	1000.0
KU63794	PIK3CA(E545K)	2.0	10000.0
ERK5-IN-1	EPHB6	100.0	1000.0
MRT67307	EPHB4	100.0	10000.0
Taselisib	PLK4	100.0	1000.0
AZD 5438	MAPKAPK5	87.0	10000.0
Omipalisib	PGFRA	71.0	10000.0
PHA-793887	MLK3	89.0	10000.0
QL-XI-92	EIF2AK1	100.0	10000.0
JWE-035	TESK1	73.0	10000.0
AZD 5438	FLT3(R834Q)	25.0	10000.0
HG-5-113-01	EPHA5	100.0	10000.0
WZ4002	MARK1	11.0	10000.0
XMD8-92	RPS6KA2(Kin.Dom.2)	100.0	10000.0
(s)-CR8	MK01	99.0	10000.0
BMS345541	FGR	100.0	10000.0
Abemaciclib	OSR1	85.0	1000.0
Torkinib	CDK14	100.0	10000.0
SB590885	CLK4	68.0	10000.0
CGP74514A	MAP4K2	2.4	10000.0
Sigma A6730	GRK1	100.0	10000.0
Lapatinib	KKCC1	100.0	10000.0
HG-5-88-01	PRKX	100.0	10000.0
BMS-536924	KPCD	100.0	1000.0
HG-5-113-01	ABL1(F317L)	28.0	10000.0
Torkinib	DAPK1	3.0	10000.0
Momelotinib	ERN1	100.0	10000.0
GW843682X	FLT3(R834Q)	27.0	10000.0
XMD13-2	JNK1	40.0	10000.0
AZ-628	YES	4.6	10000.0
Taselisib	GRK4	71.0	1000.0
QL-XI-92	TRKB	84.0	10000.0
ZG-10	KPCT	68.0	10000.0
BMS345541	KIT(V559D,T670I)	39.0	10000.0
PHA-767491	AXL	77.0	10000.0
PHA-767491	SNARK	4.6	10000.0
HG-6-64-01	PAK6	54.0	10000.0
Neratinib	NEK4	100.0	10000.0
JNK-IN-8	ABL2	97.0	1000.0
JNK-9L	SIK2	33.0	10000.0
GW843682X	ADCK3	61.0	10000.0
PHA-767491	CHEK1	100.0	10000.0
5z-7-oxozeaenol	PGFRB	0.1	10000.0
AS-252424	RET(V804M)	100.0	10000.0
CP724714	CLK3	100.0	10000.0
Momelotinib	ACVR1	1.0	10000.0
AZD-6482	TIE2	100.0	10000.0
PHA-767491	MP2K3	16.0	10000.0
KIN001-220	MYLK4	11.0	10000.0
JNK-IN-8	PHKG2	89.0	1000.0
XMD16-144	VRK2	73.0	10000.0
BMS-536924	EPHA6	21.0	1000.0
Omipalisib	HIPK1	54.0	10000.0
ZSTK474	FGFR2	100.0	1000.0
ALW-II-49-7	CSNK1A1L	100.0	10000.0
BI-D1870	EGFR(L747-E749del,A750P)	13.0	10000.0
ALW-II-49-7	PCTK3	100.0	10000.0
ERK5-IN-1	MYO3A	100.0	1000.0
MPS-1-IN-1	CDKL2	100.0	1000.0
Buparlisib	YANK1	100.0	1000.0
AZD 5438	NEK1	55.0	10000.0
Alpelisib	ABL1(E255K)-phosphorylated	80.0	1000.0
PD0325901	ROS1	92.0	10000.0
JNK-IN-5A	M3K13	83.0	10000.0
XMD11-50	TRPM6	100.0	10000.0
ERK5-IN-1	PIK3CA(M1043I)	92.0	1000.0
Seliciclib	CDK4-cyclinD1	72.0	10000.0
PHA-793887	ABL1(H396P)-nonphosphorylated	66.0	10000.0
JNK-IN-11	ICK	100.0	1000.0
AG1478	PIK3CG	44.0	10000.0
WZ3105	EGFR(L747-E749del,A750P)	76.0	10000.0
BI-2536	DDR2	100.0	10000.0
Sigma A6730	MAP4K4	100.0	10000.0
ZM-447439	LTK	6.3	10000.0
NU7441	MST1R	97.0	10000.0
CGP60474	ABL1(F317I)	100.0	10000.0
(s)-CR8	TAOK2	99.0	10000.0
THZ1	RET	0.0	10000.0
MRT67307	SRPK2	1.4	10000.0
Palbociclib	FGFR4	100.0	1000.0
Palbociclib	ACVR2B	97.0	1000.0
ZG-10	RSK4(Kin.Dom.1-N-terminal)	51.0	10000.0
WZ-7043	CDC2L2	26.0	10000.0
SB590885	CDK4-cyclinD3	86.0	10000.0
Ribociclib	ERBB2	94.0	1000.0
PD173074	TYRO3	100.0	10000.0
THZ1	BRSK1	46.0	10000.0
GW843682X	ERN1	75.0	10000.0
NU7441	ADCK4	73.0	10000.0
SCH772984	FGFR2	73.0	1000.0
ZG-10	RPS6KA5(Kin.Dom.2-C-terminal)	98.0	10000.0
SCH772984	MAP4K5	71.0	1000.0
PD0325901	YANK2	96.0	10000.0
Dinaciclib	SIK1	92.0	10000.0
AZ-628	IKKB	94.0	10000.0
RO-3306	HASP	0.3	10000.0
CP724714	PIK4CB	100.0	10000.0
AG1478	NEK3	78.0	10000.0
PHA-793887	CDC2L5	16.0	10000.0
ALW-II-38-3	MYLK2	100.0	10000.0
Ibrutinib	MK11	100.0	1000.0
NU7441	MAP3K15	100.0	10000.0
WZ4003	BRSK1	100.0	1000.0
XMD11-85h	FLT3(N841I)	100.0	10000.0
JNK-IN-8	ULK1	100.0	1000.0
Dinaciclib	PIK3CA(E542K)	96.0	10000.0
Abemaciclib	AURKC	61.0	1000.0
CGP74514A	GRK4	78.0	10000.0
JNK-9L	CSK	66.0	10000.0
BGJ398	TLK1	78.0	1000.0
ERK5-IN-1	BRSK2	92.0	1000.0
BMX-IN-1	MAP3K3	79.0	10000.0
PLX-4720	PIM3	65.0	10000.0
XMD13-2	HUNK	64.0	10000.0
Barasertib	PAK3	57.0	10000.0
WYE-125132	PFCDPK1(P.falciparum)	86.0	10000.0
Dactolisib	KKCC1	100.0	1000.0
BX-912	ERBB4	56.0	10000.0
HG-9-91-01	CDKL2	40.0	10000.0
RO-3306	EPHA6	78.0	10000.0
5z-7-oxozeaenol	KIT	0.6	10000.0
NU7441	AKT3	98.0	10000.0
GW-5074	TLK2	83.0	10000.0
BS-181	EPHB3	91.0	10000.0
BX-912	PI42C	2.0	10000.0
PLX-4720	ABL1(T315I)-nonphosphorylated	77.0	10000.0
ERK5-IN-1	MP2K1	100.0	1000.0
WZ-4-145	RIPK2	100.0	10000.0
QL-XI-92	DCLK1	100.0	10000.0
JNK-IN-5A	DCAMKL3	100.0	10000.0
OTSSP167	MYLK2	7.4	10000.0
JNK-IN-5A	CDK3	97.0	10000.0
KIN001-111	PIK3CD	100.0	1000.0
MPS-1-IN-1	MELK	100.0	1000.0
HG-9-91-01	NEK9	100.0	10000.0
Ceritinib	FAK2	9.4	1000.0
WZ-4-145	FRK	0.7	10000.0
Alpelisib	ABL1(Q252H)-nonphosphorylated	74.0	1000.0
XMD-12	TNNI3K	100.0	1000.0
AZD 5438	AMPK-alpha2	17.0	10000.0
CH5424802	RSK1(Kin.Dom.2-C-terminal)	32.0	1000.0
Lapatinib	CDKL2	94.0	10000.0
ZM-447439	MRCKB	100.0	10000.0
KIN001-127	CDK5	100.0	10000.0
KIN001-220	ADCK3	43.0	10000.0
R406	RPS6KA5(Kin.Dom.2)	9.0	1000.0
Ceritinib	KGP1	68.0	1000.0
WZ3105	PRKR	78.0	10000.0
R406	EGFR(L747-E749del,A750P)	0.8	1000.0
XMD8-92	CDC2L1	100.0	10000.0
BMS-536924	MP2K4	100.0	1000.0
Canertinib	TLK2	100.0	1000.0
Buparlisib	VGFR1	100.0	1000.0
JW-7-24-1	STK33	100.0	10000.0
GW843682X	ABL1(T315I)-nonphosphorylated	77.0	10000.0
MPS-1-IN-1	SNARK	30.0	1000.0
SCH772984	PRKX	81.0	1000.0
R406	TXK	2.4	1000.0
JW-7-24-1	KPCD	3.0	10000.0
XMD13-2	MAP4K4	84.0	10000.0
Torin1	PLK3	87.0	10000.0
Dabrafenib	EPHB2	89.0	10000.0
Baricitinib	PLK2	23.0	10000.0
JNK-IN-11	TNK2	100.0	1000.0
CGP60474	SRMS	100.0	10000.0
BMX-IN-1	KIT(L576P)	83.0	10000.0
CGP74514A	PIK3CD	58.0	10000.0
KU63794	ABL1(F317L)-phosphorylated	72.0	10000.0
WH-4-023	CDK2	65.0	10000.0
HG-14-8-02	TIE2	99.0	10000.0
MRT67307	MP2K2	25.0	10000.0
SP600125	M4K1	100.0	10000.0
CGP74514A	DDR2	19.0	10000.0
KIN001-021	ITK	100.0	1000.0
NU7441	YANK2	95.0	10000.0
ZSTK474	CDK16	100.0	1000.0
KIN001-021	EGFR(E746-A750del)	100.0	1000.0
Buparlisib	MK03	100.0	1000.0
QL-XII-47	MAP3K3	98.0	1000.0
JWE-035	PIK3C2G	17.0	10000.0
HG-5-113-01	FER	1.1	10000.0
BS-181	NEK5	99.0	10000.0
KIN001-021	TYK2(Kin.Dom.1)	100.0	1000.0
Torin1	CSNK2A2	11.0	10000.0
BS-181	TRPM6	100.0	10000.0
AG1478	EPHB4	38.0	10000.0
JWE-035	ACVRL1	100.0	10000.0
CGP74514A	AXL	2.6	10000.0
KIN001-127	RPS6KA5(Kin.Dom.1)	100.0	10000.0
KU63794	TIE1	100.0	10000.0
GW843682X	TNK1	36.0	10000.0
QL-XI-92	MLK1	98.0	10000.0
Neratinib	MAP3K1	96.0	10000.0
SB590885	ABL1-phosphorylated	6.0	10000.0
XMD14-99	ABL1(E255K)-phosphorylated	90.0	10000.0
CP724714	KPCE	100.0	10000.0
Sigma A6730	PIK3CB	6.7	10000.0
HG-14-10-04	MAP3K14	13.0	10000.0
Sorafenib	FES	74.0	10000.0
PHA-767491	FLT3(D835H)	57.0	10000.0
PHA-767491	CDKL3	30.0	10000.0
Canertinib	PGFRA	100.0	1000.0
WZ4003	TYRO3	100.0	1000.0
Seliciclib	KCC4	66.0	10000.0
AZD-6482	OSR1	100.0	10000.0
Pictilisib	KIT(V559D)	100.0	1000.0
MRT67307	FES	79.0	10000.0
R406	JAK3(Kin.Dom.2)	0.8	1000.0
XMD11-85h	ROCK1	100.0	10000.0
ALW-II-49-7	CSNK1E	100.0	10000.0
XMD13-2	CDC2L5	82.0	10000.0
JW-7-24-1	FRK	100.0	10000.0
BMS345541	LIMK1	100.0	10000.0
Dinaciclib	ABL1-phosphorylated	96.0	10000.0
ZSTK474	CDK5	100.0	1000.0
TGX221	CDK8	100.0	1000.0
ALW-II-38-3	PIM2	100.0	10000.0
Barasertib	TIE2	13.0	10000.0
Dactolisib	AMPK-alpha1	100.0	1000.0
BMX-IN-1	FAK1	100.0	10000.0
RO-3306	PGFRA	44.0	10000.0
BMX-IN-1	EGFR(G719S)	85.0	10000.0
JNK-IN-8	DMPK	63.0	1000.0
Sorafenib	DYRK1A	100.0	10000.0
Sorafenib	ABL2	35.0	10000.0
RO-3306	IKKA	58.0	10000.0
KIN001-111	KCC2D	100.0	1000.0
NU7441	MLTK	93.0	10000.0
CP724714	ULK1	47.0	10000.0
Torin1	HIPK1	63.0	10000.0
CG-930	CSNK1G3	100.0	10000.0
BGJ398	ACVR2A	100.0	1000.0
Vemurafenib	TRKB	78.0	10000.0
ZM-447439	MAK	59.0	10000.0
KIN001-220	LKB1	12.0	10000.0
BX-912	CDKL3	75.0	10000.0
Baricitinib	DDR1	100.0	10000.0
XMD8-92	BRSK2	100.0	10000.0
JNK-9L	PIP5K1C	100.0	10000.0
MLN8054	RIPK1	100.0	10000.0
JNK-IN-11	YES	12.0	1000.0
AZD7762	PKAC-alpha	1.4	10000.0
KIN001-127	ZAP70	100.0	10000.0
Omipalisib	DAPK2	57.0	10000.0
Lapatinib	PKAC-beta	96.0	10000.0
Buparlisib	TSSK3	100.0	1000.0
Omipalisib	BMPR2	44.0	10000.0
Torin2	VRK2	100.0	10000.0
Torkinib	CSF1R	33.0	10000.0
Ceritinib	PAK4	100.0	1000.0
ERK5-IN-1	PDPK1	99.0	1000.0
WZ4003	PIM1	100.0	1000.0
CGP74514A	M3K13	100.0	10000.0
HG-5-113-01	FGR	5.0	10000.0
XMD8-92	EGFR	100.0	10000.0
ALW-II-38-3	MAP4K4	100.0	10000.0
SCH772984	EPHA4	81.0	1000.0
AS-252424	TAOK1	8.5	10000.0
NU7441	TAOK1	100.0	10000.0
HG-14-10-04	BRAF(V600E)	100.0	10000.0
PHA-793887	RSK1(Kin.Dom.2-C-terminal)	72.0	10000.0
Pictilisib	NEK2	100.0	1000.0
GW843682X	EPHA7	79.0	10000.0
WZ-4-145	FLT3(N841I)	8.4	10000.0
JNK-IN-8	EPHB3	100.0	1000.0
TGX221	PAK6	100.0	1000.0
Abemaciclib	CDC2L1	100.0	1000.0
ALW-II-49-7	M3K5	100.0	10000.0
QL-XII-47	NEK4	100.0	1000.0
Sigma A6730	YANK2	88.0	10000.0
KIN001-220	SBK1	75.0	10000.0
WZ4003	TTK	1.8	1000.0
BMX-IN-1	AMPK-alpha2	92.0	10000.0
XMD8-85	KPCD3	5.4	10000.0
AG1478	AXL	19.0	10000.0
Canertinib	FAK2	100.0	1000.0
XMD-12	EPHA2	99.0	1000.0
JNK-IN-5A	SRMS	84.0	10000.0
ALW-II-49-7	ALK	100.0	10000.0
QL-XI-92	TYK2(JH1domain-catalytic)	98.0	10000.0
QL-X-138	RIOK2	12.0	10000.0
AZD-6482	RIOK2	54.0	10000.0
A443654	IKKE	24.0	10000.0
Taselisib	MET(Y1235D)	79.0	1000.0
XMD11-85h	RPS6KA1(Kin.Dom.1)	100.0	10000.0
AZD 5438	TRKA	31.0	10000.0
XMD14-99	NEK3	89.0	10000.0
AZD-6482	KPCE	100.0	10000.0
Sorafenib	KGP1	95.0	10000.0
Buparlisib	LIMK2	100.0	1000.0
HG-5-113-01	ERK8	8.0	10000.0
BMS345541	PI42C	100.0	10000.0
JNK-IN-5A	MRCKA	100.0	10000.0
NU7441	MUSK	100.0	10000.0
Omipalisib	EPHB1	88.0	10000.0
BX-912	CDK5	24.0	10000.0
Momelotinib	PFPK5(P.falciparum)	100.0	10000.0
MPS-1-IN-1	ULK1	30.0	1000.0
CGP60474	MYLK4	100.0	10000.0
CH5424802	PIK3CG	100.0	1000.0
RO-3306	PAK3	76.0	10000.0
MRT67307	CSNK1G3	77.0	10000.0
TGX221	SRMS	100.0	1000.0
BS-181	PFCDPK1(P.falciparum)	100.0	10000.0
ALW-II-49-7	KIT	0.0	1000.0
Lapatinib	GRK4	93.0	10000.0
Pictilisib	CDKL3	100.0	1000.0
Torin1	ITK	100.0	10000.0
Seliciclib	JNK1	64.0	10000.0
Alpelisib	PIK3CA(E545K)	0.0	1000.0
BI-2536	TNK1	32.0	10000.0
NU7441	GAK	89.0	10000.0
ALW-II-49-7	IKKB	100.0	10000.0
XMD8-92	MAK	100.0	10000.0
(s)-CR8	PIK3CD	54.0	10000.0
CH5424802	ROS1	77.0	1000.0
ALW-II-38-3	CDK7	100.0	10000.0
AZD7762	STK35	1.1	10000.0
AZD-6482	M4K3	88.0	10000.0
AZD4547	DYRK1A	75.0	10000.0
Momelotinib	KPCI	75.0	10000.0
XMD-12	KGP2	95.0	1000.0
Omipalisib	NEK3	74.0	10000.0
NPK76-II-72-1	DRAK1	100.0	10000.0
Seliciclib	LOK	98.0	10000.0
A443654	ABL1(F317L)	100.0	10000.0
HG-14-10-04	CAMK1	9.2	10000.0
Buparlisib	PLK4	100.0	1000.0
Abemaciclib	BARK2	97.0	1000.0
WZ3105	DRAK1	100.0	10000.0
Baricitinib	PHKG1	18.0	10000.0
NVP-TAE684	CDK16	2.2	1000.0
MLN8054	EGFR(L747-S752del,P753S)	28.0	10000.0
Taselisib	BMPR1A	100.0	1000.0
Omipalisib	PIK3CA(C420R)	0.3	10000.0
NU7441	NEK11	100.0	10000.0
HG-14-10-04	RET(M918T)	0.1	10000.0
PD0325901	SRPK3	100.0	10000.0
OTSSP167	PIK3CD	55.0	10000.0
Torkinib	MARK3	100.0	10000.0
JNK-9L	SRPK1	30.0	10000.0
KIN001-123	IKKE	100.0	1000.0
CP724714	WEE1	100.0	10000.0
Barasertib	CSF1R	5.0	10000.0
(s)-CR8	ABL1(T315I)-phosphorylated	86.0	10000.0
JW-7-24-1	PRKX	100.0	10000.0
XMD11-50	RIOK1	100.0	10000.0
NU7441	BRAF	100.0	10000.0
Omipalisib	PFCDPK1(P.falciparum)	49.0	10000.0
JNK-IN-11	RIPK2	12.0	1000.0
WZ-4-145	MAP3K3	5.8	10000.0
MLN8054	PAK2	71.0	10000.0
MLN8054	SIK3	98.0	10000.0
CH5424802	ERK4	97.0	1000.0
MRT67307	JAK3(JH1domain-catalytic)	0.0	10000.0
Neratinib	PFCDPK1(P.falciparum)	88.0	10000.0
Seliciclib	KIT	85.0	10000.0
Canertinib	CLK4	100.0	1000.0
AG1478	ROS1	61.0	10000.0
BMS345541	MARK2	100.0	10000.0
NG25	ITK	100.0	10000.0
Torkinib	PKAC-alpha	47.0	10000.0
ERK5-IN-1	MP2K2	89.0	1000.0
BS-181	RSK3(Kin.Dom.2-C-terminal)	88.0	10000.0
QL-XI-92	CSNK1G3	96.0	10000.0
AZD7762	RIOK1	0.4	10000.0
GSK461364	ABL1(H396P)-phosphorylated	83.0	10000.0
Dactolisib	EPHB2	100.0	1000.0
ZSTK474	AURKC	100.0	1000.0
HG-5-88-01	KPCD2	100.0	10000.0
ZM-447439	CLK4	100.0	10000.0
PD0325901	KIT(V559D,T670I)	90.0	10000.0
GW843682X	KCC4	100.0	10000.0
GW843682X	EGFR(G719C)	94.0	10000.0
Dabrafenib	NEK3	100.0	10000.0
Neratinib	PRP4	92.0	10000.0
WZ4003	ITK	26.0	1000.0
BGJ398	PIP5K1C	63.0	1000.0
XMD-12	CAMKK2	55.0	1000.0
ZG-10	CASK	98.0	10000.0
OTSSP167	MAST1	91.0	10000.0
XMD-12	STK39	62.0	1000.0
KIN001-111	CSNK1G3	100.0	1000.0
AZD-6482	BRAF(V600E)	92.0	10000.0
XMD14-99	ADCK4	81.0	10000.0
NPK76-II-72-1	ADCK3	100.0	10000.0
BMX-IN-1	IKKB	100.0	10000.0
Pictilisib	GCN2(Kin.Dom.2,S808G)	94.0	1000.0
Abemaciclib	BMPR2	100.0	1000.0
ZM-447439	TAOK1	95.0	10000.0
AS-252424	ROCK2	96.2	10000.0
5z-7-oxozeaenol	ABL1(T315I)-nonphosphorylated	91.0	10000.0
WZ-4-145	MAP4K2	100.0	10000.0
BMX-IN-1	LRRK2	100.0	10000.0
CP466722	RSK1(Kin.Dom.2-C-terminal)	14.0	10000.0
Abemaciclib	NEK10	0.7	1000.0
CP724714	TAOK2	100.0	10000.0
SCH772984	CSK	100.0	1000.0
AZD4547	BLK	3.8	10000.0
RO-3306	MARK1	100.0	10000.0
THZ1	CDK8	81.0	10000.0
XMD11-50	EPHA6	89.0	10000.0
Dabrafenib	MKNK2	0.3	10000.0
Palbociclib	KIT(D816V)	97.0	1000.0
MLN8054	MK12	97.0	10000.0
Neratinib	NIM1	90.0	10000.0
Vemurafenib	ROS1	100.0	10000.0
GSK461364	MK03	100.0	10000.0
BS-181	PKNB(M.tuberculosis)	85.0	10000.0
WYE-125132	MP2K6	95.0	10000.0
GSK1059615	TRPM6	97.0	10000.0
ZM-447439	EPHA6	85.0	10000.0
MRT67307	MAST1	3.4	10000.0
Neratinib	MP2K6	100.0	10000.0
QL-XII-47	PTK6	97.0	1000.0
CP724714	FAK2	80.0	10000.0
THZ1	MINK	14.0	10000.0
Dinaciclib	ABL1(F317I)-nonphosphorylated	85.0	10000.0
KIN001-021	PRKR	100.0	1000.0
Abemaciclib	DCAMKL3	4.8	1000.0
BMS345541	EGFR(L858R,T790M)	100.0	10000.0
AZD 5438	TXK	91.0	10000.0
CGP74514A	TXK	14.0	10000.0
OTSSP167	MK12	21.0	10000.0
Palbociclib	FRK	100.0	1000.0
BMS-536924	AXL	0.3	1000.0
XMD8-85	CDK5	100.0	10000.0
ZM-447439	CLK1	100.0	10000.0
ERK5-IN-1	KPCE	98.0	1000.0
Taselisib	GSK3B	100.0	1000.0
Seliciclib	RSK4(Kin.Dom.2-C-terminal)	63.0	10000.0
HG-6-64-01	ACVR2A	100.0	10000.0
Abemaciclib	SGK2	2.7	1000.0
Pictilisib	EIF2AK1	100.0	1000.0
SCH772984	NEK11	97.0	1000.0
BI-2536	ABL1(H396P)	100.0	10000.0
BI-D1870	MUSK	3.6	10000.0
BX-912	ABL1(H396P)-phosphorylated	0.1	10000.0
Seliciclib	NDR1	82.0	10000.0
BGJ398	SIK2	90.0	1000.0
SB590885	KIT(V559D,V654A)	93.0	10000.0
SP600125	MLTK	100.0	10000.0
KIN001-111	PKAC-alpha	100.0	1000.0
WH-4-023	S6K1	72.0	10000.0
JNK-IN-5A	EPHA7	84.0	10000.0
KIN001-123	DAPK3	100.0	1000.0
SB590885	ULK3	88.0	10000.0
Baricitinib	MELK	10.0	10000.0
Buparlisib	PRKX	95.0	1000.0
OTSSP167	MP2K1	0.1	10000.0
ALW-II-38-3	PRKR	100.0	10000.0
5z-7-oxozeaenol	MUSK	91.0	10000.0
Sorafenib	MKNK2	0.1	10000.0
NVP-TAE684	PAK3	0.9	1000.0
SB590885	ICK	100.0	10000.0
JNK-9L	FGFR1	93.0	10000.0
GSK461364	LRRK2(G2019S)	40.0	10000.0
MPS-1-IN-1	RPS6KA6(Kin.Dom.2)	100.0	1000.0
WH-4-023	EPHA6	0.0	10000.0
AG1478	SRPK1	67.0	10000.0
BS-181	FLT3(N841I)	62.0	10000.0
AS-252424	RET	100.0	10000.0
AZD 5438	NEK11	88.0	10000.0
CG-930	CDK11	100.0	10000.0
QL-XI-92	PIK3CA(H1047Y)	95.0	10000.0
XMD11-85h	TTK	100.0	10000.0
GW843682X	ERK5	100.0	10000.0
ZM-447439	BMPR2	26.0	10000.0
BMS-536924	PIK3CD	100.0	1000.0
Crizotinib	NEK5	63.0	10000.0
SB590885	RSK1(Kin.Dom.2-C-terminal)	91.0	10000.0
CG-930	TESK1	78.0	10000.0
WYE-125132	CLK3	31.0	10000.0
PHA-767491	MELK	35.0	10000.0
ERK5-IN-1	CSNK2A1	89.0	1000.0
Alpelisib	LYN	90.0	1000.0
CGP60474	JAK2(JH1domain-catalytic)	100.0	10000.0
KIN001-021	AKT3	100.0	1000.0
BI-2536	STK33	14.0	10000.0
Neratinib	NEK2	12.0	10000.0
PLX-4720	RIOK1	100.0	10000.0
ZM-447439	AURKA	8.6	10000.0
WZ-4-145	TRKA	100.0	10000.0
CGP60474	KCC4	100.0	10000.0
Ibrutinib	NEK11	96.0	1000.0
TGX221	PIK3CA(E545K)	100.0	1000.0
NG25	VGFR1	1.4	10000.0
PHA-793887	MKNK1	100.0	10000.0
BI-D1870	RIOK1	3.6	10000.0
CP724714	NEK3	95.0	10000.0
JW-7-24-1	BMPR1B	100.0	10000.0
BI-2536	LYN	100.0	10000.0
A443654	EPHB2	100.0	10000.0
XMD-12	MAP4K4	85.0	1000.0
ZM-447439	PIK3CA(Q546K)	17.0	10000.0
Torkinib	NIM1	88.0	10000.0
TGX221	TESK1	100.0	1000.0
CG-930	MST1	100.0	10000.0
ALW-II-38-3	VGFR2	100.0	10000.0
Ribociclib	CLK1	85.0	1000.0
XMD16-144	RSK2(Kin.Dom.1-N-terminal)	29.0	10000.0
AZD-6482	TGFBR2	95.0	10000.0
Dabrafenib	CSNK1A1L	50.0	10000.0
HG-14-8-02	PAK7	84.0	10000.0
JWE-035	FGFR2	50.0	10000.0
GSK461364	SIK1	78.0	10000.0
XMD-12	CASK	78.0	1000.0
PD173074	CDC2L1	100.0	10000.0
JW-7-24-1	FGFR4	100.0	10000.0
Neratinib	PAK1	16.0	10000.0
WZ3105	MK14	95.0	10000.0
Dactolisib	TEC	100.0	1000.0
Crizotinib	MARK4	48.0	10000.0
HG-6-64-01	BRAF(V600E)	0.1	10000.0
PHA-793887	PIK3CA(H1047Y)	100.0	10000.0
Ibrutinib	EGFR(L747-E749del,A750P)	4.2	1000.0
SP600125	TGFBR2	100.0	10000.0
Dabrafenib	PIK3CA(E542K)	100.0	10000.0
XMD-12	CDK11	100.0	1000.0
Pictilisib	EPHA1	100.0	1000.0
Pictilisib	IGF1R	100.0	1000.0
XMD13-2	NEK7	100.0	10000.0
JNK-IN-8	TRKB	96.0	1000.0
BX-912	TBK1	0.7	10000.0
Alpelisib	MET(Y1235D)	94.0	1000.0
KIN001-021	TEC	100.0	1000.0
NG25	DYRK1B	100.0	10000.0
MPS-1-IN-1	FGFR4	100.0	1000.0
HG-14-10-04	RET	0.0	10000.0
KIN001-021	AKT2	100.0	1000.0
NU7441	CDK8	100.0	10000.0
SB590885	CDKL2	100.0	10000.0
WZ-4-145	TEC	7.2	10000.0
RO-3306	CTK	53.0	10000.0
5z-7-oxozeaenol	CSK	87.0	10000.0
JNK-9L	EGFR(G719C)	71.0	10000.0
TAK-715	MYLK	84.0	10000.0
Baricitinib	TGFBR2	100.0	10000.0
Vemurafenib	PGFRA	0.5	10000.0
JW-7-24-1	PAK2	100.0	10000.0
ALW-II-49-7	PAK3	100.0	10000.0
QL-X-138	ABL1(F317L)-nonphosphorylated	88.0	10000.0
AG1478	RIPK5	43.0	10000.0
JNK-IN-8	AURKB	82.0	1000.0
KIN001-220	DMPK2	66.0	10000.0
Dactolisib	ULK3	100.0	1000.0
AZD 5438	EPHA1	22.0	10000.0
Ceritinib	PIK3C2B	77.0	1000.0
ALW-II-49-7	TYK2(Kin.Dom.1)	100.0	10000.0
TAK-715	CDK5	100.0	10000.0
Abemaciclib	EPHA6	100.0	1000.0
HG-9-91-01	BRSK1	77.0	10000.0
R406	DAPK1	0.9	1000.0
BMS-536924	ACVR1	2.6	1000.0
BGJ398	YANK3	99.0	1000.0
AG1478	PI42C	31.0	10000.0
ZSTK474	EPHA7	100.0	1000.0
Torin1	KPCT	91.0	10000.0
XMD11-85h	PIK3CA(H1047L)	100.0	10000.0
QL-X-138	BMPR1A	99.0	10000.0
WZ-7043	JAK2(JH1domain-catalytic)	100.0	10000.0
XMD11-85h	RET(V804M)	100.0	10000.0
WZ3105	BRSK2	100.0	10000.0
HG-5-113-01	HIPK1	100.0	10000.0
Buparlisib	DAPK3	98.0	1000.0
Seliciclib	STK36	100.0	10000.0
BMS345541	ABL1(F317I)-phosphorylated	100.0	10000.0
ZSTK474	BRAF(V600E)	100.0	1000.0
XMD13-2	ABL1(M351T)-phosphorylated	57.0	10000.0
HG-14-8-02	LOK	49.0	10000.0
BMS345541	FLT3	100.0	10000.0
XMD8-85	KKCC1	100.0	10000.0
QL-XI-92	EPHA8	3.6	10000.0
Omipalisib	MRCKB	84.0	10000.0
THZ1	ERK5	69.0	10000.0
KU63794	CSNK1G3	92.0	10000.0
KU63794	PKNB(M.tuberculosis)	100.0	10000.0
ALW-II-38-3	EPHA3	12.0	1000.0
ERK5-IN-1	GRK1	100.0	1000.0
(s)-CR8	PIK3CG	90.0	10000.0
MPS-1-IN-1	CSNK1A1L	100.0	1000.0
KIN001-220	MYLK2	66.0	10000.0
SCH772984	MYLK4	3.6	1000.0
R406	PLK3	0.0	1000.0
HG-6-64-01	TIE1	4.6	10000.0
AS-252424	PLK4	74.6	10000.0
Pictilisib	ALK	96.0	1000.0
Lapatinib	SgK110	100.0	10000.0
TAK-715	NIM1	100.0	10000.0
JNK-IN-11	EGFR(L858R)	0.8	1000.0
HG-5-88-01	DCAMKL3	100.0	10000.0
BI-2536	LATS1	100.0	10000.0
OTSSP167	FLT3(D835H)	9.6	10000.0
CG-930	SgK110	100.0	10000.0
WZ4002	ITK	0.6	10000.0
NG25	MAP4K2	0.1	10000.0
WH-4-023	LIMK2	0.0	10000.0
JNK-IN-11	TBK1	100.0	1000.0
ZG-10	KPCE	75.0	10000.0
Pictilisib	RSK4(Kin.Dom.2-C-terminal)	93.0	1000.0
Abemaciclib	RIOK2	34.0	1000.0
BMX-IN-1	FLT3(D835Y)	100.0	10000.0
XMD8-92	CAMK1G	100.0	10000.0
Momelotinib	LATS1	100.0	10000.0
WZ4002	TIE1	100.0	10000.0
WZ-7043	MYLK	100.0	10000.0
KIN001-123	BMPR1A	100.0	1000.0
Lapatinib	BTK	100.0	10000.0
Sorafenib	ABL1-nonphosphorylated	0.2	10000.0
AZD4547	ERBB4	99.0	10000.0
JW-7-24-1	PIK3CB	17.0	10000.0
THZ1	CAMK2A	69.0	10000.0
XMD14-99	EPHA3	82.0	10000.0
NPK76-II-72-1	PIK3CB	100.0	10000.0
(s)-CR8	KIT(L576P)	100.0	10000.0
KIN001-123	BRSK1	100.0	1000.0
XMD11-50	FRK	34.0	10000.0
Dactolisib	TXK	100.0	1000.0
CG-930	JAK3(JH1domain-catalytic)	90.0	10000.0
NG25	PCTK2	0.9	10000.0
KIN001-123	BMPR2	100.0	1000.0
XMD13-2	MST4	94.0	10000.0
Torkinib	JNK3	72.0	10000.0
GW-5074	ABL1(F317L)-phosphorylated	52.0	10000.0
BI-D1870	FLT4	28.0	10000.0
Seliciclib	MUSK	100.0	10000.0
PHA-793887	ERN1	100.0	10000.0
JW-7-24-1	ROS1	100.0	10000.0
WYE-125132	CSNK1A1	100.0	10000.0
PD173074	MK03	100.0	10000.0
GW-5074	PCTK3	100.0	10000.0
CH5424802	PAK4	85.0	1000.0
GW843682X	ULK3	77.0	10000.0
XMD11-50	PKAC-beta	100.0	10000.0
TAK-715	MAST1	100.0	10000.0
QL-XI-92	PKN1	96.0	10000.0
Ceritinib	S6K1	100.0	1000.0
NVP-TAE684	MK13	100.0	1000.0
AG1478	ITK	100.0	10000.0
AZD7762	CSNK1A1	0.5	10000.0
ZSTK474	ABL1(H396P)	100.0	1000.0
PD173074	AURKB	100.0	10000.0
BMS-536924	CDC2L1	100.0	1000.0
THZ1	NLK	100.0	10000.0
Buparlisib	IGF1R	100.0	1000.0
XMD11-85h	MET(Y1235D)	100.0	10000.0
GSK461364	SRPK2	59.0	10000.0
WZ-7043	CSNK1D	100.0	10000.0
5z-7-oxozeaenol	CAMKK2	88.0	10000.0
CH5424802	TSSK3	93.0	1000.0
AZD 5438	NEK4	77.0	10000.0
BI-2536	JAK2(Kin.Dom.2)	100.0	10000.0
ALW-II-49-7	EGFR(L747-E749del,A750P)	100.0	10000.0
AZD-6482	MINK	100.0	10000.0
HG-14-8-02	ABL1(T315I)-phosphorylated	47.0	10000.0
NVP-TAE684	FGFR3(G697C)	0.3	1000.0
Neratinib	RIPK1	100.0	10000.0
QL-XI-92	FLT3(D835H)	100.0	10000.0
CH5424802	PIK3C2G	64.0	1000.0
KIN001-111	EPHB4	100.0	1000.0
NVP-TAE684	AAK1	2.8	1000.0
XMD14-99	M4K1	90.0	10000.0
Dactolisib	LCK	100.0	1000.0
CP466722	TYRO3	63.0	10000.0
CG-930	TIE2	100.0	10000.0
PHA-793887	JAK1(JH1domain-catalytic)	100.0	10000.0
KIN001-021	EPHA1	100.0	1000.0
GW-5074	JAK1(JH2domain-pseudokinase)	0.6	10000.0
SB590885	FAK1	100.0	10000.0
GSK461364	ICK	85.0	10000.0
JNK-IN-11	MP2K7	89.0	1000.0
KU63794	RIPK4	71.0	10000.0
ERK5-IN-1	FGFR2	100.0	1000.0
XMD11-50	EPHA2	92.0	10000.0
GSK461364	TXK	71.0	10000.0
Ibrutinib	RPS6KA4(Kin.Dom.2-C-terminal)	84.0	1000.0
SP600125	ABL1(H396P)	100.0	10000.0
TAK-715	MLK2	100.0	10000.0
BGJ398	TYK2(JH1domain-catalytic)	78.0	1000.0
Dabrafenib	GRK1	63.0	10000.0
JW-7-24-1	MST4	100.0	10000.0
(s)-CR8	ERK8	88.0	10000.0
HG-14-8-02	STK33	13.0	10000.0
Pictilisib	FLT3(N841I)	100.0	1000.0
BI-2536	DDR1	100.0	10000.0
KIN001-123	PGFRA	100.0	1000.0
CP466722	KIT(V559D,V654A)	82.0	10000.0
Pictilisib	YANK2	100.0	1000.0
Sorafenib	NEK11	100.0	10000.0
KIN001-021	YES	100.0	1000.0
CG-930	RSK4(Kin.Dom.1-N-terminal)	49.0	10000.0
WZ4003	NUAK1	0.9	1000.0
Palbociclib	JAK1(JH2domain-pseudokinase)	85.0	1000.0
JNK-IN-5A	ACVRL1	100.0	10000.0
WZ4003	TNK1	2.6	1000.0
BI-2536	DYRK1B	100.0	10000.0
Momelotinib	MK14	100.0	10000.0
XMD14-99	MYO3A	85.0	10000.0
WZ-7043	LYN	34.0	10000.0
SB590885	KPCD3	40.0	10000.0
R406	BRSK2	100.0	1000.0
CP724714	PAK4	87.0	10000.0
(s)-CR8	ROS1	96.0	10000.0
Dactolisib	GRK1	100.0	1000.0
JNK-9L	ABL1(H396P)-nonphosphorylated	19.0	10000.0
KIN001-111	SRMS	0.0	1000.0
BS-181	MP2K6	99.0	10000.0
BX-912	DRAK1	0.2	10000.0
JNK-IN-11	NEK4	100.0	1000.0
(s)-CR8	RPS6KA5(Kin.Dom.1-N-terminal)	99.0	10000.0
BMS345541	SgK110	100.0	10000.0
Alpelisib	ACVR2A	93.0	1000.0
Barasertib	FGR	82.0	10000.0
KIN001-127	ERBB4	100.0	10000.0
JW-7-24-1	FGFR3(G697C)	100.0	10000.0
WZ4003	MK14	100.0	1000.0
Taselisib	EPHB2	100.0	1000.0
Seliciclib	PCTK3	78.0	10000.0
NVP-TAE684	CSNK1E	100.0	1000.0
JNK-IN-11	RET	8.3	1000.0
QL-XI-92	CDK7	91.0	10000.0
R406	FLT3(D835H)	0.1	1000.0
JNK-IN-8	RSK3(Kin.Dom.1-N-terminal)	100.0	1000.0
GSK429286A	SNARK	6.0	10000.0
BMX-IN-1	SRMS	100.0	10000.0
AZD4547	TAOK3	5.2	10000.0
RO-3306	FLT3(N841I)	36.0	10000.0
XMD14-99	EPHA5	100.0	10000.0
Ceritinib	DDR2	100.0	1000.0
JNK-IN-5A	MAP3K4	86.0	10000.0
Buparlisib	BRSK1	100.0	1000.0
XMD13-2	TESK1	100.0	10000.0
Pictilisib	ABL1(E255K)	100.0	10000.0
ZM-447439	FAK1	62.0	10000.0
XMD14-99	M3K5	100.0	10000.0
A443654	EGFR(L861Q)	100.0	10000.0
WH-4-023	EPHA8	0.2	10000.0
XMD8-92	KPCE	100.0	10000.0
BMX-IN-1	RAF1	100.0	10000.0
Torkinib	MAP3K15	76.0	10000.0
CG-930	MLCK	94.0	10000.0
GSK429286A	MP2K6	95.0	10000.0
WZ4003	BMPR2	100.0	1000.0
WYE-125132	ABL1(F317L)-phosphorylated	96.0	10000.0
XMD8-85	RIPK1	100.0	10000.0
CP724714	CAMK2A	93.0	10000.0
JNK-IN-11	MYO3B	97.0	1000.0
BMS345541	EPHA1	79.0	10000.0
SB590885	CSNK1A1L	88.0	10000.0
Seliciclib	MLTK	100.0	10000.0
JNK-9L	M3K5	100.0	10000.0
XMD-12	PIK3CA(Q546K)	100.0	1000.0
Vemurafenib	CSF1R	8.0	10000.0
Torin1	SLK	94.0	10000.0
R406	EPHB3	100.0	1000.0
CGP74514A	S6K1	22.0	10000.0
BMS-536924	PAK1	35.0	1000.0
Buparlisib	KGP1	82.0	1000.0
WZ-7043	TLK2	100.0	10000.0
AZD 5438	KIT-autoinhibited	69.0	10000.0
Palbociclib	PLK4	100.0	1000.0
HG-9-91-01	ABL2	0.2	10000.0
Taselisib	BMPR2	100.0	1000.0
5z-7-oxozeaenol	CASK	76.0	10000.0
AZD-6482	ABL2	95.0	10000.0
WZ-4-145	NEK2	100.0	10000.0
HG-5-88-01	ANKK1	100.0	10000.0
KIN001-127	LATS2	100.0	10000.0
Ceritinib	MLK1	82.0	1000.0
Torkinib	RET(V804L)	12.0	10000.0
XMD13-2	ERK4	100.0	10000.0
JWE-035	CAMK2A	53.0	10000.0
NG25	CSNK2A2	100.0	10000.0
AZ-628	MAP4K4	10.0	10000.0
AZD 5438	MELK	33.0	10000.0
CGP74514A	AMPK-alpha1	22.0	10000.0
GSK461364	ROCK2	16.0	10000.0
Vemurafenib	MRCKB	79.0	10000.0
CGP74514A	YSK1	26.0	10000.0
AZD4547	IKKA	60.0	10000.0
JWE-035	FLT3(D835Y)	3.5	10000.0
MPS-1-IN-1	ACVR1	100.0	1000.0
BS-181	PAK2	86.0	10000.0
AZD-6482	CAMK2A	75.0	10000.0
XMD11-85h	SNARK	100.0	10000.0
MLN8054	YANK3	50.0	10000.0
JNK-9L	TLK1	39.0	10000.0
NG25	NEK6	100.0	10000.0
Omipalisib	MST2	100.0	10000.0
Pictilisib	TEC	100.0	1000.0
JNK-9L	MP2K3	18.0	10000.0
Abemaciclib	JAK1(JH2domain-pseudokinase)	90.0	1000.0
XMD8-85	CAMK1G	100.0	10000.0
Vemurafenib	VRK2	100.0	10000.0
HG-9-91-01	FER	19.0	10000.0
KIN001-111	CDK15	100.0	1000.0
JNK-IN-8	PCTK3	100.0	1000.0
GSK429286A	PI42C	98.0	10000.0
AG1478	DMPK	79.0	10000.0
QL-XI-92	TEC	100.0	10000.0
BMX-IN-1	CSNK2A1	51.0	10000.0
KU63794	ABL1(E255K)-phosphorylated	100.0	10000.0
BMS-536924	CAMK1	8.8	1000.0
WZ-7043	DAPK2	100.0	10000.0
JW-7-24-1	NDR2	100.0	10000.0
R406	EGFR(L747-S752del,P753S)	5.0	1000.0
WYE-125132	PRKX	100.0	10000.0
KU63794	ADCK4	87.0	10000.0
KU63794	LRRK2	100.0	10000.0
HG-14-8-02	BUB1	74.0	10000.0
PHA-767491	AKT3	100.0	10000.0
PLX-4720	TAOK2	43.0	10000.0
MLN8054	PIK3CA(Q546K)	14.0	10000.0
XMD11-85h	NEK7	100.0	10000.0
AZ-628	MLTK	6.5	10000.0
NG25	ABL1(H396P)	0.5	10000.0
Pictilisib	YANK3	100.0	1000.0
Seliciclib	JAK1(JH2domain-pseudokinase)	79.0	10000.0
HG-9-91-01	NEK11	18.0	10000.0
PHA-793887	ITK	100.0	10000.0
MRT67307	ULK1	0.0	10000.0
KU63794	MARK3	96.0	10000.0
KIN001-021	LKB1	100.0	1000.0
RO-3306	EPHA2	78.0	10000.0
KU63794	PGFRA	94.0	10000.0
MPS-1-IN-1	KPCL	100.0	1000.0
HG-14-10-04	NDR2	48.0	10000.0
ERK5-IN-1	MAP3K1	93.0	1000.0
PHA-793887	ABL1(M351T)-phosphorylated	95.0	10000.0
SP600125	TRKA	100.0	10000.0
XMD11-85h	FGFR1	100.0	10000.0
(s)-CR8	YSK1	100.0	10000.0
ALW-II-49-7	PKAC-alpha	100.0	10000.0
CH5424802	CSF1R-autoinhibited	100.0	1000.0
JNK-IN-5A	PIK3CA(E545A)	80.0	10000.0
XMD16-144	HCK	13.0	10000.0
SCH772984	RSK1(Kin.Dom.2-C-terminal)	87.0	1000.0
SCH772984	SRPK2	100.0	1000.0
JWE-035	MK01	77.0	10000.0
BI-D1870	FLT3	5.3	10000.0
Vemurafenib	IRAK4	86.0	10000.0
NPK76-II-72-1	IRAK3	100.0	10000.0
Torkinib	EPHA1	2.7	10000.0
Baricitinib	KIT(D816V)	3.9	10000.0
KIN001-111	MST1R	100.0	1000.0
BI-2536	NEK5	100.0	10000.0
HG-9-91-01	KPCD3	9.4	10000.0
KIN001-127	ERK8	100.0	10000.0
MLN8054	AAK1	90.0	10000.0
Momelotinib	DAPK2	41.0	10000.0
WYE-125132	YSK1	91.0	10000.0
BMS345541	ABL1(H396P)-phosphorylated	100.0	10000.0
ERK5-IN-1	MST1R	100.0	1000.0
AZD7762	MRCKA	62.0	10000.0
WZ4002	AKT2	100.0	10000.0
XMD11-50	PHKG2	33.0	10000.0
XMD14-99	PIK3CA(C420R)	100.0	10000.0
CGP74514A	LIMK2	73.0	10000.0
Dactolisib	CDK8	100.0	1000.0
CGP60474	CDK8	100.0	10000.0
BMX-IN-1	RIOK2	43.0	10000.0
GW843682X	STK33	67.0	10000.0
TAK-715	MAP4K5	36.0	10000.0
BGJ398	KPCL	100.0	1000.0
Barasertib	TRKB	8.2	10000.0
AZ-628	ABL1(E255K)-phosphorylated	3.4	10000.0
Seliciclib	PFPK5(P.falciparum)	100.0	10000.0
AZD4547	CAMK2A	13.0	10000.0
HG-9-91-01	MET(Y1235D)	13.0	10000.0
THZ1	PIK3CA(I800L)	100.0	10000.0
GW843682X	CSNK1A1L	78.0	10000.0
R406	NLK	100.0	1000.0
JNK-9L	PKAC-beta	100.0	10000.0
QL-XI-92	SgK110	100.0	10000.0
AG1478	IGF1R	100.0	10000.0
Lapatinib	MYLK2	91.0	10000.0
(s)-CR8	ABL1(T315I)-nonphosphorylated	100.0	10000.0
GSK1059615	CSNK1A1	24.0	10000.0
HG-9-91-01	SNRK	100.0	10000.0
GSK461364	MET(Y1235D)	98.0	10000.0
NPK76-II-72-1	FGFR3(G697C)	100.0	10000.0
Lapatinib	DYRK1B	87.0	10000.0
QL-XII-47	JNK3	75.0	1000.0
AZD4547	CDK15	86.0	10000.0
Dactolisib	RIOK3	100.0	1000.0
Vemurafenib	FLT3(K663Q)	7.2	10000.0
BI-2536	PRKR	100.0	10000.0
HG-14-10-04	FRK	0.9	10000.0
WYE-125132	GSK3B	69.0	10000.0
SP600125	FLT3(ITD)	100.0	10000.0
HG-5-88-01	TGFBR1	100.0	10000.0
Pictilisib	ABL1(T315I)	100.0	10000.0
Torkinib	PAK3	59.0	10000.0
XMD-12	KIT(V559D)	80.0	1000.0
JWE-035	KIT(L576P)	46.0	10000.0
BX-912	CDK9	66.0	10000.0
Ibrutinib	KPCD	95.0	1000.0
Taselisib	EPHA2	100.0	1000.0
TAK-715	EGFR(G719C)	0.4	10000.0
XMD16-144	IKKA	100.0	10000.0
(s)-CR8	MP2K3	95.0	10000.0
XMD13-2	TRKA	60.0	10000.0
Ceritinib	BRSK2	78.0	1000.0
CP724714	MP2K1	9.4	10000.0
XMD11-50	ERK3	100.0	10000.0
XMD16-144	PLK4	0.0	10000.0
AZ-628	PLK2	99.0	10000.0
AG1478	CHEK1	100.0	10000.0
BGJ398	CLK2	80.0	1000.0
JNK-IN-5A	MARK2	100.0	10000.0
Taselisib	PRP4	63.0	1000.0
Seliciclib	FLT3(D835H)	100.0	10000.0
WZ4003	EPHA4	100.0	1000.0
JNK-IN-5A	RET(V804L)	90.0	10000.0
Vemurafenib	PCTK3	100.0	10000.0
HG-9-91-01	RET(V804L)	94.0	10000.0
SB590885	PCTK2	87.0	10000.0
SB590885	TSSK1	86.0	10000.0
TAK-715	CDC2L5	100.0	10000.0
Dinaciclib	KIT(D816H)	97.0	10000.0
KIN001-220	MP2K5	9.8	10000.0
Lapatinib	CLK3	99.0	10000.0
JWE-035	PIK3CA(I800L)	12.0	10000.0
Torin2	CDKL1	97.0	10000.0
WH-4-023	CDC2L1	58.0	10000.0
HG-14-8-02	MLCK	100.0	10000.0
Pictilisib	MAP3K14	100.0	1000.0
THZ1	ADCK4	2.0	10000.0
RO-3306	EIF2AK1	93.0	10000.0
ZSTK474	CLK4	100.0	1000.0
AZD7762	CSNK1A1L	2.4	10000.0
Taselisib	PIM1	100.0	1000.0
WYE-125132	RIOK2	90.0	10000.0
MRT67307	EGFR(E746-A750del)	100.0	10000.0
AS-252424	INSRR	55.9	10000.0
BMX-IN-1	RSK3(Kin.Dom.2-C-terminal)	68.0	10000.0
WZ-4-145	AURKA	100.0	10000.0
Seliciclib	SRMS	100.0	10000.0
ZSTK474	MET	100.0	1000.0
WH-4-023	LATS2	70.0	10000.0
CGP60474	PKN1	100.0	10000.0
MLN8054	ICK	86.0	10000.0
XMD8-85	MLTK	100.0	10000.0
JNK-IN-11	CASK	52.0	1000.0
ALW-II-49-7	KPCL	100.0	10000.0
XMD13-2	KIT	37.0	10000.0
XMD8-92	RIOK2	100.0	10000.0
AZD4547	CLK4	7.6	10000.0
Ribociclib	CDKL2	100.0	1000.0
BX-912	PCTK3	100.0	10000.0
GW-5074	MARK3	68.0	10000.0
ZG-10	ACVR1	53.0	10000.0
5z-7-oxozeaenol	BRSK1	80.0	10000.0
Alpelisib	EPHA2	84.0	1000.0
R406	DYRK1B	14.0	1000.0
ZG-10	EPHB1	100.0	10000.0
JNK-9L	ADCK4	0.3	10000.0
Momelotinib	KPCD1	22.0	10000.0
Neratinib	CDK16	100.0	10000.0
PHA-793887	SRC	64.0	10000.0
KIN001-111	MLCK	100.0	1000.0
AZ-628	ROS1	100.0	10000.0
Taselisib	ACVR2A	97.0	1000.0
Vemurafenib	PIK3CA(H1047Y)	88.0	10000.0
Torin1	PIM2	62.0	10000.0
CGP74514A	EPHB6	43.0	10000.0
QL-X-138	GAK	18.0	10000.0
Sorafenib	BIKE	100.0	10000.0
BMX-IN-1	GAK	23.0	10000.0
PD173074	FYN	100.0	10000.0
ALW-II-49-7	FAK2	100.0	10000.0
Vemurafenib	ERBB4	86.0	10000.0
BMS345541	CSNK1E	58.0	10000.0
Baricitinib	YES	55.0	10000.0
Pictilisib	PIK4CB	100.0	1000.0
Torin2	HUNK	100.0	10000.0
Dinaciclib	DYRK1B	6.0	10000.0
PHA-793887	ABL1(F317I)-phosphorylated	91.0	10000.0
JNK-9L	CAMK2A	16.0	10000.0
Ribociclib	AURKA	49.0	1000.0
WZ-4-145	MAPKAPK2	100.0	10000.0
HG-14-10-04	EGFR(G719C)	2.2	10000.0
PHA-793887	MET	100.0	10000.0
KIN001-123	KPCE	100.0	1000.0
CH5424802	STK33	12.0	1000.0
NG25	IKKA	1.0	10000.0
HG-9-91-01	PKN2	23.0	10000.0
Canertinib	PIK3CA	23.0	1000.0
SB590885	DCLK1	88.0	10000.0
AZD-6482	PIM2	70.0	10000.0
Canertinib	EGFR(L747-T751del,Sins)	0.0	1000.0
Lapatinib	AMPK-alpha1	70.0	10000.0
AZ-628	TRPM6	100.0	10000.0
KU63794	LIMK2	94.0	10000.0
CH5424802	NEK10	72.0	1000.0
JW-7-24-1	FLT3(K663Q)	100.0	10000.0
ALW-II-49-7	PIK3C2B	100.0	10000.0
CP724714	ABL1(F317I)-nonphosphorylated	100.0	10000.0
GSK1059615	RPS6KA4(Kin.Dom.1-N-terminal)	79.0	10000.0
R406	KC1G1	100.0	1000.0
SP600125	VGFR2	100.0	10000.0
KU63794	PIK3C2B	85.0	10000.0
BMS345541	EGFR(E746-A750del)	100.0	10000.0
Momelotinib	MK11	100.0	10000.0
THZ1	CDK16	9.2	10000.0
R406	SgK110	1.6	1000.0
ALW-II-49-7	RET	100.0	10000.0
GW-5074	YES	90.0	10000.0
CH5424802	KPCI	100.0	1000.0
Omipalisib	RET(V804L)	99.0	10000.0
NU7441	NEK6	100.0	10000.0
AZD 5438	PIK3CG	0.2	10000.0
JNK-IN-5A	YANK2	83.0	10000.0
QL-XI-92	CDK14	93.0	10000.0
CGP60474	ROCK2	100.0	10000.0
PHA-793887	PAK6	5.7	10000.0
MPS-1-IN-1	ADCK3	100.0	1000.0
ERK5-IN-1	ROCK2	83.0	1000.0
ALW-II-49-7	LKB1	100.0	10000.0
WZ-7043	AURKB	100.0	10000.0
R406	MYO3B	100.0	1000.0
HG-6-64-01	CSNK1G3	48.0	10000.0
ZM-447439	EPHA1	100.0	10000.0
JNK-IN-5A	OSR1	100.0	10000.0
XMD14-99	PAK2	100.0	10000.0
CP466722	PIP5K1A	6.4	10000.0
TAK-715	RIPK2	1.2	10000.0
MRT67307	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
JNK-9L	ABL2	67.0	10000.0
BMS-536924	AKT1	100.0	1000.0
Seliciclib	FRK	100.0	10000.0
BS-181	GAK	74.0	10000.0
Momelotinib	KIT-autoinhibited	100.0	10000.0
JNK-IN-11	IGF1R	100.0	1000.0
WZ4002	EGFR(L747-E749del,A750P)	0.1	10000.0
XMD16-144	TNIK	29.0	10000.0
PHA-767491	DDR1	96.0	10000.0
Sigma A6730	DCAMKL3	91.0	10000.0
AZD7762	MK11	77.0	10000.0
ALW-II-38-3	EGFR(L858R)	100.0	10000.0
Dactolisib	M3K2	100.0	1000.0
JW-7-24-1	SRPK3	100.0	10000.0
ZG-10	TIE2	94.0	10000.0
BMX-IN-1	PIK3CA	9.9	10000.0
Ribociclib	MST4	100.0	1000.0
Dactolisib	EGFR(L858R,T790M)	100.0	1000.0
KIN001-021	MAP4K5	100.0	1000.0
AZ-628	MST1R	100.0	10000.0
GSK461364	ACVRL1	100.0	10000.0
ALW-II-49-7	MP2K6	100.0	10000.0
XMD16-144	TIE2	35.0	10000.0
HG-14-8-02	PLK1	15.0	10000.0
PD0325901	PAK7	100.0	10000.0
QL-X-138	M3K2	88.0	10000.0
Ribociclib	CLK3	61.0	1000.0
WYE-125132	TYK2(JH2domain-pseudokinase)	100.0	10000.0
AZD7762	EGFR(G719C)	0.1	10000.0
Omipalisib	KIT(V559D)	63.0	10000.0
Sigma A6730	EGFR(T790M)	67.0	10000.0
PHA-793887	JAK3(JH1domain-catalytic)	88.0	10000.0
Buparlisib	CHK2	100.0	1000.0
CH5424802	ACVRL1	95.0	1000.0
AZD4547	INSR	2.0	10000.0
KIN001-127	PIK3CG	100.0	10000.0
PD173074	FAK1	100.0	10000.0
R406	SRPK1	0.5	1000.0
PD0325901	MK11	100.0	10000.0
JWE-035	NDR1	95.0	10000.0
Seliciclib	ZAP70	85.0	10000.0
MLN8054	HCK	3.2	10000.0
XMD14-99	MK14	94.0	10000.0
HG-5-88-01	PDPK1	100.0	10000.0
HG-14-8-02	KPCI	100.0	10000.0
BS-181	PKN2	100.0	10000.0
ZM-447439	PIK3CA(M1043I)	99.0	10000.0
GSK461364	EPHA3	100.0	10000.0
AZD7762	MAST1	4.1	10000.0
WH-4-023	CDKL5	100.0	10000.0
HG-5-113-01	MAP4K2	11.0	10000.0
BMX-IN-1	FGFR1	98.0	10000.0
Ibrutinib	STK39	52.0	1000.0
Torkinib	RAF1	41.0	10000.0
Pictilisib	CLK2	55.0	1000.0
Canertinib	ROS1	100.0	1000.0
AZD 5438	GRK4	1.4	10000.0
5z-7-oxozeaenol	TAOK1	100.0	10000.0
JWE-035	EPHB2	100.0	10000.0
ZM-447439	TGFBR1	100.0	10000.0
BI-2536	EGFR(L858R)	24.0	10000.0
JNK-9L	PIK3CA(C420R)	100.0	10000.0
WZ-7043	TRKA	100.0	10000.0
XMD8-92	TESK1	100.0	10000.0
XMD-12	MET(M1250T)	53.0	1000.0
Torkinib	RSK3(Kin.Dom.2-C-terminal)	62.0	10000.0
KIN001-220	PKAC-beta	76.0	10000.0
Baricitinib	SNRK	55.0	10000.0
Momelotinib	CASK	100.0	10000.0
KIN001-111	ABL1(Y253F)	2.0	1000.0
KIN001-220	EPHA1	27.0	10000.0
XMD14-99	AMPK-alpha1	81.0	10000.0
RO-3306	CAMKK2	19.0	10000.0
PLX-4720	MK01	100.0	10000.0
XMD11-50	MRCKA	100.0	10000.0
ALW-II-49-7	ABL1(M351T)	27.0	10000.0
MLN8054	ABL1-nonphosphorylated	2.8	10000.0
CP724714	EGFR(L747-T751del,Sins)	1.8	10000.0
WZ3105	NLK	96.0	10000.0
NG25	RPS6KA4(Kin.Dom.2)	100.0	10000.0
HG-14-8-02	ABL1(T315I)-nonphosphorylated	72.0	10000.0
Torkinib	MST1R	89.0	10000.0
ZSTK474	GSK3B	100.0	1000.0
HG-5-88-01	RPS6KA6(Kin.Dom.1)	100.0	10000.0
Neratinib	PAK6	74.0	10000.0
Sigma A6730	LATS1	93.0	10000.0
Torin1	ACVR1	28.0	10000.0
ZM-447439	CDK2	82.0	10000.0
AZD-6482	AURKB	96.0	10000.0
HG-6-64-01	STK39	100.0	10000.0
Barasertib	SBK1	100.0	10000.0
WZ3105	TYK2(JH1domain-catalytic)	34.0	10000.0
RO-3306	RIPK2	40.0	10000.0
GSK461364	BIKE	1.0	10000.0
Dactolisib	PAK2	100.0	1000.0
Vemurafenib	PIM1	95.0	10000.0
CGP74514A	CAMK2B	90.0	10000.0
Canertinib	AMPK-alpha1	100.0	1000.0
A443654	MP2K4	100.0	10000.0
Barasertib	HUNK	94.0	10000.0
AZD 5438	EPHA6	34.0	10000.0
KIN001-220	ABL1(T315I)-nonphosphorylated	25.0	10000.0
CP724714	EIF2AK1	100.0	10000.0
WH-4-023	STK35	24.0	10000.0
ERK5-IN-1	CAMK2A	100.0	1000.0
THZ1	IKKB	32.0	10000.0
Momelotinib	STK16	6.2	10000.0
KIN001-127	FLT3(K663Q)	100.0	10000.0
Pictilisib	ACVR2B	100.0	1000.0
BI-2536	PIK3CD	100.0	10000.0
(s)-CR8	MAST1	100.0	10000.0
JW-7-24-1	TLK2	100.0	10000.0
KIN001-123	PKMYT1	100.0	1000.0
GSK429286A	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
R406	PAK4	3.4	1000.0
KIN001-111	KC1G2	100.0	1000.0
Ceritinib	KIT(V559D,T670I)	90.0	1000.0
Neratinib	HIPK4	42.0	10000.0
WZ4002	RPS6KA1(Kin.Dom.1)	12.0	10000.0
Alpelisib	TNK2	96.0	1000.0
ZSTK474	IKKB	100.0	1000.0
AS-252424	MYLK2	75.4	10000.0
QL-X-138	BRSK2	67.0	10000.0
HG-6-64-01	TRKB	5.2	10000.0
HG-14-8-02	TIE1	58.0	10000.0
QL-X-138	STK16	52.0	10000.0
BMS345541	JAK2(JH1domain-catalytic)	100.0	10000.0
Sigma A6730	AAK1	100.0	10000.0
OTSSP167	IKKE	19.0	10000.0
NU7441	MP2K5	98.0	10000.0
THZ1	JNK3	0.1	10000.0
GW843682X	ULK1	92.0	10000.0
Torin2	MYLK2	100.0	10000.0
Crizotinib	WEE2	100.0	10000.0
PLX-4720	LCK	3.2	10000.0
BMS-536924	EGFR(L747-S752del,P753S)	8.8	1000.0
JW-7-24-1	TRKC	100.0	10000.0
Alpelisib	KKCC1	99.0	1000.0
BMS345541	NDR2	100.0	10000.0
Vemurafenib	M3K6	100.0	10000.0
WZ3105	EGFR(L747-S752del,P753S)	90.0	10000.0
JNK-IN-5A	PLK4	82.0	10000.0
5z-7-oxozeaenol	CLK2	67.0	10000.0
Barasertib	EGFR(L747-S752del,P753S)	56.0	10000.0
XMD8-92	PLK2	100.0	10000.0
AG1478	RSK2(Kin.Dom.1-N-terminal)	67.0	10000.0
BGJ398	KIT(V559D)	12.0	1000.0
GSK461364	RAF1	100.0	10000.0
XMD16-144	PIM3	100.0	10000.0
KU63794	MK03	100.0	10000.0
PLX-4720	HCK	19.0	10000.0
Neratinib	STK33	42.0	10000.0
Seliciclib	EPHA8	100.0	10000.0
QL-XII-47	ABL1(Q252H)-nonphosphorylated	76.0	1000.0
CP724714	NIM1	87.0	10000.0
XMD13-2	M3K12	30.0	10000.0
OTSSP167	TNNI3K	9.7	10000.0
QL-X-138	MP2K7	14.0	10000.0
TGX221	SIK2	100.0	1000.0
Ceritinib	TTK	40.0	1000.0
PLX-4720	JAK3(JH1domain-catalytic)	24.0	10000.0
GSK1059615	DAPK1	6.4	10000.0
QL-X-138	EGFR(E746-A750del)	58.0	10000.0
XMD8-85	BLK	100.0	10000.0
Baricitinib	MET	100.0	10000.0
ZG-10	GSK3A	26.0	10000.0
WYE-125132	PIK3CA	16.0	10000.0
AZ-628	PI42C	100.0	10000.0
HG-6-64-01	ALK	51.0	10000.0
CP466722	MARK3	100.0	10000.0
SCH772984	CSNK1D	88.0	1000.0
XMD11-85h	EPHB3	100.0	10000.0
BX-912	CSK	24.0	10000.0
Alpelisib	RIOK3	83.0	1000.0
MPS-1-IN-1	PAK3	100.0	1000.0
XMD11-85h	LIMK1	100.0	10000.0
Sorafenib	CAMK2G	93.0	10000.0
Canertinib	MK14	100.0	1000.0
WZ4003	YANK3	100.0	1000.0
XMD11-50	TSSK1	60.0	10000.0
Ibrutinib	ADCK3	100.0	1000.0
XMD8-85	RPS6KA1(Kin.Dom.2)	18.0	10000.0
XMD13-2	TRPM6	100.0	10000.0
HG-5-88-01	MRCKA	100.0	10000.0
SP600125	TYK2(Kin.Dom.2)	100.0	10000.0
CG-930	AAK1	100.0	10000.0
HG-14-10-04	CAMK1D	0.2	10000.0
PD173074	FGR	100.0	10000.0
CG-930	EGFR(S752-I759del)	9.4	10000.0
(s)-CR8	ALK(C1156Y)	88.0	10000.0
BGJ398	CDK8	77.0	1000.0
Ceritinib	CSK	83.0	1000.0
WZ3105	NEK7	76.0	10000.0
GSK461364	EPHB1	99.0	10000.0
Sorafenib	PAK4	91.0	10000.0
5z-7-oxozeaenol	GRK1	87.0	10000.0
HG-14-10-04	EPHA7	15.0	10000.0
HG-14-8-02	M4K1	43.0	10000.0
Abemaciclib	YES	100.0	1000.0
CGP74514A	FGFR2	67.0	10000.0
Neratinib	MET(Y1235D)	86.0	10000.0
Sorafenib	EPHB4	21.0	10000.0
Vemurafenib	MK09	50.0	10000.0
(s)-CR8	CAMK2A	89.0	10000.0
SB590885	STK35	100.0	10000.0
QL-XII-47	ULK3	91.0	1000.0
Dactolisib	KPCL	100.0	1000.0
BI-D1870	PLK1	3.2	10000.0
GSK429286A	FGFR3(G697C)	84.0	10000.0
OTSSP167	NEK2	50.0	10000.0
5z-7-oxozeaenol	DMPK	100.0	10000.0
HG-14-10-04	TBK1	4.6	10000.0
GSK1059615	PAK7	91.0	10000.0
WZ-7043	LKB1	100.0	10000.0
AZD 5438	AMPK-alpha1	28.0	10000.0
Neratinib	DYRK1B	99.0	10000.0
KIN001-220	PGFRA	38.0	10000.0
HG-5-113-01	MYLK2	100.0	10000.0
CG-930	MET	100.0	10000.0
WYE-125132	MK12	54.0	10000.0
JNK-9L	HIPK2	6.2	10000.0
NU7441	RET(V804M)	95.0	10000.0
BGJ398	KIT(V559D,T670I)	57.0	1000.0
GW843682X	EPHA3	78.0	10000.0
HG-5-88-01	PIK3CG	100.0	10000.0
KU63794	JNK3	81.0	10000.0
R406	PHKG2	14.0	1000.0
Lapatinib	MAP4K4	70.0	10000.0
BI-2536	YANK2	100.0	10000.0
XMD8-85	CDK3	100.0	10000.0
WZ3105	KIT	52.0	10000.0
ZG-10	CDC2L2	100.0	10000.0
KU63794	VGFR2	98.0	10000.0
PHA-793887	EPHB4	97.0	10000.0
KIN001-127	SNARK	25.0	10000.0
JNK-9L	PIK3CA(E542K)	100.0	10000.0
Pictilisib	WEE2	100.0	1000.0
Baricitinib	PIK3CA(C420R)	65.0	10000.0
NG25	ERK5	100.0	10000.0
XMD13-2	RSK4(Kin.Dom.1-N-terminal)	91.0	10000.0
BMX-IN-1	WEE1	92.0	10000.0
JWE-035	ABL1(T315I)-nonphosphorylated	0.0	10000.0
Seliciclib	CLK4	13.0	10000.0
Baricitinib	DMPK	0.4	10000.0
CP724714	SLK	60.0	10000.0
BS-181	KIT(V559D,V654A)	98.0	10000.0
Sigma A6730	BRSK1	100.0	10000.0
CGP60474	OSR1	100.0	10000.0
CP466722	PIP5K1C	5.0	10000.0
TAK-715	PIK3CA(E545A)	54.0	10000.0
Ribociclib	MUSK	97.0	1000.0
WZ-7043	MP2K3	100.0	10000.0
GW-5074	CDKL2	82.0	10000.0
Sorafenib	CSNK1E	100.0	10000.0
WZ4003	NEK7	13.0	1000.0
THZ1	CASK	77.0	10000.0
HG-14-8-02	MAK	100.0	10000.0
KIN001-220	INSR	78.0	10000.0
TGX221	MAP4K4	100.0	1000.0
AZD 5438	FER	73.0	10000.0
BI-2536	CDC2L2	100.0	10000.0
WZ4003	MK03	100.0	1000.0
XMD13-2	MLK3	100.0	10000.0
NU7441	ABL1(Y253F)-phosphorylated	100.0	10000.0
XMD-12	CAMK2G	100.0	1000.0
AZD7762	SgK110	0.0	10000.0
ZG-10	MAPKAPK5	100.0	10000.0
CGP74514A	RSK3(Kin.Dom.2-C-terminal)	44.0	10000.0
NVP-TAE684	PLK3	0.0	1000.0
SP600125	PIM1	24.0	10000.0
HG-6-64-01	EGFR(S752-I759del)	0.0	10000.0
WZ-4-145	TNK1	28.0	10000.0
AZD7762	WEE1	50.0	10000.0
SP600125	TIE1	100.0	10000.0
Buparlisib	EGFR(L747-E749del,A750P)	100.0	1000.0
Sigma A6730	DMPK	98.0	10000.0
XMD14-99	TAOK3	12.0	10000.0
A443654	M4K3	9.5	10000.0
AS-252424	MLCK	29.1	10000.0
XMD13-2	EGFR(L747-T751del,Sins)	74.0	10000.0
WZ-4-145	MLK1	12.0	10000.0
JNK-IN-8	EPHB1	100.0	1000.0
GW-5074	PFCDPK1(P.falciparum)	24.0	10000.0
XMD8-85	SBK1	8.9	10000.0
TAK-715	TNK1	88.0	10000.0
MRT67307	CAMK2G	28.0	10000.0
Ribociclib	ERK8	67.0	1000.0
AZD 5438	CDK11	44.0	10000.0
Neratinib	MK13	99.0	10000.0
Dinaciclib	ACVRL1	65.0	10000.0
XMD11-85h	FYN	100.0	10000.0
RO-3306	ERBB4	96.0	10000.0
WZ3105	RIPK1	100.0	10000.0
BS-181	KIT-autoinhibited	90.0	10000.0
AZ-628	EGFR(E746-A750del)	15.0	10000.0
Dabrafenib	PFCDPK1(P.falciparum)	0.1	10000.0
SCH772984	PIP5K1A	23.0	1000.0
Dinaciclib	CHK2	57.0	10000.0
HG-14-8-02	CHK2	31.0	10000.0
AZD 5438	WEE1	98.0	10000.0
Dinaciclib	CSK	100.0	10000.0
XMD13-2	EPHA4	100.0	10000.0
WZ4003	PIK3CD	100.0	1000.0
ALW-II-49-7	EGFR(G719S)	100.0	10000.0
GSK461364	NDR1	71.0	10000.0
ZG-10	KIT(L576P)	0.4	10000.0
AZD4547	RSK2(Kin.Dom.1-N-terminal)	15.0	10000.0
AZ-628	M4K3	94.0	10000.0
ALW-II-49-7	BRSK1	100.0	10000.0
WH-4-023	PTK6	0.0	10000.0
Ceritinib	MP2K6	79.0	1000.0
SCH772984	TLK1	91.0	1000.0
WZ3105	WEE2	100.0	10000.0
KIN001-127	RPS6KA6(Kin.Dom.1)	100.0	10000.0
Buparlisib	KCC4	100.0	1000.0
WZ3105	TYK2(JH2domain-pseudokinase)	100.0	10000.0
NPK76-II-72-1	SRPK3	100.0	10000.0
JNK-IN-11	IKKE	95.0	1000.0
Vemurafenib	MAK	100.0	10000.0
HG-14-10-04	EGFR(E746-A750del)	0.5	10000.0
Dinaciclib	STK16	100.0	10000.0
Dinaciclib	DDR2	78.0	10000.0
ZM-447439	TEC	76.0	10000.0
GW-5074	PLK2	71.0	10000.0
Torin2	KPCD3	100.0	10000.0
Alpelisib	TRKC	100.0	1000.0
ZSTK474	ABL1(Y253F)	100.0	1000.0
AG1478	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
JWE-035	KCC4	100.0	10000.0
TAK-715	MERTK	100.0	10000.0
Neratinib	NEK9	100.0	10000.0
JNK-9L	CDKL5	7.0	10000.0
AG1478	MK09	18.0	10000.0
QL-X-138	ERK4	100.0	10000.0
Ribociclib	TRPM6	100.0	1000.0
HG-14-8-02	TXK	7.2	10000.0
Seliciclib	BMPR1A	100.0	10000.0
PLX-4720	FGFR4	100.0	10000.0
Taselisib	SRMS	100.0	1000.0
SCH772984	TAOK1	59.0	1000.0
ZM-447439	LCK	0.2	10000.0
MLN8054	GSK3A	100.0	10000.0
SB590885	BRSK1	76.0	10000.0
QL-XI-92	LYN	34.0	10000.0
XMD16-144	FGR	4.2	10000.0
PD0325901	DYRK2	95.0	10000.0
KU63794	LYN	100.0	10000.0
ALW-II-38-3	KPCD1	100.0	10000.0
JNK-IN-5A	CSF1R	100.0	10000.0
KU63794	TAOK2	76.0	10000.0
MRT67307	DYRK2	39.0	10000.0
NG25	RIOK1	100.0	10000.0
BMX-IN-1	MELK	75.0	10000.0
Dinaciclib	MLK2	85.0	10000.0
CH5424802	CHK2	16.0	1000.0
BGJ398	RSK4(Kin.Dom.1-N-terminal)	81.0	1000.0
Dactolisib	LIMK1	100.0	1000.0
PD0325901	MP2K7	100.0	10000.0
Ribociclib	STK35	100.0	1000.0
PHA-793887	NEK5	100.0	10000.0
HG-9-91-01	ABL1(Q252H)-phosphorylated	0.3	10000.0
BI-2536	BMPR1B	100.0	10000.0
AZD7762	PIK3CA(I800L)	100.0	10000.0
PD0325901	PCTK2	95.0	10000.0
ALW-II-49-7	CDK5	100.0	10000.0
Pictilisib	FLT3	67.0	1000.0
JW-7-24-1	PLK4	100.0	10000.0
NG25	DAPK2	100.0	10000.0
MPS-1-IN-1	NEK1	100.0	1000.0
HG-14-10-04	MLK3	2.0	10000.0
BMS-536924	BRAF(V600E)	100.0	1000.0
BMS-536924	CDC2L2	100.0	1000.0
GW843682X	RSK2(Kin.Dom.1-N-terminal)	22.0	10000.0
BMX-IN-1	ABL1(F317I)-phosphorylated	100.0	10000.0
ALW-II-49-7	CDK11	25.0	10000.0
Torin1	M3K2	62.0	10000.0
WZ4003	FGFR1	15.0	1000.0
Pictilisib	MARK3	100.0	1000.0
Lapatinib	DYRK2	100.0	10000.0
NU7441	HIPK3	92.0	10000.0
NG25	MAP4K5	11.0	10000.0
(s)-CR8	ABL2	91.0	10000.0
Abemaciclib	ABL1(T315I)-phosphorylated	31.0	1000.0
BGJ398	ACVR2B	100.0	1000.0
SB590885	CDK2	100.0	10000.0
XMD16-144	CDK16	95.0	10000.0
XMD8-85	MAP3K3	100.0	10000.0
QL-XII-47	PFCDPK1(P.falciparum)	100.0	1000.0
HG-14-8-02	LATS2	100.0	10000.0
Ibrutinib	KIT(V559D)	25.0	1000.0
TAK-715	M3K6	100.0	10000.0
HG-9-91-01	TEC	30.0	10000.0
CG-930	HIPK4	98.0	10000.0
CGP74514A	EIF2AK1	46.0	10000.0
JNK-IN-8	MYO3A	81.0	1000.0
5z-7-oxozeaenol	FER	93.0	10000.0
Ceritinib	RET(M918T)	99.0	1000.0
SB590885	TBK1	84.0	10000.0
Dactolisib	RPS6KA2(Kin.Dom.1)	100.0	1000.0
Dinaciclib	RIPK5	21.0	10000.0
Torkinib	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
AZD7762	PIK4CB	100.0	10000.0
Momelotinib	NEK11	100.0	10000.0
Alpelisib	YES	100.0	1000.0
CGP74514A	CDK3	2.6	10000.0
Vemurafenib	CASK	80.0	10000.0
PD173074	NUAK1	100.0	10000.0
CH5424802	IRAK3	89.0	1000.0
SP600125	EGFR(S752-I759del)	100.0	10000.0
WZ4003	MLK2	100.0	1000.0
JNK-IN-5A	EPHA4	100.0	10000.0
MPS-1-IN-1	KPCD1	100.0	1000.0
WZ-4-145	DCAMKL2	100.0	10000.0
Momelotinib	HIPK3	17.0	10000.0
TAK-715	LKB1	96.0	10000.0
Ceritinib	MUSK	97.0	1000.0
MLN8054	INSRR	100.0	10000.0
NG25	TNIK	8.2	10000.0
KIN001-111	EPHA7	100.0	1000.0
KIN001-021	JAK3(Kin.Dom.2)	100.0	1000.0
XMD8-92	TBK1	100.0	10000.0
AZD 5438	CSNK2A2	0.1	10000.0
Baricitinib	JNK1	36.0	10000.0
BMX-IN-1	CDK15	72.0	10000.0
KU63794	YSK4	100.0	10000.0
NG25	NLK	11.0	10000.0
HG-5-113-01	TIE1	0.2	10000.0
GSK1059615	MLCK	6.2	10000.0
KIN001-123	PIM3	100.0	1000.0
Vemurafenib	TNK1	100.0	10000.0
QL-XII-47	EGFR	100.0	1000.0
Crizotinib	CDK7	1.2	10000.0
WH-4-023	DYRK1B	68.0	10000.0
BI-D1870	MAP3K3	5.8	10000.0
Neratinib	CAMK1D	76.0	10000.0
PLX-4720	KKCC1	75.0	10000.0
WZ-7043	DCAMKL3	100.0	10000.0
KIN001-220	MLK2	7.2	10000.0
AZD7762	STK33	0.0	10000.0
ZSTK474	YSK1	100.0	1000.0
WYE-125132	JAK3(JH1domain-catalytic)	90.0	10000.0
KIN001-111	LTK	100.0	1000.0
AZD4547	KC1G2	95.0	10000.0
MLN8054	MARK3	100.0	10000.0
RO-3306	GSK3B	65.0	10000.0
Dinaciclib	KPCL	100.0	10000.0
QL-X-138	PKN1	100.0	10000.0
JNK-IN-5A	SRPK2	100.0	10000.0
TAK-715	ABL1(Q252H)-nonphosphorylated	4.6	10000.0
BGJ398	PLK2	68.0	1000.0
ALW-II-49-7	KPCE	100.0	10000.0
XMD14-99	ABL2	82.0	10000.0
(s)-CR8	EPHB2	100.0	10000.0
Sigma A6730	MAPKAPK2	100.0	10000.0
AZD7762	VGFR2	0.1	10000.0
Taselisib	ADCK3	100.0	1000.0
CG-930	SIK2	33.0	10000.0
AZ-628	TLK1	100.0	10000.0
Seliciclib	DYRK2	69.0	10000.0
CH5424802	CDK7	65.0	1000.0
AG1478	MK03	88.0	10000.0
AZD-6482	M3K2	100.0	10000.0
PLX-4720	NEK3	69.0	10000.0
Dactolisib	GRK4	100.0	1000.0
Barasertib	MTOR	100.0	10000.0
PHA-767491	NIM1	56.0	10000.0
Sorafenib	CAMKK2	72.0	10000.0
KIN001-111	PGFRA	2.9	1000.0
HG-9-91-01	RSK3(Kin.Dom.2-C-terminal)	76.0	10000.0
OTSSP167	ABL1(F317L)-nonphosphorylated	94.0	10000.0
NVP-TAE684	MAPKAPK2	100.0	1000.0
Torin1	RIOK2	24.0	10000.0
(s)-CR8	EGFR(L747-S752del,P753S)	94.0	10000.0
Barasertib	WEE2	100.0	10000.0
QL-XII-47	TSSK1	96.0	1000.0
JWE-035	ABL1(H396P)-nonphosphorylated	0.0	10000.0
Momelotinib	RIPK5	38.0	10000.0
WYE-125132	CDKL1	84.0	10000.0
JNK-IN-11	SRC	18.0	1000.0
TAK-715	CDKL5	100.0	10000.0
Momelotinib	M3K6	100.0	10000.0
BGJ398	VRK2	90.0	1000.0
WZ-7043	EPHB6	5.2	10000.0
Dabrafenib	MKNK1	50.0	10000.0
KU63794	AXL	100.0	10000.0
SCH772984	MLCK	70.0	1000.0
HG-9-91-01	JAK2(JH1domain-catalytic)	17.0	10000.0
ALW-II-38-3	CIT	17.0	1000.0
XMD13-2	DYRK2	36.0	10000.0
TAK-715	SNARK	100.0	10000.0
NVP-TAE684	SgK110	0.0	1000.0
WH-4-023	M3K13	70.0	10000.0
AZD4547	DRAK1	1.8	10000.0
CGP74514A	KPCD2	65.0	10000.0
GW843682X	STK16	49.0	10000.0
SCH772984	TSSK1	66.0	1000.0
JNK-IN-5A	BTK	90.0	10000.0
A443654	FLT4	100.0	10000.0
SP600125	SIK2	100.0	10000.0
BX-912	FES	33.0	10000.0
BI-2536	ACVR2A	100.0	10000.0
JNK-9L	EIF2AK1	100.0	10000.0
RO-3306	STK39	76.0	10000.0
AZD-6482	TSSK1	100.0	10000.0
BGJ398	CDK11	98.0	1000.0
PD0325901	FLT3	82.0	10000.0
Canertinib	BRAF(V600E)	100.0	1000.0
Buparlisib	BTK	100.0	1000.0
OTSSP167	PIK3CB	24.0	10000.0
PD0325901	PIK3CA	56.0	10000.0
Omipalisib	ULK2	100.0	10000.0
WH-4-023	PIM1	100.0	10000.0
XMD-12	PHKG1	95.0	1000.0
BGJ398	LATS1	93.0	1000.0
QL-XI-92	WEE2	84.0	10000.0
CGP74514A	FLT3(K663Q)	1.6	10000.0
RO-3306	CLK4	0.5	10000.0
ERK5-IN-1	AMPK-alpha1	100.0	1000.0
XMD8-92	LKB1	100.0	10000.0
CGP60474	YANK2	100.0	10000.0
Omipalisib	PRKR	57.0	10000.0
TAK-715	AXL	80.0	10000.0
CH5424802	TIE1	99.0	1000.0
WZ3105	TGFBR1	100.0	10000.0
JW-7-24-1	RPS6KA2(Kin.Dom.2)	100.0	10000.0
KIN001-021	KCC2D	100.0	1000.0
BS-181	TNNI3K	90.0	10000.0
Vemurafenib	CIT	30.0	10000.0
MLN8054	BRSK1	100.0	10000.0
AZD7762	CSF1R	0.0	10000.0
Alpelisib	PAK2	89.0	1000.0
ALW-II-38-3	M4K3	100.0	10000.0
XMD11-50	DYRK1A	99.0	10000.0
XMD16-144	FGFR1	3.5	10000.0
BMS-536924	ULK1	22.0	1000.0
Torin2	M3K2	78.0	10000.0
WZ3105	TNNI3K	62.0	10000.0
GW-5074	CSNK1A1	81.0	10000.0
Baricitinib	FGFR4	34.0	10000.0
Crizotinib	CDK4-cyclinD1	51.0	10000.0
KU63794	TNNI3K	100.0	10000.0
XMD-12	PKNB(M.tuberculosis)	81.0	1000.0
WZ3105	M4K3	25.0	10000.0
XMD13-2	BRAF	74.0	10000.0
JW-7-24-1	CSNK2A2	31.0	10000.0
NPK76-II-72-1	MAPKAPK5	100.0	10000.0
Dinaciclib	CAMK1	100.0	10000.0
PD0325901	IRAK4	100.0	10000.0
Torkinib	INSR	100.0	10000.0
ZM-447439	RSK3(Kin.Dom.1-N-terminal)	84.0	10000.0
Dactolisib	TLK2	100.0	1000.0
Momelotinib	KPCE	59.0	10000.0
PLX-4720	EGFR(L861Q)	34.0	10000.0
Dinaciclib	ABL2	95.0	10000.0
XMD14-99	TRKB	80.0	10000.0
WZ-4-145	TAOK3	0.9	10000.0
BI-2536	TRKB	100.0	10000.0
JNK-9L	LCK	48.0	10000.0
SB590885	AMPK-alpha1	100.0	10000.0
KIN001-220	DYRK1A	47.0	10000.0
PHA-793887	JAK2(JH1domain-catalytic)	92.0	10000.0
PD0325901	LATS1	100.0	10000.0
Canertinib	DAPK3	100.0	1000.0
AZD 5438	CSNK2A1	0.6	10000.0
QL-X-138	PTK6	100.0	10000.0
WZ3105	SRPK1	52.0	10000.0
BI-D1870	ICK	29.0	10000.0
NG25	EGFR(L858R)	14.0	10000.0
AZD 5438	PKAC-alpha	95.0	10000.0
WH-4-023	TNK2	0.0	10000.0
Abemaciclib	KC1G1	100.0	1000.0
MPS-1-IN-1	PKAC-alpha	100.0	1000.0
HG-14-10-04	TNK1	0.5	10000.0
Canertinib	RIOK3	100.0	1000.0
AZD7762	TEC	0.4	10000.0
Dinaciclib	PKAC-alpha	100.0	10000.0
Pictilisib	NDR1	90.0	1000.0
WZ3105	RIOK3	34.0	10000.0
GSK461364	ROS1	84.0	10000.0
WH-4-023	PIK3CA(M1043I)	99.0	10000.0
XMD8-85	MLCK	100.0	10000.0
Abemaciclib	PAK2	48.0	1000.0
Palbociclib	DYRK1A	92.0	1000.0
Pictilisib	CSNK2A2	95.0	1000.0
Torin1	MK01	100.0	10000.0
Baricitinib	CTK	30.0	10000.0
ERK5-IN-1	GSK3B	98.0	1000.0
NG25	KPCD1	100.0	10000.0
GSK429286A	LRRK2(G2019S)	70.0	10000.0
HG-9-91-01	PGFRA	9.4	10000.0
QL-X-138	TAOK1	22.0	10000.0
PD0325901	MAP4K5	69.0	10000.0
HG-9-91-01	MAP3K3	0.5	10000.0
Alpelisib	TSSK3	100.0	1000.0
WZ3105	ALK	21.0	10000.0
OTSSP167	CDKL5	0.9	10000.0
BX-912	EPHA5	92.0	10000.0
CP724714	CDK3	100.0	10000.0
XMD13-2	TGFBR1	77.0	10000.0
THZ1	NEK9	0.8	10000.0
AZ-628	ABL1(F317L)-nonphosphorylated	4.6	10000.0
CGP74514A	SRMS	52.0	10000.0
WYE-125132	MAP3K1	58.0	10000.0
BMX-IN-1	PIK3CA(H1047L)	86.0	10000.0
AZD4547	PAK2	46.0	10000.0
BMS-536924	CAMK2G	100.0	1000.0
BMS-536924	SIK1	17.0	1000.0
WH-4-023	MP2K4	100.0	10000.0
Seliciclib	PIK3CA(E545A)	78.0	10000.0
ALW-II-49-7	ACVR1B	100.0	10000.0
WZ-4-145	PIK3C2B	100.0	10000.0
Alpelisib	CAMK1G	100.0	1000.0
Ribociclib	EGFR(S752-I759del)	100.0	1000.0
RO-3306	DAPK3	9.4	10000.0
AZD-6482	LATS1	100.0	10000.0
AZ-628	PKAC-alpha	100.0	10000.0
KIN001-123	NDR2	100.0	1000.0
HG-14-10-04	MERTK	0.0	10000.0
Baricitinib	DRAK2	1.4	10000.0
Dinaciclib	JNK3	24.0	10000.0
Taselisib	MET(M1250T)	93.0	1000.0
BX-912	CDKL5	1.8	10000.0
GW-5074	CDK16	89.0	10000.0
MPS-1-IN-1	HIPK1	100.0	1000.0
CGP60474	MLK3	100.0	10000.0
QL-XI-92	CLK2	80.0	10000.0
QL-XII-47	KIT(D816H)	96.0	1000.0
TAK-715	ERN1	100.0	10000.0
WZ-4-145	CSNK1G3	100.0	10000.0
AZ-628	MK13	9.6	10000.0
BS-181	MARK2	78.0	10000.0
AG1478	PKAC-alpha	94.0	10000.0
JW-7-24-1	FAK2	100.0	10000.0
Torin2	EPHA7	100.0	10000.0
ZM-447439	STK35	64.0	10000.0
BMX-IN-1	CHEK1	79.0	10000.0
WZ-4-145	MYLK	100.0	10000.0
Vemurafenib	DAPK3	95.0	10000.0
Ribociclib	FLT3(K663Q)	84.0	1000.0
WH-4-023	CHEK1	100.0	10000.0
NU7441	IKKB	100.0	10000.0
Dinaciclib	RET(M918T)	100.0	10000.0
XMD11-50	CDKL1	78.0	10000.0
KIN001-127	ACVRL1	100.0	10000.0
Torkinib	MTOR	0.0	10000.0
Abemaciclib	TRKB	53.0	1000.0
QL-X-138	TRPM6	71.0	10000.0
WZ3105	DRAK2	22.0	10000.0
XMD-12	BMPR1A	61.0	1000.0
WZ4002	EPHA7	100.0	10000.0
CP724714	FLT3(ITD)	87.0	10000.0
AZD-6482	PKN2	98.0	10000.0
BX-912	LRRK2(G2019S)	8.4	10000.0
Torin1	RIPK2	44.0	10000.0
AZD 5438	PDPK1	88.0	10000.0
XMD8-92	PAK6	100.0	10000.0
PHA-793887	ERBB3	99.0	10000.0
Dabrafenib	FLT3	52.0	10000.0
JNK-IN-8	MST1R	100.0	1000.0
CG-930	TBK1	74.0	10000.0
AZ-628	ERN1	86.0	10000.0
Canertinib	EGFR(L861Q)	0.0	1000.0
Torin2	ABL1(Y253F)-phosphorylated	87.0	10000.0
BMS345541	OSR1	100.0	10000.0
PLX-4720	CSNK1E	60.0	10000.0
HG-6-64-01	NEK7	64.0	10000.0
Canertinib	GSK3A	100.0	1000.0
GSK1059615	TSSK1	2.2	10000.0
BS-181	MET(Y1235D)	30.0	10000.0
WZ3105	SRC	4.0	10000.0
Baricitinib	RIPK4	12.0	10000.0
PD173074	JAK2(Kin.Dom.2)	100.0	10000.0
ALW-II-38-3	BMPR2	100.0	10000.0
GSK429286A	KCC2D	100.0	10000.0
JNK-IN-5A	PKAC-alpha	78.0	10000.0
ALW-II-38-3	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
THZ1	BRSK2	42.0	10000.0
PHA-767491	IRAK4	46.0	10000.0
CP724714	HIPK1	88.0	10000.0
Omipalisib	PLK2	78.0	10000.0
HG-5-88-01	EGFR(L858R)	0.3	10000.0
HG-5-113-01	CDK15	18.0	10000.0
KIN001-220	PIK4CB	100.0	10000.0
NPK76-II-72-1	IKKA	100.0	10000.0
Torin1	KPCD	82.0	10000.0
AZD 5438	BLK	84.0	10000.0
NU7441	M3K6	100.0	10000.0
Crizotinib	PLK4	0.1	10000.0
BS-181	RPS6KA5(Kin.Dom.1-N-terminal)	74.0	10000.0
PHA-793887	HUNK	89.0	10000.0
Lapatinib	MP2K7	35.0	10000.0
Taselisib	EPHA4	95.0	1000.0
XMD8-92	HIPK2	100.0	10000.0
Baricitinib	PIK3CA(Q546K)	56.0	10000.0
Torin2	IKKE	89.0	10000.0
XMD-12	NEK11	64.0	1000.0
PLX-4720	IKKA	89.0	10000.0
JWE-035	NEK5	77.0	10000.0
CGP60474	CLK1	2.2	10000.0
Ibrutinib	SYK	100.0	1000.0
ALW-II-38-3	PLK1	100.0	10000.0
ALW-II-38-3	SgK110	100.0	10000.0
XMD11-50	DRAK2	93.0	10000.0
Dactolisib	BMPR1B	100.0	1000.0
Ribociclib	CDK3	100.0	1000.0
Omipalisib	MP2K7	48.0	10000.0
Baricitinib	DAPK3	0.3	10000.0
R406	EPHA8	6.3	1000.0
Lapatinib	MAP3K4	84.0	10000.0
ALW-II-49-7	FLT3(ITD)	100.0	10000.0
Crizotinib	ABL1-phosphorylated	0.0	10000.0
CH5424802	FLT3(K663Q)	50.0	1000.0
AZD 5438	MK03	90.0	10000.0
Neratinib	MK03	100.0	10000.0
Dactolisib	EPHB1	100.0	1000.0
BMX-IN-1	DRAK2	100.0	10000.0
(s)-CR8	IRAK4	99.0	10000.0
QL-XI-92	SIK3	82.0	10000.0
Momelotinib	PAK7	56.0	10000.0
KIN001-220	IGF1R	46.0	10000.0
RO-3306	CDKL5	100.0	10000.0
XMD11-50	DDR1	100.0	10000.0
GSK1059615	FGFR2	100.0	10000.0
WH-4-023	KIT(A829P)	56.0	10000.0
Abemaciclib	NEK1	83.0	1000.0
Buparlisib	M4K1	82.0	1000.0
SCH772984	CDK16	100.0	1000.0
TAK-715	ROCK1	97.0	10000.0
BMX-IN-1	MYO3A	85.0	10000.0
WZ4002	FAK2	25.0	10000.0
GW-5074	DCAMKL2	94.0	10000.0
JNK-IN-11	MARK4	100.0	1000.0
GW843682X	FGFR1	43.0	10000.0
ZM-447439	MP2K5	0.3	10000.0
GSK1059615	PIM1	1.0	10000.0
Seliciclib	ABL1(T315I)-phosphorylated	100.0	10000.0
KIN001-127	KPCD1	100.0	10000.0
PHA-793887	AXL	100.0	10000.0
Lapatinib	IGF1R	89.0	10000.0
ALW-II-49-7	PGFRB	0.1	1000.0
MRT67307	TNK2	98.0	10000.0
QL-XI-92	LCK	45.0	10000.0
CGP60474	TYK2(JH1domain-catalytic)	100.0	10000.0
KIN001-021	EPHB2	100.0	1000.0
KIN001-021	GSK3A	100.0	1000.0
KIN001-220	CSNK1A1	96.0	10000.0
JNK-IN-8	CAMK2G	100.0	1000.0
BMX-IN-1	GRK7	84.0	10000.0
Ceritinib	TRKA	88.0	1000.0
BMS-536924	M3K5	100.0	1000.0
PD173074	JNK3	100.0	10000.0
CG-930	ROCK2	100.0	10000.0
GW-5074	PIP5K1C	19.0	10000.0
WZ4003	FGFR3(G697C)	100.0	1000.0
Ceritinib	MYO3A	61.0	1000.0
THZ1	NUAK1	2.8	10000.0
PD0325901	MK13	6.1	10000.0
Omipalisib	EPHA5	72.0	10000.0
THZ1	ERBB3	79.0	10000.0
GW-5074	MP2K4	3.4	10000.0
Baricitinib	CDC2L2	72.0	10000.0
Baricitinib	BTK	75.0	10000.0
KU63794	CAMKK2	64.0	10000.0
BMX-IN-1	CAMK2B	74.0	10000.0
KIN001-021	KPCT	100.0	1000.0
AS-252424	BRSK1	80.7	10000.0
WYE-125132	MST3	96.0	10000.0
RO-3306	INSR	42.0	10000.0
Baricitinib	BUB1	22.0	10000.0
Torkinib	RIOK2	38.0	10000.0
TGX221	SRPK2	100.0	1000.0
PD173074	EPHA4	100.0	10000.0
Dactolisib	KC1G2	100.0	1000.0
ZM-447439	JNK3	42.0	10000.0
THZ1	ACVR2B	46.0	10000.0
BI-2536	MARK1	100.0	10000.0
Crizotinib	PIK3CA(H1047L)	48.0	10000.0
HG-9-91-01	FLT3(N841I)	36.0	10000.0
JNK-IN-5A	MLK2	100.0	10000.0
SCH772984	TRKC	76.0	1000.0
Canertinib	PKN1	100.0	1000.0
ALW-II-49-7	AURKC	100.0	10000.0
AZD-6482	NDR1	100.0	10000.0
XMD8-85	MET(Y1235D)	100.0	10000.0
PHA-767491	PIK3CA	96.0	10000.0
XMD11-85h	CTK	100.0	10000.0
BX-912	RPS6KA4(Kin.Dom.1-N-terminal)	2.1	10000.0
Ceritinib	DCLK1	12.0	1000.0
BGJ398	PKAC-beta	100.0	1000.0
NPK76-II-72-1	BRAF(V600E)	100.0	10000.0
Pictilisib	FER	83.0	1000.0
WH-4-023	YANK3	19.0	10000.0
PHA-767491	MK14	99.0	10000.0
CGP60474	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
Neratinib	KPCD3	65.0	10000.0
JNK-IN-5A	EPHA2	100.0	10000.0
CGP60474	ABL1(Y253F)	100.0	10000.0
PHA-767491	ABL1(T315I)-nonphosphorylated	60.0	10000.0
JWE-035	PLK2	100.0	10000.0
GSK429286A	RPS6KA5(Kin.Dom.2-C-terminal)	87.0	10000.0
BMS-536924	PIP5K2B	3.8	1000.0
OTSSP167	PIK3CA(E545K)	4.7	10000.0
Dinaciclib	PI42C	97.0	10000.0
CH5424802	EGFR(T790M)	41.0	1000.0
Sorafenib	CDK15	19.0	10000.0
Dinaciclib	M3K5	86.0	10000.0
XMD11-50	DCAMKL3	90.0	10000.0
Ribociclib	MLK2	86.0	1000.0
XMD16-144	DCAMKL3	0.5	10000.0
Taselisib	VRK2	100.0	1000.0
NG25	KIT(V559D,V654A)	2.7	10000.0
SP600125	MET	100.0	10000.0
QL-XII-47	TIE1	100.0	1000.0
KIN001-220	FLT3	0.7	10000.0
BX-912	TYK2(JH2domain-pseudokinase)	0.0	10000.0
AG1478	LTK	48.0	10000.0
NG25	DCAMKL2	100.0	10000.0
Vemurafenib	MST2	1.9	10000.0
JWE-035	MTOR	39.0	10000.0
WZ4003	FLT3	3.9	1000.0
ZM-447439	KCC4	100.0	10000.0
Canertinib	CLK3	100.0	1000.0
JNK-IN-11	ACVR2B	9.6	1000.0
AZD-6482	CDK11	91.0	10000.0
WZ-4-145	WEE2	100.0	10000.0
KIN001-127	CDC2L1	100.0	10000.0
5z-7-oxozeaenol	RIOK1	15.0	10000.0
KIN001-127	ABL1(H396P)	100.0	10000.0
Canertinib	ANKK1	100.0	1000.0
JNK-IN-8	PRP4	100.0	1000.0
BGJ398	ABL1(Q252H)-phosphorylated	80.0	1000.0
Sigma A6730	PKN2	92.0	10000.0
CH5424802	RET(V804L)	0.7	1000.0
Buparlisib	BMX	100.0	1000.0
BMS345541	ITK	100.0	10000.0
XMD13-2	GSK3A	84.0	10000.0
AZ-628	PLK4	87.0	10000.0
ZM-447439	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
Alpelisib	DMPK	100.0	1000.0
NU7441	TNK1	100.0	10000.0
JNK-IN-11	CDKL3	100.0	1000.0
Sigma A6730	PAK6	85.0	10000.0
Palbociclib	MK03	100.0	1000.0
ALW-II-49-7	MET	100.0	10000.0
GW843682X	RSK1(Kin.Dom.1-N-terminal)	96.0	10000.0
Ribociclib	PIK3CB	100.0	1000.0
ERK5-IN-1	M4K1	94.0	1000.0
Baricitinib	CDK16	95.0	10000.0
BX-912	SRPK3	6.2	10000.0
BI-2536	FGFR4	100.0	10000.0
XMD8-85	MAP3K1	100.0	10000.0
NG25	INSRR	23.0	10000.0
KIN001-123	FLT4	0.6	1000.0
Vemurafenib	KPCL	100.0	10000.0
BS-181	RSK4(Kin.Dom.2-C-terminal)	96.0	10000.0
WZ3105	PDPK1	100.0	10000.0
Barasertib	FAK2	100.0	10000.0
MRT67307	PIK3CA(C420R)	100.0	10000.0
CGP74514A	SIK2	44.0	10000.0
JNK-IN-5A	FYN	63.0	10000.0
Ribociclib	KIT	100.0	1000.0
Abemaciclib	PFCDPK1(P.falciparum)	60.0	1000.0
RO-3306	DYRK2	8.0	10000.0
PLX-4720	MAP4K2	74.0	10000.0
XMD14-99	ERK3	100.0	10000.0
Vemurafenib	HUNK	9.1	10000.0
PHA-793887	CDK4-cyclinD3	3.8	10000.0
WYE-125132	RET(M918T)	73.0	10000.0
ZG-10	CSNK1A1	27.0	10000.0
HG-5-88-01	YANK3	33.0	10000.0
KIN001-111	MARK3	100.0	1000.0
HG-14-8-02	BRAF	56.0	10000.0
Ribociclib	PKN1	100.0	1000.0
SB590885	CSNK1D	4.0	10000.0
AZD-6482	AAK1	95.0	10000.0
WZ-4-145	RPS6KA6(Kin.Dom.1)	100.0	10000.0
PLX-4720	PFPK5(P.falciparum)	91.0	10000.0
Torin1	MP2K5	100.0	10000.0
XMD8-92	DRAK2	100.0	10000.0
WH-4-023	KC1G2	33.0	10000.0
AZD-6482	JAK3(JH1domain-catalytic)	94.0	10000.0
BMS-536924	RPS6KA3(Kin.Dom.1)	100.0	1000.0
HG-6-64-01	JAK1(JH2domain-pseudokinase)	41.0	10000.0
BI-2536	ZAP70	100.0	10000.0
Momelotinib	WNK1	75.0	10000.0
HG-6-64-01	RIPK4	56.0	10000.0
QL-XII-47	BRSK1	84.0	1000.0
GW-5074	GRK7	73.0	10000.0
GW843682X	ABL1(Q252H)-phosphorylated	73.0	10000.0
HG-5-113-01	MP2K6	29.0	10000.0
Barasertib	RPS6KA4(Kin.Dom.2-C-terminal)	79.0	10000.0
Ibrutinib	PAK2	92.0	1000.0
XMD13-2	ADCK3	78.0	10000.0
BGJ398	M3K5	87.0	1000.0
MLN8054	AKT2	100.0	10000.0
AZD4547	CDK3	83.0	10000.0
SCH772984	ABL1-nonphosphorylated	70.0	1000.0
BMS345541	ERK3	27.0	10000.0
GSK1059615	MP2K7	38.0	10000.0
Sigma A6730	PGFRB	72.0	10000.0
SCH772984	TNIK	29.0	1000.0
AZD-6482	TLK1	96.0	10000.0
KU63794	MET(M1250T)	100.0	10000.0
QL-X-138	ACVR2B	21.0	10000.0
Taselisib	KGP2	96.0	1000.0
ZG-10	ABL1(F317I)-phosphorylated	96.0	10000.0
AG1478	MARK1	100.0	10000.0
ALW-II-49-7	TAOK3	100.0	10000.0
Ibrutinib	RSK3(Kin.Dom.2-C-terminal)	100.0	1000.0
KIN001-021	PIP5K1A	100.0	1000.0
Ibrutinib	EPHA8	52.0	1000.0
CP724714	MK01	100.0	10000.0
PHA-767491	FGR	98.0	10000.0
HG-6-64-01	INSR	79.0	10000.0
XMD-12	HIPK1	95.0	1000.0
GW-5074	TNNI3K	76.0	10000.0
Baricitinib	MLK1	63.0	10000.0
WZ3105	AURKC	69.0	10000.0
ALW-II-49-7	PHKG1	100.0	10000.0
WZ4002	MUSK	100.0	10000.0
SCH772984	EIF2AK1	100.0	1000.0
Lapatinib	FES	89.0	10000.0
JNK-IN-8	MAPKAPK2	100.0	1000.0
ALW-II-49-7	TIE2	100.0	10000.0
Palbociclib	DAPK1	45.0	1000.0
(s)-CR8	MYLK2	100.0	10000.0
CG-930	SRMS	89.0	10000.0
BMS345541	EPHB6	44.0	10000.0
Canertinib	CAMK1	100.0	1000.0
BGJ398	JNK1	83.0	1000.0
Neratinib	CDK11	100.0	10000.0
Palbociclib	IKKA	100.0	1000.0
BMX-IN-1	KGP1	100.0	10000.0
KU63794	ABL2	95.0	10000.0
ALW-II-38-3	KC1G2	100.0	10000.0
Pictilisib	SYK	97.0	1000.0
R406	AAK1	12.0	1000.0
GSK1059615	PIP5K1A	48.0	10000.0
CP724714	HCK	58.0	10000.0
Dabrafenib	VGFR1	28.0	10000.0
(s)-CR8	CSNK2A1	100.0	10000.0
KIN001-220	DYRK2	18.0	10000.0
5z-7-oxozeaenol	PAK1	93.0	10000.0
KIN001-021	PIM1	100.0	1000.0
XMD-12	HIPK3	72.0	1000.0
Sigma A6730	EGFR(L858R)	53.0	10000.0
Ribociclib	ABL1(M351T)-phosphorylated	100.0	1000.0
HG-6-64-01	EGFR(E746-A750del)	3.8	10000.0
CP466722	VGFR2	52.0	10000.0
GSK1059615	ACVRL1	85.0	10000.0
ZM-447439	MET(Y1235D)	3.8	10000.0
MRT67307	EGFR(G719C)	90.0	10000.0
MRT67307	KIT(V559D,V654A)	16.0	10000.0
Sigma A6730	M3K5	83.0	10000.0
PD0325901	MELK	80.0	10000.0
Ibrutinib	MP2K1	18.0	1000.0
AS-252424	JAK3(JH1domain-catalytic)	85.1	10000.0
HG-14-8-02	FGFR2	97.0	10000.0
Canertinib	KKCC1	100.0	1000.0
Dabrafenib	PIK3CA(I800L)	100.0	10000.0
Torin2	KIT(V559D,V654A)	100.0	10000.0
XMD14-99	EGFR(L747-S752del,P753S)	89.0	10000.0
BMS345541	KC1G2	97.0	10000.0
AZD 5438	NEK6	63.0	10000.0
NU7441	TNIK	100.0	10000.0
Dinaciclib	KPCD1	73.0	10000.0
ALW-II-38-3	ABL1(M351T)	3.4	1000.0
Canertinib	AURKA	100.0	1000.0
NVP-TAE684	IKKA	100.0	1000.0
HG-6-64-01	CDC2L2	5.4	10000.0
WZ4003	AAK1	5.2	1000.0
MRT67307	GSK3A	100.0	10000.0
ZM-447439	KIT(D816V)	42.0	10000.0
GW843682X	RPS6KA4(Kin.Dom.1-N-terminal)	69.0	10000.0
BX-912	LTK	66.0	10000.0
JNK-9L	NUAK1	100.0	10000.0
NPK76-II-72-1	CAMK1G	100.0	10000.0
WYE-125132	SRC	75.0	10000.0
Alpelisib	NEK7	100.0	1000.0
Vemurafenib	KPCD1	8.2	10000.0
Abemaciclib	TRPM6	100.0	1000.0
MPS-1-IN-1	DAPK1	100.0	1000.0
QL-XII-47	PIK3CA(H1047L)	83.0	1000.0
JNK-IN-8	TYK2(JH1domain-catalytic)	96.0	1000.0
Sigma A6730	NEK1	100.0	10000.0
KIN001-123	INSRR	100.0	1000.0
GW843682X	CDK9	100.0	10000.0
JNK-IN-5A	FLT3(ITD)	97.0	10000.0
Momelotinib	TTK	22.0	10000.0
XMD8-92	NEK6	100.0	10000.0
PLX-4720	TNIK	24.0	10000.0
NU7441	LTK	93.0	10000.0
CH5424802	NEK11	100.0	1000.0
QL-X-138	PIP5K1C	42.0	10000.0
BMX-IN-1	ACVR2B	84.0	10000.0
GSK461364	PIK3CA(H1047Y)	32.0	10000.0
MPS-1-IN-1	IKKB	100.0	1000.0
SB590885	KGP2	29.0	10000.0
Sorafenib	BRSK1	92.0	10000.0
Vemurafenib	FLT3(D835Y)	29.0	10000.0
Seliciclib	DDR1	100.0	10000.0
GW843682X	STK36	76.0	10000.0
Baricitinib	KIT(V559D,T670I)	63.0	10000.0
Momelotinib	LATS2	74.0	10000.0
Dabrafenib	KPCI	51.0	10000.0
HG-5-113-01	MST1R	100.0	10000.0
Omipalisib	CDKL3	73.0	10000.0
Abemaciclib	SIK3	100.0	1000.0
JNK-IN-8	JAK3(JH1domain-catalytic)	87.0	1000.0
XMD13-2	ERBB4	95.0	10000.0
CG-930	ABL1(F317I)-nonphosphorylated	91.0	10000.0
XMD14-99	DYRK2	89.0	10000.0
CGP60474	PIK3CA(H1047Y)	100.0	10000.0
Sorafenib	DDR2	14.0	10000.0
Torkinib	EPHA7	61.0	10000.0
BI-2536	NUAK1	100.0	10000.0
XMD16-144	MYO3B	100.0	10000.0
AZD-6482	EPHA2	70.0	10000.0
CP466722	PCTK2	59.0	10000.0
Seliciclib	NLK	100.0	10000.0
Lapatinib	RPS6KA5(Kin.Dom.1-N-terminal)	67.0	10000.0
Omipalisib	TNK1	71.0	10000.0
BS-181	ABL1(T315I)-phosphorylated	88.0	10000.0
Dabrafenib	CLK4	97.0	10000.0
Torin1	CAMKK2	85.0	10000.0
Pictilisib	TNIK	73.0	1000.0
Omipalisib	EGFR(G719C)	72.0	10000.0
RO-3306	BUB1	93.0	10000.0
Sorafenib	PIK4CB	84.0	10000.0
PHA-793887	FLT3(D835H)	100.0	10000.0
Neratinib	RET(V804M)	91.0	10000.0
XMD-12	MST2	27.0	1000.0
AZ-628	CAMK1G	100.0	10000.0
SCH772984	CSF1R	83.0	1000.0
BI-2536	MINK	100.0	10000.0
Abemaciclib	TESK1	97.0	1000.0
Canertinib	M3K12	100.0	1000.0
PD0325901	MTOR	100.0	10000.0
GW-5074	KKCC1	7.6	10000.0
HG-9-91-01	PDPK1	100.0	10000.0
ALW-II-38-3	HIPK2	100.0	10000.0
TGX221	CSF1R	100.0	1000.0
AZD7762	LOK	0.0	10000.0
XMD14-99	YES	95.0	10000.0
ZSTK474	SRPK2	100.0	1000.0
BMX-IN-1	MLK3	87.0	10000.0
GW-5074	CDK9	93.0	10000.0
PHA-793887	PCTK2	1.1	10000.0
5z-7-oxozeaenol	MLK3	84.0	10000.0
JNK-IN-5A	JAK1(JH1domain-catalytic)	78.0	10000.0
Omipalisib	TLK1	98.0	10000.0
Ceritinib	MELK	85.0	1000.0
WYE-125132	MINK	100.0	10000.0
Pictilisib	CDK4-cyclinD3	100.0	1000.0
HG-14-8-02	GSK3B	99.0	10000.0
Sigma A6730	MARK4	99.0	10000.0
XMD16-144	ERK4	100.0	10000.0
MRT67307	ABL1(F317L)-nonphosphorylated	52.0	10000.0
PLX-4720	BMPR2	74.0	10000.0
Palbociclib	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	1000.0
GW-5074	EPHA4	100.0	10000.0
A443654	CAMK1D	11.0	10000.0
(s)-CR8	HIPK3	100.0	10000.0
BMS-536924	DMPK2	0.2	1000.0
Lapatinib	NDR2	95.0	10000.0
AZD7762	MARK1	2.6	10000.0
Buparlisib	RET	94.0	1000.0
XMD-12	DCLK1	1.8	1000.0
PHA-793887	MELK	37.0	10000.0
Abemaciclib	BARK1	100.0	1000.0
Canertinib	LTK	100.0	1000.0
MRT67307	ABL1(Y253F)-phosphorylated	31.0	10000.0
MRT67307	MP2K3	49.0	10000.0
ZSTK474	CSNK1D	100.0	1000.0
JW-7-24-1	MP2K4	23.0	10000.0
WZ3105	KIT(V559D)	42.0	10000.0
CH5424802	ALK(L1196M)	0.6	1000.0
AG1478	KIT(A829P)	27.0	10000.0
JW-7-24-1	FYN	100.0	10000.0
AZ-628	CDK14	100.0	10000.0
(s)-CR8	WNK3	75.0	10000.0
CGP74514A	FAK2	18.0	10000.0
TAK-715	PAK1	76.0	10000.0
CP724714	JNK3	68.0	10000.0
CG-930	EPHA1	100.0	10000.0
XMD-12	TAOK2	0.6	1000.0
JNK-IN-5A	LATS2	75.0	10000.0
Torin2	KC1G2	100.0	10000.0
QL-X-138	LATS1	100.0	10000.0
NVP-TAE684	MP2K3	0.8	1000.0
QL-XI-92	AURKB	100.0	10000.0
CH5424802	ULK1	71.0	1000.0
XMD13-2	GRK4	14.0	10000.0
WZ-7043	CSNK2A1	100.0	10000.0
JW-7-24-1	ERK5	100.0	10000.0
WYE-125132	MAP4K4	85.0	10000.0
Taselisib	KIT(V559D,T670I)	100.0	1000.0
ERK5-IN-1	EPHB2	100.0	1000.0
PLX-4720	ABL1-phosphorylated	43.0	10000.0
Torin1	MKNK2	54.0	10000.0
BMX-IN-1	ERBB4	18.0	10000.0
NU7441	CSK	100.0	10000.0
NVP-TAE684	PIK3CD	100.0	1000.0
XMD-12	STK35	96.0	1000.0
BMX-IN-1	MLTK	12.0	10000.0
Pictilisib	PIK3CA(M1043I)	0.4	1000.0
BMS345541	FGFR1	100.0	10000.0
Seliciclib	AMPK-alpha2	91.0	10000.0
JNK-IN-11	MKNK2	100.0	1000.0
MRT67307	CLK1	1.5	10000.0
WH-4-023	ACVR1B	1.0	10000.0
BMS-536924	MK03	100.0	1000.0
CGP60474	SgK110	100.0	10000.0
(s)-CR8	RPS6KA5(Kin.Dom.2-C-terminal)	95.0	10000.0
QL-XI-92	ULK2	100.0	10000.0
TGX221	CDK15	100.0	1000.0
WZ3105	EPHA3	54.0	10000.0
QL-XI-92	AKT3	100.0	10000.0
BX-912	TAOK2	5.3	10000.0
WYE-125132	NUAK1	82.0	10000.0
Torkinib	EPHA5	55.0	10000.0
Buparlisib	TYK2(JH2domain-pseudokinase)	100.0	1000.0
GW-5074	SRC	100.0	10000.0
Seliciclib	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
Dactolisib	CSNK2A1	100.0	1000.0
MPS-1-IN-1	TSSK1	100.0	1000.0
AZD4547	MARK2	2.8	10000.0
AZD4547	NEK6	89.0	10000.0
BMX-IN-1	KIT(V559D,V654A)	100.0	10000.0
THZ1	PLK2	2.4	10000.0
Ibrutinib	LIMK2	97.0	1000.0
Barasertib	CSNK1D	71.0	10000.0
ERK5-IN-1	IGF1R	100.0	1000.0
ALW-II-38-3	JAK1(JH2domain-pseudokinase)	100.0	10000.0
NU7441	MK14	98.0	10000.0
HG-5-88-01	WEE1	100.0	10000.0
XMD-12	FLT3(K663Q)	85.0	1000.0
WYE-125132	MARK4	94.0	10000.0
(s)-CR8	OSR1	64.0	10000.0
(s)-CR8	FGR	93.0	10000.0
Barasertib	MKNK1	68.0	10000.0
(s)-CR8	AURKB	82.0	10000.0
Torin2	WEE2	100.0	10000.0
Dactolisib	SIK3	100.0	1000.0
WYE-125132	SGK1	100.0	10000.0
Buparlisib	PIM1	100.0	1000.0
Sorafenib	ABL1(T315I)-nonphosphorylated	0.4	10000.0
WZ-4-145	SYK	100.0	10000.0
Ceritinib	EPHA7	100.0	1000.0
HG-14-8-02	CDKL1	56.0	10000.0
OTSSP167	IGF1R	31.0	10000.0
Vemurafenib	CLK3	92.0	10000.0
SP600125	CHEK1	100.0	10000.0
NVP-TAE684	HIPK1	100.0	1000.0
TGX221	ULK2	100.0	1000.0
ERK5-IN-1	TIE2	100.0	1000.0
Dinaciclib	FLT3(N841I)	76.0	10000.0
CP466722	CSNK1A1L	32.0	10000.0
BMX-IN-1	ULK1	100.0	10000.0
AZD7762	FLT3(ITD)	0.0	10000.0
Sigma A6730	CDK8	100.0	10000.0
THZ1	YANK3	32.0	10000.0
MRT67307	RSK3(Kin.Dom.2-C-terminal)	73.0	10000.0
Ibrutinib	HIPK3	75.0	1000.0
THZ1	ABL1-nonphosphorylated	0.7	10000.0
(s)-CR8	NLK	12.0	10000.0
Sigma A6730	PIP5K1C	29.0	10000.0
BS-181	PLK2	96.0	10000.0
BMS345541	PIK3CG	100.0	10000.0
XMD11-50	EGFR(G719S)	86.0	10000.0
PHA-793887	MRCKB	89.0	10000.0
XMD11-50	NDR2	100.0	10000.0
Palbociclib	FLT3(D835H)	75.0	1000.0
WYE-125132	MP2K7	100.0	10000.0
Sigma A6730	CLK2	90.0	10000.0
(s)-CR8	EGFR(L747-E749del,A750P)	81.0	10000.0
ZSTK474	CSNK1E	100.0	1000.0
Baricitinib	NEK6	9.6	10000.0
Baricitinib	PIM2	100.0	10000.0
Buparlisib	ROCK2	100.0	1000.0
5z-7-oxozeaenol	YES	100.0	10000.0
CGP60474	RIPK4	100.0	10000.0
Vemurafenib	BMPR1B	34.0	10000.0
CH5424802	MTOR	100.0	1000.0
KIN001-127	TTK	100.0	10000.0
HG-9-91-01	FAK2	3.6	10000.0
AZ-628	ABL1(Q252H)-phosphorylated	3.0	10000.0
WZ-7043	RPS6KA1(Kin.Dom.2)	100.0	10000.0
TGX221	DYRK1B	100.0	1000.0
AG1478	MLK2	100.0	10000.0
HG-14-8-02	ABL1(H396P)-phosphorylated	63.0	10000.0
Omipalisib	TIE2	83.0	10000.0
Alpelisib	STK33	100.0	1000.0
XMD8-85	MET	100.0	10000.0
Abemaciclib	RET(V804L)	100.0	1000.0
XMD11-85h	ROCK2	100.0	10000.0
AZ-628	EPHA3	5.1	10000.0
Baricitinib	AKT1	55.0	10000.0
Palbociclib	BMPR1B	100.0	1000.0
GSK429286A	DDR2	100.0	10000.0
AG1478	SNARK	49.0	10000.0
BS-181	AAK1	100.0	10000.0
BGJ398	PIK4CB	94.0	1000.0
Buparlisib	BMPR1B	100.0	1000.0
KIN001-021	PAK1	100.0	1000.0
Dabrafenib	GSK3B	95.0	10000.0
MLN8054	TGFBR1	98.0	10000.0
Ribociclib	MLK3	100.0	1000.0
AZD-6482	JAK1(JH2domain-pseudokinase)	100.0	10000.0
QL-X-138	NEK2	100.0	10000.0
GW-5074	EPHB4	100.0	10000.0
HG-9-91-01	IRAK1	15.0	10000.0
CH5424802	KKCC1	18.0	1000.0
WZ-4-145	MKNK2	100.0	10000.0
KIN001-127	SRPK1	100.0	10000.0
SB590885	ABL1-nonphosphorylated	10.0	10000.0
KIN001-111	PAK2	100.0	1000.0
Lapatinib	RIOK3	81.0	10000.0
Ceritinib	EPHA5	94.0	1000.0
JW-7-24-1	RET(V804M)	100.0	10000.0
AZD 5438	MYLK	24.0	10000.0
XMD16-144	IKKB	100.0	10000.0
JNK-IN-11	FGFR3	100.0	1000.0
MLN8054	PLK3	18.0	10000.0
JNK-IN-8	CDKL3	100.0	1000.0
Barasertib	GCN2(Kin.Dom.2,S808G)	62.0	10000.0
HG-14-10-04	STK33	3.0	10000.0
HG-14-8-02	M3K12	100.0	10000.0
WZ3105	TLK2	100.0	10000.0
PHA-767491	FGFR3	100.0	10000.0
Dinaciclib	MP2K7	95.0	10000.0
QL-XI-92	FLT3(D835Y)	100.0	10000.0
SCH772984	MAP3K15	50.0	1000.0
Canertinib	ERK5	100.0	1000.0
Buparlisib	FER	100.0	1000.0
Dabrafenib	YANK1	83.0	10000.0
JW-7-24-1	TNNI3K	19.0	10000.0
JNK-IN-5A	KIT-autoinhibited	96.0	10000.0
AZ-628	HUNK	100.0	10000.0
AZ-628	PIK3CA(H1047Y)	100.0	10000.0
PD0325901	PAK3	100.0	10000.0
GW843682X	WEE1	83.0	10000.0
WZ4002	TNNI3K	100.0	10000.0
ZM-447439	PKN1	100.0	10000.0
JNK-IN-8	ACVRL1	96.0	1000.0
HG-6-64-01	EGFR(G719S)	0.0	10000.0
ZM-447439	SNARK	94.0	10000.0
KU63794	EPHB3	98.0	10000.0
Omipalisib	PIK3CB	9.2	10000.0
QL-XII-47	VGFR1	78.0	1000.0
Ceritinib	MYLK	41.0	1000.0
HG-6-64-01	PAK3	6.0	10000.0
WZ3105	CLK2	0.5	10000.0
TAK-715	FRK	36.0	10000.0
CGP60474	MST3	100.0	10000.0
Omipalisib	ABL1(F317I)-phosphorylated	64.0	10000.0
Dinaciclib	ACVR2A	98.0	10000.0
WZ4003	TNIK	100.0	1000.0
Dabrafenib	KPCD	83.0	10000.0
GSK1059615	ERK5	59.0	10000.0
Vemurafenib	CDK5	96.0	10000.0
NPK76-II-72-1	PCTK3	100.0	10000.0
THZ1	ULK3	0.3	10000.0
ALW-II-49-7	PKN1	100.0	10000.0
Alpelisib	JNK1	89.0	1000.0
BMS345541	CTK	100.0	10000.0
AZD4547	PIP5K1A	19.0	10000.0
Taselisib	PAK6	93.0	1000.0
Neratinib	BRAF	95.0	10000.0
HG-5-113-01	BMPR1A	100.0	10000.0
QL-XII-47	MP2K7	98.0	1000.0
QL-XII-47	BMX	43.0	1000.0
5z-7-oxozeaenol	TYRO3	69.0	10000.0
Torin2	TRKB	72.0	10000.0
KIN001-021	RPS6KA4(Kin.Dom.1)	100.0	1000.0
PHA-767491	CDK5	54.0	10000.0
ZM-447439	ABL1(F317I)-nonphosphorylated	20.0	10000.0
ZG-10	CDKL5	60.0	10000.0
Ibrutinib	TNIK	100.0	1000.0
WZ4003	MARK1	12.0	1000.0
XMD11-50	MRCKB	100.0	10000.0
GSK461364	PIK3CA	52.0	10000.0
KIN001-123	CSNK1D	100.0	1000.0
CGP74514A	EGFR(G719S)	65.0	10000.0
Baricitinib	NEK4	100.0	10000.0
Seliciclib	MP2K2	82.0	10000.0
ZM-447439	PKAC-beta	100.0	10000.0
Ibrutinib	CSNK1G3	100.0	1000.0
BMS-536924	FYN	0.9	1000.0
KIN001-111	MST2	23.0	1000.0
HG-5-113-01	MST1	4.2	10000.0
NG25	NDR2	7.2	10000.0
WZ4003	AMPK-alpha2	100.0	1000.0
Neratinib	MK01	100.0	10000.0
KIN001-220	PKN1	56.0	10000.0
XMD11-50	M3K12	81.0	10000.0
AZD 5438	ZAP70	41.0	10000.0
JNK-IN-11	KPCI	46.0	1000.0
Torkinib	BRAF(V600E)	4.4	10000.0
Dinaciclib	MINK	81.0	10000.0
PLX-4720	PAK2	37.0	10000.0
SB590885	MK13	87.0	10000.0
ZG-10	STK33	100.0	10000.0
Vemurafenib	KIT(D816V)	52.0	10000.0
ALW-II-49-7	MP2K4	100.0	10000.0
SP600125	MP2K2	6.0	10000.0
Lapatinib	ABL1-nonphosphorylated	100.0	10000.0
Sigma A6730	AURKC	88.0	10000.0
Ribociclib	M4K1	100.0	1000.0
KIN001-220	TYRO3	79.0	10000.0
MLN8054	RIPK4	100.0	10000.0
JNK-IN-11	MRCKA	13.0	1000.0
Abemaciclib	MST1R	97.0	1000.0
CGP74514A	ERK8	0.2	10000.0
PD173074	CAMK2G	100.0	10000.0
ALW-II-38-3	ABL1(H396P)	11.0	1000.0
CGP74514A	MAK	85.0	10000.0
NPK76-II-72-1	MK01	100.0	10000.0
Torin2	DAPK3	81.0	10000.0
CG-930	EPHA2	99.0	10000.0
JNK-IN-5A	MP2K5	100.0	10000.0
OTSSP167	MAK	69.0	10000.0
Omipalisib	OSR1	78.0	10000.0
WZ-7043	NDR2	100.0	10000.0
HG-6-64-01	CSNK1E	45.0	10000.0
Torin1	NDR1	100.0	10000.0
Momelotinib	EGFR	100.0	10000.0
TAK-715	FGFR1	72.0	10000.0
CP724714	MK13	100.0	10000.0
RO-3306	WNK1	79.0	10000.0
A443654	TIE2	100.0	10000.0
AG1478	RSK4(Kin.Dom.2-C-terminal)	38.0	10000.0
XMD8-85	WEE2	100.0	10000.0
Canertinib	MRCKB	100.0	1000.0
HG-5-113-01	BTK	0.7	10000.0
Neratinib	HUNK	86.0	10000.0
Omipalisib	ERBB3	100.0	10000.0
XMD16-144	ABL1(E255K)-phosphorylated	0.1	10000.0
NVP-TAE684	LOK	0.0	1000.0
PD173074	FLT3(D835Y)	100.0	10000.0
Barasertib	BMX	88.0	10000.0
Buparlisib	IRAK1	100.0	1000.0
JNK-IN-8	CDC2L5	100.0	1000.0
Barasertib	MK12	89.0	10000.0
HG-6-64-01	ADCK4	100.0	10000.0
QL-X-138	MP2K1	69.0	10000.0
PLX-4720	ABL1(Q252H)-nonphosphorylated	1.0	10000.0
JWE-035	MAP3K15	74.0	10000.0
ZG-10	KGP2	76.0	10000.0
QL-XII-47	ABL1(Q252H)-phosphorylated	100.0	1000.0
Barasertib	MP2K6	99.0	10000.0
JNK-IN-11	EPHA5	98.0	1000.0
KIN001-123	MK01	100.0	1000.0
Dinaciclib	TYRO3	90.0	10000.0
MPS-1-IN-1	RPS6KA5(Kin.Dom.2)	100.0	1000.0
HG-9-91-01	TESK1	0.0	10000.0
GSK1059615	TYK2(JH1domain-catalytic)	38.0	10000.0
CP466722	MAP4K4	69.0	10000.0
KIN001-021	ALK	100.0	1000.0
XMD-12	S6K1	100.0	1000.0
Pictilisib	RSK2(Kin.Dom.2-C-terminal)	79.0	1000.0
GSK461364	PGFRA	100.0	10000.0
KIN001-123	RIOK3	100.0	1000.0
KIN001-111	MARK1	100.0	1000.0
XMD16-144	MET(Y1235D)	77.0	10000.0
BMS345541	CDK16	52.0	10000.0
CH5424802	MK14	100.0	1000.0
RO-3306	KIT(V559D)	25.0	10000.0
ERK5-IN-1	SRPK1	100.0	1000.0
Abemaciclib	CSK	100.0	1000.0
Baricitinib	WEE2	100.0	10000.0
5z-7-oxozeaenol	MP2K7	61.0	10000.0
CGP60474	MP2K2	100.0	10000.0
HG-14-10-04	ALK(C1156Y)	1.4	10000.0
NU7441	FAK1	70.0	10000.0
WYE-125132	DDR1	66.0	10000.0
GSK461364	INSR	100.0	10000.0
Neratinib	MLK2	88.0	10000.0
Torin2	CDK4-cyclinD1	100.0	10000.0
ERK5-IN-1	ACVR2B	100.0	1000.0
XMD8-92	MARK4	100.0	10000.0
XMD16-144	FLT3(D835Y)	1.4	10000.0
AG1478	LKB1	86.0	10000.0
TGX221	MST3	100.0	1000.0
TGX221	PIP5K1A	100.0	1000.0
PHA-767491	LATS2	8.0	10000.0
XMD8-85	ERK3	100.0	10000.0
KIN001-021	KPCD3	100.0	1000.0
CH5424802	BMX	100.0	1000.0
GW-5074	TNIK	2.7	10000.0
ZG-10	VGFR2	36.0	10000.0
Neratinib	DMPK2	100.0	10000.0
SP600125	EPHB1	100.0	10000.0
BGJ398	PIP5K2B	100.0	1000.0
XMD11-50	GRK1	91.0	10000.0
BGJ398	GRK7	100.0	1000.0
KIN001-021	CLK1	100.0	1000.0
Crizotinib	NDR1	68.0	10000.0
RO-3306	YANK3	92.0	10000.0
BI-2536	NLK	100.0	10000.0
AS-252424	CAMK2G	100.0	10000.0
CG-930	WEE2	98.0	10000.0
5z-7-oxozeaenol	WNK3	75.0	10000.0
(s)-CR8	ABL1(E255K)-phosphorylated	87.0	10000.0
KIN001-220	GCN2(Kin.Dom.2,S808G)	0.4	10000.0
Ribociclib	FLT3(R834Q)	100.0	1000.0
Dinaciclib	TBK1	84.0	10000.0
Neratinib	IRAK1	65.0	10000.0
HG-6-64-01	CSNK1A1L	100.0	10000.0
Omipalisib	KPCD2	100.0	10000.0
ALW-II-38-3	KCC4	100.0	10000.0
GW843682X	PIK3CG	18.0	10000.0
WZ4002	TXK	16.0	10000.0
Palbociclib	IRAK4	100.0	1000.0
R406	FGR	1.6	1000.0
Dabrafenib	PRP4	94.0	10000.0
HG-5-88-01	SRPK2	100.0	10000.0
JNK-IN-5A	CAMK2A	92.0	10000.0
Dabrafenib	IRAK3	61.0	10000.0
XMD11-50	CDK7	86.0	10000.0
Sorafenib	ACVR1	100.0	10000.0
GSK429286A	ABL1(Q252H)-phosphorylated	82.0	10000.0
XMD13-2	FGFR3(G697C)	100.0	10000.0
GW-5074	MET(Y1235D)	72.0	10000.0
BGJ398	LTK	63.0	1000.0
NVP-TAE684	MYLK4	100.0	1000.0
BS-181	AMPK-alpha2	91.0	10000.0
CP466722	TAOK2	42.0	10000.0
NG25	KGP1	100.0	10000.0
XMD8-92	ACVR2A	100.0	10000.0
KIN001-127	ACVR1	100.0	10000.0
Torkinib	PI42C	9.9	10000.0
NVP-TAE684	CAMKK2	0.1	1000.0
OTSSP167	CSNK2A2	0.1	10000.0
Torin2	CSNK1A1	94.0	10000.0
OTSSP167	PKAC-alpha	0.4	10000.0
Crizotinib	PAK7	49.0	10000.0
GSK429286A	NEK11	100.0	10000.0
HG-9-91-01	PIK3CA(H1047Y)	100.0	10000.0
R406	YSK1	12.0	1000.0
Dabrafenib	PHKG2	90.0	10000.0
XMD16-144	EIF2AK1	100.0	10000.0
Pictilisib	CSNK1D	66.0	1000.0
Sigma A6730	SIK1	100.0	10000.0
GSK461364	PRKR	76.0	10000.0
PD0325901	RIOK3	100.0	10000.0
CH5424802	LTK	3.5	1000.0
CGP60474	HIPK1	4.6	10000.0
PHA-793887	FYN	72.0	10000.0
KIN001-021	ACVR1	100.0	1000.0
KIN001-111	STK36	0.0	1000.0
RO-3306	SGK3	48.0	10000.0
5z-7-oxozeaenol	TAOK3	76.0	10000.0
ALW-II-38-3	PIK3C2B	100.0	10000.0
BMS-536924	PIM1	100.0	1000.0
GW-5074	LCK	38.0	10000.0
Taselisib	PHKG1	100.0	1000.0
WH-4-023	EIF2AK1	100.0	10000.0
Omipalisib	LRRK2(G2019S)	79.0	10000.0
ZSTK474	RET(V804L)	100.0	1000.0
XMD16-144	CDKL1	83.0	10000.0
NPK76-II-72-1	AAK1	100.0	10000.0
GW843682X	TLK2	100.0	10000.0
Dactolisib	FLT3(ITD)	100.0	1000.0
Pictilisib	NEK7	100.0	1000.0
CG-930	LKB1	100.0	10000.0
GSK429286A	CLK2	54.0	10000.0
XMD11-85h	PKAC-beta	100.0	10000.0
SCH772984	KGP2	96.0	1000.0
Buparlisib	MYLK	76.0	1000.0
TAK-715	KPCE	87.0	10000.0
BGJ398	SRPK2	100.0	1000.0
HG-14-8-02	ROCK2	79.0	10000.0
PLX-4720	MP2K3	53.0	10000.0
WH-4-023	ULK1	31.0	10000.0
WZ4002	GSK3B	100.0	10000.0
XMD14-99	FAK2	42.0	10000.0
PD0325901	ACVR2B	66.0	10000.0
THZ1	RPS6KA4(Kin.Dom.2-C-terminal)	61.0	10000.0
PLX-4720	PIK3CA(Q546K)	86.0	10000.0
Sorafenib	IRAK3	81.0	10000.0
KIN001-220	SRMS	58.0	10000.0
Palbociclib	RET(V804M)	93.0	1000.0
Torin2	TAOK3	80.0	10000.0
GSK1059615	CDKL2	64.0	10000.0
Neratinib	BTK	4.4	10000.0
GW-5074	NEK11	100.0	10000.0
AZD 5438	ABL1(Y253F)-phosphorylated	10.0	10000.0
HG-5-88-01	PKAC-alpha	100.0	10000.0
KIN001-111	KPCL	100.0	1000.0
Sigma A6730	EGFR(L861Q)	66.0	10000.0
JW-7-24-1	STK36	7.2	10000.0
GSK429286A	LRRK2	100.0	10000.0
CP724714	CDKL2	91.0	10000.0
TAK-715	ACVR2A	70.0	10000.0
KIN001-127	NEK7	14.0	10000.0
CG-930	FAK2	91.0	10000.0
AZD 5438	BMPR1B	0.2	10000.0
AZD7762	STK16	21.0	10000.0
XMD8-92	CAMK1	100.0	10000.0
CH5424802	ABL1(E255K)-phosphorylated	75.0	1000.0
CGP74514A	CSNK2A2	0.7	10000.0
AZD4547	PIK3CD	82.0	10000.0
TAK-715	EPHA1	56.0	10000.0
Sorafenib	JAK1(JH1domain-catalytic)	50.0	10000.0
CG-930	ABL1-phosphorylated	34.0	10000.0
XMD11-85h	ABL1(Q252H)	100.0	10000.0
Ceritinib	MYLK4	100.0	1000.0
MLN8054	DRAK1	1.9	10000.0
JW-7-24-1	TAOK1	0.1	10000.0
Ribociclib	BARK2	100.0	1000.0
WZ4003	CHK2	12.0	1000.0
HG-14-8-02	ERN1	59.0	10000.0
GSK429286A	CSF1R	68.0	10000.0
BS-181	KIT(A829P)	100.0	10000.0
HG-9-91-01	PIK3CA(H1047L)	100.0	10000.0
XMD11-85h	NDR1	100.0	10000.0
JNK-IN-5A	BIKE	86.0	10000.0
AZD 5438	PIK3CA(E545A)	41.0	10000.0
MRT67307	PLK3	51.0	10000.0
SP600125	BTK	100.0	10000.0
Crizotinib	FER	2.0	10000.0
WZ4003	AKT2	100.0	1000.0
NU7441	ABL1(H396P)-nonphosphorylated	62.0	10000.0
Torin1	SRPK3	86.0	10000.0
HG-6-64-01	TRKA	2.5	10000.0
BMS345541	PLK3	94.0	10000.0
XMD8-85	ABL1(Y253F)	100.0	10000.0
HG-14-8-02	JAK3(JH1domain-catalytic)	0.0	10000.0
Ceritinib	PIK3CA(Q546K)	79.0	1000.0
AG1478	FLT3(ITD)	24.0	10000.0
Torkinib	MET	73.0	10000.0
ALW-II-49-7	FGFR1	100.0	10000.0
JW-7-24-1	DRAK1	100.0	10000.0
PHA-767491	SRPK3	92.0	10000.0
Dinaciclib	ULK2	51.0	10000.0
MLN8054	CSNK2A2	3.4	10000.0
MLN8054	SNARK	85.0	10000.0
PHA-767491	MST3	90.0	10000.0
Omipalisib	TAOK2	84.0	10000.0
JNK-IN-11	ABL1(F317L)-phosphorylated	27.0	1000.0
BGJ398	WEE2	92.0	1000.0
QL-X-138	NEK5	100.0	10000.0
Torin1	JAK2(JH1domain-catalytic)	65.0	10000.0
Pictilisib	MP2K7	97.0	1000.0
GSK461364	JAK1(JH2domain-pseudokinase)	92.0	10000.0
JNK-IN-11	KPCL	100.0	1000.0
WZ4003	AURKA	100.0	1000.0
GW-5074	CSNK2A2	3.2	10000.0
PLX-4720	MET(M1250T)	78.0	10000.0
CGP74514A	TAOK1	1.4	10000.0
Sigma A6730	JAK1(JH2domain-pseudokinase)	79.0	10000.0
QL-X-138	PIK3CA(E545K)	21.0	10000.0
BMS345541	CHEK1	91.0	10000.0
NU7441	EGFR(E746-A750del)	69.0	10000.0
KU63794	EGFR(L747-E749del,A750P)	100.0	10000.0
OTSSP167	ALK	6.6	10000.0
BMS345541	BRAF	95.0	10000.0
GW843682X	SRMS	58.0	10000.0
Sigma A6730	KIT(D816V)	79.0	10000.0
(s)-CR8	MET(M1250T)	65.0	10000.0
QL-XII-47	CDK3	100.0	1000.0
ZG-10	MAP3K1	100.0	10000.0
AZD4547	ANKK1	45.0	10000.0
Baricitinib	LIMK2	65.0	10000.0
Ceritinib	DCAMKL2	6.0	1000.0
SB590885	PKAC-beta	74.0	10000.0
ZG-10	GAK	3.6	10000.0
Buparlisib	FLT3(K663Q)	100.0	1000.0
Neratinib	RIPK4	77.0	10000.0
BMS-536924	ABL1(Q252H)	22.0	1000.0
Dinaciclib	PKMYT1	97.0	10000.0
XMD11-85h	MLK3	100.0	10000.0
WZ4002	EPHA4	100.0	10000.0
Omipalisib	DYRK1A	54.0	10000.0
JNK-9L	MYO3B	100.0	10000.0
Alpelisib	ZAP70	100.0	1000.0
HG-14-10-04	PAK3	6.4	10000.0
NPK76-II-72-1	CDK15	100.0	10000.0
HG-14-10-04	EGFR(L861Q)	0.0	10000.0
ERK5-IN-1	RIPK2	100.0	1000.0
XMD8-85	JNK3	100.0	10000.0
JNK-IN-8	KCC4	100.0	1000.0
WYE-125132	EPHA8	81.0	10000.0
WZ4002	BMPR1B	100.0	10000.0
Seliciclib	M3K6	100.0	10000.0
KIN001-123	CDK11	100.0	1000.0
XMD11-85h	JAK1(JH1domain-catalytic)	100.0	10000.0
GSK429286A	EGFR(T790M)	40.0	10000.0
Ribociclib	FLT3	90.0	1000.0
Torkinib	PFPK5(P.falciparum)	93.0	10000.0
AZD-6482	ACVRL1	89.0	10000.0
WZ4003	ABL1	100.0	1000.0
BX-912	EGFR(L858R,T790M)	26.0	10000.0
NU7441	SRMS	62.0	10000.0
NG25	MP2K4	100.0	10000.0
Sorafenib	KPCD3	67.0	10000.0
BGJ398	FLT3(N841I)	44.0	1000.0
AS-252424	CSF1R	92.5	10000.0
Torin2	ABL1(H396P)-phosphorylated	84.0	10000.0
SCH772984	ERK4	89.0	1000.0
NG25	ULK1	100.0	10000.0
MLN8054	NLK	82.0	10000.0
Baricitinib	LYN	78.0	10000.0
KIN001-021	PKAC-alpha	100.0	1000.0
BMS-536924	ERK8	100.0	1000.0
Torin1	BTK	88.0	10000.0
BMS-536924	FLT3(D835Y)	0.0	1000.0
BI-2536	SIK1	100.0	10000.0
KIN001-021	FGFR3(G697C)	100.0	1000.0
CG-930	TNK1	97.0	10000.0
HG-6-64-01	FGFR2	3.7	10000.0
(s)-CR8	CDK11	99.0	10000.0
(s)-CR8	FGFR3	93.0	10000.0
HG-5-113-01	CDK16	22.0	10000.0
BX-912	LATS1	21.0	10000.0
PHA-793887	RSK2(Kin.Dom.2-C-terminal)	100.0	10000.0
Ribociclib	KIT(A829P)	98.0	1000.0
CG-930	RSK1(Kin.Dom.1-N-terminal)	98.0	10000.0
ZM-447439	LKB1	100.0	10000.0
NVP-TAE684	ABL1(H396P)	6.4	1000.0
XMD16-144	MLTK	79.0	10000.0
QL-X-138	LRRK2	38.0	10000.0
JNK-9L	SYK	25.0	10000.0
MLN8054	EPHA2	4.9	10000.0
CH5424802	EGFR(L747-T751del,Sins)	20.0	1000.0
GW843682X	CDK11	100.0	10000.0
BMS345541	RIOK3	100.0	10000.0
SB590885	FYN	79.0	10000.0
Ribociclib	CDK16	98.0	1000.0
AZD7762	EPHA8	0.4	10000.0
Sorafenib	CDK9	81.0	10000.0
HG-5-113-01	CLK1	0.2	10000.0
BMX-IN-1	FLT3(D835H)	100.0	10000.0
GSK429286A	PIP5K2B	100.0	10000.0
ALW-II-38-3	TBK1	100.0	10000.0
SB590885	CAMK2A	88.0	10000.0
Sigma A6730	HCK	90.0	10000.0
Buparlisib	HIPK1	100.0	1000.0
CG-930	PCTK2	100.0	10000.0
Taselisib	KCC2D	97.0	1000.0
WZ-4-145	RPS6KA2(Kin.Dom.1)	100.0	10000.0
PHA-793887	ALK	100.0	10000.0
TAK-715	FAK2	78.0	10000.0
HG-6-64-01	MAST1	100.0	10000.0
JWE-035	GRK1	78.0	10000.0
PHA-767491	ERK5	60.0	10000.0
XMD14-99	CLK4	50.0	10000.0
OTSSP167	RSK2(Kin.Dom.2-C-terminal)	3.2	10000.0
WH-4-023	M3K6	93.0	10000.0
Buparlisib	CSF1R-autoinhibited	21.0	1000.0
Dabrafenib	MP2K6	56.0	10000.0
Seliciclib	KPCL	100.0	10000.0
ALW-II-38-3	ACVR2B	100.0	10000.0
AZ-628	LYN	0.3	10000.0
PHA-767491	KPCD2	3.4	10000.0
NU7441	CSNK1G3	100.0	10000.0
AZD7762	PAK3	0.5	10000.0
JNK-IN-8	MARK1	100.0	1000.0
PHA-767491	RSK1(Kin.Dom.1-N-terminal)	93.0	10000.0
Sorafenib	STK35	34.0	10000.0
Neratinib	M3K5	100.0	10000.0
Dabrafenib	CAMK1D	1.6	10000.0
Dactolisib	PIK3C2G	4.4	1000.0
JNK-9L	KIT(V559D,V654A)	42.0	10000.0
GSK429286A	HCK	41.0	10000.0
Lapatinib	SNRK	100.0	10000.0
WZ-4-145	TESK1	100.0	10000.0
HG-9-91-01	MLCK	100.0	10000.0
WZ4002	KPCE	100.0	10000.0
XMD8-85	MK11	100.0	10000.0
KIN001-127	MP2K4	100.0	10000.0
PD0325901	CDC2L1	97.0	10000.0
AZ-628	CAMK2A	100.0	10000.0
CG-930	SIK1	100.0	10000.0
Torin2	BRAF(V600E)	95.0	10000.0
PHA-767491	DRAK2	32.0	10000.0
Ceritinib	RET	100.0	1000.0
AZD4547	KIT-autoinhibited	0.1	10000.0
Torin1	FER	96.0	10000.0
HG-5-88-01	KKCC1	18.0	10000.0
Ribociclib	EGFR(L861Q)	100.0	1000.0
ZM-447439	MARK1	100.0	10000.0
Taselisib	MLTK	97.0	1000.0
Torin1	EGFR(G719C)	82.0	10000.0
Dinaciclib	INSRR	95.0	10000.0
GSK429286A	MK11	92.0	10000.0
A443654	ULK2	12.0	10000.0
RO-3306	CLK2	2.9	10000.0
R406	DCAMKL3	1.0	1000.0
Torin1	ANKK1	93.0	10000.0
ZG-10	CAMK1G	64.0	10000.0
GSK1059615	JNK1	18.0	10000.0
XMD8-85	ANKK1	100.0	10000.0
CP466722	HIPK4	6.0	10000.0
Neratinib	AURKB	75.0	10000.0
NG25	SIK1	4.6	10000.0
A443654	MAP4K5	24.0	10000.0
JNK-IN-8	MAP3K3	95.0	1000.0
HG-14-8-02	TGFBR2	100.0	10000.0
KIN001-021	ADCK3	100.0	1000.0
SCH772984	DAPK1	62.0	1000.0
SB590885	EPHA8	100.0	10000.0
JNK-IN-8	VGFR1	100.0	1000.0
GSK461364	TNK1	87.0	10000.0
XMD16-144	NEK3	58.0	10000.0
HG-5-113-01	CDK11	100.0	10000.0
5z-7-oxozeaenol	TRPM6	88.0	10000.0
Buparlisib	ABL1(Q252H)-nonphosphorylated	91.0	1000.0
JNK-IN-11	YANK3	99.0	1000.0
CH5424802	PKAC-beta	100.0	1000.0
THZ1	EPHA4	35.0	10000.0
Alpelisib	MARK1	92.0	1000.0
HG-14-10-04	LATS1	14.0	10000.0
5z-7-oxozeaenol	CDK9	79.0	10000.0
XMD13-2	FLT3(K663Q)	61.0	10000.0
NPK76-II-72-1	MST2	100.0	10000.0
WZ-4-145	NLK	100.0	10000.0
JWE-035	AMPK-alpha1	2.4	10000.0
BI-D1870	ABL1(T315I)	3.7	10000.0
5z-7-oxozeaenol	KPCD2	2.5	10000.0
QL-X-138	LOK	94.0	10000.0
HG-14-10-04	DDR1	6.0	10000.0
Torin1	ABL1(H396P)-phosphorylated	81.0	10000.0
CGP60474	PIK3CD	100.0	10000.0
Alpelisib	MLTK	85.0	1000.0
KIN001-220	JAK3(JH1domain-catalytic)	3.7	10000.0
XMD8-85	JAK1(JH1domain-catalytic)	100.0	10000.0
BGJ398	NEK3	93.0	1000.0
Torin2	EGFR(L747-E749del,A750P)	100.0	10000.0
5z-7-oxozeaenol	RSK1(Kin.Dom.1-N-terminal)	74.0	10000.0
MPS-1-IN-1	TAK1	100.0	1000.0
MLN8054	KCC2D	95.0	10000.0
CH5424802	RIPK5	100.0	1000.0
AZ-628	STK35	75.0	10000.0
HG-5-88-01	MET	100.0	10000.0
GSK461364	LOK	0.0	10000.0
Canertinib	PKMYT1	100.0	1000.0
5z-7-oxozeaenol	NDR2	99.0	10000.0
TAK-715	PKAC-beta	95.0	10000.0
Dactolisib	ROCK1	100.0	1000.0
NU7441	ERBB2	100.0	10000.0
QL-XII-47	TRKC	100.0	1000.0
KU63794	PRKX	100.0	10000.0
HG-9-91-01	ERK5	0.1	10000.0
CG-930	CIT	96.0	10000.0
Vemurafenib	MUSK	99.0	10000.0
SCH772984	KPCD3	87.0	1000.0
GSK461364	EGFR(G719S)	100.0	10000.0
AZD 5438	SIK1	27.0	10000.0
Torin1	BLK	75.0	10000.0
ERK5-IN-1	CSNK1A1L	99.0	1000.0
Neratinib	M3K12	36.0	10000.0
THZ1	MP2K6	38.0	10000.0
A443654	FLT3(N841I)	0.1	10000.0
PHA-793887	TRPM6	100.0	10000.0
AG1478	FLT3(R834Q)	58.0	10000.0
Torin1	PCTK3	97.0	10000.0
WZ-7043	NEK2	100.0	10000.0
ALW-II-49-7	NEK2	100.0	10000.0
XMD8-85	ABL1(F317L)	17.0	10000.0
Omipalisib	CSNK1E	81.0	10000.0
Buparlisib	MARK2	100.0	1000.0
GW843682X	ABL2	79.0	10000.0
XMD11-50	MP2K5	85.0	10000.0
HG-5-113-01	PDPK1	100.0	10000.0
Taselisib	CHEK1	100.0	1000.0
Momelotinib	MAP4K2	40.0	10000.0
BX-912	PHKG2	8.9	10000.0
SCH772984	AXL	67.0	1000.0
Dinaciclib	ABL1(T315I)-phosphorylated	84.0	10000.0
PHA-793887	FAK2	100.0	10000.0
Omipalisib	PIK4CB	0.4	10000.0
Crizotinib	PDPK1	100.0	10000.0
XMD8-92	GAK	31.0	10000.0
THZ1	ABL1(E255K)-phosphorylated	1.0	10000.0
QL-X-138	MST3	95.0	10000.0
GSK461364	PIP5K1C	18.0	10000.0
WH-4-023	MP2K7	85.0	10000.0
Sorafenib	YANK1	100.0	10000.0
JWE-035	HUNK	59.0	10000.0
PD173074	CDK9	100.0	10000.0
AS-252424	MKNK2	73.0	10000.0
PLX-4720	TBK1	100.0	10000.0
Sigma A6730	KPCD1	86.0	10000.0
Torin1	IKKA	41.0	10000.0
WZ-7043	CSF1R	0.2	10000.0
JNK-IN-8	MYO3B	89.0	1000.0
PHA-793887	KPCD3	11.0	10000.0
QL-XI-92	PIK3CA	76.0	10000.0
JNK-IN-8	TBK1	100.0	1000.0
ZM-447439	HIPK3	52.0	10000.0
CH5424802	PLK3	100.0	1000.0
GW-5074	MLK1	47.0	10000.0
Torkinib	M3K12	84.0	10000.0
ZG-10	EGFR(L858R,T790M)	100.0	10000.0
PD0325901	NEK6	100.0	10000.0
CGP74514A	TRKA	2.4	10000.0
Crizotinib	DCAMKL3	42.0	10000.0
NU7441	ACVR2A	96.0	10000.0
JW-7-24-1	MK09	100.0	10000.0
AZD7762	DMPK	12.0	10000.0
AS-252424	ITK	100.0	10000.0
KIN001-123	DRAK1	100.0	1000.0
Dabrafenib	ICK	72.0	10000.0
Vemurafenib	MAP3K1	91.0	10000.0
Buparlisib	ABL1(Q252H)-phosphorylated	100.0	1000.0
XMD-12	MUSK	100.0	1000.0
Lapatinib	ABL1(F317I)-nonphosphorylated	100.0	10000.0
BMS-536924	FGFR3	2.6	1000.0
Momelotinib	ZAP70	91.0	10000.0
JNK-IN-11	CSNK2A1	74.0	1000.0
Ibrutinib	M3K13	84.0	1000.0
HG-14-10-04	CAMK2B	6.6	10000.0
QL-X-138	ABL1(M351T)-phosphorylated	64.0	10000.0
Baricitinib	MLK3	56.0	10000.0
HG-14-10-04	MAP3K3	13.0	10000.0
XMD13-2	RIPK5	71.0	10000.0
RO-3306	SBK1	38.0	10000.0
R406	ADCK3	14.0	1000.0
JNK-IN-8	TNK1	60.0	1000.0
HG-14-8-02	MLK1	22.0	10000.0
JWE-035	PTK6	29.0	10000.0
QL-X-138	MKNK2	0.2	10000.0
BI-2536	PIK3CA	100.0	10000.0
AZ-628	YANK3	100.0	10000.0
HG-5-113-01	PRKR	100.0	10000.0
THZ1	NDR1	80.0	10000.0
Abemaciclib	MP2K1	100.0	1000.0
QL-XII-47	SNARK	68.0	1000.0
RO-3306	BLK	79.0	10000.0
BX-912	ERN1	34.0	10000.0
QL-XII-47	RSK1(Kin.Dom.1-N-terminal)	72.0	1000.0
JNK-IN-11	PCTK2	100.0	1000.0
MRT67307	MARK1	5.0	10000.0
QL-X-138	MYLK4	88.0	10000.0
Momelotinib	MP2K2	100.0	10000.0
JNK-IN-5A	IKKE	100.0	10000.0
BMS-536924	CHEK1	100.0	1000.0
Baricitinib	WEE1	77.0	10000.0
RO-3306	FAK1	100.0	10000.0
BGJ398	ICK	87.0	1000.0
5z-7-oxozeaenol	HCK	45.0	10000.0
HG-14-10-04	BTK	16.0	10000.0
RO-3306	RPS6KA4(Kin.Dom.2-C-terminal)	2.5	10000.0
Barasertib	STK36	37.0	10000.0
Torkinib	NEK4	90.0	10000.0
Sigma A6730	KCC4	100.0	10000.0
CH5424802	AAK1	72.0	1000.0
RO-3306	CDK4-cyclinD1	93.0	10000.0
HG-14-8-02	SBK1	99.0	10000.0
KIN001-021	ABL1(E255K)	100.0	1000.0
ERK5-IN-1	MAP3K15	95.0	1000.0
MLN8054	CDK11	96.0	10000.0
JNK-9L	MAP3K1	100.0	10000.0
CP724714	EPHA8	98.0	10000.0
KIN001-021	TNIK	100.0	1000.0
Ribociclib	OSR1	100.0	1000.0
XMD14-99	SGK3	100.0	10000.0
XMD13-2	MYLK	63.0	10000.0
GSK429286A	NEK6	70.0	10000.0
ALW-II-38-3	CDC2L1	100.0	10000.0
QL-XII-47	TNK1	16.0	1000.0
5z-7-oxozeaenol	MK01	64.0	10000.0
BS-181	RIOK1	59.0	10000.0
PD0325901	M3K2	100.0	10000.0
Buparlisib	JAK3(JH1domain-catalytic)	100.0	1000.0
BMS-536924	MET	1.3	1000.0
XMD-12	TNK1	1.0	1000.0
ERK5-IN-1	LYN	100.0	1000.0
Lapatinib	KIT(V559D,T670I)	82.0	10000.0
NVP-TAE684	CLK1	0.4	1000.0
NVP-TAE684	CDK11	100.0	1000.0
XMD14-99	TNNI3K	82.0	10000.0
GW843682X	TLK1	96.0	10000.0
ALW-II-38-3	RIPK1	100.0	10000.0
WZ4002	STK33	1.3	10000.0
Pictilisib	RET	91.0	1000.0
Barasertib	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	10000.0
NPK76-II-72-1	RAF1	100.0	10000.0
5z-7-oxozeaenol	EPHB3	100.0	10000.0
AZD 5438	ERK8	0.0	10000.0
GW843682X	PAK1	100.0	10000.0
XMD16-144	DAPK2	69.0	10000.0
MLN8054	M3K13	100.0	10000.0
JNK-IN-11	RIPK1	73.0	1000.0
CP466722	PGFRB	3.4	10000.0
MLN8054	CHK2	100.0	10000.0
AS-252424	CAMK1G	80.8	10000.0
BMS-536924	PIP5K1A	2.9	1000.0
WZ-4-145	BMPR1A	100.0	10000.0
NVP-TAE684	CDK7	0.2	1000.0
HG-5-113-01	AMPK-alpha1	4.6	10000.0
ZM-447439	CDK4-cyclinD1	93.0	10000.0
BS-181	FLT3(D835H)	73.0	10000.0
XMD14-99	EGFR(G719S)	88.0	10000.0
CGP60474	STK35	100.0	10000.0
Crizotinib	ICK	66.0	10000.0
QL-X-138	ACVR1	29.0	10000.0
SB590885	TAOK2	65.0	10000.0
GSK1059615	HIPK1	6.9	10000.0
XMD8-92	M4K1	100.0	10000.0
Baricitinib	CDKL5	100.0	10000.0
XMD13-2	NEK9	100.0	10000.0
BS-181	EGFR(T790M)	88.0	10000.0
HG-6-64-01	FLT3(N841I)	0.3	10000.0
PHA-793887	PFCDPK1(P.falciparum)	100.0	10000.0
NPK76-II-72-1	PIM1	100.0	10000.0
BS-181	EIF2AK1	91.0	10000.0
Ceritinib	RPS6KA5(Kin.Dom.1-N-terminal)	96.0	1000.0
GSK1059615	ABL1(F317I)-nonphosphorylated	89.0	10000.0
AG1478	KIT(V559D)	16.0	10000.0
HG-6-64-01	EPHA6	0.0	10000.0
Vemurafenib	PAK4	86.0	10000.0
KIN001-021	MYO3B	100.0	1000.0
PD0325901	INSR	92.0	10000.0
Baricitinib	ABL1-nonphosphorylated	19.0	10000.0
Taselisib	M3K13	100.0	1000.0
Omipalisib	MAP3K1	73.0	10000.0
ERK5-IN-1	RET(M918T)	100.0	1000.0
MPS-1-IN-1	BIKE	100.0	1000.0
SCH772984	NEK4	100.0	1000.0
Taselisib	RSK3(Kin.Dom.2-C-terminal)	91.0	1000.0
ALW-II-49-7	KPCD1	100.0	10000.0
Omipalisib	CDK16	93.0	10000.0
RO-3306	AMPK-alpha2	91.0	10000.0
TGX221	EGFR(L747-T751del,Sins)	100.0	1000.0
OTSSP167	M3K6	0.4	10000.0
Torkinib	PKN1	85.0	10000.0
AZ-628	KGP1	100.0	10000.0
XMD14-99	EGFR(G719C)	91.0	10000.0
WH-4-023	PIK3CA(Q546K)	81.0	10000.0
RO-3306	PI42C	60.0	10000.0
XMD13-2	CAMK2A	88.0	10000.0
CGP74514A	DYRK2	31.0	10000.0
MPS-1-IN-1	ZAP70	100.0	1000.0
BMX-IN-1	GRK4	66.0	10000.0
AZD4547	MAPKAPK2	100.0	10000.0
SCH772984	SNRK	98.0	1000.0
CP724714	CSNK1A1	100.0	10000.0
AG1478	PIK3C2G	43.0	10000.0
5z-7-oxozeaenol	SIK2	66.0	10000.0
QL-X-138	SgK110	100.0	10000.0
Ribociclib	FGFR3(G697C)	100.0	1000.0
QL-XI-92	MK11	4.8	10000.0
XMD8-85	HUNK	100.0	10000.0
PHA-767491	KIT(A829P)	71.0	10000.0
GW-5074	CAMK1G	44.0	10000.0
KIN001-021	BMPR1A	100.0	1000.0
Taselisib	FAK1	96.0	1000.0
HG-14-8-02	MARK1	100.0	10000.0
MLN8054	KIT	62.0	10000.0
R406	RPS6KA1(Kin.Dom.1)	0.9	1000.0
Torin1	KPCE	86.0	10000.0
Omipalisib	KIT	65.0	10000.0
GW843682X	CSNK2A1	30.0	10000.0
AG1478	CDKL5	97.0	10000.0
BGJ398	M3K12	41.0	1000.0
QL-XII-47	CDC2L5	92.0	1000.0
TGX221	PIP5K2B	100.0	1000.0
CP466722	PIK3CA(E545A)	18.0	10000.0
CGP74514A	STK39	74.0	10000.0
BS-181	IKKA	85.0	10000.0
XMD16-144	CAMKK2	8.1	10000.0
WZ4003	CAMKK2	8.4	1000.0
HG-6-64-01	CLK2	71.0	10000.0
Ceritinib	CDK2	99.0	1000.0
XMD11-50	CSNK2A2	93.0	10000.0
JNK-IN-5A	PFCDPK1(P.falciparum)	81.0	10000.0
Sorafenib	WEE1	100.0	10000.0
Ibrutinib	YANK3	84.0	1000.0
Torin2	KIT(D816V)	61.0	10000.0
ZM-447439	STK33	67.0	10000.0
GSK1059615	CDC2L1	95.0	10000.0
Dabrafenib	PCTK2	0.0	10000.0
SB590885	DYRK1A	94.0	10000.0
AZ-628	CDK16	100.0	10000.0
GSK429286A	ABL1(T315I)-phosphorylated	99.0	10000.0
CH5424802	ACVR2B	100.0	1000.0
XMD8-92	FLT3(K663Q)	100.0	10000.0
HG-5-88-01	PLK3	100.0	10000.0
WH-4-023	PAK2	58.0	10000.0
KIN001-220	PIK3CA(E545K)	97.0	10000.0
SP600125	KGP2	100.0	10000.0
JWE-035	ABL1(T315I)-phosphorylated	0.1	10000.0
JW-7-24-1	NEK5	100.0	10000.0
XMD11-85h	BRAF(V600E)	100.0	10000.0
BI-2536	FLT3(N841I)	100.0	10000.0
CP466722	DYRK2	0.3	10000.0
Momelotinib	IGF1R	100.0	10000.0
NG25	EGFR	5.6	10000.0
OTSSP167	JNK3	0.1	10000.0
CGP60474	KPCE	100.0	10000.0
WZ4002	ACVR2B	100.0	10000.0
Omipalisib	HCK	77.0	10000.0
SCH772984	ABL1(H396P)-nonphosphorylated	82.0	1000.0
CH5424802	LYN	32.0	1000.0
PHA-793887	MP2K1	91.0	10000.0
Taselisib	VGFR2	91.0	1000.0
TAK-715	ROCK2	100.0	10000.0
Torkinib	ACVR2A	0.5	10000.0
Abemaciclib	DCAMKL2	53.0	1000.0
NPK76-II-72-1	ABL1(Y253F)	100.0	10000.0
Ribociclib	TAOK1	100.0	1000.0
HG-5-88-01	ADCK3	0.1	10000.0
CH5424802	TYK2(JH1domain-catalytic)	73.0	1000.0
MPS-1-IN-1	IKKE	100.0	1000.0
BMX-IN-1	CASK	100.0	10000.0
CGP74514A	DRAK1	15.0	10000.0
WZ3105	AAK1	45.0	10000.0
WZ3105	RIPK2	100.0	10000.0
Ribociclib	SIK3	87.0	1000.0
Torin1	CDK15	88.0	10000.0
JNK-IN-5A	SGK3	92.0	10000.0
AZD7762	ACVR2A	2.2	10000.0
PHA-793887	CDK4-cyclinD1	0.4	10000.0
NVP-TAE684	TSSK1	0.0	1000.0
HG-5-88-01	RIOK2	100.0	10000.0
Neratinib	TSSK1	100.0	10000.0
XMD11-50	CAMK2A	21.0	10000.0
KU63794	PIP5K1C	100.0	10000.0
5z-7-oxozeaenol	PI42C	92.0	10000.0
XMD8-92	MAPKAPK5	100.0	10000.0
HG-6-64-01	RET(V804M)	0.0	10000.0
Sorafenib	MRCKB	100.0	10000.0
GSK429286A	DCLK1	65.0	10000.0
BMX-IN-1	CDK5	100.0	10000.0
Lapatinib	HUNK	79.0	10000.0
PLX-4720	GSK3B	100.0	10000.0
Dactolisib	ICK	100.0	1000.0
Buparlisib	EPHB1	100.0	1000.0
XMD16-144	ANKK1	6.0	10000.0
Momelotinib	MST3	64.0	10000.0
NG25	EPHB3	100.0	10000.0
Pictilisib	CAMK1G	100.0	1000.0
MPS-1-IN-1	KC1G1	100.0	1000.0
NU7441	CSNK2A1	74.0	10000.0
SCH772984	MARK2	79.0	1000.0
WYE-125132	TRKC	93.0	10000.0
HG-9-91-01	ABL1(Y253F)-phosphorylated	0.4	10000.0
PHA-793887	CLK4	3.8	10000.0
GSK461364	LATS2	42.0	10000.0
ALW-II-38-3	ADCK4	100.0	10000.0
ZM-447439	PHKG2	76.0	10000.0
(s)-CR8	BRAF(V600E)	100.0	10000.0
SB590885	NDR1	90.0	10000.0
R406	CDK2	34.0	1000.0
Momelotinib	RIPK1	63.0	10000.0
AZ-628	FLT3(R834Q)	100.0	10000.0
GW-5074	CAMK2G	40.0	10000.0
Ibrutinib	DYRK1A	83.0	1000.0
GW-5074	AKT3	100.0	10000.0
BGJ398	RIOK2	100.0	1000.0
JNK-9L	ABL1(E255K)-phosphorylated	75.0	10000.0
PHA-793887	ANKK1	65.0	10000.0
ALW-II-38-3	IRAK1	100.0	10000.0
TAK-715	ERK5	98.0	10000.0
MRT67307	NEK7	28.0	10000.0
Dabrafenib	MST3	19.0	10000.0
Torin2	MST1	100.0	10000.0
GW-5074	ROS1	99.0	10000.0
QL-XI-92	M3K12	100.0	10000.0
Alpelisib	PIK3CD	20.0	1000.0
XMD-12	FLT3(ITD)	52.0	1000.0
ALW-II-38-3	RET	100.0	10000.0
BS-181	PAK1	81.0	10000.0
AZD7762	KKCC1	7.0	10000.0
Dinaciclib	CDK5	1.8	10000.0
PD0325901	STK35	83.0	10000.0
(s)-CR8	ROCK2	93.0	10000.0
PD173074	KCC4	100.0	10000.0
5z-7-oxozeaenol	OSR1	87.0	10000.0
AZD7762	TRKA	0.0	10000.0
JNK-IN-8	MINK	71.0	1000.0
QL-X-138	M3K5	100.0	10000.0
Seliciclib	RIOK3	83.0	10000.0
HG-9-91-01	AXL	42.0	10000.0
Baricitinib	EPHA2	57.0	10000.0
KIN001-111	MP2K1	0.5	1000.0
NVP-TAE684	RIPK2	100.0	1000.0
Dabrafenib	LATS1	38.0	10000.0
AG1478	STK39	57.0	10000.0
WZ4003	ULK3	12.0	1000.0
JWE-035	YANK2	100.0	10000.0
Ribociclib	LOK	97.0	1000.0
CGP74514A	CDC2L5	6.2	10000.0
PHA-767491	CTK	100.0	10000.0
KIN001-127	DCAMKL3	4.2	10000.0
Pictilisib	NEK4	100.0	1000.0
NU7441	MLCK	100.0	10000.0
QL-XII-47	ABL1(H396P)-nonphosphorylated	83.0	1000.0
Lapatinib	ERK3	96.0	10000.0
AZD7762	ICK	100.0	10000.0
HG-14-8-02	ABL2	100.0	10000.0
PLX-4720	MARK3	74.0	10000.0
CP466722	RPS6KA4(Kin.Dom.1-N-terminal)	9.9	10000.0
SCH772984	ABL1(Q252H)-phosphorylated	100.0	1000.0
WH-4-023	ITK	100.0	10000.0
Ribociclib	MK14	100.0	1000.0
OTSSP167	MYLK4	6.8	10000.0
JNK-9L	FLT3(D835H)	21.0	10000.0
Pictilisib	ROS1	77.0	1000.0
PHA-767491	KIT(L576P)	78.0	10000.0
CH5424802	FLT3(ITD,D835V)	1.0	1000.0
NPK76-II-72-1	MARK3	100.0	10000.0
Seliciclib	SIK2	100.0	10000.0
CP724714	CDK5	100.0	10000.0
Dabrafenib	M3K5	100.0	10000.0
BMX-IN-1	EPHA2	100.0	10000.0
XMD-12	MK11	88.0	1000.0
HG-14-10-04	EGFR(L747-S752del,P753S)	0.0	10000.0
Neratinib	MP2K1	0.4	10000.0
JNK-IN-8	FLT3	77.0	1000.0
Sigma A6730	RPS6KA5(Kin.Dom.1-N-terminal)	100.0	10000.0
BGJ398	ABL1(E255K)-phosphorylated	67.0	1000.0
XMD16-144	TRKB	4.0	10000.0
JNK-9L	SLK	10.0	10000.0
XMD8-85	EPHB3	100.0	10000.0
CG-930	PHKG2	99.0	10000.0
HG-6-64-01	NDR1	72.0	10000.0
Ceritinib	AKT3	91.0	1000.0
GW-5074	LTK	47.0	10000.0
KIN001-127	KKCC1	100.0	10000.0
HG-5-88-01	RIPK2	100.0	10000.0
HG-6-64-01	SRPK2	28.0	10000.0
KU63794	CDKL3	90.0	10000.0
Momelotinib	ERK8	0.3	10000.0
RO-3306	PRP4	68.0	10000.0
PD0325901	KPCI	70.0	10000.0
Palbociclib	MLK1	94.0	1000.0
Crizotinib	CDKL5	25.0	10000.0
MLN8054	NEK7	100.0	10000.0
OTSSP167	KPCD	6.3	10000.0
PHA-767491	ADCK4	70.0	10000.0
BGJ398	PIM2	77.0	1000.0
HG-14-8-02	PAK6	100.0	10000.0
(s)-CR8	MUSK	96.0	10000.0
BMX-IN-1	TGFBR1	100.0	10000.0
KIN001-111	MLTK	2.0	1000.0
XMD11-50	RIOK3	85.0	10000.0
GW-5074	PIK3CG	71.0	10000.0
WZ4003	KCC2D	100.0	1000.0
Dabrafenib	M3K12	81.0	10000.0
GSK461364	KIT(V559D)	38.0	10000.0
Baricitinib	KIT	56.0	10000.0
JWE-035	MAK	100.0	10000.0
BI-D1870	ULK3	2.2	10000.0
SP600125	EPHA2	100.0	10000.0
AZD4547	CLK3	60.0	10000.0
A443654	SNARK	1.9	10000.0
HG-6-64-01	PIK3CB	100.0	10000.0
5z-7-oxozeaenol	ABL1(Q252H)-nonphosphorylated	88.0	10000.0
BMS-536924	TIE2	27.0	1000.0
WZ4002	ABL1(T315I)	100.0	10000.0
NG25	FAK2	1.2	10000.0
WYE-125132	CSNK2A2	100.0	10000.0
Vemurafenib	BMPR1A	89.0	10000.0
GW843682X	EIF2AK1	87.0	10000.0
KIN001-123	PLK1	100.0	1000.0
BX-912	RPS6KA5(Kin.Dom.2-C-terminal)	31.0	10000.0
JNK-IN-8	HIPK3	100.0	1000.0
Ribociclib	ABL1(T315I)-phosphorylated	100.0	1000.0
Pictilisib	TLK2	100.0	1000.0
XMD13-2	PIK3CG	90.0	10000.0
PD0325901	YSK1	91.0	10000.0
ERK5-IN-1	LOK	100.0	1000.0
ZG-10	SGK3	65.0	10000.0
QL-XII-47	IKKB	100.0	1000.0
Neratinib	TNIK	6.0	10000.0
QL-XII-47	MAP3K1	96.0	1000.0
NVP-TAE684	EGFR	0.1	1000.0
5z-7-oxozeaenol	TRKB	77.0	10000.0
Momelotinib	PIK3CA(E545A)	88.0	10000.0
AZD7762	M3K5	40.0	10000.0
SCH772984	MP2K2	99.0	1000.0
OTSSP167	SIK2	48.0	10000.0
Pictilisib	CDK9	100.0	1000.0
BI-2536	NEK2	17.0	10000.0
RO-3306	ACVR1	62.0	10000.0
Ceritinib	FYN	100.0	1000.0
XMD8-85	FAK2	100.0	10000.0
BMS345541	CAMK1	98.0	10000.0
Buparlisib	CLK3	100.0	1000.0
Lapatinib	RSK1(Kin.Dom.2-C-terminal)	100.0	10000.0
BS-181	MRCKA	100.0	10000.0
Seliciclib	PDPK1	70.0	10000.0
XMD8-92	MP2K1	100.0	10000.0
CP724714	YANK1	100.0	10000.0
AZ-628	AURKB	100.0	10000.0
THZ1	SGK3	89.0	10000.0
PLX-4720	CAMK2A	84.0	10000.0
Dabrafenib	MK13	100.0	10000.0
PLX-4720	EGFR(G719C)	50.0	10000.0
Taselisib	FGFR3(G697C)	100.0	1000.0
XMD16-144	EPHB1	90.0	10000.0
PLX-4720	CDC2L2	95.0	10000.0
BGJ398	EGFR(S752-I759del)	77.0	1000.0
CGP60474	TYRO3	100.0	10000.0
XMD14-99	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
PD0325901	FYN	64.0	10000.0
Sorafenib	INSR	100.0	10000.0
PHA-767491	MET	28.0	10000.0
Ibrutinib	JAK2(JH1domain-catalytic)	77.0	1000.0
KIN001-123	MARK3	100.0	1000.0
XMD14-99	EGFR(S752-I759del)	89.0	10000.0
KIN001-220	FGR	43.0	10000.0
R406	PIP5K2B	8.2	1000.0
ERK5-IN-1	KIT(V559D)	100.0	1000.0
AS-252424	RET(M918T)	85.6	10000.0
JW-7-24-1	BRSK1	100.0	10000.0
AZD 5438	MK13	1.6	10000.0
HG-14-8-02	PAK4	100.0	10000.0
ZG-10	SIK2	90.0	10000.0
SB590885	CDC2L2	98.0	10000.0
Torin2	PIK3C2G	3.5	10000.0
Abemaciclib	EPHA4	100.0	1000.0
QL-XI-92	KGP1	100.0	10000.0
KIN001-220	TRPM6	96.0	10000.0
HG-5-88-01	TRKB	100.0	10000.0
GW-5074	DAPK1	6.2	10000.0
BMS-536924	KPCL	100.0	1000.0
Barasertib	ACVRL1	97.0	10000.0
Baricitinib	RPS6KA5(Kin.Dom.2-C-terminal)	2.8	10000.0
PLX-4720	KPCI	100.0	10000.0
JNK-IN-5A	LIMK2	100.0	10000.0
Palbociclib	NEK6	100.0	1000.0
ALW-II-49-7	ITK	100.0	10000.0
GSK1059615	CDKL5	76.0	10000.0
XMD11-50	M4K3	71.0	10000.0
OTSSP167	ABL1(M351T)-phosphorylated	1.2	10000.0
WH-4-023	KGP1	100.0	10000.0
QL-XI-92	NDR2	88.0	10000.0
KIN001-220	EGFR(L861Q)	52.0	10000.0
TGX221	TIE2	100.0	1000.0
Palbociclib	JAK3(JH1domain-catalytic)	72.0	1000.0
MRT67307	TGFBR1	100.0	10000.0
Torin2	JAK1(JH1domain-catalytic)	92.0	10000.0
JWE-035	CSNK1A1L	74.0	10000.0
WH-4-023	MET(Y1235D)	1.6	10000.0
Sigma A6730	NEK2	100.0	10000.0
NPK76-II-72-1	EGFR(G719S)	100.0	10000.0
WH-4-023	SLK	0.1	10000.0
BS-181	TAK1	89.0	10000.0
QL-XI-92	FAK2	91.0	10000.0
THZ1	LATS1	20.0	10000.0
Alpelisib	BLK	95.0	1000.0
Ceritinib	KPCD1	68.0	1000.0
TGX221	CDK16	100.0	1000.0
CP724714	NEK7	73.0	10000.0
ALW-II-49-7	TRKA	100.0	10000.0
OTSSP167	CLK3	21.0	10000.0
CP724714	PIK3CA(E545K)	100.0	10000.0
AG1478	CAMK1D	83.0	10000.0
TAK-715	FLT3(R834Q)	86.0	10000.0
R406	KCC2D	32.0	1000.0
TAK-715	TBK1	100.0	10000.0
JNK-IN-8	IGF1R	93.0	1000.0
Buparlisib	PAK4	100.0	1000.0
HG-5-113-01	TRKA	0.8	10000.0
Dabrafenib	RIPK2	2.6	10000.0
CG-930	KPCD	93.0	10000.0
HG-5-88-01	NEK5	100.0	10000.0
SCH772984	RET(V804M)	94.0	1000.0
BX-912	MLK3	0.8	10000.0
KIN001-220	EPHA6	46.0	10000.0
Seliciclib	PIK3CA	100.0	10000.0
HG-5-113-01	TSSK1	100.0	10000.0
PD0325901	FRK	60.0	10000.0
AZD4547	STK16	0.3	10000.0
Torin2	GRK4	92.0	10000.0
WYE-125132	KGP1	100.0	10000.0
Crizotinib	TIE1	4.4	10000.0
AZD4547	MARK3	1.2	10000.0
Ribociclib	BMPR2	93.0	1000.0
CGP60474	MAPKAPK2	100.0	10000.0
ZM-447439	M3K12	35.0	10000.0
TGX221	VGFR2	100.0	1000.0
SCH772984	MUSK	100.0	1000.0
MPS-1-IN-1	PDPK1	100.0	1000.0
XMD14-99	SIK2	100.0	10000.0
CGP74514A	GCN2(Kin.Dom.2,S808G)	42.0	10000.0
PD0325901	MET(Y1235D)	100.0	10000.0
HG-9-91-01	KIT(L576P)	0.8	10000.0
Omipalisib	PIK3CA(E545A)	0.2	10000.0
MLN8054	RIPK5	100.0	10000.0
GSK461364	ABL1(F317L)-phosphorylated	100.0	10000.0
Crizotinib	VRK2	100.0	10000.0
THZ1	TRKB	1.4	10000.0
Abemaciclib	LIMK2	90.0	1000.0
Momelotinib	JAK3(JH1domain-catalytic)	0.3	10000.0
A443654	BRAF(V600E)	100.0	10000.0
BGJ398	TNIK	50.0	1000.0
KIN001-220	PDPK1	96.0	10000.0
JNK-9L	MAP3K4	50.0	10000.0
HG-9-91-01	KIT-autoinhibited	1.6	10000.0
ERK5-IN-1	ADCK3	59.0	1000.0
(s)-CR8	MK11	96.0	10000.0
PLX-4720	ACVR1	100.0	10000.0
XMD11-50	PIK3CA(C420R)	89.0	10000.0
(s)-CR8	LATS2	83.0	10000.0
XMD14-99	MARK1	95.0	10000.0
QL-XI-92	PGFRA	41.0	10000.0
XMD11-50	CAMK1G	74.0	10000.0
Torin1	BRAF(V600E)	88.0	10000.0
WZ4002	MK09	100.0	10000.0
Lapatinib	CAMKK2	100.0	10000.0
XMD16-144	MST2	0.0	10000.0
Dinaciclib	CSNK1A1L	27.0	10000.0
TAK-715	FLT3(K663Q)	17.0	10000.0
ZM-447439	KC1G1	97.0	10000.0
Taselisib	FLT3(K663Q)	100.0	1000.0
ERK5-IN-1	RIOK3	89.0	1000.0
BS-181	CDK16	75.0	10000.0
5z-7-oxozeaenol	BLK	57.0	10000.0
BX-912	TNK1	1.4	10000.0
JNK-IN-5A	RAF1	100.0	10000.0
JNK-IN-8	ABL1(F317I)-phosphorylated	100.0	1000.0
QL-XII-47	SGK1	100.0	1000.0
SP600125	EPHA1	100.0	10000.0
Barasertib	FRK	90.0	10000.0
HG-9-91-01	EPHB6	0.9	10000.0
QL-X-138	PIM2	69.0	10000.0
BMS345541	MP2K6	88.0	10000.0
ALW-II-49-7	RPS6KA1(Kin.Dom.1)	100.0	10000.0
ALW-II-38-3	EGFR(G719S)	100.0	10000.0
JNK-9L	EPHA3	58.0	10000.0
ALW-II-49-7	MAP4K4	100.0	10000.0
HG-9-91-01	CSNK2A1	59.0	10000.0
Torin2	ABL1(T315I)-nonphosphorylated	100.0	10000.0
PD0325901	GSK3B	68.0	10000.0
XMD16-144	MST1R	93.0	10000.0
KIN001-021	PIP5K2B	100.0	1000.0
Dabrafenib	MTOR	89.0	10000.0
QL-XI-92	SRC	49.0	10000.0
QL-XI-92	SYK	100.0	10000.0
MLN8054	TNIK	61.0	10000.0
Dinaciclib	PIK3CA(C420R)	92.0	10000.0
Torin1	SNRK	60.0	10000.0
TGX221	DMPK2	100.0	1000.0
ZSTK474	MLK3	100.0	1000.0
CGP74514A	ERK4	2.7	10000.0
Baricitinib	MST2	33.0	10000.0
PLX-4720	ABL1(Y253F)-phosphorylated	27.0	10000.0
XMD8-92	FRK	100.0	10000.0
AZ-628	HIPK3	86.0	10000.0
PD0325901	IRAK3	100.0	10000.0
MPS-1-IN-1	ABL1(T315I)	100.0	1000.0
Ceritinib	GSK3B	100.0	1000.0
XMD14-99	CSF1R	67.0	10000.0
NPK76-II-72-1	CSNK1A1L	100.0	10000.0
PLX-4720	ERK8	97.0	10000.0
Alpelisib	TLK2	82.0	1000.0
ERK5-IN-1	SNARK	96.0	1000.0
ERK5-IN-1	SIK1	100.0	1000.0
HG-5-113-01	DAPK2	100.0	10000.0
BMX-IN-1	VGFR2	100.0	10000.0
HG-14-10-04	CDC2L1	89.0	10000.0
AG1478	KPCL	100.0	10000.0
Dactolisib	IRAK1	100.0	1000.0
AZD7762	MET(Y1235D)	0.6	10000.0
ERK5-IN-1	RIPK1	100.0	1000.0
AZ-628	ACVR2A	100.0	10000.0
AG1478	PHKG2	93.0	10000.0
MRT67307	LOK	100.0	10000.0
Pictilisib	PGFRB	100.0	1000.0
HG-14-10-04	MET(Y1235D)	4.6	10000.0
AZD7762	BMPR2	0.1	10000.0
GW843682X	PLK1	0.1	10000.0
WZ-4-145	PKAC-beta	100.0	10000.0
JNK-9L	ABL1(Q252H)-phosphorylated	70.0	10000.0
HG-9-91-01	STK16	1.4	10000.0
Taselisib	MK14	100.0	1000.0
PD173074	CSNK1D	100.0	10000.0
Torin2	ACVR1B	96.0	10000.0
BMS-536924	ULK2	6.2	1000.0
ALW-II-49-7	RPS6KA1(Kin.Dom.2)	100.0	10000.0
XMD14-99	BRAF(V600E)	100.0	10000.0
JWE-035	LKB1	89.0	10000.0
Torin2	PKMYT1	94.0	10000.0
Pictilisib	RET(V804L)	100.0	1000.0
WZ4003	JNK3	16.0	1000.0
NVP-TAE684	AXL	0.1	1000.0
PD0325901	CSNK1A1L	80.0	10000.0
XMD11-85h	CDK15	100.0	10000.0
CG-930	ALK	100.0	10000.0
ZG-10	MST2	100.0	10000.0
PHA-767491	M3K13	100.0	10000.0
GSK461364	ACVR1	100.0	10000.0
OTSSP167	MAP3K4	30.0	10000.0
KIN001-111	CDK11	1.1	1000.0
GSK429286A	MAP3K1	90.0	10000.0
QL-XII-47	RET(M918T)	98.0	1000.0
Canertinib	CSK	100.0	1000.0
Ceritinib	EPHA6	96.0	1000.0
XMD14-99	EPHA8	73.0	10000.0
Momelotinib	MUSK	100.0	10000.0
ERK5-IN-1	TRKA	100.0	1000.0
GSK461364	FER	100.0	10000.0
AZD-6482	RIPK2	94.0	10000.0
BS-181	CDK4-cyclinD1	79.0	10000.0
AZD7762	CAMK2B	19.0	10000.0
Ibrutinib	MARK1	84.0	1000.0
BGJ398	MYO3B	97.0	1000.0
CG-930	MK03	32.0	10000.0
Ceritinib	TBK1	76.0	1000.0
QL-X-138	LIMK2	100.0	10000.0
5z-7-oxozeaenol	PIK3CG	100.0	10000.0
NG25	LCK	0.4	10000.0
Ribociclib	CDK4-cyclinD1	0.2	1000.0
AG1478	YSK1	77.0	10000.0
KIN001-220	TRKA	19.0	10000.0
KU63794	YANK3	87.0	10000.0
HG-6-64-01	CAMK2B	100.0	10000.0
KIN001-021	LYN	100.0	1000.0
WZ-7043	MST2	100.0	10000.0
ERK5-IN-1	LIMK2	100.0	1000.0
Crizotinib	PIM2	100.0	10000.0
JNK-IN-11	STK36	2.2	1000.0
GW843682X	CDC2L5	76.0	10000.0
PD173074	LIMK1	100.0	10000.0
BS-181	PIK3CA(E542K)	93.0	10000.0
Barasertib	BIKE	70.0	10000.0
JWE-035	CDK2	68.0	10000.0
NU7441	FGFR3(G697C)	94.0	10000.0
WZ4002	TNK2	18.0	10000.0
PD173074	CLK4	100.0	10000.0
AS-252424	RSK4(Kin.Dom.1-N-terminal)	85.0	10000.0
Ribociclib	SNRK	96.0	1000.0
GSK429286A	CDK16	100.0	10000.0
JNK-9L	CDC2L2	25.0	10000.0
JWE-035	TAOK2	0.1	10000.0
MLN8054	DDR2	3.6	10000.0
JWE-035	MUSK	100.0	10000.0
JNK-IN-11	ULK2	100.0	1000.0
JWE-035	KIT(A829P)	59.0	10000.0
XMD16-144	NEK1	69.0	10000.0
XMD8-92	PIK3CA(E545A)	100.0	10000.0
Sigma A6730	SIK3	88.0	10000.0
Alpelisib	PIM3	93.0	1000.0
WZ4002	TYK2(Kin.Dom.2)	100.0	10000.0
NU7441	CAMK2G	86.0	10000.0
Ibrutinib	RSK4(Kin.Dom.2-C-terminal)	89.0	1000.0
KIN001-111	SRPK3	100.0	1000.0
XMD11-85h	MARK3	100.0	10000.0
JNK-9L	NEK9	63.0	10000.0
QL-X-138	NEK9	100.0	10000.0
Ribociclib	CDKL5	100.0	1000.0
PLX-4720	EGFR(E746-A750del)	93.0	10000.0
CGP74514A	CDK14	7.0	10000.0
ALW-II-49-7	EGFR(E746-A750del)	100.0	10000.0
JW-7-24-1	ACVR1	100.0	10000.0
Dinaciclib	EPHA4	89.0	10000.0
WZ4003	FLT3(ITD)	0.6	1000.0
Ibrutinib	CDK11	88.0	1000.0
Torkinib	AURKB	85.0	10000.0
CH5424802	NEK3	79.0	1000.0
BMS345541	VGFR2	100.0	10000.0
XMD8-85	EPHA6	100.0	10000.0
AZD4547	INSRR	0.2	10000.0
NU7441	ABL1(F317I)-phosphorylated	99.0	10000.0
TGX221	ERK5	100.0	1000.0
Omipalisib	RET(M918T)	87.0	10000.0
QL-XII-47	MP2K2	90.0	1000.0
CGP74514A	PIK4CB	32.0	10000.0
WZ-4-145	BMX	8.9	10000.0
JW-7-24-1	MK13	100.0	10000.0
CGP60474	ABL1(F317L)	100.0	10000.0
BMS345541	SIK1	100.0	10000.0
Dabrafenib	WEE1	100.0	10000.0
QL-XII-47	RET(V804L)	94.0	1000.0
ZM-447439	KIT(V559D,T670I)	1.9	10000.0
(s)-CR8	PIM1	100.0	10000.0
Pictilisib	KPCD	83.0	1000.0
RO-3306	EGFR(L747-S752del,P753S)	72.0	10000.0
GSK461364	ANKK1	26.0	10000.0
BI-2536	PHKG1	100.0	10000.0
Barasertib	MP2K7	91.0	10000.0
XMD13-2	EGFR(T790M)	100.0	10000.0
GW843682X	DYRK1A	75.0	10000.0
ALW-II-49-7	RPS6KA4(Kin.Dom.2)	100.0	10000.0
PHA-767491	MRCKB	89.0	10000.0
QL-XI-92	MYLK4	97.0	10000.0
BS-181	EPHA1	100.0	10000.0
JWE-035	EPHA5	100.0	10000.0
AS-252424	LCK	77.2	10000.0
Baricitinib	PIK4CB	100.0	10000.0
Torkinib	ITK	100.0	10000.0
ZSTK474	STK36	100.0	1000.0
WZ3105	BIKE	19.0	10000.0
XMD8-92	SLK	100.0	10000.0
(s)-CR8	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
Dabrafenib	ABL1-nonphosphorylated	0.3	10000.0
NG25	TAK1	0.1	10000.0
Baricitinib	MERTK	37.0	10000.0
Crizotinib	ANKK1	4.2	10000.0
BI-2536	ABL1	100.0	10000.0
PHA-793887	TAOK2	92.0	10000.0
XMD11-85h	AKT3	100.0	10000.0
Baricitinib	FGFR3(G697C)	70.0	10000.0
PHA-767491	BMPR2	0.9	10000.0
GW843682X	SLK	0.3	10000.0
THZ1	CDC2L1	85.0	10000.0
Lapatinib	TAOK1	98.0	10000.0
WZ4003	LATS1	100.0	1000.0
THZ1	RET(M918T)	0.0	10000.0
HG-6-64-01	KPCL	100.0	10000.0
JNK-IN-5A	EGFR(L747-T751del,Sins)	83.0	10000.0
KU63794	ACVR2A	100.0	10000.0
AS-252424	KIT(V559D,T670I)	80.6	10000.0
ZM-447439	KIT(A829P)	59.0	10000.0
A443654	JAK3(Kin.Dom.2)	32.0	10000.0
KU63794	TSSK1	91.0	10000.0
Alpelisib	CAMK2G	90.0	1000.0
NPK76-II-72-1	JNK3	100.0	10000.0
KIN001-111	ULK2	5.8	1000.0
Palbociclib	MAP3K4	100.0	1000.0
XMD8-85	GCN2(Kin.Dom.2,S808G)	100.0	10000.0
TAK-715	MK14	0.6	10000.0
SCH772984	ABL2	93.0	1000.0
Neratinib	MST3	0.4	10000.0
XMD16-144	MARK1	4.3	10000.0
SB590885	PAK4	92.0	10000.0
MLN8054	PIK3CA(I800L)	84.0	10000.0
JNK-9L	DMPK2	63.0	10000.0
JNK-IN-11	FGR	10.0	1000.0
PHA-767491	ERK4	95.0	10000.0
QL-X-138	PIK3CA(Q546K)	21.0	10000.0
Torkinib	CSNK1A1L	34.0	10000.0
CP724714	NEK9	82.0	10000.0
MPS-1-IN-1	TYK2(Kin.Dom.1)	100.0	1000.0
Omipalisib	MP2K6	53.0	10000.0
XMD11-85h	FLT3(ITD)	100.0	10000.0
PLX-4720	MK14	60.0	10000.0
HG-5-113-01	PIK3CB	100.0	10000.0
Crizotinib	STK39	99.0	10000.0
Dactolisib	MARK1	100.0	1000.0
Sigma A6730	TIE1	100.0	10000.0
Canertinib	CDK9	100.0	1000.0
CP724714	SIK3	76.0	10000.0
WH-4-023	MTOR	100.0	10000.0
BGJ398	PIK3CA(I800L)	82.0	1000.0
HG-14-8-02	GRK4	91.0	10000.0
Abemaciclib	ROS1	36.0	1000.0
JNK-IN-11	HIPK4	70.0	1000.0
Sorafenib	PGFRB	0.0	10000.0
BMX-IN-1	IRAK3	34.0	10000.0
KIN001-127	MAP3K4	12.0	10000.0
Omipalisib	CAMKK2	56.0	10000.0
Dabrafenib	MAP4K5	79.0	10000.0
RO-3306	RET(M918T)	79.0	10000.0
AZ-628	KPCI	100.0	10000.0
ALW-II-38-3	ADCK3	100.0	10000.0
BI-2536	YES	100.0	10000.0
CH5424802	PKNB(M.tuberculosis)	96.0	1000.0
Taselisib	KIT(L576P)	88.0	1000.0
Canertinib	STK16	100.0	1000.0
(s)-CR8	MP2K4	56.0	10000.0
Torkinib	HIPK1	1.9	10000.0
ZG-10	MLK2	94.0	10000.0
HG-9-91-01	TYK2(JH2domain-pseudokinase)	52.0	10000.0
AZ-628	MARK1	100.0	10000.0
TGX221	RET(M918T)	100.0	1000.0
(s)-CR8	MAP4K2	90.0	10000.0
Taselisib	MP2K2	92.0	1000.0
HG-9-91-01	ABL1(F317L)-nonphosphorylated	0.2	10000.0
(s)-CR8	MYLK	87.0	10000.0
R406	KPCD3	23.0	1000.0
CP466722	MP2K1	64.0	10000.0
BMS345541	ROCK2	100.0	10000.0
BI-D1870	YSK4	3.2	10000.0
AG1478	MP2K1	25.0	10000.0
Dactolisib	RPS6KA1(Kin.Dom.2)	100.0	1000.0
WZ-7043	CAMK2G	100.0	10000.0
ZG-10	BMPR1A	93.0	10000.0
Vemurafenib	EPHA7	100.0	10000.0
CH5424802	MRCKB	100.0	1000.0
HG-9-91-01	PIK3CD	98.0	10000.0
ZG-10	TRKB	69.0	10000.0
XMD8-92	ERN1	100.0	10000.0
BMS-536924	ABL1(T315I)	4.0	1000.0
CGP60474	IRAK1	100.0	10000.0
PHA-767491	BRSK2	37.0	10000.0
NPK76-II-72-1	TRKC	100.0	10000.0
PLX-4720	AURKA	60.0	10000.0
CGP74514A	TRKB	0.6	10000.0
XMD14-99	CSNK1D	100.0	10000.0
CGP60474	BRSK1	100.0	10000.0
PHA-767491	KIT(V559D,T670I)	86.0	10000.0
ALW-II-38-3	CSNK2A2	100.0	10000.0
Baricitinib	CSNK1E	55.0	10000.0
MPS-1-IN-1	SRMS	100.0	1000.0
WZ-7043	PDPK1	100.0	10000.0
THZ1	RET(V804M)	0.0	10000.0
NPK76-II-72-1	EPHA6	100.0	10000.0
MRT67307	MLTK	55.0	10000.0
Vemurafenib	KIT(V559D,V654A)	26.0	10000.0
TGX221	MLK2	100.0	1000.0
Omipalisib	SLK	100.0	10000.0
Crizotinib	PI42C	100.0	10000.0
NVP-TAE684	TRKC	100.0	1000.0
BGJ398	PIK3CA(H1047Y)	96.0	1000.0
GSK1059615	MRCKA	90.0	10000.0
Neratinib	CDK4-cyclinD3	78.0	10000.0
BS-181	TRKA	96.0	10000.0
5z-7-oxozeaenol	FGR	84.0	10000.0
5z-7-oxozeaenol	ABL1(F317L)-phosphorylated	100.0	10000.0
BI-2536	TGFBR1	100.0	10000.0
KIN001-220	RSK3(Kin.Dom.1-N-terminal)	65.0	10000.0
Sorafenib	ROCK1	74.0	10000.0
JNK-IN-11	KCC4	100.0	1000.0
CP466722	CSNK1A1	1.4	10000.0
JNK-IN-8	GRK1	100.0	1000.0
HG-5-88-01	GSK3A	100.0	10000.0
HG-6-64-01	ABL1(Q252H)-phosphorylated	1.2	10000.0
Sorafenib	ANKK1	100.0	10000.0
Ibrutinib	CASK	59.0	1000.0
HG-14-8-02	PAK3	39.0	10000.0
AZD 5438	IKKA	0.3	10000.0
KU63794	MK13	71.0	10000.0
XMD8-85	EPHA5	100.0	10000.0
Canertinib	FGFR4	100.0	1000.0
Momelotinib	GCN2(Kin.Dom.2,S808G)	1.2	10000.0
CH5424802	TNK1	26.0	1000.0
KIN001-021	CAMK1D	100.0	1000.0
SB590885	DYRK2	98.0	10000.0
ERK5-IN-1	CLK1	100.0	1000.0
CP466722	FLT3(D835H)	3.2	10000.0
SP600125	M3K5	100.0	10000.0
CP466722	ABL1(Y253F)-phosphorylated	0.3	10000.0
WZ4002	ABL1(F317L)	100.0	10000.0
MRT67307	LCK	24.0	10000.0
CG-930	NEK3	100.0	10000.0
ALW-II-49-7	ABL1(F317I)	13.0	1000.0
MRT67307	EPHA2	100.0	10000.0
MLN8054	ABL1(E255K)-phosphorylated	13.0	10000.0
RO-3306	TAOK2	75.0	10000.0
CGP74514A	SGK2	31.0	10000.0
GSK1059615	LRRK2(G2019S)	58.0	10000.0
Torin2	MAK	96.0	10000.0
BI-D1870	MERTK	1.0	10000.0
GSK461364	CAMK2B	19.0	10000.0
XMD14-99	CASK	35.0	10000.0
KU63794	CLK1	52.0	10000.0
Alpelisib	MK01	100.0	1000.0
GSK461364	CAMK1G	58.0	10000.0
JW-7-24-1	KC1G1	100.0	10000.0
WZ-7043	MAP3K15	100.0	10000.0
CP466722	KIT(L576P)	4.5	10000.0
MLN8054	PLK4	14.0	10000.0
AZD4547	CDK4-cyclinD1	1.8	10000.0
AS-252424	CSNK2A1	4.5	10000.0
PD0325901	TAOK2	100.0	10000.0
BX-912	M3K13	9.9	10000.0
CH5424802	TBK1	94.0	1000.0
Neratinib	PIM3	100.0	10000.0
AG1478	WNK3	78.0	10000.0
ZM-447439	HIPK2	50.0	10000.0
Crizotinib	KPCT	88.0	10000.0
Torkinib	TYRO3	77.0	10000.0
JNK-IN-8	MLK3	91.0	1000.0
XMD16-144	DRAK2	100.0	10000.0
KIN001-123	EPHA5	100.0	1000.0
Torin1	ERN1	100.0	10000.0
(s)-CR8	KIT(D816H)	98.0	10000.0
ZSTK474	DCLK1	100.0	1000.0
KIN001-021	MK13	100.0	1000.0
MPS-1-IN-1	BMPR1B	100.0	1000.0
Crizotinib	SgK110	3.4	10000.0
QL-XII-47	EGFR(L747-E749del,A750P)	100.0	1000.0
NVP-TAE684	CLK4	1.2	1000.0
CG-930	TAK1	99.0	10000.0
SB590885	EGFR(S752-I759del)	67.0	10000.0
BS-181	KPCL	95.0	10000.0
PD0325901	TGFBR1	100.0	10000.0
BMS345541	TLK2	88.0	10000.0
Ibrutinib	PHKG1	100.0	1000.0
BMS-536924	RIPK2	100.0	1000.0
JNK-IN-11	ABL1(T315I)-nonphosphorylated	6.0	1000.0
AZD-6482	ERBB2	100.0	10000.0
MLN8054	DDR1	1.2	10000.0
PD0325901	PKMYT1	80.0	10000.0
KIN001-111	RET(V804M)	100.0	1000.0
BX-912	EPHB6	0.2	10000.0
PLX-4720	KC1G2	39.0	10000.0
PHA-793887	SGK2	100.0	10000.0
Torkinib	EGFR(S752-I759del)	35.0	10000.0
MRT67307	M4K1	44.0	10000.0
Dinaciclib	MP2K4	73.0	10000.0
NG25	BMPR2	100.0	10000.0
Barasertib	PDPK1	100.0	10000.0
QL-X-138	EGFR(L747-T751del,Sins)	63.0	10000.0
CGP74514A	ERK5	12.0	10000.0
XMD16-144	ABL1(F317L)-nonphosphorylated	0.8	10000.0
Crizotinib	CDC2L1	0.1	10000.0
GW-5074	MAP3K15	80.0	10000.0
Dabrafenib	KC1G1	60.0	10000.0
ZSTK474	BMPR2	100.0	1000.0
Lapatinib	CDK15	87.0	10000.0
BS-181	CSF1R	90.0	10000.0
SCH772984	DMPK2	95.0	1000.0
GW-5074	AURKA	65.0	10000.0
Alpelisib	KPCL	99.0	1000.0
PD0325901	NUAK1	81.0	10000.0
NU7441	KIT(D816V)	58.0	10000.0
CH5424802	TNK2	10.0	1000.0
Dactolisib	TNIK	100.0	1000.0
NPK76-II-72-1	KPCT	100.0	10000.0
MRT67307	FLT4	100.0	10000.0
Momelotinib	TNK1	33.0	10000.0
R406	IGF1R	2.4	1000.0
QL-XI-92	PAK6	100.0	10000.0
XMD11-50	MP2K7	100.0	10000.0
BGJ398	CIT	96.0	1000.0
XMD-12	MP2K2	100.0	1000.0
AZD-6482	MP2K1	89.0	10000.0
5z-7-oxozeaenol	SRC	74.0	10000.0
JNK-IN-8	MKNK1	81.0	1000.0
AG1478	PLK4	30.0	10000.0
Alpelisib	ITK	100.0	1000.0
MRT67307	MAP4K4	72.0	10000.0
JNK-9L	FLT3(R834Q)	58.0	10000.0
WH-4-023	NDR2	100.0	10000.0
XMD13-2	RET(M918T)	71.0	10000.0
CH5424802	CDKL5	96.0	1000.0
NG25	MINK	100.0	10000.0
Ribociclib	PIK3C2B	100.0	1000.0
OTSSP167	CDK8	1.2	10000.0
JNK-IN-11	TAK1	47.0	1000.0
Dinaciclib	RPS6KA5(Kin.Dom.1-N-terminal)	87.0	10000.0
Torkinib	PIK3CA(H1047L)	16.0	10000.0
JNK-IN-5A	MYLK2	100.0	10000.0
Barasertib	PLK4	9.6	10000.0
BMS-536924	LCK	0.4	1000.0
PD173074	RPS6KA2(Kin.Dom.2)	100.0	10000.0
ALW-II-49-7	MST1	100.0	10000.0
JW-7-24-1	WEE2	100.0	10000.0
JNK-IN-8	CDK16	100.0	1000.0
CGP60474	TLK1	100.0	10000.0
Lapatinib	GRK7	100.0	10000.0
ZG-10	ACVR2A	53.0	10000.0
SP600125	ACVR1B	100.0	10000.0
Dabrafenib	ABL1(Q252H)-phosphorylated	27.0	10000.0
PLX-4720	JNK1	96.0	10000.0
PLX-4720	FLT3(R834Q)	100.0	10000.0
KIN001-220	MAP3K1	97.0	10000.0
HG-9-91-01	SRMS	4.2	10000.0
XMD16-144	MKNK2	0.3	10000.0
QL-XI-92	MK09	94.0	10000.0
Ceritinib	PIK3CA(M1043I)	81.0	1000.0
GSK1059615	RIPK5	61.0	10000.0
XMD8-92	DAPK1	100.0	10000.0
AZ-628	MET	89.0	10000.0
PHA-793887	IKKE	100.0	10000.0
GW843682X	MP2K1	67.0	10000.0
Torin2	EPHA4	100.0	10000.0
A443654	MYO3B	100.0	10000.0
Ribociclib	TGFBR1	100.0	1000.0
AG1478	NEK10	91.0	10000.0
XMD-12	EGFR(L747-E749del,A750P)	98.0	1000.0
ZSTK474	FGFR3	100.0	1000.0
Abemaciclib	FLT3(D835V)	4.0	1000.0
XMD11-85h	MUSK	100.0	10000.0
KIN001-220	MLK3	4.6	10000.0
JW-7-24-1	PIP5K2B	25.0	10000.0
Taselisib	BIKE	85.0	1000.0
QL-XII-47	PAK7	91.0	1000.0
CGP74514A	MERTK	1.4	10000.0
SB590885	KIT(A829P)	86.0	10000.0
HG-14-10-04	AURKA	5.4	10000.0
CP466722	CAMK2A	44.0	10000.0
Dactolisib	SgK110	100.0	1000.0
JWE-035	EPHA4	100.0	10000.0
XMD11-50	AURKA	1.2	10000.0
XMD14-99	DDR1	98.0	10000.0
GW843682X	ITK	98.0	10000.0
JW-7-24-1	CHEK1	100.0	10000.0
Torin2	EPHA2	99.0	10000.0
Seliciclib	CSNK1A1	5.2	10000.0
5z-7-oxozeaenol	BUB1	98.0	10000.0
XMD14-99	DMPK	50.0	10000.0
WH-4-023	EGFR(L747-T751del,Sins)	0.0	10000.0
JNK-9L	RET(V804M)	100.0	10000.0
ERK5-IN-1	CSF1R	100.0	1000.0
RO-3306	RSK1(Kin.Dom.1-N-terminal)	94.0	10000.0
Ribociclib	PAK1	88.0	1000.0
(s)-CR8	EGFR(S752-I759del)	100.0	10000.0
TAK-715	TTK	70.0	10000.0
JNK-IN-5A	MK09	4.8	10000.0
NPK76-II-72-1	CAMKK2	24.0	10000.0
Seliciclib	TNNI3K	100.0	10000.0
Torin2	SRMS	88.0	10000.0
CG-930	DCLK1	81.0	10000.0
Torkinib	CDKL3	100.0	10000.0
XMD8-92	MARK3	100.0	10000.0
OTSSP167	HCK	0.8	10000.0
JNK-IN-8	MK01	99.0	1000.0
XMD8-85	LTK	100.0	10000.0
BX-912	CSNK1D	73.0	10000.0
AZD4547	RET(V804M)	0.1	10000.0
SCH772984	CDC2L1	100.0	1000.0
XMD11-50	RSK1(Kin.Dom.2-C-terminal)	10.0	10000.0
AS-252424	ADCK3	100.0	10000.0
BMX-IN-1	CAMK2G	96.0	10000.0
ALW-II-38-3	EGFR(L747-T751del,Sins)	100.0	10000.0
CH5424802	RIOK2	83.0	1000.0
ZSTK474	KC1G1	100.0	1000.0
Buparlisib	FLT3(R834Q)	100.0	1000.0
XMD11-50	BMPR1A	100.0	10000.0
Omipalisib	RSK3(Kin.Dom.1-N-terminal)	78.0	10000.0
QL-XII-47	ABL1-phosphorylated	72.0	1000.0
(s)-CR8	NEK10	100.0	10000.0
Dactolisib	KPCT	100.0	1000.0
HG-6-64-01	SRMS	0.7	10000.0
ERK5-IN-1	ERK8	100.0	1000.0
WH-4-023	TNK1	0.0	10000.0
HG-5-88-01	PLK1	21.0	10000.0
HG-14-8-02	MK09	82.0	10000.0
RO-3306	KCC2D	66.0	10000.0
JNK-IN-11	MAST1	99.0	1000.0
Pictilisib	MAP3K4	100.0	1000.0
GSK461364	HUNK	78.0	10000.0
TAK-715	PLK4	100.0	10000.0
WZ3105	HIPK2	17.0	10000.0
AG1478	EGFR(L858R,T790M)	22.0	10000.0
AZ-628	EGFR(L858R,T790M)	99.0	10000.0
SP600125	INSR	100.0	10000.0
Dabrafenib	VRK2	100.0	10000.0
PHA-767491	LIMK2	99.0	10000.0
BI-2536	ABL1(E255K)	100.0	10000.0
ZM-447439	MKNK2	4.2	10000.0
TAK-715	MLCK	93.0	10000.0
Momelotinib	NIM1	100.0	10000.0
ZG-10	CHK2	86.0	10000.0
HG-14-8-02	ABL1(M351T)-phosphorylated	73.0	10000.0
PD173074	ROS1	100.0	10000.0
Neratinib	PTK6	100.0	10000.0
KIN001-123	ERK8	29.0	1000.0
KIN001-127	LATS1	100.0	10000.0
Abemaciclib	EGFR(T790M)	65.0	1000.0
WZ4002	TAOK1	100.0	10000.0
XMD11-85h	ERBB3	100.0	10000.0
Ceritinib	KIT(V559D)	85.0	1000.0
Pictilisib	INSR	100.0	1000.0
Torkinib	FLT3(ITD)	35.0	10000.0
PHA-793887	KIT(V559D,T670I)	96.0	10000.0
HG-14-8-02	TLK2	95.0	10000.0
ZG-10	CDKL2	33.0	10000.0
Alpelisib	MST2	94.0	1000.0
OTSSP167	EGFR(S752-I759del)	56.0	10000.0
AZD-6482	AXL	86.0	10000.0
Torkinib	PKN2	86.0	10000.0
NG25	TTK	24.0	10000.0
HG-9-91-01	RET(M918T)	0.4	10000.0
XMD13-2	EPHA6	100.0	10000.0
XMD11-85h	DRAK1	100.0	10000.0
WYE-125132	ERK5	100.0	10000.0
R406	TYRO3	30.0	1000.0
BGJ398	MAP3K14	90.0	1000.0
Torin1	FGFR3	42.0	10000.0
(s)-CR8	CLK3	65.0	10000.0
GSK1059615	TGFBR2	73.0	10000.0
Baricitinib	RAF1	96.0	10000.0
PHA-767491	TNNI3K	83.0	10000.0
KU63794	RET(V804M)	94.0	10000.0
HG-6-64-01	CAMK2A	100.0	10000.0
AZ-628	YSK4	0.9	10000.0
OTSSP167	PIP5K2B	100.0	10000.0
GW843682X	ACVRL1	100.0	10000.0
BMS345541	BMPR1B	32.0	10000.0
GSK461364	YSK4	12.0	10000.0
CGP74514A	MK09	62.0	10000.0
CGP74514A	AURKA	26.0	10000.0
AZ-628	CSNK1D	100.0	10000.0
ERK5-IN-1	SYK	100.0	1000.0
Barasertib	CLK1	69.0	10000.0
AZD7762	LATS1	11.0	10000.0
HG-14-8-02	STK16	63.0	10000.0
SB590885	JAK1(JH1domain-catalytic)	100.0	10000.0
Barasertib	CAMK1G	73.0	10000.0
THZ1	MST4	40.0	10000.0
WZ3105	CDK14	98.0	10000.0
PD0325901	PIK3CD	40.0	10000.0
GW843682X	AMPK-alpha2	92.0	10000.0
CG-930	CSNK1A1	100.0	10000.0
JNK-IN-8	TNK2	90.0	1000.0
Sigma A6730	KIT(V559D)	100.0	10000.0
XMD14-99	RET(V804M)	100.0	10000.0
XMD11-85h	GRK4	100.0	10000.0
RO-3306	ABL1(Q252H)-nonphosphorylated	69.0	10000.0
AZD4547	CAMK2B	15.0	10000.0
Momelotinib	LKB1	61.0	10000.0
GSK1059615	PTK6	87.0	10000.0
XMD8-92	CAMK2B	100.0	10000.0
Palbociclib	CAMK2B	86.0	1000.0
GSK1059615	CDK16	71.0	10000.0
BGJ398	EGFR(G719C)	93.0	1000.0
RO-3306	AURKC	24.0	10000.0
JWE-035	CAMK1	78.0	10000.0
WYE-125132	PGFRA	80.0	10000.0
QL-XI-92	MST2	100.0	10000.0
GSK461364	MAP4K2	24.0	10000.0
HG-6-64-01	CAMK2G	100.0	10000.0
KIN001-127	EPHA6	11.0	10000.0
Sigma A6730	MAP3K1	80.0	10000.0
KIN001-220	CHK2	70.0	10000.0
SB590885	SNARK	95.0	10000.0
AZD 5438	MLTK	33.0	10000.0
Seliciclib	JAK2(JH1domain-catalytic)	100.0	10000.0
CP466722	KIT(D816H)	12.0	10000.0
Abemaciclib	FGR	93.0	1000.0
WZ-4-145	MYLK2	100.0	10000.0
MRT67307	CHEK1	1.5	10000.0
Palbociclib	SGK3	94.0	1000.0
MLN8054	PKN2	79.0	10000.0
XMD16-144	KPCT	83.0	10000.0
5z-7-oxozeaenol	TRKA	82.0	10000.0
XMD-12	NEK1	93.0	1000.0
AZD-6482	ABL1(H396P)-phosphorylated	87.0	10000.0
Neratinib	EPHA3	85.0	10000.0
SCH772984	PKN1	80.0	1000.0
CGP60474	TAOK2	100.0	10000.0
Ribociclib	RSK2(Kin.Dom.1-N-terminal)	92.0	1000.0
BI-2536	AURKA	100.0	10000.0
Ibrutinib	GCN2(Kin.Dom.2,S808G)	100.0	1000.0
QL-XII-47	MK14	100.0	1000.0
Lapatinib	CAMK1	100.0	10000.0
KIN001-127	TIE2	29.0	10000.0
ZM-447439	IRAK3	17.0	10000.0
MRT67307	BRSK1	100.0	10000.0
Neratinib	PHKG1	92.0	10000.0
HG-9-91-01	ERN1	20.0	10000.0
KIN001-123	SIK1	100.0	1000.0
Ribociclib	CSF1R	97.0	1000.0
KIN001-021	PTK6	100.0	1000.0
AZD-6482	M3K6	95.0	10000.0
Ribociclib	AKT3	97.0	1000.0
Barasertib	FGFR3	92.0	10000.0
Ribociclib	LIMK2	100.0	1000.0
GW843682X	SGK3	83.0	10000.0
BMX-IN-1	PLK1	100.0	10000.0
Canertinib	DDR1	100.0	1000.0
Pictilisib	MARK4	84.0	1000.0
XMD11-85h	MST1R	100.0	10000.0
GW-5074	KIT(V559D)	1.8	10000.0
TAK-715	EPHA6	47.0	10000.0
KU63794	ABL1(H396P)-phosphorylated	100.0	10000.0
RO-3306	NLK	100.0	10000.0
WZ3105	PI42C	66.0	10000.0
BMX-IN-1	PCTK2	95.0	10000.0
HG-6-64-01	LCK	0.2	10000.0
WZ4002	MP2K6	100.0	10000.0
BMS-536924	MKNK2	33.0	1000.0
JNK-9L	TIE1	30.0	10000.0
CH5424802	TSSK1	49.0	1000.0
CP724714	TNIK	89.0	10000.0
THZ1	NEK11	56.0	10000.0
NPK76-II-72-1	BMPR1B	100.0	10000.0
5z-7-oxozeaenol	MYO3B	100.0	10000.0
Abemaciclib	RPS6KA5(Kin.Dom.2-C-terminal)	34.0	1000.0
PHA-767491	EPHB1	98.0	10000.0
Buparlisib	TGFBR1	90.0	1000.0
XMD14-99	STK16	90.0	10000.0
GW843682X	WEE2	100.0	10000.0
NPK76-II-72-1	MYLK4	100.0	10000.0
KU63794	DCAMKL2	100.0	10000.0
HG-14-8-02	BMPR2	100.0	10000.0
SB590885	RPS6KA4(Kin.Dom.2-C-terminal)	81.0	10000.0
ZM-447439	HCK	2.0	10000.0
(s)-CR8	ABL1(F317I)-phosphorylated	100.0	10000.0
JNK-IN-11	CSNK1A1L	5.5	1000.0
Dabrafenib	CDK16	0.0	10000.0
Ibrutinib	TIE2	68.0	1000.0
Seliciclib	FYN	100.0	10000.0
MRT67307	PAK1	57.0	10000.0
JW-7-24-1	RPS6KA4(Kin.Dom.1)	100.0	10000.0
BI-2536	DAPK1	5.4	10000.0
BMX-IN-1	PKN1	99.0	10000.0
KIN001-123	CSNK1G3	100.0	1000.0
HG-6-64-01	MP2K3	68.0	10000.0
QL-X-138	FLT3(K663Q)	18.0	10000.0
XMD13-2	HIPK2	36.0	10000.0
HG-14-10-04	CDK8	100.0	10000.0
WZ-7043	PHKG1	100.0	10000.0
HG-14-8-02	MAP4K5	78.0	10000.0
JNK-9L	CDC2L1	32.0	10000.0
GSK1059615	EPHB6	39.0	10000.0
KIN001-220	KPCI	77.0	10000.0
ALW-II-49-7	TNK2	100.0	10000.0
XMD13-2	NUAK1	100.0	10000.0
AZD 5438	DYRK1A	3.6	10000.0
QL-X-138	MAP3K3	91.0	10000.0
XMD11-50	KPCD3	42.0	10000.0
TAK-715	EPHB6	16.0	10000.0
Dabrafenib	FGFR3(G697C)	100.0	10000.0
BMS-536924	CSK	14.0	1000.0
Taselisib	LTK	73.0	1000.0
5z-7-oxozeaenol	GSK3B	100.0	10000.0
NU7441	PIK3CA(E545A)	8.2	10000.0
BMS-536924	TEC	7.2	1000.0
Dactolisib	AKT3	100.0	1000.0
JNK-IN-5A	S6K1	90.0	10000.0
WH-4-023	INSRR	100.0	10000.0
MPS-1-IN-1	AKT2	100.0	1000.0
KIN001-123	LATS2	100.0	1000.0
Torin1	ABL1(T315I)-phosphorylated	100.0	10000.0
A443654	CLK4	2.6	10000.0
GSK429286A	SNRK	100.0	10000.0
CGP74514A	MP2K1	18.0	10000.0
XMD-12	RSK1(Kin.Dom.2-C-terminal)	45.0	1000.0
WZ-7043	CSNK1A1L	100.0	10000.0
Pictilisib	CAMK1B	100.0	1000.0
Ceritinib	CSF1R-autoinhibited	100.0	1000.0
PHA-793887	ULK3	86.0	10000.0
WYE-125132	CHEK1	100.0	10000.0
JW-7-24-1	YANK2	100.0	10000.0
CH5424802	SRPK3	86.0	1000.0
HG-14-10-04	MET	17.0	10000.0
Crizotinib	ERK3	90.0	10000.0
NVP-TAE684	CAMK2B	5.8	1000.0
AZD-6482	SGK3	86.0	10000.0
JNK-IN-8	ABL1(H396P)-phosphorylated	60.0	1000.0
Palbociclib	EPHB3	98.0	1000.0
QL-X-138	MAK	94.0	10000.0
JNK-IN-8	MYLK4	9.6	1000.0
Seliciclib	TYK2(JH2domain-pseudokinase)	100.0	10000.0
ZM-447439	FLT3(N841I)	6.0	10000.0
BMX-IN-1	MAK	100.0	10000.0
GSK429286A	SBK1	78.0	10000.0
AZD 5438	MK01	80.0	10000.0
HG-9-91-01	DYRK1A	100.0	10000.0
JNK-IN-8	PAK3	100.0	1000.0
MRT67307	NEK5	29.0	10000.0
BMS345541	TEC	100.0	10000.0
ALW-II-49-7	NEK9	100.0	10000.0
QL-XI-92	BRSK2	100.0	10000.0
WZ3105	EPHA6	73.0	10000.0
SCH772984	STK16	88.0	1000.0
TGX221	DCAMKL2	100.0	1000.0
JW-7-24-1	MARK1	100.0	10000.0
PD173074	TNIK	100.0	10000.0
ZG-10	TNNI3K	100.0	10000.0
GSK461364	GAK	100.0	10000.0
Crizotinib	CSNK1A1	61.0	10000.0
XMD8-85	STK39	23.0	10000.0
Neratinib	EGFR(E746-A750del)	2.8	10000.0
KIN001-123	FLT3(D835Y)	2.0	1000.0
WZ4002	SYK	100.0	10000.0
AZD4547	KIT(D816V)	0.5	10000.0
PHA-767491	MST4	29.0	10000.0
KIN001-111	IKKB	100.0	1000.0
MRT67307	LATS2	37.0	10000.0
CGP74514A	DDR1	47.0	10000.0
KIN001-127	INSRR	0.4	10000.0
Vemurafenib	MELK	100.0	10000.0
Pictilisib	RIPK2	98.0	1000.0
KIN001-220	MAP3K3	49.0	10000.0
BGJ398	RSK4(Kin.Dom.2-C-terminal)	89.0	1000.0
ALW-II-38-3	FGFR3	100.0	10000.0
GSK461364	MYO3B	100.0	10000.0
ZG-10	MYLK2	53.0	10000.0
JNK-9L	BLK	86.0	10000.0
NU7441	TIE2	100.0	10000.0
Ribociclib	EPHA7	100.0	1000.0
Crizotinib	LATS1	100.0	10000.0
XMD14-99	STK33	83.0	10000.0
WZ4002	EGFR(S752-I759del)	0.3	10000.0
WH-4-023	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	10000.0
ALW-II-49-7	PAK1	100.0	10000.0
AZD-6482	YSK1	76.0	10000.0
Vemurafenib	CAMK2G	95.0	10000.0
Pictilisib	SIK2	99.0	1000.0
ALW-II-49-7	PIP5K2B	100.0	10000.0
AZD4547	CASK	56.0	10000.0
Barasertib	MAP3K4	90.0	10000.0
Torin2	AXL	74.0	10000.0
GW-5074	CDC2L5	100.0	10000.0
Seliciclib	EGFR(G719S)	100.0	10000.0
5z-7-oxozeaenol	SNRK	92.0	10000.0
GSK429286A	PTK6	60.0	10000.0
QL-X-138	MP2K3	8.6	10000.0
CP724714	IGF1R	83.0	10000.0
HG-14-8-02	PAK2	100.0	10000.0
CGP60474	MARK2	100.0	10000.0
AZD 5438	KC1G2	0.5	10000.0
MRT67307	MELK	6.2	10000.0
ZG-10	AKT3	100.0	10000.0
QL-XI-92	EPHA1	99.0	10000.0
BGJ398	MET(M1250T)	96.0	1000.0
Ibrutinib	NEK10	63.0	1000.0
HG-6-64-01	PLK3	83.0	10000.0
CP724714	YSK4	100.0	10000.0
BS-181	RPS6KA4(Kin.Dom.2-C-terminal)	84.0	10000.0
SCH772984	CSNK1G3	71.0	1000.0
JNK-IN-5A	PIK3CA(M1043I)	100.0	10000.0
WZ3105	PGFRA	59.0	10000.0
KIN001-111	DAPK2	100.0	1000.0
Dinaciclib	EPHB3	92.0	10000.0
XMD-12	MK12	100.0	1000.0
PHA-793887	SBK1	24.0	10000.0
Torin2	CSNK1E	2.7	10000.0
Baricitinib	EGFR(S752-I759del)	76.0	10000.0
ZSTK474	BLK	100.0	1000.0
BMX-IN-1	RSK1(Kin.Dom.1-N-terminal)	78.0	10000.0
Taselisib	ABL1(F317L)-nonphosphorylated	99.0	1000.0
THZ1	YSK1	41.0	10000.0
Torin2	MERTK	87.0	10000.0
WZ-7043	CSNK1E	100.0	10000.0
Dinaciclib	YANK2	100.0	10000.0
QL-X-138	PIK3CA(E542K)	20.0	10000.0
Pictilisib	PIK3CA(E542K)	0.0	1000.0
XMD13-2	DAPK3	69.0	10000.0
Ribociclib	LRRK2(G2019S)	96.0	1000.0
QL-XI-92	PLK4	91.0	10000.0
CH5424802	FGFR3(G697C)	100.0	1000.0
CH5424802	PI42C	53.0	1000.0
ALW-II-49-7	AURKA	100.0	10000.0
KU63794	DRAK2	100.0	10000.0
Ceritinib	PRP4	100.0	1000.0
Ceritinib	TYK2(JH2domain-pseudokinase)	71.0	1000.0
Alpelisib	EGFR(L747-E749del,A750P)	97.0	1000.0
Abemaciclib	KIT(V559D)	100.0	1000.0
Sorafenib	CIT	17.0	10000.0
BMS345541	SIK3	100.0	10000.0
KIN001-111	FLT3(ITD)	100.0	1000.0
BX-912	ABL1(M351T)-phosphorylated	0.5	10000.0
WYE-125132	KGP2	88.0	10000.0
BMX-IN-1	MET(M1250T)	90.0	10000.0
HG-9-91-01	VGFR2	11.0	10000.0
Ceritinib	AMPK-alpha1	70.0	1000.0
XMD8-92	MKNK2	100.0	10000.0
A443654	PKAC-beta	0.5	10000.0
Momelotinib	NEK3	0.6	10000.0
XMD16-144	ICK	70.0	10000.0
TGX221	MYO3A	100.0	1000.0
AG1478	CAMK2G	77.0	10000.0
ZG-10	JAK1(JH1domain-catalytic)	100.0	10000.0
Ceritinib	CAMK2B	73.0	1000.0
MRT67307	PIK3CA(E542K)	96.0	10000.0
GSK461364	EGFR(L858R)	86.0	10000.0
BI-D1870	PAK3	6.2	10000.0
XMD-12	CAMK2B	100.0	1000.0
PD0325901	MAP3K1	54.0	10000.0
MPS-1-IN-1	ACVR1B	100.0	1000.0
Taselisib	EGFR(T790M)	100.0	1000.0
GW843682X	RSK1(Kin.Dom.2-C-terminal)	63.0	10000.0
KIN001-111	CIT	5.9	1000.0
WYE-125132	CDK5	88.0	10000.0
XMD-12	PIK3CD	58.0	1000.0
ZM-447439	SIK2	63.0	10000.0
AZD7762	MK09	38.0	10000.0
XMD8-85	RET(V804L)	100.0	10000.0
PLX-4720	PGFRA	0.2	10000.0
Sorafenib	KIT(D816H)	36.0	10000.0
XMD13-2	AMPK-alpha1	60.0	10000.0
XMD13-2	RSK4(Kin.Dom.2-C-terminal)	60.0	10000.0
JW-7-24-1	KIT(D816V)	3.7	10000.0
AZ-628	NEK3	57.0	10000.0
XMD8-85	PRKR	100.0	10000.0
Seliciclib	ABL1-nonphosphorylated	77.0	10000.0
GSK429286A	MK03	53.0	10000.0
R406	ERK8	2.7	1000.0
RO-3306	AKT2	91.0	10000.0
WZ3105	STK16	72.0	10000.0
GW843682X	DYRK1B	87.0	10000.0
Baricitinib	PHKG2	9.6	10000.0
AS-252424	TIE1	25.2	10000.0
KIN001-111	LATS2	0.2	1000.0
AG1478	PKNB(M.tuberculosis)	100.0	10000.0
AZD-6482	GRK4	90.0	10000.0
Seliciclib	MET	93.0	10000.0
PHA-767491	MYLK2	30.0	10000.0
CP724714	RIPK5	75.0	10000.0
Abemaciclib	PLK2	100.0	1000.0
SP600125	NUAK1	100.0	10000.0
Lapatinib	BMPR1B	100.0	10000.0
NG25	PRKX	100.0	10000.0
BX-912	PLK1	41.0	10000.0
Torin1	EPHB3	85.0	10000.0
AZD 5438	TAOK2	11.0	10000.0
HG-6-64-01	MYLK2	0.6	10000.0
XMD-12	WEE2	70.0	1000.0
SCH772984	SgK110	97.0	1000.0
TAK-715	MST2	97.0	10000.0
BI-2536	TIE1	100.0	10000.0
Sorafenib	RSK2(Kin.Dom.1-N-terminal)	81.0	10000.0
Pictilisib	VRK2	54.0	1000.0
NG25	ERBB2	100.0	10000.0
CGP74514A	DYRK1A	3.5	10000.0
WZ4003	GSK3B	100.0	1000.0
Torkinib	DYRK1A	27.0	10000.0
Alpelisib	PRP4	98.0	1000.0
Dinaciclib	ANKK1	100.0	10000.0
WZ3105	YANK3	98.0	10000.0
5z-7-oxozeaenol	PTK6	78.0	10000.0
5z-7-oxozeaenol	TIE1	100.0	10000.0
PHA-767491	NEK6	91.0	10000.0
XMD8-85	FYN	100.0	10000.0
CP724714	PIK3CA(Q546K)	38.0	10000.0
XMD8-92	EPHA2	100.0	10000.0
HG-14-10-04	SLK	0.1	10000.0
BX-912	KIT	0.2	10000.0
XMD14-99	MTOR	100.0	10000.0
PHA-793887	NDR1	63.0	10000.0
HG-14-10-04	KC1G2	94.0	10000.0
JNK-IN-5A	ROS1	90.0	10000.0
XMD8-92	BIKE	100.0	10000.0
Torkinib	PIK3CB	0.0	10000.0
GSK461364	FGFR1	37.0	10000.0
HG-14-10-04	WEE1	18.0	10000.0
Ribociclib	YANK1	100.0	1000.0
PD173074	EPHA5	100.0	10000.0
KIN001-021	WEE2	100.0	1000.0
NPK76-II-72-1	EGFR(L747-E749del,A750P)	100.0	10000.0
CP466722	DAPK1	3.6	10000.0
SP600125	AURKA	100.0	10000.0
BMS345541	PTK6	99.0	10000.0
JW-7-24-1	MP2K3	100.0	10000.0
NVP-TAE684	KIT(D816V)	3.1	1000.0
MLN8054	PIK3CA(C420R)	67.0	10000.0
AZD-6482	MRCKA	96.0	10000.0
Palbociclib	ERBB4	96.0	1000.0
SB590885	CDK8	83.0	10000.0
Lapatinib	MAST1	95.0	10000.0
Abemaciclib	ABL1(F317L)-phosphorylated	100.0	1000.0
XMD11-85h	RET	100.0	10000.0
Neratinib	HIPK3	81.0	10000.0
CP466722	MST4	68.0	10000.0
GW-5074	FLT3(N841I)	12.0	10000.0
KIN001-123	ERK5	100.0	1000.0
CGP74514A	MTOR	61.0	10000.0
Baricitinib	RSK2(Kin.Dom.2-C-terminal)	3.8	10000.0
XMD14-99	FLT3(D835Y)	100.0	10000.0
NVP-TAE684	PCTK3	100.0	1000.0
ZSTK474	CDK14	100.0	1000.0
BI-D1870	PLK3	0.2	10000.0
THZ1	FGFR3	0.1	10000.0
Dabrafenib	CHK2	31.0	10000.0
HG-6-64-01	EGFR	0.4	10000.0
(s)-CR8	EPHA6	80.0	10000.0
XMD11-85h	TYK2(JH2domain-pseudokinase)	100.0	10000.0
Torkinib	HIPK4	27.0	10000.0
KIN001-220	PRP4	18.0	10000.0
TAK-715	EPHA7	92.0	10000.0
MLN8054	PAK4	90.0	10000.0
JNK-IN-8	FGFR3	100.0	1000.0
Palbociclib	KPCD	100.0	1000.0
HG-6-64-01	M3K13	20.0	10000.0
AS-252424	DAPK2	12.5	10000.0
OTSSP167	EGFR(L747-T751del,Sins)	25.0	10000.0
Ibrutinib	DYRK2	82.0	1000.0
Neratinib	PIM1	100.0	10000.0
CGP60474	BRAF	100.0	10000.0
WZ3105	PFPK5(P.falciparum)	100.0	10000.0
OTSSP167	RSK4(Kin.Dom.1-N-terminal)	0.1	10000.0
JNK-IN-11	RSK1(Kin.Dom.2-C-terminal)	36.0	1000.0
CP724714	KPCD1	85.0	10000.0
Lapatinib	GCN2(Kin.Dom.2,S808G)	89.0	10000.0
GW843682X	PFCDPK1(P.falciparum)	75.0	10000.0
Dabrafenib	EPHB4	95.0	10000.0
Vemurafenib	MKNK1	70.0	10000.0
HG-9-91-01	GSK3A	95.0	10000.0
Palbociclib	LKB1	94.0	1000.0
GSK1059615	TGFBR1	20.0	10000.0
Palbociclib	PLK1	33.0	1000.0
TAK-715	EGFR(T790M)	8.9	10000.0
Torin1	MK12	71.0	10000.0
HG-9-91-01	MET(M1250T)	39.0	10000.0
KIN001-111	TRKC	100.0	1000.0
SCH772984	EGFR	96.0	1000.0
Torkinib	SGK3	81.0	10000.0
QL-XII-47	PRKR	100.0	1000.0
AZD-6482	FAK2	100.0	10000.0
Neratinib	EIF2AK1	100.0	10000.0
JNK-9L	EPHB6	14.0	10000.0
Ibrutinib	CDK4-cyclinD3	84.0	1000.0
AG1478	SGK2	84.0	10000.0
NG25	EPHA2	3.1	10000.0
PD0325901	SGK3	89.0	10000.0
BI-2536	ADCK4	100.0	10000.0
Torin2	RET(M918T)	79.0	10000.0
PD0325901	JAK2(JH1domain-catalytic)	100.0	10000.0
Sigma A6730	MK13	100.0	10000.0
Palbociclib	PIP5K2B	99.0	1000.0
AG1478	NEK9	78.0	10000.0
CH5424802	WEE1	100.0	1000.0
OTSSP167	CAMK2G	3.0	10000.0
AZD4547	MELK	6.7	10000.0
Seliciclib	AMPK-alpha1	100.0	10000.0
PLX-4720	CHEK1	82.0	10000.0
CG-930	PAK4	100.0	10000.0
ZSTK474	CSNK2A1	100.0	1000.0
BMS345541	ABL1-nonphosphorylated	100.0	10000.0
Omipalisib	TXK	76.0	10000.0
KIN001-220	EGFR(L747-S752del,P753S)	38.0	10000.0
AG1478	RIPK4	43.0	10000.0
WZ3105	SGK3	85.0	10000.0
XMD11-85h	KPCD3	100.0	10000.0
XMD-12	MP2K6	100.0	1000.0
(s)-CR8	PRKX	98.0	10000.0
BGJ398	BLK	39.0	1000.0
OTSSP167	CDK16	0.0	10000.0
WZ-7043	SRMS	100.0	10000.0
BI-2536	M4K3	100.0	10000.0
Momelotinib	IKKE	5.2	10000.0
BMX-IN-1	HUNK	100.0	10000.0
WZ-7043	ABL1(F317L)	100.0	10000.0
Torin2	KPCL	99.0	10000.0
XMD8-85	PIK3CA(E545K)	100.0	10000.0
SB590885	TLK1	99.0	10000.0
XMD11-85h	JNK3	100.0	10000.0
GW-5074	PTK6	85.0	10000.0
CH5424802	PDPK1	97.0	1000.0
Neratinib	FLT4	100.0	10000.0
HG-5-88-01	CSNK1G3	100.0	10000.0
OTSSP167	CSF1R	11.0	10000.0
JNK-IN-11	PIP5K1C	87.0	1000.0
AZ-628	EPHA2	3.2	10000.0
GW843682X	YES	97.0	10000.0
BGJ398	PAK6	85.0	1000.0
BMS-536924	MAP4K4	2.4	1000.0
Torkinib	TYK2(JH2domain-pseudokinase)	2.6	10000.0
Baricitinib	ABL1(Q252H)-nonphosphorylated	13.0	10000.0
Ceritinib	CDK3	85.0	1000.0
Taselisib	MST1R	96.0	1000.0
BX-912	EPHA8	94.0	10000.0
XMD-12	CLK1	75.0	1000.0
QL-XI-92	KPCT	100.0	10000.0
CGP60474	ERBB4	100.0	10000.0
HG-6-64-01	TSSK1	100.0	10000.0
HG-14-10-04	BRSK1	72.0	10000.0
KIN001-220	FGFR4	71.0	10000.0
Pictilisib	DRAK2	100.0	1000.0
Seliciclib	LTK	43.0	10000.0
Ibrutinib	ALK(L1196M)	82.0	1000.0
XMD11-85h	SIK2	100.0	10000.0
QL-XII-47	SgK110	100.0	1000.0
Dabrafenib	BMPR2	7.2	10000.0
Barasertib	CAMK2B	84.0	10000.0
Crizotinib	INSR	0.2	10000.0
HG-14-8-02	TESK1	99.0	10000.0
ZM-447439	M3K5	100.0	10000.0
Ceritinib	TIE1	73.0	1000.0
Taselisib	MP2K1	89.0	1000.0
Sorafenib	FGFR1	5.2	10000.0
JWE-035	KPCD1	17.0	10000.0
Ribociclib	HUNK	100.0	1000.0
XMD14-99	PIK3CA(M1043I)	100.0	10000.0
Lapatinib	CDK9	95.0	10000.0
Seliciclib	PI42C	73.0	10000.0
AZD 5438	ERBB2	93.0	10000.0
BS-181	ABL1(Q252H)-phosphorylated	89.0	10000.0
Dinaciclib	NEK5	100.0	10000.0
QL-XII-47	SBK1	42.0	1000.0
BI-2536	FLT3	100.0	10000.0
Ibrutinib	ALK(C1156Y)	74.0	1000.0
BX-912	TXK	17.0	10000.0
AZD-6482	FYN	100.0	10000.0
KIN001-127	MK09	100.0	10000.0
Torkinib	TNK2	48.0	10000.0
JNK-IN-8	DAPK2	77.0	1000.0
Baricitinib	CAMK1D	0.5	10000.0
KIN001-220	AKT1	100.0	10000.0
HG-5-88-01	CAMK1	100.0	10000.0
QL-XII-47	EPHB4	100.0	1000.0
Omipalisib	MARK1	84.0	10000.0
CP466722	ERK4	85.0	10000.0
WZ4003	SLK	100.0	1000.0
KU63794	NEK5	100.0	10000.0
AZD 5438	ACVR1B	40.0	10000.0
TAK-715	DDR2	16.0	10000.0
BMS-536924	PTK6	100.0	1000.0
HG-9-91-01	LCK	0.4	10000.0
BMS345541	CAMKK2	93.0	10000.0
Torkinib	IKKA	41.0	10000.0
ERK5-IN-1	PIK3CA(C420R)	99.0	1000.0
GSK429286A	ERBB4	41.0	10000.0
PHA-767491	PIP5K2B	52.0	10000.0
ZM-447439	CHEK1	100.0	10000.0
Ceritinib	CDKL5	83.0	1000.0
KU63794	DDR2	100.0	10000.0
Vemurafenib	CSNK2A1	100.0	10000.0
MLN8054	MAP3K15	82.0	10000.0
BGJ398	TIE1	29.0	1000.0
HG-14-8-02	CAMK1	92.0	10000.0
Vemurafenib	MAPKAPK5	100.0	10000.0
XMD8-92	ACVRL1	100.0	10000.0
Baricitinib	DCAMKL3	1.0	10000.0
WH-4-023	MYLK	100.0	10000.0
AG1478	PIK3CA(E542K)	55.0	10000.0
HG-5-88-01	MP2K4	22.0	10000.0
KIN001-123	MST2	17.0	1000.0
Torkinib	STK39	97.0	10000.0
MRT67307	HIPK1	6.6	10000.0
Ceritinib	KIT(D816V)	79.0	1000.0
Lapatinib	AURKB	50.0	10000.0
AG1478	FLT4	79.0	10000.0
Crizotinib	AAK1	21.0	10000.0
WYE-125132	HIPK3	42.0	10000.0
ZSTK474	FLT3(D835H)	100.0	1000.0
XMD16-144	KKCC1	39.0	10000.0
Buparlisib	RPS6KA4(Kin.Dom.2-C-terminal)	100.0	1000.0
XMD11-85h	KIT(V559D)	100.0	10000.0
CP466722	WEE2	100.0	10000.0
Canertinib	DMPK2	100.0	1000.0
BMS345541	PAK3	62.0	10000.0
AZD4547	PIK4CB	69.0	10000.0
XMD8-85	RET(V804M)	100.0	10000.0
PD0325901	AKT3	89.0	10000.0
SCH772984	DCLK1	79.0	1000.0
KIN001-021	ERK8	100.0	1000.0
KIN001-111	EGFR(L747-E749del,A750P)	30.0	1000.0
CGP60474	ICK	2.2	10000.0
Sigma A6730	MAPKAPK5	59.0	10000.0
BX-912	ABL1(Q252H)-phosphorylated	0.0	10000.0
HG-14-8-02	JNK3	52.0	10000.0
WZ-4-145	CDK16	100.0	10000.0
Taselisib	ALK	100.0	1000.0
WYE-125132	TTK	100.0	10000.0
Baricitinib	NEK5	39.0	10000.0
SCH772984	PLK1	100.0	1000.0
HG-6-64-01	AMPK-alpha1	20.0	10000.0
OTSSP167	IKKA	11.0	10000.0
XMD11-50	KIT(V559D,V654A)	100.0	10000.0
PLX-4720	AKT1	100.0	10000.0
KIN001-220	MK13	100.0	10000.0
AZD-6482	RSK4(Kin.Dom.1-N-terminal)	71.0	10000.0
Dinaciclib	TYK2(JH1domain-catalytic)	70.0	10000.0
Ibrutinib	DAPK1	100.0	1000.0
XMD-12	GAK	37.0	1000.0
MPS-1-IN-1	MK14	100.0	1000.0
WYE-125132	DCLK1	100.0	10000.0
CP724714	M3K2	100.0	10000.0
Seliciclib	CSF1R	100.0	10000.0
ZSTK474	MYO3B	100.0	1000.0
Momelotinib	MRCKA	67.0	10000.0
BMS345541	PIK3CA(H1047Y)	26.0	10000.0
Neratinib	CSNK1E	26.0	10000.0
JNK-9L	MYO3A	69.0	10000.0
CH5424802	PIK3CA	89.0	1000.0
Torin1	CIT	59.0	10000.0
BS-181	CHEK1	100.0	10000.0
MPS-1-IN-1	TRKB	100.0	1000.0
ZM-447439	CAMK1G	66.0	10000.0
AG1478	INSRR	100.0	10000.0
NPK76-II-72-1	YSK1	100.0	10000.0
KIN001-220	PIK3CA(M1043I)	100.0	10000.0
HG-9-91-01	KIT(D816H)	7.4	10000.0
MPS-1-IN-1	PKAC-beta	100.0	1000.0
JW-7-24-1	ZAP70	100.0	10000.0
QL-X-138	TGFBR2	82.0	10000.0
PHA-767491	RSK2(Kin.Dom.1-N-terminal)	36.0	10000.0
PHA-793887	PRP4	60.0	10000.0
BMS-536924	MARK2	2.2	1000.0
ERK5-IN-1	ITK	100.0	1000.0
CH5424802	LRRK2	5.1	1000.0
R406	EGFR	2.4	1000.0
HG-5-113-01	WEE1	100.0	10000.0
WZ-7043	TYRO3	100.0	10000.0
NG25	STK35	3.0	10000.0
WH-4-023	SBK1	100.0	10000.0
GSK429286A	PCTK3	100.0	10000.0
NG25	DMPK	100.0	10000.0
AZD 5438	JAK2(JH1domain-catalytic)	0.0	10000.0
Pictilisib	ABL1(F317L)	100.0	10000.0
XMD8-85	MK01	100.0	10000.0
QL-XII-47	EGFR(L747-S752del,P753S)	98.0	1000.0
XMD8-85	JAK2(JH1domain-catalytic)	100.0	10000.0
QL-X-138	AURKA	63.0	10000.0
AZD4547	KGP1	88.0	10000.0
Torkinib	MAP3K3	3.2	10000.0
NG25	PIK3C2B	100.0	10000.0
XMD8-92	PKN2	100.0	10000.0
NPK76-II-72-1	KIT	100.0	10000.0
ERK5-IN-1	RIOK2	81.0	1000.0
PD173074	MRCKB	100.0	10000.0
HG-14-8-02	CDK15	100.0	10000.0
(s)-CR8	SIK2	100.0	10000.0
XMD8-92	HIPK3	100.0	10000.0
XMD14-99	KC1G1	100.0	10000.0
BX-912	SBK1	3.6	10000.0
Torkinib	GRK4	83.0	10000.0
MLN8054	PIM3	42.0	10000.0
XMD16-144	EGFR(G719C)	14.0	10000.0
KIN001-220	NEK5	7.9	10000.0
CH5424802	MYO3B	60.0	1000.0
Baricitinib	DYRK1A	16.0	10000.0
XMD11-50	AURKC	50.0	10000.0
XMD16-144	PAK3	14.0	10000.0
5z-7-oxozeaenol	RAF1	100.0	10000.0
QL-XII-47	ANKK1	51.0	1000.0
MPS-1-IN-1	NUAK1	100.0	1000.0
XMD-12	BLK	12.0	1000.0
SCH772984	LOK	100.0	1000.0
Ribociclib	PKAC-beta	94.0	1000.0
HG-5-88-01	CHK2	14.0	10000.0
XMD8-85	CDC2L2	100.0	10000.0
PHA-793887	AMPK-alpha2	74.0	10000.0
Canertinib	SRC	100.0	1000.0
NVP-TAE684	DAPK3	4.5	1000.0
PLX-4720	CTK	90.0	10000.0
ZM-447439	MYLK	92.0	10000.0
Crizotinib	MARK1	36.0	10000.0
XMD8-85	KPCE	100.0	10000.0
BMX-IN-1	FRK	98.0	10000.0
GSK429286A	CAMK2G	97.0	10000.0
HG-14-8-02	FLT3(ITD)	12.0	10000.0
HG-5-88-01	TESK1	100.0	10000.0
WZ-7043	KPCD	100.0	10000.0
HG-14-8-02	TYK2(JH2domain-pseudokinase)	100.0	10000.0
MLN8054	S6K1	54.0	10000.0
AS-252424	GSK3B	92.4	10000.0
Abemaciclib	CHEK1	100.0	1000.0
KIN001-021	MST2	100.0	1000.0
5z-7-oxozeaenol	PIK3C2B	100.0	10000.0
NVP-TAE684	LATS2	17.0	1000.0
WH-4-023	M4K1	0.3	10000.0
PD173074	MP2K1	100.0	10000.0
CGP60474	HIPK3	100.0	10000.0
XMD8-85	MYLK2	100.0	10000.0
Momelotinib	BTK	75.0	10000.0
HG-14-8-02	HIPK1	14.0	10000.0
QL-XII-47	EGFR(S752-I759del)	74.0	1000.0
ALW-II-38-3	TGFBR2	100.0	10000.0
NVP-TAE684	ULK1	0.1	1000.0
BMS345541	RSK1(Kin.Dom.2-C-terminal)	46.0	10000.0
A443654	RPS6KA1(Kin.Dom.2)	100.0	10000.0
AZD-6482	RSK3(Kin.Dom.1-N-terminal)	97.0	10000.0
Neratinib	PIK3CA(M1043I)	100.0	10000.0
Alpelisib	CDK16	100.0	1000.0
Buparlisib	FYN	89.0	1000.0
BS-181	TLK2	95.0	10000.0
WZ3105	NEK9	100.0	10000.0
ZSTK474	BMPR1B	100.0	1000.0
ZSTK474	FES	100.0	1000.0
OTSSP167	RIOK2	24.0	10000.0
NG25	RET	0.0	10000.0
GSK429286A	FLT3(K663Q)	78.0	10000.0
JNK-IN-11	BRAF(V600E)	21.0	1000.0
SB590885	MP2K7	94.0	10000.0
Abemaciclib	M3K5	100.0	1000.0
Torin1	ACVR2A	47.0	10000.0
Seliciclib	ABL1(F317I)-nonphosphorylated	100.0	10000.0
THZ1	PIM3	43.0	10000.0
ALW-II-38-3	CDK15	100.0	10000.0
ALW-II-49-7	MKNK2	100.0	10000.0
XMD8-85	BRSK2	100.0	10000.0
ALW-II-49-7	GSK3B	100.0	10000.0
AZD 5438	CDK16	0.0	10000.0
Dabrafenib	AKT3	100.0	10000.0
Vemurafenib	ABL1(H396P)-phosphorylated	63.0	10000.0
XMD14-99	DCAMKL2	4.1	10000.0
Ibrutinib	LATS2	95.0	1000.0
GW843682X	CLK4	45.0	10000.0
ERK5-IN-1	PIP5K1C	100.0	1000.0
MRT67307	RPS6KA4(Kin.Dom.1-N-terminal)	9.5	10000.0
XMD13-2	GRK7	84.0	10000.0
NU7441	MK03	100.0	10000.0
BMS345541	FYN	100.0	10000.0
AS-252424	STK36	100.0	10000.0
AZD7762	SNARK	2.2	10000.0
BI-2536	TIE2	100.0	10000.0
HG-14-10-04	RIPK1	68.0	10000.0
WYE-125132	PIP5K1C	100.0	10000.0
GSK461364	DRAK2	100.0	10000.0
Ribociclib	RPS6KA5(Kin.Dom.2-C-terminal)	100.0	1000.0
WZ-7043	TRKB	100.0	10000.0
NG25	PGFRB	0.0	10000.0
ZM-447439	YANK2	100.0	10000.0
XMD11-85h	IKKB	100.0	10000.0
QL-XI-92	ITK	93.0	10000.0
GSK429286A	CDK4-cyclinD1	71.0	10000.0
Torin1	FRK	60.0	10000.0
Torin2	EGFR(L858R,T790M)	100.0	10000.0
XMD13-2	CAMK2G	89.0	10000.0
